Citrus Sinensis ID: 048535

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------41
Protein Sequence
MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVSVGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNRSSSPSLNASDVLLEGR
Secondary Structure (PSIPRED)
cEEEEEcccccccccEEEEEEEEccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHEEEEEEcccccccccccccccccccccEEEHHHHHHHHccccccccccccccccccEEEEcccEEEEEEccccccHHHHHHHHHHHHHHHcccccccccccEEcccccEEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccEEEEEEccccccccccccccccccccccccccccccEEcccccccccccccHHHHHHHHcccccccccccccccccccccHHHHHHHHHHHHccccccccccccHHHHHHHHcccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cEEEEEcccccEcccEEEEEEEEcccccccccccccccccccccccccccccHEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHccccccccEccccccEEEEcEccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccEEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHHHcEEEEEEccccccEEEccHcccccccccHHEEEccccEEccccccccccHHHHHHHHHHHHcccHHHHHcHHHHHcccccHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccEccccc
Coil and Loop (DISEMBL)
mhvgfsagtgqlVESHKILAWsfsnsnfsigdalvtthlpsfelpkdsvfrskGFILGVSVGGLLIMGCGVVVYMVCLKrkgkkmkdveETEDWeleywphrvsYQEIHaatkgfseenviglggngkvykGQLLGVEVALKRISLDSEHGMREFLAEVSSlgrlkhrnlvglrgwckkEKESLILIYDYMengsldkwIFECDESIALSWEQRIKVLKDVASGILYLYegweskvlhRDIKASNVLLDKKMnarlgdfglakmhhhgqvmsgrrpieeGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLlcahpeansrpTIRQVLKMLEgqtegtgledegMNVHLLKRIGtramtsswkfagsrghptfneinknrssspslnasdvllegr
Flexible Loop (DISEMBL)
mhvgfsagtgqLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVSVGGLLIMGCGVVVYMVCLKRkgkkmkdveETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAevsslgrlkhrnlvglrgwckkeKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYegweskvlhRDIKASNVLLDKKMNARLGDFGLAKMhhhgqvmsgrrpieegkRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLcahpeansrptIRQVLKMLEGQTegtgledegmNVHLLKRIGTRAMTSSWKFAGSRGHPTfneinknrssspslnasdvllegr
Low Complexity Region (SEG)
MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVSVGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNRSSSPSLNASDVLLEGR
Disordered region (IsUnstruct)
*********GQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVSVGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG**************NLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEA****TIRQVLKML*************MNVHLLKRIGTRAMTSSWKF********************************
Disordered Region (DISOPRED)
MHVGFSAGTGQLVESHKILAWSFSNSNFSIG***********************FILGVSVGGLLIMGCGVVVYMVCLKRKG***********WELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD***GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGM********************************************DV*L*G*
Disordered Region (DISEMBL)
********TGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVSVGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNRSSSPSLNASDVLLEGR
Disordered Region (DISPRO)
MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVSVGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTS************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVSVGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNRSSSPSLNASDVLLEGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	409	2.2.26 [Sep-21-2011]
O49445	681	Probable L-type lectin-do	yes	no	0.975	0.585	0.505	1e-111
Q9S9U1	686	L-type lectin-domain cont	yes	no	0.997	0.594	0.503	1e-111
Q9M2S4	684	L-type lectin-domain cont	no	no	0.819	0.489	0.428	2e-79
Q9SZD5	669	L-type lectin-domain cont	no	no	0.811	0.496	0.400	3e-72
Q9M345	677	L-type lectin-domain cont	no	no	0.823	0.497	0.398	6e-71
Q9M9E0	656	L-type lectin-domain cont	no	no	0.826	0.515	0.397	4e-69
O81292	674	L-type lectin-domain cont	no	no	0.831	0.504	0.383	5e-68
Q9M020	688	Lectin-domain containing	no	no	0.848	0.504	0.366	5e-68
O04533	656	Putative L-type lectin-do	no	no	0.814	0.507	0.380	7e-68
O04534	666	Putative L-type lectin-do	no	no	0.819	0.503	0.387	4e-67

>sp|O49445|LRK72_ARATH Probable L-type lectin-domain containing receptor kinase VII.2 OS=Arabidopsis thaliana GN=LECRK72 PE=1 SV=2

 Score =  402 bits (1032), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 230/455 (50%), Positives = 309/455 (67%), Gaps = 56/455 (12%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
           M VGF+A TGQLV+SH+IL+WSFSNSNFSIGDAL+T +LPSF+L  DSV +SKGFI GVS
Sbjct: 237 MFVGFTASTGQLVQSHRILSWSFSNSNFSIGDALITRNLPSFKLSGDSVLKSKGFIAGVS 296

Query: 61  VGGLLIMGC-GVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEEN 119
            G +L++   G++ + V  +R+ +   DV   EDWE EYWPHRV Y+++  ATKGFS+EN
Sbjct: 297 SGVVLLVSVIGLLCFYVVRRRRQRLEGDV---EDWETEYWPHRVQYKDVLEATKGFSDEN 353

Query: 120 VIGLGGNGKVYKGQLLGVEVALKRISL---DSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           +IG GGN KVY+G L G EVA+KRI +   +S     EFLAEVSSLGRL+H+N+VGL+GW
Sbjct: 354 MIGYGGNSKVYRGVLEGKEVAVKRIMMSPRESVGATSEFLAEVSSLGRLRHKNIVGLKGW 413

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
            KK  ESLILIY+YMENGS+DK IF+C+E   L+WE+R++V++D+ASG+LYL+EGWE+KV
Sbjct: 414 SKKGGESLILIYEYMENGSVDKRIFDCNE--MLNWEERMRVIRDLASGMLYLHEGWETKV 471

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAKMHHHG---------------------------- 268
           LHRDIK+SNVLLDK MNAR+GDFGLAK+ +                              
Sbjct: 472 LHRDIKSSNVLLDKDMNARVGDFGLAKLQNTSKEMVSTTHVVGTAGYMAPELVKTGRASA 531

Query: 269 ------------QVMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVV 316
                       +V+ GRRPIEEG+  +V+ +W L E+ +++  LDER+KA G +  E V
Sbjct: 532 QTDVYSFGVFVLEVVCGRRPIEEGREGIVEWIWGLMEKDKVVDGLDERIKANGVFVVEEV 591

Query: 317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEG-MNVHLLKRIGTRAMTSSW 375
           E  L +GLLC HP+   RP +RQV+++LE   +G  +ED G   + LL+R+ +  +  + 
Sbjct: 592 EMALRIGLLCVHPDPRVRPKMRQVVQILE---QGRLVEDGGEREISLLERVKSSYLLETG 648

Query: 376 KFAGSR-GHPTFNEINKNRSSSPSLNASDVLLEGR 409
           +  GSR  HPTF ++  + S S S    D +L GR
Sbjct: 649 E--GSRQQHPTFQDVWNSSSYSNSFQTYDSILHGR 681

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9S9U1|LRK71_ARATH L-type lectin-domain containing receptor kinase VII.1 OS=Arabidopsis thaliana GN=LECRK71 PE=2 SV=1

 Score =  401 bits (1030), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 229/455 (50%), Positives = 301/455 (66%), Gaps = 47/455 (10%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
           M VGF+A TG+LV+SHKILAWSFSNSNFS+ ++L+TT LPSF LPKDS+ ++K F+  + 
Sbjct: 233 MFVGFTAATGRLVQSHKILAWSFSNSNFSLSNSLITTGLPSFVLPKDSIVKAKWFVFVLV 292

Query: 61  VGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENV 120
           +   L++    +V    ++++ ++ +     EDWE+EYWPHR+ Y+EI + TKGF E+NV
Sbjct: 293 LICFLVVALVGLVLFAVVRKRLERARKRALMEDWEMEYWPHRIPYEEIESGTKGFDEKNV 352

Query: 121 IGLGGNGKVYKGQLLG--VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           IG+GGNGKVYKG L G  VEVA+KRIS +S  GMREF+AE+SSLGRLKHRNLV LRGWCK
Sbjct: 353 IGIGGNGKVYKGLLQGGVVEVAVKRISQESSDGMREFVAEISSLGRLKHRNLVSLRGWCK 412

Query: 179 KEKESLILIYDYMENGSLDKWIFECDESI-ALSWEQRIKVLKDVASGILYLYEGWESKVL 237
           KE  S +L+YDYMENGSLD+WIFE DE I  LS E+RI++LK VASGILYL+EGWESKVL
Sbjct: 413 KEVGSFMLVYDYMENGSLDRWIFENDEKITTLSCEERIRILKGVASGILYLHEGWESKVL 472

Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---------------------------- 269
           HRDIKASNVLLD+ M  RL DFGLA++H H Q                            
Sbjct: 473 HRDIKASNVLLDRDMIPRLSDFGLARVHGHEQPVRTTRVVGTAGYLAPEVVKTGRASTQT 532

Query: 270 -----------VMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEV--V 316
                      VM GRRPIEEGK+ L+D +W L ER E+L+ LD ++    G  + +   
Sbjct: 533 DVFAYGILVLEVMCGRRPIEEGKKPLMDWVWGLMERGEILNGLDPQMMMTQGVTEVIDEA 592

Query: 317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVH--LLKRIGTRAMTSS 374
           E+VL LGLLCAHP+   RP++RQV+++ EG        +   +V   +L ++G+R  +  
Sbjct: 593 ERVLQLGLLCAHPDPAKRPSMRQVVQVFEGDKAEIFEAESSEDVESWMLMKMGSRGSSRE 652

Query: 375 WKFAGSRGHPTFNEINKNRSSSPSLNASDVLLEGR 409
           + + GS  HPT  +I     S    + +  +LEGR
Sbjct: 653 FWY-GSSSHPTIEQIRLQSLSVSLSSWNSSILEGR 686

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1

 Score =  296 bits (757), Expect = 2e-79,   Method: Compositional matrix adjust.
 Identities = 170/397 (42%), Positives = 240/397 (60%), Gaps = 62/397 (15%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRS----KGFI 56
           M+VGFSA TG L  SH IL W+F+ S    G+A  +  LPS      S+ +     +  I
Sbjct: 236 MYVGFSASTGLLASSHYILGWNFNMS----GEAF-SLSLPSLPRIPSSIKKRKKKRQSLI 290

Query: 57  LGVSV-GGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGF 115
           LGVS+   LLI    V   +  ++    K+KD +  E+WEL++ PHR SY+E+  AT GF
Sbjct: 291 LGVSLLCSLLIFAVLVAASLFVVR----KVKDEDRVEEWELDFGPHRFSYRELKKATNGF 346

Query: 116 SEENVIGLGGNGKVYKGQLLGVE--VALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
            ++ ++G GG GKVYKG+L G +  VA+KRIS +S  G+REF++EVSS+G L+HRNLV L
Sbjct: 347 GDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQL 406

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            GWC++ ++ L+L+YD+M NGSLD ++F+ +  + L+W+QR K++K VASG+LYL+EGWE
Sbjct: 407 LGWCRR-RDDLLLVYDFMPNGSLDMYLFDENPEVILTWKQRFKIIKGVASGLLYLHEGWE 465

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG------------------------- 268
             V+HRDIKA+NVLLD +MN R+GDFGLAK++ HG                         
Sbjct: 466 QTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKL 525

Query: 269 --------------QVMSGRRPIEEGKRN----LVDRMWSLTERSELLSVLDERLKAKGG 310
                         +V  GRRPIE         +VD +WS  +  ++  V+D RL   G 
Sbjct: 526 TTSTDVYAFGAVLLEVACGRRPIETSALPEELVMVDWVWSRWQSGDIRDVVDRRL--NGE 583

Query: 311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ 347
           + +E V  V+ LGLLC++     RPT+RQV+  LE Q
Sbjct: 584 FDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYLEKQ 620

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1

 Score =  272 bits (696), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 159/397 (40%), Positives = 229/397 (57%), Gaps = 65/397 (16%)

Query: 1   MHVGFSAGTGQLVESHKILAWSF----SNSNFSIGDALVTTHLPSFELPKDSVFRSKGFI 56
           M+VGF++ TG+L  SH IL W+F    + SN  I      + LP  +LP+DS   S   I
Sbjct: 236 MYVGFTSATGRLRSSHYILGWTFKLNGTASNIDI------SRLP--KLPRDSRSTSVKKI 287

Query: 57  LGVSVG--GLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKG 114
           L +S+    L I+    + YM+ LKRK    K +E  EDWE+++ PHR +Y++++ ATKG
Sbjct: 288 LAISLSLTSLAILVFLTISYMLFLKRK----KLMEVLEDWEVQFGPHRFAYKDLYIATKG 343

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           F    ++G GG GKVYKG L    +++A+K++S DS  GMREF+AE++++GRL+H NLV 
Sbjct: 344 FRNSELLGKGGFGKVYKGTLSTSNMDIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVR 403

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
           L G+C+++ E L L+YD M  GSLDK+++   E  +L W QR K++KDVASG+ YL+  W
Sbjct: 404 LLGYCRRKGE-LYLVYDCMPKGSLDKFLYHQPEQ-SLDWSQRFKIIKDVASGLCYLHHQW 461

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG------------------------ 268
              ++HRDIK +NVLLD  MN +LGDFGLAK+  HG                        
Sbjct: 462 VQVIIHRDIKPANVLLDDSMNGKLGDFGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGK 521

Query: 269 ---------------QVMSGRRPI---EEGKRNLVDRMWSLTE-RSELLSVLDERLKAKG 309
                          ++  GRRP+         +V   W L     ++L V+DER+K   
Sbjct: 522 ASTSSDVFAFGILMLEITCGRRPVLPRASSPSEMVLTDWVLDCWEDDILQVVDERVKQDD 581

Query: 310 GYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG 346
            Y +E V  VL LGL C+HP A  RP++  V++ L+G
Sbjct: 582 KYLEEQVALVLKLGLFCSHPVAAVRPSMSSVIQFLDG 618

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1

 Score =  268 bits (685), Expect = 6e-71,   Method: Compositional matrix adjust.
 Identities = 157/394 (39%), Positives = 231/394 (58%), Gaps = 57/394 (14%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFS-NSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGV 59
           M+VGFS+ TG ++  H ++ WSF  N    +        LP FE  + S F    + +G+
Sbjct: 239 MYVGFSSATGSVLSEHFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRISEF----YKIGM 294

Query: 60  SVGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEEN 119
            +  L ++   + +    ++RK K     EE +DWE E+  +R  ++E++ ATKGF E++
Sbjct: 295 PLISLSLIFSIIFLAFYIVRRKKKYE---EELDDWETEFGKNRFRFKELYHATKGFKEKD 351

Query: 120 VIGLGGNGKVYKGQL--LGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
           ++G GG G+VY+G L    +EVA+KR+S DS+ GM+EF+AE+ S+GR+ HRNLV L G+C
Sbjct: 352 LLGSGGFGRVYRGILPTTKLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYC 411

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
           ++  E L+L+YDYM NGSLDK+++   E+  L W+QR  ++K VASG+ YL+E WE  V+
Sbjct: 412 RRRGE-LLLVYDYMPNGSLDKYLYNNPET-TLDWKQRSTIIKGVASGLFYLHEEWEQVVI 469

Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKMHHHG----------------------------- 268
           HRD+KASNVLLD   N RLGDFGLA+++ HG                             
Sbjct: 470 HRDVKASNVLLDADFNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTT 529

Query: 269 ----------QVMSGRRPIE-----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYAD 313
                     +V+SGRRPIE     +    LV+ ++SL  R  ++   D +L    GY  
Sbjct: 530 DVYAFGAFLLEVVSGRRPIEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKL-GSSGYDL 588

Query: 314 EVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ 347
           E VE VL LGLLC+H +  +RP++RQVL+ L G 
Sbjct: 589 EEVEMVLKLGLLCSHSDPRARPSMRQVLQYLRGD 622

Required during pollen development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M9E0|LRKS1_ARATH L-type lectin-domain containing receptor kinase S.1 OS=Arabidopsis thaliana GN=LECRKS1 PE=1 SV=1

 Score =  262 bits (669), Expect = 4e-69,   Method: Compositional matrix adjust.
 Identities = 158/397 (39%), Positives = 237/397 (59%), Gaps = 59/397 (14%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
           M+ GFSA      E+ +ILAWS S++       + TT+LP F L   S   S G I G+ 
Sbjct: 250 MYAGFSASKTNWNEARRILAWSLSDT--GALREINTTNLPVFFLENSSSSLSTGAIAGI- 306

Query: 61  VGGLLIMGCGVVVYMV-----CLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGF 115
                ++GC V V ++      + +K  + ++ EE E+WELE+WPHR SY+E+ AAT+ F
Sbjct: 307 -----VIGCVVFVALIGFGGYLIWKKLMREEEEEEIEEWELEFWPHRFSYEELAAATEVF 361

Query: 116 SEENVIGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
           S + ++G GG GKVY+G L    E+A+K ++ DS+ G+REF+AE+SS+GRL+H+NLV +R
Sbjct: 362 SNDRLLGSGGFGKVYRGILSNNSEIAVKCVNHDSKQGLREFMAEISSMGRLQHKNLVQMR 421

Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
           GWC+++ E L+L+YDYM NGSL++WIF+  +   + W +R +V+ DVA G+ YL+ GW+ 
Sbjct: 422 GWCRRKNE-LMLVYDYMPNGSLNQWIFDNPKE-PMPWRRRRQVINDVAEGLNYLHHGWDQ 479

Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG-------------------------- 268
            V+HRDIK+SN+LLD +M  RLGDFGLAK++ HG                          
Sbjct: 480 VVIHRDIKSSNILLDSEMRGRLGDFGLAKLYEHGGAPNTTRVVGTLGYLAPELASASAPT 539

Query: 269 -------------QVMSGRRPIEEGKRN---LVDRMWSLTERSELLSVLDERLKAKGGYA 312
                        +V+SGRRPIE  +     LVD +  L     ++   DER++++    
Sbjct: 540 EASDVYSFGVVVLEVVSGRRPIEYAEEEDMVLVDWVRDLYGGGRVVDAADERVRSECETM 599

Query: 313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE 349
           +E VE +L LGL C HP+   RP +R+++ +L G  +
Sbjct: 600 EE-VELLLKLGLACCHPDPAKRPNMREIVSLLLGSPQ 635

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1

 Score =  258 bits (659), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 152/396 (38%), Positives = 223/396 (56%), Gaps = 56/396 (14%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILG-V 59
           M++GFSA TG ++  H +  WSF          L  + +P F  P+      + F    +
Sbjct: 241 MYLGFSAATGYVLSEHFVFGWSFMVKG-KTAPPLTLSKVPKF--PRVGPTSLQRFYKNRM 297

Query: 60  SVGGLLIMGCGVVVYMVCLKR--KGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSE 117
            +  LL++    VV ++ L R    ++ K  EE EDWE E+  +R+ +++++ ATKGF +
Sbjct: 298 PLFSLLLIPVLFVVSLIFLVRFIVRRRRKFAEEFEDWETEFGKNRLRFKDLYYATKGFKD 357

Query: 118 ENVIGLGGNGKVYKGQLLGV--EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
           ++++G GG G+VY+G +     E+A+KR+S +S  G++EF+AE+ S+GR+ HRNLV L G
Sbjct: 358 KDLLGSGGFGRVYRGVMPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLG 417

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
           +C++  E L+L+YDYM NGSLDK++++C E + L W+QR  V+  VASG+ YL+E WE  
Sbjct: 418 YCRRRDE-LLLVYDYMPNGSLDKYLYDCPE-VTLDWKQRFNVIIGVASGLFYLHEEWEQV 475

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG--------------------------- 268
           V+HRDIKASNVLLD + N RLGDFGLA++  HG                           
Sbjct: 476 VIHRDIKASNVLLDAEYNGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATT 535

Query: 269 ------------QVMSGRRPIE---EGKRN--LVDRMWSLTERSELLSVLDERLKAKGGY 311
                       +V  GRRPIE   E   +  LVD ++       +L   D  L +   Y
Sbjct: 536 ATDVFAFGVLLLEVACGRRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNLGSV--Y 593

Query: 312 ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ 347
               VE VL LGLLC+H +   RPT+RQVL+ L G 
Sbjct: 594 DQREVETVLKLGLLCSHSDPQVRPTMRQVLQYLRGD 629

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M020|LRK63_ARATH Lectin-domain containing receptor kinase VI.3 OS=Arabidopsis thaliana GN=LECRK63 PE=2 SV=1

 Score =  258 bits (659), Expect = 5e-68,   Method: Compositional matrix adjust.
 Identities = 149/406 (36%), Positives = 227/406 (55%), Gaps = 59/406 (14%)

Query: 1   MHVGFSAGTGQLVES-HKILAWSFSNSNFSIGDALVTTHL---PSFELPKDSVFRSKGFI 56
           M+VGF+A TG+   S H ++ WSFS+    + +  +       P     K   + S+   
Sbjct: 247 MYVGFTAATGRDQSSAHYVMGWSFSSGGDLLTEDTLDLLELPRPPPNTAKKRGYNSQVLA 306

Query: 57  LGVSVGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFS 116
           L V++ G+ ++   ++ + V  K   K+++  E  EDWE+ + PHR+ Y++++AAT GF 
Sbjct: 307 LIVALSGVTVILLALLFFFVMYK---KRLQQGEVLEDWEINH-PHRLRYKDLYAATDGFK 362

Query: 117 EENVIGLGGNGKVYKGQLLGV---EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           E  ++G GG G V++G L      ++A+K+I+ +S  G+REF+AE+ SLGRL+H+NLV L
Sbjct: 363 ENRIVGTGGFGTVFRGNLSSPSSDQIAVKKITPNSMQGVREFIAEIESLGRLRHKNLVNL 422

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDES--IALSWEQRIKVLKDVASGILYLYEG 231
           +GWCK +K  L+LIYDY+ NGSLD  ++       + LSW  R K+ K +ASG+LYL+E 
Sbjct: 423 QGWCK-QKNDLLLIYDYIPNGSLDSLLYSRPRQSGVVLSWNARFKIAKGIASGLLYLHEE 481

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG----------------------- 268
           WE  V+HRDIK SNVL++  MN RLGDFGLA+++  G                       
Sbjct: 482 WEKVVIHRDIKPSNVLIEDDMNPRLGDFGLARLYERGSQSNTTVVVGTIGYMAPELARNG 541

Query: 269 ----------------QVMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYA 312
                           +++SGRRP + G   L D +  L  R E+L  +D RL    G+ 
Sbjct: 542 KSSSASDVFAFGVLLLEIVSGRRPTDSGTFFLADWVMELHARGEILHAVDPRL----GFG 597

Query: 313 DEVVEKVLHL--GLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDE 356
            + VE  L L  GLLC H    SRP++R VL+ L G  +   ++++
Sbjct: 598 YDGVEARLALVVGLLCCHQRPTSRPSMRTVLRYLNGDDDVPEIDND 643

Involved in negative regulation of abscisic acid response in seed germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04533|LRK52_ARATH Putative L-type lectin-domain containing receptor kinase V.2 OS=Arabidopsis thaliana GN=LECRK52 PE=3 SV=1

 Score =  258 bits (658), Expect = 7e-68,   Method: Compositional matrix adjust.
 Identities = 150/394 (38%), Positives = 230/394 (58%), Gaps = 61/394 (15%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRS---KGFIL 57
           M++GF++  G    SH IL WSF+N   ++ D +  + LP  ++P +   RS   K   +
Sbjct: 226 MYIGFTS-VGSPTSSHYILGWSFNNKG-AVSD-INLSRLP--KVPDEDQERSLSSKILAI 280

Query: 58  GVSVGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSE 117
            +S+ G+ ++   ++  M+ LKRK    K +E  EDWE+++ PH+ +Y+++  ATKGF  
Sbjct: 281 SLSISGVTLVIVLILGVMLFLKRK----KFLEVIEDWEVQFGPHKFTYKDLFIATKGFKN 336

Query: 118 ENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
             V+G GG GKV+KG   L  + +A+K+IS DS  GMREFLAE++++GRL+H +LV L G
Sbjct: 337 SEVLGKGGFGKVFKGILPLSSIPIAVKKISHDSRQGMREFLAEIATIGRLRHPDLVRLLG 396

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
           +C+++ E L L+YD+M  GSLDK+++     I L W QR  ++KDVASG+ YL++ W   
Sbjct: 397 YCRRKGE-LYLVYDFMPKGSLDKFLYNQPNQI-LDWSQRFNIIKDVASGLCYLHQQWVQV 454

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG--------------------------- 268
           ++HRDIK +N+LLD+ MNA+LGDFGLAK+  HG                           
Sbjct: 455 IIHRDIKPANILLDENMNAKLGDFGLAKLCDHGIDSQTSNVAGTFGYISPELSRTGKSST 514

Query: 269 ------------QVMSGRRPI----EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYA 312
                       ++  GRRPI       +  L D +    +  ++L V+DE+L  +  Y 
Sbjct: 515 SSDVFAFGVFMLEITCGRRPIGPRGSPSEMVLTDWVLDCWDSGDILQVVDEKLGHR--YL 572

Query: 313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG 346
            E V  VL LGLLC+HP A +RP++  V++ L+G
Sbjct: 573 AEQVTLVLKLGLLCSHPVAATRPSMSSVIQFLDG 606

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04534|LRK51_ARATH Putative L-type lectin-domain containing receptor kinase V.1 OS=Arabidopsis thaliana GN=LECRK51 PE=3 SV=1

 Score =  255 bits (652), Expect = 4e-67,   Method: Compositional matrix adjust.
 Identities = 152/392 (38%), Positives = 225/392 (57%), Gaps = 57/392 (14%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
           M+VGF++ TG L  SH IL W+F   N +  D +  + LP          +S   IL +S
Sbjct: 234 MYVGFTSTTGDLTASHYILGWTFK-MNGTTPD-IDPSRLPKIPRYNQPWIQSPNGILTIS 291

Query: 61  --VGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEE 118
             V G++I+    +   + LKRK    K +E  EDWE+++ PHR +++++H ATKGF + 
Sbjct: 292 LTVSGVIILIILSLSLWLFLKRK----KLLEVLEDWEVQFGPHRFAFKDLHIATKGFKDT 347

Query: 119 NVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
            V+G GG GKVYKG L    VE+A+K +S DS  GMREF+AE++++GRL+H NLV L+G+
Sbjct: 348 EVLGKGGFGKVYKGTLPVSNVEIAVKMVSHDSRQGMREFIAEIATIGRLRHPNLVRLQGY 407

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
           C+ + E L L+YD M  GSLDK+++   ++  L W QR K++KDVASG+ YL++ W   +
Sbjct: 408 CRHKGE-LYLVYDCMAKGSLDKFLYH-QQTGNLDWSQRFKIIKDVASGLYYLHQQWVQVI 465

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAKMHHHG---------------------------- 268
           +HRDIK +N+LLD  MNA+LGDFGLAK+  HG                            
Sbjct: 466 IHRDIKPANILLDANMNAKLGDFGLAKLCDHGTDPQTSHVAGTLGYISPELSRTGKASTR 525

Query: 269 -----------QVMSGRRPI--EEGKRNLVDRMWSLT--ERSELLSVLDERLKAKGGYAD 313
                      ++  GR+PI     +R +V   W L   E  +++ VLD ++  +  Y +
Sbjct: 526 SDVFAFGIVMLEIACGRKPILPRASQREMVLTDWVLECWENEDIMQVLDHKIGQE--YVE 583

Query: 314 EVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE 345
           E    VL LGL C+HP A  RP +  V+++L+
Sbjct: 584 EQAALVLKLGLFCSHPVAAIRPNMSSVIQLLD 615

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	409
255553729	694	kinase, putative [Ricinus communis] gi|2	0.992	0.585	0.574	1e-140
255536803	728	kinase, putative [Ricinus communis] gi|2	0.995	0.559	0.562	1e-139
356549325	684	PREDICTED: L-type lectin-domain containi	0.992	0.593	0.555	1e-133
126143480	697	lectin-receptor like protein kinase 3 [N	1.0	0.586	0.563	1e-131
359485380	720	PREDICTED: L-type lectin-domain containi	0.977	0.555	0.575	1e-130
356555321	679	PREDICTED: L-type lectin-domain containi	0.987	0.594	0.553	1e-130
302143298	1442	unnamed protein product [Vitis vinifera]	0.977	0.277	0.575	1e-130
356515182	670	PREDICTED: probable L-type lectin-domain	0.924	0.564	0.569	1e-129
449457833	685	PREDICTED: L-type lectin-domain containi	0.985	0.588	0.540	1e-129
356544956	672	PREDICTED: probable L-type lectin-domain	0.936	0.569	0.566	1e-128

>gi|255553729|ref|XP_002517905.1| kinase, putative [Ricinus communis] gi|223542887|gb|EEF44423.1| kinase, putative [Ricinus communis]

 Score =  504 bits (1297), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 258/449 (57%), Positives = 328/449 (73%), Gaps = 43/449 (9%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
           M++GF   TG+LV+SH+IL+WSFSN++FSIG+ALVT +LPSF LPK SVF+S+GFI+G+S
Sbjct: 249 MYIGFCGATGRLVQSHRILSWSFSNTSFSIGNALVTRNLPSFGLPKKSVFKSEGFIIGIS 308

Query: 61  VGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENV 120
           V G++++G G+V+Y V  +R+ ++ K+ +E EDWELEYWPHR+ YQ+I AATKGF+EENV
Sbjct: 309 VAGVVVIGFGIVMYEVLARRRRRQWKEKQEMEDWELEYWPHRIDYQQISAATKGFAEENV 368

Query: 121 IGLGGNGKVYKGQL-LGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG GGNGKVYKG L  G EVA+KRIS  SE G REFLAEVSSLGRLKHRNLVG+RGWCK+
Sbjct: 369 IGFGGNGKVYKGTLECGAEVAVKRISHQSEKGTREFLAEVSSLGRLKHRNLVGMRGWCKQ 428

Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            KESL+L+YDYMENGSLDK +F  + +  LSWE+RIK+LKDVA+GILYL+EGWE+KVLHR
Sbjct: 429 HKESLMLLYDYMENGSLDKRLFNFNLNSTLSWEERIKILKDVANGILYLHEGWEAKVLHR 488

Query: 240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQ------------------------------ 269
           DIKASNVLLDK MNARLGDFGLA++HHHGQ                              
Sbjct: 489 DIKASNVLLDKDMNARLGDFGLARVHHHGQLASTTQVVGTVGYMAPEVIRTGRASTQTDV 548

Query: 270 ---------VMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVL 320
                    V+ GRRP E GK  LV+ +W L E+ EL++ +DERLKA GGY +E VE+VL
Sbjct: 549 FSFGVLLLEVVCGRRPSEVGKPGLVEFVWRLMEKGELINAIDERLKAMGGYNNEEVERVL 608

Query: 321 HLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGS 380
            LGLLCA+P+A++RP +RQV+K+LEG ++G+    E M VHLL  I    M SS      
Sbjct: 609 QLGLLCAYPDASARPAMRQVVKVLEGSSDGSECIGEEMEVHLLDGIRRTRMWSSSSQQHH 668

Query: 381 RGHPTFNEINKNRSSSPSLNASDVLLEGR 409
             +PT + I  + S     ++SD++ EGR
Sbjct: 669 HAYPTMDGIFSSLSLL---SSSDIISEGR 694

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255536803|ref|XP_002509468.1| kinase, putative [Ricinus communis] gi|223549367|gb|EEF50855.1| kinase, putative [Ricinus communis]

 Score =  501 bits (1291), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 253/450 (56%), Positives = 325/450 (72%), Gaps = 43/450 (9%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
           M+VGF+A TG+LVESHKILAWSFSNS+FS+ D L+T  LPSF LPK S FRSKGFI G +
Sbjct: 247 MYVGFTASTGRLVESHKILAWSFSNSDFSLSDRLITVGLPSFVLPKGSFFRSKGFIAGAT 306

Query: 61  VGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENV 120
            G  +++    ++ +  ++RK +K ++  + E+WELEYWPHR++YQEI AATKGFSEENV
Sbjct: 307 AGSFVVIVSAALITLFFIRRKQRKARERADIEEWELEYWPHRITYQEIEAATKGFSEENV 366

Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG+GGNGKVYKG L G  EVA+KRIS +++ GMREFLAE+SSLGRLKHRNLVGLRGWCKK
Sbjct: 367 IGIGGNGKVYKGVLPGGAEVAVKRISHEND-GMREFLAEISSLGRLKHRNLVGLRGWCKK 425

Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
           EK S +L+YDY+ENGSLDK +F+CDES  LS E+RI++LKDVASG+LYL+EGWES+VLHR
Sbjct: 426 EKGSFMLVYDYLENGSLDKRVFDCDESKMLSCEERIRILKDVASGVLYLHEGWESRVLHR 485

Query: 240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS--------------------------- 272
           DIKASNVLLDK M  ++GDFGLA+MH HGQV S                           
Sbjct: 486 DIKASNVLLDKDMKGKIGDFGLARMHSHGQVASTTRVVGTVGYLAPEVVRSGRASSQTDV 545

Query: 273 ------------GRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVL 320
                       GRRPIEEGK+ LV+ +W    R +LL  LD R+KA+GG+ +E VE+VL
Sbjct: 546 FGFGVLILEVICGRRPIEEGKQPLVELVWQSMMRGQLLDALDPRIKARGGFDEEEVERVL 605

Query: 321 HLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSW-KFAG 379
           HLGLLC +P+A+ RPT+RQV+K+LEG+ E    E E M+ +LL+ + ++ M   + +  G
Sbjct: 606 HLGLLCGYPDASVRPTMRQVVKILEGKNEANETETEDMDAYLLQYVNSKEMWLDYSQRLG 665

Query: 380 SRGHPTFNEINKNRSSSPSLNASDVLLEGR 409
              HPTF +I ++ S S S   S V+++GR
Sbjct: 666 YSSHPTFEDIRQSSSMSLSWTNS-VIVDGR 694

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356549325|ref|XP_003543044.1| PREDICTED: L-type lectin-domain containing receptor kinase VII.1-like [Glycine max]

 Score =  479 bits (1234), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 250/450 (55%), Positives = 320/450 (71%), Gaps = 44/450 (9%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
           M VGF++ TGQLVESHKIL WSFSN  FS+ D L+TT LPSF LPKDS+F+SKGF+ G +
Sbjct: 238 MFVGFTSATGQLVESHKILGWSFSNEKFSLSDELITTGLPSFVLPKDSIFKSKGFVAGFT 297

Query: 61  VGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENV 120
           VG   ++   V++ +  ++RK +K +   E EDWELEYWPHR++Y+EI AATKGFSEENV
Sbjct: 298 VGVFFVICLLVLLALFLIQRKREKERKRMEMEDWELEYWPHRMTYEEIEAATKGFSEENV 357

Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG+GGNGKVYKG L G VEVA+KRIS +++ G+REFLAEVSSLGRLK RNLVGLRGWCKK
Sbjct: 358 IGVGGNGKVYKGVLRGGVEVAVKRISHEND-GLREFLAEVSSLGRLKQRNLVGLRGWCKK 416

Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
           +  + +LIYDYMENGSLDK +F+CDES  LS+E RI++LKDVA  +LYL+EGWE KV+HR
Sbjct: 417 DVGNFLLIYDYMENGSLDKRVFDCDESKMLSYEDRIRILKDVAFAVLYLHEGWEDKVVHR 476

Query: 240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS--------------------------- 272
           DIKASNVLLDK MN RLGDFGLA+MH HGQV S                           
Sbjct: 477 DIKASNVLLDKDMNGRLGDFGLARMHSHGQVASTTKLVGTVGYMAPEVFKTGRASTQTDV 536

Query: 273 ------------GRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVL 320
                       GRRP+EEGK  LV+ +W L  + ++   LDERL+AKG +  + +E+V+
Sbjct: 537 YMFGILILEVLCGRRPLEEGKPPLVEWIWQLMVQGQVECALDERLRAKGEFNVQEMERVM 596

Query: 321 HLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSW-KFAG 379
           HLGLLCA+PE  +RPT+RQV+ +LEG+ E    E E M+ +LL+++ +R + S + ++  
Sbjct: 597 HLGLLCAYPEPKTRPTMRQVVNVLEGKNEVEDSEIENMDTYLLQQLKSRDILSEYSQYFS 656

Query: 380 SRGHPTFNEINKNRSSSPSLNASDVLLEGR 409
              HPTF +I    SSS SL  S+ ++EGR
Sbjct: 657 YTSHPTFQDI--RLSSSMSLTWSESVVEGR 684

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|126143480|dbj|BAF47279.1| lectin-receptor like protein kinase 3 [Nicotiana tabacum]

 Score =  473 bits (1216), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 254/451 (56%), Positives = 316/451 (70%), Gaps = 42/451 (9%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
           M+VGF+A TG L + HKILAWSFSNSNFSI DAL+T  LPSFELPKD V RSKGFI G++
Sbjct: 247 MYVGFTASTGDLAQGHKILAWSFSNSNFSISDALITQGLPSFELPKDPVHRSKGFIAGMT 306

Query: 61  VGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENV 120
           V  L ++    VV +  +KR  +  ++ EE EDWELEYWPHR+SYQEI AATKGF++ENV
Sbjct: 307 VSLLFLVVVTAVVSLFLIKRNRRMKREREEMEDWELEYWPHRISYQEIDAATKGFADENV 366

Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG+GGNGKVYKG L G  EVA+KRIS +S  G R+FLAE+SSLGRLKHRNLV LRGWCKK
Sbjct: 367 IGIGGNGKVYKGVLAGSSEVAVKRISHESSEGARQFLAEISSLGRLKHRNLVSLRGWCKK 426

Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
           ++ SLIL+YDYMENGSLDK +FECDE+  LS+E RI++LKDVASG+LYL+EGWE+KVLHR
Sbjct: 427 DRRSLILVYDYMENGSLDKTLFECDETNMLSFEDRIRILKDVASGVLYLHEGWEAKVLHR 486

Query: 240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQ------------------------------ 269
           DIKASNVLLDK MNARLGDFGLA+MH HGQ                              
Sbjct: 487 DIKASNVLLDKDMNARLGDFGLARMHDHGQVANTTRVVGTVGYLAPEFVKTGRASTQTDV 546

Query: 270 ---------VMSGRRPI-EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKV 319
                    VM GRRPI EEGK  L+D +W L  R EL++  D RL+    + +E   +V
Sbjct: 547 FGYGVLVLEVMCGRRPIEEEGKPPLLDWLWELMRRGELINAFDRRLRTSQDFNEEEALRV 606

Query: 320 LHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAG 379
           L LG++CA  +   RPT+RQV+K  E  +E    E E M+V+LL+ + +  M S++  + 
Sbjct: 607 LQLGMICASLDPKGRPTMRQVVKFFERNSEADESEAEDMDVYLLETLRSNTMLSNFSLSL 666

Query: 380 SRG-HPTFNEINKNRSSSPSLNASDVLLEGR 409
           S G HPTF EI +  SSS S++ ++ L++GR
Sbjct: 667 SHGSHPTFEEIREGLSSSMSISWTNSLVDGR 697

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485380|ref|XP_002274156.2| PREDICTED: L-type lectin-domain containing receptor kinase VII.1-like [Vitis vinifera]

 Score =  470 bits (1210), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 262/455 (57%), Positives = 317/455 (69%), Gaps = 55/455 (12%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
           M+VGF   TGQLVE H IL+WSFS SNFSIGDAL T +L SF LP+ SVFRSKGF LGVS
Sbjct: 275 MYVGFCGATGQLVEGHIILSWSFSQSNFSIGDALETMNLASFVLPRGSVFRSKGFALGVS 334

Query: 61  VG-GLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEEN 119
           +G  +L++G GV++Y V L R+ KK    EE ++WELEYWPHR+ Y EI+ AT GFSE+N
Sbjct: 335 LGSAVLLVGLGVMLY-VALVRRRKKRAIGEEIQEWELEYWPHRIGYSEIYTATDGFSEKN 393

Query: 120 VIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           VIG   NGKVYKG L+ G EVA+K I  ++EHGM+ FLAEVSSLGRLKHRNLVGLRGWCK
Sbjct: 394 VIGFSSNGKVYKGVLVGGPEVAVKSIPHENEHGMKAFLAEVSSLGRLKHRNLVGLRGWCK 453

Query: 179 KEKESLILIYDYMENGSLDKWIF-ECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
           KEK  LIL+YDYMENGSL+K IF +  ES+ LSWE+R +VLKDV  GILYL+EGWE+ VL
Sbjct: 454 KEKGDLILVYDYMENGSLEKRIFHQYPESMMLSWEERARVLKDVGHGILYLHEGWEATVL 513

Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKMHHHG----------------------------- 268
           HRDIKASNVLLDK MNARLGDFGLA+MHHHG                             
Sbjct: 514 HRDIKASNVLLDKDMNARLGDFGLARMHHHGDLANTTRVVGTLGYMAPEVIRTGRATVQT 573

Query: 269 ----------QVMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEK 318
                     +V+ GR PI+  K  LVD +W L ER EL+  LDERLKA+G Y +E VE+
Sbjct: 574 DVFGFGVLVLEVVCGREPIQHNKPGLVDWVWRLMERGELVLALDERLKARGEYREEEVER 633

Query: 319 VLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSW--- 375
           VL +GLLCAHP+   R  +RQV+K LEG++EG+  E EGM+V LL        ++ W   
Sbjct: 634 VLQIGLLCAHPDPRRRLMMRQVVKALEGRSEGSEPE-EGMDVSLLH-------SAEWSKR 685

Query: 376 -KFAGSRGHPTFNEINKNRSSSPSLNASDVLLEGR 409
             ++   GHPTF+EI K+   S SL+ SD++LEGR
Sbjct: 686 NSYSDGGGHPTFDEIQKSLLCSTSLSVSDIILEGR 720

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356555321|ref|XP_003545982.1| PREDICTED: L-type lectin-domain containing receptor kinase VII.1-like [Glycine max]

 Score =  470 bits (1210), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 249/450 (55%), Positives = 317/450 (70%), Gaps = 46/450 (10%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
           M VGF++ TGQLVESHKIL WSFSN NFS+ D L+T  LPSF LPKDS+F+SKG + G +
Sbjct: 235 MFVGFTSATGQLVESHKILGWSFSNENFSLSDELITIGLPSFVLPKDSIFKSKGLVAGFT 294

Query: 61  VGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENV 120
           VG   ++   V++ +  ++RK  K +   E EDWELEYWPHR++Y+EI AATKGFSEENV
Sbjct: 295 VGVFFVVCLLVLLALFLIQRKRVKERKRLEMEDWELEYWPHRMAYEEIEAATKGFSEENV 354

Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG+GGNGKVYKG L G VEVA+KRIS +++ G+REFLAEVSSLGRLK RNLVGLRGWCKK
Sbjct: 355 IGVGGNGKVYKGVLRGGVEVAVKRISHEND-GLREFLAEVSSLGRLKQRNLVGLRGWCKK 413

Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
           +  + +LIYDYMEN SLDKW+F+CDES  LS+E RI++LKDVA  +LYL+EGWE+KV+HR
Sbjct: 414 DVGNFLLIYDYMENRSLDKWVFDCDESKMLSYEDRIRILKDVAFAVLYLHEGWEAKVVHR 473

Query: 240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS--------------------------- 272
           DIKASNVLLDK MN RLGDFGLA+MH H QV S                           
Sbjct: 474 DIKASNVLLDKDMNGRLGDFGLARMHSHDQVASTTKLVGTVGYMAPEVIKTGRASTQTDV 533

Query: 273 ------------GRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVL 320
                       GRRP+EEGK  LV+ +W L  + ++   LDERL+AKG +  + +E+V+
Sbjct: 534 YMFGILILEVLCGRRPLEEGKSPLVEWIWQLMVQGQVECALDERLRAKGDFNVQEMERVM 593

Query: 321 HLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSW-KFAG 379
           HLGLLCA+PE  +RPT+RQV+ +LEG+ E    E E M+ +LL+++ +R + S + ++  
Sbjct: 594 HLGLLCAYPEPKARPTMRQVVNVLEGKNEVDDSEIENMDTYLLQQLKSRDILSEYSQYFS 653

Query: 380 SRGHPTFNEINKNRSSSPSLNASDVLLEGR 409
              HPTF +I    SSS SL  S+V  EGR
Sbjct: 654 YTSHPTFQDI--RHSSSMSLTWSEV--EGR 679

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143298|emb|CBI21859.3| unnamed protein product [Vitis vinifera]

 Score =  470 bits (1209), Expect = e-130,   Method: Compositional matrix adjust.
 Identities = 262/455 (57%), Positives = 317/455 (69%), Gaps = 55/455 (12%)

Query: 1    MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
            M+VGF   TGQLVE H IL+WSFS SNFSIGDAL T +L SF LP+ SVFRSKGF LGVS
Sbjct: 997  MYVGFCGATGQLVEGHIILSWSFSQSNFSIGDALETMNLASFVLPRGSVFRSKGFALGVS 1056

Query: 61   VG-GLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEEN 119
            +G  +L++G GV++Y V L R+ KK    EE ++WELEYWPHR+ Y EI+ AT GFSE+N
Sbjct: 1057 LGSAVLLVGLGVMLY-VALVRRRKKRAIGEEIQEWELEYWPHRIGYSEIYTATDGFSEKN 1115

Query: 120  VIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
            VIG   NGKVYKG L+ G EVA+K I  ++EHGM+ FLAEVSSLGRLKHRNLVGLRGWCK
Sbjct: 1116 VIGFSSNGKVYKGVLVGGPEVAVKSIPHENEHGMKAFLAEVSSLGRLKHRNLVGLRGWCK 1175

Query: 179  KEKESLILIYDYMENGSLDKWIF-ECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
            KEK  LIL+YDYMENGSL+K IF +  ES+ LSWE+R +VLKDV  GILYL+EGWE+ VL
Sbjct: 1176 KEKGDLILVYDYMENGSLEKRIFHQYPESMMLSWEERARVLKDVGHGILYLHEGWEATVL 1235

Query: 238  HRDIKASNVLLDKKMNARLGDFGLAKMHHHG----------------------------- 268
            HRDIKASNVLLDK MNARLGDFGLA+MHHHG                             
Sbjct: 1236 HRDIKASNVLLDKDMNARLGDFGLARMHHHGDLANTTRVVGTLGYMAPEVIRTGRATVQT 1295

Query: 269  ----------QVMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEK 318
                      +V+ GR PI+  K  LVD +W L ER EL+  LDERLKA+G Y +E VE+
Sbjct: 1296 DVFGFGVLVLEVVCGREPIQHNKPGLVDWVWRLMERGELVLALDERLKARGEYREEEVER 1355

Query: 319  VLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSW--- 375
            VL +GLLCAHP+   R  +RQV+K LEG++EG+  E EGM+V LL        ++ W   
Sbjct: 1356 VLQIGLLCAHPDPRRRLMMRQVVKALEGRSEGSEPE-EGMDVSLLH-------SAEWSKR 1407

Query: 376  -KFAGSRGHPTFNEINKNRSSSPSLNASDVLLEGR 409
              ++   GHPTF+EI K+   S SL+ SD++LEGR
Sbjct: 1408 NSYSDGGGHPTFDEIQKSLLCSTSLSVSDIILEGR 1442

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356515182|ref|XP_003526280.1| PREDICTED: probable L-type lectin-domain containing receptor kinase VII.2-like [Glycine max]

 Score =  468 bits (1205), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 249/437 (56%), Positives = 306/437 (70%), Gaps = 59/437 (13%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
           M VGF   TGQLVESHKILAWSFSNSNFSIGDALVTT+LPSF L K+S+ RS GFI+G+ 
Sbjct: 241 MFVGFCGATGQLVESHKILAWSFSNSNFSIGDALVTTNLPSFVLSKESILRSTGFIVGII 300

Query: 61  VGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENV 120
           VG L ++   VV+++  L+RK  K KD EE EDWELEYWPHRVSY++I++ATKGFS+++V
Sbjct: 301 VGVLFVLSAAVVIFVFFLRRKRSKRKD-EEIEDWELEYWPHRVSYEDIYSATKGFSDQHV 359

Query: 121 IGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE 180
           IG GGNGKVYKG L GV+VA+KRI  DSEHGMREFL+E+SSLGRLKHRN+V +RGWCKK+
Sbjct: 360 IGFGGNGKVYKGLLQGVQVAVKRIPCDSEHGMREFLSEISSLGRLKHRNVVPMRGWCKKD 419

Query: 181 KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRD 240
           + SLILIYDYM+NGSLDK IF+ DE+    WE+RIKVLKDVA G+LYL+EGWE KVLHRD
Sbjct: 420 R-SLILIYDYMDNGSLDKRIFDDDENTIFGWEKRIKVLKDVAHGVLYLHEGWEVKVLHRD 478

Query: 241 IKASNVLLDKKMNARLGDFGLAKMHHHGQ------------------------------- 269
           IK+SNVLLDK MNARLGDFGLA+MH+H Q                               
Sbjct: 479 IKSSNVLLDKGMNARLGDFGLARMHNHEQIAHTSQVIGTVGFMAPELIHTGRASTQTDVF 538

Query: 270 --------VMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLH 321
                   V+ GRRP EE K  LV  +W L +R E  S LDERLK +G    + V++VLH
Sbjct: 539 SFGVLILEVVCGRRPNEENKP-LVAWLWRLKQRGEECSALDERLKKRGECNIDEVKRVLH 597

Query: 322 LGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGS- 380
           LGLLC H + + RP++R+V+K+LEG         E +++ LL +I + A      + GS 
Sbjct: 598 LGLLCTHHDPHVRPSMREVVKVLEG---------ENLDMSLLDKINSAA-----GYVGSF 643

Query: 381 --RGHPTFNEINKNRSS 395
             R HPT  +I  +  S
Sbjct: 644 VNRFHPTIEDIYSSNCS 660

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449457833|ref|XP_004146652.1| PREDICTED: L-type lectin-domain containing receptor kinase VII.1-like [Cucumis sativus] gi|449508924|ref|XP_004163445.1| PREDICTED: L-type lectin-domain containing receptor kinase VII.1-like [Cucumis sativus]

 Score =  467 bits (1201), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 241/446 (54%), Positives = 310/446 (69%), Gaps = 43/446 (9%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
           M++GF++ TGQLV+ H ILAWSFSN+NFS+ ++L+TT LPSF LPKD + +SK FI GV+
Sbjct: 238 MYMGFTSSTGQLVQGHNILAWSFSNTNFSLSESLITTGLPSFLLPKDPITKSKWFIAGVT 297

Query: 61  VGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENV 120
            GG L++     +  + +    +K +   E EDWELEYWPHR++YQEI +ATKGF+EENV
Sbjct: 298 AGGFLVVCFFATILGILIADYRRKARLRAEMEDWELEYWPHRLTYQEIESATKGFAEENV 357

Query: 121 IGLGGNGKVYKGQLLG--VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           IG+GGNGKV+KG L G   EVA+KRIS D++ GMREFLAE+SS+GRLKHRNLV L+GWCK
Sbjct: 358 IGIGGNGKVHKGILAGGSSEVAVKRISHDND-GMREFLAEISSIGRLKHRNLVSLKGWCK 416

Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLH 238
           KEK + +L+YD+MENGSLDKW+F+CDE   LSWE RI+VLK+VA+G+LYL+EGWESKVLH
Sbjct: 417 KEKGNFLLVYDFMENGSLDKWVFDCDERNMLSWEDRIRVLKNVATGVLYLHEGWESKVLH 476

Query: 239 RDIKASNVLLDKKMNARLGDFGLAKMHHHGQ----------------------------- 269
           RDIKASNVLLDK MN RLGDFGLA++H HGQ                             
Sbjct: 477 RDIKASNVLLDKDMNGRLGDFGLARVHGHGQVASTTRIVGTMGYIAPELIRTGRASTQSD 536

Query: 270 ----------VMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKV 319
                     VM GRRPIEEGK  LVD +  L    ++ + LD RL+ KG + +E V +V
Sbjct: 537 VFGFGVLILEVMCGRRPIEEGKPPLVDWVRQLAIEGKITAALDSRLRKKGEWNEEEVGRV 596

Query: 320 LHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAM-TSSWKFA 378
           LHLGL+CAH + N+RPT+RQ++K+LEG+ E    E E MN +LL+R+ +  M   S    
Sbjct: 597 LHLGLVCAHVDPNNRPTMRQIVKVLEGKIELDESESESMNAYLLQRLKSEGMLCDSGVGF 656

Query: 379 GSRGHPTFNEINKNRSSSPSLNASDV 404
           G   HPTF +  ++ S+S S   S V
Sbjct: 657 GKNLHPTFEDFLQSYSTSLSWTNSSV 682

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356544956|ref|XP_003540912.1| PREDICTED: probable L-type lectin-domain containing receptor kinase VII.2-like [Glycine max]

 Score =  463 bits (1191), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 251/443 (56%), Positives = 311/443 (70%), Gaps = 60/443 (13%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
           M+VGF   TGQLVESHKILAWSFSN+NFSIGDALVTT+LPSF   K+S+ RS GFI+G+ 
Sbjct: 240 MYVGFCGATGQLVESHKILAWSFSNTNFSIGDALVTTNLPSFVHSKESILRSTGFIVGII 299

Query: 61  VGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWE--LEYWPHRVSYQEIHAATKGFSEE 118
           +G L ++G  VV++++ L+RK  K KD E+ E  +  LEYWPHRVSY++I+AATKGFS++
Sbjct: 300 IGVLFVIGGAVVIFVLFLRRKRSKRKDEEQEEIEDWELEYWPHRVSYEDIYAATKGFSDQ 359

Query: 119 NVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +VIG GGNGKVYKG L GV+VA+KRI  DSEHGMREFL+E+SSLGRLKH+N+V LRGWCK
Sbjct: 360 HVIGFGGNGKVYKGLLQGVQVAVKRIPCDSEHGMREFLSEISSLGRLKHKNVVPLRGWCK 419

Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLH 238
           K++ SLILIYDYM+NGSLDK IF+ DE+    WE+RIKVLKDVA GILYL+EGWE KVLH
Sbjct: 420 KQR-SLILIYDYMDNGSLDKRIFDGDENTIFGWEKRIKVLKDVAHGILYLHEGWEVKVLH 478

Query: 239 RDIKASNVLLDKKMNARLGDFGLAKMHHHGQ----------------------------- 269
           RDIK+SNVLLDK MNARLGDFGLA+MHHHGQ                             
Sbjct: 479 RDIKSSNVLLDKGMNARLGDFGLARMHHHGQIAHTSQVIGTVGFMAPELIHTGRASTQTD 538

Query: 270 ----------VMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKV 319
                     V+ GRRP EE  R LV  +WSL ER E  S LDERLK +G  + + V++V
Sbjct: 539 VFSFGVLILEVVCGRRPNEE-NRPLVTWLWSLKERGEECSALDERLKRRGECSIDEVKRV 597

Query: 320 LHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAG 379
           LHLGLLC H + + RP++RQV+K+LEG         E +++ LL +I + A      + G
Sbjct: 598 LHLGLLCTHHDPHVRPSMRQVVKVLEG---------ESLDMSLLDKINSAA-----GYVG 643

Query: 380 S---RGHPTFNEINKNRSSSPSL 399
           S   R HPT  +I  +  S  +L
Sbjct: 644 SFVNRFHPTIEDIYSSNCSFTTL 666

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	409
TAIR|locus:2138381	686	AT4G04960 [Arabidopsis thalian	0.674	0.402	0.644	1.1e-116
TAIR|locus:2099941	684	AT3G55550 [Arabidopsis thalian	0.630	0.377	0.505	3.2e-79
TAIR|locus:2196608	656	AT1G15530 [Arabidopsis thalian	0.640	0.399	0.470	1.2e-75
TAIR|locus:2040681	675	RLK "receptor lectin kinase" [	0.630	0.382	0.470	4.7e-72
TAIR|locus:2084375	677	AT3G53810 [Arabidopsis thalian	0.633	0.382	0.461	9.7e-72
TAIR|locus:2119936	669	AT4G29050 [Arabidopsis thalian	0.628	0.384	0.472	2.6e-71
TAIR|locus:2149795	688	LECRKA4.2 "lectin receptor kin	0.633	0.376	0.430	9.8e-70
TAIR|locus:2133239	669	AT4G02420 [Arabidopsis thalian	0.640	0.391	0.441	4.2e-69
TAIR|locus:2020608	666	AT1G70110 [Arabidopsis thalian	0.635	0.390	0.459	1.4e-68
TAIR|locus:2020593	656	AT1G70130 [Arabidopsis thalian	0.633	0.394	0.435	1.8e-68

TAIR|locus:2138381 AT4G04960 [Arabidopsis thaliana (taxid:3702)]

 Score = 916 (327.5 bits), Expect = 1.1e-116, Sum P(2) = 1.1e-116
 Identities = 181/281 (64%), Positives = 221/281 (78%)

Query:     1 MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILG-V 59
             M VGF+A TG+LV+SHKILAWSFSNSNFS+ ++L+TT LPSF LPKDS+ ++K F+   V
Sbjct:   233 MFVGFTAATGRLVQSHKILAWSFSNSNFSLSNSLITTGLPSFVLPKDSIVKAKWFVFVLV 292

Query:    60 SVGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEEN 119
              +  L++   G+V++ V  KR  +  K     EDWE+EYWPHR+ Y+EI + TKGF E+N
Sbjct:   293 LICFLVVALVGLVLFAVVRKRLERARKRAL-MEDWEMEYWPHRIPYEEIESGTKGFDEKN 351

Query:   120 VIGLGGNGKVYKGQLLG--VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
             VIG+GGNGKVYKG L G  VEVA+KRIS +S  GMREF+AE+SSLGRLKHRNLV LRGWC
Sbjct:   352 VIGIGGNGKVYKGLLQGGVVEVAVKRISQESSDGMREFVAEISSLGRLKHRNLVSLRGWC 411

Query:   178 KKEKESLILIYDYMENGSLDKWIFECDESIA-LSWEQRIKVLKDVASGILYLYEGWESKV 236
             KKE  S +L+YDYMENGSLD+WIFE DE I  LS E+RI++LK VASGILYL+EGWESKV
Sbjct:   412 KKEVGSFMLVYDYMENGSLDRWIFENDEKITTLSCEERIRILKGVASGILYLHEGWESKV 471

Query:   237 LHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPI 277
             LHRDIKASNVLLD+ M  RL DFGLA++H H Q +   R +
Sbjct:   472 LHRDIKASNVLLDRDMIPRLSDFGLARVHGHEQPVRTTRVV 512

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)]

 Score = 683 (245.5 bits), Expect = 3.2e-79, Sum P(2) = 3.2e-79
 Identities = 139/275 (50%), Positives = 193/275 (70%)

Query:     1 MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSF-ELPKDSVFRSK---GFI 56
             M+VGFSA TG L  SH IL W+F+ S    G+A  +  LPS   +P     R K     I
Sbjct:   236 MYVGFSASTGLLASSHYILGWNFNMS----GEAF-SLSLPSLPRIPSSIKKRKKKRQSLI 290

Query:    57 LGVSV-GGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGF 115
             LGVS+   LLI    V   +  ++    K+KD +  E+WEL++ PHR SY+E+  AT GF
Sbjct:   291 LGVSLLCSLLIFAVLVAASLFVVR----KVKDEDRVEEWELDFGPHRFSYRELKKATNGF 346

Query:   116 SEENVIGLGGNGKVYKGQLLGVE--VALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
              ++ ++G GG GKVYKG+L G +  VA+KRIS +S  G+REF++EVSS+G L+HRNLV L
Sbjct:   347 GDKELLGSGGFGKVYKGKLPGSDEFVAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQL 406

Query:   174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
              GWC++ ++ L+L+YD+M NGSLD ++F+ +  + L+W+QR K++K VASG+LYL+EGWE
Sbjct:   407 LGWCRR-RDDLLLVYDFMPNGSLDMYLFDENPEVILTWKQRFKIIKGVASGLLYLHEGWE 465

Query:   234 SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
               V+HRDIKA+NVLLD +MN R+GDFGLAK++ HG
Sbjct:   466 QTVIHRDIKAANVLLDSEMNGRVGDFGLAKLYEHG 500

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2196608 AT1G15530 [Arabidopsis thaliana (taxid:3702)]

 Score = 652 (234.6 bits), Expect = 1.2e-75, Sum P(2) = 1.2e-75
 Identities = 127/270 (47%), Positives = 191/270 (70%)

Query:     1 MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
             M+ GFSA      E+ +ILAWS S++  ++ + + TT+LP F L   S   S G I G+ 
Sbjct:   250 MYAGFSASKTNWNEARRILAWSLSDTG-ALRE-INTTNLPVFFLENSSSSLSTGAIAGIV 307

Query:    61 VGGLLIMGC-GVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEEN 119
             +G ++ +   G   Y++   +K  + ++ EE E+WELE+WPHR SY+E+ AAT+ FS + 
Sbjct:   308 IGCVVFVALIGFGGYLIW--KKLMREEEEEEIEEWELEFWPHRFSYEELAAATEVFSNDR 365

Query:   120 VIGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
             ++G GG GKVY+G L    E+A+K ++ DS+ G+REF+AE+SS+GRL+H+NLV +RGWC+
Sbjct:   366 LLGSGGFGKVYRGILSNNSEIAVKCVNHDSKQGLREFMAEISSMGRLQHKNLVQMRGWCR 425

Query:   179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLH 238
             ++ E L+L+YDYM NGSL++WIF+  +   + W +R +V+ DVA G+ YL+ GW+  V+H
Sbjct:   426 RKNE-LMLVYDYMPNGSLNQWIFDNPKE-PMPWRRRRQVINDVAEGLNYLHHGWDQVVIH 483

Query:   239 RDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
             RDIK+SN+LLD +M  RLGDFGLAK++ HG
Sbjct:   484 RDIKSSNILLDSEMRGRLGDFGLAKLYEHG 513

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

GO:0005773 "vacuole" evidence=IDA

TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 617 (222.3 bits), Expect = 4.7e-72, Sum P(2) = 4.7e-72
 Identities = 128/272 (47%), Positives = 186/272 (68%)

Query:     1 MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTT-HLPSFELPKDSVFRSKGFILGV 59
             M+VGFS+ TG ++  H IL WSF  +  +   AL     LP FE  + S F   G  L +
Sbjct:   239 MYVGFSSATGSVLSEHYILGWSFGLNEKAPPLALSRLPKLPRFEPKRISEFYKIGMPL-I 297

Query:    60 SVGGLLIMGCGVVVYMVC-LKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEE 118
             S+   LI      +++VC + R+ +K    EE E+WE E+  +R  +++++ ATKGF E+
Sbjct:   298 SL--FLIFS---FIFLVCYIVRRRRKF--AEELEEWEKEFGKNRFRFKDLYYATKGFKEK 350

Query:   119 NVIGLGGNGKVYKGQLLG--VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
              ++G GG G VYKG + G  +E+A+KR+S +S  GM+EF+AE+ S+GR+ HRNLV L G+
Sbjct:   351 GLLGTGGFGSVYKGVMPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGY 410

Query:   177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
             C++  E L+L+YDYM NGSLDK+++   E + L+W+QRIKV+  VASG+ YL+E WE  V
Sbjct:   411 CRRRGE-LLLVYDYMPNGSLDKYLYNTPE-VTLNWKQRIKVILGVASGLFYLHEEWEQVV 468

Query:   237 LHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
             +HRD+KASNVLLD ++N RLGDFGLA+++ HG
Sbjct:   469 IHRDVKASNVLLDGELNGRLGDFGLARLYDHG 500

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)]

 Score = 597 (215.2 bits), Expect = 9.7e-72, Sum P(2) = 9.7e-72
 Identities = 125/271 (46%), Positives = 182/271 (67%)

Query:     1 MHVGFSAGTGQLVESHKILAWSFS-NSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGV 59
             M+VGFS+ TG ++  H ++ WSF  N    +        LP FE  + S F   G  L +
Sbjct:   239 MYVGFSSATGSVLSEHFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRISEFYKIGMPL-I 297

Query:    60 SVGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEEN 119
             S+   LI     + + + ++RK KK +  EE +DWE E+  +R  ++E++ ATKGF E++
Sbjct:   298 SLS--LIFSIIFLAFYI-VRRK-KKYE--EELDDWETEFGKNRFRFKELYHATKGFKEKD 351

Query:   120 VIGLGGNGKVYKGQL--LGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
             ++G GG G+VY+G L    +EVA+KR+S DS+ GM+EF+AE+ S+GR+ HRNLV L G+C
Sbjct:   352 LLGSGGFGRVYRGILPTTKLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYC 411

Query:   178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
             ++  E L+L+YDYM NGSLDK+++   E+  L W+QR  ++K VASG+ YL+E WE  V+
Sbjct:   412 RRRGE-LLLVYDYMPNGSLDKYLYNNPET-TLDWKQRSTIIKGVASGLFYLHEEWEQVVI 469

Query:   238 HRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
             HRD+KASNVLLD   N RLGDFGLA+++ HG
Sbjct:   470 HRDVKASNVLLDADFNGRLGDFGLARLYDHG 500

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009555 "pollen development" evidence=IMP

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2119936 AT4G29050 [Arabidopsis thaliana (taxid:3702)]

 Score = 611 (220.1 bits), Expect = 2.6e-71, Sum P(2) = 2.6e-71
 Identities = 129/273 (47%), Positives = 183/273 (67%)

Query:     1 MHVGFSAGTGQLVESHKILAWSFS-NSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGV 59
             M+VGF++ TG+L  SH IL W+F  N   S  D    + LP  +LP+DS   S   IL +
Sbjct:   236 MYVGFTSATGRLRSSHYILGWTFKLNGTASNIDI---SRLP--KLPRDSRSTSVKKILAI 290

Query:    60 SVG--GLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSE 117
             S+    L I+    + YM+ LKRK    K +E  EDWE+++ PHR +Y++++ ATKGF  
Sbjct:   291 SLSLTSLAILVFLTISYMLFLKRK----KLMEVLEDWEVQFGPHRFAYKDLYIATKGFRN 346

Query:   118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
               ++G GG GKVYKG L    +++A+K++S DS  GMREF+AE++++GRL+H NLV L G
Sbjct:   347 SELLGKGGFGKVYKGTLSTSNMDIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLG 406

Query:   176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
             +C+++ E L L+YD M  GSLDK+++   E  +L W QR K++KDVASG+ YL+  W   
Sbjct:   407 YCRRKGE-LYLVYDCMPKGSLDKFLYHQPEQ-SLDWSQRFKIIKDVASGLCYLHHQWVQV 464

Query:   236 VLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
             ++HRDIK +NVLLD  MN +LGDFGLAK+  HG
Sbjct:   465 IIHRDIKPANVLLDDSMNGKLGDFGLAKLCEHG 497

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2149795 LECRKA4.2 "lectin receptor kinase a4.1" [Arabidopsis thaliana (taxid:3702)]

 Score = 591 (213.1 bits), Expect = 9.8e-70, Sum P(2) = 9.8e-70
 Identities = 121/281 (43%), Positives = 183/281 (65%)

Query:     1 MHVGFSAGTGQLVES-HKILAWSFSNSNFSIGDALVTTHLPSFELPKD--SVFRSKGF-- 55
             M+VGF+A TG+   S H ++ WSFS+     GD L    L   ELP+   +  + +G+  
Sbjct:   247 MYVGFTAATGRDQSSAHYVMGWSFSSG----GDLLTEDTLDLLELPRPPPNTAKKRGYNS 302

Query:    56 -ILG--VSVGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAAT 112
              +L   V++ G+ ++   ++ + V  K   K+++  E  EDWE+ + PHR+ Y++++AAT
Sbjct:   303 QVLALIVALSGVTVILLALLFFFVMYK---KRLQQGEVLEDWEINH-PHRLRYKDLYAAT 358

Query:   113 KGFSEENVIGLGGNGKVYKGQLLGV---EVALKRISLDSEHGMREFLAEVSSLGRLKHRN 169
              GF E  ++G GG G V++G L      ++A+K+I+ +S  G+REF+AE+ SLGRL+H+N
Sbjct:   359 DGFKENRIVGTGGFGTVFRGNLSSPSSDQIAVKKITPNSMQGVREFIAEIESLGRLRHKN 418

Query:   170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC--DESIALSWEQRIKVLKDVASGILY 227
             LV L+GWCK +K  L+LIYDY+ NGSLD  ++       + LSW  R K+ K +ASG+LY
Sbjct:   419 LVNLQGWCK-QKNDLLLIYDYIPNGSLDSLLYSRPRQSGVVLSWNARFKIAKGIASGLLY 477

Query:   228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
             L+E WE  V+HRDIK SNVL++  MN RLGDFGLA+++  G
Sbjct:   478 LHEEWEKVVIHRDIKPSNVLIEDDMNPRLGDFGLARLYERG 518

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=IMP

GO:0009845 "seed germination" evidence=IMP

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)]

 Score = 588 (212.0 bits), Expect = 4.2e-69, Sum P(2) = 4.2e-69
 Identities = 120/272 (44%), Positives = 183/272 (67%)

Query:     1 MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTT-HLPSFELPKDSVFRS-KGFILG 58
             M VGFS+ TG +V    +L WSF  +  +   AL     LP ++L    V+R  K ++  
Sbjct:   238 MFVGFSSATGNIVSEIFVLGWSFGVNGEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVPL 297

Query:    59 VSVGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEE 118
             +S   LL++   +++++V    K ++ K  EE EDWE E+  +R+ +++++ ATKGF ++
Sbjct:   298 IS---LLLIPFLLIIFLVRFIMK-RRRKFAEEVEDWETEFGKNRLRFKDLYYATKGFKDK 353

Query:   119 NVIGLGGNGKVYKGQLLGV--EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
             N++G GG G VYKG +     E+A+KR+S +S  G++EF+AE+ S+G++ HRNLV L G+
Sbjct:   354 NILGSGGFGSVYKGIMPKTKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGY 413

Query:   177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
             C++  E L+L+YDYM NGSLDK+++   E + L W+QR KV+  VAS + YL+E WE  V
Sbjct:   414 CRRRDE-LLLVYDYMPNGSLDKYLYNSPE-VTLDWKQRFKVINGVASALFYLHEEWEQVV 471

Query:   237 LHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
             +HRD+KASNVLLD ++N RLGDFGLA++  HG
Sbjct:   472 IHRDVKASNVLLDAELNGRLGDFGLAQLCDHG 503

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2020608 AT1G70110 [Arabidopsis thaliana (taxid:3702)]

 Score = 598 (215.6 bits), Expect = 1.4e-68, Sum P(2) = 1.4e-68
 Identities = 125/272 (45%), Positives = 180/272 (66%)

Query:     1 MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSVFRSKGFILGVS 60
             M+VGF++ TG L  SH IL W+F   N +  D +  + LP          +S   IL +S
Sbjct:   234 MYVGFTSTTGDLTASHYILGWTFK-MNGTTPD-IDPSRLPKIPRYNQPWIQSPNGILTIS 291

Query:    61 --VGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEE 118
               V G++I+    +   + LKRK    K +E  EDWE+++ PHR +++++H ATKGF + 
Sbjct:   292 LTVSGVIILIILSLSLWLFLKRK----KLLEVLEDWEVQFGPHRFAFKDLHIATKGFKDT 347

Query:   119 NVIGLGGNGKVYKGQL--LGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
              V+G GG GKVYKG L    VE+A+K +S DS  GMREF+AE++++GRL+H NLV L+G+
Sbjct:   348 EVLGKGGFGKVYKGTLPVSNVEIAVKMVSHDSRQGMREFIAEIATIGRLRHPNLVRLQGY 407

Query:   177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
             C+ + E L L+YD M  GSLDK+++   ++  L W QR K++KDVASG+ YL++ W   +
Sbjct:   408 CRHKGE-LYLVYDCMAKGSLDKFLYH-QQTGNLDWSQRFKIIKDVASGLYYLHQQWVQVI 465

Query:   237 LHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
             +HRDIK +N+LLD  MNA+LGDFGLAK+  HG
Sbjct:   466 IHRDIKPANILLDANMNAKLGDFGLAKLCDHG 497

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2020593 AT1G70130 [Arabidopsis thaliana (taxid:3702)]

 Score = 588 (212.0 bits), Expect = 1.8e-68, Sum P(2) = 1.8e-68
 Identities = 118/271 (43%), Positives = 181/271 (66%)

Query:     1 MHVGFSAGTGQLVESHKILAWSFSNSNFSIGDALVTTHLPSF-ELPKDSVFRSKGFILGV 59
             M++GF++  G    SH IL WSF+N   ++ D +  + LP   +  ++    SK   + +
Sbjct:   226 MYIGFTS-VGSPTSSHYILGWSFNNKG-AVSD-INLSRLPKVPDEDQERSLSSKILAISL 282

Query:    60 SVGGLLIMGCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEEN 119
             S+ G+ ++   ++  M+ LKRK    K +E  EDWE+++ PH+ +Y+++  ATKGF    
Sbjct:   283 SISGVTLVIVLILGVMLFLKRK----KFLEVIEDWEVQFGPHKFTYKDLFIATKGFKNSE 338

Query:   120 VIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
             V+G GG GKV+KG   L  + +A+K+IS DS  GMREFLAE++++GRL+H +LV L G+C
Sbjct:   339 VLGKGGFGKVFKGILPLSSIPIAVKKISHDSRQGMREFLAEIATIGRLRHPDLVRLLGYC 398

Query:   178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
             +++ E L L+YD+M  GSLDK+++     I L W QR  ++KDVASG+ YL++ W   ++
Sbjct:   399 RRKGE-LYLVYDFMPKGSLDKFLYNQPNQI-LDWSQRFNIIKDVASGLCYLHQQWVQVII 456

Query:   238 HRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
             HRDIK +N+LLD+ MNA+LGDFGLAK+  HG
Sbjct:   457 HRDIKPANILLDENMNAKLGDFGLAKLCDHG 487

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	409
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-31
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-30
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-29
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-29
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	4e-29
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-28
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-25
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-22
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-21
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-20
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-19
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-18
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-17
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-16
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-15
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-15
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-14
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-14
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-14
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-14
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	8e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	9e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-13
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-13
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	6e-13
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-12
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-12
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-12
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-12
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-12
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-12
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-12
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-11
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-11
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-11
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-11
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-10
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-10
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-10
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-10
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	7e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-10
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-09
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-09
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-09
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-09
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-09
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	9e-09
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-08
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-08
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-08
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-08
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-08
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-08
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-08
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-07
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-07
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-07
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-07
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-07
pfam00139	231	pfam00139, Lectin_legB, Legume lectin domain	2e-07
cd06899	236	cd06899, lectin_legume_LecRK_Arcelin_ConA, legume	3e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-07
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-07
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-07
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-07
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-07
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-07
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-06
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-06
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-06
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-06
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-06
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-06
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-06
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-06
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-06
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-06
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-06
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-06
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-06
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	9e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-05
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-05
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-05
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-05
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-05
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-05
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	8e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	9e-05
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-04
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-04
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-04
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-04
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-04
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-04
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-04
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-04
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-04
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-04
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-04
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-04
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-04
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	0.001
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.001
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	0.001
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	0.001
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	0.001
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	0.002
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.002
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	0.002
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	0.002
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.002
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	0.002
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	0.003
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	0.003
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	0.003
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.003
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	0.003
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	0.003
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.004
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	0.004
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  118 bits (298), Expect = 3e-31
 Identities = 64/240 (26%), Positives = 108/240 (45%), Gaps = 41/240 (17%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGLRGWC 177
           +G GG G VY  +    G +VA+K I  +    + E  L E+  L +L H N+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
           + E   L L+ +Y E GSL   + E +    LS ++ +++L  +  G+ YL+    + ++
Sbjct: 61  EDENH-LYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGII 114

Query: 238 HRDIKASNVLLDKK-MNARLGDFGLAK-MHHHGQVMSGR------RPIEEGKRNL----- 284
           HRD+K  N+LLD      +L DFGL+K +     ++            E           
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 285 VDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKML 344
            D +WSL     +L  L E          +++ K+L         +   RP+ +++L+ L
Sbjct: 175 SD-IWSL---GVILYELPE--------LKDLIRKML-------QKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  118 bits (297), Expect = 1e-30
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 11/155 (7%)

Query: 120 VIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGM--REFLAEVSSLGRLKHRNLVGLRG 175
            +G G  G VYK +    G  VA+K +   SE     +    E+  L RL H N+V L  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
             + +K+ L L+ +Y E G L  ++        LS ++  K+   +  G+ YL+    + 
Sbjct: 66  AFE-DKDHLYLVMEYCEGGDLFDYLSR---GGPLSEDEAKKIALQILRGLEYLHS---NG 118

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV 270
           ++HRD+K  N+LLD+    ++ DFGLAK       
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSS 153

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  115 bits (290), Expect = 1e-29
 Identities = 63/260 (24%), Positives = 105/260 (40%), Gaps = 40/260 (15%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLV 171
           +     +G G  GKVY  +    G  VA+K I        RE  L E+  L +LKH N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L    + +++ L L+ +Y E G L   +    +   LS ++    L+ + S + YL+  
Sbjct: 61  RLYDVFE-DEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS- 115

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGR------RPIEEGKRNLV 285
               ++HRD+K  N+LLD+  + +L DFGLA+    G+ ++           E       
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGY 173

Query: 286 DR---MWSL-----------------TERSELLSVLDERLKAKGGYADEVVEKVLHL--G 323
            +   +WSL                  +  EL   + +          ++  +   L   
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233

Query: 324 LLCAHPEANSRPTIRQVLKM 343
           LL   PE   R T  + L+ 
Sbjct: 234 LLVKDPE--KRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  114 bits (289), Expect = 1e-29
 Identities = 58/171 (33%), Positives = 88/171 (51%), Gaps = 18/171 (10%)

Query: 118 ENVIGLGGNGKVYKGQLLG------VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNL 170
              +G G  G+VYKG+L G      VEVA+K +  D SE  + EFL E   + +L H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
           V L G C +E E L ++ +YME G L  ++ +      LS    +     +A G+ YL  
Sbjct: 64  VKLLGVCTEE-EPLYIVMEYMEGGDLLSYLRKNRP--KLSLSDLLSFALQIARGMEYL-- 118

Query: 231 GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---VMSGRRPI 277
             ESK  +HRD+ A N L+ + +  ++ DFGL++  +         G+ PI
Sbjct: 119 --ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI 167

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  114 bits (289), Expect = 1e-29
 Identities = 54/158 (34%), Positives = 82/158 (51%), Gaps = 18/158 (11%)

Query: 119 NVIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
             +G G  G+VYKG+L G      EVA+K +  D+    R +FL E   + +L H N+V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWI------FECDESIALSWEQRIKVLKDVASGIL 226
           L G C  E+E L L+ +YME G L  ++      F   E   LS +  +     +A G+ 
Sbjct: 61  LLGVCT-EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 227 YLYEGWESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
           YL     SK  +HRD+ A N L+ + +  ++ DFGL++
Sbjct: 120 YL----ASKKFVHRDLAARNCLVGEDLVVKISDFGLSR 153

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  113 bits (285), Expect = 4e-29
 Identities = 57/171 (33%), Positives = 87/171 (50%), Gaps = 17/171 (9%)

Query: 118 ENVIGLGGNGKVYKGQLLG------VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNL 170
              +G G  G+VYKG L G      VEVA+K +  D SE  + EFL E   + +L H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
           V L G C +E E L+++ +YM  G L  ++ +      LS    +     +A G+ YL  
Sbjct: 64  VKLLGVCTEE-EPLMIVMEYMPGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYL-- 119

Query: 231 GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM---SGRRPI 277
             ESK  +HRD+ A N L+ + +  ++ DFGL++  +         G+ PI
Sbjct: 120 --ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI 168

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  110 bits (278), Expect = 5e-28
 Identities = 52/170 (30%), Positives = 85/170 (50%), Gaps = 19/170 (11%)

Query: 120 VIGLGGNGKVYKGQLLG------VEVALKRISLDSEH-GMREFLAEVSSLGRLKHRNLVG 172
            +G G  G+VYKG L G       +VA+K +   +      EFL E S + +L H N+V 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
           L G C +  E L ++ +YM  G L  ++ +  E + L     +++   +A G+ YL    
Sbjct: 66  LLGVCTQG-EPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYL---- 118

Query: 233 ESK-VLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM----SGRRPI 277
           ESK  +HRD+ A N L+ + +  ++ DFGL++  +          G+ PI
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI 168

Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 3e-25
 Identities = 57/151 (37%), Positives = 80/151 (52%), Gaps = 17/151 (11%)

Query: 119 NVIGLGGNGKVYKG--QLLGVEVALKRISL--DSEHGMREFLAEVSSLGRLKHRNLVGLR 174
           ++IG G  G VYKG     G  VA+K+ISL    E  ++  + E+  L  LKH N+V   
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 175 GWCKKEKESLILIYDYMENGSLDKWI--FE-CDESIALSWEQRIKVLKDVASGILYLYEG 231
           G   +  +SL +I +Y ENGSL + I  F    ES+          +  V  G+ YL+E 
Sbjct: 66  G-SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV------AVYVYQVLQGLAYLHE- 117

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
               V+HRDIKA+N+L  K    +L DFG+A
Sbjct: 118 --QGVIHRDIKAANILTTKDGVVKLADFGVA 146

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 94.0 bits (234), Expect = 6e-22
 Identities = 76/252 (30%), Positives = 113/252 (44%), Gaps = 38/252 (15%)

Query: 121 IGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE 180
           IG G  G V  G   G +VA+K +  DS    + FLAE S +  L+H NLV L G    +
Sbjct: 14  IGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL-Q 71

Query: 181 KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRD 240
              L ++ +YM  GSL  ++        ++  Q++    DV  G+ YL E      +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRD 127

Query: 241 IKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPI--------EEGKRNLVDRMWS-- 290
           + A NVL+ + + A++ DFGLAK    GQ  SG+ P+         E K +    +WS  
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQD-SGKLPVKWTAPEALREKKFSTKSDVWSFG 186

Query: 291 --LTE----------RSELLSVLDE-----RLKAKGGYADEVVEKVLHLGLLCAHPEANS 333
             L E          R  L  V+       R++A  G   EV + +      C   +   
Sbjct: 187 ILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKD----CWELDPAK 242

Query: 334 RPTIRQVLKMLE 345
           RPT +Q+ + L 
Sbjct: 243 RPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 91.6 bits (228), Expect = 4e-21
 Identities = 55/152 (36%), Positives = 88/152 (57%), Gaps = 12/152 (7%)

Query: 118 ENVIGLGGNGKVYKGQLL-----GVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLV 171
           E VIG G  G+V +G+L       ++VA+K +   S    R +FL E S +G+  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G   K +  +I I +YMENGSLDK++ E D     +  Q + +L+ +ASG+ YL E 
Sbjct: 69  RLEGVVTKSRPVMI-ITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYLSE- 124

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
                +HRD+ A N+L++  +  ++ DFGL++
Sbjct: 125 --MNYVHRDLAARNILVNSNLVCKVSDFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 90.3 bits (225), Expect = 1e-20
 Identities = 45/170 (26%), Positives = 76/170 (44%), Gaps = 23/170 (13%)

Query: 119 NVIGLGGNGKVYKGQLL--GVEVALKRISL--DSEHGMREFLAEVSSLGRLKHRNLVGLR 174
            ++G G  G VY       G  +A+K + L  DSE  +     E+  L  L+H N+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 175 GWCKKEKESLILIY-DYMENGSL-----DKWIFECDESIALSWEQRIKVL-KDVASGILY 227
           G  + E+++ + I+ +Y+  GSL                    E  I+   + +  G+ Y
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP---------EPVIRKYTRQILEGLAY 116

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPI 277
           L+    + ++HRDIK +N+L+D     +L DFG AK     +   G   +
Sbjct: 117 LHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV 163

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 89.9 bits (224), Expect = 2e-20
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 19/157 (12%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHG------MREFLAEVSSLGRLK 166
           + +   +G G  G VYK +    G  VALK+I LD+E        +RE    +S L  LK
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE----ISLLKELK 56

Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E+  L L+++Y +   L K++ +    ++ +  + I  +  +  G+ 
Sbjct: 57  HPNIVKLLDVIHTER-KLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSI--MYQLLRGLA 112

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           Y +      +LHRD+K  N+L+++    +L DFGLA+
Sbjct: 113 YCHSHR---ILHRDLKPQNILINRDGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 89.5 bits (223), Expect = 3e-20
 Identities = 59/189 (31%), Positives = 94/189 (49%), Gaps = 33/189 (17%)

Query: 121 IGLGGNGKVYKGQLLGVE--VALKRISLDSEH-GM-REFLAEVSSLGRLKHRNLVGLRG- 175
           IG G  G+VYK +       VALK+I +++E  G     + E+  L +L+H N+V L+  
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 176 WCKKEKESLILIYDYME---NGSLDKWIFECDESIALSWEQRIK-VLKDVASGILYLYEG 231
              K K S+ ++++YM+    G LD         +  + E +IK  +K +  G+ YL+  
Sbjct: 67  VTSKGKGSIYMVFEYMDHDLTGLLDS------PEVKFT-ESQIKCYMKQLLEGLQYLHS- 118

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIE-EGKRNLVDRMWS 290
             + +LHRDIK SN+L++     +L DFGLA            RP       +  +R+ +
Sbjct: 119 --NGILHRDIKGSNILINNDGVLKLADFGLA------------RPYTKRNSADYTNRVIT 164

Query: 291 LTERS-ELL 298
           L  R  ELL
Sbjct: 165 LWYRPPELL 173

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 87.9 bits (219), Expect = 7e-20
 Identities = 48/155 (30%), Positives = 71/155 (45%), Gaps = 9/155 (5%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISL--DSEHGMREFLAEVSSLGRLKHRNL 170
           +     IG G  GKVY  +    G    LK I L   SE    + L EV  L +L H N+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLY 229
           +       +EK  L ++ +Y + G L + I +   E      EQ +     +   + YL+
Sbjct: 62  IKYYE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                K+LHRDIK  N+ L      +LGDFG++K+
Sbjct: 121 S---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 86.2 bits (213), Expect = 4e-19
 Identities = 55/164 (33%), Positives = 97/164 (59%), Gaps = 14/164 (8%)

Query: 107 EIHAATKGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMREFLAEVS 160
           EIH +    +++ VIG G  G+V++G L       V VA+K +    +E   ++FL+E S
Sbjct: 1   EIHPSH--ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEAS 58

Query: 161 SLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD 220
            +G+  H N++ L G   K K ++I I +YMENG+LDK++ + D     S  Q + +L+ 
Sbjct: 59  IMGQFSHHNIIRLEGVVTKFKPAMI-ITEYMENGALDKYLRDHDGE--FSSYQLVGMLRG 115

Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           +A+G+ YL +      +HRD+ A N+L++  +  ++ DFGL+++
Sbjct: 116 IAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRV 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 83.4 bits (207), Expect = 3e-18
 Identities = 50/152 (32%), Positives = 83/152 (54%), Gaps = 10/152 (6%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           F     IG GG G+VYK +    G EVA+K I L+S+    + + E+  L + KH N+V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYLYEG 231
             G    +K+ L ++ ++   GSL   +   ++++    E +I  V K++  G+ YL+  
Sbjct: 62  YYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLT---ESQIAYVCKELLKGLEYLHS- 116

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             + ++HRDIKA+N+LL      +L DFGL+ 
Sbjct: 117 --NGIIHRDIKAANILLTSDGEVKLIDFGLSA 146

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 83.4 bits (206), Expect = 3e-18
 Identities = 49/152 (32%), Positives = 88/152 (57%), Gaps = 12/152 (7%)

Query: 118 ENVIGLGGNGKVYKGQL-----LGVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
           E VIG G  G+V +G+L       + VA+K +    +E   R+FL+E S +G+  H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G   K +  +I+  ++MENG+LD ++ + D    +   Q + +L+ +A+G+ YL   
Sbjct: 69  HLEGVVTKSRPVMIIT-EFMENGALDSFLRQNDGQFTVI--QLVGMLRGIAAGMKYLS-- 123

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            E   +HRD+ A N+L++  +  ++ DFGL++
Sbjct: 124 -EMNYVHRDLAARNILVNSNLVCKVSDFGLSR 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 20/167 (11%)

Query: 119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLR 174
             IG G  G V K +    G  +  K I     +E   ++ ++EV+ L  LKH N+V   
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 175 GWCK-KEKESLILIYDYMENGSLDKWIFEC-------DESIALSWEQRIKVLKDVASGIL 226
                +  ++L ++ +Y E G L + I +C       +E          ++L  +   + 
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI------WRILTQLLLALY 119

Query: 227 YLYEGWESK--VLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
             +   +    VLHRD+K +N+ LD   N +LGDFGLAK+  H    
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 47/151 (31%), Positives = 76/151 (50%), Gaps = 11/151 (7%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +     IG G +G+VYK      G EVA+K++ L  ++     + E+  +   KH N+V 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN-KELIINEILIMKDCKHPNIVD 79

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGILYLYEG 231
                    + L ++ +YM+ GSL   I +    +    E +I  V ++V  G+ YL+  
Sbjct: 80  YYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMN---EPQIAYVCREVLQGLEYLHSQ 135

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
               V+HRDIK+ N+LL K  + +L DFG A
Sbjct: 136 ---NVIHRDIKSDNILLSKDGSVKLADFGFA 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 13/153 (8%)

Query: 119 NVIGLGGNGKVYKGQL------LGVEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLV 171
             +G G  GKV   +        G +VA+K ++   E     +F  E+  L  L H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 172 GLRGWCKKEKE-SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
             +G C+K    SL LI +Y+ +GSL  ++    + I L   + +     +  G+ YL  
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYLGS 127

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               + +HRD+ A N+L++ +   ++ DFGLAK
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 80.3 bits (198), Expect = 4e-17
 Identities = 52/153 (33%), Positives = 88/153 (57%), Gaps = 12/153 (7%)

Query: 118 ENVIGLGGNGKVYKGQL-----LGVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
           E VIG G  G+V  G+L       + VA+K +    +E   R+FL+E S +G+  H N++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G   K K  +I+  +YMENGSLD ++ + D    +   Q + +L+ +ASG+ YL   
Sbjct: 69  HLEGVVTKSKPVMIVT-EYMENGSLDAFLRKHDGQFTVI--QLVGMLRGIASGMKYLS-- 123

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            +   +HRD+ A N+L++  +  ++ DFGL+++
Sbjct: 124 -DMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 79.4 bits (196), Expect = 9e-17
 Identities = 51/146 (34%), Positives = 78/146 (53%), Gaps = 8/146 (5%)

Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGM-REFLAEVSSLGRLKHRNLVGLRGWC 177
           +G G    VYKG+    G  VALK I LD+E G     + E+S +  LKH N+V L    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
             E + L+L+++YM+   L K++       AL           +  GI + +E   ++VL
Sbjct: 68  HTENK-LMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVL 122

Query: 238 HRDIKASNVLLDKKMNARLGDFGLAK 263
           HRD+K  N+L++K+   +L DFGLA+
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 80.9 bits (198), Expect = 1e-16
 Identities = 48/155 (30%), Positives = 78/155 (50%), Gaps = 10/155 (6%)

Query: 114 GFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHG---MREFLAEVSSLGRLKH-RN 169
            +     +G G  G+VY  +     VALK ++   E     +  FL E+  L  L H  N
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           +V L     +++ SL L+ +Y++ GSL+  + +      LS  + + +L  + S + YL+
Sbjct: 60  IVKLYD-FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 230 EGWESKVLHRDIKASNVLLDKKMN-ARLGDFGLAK 263
                 ++HRDIK  N+LLD+     +L DFGLAK
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAK 150

Length = 384

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 77.1 bits (190), Expect = 5e-16
 Identities = 48/151 (31%), Positives = 80/151 (52%), Gaps = 6/151 (3%)

Query: 115 FSEENVIGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           F+ E  +G G  G+V++G     V VA+K +  D     ++F  EV +L RL+H++L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
              C    E + +I + ME GSL  ++   +    L     I +   VA G+ YL E   
Sbjct: 68  FAVCS-VGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEE--- 122

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
              +HRD+ A N+L+ + +  ++ DFGLA++
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARL 153

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 53/146 (36%), Positives = 77/146 (52%), Gaps = 6/146 (4%)

Query: 118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
              IG G  G V  G   G +VA+K I  D+    + FLAE S + +L+H NLV L G  
Sbjct: 11  LQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
            +EK  L ++ +YM  GSL  ++     S+ L  +  +K   DV   + YL E   +  +
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL-EA--NNFV 124

Query: 238 HRDIKASNVLLDKKMNARLGDFGLAK 263
           HRD+ A NVL+ +   A++ DFGL K
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 43/150 (28%), Positives = 79/150 (52%), Gaps = 15/150 (10%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLA-EVSSLGRLKHRNLVGLRG- 175
           V+G G +G VYK +    G   ALK+I +D +   R+ L  E+ +L   +   +V   G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI--KVLKDVASGILYLYEGWE 233
           + K+ + S++L  +YM+ GSL   +            + +   + + +  G+ YL+   +
Sbjct: 68  FYKEGEISIVL--EYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYLHT--K 118

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             ++HRDIK SN+L++ K   ++ DFG++K
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISK 148

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 46/149 (30%), Positives = 79/149 (53%), Gaps = 15/149 (10%)

Query: 121 IGLGGNGKVYKGQLLG-VEVALKRI---SLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           +G G  G+V+ G   G  +VA+K +   ++  E     FL E   + +L+H  LV L   
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE----AFLQEAQIMKKLRHDKLVQLYAV 69

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK- 235
           C +E E + ++ +YM  GSL  ++    E   L   Q + +   +A G+ YL    ES+ 
Sbjct: 70  CSEE-EPIYIVTEYMSKGSLLDFLKS-GEGKKLRLPQLVDMAAQIAEGMAYL----ESRN 123

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            +HRD+ A N+L+ + +  ++ DFGLA++
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARL 152

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 60/190 (31%), Positives = 100/190 (52%), Gaps = 35/190 (18%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREF-----LAEVSSLGRLKHRNLVGL 173
           +G G  G+VYK + +  G  VALK+I + +E   ++      L E+  L +LKH N+V L
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNE---KDGFPITALREIKILKKLKHPNVVPL 72

Query: 174 -------RGWCKKEKESLILIYDYME---NGSLDKWIFECDESIALSWEQRIK-VLKDVA 222
                      K+++ S+ ++  YM+   +G L+      + S+ L+ E +IK  +  + 
Sbjct: 73  IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE------NPSVKLT-ESQIKCYMLQLL 125

Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIEEGKR 282
            GI YL+E   + +LHRDIKA+N+L+D +   ++ DFGLA+  + G   + +     G R
Sbjct: 126 EGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLAR-PYDGPPPNPKGGGGGGTR 181

Query: 283 ---NLVDRMW 289
              NLV   W
Sbjct: 182 KYTNLVVTRW 191

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 31/180 (17%)

Query: 107 EIHAATKGFSEENVIGLGGNGKVYKGQLLG-------VEVALKRISLDSEHGMR---EFL 156
           EI  +   F EE  +G G  GKVYKG+L G         VA+K  +L      +   EF 
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIK--TLKENAEPKVQQEFR 56

Query: 157 AEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIF-----------ECDE 205
            E   +  L+H N+V L G C KE +   ++++Y+ +G L +++              DE
Sbjct: 57  QEAELMSDLQHPNIVCLLGVCTKE-QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDE 115

Query: 206 SIALSWEQR--IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           ++  S +    + +   +A+G+ YL        +HRD+ A N L+ + +  ++ DFGL++
Sbjct: 116 TVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 73.9 bits (182), Expect = 6e-15
 Identities = 52/150 (34%), Positives = 77/150 (51%), Gaps = 16/150 (10%)

Query: 121 IGLGGNGKVYKGQLL-----GVEVALKRISLDSE-HGMREFLAEVSSLGRLKHRNLVGLR 174
           +G G  G V KG  L      VEVA+K +  +    G +EFL E S + +L H  +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVL-KDVASGILYLYEGWE 233
           G CK E   L+L+ +    G L K++ +    I +S    +K L   VA G+ YL     
Sbjct: 63  GVCKGE--PLMLVMELAPLGPLLKYLKK-RREIPVS---DLKELAHQVAMGMAYLES--- 113

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
              +HRD+ A NVLL  +  A++ DFG+++
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSR 143

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 55/174 (31%), Positives = 88/174 (50%), Gaps = 29/174 (16%)

Query: 119 NVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLA--EVSSLGRLKHRNLVGLR 174
             IG G  G+VYK   +  G  VALK++ LD+E       A  E+  L +L HRN+V L+
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 175 GWC---------KKEKESLILIYDYMEN---GSLDKWIFECDESIALSWEQRIKVLKDVA 222
                       KK+K +  L+++YM++   G L+  +      +  S +     +K + 
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL------VHFSEDHIKSFMKQLL 126

Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRP 276
            G+ Y ++      LHRDIK SN+LL+ K   +L DFGLA++++  +     RP
Sbjct: 127 EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE----SRP 173

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 17/162 (10%)

Query: 121 IGLGGNGKVYKGQL------LGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
           +G G  G V +GQL      L V V   +I++ +   M +FL+E   +    H N++ L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 175 GWCKKEKE-----SLILIYDYMENGSLDKWIFEC---DESIALSWEQRIKVLKDVASGIL 226
           G C +  E     S ++I  +M++G L  ++      D    L  +  +K + D+ASG+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
           YL        +HRD+ A N +L++ MN  + DFGL+K  ++G
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG 165

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 57/208 (27%), Positives = 105/208 (50%), Gaps = 19/208 (9%)

Query: 55  FILGVSVGGLLIMGCGVVVYMVCLKRKGKKMKDVEETED--WELEYWPHRVSYQ-EIHAA 111
           F +  ++G  L++      ++    R   ++K VE  ED  WEL+++  +VS    I+  
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVEN-EDGTWELQFFDSKVSKSITINDI 688

Query: 112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHR 168
                EENVI  G  G  YKG+ +  G++  +K I+ ++S         E++ +G+L+H 
Sbjct: 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS-----EIADMGKLQHP 743

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L G C+ EK +  LI++Y+E  +L + +        LSWE+R K+   +A  + +L
Sbjct: 744 NIVKLIGLCRSEKGAY-LIHEYIEGKNLSEVL------RNLSWERRRKIAIGIAKALRFL 796

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARL 256
           +      V+  ++    +++D K    L
Sbjct: 797 HCRCSPAVVVGNLSPEKIIIDGKDEPHL 824

Length = 968

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 71.8 bits (177), Expect = 5e-14
 Identities = 49/153 (32%), Positives = 78/153 (50%), Gaps = 16/153 (10%)

Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLA-----EVSSLGRLKHRNLVGL 173
           +G G    VYK +    G  VA+K+I L      ++ +      E+  L  LKH N++GL
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGILYLYEGW 232
                  K ++ L++++ME   L+K I   D+SI L+    IK  +     G+ YL+  W
Sbjct: 68  LD-VFGHKSNINLVFEFME-TDLEKVIK--DKSIVLT-PADIKSYMLMTLRGLEYLHSNW 122

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
              +LHRD+K +N+L+      +L DFGLA+  
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLARSF 152

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 43/150 (28%), Positives = 79/150 (52%), Gaps = 10/150 (6%)

Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           F     +G G  G VYK   +  G  VA+K + ++ +  ++E + E+S L +     +V 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVK 62

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
             G   K  + L ++ +Y   GS+   +   +++  L+ E+   +L     G+ YL+   
Sbjct: 63  YYGSYFKNTD-LWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYLHS-- 117

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
            +K +HRDIKA N+LL+++  A+L DFG++
Sbjct: 118 -NKKIHRDIKAGNILLNEEGQAKLADFGVS 146

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 48/148 (32%), Positives = 75/148 (50%), Gaps = 13/148 (8%)

Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISL--DSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           IG G  G VYK +  L G  VA+K+I L  +SE   +  L E+  L  L H N++ L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD- 65

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGILYLYEGWESK 235
             + K  L L++++M+    D +    D    L  E  IK  L  +  G+ + +      
Sbjct: 66  VFRHKGDLYLVFEFMDT---DLYKLIKDRQRGLP-ESLIKSYLYQLLQGLAFCHSHG--- 118

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +LHRD+K  N+L++ +   +L DFGLA+
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 70.9 bits (174), Expect = 9e-14
 Identities = 52/153 (33%), Positives = 82/153 (53%), Gaps = 11/153 (7%)

Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  GKVYK Q    G+  A K I ++SE  + +F+ E+  L   KH N+VGL     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGILYLYEGWESKVL 237
            E +  ILI ++ + G+LD  + E +  +    E +I+ V + +   + +L+     KV+
Sbjct: 73  YENKLWILI-EFCDGGALDSIMLELERGLT---EPQIRYVCRQMLEALNFLHS---HKVI 125

Query: 238 HRDIKASNVLLDKKMNARLGDFGL-AKMHHHGQ 269
           HRD+KA N+LL    + +L DFG+ AK     Q
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 48/156 (30%), Positives = 85/156 (54%), Gaps = 21/156 (13%)

Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREF----LAEVSSLGRLKHRNLVGLR 174
           IG G  G+V+K +       VALK++ +++E     F    L E+  L  LKH N+V L 
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLI 77

Query: 175 GWCKKE-------KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
             C+ +       K S  L++++ E+   D      ++++  +  +  KV+K + +G+ Y
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH---DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           ++    +K+LHRD+KA+N+L+ K    +L DFGLA+
Sbjct: 135 IHR---NKILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 8/148 (5%)

Query: 119 NVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVGLRG 175
             +G G +G V K      G  +A+K I L+    ++ + L E+  L +     +VG  G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
                 + + +  +YM+ GSLDK + E    I      +I V   V  G+ YL+E  + K
Sbjct: 67  AFYNNGD-ISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYLHE--KHK 121

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAK 263
           ++HRD+K SN+L++ +   +L DFG++ 
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSG 149

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 19/160 (11%)

Query: 119 NVIGLGGNGKVYKGQLLG-------VEVALKRI-SLDSEHGMREFLAEVSSLGRLKHRNL 170
             +G G  G+VY+G   G       ++VA+K +    SE    +FL E   + +  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGIL 226
           V L G   +     IL+ + M  G L  ++ E     +   +L+ +  +   +DVA G  
Sbjct: 72  VRLIGVSFERLPRFILL-ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNAR---LGDFGLAK 263
           YL E   +  +HRDI A N LL  K   R   + DFG+A+
Sbjct: 131 YLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 51/156 (32%), Positives = 72/156 (46%), Gaps = 14/156 (8%)

Query: 113 KGFSEENVIGLGGNGKVYKGQL--LGVEVALKRISLDSEHG-MREFLAEVSSLGRLKHRN 169
           +   E + +G G  G V K +L   G+  ALK I+ D      ++ L E+      K   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 170 LVGLRGWCKKEKESLILI-YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL-- 226
           +V   G    E  S I I  +Y E GSLD    +  +      E   KVL  +A  +L  
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE---KVLGKIAESVLKG 117

Query: 227 --YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG 260
             YL+     K++HRDIK SN+LL +K   +L DFG
Sbjct: 118 LSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFG 150

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 49/162 (30%), Positives = 83/162 (51%), Gaps = 12/162 (7%)

Query: 121 IGLGGNGKVYKGQL-LGVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGLRGWCK 178
           IG G  G VYKG L    EVA+K         ++  FL E   L +  H N+V L G C 
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
            +K+ + ++ + +  GSL  ++ +  +   L+ ++ +++  D A+G+ YL    ESK  +
Sbjct: 63  -QKQPIYIVMELVPGGSLLTFLRK--KKNRLTVKKLLQMSLDAAAGMEYL----ESKNCI 115

Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKMHHHG--QVMSGRRPI 277
           HRD+ A N L+ +    ++ DFG+++    G   V  G + I
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 45/150 (30%), Positives = 82/150 (54%), Gaps = 10/150 (6%)

Query: 118 ENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
           ++ +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 69

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
            C +E    I I ++M  G+L  ++ EC+    ++    + +   ++S + YL    E K
Sbjct: 70  VCTREPPFYI-ITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYL----EKK 123

Query: 236 -VLHRDIKASNVLLDKKMNARLGDFGLAKM 264
             +HRD+ A N L+ +    ++ DFGL+++
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRL 153

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 47/149 (31%), Positives = 82/149 (55%), Gaps = 15/149 (10%)

Query: 121 IGLGGNGKVYKGQLLG-VEVALKRI---SLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           +G G  G+V++G       VA+K +   ++D +    +FLAE   + +L+H  L+ L   
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK----DFLAEAQIMKKLRHPKLIQLYAV 69

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK- 235
           C  E E + ++ + M+ GSL +++ +     AL   Q I +   VASG+ YL    E++ 
Sbjct: 70  CTLE-EPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYL----EAQN 123

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            +HRD+ A NVL+ +    ++ DFGLA++
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARV 152

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 22/168 (13%)

Query: 119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRG 175
            VIG+G    VY    L    +VA+KRI L+  +  + E   EV ++ +  H N+V    
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-- 64

Query: 176 WCK-KEKESLILIYDYMENGS-LD--KWIFEC---DESIALSWEQRIKVLKDVASGILYL 228
           +      + L L+  Y+  GS LD  K  +     DE+I  +      VLK+V  G+ YL
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIAT------VLKEVLKGLEYL 118

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGL-AKMHHHGQVMSGRR 275
           +    +  +HRDIKA N+LL +  + ++ DFG+ A +   G      R
Sbjct: 119 HS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 54/147 (36%), Positives = 82/147 (55%), Gaps = 12/147 (8%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVGLRGWC 177
           +G G    VYKG  +L    VALK I L+ E G     + EVS L  LKH N+V L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGILYLYEGWESKV 236
             EK SL L+++Y++   L +++ +C  SI +     +K+ L  +  G+ Y +     KV
Sbjct: 74  HTEK-SLTLVFEYLDK-DLKQYLDDCGNSINM---HNVKLFLFQLLRGLNYCHR---RKV 125

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAK 263
           LHRD+K  N+L++++   +L DFGLA+
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 68.4 bits (167), Expect = 5e-13
 Identities = 52/160 (32%), Positives = 86/160 (53%), Gaps = 11/160 (6%)

Query: 120 VIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +IG G  G V +G+  G +VA+K I  D     + FL E + + +L H+NLV L G    
Sbjct: 13  IIGEGEFGAVLQGEYTGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLH 238
               L ++ + M  G+L  ++        +S  Q ++   DVA G+ YL    ESK ++H
Sbjct: 71  N--GLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYL----ESKKLVH 123

Query: 239 RDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIE 278
           RD+ A N+L+ +   A++ DFGLA++   G V + + P++
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVK 162

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 52/155 (33%), Positives = 80/155 (51%), Gaps = 25/155 (16%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLA--EVSSLGRLKHRNLVGLRGW 176
           IG G  G VYKG  +  G  VA+K+I L+SE       A  E+S L  L+H N+V L+  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 177 CKKEKESLILIYD--------YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
             +E   L LI++        Y+++    +++   D  +  S+      L  +  GIL+ 
Sbjct: 68  LMQESR-LYLIFEFLSMDLKKYLDSLPKGQYM---DAELVKSY------LYQILQGILFC 117

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +     +VLHRD+K  N+L+D K   +L DFGLA+
Sbjct: 118 HS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 22/156 (14%)

Query: 120 VIGLGGNGKVYKG------QLLGVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVG 172
           V+G G  G VYKG      + + + VA+K +  ++     +E L E   +  + H ++V 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVASGILYL 228
           L G C      + LI   M  G L  ++    ++I     L+W  +I      A G+ YL
Sbjct: 74  LLGICLSS--QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYL 125

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            E    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 126 EE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 27/165 (16%)

Query: 120 VIGLGGNGKVYKGQLLGVE-------VA---LKRISLDSEHGMREFLAEVSSLGRLKHRN 169
            +G G  GKV+ G+   +E       VA   LK  + +     ++F  E   L   +H N
Sbjct: 12  ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNFQHEN 69

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKW-----------IFECDESIALSWEQRIKVL 218
           +V   G C  E +  I++++YME+G L+K+                    L+  Q +++ 
Sbjct: 70  IVKFYGVCT-EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             +ASG++YL        +HRD+   N L+   +  ++GDFG+++
Sbjct: 129 VQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 14/159 (8%)

Query: 108 IHAATKGFSEENVIGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMRE--FLAEVSSLGR 164
           I  +   F +E  +G G  G V+ G+  G  +VA+K I    E  M E  F+ E   + +
Sbjct: 1   IDPSELTFLKE--LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMK 55

Query: 165 LKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASG 224
           L H NLV L G C K++  + ++ +YM NG L  ++ E    +    E  + +  DV   
Sbjct: 56  LSHPNLVQLYGVCTKQR-PIFIVTEYMANGCLLNYLRERKGKLGT--EWLLDMCSDVCEA 112

Query: 225 ILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           + YL     +  +HRD+ A N L+ +    ++ DFGLA+
Sbjct: 113 MEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 44/152 (28%), Positives = 74/152 (48%), Gaps = 13/152 (8%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
           F+    IG G  G+VYK         VA+K I L+ +E  + +   E+  L + +   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGILYLYE 230
              G    +   L +I +Y   GS      +  +   L  E  I  +L++V  G+ YL+E
Sbjct: 63  KYYG-SFLKGSKLWIIMEYCGGGS----CLDLLKPGKLD-ETYIAFILREVLLGLEYLHE 116

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
                 +HRDIKA+N+LL ++ + +L DFG++
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVS 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 51/151 (33%), Positives = 78/151 (51%), Gaps = 19/151 (12%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHRNLVGLRGW 176
           IG G  G V+K   +     VALKR+ LD +  G+    L E+  L  LKH+N+V L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 177 CKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYLYEGW 232
              +K+ L L+++Y +   L K+   C    D  I  S+    ++LK    G+ + +   
Sbjct: 68  LHSDKK-LTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSF--MFQLLK----GLAFCHS-- 117

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
              VLHRD+K  N+L++K    +L DFGLA+
Sbjct: 118 -HNVLHRDLKPQNLLINKNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 42/150 (28%), Positives = 77/150 (51%), Gaps = 14/150 (9%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDSEHG-----MREFLAEVSSLGRLKHRNLVGL 173
           +G G  G VY+G  L  G   A+K +SL  +       +++   E++ L +L+H N+V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G  ++E+++L +  + +  GSL K + +     +          + +  G+ YL++   
Sbjct: 68  LG-TEREEDNLYIFLELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHD--- 120

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
              +HRDIK +N+L+D     +L DFG+AK
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAK 150

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 50/147 (34%), Positives = 82/147 (55%), Gaps = 12/147 (8%)

Query: 121 IGLGGNGKVYKGQLLGVE--VALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVGLRGWC 177
           +G G    V+KG+    E  VALK I L+ E G     + EVS L  LKH N+V L    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGILYLYEGWESKV 236
             +K SL L+++Y++   L +++ +C   +++     +K+ L  +  G+ Y +     KV
Sbjct: 74  HTDK-SLTLVFEYLDK-DLKQYMDDCGNIMSM---HNVKIFLYQILRGLAYCHR---RKV 125

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAK 263
           LHRD+K  N+L++++   +L DFGLA+
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 66.0 bits (161), Expect = 3e-12
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 26/165 (15%)

Query: 119 NVIGLGGNGKVYKGQLLGV--------EVA---LKRISLDSEHGMREFLAEVSSLGRLKH 167
           N +G G  G+VY+G    +         VA   L++ + D E   +EFL E   +    H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNH 58

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWI----FECDESIALSWEQRIKVLKDVAS 223
            N+V L G C    E   +I + ME G L  ++     E      L+ ++ + +  DVA 
Sbjct: 59  PNIVKLLGVC-LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNAR-----LGDFGLAK 263
           G +YL    +   +HRD+ A N L+ +K         +GDFGLA+
Sbjct: 118 GCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 17/172 (9%)

Query: 114 GFSEENVIGLGGNGKVYKGQLLGVE--VALKRIS---LDSEHGMREFLAEVSSLGRLKHR 168
            F    VIG G  GKV   Q    +   A+K ++      +  +R  L E   L  L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGILY 227
            LV L  +  +++E++ L+ D +  G L    +   + +  S E+++K  + ++   + Y
Sbjct: 61  FLVNLW-YSFQDEENMYLVVDLLLGGDLR---YHLSQKVKFS-EEQVKFWICEIVLALEY 115

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV---MSGRRP 276
           L+      ++HRDIK  N+LLD++ +  + DF +A       +    SG   
Sbjct: 116 LHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPG 164

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 10/145 (6%)

Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  GKVYK Q    GV  A K I   SE  + +++ E+  L    H N+V L     
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVL-KDVASGILYLYEGWESKVL 237
            E    ILI ++   G++D  + E +  +    E +I+V+ K     + YL+E   +K++
Sbjct: 73  YENNLWILI-EFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHE---NKII 125

Query: 238 HRDIKASNVLLDKKMNARLGDFGLA 262
           HRD+KA N+L     + +L DFG++
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 48/147 (32%), Positives = 81/147 (55%), Gaps = 12/147 (8%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVGLRGWC 177
           +G G    V+KG  +L    VALK I L+ E G     + EVS L  LKH N+V L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLK-DVASGILYLYEGWESKV 236
             E+  L L+++Y+++  L +++  C   +++     +K+    +  G+ Y ++    K+
Sbjct: 73  HTER-CLTLVFEYLDS-DLKQYLDNCGNLMSM---HNVKIFMFQLLRGLSYCHK---RKI 124

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAK 263
           LHRD+K  N+L+++K   +L DFGLA+
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 54/150 (36%), Positives = 83/150 (55%), Gaps = 15/150 (10%)

Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSE-HGM-REFLAEVSSLGRLKHRNLVGLRGW 176
           IG G  G VYK +  +    +ALK+I L+ E  G+    + E+S L  ++H N+V L+  
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR-IKV-LKDVASGILYLYEGWES 234
              EK  L L+++Y++   L K +   D S   +   R IK  L  +  GI Y +     
Sbjct: 70  VHSEKR-LYLVFEYLDL-DLKKHM---DSSPDFAKNPRLIKTYLYQILRGIAYCHS---H 121

Query: 235 KVLHRDIKASNVLLDKKMNA-RLGDFGLAK 263
           +VLHRD+K  N+L+D++ NA +L DFGLA+
Sbjct: 122 RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 65.6 bits (160), Expect = 5e-12
 Identities = 48/147 (32%), Positives = 76/147 (51%), Gaps = 10/147 (6%)

Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSE-HGM-REFLAEVSSLGRLKHRNLVGLRGW 176
           IG G  G VYK +  L G  VALK+I LD+E  G+    + E+S L  L H N+V L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
              E   L L+++++ +  L K++     S  +        L  +  G+ + +     +V
Sbjct: 68  IHTEN-KLYLVFEFL-HQDLKKFMDASPLS-GIPLPLIKSYLFQLLQGLAFCHS---HRV 121

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAK 263
           LHRD+K  N+L++ +   +L DFGLA+
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 5e-12
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 14/149 (9%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLA--EVSSLGRLKHRNLVGLRG 175
            +G G    VYKG+  L G  VALK I L+ E G   F A  E S L  LKH N+V L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTLHD 70

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGILYLYEGWES 234
                K++L L+++Y++   L +++ +C   +++     +++ L  +  G+ Y ++    
Sbjct: 71  IIHT-KKTLTLVFEYLDT-DLKQYMDDCGGGLSMH---NVRLFLFQLLRGLAYCHQ---R 122

Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +VLHRD+K  N+L+ ++   +L DFGLA+
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 37/126 (29%), Positives = 62/126 (49%), Gaps = 8/126 (6%)

Query: 138 EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLD 197
           EV L R+S   E   R+ L E+  L  L+H N++        +  +L++  +Y   G+L 
Sbjct: 32  EVNLTRLS---EKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-TLLIEMEYANGGTLY 87

Query: 198 KWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLG 257
             I      +    E  +  L  + S + Y+++   + +LHRDIK  N+ L K    +LG
Sbjct: 88  DKIVRQKGQL-FEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLG 143

Query: 258 DFGLAK 263
           DFG++K
Sbjct: 144 DFGISK 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 7e-12
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 18/151 (11%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDSEH------GMREFLAEVSSLGRLKHRNLVG 172
           IG G  G VYK +    G  VALK+I L++E        +RE    +S L  L H N+V 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE----ISLLKELNHPNIVR 62

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
           L      E + L L+++++ +  L K++        L        L  +  GI Y +   
Sbjct: 63  LLDVVHSENK-LYLVFEFL-DLDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHS-- 117

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             +VLHRD+K  N+L+D++   +L DFGLA+
Sbjct: 118 -HRVLHRDLKPQNLLIDREGALKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 64.9 bits (158), Expect = 8e-12
 Identities = 46/148 (31%), Positives = 84/148 (56%), Gaps = 14/148 (9%)

Query: 121 IGLGGNGKVYKGQLLG-VEVALKRI---SLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           +G G  G+V+ G   G  +VA+K +   S+  E     FLAE + + +L+H  LV L  +
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE----AFLAEANLMKQLQHPRLVRL--Y 67

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
               +E + +I +YMENGSL  ++ +  E I L+  + I +   +A G+ ++        
Sbjct: 68  AVVTQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIER---KNY 123

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAKM 264
           +HRD++A+N+L+ + +  ++ DFGLA++
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARL 151

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 64.8 bits (158), Expect = 8e-12
 Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 18/159 (11%)

Query: 120 VIGLGGNGKVYKGQL-----LGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVG 172
           ++G G  G V +GQL       ++VA+K + LD  +   + EFL+E + +    H N++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 173 LRGWC--KKEKESL---ILIYDYMENGSLDKWIFEC---DESIALSWEQRIKVLKDVASG 224
           L G C      + +   ++I  +M++G L  ++           L  +  +K + D+A G
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 225 ILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           + YL        +HRD+ A N +L + M   + DFGL+K
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 65.1 bits (158), Expect = 9e-12
 Identities = 41/160 (25%), Positives = 83/160 (51%), Gaps = 21/160 (13%)

Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           +G G  GKV+  +          + VA+K +   S++  ++F  E   L  L+H ++V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWI----------FECDESIALSWEQRIKVLKDVAS 223
            G C  E + LI++++YM++G L+K++           E +    L+  Q + + + +A+
Sbjct: 73  YGVCV-EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           G++YL        +HRD+   N L+ + +  ++GDFG+++
Sbjct: 132 GMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSR 168

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 52/147 (35%), Positives = 78/147 (53%), Gaps = 14/147 (9%)

Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMRE--FLAEVSSLGRLKHRNLVGLRGWC 177
           +G G  G V  G+  G  +VA+K I    E  M E  F+ E   + +L H  LV L G C
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-V 236
            K++   I + +YM NG L  ++ E  +    S  Q +++ KDV  G+ YL    ESK  
Sbjct: 69  TKQRPIYI-VTEYMSNGCLLNYLREHGKRFQPS--QLLEMCKDVCEGMAYL----ESKQF 121

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAK 263
           +HRD+ A N L+D +   ++ DFGL++
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSR 148

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 50/173 (28%), Positives = 82/173 (47%), Gaps = 30/173 (17%)

Query: 114 GFSEENVIGLGGNGKVYKGQLL----GVEVALKRISLDSEHG-------MREFLAEVSSL 162
            +  E  IG G  G+VYK +      G E A+K+   D E          RE    ++ L
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALL 56

Query: 163 GRLKHRNLVGLRGWCKKEKE-SLILIYDYMENGSLDKW--IFECDESIALSWEQRI--KV 217
             LKH N+V L     +  + S+ L++DY E+   D W  I    ++  +S    +   +
Sbjct: 57  RELKHENVVSLVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPSMVKSL 113

Query: 218 LKDVASGILYLYEGWESKVLHRDIKASNVLL--DKKMNAR--LGDFGLAKMHH 266
           L  + +G+ YL+  W   VLHRD+K +N+L+  +        +GD GLA++ +
Sbjct: 114 LWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 54/164 (32%), Positives = 85/164 (51%), Gaps = 23/164 (14%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEH-GMR-EFLAEVSSLGRLKHRNL 170
           F + N IG G  G VY+ +    G  VALK++ +D+E  G+    L E++ L  L+H N+
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 171 VGLR----GWCKKEKESLILIYDYMEN--GSLDKWIFECDESIALSWEQRIKVL-KDVAS 223
           V L+    G   K  +S+ L+ +Y E    SL       D       E ++K L   +  
Sbjct: 69  VELKEVVVG---KHLDSIFLVMEYCEQDLASL------LDNMPTPFSESQVKCLMLQLLR 119

Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
           G+ YL+E +   ++HRD+K SN+LL  K   ++ DFGLA+ +  
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (157), Expect = 1e-11
 Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 17/156 (10%)

Query: 120 VIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGW 176
           VIG G  GKVYK +    G  VA+K + +  +    E   E + L +   H N+    G 
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 177 CKKEKES-----LILIYDYMENGS---LDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
             K+        L L+ +    GS   L K + +  + +   W   I  L++   G+ YL
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI--LRETLRGLAYL 129

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           +E   +KV+HRDIK  N+LL K    +L DFG++  
Sbjct: 130 HE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 51/162 (31%), Positives = 81/162 (50%), Gaps = 19/162 (11%)

Query: 110 AATKGFSE---ENVIGLGGNGKVYK--GQLLGVEVALKRISLDSEHGMREFLA-EVSSLG 163
           +A K  SE    N IG G  G VYK   +  G   ALK I  + E  +R  +  E+  L 
Sbjct: 68  SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR 127

Query: 164 RLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVA 222
            + H N+V          E  +L+ ++M+ GSL        E   ++ EQ +  V + + 
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLL-EFMDGGSL--------EGTHIADEQFLADVARQIL 178

Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           SGI YL+      ++HRDIK SN+L++   N ++ DFG++++
Sbjct: 179 SGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRI 217

Length = 353

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 50/160 (31%), Positives = 79/160 (49%), Gaps = 14/160 (8%)

Query: 108 IHAATKGFSEENVIGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMRE--FLAEVSSLGR 164
           IH +     +E  IG G  G V+ G  L   +VA+K I    E  M E  F+ E   + +
Sbjct: 1   IHPSELTLVQE--IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMK 55

Query: 165 LKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASG 224
           L H  LV L G C  E+  + L++++ME+G L  ++    +    S E  + +  DV  G
Sbjct: 56  LSHPKLVQLYGVCT-ERSPICLVFEFMEHGCLSDYLRA--QRGKFSQETLLGMCLDVCEG 112

Query: 225 ILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           + YL     S V+HRD+ A N L+ +    ++ DFG+ + 
Sbjct: 113 MAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRF 149

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 47/150 (31%), Positives = 77/150 (51%), Gaps = 14/150 (9%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISL--DSEHGMREFLA---EVSSLGRLKHRNLVGL 173
           +G G  G+VY    +  G E+A+K++    DS    +E  A   E+  L  L+H  +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C ++ E+L +  +YM  GS+   +       AL+     K  + +  G+ YL+    
Sbjct: 70  YG-CLRDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTRKYTRQILEGVEYLHS--- 122

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           + ++HRDIK +N+L D   N +LGDFG +K
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGASK 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 24/180 (13%)

Query: 118 ENVIGLGGNGKVYKGQL----LGVEVALKRIS-LDSEHGMREFLAEVSSLGRL-KHRNLV 171
           ++VIG G  G+V K ++    L ++ A+KR+    S+   R+F  E+  L +L  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKW-----IFECDESIA--------LSWEQRIKVL 218
            L G C+  +  L L  +Y  +G+L  +     + E D + A        LS +Q +   
Sbjct: 72  NLLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH-HGQVMSGRRPI 277
            DVA G+ YL +    + +HRD+ A N+L+ +   A++ DFGL++    + +   GR P+
Sbjct: 131 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 187

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 63.0 bits (154), Expect = 4e-11
 Identities = 45/156 (28%), Positives = 81/156 (51%), Gaps = 23/156 (14%)

Query: 119 NVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREF----LAEVSSLGRLKHRNLVG 172
           N I  G  G VY+ +    G  VALK++ ++ E     F    L E++ L +L+H N+V 
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE--KEGFPITSLREINILLKLQHPNIVT 68

Query: 173 LR----GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVL-KDVASGILY 227
           ++    G      + + ++ +Y+E+  L   +    +    S    +K L   + SG+ +
Sbjct: 69  VKEVVVG---SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS---EVKCLMLQLLSGVAH 121

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           L++ W   +LHRD+K SN+LL+ +   ++ DFGLA+
Sbjct: 122 LHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 44/170 (25%), Positives = 83/170 (48%), Gaps = 31/170 (18%)

Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           IG G  G+V++ +  G+        VA+K +  ++   M+ +F  E + +    H N+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECD----ESIA---------------LSWEQ 213
           L G C    + + L+++YM  G L++++         S++               LS  +
Sbjct: 73  LLGVCA-VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 214 RIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           ++ + K VA+G+ YL E    K +HRD+   N L+ + M  ++ DFGL++
Sbjct: 132 QLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 62.2 bits (152), Expect = 6e-11
 Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 14/150 (9%)

Query: 121 IGLGGNGKVY--KGQLLGVEVALKRISLDS--EHGMREF-LAEVSSLGRLKHRNLVGLRG 175
           +G G  GKV   + +  G   A+K +      +    E  L E + L R+ H  +V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGILYLYEGWES 234
           +  + +E L L+ +Y   G L   +    +    S E+R +    ++   + YL+     
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS-EERARFYAAEIVLALEYLHS---L 112

Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            +++RD+K  N+LLD   + +L DFGLAK 
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKE 142

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 44/145 (30%), Positives = 75/145 (51%), Gaps = 10/145 (6%)

Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  GKVYK +    G   A K I   SE  + +++ E+  L    H  +V L G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVL-KDVASGILYLYEGWESKVL 237
            + +  I+I ++   G++D  + E D  +    E +I+V+ + +   + YL+     K++
Sbjct: 80  WDGKLWIMI-EFCPGGAVDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS---MKII 132

Query: 238 HRDIKASNVLLDKKMNARLGDFGLA 262
           HRD+KA NVLL    + +L DFG++
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 52/176 (29%), Positives = 87/176 (49%), Gaps = 27/176 (15%)

Query: 107 EIHAATKGFSEENVIGLGGNGKVYKGQLLGVE-------VALKRISLDSEHGMRE-FLAE 158
           EI+ +T  F EE  +G    GKVYKG L G         VA+K +   +E  +RE F  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 159 VSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIF-----------ECDESI 207
                RL+H N+V L G   KE + L +I+ Y  +  L +++            + D+++
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKE-QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 208 ALSWEQR--IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL 261
             + E    + ++  +A+G+ +L       V+H+D+   NVL+  K+N ++ D GL
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGL 170

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 62.2 bits (151), Expect = 8e-11
 Identities = 63/254 (24%), Positives = 104/254 (40%), Gaps = 51/254 (20%)

Query: 136 GVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGLRGWCKKEKE-SLILIYDYMEN 193
           G  VA+K +  +        +  E++ L  L H N+V  +G C ++    L LI +Y+  
Sbjct: 33  GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92

Query: 194 GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN 253
           GSL  ++ +    + L+  Q +   + +  G+ YL+       +HRD+ A NVLLD    
Sbjct: 93  GSLRDYLPK--HKLNLA--QLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRL 145

Query: 254 ARLGDFGLAKMHHHGQVM-----SGRRPI--------EEGKRNLVDRMWSL-TERSELLS 299
            ++GDFGLAK    G         G  P+        +E K +    +WS      ELL+
Sbjct: 146 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Query: 300 VLDERLKAKGGYAD---------------EVVEK-------------VLHLGLLCAHPEA 331
             D +      + +               E++E+             V  L   C   EA
Sbjct: 206 HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEA 265

Query: 332 NSRPTIRQVLKMLE 345
             RPT R ++ +L+
Sbjct: 266 KFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 8e-11
 Identities = 47/151 (31%), Positives = 76/151 (50%), Gaps = 10/151 (6%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +     IG G  G VYK + +  G  VA+K I L+          E+S L   +H N+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 173 LRG-WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
             G + +++K  L ++ +Y   GSL   I+       LS  Q   V ++   G+ YL+E 
Sbjct: 65  YFGSYLRRDK--LWIVMEYCGGGSLQD-IY-QVTRGPLSELQIAYVCRETLKGLAYLHE- 119

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             +  +HRDIK +N+LL +  + +L DFG++
Sbjct: 120 --TGKIHRDIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 61.9 bits (150), Expect = 9e-11
 Identities = 70/277 (25%), Positives = 116/277 (41%), Gaps = 53/277 (19%)

Query: 115 FSEENVIGLGGNGKVYKGQL-----LGVEVALKRISLD--SEHGMREFLAEVSSLGRLKH 167
           F+   ++G G  G V + QL        +VA+K +  D  S   + EFL E + +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 168 RNL-----VGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQRIKVLK 219
            N+     V LR   K      ++I  +M++G L  ++      +E   L  +  ++ + 
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG----QVMSGRR 275
           D+ASG+ YL        +HRD+ A N +L++ M   + DFGL+K  + G    Q  + + 
Sbjct: 121 DIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 276 PIEE-GKRNLVDR--------------MWSLT----------ERSELLSVL--DERLKAK 308
           P++     +L D               MW +           E SE+ + L    RLK  
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ- 236

Query: 309 GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE 345
                + +E V  L   C  PE   RP+ + +   LE
Sbjct: 237 ---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 9e-11
 Identities = 45/160 (28%), Positives = 83/160 (51%), Gaps = 16/160 (10%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISL-DSEHGMREF-LAEVSSLGRLK---H 167
           + E   IG G  G VYK + L  G  VALK++ +  SE G+    L E++ L +L+   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 168 RNLVGLR----GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
            N+V L     G     +  L L++++++   L  ++ +C +   L  E    +++ +  
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKP-GLPPETIKDLMRQLLR 118

Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           G+ +L+     +++HRD+K  N+L+      ++ DFGLA+
Sbjct: 119 GVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 50/165 (30%), Positives = 86/165 (52%), Gaps = 23/165 (13%)

Query: 118 ENVIGLGGNGKVYKGQL----LGVEVALKRI-SLDSEHGMREFLAEVSSLGRL-KHRNLV 171
           E+VIG G  G+V +  +    L +  A+K +    SE+  R+F  E+  L +L  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKW-----IFECDESIA--------LSWEQRIKVL 218
            L G C+      I I +Y   G+L  +     + E D + A        L+ +Q ++  
Sbjct: 67  NLLGACENRGYLYIAI-EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            DVA+G+ YL E    + +HRD+ A NVL+ + + +++ DFGL++
Sbjct: 126 SDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 15/132 (11%)

Query: 139 VALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLD 197
           VA+K +  D S++   +FL EV  L RL   N+  L G C  +   L +I +YMENG L+
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVD-PPLCMIMEYMENGDLN 107

Query: 198 KWI--------FECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLHRDIKASNVLL 248
           +++             S +LS+   + +   +ASG+ YL    ES   +HRD+   N L+
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL----ESLNFVHRDLATRNCLV 163

Query: 249 DKKMNARLGDFG 260
            K    ++ DFG
Sbjct: 164 GKNYTIKIADFG 175

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 40/137 (29%), Positives = 71/137 (51%), Gaps = 14/137 (10%)

Query: 137 VEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS 195
           V VA+K +  D     R +FL E+  + RLK+ N++ L G C  + + L +I +YMENG 
Sbjct: 45  VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD-DPLCMITEYMENGD 103

Query: 196 LDKWI--------FECDESI-ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNV 246
           L++++        F    +I ++S    + +   +ASG+ YL        +HRD+   N 
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160

Query: 247 LLDKKMNARLGDFGLAK 263
           L+      ++ DFG+++
Sbjct: 161 LVGNHYTIKIADFGMSR 177

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 47/150 (31%), Positives = 78/150 (52%), Gaps = 12/150 (8%)

Query: 120 VIGLGGNGKVY--KGQLLGVEVALKRISLDSEHGMREFLA---EVSSLGRLKHRNLVGLR 174
            IG G  GK+Y  K +       +K I L ++  ++E  A   EV  L ++KH N+V   
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
               +E   L ++ +Y + G L K I      +  S +Q +     ++ G+ ++++    
Sbjct: 66  A-SFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD---R 120

Query: 235 KVLHRDIKASNVLLDKK-MNARLGDFGLAK 263
           K+LHRDIK+ N+ L K  M A+LGDFG+A+
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 39/158 (24%), Positives = 74/158 (46%), Gaps = 19/158 (12%)

Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G   GV        VA+K ++ + S     EFL E S +      ++V 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFEC--DESIA-----LSWEQRIKVLKDVASGI 225
           L G     + +L+ + + M  G L  ++     +          + ++ I++  ++A G+
Sbjct: 74  LLGVVSTGQPTLV-VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            YL      K +HRD+ A N ++ + +  ++GDFG+ +
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 9/154 (5%)

Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDS-EHGMR-EFLAEVSSLGRLKHRNL 170
           F   N IG G  G V+K   +      A+K+I L       R E + E   L +L    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
           +        +K  L ++ +Y ENG L K + +      L  +Q  +    +  G+ +L+ 
Sbjct: 62  IRYYE-SFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
               K+LHRDIK+ N+ LD   N ++GD G+AK+
Sbjct: 120 ---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 19/152 (12%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDSEHG------MREFLAEVSSLGRLKHRNLVG 172
           IG G +G V+K +    G  VALK+++L    G      +RE  A    L   +H  +V 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKA----LQACQHPYVVK 63

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
           L           +L+ +YM    L + +   DE   L   Q    ++ +  G+ Y++   
Sbjct: 64  LLD-VFPHGSGFVLVMEYMP-SDLSEVL--RDEERPLPEAQVKSYMRMLLKGVAYMHA-- 117

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            + ++HRD+K +N+L+      ++ DFGLA++
Sbjct: 118 -NGIMHRDLKPANLLISADGVLKIADFGLARL 148

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 60.6 bits (148), Expect = 3e-10
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 27/159 (16%)

Query: 119 NVIGLGGNGKVYKG--QLLGVEVALKRISL---DSEHGMREFLAEVSSLGRLKHRNLVGL 173
             IG G  G V     +  G +VA+K+IS    D     R  L E+  L  L+H N++GL
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-ILREIKLLRHLRHENIIGL 64

Query: 174 RGWCKKEK----ESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-----VLKDVASG 224
               +         + ++ + ME   L K I        L+ +  I+     +L+    G
Sbjct: 65  LDILRPPSPEDFNDVYIVTELMET-DLHKVIKS---PQPLT-DDHIQYFLYQILR----G 115

Query: 225 ILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           + YL+    + V+HRD+K SN+L++   + ++ DFGLA+
Sbjct: 116 LKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR 151

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 27/159 (16%)

Query: 119 NVIGLGGNGKVYKGQLLG-----VEVALKRIS--LDSEHGMREFLAEVSSLGRLKHRNLV 171
            VIG G  G VY G L+      +  A+K ++   D E  + +FL E   +    H N++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE-VEQFLKEGIIMKDFSHPNVL 59

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD-------VASG 224
            L G C   + S +++  YM++G L  +I           E     +KD       VA G
Sbjct: 60  SLLGICLPSEGSPLVVLPYMKHGDLRNFIRS---------ETHNPTVKDLIGFGLQVAKG 110

Query: 225 ILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           + YL      K +HRD+ A N +LD+    ++ DFGLA+
Sbjct: 111 MEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 59.0 bits (143), Expect = 6e-10
 Identities = 70/265 (26%), Positives = 109/265 (41%), Gaps = 41/265 (15%)

Query: 112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRIS---LDSEHGMREFLAEVSSLGRLK 166
              F  E  IG G    VYK   L  G  VALK++    +      ++ L E+  L +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGI 225
           H N++       +  E L ++ +  + G L + I    +   L  E+ I K    + S +
Sbjct: 61  HPNVIKYLASFIENNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK------MHHHGQV-----MSGR 274
            +++     +++HRDIK +NV +      +LGD GL +         H  V     MS  
Sbjct: 120 EHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 275 RPIEEGKRNLVDRMWS----LTERSEL----------LSVLDERLKAKGGY----ADEVV 316
           R  E G  N    +WS    L E + L          L  L ++++ K  Y    AD   
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-KCDYPPLPADHYS 234

Query: 317 EKVLHLGLLCAHPEANSRPTIRQVL 341
           E++  L   C +P+   RP I  VL
Sbjct: 235 EELRDLVSRCINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 59.4 bits (144), Expect = 7e-10
 Identities = 37/134 (27%), Positives = 68/134 (50%), Gaps = 14/134 (10%)

Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC-KKEKESLILIYDYMENG 194
           G  VA+K++   +   +R+F  E+  L  L+H N+V  +G C    + +L L+ +Y+  G
Sbjct: 33  GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92

Query: 195 SLDKWIFE----CDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK 250
           SL  ++ +     D    L +  +I        G+ YL      + +HRD+   N+L++ 
Sbjct: 93  SLRDYLQKHRERLDHRKLLLYASQI------CKGMEYLGS---KRYVHRDLATRNILVES 143

Query: 251 KMNARLGDFGLAKM 264
           +   ++GDFGL K+
Sbjct: 144 ENRVKIGDFGLTKV 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 58.9 bits (143), Expect = 7e-10
 Identities = 50/151 (33%), Positives = 74/151 (49%), Gaps = 13/151 (8%)

Query: 119 NVIGLGGNGKVYKGQLL--GVEVALKRISL-DSEHGMREFLA-EVSSLGRLKHRNLVGLR 174
           N IG G  GKVY    L  G  +A+K I + D++    + +A E+  L  LKH NLV   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVL-KDVASGILYLYEGWE 233
           G  +  +E + +  +Y   G+L     E  E   +  E  I+V    +  G+ YL+    
Sbjct: 66  G-VEVHREKVYIFMEYCSGGTL----EELLEHGRILDEHVIRVYTLQLLEGLAYLHS--- 117

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
             ++HRDIK +N+ LD     +LGDFG A  
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVK 148

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 26/155 (16%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRISLDS-EHGMREFLAEVSSLGRLKH---RNLVGL 173
           +IG G  G VY+G+    G  VALK I+LD+ +  + +   EV+ L +L+     N+   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK------VLKDVASGILY 227
            G    +   L +I +Y E GS+            L     I       ++++V   + Y
Sbjct: 68  YG-SYLKGPRLWIIMEYAEGGSV----------RTLMKAGPIAEKYISVIIREVLVALKY 116

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           +++     V+HRDIKA+N+L+    N +L DFG+A
Sbjct: 117 IHK---VGVIHRDIKAANILVTNTGNVKLCDFGVA 148

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 23/162 (14%)

Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           +G G  GKV+  +   +        VA+K +   SE   ++F  E   L  L+H+++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 174 RGWCKKEKESLILIYDYMENGSLDKW---------IFECDESIA---LSWEQRIKVLKDV 221
            G C  E   L+++++YM +G L+++         I    E +A   L+  Q + +   +
Sbjct: 73  YGVCT-EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 222 ASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           ASG++YL        +HRD+   N L+ + +  ++GDFG+++
Sbjct: 132 ASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 58.8 bits (142), Expect = 1e-09
 Identities = 44/151 (29%), Positives = 74/151 (49%), Gaps = 21/151 (13%)

Query: 129 VYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY 188
           V KG+ L V V + R    +++   +FL EV  L RLK  N++ L G C  E + L +I 
Sbjct: 41  VRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDE-DPLCMIT 98

Query: 189 DYMENGSLDKWI----------------FECDESIALSWEQRIKVLKDVASGILYLYEGW 232
           +YMENG L++++                       A+S+   + V   +ASG+ YL    
Sbjct: 99  EYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-- 156

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               +HRD+   N L+ + +  ++ DFG+++
Sbjct: 157 -LNFVHRDLATRNCLVGENLTIKIADFGMSR 186

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 21/153 (13%)

Query: 120 VIGLGGNGKVYK------GQLLGVEVALK--RISLDSEHGMREFLAEVSSLGRLKHRNLV 171
           V+G G  G V K      G++    VA+K  + S D E   +  L EV  L +L+H N+V
Sbjct: 8   VVGEGAYGVVLKCRNKATGEI----VAIKKFKESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA-LSWEQRIKVLKDVASGILYLYE 230
            L+   +++   L L+++Y+E   L+      + S   L  +     +  +   I Y + 
Sbjct: 64  NLKEAFRRKGR-LYLVFEYVERTLLE----LLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
                ++HRDIK  N+L+ +    +L DFG A+
Sbjct: 119 ---HNIIHRDIKPENILVSESGVLKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 41/141 (29%), Positives = 72/141 (51%), Gaps = 13/141 (9%)

Query: 137 VEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS 195
           V VA+K +  D+    R +FL E+  + RLK  N++ L   C    + L +I +YMENG 
Sbjct: 47  VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI-TSDPLCMITEYMENGD 105

Query: 196 LDKWI--------FECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVL 247
           L++++         E  + + +S+   I +   +ASG+ YL        +HRD+   N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCL 162

Query: 248 LDKKMNARLGDFGLAKMHHHG 268
           + K    ++ DFG+++  + G
Sbjct: 163 VGKNYTIKIADFGMSRNLYSG 183

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 24/179 (13%)

Query: 119 NVIGLGGNGKVYKGQL----LGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKHR-NLVG 172
           +VIG G  G+V K ++    L ++ A+KR+    S+   R+F  E+  L +L H  N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKW-----IFECDESIA--------LSWEQRIKVLK 219
           L G C+  +  L L  +Y  +G+L  +     + E D + A        LS +Q +    
Sbjct: 61  LLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH-HGQVMSGRRPI 277
           DVA G+ YL +    + +HRD+ A N+L+ +   A++ DFGL++    + +   GR P+
Sbjct: 120 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 175

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 47/153 (30%), Positives = 82/153 (53%), Gaps = 13/153 (8%)

Query: 121 IGLGGNGKVYKGQLLG--VEVALK--RISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           IG G  G+V+ G+L      VA+K  R +L  +   + FL E   L +  H N+V L G 
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 61

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK- 235
           C  +K+ + ++ + ++ G  D   F   E   L  ++ I+++++ A+G+ YL    ESK 
Sbjct: 62  CT-QKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYL----ESKH 114

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
            +HRD+ A N L+ +K   ++ DFG+++    G
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 41/136 (30%), Positives = 76/136 (55%), Gaps = 8/136 (5%)

Query: 129 VYKGQLLGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI 187
           VYK +   ++VA+K +  ++E  +R E + E   + +L +  +V + G C  E E+L+L+
Sbjct: 15  VYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC--EAEALMLV 72

Query: 188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVL 247
            +    G L+K++    + I +S    ++++  V+ G+ YL        +HRD+ A NVL
Sbjct: 73  MEMASGGPLNKFLSGKKDEITVS--NVVELMHQVSMGMKYLEG---KNFVHRDLAARNVL 127

Query: 248 LDKKMNARLGDFGLAK 263
           L  +  A++ DFGL+K
Sbjct: 128 LVNQHYAKISDFGLSK 143

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 48/153 (31%), Positives = 80/153 (52%), Gaps = 17/153 (11%)

Query: 121 IGLGGNGKVY------KGQLLGVEVALKRISLDSEHG---MREFLAEVSSLGRLKHRNLV 171
           +G G  GKV       +G   G +VA+K  SL  E G   + +   E+  L  L H N+V
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 172 GLRGWCKKEKESLI-LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
             +G C ++  + I LI +++ +GSL +++      I L  +Q++K    +  G+ YL  
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDYL-- 125

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               + +HRD+ A NVL++ +   ++GDFGL K
Sbjct: 126 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 40/145 (27%), Positives = 75/145 (51%), Gaps = 8/145 (5%)

Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +          FL E   + +L+H  LV L  +   
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 70

Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126

Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+ + +  ++ DFGLA++
Sbjct: 127 DLRAANILVGENLVCKVADFGLARL 151

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 53/208 (25%), Positives = 100/208 (48%), Gaps = 35/208 (16%)

Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIF-------------ECDESIALSWEQRIK 216
           ++ L G C ++   L +I +Y   G+L +++                     LS++  + 
Sbjct: 86  IINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 217 VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH----GQVMS 272
               VA G+ YL      K +HRD+ A NVL+ +    ++ DFGLA+  HH     +  +
Sbjct: 145 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201

Query: 273 GRRPIE-EGKRNLVDRMWSLTERSELLS 299
           GR P++      L DR++  T +S++ S
Sbjct: 202 GRLPVKWMAPEALFDRIY--THQSDVWS 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 45/146 (30%), Positives = 79/146 (54%), Gaps = 9/146 (6%)

Query: 121 IGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G      +VA+K +   +   ++ FL E + +  L+H  LV L     K
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72

Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLH 238
           E E + +I +YM  GSL  ++ + DE   +   + I     +A G+ Y+    E K  +H
Sbjct: 73  E-EPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYI----ERKNYIH 126

Query: 239 RDIKASNVLLDKKMNARLGDFGLAKM 264
           RD++A+NVL+ + +  ++ DFGLA++
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARV 152

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 26/158 (16%)

Query: 120 VIGLGGNGKVYKG------QLLGVEVALKRISLDSEHGMR---EFLAEVSSLGRLKHRNL 170
           V+G G  G VYKG      + + + VA+K   L+   G +   EF+ E   +  + H +L
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIK--ILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVASGIL 226
           V L G C     ++ L+   M +G L  ++ E  ++I     L+W  +I      A G++
Sbjct: 72  VRLLGVCLSP--TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMM 123

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           YL E    +++HRD+ A NVL+    + ++ DFGLA++
Sbjct: 124 YLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARL 158

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 56.8 bits (138), Expect = 5e-09
 Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 29/170 (17%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRIS---LDSEHGMREFLAEVSSLGRLK-HR 168
           F    +IG G    V   +      E A+K +    L  E  ++    E   L RL  H 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDV 221
            ++ L  +  +++E+L  + +Y  NG L ++I        +C    A    + +  L+ +
Sbjct: 63  GIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAA---EILLALEYL 118

Query: 222 AS-GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV 270
            S GI+           HRD+K  N+LLDK M+ ++ DFG AK+      
Sbjct: 119 HSKGII-----------HRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 9/150 (6%)

Query: 121 IGLGGNGK--VYKGQLLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           IG G  GK  + K +  G +  +K I++   S     E   EV+ L  +KH N+V  +  
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE- 66

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
             +E  +L ++ DY E G L K I      +    +Q +     +   + ++++    K+
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD---RKI 122

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAKMHH 266
           LHRDIK+ N+ L K    +LGDFG+A++ +
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLN 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 55.8 bits (134), Expect = 6e-09
 Identities = 42/152 (27%), Positives = 79/152 (51%), Gaps = 10/152 (6%)

Query: 120 VIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVGLRGWC 177
           ++G G  G+V+KG L     VA+K    D    ++ +FL+E   L +  H N+V L G C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-V 236
             +++ + ++ + +  G    ++ +  + +    +Q +K   D A+G+ YL    ESK  
Sbjct: 62  T-QRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYL----ESKNC 114

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
           +HRD+ A N L+ +    ++ DFG+++    G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 56.0 bits (135), Expect = 8e-09
 Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 21/157 (13%)

Query: 120 VIGLGGNGKVY------KGQLLGV-EVALKRISLDSEH----GMREFL-AEVSSLGRLKH 167
           +IG G  G+VY       G+++ V +V L              M + L +E+ +L  L H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGIL 226
            N+V   G  +  +E L +  +Y+  GS    I  C  +     EQ ++   + V  G+ 
Sbjct: 68  LNIVQYLG-FETTEEYLSIFLEYVPGGS----IGSCLRTYGRFEEQLVRFFTEQVLEGLA 122

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           YL+      +LHRD+KA N+L+D     ++ DFG++K
Sbjct: 123 YLHS---KGILHRDLKADNLLVDADGICKISDFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.1 bits (135), Expect = 9e-09
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 12/147 (8%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLA--EVSSLGRLKHRNLVGLRGW 176
           +G G    VYKG  ++ G  VALK IS+ +E G+  F A  E S L  LKH N+V L   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
               KE+L  +++YM    L +++ +    +   +  R+ + + +  G+ Y++      +
Sbjct: 72  IHT-KETLTFVFEYMHT-DLAQYMIQHPGGLH-PYNVRLFMFQ-LLRGLAYIH---GQHI 124

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAK 263
           LHRD+K  N+L+      +L DFGLA+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 55.8 bits (135), Expect = 9e-09
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 25/155 (16%)

Query: 121 IGLGGNGKVYK------GQLLGVEVALKRI--SLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           IG G  G V+K      GQ+    VA+K+   S D     +  L E+  L +LKH NLV 
Sbjct: 9   IGEGSYGVVFKCRNRETGQI----VAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVN 64

Query: 173 LRGWCKKEKESLILIYDYMEN---GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           L    ++ K  L L+++Y ++     L+K      E          K++      + + +
Sbjct: 65  LIEVFRR-KRKLHLVFEYCDHTVLNELEKNPRGVPE------HLIKKIIWQTLQAVNFCH 117

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           +      +HRD+K  N+L+ K+   +L DFG A++
Sbjct: 118 K---HNCIHRDVKPENILITKQGQIKLCDFGFARI 149

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 55.7 bits (134), Expect = 9e-09
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 30/165 (18%)

Query: 112 TKGFSEENVIGLGGNGKVY-----KGQLLGVEVALKRISLD------SEHGMREFLAEVS 160
           TKG     V+G G  G VY     +GQL    +A+K++ LD      +E    +   EV 
Sbjct: 3   TKG----EVLGKGAYGTVYCGLTNQGQL----IAVKQVELDTSNVLAAEKEYEKLQEEVD 54

Query: 161 SLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWI--FECDESIALSWEQRIKVL 218
            L  LKH N+V   G C  +  ++ +  +++  GS+   +  F              K  
Sbjct: 55  LLKSLKHVNIVQYLGTCLDDN-TISIFMEFVPGGSISSILNRFGPLPEPVFC-----KYT 108

Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           K +  G+ YL+    + V+HRDIK +NV+L      +L DFG A+
Sbjct: 109 KQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 40/165 (24%), Positives = 79/165 (47%), Gaps = 28/165 (16%)

Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           +G G  GKV+  +   +        VA+K +   +    ++F  E   L  L+H ++V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWI---------------FECDESIALSWEQRIKVL 218
            G C  + + LI++++YM++G L+K++                +    + LS  Q + + 
Sbjct: 73  YGVCG-DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS--QMLHIA 129

Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             +ASG++YL        +HRD+   N L+   +  ++GDFG+++
Sbjct: 130 SQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 43/148 (29%), Positives = 74/148 (50%), Gaps = 19/148 (12%)

Query: 121 IGLGGNGKVYKG---------QLLGVEVALKRISLDSEHG--MREFLAEVSSLGRLKHRN 169
           +G G   K++KG         +L   EV LK   LD  H      F    S + +L H++
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLK--VLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           LV   G C    ES I++ +Y++ GSLD ++ +    I +SW  +++V K +A  + +L 
Sbjct: 61  LVLNYGVCVCGDES-IMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE 117

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLG 257
              +  + H ++ A NVLL ++ + + G
Sbjct: 118 ---DKGLTHGNVCAKNVLLIREEDRKTG 142

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 67/255 (26%), Positives = 115/255 (45%), Gaps = 40/255 (15%)

Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+V+ G   G  +VA+K  +L     M E FL E   + +L+H  LV L  +  
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIK--TLKPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAV 69

Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLH 238
             +E + ++ ++M  GSL  ++ E D    L   Q + +   +A G+ Y+        +H
Sbjct: 70  VSEEPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIER---MNYIH 125

Query: 239 RDIKASNVLLDKKMNARLGDFGLAKM---HHHGQVMSGRRPIE--------EGKRNLVDR 287
           RD++A+N+L+   +  ++ DFGLA++   + +      + PI+         G+  +   
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 288 MWSL-TERSELLSVLDERLKAKGGYADEVVEKV---------------LH-LGLLCAHPE 330
           +WS     +EL  V   R+   G    EV+E+V               LH L  LC   +
Sbjct: 186 VWSFGILLTEL--VTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKD 243

Query: 331 ANSRPTIRQVLKMLE 345
            + RPT   +   LE
Sbjct: 244 PDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 43/163 (26%), Positives = 78/163 (47%), Gaps = 28/163 (17%)

Query: 119 NVIGLGGNGKVYKGQ--LLGVEVALKRISL----DSEHGMREF----------LAEVSSL 162
             +G G  GKV K    L G  VA+K++ +    +     R+           L E+  +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 163 GRLKHRNLVGLRG-WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKD 220
             +KH N++GL   +   E + + L+ D M    L K +   D  I L+ E ++K +L  
Sbjct: 75  NEIKHENIMGLVDVYV--EGDFINLVMDIMA-SDLKKVV---DRKIRLT-ESQVKCILLQ 127

Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           + +G+  L++      +HRD+  +N+ ++ K   ++ DFGLA+
Sbjct: 128 ILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 14/152 (9%)

Query: 120 VIGLGGNGKVY--KGQLLGVEVALKRISLDSE--HGMREFLA---EVSSLGRLKHRNLVG 172
           ++G G  G+VY       G E+A+K++  D E     +E  A   E+  L  L H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 173 LRGWCKKEKESLILIY-DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
             G  +   E  + I+ ++M  GS+     +     AL+     K  + +  G+ YL+  
Sbjct: 69  YYGCLRDPMERTLSIFMEHMPGGSIKD---QLKSYGALTENVTRKYTRQILEGVSYLHS- 124

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             + ++HRDIK +N+L D   N +LGDFG +K
Sbjct: 125 --NMIVHRDIKGANILRDSVGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 14/152 (9%)

Query: 120 VIGLGGNGKVY--KGQLLGVEVALKRISLD--SEHGMREFLA---EVSSLGRLKHRNLVG 172
           ++G G  G+VY       G E+A+K++  D  S+   +E  A   E+  L  L+H  +V 
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 173 LRGWCKKEKESLILIY-DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
             G  +  +E  + I+ +YM  GS+     +     AL+     +  + +  G+ YL+  
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKD---QLKAYGALTENVTRRYTRQILQGVSYLHS- 124

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             + ++HRDIK +N+L D   N +LGDFG +K
Sbjct: 125 --NMIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 40/145 (27%), Positives = 75/145 (51%), Gaps = 8/145 (5%)

Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +          FL E   + +L+H  LV L  +   
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQL--YAVV 70

Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ +  E  AL     + +   VA+G+ Y+        +HR
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHR 126

Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++++N+L+   +  ++ DFGLA++
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARL 151

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 16/154 (10%)

Query: 113 KGFSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           K ++    IG G +G V+       G EVA+K+I+L  +      + E+  +  LK+ N+
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78

Query: 171 VG-LRGWCKKEKESLILIYDYMENGSLDKWIFEC--DESIALSWEQRIKVLKDVASGILY 227
           V  L  +   ++  L ++ +Y+  GSL   + E   DE+      Q   V ++    + +
Sbjct: 79  VNFLDSFLVGDE--LFVVMEYLAGGSLTDVVTETCMDEA------QIAAVCRECLQALEF 130

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL 261
           L+    ++V+HRDIK+ NVLL    + +L DFG 
Sbjct: 131 LHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 70/277 (25%), Positives = 126/277 (45%), Gaps = 59/277 (21%)

Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLV 171
           +G G  G+V K + +G++       VA+K +  D +E  + + ++E+  +  + KH+N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKD---- 220
            L G C +E   L ++ +Y  +G+L  ++                  E+ +   KD    
Sbjct: 80  NLLGVCTQEG-PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT-QKDLVSF 137

Query: 221 ---VASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH----GQVMSG 273
              VA G+ +L      K +HRD+ A NVL+ +    ++ DFGLA+  HH     +  +G
Sbjct: 138 AYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194

Query: 274 RRPIE-EGKRNLVDRMWSLTERSELLS--VLDERLKAKGG--YADEVVEK---------- 318
           R P++      L DR++  T +S++ S  VL   +   GG  Y    VE+          
Sbjct: 195 RLPVKWMAPEALFDRVY--THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR 252

Query: 319 ----------VLHLGLLCAHPEANSRPTIRQVLKMLE 345
                     + HL   C H   + RPT +Q+++ L+
Sbjct: 253 MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 47/171 (27%), Positives = 85/171 (49%), Gaps = 19/171 (11%)

Query: 118 ENVIGLGGNGKVYKGQL-------LGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           E ++G G  G++ +G L       L V +   R    S+   R FLAE  +LG+  H N+
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNI 68

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
           V L G   +   +++++ +YM NG+LD ++ + +  +     Q + +L  +ASG+ YL E
Sbjct: 69  VRLEGVITR-GNTMMIVTEYMSNGALDSFLRKHEGQLVAG--QLMGMLPGLASGMKYLSE 125

Query: 231 -GWESKVLHRDIKASNVLLDKKMNARLGDFGLA---KMHHHGQVMSGRRPI 277
            G+    +H+ + A  VL++  +  ++  F      K       MSG+ P+
Sbjct: 126 MGY----VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPV 172

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 41/164 (25%), Positives = 77/164 (46%), Gaps = 18/164 (10%)

Query: 114 GFSEENVIGLGGNGKVYKGQLLGVE-------VALKRI-SLDSEHGMREFLAEVSSLGRL 165
              E   +G G  G+V+  +  G+E       V +K +     E+   EF  E+    +L
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 166 KHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWI------FECDESIALSWEQRIKVLK 219
            H+N+V L G C +E E   +I +Y + G L +++       E  +   LS +Q++ +  
Sbjct: 66  SHKNVVRLLGLC-REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124

Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +A G+ +L     ++ +HRD+ A N L+  +   ++    L+K
Sbjct: 125 QIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK 165

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 54.5 bits (131), Expect = 2e-08
 Identities = 46/160 (28%), Positives = 81/160 (50%), Gaps = 28/160 (17%)

Query: 120 VIGLGGNGKVY------KGQLLGV-EVALKRISLDSEHGMREFLA----EVSSLGRLKHR 168
           +IG G  G VY       G+L+ V +V L  +S  S+   R  L     E++ L  L+H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGS----LDKW-IFECDESIALSWEQRIKVLKDVAS 223
           N+V   G    + + L +  +Y+  GS    L+ +  FE  E++  ++      ++ +  
Sbjct: 67  NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFE--ETLVRNF------VRQILK 117

Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           G+ YL+      ++HRDIK +N+L+D K   ++ DFG++K
Sbjct: 118 GLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK 154

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 14/152 (9%)

Query: 120 VIGLGGNGKVYKGQLL--GVEVALKRISLDSE--HGMREFLA---EVSSLGRLKHRNLVG 172
           ++G G  G+VY    +  G E+A K++  D E     +E  A   E+  L  L+H  +V 
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 173 LRGWCKKEKESLILIY-DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
             G  +   E  + I+ +YM  GS+     +     AL+     K  + +  G+ YL+  
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKD---QLKAYGALTESVTRKYTRQILEGMSYLHS- 124

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             + ++HRDIK +N+L D   N +LGDFG +K
Sbjct: 125 --NMIVHRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 54.9 bits (133), Expect = 3e-08
 Identities = 45/138 (32%), Positives = 67/138 (48%), Gaps = 28/138 (20%)

Query: 139 VALKRI------SLDSEHGMRE--FLAEVSSLGRLKHRNLVGLRGWCKKEKESLI-LIYD 189
           VALK+I      + D++   RE  FL E+       H N+V L    K E +  I L+++
Sbjct: 35  VALKKIFDAFRNATDAQRTFREIMFLQELG-----DHPNIVKLLNVIKAENDKDIYLVFE 89

Query: 190 YME---NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNV 246
           YME   +  +   I E      + + Q +K LK + SG           V+HRD+K SN+
Sbjct: 90  YMETDLHAVIRANILEDVHKRYIMY-QLLKALKYIHSG----------NVIHRDLKPSNI 138

Query: 247 LLDKKMNARLGDFGLAKM 264
           LL+     +L DFGLA+ 
Sbjct: 139 LLNSDCRVKLADFGLARS 156

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 53/206 (25%), Positives = 104/206 (50%), Gaps = 31/206 (15%)

Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + LG++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E    IA   ++++   KD+ 
Sbjct: 83  IINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM-TFKDLV 140

Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGR 274
           S    +  G E     K +HRD+ A NVL+ +    ++ DFGLA+    + ++ +  +GR
Sbjct: 141 SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGR 200

Query: 275 RPIE-EGKRNLVDRMWSLTERSELLS 299
            P++      L DR++  T +S++ S
Sbjct: 201 LPVKWMAPEALFDRVY--THQSDVWS 224

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 44/146 (30%), Positives = 76/146 (52%), Gaps = 12/146 (8%)

Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMRE--FLAEVSSLGRLKHRNLVGLRGWC 177
           +G G  G V+ G+    ++VA+K I+   E  M E  F+ E   + +L H  LV L G C
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
            ++K  L ++ ++MENG L  ++ +      LS +  + + +DV  G+ YL     +  +
Sbjct: 69  TQQK-PLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLER---NSFI 122

Query: 238 HRDIKASNVLLDKKMNARLGDFGLAK 263
           HRD+ A N L+      ++ DFG+ +
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 17/152 (11%)

Query: 120 VIGLGGNGKVY------KGQLLGVEVALKRISLDSEHGMREFLAEVSSL-GRLKHRNLVG 172
           VIG G  GKV        G+   V+V  K+  L  +   +  +AE + L   +KH  LVG
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKE-QKHIMAERNVLLKNVKHPFLVG 60

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLK-DVASGILYLYEG 231
           L  +  +  + L  + DY+  G L    F      +   E R +    ++AS + YL+  
Sbjct: 61  LH-YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFP-EPRARFYAAEIASALGYLHS- 114

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               +++RD+K  N+LLD + +  L DFGL K
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 40/151 (26%), Positives = 71/151 (47%), Gaps = 15/151 (9%)

Query: 121 IGLGGNGKVYKGQL-LGVEVA------LKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           IG G  GKV  G+   G+  A      L+  +   E     FL EV     L H N++  
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVLQC 60

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI--KVLKDVASGILYLYEG 231
            G C  E    +L+ ++   G L  ++      +A   ++ +  ++  +VASG+L+L++ 
Sbjct: 61  LGQCI-ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ- 118

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             +  +H D+   N  L   ++ ++GD+GLA
Sbjct: 119 --ADFIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 32/110 (29%), Positives = 59/110 (53%), Gaps = 6/110 (5%)

Query: 155 FLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR 214
           FLAE + +  L+H  LV L     KE   + +I ++M  GSL  ++ + DE       + 
Sbjct: 48  FLAEANVMKTLQHDKLVKLHAVVTKE--PIYIITEFMAKGSLLDFL-KSDEGSKQPLPKL 104

Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           I     +A G+ ++ +      +HRD++A+N+L+   +  ++ DFGLA++
Sbjct: 105 IDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARV 151

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 53.4 bits (128), Expect = 6e-08
 Identities = 68/279 (24%), Positives = 129/279 (46%), Gaps = 61/279 (21%)

Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V + +  G++         VA+K +  + ++  + + ++E+  +  + KH+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-----------FECDESIA--LSWEQRIK 216
           ++ L G C +E   L +I +Y   G+L +++           F+  +     LS++  + 
Sbjct: 80  IINLLGVCTQEG-PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 217 VLKDVASGILYLYEGWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKMHHH----GQVM 271
               VA G+ YL    ES+  +HRD+ A NVL+ +    ++ DFGLA+  H      +  
Sbjct: 139 CAYQVARGMEYL----ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194

Query: 272 SGRRPIE-EGKRNLVDRMWSLTERSELLS--VLDERLKAKGG--YADEVVEKVLHL---- 322
           +GR P++      L DR++  T +S++ S  +L   +   GG  Y    VE++  L    
Sbjct: 195 NGRLPVKWMAPEALFDRVY--THQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG 252

Query: 323 --------------GLL--CAHPEANSRPTIRQVLKMLE 345
                          L+  C H     RPT +Q+++ L+
Sbjct: 253 HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 24/158 (15%)

Query: 113 KGFSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           K ++    IG G +G VY       G EVA+K+++L  +      + E+  +   KH N+
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI 78

Query: 171 VG-----LRGWCKKEKESLILIYDYMENGSLDKWIFEC--DESIALSWEQRIKVLKDVAS 223
           V      L G      + L ++ +Y+  GSL   + E   DE       Q   V ++   
Sbjct: 79  VNYLDSYLVG------DELWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQ 126

Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL 261
            + +L+    ++V+HRDIK+ N+LL    + +L DFG 
Sbjct: 127 ALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 52.7 bits (126), Expect = 9e-08
 Identities = 47/158 (29%), Positives = 84/158 (53%), Gaps = 19/158 (12%)

Query: 121 IGLGGNGKVYKGQLL---GVEVALKRISLD-SEHGM-----REFLAEVSSLGRLKHRNLV 171
           IG G  GKV+K + L   G  VALKR+ +   E GM     RE +A +  L   +H N+V
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFEHPNVV 67

Query: 172 GLRGWC---KKEKES-LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
            L   C   + ++E+ L L++++++   L  ++ +  E   +  E    ++  +  G+ +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDF 125

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
           L+     +V+HRD+K  N+L+      +L DFGLA+++
Sbjct: 126 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 31/114 (27%), Positives = 62/114 (54%), Gaps = 8/114 (7%)

Query: 155 FLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC-----DESIAL 209
            L E   L  L H+N++ +   C ++ E   ++Y YM  G+L  ++ +C     +   AL
Sbjct: 55  LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114

Query: 210 SWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           S +Q + +   +A G+ YL++     V+H+DI A N ++D+++  ++ D  L++
Sbjct: 115 STQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSR 165

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 45/157 (28%), Positives = 76/157 (48%), Gaps = 14/157 (8%)

Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
            ++  L G C     ++ LI   M  G L  ++ E  ++I   +     V   +A G+ Y
Sbjct: 69  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV--QIAKGMNY 124

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           L E    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 125 LEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 20/152 (13%)

Query: 118 ENVIGLGGNGKVYK------GQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
           + ++G G  G VYK       ++L V+V    I+++ +   ++ ++E+  L +     ++
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQ---KQIMSELEILYKCDSPYII 62

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
           G  G    E   + +  ++M+ GSLD +       I      RI V   V  G+ YL   
Sbjct: 63  GFYGAFFVENR-ISICTEFMDGGSLDVY-----RKIPEHVLGRIAVA--VVKGLTYL--- 111

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           W  K+LHRD+K SN+L++ +   +L DFG++ 
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVST 143

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 37/149 (24%), Positives = 72/149 (48%), Gaps = 11/149 (7%)

Query: 121 IGLGGNGKVYKGQ----LLGVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRG 175
           IG G  GKV  G+        +V +K + +  S     +FL E      L+H NL+   G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI--KVLKDVASGILYLYEGWE 233
            C  E    +L+ ++   G L  ++  C ++  ++ +     ++  ++A G+L+L++   
Sbjct: 63  QCT-EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--- 118

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           +  +H D+   N LL   +  ++GD+GL+
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 42/133 (31%), Positives = 63/133 (47%), Gaps = 17/133 (12%)

Query: 137 VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS 195
           + VA+K +  D     M +FL E + +  L H NL+ L G        L+++ +    GS
Sbjct: 24  IPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTH--PLMMVTELAPLGS 81

Query: 196 LDKWIFECDESIALSWEQRIKVLKD----VASGILYLYEGWESK-VLHRDIKASNVLLDK 250
           L     +     AL     I  L D    +A+G+ YL    ESK  +HRD+ A N+LL  
Sbjct: 82  L----LDRLRKDALG-HFLISTLCDYAVQIANGMRYL----ESKRFIHRDLAARNILLAS 132

Query: 251 KMNARLGDFGLAK 263
               ++GDFGL +
Sbjct: 133 DDKVKIGDFGLMR 145

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 42/152 (27%), Positives = 75/152 (49%), Gaps = 19/152 (12%)

Query: 120 VIGLGGNGKVYK------GQLLGVEVALKRI--SLDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++G G  G V K      GQ+    VA+K+   S D +   +  + E+  L +L+H NLV
Sbjct: 8   LVGEGSYGMVMKCKHKETGQI----VAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLV 63

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L    +++K  L L+++++++  LD      +    L   +  K L  +  GI + +  
Sbjct: 64  NLIEVFRRKKR-LYLVFEFVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHS- 118

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               ++HRDIK  N+L+ +    +L DFG A+
Sbjct: 119 --HNIIHRDIKPENILVSQSGVVKLCDFGFAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 27/157 (17%)

Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGL 173
            IG G  G VY+G  +      + VA+K     +   +RE FL E   + +  H ++V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE--- 230
            G     +  + ++ +    G L  ++            Q  K   D+AS ILY Y+   
Sbjct: 73  IGVI--TENPVWIVMELAPLGELRSYL------------QVNKYSLDLASLILYSYQLST 118

Query: 231 ---GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
                ESK  +HRDI A NVL+      +LGDFGL++
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 41/145 (28%), Positives = 72/145 (49%), Gaps = 6/145 (4%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
           +G G  G VYK   +  GV +A+K I L+  E    + + E+  L +     +V   G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
             E  ++ +  +YM+ GSLDK       +  +  +   ++   V  G+ +L E  E  ++
Sbjct: 69  FIEG-AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNII 125

Query: 238 HRDIKASNVLLDKKMNARLGDFGLA 262
           HRD+K +NVL++     +L DFG++
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 36/157 (22%), Positives = 72/157 (45%), Gaps = 26/157 (16%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRISL------DSEHGMREFLAEVSSLGRLKHRNLV 171
            +G G     Y+ +    G  +A+K+++       + E  +     E+  + RL H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWI-----FECDESIALSWEQRIKVLKDVASGIL 226
            + G    E     L  ++M  GS+   +     F+  E++       I   + +  G+ 
Sbjct: 67  RMLG-ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFK--EAVI------INYTEQLLRGLS 117

Query: 227 YLYEGWESKVLHRDIKASNVLLDKK-MNARLGDFGLA 262
           YL+E   ++++HRD+K +N+L+D      R+ DFG A
Sbjct: 118 YLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAA 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 50/147 (34%), Positives = 72/147 (48%), Gaps = 12/147 (8%)

Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLA--EVSSLGRLKHRNLVGLRGW 176
           +G G    VYKG+  + G  VALK I L  E G   F A  E S L  LKH N+V L   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKGLKHANIVLLHDI 71

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
               KE+L L+++Y+     D   +       L  E     L  +  G+ Y+++ +   +
Sbjct: 72  IHT-KETLTLVFEYVHT---DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAK 263
           LHRD+K  N+L+      +L DFGLA+
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 15/24 (62%), Positives = 19/24 (79%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFS 24
           ++VGFSA TG   ESH +L+WSFS
Sbjct: 208 VYVGFSASTGGATESHYVLSWSFS 231

Length = 231

>gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

 Score = 51.1 bits (123), Expect = 3e-07
 Identities = 16/26 (61%), Positives = 21/26 (80%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNS 26
           ++VGFSA TG L E H IL+WSFS++
Sbjct: 210 VYVGFSASTGLLTELHYILSWSFSSN 235

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 50/152 (32%), Positives = 70/152 (46%), Gaps = 17/152 (11%)

Query: 120 VIGLGGNGKVY------KGQLLGVEVALKRISLDSEHGMREFLAEVSSLGR-LKHRNLVG 172
           VIG G  GKV        G    V+V  K+  L  +      +AE + L + LKH  LVG
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVG 60

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLK-DVASGILYLYEG 231
           L  +  +  E L  + DY+  G L    F          E R +    +VAS I YL+  
Sbjct: 61  LH-YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFL-EPRARFYAAEVASAIGYLHS- 114

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               +++RD+K  N+LLD + +  L DFGL K
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 65/278 (23%), Positives = 127/278 (45%), Gaps = 59/278 (21%)

Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D ++  + + ++E+  +  + KH+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFE-----CDESI--------ALSWEQRIK 216
           ++ L G C ++    +L+ +Y   G+L +++        D S          L+++  + 
Sbjct: 80  IINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 217 VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMS 272
               VA G+ YL      K +HRD+ A NVL+ +    ++ DFGLA+    + ++ +  +
Sbjct: 139 CAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Query: 273 GRRPIE-EGKRNLVDRMWSLTERSELLS--VLDERLKAKGG--YADEVVEKVLHL----- 322
           GR P++      L DR++  T +S++ S  VL   +   GG  Y    VE++  L     
Sbjct: 196 GRLPVKWMAPEALFDRVY--THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGH 253

Query: 323 ---------------GLLCAHPEANSRPTIRQVLKMLE 345
                             C H   + RPT +Q+++ L+
Sbjct: 254 RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 45/149 (30%), Positives = 80/149 (53%), Gaps = 14/149 (9%)

Query: 121 IGLGGNGKVYKG--QLLGVE--VALKRISLDSEHGM--REFLAEVSSLGRLKHRNLVGLR 174
           +G G  G V KG  ++   E  VA+K +  D+       E L E + + +L +  +V + 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
           G C  E ES +L+ +  E G L+K++    ++  ++ +   +++  V+ G+ YL E   +
Sbjct: 63  GIC--EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEE---T 114

Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             +HRD+ A NVLL  +  A++ DFGL+K
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSK 143

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 46/161 (28%), Positives = 72/161 (44%), Gaps = 11/161 (6%)

Query: 114 GFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           GF E   + +   GK+Y  +       L +  L  + G +  L E   L ++    +V L
Sbjct: 5   GFGEVCAVQVKNTGKMYACK------KLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL 58

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
             +  + K  L L+   M  G L   I+   E   L  E+ I     +  GIL+L+    
Sbjct: 59  -AYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHS--- 113

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGR 274
             +++RD+K  NVLLD + N RL D GLA     G+ ++ R
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR 154

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 65/263 (24%), Positives = 108/263 (41%), Gaps = 39/263 (14%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRIS---LDSEHGMREFLAEVSSLGRLKHRN 169
           F  E  IG G   +VY+   L  GV VALK++    L       + + E+  L +L H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYL 228
           ++       ++ E L ++ +  + G L + I    +   L  E+ + K    + S + ++
Sbjct: 64  VIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH------HGQV-----MSGRRPI 277
           +     +V+HRDIK +NV +      +LGD GL +         H  V     MS  R I
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER-I 178

Query: 278 EEGKRNLVDRMWSL---------------TERSELLSVLD--ERLKAKGGYADEVVEKVL 320
            E   N    +WSL                ++  L S+    E+       +D   E++ 
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238

Query: 321 HLGLLCAHPEANSRPTIRQVLKM 343
            L  +C +P+   RP I  V  +
Sbjct: 239 QLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 11/151 (7%)

Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
           F++   IG G  G+V+KG        VA+K I L+ +E  + +   E++ L +     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
              G   K+ + L +I +Y+  GS      +  E   L   Q   +L+++  G+ YL+  
Sbjct: 66  KYYGSYLKDTK-LWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS- 119

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
              K +HRDIKA+NVLL +    +L DFG+A
Sbjct: 120 --EKKIHRDIKAANVLLSEHGEVKLADFGVA 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 50.9 bits (122), Expect = 4e-07
 Identities = 50/166 (30%), Positives = 78/166 (46%), Gaps = 18/166 (10%)

Query: 120 VIGLGGNGKVYKGQLLG-------VEVALKRISLDSEHGMREFL-AEVSSLGRL-KHRNL 170
            +G G  GKV +    G       ++VA+K +   +    RE L +E+  +  L  H N+
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
           V L G C      +++I +Y   G L  ++    ES  L+ E  +     VA G+ +L  
Sbjct: 102 VNLLGACTIGG-PILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFL-- 157

Query: 231 GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAK--MHHHGQVMSG 273
              SK  +HRD+ A NVLL      ++ DFGLA+  M+    V+ G
Sbjct: 158 --ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKG 201

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 12/157 (7%)

Query: 113 KGFSEENVIGLGGNGKVY--KGQLLGVEVALKRISLD---SEHGMREFLAEVSSLGRLKH 167
           K F++   IG G  G VY  +       VA+K++S     S    ++ + EV  L +L+H
Sbjct: 15  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
            N +  +G C   + +  L+ +Y    + D  I E  +   L   +   +      G+ Y
Sbjct: 75  PNTIEYKG-CYLREHTAWLVMEYCLGSASD--ILEVHKK-PLQEVEIAAICHGALQGLAY 130

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           L+     + +HRDIKA N+LL +    +L DFG A +
Sbjct: 131 LHS---HERIHRDIKAGNILLTEPGTVKLADFGSASL 164

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 50.6 bits (121), Expect = 4e-07
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 16/153 (10%)

Query: 120 VIGLGGNGKVY--KGQLLGVEVALKRISLDSEHGMRE-----FLAEVSSLGRLKHRNLVG 172
           V+G G  G V+  + +     V +K+I +     M +        E   L  L H N++ 
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPV---EQMTKDERLAAQNECQVLKLLSHPNIIE 63

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
                 ++K +L+++ +Y   G+L ++I       +L  E  I  L      +L L+   
Sbjct: 64  YYENFLEDK-ALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTI--LHFFVQILLALHHVH 118

Query: 233 ESKVLHRDIKASNVLLDK-KMNARLGDFGLAKM 264
              +LHRD+K  N+LLDK KM  ++GDFG++K+
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKI 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 17/152 (11%)

Query: 120 VIGLGGNGKVY------KGQLLGVEVALKRISLDSEHGMREFLAEVSSLGR-LKHRNLVG 172
           VIG G  GKV        G+   V+V  K+I L+ +   +  +AE + L + +KH  LVG
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFLVG 60

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGILYLYEG 231
           L  +  +  E L  + D++  G L    F      +   E R +    ++AS + YL+  
Sbjct: 61  LH-YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFP-EPRARFYAAEIASALGYLHS- 114

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               +++RD+K  N+LLD + +  L DFGL K
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 50/162 (30%), Positives = 78/162 (48%), Gaps = 23/162 (14%)

Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGM--REFLAEVSSLGRLKHRNL 170
           +   + IG G  G V     +  GV+VA+K+IS   EH    +  L E+  L R KH N+
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHENI 65

Query: 171 VGLRGWCKKEK-ESLILIY---DYMENGSLDKWIFE---CDESIALSWEQRIKVLKDVAS 223
           +G+    +    ES   +Y   + ME   L K I      ++ I     Q ++ LK + S
Sbjct: 66  IGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHS 124

Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
                     + VLHRD+K SN+LL+   + ++ DFGLA++ 
Sbjct: 125 ----------ANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 50.8 bits (122), Expect = 6e-07
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 14/156 (8%)

Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS--LDSEHGMREFLAEVSSLGRLKHRNL 170
           +     IG G  G V        G +VA+K+I    D     +  L E+  L   KH N+
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66

Query: 171 VGLRGWCKKEKESLILIY---DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           + +R   +        +Y   D ME+  L   I   D+   L+ E     L  +  G+ Y
Sbjct: 67  IAIRDILRPPGADFKDVYVVMDLMES-DLHH-IIHSDQP--LTEEHIRYFLYQLLRGLKY 122

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           ++    + V+HRD+K SN+L+++    R+GDFG+A+
Sbjct: 123 IHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 49.8 bits (119), Expect = 7e-07
 Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 28/164 (17%)

Query: 115 FSEEN---VIGLGGNGKVYKGQLLG--VEVALKRISLDSEHGMREFLAEVSSLGRLKHRN 169
           + E     V+G G  G VY  + L   V +A+K I       ++    E++    LKHRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 170 LVGLRGWCKKEKESLILIYDYMEN---GSLD-----KWIFECDESIALSWEQRIKVL-KD 220
           +V   G   +     I    +ME    GSL      KW    D       EQ I    K 
Sbjct: 67  IVQYLGSDSENGFFKI----FMEQVPGGSLSALLRSKWGPLKDN------EQTIIFYTKQ 116

Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNA-RLGDFGLAK 263
           +  G+ YL++   ++++HRDIK  NVL++      ++ DFG +K
Sbjct: 117 ILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK 157

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 49.7 bits (118), Expect = 9e-07
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 27/159 (16%)

Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
           F++   IG G  G+V+KG        VA+K I L+ +E  + +   E++ L +     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 172 GLRG-WCKKEKESLILIY-------DYMENGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
              G + K  K  +I+ Y       D +  G  D++             Q   +LK++  
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEF-------------QIATMLKEILK 112

Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           G+ YL+     K +HRDIKA+NVLL ++ + +L DFG+A
Sbjct: 113 GLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVA 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 49.4 bits (118), Expect = 1e-06
 Identities = 32/122 (26%), Positives = 64/122 (52%), Gaps = 8/122 (6%)

Query: 130 YKGQLLGVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY 188
                 G EV++    L S+H     F    S + +L H++LV L G C +++   I++ 
Sbjct: 22  LDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN--IMVE 79

Query: 189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL 248
           +Y++ G LD ++     +++L W  ++ V K +AS + YL    + K++H ++   N+L+
Sbjct: 80  EYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE---DKKLVHGNVCGKNILV 134

Query: 249 DK 250
            +
Sbjct: 135 AR 136

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 44/148 (29%), Positives = 69/148 (46%), Gaps = 10/148 (6%)

Query: 121 IGLGGNGKVYKGQL--LGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
           +G GG G+V   Q+   G   A K+++   L    G    + E   L ++  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR-IKVLKDVASGILYLYEGWES 234
           +  + K  L L+   M  G L   I+  DE      E R       + SG+ +L++    
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---R 116

Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLA 262
           ++++RD+K  NVLLD   N R+ D GLA
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 43/170 (25%), Positives = 85/170 (50%), Gaps = 27/170 (15%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVE----VALKRIS-LDSEHGMREFLAEVSSLGRLKH 167
           F EE  +G    GK+YKG L   G++    VA+K +  +++     EF  E S +  L H
Sbjct: 9   FMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH 66

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIF----------ECDE----SIALSWEQ 213
            N+V L G   +E + + ++++Y+  G L +++             DE      +L    
Sbjct: 67  PNIVCLLGVVTQE-QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGD 125

Query: 214 RIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            + +   +A+G+ YL   +    +H+D+ A N+L+ ++++ ++ D GL++
Sbjct: 126 FLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 22/158 (13%)

Query: 117 EENVIGLGGNGKVYK--GQLLGVEVALKRISLDS-EHGMREFLAEVSSLGRLKH-RNLVG 172
           +   IG G  G V K   +  G  +A+KRI     E   +  L ++  + R      +V 
Sbjct: 8   DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67

Query: 173 LRGWCKKEKESLILIYDYME--NGSLDKWIFECDESIALSWEQRI--KVLKDVASGIL-- 226
             G   +E +  I     ME  + SLDK      + +    +  I  ++L  +A   +  
Sbjct: 68  FYGALFREGDCWIC----MELMDISLDK----FYKYVYEVLKSVIPEEILGKIAVATVKA 119

Query: 227 --YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             YL E  E K++HRD+K SN+LLD+  N +L DFG++
Sbjct: 120 LNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 45/151 (29%), Positives = 79/151 (52%), Gaps = 18/151 (11%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRI--SLDS-EHGMREFLAEVSSLGRLK-HRNLVGLR 174
           +G G  G VY  +    G  VA+K++     S E  M   L EV SL +L  H N+V L+
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKLK 64

Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGILYLYE-GW 232
               +E + L  +++YME G+L + + +  +    S E  I+ ++  +  G+ ++++ G+
Sbjct: 65  E-VFRENDELYFVFEYME-GNLYQLMKD-RKGKPFS-ESVIRSIIYQILQGLAHIHKHGF 120

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
                HRD+K  N+L+      ++ DFGLA+
Sbjct: 121 ----FHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 42/156 (26%), Positives = 81/156 (51%), Gaps = 16/156 (10%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMR-EFLAEVSSLGRLK---HRNLVGL 173
           IG+G  G VYK +    G  VALK + + + E G+    + EV+ L RL+   H N+V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 174 RGWC---KKEKESLI-LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
              C   + ++E+ + L++++++     +   +      L  E    +++    G+ +L+
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDL--RTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
               + ++HRD+K  N+L+      +L DFGLA+++
Sbjct: 126 A---NCIVHRDLKPENILVTSGGQVKLADFGLARIY 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 8/149 (5%)

Query: 120 VIGLGGNGKV--YKGQLLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRG 175
           V+G G  G+V   + +  G +  +K+++L   S    +    E   L +LKH N+V  R 
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
             + E   L ++  + E G L   + E  +   L   Q ++    +A  + YL+E     
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKE-QKGKLLPENQVVEWFVQIAMALQYLHE---KH 122

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           +LHRD+K  NV L +    ++GD G+A++
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARV 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 36/134 (26%), Positives = 62/134 (46%), Gaps = 16/134 (11%)

Query: 140 ALKRISL-DSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDK 198
           A+K I L  S   + +   E   L ++KH N+V  +   + +   L ++ +Y + G L +
Sbjct: 29  AMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGH-LYIVMEYCDGGDLMQ 87

Query: 199 WIFE-----CDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN 253
            I         E   L W         +  G+ +++E    +VLHRDIK+ N+ L +   
Sbjct: 88  KIKLQRGKLFPEDTILQW------FVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGK 138

Query: 254 ARLGDFGLAKMHHH 267
            +LGDFG A++   
Sbjct: 139 VKLGDFGSARLLTS 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 71/284 (25%), Positives = 123/284 (43%), Gaps = 64/284 (22%)

Query: 120 VIGLGGNGKVYKG---QLLG----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLV 171
            +G G  GKV K    +L G      VA+K +  ++    +R+ L+E + L ++ H +++
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFEC---------------------DESIALS 210
            L G C ++   L+LI +Y + GSL  ++ E                       +  AL+
Sbjct: 67  KLYGACSQD-GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV 270
               I     ++ G+ YL E    K++HRD+ A NVL+ +    ++ DFGL++  +    
Sbjct: 126 MGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182

Query: 271 M----SGRRPIE-EGKRNLVDRMWSLTERSELLS------------------VLDERLKA 307
                 GR P++     +L D ++  T +S++ S                  +  ERL  
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240

Query: 308 --KGGY----ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE 345
             K GY     +   E++ +L L C   E + RPT   + K LE
Sbjct: 241 LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 19/153 (12%)

Query: 120 VIGLGGNGKV----YKG--QLLGVEVALKRISL---DSEHGMREFLAEVSSLGRLKHRNL 170
           V+G G  GKV     KG  +L  V+V  K + L   D E  M E    V +L   KH  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTE--KRVLALAG-KHPFL 58

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
             L   C + K+ L  + +Y+  G L   +F    S      +      ++  G+ +L+E
Sbjct: 59  TQLHS-CFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEIVLGLQFLHE 114

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
                +++RD+K  NVLLD + + ++ DFG+ K
Sbjct: 115 ---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 45/152 (29%), Positives = 79/152 (51%), Gaps = 11/152 (7%)

Query: 115 FSEENVIGLGGNGKVYK--GQLLGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLV 171
           F + + +G G  G V+K   +  G+ +A K I L+ +  +R + + E+  L       +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYLYE 230
           G  G    + E  I + ++M+ GSLD    +  +      EQ + KV   V  G+ YL E
Sbjct: 67  GFYGAFYSDGEISICM-EHMDGGSLD----QVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             + K++HRD+K SN+L++ +   +L DFG++
Sbjct: 122 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 12/157 (7%)

Query: 113 KGFSEENVIGLGGNGKVYKGQLLGVE--VALKRISLD---SEHGMREFLAEVSSLGRLKH 167
           K F++   IG G  G VY  + +     VA+K++S     S    ++ + EV  L R+KH
Sbjct: 25  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
            N +  +G C   + +  L+ +Y    + D  + E  +   L   +   +      G+ Y
Sbjct: 85  PNSIEYKG-CYLREHTAWLVMEYCLGSASD--LLEVHKK-PLQEVEIAAITHGALQGLAY 140

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           L+      ++HRDIKA N+LL +    +L DFG A +
Sbjct: 141 LHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASI 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 15/151 (9%)

Query: 121 IGLGGNGKV--YKGQLLGVEVALKRIS--LDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           IG G  G V   K      +VA+K+I+   D+    +  L E+  L  L H N++ ++  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 177 ----CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
                ++    + ++Y+ M+   L + I     S  LS +     L  +  G+ Y++   
Sbjct: 73  MPPPHREAFNDVYIVYELMDT-DLHQII---RSSQTLSDDHCQYFLYQLLRGLKYIHS-- 126

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            + VLHRD+K SN+LL+   + ++ DFGLA+
Sbjct: 127 -ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 22/156 (14%)

Query: 120 VIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           ++G G  G V+KG        + + VA+K I         +E    + ++G L H  +V 
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVASGILYL 228
           L G C     SL L+      GSL   + +  +S+     L+W  +I      A G+ YL
Sbjct: 74  LLGICPGA--SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            E    +++HR++ A N+LL      ++ DFG+A +
Sbjct: 126 EE---HRMVHRNLAARNILLKSDSIVQIADFGVADL 158

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 30/112 (26%), Positives = 56/112 (50%), Gaps = 17/112 (15%)

Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLIL-------IYDYMENGSLDKWIFECDESIALS 210
           E+ +LGRL H N++ +    + E  + ++       +Y +M + + D W     +   L 
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFD-W-----KDRPLL 266

Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
            + R  ++K +   + Y+++    K++HRDIK  N+ L+      LGDFG A
Sbjct: 267 KQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGDFGTA 314

Length = 501

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 21/162 (12%)

Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRN 169
            F     +G G  G VYK + L      ALK + L   S+    + + E+  L  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 170 LVGLRGWCKKEKES------LILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVA 222
           ++         KE+      L ++ +Y   G L K I +  +   L  EQ I ++   + 
Sbjct: 61  IISY-------KEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113

Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            G+  L+E    K+LHRD+K++N+LL      ++GD G++K+
Sbjct: 114 RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV 152

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 19/158 (12%)

Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G   GV        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWI------FECDESIAL-SWEQRIKVLKDVASGI 225
           L G   + + +L+ I + M  G L  ++       E +   A  S ++ I++  ++A G+
Sbjct: 74  LLGVVSQGQPTLV-IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            YL     +K +HRD+ A N ++ +    ++GDFG+ +
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 45/144 (31%), Positives = 68/144 (47%), Gaps = 9/144 (6%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G VYK + L  G   A+K I L+          E+  +   KH N+V   G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG-SY 75

Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLH 238
             +E L +  +Y   GSL   I+    +  LS  Q   V ++   G+ YL+   +   +H
Sbjct: 76  LSREKLWICMEYCGGGSLQD-IYHV--TGPLSELQIAYVCRETLQGLAYLHSKGK---MH 129

Query: 239 RDIKASNVLLDKKMNARLGDFGLA 262
           RDIK +N+LL    + +L DFG+A
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVA 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 12/157 (7%)

Query: 113 KGFSEENVIGLGGNGKVYKGQLLGVE--VALKRISLD---SEHGMREFLAEVSSLGRLKH 167
           K FS+   IG G  G VY  + +     VA+K++S     S    ++ + EV  L +L+H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
            N +  RG C   + +  L+ +Y    + D  + E  +   L   +   V      G+ Y
Sbjct: 75  PNTIQYRG-CYLREHTAWLVMEYCLGSASD--LLEVHKK-PLQEVEIAAVTHGALQGLAY 130

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           L+      ++HRD+KA N+LL +    +LGDFG A +
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.2 bits (115), Expect = 4e-06
 Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 24/160 (15%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG------ 172
           +G G NG V+          VA+K+I L     ++  L E+  + RL H N+V       
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72

Query: 173 -----LRGWCKKEKE--SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGI 225
                L        E  S+ ++ +YME   L   +    E   LS E     +  +  G+
Sbjct: 73  PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL----EQGPLSEEHARLFMYQLLRGL 127

Query: 226 LYLYEGWESKVLHRDIKASNVLLDKK-MNARLGDFGLAKM 264
            Y++    + VLHRD+K +NV ++ + +  ++GDFGLA++
Sbjct: 128 KYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 47/152 (30%), Positives = 78/152 (51%), Gaps = 13/152 (8%)

Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
           F++   IG G  G+VYKG        VA+K I L+ +E  + +   E++ L +     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 172 GLRG-WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
              G + K  K  L +I +Y+  GS      +  +   L       +L+++  G+ YL+ 
Sbjct: 66  RYYGSYLKGTK--LWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHS 119

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             E K+ HRDIKA+NVLL ++ + +L DFG+A
Sbjct: 120 --ERKI-HRDIKAANVLLSEQGDVKLADFGVA 148

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 10/165 (6%)

Query: 115 FSEENVIGLGGNGKVYKGQL--LGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKHRN 169
           F +  V+G GG G+V   Q+   G   A K++    +    G    L E   L ++  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           +V L  +  + K++L L+   M  G L   I+   E+      + +    ++  G+  L+
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLH 119

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGR 274
           +    ++++RD+K  N+LLD   + R+ D GLA     GQ + GR
Sbjct: 120 Q---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 161

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 40/173 (23%), Positives = 77/173 (44%), Gaps = 38/173 (21%)

Query: 112 TKGFSEENVIGLGGNGKV--YKGQLLGVEVALKRI------SLDSEHGMREFLAEVSSLG 163
           T  + +   +G+G  G V   + QL G  VA+K+I       + ++   RE    +  L 
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE----LKLLK 64

Query: 164 RLKHRNLVGLRGWCKKEKESLILIYDYM--------ENGSLDKWIFECDESIALSWEQRI 215
            L+H N++ L        E +  + + +         +  L+K              Q I
Sbjct: 65  HLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEK--------------QFI 110

Query: 216 K-VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
           +  L  +  G+ Y++    + V+HRD+K SN+L+++  + ++ DFGLA++   
Sbjct: 111 QYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 44/145 (30%), Positives = 76/145 (52%), Gaps = 9/145 (6%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVGLRGWC 177
           +G G  G V K Q    G+ +A K I L+ +  +R + + E+  L       +VG  G  
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
             + E  I + ++M+ GSLD+ +    E+  +  E   KV   V  G+ YL E  + +++
Sbjct: 73  YSDGEISICM-EHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIM 126

Query: 238 HRDIKASNVLLDKKMNARLGDFGLA 262
           HRD+K SN+L++ +   +L DFG++
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVS 151

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.4 bits (112), Expect = 5e-06
 Identities = 43/145 (29%), Positives = 71/145 (48%), Gaps = 11/145 (7%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG-WC 177
           IG G  G VYK + +  G   A+K I L+          E+  +   KH N+V   G + 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
           +++K  L +  ++   GSL   I+    +  LS  Q   V ++   G+ YL+   +   +
Sbjct: 77  RRDK--LWICMEFCGGGSLQD-IYHV--TGPLSESQIAYVSRETLQGLYYLHSKGK---M 128

Query: 238 HRDIKASNVLLDKKMNARLGDFGLA 262
           HRDIK +N+LL    + +L DFG++
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 63/264 (23%), Positives = 111/264 (42%), Gaps = 41/264 (15%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRIS----LDSEHGMREFLAEVSSLGRLKHR 168
           F  E  IG G   +VY+   L     VALK++     +D++   ++ + E+  L +L H 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAK-ARQDCVKEIDLLKQLNHP 62

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILY 227
           N++       ++ E L ++ +  + G L + I    +   L  E+ + K    + S + +
Sbjct: 63  NVIKYLDSFIEDNE-LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH------HGQV-----MSGRRP 276
           ++     +V+HRDIK +NV +      +LGD GL +         H  V     MS  R 
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER- 177

Query: 277 IEEGKRNLVDRMWSL---------------TERSELLSVLD--ERLKAKGGYADEVVEKV 319
           I E   N    +WSL                ++  L S+    E+        +   EK+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237

Query: 320 LHLGLLCAHPEANSRPTIRQVLKM 343
             L  +C +P+ + RP I  V ++
Sbjct: 238 RELVSMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 13/156 (8%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKH-RNLV 171
           F    V+G G  G+VYKG+ +  G   A+K + + +E    E   E++ L +  H RN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEINMLKKYSHHRNIA 76

Query: 172 GLRG-WCKK----EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
              G + KK      + L L+ ++   GS+   + +  +  AL  +    + +++  G+ 
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALKEDWIAYICREILRGLA 135

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           +L+     KV+HRDIK  NVLL +    +L DFG++
Sbjct: 136 HLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 168

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 46.7 bits (111), Expect = 8e-06
 Identities = 39/145 (26%), Positives = 75/145 (51%), Gaps = 9/145 (6%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVGLRGWC 177
           +G G  G V K + +  G  +A K + + ++  +R + L E+  +   +   +V   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
             E   + +  ++M+ GSLD+ I++  +   +  E   K+   V  G+ YLY     +++
Sbjct: 73  LNENN-ICMCMEFMDCGSLDR-IYK--KGGPIPVEILGKIAVAVVEGLTYLYN--VHRIM 126

Query: 238 HRDIKASNVLLDKKMNARLGDFGLA 262
           HRDIK SN+L++ +   +L DFG++
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.7 bits (111), Expect = 9e-06
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 18/156 (11%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALK--RISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           IG G  GKVYK +    G  VALK  R+ +D E      L E+S L  L     + +R  
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI-VRLL 67

Query: 177 C------KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI--KVLKDVASGILYL 228
                  K  K SL L+++Y+++  L K++             +     +  +  G+ + 
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126

Query: 229 YEGWESKVLHRDIKASNVLLDK-KMNARLGDFGLAK 263
           ++     V+HRD+K  N+L+DK K   ++ D GL +
Sbjct: 127 HK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 21/161 (13%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLV 171
           F +   +G G  G V K      G+ +A K I L+ +  +R + + E+  L       +V
Sbjct: 3   FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI------KVLKDVASGI 225
           G  G    + E  I + ++M+ GSLD           L    RI      K+   V  G+
Sbjct: 63  GFYGAFYSDGEISICM-EHMDGGSLD---------QVLKKAGRIPENILGKISIAVLRGL 112

Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH 266
            YL E  + K++HRD+K SN+L++ +   +L DFG++    
Sbjct: 113 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 44/160 (27%), Positives = 79/160 (49%), Gaps = 21/160 (13%)

Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKH- 167
           F    ++G G  G+VYKG      QL  ++V    ++ D E  +++   E++ L +  H 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQ---EINMLKKYSHH 62

Query: 168 RNLVGLRGWCKKEK-----ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVA 222
           RN+    G   K+      + L L+ ++   GS+   I +  +   L  E    + +++ 
Sbjct: 63  RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREIL 121

Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
            G+ +L++    KV+HRDIK  NVLL +    +L DFG++
Sbjct: 122 RGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 158

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 46.3 bits (109), Expect = 1e-05
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 16/154 (10%)

Query: 113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           K ++    IG G +G VY    +  G EVA+K+++L  +      + E+  +   K+ N+
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 171 VG-LRGWCKKEKESLILIYDYMENGSLDKWIFEC--DESIALSWEQRIKVLKDVASGILY 227
           V  L  +   ++  L ++ +Y+  GSL   + E   DE       Q   V ++    + +
Sbjct: 79  VNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALDF 130

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL 261
           L+    ++V+HRDIK+ N+LL    + +L DFG 
Sbjct: 131 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 35/126 (27%), Positives = 61/126 (48%), Gaps = 10/126 (7%)

Query: 136 GVEVALKRISLDSEHGMREFL-AEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENG 194
           G +VA+K++ L  +   RE L  EV  +   +H N+V +        E L ++ +++E G
Sbjct: 44  GRQVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE-LWVVMEFLEGG 101

Query: 195 SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNA 254
           +L   +        ++ EQ   V   V   + +L+      V+HRDIK+ ++LL      
Sbjct: 102 ALTDIV----THTRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRV 154

Query: 255 RLGDFG 260
           +L DFG
Sbjct: 155 KLSDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 24/86 (27%), Positives = 48/86 (55%), Gaps = 5/86 (5%)

Query: 180 EKESLILIYDYMENGSLDKWIFECDES-IALSWEQRIKVLKDVASGILYLYEGWESKVLH 238
           E+++  +I +Y E   LD  + E   +   LS  Q  +    +  G+ Y+++    ++LH
Sbjct: 73  ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILH 129

Query: 239 RDIKASNVLLDKKMNARLGDFGLAKM 264
           RD+KA N+ L   +  ++GDFG++++
Sbjct: 130 RDLKAKNIFLKNNL-LKIGDFGVSRL 154

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 19/158 (12%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLD-SEHGM--REFLAEVSSLGRLKHRNLVGLRG 175
           IG GG G+VY     +    VALK+I  D SE+ +  + FL E      L H  +V +  
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 176 WCKKEKESLILIYDYMENGSLD---KWIFECDE-----SIALSWEQRIKVLKDVASGILY 227
            C  + + +     Y+E  +L    K +++ +      +   S    + +   + + I Y
Sbjct: 70  ICS-DGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY 128

Query: 228 LYEGWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    SK VLHRD+K  N+LL       + D+G A  
Sbjct: 129 VH----SKGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162

Length = 932

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 45.9 bits (108), Expect = 2e-05
 Identities = 41/154 (26%), Positives = 75/154 (48%), Gaps = 16/154 (10%)

Query: 113 KGFSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           K ++    IG G +G VY       G EVA+++++L  +      + E+  +   K+ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 171 VG-LRGWCKKEKESLILIYDYMENGSLDKWIFEC--DESIALSWEQRIKVLKDVASGILY 227
           V  L  +   ++  L ++ +Y+  GSL   + E   DE       Q   V ++    + +
Sbjct: 80  VNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEG------QIAAVCRECLQALEF 131

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL 261
           L+    ++V+HRDIK+ N+LL    + +L DFG 
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 10/159 (6%)

Query: 121 IGLGGNGKVYKGQL--LGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
           +G GG G+V   Q+   G   A K++    L    G +  L E   L ++  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
           +  + K+ L L+   M  G L   I+   E       + I     +  G+ +L++    +
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEP-GFPEARAIFYAAQIICGLEHLHQ---RR 115

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGR 274
           +++RD+K  NVLLD   N R+ D GLA     G+ + GR
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR 154

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 23/59 (38%), Positives = 33/59 (55%), Gaps = 3/59 (5%)

Query: 204 DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           D S  L  EQ I + + +   + YL+      ++HRD+K  N+ LD+  NA LGDFG A
Sbjct: 177 DRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 45.1 bits (106), Expect = 3e-05
 Identities = 36/139 (25%), Positives = 66/139 (47%), Gaps = 13/139 (9%)

Query: 125 GNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL 184
            +GK Y  ++L  EV +      ++  +   L E   L   +H  L  L+ +  + K+ L
Sbjct: 18  ASGKYYAMKILKKEVII------AKDEVAHTLTESRVLKNTRHPFLTSLK-YSFQTKDRL 70

Query: 185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKAS 244
             + +Y+  G L    F        S ++      ++ S + YL+ G   K+++RD+K  
Sbjct: 71  CFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLE 124

Query: 245 NVLLDKKMNARLGDFGLAK 263
           N++LDK  + ++ DFGL K
Sbjct: 125 NLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 10/165 (6%)

Query: 115 FSEENVIGLGGNGKVYKGQL--LGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKHRN 169
           F    V+G GG G+V   Q+   G   A K++    +    G    L E   L ++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           +V L  +  + K++L L+   M  G L   I+          ++ I    ++  G+  L 
Sbjct: 62  VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQ 119

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGR 274
                ++++RD+K  N+LLD + + R+ D GLA     G+ + GR
Sbjct: 120 R---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR 161

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 44.9 bits (106), Expect = 5e-05
 Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 25/156 (16%)

Query: 120 VIGLGGNGKVY------KGQLLGVEVALKRISL---DSEHGMREFLAEVSSLGRLKHRNL 170
           V+G G  GKV        G+L  V+V  K + L   D E  M E    + SL R  H  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTE--KRILSLAR-NHPFL 58

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQRIKVLKDVASGILY 227
             L   C +  + L  + +++  G L   I +    DE+ A  +        ++ S +++
Sbjct: 59  TQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA------AEITSALMF 111

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           L++     +++RD+K  NVLLD + + +L DFG+ K
Sbjct: 112 LHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 38/143 (26%), Positives = 67/143 (46%), Gaps = 10/143 (6%)

Query: 121 IGLGGNGKV--YKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           IG G  G V   + +  G +VA+K + L  +        EV  +   +H+N+V +     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK-SY 87

Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLH 238
              E L ++ ++++ G+L   + +      L+ EQ   V + V   + YL+      V+H
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHS---QGVIH 140

Query: 239 RDIKASNVLLDKKMNARLGDFGL 261
           RDIK+ ++LL      +L DFG 
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGF 163

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 43.8 bits (103), Expect = 8e-05
 Identities = 43/165 (26%), Positives = 73/165 (44%), Gaps = 10/165 (6%)

Query: 115 FSEENVIGLGGNGKVYKGQL--LGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKHRN 169
           F +  V+G GG G+V   Q+   G   A KR+    +    G    L E   L ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           +V L  +  + K++L L+   M  G L   I+          E+ +    ++  G+  L+
Sbjct: 62  VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLH 119

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGR 274
                  ++RD+K  N+LLD   + R+ D GLA     G+ + GR
Sbjct: 120 R---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 45/197 (22%), Positives = 86/197 (43%), Gaps = 39/197 (19%)

Query: 121 IGLGGNGKVY--KGQLLGVEVALKRISLDSEHGMRE---FLAEVSSLGRLKHRNLVGLRG 175
           +G G  G+V+  + ++     ALK +++     +++      E   L  + H  ++ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF- 67

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQRIKVLKDVASGILYLYEGW 232
           W + ++  L ++ +Y+  G L  ++        S  L +   I         + YL+   
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI------VCALEYLHS-- 119

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIEEGKRNLVDRMWSLT 292
             ++++RD+K  N+LLDK+ + +L DFG AK                    L DR W+L 
Sbjct: 120 -KEIVYRDLKPENILLDKEGHIKLTDFGFAK-------------------KLRDRTWTLC 159

Query: 293 ERSELLSVLDERLKAKG 309
              E L+   E +++KG
Sbjct: 160 GTPEYLA--PEVIQSKG 174

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 31/104 (29%), Positives = 56/104 (53%), Gaps = 13/104 (12%)

Query: 155 FLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR 214
           F    S + ++ H +L  + G C +  E+ I++ +++E+G LD  + +    + ++W  +
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSEN-IMVEEFVEHGPLDVCLRKEKGRVPVAW--K 119

Query: 215 IKVLKDVASGILYLYEGWESKVL-HRDIKASNVLLDKKMNARLG 257
           I V + +AS + YL    E K L H ++ A N+LL     ARLG
Sbjct: 120 ITVAQQLASALSYL----EDKNLVHGNVCAKNILL-----ARLG 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 2/47 (4%)

Query: 216 KVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           K+   +   + YL E  +  V+HRD+K SN+LLD   N +L DFG++
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 40/158 (25%), Positives = 65/158 (41%), Gaps = 26/158 (16%)

Query: 124 GGNGKVYKGQLLGVEVALKRISLDS-EHGMREFL-AEVSSLGRLKHRNLVGLRGWCKKEK 181
                + K +     VA+K+I+LDS      + L  E+ +  +L+H N++          
Sbjct: 13  LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT-SFIVD 71

Query: 182 ESLILIYDYMENGS---LDKWIFECD---ES-IALSWEQRIKVLKDVASGILYLYEGWES 234
             L ++   M  GS   L K  F  +   E  IA        +LKDV + + Y++     
Sbjct: 72  SELYVVSPLMAYGSCEDLLKTHF-PEGLPELAIAF-------ILKDVLNALDYIHS---K 120

Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAKMHH---HGQ 269
             +HR +KAS++LL       L   GL        HG+
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGK 156

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 22/156 (14%)

Query: 120 VIGLGGNGKVYKG------QLLGVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVG 172
           V+G G  G VYKG      + + + VA+K +  + S    +E L E   +  +    +  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVASGILYL 228
           L G C     ++ L+   M  G L  ++ E  + I     L+W  +I      A G+ YL
Sbjct: 74  LLGICLTS--TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYL 125

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            E    +++HRD+ A NVL+    + ++ DFGLA++
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 24/92 (26%), Positives = 47/92 (51%), Gaps = 6/92 (6%)

Query: 181 KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRD 240
           KE L  + +Y+  G L   +F    S      +      ++  G+ +L++     +++RD
Sbjct: 68  KEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRD 121

Query: 241 IKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
           +K  NVLLDK  + ++ DFG+ K + +G+  +
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 12/147 (8%)

Query: 121 IGLGGNGKVY--KGQLLGVEVALKRISLDSEH---GMREFLAEVSSLGRLKHRNLVGLRG 175
           IG G  G VY          VA+K++S   +      ++ + EV  L +LKH N +  +G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
            C  ++ +  L+ +Y    + D  + E  +   L   +   +      G+ YL+      
Sbjct: 89  -CYLKEHTAWLVMEYCLGSASD--LLEVHKK-PLQEVEIAAITHGALQGLAYLHS---HN 141

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLA 262
           ++HRDIKA N+LL +    +L DFG A
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA 168

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 41/170 (24%), Positives = 81/170 (47%), Gaps = 20/170 (11%)

Query: 113 KGFSEENVIGLG--GNGKVYKGQLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K F  ++++G G  G  +V + +  G   A+K +    L ++  +  F  E   L     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSL----DKWIFECDESIALSWEQRIKVLKDVAS 223
             +  L+ +  ++K++L L+ +Y   G L    +++  + DE +A  +         +A 
Sbjct: 61  PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY---------LAE 110

Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG-LAKMHHHGQVMS 272
            +L ++   +   +HRDIK  NVL+D+  + +L DFG  A++  +  V S
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 24/161 (14%)

Query: 121 IGLGGNGKVYK------GQLLGVEVALKRISL----------DSEHGMREFLAEVSSLG- 163
           +G G  G VYK      GQ L   +ALK I++          + +  + + ++EV+ +  
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNL---LALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64

Query: 164 RLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVA 222
           +L+H N+V        E + L ++ D +E   L +      E      E+RI  +   + 
Sbjct: 65  QLRHPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV 123

Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             + YL++  E +++HRD+  +N++L +     + DFGLAK
Sbjct: 124 LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 20/170 (11%)

Query: 115 FSEENVIGLGGNGKVYKGQL--LGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKHRN 169
           F    V+G GG G+V   Q+   G   A K++    +    G    L E   L ++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC-----DESIALSWEQRIKVLKDVASG 224
           +V L  +  + K++L L+   M  G L   I+       DE  A+ +   I        G
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC------G 114

Query: 225 ILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGR 274
           +  L+     ++++RD+K  N+LLD   + R+ D GLA     G+ + GR
Sbjct: 115 LEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR 161

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 18/160 (11%)

Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K + +   IG G  G V      +LG+ VA+K++S    +  H  R +  E+  L  + H
Sbjct: 21  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNH 79

Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++ L      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 80  KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-----HMELDHERMSYLLYQMLC 134

Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 21/137 (15%)

Query: 138 EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLD 197
           +V  K + L+ E       +E+  L    H  +V      K + + L+LI +Y   G L+
Sbjct: 95  KVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-DKLLLIMEYGSGGDLN 153

Query: 198 KWIFECDESIALSWEQRIK---VLKDVASGILY------LYEGWESKVLHRDIKASNVLL 248
           K I           +QR+K     ++   G+L+      L E    K++HRD+K++N+ L
Sbjct: 154 KQI-----------KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL 202

Query: 249 DKKMNARLGDFGLAKMH 265
                 +LGDFG +K +
Sbjct: 203 MPTGIIKLGDFGFSKQY 219

Length = 478

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 60/267 (22%), Positives = 111/267 (41%), Gaps = 46/267 (17%)

Query: 121 IGLGGNGKVYKGQL-------LGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G             VA+K ++  +    R EFL E S +      ++V 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWI--FECDE-----SIALSWEQRIKVLKDVASGI 225
           L G   K + +L+ + + M +G L  ++     +          + ++ I++  ++A G+
Sbjct: 74  LLGVVSKGQPTLV-VMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGRRPI---- 277
            YL      K +HRD+ A N ++      ++GDFG+ +      ++ +   G  P+    
Sbjct: 133 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 278 ----EEGKRNLVDRMWSLTERSELLSVLDER----------LK--AKGGYADE---VVEK 318
               ++G       MWS       ++ L E+          LK    GGY D+     E+
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 249

Query: 319 VLHLGLLCAHPEANSRPTIRQVLKMLE 345
           V  L  +C       RPT  +++ +L+
Sbjct: 250 VTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 34/147 (23%), Positives = 72/147 (48%), Gaps = 13/147 (8%)

Query: 102 RVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSS 161
           R +  +I+A    + +++        K  K  L  ++ + + ISL        F    S 
Sbjct: 5   RGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISL-------AFFETASM 57

Query: 162 LGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDV 221
           + ++ H+++V L G C ++ E+ I++ +++E G LD ++    + +   W  + KV K +
Sbjct: 58  MRQVSHKHIVLLYGVCVRDVEN-IMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQL 114

Query: 222 ASGILYLYEGWESKVLHRDIKASNVLL 248
           AS + YL    +  ++H ++   N+LL
Sbjct: 115 ASALSYLE---DKDLVHGNVCTKNILL 138

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 15/42 (35%), Positives = 27/42 (64%), Gaps = 2/42 (4%)

Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           +   + YL+   +  V+HRD+K SNVL+++    +L DFG++
Sbjct: 112 IVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 19/37 (51%), Positives = 23/37 (62%), Gaps = 1/37 (2%)

Query: 237 LHRDIKASNVLLDKKMNARLGDFG-LAKMHHHGQVMS 272
           +HRDIK  NVLLDK  + RL DFG   ++   G V S
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 7/94 (7%)

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           +VGL+ +  +    L L+ DYM  G L  W  + +   +   E R K    +A  +L L 
Sbjct: 58  IVGLK-FSFQTDSDLYLVTDYMSGGEL-FWHLQKEGRFS---EDRAKFY--IAELVLALE 110

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
              +  +++RD+K  N+LLD   +  L DFGL+K
Sbjct: 111 HLHKYDIVYRDLKPENILLDATGHIALCDFGLSK 144

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 19/153 (12%)

Query: 120 VIGLGGNGKVYKGQLLG------VEVALKRISL---DSEHGMREFLAEVSSLGRLKHRNL 170
           V+G G  GKV   +L G      ++V  K + L   D +  M E    + +L   KH  L
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTE--KRILALAA-KHPFL 58

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
             L   C + K+ L  + +Y+  G L   +F+   S      +      +V   +++L+ 
Sbjct: 59  TALHC-CFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHR 114

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
                V++RD+K  N+LLD + + +L DFG+ K
Sbjct: 115 ---HGVIYRDLKLDNILLDAEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 23/108 (21%), Positives = 50/108 (46%), Gaps = 7/108 (6%)

Query: 156 LAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI 215
           L E   L  + H +++ ++        + +++  Y    S D + +    S  L  +Q +
Sbjct: 105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY----SSDLYTYLTKRSRPLPIDQAL 160

Query: 216 KVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            + K +  G+ YL+     +++HRD+K  N+ ++      +GD G A+
Sbjct: 161 IIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 41.5 bits (98), Expect = 6e-04
 Identities = 14/27 (51%), Positives = 19/27 (70%)

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAK 263
           +HRDIK  N+L+D   + +L DFGL K
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCK 149

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 38/152 (25%), Positives = 70/152 (46%), Gaps = 17/152 (11%)

Query: 121 IGLGGNGKVY--KGQLLGVEVALKRI---SLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
           I  G  G VY  K +  G   A+K +    + +++ +    AE + +        V    
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 176 WCKKEKESLILIYDYMENG---SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
           +  + K+ L L+ +Y+  G   SL K +    E  A  +      + +V  G+  L++  
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY------IAEVVLGVEDLHQ-- 115

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
              ++HRDIK  N+L+D+  + +L DFGL++ 
Sbjct: 116 -RGIIHRDIKPENLLIDQTGHLKLTDFGLSRN 146

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 21/154 (13%)

Query: 120 VIGLGGNGKVYKGQ------LLGVEVALKRISL---DSEHGMREFLAEVSSLGRLKHRNL 170
           VIG G  GKV   +         V+V  K+  L   + +H M E       L  +KH  L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSE---RNVLLKNVKHPFL 58

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLK-DVASGILYLY 229
           VGL  +  +  + L  + DY+  G L    F   +      E R +    ++AS + YL+
Sbjct: 59  VGLH-FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLH 113

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
                 +++RD+K  N+LLD + +  L DFGL K
Sbjct: 114 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 40.7 bits (96), Expect = 7e-04
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 18/152 (11%)

Query: 121 IGLGGNGKVY--KGQLLGVEVALKRISLDSEHGMREF---LAEVSSLGRLKHRNLVGLRG 175
           I  G  G+V+  K +  G   A+K I         +    L E   L + +   +V L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 176 WCKKEKESLILIYDYMENGSLDKWI--FEC-DESIALSWEQRIKVLKDVASGILYLYEGW 232
           +  + K++L L+ +Y+  G L   +      DE +A     RI  + ++   + YL+   
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA-----RI-YIAEIVLALEYLHS-- 111

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            + ++HRD+K  N+L+D   + +L DFGL+K+
Sbjct: 112 -NGIIHRDLKPDNILIDSNGHLKLTDFGLSKV 142

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 40.8 bits (95), Expect = 8e-04
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 7/97 (7%)

Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H  LVGL   C + +  L  + +Y+  G L   +F       L  E       +++  + 
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALN 110

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           YL+E     +++RD+K  NVLLD + + +L D+G+ K
Sbjct: 111 YLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 41/156 (26%), Positives = 76/156 (48%), Gaps = 15/156 (9%)

Query: 118 ENVIGLGGNGKV--YKGQLLGVEVALKRISLDSEH--GMREFLAEVSSLGRLKHRNLVGL 173
           + VIG G  G V        G +VA+K+I+   EH       L E+  L  L+H ++V +
Sbjct: 5   QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEI 64

Query: 174 RGW----CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           +       ++E + + ++++ ME+  L + I   D+   L+ E     L  +   + Y++
Sbjct: 65  KHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDD---LTPEHHQFFLYQLLRALKYIH 120

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
               + V HRD+K  N+L +     ++ DFGLA++ 
Sbjct: 121 T---ANVFHRDLKPKNILANADCKLKICDFGLARVA 153

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 25/161 (15%)

Query: 121 IGLGGNGKVYKGQLLG----VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG- 175
           +G G  G VYK +        E ALK+I  +          E++ L  LKH N++ L+  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 176 WCKKEKESLILIYDYMENGSLDKWIF--------ECDESIALSWEQRIKVLKDVASGILY 227
           +       + L++DY E+   D W             + + L       +L  +  GI Y
Sbjct: 67  FLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 228 LYEGWESKVLHRDIKASNVLL----DKKMNARLGDFGLAKM 264
           L+  W   VLHRD+K +N+L+     ++   ++ D G A++
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 29/108 (26%), Positives = 50/108 (46%), Gaps = 6/108 (5%)

Query: 156 LAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI 215
           L E   L   +H  L  L+ +  +  + L  + +Y   G L    F        S ++  
Sbjct: 43  LTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRAR 98

Query: 216 KVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               ++ S + YL+   E  V++RD+K  N++LDK  + ++ DFGL K
Sbjct: 99  FYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 27/166 (16%)

Query: 120 VIGLGGNGKVY---------KGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           V+G GG GKV+          G++  ++V  K   + ++       AE + L  +KH  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVA----SGIL 226
           V L  +  +    L LI +Y+  G L            +  E+    ++D A    S I 
Sbjct: 63  VDLI-YAFQTGGKLYLILEYLSGGEL-----------FMHLEREGIFMEDTACFYLSEIS 110

Query: 227 YLYEGWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKMH-HHGQV 270
              E    + +++RD+K  N+LLD + + +L DFGL K   H G V
Sbjct: 111 LALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV 156

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 20/154 (12%)

Query: 121 IGLGGNGKVYK--GQLLGVEVALKRISLDSEHGM-REFLAEVSSLGRLK-HRNLVGLRG- 175
           IG G  GKV+K   +  G + A+K   LD  H +  E  AE + L  L  H N+V   G 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVK--ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 176 WCKKEK---ESLILIYDYMENGS---LDKWIFECDESIALSWEQRIK-VLKDVASGILYL 228
           + KK+    + L L+ +    GS   L K   +  E +    E  I  +L +   G+ +L
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME---EPIIAYILHEALMGLQHL 140

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           +    +K +HRD+K +N+LL  +   +L DFG++
Sbjct: 141 HV---NKTIHRDVKGNNILLTTEGGVKLVDFGVS 171

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 20/172 (11%)

Query: 102 RVSYQEIHAATK----------GFSEENVIGLGGNGKV--YKGQLLGVEVALKRISLDSE 149
           RVS+++  AA +                 IG G  G V     +  G +VA+K++ L  +
Sbjct: 1   RVSHEQFRAALQLVVSPGDPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ 60

Query: 150 HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIAL 209
                   EV  +    H N+V +        E L ++ +++E G+L   +        +
Sbjct: 61  QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE-LWVVMEFLEGGALTDIV----THTRM 115

Query: 210 SWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL 261
           + EQ   V   V   + YL+      V+HRDIK+ ++LL      +L DFG 
Sbjct: 116 NEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGF 164

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 32/189 (16%)

Query: 114 GFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
            F E  ++     G VY  ++L     L++  +      R+ L E  SL  +K       
Sbjct: 13  AFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF----- 67

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
             +  ++K +L LI +++  G +   + + D       E+  +    +A  +L +    +
Sbjct: 68  --YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT----EEETQFY--IAETVLAIDSIHQ 119

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLA----KMH--------HHG-------QVMSGR 274
              +HRDIK  N+LLD K + +L DFGL     K H        +H        Q M+ +
Sbjct: 120 LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179

Query: 275 RPIEEGKRN 283
           R  E  KRN
Sbjct: 180 RKAETWKRN 188

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 15/30 (50%), Positives = 23/30 (76%)

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
           ++HRDIK++N+LL      +LGDFG +KM+
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMY 193

Length = 496

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.7 bits (93), Expect = 0.002
 Identities = 15/27 (55%), Positives = 19/27 (70%)

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAK 263
           +HRDIK  N+LLD K + +L DFGL  
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 18/152 (11%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
           IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H+N++GL  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGLLN 90

Query: 176 WCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
               +K  E    +Y  ME  + +L + I      + L  E+   +L  +  GI +L+  
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLCGIKHLHS- 144

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 145 --AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 30/159 (18%)

Query: 120 VIGLGGNGKV----YK--GQLLGVEVALKR---------ISLDSEHGMREFLAEVSSLGR 164
           V+G G  GKV    YK  G+L  ++ ALK+          SL  E   R F         
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIK-ALKKGDIIARDEVESLMCEK--RIFET----ANS 58

Query: 165 LKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASG 224
            +H  LV L   C + ++ +  + +Y   G L   I     +   S  + +     V  G
Sbjct: 59  ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHI----HTDVFSEPRAVFYAACVVLG 113

Query: 225 ILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           + YL+E   +K+++RD+K  N+LLD +   ++ DFGL K
Sbjct: 114 LQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK 149

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 14/30 (46%), Positives = 21/30 (70%)

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAKMHH 266
           +HRDIK  N+L+D+  + +L DFGL+   H
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 21/154 (13%)

Query: 120 VIGLGGNGKVY------KGQLLGVEVALKRISL---DSEHGMREFLAEVSSLGRLKHRNL 170
           ++G G  GKV+        Q   ++   K + L   D E  M E    V SL   +H  L
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVE--KRVLSLA-WEHPFL 58

Query: 171 VGLRGWCK-KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
             L  +C  + KE+L  + +Y+  G L   I  C +       +      ++  G+ +L+
Sbjct: 59  THL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLH 113

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
                 +++RD+K  N+LLD   + ++ DFG+ K
Sbjct: 114 S---KGIVYRDLKLDNILLDTDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 7/94 (7%)

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           LVGL   C +    L L+ +Y+  G L   +F       L  E       ++   + +L+
Sbjct: 58  LVGLHS-CFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLH 113

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           E     +++RD+K  NVLLD   + +L D+G+ K
Sbjct: 114 E---RGIIYRDLKLDNVLLDADGHIKLTDYGMCK 144

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 39.3 bits (91), Expect = 0.003
 Identities = 31/120 (25%), Positives = 56/120 (46%), Gaps = 19/120 (15%)

Query: 158 EVSSLGRLKHRNLVGLRG-WCKKEKESLILIYDYMENGSLDKWIF--------ECDESIA 208
           E++ L  LKH N++ L+  +       + L++DY E+   D W             + + 
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH---DLWHIIKFHRASKANKKPVQ 104

Query: 209 LSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL----DKKMNARLGDFGLAKM 264
           L       +L  +  GI YL+  W   VLHRD+K +N+L+     ++   ++ D G A++
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 44/181 (24%), Positives = 87/181 (48%), Gaps = 28/181 (15%)

Query: 110 AATKGFSEENVIGLGGNGKVYKGQLLGV--EVALKRISLDSEHGMREFLAEVSSLGRLKH 167
           +  K +   N+IG G  G VY+   +    +VA+K++  D ++  RE L     +  L H
Sbjct: 63  SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNH 118

Query: 168 RNLVGLRGW----CKKEKESLILIYDYME--NGSLDKWI---FECDESIALSWEQRIKVL 218
            N++ L+ +    C K+ E  I +   ME    ++ K++      + ++ L     +K+ 
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFL---VKLY 175

Query: 219 K-DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQVMSGRRP 276
              +   + Y++  +   + HRD+K  N+L+D   +  +L DFG AK      +++G+R 
Sbjct: 176 SYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAK-----NLLAGQRS 227

Query: 277 I 277
           +
Sbjct: 228 V 228

Length = 440

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 30/109 (27%), Positives = 50/109 (45%), Gaps = 9/109 (8%)

Query: 156 LAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI 215
           L E   L   +H  L  L+ +  +  + L  + +Y   G L    F        S E R 
Sbjct: 43  LTESRVLQNTRHPFLTALK-YSFQTHDRLCFVMEYANGGEL---FFHLSRERVFS-EDRA 97

Query: 216 KVL-KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +    ++ S + YL+      V++RD+K  N++LDK  + ++ DFGL K
Sbjct: 98  RFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 22/53 (41%), Positives = 30/53 (56%), Gaps = 1/53 (1%)

Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG-LAKMHHHGQVMS 272
           +A  +L ++   +   +HRDIK  NVLLD   + RL DFG   KM+  G V S
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 38.8 bits (90), Expect = 0.004
 Identities = 20/89 (22%), Positives = 45/89 (50%), Gaps = 6/89 (6%)

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
           C +  + L  + +Y+  G L   ++   +       Q +    +++ G+ +L+      +
Sbjct: 69  CFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFLHR---RGI 122

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAKMH 265
           ++RD+K  NV+LD + + ++ DFG+ K H
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEH 151

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 45/154 (29%), Positives = 77/154 (50%), Gaps = 20/154 (12%)

Query: 120 VIGLGGNGKVY---------KGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           V+G G  GKV+          GQL  ++V LK+ +L     +R  + E   L  + H  +
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKV-LKKATLKVRDRVRTKM-ERDILAEVNHPFI 60

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGILYLY 229
           V L    + E + L LI D++  G L    F       +  E+ +K  L ++A  + +L+
Sbjct: 61  VKLHYAFQTEGK-LYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH 115

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
                 +++RD+K  N+LLD++ + +L DFGL+K
Sbjct: 116 S---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	409
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.98
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.98
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.98
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.98
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.98
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.98
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.98
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.98
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.98
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.98
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.98
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.98
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.98
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.98
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.98
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.98
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.98
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.98
PTZ00036	440	glycogen synthase kinase; Provisional	99.98
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.98
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.98
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.98
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.98
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.98
PTZ00284	467	protein kinase; Provisional	99.98
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.98
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.98
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.98
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.98
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.98
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.98
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.98
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.98
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.98
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.98
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.98
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.98
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.98
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.98
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.97
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.97
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.97
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
KOG0610	459	consensus Putative serine/threonine protein kinase	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
PHA03210	501	serine/threonine kinase US3; Provisional	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.96
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.96
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.96
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.96
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.96
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.96
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.96
PLN00009	294	cyclin-dependent kinase A; Provisional	99.96
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.96
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.96
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.96
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.96
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.96
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.96
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.95
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.95
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.95
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.95
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.95
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.95
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.95
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.95
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.94
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.94
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.94
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.93
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.93
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.93
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.93
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.93
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.92
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.92
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.9
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.89
KOG1152	772	consensus Signal transduction serine/threonine kin	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.87
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.87
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.87
PRK10345	210	hypothetical protein; Provisional	99.87
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.85
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
smart00090	237	RIO RIO-like kinase.	99.82
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.79
PLN00181	793	protein SPA1-RELATED; Provisional	99.78
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.77
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.74
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.71
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.7
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.69
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.62
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.62
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.61
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.6
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.6
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.5
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.46
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.45
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.45
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.34
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.34
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.29
KOG3087	229	consensus Serine/threonine protein kinase [General	99.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.27
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.13
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.1
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.06
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.03
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.01
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.93
KOG1243	690	consensus Protein kinase [General function predict	98.91
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.87
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.85
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.78
PRK09902	216	hypothetical protein; Provisional	98.74
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.73
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.6
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.52
PF01636	239	APH: Phosphotransferase enzyme family This family	98.45
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.43
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.41
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.39
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.34
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.3
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.28
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.24
PLN02876	822	acyl-CoA dehydrogenase	98.21
PRK10593	297	hypothetical protein; Provisional	98.0
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.0
KOG0606	1205	consensus Microtubule-associated serine/threonine	97.94
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.9
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.8
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.67
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.65
PRK05231	319	homoserine kinase; Provisional	97.61
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.59
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.4
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.29
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.12
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	96.92
PLN02236	344	choline kinase	96.87
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.8
PLN02756	418	S-methyl-5-thioribose kinase	96.76
KOG2137	700	consensus Protein kinase [Signal transduction mech	96.69
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.58
KOG2270	520	consensus Serine/threonine protein kinase involved	96.56
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.56
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.48
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	96.46
KOG0576	829	consensus Mitogen-activated protein kinase kinase	96.35
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.33
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.1
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.93
COG4248	637	Uncharacterized protein with protein kinase and he	95.91
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.72
PRK12396	409	5-methylribose kinase; Reviewed	95.71
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.51
COG2334	331	Putative homoserine kinase type II (protein kinase	95.49
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.26
PRK06148	1013	hypothetical protein; Provisional	95.08
PRK11768	325	serine/threonine protein kinase; Provisional	94.66
PTZ00384	383	choline kinase; Provisional	94.54
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	94.33
PTZ00296	442	choline kinase; Provisional	94.0

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-49  Score=381.27  Aligned_cols=249  Identities=45%  Similarity=0.752  Sum_probs=215.5

Q ss_pred             CCccccHHHHHHHhCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEE
Q 048535           99 WPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC  177 (409)
Q Consensus        99 ~~~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~  177 (409)
                      ..+.|+++++..+|++|...+.||+|+||.||+|... |..||||++.....+..++|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            4567999999999999999999999999999999999 589999988765433146699999999999999999999999


Q ss_pred             EccCC-eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEE
Q 048535          178 KKEKE-SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARL  256 (409)
Q Consensus       178 ~~~~~-~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl  256 (409)
                      .+ .+ ..+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||
T Consensus       141 ~e-~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LE-GGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ec-CCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            98 45 589999999999999999875443 8999999999999999999999988889999999999999999999999


Q ss_pred             ecccCcccccC----------Cc-----------------------------eeeecccccc----CCCcHHHHHHhhhc
Q 048535          257 GDFGLAKMHHH----------GQ-----------------------------VMSGRRPIEE----GKRNLVDRMWSLTE  293 (409)
Q Consensus       257 ~DFGla~~~~~----------~~-----------------------------~~~g~~p~~~----~~~~~~~~vws~~~  293 (409)
                      +|||+|+....          ++                             +++|+++.+.    +...+..|+|....
T Consensus       219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            99999987653          11                             4567766653    33457888888888


Q ss_pred             cCcHHHHhhHHhhhcCCCCH-HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          294 RSELLSVLDERLKAKGGYAD-EVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       294 ~~~~~~~~~~~l~~~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      .+.+.+++|+++.. ..++. ..+.++..++.+|++.+|.+||+|.||+++|+.....
T Consensus       299 ~~~~~eiiD~~l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  299 EGKLREIVDPRLKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             CcchhheeCCCccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            88999999999864 34454 6888899999999999999999999999999665433

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=335.03  Aligned_cols=230  Identities=28%  Similarity=0.483  Sum_probs=189.6

Q ss_pred             CCCCccceeecCCceEEEEEEECCc-EEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~~~-~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      +.++..+.||+|.||.||.|.+.+. .||+|.++.. ....+.|.+|+.+|++|+|+|||+++|+|.. +..+|||||||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-~~piyIVtE~m  283 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK-QEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEec-CCceEEEEEec
Confidence            3345568899999999999999965 9999999865 2334789999999999999999999999987 55799999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM  271 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  271 (409)
                      +.|+|.+||.. ..+..+...+.+.++.|||+||+||+   ++++|||||.++|||++++..+||+||||||....+...
T Consensus       284 ~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~  359 (468)
T KOG0197|consen  284 PKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT  359 (468)
T ss_pred             ccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence            99999999976 34567999999999999999999999   899999999999999999999999999999966655432


Q ss_pred             ---eecccc--------ccCCCcHHHHHHhhhc--------------c---CcHHHHhhHHhhhcCCCCHHHHHHHHHHH
Q 048535          272 ---SGRRPI--------EEGKRNLVDRMWSLTE--------------R---SELLSVLDERLKAKGGYADEVVEKVLHLG  323 (409)
Q Consensus       272 ---~g~~p~--------~~~~~~~~~~vws~~~--------------~---~~~~~~~~~~l~~~~~~~~~~~~~l~~l~  323 (409)
                         .++.|+        ..+.++.++||||++.              .   .+..+.++...+  -+.|..++.++.+|+
T Consensus       360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyR--lp~P~~CP~~vY~lM  437 (468)
T KOG0197|consen  360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYR--LPRPEGCPDEVYELM  437 (468)
T ss_pred             ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCc--CCCCCCCCHHHHHHH
Confidence               234443        2377889999998821              1   122333333333  356777889999999


Q ss_pred             HHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          324 LLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      ..||+.+|++|||++.+...|+.....
T Consensus       438 ~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  438 KSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             HHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            999999999999999999998876543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-41  Score=312.63  Aligned_cols=224  Identities=25%  Similarity=0.381  Sum_probs=184.8

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC-eEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE-SLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~~lv~E  189 (409)
                      +++..+.||+|..|+|||+.++  ++.+|+|++... ++...+++.+|++++++.+||+||+++|.|.. +. .+.|+||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~-~~~~isI~mE  158 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS-NGEEISICME  158 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe-CCceEEeehh
Confidence            3445688999999999999998  899999999655 55667899999999999999999999999998 55 5999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      ||++|||++++..   .+.+++...-+|+.+|++||.|||+  +.+||||||||+|||++..|++||||||.++.+..+.
T Consensus       159 YMDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~  233 (364)
T KOG0581|consen  159 YMDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSI  233 (364)
T ss_pred             hcCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhh
Confidence            9999999999953   3579999999999999999999995  4899999999999999999999999999999876652


Q ss_pred             --eeeeccccc------cCCCcHHHHHHhhh-------------c-----cCcHHHHhhHHhhh-cCCCCHH-HHHHHHH
Q 048535          270 --VMSGRRPIE------EGKRNLVDRMWSLT-------------E-----RSELLSVLDERLKA-KGGYADE-VVEKVLH  321 (409)
Q Consensus       270 --~~~g~~p~~------~~~~~~~~~vws~~-------------~-----~~~~~~~~~~~l~~-~~~~~~~-~~~~l~~  321 (409)
                        ...|...+.      .+.|+..+|+|+++             .     ...+.+.++..... .+..+.+ +++++..
T Consensus       234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~  313 (364)
T KOG0581|consen  234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRS  313 (364)
T ss_pred             cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence              233444432      36788889999982             0     12445555555542 2344554 7888999


Q ss_pred             HHHHccCcCCCCCCCHHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ++..|++.||.+|||++|+++.
T Consensus       314 FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  314 FVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             HHHHHhcCCcccCCCHHHHhcC
Confidence            9999999999999999999863

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-42  Score=339.17  Aligned_cols=230  Identities=29%  Similarity=0.533  Sum_probs=194.0

Q ss_pred             CCccceeecCCceEEEEEEEC--C---cEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--G---VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ..+++.||.|.||+||+|.++  |   ..||||.++.. .++++.+|+.|+.||.+++||||++|.|+... .....||+
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-s~PvMIiT  709 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-SKPVMIIT  709 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-CceeEEEh
Confidence            346689999999999999997  3   56999999877 67788999999999999999999999999987 66789999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      |||+||+|+.||+.++  +.+++.++..++++||.||.||.   +.++|||||.++|||++.+..+|++||||+|.+.++
T Consensus       710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence            9999999999998755  45999999999999999999999   899999999999999999999999999999987554


Q ss_pred             c-----eeeeccccc--------cCCCcHHHHHHhhh-----------------ccCcHHHHhhHHhhhcCCCCHHHHHH
Q 048535          269 Q-----VMSGRRPIE--------EGKRNLVDRMWSLT-----------------ERSELLSVLDERLKAKGGYADEVVEK  318 (409)
Q Consensus       269 ~-----~~~g~~p~~--------~~~~~~~~~vws~~-----------------~~~~~~~~~~~~l~~~~~~~~~~~~~  318 (409)
                      .     ..-|+-|+.        ..+.+..+|||+++                 ...+....+....+  -+.|.+++..
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyR--LPpPmDCP~a  862 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYR--LPPPMDCPAA  862 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccC--CCCCCCCcHH
Confidence            3     233454543        35678889999981                 11223334444444  4567788899


Q ss_pred             HHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCCC
Q 048535          319 VLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTG  352 (409)
Q Consensus       319 l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~  352 (409)
                      +.+|++.||+.|-.+||++.|++..|+++...|.
T Consensus       863 L~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  863 LYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             HHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence            9999999999999999999999999998876654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=321.81  Aligned_cols=228  Identities=28%  Similarity=0.453  Sum_probs=178.5

Q ss_pred             CccceeecCCceEEEEEEECCcE-EEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          116 SEENVIGLGGNGKVYKGQLLGVE-VALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       116 ~~~~~lG~G~fg~Vy~~~~~~~~-vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      ...+.||+|+||+||+|.+.|+. ||||++...  +....++|.+|+.+|.+++|||||+++|+|.+....++||||||+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            33456999999999999999888 999999764  233367999999999999999999999999974337999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-eeecCCCCCCeeeCCCC-cEEEecccCcccccCC-c
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLHRDIKASNVLLDKKM-NARLGDFGLAKMHHHG-Q  269 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~-~  269 (409)
                      +|+|.++++.. ....+++..+++++.|||+||.|||   +.+ ||||||||+|||++.++ ++||||||+++..... .
T Consensus       124 ~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~  199 (362)
T KOG0192|consen  124 GGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKT  199 (362)
T ss_pred             CCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeeccccc
Confidence            99999999764 4567999999999999999999999   677 99999999999999997 9999999999876642 1


Q ss_pred             e---eeecccc------c--cCCCcHHHH-------HHhhhccCcHH----------HHhhHHhhhcCCCCHHHHHHHHH
Q 048535          270 V---MSGRRPI------E--EGKRNLVDR-------MWSLTERSELL----------SVLDERLKAKGGYADEVVEKVLH  321 (409)
Q Consensus       270 ~---~~g~~p~------~--~~~~~~~~~-------vws~~~~~~~~----------~~~~~~l~~~~~~~~~~~~~l~~  321 (409)
                      .   .+|...+      .  ...++.+.|       +|++......+          .++....+  +..+..+...+..
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R--p~~p~~~~~~l~~  277 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR--PPIPKECPPHLSS  277 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC--CCCCccCCHHHHH
Confidence            1   1222221      1  113444445       45553332111          11112222  4456668889999


Q ss_pred             HHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          322 LGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      ++.+||+.||+.||++.+++..|+.+..
T Consensus       278 l~~~CW~~dp~~RP~f~ei~~~l~~~~~  305 (362)
T KOG0192|consen  278 LMERCWLVDPSRRPSFLEIVSRLESIMS  305 (362)
T ss_pred             HHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence            9999999999999999999999987654

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-39  Score=300.20  Aligned_cols=244  Identities=24%  Similarity=0.365  Sum_probs=190.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ..+|...+.||+|+||+||+|+++  +..||||.+...  ..+..+.+..|+.+|+.++|||||++++++.+ ++.+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-DDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-CCeEEEE
Confidence            467888889999999999999997  899999999766  56677788999999999999999999999987 7899999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC------CcEEEecccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK------MNARLGDFGL  261 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~------~~~kl~DFGl  261 (409)
                      ||||.+|||.+||+.   .+.+++.....++.|+|.||++||   +++||||||||.||||+..      -.+||+|||+
T Consensus        88 MEyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            999999999999964   347999999999999999999999   8999999999999999765      4589999999


Q ss_pred             cccccCCc---eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCC
Q 048535          262 AKMHHHGQ---VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEAN  332 (409)
Q Consensus       262 a~~~~~~~---~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~  332 (409)
                      ||....+.   .++|.+-+.      ...|+.+.|+|+++  ..+++.+                         .-..|-
T Consensus       162 AR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG--~Ilyq~l-------------------------~g~~Pf  214 (429)
T KOG0595|consen  162 ARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIG--TILYQCL-------------------------TGKPPF  214 (429)
T ss_pred             hhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHH--HHHHHHH-------------------------hCCCCc
Confidence            99998765   456766553      36788899999986  2223222                         234555


Q ss_pred             CCCCHHHHHHHHhcCcCCCCCCCCC-cc--hhHHhhhcccCCCCcccccccCCCCCcccc
Q 048535          333 SRPTIRQVLKMLEGQTEGTGLEDEG-MN--VHLLKRIGTRAMTSSWKFAGSRGHPTFNEI  389 (409)
Q Consensus       333 ~RPt~~evl~~L~~~~~~~~~~~~~-~~--~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~  389 (409)
                      ++.|..|++...+.........+.. .+  .+++-..+..++..|++..+-..||+...-
T Consensus       215 ~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  215 DAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             cccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence            6666666666665443322222211 11  366666666766777776666666654443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-39  Score=316.55  Aligned_cols=224  Identities=22%  Similarity=0.385  Sum_probs=190.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ..|...+.||+|||+.||+++..  |+.||+|++...   ...+.+...+||++.+.|+|||||+++++|.+ .+++|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-s~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-SNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-CCceEEE
Confidence            56889999999999999999984  999999999764   55667889999999999999999999999998 7899999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      .|+|++|+|..+++   ...++++.++..++.||+.||.|||   +.+|+|||||..|++|++++++||+|||||.....
T Consensus        97 LELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   97 LELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EEecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecC
Confidence            99999999999995   4467999999999999999999999   89999999999999999999999999999988774


Q ss_pred             C----ceeeecccccc------CCCcHHHHHHhhh-------------ccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHH
Q 048535          268 G----QVMSGRRPIEE------GKRNLVDRMWSLT-------------ERSELLSVLDERLKAKGGYADEVVEKVLHLGL  324 (409)
Q Consensus       268 ~----~~~~g~~p~~~------~~~~~~~~vws~~-------------~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~  324 (409)
                      +    ..+||.+.+-.      ...++..|+|+++             ....+.+..+......-..|...+.+..+|+.
T Consensus       171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~  250 (592)
T KOG0575|consen  171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIR  250 (592)
T ss_pred             cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHH
Confidence            4    27788876543      5568899999984             22334444444333333445566778899999


Q ss_pred             HccCcCCCCCCCHHHHHHH
Q 048535          325 LCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       325 ~Cl~~dP~~RPt~~evl~~  343 (409)
                      ..|+.||.+|||+++|+..
T Consensus       251 ~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  251 KLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             HHhcCCcccCCCHHHHhcC
Confidence            9999999999999999863

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.7e-40  Score=332.53  Aligned_cols=235  Identities=23%  Similarity=0.411  Sum_probs=190.0

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeEeeEEEccCC
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLDSE-HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  182 (409)
                      .+.+.+..+.||+|.||.||+|+..       ...||||.++.... +..++|.+|+++|..|+|||||+++|+|.+ ++
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-~~  562 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-GD  562 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-CC
Confidence            3455666789999999999999876       25699999987744 478899999999999999999999999998 78


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC
Q 048535          183 SLILIYDYMENGSLDKWIFECD-------E----SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK  251 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~  251 (409)
                      .+++|+|||..|||.+||+...       .    ..+|+..+.+.||.|||.||+||-   ++.+|||||..+|+||+++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccc
Confidence            8999999999999999997431       1    234899999999999999999999   8999999999999999999


Q ss_pred             CcEEEecccCcccccCCceee------------eccccccCCCcHHHHHHhhhcc-----------------CcHHHHhh
Q 048535          252 MNARLGDFGLAKMHHHGQVMS------------GRRPIEEGKRNLVDRMWSLTER-----------------SELLSVLD  302 (409)
Q Consensus       252 ~~~kl~DFGla~~~~~~~~~~------------g~~p~~~~~~~~~~~vws~~~~-----------------~~~~~~~~  302 (409)
                      ..+||+||||+|..-..++.-            ....+..+.++..+|||+++.-                 .+..+.+.
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~  719 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR  719 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence            999999999999765443221            1222345788888999887211                 11112222


Q ss_pred             HHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCC
Q 048535          303 ERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGT  351 (409)
Q Consensus       303 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  351 (409)
                      .+-.  -+.++.++.++..|+..||+.+|.+||+++||-..|+...+..
T Consensus       720 ~g~l--L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  720 AGQL--LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             cCCc--ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence            1111  3567788899999999999999999999999999998765543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-39  Score=303.66  Aligned_cols=224  Identities=24%  Similarity=0.330  Sum_probs=180.3

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChH-------HHHHHHHHHHHhccCCCCceeeEeeEEEccCC
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEH-------GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  182 (409)
                      .+.|-..+.||+|+||.|-+|..+  |+.||||+++.....       ......+|+++|++|+|||||++++++.. ..
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-~d  249 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-PD  249 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec-CC
Confidence            355777899999999999999887  999999999754111       12235799999999999999999999987 67


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC---CcEEEecc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK---MNARLGDF  259 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kl~DF  259 (409)
                      ..|+||||++||+|.+++-   .+..+.+..-.-++.|++.|+.|||   ++||+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEeccc
Confidence            7899999999999999985   3456888888999999999999999   8999999999999999766   77999999


Q ss_pred             cCcccccCCc---eeeecccccc---------CCCcHHHHHHhhhc-----------------cC-cHHHHhhHHhhhcC
Q 048535          260 GLAKMHHHGQ---VMSGRRPIEE---------GKRNLVDRMWSLTE-----------------RS-ELLSVLDERLKAKG  309 (409)
Q Consensus       260 Gla~~~~~~~---~~~g~~p~~~---------~~~~~~~~vws~~~-----------------~~-~~~~~~~~~l~~~~  309 (409)
                      |+|+....+.   .+||.+.+-.         ..+.-+.|+|+++.                 .. -..++...+....+
T Consensus       324 GlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p  403 (475)
T KOG0615|consen  324 GLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP  403 (475)
T ss_pred             chhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence            9999987654   5577766532         22334669999821                 11 12334444555445


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          310 GYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       310 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+.+..++.++++.++|..||++|||+.|+++
T Consensus       404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  404 LQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            566778899999999999999999999998875

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.9e-38  Score=280.28  Aligned_cols=265  Identities=22%  Similarity=0.305  Sum_probs=207.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChH--HHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEH--GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ..|...+.||+|.||.||+|++.  |+.||||+++.....  -....++|+..|+.++|+||+.+++.|-. .+.+.||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-KSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-CCceEEEE
Confidence            45777899999999999999987  999999999876322  23567899999999999999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      |||+. +|...+++  +...++..++..++.++++||+|||   .+.|+||||||.|+|++++|.+||+|||+|+.+...
T Consensus        81 Efm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             Eeccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            99988 99999975  4567999999999999999999999   899999999999999999999999999999987643


Q ss_pred             c------eeee-cccc----ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 048535          269 Q------VMSG-RRPI----EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI  337 (409)
Q Consensus       269 ~------~~~g-~~p~----~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  337 (409)
                      .      +.|. .++.    ....|....|+|+.+  +.+.+++-...-..++.   ..+++..+....-.+.|++=|.|
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavG--CI~AELllr~P~fpG~s---DidQL~~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVG--CIFAELLLRVPFFPGDS---DIDQLSKIFRALGTPTPDQWPEM  229 (318)
T ss_pred             CcccccceeeeeccChHHhccchhcCCcchhhhHH--HHHHHHHccCCCCCCCc---hHHHHHHHHHHcCCCCcccCccc
Confidence            2      1221 1111    234567778999987  45555554443333333   34455556666678899999988


Q ss_pred             HHHHHHHhcCcCCCCCCC-------CCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          338 RQVLKMLEGQTEGTGLED-------EGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       338 ~evl~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      .++-+..+=. ..|.++.       .....|++.+|+..+|.+|+++++++.||||++..
T Consensus       230 ~~lpdY~~~~-~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  230 TSLPDYVKIQ-QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             cccccHHHHh-cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence            8876654422 1111111       11238999999999999999999999999999744

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-39  Score=289.48  Aligned_cols=231  Identities=25%  Similarity=0.385  Sum_probs=185.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCe-EEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES-LILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~-~~lv  187 (409)
                      .+|++.++||+|.||+||++...  |..||.|.++.+  +.+..+.+..|+.+|++|+|||||+++++...++.. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            45778899999999999999876  999999999865  666778899999999999999999999954433444 8999


Q ss_pred             EEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          188 YDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESK--VLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ||||..|+|.+.+... ..+..+++..+++++.|++.||..+|..+ ++  |+||||||.||+|+.+|.+||+||||++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999754 34557999999999999999999999533 44  99999999999999999999999999999


Q ss_pred             ccCCc----eeeecccc------ccCCCcHHHHHHhhh-------------ccCcHHHHhhHHhhhcCCC---C-HHHHH
Q 048535          265 HHHGQ----VMSGRRPI------EEGKRNLVDRMWSLT-------------ERSELLSVLDERLKAKGGY---A-DEVVE  317 (409)
Q Consensus       265 ~~~~~----~~~g~~p~------~~~~~~~~~~vws~~-------------~~~~~~~~~~~~l~~~~~~---~-~~~~~  317 (409)
                      +....    .+.|.+.+      ....|+.++|+|+++             ....+.++-.+.-.  +++   + ...+.
T Consensus       178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~q--gd~~~~p~~~YS~  255 (375)
T KOG0591|consen  178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQ--GDYPPLPDEHYST  255 (375)
T ss_pred             hcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHc--CCCCCCcHHHhhh
Confidence            87655    23344433      247899999999983             11233333333222  333   3 56788


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      .+..|+..|+..||+.||+...+++.+..
T Consensus       256 ~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  256 DLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             HHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            89999999999999999996666665554

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-38  Score=301.28  Aligned_cols=261  Identities=25%  Similarity=0.380  Sum_probs=201.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~~l  186 (409)
                      .+.|+.+++||+|.||.||+|+..  |+.||+|+++.+.  +....-..+||.+|++|+||||++|.+...+. ...+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            356778899999999999999987  9999999998764  34455678999999999999999999998874 468999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      |+|||+. ||.-++..  ....+++.++..++.|++.||+|+|   .++|+|||||.+|||||.+|.+||+|||||+++.
T Consensus       196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999998 99988843  4567999999999999999999999   8999999999999999999999999999999776


Q ss_pred             CCc--eeee------ccccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCC
Q 048535          267 HGQ--VMSG------RRPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSR  334 (409)
Q Consensus       267 ~~~--~~~g------~~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R  334 (409)
                      ...  .+|.      ++|.+    ...|+...|+|+.+  +.+.+++..+.-..+   ..+++++-.|-..|-.+.++-=
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~G--CIl~El~~gkPI~~G---~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVG--CILAELFLGKPILQG---RTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhh--HHHHHHHcCCCCcCC---ccHHHHHHHHHHHhCCCChhcc
Confidence            543  1222      22322    36688889999987  556666554433222   3455666777777877766543


Q ss_pred             CCHHHHH------------HHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          335 PTIRQVL------------KMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       335 Pt~~evl------------~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      | ...+-            ..|.+...    ..+....+|++.|+..||.+|.++.+++.|+||+.
T Consensus       345 ~-~~kLP~~~~~kp~~~y~r~l~E~~~----~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  345 P-VSKLPHATIFKPQQPYKRRLRETFK----DFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             c-cccCCcccccCCCCcccchHHHHhc----cCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            3 11110            11111100    11223589999999999999999999999999944

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=298.69  Aligned_cols=236  Identities=26%  Similarity=0.417  Sum_probs=184.7

Q ss_pred             hCCCCccceeecCCceEEEEEEEC---C--cE-EEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL---G--VE-VALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~---~--~~-vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  182 (409)
                      -++....++||+|+||.||+|++.   +  .. ||||..+..   ......+|++|+++|++++|||||+++|++.. ..
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~-~~  234 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL-EE  234 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC-CC
Confidence            344555689999999999999987   2  23 899999853   56778999999999999999999999999998 77


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      .++||||+|+||+|.+||.+..  ..++..+++.++.|.|.||+|||   ++++|||||.++|+|++.++.+||+||||+
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccc
Confidence            8999999999999999997533  26999999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCceee--ecccc--------ccCCCcHHHHHHhhh-------cc-------CcHHHHhhHHhh--hcCCCCHHHH
Q 048535          263 KMHHHGQVMS--GRRPI--------EEGKRNLVDRMWSLT-------ER-------SELLSVLDERLK--AKGGYADEVV  316 (409)
Q Consensus       263 ~~~~~~~~~~--g~~p~--------~~~~~~~~~~vws~~-------~~-------~~~~~~~~~~l~--~~~~~~~~~~  316 (409)
                      +.........  -+.|.        ..+.++...|||+++       ..       ....++......  .....+...+
T Consensus       310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p  389 (474)
T KOG0194|consen  310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTP  389 (474)
T ss_pred             cCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCH
Confidence            8765211111  01222        236778889999872       11       111111111101  1123445667


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCCCC
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGL  353 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~  353 (409)
                      ..+..++.+||..+|++||||.++.+.|+........
T Consensus       390 ~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  390 KELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            7788899999999999999999999999887655443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.4e-37  Score=277.22  Aligned_cols=172  Identities=24%  Similarity=0.346  Sum_probs=142.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      +.|+...++|+|+||.||+|+.+  |+.||||++...  ++.-.+-.++|+++|++++|+|+|.++.+|.. ...++||+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEEe
Confidence            35777789999999999999987  999999999654  34445667899999999999999999999987 78999999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc-C
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH-H  267 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~  267 (409)
                      |||+. ++.+-|..  ....++...+.+++.|+++|+.|+|   ++++|||||||+||||+.++.+||||||+|+.+. .
T Consensus        81 E~~dh-TvL~eLe~--~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   81 EYCDH-TVLHELER--YPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             eecch-HHHHHHHh--ccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            99988 44444433  2345899999999999999999999   8999999999999999999999999999999887 4


Q ss_pred             Cceeeecccc----------ccCCCcHHHHHHhh
Q 048535          268 GQVMSGRRPI----------EEGKRNLVDRMWSL  291 (409)
Q Consensus       268 ~~~~~g~~p~----------~~~~~~~~~~vws~  291 (409)
                      ++..|.....          ....|....|+|++
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAi  188 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAI  188 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhh
Confidence            4433332211          12456777899987

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=301.93  Aligned_cols=239  Identities=22%  Similarity=0.411  Sum_probs=198.0

Q ss_pred             HHHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC
Q 048535          105 YQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       105 ~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  182 (409)
                      +++++....+.....+||-|.||.||.|.|+  ...||||.++.+. ...++|+.|+.+|+.++|||+|+|+|+|.. ..
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~-Ep  336 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTH-EP  336 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhcc-CC
Confidence            3556666666777789999999999999998  7889999998653 456899999999999999999999999997 66


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      .+|||+|||.+|+|.+||++++. ..++.-..+.++.||+.||+||.   .+++|||||.++|+|+.++..+||+||||+
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLs  412 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLS  412 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchh
Confidence            78999999999999999998654 46788889999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCceee---ecccc--------ccCCCcHHHHHHhhh-----------------ccCcHHHHhhHHhhhcCCCCHH
Q 048535          263 KMHHHGQVMS---GRRPI--------EEGKRNLVDRMWSLT-----------------ERSELLSVLDERLKAKGGYADE  314 (409)
Q Consensus       263 ~~~~~~~~~~---g~~p~--------~~~~~~~~~~vws~~-----------------~~~~~~~~~~~~l~~~~~~~~~  314 (409)
                      +++..+++..   .+.|+        ..+.++.++|||.+.                 +....++++....+  .+-++.
T Consensus       413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR--M~~PeG  490 (1157)
T KOG4278|consen  413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR--MDGPEG  490 (1157)
T ss_pred             hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc--ccCCCC
Confidence            9988766332   12232        236678889999872                 11234455555544  455778


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCC
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGT  351 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  351 (409)
                      |++.+.+|++.||+++|.+||+++|+-+.++.+....
T Consensus       491 CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  491 CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            8899999999999999999999999999887654443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-37  Score=294.83  Aligned_cols=248  Identities=21%  Similarity=0.270  Sum_probs=189.5

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCe
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  183 (409)
                      ...++|..++.||.|+|++|++|+..  ++.+|||++.+.   .....+-...|-.+|.+| .||.|++|+-.|.+ ...
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD-~~s  148 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD-EES  148 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec-ccc
Confidence            34578999999999999999999987  899999999754   222234466788999999 89999999998887 788


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      +|.|+||+++|+|.++|++   .+.+++.....++.||+.||+|||   ++|||||||||+|||||+||++||+|||.|+
T Consensus       149 LYFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccc
Confidence            9999999999999999954   467999999999999999999999   9999999999999999999999999999999


Q ss_pred             cccCCcee-----------------eecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHH
Q 048535          264 MHHHGQVM-----------------SGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVL  320 (409)
Q Consensus       264 ~~~~~~~~-----------------~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~  320 (409)
                      .+......                 .|..-+      .....+..+|+|.++  +.+++++.+..++.+.   ++..-+.
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlG--CilyQmlaG~PPFra~---NeyliFq  297 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALG--CILYQMLAGQPPFRAA---NEYLIFQ  297 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHH--HHHHHHhcCCCCCccc---cHHHHHH
Confidence            87654311                 121111      124446778899887  6677776655443221   2222223


Q ss_pred             HHHHHccCcCCCCCCCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          321 HLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       321 ~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      +++..-...-|.-+                      ....+|+.+++..+|..|++++++..||||++|+-
T Consensus       298 kI~~l~y~fp~~fp----------------------~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw  346 (604)
T KOG0592|consen  298 KIQALDYEFPEGFP----------------------EDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW  346 (604)
T ss_pred             HHHHhcccCCCCCC----------------------HHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence            33222222222222                      23367778888889999999999999999998873

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-37  Score=297.02  Aligned_cols=235  Identities=24%  Similarity=0.399  Sum_probs=191.3

Q ss_pred             cccHHHHHHHhCCCCccceeecCCceEEEEEEECCcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEc
Q 048535          102 RVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK  179 (409)
Q Consensus       102 ~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  179 (409)
                      +.+.+++....+.+.+.+.||+|.||+||+|.|.|. ||||+++.+  ++.+.+.|.+|+..+++-+|.||+-+.|||..
T Consensus       381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             CccccccccCHHHhhccceeccccccceeecccccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            445567777778888899999999999999999985 999999876  56678899999999999999999999999986


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 048535          180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDF  259 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF  259 (409)
                       + .+.||+.+|+|-+|+.+||..+  ..+...+.+.|+.|||+||.|||   .++|||||||..||+|.+++++||+||
T Consensus       460 -p-~~AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  460 -P-PLAIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             -C-ceeeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecc
Confidence             3 3489999999999999998643  56899999999999999999999   899999999999999999999999999


Q ss_pred             cCcccccCCceeeecc------------------ccccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCC-----------
Q 048535          260 GLAKMHHHGQVMSGRR------------------PIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGG-----------  310 (409)
Q Consensus       260 Gla~~~~~~~~~~g~~------------------p~~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~-----------  310 (409)
                      ||+..-..   +.|..                  -.+...+++.+||++++  ..+++++...++....           
T Consensus       533 GLatvk~~---w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFG--iV~YELltg~lPysi~~~dqIifmVGr  607 (678)
T KOG0193|consen  533 GLATVKTR---WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFG--IVWYELLTGELPYSIQNRDQIIFMVGR  607 (678)
T ss_pred             cceeeeee---eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhh--HHHHHHHhCcCCcCCCChhheEEEecc
Confidence            99864221   11111                  11235677888888875  3455555554443211           


Q ss_pred             ---------CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          311 ---------YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       311 ---------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                               ....+.+++.+|+..||..++++||.+.+++..|+....
T Consensus       608 G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  608 GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             cccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence                     122456689999999999999999999999998887655

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-36  Score=279.17  Aligned_cols=246  Identities=25%  Similarity=0.292  Sum_probs=190.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .++|+..+.||+|+||.||.++..  ++.+|+|++++.   .....+...+|..+|.+++||.||+++-.|.+ .+.+|+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt-~~kLyl  102 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT-EEKLYL  102 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc-CCeEEE
Confidence            478999999999999999999876  899999999765   33456778899999999999999999988887 889999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      |+||+.||.|..+|.   ..+.+++..+.-++.+|+.||.|||   +.+||||||||+|||||.+|.++|+||||++...
T Consensus       103 Vld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            999999999999994   4467999999999999999999999   8999999999999999999999999999999543


Q ss_pred             CC----ceeeecccccc------CCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCC
Q 048535          267 HG----QVMSGRRPIEE------GKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPT  336 (409)
Q Consensus       267 ~~----~~~~g~~p~~~------~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt  336 (409)
                      ..    ...+|+..+..      ..|+-..|.|+++  ..+++++....+    +..+...++.+-+..+=         
T Consensus       177 ~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLG--illYeML~G~pP----F~~~~~~~~~~~I~~~k---------  241 (357)
T KOG0598|consen  177 KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLG--ILLYEMLTGKPP----FYAEDVKKMYDKILKGK---------  241 (357)
T ss_pred             cCCCccccccCCccccChHHHhcCCCCcccchHhHH--HHHHHHhhCCCC----CcCccHHHHHHHHhcCc---------
Confidence            32    35677777643      5778889999997  344555443322    22222222222111110         


Q ss_pred             HHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcc----cccccCCCCCccccc
Q 048535          337 IRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSW----KFAGSRGHPTFNEIN  390 (409)
Q Consensus       337 ~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~----~~~~~~~hp~~~~~~  390 (409)
                                 ...++.--....++++.+++..+|.+|+    ...++..||||..++
T Consensus       242 -----------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in  288 (357)
T KOG0598|consen  242 -----------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN  288 (357)
T ss_pred             -----------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence                       1111111122348889999999999996    356888999999987

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-36  Score=294.45  Aligned_cols=233  Identities=24%  Similarity=0.390  Sum_probs=177.9

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccC
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEK  181 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  181 (409)
                      +.++|++.+.||+|+||.||+|.+.       ++.||||+++.. .....+.+.+|+.++.++ +||||++++++|....
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            4567899999999999999999752       467999999754 334456799999999999 8999999999988756


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCC--------------------------------------------------------
Q 048535          182 ESLILIYDYMENGSLDKWIFECDE--------------------------------------------------------  205 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~--------------------------------------------------------  205 (409)
                      ..+++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            678999999999999999964311                                                        


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc--eeee-------
Q 048535          206 ---SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ--VMSG-------  273 (409)
Q Consensus       206 ---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~--~~~g-------  273 (409)
                         ...+++..+..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+++......  ...+       
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               134888999999999999999999   8999999999999999999999999999998653221  1111       


Q ss_pred             ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HH---------------hhh--cCCCCHHHHHHHHHHHHHccCcCCC
Q 048535          274 RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ER---------------LKA--KGGYADEVVEKVLHLGLLCAHPEAN  332 (409)
Q Consensus       274 ~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~---------------l~~--~~~~~~~~~~~l~~l~~~Cl~~dP~  332 (409)
                      ..+.+   ...++..+|+|+++  ..+++++. ..               +..  ....+......+.+++.+||+.||+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG--~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~  319 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFG--VLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK  319 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHH--HHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence            11111   24456778899874  22222221 11               100  0111233456789999999999999


Q ss_pred             CCCCHHHHHHHHhcCc
Q 048535          333 SRPTIRQVLKMLEGQT  348 (409)
Q Consensus       333 ~RPt~~evl~~L~~~~  348 (409)
                      +|||+.|+++.|+...
T Consensus       320 ~RPs~~el~~~l~~~~  335 (338)
T cd05102         320 ERPTFSALVEILGDLL  335 (338)
T ss_pred             hCcCHHHHHHHHHHHH
Confidence            9999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-37  Score=291.12  Aligned_cols=270  Identities=18%  Similarity=0.260  Sum_probs=202.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChH-HHHHHHHHHHHhccCC-CCceeeEeeEEEccCCeEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEH-GMREFLAEVSSLGRLK-HRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~lv  187 (409)
                      -++|...++||.|.||.||+|+..  |..||||+++..-.. +...=++|+..|++|+ |||||++..++.+....+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            367888899999999999999887  899999999765221 1122468999999998 999999999999855589999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||||+. +|++++++.  ...+++..+..|+.||++||+|+|   .+|+.|||+||+|||+..+..+||+||||||....
T Consensus        89 fE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   89 FEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             HHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccccccc
Confidence            999977 999999864  568999999999999999999999   89999999999999999888999999999998765


Q ss_pred             Cceee----eccc------cccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 048535          268 GQVMS----GRRP------IEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI  337 (409)
Q Consensus       268 ~~~~~----g~~p------~~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  337 (409)
                      ..-.|    .+-.      ...+.|+...|+|+++  +...++..-+..+++.   .+.+++.++..-.-.++-+.=|+-
T Consensus       163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~G--cI~aEl~sLrPLFPG~---sE~Dqi~KIc~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVG--CIMAELYSLRPLFPGA---SEIDQIYKICEVLGTPDKDSWPEG  237 (538)
T ss_pred             CCCcchhhhcccccchHHhhhccccCCchHHHHHH--HHHHHHHHhcccCCCC---cHHHHHHHHHHHhCCCccccchhH
Confidence            43222    1111      1247788999999997  3344443322222232   334445555444445555555776


Q ss_pred             HHHHHHHhcCcCC-CC-------CCCCCcchhHHhhhcccCCCCcccccccCCCCCccccccc
Q 048535          338 RQVLKMLEGQTEG-TG-------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKN  392 (409)
Q Consensus       338 ~evl~~L~~~~~~-~~-------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~  392 (409)
                      .++...|.=..+. .+       +.-......++.+|+.-||.+|.++++++.||||..-.+.
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~  300 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS  300 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence            7777766422111 10       0011123789999999999999999999999999876544

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-36  Score=281.90  Aligned_cols=227  Identities=24%  Similarity=0.355  Sum_probs=176.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC-eEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE-SLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-~~~lv~E  189 (409)
                      .++...+.||+|+||.||++...  |...|||.+...+....+.+.+|+.+|++++|||||+++|......+ .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45677899999999999999987  79999999976643346778999999999999999999997554333 6899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC-CCcEEEecccCcccccC-
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK-KMNARLGDFGLAKMHHH-  267 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DFGla~~~~~-  267 (409)
                      |+++|||.+++.....  .+++..+.++..||++||+|||   +++||||||||+|||++. ++.+||+|||+++.... 
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999965432  6999999999999999999999   899999999999999999 79999999999987663 


Q ss_pred             -C-----ceeeeccccc------cC-CCcHHHHHHhhhcc-------CcH-HH-------HhhHHhh-hcCCCCHHHHHH
Q 048535          268 -G-----QVMSGRRPIE------EG-KRNLVDRMWSLTER-------SEL-LS-------VLDERLK-AKGGYADEVVEK  318 (409)
Q Consensus       268 -~-----~~~~g~~p~~------~~-~~~~~~~vws~~~~-------~~~-~~-------~~~~~l~-~~~~~~~~~~~~  318 (409)
                       .     ....|.+.+.      .+ ......|+|+++..       ... .+       ++..... ..+.++...+.+
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~  251 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDE  251 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHH
Confidence             1     1223332221      11 12247899998421       111 11       1111100 113566677788


Q ss_pred             HHHHHHHccCcCCCCCCCHHHHHHHH
Q 048535          319 VLHLGLLCAHPEANSRPTIRQVLKML  344 (409)
Q Consensus       319 l~~l~~~Cl~~dP~~RPt~~evl~~L  344 (409)
                      ..+++..|++.||++|||+.++++..
T Consensus       252 a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  252 AKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhhCh
Confidence            99999999999999999999999864

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=287.62  Aligned_cols=232  Identities=27%  Similarity=0.458  Sum_probs=182.0

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      +.+...+.++||+|-||.|.+++.. +..||||+++.+. ...+++|.+|+++|.+|+|||||+++|+|.. ++.+++|+
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-DePicmI~  614 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-DDPLCMIT  614 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-CCchHHHH
Confidence            3445667789999999999999998 5999999998774 4456899999999999999999999999998 67899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      |||++|+|.+|+..+... .+.-...++|+.|||.||+||.   +.++|||||.++|||+|.++++||+|||++|.+-.+
T Consensus       615 EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccC
Confidence            999999999999765322 2455667889999999999999   899999999999999999999999999999965544


Q ss_pred             c--eeeecc--cc--------ccCCCcHHHHHHhhhcc----------CcHHHHhhHHhh-------------hcCCCCH
Q 048535          269 Q--VMSGRR--PI--------EEGKRNLVDRMWSLTER----------SELLSVLDERLK-------------AKGGYAD  313 (409)
Q Consensus       269 ~--~~~g~~--p~--------~~~~~~~~~~vws~~~~----------~~~~~~~~~~l~-------------~~~~~~~  313 (409)
                      .  -+.|+.  |+        --++.+.++|+|.+...          ....++.|+...             .....|.
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~  770 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPP  770 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCC
Confidence            3  223332  11        12667778888876321          111122222111             0112344


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      -++..+.+++++||..|.++||+++++...|+..
T Consensus       771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  771 ACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            5677899999999999999999999999988754

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=310.10  Aligned_cols=235  Identities=28%  Similarity=0.448  Sum_probs=187.4

Q ss_pred             hCCCCccceeecCCceEEEEEEEC---Cc----EEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL---GV----EVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~---~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  183 (409)
                      ....+..+.||+|.||.||.|...   |.    .||||.++.. +.+...+|++|..+|++++|||||+++|+|.+ ...
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~  769 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGP  769 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCC
Confidence            345566788999999999999986   33    4999999766 66778899999999999999999999999998 778


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 048535          184 LILIYDYMENGSLDKWIFECDE----SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDF  259 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF  259 (409)
                      .+|++|||++|||..||++.+.    ...++....+.++.|||+|+.||+   ++++|||||.++|+||+....+||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEccc
Confidence            8999999999999999987522    346899999999999999999999   899999999999999999999999999


Q ss_pred             cCcccccCCceee----ecccc--------ccCCCcHHHHHHhhh--------------ccCcHHHHhhHHh-hhcCCCC
Q 048535          260 GLAKMHHHGQVMS----GRRPI--------EEGKRNLVDRMWSLT--------------ERSELLSVLDERL-KAKGGYA  312 (409)
Q Consensus       260 Gla~~~~~~~~~~----g~~p~--------~~~~~~~~~~vws~~--------------~~~~~~~~~~~~l-~~~~~~~  312 (409)
                      ||||.+...++..    +..|.        ..+.++.++|+|+++              ....-.+++..-+ ...-+.+
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P  926 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP  926 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC
Confidence            9999554433221    12222        236677788888872              1111122222111 1123567


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      ..++..+.+|+..||+.+|++||++..+++.+..+...
T Consensus       927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            77888999999999999999999999999988776544

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-36  Score=278.62  Aligned_cols=269  Identities=20%  Similarity=0.313  Sum_probs=199.4

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEec--cCChHHHHHHHHHHHHhccCCCCceeeEeeEEEc----cC
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRIS--LDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK----EK  181 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~  181 (409)
                      .....|...+.||+|+||.|+.+...  |+.||||++.  .+.....++-.+|+.+|+.++|+||+.+++.+..    .-
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            34456666789999999999999987  9999999997  4566677889999999999999999999998865    23


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      ..+|+|+|+|+. +|.+.++   .+..|+.....-++.|+++||.|+|   +.+|+||||||+|+|++.+...|||||||
T Consensus        99 ~DvYiV~elMet-DL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   99 NDVYLVFELMET-DLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ceeEEehhHHhh-HHHHHHH---cCccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccc
Confidence            469999999955 9999994   3445999999999999999999999   89999999999999999999999999999


Q ss_pred             cccccC---Cceeeecccc----------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccC
Q 048535          262 AKMHHH---GQVMSGRRPI----------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAH  328 (409)
Q Consensus       262 a~~~~~---~~~~~g~~p~----------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~  328 (409)
                      ||....   ...+|+....          ....|+...|+|+.+  +.+.+++..+..+.+.-..+....+.+   .+=.
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvG--CI~AEmL~gkplFpG~d~v~Ql~lI~~---~lGt  246 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVG--CILAEMLTGKPLFPGKDYVHQLQLILE---LLGT  246 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhh--HHHHHHHcCCCCCCCCchHHHHHHHHH---hcCC
Confidence            998863   3333433222          136788899999997  566677666554444333333333222   2222


Q ss_pred             cCCC--CCCCHHHHHHHHhcCcCCCCCC-------CCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          329 PEAN--SRPTIRQVLKMLEGQTEGTGLE-------DEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       329 ~dP~--~RPt~~evl~~L~~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ++++  .+-+-..+...+++....+..+       ......+++++|+..||.+|+|.++++.||+++...
T Consensus       247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence            2221  1222222222333332222211       112348999999999999999999999999988644

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.9e-35  Score=278.07  Aligned_cols=229  Identities=25%  Similarity=0.424  Sum_probs=174.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC------------------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceee
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL------------------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVG  172 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~------------------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~  172 (409)
                      .++|...+.||+|+||.||+|.+.                  +..||+|.+... ......+|.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            357888999999999999999753                  346999999765 3445678999999999999999999


Q ss_pred             EeeEEEccCCeEEEEEEeCCCCCHHHHHhcCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 048535          173 LRGWCKKEKESLILIYDYMENGSLDKWIFECD----------------ESIALSWEQRIKVLKDVASGILYLYEGWESKV  236 (409)
Q Consensus       173 l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  236 (409)
                      +++++.+ .+..++||||+++|+|.+++....                ....+++..+.+++.||+.||.|||   +.+|
T Consensus        84 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i  159 (304)
T cd05096          84 LLGVCVD-EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNF  159 (304)
T ss_pred             EEEEEec-CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCc
Confidence            9999987 677899999999999999985421                1134788999999999999999999   8999


Q ss_pred             eecCCCCCCeeeCCCCcEEEecccCcccccCCce--eeec-------ccc---ccCCCcHHHHHHhhhccCcHHHHhh--
Q 048535          237 LHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV--MSGR-------RPI---EEGKRNLVDRMWSLTERSELLSVLD--  302 (409)
Q Consensus       237 vHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~--~~g~-------~p~---~~~~~~~~~~vws~~~~~~~~~~~~--  302 (409)
                      +||||||+|||++.++.+||+|||+++.......  .++.       .+.   ....++..+|+|+++.  .+++++.  
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~--~l~el~~~~  237 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV--TLWEILMLC  237 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH--HHHHHHHcc
Confidence            9999999999999999999999999986543221  1111       111   1245677889999741  1222111  


Q ss_pred             ---------------H---Hhhh-----cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          303 ---------------E---RLKA-----KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       303 ---------------~---~l~~-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                                     .   .+..     ....+..++..+.+++.+||+.||++|||+.++.+.|++
T Consensus       238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence                           0   0000     001122344678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=264.59  Aligned_cols=244  Identities=22%  Similarity=0.296  Sum_probs=194.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||.|+||.|.+++.+  |.-+|+|+++..   ..++.+...+|..+|+.+.||.++++++.|.+ ...+|+|
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-~~~lymv  122 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-NSNLYMV  122 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-CCeEEEE
Confidence            56888899999999999999987  889999999866   34456678899999999999999999999988 7899999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||.+||.|..++++   .+.+++..+..++.||+.||+|||   +..|++|||||+|||||.+|.+||+|||+|+....
T Consensus       123 meyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            999999999999954   457999999999999999999999   89999999999999999999999999999998776


Q ss_pred             Cc-eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 048535          268 GQ-VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQV  340 (409)
Q Consensus       268 ~~-~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev  340 (409)
                      .+ .+||.+-+-      ...++...|.|+++  --+++++....++.                       ..+| |.--
T Consensus       197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalG--VLIYEMlaG~pPF~-----------------------~~~~-~~iY  250 (355)
T KOG0616|consen  197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALG--VLIYEMLAGYPPFY-----------------------DDNP-IQIY  250 (355)
T ss_pred             cEEEecCCccccChHHhhcCCCCcchhHHHHH--HHHHHHHcCCCCCc-----------------------CCCh-HHHH
Confidence            54 677776543      25677888999986  23444444333211                       1222 4444


Q ss_pred             HHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCccc-----ccccCCCCCccccc
Q 048535          341 LKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWK-----FAGSRGHPTFNEIN  390 (409)
Q Consensus       341 l~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-----~~~~~~hp~~~~~~  390 (409)
                      -+.+++....|..-.+ ...||+.++++.|-++|..     ..++..||||++++
T Consensus       251 ~KI~~~~v~fP~~fs~-~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~  304 (355)
T KOG0616|consen  251 EKILEGKVKFPSYFSS-DAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD  304 (355)
T ss_pred             HHHHhCcccCCcccCH-HHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence            4555665555544333 2367777777777777743     45789999999876

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-35  Score=275.96  Aligned_cols=231  Identities=23%  Similarity=0.318  Sum_probs=171.5

Q ss_pred             CCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhc--cCCCCceeeEeeEEEcc---CCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLG--RLKHRNLVGLRGWCKKE---KESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~--~l~H~niv~l~g~~~~~---~~~~~lv  187 (409)
                      ...+..+.||+|+||.||||.+.++.||||++..   +..+.|.+|-++.+  .++|+||++++++-...   ...++||
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             CchhhHHHhhcCccceeehhhccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            4455668899999999999999999999999974   44567888877765  45899999999876541   2368999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG------WESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      +||.++|||.+||..    ..++|....+|+.-+++||+|||+.      +.++|+|||||++|||+.+|+++.|+||||
T Consensus       287 t~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            999999999999943    4699999999999999999999974      467899999999999999999999999999


Q ss_pred             cccccCCc------------------eeeecccccc-------CCCcHHHHHHhhhccCcHH------------------
Q 048535          262 AKMHHHGQ------------------VMSGRRPIEE-------GKRNLVDRMWSLTERSELL------------------  298 (409)
Q Consensus       262 a~~~~~~~------------------~~~g~~p~~~-------~~~~~~~~vws~~~~~~~~------------------  298 (409)
                      |..+..+.                  ++-|...+..       +.|.+.--+|++..+....                  
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            98876543                  2222222221       2222233345553332211                  


Q ss_pred             --------H-HhhHHhhhcCCCCHH-----HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCCC
Q 048535          299 --------S-VLDERLKAKGGYADE-----VVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTG  352 (409)
Q Consensus       299 --------~-~~~~~l~~~~~~~~~-----~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~  352 (409)
                              + ++.++.+  +.++..     .+.-+.+.+..||+.||+.|-|+.=|.+++.++....+
T Consensus       443 hPt~e~mq~~VV~kK~R--P~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQR--PKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             CCCHHHHHHHHHhhccC--CCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence                    0 1111111  233332     24567889999999999999999999888877665543

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.4e-36  Score=278.69  Aligned_cols=260  Identities=22%  Similarity=0.290  Sum_probs=199.0

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC----eEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE----SLILI  187 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~----~~~lv  187 (409)
                      .|...+++|.|+||.||+|...  ++.||||++-.+..    ---+|+.+|++++|||||+++-+|....+    ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            3556789999999999999987  78999999965532    12269999999999999999988865332    35689


Q ss_pred             EEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC-CcEEEecccCcccc
Q 048535          188 YDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK-MNARLGDFGLAKMH  265 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFGla~~~  265 (409)
                      |||||. +|.++++.. ..+..++...+.-+..||.+||.|||   ..+|+||||||.|+|+|.+ |.+||||||.|+..
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999999 999998642 23456888888899999999999999   8999999999999999987 89999999999987


Q ss_pred             cCCc----eeeecc--cc----ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCC
Q 048535          266 HHGQ----VMSGRR--PI----EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRP  335 (409)
Q Consensus       266 ~~~~----~~~g~~--p~----~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  335 (409)
                      ..++    +.+.+.  |.    ....|+...|+||.+  +.+.+++-++.-+.++...+...++.++.         -.|
T Consensus       177 ~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaG--CV~aELl~g~plFpG~s~~dQL~eIik~l---------G~P  245 (364)
T KOG0658|consen  177 VKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAG--CVMAELLKGQPLFPGDSSVDQLVEIIKVL---------GTP  245 (364)
T ss_pred             ccCCCceeEEEeccccCHHHHcCccccCceeEEhhhh--HHHHHHhcCCcccCCCCHHHHHHHHHHHh---------CCC
Confidence            7655    333322  22    236778889999997  66777777766665666666665555543         467


Q ss_pred             CHHHHHHHHhcC--cCCCCC-----------CCCCcchhHHhhhcccCCCCcccccccCCCCCccccccc
Q 048535          336 TIRQVLKMLEGQ--TEGTGL-----------EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKN  392 (409)
Q Consensus       336 t~~evl~~L~~~--~~~~~~-----------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~  392 (409)
                      |-+++-.|--+.  .+.+..           ..+....+++.+++.++|.+|.+..+++.||||++....
T Consensus       246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            777777665441  111111           111234899999999999999999999999999987643

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.2e-35  Score=269.44  Aligned_cols=266  Identities=22%  Similarity=0.266  Sum_probs=196.3

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChH--HHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEH--GMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~~l  186 (409)
                      .++|+..+.|++|.||.||+|+++  ++.||+|+++.+...  .--.-++||.+|.+++|||||.+-.+.... -+.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            356888899999999999999998  889999999866321  112357999999999999999998876532 356999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      |||||+. ||..++..-  .+++...++.-++.|+++|++|||   .+.|+|||||++|+|++..|.+||+||||||.+.
T Consensus       155 VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999988 999999653  367999999999999999999999   8999999999999999999999999999999877


Q ss_pred             CCc------eee-ecccc----ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCC
Q 048535          267 HGQ------VMS-GRRPI----EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRP  335 (409)
Q Consensus       267 ~~~------~~~-g~~p~----~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  335 (409)
                      ...      ++| =+++.    ....|+...|+|+++  +.+.+++.......+....+....   +....-.++-+.=|
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvG--CI~aE~l~~kPlf~G~sE~dQl~~---If~llGtPte~iwp  303 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVG--CIFAELLTQKPLFPGKSEIDQLDK---IFKLLGTPSEAIWP  303 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHH--HHHHHHHhcCCCCCCCchHHHHHH---HHHHhCCCccccCC
Confidence            642      111 12222    235678889999997  455555554443334433344333   33333344433344


Q ss_pred             CHHHHH------------HHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          336 TIRQVL------------KMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       336 t~~evl------------~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      -+.++-            ..|++.-  +...-....++++..++..+|.+|+|+.+++.|+||.+.+
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF--~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKF--GALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhc--cccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence            444332            1222211  1111223568999999999999999999999999999854

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-35  Score=276.73  Aligned_cols=248  Identities=23%  Similarity=0.270  Sum_probs=182.1

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh--------------HHHHHHHHHHHHhccCCCCceeeEe
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE--------------HGMREFLAEVSSLGRLKHRNLVGLR  174 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~  174 (409)
                      ..+.|++.+.||+|.||.|-+|+..  ++.||||++.....              ...+...+||.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3578999999999999999999987  89999999964310              1135788999999999999999999


Q ss_pred             eEEEcc-CCeEEEEEEeCCCCCHHHHHhcCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC
Q 048535          175 GWCKKE-KESLILIYDYMENGSLDKWIFECDESIA-LSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM  252 (409)
Q Consensus       175 g~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~  252 (409)
                      .+..+. .+.+|||+|||..|.+...=    ...+ +++.++++++.++..||+|||   .++||||||||+|+||+++|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCC
Confidence            987653 35799999999999886532    2334 999999999999999999999   89999999999999999999


Q ss_pred             cEEEecccCcccccCCc---------eeeecccccc----------CCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCH
Q 048535          253 NARLGDFGLAKMHHHGQ---------VMSGRRPIEE----------GKRNLVDRMWSLTERSELLSVLDERLKAKGGYAD  313 (409)
Q Consensus       253 ~~kl~DFGla~~~~~~~---------~~~g~~p~~~----------~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~  313 (409)
                      ++||+|||.+.....+.         ...|.+.+..          ...+...|+|+++  -.++.++-..+++.++   
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalG--VTLYCllfG~~PF~~~---  322 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALG--VTLYCLLFGQLPFFDD---  322 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhh--hhHHHhhhccCCcccc---
Confidence            99999999998663221         2334443321          1235778999997  4566666666543222   


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ...+..-+++     .+|-.=|+..++-               ....|++.+|+..||..|++..++-.|||.+.-.
T Consensus       323 ~~~~l~~KIv-----n~pL~fP~~pe~~---------------e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  323 FELELFDKIV-----NDPLEFPENPEIN---------------EDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             hHHHHHHHHh-----cCcccCCCccccc---------------HHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            2222222222     1333333332221               1236788888888888888888888888877653

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=282.00  Aligned_cols=225  Identities=23%  Similarity=0.340  Sum_probs=180.9

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC----Ch-HHHHHHHHHHHHhccCC-CCceeeEeeEEEccC
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD----SE-HGMREFLAEVSSLGRLK-HRNLVGLRGWCKKEK  181 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~  181 (409)
                      ...++|...+.||+|+||.|+.|...  +..||+|.+...    .. ...+.+.+|+.++++++ ||||++++.++.. .
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-~   92 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-P   92 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec-C
Confidence            34578999999999999999999886  899999977653    11 23445668999999998 9999999999988 6


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC-CcEEEeccc
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK-MNARLGDFG  260 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFG  260 (409)
                      ..+++||||+.+|+|.+++.+   ...+.+..+..++.|++.|++|+|   +++|+||||||+|||++.+ +++||+|||
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            679999999999999999954   467999999999999999999999   8999999999999999999 999999999


Q ss_pred             Cccccc-CC---ceeeecccccc-------C-CCcHHHHHHhhh-------------ccCcHHHHhhHHhhhcCCCCHHH
Q 048535          261 LAKMHH-HG---QVMSGRRPIEE-------G-KRNLVDRMWSLT-------------ERSELLSVLDERLKAKGGYADEV  315 (409)
Q Consensus       261 la~~~~-~~---~~~~g~~p~~~-------~-~~~~~~~vws~~-------------~~~~~~~~~~~~l~~~~~~~~~~  315 (409)
                      ++.... .+   ...+|.+.+..       . ......|+|+++             .......+........-.++...
T Consensus       167 ~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~  246 (370)
T KOG0583|consen  167 LSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYL  246 (370)
T ss_pred             cccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCc
Confidence            999873 32   24556655532       2 225789999983             22222233333333223445555


Q ss_pred             -HHHHHHHHHHccCcCCCCCCCHHHHH
Q 048535          316 -VEKVLHLGLLCAHPEANSRPTIRQVL  341 (409)
Q Consensus       316 -~~~l~~l~~~Cl~~dP~~RPt~~evl  341 (409)
                       ..++..++.+|+..||.+|+|+.+++
T Consensus       247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  247 LSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence             78889999999999999999999998

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.7e-34  Score=271.35  Aligned_cols=225  Identities=16%  Similarity=0.233  Sum_probs=172.6

Q ss_pred             cceeecCCceEEEEEEECCcEEEEEEeccCCh---HHHHHHHHHHHHhccCCCCceeeEeeEEEc--c-CCeEEEEEEeC
Q 048535          118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSE---HGMREFLAEVSSLGRLKHRNLVGLRGWCKK--E-KESLILIYDYM  191 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~--~-~~~~~lv~E~~  191 (409)
                      ...||+|++|.||+|.+.|+.||||+++....   ...+.|.+|+.+|++++||||++++|++.+  + ....++||||+
T Consensus        25 ~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         25 SVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             CeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            36799999999999999999999999975422   225778899999999999999999999865  2 34689999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce-
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV-  270 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~-  270 (409)
                      ++|+|.+++..   ...+++....+++.|++.||.|||.  ..+++||||||+|||+++++.+||+|||+++....... 
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~  179 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK  179 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccccc
Confidence            99999999954   3468999999999999999999993  24888999999999999999999999999986443211 


Q ss_pred             eeec---cccc-----cCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhh--cCCCCHHHHHHHHHHHHHcc
Q 048535          271 MSGR---RPIE-----EGKRNLVDRMWSLTE-------------RSELLSVLDERLKA--KGGYADEVVEKVLHLGLLCA  327 (409)
Q Consensus       271 ~~g~---~p~~-----~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~--~~~~~~~~~~~l~~l~~~Cl  327 (409)
                      ..|.   .+.+     ...++..+|+|+++.             .....++.+.....  ....+...+..+.+++.+||
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl  259 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACT  259 (283)
T ss_pred             ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHh
Confidence            1111   1111     135677889998731             11112222221111  12233356678999999999


Q ss_pred             CcCCCCCCCHHHHHHHHhcC
Q 048535          328 HPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~  347 (409)
                      +.||++|||++|+++.|+..
T Consensus       260 ~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        260 SHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             cCCcccCcCHHHHHHHHHHH
Confidence            99999999999999999764

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=4.9e-35  Score=288.31  Aligned_cols=233  Identities=24%  Similarity=0.368  Sum_probs=176.5

Q ss_pred             HHHhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEc
Q 048535          109 HAATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKK  179 (409)
Q Consensus       109 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  179 (409)
                      ....++|+..+.||+|+||.||+|++.       +..||||+++.. .....+.+.+|+.++..+ +||||++++++|..
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            344567999999999999999999752       457999999754 334456789999999999 89999999999987


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCCC------------------------------------------------------
Q 048535          180 EKESLILIYDYMENGSLDKWIFECDE------------------------------------------------------  205 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------  205 (409)
                       .+..++|||||++|+|.+++.....                                                      
T Consensus       111 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         111 -GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             -CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence             6788999999999999999864211                                                      


Q ss_pred             ------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          206 ------------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       206 ------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                                        ...+++..+.+++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                              125789999999999999999999   89999999999999999999999999999986543


Q ss_pred             Cc--eeee-------ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HH---------------hhh--cCCCCHHHHH
Q 048535          268 GQ--VMSG-------RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ER---------------LKA--KGGYADEVVE  317 (409)
Q Consensus       268 ~~--~~~g-------~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~---------------l~~--~~~~~~~~~~  317 (409)
                      ..  ...|       ..+.+   ...++..+|+|+++  ..+++++. ..               +..  ....+.....
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG--~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG--ILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPS  344 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHH--HHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCH
Confidence            22  1111       11111   23456677888873  12222221 00               000  0111222346


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      ++.+++.+||+.||++|||+.|++++|++.
T Consensus       345 ~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         345 EMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.8e-34  Score=270.68  Aligned_cols=227  Identities=24%  Similarity=0.395  Sum_probs=177.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|++.+.||+|+||.||+|.+.     +..||+|.++.. .......|.+|+..+.+++||||++++|++.. ++..++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l   83 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-GNTMMI   83 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-CCCcEE
Confidence            56888999999999999999864     568999999765 33445679999999999999999999999887 678999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++...  ...+++..++.++.|++.||+|||   +.+++||||||+|||++.++.+|++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999999643  346899999999999999999999   8999999999999999999999999999876543


Q ss_pred             CCcee---ee-----cccc---ccCCCcHHHHHHhhhccCcHHHHh----------------hHHhh-hcCCCCHHHHHH
Q 048535          267 HGQVM---SG-----RRPI---EEGKRNLVDRMWSLTERSELLSVL----------------DERLK-AKGGYADEVVEK  318 (409)
Q Consensus       267 ~~~~~---~g-----~~p~---~~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~-~~~~~~~~~~~~  318 (409)
                      .....   .+     ..+.   ....++..+|+|+++  ..+++++                ..... .....+..++..
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFG--IVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNL  236 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHH--HHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence            22111   11     1111   224566788999873  1122211                11000 011233445678


Q ss_pred             HHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          319 VLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       319 l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      +.+++..||+.+|++|||+.++.+.|++.
T Consensus       237 ~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         237 LHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            89999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.3e-35  Score=286.61  Aligned_cols=241  Identities=25%  Similarity=0.361  Sum_probs=191.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++|.+.+.||+|+||.||||+.+  .+.||+|.+.+.  ..+..+.+.+|++++++++|||||.++++|.. ..++++|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-SAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-cceEEEEe
Confidence            56888899999999999999887  788999999755  55677889999999999999999999999987 78899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      |||.+ +|..+|.   ....++++++..++.|++.||.|||   +.+|+|||+||.|||++..+.+|+||||+||.+...
T Consensus        81 e~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   81 EYAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            99987 9999994   4567999999999999999999999   899999999999999999999999999999988776


Q ss_pred             cee----eeccc------cccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 048535          269 QVM----SGRRP------IEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIR  338 (409)
Q Consensus       269 ~~~----~g~~p------~~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  338 (409)
                      +.+    .|.+-      .+...|+..+|+|+++  ..+++...++.    ++   +...+.+|+..-+. ||-+-|+  
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslG--cilYE~~~G~P----PF---~a~si~~Lv~~I~~-d~v~~p~--  221 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLG--CILYELYVGQP----PF---YARSITQLVKSILK-DPVKPPS--  221 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHH--HHHHHHhcCCC----Cc---hHHHHHHHHHHHhc-CCCCCcc--
Confidence            522    23322      3457789999999997  55565544332    22   22333333333222 3333332  


Q ss_pred             HHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          339 QVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       339 evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                                     ........+++.++..||.+|++-.+.+.|||.++
T Consensus       222 ---------------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  222 ---------------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             ---------------cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence                           11112367889999999999999999999998664

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-34  Score=268.67  Aligned_cols=263  Identities=24%  Similarity=0.359  Sum_probs=196.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChH--HHHHHHHHHHHhccCCCCc-eeeEeeEEEccCC-----
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEH--GMREFLAEVSSLGRLKHRN-LVGLRGWCKKEKE-----  182 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~-----  182 (409)
                      ..|...++||+|.||+||+|+..  |+.||+|+++.....  ......+|+.+|+.++|+| ||++++++.....     
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34666788999999999999987  899999999876332  2345689999999999999 9999999987443     


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          183 SLILIYDYMENGSLDKWIFECDES-IALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      .+++|+||++. +|.+|+...... ..++...+..++.||++||+|||   +++|+||||||.||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence            89999999977 999999764322 45777899999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCc------eeee-ccccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcC
Q 048535          262 AKMHHHGQ------VMSG-RRPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPE  330 (409)
Q Consensus       262 a~~~~~~~------~~~g-~~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~d  330 (409)
                      |+......      +.|+ .+|.+    ...|+...|+|+++  +.+.+++..+..+.+..+.+   .+..+-...=.++
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~G--cIfaEm~~~~~LFpG~se~~---ql~~If~~lGtP~  241 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLG--CIFAEMFTRRPLFPGDSEID---QLFRIFRLLGTPN  241 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHH--HHHHHHHhCCCCCCCCcHHH---HHHHHHHHcCCCC
Confidence            99765322      2332 23322    23577788999997  56667766554444444433   3333333333333


Q ss_pred             CCCCCC----------------HHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccccccc
Q 048535          331 ANSRPT----------------IRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKN  392 (409)
Q Consensus       331 P~~RPt----------------~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~  392 (409)
                      .+.=|.                ...+...+....        ....+++.+|+.++|.+|++.+.++.||+|.+.+..
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~--------~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLD--------PDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccC--------ccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            333332                333333322211        245899999999999999999999999999998633

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.6e-34  Score=311.83  Aligned_cols=228  Identities=24%  Similarity=0.402  Sum_probs=171.7

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ...|+..+.||+|+||.||+|+..  +..||||++......    ...|++.+++++|||||+++|+|.+ .+..++|||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~-~~~~~lv~E  763 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS-EKGAYLIHE  763 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc-CCCCEEEEe
Confidence            356788899999999999999975  899999998644221    2356889999999999999999987 667899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.++++      .++|..+.+++.|+|+||+|||+.++++|+||||||+||+++.++.+++. ||.+.......
T Consensus       764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~  836 (968)
T PLN00113        764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT  836 (968)
T ss_pred             CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC
Confidence            999999999994      38999999999999999999998778899999999999999999988876 66655432221


Q ss_pred             eeee---cccc---ccCCCcHHHHHHhhh-------ccC------------------------cHHHHhhHHhhhcCCCC
Q 048535          270 VMSG---RRPI---EEGKRNLVDRMWSLT-------ERS------------------------ELLSVLDERLKAKGGYA  312 (409)
Q Consensus       270 ~~~g---~~p~---~~~~~~~~~~vws~~-------~~~------------------------~~~~~~~~~l~~~~~~~  312 (409)
                      ...|   ..+.   ....++..+|||+++       ...                        .....+|+.+......+
T Consensus       837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  916 (968)
T PLN00113        837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN  916 (968)
T ss_pred             CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence            1111   1111   123455667777762       100                        01111222222112334


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCC
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGT  351 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  351 (409)
                      .....++.+++.+||+.||++||||+|+++.|++.....
T Consensus       917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            566678899999999999999999999999999876543

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.1e-35  Score=271.84  Aligned_cols=221  Identities=28%  Similarity=0.453  Sum_probs=167.3

Q ss_pred             ccceeecCCceEEEEEEEC------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          117 EENVIGLGGNGKVYKGQLL------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       117 ~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ..+.||.|.||.||+|.+.      +..|+||.++.. .....+.|.+|++.+++++||||++++|+|.. .+..++|||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-~~~~~lv~e   81 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-NEPLFLVME   81 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-SSSEEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-ccccccccc
Confidence            3578999999999999987      678999999654 44557899999999999999999999999996 667899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.++|... ....+++..+..|+.||++||.|||   +.+++|+||+++|||+++++.+||+|||+++......
T Consensus        82 ~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   82 YCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             --TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             cccccccccccccc-ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            99999999999764 2456999999999999999999999   7899999999999999999999999999998763221


Q ss_pred             ee------eec---ccc---ccCCCcHHHHHHhhhccCcHHHHhh----------------HHhh-hcCCCCHHHHHHHH
Q 048535          270 VM------SGR---RPI---EEGKRNLVDRMWSLTERSELLSVLD----------------ERLK-AKGGYADEVVEKVL  320 (409)
Q Consensus       270 ~~------~g~---~p~---~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~-~~~~~~~~~~~~l~  320 (409)
                      ..      ...   .+.   ....++..+|||+++  -.+++++.                .... .....+..+...+.
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG--~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFG--MLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIY  235 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHH--HHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccceeccchhHHHH
Confidence            00      000   111   124467889999873  11122111                1111 01223444566789


Q ss_pred             HHHHHccCcCCCCCCCHHHHHHHH
Q 048535          321 HLGLLCAHPEANSRPTIRQVLKML  344 (409)
Q Consensus       321 ~l~~~Cl~~dP~~RPt~~evl~~L  344 (409)
                      +++..||+.||++|||+.++++.|
T Consensus       236 ~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  236 SLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHhcC
Confidence            999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-34  Score=268.49  Aligned_cols=226  Identities=24%  Similarity=0.360  Sum_probs=180.7

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE-HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .+.|+..+.||.|..++||+|...  ++.||||++..+.. ...+.+.+|+..|+.++||||++++..|.. +..+|+||
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-~~~LWvVm  103 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-DSELWVVM  103 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-cceeEEee
Confidence            477899999999999999999987  89999999987633 346889999999999999999999998887 78999999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC-
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH-  267 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~-  267 (409)
                      .||.+||+.+.++..-. ..+++..+..|.+++++||.|||   .+|.||||||+.||||+++|.+||+|||.+..+.. 
T Consensus       104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            99999999999976533 34999999999999999999999   89999999999999999999999999998754332 


Q ss_pred             Cc-------eeeeccccc--------cCCCcHHHHHHhhhcc-------------CcHHHHhhHHhhhcCC------CCH
Q 048535          268 GQ-------VMSGRRPIE--------EGKRNLVDRMWSLTER-------------SELLSVLDERLKAKGG------YAD  313 (409)
Q Consensus       268 ~~-------~~~g~~p~~--------~~~~~~~~~vws~~~~-------------~~~~~~~~~~l~~~~~------~~~  313 (409)
                      +.       ...|.+++.        ...|++++|+|+++-.             -...+++-..+...++      .+.
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~  259 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK  259 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence            21       223444432        2578999999998421             1122333333332221      112


Q ss_pred             ----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          314 ----EVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       314 ----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                          .....+.+++..|++.||.+|||++++++
T Consensus       260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                23457889999999999999999999985

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-34  Score=290.42  Aligned_cols=240  Identities=24%  Similarity=0.322  Sum_probs=186.2

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeEee-EEEcc---C--
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLRG-WCKKE---K--  181 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g-~~~~~---~--  181 (409)
                      ...++++.+.|.+|||+.||++...  |..||+|++-..+....+.+.+|+++|++|. |+|||.+++ .....   .  
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            3456677899999999999999998  4899999998778888999999999999995 999999999 33221   1  


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      -+++|.||||.+|+|-+++...- ...|++.++++|+.|+++|+++||.. ..+|||||||-+||||+.++..||||||.
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rl-q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRL-QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHH-hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            25789999999999999997532 34599999999999999999999965 67899999999999999999999999999


Q ss_pred             cccccCCc-----------------eeeeccc-----cccCCCcHHHHHHhhh-------------ccCcHHHHhhHHhh
Q 048535          262 AKMHHHGQ-----------------VMSGRRP-----IEEGKRNLVDRMWSLT-------------ERSELLSVLDERLK  306 (409)
Q Consensus       262 a~~~~~~~-----------------~~~g~~p-----~~~~~~~~~~~vws~~-------------~~~~~~~~~~~~l~  306 (409)
                      |.......                 ..+-+.|     +.....+.++|+|.++             +......+++....
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~  272 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYS  272 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEecccc
Confidence            86432110                 1111112     1123457889999984             11112334444433


Q ss_pred             hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCCCCC
Q 048535          307 AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLE  354 (409)
Q Consensus       307 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~  354 (409)
                      .  +..+.....+.+||..||++||++||++-||+..+-.+...+.+-
T Consensus       273 ~--P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~  318 (738)
T KOG1989|consen  273 F--PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPI  318 (738)
T ss_pred             C--CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCc
Confidence            2  223578889999999999999999999999999887766544433

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-34  Score=271.63  Aligned_cols=245  Identities=18%  Similarity=0.212  Sum_probs=178.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||+|...  ++.||+|++...   .....+.+.+|+.++++++||||+++++++.+ ....++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEE
Confidence            46888999999999999999987  899999999643   22345678899999999999999999998887 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++..   ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        80 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          80 MEYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            999999999999954   346899999999999999999999   89999999999999999999999999999986543


Q ss_pred             Cc-eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 048535          268 GQ-VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQV  340 (409)
Q Consensus       268 ~~-~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev  340 (409)
                      .. ...|...+      ....++...|+|+++  ..+++++........                         .+..++
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG--~il~~l~~g~~pf~~-------------------------~~~~~~  206 (291)
T cd05612         154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALG--ILIYEMLVGYPPFFD-------------------------DNPFGI  206 (291)
T ss_pred             CcccccCChhhcCHHHHcCCCCCchhhHHHHH--HHHHHHHhCCCCCCC-------------------------CCHHHH
Confidence            32 12232222      123456778999986  334444433322111                         111111


Q ss_pred             HHHHh-cCcCCCCCCCCCcchhHHhhhcccCCCCccc-----ccccCCCCCccccccc
Q 048535          341 LKMLE-GQTEGTGLEDEGMNVHLLKRIGTRAMTSSWK-----FAGSRGHPTFNEINKN  392 (409)
Q Consensus       341 l~~L~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-----~~~~~~hp~~~~~~~~  392 (409)
                      .+.+. +..+.+... .....+++.+|+..+|.+|.+     .++++.||||..++..
T Consensus       207 ~~~i~~~~~~~~~~~-~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~  263 (291)
T cd05612         207 YEKILAGKLEFPRHL-DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD  263 (291)
T ss_pred             HHHHHhCCcCCCccC-CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence            11111 111111111 112357777777777777774     6788888888776543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=7.2e-34  Score=269.85  Aligned_cols=261  Identities=25%  Similarity=0.340  Sum_probs=185.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|+..+.||+|+||.||+|...  +..||+|.++... ......+.+|+.++++++||||+++++++.. ....++|||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-ERCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEEe
Confidence            56888999999999999999886  8899999997542 2234567899999999999999999999887 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++ +|.+++...  ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          84 YLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            9975 999988542  235789999999999999999999   8999999999999999999999999999997643221


Q ss_pred             ----eeeec---cccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHcc-CcCCCCCCCH
Q 048535          270 ----VMSGR---RPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCA-HPEANSRPTI  337 (409)
Q Consensus       270 ----~~~g~---~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl-~~dP~~RPt~  337 (409)
                          ...|.   .+.+    ...++...|+|+++  ..+++++..........    ..+....+..++ .+.++..|..
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG--~~l~~l~~g~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVG--CILYEMATGRPMFPGST----VKEELHLIFRLLGTPTEETWPGI  231 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHH--HHHHHHHhCCCCCCCCC----HHHHHHHHHHHhCCCChHHhhcc
Confidence                01111   1111    13467789999996  44566665543322221    122222233333 2333333332


Q ss_pred             HHHHHHHhcCcCC--------CCCCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          338 RQVLKMLEGQTEG--------TGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       338 ~evl~~L~~~~~~--------~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      ....+.-+...+.        ..+.-.....+++.+|+..+|.+|+|++++++||||
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            2211111000000        001112234899999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-35  Score=281.97  Aligned_cols=222  Identities=22%  Similarity=0.350  Sum_probs=183.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ...|..-.+||+|+.|.||.+...  ++.||||++........+-+++|+.+|+..+|+|||++++.|.. .+.+|+|||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-~deLWVVME  350 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV-GDELWVVME  350 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc-cceeEEEEe
Confidence            456777889999999999999876  88899999987766666778999999999999999999998887 688999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      ||++|+|.+.+.    ...+++.++..|+.++++||+|||   .++|+|||||.+|||++.+|.+||+|||++..+....
T Consensus       351 ym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  351 YMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             ecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            999999999983    345999999999999999999999   8999999999999999999999999999998766543


Q ss_pred             ----eeeecccccc------CCCcHHHHHHhhhccCcHHHHhhHHhhhc------------------CCCCHHHHHHHHH
Q 048535          270 ----VMSGRRPIEE------GKRNLVDRMWSLTERSELLSVLDERLKAK------------------GGYADEVVEKVLH  321 (409)
Q Consensus       270 ----~~~g~~p~~~------~~~~~~~~vws~~~~~~~~~~~~~~l~~~------------------~~~~~~~~~~l~~  321 (409)
                          .+.|.+++..      ..|+...|||+++  --..+++++..+..                  -..++..+..+.+
T Consensus       424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLG--IMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd  501 (550)
T KOG0578|consen  424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLG--IMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD  501 (550)
T ss_pred             CccccccCCCCccchhhhhhcccCccccchhhh--hHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence                4556655432      5678899999995  22333333322111                  1234556678899


Q ss_pred             HHHHccCcCCCCCCCHHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ++.+||+.|+++||++.|+|+.
T Consensus       502 FL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  502 FLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             HHHHHhhcchhcCCCHHHHhcC
Confidence            9999999999999999999863

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.9e-34  Score=275.20  Aligned_cols=247  Identities=20%  Similarity=0.201  Sum_probs=186.6

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      ..++|+..+.||+|+||.||+|+-+  |..+|+|++++.   ...+.+....|-.+|...++|+||+|+-.|.+ ...+|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD-~~~LY  217 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD-KEYLY  217 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC-CCeeE
Confidence            4578999999999999999999887  999999999876   34456678899999999999999999988887 88999


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      |||||+||||+..+|.   ....|++..+..++.+++.|++-||   +.|+|||||||+|+|||..|++||+||||+.-+
T Consensus       218 LiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchh
Confidence            9999999999999994   4568999999999999999999999   899999999999999999999999999999643


Q ss_pred             cCCc---------------------------------------------------eeeecccc------ccCCCcHHHHH
Q 048535          266 HHGQ---------------------------------------------------VMSGRRPI------EEGKRNLVDRM  288 (409)
Q Consensus       266 ~~~~---------------------------------------------------~~~g~~p~------~~~~~~~~~~v  288 (409)
                      ....                                                   -+.|.+-+      ....|+...|.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            2210                                                   01111111      11345666777


Q ss_pred             HhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHH--HccCcCCCCCCCHHHHHHHHhcCcCCCCCCCCCcchhHHhhh
Q 048535          289 WSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGL--LCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRI  366 (409)
Q Consensus       289 ws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~--~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~  366 (409)
                      |+++  ..+++++-+..++..+.+.+.   +.+|+.  .||..-++.+.+                    ....|++.++
T Consensus       372 WSLG--~ImyEmLvGyPPF~s~tp~~T---~rkI~nwr~~l~fP~~~~~s--------------------~eA~DLI~rl  426 (550)
T KOG0605|consen  372 WSLG--CIMYEMLVGYPPFCSETPQET---YRKIVNWRETLKFPEEVDLS--------------------DEAKDLITRL  426 (550)
T ss_pred             HHHH--HHHHHHHhCCCCCCCCCHHHH---HHHHHHHhhhccCCCcCccc--------------------HHHHHHHHHH
Confidence            8876  445555544433322222222   333332  356655555544                    2235666777


Q ss_pred             cccCCCCccc---ccccCCCCCccccc
Q 048535          367 GTRAMTSSWK---FAGSRGHPTFNEIN  390 (409)
Q Consensus       367 ~~~~~~~~~~---~~~~~~hp~~~~~~  390 (409)
                      +. ++..|..   .+++..||||+.|+
T Consensus       427 l~-d~~~RLG~~G~~EIK~HPfF~~v~  452 (550)
T KOG0605|consen  427 LC-DPENRLGSKGAEEIKKHPFFKGVD  452 (550)
T ss_pred             hc-CHHHhcCcccHHHHhcCCccccCC
Confidence            66 6666765   66999999999987

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3e-34  Score=282.62  Aligned_cols=233  Identities=24%  Similarity=0.387  Sum_probs=177.4

Q ss_pred             HHHhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEc
Q 048535          109 HAATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKK  179 (409)
Q Consensus       109 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  179 (409)
                      ....++|+..+.||+|+||.||+|...       +..||+|+++.. .......+.+|+.+++.+ +|+|||+++++|..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            344567999999999999999999863       357999999754 334456789999999999 89999999999987


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCC-------------------------------------------------------
Q 048535          180 EKESLILIYDYMENGSLDKWIFECD-------------------------------------------------------  204 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------------------------  204 (409)
                       .+..++|||||++|+|.+++....                                                       
T Consensus       114 -~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         114 -GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             -CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence             678999999999999999985421                                                       


Q ss_pred             ------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc--e
Q 048535          205 ------------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ--V  270 (409)
Q Consensus       205 ------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~--~  270 (409)
                                  ....+++..+.+++.||+.||.|||   +++|+||||||+|||+++++.+||+|||+++......  .
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                        1124788999999999999999999   8999999999999999999999999999998654322  1


Q ss_pred             eee-------cccc---ccCCCcHHHHHHhhhccCcHHHHhh-HHh---------------hh--cCCCCHHHHHHHHHH
Q 048535          271 MSG-------RRPI---EEGKRNLVDRMWSLTERSELLSVLD-ERL---------------KA--KGGYADEVVEKVLHL  322 (409)
Q Consensus       271 ~~g-------~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~~l---------------~~--~~~~~~~~~~~l~~l  322 (409)
                      ..+       ..+.   ....++..+|+|+++  ..+++++. ...               ..  ....+...+..+.++
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG--vil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  347 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYG--ILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSI  347 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHH--HHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHH
Confidence            111       1111   124456778899874  12222221 110               00  011122235678999


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          323 GLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      +.+||+.||.+|||+.+++++|+++
T Consensus       348 i~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         348 MKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.7e-34  Score=281.13  Aligned_cols=233  Identities=23%  Similarity=0.376  Sum_probs=178.3

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCC-CCceeeEeeEEEcc
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKE  180 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~  180 (409)
                      ...++|.+.+.||+|+||.||+|++.       +..||||+++.. .....+.|.+|+++|+++. ||||++++++|.+ 
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-  112 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-  112 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-
Confidence            34678899999999999999999864       246999999754 3344567999999999995 9999999999987 


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCCC-------------------------------------------------------
Q 048535          181 KESLILIYDYMENGSLDKWIFECDE-------------------------------------------------------  205 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------------  205 (409)
                      .+..++|||||++|+|.++|.....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            6789999999999999999864210                                                       


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCee
Q 048535          206 --------------------------------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVL  247 (409)
Q Consensus       206 --------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NIL  247 (409)
                                                            ...+++..+..++.|+++||.|||   +.+|+||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEE
Confidence                                                  124788899999999999999999   899999999999999


Q ss_pred             eCCCCcEEEecccCcccccCCcee--e----e---cccc---ccCCCcHHHHHHhhhccCcHHHHhh-------------
Q 048535          248 LDKKMNARLGDFGLAKMHHHGQVM--S----G---RRPI---EEGKRNLVDRMWSLTERSELLSVLD-------------  302 (409)
Q Consensus       248 l~~~~~~kl~DFGla~~~~~~~~~--~----g---~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-------------  302 (409)
                      +++++.+||+|||+++........  .    +   ..+.   ....++...|+|+++  ..+++++.             
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlG--vil~ellt~g~~P~~~~~~~~  347 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYG--ILLWEIFSLGGTPYPGMIVDS  347 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHH--HHHHHHHHCCCCCCcccchhH
Confidence            999999999999999865332110  0    1   1111   124456778999874  12222211             


Q ss_pred             ---HHhhh--cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          303 ---ERLKA--KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       303 ---~~l~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                         ..+..  ....+......+.+++.+||+.||++|||+.++.++|+...
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence               01110  01223345667899999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.1e-34  Score=266.22  Aligned_cols=233  Identities=26%  Similarity=0.419  Sum_probs=182.3

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++..+|+..+.||.|+||.||+|... +..+|+|.+..........+.+|+.+++.++||||+++++++.. ....++||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~   81 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-GEPVYIIT   81 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec-CCCeEEEE
Confidence            34567888999999999999999988 78899999987666566789999999999999999999999987 67889999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++|+|.+++... ....+++..+..++.|++.||.|||   +.+|+|+||||+||++++++.+||+|||++......
T Consensus        82 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~  157 (261)
T cd05148          82 ELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED  157 (261)
T ss_pred             eecccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence            999999999999753 2356899999999999999999999   899999999999999999999999999999765433


Q ss_pred             ceee-------ecccc---ccCCCcHHHHHHhhh-------ccC-------cHHHHhhHHhhh-cCCCCHHHHHHHHHHH
Q 048535          269 QVMS-------GRRPI---EEGKRNLVDRMWSLT-------ERS-------ELLSVLDERLKA-KGGYADEVVEKVLHLG  323 (409)
Q Consensus       269 ~~~~-------g~~p~---~~~~~~~~~~vws~~-------~~~-------~~~~~~~~~l~~-~~~~~~~~~~~l~~l~  323 (409)
                      ....       +..+.   ....++..+|+|+++       ..+       ...+.+...... ....+...+..+.+++
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  237 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM  237 (261)
T ss_pred             cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence            2110       11111   123456678999874       101       011111111110 1122344557789999


Q ss_pred             HHccCcCCCCCCCHHHHHHHHhcC
Q 048535          324 LLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      .+||+.||.+|||++++++.|++.
T Consensus       238 ~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         238 LECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHHcCCCchhCcCHHHHHHHHhcC
Confidence            999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.6e-33  Score=264.95  Aligned_cols=228  Identities=22%  Similarity=0.392  Sum_probs=176.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~~  185 (409)
                      ++|++.+.||+|+||.||++...      +..||+|.+........+.|.+|++++++++||||+++++++... ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            57888999999999999999752      778999999877666778899999999999999999999987642 34689


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +||||+++|+|.+++...  ...+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999999642  235899999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCce--ee---e-----cccc---ccCCCcHHHHHHhhhccCcHHHHhhH-----------------------------
Q 048535          266 HHGQV--MS---G-----RRPI---EEGKRNLVDRMWSLTERSELLSVLDE-----------------------------  303 (409)
Q Consensus       266 ~~~~~--~~---g-----~~p~---~~~~~~~~~~vws~~~~~~~~~~~~~-----------------------------  303 (409)
                      .....  ..   +     ..+.   ....++...|+|+++.  .+++++..                             
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~--~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGV--VLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHH--HHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            43221  00   0     1111   1244667889999741  11221110                             


Q ss_pred             -Hhhh--cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          304 -RLKA--KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       304 -~l~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                       .+..  ....+......+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence             0000  0011223346789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.5e-33  Score=271.60  Aligned_cols=185  Identities=26%  Similarity=0.379  Sum_probs=149.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .++|+..+.||+|+||.||++...  +..||+|.+... .....+.+.+|+++|++++||||+++++++.. .+..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEEe
Confidence            367899999999999999999987  888999999765 34455779999999999999999999999987 67899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          83 EHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            99999999999954   3458999999999999999999993  246999999999999999999999999999765332


Q ss_pred             c--eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHH
Q 048535          269 Q--VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDER  304 (409)
Q Consensus       269 ~--~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~  304 (409)
                      .  ...|...+      ....++..+|+|+++  ..+++++..+
T Consensus       158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG--~il~el~tg~  199 (331)
T cd06649         158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMG--LSLVELAIGR  199 (331)
T ss_pred             ccccCCCCcCcCCHhHhcCCCCCchHhHHHHH--HHHHHHHhCC
Confidence            1  11222221      124467789999986  3444444433

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.6e-33  Score=269.33  Aligned_cols=269  Identities=22%  Similarity=0.300  Sum_probs=187.7

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .++|++.+.||+|+||.||+|...  ++.||+|+++... ......+.+|+.+++.++||||+++++++.+ ....++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-CCeEEEEE
Confidence            468999999999999999999986  8899999997542 2223467889999999999999999999987 67899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||++ ++|.+++...  ...+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  156 (303)
T cd07869          83 EYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP  156 (303)
T ss_pred             ECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence            9996 5888888542  345899999999999999999999   899999999999999999999999999999754321


Q ss_pred             c----eeeecc---ccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 048535          269 Q----VMSGRR---PIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI  337 (409)
Q Consensus       269 ~----~~~g~~---p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  337 (409)
                      .    ...|..   +.+    ...++..+|+|+++  ..+++++.......+..  +....+..+...--.++....|..
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG--~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVG--CIFVEMIQGVAAFPGMK--DIQDQLERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCc--cHHHHHHHHHHHhCCCChhhccch
Confidence            1    011111   111    13456788999996  45566655444322211  111222222221122233333333


Q ss_pred             HHHHHHHhcCcCC----------CCCCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          338 RQVLKMLEGQTEG----------TGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       338 ~evl~~L~~~~~~----------~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      ...-.........          ..........+++.+|+..+|.+|+|+.+++.||||+.++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~  296 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP  296 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence            2211100000000          00001123468999999999999999999999999998753

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=9.8e-34  Score=272.48  Aligned_cols=229  Identities=24%  Similarity=0.374  Sum_probs=175.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC--Cc----EEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GV----EVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      .+|+..+.||+|+||.||+|.+.  +.    .||+|.++.. .....++|.+|+.+++.++||||++++|+|..  ...+
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~--~~~~   84 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQ   84 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC--CCce
Confidence            56889999999999999999874  33    4899999754 34556789999999999999999999999975  3567


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +++||+++|+|.+++...  ...+++..++.++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++..
T Consensus        85 ~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          85 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccc
Confidence            999999999999999653  345889999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCce-e--ee------cccc---ccCCCcHHHHHHhhhccCcHHHHhh-H--------------Hhhh--cCCCCHHHH
Q 048535          266 HHGQV-M--SG------RRPI---EEGKRNLVDRMWSLTERSELLSVLD-E--------------RLKA--KGGYADEVV  316 (409)
Q Consensus       266 ~~~~~-~--~g------~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~--------------~l~~--~~~~~~~~~  316 (409)
                      ..... .  .+      ..+.   ....++...|+|+++  ..+++++. .              .+..  ....+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG--v~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG--VTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT  237 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHH--HHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCC
Confidence            53321 0  00      1111   124456678888874  11222211 0              0100  011122344


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      ..+.+++..||+.+|++|||+.+++..|......
T Consensus       238 ~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         238 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            5788999999999999999999999998866543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.4e-33  Score=259.45  Aligned_cols=219  Identities=24%  Similarity=0.410  Sum_probs=170.9

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS  195 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gs  195 (409)
                      +.||+|+||.||+|+..  ++.||+|.+... .......|.+|++++++++||||+++++++.. ....++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEEeeccCCc
Confidence            46999999999999985  889999988654 34455779999999999999999999999987 678899999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCceee---
Q 048535          196 LDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS---  272 (409)
Q Consensus       196 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~---  272 (409)
                      |.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++........+   
T Consensus        80 L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          80 FLTFLRTE--GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            99999542  345899999999999999999999   8999999999999999999999999999987644321100   


Q ss_pred             ------eccc---cccCCCcHHHHHHhhhccCcHHHHhh---------------HHhh--hcCCCCHHHHHHHHHHHHHc
Q 048535          273 ------GRRP---IEEGKRNLVDRMWSLTERSELLSVLD---------------ERLK--AKGGYADEVVEKVLHLGLLC  326 (409)
Q Consensus       273 ------g~~p---~~~~~~~~~~~vws~~~~~~~~~~~~---------------~~l~--~~~~~~~~~~~~l~~l~~~C  326 (409)
                            ...+   .....++..+|+|+++  ..+++++.               ..+.  .....+...+..+.+++.+|
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG--~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  232 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFG--ILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERC  232 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHH--HHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHH
Confidence                  0111   1224456778999973  11122111               0000  01223344567889999999


Q ss_pred             cCcCCCCCCCHHHHHHHHh
Q 048535          327 AHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       327 l~~dP~~RPt~~evl~~L~  345 (409)
                      |+.+|++|||+.+++++|+
T Consensus       233 l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         233 WEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCChhhCcCHHHHHHHHh
Confidence            9999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-33  Score=260.13  Aligned_cols=226  Identities=30%  Similarity=0.435  Sum_probs=179.7

Q ss_pred             hCCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      .++|+..+.||+|+||.||+|...++.||+|.+..... ..+++.+|+.++++++|+||+++++++.+ ....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEEec
Confidence            35788899999999999999999999999999976544 56789999999999999999999999987 67889999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM  271 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  271 (409)
                      ++++|.+++... ....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            999999999653 2236899999999999999999999   89999999999999999999999999999987643221 


Q ss_pred             eecc-----cc---ccCCCcHHHHHHhhhccCcHHHHhh---------------HHhh--hcCCCCHHHHHHHHHHHHHc
Q 048535          272 SGRR-----PI---EEGKRNLVDRMWSLTERSELLSVLD---------------ERLK--AKGGYADEVVEKVLHLGLLC  326 (409)
Q Consensus       272 ~g~~-----p~---~~~~~~~~~~vws~~~~~~~~~~~~---------------~~l~--~~~~~~~~~~~~l~~l~~~C  326 (409)
                      .+..     +.   ....++...|+|+++.  .+++++.               ..+.  .....+...+..+.+++.+|
T Consensus       158 ~~~~~~~~~ape~~~~~~~~~~~Di~slG~--il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (256)
T cd05039         158 SGKLPVKWTAPEALREKKFSTKSDVWSFGI--LLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC  235 (256)
T ss_pred             cCCCcccccCchhhcCCcCCcHHHHHHHHH--HHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence            1111     11   1244556789999741  1112111               0110  01122334467889999999


Q ss_pred             cCcCCCCCCCHHHHHHHHhc
Q 048535          327 AHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       327 l~~dP~~RPt~~evl~~L~~  346 (409)
                      |+.+|++|||+.+++++|++
T Consensus       236 l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         236 WELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             hccChhhCcCHHHHHHHHhc
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.7e-33  Score=264.61  Aligned_cols=228  Identities=24%  Similarity=0.430  Sum_probs=176.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC--C-----cEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--G-----VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~-----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      ++|+..+.||+|+||.||+|...  +     ..||+|.+... .......|.+|+.++.+++||||+++++++.. ....
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-EQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-CCce
Confidence            46788899999999999999875  2     56999999754 34455679999999999999999999999886 6678


Q ss_pred             EEEEEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC
Q 048535          185 ILIYDYMENGSLDKWIFECDE-------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK  251 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~  251 (409)
                      +++|||+++|+|.+++.....             ...+++..+..++.|++.||.|||   +.+++||||||+||+++++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCC
Confidence            999999999999999965321             145889999999999999999999   8999999999999999999


Q ss_pred             CcEEEecccCcccccCCce--ee----e---cccc---ccCCCcHHHHHHhhhccCcHHHHhh---------------HH
Q 048535          252 MNARLGDFGLAKMHHHGQV--MS----G---RRPI---EEGKRNLVDRMWSLTERSELLSVLD---------------ER  304 (409)
Q Consensus       252 ~~~kl~DFGla~~~~~~~~--~~----g---~~p~---~~~~~~~~~~vws~~~~~~~~~~~~---------------~~  304 (409)
                      +.+||+|||+++.......  ..    +   ..+.   ....++..+|+|+++  ..+++++.               ..
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG--~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFG--VVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHH--HHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999999976432210  00    0   1111   124556778999974  11222221               01


Q ss_pred             hh--hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          305 LK--AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       305 l~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      +.  .....+...+.++.+|+.+||+.||.+||+++|+++.|++
T Consensus       239 i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         239 IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            10  0122344566789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-33  Score=262.41  Aligned_cols=228  Identities=29%  Similarity=0.481  Sum_probs=176.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      .++|+..+.||+|+||.||+|.+.     ...||||.++.. .......|.+|+.++++++||||+++++++.. .+..+
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   81 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-SRPVM   81 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-CCceE
Confidence            357888999999999999999885     347999998755 34455789999999999999999999999886 67789


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      ++|||+++|+|.+++...  ...+++..+..++.|++.||+|||   +++|+|+||||+|||+++++.+||+|||+++..
T Consensus        82 iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          82 IITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            999999999999999653  236899999999999999999999   899999999999999999999999999999876


Q ss_pred             cC--Cceee--ec-----ccc---ccCCCcHHHHHHhhhccCcHHH----------------HhhHHhhh-cCCCCHHHH
Q 048535          266 HH--GQVMS--GR-----RPI---EEGKRNLVDRMWSLTERSELLS----------------VLDERLKA-KGGYADEVV  316 (409)
Q Consensus       266 ~~--~~~~~--g~-----~p~---~~~~~~~~~~vws~~~~~~~~~----------------~~~~~l~~-~~~~~~~~~  316 (409)
                      ..  ....+  +.     .+.   ....++...|+|+++.  .+++                ..+..... ..+.+...+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~--~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGI--VMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCP  234 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHH--HHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            42  11111  11     111   1134456778888631  1111                11111110 112233456


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      ..+.+++.+||+.+|++||++.++++.|++.
T Consensus       235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         235 SALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            6889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-33  Score=273.07  Aligned_cols=215  Identities=17%  Similarity=0.220  Sum_probs=163.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||+|+..  ++.||+|.+...   .....+.+.+|+.++++++||||+++++++.+ .+..++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-ENRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-CCEEEEE
Confidence            57888999999999999999987  889999999653   22345678999999999999999999999987 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++..   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            999999999999954   346899999999999999999999   89999999999999999999999999999987654


Q ss_pred             Cc-eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhh---------------hcCCCCHHHHHHHHHHHHH
Q 048535          268 GQ-VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLK---------------AKGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       268 ~~-~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~---------------~~~~~~~~~~~~l~~l~~~  325 (409)
                      .. ...|...+      ....++...|+|+++  ..+++++.....               ....++......+.+++.+
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  248 (329)
T PTZ00263        171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMG--VLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG  248 (329)
T ss_pred             CcceecCChhhcCHHHHcCCCCCCcceeechH--HHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence            32 22233221      123345667888874  223333222111               1111222234456667777


Q ss_pred             ccCcCCCCCCC
Q 048535          326 CAHPEANSRPT  336 (409)
Q Consensus       326 Cl~~dP~~RPt  336 (409)
                      ||+.||.+||+
T Consensus       249 ~L~~dP~~R~~  259 (329)
T PTZ00263        249 LLQTDHTKRLG  259 (329)
T ss_pred             HhhcCHHHcCC
Confidence            77777777776

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.8e-33  Score=265.30  Aligned_cols=231  Identities=21%  Similarity=0.365  Sum_probs=176.5

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK  181 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  181 (409)
                      ..+++|+..+.||+|+||.||+|.+.       +..||+|.+... ......+|.+|+.+++.++||||+++++++.+ .
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~   81 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-G   81 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-C
Confidence            35678999999999999999999864       357999998644 33445679999999999999999999999876 6


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcE
Q 048535          182 ESLILIYDYMENGSLDKWIFECDE-------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNA  254 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~  254 (409)
                      ...++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||   +.+++||||||+|||+++++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCE
Confidence            788999999999999999865321       234688899999999999999999   8999999999999999999999


Q ss_pred             EEecccCcccccCCceee---------eccccc---cCCCcHHHHHHhhhccCcHHHHhh----------------HHhh
Q 048535          255 RLGDFGLAKMHHHGQVMS---------GRRPIE---EGKRNLVDRMWSLTERSELLSVLD----------------ERLK  306 (409)
Q Consensus       255 kl~DFGla~~~~~~~~~~---------g~~p~~---~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~  306 (409)
                      ||+|||+++.........         +..+.+   ...++...|+|+++.  .+++++.                ....
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~--~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV--VLWEIATLAEQPYQGMSNEQVLRFVME  236 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHH--HHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999997653322110         011111   244567789999741  1122211                0000


Q ss_pred             -hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          307 -AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       307 -~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                       .....+......+.+++.+||+.||++|||+.|+++.|++
T Consensus       237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         237 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence             0012233455678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.8e-33  Score=259.86  Aligned_cols=226  Identities=24%  Similarity=0.381  Sum_probs=172.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      ++|+..+.||+|+||.||++.+. +..+|+|.+.... ....+|.+|+.++++++||||+++++++.. ....++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-QKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEcc-CCCEEEEEEcC
Confidence            45778899999999999999987 6689999986442 234678999999999999999999999887 67899999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM  271 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  271 (409)
                      ++|+|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+||++++++.+||+|||+++........
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          82 ENGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            999999998643  235899999999999999999999   899999999999999999999999999999865433221


Q ss_pred             ee--------ccccc---cCCCcHHHHHHhhhcc-------C-------cHHHHhhHHhhh-cCCCCHHHHHHHHHHHHH
Q 048535          272 SG--------RRPIE---EGKRNLVDRMWSLTER-------S-------ELLSVLDERLKA-KGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       272 ~g--------~~p~~---~~~~~~~~~vws~~~~-------~-------~~~~~~~~~l~~-~~~~~~~~~~~l~~l~~~  325 (409)
                      ..        ..+.+   ...++...|+|+++..       +       ...+.+...... ....+......+.+++.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  236 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS  236 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence            11        11111   1345667899987410       1       011111111110 011122344578999999


Q ss_pred             ccCcCCCCCCCHHHHHHHHh
Q 048535          326 CAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~~L~  345 (409)
                      ||+.+|++|||+.++++.|.
T Consensus       237 c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         237 CWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             HccCCcccCcCHHHHHHhhC
Confidence            99999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-34  Score=269.02  Aligned_cols=223  Identities=23%  Similarity=0.383  Sum_probs=173.4

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ..+|++.+.||+|.||.|-++...  |+.||||.++.+   +.++.-.+.+|+++|+.|+||||++++.+|.. .+.+.|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-kdKIvi  130 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-KDKIVI  130 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-CceEEE
Confidence            356777789999999999999875  999999999866   55566678899999999999999999999987 789999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||..+|.|++|+.+   .+.|++.+..++++||..|+.|+|   .++++|||||.+|||||.|+++||+||||+.++.
T Consensus       131 vMEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  131 VMEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            9999999999999954   457999999999999999999999   8999999999999999999999999999998877


Q ss_pred             CCc---eeeecccccc------CC-CcHHHHHHhhh-------------ccCcHHHHhhHHhhhcCCC-CHHHHHHHHHH
Q 048535          267 HGQ---VMSGRRPIEE------GK-RNLVDRMWSLT-------------ERSELLSVLDERLKAKGGY-ADEVVEKVLHL  322 (409)
Q Consensus       267 ~~~---~~~g~~p~~~------~~-~~~~~~vws~~-------------~~~~~~~~~~~~l~~~~~~-~~~~~~~l~~l  322 (409)
                      .+.   ..||.+-+..      .. .....|-|+++             +..+...++...-.  +.| .+..+....-|
T Consensus       205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~--GaYrEP~~PSdA~gL  282 (668)
T KOG0611|consen  205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR--GAYREPETPSDASGL  282 (668)
T ss_pred             cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc--ccccCCCCCchHHHH
Confidence            654   2344332221      01 12234566663             11111122221111  111 22233445678


Q ss_pred             HHHccCcCCCCCCCHHHHHHH
Q 048535          323 GLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      +.+++-.||++|.|+.++...
T Consensus       283 IRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  283 IRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             HHHHHhcCcccchhHHHHhhh
Confidence            999999999999999999864

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.9e-33  Score=271.43  Aligned_cols=215  Identities=19%  Similarity=0.262  Sum_probs=168.7

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMEN  193 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~  193 (409)
                      +.||+|+||.||++...  |+.||+|+++..   .......+.+|+.++++++||||+++++++.. .+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-HDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-CCEEEEEEeCCCC
Confidence            46999999999999986  899999999754   23345678899999999999999999999887 7789999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC----c
Q 048535          194 GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG----Q  269 (409)
Q Consensus       194 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~----~  269 (409)
                      |+|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....    .
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  153 (323)
T cd05571          80 GELFFHLSR---ERVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence            999999853   346899999999999999999999   899999999999999999999999999999753221    1


Q ss_pred             eeeeccccc------cCCCcHHHHHHhhhccCcHHHHh---------------hHHhhhcCCCCHHHHHHHHHHHHHccC
Q 048535          270 VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVL---------------DERLKAKGGYADEVVEKVLHLGLLCAH  328 (409)
Q Consensus       270 ~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~---------------~~~l~~~~~~~~~~~~~l~~l~~~Cl~  328 (409)
                      ...|...+.      ...++...|+|+++  ..+++++               .........++......+.+++.+||+
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG--~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~  231 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLG--VVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLK  231 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccc--hhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcc
Confidence            222333221      24456778999874  1222222               222221223444556788999999999


Q ss_pred             cCCCCCC-----CHHHHHH
Q 048535          329 PEANSRP-----TIRQVLK  342 (409)
Q Consensus       329 ~dP~~RP-----t~~evl~  342 (409)
                      .||++||     ++.++++
T Consensus       232 ~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         232 KDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCHHHcCCCCCCCHHHHHc
Confidence            9999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.2e-34  Score=275.31  Aligned_cols=233  Identities=24%  Similarity=0.355  Sum_probs=177.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCC
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  182 (409)
                      .++|++.+.||+|+||.||+|...       ++.||+|+++.. .....+.+.+|+.++.++ +|+||++++++|.....
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357888999999999999999753       368999999754 334456788999999999 89999999999887667


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCC---------------------------------------------------------
Q 048535          183 SLILIYDYMENGSLDKWIFECDE---------------------------------------------------------  205 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------  205 (409)
                      .++++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            89999999999999999864211                                                         


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc--eeee-------cc
Q 048535          206 -SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ--VMSG-------RR  275 (409)
Q Consensus       206 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~--~~~g-------~~  275 (409)
                       ...++|..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++......  ...+       ..
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             126899999999999999999999   8999999999999999999999999999998653221  0000       11


Q ss_pred             cc---ccCCCcHHHHHHhhhccCcHHHHhh-HHhhhc-----------------CCCCHHHHHHHHHHHHHccCcCCCCC
Q 048535          276 PI---EEGKRNLVDRMWSLTERSELLSVLD-ERLKAK-----------------GGYADEVVEKVLHLGLLCAHPEANSR  334 (409)
Q Consensus       276 p~---~~~~~~~~~~vws~~~~~~~~~~~~-~~l~~~-----------------~~~~~~~~~~l~~l~~~Cl~~dP~~R  334 (409)
                      +.   ....++..+|+|+++  ..+++++. ......                 ...+......+.+++.+||+.+|++|
T Consensus       243 aPE~~~~~~~~~~~Di~SlG--v~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~R  320 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFG--VLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR  320 (337)
T ss_pred             CcHHhcCCCCCccccHHHHH--HHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhC
Confidence            11   124456678999874  22222221 111100                 11122345678999999999999999


Q ss_pred             CCHHHHHHHHhcCcC
Q 048535          335 PTIRQVLKMLEGQTE  349 (409)
Q Consensus       335 Pt~~evl~~L~~~~~  349 (409)
                      |++.|+++.|+...+
T Consensus       321 Ps~~ell~~l~~~~~  335 (337)
T cd05054         321 PTFSELVEILGDLLQ  335 (337)
T ss_pred             cCHHHHHHHHHHHHh
Confidence            999999999987543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.5e-33  Score=262.28  Aligned_cols=227  Identities=23%  Similarity=0.391  Sum_probs=178.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      .+|+..+.||+|+||.||+|.+.  ++.||+|.+..+ .....++.+|++++++++||||+++++++.. .+..+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcC-CCCcEEEEEe
Confidence            45777899999999999999986  889999998754 3345679999999999999999999999887 6788999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV  270 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  270 (409)
                      +++|+|.+++... ....+++..++.++.|+++||+|||   +.+++||||||+|||+++++.+||+|||+++.......
T Consensus        84 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          84 MTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             CCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            9999999999653 2346899999999999999999999   89999999999999999999999999999987654321


Q ss_pred             ee--------ecccc---ccCCCcHHHHHHhhhccCcHHHHhh----------------HHhh-hcCCCCHHHHHHHHHH
Q 048535          271 MS--------GRRPI---EEGKRNLVDRMWSLTERSELLSVLD----------------ERLK-AKGGYADEVVEKVLHL  322 (409)
Q Consensus       271 ~~--------g~~p~---~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~-~~~~~~~~~~~~l~~l  322 (409)
                      ..        +..+.   .....+...|+|+++  ..+++++.                .... .....+...+..+.++
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG--~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  237 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG--VLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYEL  237 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHH--HHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHH
Confidence            11        11111   123445678999874  11222211                1110 0123334456789999


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          323 GLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      +.+||+.||++|||+.+++++|+..
T Consensus       238 i~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         238 MRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHHccCCcccCCCHHHHHHHHHhh
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.5e-33  Score=258.30  Aligned_cols=226  Identities=31%  Similarity=0.399  Sum_probs=176.9

Q ss_pred             CCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      ++|+..+.||+|+||.||++...+..||+|.++...  ..+.|.+|+.++++++|+|++++++++...++..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            468888999999999999999999999999986543  346789999999999999999999987665677899999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce--
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV--  270 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~--  270 (409)
                      +|+|.+++... ....+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.......  
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  159 (256)
T cd05082          84 KGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG  159 (256)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccCCCC
Confidence            99999999653 2335899999999999999999999   89999999999999999999999999999986543210  


Q ss_pred             --eeecccc---ccCCCcHHHHHHhhhccCcHHHHhh---------------HHhhh--cCCCCHHHHHHHHHHHHHccC
Q 048535          271 --MSGRRPI---EEGKRNLVDRMWSLTERSELLSVLD---------------ERLKA--KGGYADEVVEKVLHLGLLCAH  328 (409)
Q Consensus       271 --~~g~~p~---~~~~~~~~~~vws~~~~~~~~~~~~---------------~~l~~--~~~~~~~~~~~l~~l~~~Cl~  328 (409)
                        ..+..+.   ....++...|+|+++  ..+++++.               +.+..  ....+...+..+.+++.+||+
T Consensus       160 ~~~~~y~aPE~~~~~~~~~~~Dv~slG--~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  237 (256)
T cd05082         160 KLPVKWTAPEALREKKFSTKSDVWSFG--ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWH  237 (256)
T ss_pred             ccceeecCHHHHccCCCCchhhhHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhc
Confidence              0111111   123456678999874  11222221               11110  112223445678999999999


Q ss_pred             cCCCCCCCHHHHHHHHhc
Q 048535          329 PEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       329 ~dP~~RPt~~evl~~L~~  346 (409)
                      .+|++|||+.++++.|+.
T Consensus       238 ~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         238 LDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CChhhCcCHHHHHHHHhc
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.4e-33  Score=271.91  Aligned_cols=270  Identities=20%  Similarity=0.254  Sum_probs=196.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .++|+..+.||+|+||.||++.+.  +..+|+|.+... .......+.+|++++++++||||++++++|.+ ++..++||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   82 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM   82 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CCEEEEEE
Confidence            368999999999999999999987  788999998765 33445679999999999999999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++.....
T Consensus        83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          83 EHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            99999999999954   3458999999999999999999993  247999999999999999999999999999754322


Q ss_pred             c--eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHH------------------HHHHH
Q 048535          269 Q--VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVE------------------KVLHL  322 (409)
Q Consensus       269 ~--~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~------------------~l~~l  322 (409)
                      .  ...|...+      ....++...|+|+++  ..+++++........... ....                  .....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG--~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMG--LSLVEMAIGRYPIPPPDA-KELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             ccccCCCCccccCHHHhcCCCCCcHHHHHHHH--HHHHHHHHCCCCCCCcch-hHHHHHhcCcccCCccccccCcccCCc
Confidence            1  11222221      123456789999986  344555544332111110 0100                  11112


Q ss_pred             HHHccCcCCCCCCCHHH--HHHHHhcCcCCCCC--CCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          323 GLLCAHPEANSRPTIRQ--VLKMLEGQTEGTGL--EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~e--vl~~L~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ...|....|..||++..  +...+.........  .....-.+++.+|+..+|.+|++..+++.||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence            33455567888887642  23332221111111  0112236899999999999999999999999998765

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=280.03  Aligned_cols=226  Identities=22%  Similarity=0.392  Sum_probs=182.9

Q ss_pred             CCccceeecCCceEEEEEEEC----C--cEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLL----G--VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~----~--~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ....++||.|.||.||+|.+.    |  -.||||..+.+ .....+.|+.|..+|++++|||||+++|.|.+  ...|||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e--~P~Wiv  468 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE--QPMWIV  468 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec--cceeEE
Confidence            344578999999999999886    2  35999999875 66678899999999999999999999999986  568999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||.++.|.|+.||..  ++..|+......++.||+.||+|||   +.+.|||||.++|||+.+.-.+||+||||+|....
T Consensus       469 mEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  469 MELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             EecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            999999999999975  3456999999999999999999999   89999999999999999999999999999999887


Q ss_pred             Ccee---eecccccc--------CCCcHHHHHHhhhccCcHHHHhhHHh-----------------hhcCCCCHHHHHHH
Q 048535          268 GQVM---SGRRPIEE--------GKRNLVDRMWSLTERSELLSVLDERL-----------------KAKGGYADEVVEKV  319 (409)
Q Consensus       268 ~~~~---~g~~p~~~--------~~~~~~~~vws~~~~~~~~~~~~~~l-----------------~~~~~~~~~~~~~l  319 (409)
                      ..+.   .|+.|+..        -.++.++|||-++.  .+++++.-..                 ....+.++.+++.+
T Consensus       544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgV--CmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~L  621 (974)
T KOG4257|consen  544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGV--CMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPAL  621 (974)
T ss_pred             cchhhccccccceeecCccccchhcccchhhHHHHHH--HHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHH
Confidence            6533   45556532        23456677776521  1111111100                 01135678889999


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      ..|+.+||+.+|.+||++.++...|..+.+
T Consensus       622 YslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  622 YSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             HHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            999999999999999999999988876543

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4.7e-33  Score=261.30  Aligned_cols=228  Identities=25%  Similarity=0.417  Sum_probs=171.8

Q ss_pred             CCccceeecCCceEEEEEEEC--C--cEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-----CCe
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--G--VEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-----KES  183 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~--~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  183 (409)
                      |.+.+.||+|+||.||+|.+.  +  ..||+|.++..  .....+.+.+|+.+++.++|+||+++++++...     ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            356788999999999999986  3  36999998754  345567899999999999999999999987532     124


Q ss_pred             EEEEEEeCCCCCHHHHHhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEeccc
Q 048535          184 LILIYDYMENGSLDKWIFEC---DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG  260 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG  260 (409)
                      .+++|||+++|+|.+++...   .....+++.....++.|++.||+|||   +++|+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            68999999999999987432   12345899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCce-eee-----cccc------ccCCCcHHHHHHhhhccCcHHHHhh----------------HHhhh-cCCC
Q 048535          261 LAKMHHHGQV-MSG-----RRPI------EEGKRNLVDRMWSLTERSELLSVLD----------------ERLKA-KGGY  311 (409)
Q Consensus       261 la~~~~~~~~-~~g-----~~p~------~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~~-~~~~  311 (409)
                      +++....... .++     ...+      ....++...|+|+++  ..+++++.                ..... ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG--~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFG--VTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ  235 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHH--HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            9987643321 111     1101      123456778999874  11222221                11110 0112


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          312 ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       312 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      +......+.+++.+||+.||++|||+.++++.|++.
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         236 PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            334456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-33  Score=260.33  Aligned_cols=227  Identities=25%  Similarity=0.391  Sum_probs=177.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      .++|+..+.||+|+||.||+|.+. ++.||+|.++... ...+++.+|+.++++++||||+++++++.. .+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-EEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEec-CCCeeeeeec
Confidence            466888999999999999999986 7789999997543 235678999999999999999999999887 6778999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV  270 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  270 (409)
                      +++++|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||+++.......
T Consensus        83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999996532 346899999999999999999999   89999999999999999999999999999987543211


Q ss_pred             --eee------ccccc---cCCCcHHHHHHhhhccCcHHHHh----------------hHHhhh-cCCCCHHHHHHHHHH
Q 048535          271 --MSG------RRPIE---EGKRNLVDRMWSLTERSELLSVL----------------DERLKA-KGGYADEVVEKVLHL  322 (409)
Q Consensus       271 --~~g------~~p~~---~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~~-~~~~~~~~~~~l~~l  322 (409)
                        ..|      ..+.+   ....+..+|+|+++.  .+++++                ...... ....+......+.++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~--~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGI--LLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDI  236 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHH--HHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence              011      11111   134466789998731  111111                111110 012334456789999


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHhc
Q 048535          323 GLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      +.+||+.+|.+||++.++++.|++
T Consensus       237 i~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         237 MLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             HHHHhhcCcccCCCHHHHHHHHhc
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.4e-33  Score=271.64  Aligned_cols=181  Identities=21%  Similarity=0.291  Sum_probs=147.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC---CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL---GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|+..+.||+|+||.||+|.+.   +..||+|.+...   .....+.+.+|+.+++.++||||+++++++.+ .+..++
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~l  108 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-ESYLYL  108 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-CCEEEE
Confidence            56889999999999999999875   368999998643   23345678899999999999999999999987 678999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999999954   346899999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCc-eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhh
Q 048535          267 HGQ-VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLD  302 (409)
Q Consensus       267 ~~~-~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~  302 (409)
                      ... ...|...+.      ...++..+|+|+++  ..+++++.
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG--vil~ell~  223 (340)
T PTZ00426        183 TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLG--IFIYEILV  223 (340)
T ss_pred             CCcceecCChhhcCHHHHhCCCCCccccccchh--hHHHHHhc
Confidence            322 222332221      23356678899885  33444443

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.2e-34  Score=249.32  Aligned_cols=176  Identities=24%  Similarity=0.359  Sum_probs=150.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .++|++++.||+|-||.||.|+.+  +-.||+|++...   ..+..+++.+|+++-+.|+||||+++++||.+ ....||
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd-~~riyL   99 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD-SKRIYL   99 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-cceeEE
Confidence            467999999999999999999987  778999999654   22334678999999999999999999999998 778999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ++||.++|+|++.|.+. ....+++.....++.|+|.||.|+|   .++||||||||+|+|++.++..||+|||-+-..+
T Consensus       100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            99999999999999753 3346888889999999999999999   9999999999999999999999999999987765


Q ss_pred             CC--ceeeeccccc------cCCCcHHHHHHhhh
Q 048535          267 HG--QVMSGRRPIE------EGKRNLVDRMWSLT  292 (409)
Q Consensus       267 ~~--~~~~g~~p~~------~~~~~~~~~vws~~  292 (409)
                      .+  ..+||..-+.      ...++...|+|.+.
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lg  209 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLG  209 (281)
T ss_pred             CCCceeeecccccCCHhhcCCCCccchhhHHHHH
Confidence            43  3667765432      34567778999884

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.4e-33  Score=277.96  Aligned_cols=234  Identities=21%  Similarity=0.322  Sum_probs=177.0

Q ss_pred             HHHhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCC-CCceeeEeeEEEc
Q 048535          109 HAATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLK-HRNLVGLRGWCKK  179 (409)
Q Consensus       109 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~  179 (409)
                      ....++|.+.+.||+|+||.||+|++.       ++.||+|+++.. .....+.+.+|+.+|.++. |||||+++++|..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            344567888899999999999999864       357999999755 2333457899999999997 9999999999987


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCCC------------------------------------------------------
Q 048535          180 EKESLILIYDYMENGSLDKWIFECDE------------------------------------------------------  205 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~~------------------------------------------------------  205 (409)
                       ....++||||+++|+|.++++....                                                      
T Consensus       113 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         113 -GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             -CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence             6689999999999999999975311                                                      


Q ss_pred             -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q 048535          206 -----------------------------------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKAS  244 (409)
Q Consensus       206 -----------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~  244 (409)
                                                               ...+++..++.++.|++.||.|||   +.+|+||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcc
Confidence                                                     124788889999999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEecccCcccccCCce------eee---cccc---ccCCCcHHHHHHhhhccCcHHHHhh-HH-------
Q 048535          245 NVLLDKKMNARLGDFGLAKMHHHGQV------MSG---RRPI---EEGKRNLVDRMWSLTERSELLSVLD-ER-------  304 (409)
Q Consensus       245 NILl~~~~~~kl~DFGla~~~~~~~~------~~g---~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~~-------  304 (409)
                      |||+++++.+||+|||+++.......      ..+   ..+.   ....++...|+|+++  ..+++++. ..       
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG--vil~e~l~~g~~P~~~~~  346 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFG--ILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHH--HHHHHHHHcCCCCCCCCC
Confidence            99999999999999999986432210      001   0111   123456678999873  12222221 11       


Q ss_pred             --------hhh--cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          305 --------LKA--KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       305 --------l~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                              +..  ....+......+.+++..||+.+|.+||+++|+++.|++..
T Consensus       347 ~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         347 MNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             chHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                    100  01122334567899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.4e-33  Score=264.82  Aligned_cols=216  Identities=22%  Similarity=0.340  Sum_probs=161.6

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .|+..+.||+|+||.||+|...  ++.||+|.+....   ......+.+|+.++.+++|+||+++++++.+ .+..++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-~~~~~lv~   79 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-KDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-CCeEEEEE
Confidence            3777899999999999999886  8999999986542   2234568899999999999999999998887 67899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++|+|.+++... ....+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus        80 e~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          80 TIMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             EecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            999999999888643 2346899999999999999999999   899999999999999999999999999999875433


Q ss_pred             cee---eecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhc-------------------CCCCHHHHHHHH
Q 048535          269 QVM---SGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAK-------------------GGYADEVVEKVL  320 (409)
Q Consensus       269 ~~~---~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~-------------------~~~~~~~~~~l~  320 (409)
                      ...   .|...+      ....++...|+|+++  ..+++++....+..                   ..++......+.
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG--vil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  233 (285)
T cd05631         156 ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLG--CLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAK  233 (285)
T ss_pred             CeecCCCCCCCccCHhhhcCCCCCcccCchhHH--HHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHH
Confidence            221   122211      123456678899874  22333332222111                   122233444566


Q ss_pred             HHHHHccCcCCCCCCC
Q 048535          321 HLGLLCAHPEANSRPT  336 (409)
Q Consensus       321 ~l~~~Cl~~dP~~RPt  336 (409)
                      +|+.+||+.||.+||+
T Consensus       234 ~li~~~l~~~P~~R~~  249 (285)
T cd05631         234 SICRMLLTKNPKERLG  249 (285)
T ss_pred             HHHHHHhhcCHHHhcC
Confidence            6677777777777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.5e-33  Score=262.76  Aligned_cols=228  Identities=21%  Similarity=0.365  Sum_probs=174.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      ++|+..+.||+|+||.||+|.+.      +..||+|.+... .......|.+|++++++++||||+++++++.. ....+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-EQPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CCceE
Confidence            46778899999999999999852      578999999754 34455789999999999999999999999887 67889


Q ss_pred             EEEEeCCCCCHHHHHhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC
Q 048535          186 LIYDYMENGSLDKWIFECD--------------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK  251 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~  251 (409)
                      +||||+++|+|.+++....              ....+++.+.+.++.|++.||+|||   +++|+||||||+|||++++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCC
Confidence            9999999999999985321              1235889999999999999999999   8999999999999999999


Q ss_pred             CcEEEecccCcccccCCce------eee---cccc---ccCCCcHHHHHHhhhccCcHHHHhh-H--------------H
Q 048535          252 MNARLGDFGLAKMHHHGQV------MSG---RRPI---EEGKRNLVDRMWSLTERSELLSVLD-E--------------R  304 (409)
Q Consensus       252 ~~~kl~DFGla~~~~~~~~------~~g---~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~--------------~  304 (409)
                      +.+||+|||+++.......      ..+   ..+.   ....++...|+|+++  ..+++++. .              .
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG--~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFG--VVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHH--HHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            9999999999976533210      000   1111   124456778999874  12222221 1              0


Q ss_pred             hh--hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          305 LK--AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       305 l~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      +.  .....+......+.+++.+||+.||++||++.++++.|..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            10  0012233445678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.3e-33  Score=258.92  Aligned_cols=231  Identities=23%  Similarity=0.346  Sum_probs=177.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|++.+.||+|+||.||+|+..  ++.||||.++..   .......+.+|+++++.++||||+++++++.+ .+..+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-DNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-CCeEEEE
Confidence            57889999999999999999986  899999988642   34455678999999999999999999999887 6788999


Q ss_pred             EEeCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          188 YDYMENGSLDKWIFECD-ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      +||+++|+|.+++.... ....+++..+..++.|+++||.|||   +.+++|+||||+|||++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            99999999999885432 2345889999999999999999999   8999999999999999999999999999988654


Q ss_pred             CCc----eeeeccc---c---ccCCCcHHHHHHhhhcc-------C--------cHHHHhhHHhh--hcCCCCHHHHHHH
Q 048535          267 HGQ----VMSGRRP---I---EEGKRNLVDRMWSLTER-------S--------ELLSVLDERLK--AKGGYADEVVEKV  319 (409)
Q Consensus       267 ~~~----~~~g~~p---~---~~~~~~~~~~vws~~~~-------~--------~~~~~~~~~l~--~~~~~~~~~~~~l  319 (409)
                      ...    ...|...   .   .....+...|+|+++..       .        ...+.......  ............+
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL  237 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence            322    1112211   1   12344667889987310       0        11111111110  0011123455679


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      .+++.+||+.+|++||++.++++.|+++
T Consensus       238 ~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         238 RELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             HHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            9999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.1e-33  Score=263.59  Aligned_cols=225  Identities=28%  Similarity=0.431  Sum_probs=171.4

Q ss_pred             CCccceeecCCceEEEEEEEC------CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeEEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLL------GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLIL  186 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~~l  186 (409)
                      |+..+.||+|+||.||++...      +..||+|.++... ......|.+|++++++++||||+++++++... ....++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            378899999999999887532      6789999997653 34567789999999999999999999988653 345889


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      +|||+++|+|.+++..    ..+++.++..++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999999953    35999999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCcee-------ee---cccc---ccCCCcHHHHHHhhhccCcHHHHhhHHhh---------------------------
Q 048535          267 HGQVM-------SG---RRPI---EEGKRNLVDRMWSLTERSELLSVLDERLK---------------------------  306 (409)
Q Consensus       267 ~~~~~-------~g---~~p~---~~~~~~~~~~vws~~~~~~~~~~~~~~l~---------------------------  306 (409)
                      .+...       .+   ..+.   .....+..+|+|+++  ..+++++....+                           
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG--~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFG--VTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHH--HHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            32210       00   0111   124456678888873  112222211000                           


Q ss_pred             ----hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          307 ----AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       307 ----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                          .....+...+.++.+++..||+.+|++|||++++++.|+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence                000112233568999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-33  Score=272.15  Aligned_cols=233  Identities=25%  Similarity=0.374  Sum_probs=175.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccCC-hHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCC
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLDS-EHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  182 (409)
                      .++|++.+.||+|+||.||+|.+.       ++.||||+++... ......+.+|+.++.++ +||||++++++|...+.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            467899999999999999999742       6789999997642 34456788999999999 78999999999876566


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCC---------------------------------------------------------
Q 048535          183 SLILIYDYMENGSLDKWIFECDE---------------------------------------------------------  205 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~---------------------------------------------------------  205 (409)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            78999999999999999864211                                                         


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc--eeee---
Q 048535          206 -------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ--VMSG---  273 (409)
Q Consensus       206 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~--~~~g---  273 (409)
                             ...+++..+..++.|+++||+|||   +++|+||||||+|||++.++++||+|||+++......  ...+   
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   124788899999999999999999   8999999999999999999999999999998643221  0001   


Q ss_pred             ----cccc---ccCCCcHHHHHHhhhccCcHHHHhh----------------HHhhh--cCCCCHHHHHHHHHHHHHccC
Q 048535          274 ----RRPI---EEGKRNLVDRMWSLTERSELLSVLD----------------ERLKA--KGGYADEVVEKVLHLGLLCAH  328 (409)
Q Consensus       274 ----~~p~---~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~~--~~~~~~~~~~~l~~l~~~Cl~  328 (409)
                          ..+.   ....++..+|+|+++  ..+++++.                ..+..  ....+......+.+++..||+
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG--~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~  320 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFG--VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  320 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHH--HHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence                1111   124456778999874  11222211                00000  011122234578999999999


Q ss_pred             cCCCCCCCHHHHHHHHhcCcC
Q 048535          329 PEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       329 ~dP~~RPt~~evl~~L~~~~~  349 (409)
                      .||++|||+.|+++.|+...+
T Consensus       321 ~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         321 GEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999987543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.5e-33  Score=261.57  Aligned_cols=230  Identities=22%  Similarity=0.321  Sum_probs=173.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC--Cc----EEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GV----EVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      ++|+..+.||+|+||.||+|.+.  +.    .+++|.+.... .....++..|+..+++++||||+++++++..  ...+
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--~~~~   84 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--ASLQ   84 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC--CccE
Confidence            46788899999999999999984  43    58888886442 3345678889999999999999999998753  4578


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +++||+++|+|.+++...  ...+++..+..++.||+.||+|||   +++++||||||+|||+++++.+||+|||+++..
T Consensus        85 ~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            999999999999999643  346899999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCc------eeee---cccc---ccCCCcHHHHHHhhhccCcHHHHhh-HHhhhc----------------CCCCHHHH
Q 048535          266 HHGQ------VMSG---RRPI---EEGKRNLVDRMWSLTERSELLSVLD-ERLKAK----------------GGYADEVV  316 (409)
Q Consensus       266 ~~~~------~~~g---~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~~l~~~----------------~~~~~~~~  316 (409)
                      ....      ...+   ..+.   ....++..+|+|+++  ..+++++. ......                ...+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG--~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYG--VTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICT  237 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHH--HHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCC
Confidence            3321      0011   1111   124566778999874  12222221 110000                01112234


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCC
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGT  351 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  351 (409)
                      ..+.+++.+||+.||++|||+.|+++.|+.+...+
T Consensus       238 ~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         238 IDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence            46788999999999999999999999998765443

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.3e-33  Score=262.96  Aligned_cols=229  Identities=27%  Similarity=0.414  Sum_probs=174.9

Q ss_pred             CCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      +|+..+.||+|+||.||+|...       ...+|+|.+... .......+.+|+.+++.++||||+++++.+.. .+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-DGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCCcE
Confidence            4778899999999999999864       256999998755 33445789999999999999999999999887 67789


Q ss_pred             EEEEeCCCCCHHHHHhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q 048535          186 LIYDYMENGSLDKWIFECD---------------------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKAS  244 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~  244 (409)
                      +++||+++|+|.+++....                     ....+++..++.++.|++.||.|||   +.+|+||||||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~  156 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAAR  156 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhh
Confidence            9999999999999986421                     1235889999999999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEecccCcccccCCce------ee---ecccc---ccCCCcHHHHHHhhhccCcHHHHhh-HH-------
Q 048535          245 NVLLDKKMNARLGDFGLAKMHHHGQV------MS---GRRPI---EEGKRNLVDRMWSLTERSELLSVLD-ER-------  304 (409)
Q Consensus       245 NILl~~~~~~kl~DFGla~~~~~~~~------~~---g~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~~-------  304 (409)
                      |||+++++.+||+|||+++.......      ..   ...+.   ....++...|+|+++.  .+++++. ..       
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~--~l~el~t~g~~p~~~~~  234 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV--LLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHH--HHHHHHhcCCCCCCCCC
Confidence            99999999999999999976432110      00   01111   1234567789998741  1222221 11       


Q ss_pred             -------hh--hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          305 -------LK--AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       305 -------l~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                             +.  .....+......+.+++..||+.+|++||++.++++.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         235 PERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence                   00  001223345568899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=286.85  Aligned_cols=226  Identities=27%  Similarity=0.417  Sum_probs=180.0

Q ss_pred             CCccceeecCCceEEEEEEEC------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLL------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .+..++||+|+||+||+|.|-      ..+||+|++... ..+...++++|+.+|.+++|||+++++|+|..  ..+.||
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~--s~~qlv  775 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML--STLQLV  775 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc--chHHHH
Confidence            445688999999999999885      457999999755 55667899999999999999999999999986  347899


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ++|||.|+|.+|++.++  ..+.....+.|+.|||+||.|||   +++++||||.++|||+.+-..+||.|||+|+....
T Consensus       776 tq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            99999999999998754  45888999999999999999999   89999999999999999999999999999998876


Q ss_pred             Cc----eeeeccccc--------cCCCcHHHHHHhhhcc-----------------CcHHHHhhHHhhhcCCCCHHHHHH
Q 048535          268 GQ----VMSGRRPIE--------EGKRNLVDRMWSLTER-----------------SELLSVLDERLKAKGGYADEVVEK  318 (409)
Q Consensus       268 ~~----~~~g~~p~~--------~~~~~~~~~vws~~~~-----------------~~~~~~~~~~l~~~~~~~~~~~~~  318 (409)
                      +.    .-.|+.|+.        ...+.-.+|||+++..                 .++.+.+....+  -..++.+...
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR--LsqPpiCtiD  928 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER--LSQPPICTID  928 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc--CCCCCCccHH
Confidence            54    223444443        2455666777766311                 112222222222  2345566677


Q ss_pred             HHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          319 VLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       319 l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      +..++.+||..|+..||+++++...+.+...
T Consensus       929 Vy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  929 VYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             HHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            8899999999999999999999988766543

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6e-33  Score=259.12  Aligned_cols=227  Identities=22%  Similarity=0.398  Sum_probs=177.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      .++|+..++||+|+||.||+|... +..||+|.+.... ...+.+.+|+.++++++|+||+++++.+.. .+..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK-EEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCcEEEEec
Confidence            357888999999999999999987 7789999986543 235789999999999999999999998876 6778999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV  270 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  270 (409)
                      +++|+|.+++... ....+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.......
T Consensus        83 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          83 MAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            9999999999653 3346899999999999999999999   89999999999999999999999999999987654321


Q ss_pred             ee--------ecccc---ccCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHHHHHHHHHH
Q 048535          271 MS--------GRRPI---EEGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADEVVEKVLHL  322 (409)
Q Consensus       271 ~~--------g~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~~~~~l~~l  322 (409)
                      ..        +..+.   ....++...|+|+++  ..+++++. .....                ..+.....+..+.++
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG--ILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDI  236 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhH--HHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            11        11111   124456678999874  12222221 11110                011122345678999


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHhc
Q 048535          323 GLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      +.+||+.+|++|||++++.+.|+.
T Consensus       237 i~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         237 MKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             HHHHccCCcccCcCHHHHHHHHhc
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-33  Score=268.92  Aligned_cols=217  Identities=20%  Similarity=0.221  Sum_probs=165.2

Q ss_pred             eecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCC
Q 048535          121 IGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS  195 (409)
Q Consensus       121 lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gs  195 (409)
                      ||+|+||.||+|...  ++.||+|.++..   .......+.+|+.++.+++||||+++++++.. .+..++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCc
Confidence            799999999999987  789999999643   33445678899999999999999999998887 678999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc----ee
Q 048535          196 LDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ----VM  271 (409)
Q Consensus       196 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~----~~  271 (409)
                      |.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......    ..
T Consensus        80 L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  153 (312)
T cd05585          80 LFHHLQR---EGRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF  153 (312)
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence            9999954   346899999999999999999999   8999999999999999999999999999998642211    12


Q ss_pred             eeccccc------cCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCC
Q 048535          272 SGRRPIE------EGKRNLVDRMWSLTE-------------RSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEAN  332 (409)
Q Consensus       272 ~g~~p~~------~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~  332 (409)
                      .|...+.      ...++...|+|+++.             .....+.....+.....++......+.+++.+||+.||.
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  233 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPT  233 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHH
Confidence            2332221      234566678888731             111222222222222234445566788999999999999


Q ss_pred             CCCCHHHHHHHH
Q 048535          333 SRPTIRQVLKML  344 (409)
Q Consensus       333 ~RPt~~evl~~L  344 (409)
                      +||++.++.+.|
T Consensus       234 ~R~~~~~~~e~l  245 (312)
T cd05585         234 RRLGYNGAQEIK  245 (312)
T ss_pred             HcCCCCCHHHHH
Confidence            998654443333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-34  Score=278.88  Aligned_cols=224  Identities=21%  Similarity=0.313  Sum_probs=175.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .-|+.++.||.|+.|.|-+|++.  |+.+|||++...   .......+.+|+.+|+-+.||||+++++++.+ +.++|+|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-~~~lylv   90 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-KQHLYLV   90 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-CceEEEE
Confidence            34677899999999999999987  999999999765   23334568899999999999999999999987 7899999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      .||+++|.|++|+.   .++++++.++.+++.||+.|+.|+|   ..+|+||||||+|+|||..+++||+|||+|.+...
T Consensus        91 lEyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   91 LEYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EEecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            99999999999994   4568999999999999999999999   89999999999999999999999999999998776


Q ss_pred             Ccee---eecccccc-------CCCcHHHHHHhhh-------------ccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHH
Q 048535          268 GQVM---SGRRPIEE-------GKRNLVDRMWSLT-------------ERSELLSVLDERLKAKGGYADEVVEKVLHLGL  324 (409)
Q Consensus       268 ~~~~---~g~~p~~~-------~~~~~~~~vws~~-------------~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~  324 (409)
                      +.++   ||.+-+..       .....++|||+.+             +.+.+..++.+--.+.-+.|...+.+..+|+.
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr  244 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLR  244 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHH
Confidence            6532   33332211       2235678999873             22333333333333223344555666777777


Q ss_pred             HccCcCCCCCCCHHHHHHH
Q 048535          325 LCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       325 ~Cl~~dP~~RPt~~evl~~  343 (409)
                      +++..||+.|-|++||++.
T Consensus       245 ~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  245 RMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             HHhccCccccccHHHHhhC
Confidence            7777777777777777763

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3.3e-33  Score=265.49  Aligned_cols=233  Identities=24%  Similarity=0.407  Sum_probs=178.6

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEcc
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKE  180 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  180 (409)
                      ...++|+..+.||+|+||.||++...       ...+|+|.+... .......+.+|+.++.++ +|+||+++++++.. 
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-   87 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-   87 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC-
Confidence            34567888999999999999999875       267999998754 344556789999999999 89999999999987 


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCee
Q 048535          181 KESLILIYDYMENGSLDKWIFEC-------------DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVL  247 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NIL  247 (409)
                      .+..+++|||+++|+|.+++...             .....+++..++.++.|++.||+|||   +.+|+||||||+|||
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEE
Confidence            67899999999999999999642             12346899999999999999999999   899999999999999


Q ss_pred             eCCCCcEEEecccCcccccCCce----eee-----ccccc---cCCCcHHHHHHhhhccCcHHHHh--------------
Q 048535          248 LDKKMNARLGDFGLAKMHHHGQV----MSG-----RRPIE---EGKRNLVDRMWSLTERSELLSVL--------------  301 (409)
Q Consensus       248 l~~~~~~kl~DFGla~~~~~~~~----~~g-----~~p~~---~~~~~~~~~vws~~~~~~~~~~~--------------  301 (409)
                      +++++.+||+|||+++.......    ..+     ..+.+   ...++...|+|+++  ..+++++              
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG--VLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehh--hHHHHHhcCCCCCCCCCCHHH
Confidence            99999999999999986543221    011     11111   23455667888863  1122221              


Q ss_pred             --hHHhhh-cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          302 --DERLKA-KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       302 --~~~l~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                        +..... ....+......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              111110 01223344567899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-33  Score=271.95  Aligned_cols=227  Identities=24%  Similarity=0.362  Sum_probs=186.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++|...+.+|+|+||.++..+.+  ++.+++|.+...  +...++...+|+.++++++|||||.+.+.|..++..++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56788899999999999988877  789999999765  44455678899999999999999999999998555599999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      +||+||+|.+.|.+.+ ...++++.+..++.|++.|+.|||   ++.|+|||||+.||+++.+..+||+|||+|+.....
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999997754 567999999999999999999999   899999999999999999999999999999998776


Q ss_pred             c----eeeecccc------ccCCCcHHHHHHhhh-------------ccCcHHHHhhHHhhhc-CCCCHHHHHHHHHHHH
Q 048535          269 Q----VMSGRRPI------EEGKRNLVDRMWSLT-------------ERSELLSVLDERLKAK-GGYADEVVEKVLHLGL  324 (409)
Q Consensus       269 ~----~~~g~~p~------~~~~~~~~~~vws~~-------------~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~l~~  324 (409)
                      .    .+.|.+.+      ....|+.++|+|+++             ...+....+....... .+.+.....++..++.
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~  239 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVK  239 (426)
T ss_pred             hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHHH
Confidence            4    23343332      246789999999995             1122333333333322 3455667788999999


Q ss_pred             HccCcCCCCCCCHHHHHHH
Q 048535          325 LCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       325 ~Cl~~dP~~RPt~~evl~~  343 (409)
                      .|++.+|..||++.+++.+
T Consensus       240 ~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  240 SMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHhhcCCccCCCHHHHhhC
Confidence            9999999999999999865

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.2e-33  Score=258.33  Aligned_cols=224  Identities=29%  Similarity=0.435  Sum_probs=172.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      ++|+..+.||+|+||.||+|.+. +..+|+|.+.... .....|.+|+.++++++||||+++++++.. ....+++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-QRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CCCcEEEEEcC
Confidence            45778899999999999999887 5569999987543 234679999999999999999999999876 66789999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM  271 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  271 (409)
                      ++|+|.+++...  ...+++.+++.++.|++.||.|||   +.+++|+||||+||++++++.+||+|||+++........
T Consensus        82 ~~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05113          82 SNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT  156 (256)
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence            999999999653  236899999999999999999999   899999999999999999999999999999865433211


Q ss_pred             e--e------ccccc---cCCCcHHHHHHhhhccCcHHHHh----------------hHHhhhc-CCCCHHHHHHHHHHH
Q 048535          272 S--G------RRPIE---EGKRNLVDRMWSLTERSELLSVL----------------DERLKAK-GGYADEVVEKVLHLG  323 (409)
Q Consensus       272 ~--g------~~p~~---~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~~~-~~~~~~~~~~l~~l~  323 (409)
                      .  +      ..+.+   ...++..+|+|+++  ..+++++                +...... ...+......+.+++
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG--~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  234 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFG--VLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIM  234 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHH--HHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence            1  1      11111   13456778999873  1111111                1111110 111223456789999


Q ss_pred             HHccCcCCCCCCCHHHHHHHHh
Q 048535          324 LLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                      .+||+.||.+|||+.++++.|+
T Consensus       235 ~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         235 YSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHcCCCcccCCCHHHHHHhhC
Confidence            9999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-32  Score=259.37  Aligned_cols=218  Identities=23%  Similarity=0.363  Sum_probs=163.3

Q ss_pred             eeecCCceEEEEEEEC--------------------------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeE
Q 048535          120 VIGLGGNGKVYKGQLL--------------------------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL  173 (409)
Q Consensus       120 ~lG~G~fg~Vy~~~~~--------------------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l  173 (409)
                      .||+|+||.||+|.+.                          ...||+|.+..........|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5999999999999752                          13589999976555555678999999999999999999


Q ss_pred             eeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC-
Q 048535          174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM-  252 (409)
Q Consensus       174 ~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-  252 (409)
                      +++|.+ ....++||||+++|+|..++...  ...+++..+..++.|+++||+|||   +++|+||||||+|||++.++ 
T Consensus        82 ~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVR-GSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEe-CCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCc
Confidence            999987 67789999999999999998642  346899999999999999999999   89999999999999997643 


Q ss_pred             ------cEEEecccCcccccCCceeeecccc---c----cCCCcHHHHHHhhhccCcHHHHh-hHH--------------
Q 048535          253 ------NARLGDFGLAKMHHHGQVMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVL-DER--------------  304 (409)
Q Consensus       253 ------~~kl~DFGla~~~~~~~~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~-~~~--------------  304 (409)
                            .+|++|||++..........+..++   +    ...++...|+|+++.  .+++++ ...              
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~--~l~el~~~g~~p~~~~~~~~~~~~  233 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGT--TLLEICFDGEVPLKERTPSEKERF  233 (274)
T ss_pred             ccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHH--HHHHHHhCCCCCccccChHHHHHH
Confidence                  3799999998654322211122211   1    133567789998741  122221 100              


Q ss_pred             hhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 048535          305 LKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       305 l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                      .......+......+.+++.+||+.+|++|||+.++++.|.
T Consensus       234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         234 YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            01001122222356889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-33  Score=270.31  Aligned_cols=222  Identities=23%  Similarity=0.248  Sum_probs=172.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|++.+.||+|+||.||+|...  ++.||+|+++..   .....+.+.+|++++..++||||+++++++.. .+..|+|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-DEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-CCEEEEE
Confidence            46889999999999999999986  889999999754   22345678899999999999999999999887 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        80 ~e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          80 MEYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            999999999999953   346899999999999999999999   89999999999999999999999999999986543


Q ss_pred             C-ceeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh--------------------cCCCC---HHHHH
Q 048535          268 G-QVMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKA--------------------KGGYA---DEVVE  317 (409)
Q Consensus       268 ~-~~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~--------------------~~~~~---~~~~~  317 (409)
                      . ....|...+      ....++...|+|+++.  .+++++....+.                    .+...   .....
T Consensus       154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~--il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~  231 (333)
T cd05600         154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGC--MLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD  231 (333)
T ss_pred             ccCCcccCccccChhHhcCCCCCCccceecchH--HHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCH
Confidence            1 111222221      1234567788888741  122222111110                    00111   13356


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      .+.+++.+||+.+|.+||++.++++.
T Consensus       232 ~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         232 EAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            78899999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=7.5e-33  Score=262.24  Aligned_cols=261  Identities=22%  Similarity=0.261  Sum_probs=179.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++|++.+.||+|+||.||+|+..  ++.||+|++...  .....+.+.+|+.++++++||||+++++++.. .+..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEE
Confidence            46889999999999999999997  788999999754  23345678899999999999999999999887 67899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||++++.+..+..   ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        80 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          80 EYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             ecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            9999977765542   2346899999999999999999999   899999999999999999999999999999875432


Q ss_pred             c-----eeeecccc---c---cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCC-----
Q 048535          269 Q-----VMSGRRPI---E---EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEAN-----  332 (409)
Q Consensus       269 ~-----~~~g~~p~---~---~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~-----  332 (409)
                      .     ...|...+   +   ...++...|+|+++  ..+++++............+.   +..+ ..+....|.     
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG--vil~el~~g~~pf~~~~~~~~---~~~~-~~~~~~~~~~~~~~  227 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVG--CILGELSDGQPLFPGESEIDQ---LFTI-QKVLGPLPAEQMKL  227 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHH--HHHHHHHhCCCCCCCCCHHHH---HHHH-HHhhCCCCHHHHHh
Confidence            1     11222221   1   24456788999986  345555544433211111111   1111 111111110     


Q ss_pred             --CCCCHHHHH----HHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          333 --SRPTIRQVL----KMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       333 --~RPt~~evl----~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                        ..|......    ..-+.........-+....+++.+|+..+|.+|+++++++.||||
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence              000000000    000000000000112346899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.2e-33  Score=267.90  Aligned_cols=215  Identities=20%  Similarity=0.273  Sum_probs=167.4

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMEN  193 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~  193 (409)
                      +.||+|+||.||++...  |..||+|.++..   .......+.+|+.++++++||||+++++++.. .+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCEEEEEEeCCCC
Confidence            46999999999999986  899999999754   23345678899999999999999999999887 6789999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc----
Q 048535          194 GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ----  269 (409)
Q Consensus       194 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~----  269 (409)
                      |+|..++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++......    
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  153 (323)
T cd05595          80 GELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence            999998853   346899999999999999999999   8999999999999999999999999999987532211    


Q ss_pred             eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHH---------------hhhcCCCCHHHHHHHHHHHHHccC
Q 048535          270 VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDER---------------LKAKGGYADEVVEKVLHLGLLCAH  328 (409)
Q Consensus       270 ~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~---------------l~~~~~~~~~~~~~l~~l~~~Cl~  328 (409)
                      ...|...+      ....++...|+|+++  ..+++++...               ......++......+.+++.+||+
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG--vil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~  231 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLG--VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLK  231 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhH--HHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcc
Confidence            11222221      124456788999984  2222222221               111122334456678899999999


Q ss_pred             cCCCCCC-----CHHHHHH
Q 048535          329 PEANSRP-----TIRQVLK  342 (409)
Q Consensus       329 ~dP~~RP-----t~~evl~  342 (409)
                      .||.+||     ++.++++
T Consensus       232 ~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         232 KDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCHHHhCCCCCCCHHHHHc
Confidence            9999998     7888775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-32  Score=258.23  Aligned_cols=228  Identities=24%  Similarity=0.431  Sum_probs=173.7

Q ss_pred             CCccceeecCCceEEEEEEEC-----CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC-----
Q 048535          115 FSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE-----  182 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  182 (409)
                      |++.+.||+|+||.||+|...     +..||+|+++..  .......+.+|++.++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567889999999999999875     367999999754  34456789999999999999999999998865322     


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 048535          183 SLILIYDYMENGSLDKWIFECD---ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDF  259 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF  259 (409)
                      ..++++||+++|+|..++....   ....+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence            3789999999999999985431   2346899999999999999999999   899999999999999999999999999


Q ss_pred             cCcccccCCce------eeecc---cc---ccCCCcHHHHHHhhhccCcHHHHhh----------------HHhh-hcCC
Q 048535          260 GLAKMHHHGQV------MSGRR---PI---EEGKRNLVDRMWSLTERSELLSVLD----------------ERLK-AKGG  310 (409)
Q Consensus       260 Gla~~~~~~~~------~~g~~---p~---~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~-~~~~  310 (409)
                      |+++.......      ..+..   +.   ....++..+|+|+++  ..+++++.                .... ....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG--~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG--VTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK  235 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99986543221      01111   11   123455678888874  12222221                1111 0112


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       311 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      .+...+..+.+++.+||+.||++|||+.|+++.|++.
T Consensus       236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            3344567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-32  Score=259.51  Aligned_cols=231  Identities=22%  Similarity=0.369  Sum_probs=177.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--Cc----EEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GV----EVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      .++|+..+.||+|+||+||+|++.  +.    .||+|.++.. .....+.+.+|+.+++.++||||+++++++..  ...
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~   83 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--STV   83 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--CCc
Confidence            357888899999999999999874  43    5899999754 44456789999999999999999999999875  457


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++++||+++|+|.+++...  ...+++..++.++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++.
T Consensus        84 ~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          84 QLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceee
Confidence            7999999999999999643  346899999999999999999999   89999999999999999999999999999987


Q ss_pred             ccCCce---eee------ccccc---cCCCcHHHHHHhhhccCcHHHHhh-H--------------Hhhh--cCCCCHHH
Q 048535          265 HHHGQV---MSG------RRPIE---EGKRNLVDRMWSLTERSELLSVLD-E--------------RLKA--KGGYADEV  315 (409)
Q Consensus       265 ~~~~~~---~~g------~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~--------------~l~~--~~~~~~~~  315 (409)
                      ......   ..+      ..+.+   ...++...|+|+++  ..+++++. .              .+..  ....+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG--~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYG--VTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPIC  236 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHH--HHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccC
Confidence            643221   000      11111   23456778999974  12222221 0              0100  01223344


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCC
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGT  351 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  351 (409)
                      ...+.+++..||+.||++||++.++++.|+.....+
T Consensus       237 ~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         237 TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            567889999999999999999999999998776554

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-34  Score=276.31  Aligned_cols=213  Identities=22%  Similarity=0.366  Sum_probs=169.4

Q ss_pred             cceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCCHH
Q 048535          118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLD  197 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gsL~  197 (409)
                      .+.||+|+-|.||+|++.++.||||+++.-.       ..+|+-|++|+||||+.+.|+|.. ...+|||||||+.|-|+
T Consensus       129 LeWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq-sPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ-SPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC-CceeEEeeeccccccHH
Confidence            4789999999999999999999999986332       257888999999999999999998 77899999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---eeeec
Q 048535          198 KWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---VMSGR  274 (409)
Q Consensus       198 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---~~~g~  274 (409)
                      +.|+   ....++....+.|..+||.||.|||   .+.|||||||.-||||..+-.+||+|||.++....-.   -++|.
T Consensus       201 ~VLk---a~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGT  274 (904)
T KOG4721|consen  201 EVLK---AGRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGT  274 (904)
T ss_pred             HHHh---ccCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhh
Confidence            9995   4567899999999999999999999   8999999999999999999999999999998754321   12232


Q ss_pred             ccc------cc-------CCCcHHHHHHhhhccCcHHHHhhH----------HhhhcCCCCHHHHHHHHHHHHHccCcCC
Q 048535          275 RPI------EE-------GKRNLVDRMWSLTERSELLSVLDE----------RLKAKGGYADEVVEKVLHLGLLCAHPEA  331 (409)
Q Consensus       275 ~p~------~~-------~~~~~~~~vws~~~~~~~~~~~~~----------~l~~~~~~~~~~~~~l~~l~~~Cl~~dP  331 (409)
                      ...      ..       +.+++..-+|++...+..+.-+|.          .+.  ...+..+++-+.-|+.+||+..|
T Consensus       275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~--LpvPstcP~GfklL~Kqcw~sKp  352 (904)
T KOG4721|consen  275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLH--LPVPSTCPDGFKLLLKQCWNSKP  352 (904)
T ss_pred             HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccc--ccCcccCchHHHHHHHHHHhcCC
Confidence            221      12       334444444554444333332322          111  23466778889999999999999


Q ss_pred             CCCCCHHHHHHHHhc
Q 048535          332 NSRPTIRQVLKMLEG  346 (409)
Q Consensus       332 ~~RPt~~evl~~L~~  346 (409)
                      .+||++++++..|+=
T Consensus       353 RNRPSFrqil~HldI  367 (904)
T KOG4721|consen  353 RNRPSFRQILLHLDI  367 (904)
T ss_pred             CCCccHHHHHHHHhh
Confidence            999999999999864

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-32  Score=261.64  Aligned_cols=228  Identities=25%  Similarity=0.428  Sum_probs=173.3

Q ss_pred             CCCCccceeecCCceEEEEEEECC----------------cEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEee
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLLG----------------VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRG  175 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~~----------------~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g  175 (409)
                      ++|++.+.||+|+||.||++...+                ..||+|.++.. .......|.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578889999999999999987642                35899999765 3445567999999999999999999999


Q ss_pred             EEEccCCeEEEEEEeCCCCCHHHHHhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 048535          176 WCKKEKESLILIYDYMENGSLDKWIFECD---------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNV  246 (409)
Q Consensus       176 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NI  246 (409)
                      ++.. .+..++||||+++++|.+++....         ....+++..+..++.|++.||+|||   +.+++||||||+||
T Consensus        85 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni  160 (295)
T cd05097          85 VCVS-DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC  160 (295)
T ss_pred             EEcC-CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence            9987 678899999999999999985421         1124789999999999999999999   89999999999999


Q ss_pred             eeCCCCcEEEecccCcccccCCce--eeec-------ccc---ccCCCcHHHHHHhhhccCcHHHHhh------------
Q 048535          247 LLDKKMNARLGDFGLAKMHHHGQV--MSGR-------RPI---EEGKRNLVDRMWSLTERSELLSVLD------------  302 (409)
Q Consensus       247 Ll~~~~~~kl~DFGla~~~~~~~~--~~g~-------~p~---~~~~~~~~~~vws~~~~~~~~~~~~------------  302 (409)
                      |+++++.+||+|||+++.......  ..+.       .+.   ....++...|+|+++.  .+++++.            
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~--~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV--TLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHH--HHHHHHHcCCCCCCcccCh
Confidence            999999999999999976543221  1111       111   1244577889999741  1111111            


Q ss_pred             -----HHh---h-----hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          303 -----ERL---K-----AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       303 -----~~l---~-----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                           ...   .     .....+...+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence                 000   0     0001122234678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.6e-33  Score=272.10  Aligned_cols=218  Identities=25%  Similarity=0.357  Sum_probs=163.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|+..+.||+|+||.||+|++.  ++.||||++... .......+.+|++++++++|+||+++++++.. .+..++|||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  152 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQVLLE  152 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeEEEEEe
Confidence            34556788999999999999986  899999999654 33445679999999999999999999999877 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+..       ...+..+..++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||+++......
T Consensus       153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            99999986532       3567788899999999999999   8999999999999999999999999999998654321


Q ss_pred             ----eeeecccc---cc--------CCCcHHHHHHhhhccCcHHHHhhHHhhh-------------------cCCCCHHH
Q 048535          270 ----VMSGRRPI---EE--------GKRNLVDRMWSLTERSELLSVLDERLKA-------------------KGGYADEV  315 (409)
Q Consensus       270 ----~~~g~~p~---~~--------~~~~~~~~vws~~~~~~~~~~~~~~l~~-------------------~~~~~~~~  315 (409)
                          ...|...+   +.        ...+...|+|+++  ..+++++......                   ....+...
T Consensus       223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslG--vil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
T PLN00034        223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLG--VSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA  300 (353)
T ss_pred             ccccccccCccccCccccccccccCcCCCcchhHHHHH--HHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCcc
Confidence                11222221   10        1123478999985  2233333222211                   01122334


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ..++.+++.+||+.||++|||+.|+++.
T Consensus       301 ~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        301 SREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            4567888888888888888888888763

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=8e-33  Score=267.73  Aligned_cols=216  Identities=20%  Similarity=0.273  Sum_probs=167.4

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMEN  193 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~  193 (409)
                      +.||+|+||.||++...  ++.||+|++...   .......+.+|+.+++.++||||+++++++.. .+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCC
Confidence            46999999999999886  899999999754   23445678899999999999999999998887 7789999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc----
Q 048535          194 GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ----  269 (409)
Q Consensus       194 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~----  269 (409)
                      |+|.+++..   ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......    
T Consensus        80 g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  153 (328)
T cd05593          80 GELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK  153 (328)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence            999998853   346899999999999999999999   8999999999999999999999999999997532211    


Q ss_pred             eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHh---------------hhcCCCCHHHHHHHHHHHHHccC
Q 048535          270 VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERL---------------KAKGGYADEVVEKVLHLGLLCAH  328 (409)
Q Consensus       270 ~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l---------------~~~~~~~~~~~~~l~~l~~~Cl~  328 (409)
                      ...|...+.      ...++...|+|+++  ..+++++....               .....++......+.+++.+||+
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG--vil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~  231 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLG--VVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLI  231 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccc--hHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcC
Confidence            122332221      23456677888874  22222222221               11122333445678899999999


Q ss_pred             cCCCCCC-----CHHHHHHH
Q 048535          329 PEANSRP-----TIRQVLKM  343 (409)
Q Consensus       329 ~dP~~RP-----t~~evl~~  343 (409)
                      .||++||     ++.|+++.
T Consensus       232 ~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         232 KDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCHHHcCCCCCCCHHHHhcC
Confidence            9999997     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.2e-32  Score=261.35  Aligned_cols=231  Identities=22%  Similarity=0.370  Sum_probs=176.0

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  182 (409)
                      .+++|++.+.||+|+||.||+|...       +..||+|.++... ......+.+|+.++++++||||+++++++.+ ..
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK-GQ   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CC
Confidence            4578999999999999999999753       4579999986543 3344578899999999999999999999887 66


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEE
Q 048535          183 SLILIYDYMENGSLDKWIFECD-------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNAR  255 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k  255 (409)
                      ..++||||+++|+|.+++....       ....+++..+..++.|++.||.|||   +++|+||||||+|||+++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEE
Confidence            7899999999999999996421       1234577889999999999999999   89999999999999999999999


Q ss_pred             EecccCcccccCCcee-e--------ecccc---ccCCCcHHHHHHhhhccCcHHHHh----------------hHHhhh
Q 048535          256 LGDFGLAKMHHHGQVM-S--------GRRPI---EEGKRNLVDRMWSLTERSELLSVL----------------DERLKA  307 (409)
Q Consensus       256 l~DFGla~~~~~~~~~-~--------g~~p~---~~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~~  307 (409)
                      |+|||+++........ .        ...+.   ....++..+|+|+++.  .+++++                +.....
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~--~l~el~~~~~~p~~~~~~~~~~~~~~~~  237 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV--VLWEITSLAEQPYQGLSNEQVLKFVMDG  237 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHH--HHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999854332210 0        01111   1245577889999741  112221                111110


Q ss_pred             -cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          308 -KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       308 -~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                       ....+......+.+++.+||+.||++|||+.++++.|++.
T Consensus       238 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         238 GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence             0122334457899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.3e-32  Score=256.43  Aligned_cols=218  Identities=25%  Similarity=0.359  Sum_probs=169.1

Q ss_pred             eeecCCceEEEEEEEC----CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCC
Q 048535          120 VIGLGGNGKVYKGQLL----GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMEN  193 (409)
Q Consensus       120 ~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~  193 (409)
                      +||+|+||.||+|.+.    +..+|+|+++..  .....+++.+|+.++++++||||+++++++..  ...++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA--ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCcEEEEecCCC
Confidence            5899999999999763    678999998654  33456789999999999999999999998853  467899999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce---
Q 048535          194 GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV---  270 (409)
Q Consensus       194 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~---  270 (409)
                      |+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.......   
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          80 GPLNKFLQK---NKHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            999999953   346899999999999999999999   89999999999999999999999999999987543321   


Q ss_pred             --eeec-----cccc---cCCCcHHHHHHhhhccCcHHHHhh-HHhh----------------hcCCCCHHHHHHHHHHH
Q 048535          271 --MSGR-----RPIE---EGKRNLVDRMWSLTERSELLSVLD-ERLK----------------AKGGYADEVVEKVLHLG  323 (409)
Q Consensus       271 --~~g~-----~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~----------------~~~~~~~~~~~~l~~l~  323 (409)
                        ..+.     .+.+   ...++..+|+|+++  ..+++++. ....                ...+.+...+..+.+++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  231 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFG--VLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLM  231 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence              0111     0111   13455678999873  11222221 1110                01233445567889999


Q ss_pred             HHccCcCCCCCCCHHHHHHHHhcC
Q 048535          324 LLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      .+||+.||++||++.+|.+.|++.
T Consensus       232 ~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         232 KLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             HHHhccCchhCcCHHHHHHHHhcc
Confidence            999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.4e-32  Score=261.27  Aligned_cols=232  Identities=23%  Similarity=0.398  Sum_probs=179.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      .+|...+.||+|+||.||+|...       +..+++|.+........+.+.+|++++++++|+||+++++++.. ....+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-GDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-CCceE
Confidence            45777899999999999999753       45699999987666666789999999999999999999999987 67789


Q ss_pred             EEEEeCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC
Q 048535          186 LIYDYMENGSLDKWIFECD-------------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM  252 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~  252 (409)
                      +||||+++++|.+++....             ....+++..++.++.|++.||+|||   +++|+||||||+|||++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence            9999999999999996432             1235899999999999999999999   89999999999999999999


Q ss_pred             cEEEecccCcccccCCce------eee---ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HHhh-------------
Q 048535          253 NARLGDFGLAKMHHHGQV------MSG---RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ERLK-------------  306 (409)
Q Consensus       253 ~~kl~DFGla~~~~~~~~------~~g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~-------------  306 (409)
                      .+||+|||+++.......      ..+   ..+.+   ...++..+|+|+++  ..+++++. ....             
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG--VILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999976533211      001   11111   23456678999874  12222221 1111             


Q ss_pred             --h-cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          307 --A-KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       307 --~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                        . ....+...+..+.+++.+||+.+|++|||+++++++|+.+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence              0 0112233456789999999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.3e-32  Score=259.32  Aligned_cols=232  Identities=23%  Similarity=0.434  Sum_probs=179.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      ++|.+.+.||+|+||.||++...       +..+|+|.+........+.+.+|++++++++||||+++++++.. .+..+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccE
Confidence            57888999999999999999752       45699999987666667789999999999999999999999987 67899


Q ss_pred             EEEEeCCCCCHHHHHhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEE
Q 048535          186 LIYDYMENGSLDKWIFECD----------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNAR  255 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k  255 (409)
                      +||||+++|+|.+++....          ....+++..+..++.|++.||+|||   +.+++||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEE
Confidence            9999999999999996431          1235899999999999999999999   89999999999999999999999


Q ss_pred             EecccCcccccCCce--eee-------cccc---ccCCCcHHHHHHhhhccCcHHHHhh----------------HHhhh
Q 048535          256 LGDFGLAKMHHHGQV--MSG-------RRPI---EEGKRNLVDRMWSLTERSELLSVLD----------------ERLKA  307 (409)
Q Consensus       256 l~DFGla~~~~~~~~--~~g-------~~p~---~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~~  307 (409)
                      |+|||+++.......  ..+       ..+.   ....++..+|+|+++  ..+++++.                .....
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG--~il~~l~t~g~~p~~~~~~~~~~~~i~~~  238 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG--VVLWEIFTYGKQPWYQLSNNEVIECITQG  238 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            999999986533221  011       1111   124456789999973  11222221                11110


Q ss_pred             c-CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          308 K-GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       308 ~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      . ...+......+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            0 111223456789999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.5e-32  Score=255.92  Aligned_cols=228  Identities=27%  Similarity=0.499  Sum_probs=176.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--C---cEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--G---VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      +++|+..+.||+|+||.||+|...  +   ..+|+|.+... .....+.+.+|++++++++||||+++++++.. .+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   82 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-FKPAM   82 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-CCCcE
Confidence            356788899999999999999875  3   37999999765 34456789999999999999999999999987 67889


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +||||+++|+|.+++...  ...+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++...
T Consensus        83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          83 IITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence            999999999999999642  346899999999999999999999   899999999999999999999999999999765


Q ss_pred             cCCc--eee--------eccccc---cCCCcHHHHHHhhhccCcHHHHhh-HH--------------hh--hcCCCCHHH
Q 048535          266 HHGQ--VMS--------GRRPIE---EGKRNLVDRMWSLTERSELLSVLD-ER--------------LK--AKGGYADEV  315 (409)
Q Consensus       266 ~~~~--~~~--------g~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~--------------l~--~~~~~~~~~  315 (409)
                      ....  ..+        ...+.+   ...++...|+|+++  ..+++++. ..              +.  ...+.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG--~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~  235 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFG--IVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDC  235 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHH--HHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCC
Confidence            4321  000        011111   23456778999873  11222111 11              00  011223344


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      ...+.+++.+||+.+|++||++.++++.|+++
T Consensus       236 ~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         236 PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            56789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.1e-32  Score=260.15  Aligned_cols=232  Identities=22%  Similarity=0.363  Sum_probs=179.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      .++|+..+.||+|+||.||+|.+.      +..|++|++... .....+.+.+|+.++++++||||+++++++...+...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            467888999999999999999875      377999998754 4455677999999999999999999999988756778


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 048535          185 ILIYDYMENGSLDKWIFECDES-----IALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDF  259 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF  259 (409)
                      ++++||+++|+|.+++......     ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998654222     46899999999999999999999   899999999999999999999999999


Q ss_pred             cCcccccCCcee------ee---ccccc---cCCCcHHHHHHhhhccCcHHHHhh-H--------------Hhhh--cCC
Q 048535          260 GLAKMHHHGQVM------SG---RRPIE---EGKRNLVDRMWSLTERSELLSVLD-E--------------RLKA--KGG  310 (409)
Q Consensus       260 Gla~~~~~~~~~------~g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~--------------~l~~--~~~  310 (409)
                      |+++....+...      .+   ..+.+   ...++..+|+|+++.  .+++++. .              .+..  ...
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~--~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGV--LLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA  239 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHH--HHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence            999865432211      01   11111   234567789998741  1222211 0              0100  011


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       311 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      .+...+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            22334567899999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-32  Score=270.46  Aligned_cols=263  Identities=17%  Similarity=0.171  Sum_probs=182.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|++.+.||+|+||.||++...  ++.||+|...      ...+.+|++++++++|||||++++++.. ....++|+|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY-NKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-CCeeEEEEe
Confidence            367999999999999999999986  8899999753      2356789999999999999999999987 678899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      ++. ++|..++..   ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+|+......
T Consensus       164 ~~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        164 RYK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             cCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            995 699998853   346899999999999999999999   8899999999999999999999999999997532211


Q ss_pred             -----eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCC--C-HHHHHHHHHHHHHccCcCCCCCC
Q 048535          270 -----VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGY--A-DEVVEKVLHLGLLCAHPEANSRP  335 (409)
Q Consensus       270 -----~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~--~-~~~~~~l~~l~~~Cl~~dP~~RP  335 (409)
                           ...|...+      ....++...|+|+++  ..+++++..........  . .......+..+..++...|.+.|
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG--vil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAG--IVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHH--HHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence                 11222221      124567889999996  34555544321100000  0 00011112222223333333333


Q ss_pred             C-----HHHHH-HHHhcCcCCCCCC--------CCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          336 T-----IRQVL-KMLEGQTEGTGLE--------DEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       336 t-----~~evl-~~L~~~~~~~~~~--------~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      .     ..++. .........+...        .+..-.+++.+|++.+|.+|.++.+++.||||.++.
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence            1     11111 1111111111000        011236789999999999999999999999998875

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.9e-33  Score=260.88  Aligned_cols=175  Identities=27%  Similarity=0.387  Sum_probs=138.8

Q ss_pred             eecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCC
Q 048535          121 IGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS  195 (409)
Q Consensus       121 lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gs  195 (409)
                      ||+|+||.||++...  |+.||+|.+....   ....+.+..|++++++++||||+++++++.. +...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence            799999999999886  8999999996431   1223456679999999999999999998886 678999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee---e
Q 048535          196 LDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM---S  272 (409)
Q Consensus       196 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~---~  272 (409)
                      |.+++... ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++.........   .
T Consensus        80 L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  155 (277)
T cd05607          80 LKYHIYNV-GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA  155 (277)
T ss_pred             HHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence            99988643 3345899999999999999999999   899999999999999999999999999999765443211   1


Q ss_pred             ecccc------ccCCCcHHHHHHhhhccCcHHHHhh
Q 048535          273 GRRPI------EEGKRNLVDRMWSLTERSELLSVLD  302 (409)
Q Consensus       273 g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~  302 (409)
                      |...+      ....++...|+|+++  ..+++++.
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslG--v~l~el~~  189 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMG--CSIYEMVA  189 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHH--HHHHHHHh
Confidence            11111      123456778999985  33444443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.6e-32  Score=258.70  Aligned_cols=228  Identities=23%  Similarity=0.396  Sum_probs=176.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLDSEH-GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      ++|.+.+.||+|+||.||+|...       +..||+|.++..... ..+.|.+|++++++++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-GDPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-CCCe
Confidence            56788899999999999999864       367999999765433 56789999999999999999999999987 6789


Q ss_pred             EEEEEeCCCCCHHHHHhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc
Q 048535          185 ILIYDYMENGSLDKWIFECD-----------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN  253 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~  253 (409)
                      ++||||+++|+|.+++....           ....+++.++..++.|++.||.|||   +.+++||||||+|||++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence            99999999999999996532           1245889999999999999999999   899999999999999999999


Q ss_pred             EEEecccCcccccCCcee--ee-------cccc---ccCCCcHHHHHHhhhccCcHHHHhh----------------HHh
Q 048535          254 ARLGDFGLAKMHHHGQVM--SG-------RRPI---EEGKRNLVDRMWSLTERSELLSVLD----------------ERL  305 (409)
Q Consensus       254 ~kl~DFGla~~~~~~~~~--~g-------~~p~---~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l  305 (409)
                      +||+|||+++........  .+       ..+.   ....++..+|+|+++  ..+++++.                ...
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG--VVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHH--HHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            999999999754322110  00       1111   224556778999974  12222221                111


Q ss_pred             hh-cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          306 KA-KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       306 ~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      .. ....+......+.+++.+||+.||++|||+.|+++.|++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         239 QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            10 011233455688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.8e-32  Score=259.34  Aligned_cols=229  Identities=27%  Similarity=0.411  Sum_probs=175.4

Q ss_pred             hCCCCccceeecCCceEEEEEEEC------------------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceee
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL------------------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVG  172 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~------------------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~  172 (409)
                      .++|++.+.||+|+||.||++...                  +..||+|.+... .....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            467889999999999999998765                  145899999765 3445678999999999999999999


Q ss_pred             EeeEEEccCCeEEEEEEeCCCCCHHHHHhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q 048535          173 LRGWCKKEKESLILIYDYMENGSLDKWIFECD--------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKAS  244 (409)
Q Consensus       173 l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~  244 (409)
                      +++++.. ++..+++|||+++++|.+++....        ....+++..+..++.|++.||+|||   +.+|+||||||+
T Consensus        84 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~  159 (296)
T cd05051          84 LLGVCTV-DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATR  159 (296)
T ss_pred             EEEEEec-CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchh
Confidence            9999987 578999999999999999996532        1126899999999999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEecccCcccccCCce--eee-------ccccc---cCCCcHHHHHHhhhccCcHHHHhh----------
Q 048535          245 NVLLDKKMNARLGDFGLAKMHHHGQV--MSG-------RRPIE---EGKRNLVDRMWSLTERSELLSVLD----------  302 (409)
Q Consensus       245 NILl~~~~~~kl~DFGla~~~~~~~~--~~g-------~~p~~---~~~~~~~~~vws~~~~~~~~~~~~----------  302 (409)
                      ||+++.++.++|+|||+++.......  ..+       ..+.+   ...++..+|+|+++.  .+++++.          
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~--~l~el~~~~~~~p~~~~  237 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV--TLWEILTLCREQPYEHL  237 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHH--HHHHHHhcCCCCCCCCc
Confidence            99999999999999999986533221  111       11111   234567788998741  1222111          


Q ss_pred             -------HHhhh--------cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          303 -------ERLKA--------KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       303 -------~~l~~--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                             .....        ....+...+.++.+++.+||+.||++|||+.|+++.|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence                   10000        011122234679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-32  Score=261.38  Aligned_cols=264  Identities=21%  Similarity=0.284  Sum_probs=185.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC---CcEEEEEEeccCC--hHHHHHHHHHHHHhccC---CCCceeeEeeEEEc----c
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL---GVEVALKRISLDS--EHGMREFLAEVSSLGRL---KHRNLVGLRGWCKK----E  180 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----~  180 (409)
                      ++|+..+.||+|+||.||+|...   ++.||+|.++...  ......+.+|+.+++.+   +||||++++++|..    .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            46888999999999999999874   6789999986542  22234566777776655   69999999998852    2


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEeccc
Q 048535          181 KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG  260 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG  260 (409)
                      ....++||||++ ++|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcccc
Confidence            456899999997 5999998653 2345899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCce---eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCC
Q 048535          261 LAKMHHHGQV---MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEA  331 (409)
Q Consensus       261 la~~~~~~~~---~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP  331 (409)
                      +++.......   ..|...+      ....++..+|+|+++  ..+++++.......+...   ...+..++..+..+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG--~il~el~~g~~~f~~~~~---~~~~~~i~~~~~~~~~  230 (290)
T cd07862         156 LARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG--CIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLPGE  230 (290)
T ss_pred             ceEeccCCcccccccccccccChHHHhCCCCCCccchHHHH--HHHHHHHcCCCCcCCCCH---HHHHHHHHHHhCCCCh
Confidence            9986543321   1122211      124456678999997  355566544333222222   2334455555555566


Q ss_pred             CCCCCHHHHHHHHhcCcCCC-----CCCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          332 NSRPTIRQVLKMLEGQTEGT-----GLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       332 ~~RPt~~evl~~L~~~~~~~-----~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      .++|....+.+..-......     .+..+....+++.+|++.+|.+|+++.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            66655432221110000000     00112234789999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.4e-32  Score=256.20  Aligned_cols=227  Identities=28%  Similarity=0.480  Sum_probs=175.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|++.+.||+|+||.||+|.+.     +..+|+|.++.. .....+.|.+|+.++++++||||+++++++.. ++..++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   82 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SKPVMI   82 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccEE
Confidence            56788899999999999999874     337999998754 34456789999999999999999999999876 678999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++...  ...+++.++..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++...
T Consensus        83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          83 VTEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            99999999999999643  245899999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCc--eee--e------ccccc---cCCCcHHHHHHhhhccCcHHHHh----------------hHHhhh-cCCCCHHHH
Q 048535          267 HGQ--VMS--G------RRPIE---EGKRNLVDRMWSLTERSELLSVL----------------DERLKA-KGGYADEVV  316 (409)
Q Consensus       267 ~~~--~~~--g------~~p~~---~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~~-~~~~~~~~~  316 (409)
                      ...  ..+  +      ..+.+   ...++...|+|+++  ..+++++                +..... ..+.+...+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG--~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYG--IVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCP  235 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHH--HHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCC
Confidence            321  111  0      11111   23456678999873  1111111                111100 011222345


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      ..+.+++.+||+.+|.+||++.++++.|++.
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         236 AALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            6789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.8e-32  Score=254.09  Aligned_cols=232  Identities=24%  Similarity=0.358  Sum_probs=179.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||+|...  ++.||+|.++..   .....+.+.+|++++++++|+||+++++++.. .+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-NNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEEE
Confidence            67899999999999999999987  899999988642   33446789999999999999999999999987 6789999


Q ss_pred             EEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          188 YDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      |||+++|+|.+++... .....+++.++..++.|+++||.|||   +.+|+|+||||+||+++.++.++|+|||+++...
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            9999999999998653 22356899999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCc----eeeeccc---c---ccCCCcHHHHHHhhhcc---------------CcHHHHhhHHhhh-cCCCCH-HHHHHH
Q 048535          267 HGQ----VMSGRRP---I---EEGKRNLVDRMWSLTER---------------SELLSVLDERLKA-KGGYAD-EVVEKV  319 (409)
Q Consensus       267 ~~~----~~~g~~p---~---~~~~~~~~~~vws~~~~---------------~~~~~~~~~~l~~-~~~~~~-~~~~~l  319 (409)
                      ...    ...+...   .   ....++...|+|+++.-               ....+..+..... ....+. .....+
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL  237 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence            321    1112111   1   12345667889987311               0111111111110 011222 455678


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      .+++.+||+.+|++|||+.+++++|+++.
T Consensus       238 ~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         238 RDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            99999999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.6e-32  Score=260.24  Aligned_cols=232  Identities=26%  Similarity=0.419  Sum_probs=176.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--C--cEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--G--VEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~--~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|++.+.||+|+||.||+|...  +  ..+++|.++.. .....+.|.+|+.++.++ +||||+++++++.. .+..++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-RGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-CCcceE
Confidence            57888999999999999999886  3  35789988743 444567899999999999 79999999999877 677999


Q ss_pred             EEEeCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc
Q 048535          187 IYDYMENGSLDKWIFECD-------------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN  253 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~  253 (409)
                      ++||+++|+|.+++....             ....+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCe
Confidence            999999999999996431             1135889999999999999999999   899999999999999999999


Q ss_pred             EEEecccCcccccCCc-eeee-----ccccc---cCCCcHHHHHHhhhccCcHHHHh----------------hHHhhh-
Q 048535          254 ARLGDFGLAKMHHHGQ-VMSG-----RRPIE---EGKRNLVDRMWSLTERSELLSVL----------------DERLKA-  307 (409)
Q Consensus       254 ~kl~DFGla~~~~~~~-~~~g-----~~p~~---~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~~-  307 (409)
                      +||+|||++....... ...+     ..+.+   ...++..+|+|+++  ..+++++                ...... 
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG--~il~el~t~g~~pf~~~~~~~~~~~~~~~~  235 (297)
T cd05089         158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFG--VLLWEIVSLGGTPYCGMTCAELYEKLPQGY  235 (297)
T ss_pred             EEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHH--HHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence            9999999986432210 0011     11111   23456789999974  1222222                111110 


Q ss_pred             cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          308 KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       308 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      ....+......+.+++.+||+.+|.+|||+.++++.|++....
T Consensus       236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            0112334556789999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-32  Score=255.63  Aligned_cols=223  Identities=25%  Similarity=0.386  Sum_probs=172.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      .+|+..+.||+|+||.||+|.+. +..+|+|.+.... .....|.+|++++++++||||+++++++.. ....++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK-QRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC-CCceEEEEecC
Confidence            35778899999999999999887 5689999986432 233578899999999999999999999876 67889999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM  271 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  271 (409)
                      ++++|.+++...  ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++........
T Consensus        82 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          82 ANGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            999999999643  236899999999999999999999   899999999999999999999999999999865432211


Q ss_pred             ee--------cccc---ccCCCcHHHHHHhhhccCcHHHHhh----------------HHhhh-cCCCCHHHHHHHHHHH
Q 048535          272 SG--------RRPI---EEGKRNLVDRMWSLTERSELLSVLD----------------ERLKA-KGGYADEVVEKVLHLG  323 (409)
Q Consensus       272 ~g--------~~p~---~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~~-~~~~~~~~~~~l~~l~  323 (409)
                      +.        ..+.   ....++..+|+|+++.  .+++++.                ..... ....+...+.++.+++
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~--il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  234 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGV--LMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIM  234 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHH--HHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHH
Confidence            11        1111   1244566789998731  1111111                11000 0122233566899999


Q ss_pred             HHccCcCCCCCCCHHHHHHHH
Q 048535          324 LLCAHPEANSRPTIRQVLKML  344 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~~L  344 (409)
                      .+||+.+|++|||+.|+++.|
T Consensus       235 ~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         235 YSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHhcCChhhCcCHHHHHHHh
Confidence            999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-32  Score=262.68  Aligned_cols=235  Identities=22%  Similarity=0.373  Sum_probs=178.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC---------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEcc
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL---------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKE  180 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  180 (409)
                      ..+|.+.+.||+|+||.||+|...         +..||+|.+... .....+.+.+|+.+++.+ +||||+++++++.. 
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-   92 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-   92 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence            467888899999999999999752         347999998754 344567899999999999 89999999999987 


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCee
Q 048535          181 KESLILIYDYMENGSLDKWIFECDE-------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVL  247 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NIL  247 (409)
                      ....+++|||+++|+|.+++.....             ...+++.++..++.|+++||.|||   +++|+||||||+|||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEE
Confidence            6788999999999999999975321             235889999999999999999999   899999999999999


Q ss_pred             eCCCCcEEEecccCcccccCCce----eee-----ccccc---cCCCcHHHHHHhhhcc-------C-------cHHHHh
Q 048535          248 LDKKMNARLGDFGLAKMHHHGQV----MSG-----RRPIE---EGKRNLVDRMWSLTER-------S-------ELLSVL  301 (409)
Q Consensus       248 l~~~~~~kl~DFGla~~~~~~~~----~~g-----~~p~~---~~~~~~~~~vws~~~~-------~-------~~~~~~  301 (409)
                      +++++.+||+|||+++.......    ..+     ..+.+   ...++..+|+|+++..       +       ...++.
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  249 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  249 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence            99999999999999986543210    011     11111   2345677899987411       0       111111


Q ss_pred             hHHhhh-cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          302 DERLKA-KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       302 ~~~l~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      ...... ....+...+..+.+++.+||+.+|.+|||+.|+++.|+++...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         250 KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            111100 0112334556789999999999999999999999999876554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.6e-32  Score=254.81  Aligned_cols=223  Identities=26%  Similarity=0.403  Sum_probs=169.9

Q ss_pred             ceeecCCceEEEEEEEC-----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||+|.+.     +..||+|.+... .....+.+.+|+.+++.++||||+++++++...++..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999864     357999998543 445567899999999999999999999988754667889999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee-
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM-  271 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~-  271 (409)
                      +|+|.+++...  ...+++..+..++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999999642  234688888999999999999999   899999999999999999999999999999754322100 


Q ss_pred             -------ee---cccc---ccCCCcHHHHHHhhhccCcHHHHhhH----------------Hhhh-cCCCCHHHHHHHHH
Q 048535          272 -------SG---RRPI---EEGKRNLVDRMWSLTERSELLSVLDE----------------RLKA-KGGYADEVVEKVLH  321 (409)
Q Consensus       272 -------~g---~~p~---~~~~~~~~~~vws~~~~~~~~~~~~~----------------~l~~-~~~~~~~~~~~l~~  321 (409)
                             .+   ..+.   ....++...|+|+++  ..+++++..                .... ....+...+..+.+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFG--VLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYE  233 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHH--HHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence                   00   0111   124556789999974  122222221                1100 01122234567899


Q ss_pred             HHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          322 LGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      ++..||+.+|++||++.++++.|++..
T Consensus       234 li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         234 VMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             HHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=9.6e-33  Score=267.20  Aligned_cols=149  Identities=23%  Similarity=0.271  Sum_probs=132.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||++...  ++.||+|+++..   .....+.+.+|+.+++.++||||+++++++.+ .+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-KDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCeEEEE
Confidence            47889999999999999999986  889999999754   22345678899999999999999999998887 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        80 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          80 MEYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             ECCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            9999999999999653  246999999999999999999999   89999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.5e-32  Score=264.76  Aligned_cols=267  Identities=21%  Similarity=0.270  Sum_probs=184.4

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC----CeEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK----ESLI  185 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~~  185 (409)
                      +|++.+.||+|+||.||+|...  +..||||++...  .......+.+|+.++++++||||+++++++....    ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999986  899999998643  2334567899999999999999999999886422    3589


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +|||||+ ++|.+++..   ...+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 699999853   346899999999999999999999   899999999999999999999999999999854


Q ss_pred             cCCc-------eeeecccc---c---c--CCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcC
Q 048535          266 HHGQ-------VMSGRRPI---E---E--GKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPE  330 (409)
Q Consensus       266 ~~~~-------~~~g~~p~---~---~--~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~d  330 (409)
                      ....       ...|...+   +   .  ..++...|+|+++  ..+++++.......+..    ......++..+....
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlG--vvl~el~tg~~pf~~~~----~~~~~~~~~~~~~~~  227 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG--CIFAEVLTGKPLFPGKN----VVHQLDLITDLLGTP  227 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHH--HHHHHHHcCCCCCCCCC----hHHHHHHHHHHhCCC
Confidence            3211       01122111   1   1  3456789999996  34555555433221111    111222222222221


Q ss_pred             CCCC------CCHHHHHHHHhcCcCCCC----CCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccccc
Q 048535          331 ANSR------PTIRQVLKMLEGQTEGTG----LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNR  393 (409)
Q Consensus       331 P~~R------Pt~~evl~~L~~~~~~~~----~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~~  393 (409)
                      |...      ....+.+..+......+.    +.-+....+++.+|+..+|..|++.++++.||||+.+....
T Consensus       228 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~  300 (338)
T cd07859         228 SPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE  300 (338)
T ss_pred             CHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence            1110      011122222221111100    00111236899999999999999999999999999877543

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.4e-32  Score=260.21  Aligned_cols=229  Identities=26%  Similarity=0.437  Sum_probs=174.3

Q ss_pred             hCCCCccceeecCCceEEEEEEEC------------------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceee
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL------------------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVG  172 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~------------------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~  172 (409)
                      .++|++.+.||+|+||.||++...                  +..||+|.+... .......|.+|+.++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356889999999999999998542                  346999999755 3445678999999999999999999


Q ss_pred             EeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q 048535          173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDE--------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKAS  244 (409)
Q Consensus       173 l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~  244 (409)
                      +++++.. .+..+++|||+++|+|.+++.....        ...+++.++..++.|++.||+|||   +.+++||||||+
T Consensus        84 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~  159 (296)
T cd05095          84 LLAVCIT-SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATR  159 (296)
T ss_pred             EEEEEec-CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChh
Confidence            9999987 6778999999999999999865321        124788899999999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEecccCcccccCCce--eeecc--------c--cccCCCcHHHHHHhhhccCcHHHHhh----------
Q 048535          245 NVLLDKKMNARLGDFGLAKMHHHGQV--MSGRR--------P--IEEGKRNLVDRMWSLTERSELLSVLD----------  302 (409)
Q Consensus       245 NILl~~~~~~kl~DFGla~~~~~~~~--~~g~~--------p--~~~~~~~~~~~vws~~~~~~~~~~~~----------  302 (409)
                      |||++.++.+||+|||+++.......  ..+..        |  ...+.++..+|+|+++  ..+++++.          
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG--~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFG--VTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHH--HHHHHHHHhCCCCCcccc
Confidence            99999999999999999986533221  11110        0  1124456788999974  12222221          


Q ss_pred             -------HH---h-----hhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          303 -------ER---L-----KAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       303 -------~~---l-----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                             ..   .     ....+.+..++..+.+++.+||+.||++|||+.++++.|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                   00   0     00011122345678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.3e-32  Score=276.37  Aligned_cols=223  Identities=22%  Similarity=0.255  Sum_probs=175.6

Q ss_pred             CCCccceeecCCceEEEEEEEC---CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL---GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      .|...+.||+|+||.||+|...   +..||+|.+..........+.+|+.+|+.++|||||++++++.. .+..+|||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-DDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-CCEEEEEEEC
Confidence            4888999999999999999875   56799998876666666678899999999999999999999987 7789999999


Q ss_pred             CCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          191 MENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       191 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      +++|+|.+++... .....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            9999999988642 23456899999999999999999999   8999999999999999999999999999998754321


Q ss_pred             ------eeeecccc------ccCCCcHHHHHHhhhccCcHHHH---------------hhHHhhhc-CCCCHHHHHHHHH
Q 048535          270 ------VMSGRRPI------EEGKRNLVDRMWSLTERSELLSV---------------LDERLKAK-GGYADEVVEKVLH  321 (409)
Q Consensus       270 ------~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~---------------~~~~l~~~-~~~~~~~~~~l~~  321 (409)
                            ...|...+      ....++...|+|+++  ..++++               +...+... ...+......+.+
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG--~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  301 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLG--VILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA  301 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence                  11232222      124567789999984  122222               22222110 1223345567899


Q ss_pred             HHHHccCcCCCCCCCHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ++..||+.||++||++.+++.
T Consensus       302 li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        302 LLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHHHHhccChhhCcCHHHHHh
Confidence            999999999999999999864

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.1e-32  Score=254.27  Aligned_cols=219  Identities=23%  Similarity=0.377  Sum_probs=166.2

Q ss_pred             ceeecCCceEEEEEEEC--------------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          119 NVIGLGGNGKVYKGQLL--------------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      +.||+|+||.||+|+..              ...||+|.+..........|.+|+.+++.++||||+++++++.. ....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-DVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCCC
Confidence            46899999999999853              23589999876655556688999999999999999999999987 6678


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc-------EEEe
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN-------ARLG  257 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~-------~kl~  257 (409)
                      ++||||+++|+|..++...  ...+++..+..++.||++||+|||   +++|+||||||+|||++.++.       +|++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            9999999999999988542  346899999999999999999999   899999999999999987664       8999


Q ss_pred             cccCcccccCCceeeecccc---c----cCCCcHHHHHHhhhccCcHHHHh-hHHhhhc--------------CCCCHHH
Q 048535          258 DFGLAKMHHHGQVMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVL-DERLKAK--------------GGYADEV  315 (409)
Q Consensus       258 DFGla~~~~~~~~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~-~~~l~~~--------------~~~~~~~  315 (409)
                      |||++..........+..++   +    ...++..+|+|+++  ..+++++ .......              .......
T Consensus       155 d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG--~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  232 (262)
T cd05077         155 DPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFG--TTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPS  232 (262)
T ss_pred             CCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHH--HHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCC
Confidence            99998765433222222221   1    23456678999874  2233332 1111100              0111112


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                      ...+.+++.+||+.||.+||++.++++.|+
T Consensus       233 ~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         233 CKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            456889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2e-32  Score=264.59  Aligned_cols=218  Identities=19%  Similarity=0.241  Sum_probs=167.0

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMEN  193 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~  193 (409)
                      +.||+|+||.||++...  ++.||+|.++..   .......+..|++++..++||||+++++++.. ....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-CCEEEEEEeCCCC
Confidence            46999999999999876  889999999754   23345677899999999999999999998887 6789999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---
Q 048535          194 GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE-SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---  269 (409)
Q Consensus       194 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---  269 (409)
                      |+|.+++..   ...+++..+..++.||+.||.|||   + .+|+||||||+|||++.++.+||+|||+++......   
T Consensus        80 ~~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  153 (325)
T cd05594          80 GELFFHLSR---ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM  153 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence            999998843   346899999999999999999999   5 799999999999999999999999999987532211   


Q ss_pred             -eeeeccccc------cCCCcHHHHHHhhhcc-------------CcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCc
Q 048535          270 -VMSGRRPIE------EGKRNLVDRMWSLTER-------------SELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHP  329 (409)
Q Consensus       270 -~~~g~~p~~------~~~~~~~~~vws~~~~-------------~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~  329 (409)
                       ...|...+.      ...++...|+|+++..             ....+...........++......+.+++.+||+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~  233 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKK  233 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhc
Confidence             122332221      2445677899997311             11111111111111223344566789999999999


Q ss_pred             CCCCCC-----CHHHHHHH
Q 048535          330 EANSRP-----TIRQVLKM  343 (409)
Q Consensus       330 dP~~RP-----t~~evl~~  343 (409)
                      ||++|+     ++.++++.
T Consensus       234 dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         234 DPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CHHHhCCCCCCCHHHHhcC
Confidence            999996     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3e-32  Score=254.41  Aligned_cols=219  Identities=23%  Similarity=0.349  Sum_probs=168.2

Q ss_pred             eeecCCceEEEEEEEC----CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCC
Q 048535          120 VIGLGGNGKVYKGQLL----GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENG  194 (409)
Q Consensus       120 ~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~g  194 (409)
                      .||+|+||.||+|.+.    +..||+|.+.... ....+.|.+|+.++++++||||+++++++..  ...++||||+++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCCC
Confidence            3899999999999875    4569999997653 3445679999999999999999999998853  5689999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce----
Q 048535          195 SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV----  270 (409)
Q Consensus       195 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~----  270 (409)
                      +|.+++...  ...+++..+.+++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++.......    
T Consensus        80 ~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          80 PLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            999998642  346899999999999999999999   89999999999999999999999999999976543220    


Q ss_pred             ee-ec-----ccc---ccCCCcHHHHHHhhhccCcHHHHhh-HHhh----------------hcCCCCHHHHHHHHHHHH
Q 048535          271 MS-GR-----RPI---EEGKRNLVDRMWSLTERSELLSVLD-ERLK----------------AKGGYADEVVEKVLHLGL  324 (409)
Q Consensus       271 ~~-g~-----~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~~l~----------------~~~~~~~~~~~~l~~l~~  324 (409)
                      .+ +.     .+.   ....++...|+|+++  ..+++++. ...+                .....+.....++.+++.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYG--ITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMK  232 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHH--HHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence            01 11     111   123456678999874  11222221 1100                011233345678899999


Q ss_pred             HccCcCCCCCCCHHHHHHHHhcC
Q 048535          325 LCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       325 ~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      +||+.+|++||++.+|.+.|+..
T Consensus       233 ~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         233 DCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHcCCChhhCcCHHHHHHHHhhh
Confidence            99999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.5e-32  Score=266.10  Aligned_cols=146  Identities=26%  Similarity=0.300  Sum_probs=131.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||+||++...  ++.||+|+++..   .......+.+|+.++.+++|+||+++++.+.+ ....|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-KLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCeEEEE
Confidence            47889999999999999999886  889999999753   22334578889999999999999999999887 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      |||+++|+|.+++..   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        80 ~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~  151 (363)
T cd05628          80 MEFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL  151 (363)
T ss_pred             EcCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccc
Confidence            999999999999954   346999999999999999999999   899999999999999999999999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.3e-32  Score=260.14  Aligned_cols=227  Identities=25%  Similarity=0.350  Sum_probs=173.5

Q ss_pred             CCCccceeecCCceEEEEEEEC-------CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      +|+..+.||+|+||.||+|...       +..||+|+++... ....+.|.+|+.++++++||||+++++++.. ....+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~   84 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-EQPLS   84 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CCceE
Confidence            3666788999999999999874       4679999997553 3345678999999999999999999999987 66789


Q ss_pred             EEEEeCCCCCHHHHHhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC
Q 048535          186 LIYDYMENGSLDKWIFEC-------------DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM  252 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~  252 (409)
                      +++||+++++|.+++...             .....+++..+..++.|++.||.|||   +.+|+||||||+|||+++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence            999999999999998521             11235889999999999999999999   89999999999999999999


Q ss_pred             cEEEecccCcccccCCcee--ee-------cccc---ccCCCcHHHHHHhhhccCcHHHH----------------hhHH
Q 048535          253 NARLGDFGLAKMHHHGQVM--SG-------RRPI---EEGKRNLVDRMWSLTERSELLSV----------------LDER  304 (409)
Q Consensus       253 ~~kl~DFGla~~~~~~~~~--~g-------~~p~---~~~~~~~~~~vws~~~~~~~~~~----------------~~~~  304 (409)
                      .+||+|||+++........  .+       ..+.   ..+.++...|+|+++  ..++++                .+..
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG--~~l~el~~~g~~p~~~~~~~~~~~~i  239 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYG--VVLWEVFSYGLQPYCGYSNQDVIEMI  239 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHH--HHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999998865432211  11       1111   124456678899873  112221                2211


Q ss_pred             hhh-cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          305 LKA-KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       305 l~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      ... ....+...+..+.+++..||+.+|.+||+++++++.|+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            111 012344566678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.5e-32  Score=261.81  Aligned_cols=269  Identities=23%  Similarity=0.331  Sum_probs=188.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|...+.||+|+||.||+|+..  ++.||+|.++... ......+.+|+.++++++||||+++++++.. ++..++|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-DKSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-CCeEEEEEe
Confidence            56888999999999999999886  7889999997542 2233467889999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++ +|.+++...  ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus        85 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          85 YLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            9985 898888543  345889999999999999999999   8999999999999999999999999999997643221


Q ss_pred             e----eeec---cccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 048535          270 V----MSGR---RPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIR  338 (409)
Q Consensus       270 ~----~~g~---~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  338 (409)
                      .    ..+.   .+.+    ...++...|+|+++  ..+++++............+....   +....-.+.+...|...
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG--~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVG--CIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGIS  233 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhc
Confidence            0    1111   1111    13457789999996  445666655443222222222222   22222222222223222


Q ss_pred             HHHHHH--hcCcCCC------CCCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccccc
Q 048535          339 QVLKML--EGQTEGT------GLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNR  393 (409)
Q Consensus       339 evl~~L--~~~~~~~------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~~  393 (409)
                      ......  +.....+      .+.-+....+++.+|+..+|.+|+++++++.||||..+....
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~  296 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRI  296 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccccc
Confidence            111110  0000000      000112347999999999999999999999999999887554

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-32  Score=266.30  Aligned_cols=174  Identities=28%  Similarity=0.370  Sum_probs=148.7

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh---HHHHHHHHHHHHhccCC-CCceeeEeeEEEccCCeE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE---HGMREFLAEVSSLGRLK-HRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~  184 (409)
                      ....|+..+.||+|.||.||+++.+  |+.+|+|.+.....   .....+.+|+.+|+++. |||||.+.+.+.+ ....
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-~~~~  111 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-PDSV  111 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-CCeE
Confidence            4567888899999999999999987  89999999976532   34568899999999997 9999999999998 7789


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC----CcEEEeccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK----MNARLGDFG  260 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~----~~~kl~DFG  260 (409)
                      ++|||+|.||.|.+.+...    .+++..+..++.|++.++.|||   +.+|+||||||+|+|+...    +.+|++|||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999999654    3999999999999999999999   8999999999999999543    479999999


Q ss_pred             CcccccCCc---eeeeccccc------cCCCcHHHHHHhhh
Q 048535          261 LAKMHHHGQ---VMSGRRPIE------EGKRNLVDRMWSLT  292 (409)
Q Consensus       261 la~~~~~~~---~~~g~~p~~------~~~~~~~~~vws~~  292 (409)
                      +|.....+.   .++|.+.+.      ...|+...|+|++.
T Consensus       185 la~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~G  225 (382)
T KOG0032|consen  185 LAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIG  225 (382)
T ss_pred             CceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHH
Confidence            999887744   334444332      25678889999985

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-32  Score=258.16  Aligned_cols=229  Identities=21%  Similarity=0.361  Sum_probs=176.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  183 (409)
                      .++|++.+.||+|+||.||+|...       +..||+|.+... .......+.+|+.+++.++||||+++++++.. ...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST-GQP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-CCC
Confidence            357888899999999999999875       267999998755 33455678999999999999999999999887 678


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEE
Q 048535          184 LILIYDYMENGSLDKWIFECDE-------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARL  256 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl  256 (409)
                      .++||||+++|+|.+++.....       ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEE
Confidence            9999999999999999964321       234789999999999999999999   899999999999999999999999


Q ss_pred             ecccCcccccCCcee------e---eccccc---cCCCcHHHHHHhhhccCcHHHHh----------------hHHhh-h
Q 048535          257 GDFGLAKMHHHGQVM------S---GRRPIE---EGKRNLVDRMWSLTERSELLSVL----------------DERLK-A  307 (409)
Q Consensus       257 ~DFGla~~~~~~~~~------~---g~~p~~---~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~-~  307 (409)
                      +|||+++........      .   +..+.+   ....+..+|+|+++  ..+++++                ..... .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~el~t~g~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFG--VVLWEMATLAEQPYQGLSNEEVLKFVIDGG  238 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHH--HHHHHhhccCCCCCccCCHHHHHHHHhcCC
Confidence            999999765432210      0   111111   23456668888873  1111211                11110 0


Q ss_pred             cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          308 KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       308 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      ....+......+.+++.+||+.+|++|||+.++++.|++
T Consensus       239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         239 HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            112344456789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9e-33  Score=257.85  Aligned_cols=219  Identities=22%  Similarity=0.355  Sum_probs=168.9

Q ss_pred             ceeecCCceEEEEEEEC---------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          119 NVIGLGGNGKVYKGQLL---------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +.||+|+||.||+|...         ...||+|.+........+.+.+|+.+++.++||||+++++++.. +...++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-GDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-CCCcEEEEe
Confidence            46899999999999874         23489999876555566789999999999999999999999987 667899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc--------EEEecccC
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN--------ARLGDFGL  261 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~--------~kl~DFGl  261 (409)
                      |+++|+|.+++...  ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.        +|++|||+
T Consensus        80 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          80 YVKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             cCCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            99999999999653  236899999999999999999999   899999999999999987765        69999999


Q ss_pred             cccccCCceeeecccccc-------CCCcHHHHHHhhhccCcHHHHhhH---------------HhhhcCCCCHHHHHHH
Q 048535          262 AKMHHHGQVMSGRRPIEE-------GKRNLVDRMWSLTERSELLSVLDE---------------RLKAKGGYADEVVEKV  319 (409)
Q Consensus       262 a~~~~~~~~~~g~~p~~~-------~~~~~~~~vws~~~~~~~~~~~~~---------------~l~~~~~~~~~~~~~l  319 (409)
                      +..........+..++..       ..++..+|+|+++  ..+++++..               ........+.....++
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG--~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (258)
T cd05078         155 SITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFG--TTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTEL  232 (258)
T ss_pred             ccccCCchhccccCCccCchhccCCCCCCchhhHHHHH--HHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHH
Confidence            876655444444333211       2346678999873  111221111               0011112222334578


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHHHHh
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                      .+++.+||+.||++|||++++++.|+
T Consensus       233 ~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         233 ANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHHHHhccChhhCCCHHHHHHhcC
Confidence            99999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.7e-32  Score=258.30  Aligned_cols=228  Identities=23%  Similarity=0.383  Sum_probs=174.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESL  184 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~  184 (409)
                      +.|++.+.||+|+||.||++.+.      +..||+|.++.. .......+.+|+.++++++||||+++++++... ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            45788899999999999999742      678999999755 344557899999999999999999999998764 3568


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++||||+++++|.+++...  ...+++..+..++.|++.||+|||   +++++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccc
Confidence            9999999999999999542  235899999999999999999999   89999999999999999999999999999986


Q ss_pred             ccCCce-------eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhH----------------------------
Q 048535          265 HHHGQV-------MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDE----------------------------  303 (409)
Q Consensus       265 ~~~~~~-------~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~----------------------------  303 (409)
                      ......       ..+...+      ....++...|+|+++.  .+++++..                            
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~--il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGV--TLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV  236 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhh--hhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence            543221       1111111      1133456688998741  12222110                            


Q ss_pred             -Hhh--hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          304 -RLK--AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       304 -~l~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                       .+.  ...+.+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence             000  00111233456899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.1e-32  Score=269.34  Aligned_cols=260  Identities=21%  Similarity=0.290  Sum_probs=181.3

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC----CeEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK----ESLI  185 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~~  185 (409)
                      +|+..+.||+|+||.||++...  ++.||+|++...  .....+.+.+|+++++.++||||+++++++....    ...|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999975  899999998643  3344567899999999999999999999987632    2689


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +||||+. ++|.+++.   ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999997 58888884   3456999999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCc--eee---ecc---ccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHH------------
Q 048535          266 HHGQ--VMS---GRR---PIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLH------------  321 (409)
Q Consensus       266 ~~~~--~~~---g~~---p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~------------  321 (409)
                      ....  ..+   +..   +.+    ...++...|+|+++  ..+++++..........+.+....+.+            
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG--~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVG--CIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHH--HHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            4321  111   111   111    12356788999996  345555544433222222222111111            


Q ss_pred             ---HHHHccCcCCCCCCCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          322 ---LGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       322 ---l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                         -....+...+...|....+...       . ........+++.+|+..+|.+|++..+++.||||.+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~-~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTL-------S-SQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhccc-------C-CCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence               1111112223333322221110       0 00112237889999999999999999999999988743

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.5e-32  Score=255.69  Aligned_cols=229  Identities=24%  Similarity=0.373  Sum_probs=176.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||++...  ++.+|||.+...   ......++.+|+.+++.++||||+++++++.. ++..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-CCeEEEE
Confidence            46788899999999999999975  899999988643   33445688999999999999999999999887 6789999


Q ss_pred             EEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          188 YDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      |||+++++|.+++... .....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            9999999999998642 22356899999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCce----eeecc---cc---ccCCCcHHHHHHhhhccCcHHHHhhHHhh-------------------hcCCCCHHHHH
Q 048535          267 HGQV----MSGRR---PI---EEGKRNLVDRMWSLTERSELLSVLDERLK-------------------AKGGYADEVVE  317 (409)
Q Consensus       267 ~~~~----~~g~~---p~---~~~~~~~~~~vws~~~~~~~~~~~~~~l~-------------------~~~~~~~~~~~  317 (409)
                      ....    ..|..   +.   .....+...|+|+++.  .+++++....+                   ...........
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~--il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGC--LLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  235 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHH--HHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccH
Confidence            3221    11211   11   1234566789998741  11121111100                   00111234566


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      .+.+++.+||+.||++||||.+|++++++.
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.8e-32  Score=257.17  Aligned_cols=229  Identities=24%  Similarity=0.369  Sum_probs=175.2

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  182 (409)
                      .+++|+..+.||+|+||.||+|.+.       +..||+|.+... .......|.+|+.++++++|+||+++++++.+ ..
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE-RL   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CC
Confidence            3467889999999999999999885       367999998754 33445679999999999999999999998887 56


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC---cEE
Q 048535          183 SLILIYDYMENGSLDKWIFECDE----SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM---NAR  255 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~~k  255 (409)
                      ..++||||+++|+|.+++.....    ...+++..+++++.||+.||+|||   +.+++||||||+|||++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceE
Confidence            78999999999999999965421    135899999999999999999999   88999999999999998764   599


Q ss_pred             EecccCcccccCCcee--e-------ecccc---ccCCCcHHHHHHhhhccCcHHHHh----------------hHHhh-
Q 048535          256 LGDFGLAKMHHHGQVM--S-------GRRPI---EEGKRNLVDRMWSLTERSELLSVL----------------DERLK-  306 (409)
Q Consensus       256 l~DFGla~~~~~~~~~--~-------g~~p~---~~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~-  306 (409)
                      |+|||+++........  .       ...+.   ....++...|+|+++.  .+++++                +.... 
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~--il~el~~~g~~pf~~~~~~~~~~~~~~~  237 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGV--LLWEIFSLGYMPYPGRTNQEVMEFVTGG  237 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHH--HHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999875332211  0       01111   1245677899998741  122211                11110 


Q ss_pred             hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 048535          307 AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       307 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                      .....+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus       238 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         238 GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            011233344567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.4e-32  Score=262.38  Aligned_cols=167  Identities=23%  Similarity=0.344  Sum_probs=135.7

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||+|...  ++.||+|+++..   .....+.+..|..++..+ +||||+++++++.. .+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-PDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-CCEEEEEEcCCC
Confidence            46999999999999987  789999999753   233456778899998877 79999999999887 778999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---  269 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---  269 (409)
                      +|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......   
T Consensus        80 ~g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~  153 (320)
T cd05590          80 GGDLMFHIQK---SRRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT  153 (320)
T ss_pred             CchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence            9999999854   346899999999999999999999   8999999999999999999999999999987532211   


Q ss_pred             -eeeecccc------ccCCCcHHHHHHhhh
Q 048535          270 -VMSGRRPI------EEGKRNLVDRMWSLT  292 (409)
Q Consensus       270 -~~~g~~p~------~~~~~~~~~~vws~~  292 (409)
                       ...|...+      ....++...|+|+++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  183 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMG  183 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhH
Confidence             12222222      123456677888875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.9e-32  Score=269.20  Aligned_cols=144  Identities=22%  Similarity=0.294  Sum_probs=129.8

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .|+..+.||+|+||+||+|...  ++.||+|++...   .......+.+|+.++++++||||+++++++.+ .+..++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-CCEEEEEE
Confidence            5788999999999999999986  889999999654   23445678999999999999999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||   ..+|+||||||+|||++.++++||+|||+++.
T Consensus        81 E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          81 DYIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            99999999999954   346899999999999999999999   89999999999999999999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-33  Score=233.41  Aligned_cols=261  Identities=23%  Similarity=0.311  Sum_probs=197.8

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|+..++||+|.||+||+|+..  ++.||+|+++.++  +.-....++|+.+|+.++|.|||++++.... +..+-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-dkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-CceeEEeHH
Confidence            4666789999999999999887  8899999998663  2234567899999999999999999998877 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      ||.. +|.+|....  ++.++.+....++.|+++||.|+|   ++++.||||||.|.||+.+|+.|++|||+|+.+....
T Consensus        82 ~cdq-dlkkyfdsl--ng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSL--NGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             HhhH-HHHHHHHhc--CCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            9977 999998654  356899999999999999999999   8999999999999999999999999999999765432


Q ss_pred             ------e-eeeccccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 048535          270 ------V-MSGRRPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIR  338 (409)
Q Consensus       270 ------~-~~g~~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  338 (409)
                            + .--.+|.+    ...|+...|+|+..  ..+.++.+..-+.-+  -.+...++..+-...-.+.-++=|+|.
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsag--cifaelanagrplfp--g~dvddqlkrif~~lg~p~ed~wps~t  231 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG--CIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEDQWPSMT  231 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcc--hHHHHHhhcCCCCCC--CCcHHHHHHHHHHHhCCCccccCCccc
Confidence                  1 11122222    24567778999986  445555554332111  123334455555555566777778887


Q ss_pred             HHHHHHhcCcCCCCCCC-----------CCcchhHHhhhcccCCCCcccccccCCCCCcccc
Q 048535          339 QVLKMLEGQTEGTGLED-----------EGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEI  389 (409)
Q Consensus       339 evl~~L~~~~~~~~~~~-----------~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~  389 (409)
                      ++-.    ....|..++           ....+|++++++.-.|..|++.+++++||+|+..
T Consensus       232 ~lpd----yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  232 KLPD----YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cCCC----CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            6532    222222111           1234899999999999999999999999999864

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.9e-32  Score=255.74  Aligned_cols=227  Identities=27%  Similarity=0.462  Sum_probs=175.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC--C---cEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--G---VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|+..+.||+|+||.||+|...  +   ..||||.+... ......+|..|+.++++++||||+++++++.+ ....++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~l   82 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SRPVMI   82 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-CCceEE
Confidence            35778899999999999999986  3   36999999765 45556789999999999999999999999876 677899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++...  ...+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++...
T Consensus        83 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          83 ITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            99999999999999643  345899999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCce-------ee-----ecccc---ccCCCcHHHHHHhhhccCcHHHHh----------------hHHhh-hcCCCCHH
Q 048535          267 HGQV-------MS-----GRRPI---EEGKRNLVDRMWSLTERSELLSVL----------------DERLK-AKGGYADE  314 (409)
Q Consensus       267 ~~~~-------~~-----g~~p~---~~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~-~~~~~~~~  314 (409)
                      ....       ..     ...+.   ....++...|+|+++.  .+++++                ..... ...+.+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~--~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  235 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGI--VMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMD  235 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHH--HHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCccc
Confidence            3210       00     01111   1234566788888631  111111                11100 00122334


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      .+..+.+++..||+.+|.+||++.++++.|++.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         236 CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.5e-32  Score=262.84  Aligned_cols=230  Identities=26%  Similarity=0.406  Sum_probs=173.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--Cc--EEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GV--EVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|++.+.||+|+||.||+|.+.  +.  .+|+|.++.. .......+.+|++++.++ +||||+++++++.. .+..++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-~~~~~l   85 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYL   85 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-CCCceE
Confidence            57888899999999999999875  43  4688887643 344567889999999999 89999999999887 678999


Q ss_pred             EEEeCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc
Q 048535          187 IYDYMENGSLDKWIFECD-------------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN  253 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~  253 (409)
                      ||||+++|+|.+++....             ....+++.+++.++.|++.||+|||   +++|+||||||+|||+++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999996432             1235889999999999999999999   899999999999999999999


Q ss_pred             EEEecccCcccccCCc---eee---ecccc---ccCCCcHHHHHHhhhccCcHHHHhh----------------HHhhh-
Q 048535          254 ARLGDFGLAKMHHHGQ---VMS---GRRPI---EEGKRNLVDRMWSLTERSELLSVLD----------------ERLKA-  307 (409)
Q Consensus       254 ~kl~DFGla~~~~~~~---~~~---g~~p~---~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~~-  307 (409)
                      +||+|||+++......   ...   ...+.   ....++..+|+|+++  ..+++++.                ..... 
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~ellt~g~~p~~~~~~~~~~~~~~~~~  240 (303)
T cd05088         163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG--VLLWEIVSLGGTPYCGMTCAELYEKLPQGY  240 (303)
T ss_pred             EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhh--hHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence            9999999996432110   000   01111   113345667888874  12222221                11100 


Q ss_pred             cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          308 KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       308 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      ....+......+.+++.+||+.+|++||++.++++.|+.+.
T Consensus       241 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~  281 (303)
T cd05088         241 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  281 (303)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            01122234567899999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.1e-32  Score=260.88  Aligned_cols=234  Identities=23%  Similarity=0.378  Sum_probs=178.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC---------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEcc
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL---------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKE  180 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  180 (409)
                      .++|.+.+.||+|+||.||++...         ...+|+|.+... ......++.+|+.++.++ +||||+++++++.. 
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-   95 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   95 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence            357899999999999999999863         246999999754 344566788999999999 89999999999987 


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCee
Q 048535          181 KESLILIYDYMENGSLDKWIFECDE-------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVL  247 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NIL  247 (409)
                      .+..++||||+++|+|.+++.....             ...+++.++++++.|++.||+|||   +.+++||||||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nil  172 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  172 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheE
Confidence            6789999999999999999975321             235899999999999999999999   899999999999999


Q ss_pred             eCCCCcEEEecccCcccccCCce----eee-----cccc---ccCCCcHHHHHHhhhcc-------C-------cHHHHh
Q 048535          248 LDKKMNARLGDFGLAKMHHHGQV----MSG-----RRPI---EEGKRNLVDRMWSLTER-------S-------ELLSVL  301 (409)
Q Consensus       248 l~~~~~~kl~DFGla~~~~~~~~----~~g-----~~p~---~~~~~~~~~~vws~~~~-------~-------~~~~~~  301 (409)
                      ++.++.+||+|||+++.......    ..+     ..+.   ....++...|+|+++..       +       ...++.
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~  252 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  252 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence            99999999999999976543210    011     1111   12345677899987311       0       111111


Q ss_pred             hHHhhh-cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          302 DERLKA-KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       302 ~~~l~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      ...... ..+.+......+.+++.+||+.+|++|||+.++++.|+.+.+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~  301 (307)
T cd05098         253 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA  301 (307)
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence            111110 112334456788999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.3e-32  Score=258.10  Aligned_cols=229  Identities=23%  Similarity=0.384  Sum_probs=175.7

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  183 (409)
                      .++|+..+.||+|+||.||++...       +..||+|.+... .....+.|.+|+.++++++||||+++++++.. ...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV-GKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCc
Confidence            467889999999999999999863       578999999755 34455779999999999999999999999887 667


Q ss_pred             EEEEEEeCCCCCHHHHHhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCC
Q 048535          184 LILIYDYMENGSLDKWIFECD-------------------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKAS  244 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~  244 (409)
                      .+++|||+++|+|.+++....                   ....+++..++.++.|++.||+|||   +.+++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence            899999999999999996421                   1134788999999999999999999   899999999999


Q ss_pred             CeeeCCCCcEEEecccCcccccCCce------eee---cccc---ccCCCcHHHHHHhhhccCcHHHHhh----------
Q 048535          245 NVLLDKKMNARLGDFGLAKMHHHGQV------MSG---RRPI---EEGKRNLVDRMWSLTERSELLSVLD----------  302 (409)
Q Consensus       245 NILl~~~~~~kl~DFGla~~~~~~~~------~~g---~~p~---~~~~~~~~~~vws~~~~~~~~~~~~----------  302 (409)
                      |||+++++.+||+|||+++.......      ...   ..+.   ....++...|+|+++  ..+++++.          
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG--~il~el~~~~~~p~~~~~  237 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYG--VVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHH--HHHHHHHhCCCCCCCCCC
Confidence            99999999999999999875432210      000   1111   124456778999974  11222211          


Q ss_pred             ------HHhhh-cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          303 ------ERLKA-KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       303 ------~~l~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                            ..... ....+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 HEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                  10000 001233445789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.4e-32  Score=255.77  Aligned_cols=228  Identities=22%  Similarity=0.388  Sum_probs=176.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      .+|+..++||+|+||.||++...       +..+|+|.+..........|.+|+++++.++|+||+++++++.. ....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-GRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-CCceE
Confidence            46777899999999999999642       56799999887666667889999999999999999999999887 67789


Q ss_pred             EEEEeCCCCCHHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc
Q 048535          186 LIYDYMENGSLDKWIFECDE------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN  253 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~  253 (409)
                      ++|||+++|+|.+++.....            ...+++..+..++.|++.||+|||   +.+++||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCC
Confidence            99999999999999965321            134899999999999999999999   899999999999999999999


Q ss_pred             EEEecccCcccccCCce--eee-------cccc---ccCCCcHHHHHHhhhccCcHHHHhh----------------HHh
Q 048535          254 ARLGDFGLAKMHHHGQV--MSG-------RRPI---EEGKRNLVDRMWSLTERSELLSVLD----------------ERL  305 (409)
Q Consensus       254 ~kl~DFGla~~~~~~~~--~~g-------~~p~---~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l  305 (409)
                      +||+|||+++.......  ..+       ..+.   ....++...|+|+++  ..+++++.                ...
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~el~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG--VVLWEIFTYGKQPWYQLSNTEAIECIT  238 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHH--HHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            99999999975533211  000       1111   124456778999873  11222221                111


Q ss_pred             hh-cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          306 KA-KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       306 ~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      .. ....+...+..+.+++.+||+.||.+||++.++++.|+.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence            10 011223445678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8e-32  Score=260.20  Aligned_cols=215  Identities=19%  Similarity=0.251  Sum_probs=157.9

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCC-ceeeEeeEEEccCCeEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHR-NLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~~lv  187 (409)
                      +|+..+.||+|+||.||+|...  ++.||+|++...   .....+.+..|.+++..++|+ +|+++++++.. .+..|+|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEE
Confidence            5788899999999999999987  678999999754   234456788999999999765 57888888876 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        80 ~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          80 MEYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            999999999999853   346899999999999999999999   89999999999999999999999999999875321


Q ss_pred             C----ceeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhh---------------cCCCCHHHHHHHHHH
Q 048535          268 G----QVMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKA---------------KGGYADEVVEKVLHL  322 (409)
Q Consensus       268 ~----~~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~---------------~~~~~~~~~~~l~~l  322 (409)
                      .    ....|...+.      ...++...|+|+++  ..+++++......               ...++......+.++
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--vil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  231 (324)
T cd05587         154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFG--VLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSI  231 (324)
T ss_pred             CCCceeeecCCccccChhhhcCCCCCcccchhhhH--HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            1    1122332221      13456678999885  2333333322221               111222333455566


Q ss_pred             HHHccCcCCCCCCCH
Q 048535          323 GLLCAHPEANSRPTI  337 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~  337 (409)
                      +.+||+.||.+|++.
T Consensus       232 i~~~l~~~P~~R~~~  246 (324)
T cd05587         232 CKGLLTKHPAKRLGC  246 (324)
T ss_pred             HHHHhhcCHHHcCCC
Confidence            666666666666665

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-32  Score=267.86  Aligned_cols=146  Identities=26%  Similarity=0.319  Sum_probs=131.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||+|...  ++.||||++...   .......+.+|+.++..++||||+++++++.+ ++..++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-ENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCeEEEE
Confidence            47889999999999999999986  889999999753   23345668899999999999999999999987 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      |||+++|+|.+++..   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        80 ~E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  151 (364)
T cd05599          80 MEYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL  151 (364)
T ss_pred             ECCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence            999999999999954   346899999999999999999999   899999999999999999999999999998754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.5e-32  Score=253.22  Aligned_cols=227  Identities=24%  Similarity=0.385  Sum_probs=175.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      .++|++.+.||+|+||.||+|.+. ...||+|.++.... ..+.|.+|+.++++++||||+++++++.+  ...++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC--CCcEEEEEc
Confidence            356888999999999999999887 56799999975432 33578999999999999999999998753  457899999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV  270 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  270 (409)
                      +++|+|.+++... ....+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          82 MSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             CCCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            9999999999653 2345899999999999999999999   89999999999999999999999999999986543321


Q ss_pred             ee-----e---ccccc---cCCCcHHHHHHhhhccCcHHHHhh----------------HHhhh-cCCCCHHHHHHHHHH
Q 048535          271 MS-----G---RRPIE---EGKRNLVDRMWSLTERSELLSVLD----------------ERLKA-KGGYADEVVEKVLHL  322 (409)
Q Consensus       271 ~~-----g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~~-~~~~~~~~~~~l~~l  322 (409)
                      ..     +   ..+.+   ...++...|+|+++.  .+++++.                ..... ....+...+..+.++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~--~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  235 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI--LLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL  235 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHH--HHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence            11     1   11111   234567889999741  1222221                11110 012234556788999


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          323 GLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      +.+||+.||++|||+.++++.|+..
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             HHHHccCCcccCCCHHHHHHHHHHh
Confidence            9999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.2e-32  Score=258.94  Aligned_cols=229  Identities=23%  Similarity=0.371  Sum_probs=175.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCC
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  182 (409)
                      .++|...+.||+|+||.||++...       +..||+|.++.. .....+.+.+|+.+++++ +||||+++++++.. .+
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~  112 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-GG  112 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-CC
Confidence            357889999999999999999752       457999998754 334456799999999999 89999999999887 67


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..+++|||+++|+|.+++.... ...+++.++..++.|++.||.|||   +++|+|+||||+|||++.++.+||+|||++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            7999999999999999996532 234899999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCc--eeee-------cccc---ccCCCcHHHHHHhhhccCcHHHHhh-H---------------Hhhh--cCCCC
Q 048535          263 KMHHHGQ--VMSG-------RRPI---EEGKRNLVDRMWSLTERSELLSVLD-E---------------RLKA--KGGYA  312 (409)
Q Consensus       263 ~~~~~~~--~~~g-------~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~---------------~l~~--~~~~~  312 (409)
                      +......  ...+       ..+.   ....++...|+|+++  ..+++++. .               ....  ....+
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG--vil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~  266 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG--ILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQP  266 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHH--HHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCC
Confidence            8654321  1111       1111   123456778999973  11222211 0               0000  01122


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      .....++.+++.+||+.+|++|||+.|+++.|+..
T Consensus       267 ~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         267 EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            23456789999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-32  Score=264.87  Aligned_cols=214  Identities=22%  Similarity=0.257  Sum_probs=164.4

Q ss_pred             ceeecCCceEEEEEEEC-----CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          119 NVIGLGGNGKVYKGQLL-----GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      +.||+|+||.||++...     |+.||+|++....  ......+..|++++++++||||+++++++.+ .+..|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-EGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCEEEEEEcCC
Confidence            57999999999998752     7899999997542  2234567889999999999999999999987 67899999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc--
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ--  269 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~--  269 (409)
                      ++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++......  
T Consensus        81 ~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          81 RGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence            99999999953   346899999999999999999999   8999999999999999999999999999998654331  


Q ss_pred             --eeeecccc---c---cCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccC
Q 048535          270 --VMSGRRPI---E---EGKRNLVDRMWSLTE-------------RSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAH  328 (409)
Q Consensus       270 --~~~g~~p~---~---~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~  328 (409)
                        ...|...+   +   ...++...|+|+++.             .....+............+......+.+++.+||+
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~  234 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFK  234 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence              11222211   1   234466789998731             11112222222222223344456678999999999


Q ss_pred             cCCCCCCCHHH
Q 048535          329 PEANSRPTIRQ  339 (409)
Q Consensus       329 ~dP~~RPt~~e  339 (409)
                      .||++||++.+
T Consensus       235 ~~P~~R~~a~~  245 (318)
T cd05582         235 RNPANRLGAGP  245 (318)
T ss_pred             cCHhHcCCCCC
Confidence            99999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.6e-32  Score=253.14  Aligned_cols=227  Identities=23%  Similarity=0.410  Sum_probs=174.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      ++|++.+.||+|+||.||+|... +..||+|.+..... ..+.|.+|+.++++++|+|++++++++.  ....+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~lv~e~~   82 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS--EEPIYIVTEYM   82 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC--CCCcEEEEEec
Confidence            56888899999999999999887 67899999975432 3467899999999999999999999875  34678999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM  271 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  271 (409)
                      ++++|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++.........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            999999999653 2345899999999999999999999   889999999999999999999999999999765432210


Q ss_pred             e--------eccccc---cCCCcHHHHHHhhhcc-------C-------cHHHHhhHHhhh-cCCCCHHHHHHHHHHHHH
Q 048535          272 S--------GRRPIE---EGKRNLVDRMWSLTER-------S-------ELLSVLDERLKA-KGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       272 ~--------g~~p~~---~~~~~~~~~vws~~~~-------~-------~~~~~~~~~l~~-~~~~~~~~~~~l~~l~~~  325 (409)
                      .        +..+.+   ....+...|+|+++..       +       ...+..+..... ..+.+......+.+++.+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQ  238 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence            0        011111   1345567889987311       1       111111111110 122334456688999999


Q ss_pred             ccCcCCCCCCCHHHHHHHHhc
Q 048535          326 CAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      ||+.+|++|||+.++.+.|++
T Consensus       239 ~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         239 CWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.3e-32  Score=253.59  Aligned_cols=224  Identities=24%  Similarity=0.329  Sum_probs=172.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|++.+.||+|+||.||+|+..  ++.||+|++..........+.+|+.++++++||||+++++++.. .+..++|||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-~~~~~iv~e   86 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-REKLWICME   86 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-CCEEEEEEe
Confidence            357899999999999999999985  88999999976554555678899999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||+++......
T Consensus        87 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          87 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            9999999999853   346899999999999999999999   8999999999999999999999999999998653221


Q ss_pred             ----eeeecc---ccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhh-----------------cC---CCCHHHH
Q 048535          270 ----VMSGRR---PIE------EGKRNLVDRMWSLTERSELLSVLDERLKA-----------------KG---GYADEVV  316 (409)
Q Consensus       270 ----~~~g~~---p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~-----------------~~---~~~~~~~  316 (409)
                          ...|..   +.+      ....+...|+|+++.  .+++++......                 ..   .......
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~--il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGI--TAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWS  238 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHH--HHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccC
Confidence                111111   111      122456789999741  122221111000                 00   0012245


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKML  344 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L  344 (409)
                      ..+.+++.+||+.+|++|||++++++.|
T Consensus       239 ~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         239 STFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             HHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            6789999999999999999999998743

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-32  Score=257.32  Aligned_cols=215  Identities=22%  Similarity=0.332  Sum_probs=161.7

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      +|+..+.||+|+||.||++...  ++.||+|.+....   ......+.+|+.++++++||||+++++.+.. ++..++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-CCeEEEEE
Confidence            4778899999999999999986  8899999996542   2233567889999999999999999999887 67899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++|+|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||+++.....
T Consensus        80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          80 TLMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             eccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            999999999988643 2346899999999999999999999   899999999999999999999999999999875433


Q ss_pred             cee---eecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh-------------------cCCCCHHHHHHHH
Q 048535          269 QVM---SGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKA-------------------KGGYADEVVEKVL  320 (409)
Q Consensus       269 ~~~---~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~-------------------~~~~~~~~~~~l~  320 (409)
                      ...   .|...+      ....++...|+|+++  ..+++++......                   ...++......+.
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G--~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (285)
T cd05605         156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLG--CLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAAR  233 (285)
T ss_pred             CccccccCCCCccCcHHhcCCCCCccccchhHH--HHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHH
Confidence            211   121111      123455677889873  1222222221111                   1122333455667


Q ss_pred             HHHHHccCcCCCCCC
Q 048535          321 HLGLLCAHPEANSRP  335 (409)
Q Consensus       321 ~l~~~Cl~~dP~~RP  335 (409)
                      +++..||+.||++||
T Consensus       234 ~li~~~l~~~P~~R~  248 (285)
T cd05605         234 SICRQLLTKDPGFRL  248 (285)
T ss_pred             HHHHHHccCCHHHhc
Confidence            777777777777777

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-32  Score=252.09  Aligned_cols=220  Identities=28%  Similarity=0.432  Sum_probs=169.7

Q ss_pred             ceeecCCceEEEEEEEC--C---cEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--G---VEVALKRISLDSE-HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~---~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      ++||+|+||.||+|.+.  +   ..+|+|.+..... ...+++.+|+.++++++||||+++++++..  ...++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG--EPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC--CceEEEEEeCC
Confidence            46999999999999875  2   6799999976533 355679999999999999999999998763  46799999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce-e
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV-M  271 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~-~  271 (409)
                      +|+|.+++...   ..+++..+..++.|++.||+|||   ..+++|+||||+|||++.++.+||+|||+++....... .
T Consensus        79 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          79 LGPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999999542   36899999999999999999999   88999999999999999999999999999986543221 0


Q ss_pred             ----ee-----cccc---ccCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHHHHHHHHHH
Q 048535          272 ----SG-----RRPI---EEGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADEVVEKVLHL  322 (409)
Q Consensus       272 ----~g-----~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~~~~~l~~l  322 (409)
                          .+     ..+.   ....++..+|+|+++  ..+++++. .....                ....+...+..+.++
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  230 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYG--VTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSI  230 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHH--HHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence                11     1111   123456678899874  12222221 11100                012233445678999


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          323 GLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      +.+||+.+|++||++.++++.|++..
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            99999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.6e-32  Score=249.55  Aligned_cols=219  Identities=23%  Similarity=0.403  Sum_probs=169.6

Q ss_pred             ceeecCCceEEEEEEEC-CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCCH
Q 048535          119 NVIGLGGNGKVYKGQLL-GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSL  196 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gsL  196 (409)
                      +.||+|+||.||+|... +..+|+|.+.... ......|.+|++++++++||||+++++++.. ....++||||+++|+|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-RQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-CCccEEEEECCCCCcH
Confidence            36899999999999876 7889999987653 3344578999999999999999999999987 6688999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee-----
Q 048535          197 DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM-----  271 (409)
Q Consensus       197 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~-----  271 (409)
                      .+++...  ...+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||++.........     
T Consensus        80 ~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          80 LSFLRKK--KDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            9998643  345899999999999999999999   899999999999999999999999999999754332110     


Q ss_pred             e---ecccc---ccCCCcHHHHHHhhhccCcHHHHhh---------------HHhh-h-cCCCCHHHHHHHHHHHHHccC
Q 048535          272 S---GRRPI---EEGKRNLVDRMWSLTERSELLSVLD---------------ERLK-A-KGGYADEVVEKVLHLGLLCAH  328 (409)
Q Consensus       272 ~---g~~p~---~~~~~~~~~~vws~~~~~~~~~~~~---------------~~l~-~-~~~~~~~~~~~l~~l~~~Cl~  328 (409)
                      .   +..+.   ....++...|+|+++.  .+++++.               .... . ....+...+..+.+++.+||+
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~--ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  232 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGI--LLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWD  232 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHH--HHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            0   01111   1244566789998741  1111111               0110 0 112233456789999999999


Q ss_pred             cCCCCCCCHHHHHHHHh
Q 048535          329 PEANSRPTIRQVLKMLE  345 (409)
Q Consensus       329 ~dP~~RPt~~evl~~L~  345 (409)
                      .+|++||++.++++.|.
T Consensus       233 ~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         233 YKPENRPKFSELQKELA  249 (250)
T ss_pred             cCcccCCCHHHHHHHhc
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-31  Score=250.75  Aligned_cols=225  Identities=24%  Similarity=0.417  Sum_probs=173.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      ++|.+.+.||+|+||.||+|.+. +..+|+|.+.... ...+.+.+|+.++++++|+|++++++++..  ...+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE--EPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCcEEEEEcC
Confidence            45788899999999999999987 5679999986543 234678899999999999999999998753  4678999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM  271 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  271 (409)
                      ++|+|.+++... ....+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||+++........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            999999999653 2345899999999999999999999   899999999999999999999999999999865433211


Q ss_pred             e--------eccccc---cCCCcHHHHHHhhhccCcHHHHhh-HH---------------hhh-cCCCCHHHHHHHHHHH
Q 048535          272 S--------GRRPIE---EGKRNLVDRMWSLTERSELLSVLD-ER---------------LKA-KGGYADEVVEKVLHLG  323 (409)
Q Consensus       272 ~--------g~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~---------------l~~-~~~~~~~~~~~l~~l~  323 (409)
                      .        +..+.+   ....+...|+|+++.  .+++++. ..               ... ....+...+..+.+++
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~--~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI--LLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM  236 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHH--HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence            0        011111   234567789999741  1222221 11               100 1122344567899999


Q ss_pred             HHccCcCCCCCCCHHHHHHHHhc
Q 048535          324 LLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      .+||+.||++||+++++++.|++
T Consensus       237 ~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         237 KLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHccCCcccCcCHHHHHHHHhc
Confidence            99999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.3e-32  Score=261.46  Aligned_cols=218  Identities=22%  Similarity=0.286  Sum_probs=164.0

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHh---ccCCCCceeeEeeEEEccCCeEEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSL---GRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l---~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      |++.+.||+|+||.||+|...  ++.||||.++..   .....+.+.+|+.++   ++++||||+++++++.. .+..|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-EDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-CCEEEE
Confidence            567889999999999999986  889999999754   223345566676554   67789999999999887 778999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|..++..    ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        80 v~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          80 VMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            9999999999988842    46999999999999999999999   8999999999999999999999999999987532


Q ss_pred             CCc----eeeecccc------ccCCCcHHHHHHhhhccCcHHHH---------------hhHHhhhcCCCCHHHHHHHHH
Q 048535          267 HGQ----VMSGRRPI------EEGKRNLVDRMWSLTERSELLSV---------------LDERLKAKGGYADEVVEKVLH  321 (409)
Q Consensus       267 ~~~----~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~---------------~~~~l~~~~~~~~~~~~~l~~  321 (409)
                      ...    ...|...+      ....++...|+|+++  ..++++               .+........++......+.+
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG--~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  230 (324)
T cd05589         153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLG--VLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAIS  230 (324)
T ss_pred             CCCCcccccccCccccCHhHhcCCCCCcccchhhHH--HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            211    12222221      123456678899874  122222               222222122233445667889


Q ss_pred             HHHHccCcCCCCCCC-----HHHHHH
Q 048535          322 LGLLCAHPEANSRPT-----IRQVLK  342 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt-----~~evl~  342 (409)
                      ++.+||+.||.+||+     +.++++
T Consensus       231 li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         231 IMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             HHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            999999999999994     555544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.9e-32  Score=262.47  Aligned_cols=214  Identities=22%  Similarity=0.267  Sum_probs=161.3

Q ss_pred             CCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC----ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCe
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD----SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  183 (409)
                      +|++.+.||+|+||.||+++..     ++.||+|++...    .....+.+..|+.++.++ +||||+++++++.. .+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCE
Confidence            4788899999999999998763     788999999643    223345688999999999 59999999998876 678


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      .++||||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        80 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            9999999999999999954   346899999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCc-----eeeeccccc-------cCCCcHHHHHHhhhccCcHHHHhhHH-------------------hhhcCCCC
Q 048535          264 MHHHGQ-----VMSGRRPIE-------EGKRNLVDRMWSLTERSELLSVLDER-------------------LKAKGGYA  312 (409)
Q Consensus       264 ~~~~~~-----~~~g~~p~~-------~~~~~~~~~vws~~~~~~~~~~~~~~-------------------l~~~~~~~  312 (409)
                      ......     ...|...+.       ...++...|+|+++  ..+++++...                   .......+
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG--~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLG--ILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP  231 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccch--hhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            643221     122322221       12245678899874  1222222211                   11112233


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCC
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPT  336 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt  336 (409)
                      ......+.+++.+||+.||++||+
T Consensus       232 ~~~~~~~~~li~~~l~~dp~~R~~  255 (332)
T cd05614         232 SFIGPEAQDLLHKLLRKDPKKRLG  255 (332)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCC
Confidence            344556778888888888888883

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.3e-32  Score=274.42  Aligned_cols=231  Identities=21%  Similarity=0.281  Sum_probs=177.5

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC---
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE---  182 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---  182 (409)
                      ...++|.+.+.||+|+||+||+|...  ++.||||++...  +......+.+|+.++..++|+||+++++.+.....   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            44578999999999999999999875  899999999654  44556778999999999999999999887653211   


Q ss_pred             ----eEEEEEEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEe
Q 048535          183 ----SLILIYDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLG  257 (409)
Q Consensus       183 ----~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~  257 (409)
                          .+++||||+++|+|.+++... .....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence                368999999999999998643 22356899999999999999999999   8999999999999999999999999


Q ss_pred             cccCcccccCC------ceeeecccc------ccCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhh-cCCC
Q 048535          258 DFGLAKMHHHG------QVMSGRRPI------EEGKRNLVDRMWSLTE-------------RSELLSVLDERLKA-KGGY  311 (409)
Q Consensus       258 DFGla~~~~~~------~~~~g~~p~------~~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~-~~~~  311 (409)
                      |||+++.....      ....|...+      ....++...|+|+++.             .....+++...+.. ....
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~  265 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL  265 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            99999865432      112232222      1245678899999841             11122222222211 1123


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          312 ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       312 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      +......+.+++..||+.||.+||++.++++.
T Consensus       266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            44556789999999999999999999999863

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-31  Score=257.49  Aligned_cols=266  Identities=19%  Similarity=0.243  Sum_probs=183.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|++.+.||+|+||.||++...  +..+|+|.+... ......++.+|++++.+++||||+++++++.. ++..++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-DGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCEEEEEee
Confidence            46889999999999999999986  788999998755 33445678999999999999999999999987 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+++..   ...+++..+..++.|+++||.|||+  ..+++||||||+|||++.++.+||+|||++.......
T Consensus        80 y~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (308)
T cd06615          80 HMDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  154 (308)
T ss_pred             ccCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence            9999999999954   2468999999999999999999993  2589999999999999999999999999987653321


Q ss_pred             --eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCc------------
Q 048535          270 --VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHP------------  329 (409)
Q Consensus       270 --~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~------------  329 (409)
                        ...|...+      ....++...|+|+++  ..+++++......    .......+..+.....+.            
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG--~~l~~l~~g~~p~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLG--LSLVEMAIGRYPI----PPPDAKELEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             cccCCCCcCccChhHhcCCCCCccchHHHHH--HHHHHHHhCCCCC----CCcchhhHHHhhcCccccccccCCcccccC
Confidence              11122111      123355678999985  3345554433321    111111222222111110            


Q ss_pred             CCCCCCC---HHHHHHHHhcCcC--CCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          330 EANSRPT---IRQVLKMLEGQTE--GTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       330 dP~~RPt---~~evl~~L~~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      .+...+.   ..++.+.+.+...  .+...-...-.+++.+|+..+|.+|.+..+++.||||....
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence            1111111   1222332222111  11111123457888888888888888888888888886543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.7e-32  Score=262.30  Aligned_cols=233  Identities=22%  Similarity=0.379  Sum_probs=178.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC---------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL---------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEK  181 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  181 (409)
                      .+|++.+.||+|+||.||++...         +..||+|.++.. .....+++.+|+.+++++ +||||++++++|.. .
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~   90 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-D   90 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-C
Confidence            46888999999999999999753         236899998754 344567899999999999 89999999999987 6


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee
Q 048535          182 ESLILIYDYMENGSLDKWIFECD-------------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL  248 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl  248 (409)
                      +..+++|||+++|+|.+++....             ....+++.+++.++.|++.||.|||   +++|+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEE
Confidence            68899999999999999996532             1235889999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEecccCcccccCCce----eee-----cccc---ccCCCcHHHHHHhhhccCcHHHHh---------------
Q 048535          249 DKKMNARLGDFGLAKMHHHGQV----MSG-----RRPI---EEGKRNLVDRMWSLTERSELLSVL---------------  301 (409)
Q Consensus       249 ~~~~~~kl~DFGla~~~~~~~~----~~g-----~~p~---~~~~~~~~~~vws~~~~~~~~~~~---------------  301 (409)
                      +.++.+||+|||+++.......    ..+     ..+.   ....++..+|+|+++.  .+++++               
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~--il~el~~~g~~p~~~~~~~~~  245 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV--LLWEIFTLGGSPYPGIPVEEL  245 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHH--HHHHHHhcCCCCCCCCCHHHH
Confidence            9999999999999986543210    111     1111   1234566789998731  111211               


Q ss_pred             -hHHhh-hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCC
Q 048535          302 -DERLK-AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGT  351 (409)
Q Consensus       302 -~~~l~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  351 (409)
                       ..... ...+.+......+.+++.+||+.+|++|||+.|+++.|+.+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~  297 (334)
T cd05100         246 FKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT  297 (334)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence             11111 011223344567899999999999999999999999999876544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=9e-32  Score=252.79  Aligned_cols=224  Identities=27%  Similarity=0.433  Sum_probs=168.7

Q ss_pred             ceeecCCceEEEEEEEC--C--cEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--G--VEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~--~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||+|.+.  +  ..+|+|.++.. .....+.+.+|++++.++ +||||+++++++.. .+..++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-CCCceEEEEeCC
Confidence            36899999999999986  3  35799988753 344557899999999999 89999999999987 667899999999


Q ss_pred             CCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 048535          193 NGSLDKWIFECD-------------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDF  259 (409)
Q Consensus       193 ~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF  259 (409)
                      +|+|.+++....             ....+++.++..++.|++.||+|||   +.+++||||||+|||+++++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCC
Confidence            999999996532             1234889999999999999999999   899999999999999999999999999


Q ss_pred             cCcccccCCc-eeee-----ccccc---cCCCcHHHHHHhhhccCcHHHHh----------------hHHhhh-cCCCCH
Q 048535          260 GLAKMHHHGQ-VMSG-----RRPIE---EGKRNLVDRMWSLTERSELLSVL----------------DERLKA-KGGYAD  313 (409)
Q Consensus       260 Gla~~~~~~~-~~~g-----~~p~~---~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~~-~~~~~~  313 (409)
                      |+++...... -..+     ..+.+   ...++...|+|+++  ..+++++                ...... ..+.+.
T Consensus       157 gl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG--~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (270)
T cd05047         157 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG--VLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL  234 (270)
T ss_pred             CCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHH--HHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence            9986332110 0001     11111   23456678999874  1122221                111100 011223


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      .....+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         235 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            34567899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.7e-32  Score=252.54  Aligned_cols=220  Identities=21%  Similarity=0.354  Sum_probs=162.7

Q ss_pred             ceeecCCceEEEEEEEC----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCC
Q 048535          119 NVIGLGGNGKVYKGQLL----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMEN  193 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~  193 (409)
                      ++||+|+||.||+|...    ...+|+|.+... .......|.+|+.+++.++||||+++++++.. ....++||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-SIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-CCceEEEEEeCCC
Confidence            36899999999999764    357899988654 33445678999999999999999999999987 6789999999999


Q ss_pred             CCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee
Q 048535          194 GSLDKWIFECDE--SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM  271 (409)
Q Consensus       194 gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  271 (409)
                      |+|.+++.....  ....++.....++.|++.||+|||   +.+|+||||||+|||+++++++||+|||+++........
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            999999975432  233568888999999999999999   899999999999999999999999999998754322110


Q ss_pred             ------ee---ccccc----------cCCCcHHHHHHhhhccCcHHHHhh----------------HHhhh------cCC
Q 048535          272 ------SG---RRPIE----------EGKRNLVDRMWSLTERSELLSVLD----------------ERLKA------KGG  310 (409)
Q Consensus       272 ------~g---~~p~~----------~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~~------~~~  310 (409)
                            .+   ..+.+          ....+...|+|+++  ..+++++.                .....      .+.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG--~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLG--VTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ  234 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHH--HHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence                  00   11111          12346678999873  11111111                11100      011


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 048535          311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       311 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                      .+......+.+++..|| .||++|||+++|++.|.
T Consensus       235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            22234566778889999 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.5e-32  Score=269.80  Aligned_cols=266  Identities=21%  Similarity=0.283  Sum_probs=191.9

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC-C-----CceeeEeeEEEccCCeEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-H-----RNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~~  185 (409)
                      +|.+.+.||+|.||.|.+|.+.  ++.||||+++.. .....+-..|+.+|..|+ |     -|+|+++++|.. .+++|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-r~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-RNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-cccee
Confidence            6788999999999999999987  899999999865 334566778999999996 4     379999999998 88999


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC--cEEEecccCcc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM--NARLGDFGLAK  263 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~--~~kl~DFGla~  263 (409)
                      ||+|.+.. +|+++|+.+. -..++...+..++.||+.||.+||   +.+|||+||||+||||.+-.  .+||+|||.|+
T Consensus       265 iVfELL~~-NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  265 IVFELLST-NLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeehhhhh-hHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence            99999977 9999998753 346999999999999999999999   89999999999999997644  59999999998


Q ss_pred             cccCCce--eeec-----cccccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHH-------------
Q 048535          264 MHHHGQV--MSGR-----RPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLG-------------  323 (409)
Q Consensus       264 ~~~~~~~--~~g~-----~p~~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~-------------  323 (409)
                      .....-.  +..+     .-+-...|+...|+||++  +.+.++..+.....++...+....+.++.             
T Consensus       340 ~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLG--CIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~  417 (586)
T KOG0667|consen  340 FESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLG--CILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK  417 (586)
T ss_pred             ccCCcceeeeeccccccchhhccCCCCCccceeehh--hhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            8665431  1111     112236778889999996  55555555544433433333333332221             


Q ss_pred             ------------HHccCcCCCCCCCHHHHHHHHhcCcC---CC-CC---------CCCCcchhHHhhhcccCCCCccccc
Q 048535          324 ------------LLCAHPEANSRPTIRQVLKMLEGQTE---GT-GL---------EDEGMNVHLLKRIGTRAMTSSWKFA  378 (409)
Q Consensus       324 ------------~~Cl~~dP~~RPt~~evl~~L~~~~~---~~-~~---------~~~~~~~~~l~~~~~~~~~~~~~~~  378 (409)
                                  ..|...+-.+-+...++.+.+.....   .| ..         .++....|++.+|+..||..||+..
T Consensus       418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~  497 (586)
T KOG0667|consen  418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA  497 (586)
T ss_pred             cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence                        11333221111122233333322211   11 10         1112237999999999999999999


Q ss_pred             ccCCCCCccc
Q 048535          379 GSRGHPTFNE  388 (409)
Q Consensus       379 ~~~~hp~~~~  388 (409)
                      ++++|||++.
T Consensus       498 qal~Hpfl~~  507 (586)
T KOG0667|consen  498 QALNHPFLTG  507 (586)
T ss_pred             HHhcCccccc
Confidence            9999999994

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5e-32  Score=260.36  Aligned_cols=233  Identities=23%  Similarity=0.404  Sum_probs=177.6

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC---------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEc
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL---------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKK  179 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  179 (409)
                      ...+|.+.+.||+|+||.||+++..         ...+|+|.++.. .......+.+|+.+++++ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3467888999999999999999752         356999998754 344567789999999999 69999999999987


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 048535          180 EKESLILIYDYMENGSLDKWIFECD-------------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNV  246 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NI  246 (409)
                       ....+++|||+++|+|.+++....             ....+++.++.+++.|++.||.|||   +.+|+||||||+||
T Consensus        90 -~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Ni  165 (314)
T cd05099          90 -EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNV  165 (314)
T ss_pred             -CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeE
Confidence             677899999999999999996532             1235899999999999999999999   89999999999999


Q ss_pred             eeCCCCcEEEecccCcccccCCc----eeeecc-----cc---ccCCCcHHHHHHhhhccCcHHHHhh------------
Q 048535          247 LLDKKMNARLGDFGLAKMHHHGQ----VMSGRR-----PI---EEGKRNLVDRMWSLTERSELLSVLD------------  302 (409)
Q Consensus       247 Ll~~~~~~kl~DFGla~~~~~~~----~~~g~~-----p~---~~~~~~~~~~vws~~~~~~~~~~~~------------  302 (409)
                      |++.++.+||+|||+++......    ...+..     +.   ....++..+|+|+++.  .+++++.            
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~--~l~el~~~g~~p~~~~~~~  243 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGI--LMWEIFTLGGSPYPGIPVE  243 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHH--HHHHHHhCCCCCCCCCCHH
Confidence            99999999999999998654321    111111     11   1244566788888741  1111111            


Q ss_pred             ---HHhhh--cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          303 ---ERLKA--KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       303 ---~~l~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                         ..+..  ....+......+.+++.+||+.+|++|||+.++++.|++...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         244 ELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence               11110  012233445678899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.3e-32  Score=251.33  Aligned_cols=224  Identities=28%  Similarity=0.397  Sum_probs=173.2

Q ss_pred             CCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      ++|++.+.||+|+||.||+|...++.||+|.++...  ....+.+|+.++++++|||++++++++..  +..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH--NGLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC--CCcEEEEECCC
Confidence            458888999999999999999889999999986543  34678999999999999999999998865  34789999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee-
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM-  271 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~-  271 (409)
                      +|+|.+++... ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++........ 
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~  157 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS  157 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccCCCC
Confidence            99999999653 2345899999999999999999999   899999999999999999999999999999764332100 


Q ss_pred             ---eecccc---ccCCCcHHHHHHhhhccCcHHHHh----------------hHHhhh-cCCCCHHHHHHHHHHHHHccC
Q 048535          272 ---SGRRPI---EEGKRNLVDRMWSLTERSELLSVL----------------DERLKA-KGGYADEVVEKVLHLGLLCAH  328 (409)
Q Consensus       272 ---~g~~p~---~~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~~-~~~~~~~~~~~l~~l~~~Cl~  328 (409)
                         ....+.   ....++...|+|+++  ..+++++                ...... ....+...+..+.+++.+||+
T Consensus       158 ~~~~~y~~pe~~~~~~~~~~~Dv~slG--~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  235 (254)
T cd05083         158 KLPVKWTAPEALKHKKFSSKSDVWSYG--VLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWE  235 (254)
T ss_pred             CCCceecCHHHhccCCcCchhhHHHHH--HHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcC
Confidence               011111   124456678888873  1112211                111000 011233445678899999999


Q ss_pred             cCCCCCCCHHHHHHHHhc
Q 048535          329 PEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       329 ~dP~~RPt~~evl~~L~~  346 (409)
                      .+|++||+++++++.|++
T Consensus       236 ~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         236 TEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CChhhCcCHHHHHHHHcc
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8e-32  Score=254.21  Aligned_cols=228  Identities=25%  Similarity=0.385  Sum_probs=174.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC------CcEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL------GVEVALKRISLDSE-HGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESL  184 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~  184 (409)
                      ..|+..+.||+|+||.||+|.+.      +..||||.++.... ...+.|.+|+++++.++||||+++++++... ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45677799999999999999864      67899999976543 2567899999999999999999999988652 3468


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      +++|||+++|+|.+++...  ...+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999999653  235999999999999999999999   89999999999999999999999999999987


Q ss_pred             ccCCce-eee---------cccc---ccCCCcHHHHHHhhhccCcHHHHh-----------------------------h
Q 048535          265 HHHGQV-MSG---------RRPI---EEGKRNLVDRMWSLTERSELLSVL-----------------------------D  302 (409)
Q Consensus       265 ~~~~~~-~~g---------~~p~---~~~~~~~~~~vws~~~~~~~~~~~-----------------------------~  302 (409)
                      ...... ...         ..+.   .....+...|+|+++.  .+++++                             .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~--~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGV--TLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhh--hhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            653210 000         0111   1234556788998731  111111                             1


Q ss_pred             HHhhhc--CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          303 ERLKAK--GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       303 ~~l~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      ..+...  ...+..+..++.+++.+||+.+|++|||+.|++++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            111100  111233446789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-32  Score=267.11  Aligned_cols=145  Identities=25%  Similarity=0.304  Sum_probs=130.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||++...  ++.||||++...   .....+.+.+|++++++++||||+++++++.+ ....|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-AQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCeeEEE
Confidence            47888999999999999999886  889999998643   23345678899999999999999999999987 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      |||+++|+|.+++..   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          80 MEFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            999999999999954   346899999999999999999999   89999999999999999999999999999963

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.7e-31  Score=250.49  Aligned_cols=229  Identities=22%  Similarity=0.330  Sum_probs=173.4

Q ss_pred             HHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          108 IHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       108 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      +..+++++.....||+|+||.||+|.+.  +..||+|.+........+.+.+|+.++++++|+||+++++++.. ++..+
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   81 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-NGFFK   81 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-CCEEE
Confidence            3455677777789999999999999876  78899999987766667789999999999999999999999887 67899


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC-CCcEEEecccCccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK-KMNARLGDFGLAKM  264 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DFGla~~  264 (409)
                      +++||+++++|.+++.........++..+..++.|++.||+|||   +.+|+||||||+||+++. ++.+||+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            99999999999999964322212288889999999999999999   899999999999999976 67899999999876


Q ss_pred             ccCCc----eeeecc---ccc---c--CCCcHHHHHHhhhccCcHHHHhhHH------------------hhhcCCCCHH
Q 048535          265 HHHGQ----VMSGRR---PIE---E--GKRNLVDRMWSLTERSELLSVLDER------------------LKAKGGYADE  314 (409)
Q Consensus       265 ~~~~~----~~~g~~---p~~---~--~~~~~~~~vws~~~~~~~~~~~~~~------------------l~~~~~~~~~  314 (409)
                      .....    ...|..   +.+   .  ..++...|+|+++.  .+++++...                  .......+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGv--vl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd06624         159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGC--TIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES  236 (268)
T ss_pred             cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHH--HHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcc
Confidence            43211    111111   111   1  12456788888731  111111110                  0111223444


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ...++.+++.+||+.+|++|||+.|++.
T Consensus       237 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         237 LSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             cCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            5667889999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.8e-33  Score=248.45  Aligned_cols=225  Identities=20%  Similarity=0.326  Sum_probs=181.4

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-----C---hHHHHHHHHHHHHhccC-CCCceeeEeeEEEc
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-----S---EHGMREFLAEVSSLGRL-KHRNLVGLRGWCKK  179 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-----~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  179 (409)
                      .-+.|...+.||.|..+.|-++..+  |..+|+|++...     +   ..-.+.-.+|+.+|+++ .||||+++.+++..
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            3456788899999999999999887  889999998643     1   12234567899999999 79999999999987


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 048535          180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDF  259 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF  259 (409)
                       +..+++|+|.|+.|.|.+||   .....+++....+|++|+.+|++|||   .++||||||||+|||+|++.++||+||
T Consensus        95 -~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   95 -DAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             -cchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEecc
Confidence             77899999999999999999   45678999999999999999999999   899999999999999999999999999


Q ss_pred             cCcccccCCc---eeeeccccc------------cCCCcHHHHHHhhhcc--------------Cc---HHHHhhHHhhh
Q 048535          260 GLAKMHHHGQ---VMSGRRPIE------------EGKRNLVDRMWSLTER--------------SE---LLSVLDERLKA  307 (409)
Q Consensus       260 Gla~~~~~~~---~~~g~~p~~------------~~~~~~~~~vws~~~~--------------~~---~~~~~~~~l~~  307 (409)
                      |+|+.+..++   -+||.+.+-            ...|+...|.|+.+..              ..   +..++.+...+
T Consensus       168 GFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF  247 (411)
T KOG0599|consen  168 GFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF  247 (411)
T ss_pred             ceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc
Confidence            9999988876   456665442            2567788899986211              11   11122233333


Q ss_pred             cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          308 KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       308 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+...+....+.+|+.+|++.||.+|-|++|+++
T Consensus       248 ~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  248 RSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            34445667778899999999999999999999874

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-32  Score=264.45  Aligned_cols=148  Identities=25%  Similarity=0.321  Sum_probs=132.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|.+.+.||+|+||.||+|...  ++.||+|+++..   .......+.+|+.++..++||||+++++++.+ ++..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-EEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-CCeEEEE
Confidence            46888999999999999999987  899999999754   22345678899999999999999999999887 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        80 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          80 MEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            9999999999999643   56899999999999999999999   89999999999999999999999999999986543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.98  E-value=1.3e-31  Score=250.04  Aligned_cols=226  Identities=27%  Similarity=0.440  Sum_probs=175.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      .++|+..++||+|+||.||+|... ++.||+|.+..... ....|.+|+.++++++|+||+++++++.  ....+++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCcEEEEEc
Confidence            467888999999999999999987 78999999875432 3467899999999999999999999874  4568999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV  270 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  270 (409)
                      +++|+|.+++... ....+++.++..++.|++.||+|||   +.+++||||||+||++++++.++|+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            9999999998653 3346899999999999999999999   89999999999999999999999999999986653221


Q ss_pred             ee-----e---ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHHHHHHHHHH
Q 048535          271 MS-----G---RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADEVVEKVLHL  322 (409)
Q Consensus       271 ~~-----g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~~~~~l~~l  322 (409)
                      ..     +   ..+.+   ...++...|+|+++  ..+++++. .....                ..+.+.....++.++
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG--~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG--ILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL  235 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHH--HHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            10     0   11111   23445678899874  12222221 11110                012223345679999


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHhc
Q 048535          323 GLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      +.+||+.+|++|||++++++.|+.
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHccCChhhCCCHHHHHHHhhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.98  E-value=2e-31  Score=256.68  Aligned_cols=211  Identities=21%  Similarity=0.299  Sum_probs=156.0

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||+|...  ++.||+|.++...   ......+..|..++..+ +||||+++++++.+ .+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-KENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-CCEEEEEEeCCC
Confidence            46999999999999987  7889999997541   23345677788888764 99999999999987 678999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---  269 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---  269 (409)
                      +|+|.+++..   ...+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......   
T Consensus        80 ~g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05619          80 GGDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT  153 (316)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence            9999999953   346899999999999999999999   8999999999999999999999999999987532211   


Q ss_pred             -eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh---------------cCCCCHHHHHHHHHHHHHcc
Q 048535          270 -VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKA---------------KGGYADEVVEKVLHLGLLCA  327 (409)
Q Consensus       270 -~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~---------------~~~~~~~~~~~l~~l~~~Cl  327 (409)
                       ...|...+      ....++...|+|+++  ..+++++....+.               ...++......+.+++.+||
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG--~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  231 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFG--VLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLF  231 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHH--HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHh
Confidence             11222221      124466788999984  2233333222111               11122223445667777777


Q ss_pred             CcCCCCCCCHH
Q 048535          328 HPEANSRPTIR  338 (409)
Q Consensus       328 ~~dP~~RPt~~  338 (409)
                      +.||++||++.
T Consensus       232 ~~~P~~R~~~~  242 (316)
T cd05619         232 VREPERRLGVK  242 (316)
T ss_pred             ccCHhhcCCCh
Confidence            77777777776

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.98  E-value=2.3e-31  Score=247.30  Aligned_cols=225  Identities=24%  Similarity=0.325  Sum_probs=173.8

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|+..+.||+|++|.||+|...  ++.|++|.+...  .......+.+|++++++++||||+++++++.+ .+..++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-KGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-CCEEEEEEE
Confidence            4777899999999999999986  899999998643  34556789999999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++++|.+++... ....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++......
T Consensus        80 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          80 YAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             eCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            99999999999763 2356899999999999999999999   8999999999999999999999999999988654322


Q ss_pred             ----eeeecccc------ccCCCcHHHHHHhhhcc-------------CcHHHHhhHHhhh-cCCCCHHHHHHHHHHHHH
Q 048535          270 ----VMSGRRPI------EEGKRNLVDRMWSLTER-------------SELLSVLDERLKA-KGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       270 ----~~~g~~p~------~~~~~~~~~~vws~~~~-------------~~~~~~~~~~l~~-~~~~~~~~~~~l~~l~~~  325 (409)
                          ...|...+      .....+...|+|+++.-             ....+........ ....+......+.+++.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ  235 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence                11222111      12334556788887310             1111111111111 112233455678999999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 048535          326 CAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~~  343 (409)
                      ||+.+|++||++.++++.
T Consensus       236 ~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         236 CLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HccCCcccCcCHHHHhhC
Confidence            999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.98  E-value=4.4e-32  Score=266.77  Aligned_cols=188  Identities=20%  Similarity=0.213  Sum_probs=150.0

Q ss_pred             HHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC
Q 048535          107 EIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK  181 (409)
Q Consensus       107 ~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  181 (409)
                      ++....++|+..+.||+|+||.||++...  ++.||+|.+...   .....+.+.+|+.+++.++||||+++++++.+ +
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~  115 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-D  115 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-C
Confidence            33445678999999999999999999987  789999998642   22334568899999999999999999999887 7


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      ...++||||+++|+|.+++..    ..+++..+..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~  188 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGT  188 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEeccc
Confidence            789999999999999999943    35889999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCc-----eeeecccccc----------CCCcHHHHHHhhhccCcHHHHhhHH
Q 048535          262 AKMHHHGQ-----VMSGRRPIEE----------GKRNLVDRMWSLTERSELLSVLDER  304 (409)
Q Consensus       262 a~~~~~~~-----~~~g~~p~~~----------~~~~~~~~vws~~~~~~~~~~~~~~  304 (409)
                      |+......     ...|...+..          ..++...|+|+++  ..+++++...
T Consensus       189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG--~ilyell~G~  244 (370)
T cd05621         189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG--VFLFEMLVGD  244 (370)
T ss_pred             ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeeh--HHHHHHHhCC
Confidence            98764322     1123222211          1245678889885  3445554433

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.98  E-value=1.7e-31  Score=252.49  Aligned_cols=183  Identities=29%  Similarity=0.428  Sum_probs=145.6

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|+..+.||+|++|.||+|+..  +..||+|.++..  .....+.+.+|+.++++++||||+++++++.+ +...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-CCeEEEEEe
Confidence            4778899999999999999986  889999998654  22234678899999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |++ ++|.+++........+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            997 699998865444457999999999999999999999   8999999999999999999999999999987543221


Q ss_pred             ee-e---ec---cccc----cCCCcHHHHHHhhhccCcHHHHhhH
Q 048535          270 VM-S---GR---RPIE----EGKRNLVDRMWSLTERSELLSVLDE  303 (409)
Q Consensus       270 ~~-~---g~---~p~~----~~~~~~~~~vws~~~~~~~~~~~~~  303 (409)
                      .. .   +.   .+.+    ...++...|+|+++  ..+++++..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG--~il~~l~tg  198 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIG--TIFAEMATK  198 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHH--HHHHHHHHC
Confidence            00 0   01   1111    12346778999986  334455444

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.98  E-value=1.2e-31  Score=252.29  Aligned_cols=228  Identities=20%  Similarity=0.329  Sum_probs=174.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLDSEH-GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      ++|+..+.||+|+||.||+|+..       .+.||+|.+...... ..+.+.+|++++++++|+||+++++++.+ ....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-AEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-CCcc
Confidence            57888999999999999999864       357999998755433 56789999999999999999999999876 6778


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEec
Q 048535          185 ILIYDYMENGSLDKWIFECDES------IALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGD  258 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D  258 (409)
                      ++||||+++|+|.+++......      ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcc
Confidence            9999999999999999654322      25899999999999999999999   89999999999999999999999999


Q ss_pred             ccCcccccCCcee--------eecccc---ccCCCcHHHHHHhhhccCcHHHHhh----------------HHhhhc--C
Q 048535          259 FGLAKMHHHGQVM--------SGRRPI---EEGKRNLVDRMWSLTERSELLSVLD----------------ERLKAK--G  309 (409)
Q Consensus       259 FGla~~~~~~~~~--------~g~~p~---~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~~~--~  309 (409)
                      ||+++........        ....+.   .....+..+|+|+++.  .+++++.                ......  .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~--~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~  238 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGV--LMWEVFTQGELPFYGLSDEEVLNRLQAGKLEL  238 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHH--HHHHHHhCCCCCccccchHHHHHHHHcCCcCC
Confidence            9998754321100        001111   1234566789999741  1111111                111000  1


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          310 GYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       310 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      ..+...+..+.+++.+||+.+|++|||+.|+++.|.+
T Consensus       239 ~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         239 PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            1123345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.98  E-value=8.2e-32  Score=254.68  Aligned_cols=210  Identities=23%  Similarity=0.317  Sum_probs=156.6

Q ss_pred             eecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCC
Q 048535          121 IGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS  195 (409)
Q Consensus       121 lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gs  195 (409)
                      ||+|+||+||++...  ++.||+|.+....   ....+.+..|++++++++|+||+++.+++.. ....++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCC
Confidence            699999999999886  8899999996542   2234567899999999999999999998876 678999999999999


Q ss_pred             HHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce----
Q 048535          196 LDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV----  270 (409)
Q Consensus       196 L~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~----  270 (409)
                      |.+++... .....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.......    
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence            99888543 23356899999999999999999999   89999999999999999999999999999976543321    


Q ss_pred             eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh-------------------cCCCCHHHHHHHHHHHHH
Q 048535          271 MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKA-------------------KGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       271 ~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~-------------------~~~~~~~~~~~l~~l~~~  325 (409)
                      ..|...+      ....++...|+|+++  ..+++++......                   ...++...+..+.+++..
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG--~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  234 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALG--VTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEA  234 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHH--HHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHH
Confidence            1122211      124456778999984  2233333222111                   111223344556667777


Q ss_pred             ccCcCCCCCCC
Q 048535          326 CAHPEANSRPT  336 (409)
Q Consensus       326 Cl~~dP~~RPt  336 (409)
                      ||+.||++||+
T Consensus       235 ~l~~~P~~R~~  245 (280)
T cd05608         235 LLAKDPEKRLG  245 (280)
T ss_pred             HhcCCHHHhcC
Confidence            77777777773

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.98  E-value=7.1e-32  Score=260.47  Aligned_cols=214  Identities=23%  Similarity=0.282  Sum_probs=160.3

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHH-HhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVS-SLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||+||+|...  |+.||+|++....   ....+.+..|.. +++.++||||+++++++.. .+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-ADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-CCEEEEEEcCCC
Confidence            46999999999999986  8999999997542   223345556655 5678999999999998887 778999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---  269 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---  269 (409)
                      +|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++......   
T Consensus        80 ~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (323)
T cd05575          80 GGELFFHLQR---ERSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT  153 (323)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence            9999999853   346899999999999999999999   8999999999999999999999999999987532211   


Q ss_pred             -eeeecccc------ccCCCcHHHHHHhhhcc-------------CcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCc
Q 048535          270 -VMSGRRPI------EEGKRNLVDRMWSLTER-------------SELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHP  329 (409)
Q Consensus       270 -~~~g~~p~------~~~~~~~~~~vws~~~~-------------~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~  329 (409)
                       ...|...+      ....++...|+|+++..             ....+..+..+......+......+.+++.+|++.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~  233 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQK  233 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence             11222221      12345667888887411             11122222222222223334466789999999999


Q ss_pred             CCCCCCCHHH
Q 048535          330 EANSRPTIRQ  339 (409)
Q Consensus       330 dP~~RPt~~e  339 (409)
                      ||.+||++++
T Consensus       234 ~p~~R~~~~~  243 (323)
T cd05575         234 DRTKRLGAKD  243 (323)
T ss_pred             CHHhCCCCCC
Confidence            9999999863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.98  E-value=7.8e-32  Score=257.73  Aligned_cols=255  Identities=22%  Similarity=0.342  Sum_probs=184.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC--Cc----EEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GV----EVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      ++|+..+.||+|+||.||+|.+.  +.    .||+|.+.... .....++.+|+.++++++||||++++|+|..  ...+
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~   84 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS--PTIQ   84 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--CCce
Confidence            56778899999999999999874  43    57999887553 3344578999999999999999999999875  3467


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +++||+++|+|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||+++++.+||+|||+++..
T Consensus        85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccc
Confidence            899999999999998643  335899999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCce---ee------ecccc---ccCCCcHHHHHHhhhccCcHHHHhh-HH--------------hhh--cCCCCHHHH
Q 048535          266 HHGQV---MS------GRRPI---EEGKRNLVDRMWSLTERSELLSVLD-ER--------------LKA--KGGYADEVV  316 (409)
Q Consensus       266 ~~~~~---~~------g~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~~--------------l~~--~~~~~~~~~  316 (409)
                      .....   ..      ...+.   ....++...|+|+++  ..+++++. ..              +..  ....+....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG--~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYG--VTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICT  237 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCC
Confidence            43221   00      11111   124456778999974  12222221 00              000  011122234


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      ..+.+++..||..+|++||+++++++.|+.....+..            .....+..+..+..+-.||+|.+
T Consensus       238 ~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~  297 (303)
T cd05110         238 IDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQR------------YLVIQGDDRMKLPSPNDSKFFQN  297 (303)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhh------------heeeccCCcCCCCCCchhhHHhc
Confidence            5688899999999999999999999999875433221            11222334444556666777665

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.98  E-value=5.5e-32  Score=261.29  Aligned_cols=217  Identities=24%  Similarity=0.286  Sum_probs=164.1

Q ss_pred             ceeecCCceEEEEEEEC-----CcEEEEEEeccC----ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          119 NVIGLGGNGKVYKGQLL-----GVEVALKRISLD----SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +.||+|+||.||+++..     ++.||+|.++..    .......+.+|+.+|+.++||||+++++++.. ++..|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-GGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-CCeEEEEEe
Confidence            67999999999999762     788999999753    22334567899999999999999999999887 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          81 YLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            9999999999853   346888999999999999999999   8999999999999999999999999999987532211


Q ss_pred             ----eeeecccc---c---cCCCcHHHHHHhhhcc-------------CcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHc
Q 048535          270 ----VMSGRRPI---E---EGKRNLVDRMWSLTER-------------SELLSVLDERLKAKGGYADEVVEKVLHLGLLC  326 (409)
Q Consensus       270 ----~~~g~~p~---~---~~~~~~~~~vws~~~~-------------~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~C  326 (409)
                          ...|...+   +   ...++...|+|+++..             ......+..........+......+.+++.+|
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  234 (323)
T cd05584         155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKL  234 (323)
T ss_pred             CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence                11222221   1   1234566788887311             11112222222222233444566789999999


Q ss_pred             cCcCCCCCC-----CHHHHHH
Q 048535          327 AHPEANSRP-----TIRQVLK  342 (409)
Q Consensus       327 l~~dP~~RP-----t~~evl~  342 (409)
                      |+.||++||     ++.++++
T Consensus       235 l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         235 LKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             cccCHhHcCCCCCCCHHHHhc
Confidence            999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.98  E-value=1.1e-31  Score=259.05  Aligned_cols=208  Identities=22%  Similarity=0.288  Sum_probs=156.8

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||+|+..  ++.||+|+++..   .....+.+..|.+++..+ +||||+++++++.. .+..|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-KDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCeEEEEEeCCC
Confidence            46999999999999987  789999999754   233456678899999876 89999999999987 678999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---  269 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---  269 (409)
                      +|+|..++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......   
T Consensus        80 ~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  153 (321)
T cd05591          80 GGDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT  153 (321)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence            9999999853   346899999999999999999999   8999999999999999999999999999987532211   


Q ss_pred             -eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHH---------------hhhcCCCCHHHHHHHHHHHHHcc
Q 048535          270 -VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDER---------------LKAKGGYADEVVEKVLHLGLLCA  327 (409)
Q Consensus       270 -~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~---------------l~~~~~~~~~~~~~l~~l~~~Cl  327 (409)
                       ...|...+      ....++...|+|+++  ..+++++...               .......+......+.+++..||
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG--~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L  231 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALG--VLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFM  231 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechh--HHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence             11222222      123455667888874  2222322222               11111222334567788888888


Q ss_pred             CcCCCCCC
Q 048535          328 HPEANSRP  335 (409)
Q Consensus       328 ~~dP~~RP  335 (409)
                      +.||++||
T Consensus       232 ~~dp~~R~  239 (321)
T cd05591         232 TKNPNKRL  239 (321)
T ss_pred             ccCHHHcC
Confidence            88888888

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=1.6e-31  Score=249.38  Aligned_cols=227  Identities=25%  Similarity=0.441  Sum_probs=177.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      .++|.+.+.||+|+||.||+|... +..||||.+.... ...+++.+|+.++++++|+||+++++++.. ....++||||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~   82 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPIYIVTEY   82 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-CCceEEEEec
Confidence            467888999999999999999987 6789999987543 234678999999999999999999999876 5778999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV  270 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  270 (409)
                      +++++|.+++... ....+++..+..++.|++.||.|||   +++++|+||||+||++++++.+||+|||+++.......
T Consensus        83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            9999999999653 2346899999999999999999999   88999999999999999999999999999986543210


Q ss_pred             e--------eecccc---ccCCCcHHHHHHhhhccCcHHHH----------------hhHHhhh-cCCCCHHHHHHHHHH
Q 048535          271 M--------SGRRPI---EEGKRNLVDRMWSLTERSELLSV----------------LDERLKA-KGGYADEVVEKVLHL  322 (409)
Q Consensus       271 ~--------~g~~p~---~~~~~~~~~~vws~~~~~~~~~~----------------~~~~l~~-~~~~~~~~~~~l~~l  322 (409)
                      .        ....+.   .....+...|+|+++  ..++++                .+..... ....+...+..+.++
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG--~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFG--ILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL  236 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            0        001111   123456778999974  111111                1111110 012233345678999


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHhc
Q 048535          323 GLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      +.+||+.+|++||+++++.+.|+.
T Consensus       237 i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         237 MLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHcccCcccCCCHHHHHHHHhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.98  E-value=1.4e-31  Score=249.23  Aligned_cols=217  Identities=25%  Similarity=0.409  Sum_probs=164.6

Q ss_pred             ceeecCCceEEEEEEEC--C----------cEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          119 NVIGLGGNGKVYKGQLL--G----------VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~----------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      +.||+|+||.||+|.+.  +          ..|++|.+...... ...|.+|+.++++++||||+++++++..  ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR--DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec--CCcEE
Confidence            46899999999999987  3          24888887654333 6789999999999999999999999876  45789


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC-------cEEEecc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM-------NARLGDF  259 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-------~~kl~DF  259 (409)
                      ||||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++       .+||+||
T Consensus        78 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          78 VEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCC
Confidence            999999999999996532  26899999999999999999999   89999999999999999888       7999999


Q ss_pred             cCcccccCCceeeecccc---c---cC--CCcHHHHHHhhhccCcHHHHhhH-Hh--------------hhcCCCCHHHH
Q 048535          260 GLAKMHHHGQVMSGRRPI---E---EG--KRNLVDRMWSLTERSELLSVLDE-RL--------------KAKGGYADEVV  316 (409)
Q Consensus       260 Gla~~~~~~~~~~g~~p~---~---~~--~~~~~~~vws~~~~~~~~~~~~~-~l--------------~~~~~~~~~~~  316 (409)
                      |+++.........+..++   +   ..  .++...|+|+++.  .+++++.. ..              ......+....
T Consensus       153 g~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~--~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  230 (259)
T cd05037         153 GIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGT--TLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPDC  230 (259)
T ss_pred             CcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHH--HHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCCc
Confidence            999875443222222221   1   12  4567789998741  12222110 00              00001111112


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                      ..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       231 ~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         231 AELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            67889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-33  Score=266.69  Aligned_cols=221  Identities=25%  Similarity=0.359  Sum_probs=179.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ..|+..++||+|.||.||+|.+.  ++.||+|++..+ .....+++.+|+.+|..++++||.+++|.+.. +..++++||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-g~~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-GTKLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-cccHHHHHH
Confidence            45677789999999999999997  899999999877 44557889999999999999999999999987 788999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      ||.+|++.+.+.   ....+.+..+.-+++++..||.|||   ..+.+|||||+.|||+..+|.+||+|||++-......
T Consensus        92 y~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~  165 (467)
T KOG0201|consen   92 YCGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV  165 (467)
T ss_pred             HhcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechh
Confidence            999999999994   3444588888889999999999999   8999999999999999999999999999998765543


Q ss_pred             ----eeeeccc------cccCCCcHHHHHHhhhccCcHHHHhhHHhh----------------hcCCCCHHHHHHHHHHH
Q 048535          270 ----VMSGRRP------IEEGKRNLVDRMWSLTERSELLSVLDERLK----------------AKGGYADEVVEKVLHLG  323 (409)
Q Consensus       270 ----~~~g~~p------~~~~~~~~~~~vws~~~~~~~~~~~~~~l~----------------~~~~~~~~~~~~l~~l~  323 (409)
                          .+.|++-      +....|+.++|+|+++-  ..+++.....+                .++.....+...+.+++
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGI--TaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV  243 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGI--TAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFV  243 (467)
T ss_pred             hccccccccccccchhhhccccccchhhhhhhhH--HHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHH
Confidence                2233332      23367899999999952  22222221111                01223345667899999


Q ss_pred             HHccCcCCCCCCCHHHHHH
Q 048535          324 LLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..|++.||+.||++.++++
T Consensus       244 ~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  244 EACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             HHHhhcCcccCcCHHHHhh
Confidence            9999999999999999985

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.98  E-value=6e-32  Score=261.69  Aligned_cols=167  Identities=23%  Similarity=0.334  Sum_probs=136.8

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||++...  ++.||+|+++..   .....+.+..|..++.++ +||||+++++++.+ ....++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-ESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-CCEEEEEEeCCC
Confidence            46999999999999986  889999999754   233456688999999998 79999999999887 678999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC-C---
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH-G---  268 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~-~---  268 (409)
                      +|+|.+++..   ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.... .   
T Consensus        80 ~g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~  153 (329)
T cd05588          80 GGDLMFHMQR---QRKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT  153 (329)
T ss_pred             CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence            9999998853   346999999999999999999999   89999999999999999999999999999875211 1   


Q ss_pred             ceeeecccc------ccCCCcHHHHHHhhh
Q 048535          269 QVMSGRRPI------EEGKRNLVDRMWSLT  292 (409)
Q Consensus       269 ~~~~g~~p~------~~~~~~~~~~vws~~  292 (409)
                      ....|...+      ....++...|+|+++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  183 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALG  183 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechH
Confidence            112232222      123456678888875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.98  E-value=3.7e-31  Score=246.14  Aligned_cols=225  Identities=22%  Similarity=0.296  Sum_probs=173.3

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      +|+..+.||+|+||.||++...  +..+|+|.++.. .....+.+.+|+.++++++|+||+++++.+.+ .+..+++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-DGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEee
Confidence            4778899999999999999886  889999998643 34456778899999999999999999999887 7789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV  270 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  270 (409)
                      +++|+|.+++... ....+++..+..++.|++.||.|||   +.+|+|+||||+||++++++.++|+|||+++.......
T Consensus        80 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          80 CDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            9999999998643 3345899999999999999999999   89999999999999999999999999999976543221


Q ss_pred             ----eeeccc------cccCCCcHHHHHHhhhcc-------------CcHHHHhhHHhh-hcCCCCHHHHHHHHHHHHHc
Q 048535          271 ----MSGRRP------IEEGKRNLVDRMWSLTER-------------SELLSVLDERLK-AKGGYADEVVEKVLHLGLLC  326 (409)
Q Consensus       271 ----~~g~~p------~~~~~~~~~~~vws~~~~-------------~~~~~~~~~~l~-~~~~~~~~~~~~l~~l~~~C  326 (409)
                          ..|...      ......+..+|+|+++..             ............ .....+......+.+++.+|
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM  235 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence                111111      112345667899987311             111111111111 01123344556789999999


Q ss_pred             cCcCCCCCCCHHHHHHH
Q 048535          327 AHPEANSRPTIRQVLKM  343 (409)
Q Consensus       327 l~~dP~~RPt~~evl~~  343 (409)
                      |+.||++|||+.+++..
T Consensus       236 l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         236 FKRNPRSRPSATTILSR  252 (255)
T ss_pred             HhCCcccCCCHHHHhhc
Confidence            99999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=1e-31  Score=254.32  Aligned_cols=225  Identities=24%  Similarity=0.357  Sum_probs=170.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|+..+.||+|+||.||++...  +..||+|.+... .......+.+|+.++++++||||+++++.+.. .+..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-EGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-CCeEEEEEe
Confidence            35788899999999999999987  899999998754 34445789999999999999999999998887 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++++|.+++........+++..+..++.|++.||.|||+  +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999999998653223478999999999999999999994  3589999999999999999999999999987653221


Q ss_pred             e--eeecc---ccc---------cCCCcHHHHHHhhhccCcHHHHhhHH------------------hh-hcCCCCHHHH
Q 048535          270 V--MSGRR---PIE---------EGKRNLVDRMWSLTERSELLSVLDER------------------LK-AKGGYADEVV  316 (409)
Q Consensus       270 ~--~~g~~---p~~---------~~~~~~~~~vws~~~~~~~~~~~~~~------------------l~-~~~~~~~~~~  316 (409)
                      .  ..+..   +.+         ...++...|+|+++  ..+++++...                  .. .....+....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG--~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLG--LSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYS  235 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHH--HHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccC
Confidence            1  11111   111         11235678888873  1112221111                  11 0122334456


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+.+++.+||+.+|++||++.++++
T Consensus       236 ~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         236 DDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHHHHHHHHcccCcccCCCHHHHhc
Confidence            67788888888888888888888876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.98  E-value=6.1e-32  Score=266.38  Aligned_cols=145  Identities=22%  Similarity=0.310  Sum_probs=129.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|++.+.||+|+||.||++...  ++.||||.+....   ......+.+|+++|++++||||+++++.+.+ ++.+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCEEEEE
Confidence            46889999999999999999986  8899999986432   2334668899999999999999999999987 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      |||+++|+|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|..
T Consensus        80 ~E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~  150 (376)
T cd05598          80 MDYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (376)
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence            999999999999954   346889999999999999999999   89999999999999999999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.98  E-value=1.3e-31  Score=269.03  Aligned_cols=262  Identities=19%  Similarity=0.250  Sum_probs=183.4

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-------C
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-------K  181 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------~  181 (409)
                      ..++|+..+.||+|+||.||+|...  ++.||||++....    ....+|+.+|+.++|||||++++++...       .
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999986  8899999986432    2234799999999999999999877431       1


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC-cEEEecc
Q 048535          182 ESLILIYDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM-NARLGDF  259 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DF  259 (409)
                      ..+++||||+++ +|.+++... .....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            246799999985 787776432 23457999999999999999999999   89999999999999998665 7999999


Q ss_pred             cCcccccCCce---eeecc---ccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCc
Q 048535          260 GLAKMHHHGQV---MSGRR---PIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHP  329 (409)
Q Consensus       260 Gla~~~~~~~~---~~g~~---p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~  329 (409)
                      |+|+.......   ..|..   +.+    ...++...|+|+++  ..+++++.......+....+.   +..++..+-  
T Consensus       216 Gla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG--vil~elltG~~pf~~~~~~~~---~~~i~~~~~--  288 (440)
T PTZ00036        216 GSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLG--CIIAEMILGYPIFSGQSSVDQ---LVRIIQVLG--  288 (440)
T ss_pred             ccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCChHHH---HHHHHHHhC--
Confidence            99986543321   11211   111    13467889999997  456666665444322222222   233322221  


Q ss_pred             CCCCCCCHHHHHHHHhcCc--CCCC-----------CCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          330 EANSRPTIRQVLKMLEGQT--EGTG-----------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       330 dP~~RPt~~evl~~L~~~~--~~~~-----------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                          .|+..++..+-....  ..+.           ...+....+++.+|+..+|.+|+++.+++.||||.++..
T Consensus       289 ----~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        289 ----TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             ----CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                233333322111000  0000           001123479999999999999999999999999998754

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.98  E-value=2.3e-31  Score=256.90  Aligned_cols=215  Identities=19%  Similarity=0.241  Sum_probs=159.8

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      +|+..+.||+|+||.||+|...  ++.||+|.++..   .....+.+..|..++..+ +|++|+++++++.+ .+..++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-MDRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-CCEEEEE
Confidence            5788899999999999999987  789999999754   223345677888888877 68999999998876 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++..   ...+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus        80 ~E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          80 MEYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             EcCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            999999999999853   346899999999999999999999   89999999999999999999999999999975432


Q ss_pred             Cc----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhh---------------cCCCCHHHHHHHHHH
Q 048535          268 GQ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKA---------------KGGYADEVVEKVLHL  322 (409)
Q Consensus       268 ~~----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~---------------~~~~~~~~~~~l~~l  322 (409)
                      ..    ...|...+.      ...++...|+|+++  ..+++++....+.               ...++.....++.++
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG--vil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  231 (323)
T cd05616         154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFG--VLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI  231 (323)
T ss_pred             CCCccccCCCChhhcCHHHhcCCCCCCccchhchh--HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHH
Confidence            11    122332221      24456778899884  2333333322211               112233344556666


Q ss_pred             HHHccCcCCCCCCCH
Q 048535          323 GLLCAHPEANSRPTI  337 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~  337 (409)
                      +.+|++.||++|++.
T Consensus       232 i~~~l~~~p~~R~~~  246 (323)
T cd05616         232 CKGLMTKHPGKRLGC  246 (323)
T ss_pred             HHHHcccCHHhcCCC
Confidence            666666666666666

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.9e-31  Score=248.98  Aligned_cols=222  Identities=24%  Similarity=0.385  Sum_probs=171.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-----hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-----EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      ++|+..+.||+|++|.||+|...  ++.||+|.+....     ....+.+.+|++++++++||||+++++++.. ....+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-DETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-CCeEE
Confidence            57899999999999999999875  8999999986431     2234578899999999999999999999987 67899


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +|+||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||+++..
T Consensus        81 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          81 IFMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            99999999999999854   345889999999999999999999   899999999999999999999999999999754


Q ss_pred             cCCce-------eeeccc---cc---cCCCcHHHHHHhhhccCcHHHHhhHHhh-----------------hcCCCCHHH
Q 048535          266 HHGQV-------MSGRRP---IE---EGKRNLVDRMWSLTERSELLSVLDERLK-----------------AKGGYADEV  315 (409)
Q Consensus       266 ~~~~~-------~~g~~p---~~---~~~~~~~~~vws~~~~~~~~~~~~~~l~-----------------~~~~~~~~~  315 (409)
                      .....       ..|...   .+   ....+..+|+|+++  ..+++++.....                 .....+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVG--CTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHV  232 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHH--HHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccC
Confidence            33210       111111   11   13356778999873  112222211110                 012233445


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ...+.+++.+||+.+|.+|||+.++++.
T Consensus       233 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         233 SPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            6678899999999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.98  E-value=1.1e-31  Score=258.73  Aligned_cols=213  Identities=25%  Similarity=0.282  Sum_probs=159.0

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHH-HhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVS-SLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||+|+..  ++.||+|++....   ......+..|.. +++.++||||+++++++.+ .+..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-AEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            46999999999999986  8899999996432   223345666655 6788999999999998887 678999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---  269 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---  269 (409)
                      +|+|..++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++......   
T Consensus        80 ~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (321)
T cd05603          80 GGELFFHLQR---ERCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT  153 (321)
T ss_pred             CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence            9999988843   346889999999999999999999   8999999999999999999999999999987532211   


Q ss_pred             -eeeeccccc------cCCCcHHHHHHhhhcc-------------CcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCc
Q 048535          270 -VMSGRRPIE------EGKRNLVDRMWSLTER-------------SELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHP  329 (409)
Q Consensus       270 -~~~g~~p~~------~~~~~~~~~vws~~~~-------------~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~  329 (409)
                       ...|...+.      ...++...|+|+++..             ....+..+.........+......+.+++.+|++.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~  233 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHK  233 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccC
Confidence             112222221      2345567888887311             11122222222222233344556788999999999


Q ss_pred             CCCCCCCHH
Q 048535          330 EANSRPTIR  338 (409)
Q Consensus       330 dP~~RPt~~  338 (409)
                      ||.+||++.
T Consensus       234 ~p~~R~~~~  242 (321)
T cd05603         234 DQRRRLGAK  242 (321)
T ss_pred             CHhhcCCCC
Confidence            999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.98  E-value=2.1e-31  Score=256.41  Aligned_cols=214  Identities=22%  Similarity=0.279  Sum_probs=161.8

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||+|...  ++.||+|.++..   .....+.+..|..++..+ +||||+++++++.. ....++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-KEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            46999999999999986  788999999754   223345566777777654 89999999999887 678999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---  269 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---  269 (409)
                      +|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......   
T Consensus        80 gg~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  153 (316)
T cd05592          80 GGDLMFHIQS---SGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA  153 (316)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence            9999999854   346899999999999999999999   8999999999999999999999999999997543211   


Q ss_pred             -eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhh---------------hcCCCCHHHHHHHHHHHHHcc
Q 048535          270 -VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLK---------------AKGGYADEVVEKVLHLGLLCA  327 (409)
Q Consensus       270 -~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~---------------~~~~~~~~~~~~l~~l~~~Cl  327 (409)
                       ...|...+.      ...++...|+|+++  ..+++++.....               ....++......+.+++.+||
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG--~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l  231 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFG--VLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLF  231 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHH--HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence             222332221      23456678889874  222222222111               112233445567889999999


Q ss_pred             CcCCCCCCCHHHHH
Q 048535          328 HPEANSRPTIRQVL  341 (409)
Q Consensus       328 ~~dP~~RPt~~evl  341 (409)
                      +.||++||++.+.+
T Consensus       232 ~~~P~~R~~~~~~l  245 (316)
T cd05592         232 ERDPTKRLGVDGDI  245 (316)
T ss_pred             cCCHHHcCCChHHH
Confidence            99999999997544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.98  E-value=4.5e-32  Score=266.77  Aligned_cols=183  Identities=21%  Similarity=0.227  Sum_probs=146.6

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      ..++|+..+.||+|+||.||++...  ++.||+|.+...   .......+.+|+.+++.++||||+++++++.+ ....+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-DKYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEE
Confidence            4567999999999999999999987  889999999643   22334567899999999999999999998887 77899


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +||||+++|+|.+++..    ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       120 lv~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            99999999999999853    34788899999999999999999   899999999999999999999999999999865


Q ss_pred             cCCc-----eeeeccccc----------cCCCcHHHHHHhhhccCcHHHHhhH
Q 048535          266 HHGQ-----VMSGRRPIE----------EGKRNLVDRMWSLTERSELLSVLDE  303 (409)
Q Consensus       266 ~~~~-----~~~g~~p~~----------~~~~~~~~~vws~~~~~~~~~~~~~  303 (409)
                      ....     ...|...+.          ...++..+|+|+++  ..+++++..
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlG--vilyelltG  243 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG--VFLYEMLVG  243 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehh--HHHHHHHhC
Confidence            4322     112222111          12255678899885  334444443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00284 protein kinase; Provisional

Probab=99.98  E-value=1.5e-31  Score=271.02  Aligned_cols=273  Identities=14%  Similarity=0.179  Sum_probs=183.3

Q ss_pred             HHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC------CCceeeEeeEE
Q 048535          106 QEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK------HRNLVGLRGWC  177 (409)
Q Consensus       106 ~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~  177 (409)
                      +++...+++|++.+.||+|+||.||+|...  ++.||||+++... ...+.+..|+.++..++      |.+++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            344456788999999999999999999886  7889999996432 22344556666666654      45689999998


Q ss_pred             EccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CceeecCCCCCCeeeCCCC----
Q 048535          178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE-SKVLHRDIKASNVLLDKKM----  252 (409)
Q Consensus       178 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlKp~NILl~~~~----  252 (409)
                      ..+....++|||++ +++|.+++..   ...+++..+..++.||+.||+|||   . .+||||||||+|||++.++    
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccc
Confidence            87667899999998 6799998854   346999999999999999999999   5 5999999999999998765    


Q ss_pred             ------------cEEEecccCcccccCCc-eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCH
Q 048535          253 ------------NARLGDFGLAKMHHHGQ-VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYAD  313 (409)
Q Consensus       253 ------------~~kl~DFGla~~~~~~~-~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~  313 (409)
                                  .+||+|||++....... ...|...+.      ...++...|+|+++  ..+++++..+..+.+....
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlG--vil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMG--CIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCChH
Confidence                        49999999886543221 222332221      24567889999996  4566666655543222221


Q ss_pred             HHHHHHHHH--------HHH--------ccC----cCCCCCCCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCC
Q 048535          314 EVVEKVLHL--------GLL--------CAH----PEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTS  373 (409)
Q Consensus       314 ~~~~~l~~l--------~~~--------Cl~----~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  373 (409)
                      +....+.++        ...        ++.    ..|...|.  .+.... ...............|++.+|+..||.+
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPK--HLARIA-RARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHH--HHHhhh-cccchhhhhchHHHHHHHHHhCCcChhh
Confidence            111111111        001        111    11111111  111111 1111111111223469999999999999


Q ss_pred             cccccccCCCCCcccccc
Q 048535          374 SWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       374 ~~~~~~~~~hp~~~~~~~  391 (409)
                      |+++.+++.||||.....
T Consensus       429 R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        429 RLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             CCCHHHHhcCccccccCC
Confidence            999999999999987543

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.98  E-value=3.2e-31  Score=250.18  Aligned_cols=228  Identities=23%  Similarity=0.371  Sum_probs=175.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--C----cEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--G----VEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      .+|+..+.||+|+||.||+|.+.  |    ..||+|.+.... ......+.+|+.++++++||||+++++++..  ...+
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   84 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQ   84 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceE
Confidence            56788899999999999999875  3    369999987653 4456789999999999999999999999875  5788


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +||||+++|+|.+++...  ...+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..
T Consensus        85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            999999999999999653  335899999999999999999999   899999999999999999999999999999875


Q ss_pred             cCCce---eee------cccc---ccCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHHHH
Q 048535          266 HHGQV---MSG------RRPI---EEGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADEVV  316 (409)
Q Consensus       266 ~~~~~---~~g------~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~~~  316 (409)
                      .....   ..+      ..+.   ....++...|+|+++.  .+++++. .....                ....+....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~--~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGV--TVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICT  237 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHH--HHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCC
Confidence            43221   001      1111   1244566788998741  1222221 11110                011122234


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      ..+.+++.+||..||++|||+.++++.|+....
T Consensus       238 ~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         238 IDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            578899999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.98  E-value=1e-31  Score=265.43  Aligned_cols=144  Identities=21%  Similarity=0.316  Sum_probs=129.2

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .|+..+.||+|+||.||+|...  ++.||+|++...   .......+.+|+.++++++||||+++++.+.+ ....++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-CCEEEEEE
Confidence            5888999999999999999986  789999999754   23345678899999999999999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      |||++|+|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        81 E~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          81 DYIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            99999999999954   246889999999999999999999   89999999999999999999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.98  E-value=1.4e-31  Score=257.87  Aligned_cols=215  Identities=21%  Similarity=0.276  Sum_probs=165.2

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||+|...  ++.||+|.++..   .......+..|.+++..+ +||||+++++++.. .+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-KDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            46999999999999987  789999999754   233456678899999888 79999999999887 678999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---  269 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---  269 (409)
                      +|+|..++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++......   
T Consensus        80 ~~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  153 (318)
T cd05570          80 GGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT  153 (318)
T ss_pred             CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence            9999998853   346999999999999999999999   8999999999999999999999999999987532111   


Q ss_pred             -eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHh---------------hhcCCCCHHHHHHHHHHHHHcc
Q 048535          270 -VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERL---------------KAKGGYADEVVEKVLHLGLLCA  327 (409)
Q Consensus       270 -~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l---------------~~~~~~~~~~~~~l~~l~~~Cl  327 (409)
                       ...|...+      ....++..+|+|+++  ..+++++....               .....++......+.+++.+||
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG--vil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l  231 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALG--VLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFL  231 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHH--HHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHc
Confidence             11222221      124556778999874  12222222111               1112233345567889999999


Q ss_pred             CcCCCCCCCH-----HHHHH
Q 048535          328 HPEANSRPTI-----RQVLK  342 (409)
Q Consensus       328 ~~dP~~RPt~-----~evl~  342 (409)
                      +.||++|||+     .++++
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhc
Confidence            9999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.98  E-value=5.7e-34  Score=250.17  Aligned_cols=246  Identities=20%  Similarity=0.234  Sum_probs=184.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++.|++.+.||+|.|+.||++...  |+.+|+|.++..  +..+.+++.+|+.+.+.|+|||||++.+.+.+ .+..|+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~-~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc-cceeEEE
Confidence            466788899999999999999876  899999998654  44467889999999999999999999998876 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC---CcEEEecccCccc
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK---MNARLGDFGLAKM  264 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kl~DFGla~~  264 (409)
                      +|+|.||+|..-|-.   ....++..+-.++.||+++|.|+|   .++|||||+||+|+||.+.   --+||+|||+|..
T Consensus        89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence            999999999765532   256788899999999999999999   8999999999999999543   3489999999999


Q ss_pred             ccCCceeeeccccc---------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCH-HHHHHHHHHHHHccCcCCCCC
Q 048535          265 HHHGQVMSGRRPIE---------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYAD-EVVEKVLHLGLLCAHPEANSR  334 (409)
Q Consensus       265 ~~~~~~~~g~~p~~---------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~-~~~~~l~~l~~~Cl~~dP~~R  334 (409)
                      ...+....|+....         .+.|+...|+|+.+.  .++-++-..+    ++.. ....-...++..-.+.++.+=
T Consensus       163 l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGV--iLfiLL~G~~----PF~~~~~~rlye~I~~g~yd~~~~~w  236 (355)
T KOG0033|consen  163 VNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV--ILYILLVGYP----PFWDEDQHRLYEQIKAGAYDYPSPEW  236 (355)
T ss_pred             eCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhH--HHHHHHhCCC----CCCCccHHHHHHHHhccccCCCCccc
Confidence            98777777665432         367888889998752  1222222222    2222 222222223322333333222


Q ss_pred             CCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          335 PTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       335 Pt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      |++.+                  ...++..+|+.-+|.+|+|..++++|||..+
T Consensus       237 ~~is~------------------~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  237 DTVTP------------------EAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             CcCCH------------------HHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            22211                  2368899999999999999999999999765

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.98  E-value=5.6e-31  Score=244.96  Aligned_cols=225  Identities=22%  Similarity=0.345  Sum_probs=170.1

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|+..+.||+|++|.||++...  ++.||+|.+...  .....+.+.+|++++++++|+|++++++.+.......+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5788999999999999999886  788999999654  334556789999999999999999999987654557899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++++|.+++... ....+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||+++......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999999653 2346899999999999999999999   8999999999999999999999999999997654321


Q ss_pred             ----eeeecccc------ccCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhh-cCCCCHHHHHHHHHHHHH
Q 048535          270 ----VMSGRRPI------EEGKRNLVDRMWSLTE-------------RSELLSVLDERLKA-KGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       270 ----~~~g~~p~------~~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~-~~~~~~~~~~~l~~l~~~  325 (409)
                          ...+...+      ....++...|+|+++.             .............. ....+......+.+++.+
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd08223         157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT  236 (257)
T ss_pred             CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence                11122111      1234456789998731             11111111111110 012334455678888888


Q ss_pred             ccCcCCCCCCCHHHHHH
Q 048535          326 CAHPEANSRPTIRQVLK  342 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~  342 (409)
                      ||+.||++|||+.++++
T Consensus       237 ~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         237 MLSKRPEKRPSVKSILR  253 (257)
T ss_pred             HhccCcccCCCHHHHhc
Confidence            89889999998888875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.98  E-value=3.7e-31  Score=248.36  Aligned_cols=220  Identities=21%  Similarity=0.357  Sum_probs=162.0

Q ss_pred             ceeecCCceEEEEEEEC----CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCC
Q 048535          119 NVIGLGGNGKVYKGQLL----GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMEN  193 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~  193 (409)
                      +.||+|+||.||+|...    +..+|+|.++... ......|.+|+.++++++||||+++++++.+ ....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-VTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCCcEEEEECCCC
Confidence            36899999999999865    4579999987653 3344578999999999999999999999886 6678999999999


Q ss_pred             CCHHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce-
Q 048535          194 GSLDKWIFECD--ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV-  270 (409)
Q Consensus       194 gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~-  270 (409)
                      |+|.+++....  .....++..+..++.|++.||.|||   +.+++||||||+||+++.++++||+|||+++....... 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            99999996532  2235677888899999999999999   89999999999999999999999999999975433221 


Q ss_pred             -----eeecc---cccc----------CCCcHHHHHHhhhccCcHHHHhh-HHhhh---------------------cCC
Q 048535          271 -----MSGRR---PIEE----------GKRNLVDRMWSLTERSELLSVLD-ERLKA---------------------KGG  310 (409)
Q Consensus       271 -----~~g~~---p~~~----------~~~~~~~~vws~~~~~~~~~~~~-~~l~~---------------------~~~  310 (409)
                           ..+..   +.+.          ..++...|+|+++  ..+++++. ...+.                     .+.
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG--~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLG--VTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR  234 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHH--HHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence                 01111   1110          1124567888873  11222221 11100                     001


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 048535          311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       311 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                      ........+.+++..|| .+|++|||++||++.|+
T Consensus       235 ~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         235 LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11123456788999999 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.98  E-value=1.9e-31  Score=254.26  Aligned_cols=221  Identities=21%  Similarity=0.334  Sum_probs=172.3

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ..+|+..+.||+|+||.||+|...  ++.||+|.+........+.+.+|+.+++.++|+||+++++.+.. ....++|||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-~~~~~lv~e   97 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVME   97 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-CCEEEEeec
Confidence            367888999999999999999875  88999999987655556788999999999999999999999887 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+++..    ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            9999999999843    35899999999999999999999   8999999999999999999999999999987643321


Q ss_pred             ----eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh------------------cCCCCHHHHHHHHH
Q 048535          270 ----VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKA------------------KGGYADEVVEKVLH  321 (409)
Q Consensus       270 ----~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~------------------~~~~~~~~~~~l~~  321 (409)
                          ...|...+      .....+...|+|+++  ..+++++......                  ....+......+.+
T Consensus       171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~G--vil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  248 (296)
T cd06654         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG--IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD  248 (296)
T ss_pred             cccCcccCCccccCHHHHcCCCCCccchHHHHH--HHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHH
Confidence                11222211      123345678999873  1122222211110                  01123344567888


Q ss_pred             HHHHccCcCCCCCCCHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ++.+||+.+|++|||+.++++
T Consensus       249 li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         249 FLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             HHHHHCcCCcccCcCHHHHhh
Confidence            999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.98  E-value=1.9e-31  Score=254.33  Aligned_cols=221  Identities=22%  Similarity=0.328  Sum_probs=172.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|+..+.||+|+||.||+|...  ++.||+|.+........+.+.+|+.+++.++|+||+++++++.. ....++|||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e   96 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVME   96 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEeec
Confidence            377899999999999999999975  89999999976655556778999999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++++|.+++.+    ..+++.++..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++.......
T Consensus        97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999999843    35899999999999999999999   8999999999999999999999999999987654322


Q ss_pred             ----eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhc------------------CCCCHHHHHHHHH
Q 048535          270 ----VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAK------------------GGYADEVVEKVLH  321 (409)
Q Consensus       270 ----~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~------------------~~~~~~~~~~l~~  321 (409)
                          ...+...+      .....+...|+|+++  ..+++++.......                  ...+......+.+
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--vil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (297)
T cd06656         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG--IMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD  247 (297)
T ss_pred             cCcCcccCCccccCHHHHcCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHH
Confidence                11122111      123456778999974  22222222211100                  0122334456778


Q ss_pred             HHHHccCcCCCCCCCHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ++.+||+.+|++||++.++++
T Consensus       248 li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         248 FLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             HHHHHccCChhhCcCHHHHhc
Confidence            888999999999999888877

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.98  E-value=2.3e-31  Score=256.18  Aligned_cols=211  Identities=20%  Similarity=0.283  Sum_probs=157.4

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||+|+..  ++.||+|.++...   ......+..|..++... +||||+++++++.+ .+..|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-KEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-CCEEEEEECCCC
Confidence            46999999999999987  8899999997541   23345677788888755 89999999999987 678999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC----
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG----  268 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~----  268 (409)
                      +|+|.+++..   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus        80 ~g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05620          80 GGDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA  153 (316)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence            9999999854   346899999999999999999999   899999999999999999999999999998753211    


Q ss_pred             ceeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh---------------cCCCCHHHHHHHHHHHHHcc
Q 048535          269 QVMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKA---------------KGGYADEVVEKVLHLGLLCA  327 (409)
Q Consensus       269 ~~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~---------------~~~~~~~~~~~l~~l~~~Cl  327 (409)
                      ....|...+      ....++...|+|+++  ..+++++......               ....+......+.+++.+||
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--vil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  231 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFG--VLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLF  231 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhH--HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHc
Confidence            112222222      124456678999874  2233333222211               11222233456777777888


Q ss_pred             CcCCCCCCCHH
Q 048535          328 HPEANSRPTIR  338 (409)
Q Consensus       328 ~~dP~~RPt~~  338 (409)
                      +.||++||++.
T Consensus       232 ~~dP~~R~~~~  242 (316)
T cd05620         232 ERDPTRRLGVV  242 (316)
T ss_pred             cCCHHHcCCCh
Confidence            88888888774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.98  E-value=2.6e-31  Score=251.01  Aligned_cols=217  Identities=23%  Similarity=0.401  Sum_probs=160.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|+..+.||+|+||.||+|...  ++.||+|.+... .....+++.+|+.++++++||||+++++++.. .+..++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-ENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-CCEEEEEEe
Confidence            36788899999999999999875  889999998755 34455679999999999999999999999987 678899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|..+.       .+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++.+||+|||++.......
T Consensus        80 ~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~  149 (279)
T cd06619          80 FMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI  149 (279)
T ss_pred             cCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence            99999997653       3788889999999999999999   8999999999999999999999999999997654321


Q ss_pred             --eeeeccc---cc---cCCCcHHHHHHhhhccCcHHHHhhHHhhhcC-----------------------C-CCHHHHH
Q 048535          270 --VMSGRRP---IE---EGKRNLVDRMWSLTERSELLSVLDERLKAKG-----------------------G-YADEVVE  317 (409)
Q Consensus       270 --~~~g~~p---~~---~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~-----------------------~-~~~~~~~  317 (409)
                        ...|...   .+   ...++...|+|+++  ..+++++....+...                       . .......
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG--~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLG--ISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSE  227 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHH--HHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCH
Confidence              1112111   11   23456678999874  223333322211100                       0 0111233


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+.+++.+||+.+|++||+++|+++
T Consensus       228 ~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         228 KFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             HHHHHHHHHhhCChhhCCCHHHHhc
Confidence            4566666667666777776666654

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.98  E-value=5.4e-31  Score=244.88  Aligned_cols=221  Identities=28%  Similarity=0.452  Sum_probs=173.4

Q ss_pred             ceeecCCceEEEEEEEC-----CcEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL-----GVEVALKRISLDSEH-GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||+|...     +..||+|.+...... ..+.+.+|++.+..++|+||+++++++.. ....+++|||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence            46999999999999886     678999999766333 36789999999999999999999999987 778999999999


Q ss_pred             CCCHHHHHhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          193 NGSLDKWIFECDE------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       193 ~gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      +|+|.+++.....      ...+++..+..++.|+++||+|||   +.+++|+||||+||+++.++.+||+|||.++...
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccccccc
Confidence            9999999965321      257999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCce------eee---cccc---ccCCCcHHHHHHhhhccCcHHHHhh----------------HHhh-hcCCCCHHHHH
Q 048535          267 HGQV------MSG---RRPI---EEGKRNLVDRMWSLTERSELLSVLD----------------ERLK-AKGGYADEVVE  317 (409)
Q Consensus       267 ~~~~------~~g---~~p~---~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~-~~~~~~~~~~~  317 (409)
                      ....      ..+   ..+.   ....++...|+|+++  ..+++++.                .... .....+...+.
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFG--VLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPD  234 (262)
T ss_pred             cccccccccCCCcCccccCHHHhccCCcchhhccHHHH--HHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCCh
Confidence            4320      000   1111   123556778999874  11222211                1110 01123344567


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                      .+.+++.+||+.+|.+|||+.|+++.|+
T Consensus       235 ~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         235 ELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            8999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.98  E-value=3.6e-31  Score=245.53  Aligned_cols=220  Identities=26%  Similarity=0.415  Sum_probs=171.9

Q ss_pred             ceeecCCceEEEEEEEC-CcEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCCH
Q 048535          119 NVIGLGGNGKVYKGQLL-GVEVALKRISLDSE-HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSL  196 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gsL  196 (409)
                      +.||+|+||.||++... ++.||+|.+..... .....+.+|++++++++|+||+++++++.+ ....++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-KQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCCeEEEEEcCCCCcH
Confidence            46899999999999987 89999999876533 356789999999999999999999999987 6788999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCceeee---
Q 048535          197 DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSG---  273 (409)
Q Consensus       197 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~g---  273 (409)
                      .+++...  ...+++..+..++.|++.||.|||   +++++||||||+|||++.++.+||+|||+++..........   
T Consensus        80 ~~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          80 LTFLRKK--KNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            9999643  235889999999999999999999   89999999999999999999999999999986542211100   


Q ss_pred             ------cccc---ccCCCcHHHHHHhhhccCcHHHHhh---------------HHhhh--cCCCCHHHHHHHHHHHHHcc
Q 048535          274 ------RRPI---EEGKRNLVDRMWSLTERSELLSVLD---------------ERLKA--KGGYADEVVEKVLHLGLLCA  327 (409)
Q Consensus       274 ------~~p~---~~~~~~~~~~vws~~~~~~~~~~~~---------------~~l~~--~~~~~~~~~~~l~~l~~~Cl  327 (409)
                            ..+.   ....++...|+|+++  ..+++++.               ..+..  ....+...+..+.+++.+||
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG--~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  232 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYG--ILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCW  232 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHH--HHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHh
Confidence                  1111   124456778999974  11122111               11110  01223345578999999999


Q ss_pred             CcCCCCCCCHHHHHHHHhc
Q 048535          328 HPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~  346 (409)
                      +.+|.+|||+.|+++.|+.
T Consensus       233 ~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         233 AYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             ccChhhCcCHHHHHHHhhC
Confidence            9999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.98  E-value=1.6e-31  Score=258.69  Aligned_cols=167  Identities=23%  Similarity=0.333  Sum_probs=136.3

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||++...  ++.||+|.++..   .....+.+..|+.++.++ +||||+++++++.. .+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-CCEEEEEEeCCC
Confidence            46999999999999987  789999999754   334456688899988877 89999999999887 678999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC----
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG----  268 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~----  268 (409)
                      +|+|..++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus        80 ~~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~  153 (329)
T cd05618          80 GGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT  153 (329)
T ss_pred             CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence            9999998853   346999999999999999999999   899999999999999999999999999999753211    


Q ss_pred             ceeeecccc------ccCCCcHHHHHHhhh
Q 048535          269 QVMSGRRPI------EEGKRNLVDRMWSLT  292 (409)
Q Consensus       269 ~~~~g~~p~------~~~~~~~~~~vws~~  292 (409)
                      ....|...+      ....++...|+|+++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  183 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALG  183 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceeccc
Confidence            112232222      123456678899885

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.98  E-value=2e-32  Score=240.92  Aligned_cols=231  Identities=25%  Similarity=0.262  Sum_probs=180.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEc----cCCeEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK----EKESLI  185 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----~~~~~~  185 (409)
                      .++|.+.+.||+|||+.||+++.-  ++.+|+|++.....++.+..++|++..++++||||+++++++..    .....|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            467899999999999999999864  88999999988877888999999999999999999999988754    234599


Q ss_pred             EEEEeCCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          186 LIYDYMENGSLDKWIFECDE-SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      |++.|...|+|.+.+..... +..+++.+.+.|+.+|++||.+||+. ..+++||||||.|||+.+++.++|.|||.++.
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            99999999999999876543 34799999999999999999999943 34599999999999999999999999999875


Q ss_pred             ccCCc----------------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhh--------------------
Q 048535          265 HHHGQ----------------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLD--------------------  302 (409)
Q Consensus       265 ~~~~~----------------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~--------------------  302 (409)
                      ..-.-                .....++.+      ....+...|+|+++  ..++.++-                    
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLG--CtLYa~mf~~sPfe~~~~~GgSlaLAv~  256 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLG--CTLYAMMFGESPFERIYQQGGSLALAVQ  256 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhh--HHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence            43210                000111111      12345678999985  33333222                    


Q ss_pred             -HHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          303 -ERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       303 -~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                       +.+..+  .....++.+.+++.+|++.||.+||++.+++..++..
T Consensus       257 n~q~s~P--~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  257 NAQISIP--NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ccccccC--CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence             112111  1122567899999999999999999999999988764

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=253.11  Aligned_cols=230  Identities=25%  Similarity=0.382  Sum_probs=170.0

Q ss_pred             hCCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhcc--CCCCceeeEeeEEEccCC---eEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGR--LKHRNLVGLRGWCKKEKE---SLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~~---~~~l  186 (409)
                      .+.....+.||+|.||+||+|.|+|+.||||++...++   +.+.+|.++.+.  |+|+||+.+++.-..+.+   ++||
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL  286 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL  286 (513)
T ss_pred             hheeEEEEEecCccccceeeccccCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence            35566779999999999999999999999999975543   567788888775  499999999986554332   5899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG-----WESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      |++|.++|||++||..    ..++....++++..+|.||++||.+     ..+.|.|||||+.|||+..++.+.|+|+||
T Consensus       287 vTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  287 VTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             eeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            9999999999999943    5799999999999999999999963     357799999999999999999999999999


Q ss_pred             cccccCCc--------eeeecccccc-------------------CCCcHHHHHHhhhccCc------------------
Q 048535          262 AKMHHHGQ--------VMSGRRPIEE-------------------GKRNLVDRMWSLTERSE------------------  296 (409)
Q Consensus       262 a~~~~~~~--------~~~g~~p~~~-------------------~~~~~~~~vws~~~~~~------------------  296 (409)
                      |-......        .-.|.+-+..                   +.|.+.--+|+...+..                  
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            97655432        1112211110                   22233333444422211                  


Q ss_pred             ---HHHHhh----HHhhhcCCC-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          297 ---LLSVLD----ERLKAKGGY-----ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       297 ---~~~~~~----~~l~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                         ..++.+    .+++  +..     ..+.+..+.+++..||..||..|-|+-.+-+.|.++.+.
T Consensus       443 DPs~eeMrkVVCv~~~R--P~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  443 DPSFEEMRKVVCVQKLR--PNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             CCCHHHHhcceeecccC--CCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence               111111    1111  111     235667889999999999999999999999988876653

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=5e-31  Score=245.45  Aligned_cols=219  Identities=23%  Similarity=0.348  Sum_probs=169.7

Q ss_pred             ceeecCCceEEEEEEEC---C--cEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL---G--VEVALKRISLDSE-HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~---~--~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|++|.||+|.+.   +  ..||+|.+..... ...+.|.+|+.++++++||||+++++++..  ...++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence            46899999999999875   2  3699999987655 567789999999999999999999999876  67899999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce--
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV--  270 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~--  270 (409)
                      +|+|.+++..... ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++.......  
T Consensus        79 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          79 LGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            9999999975432 46899999999999999999999   89999999999999999999999999999987644210  


Q ss_pred             -----ee---eccccc---cCCCcHHHHHHhhhccCcHHHHhh----------------HHhh--hcCCCCHHHHHHHHH
Q 048535          271 -----MS---GRRPIE---EGKRNLVDRMWSLTERSELLSVLD----------------ERLK--AKGGYADEVVEKVLH  321 (409)
Q Consensus       271 -----~~---g~~p~~---~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~--~~~~~~~~~~~~l~~  321 (409)
                           ..   +..+.+   ...++..+|+|+++  ..+++++.                ....  .....+...+..+.+
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG--~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFG--VTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYN  232 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHH
Confidence                 00   111111   13455668888874  11122211                1110  011122344568899


Q ss_pred             HHHHccCcCCCCCCCHHHHHHHHh
Q 048535          322 LGLLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                      ++.+||+.+|++|||+.++++.|.
T Consensus       233 li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         233 VMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHHHHCCCCcccCCCHHHHHHHhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.97  E-value=3.9e-31  Score=255.35  Aligned_cols=216  Identities=19%  Similarity=0.242  Sum_probs=157.7

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCC-CCceeeEeeEEEccCCeEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~lv  187 (409)
                      +|+..+.||+|+||.||+|...  ++.||+|+++..   .....+.+..|..++..+. |++|+++++++.+ .+..|+|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEE
Confidence            4677899999999999999986  889999999754   2234466888999998885 5678888888776 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++..   ...+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        80 ~Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          80 MEYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            999999999999853   346999999999999999999999   89999999999999999999999999999875432


Q ss_pred             Cc----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhh---------------cCCCCHHHHHHHHHH
Q 048535          268 GQ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKA---------------KGGYADEVVEKVLHL  322 (409)
Q Consensus       268 ~~----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~---------------~~~~~~~~~~~l~~l  322 (409)
                      ..    ...|...+.      ...++...|+|+++  ..+++++......               ...++......+.++
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--vil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  231 (323)
T cd05615         154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYG--VLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSI  231 (323)
T ss_pred             CCccccCccCCccccCHHHHcCCCCCCccchhhhH--HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence            11    122322221      23456678899885  2233333322211               112222334455566


Q ss_pred             HHHccCcCCCCCCCHH
Q 048535          323 GLLCAHPEANSRPTIR  338 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~  338 (409)
                      +.+||+.+|.+|++..
T Consensus       232 i~~~l~~~p~~R~~~~  247 (323)
T cd05615         232 CKGLMTKHPSKRLGCG  247 (323)
T ss_pred             HHHHcccCHhhCCCCC
Confidence            6666666666666553

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=2.3e-31  Score=249.76  Aligned_cols=227  Identities=20%  Similarity=0.297  Sum_probs=175.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|...+.||+|+||.||+|.+.     ...||+|...... ....+.+.+|+.++++++||||+++++++.+  +..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~l   83 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWI   83 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEE
Confidence            45788899999999999999875     2469999987654 4566789999999999999999999998875  45789


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++...  ...+++..+..++.|++.||+|||   +.+++|+||||+|||++.++.+||+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence            99999999999999642  235899999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCceeee--------ccccc---cCCCcHHHHHHhhhccCcHHHHh----------------hHHhh-hcCCCCHHHHHH
Q 048535          267 HGQVMSG--------RRPIE---EGKRNLVDRMWSLTERSELLSVL----------------DERLK-AKGGYADEVVEK  318 (409)
Q Consensus       267 ~~~~~~g--------~~p~~---~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~-~~~~~~~~~~~~  318 (409)
                      .......        ..+.+   ...++...|+|+++.  .+++++                ..... .....+...+..
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~--il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV--CMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT  236 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHH--HHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHH
Confidence            4321111        11111   233456788998731  111111                11000 001223445668


Q ss_pred             HHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          319 VLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       319 l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      +.+++.+||..+|++|||+.++++.|++..
T Consensus       237 ~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         237 LYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=3.9e-31  Score=265.71  Aligned_cols=260  Identities=18%  Similarity=0.135  Sum_probs=178.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      .+|.+.+.||+|+||.||+|...  ++.||||....      ..+.+|+++|++++|+|||++++++.. .+..++|||+
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~-~~~~~lv~e~  241 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVV-GGLTCLVLPK  241 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEEEc
Confidence            36888999999999999999987  78899996432      345689999999999999999999887 6788999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc-
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ-  269 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-  269 (409)
                      +. |+|.+++...  ...+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            95 6999988542  236999999999999999999999   8999999999999999999999999999998654321 


Q ss_pred             -----eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhc----CCCCHHHHHHHHHHHHHccCcCC--C
Q 048535          270 -----VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAK----GGYADEVVEKVLHLGLLCAHPEA--N  332 (409)
Q Consensus       270 -----~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~----~~~~~~~~~~l~~l~~~Cl~~dP--~  332 (409)
                           ...|...+      ....++..+|+|+++  ..+++++.......    ..........+.+++..+-...+  .
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlG--viL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAG--LVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHH--HHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence                 12233222      124467789999996  34455433211000    00001111223333333211111  0


Q ss_pred             CCCCHHHHHHHHhc----CcCC--CCC------CCCCcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          333 SRPTIRQVLKMLEG----QTEG--TGL------EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       333 ~RPt~~evl~~L~~----~~~~--~~~------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      ..+.. .+...+..    ....  ...      .......+++.+|++.||.+|.++++++.||||+.
T Consensus       394 ~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        394 QHAGS-RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             CCcch-HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            11111 11111110    0000  000      01113468999999999999999999999999964

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=6.2e-31  Score=244.68  Aligned_cols=225  Identities=23%  Similarity=0.328  Sum_probs=172.9

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|+..+.||.|+||.||.+...  ++.+++|.+...  +....+++.+|++++++++|+||+++++++.+ .+..+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeEEEEEE
Confidence            4788899999999999988876  889999998654  34556789999999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+++.... ...+++.++..++.|+++||.|||   +.+++|+||||+||++++++.+||+|||+++......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            999999999996532 346899999999999999999999   8899999999999999999999999999998654332


Q ss_pred             ----eeeecccc------ccCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhh-cCCCCHHHHHHHHHHHHH
Q 048535          270 ----VMSGRRPI------EEGKRNLVDRMWSLTE-------------RSELLSVLDERLKA-KGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       270 ----~~~g~~p~------~~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~-~~~~~~~~~~~l~~l~~~  325 (409)
                          ...|...+      .....+..+|+|+++.             .....+........ ....+......+.+++.+
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS  235 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence                11121111      1123455678888731             11111222111110 011223345678999999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 048535          326 CAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~~  343 (409)
                      ||+.+|.+||++.++++.
T Consensus       236 ~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         236 LLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HcccCcccCCCHHHHhhC
Confidence            999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.9e-31  Score=259.77  Aligned_cols=263  Identities=16%  Similarity=0.205  Sum_probs=183.3

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ...+|++.+.||+|+||.||+|...  +..||+|.....      ....|+.++++++||||+++++++.. ....++||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~  136 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS-GAITCMVL  136 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe-CCeeEEEE
Confidence            4468999999999999999999987  678999986433      23469999999999999999999987 67889999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+. |+|.+++..  ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9995 599998864  2346899999999999999999999   899999999999999999999999999999754322


Q ss_pred             c---eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCC--CC-----HHHHHHHHHHHHHccCcCCC
Q 048535          269 Q---VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGG--YA-----DEVVEKVLHLGLLCAHPEAN  332 (409)
Q Consensus       269 ~---~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~--~~-----~~~~~~l~~l~~~Cl~~dP~  332 (409)
                      .   ...|...+      ....++...|+|+++  ..+++++.........  ..     ......+.+++ .++...|.
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG--vvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~  287 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAG--IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII-STLKVHPE  287 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHH--HHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHH-HHhccChh
Confidence            1   11222211      124567789999986  3445554311110000  00     11122333333 33444554


Q ss_pred             CCC--CHHHHHHH-Hhc--CcCCCC--------CCCCCcchhHHhhhcccCCCCcccccccCCCCCcccc
Q 048535          333 SRP--TIRQVLKM-LEG--QTEGTG--------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEI  389 (409)
Q Consensus       333 ~RP--t~~evl~~-L~~--~~~~~~--------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~  389 (409)
                      ..|  .-..+... +..  ....+.        ..-+....+++.+|++.+|.+|+++.++++||||+.+
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~  357 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL  357 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence            444  11222221 111  000000        0111223578999999999999999999999999864

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=2.1e-31  Score=251.13  Aligned_cols=220  Identities=25%  Similarity=0.375  Sum_probs=171.3

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      .|+..+.||+|+||.||+|.+.  +..||+|.+... .....+.+.+|+.++++++||||+++++++.. ++..++||||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-GTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-CCceEEEEEc
Confidence            3556688999999999999886  788999998754 34455679999999999999999999999887 6789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV  270 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  270 (409)
                      +++++|.+++..    ..+++..+..++.|+++||.|||   +++++|+||+|+||++++++.+||+|||+++.......
T Consensus        84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          84 LGGGSALDLLKP----GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             cCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            999999999842    46899999999999999999999   89999999999999999999999999999976543221


Q ss_pred             ----eeecc---cc---ccCCCcHHHHHHhhhccCcHHHHhhHHhhh----------------cCCCCHHHHHHHHHHHH
Q 048535          271 ----MSGRR---PI---EEGKRNLVDRMWSLTERSELLSVLDERLKA----------------KGGYADEVVEKVLHLGL  324 (409)
Q Consensus       271 ----~~g~~---p~---~~~~~~~~~~vws~~~~~~~~~~~~~~l~~----------------~~~~~~~~~~~l~~l~~  324 (409)
                          ..|..   +.   ....++...|+|+++  ..+++++......                ...........+.+++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG--~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLG--ITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVE  234 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHH--HHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHH
Confidence                11111   11   123456778999974  2222222221110                01122234567899999


Q ss_pred             HccCcCCCCCCCHHHHHHH
Q 048535          325 LCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       325 ~Cl~~dP~~RPt~~evl~~  343 (409)
                      +||+.+|++|||+.++++.
T Consensus       235 ~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         235 ACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             HHccCCcccCcCHHHHHHh
Confidence            9999999999999999974

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=2.3e-31  Score=260.73  Aligned_cols=146  Identities=27%  Similarity=0.302  Sum_probs=130.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||++...  ++.||+|+++..   .......+.+|+.++..++||||+++++.+.+ .+..++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-KRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence            46888999999999999999986  889999999643   23345678899999999999999999999887 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      |||+++|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        80 ~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~  151 (360)
T cd05627          80 MEFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL  151 (360)
T ss_pred             EeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence            999999999999953   346899999999999999999999   899999999999999999999999999998754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-32  Score=270.13  Aligned_cols=221  Identities=24%  Similarity=0.360  Sum_probs=177.5

Q ss_pred             CCccceeecCCceEEEEEEEC---C--cEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLL---G--VEVALKRISLDSEH-GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~---~--~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ....++||+|.||.|++|.|.   |  ..||||.++.+... ...+|++|+.+|.+|+|||+++|||...+  ..+.+||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mMV~  189 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMMVF  189 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhHHh
Confidence            344578999999999999997   4  45899999877443 67899999999999999999999999985  5678999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      |+++.|||.+.|++ ..+..|.......++.|||.||.||.   .+++|||||.++|+||-....+|||||||.|-+...
T Consensus       190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            99999999999987 45567888899999999999999999   899999999999999999999999999999987655


Q ss_pred             c---eeeecccc----------ccCCCcHHHHHHhhh-------ccC----------cHHHHhhHHhhhcCCCCHHHHHH
Q 048535          269 Q---VMSGRRPI----------EEGKRNLVDRMWSLT-------ERS----------ELLSVLDERLKAKGGYADEVVEK  318 (409)
Q Consensus       269 ~---~~~g~~p~----------~~~~~~~~~~vws~~-------~~~----------~~~~~~~~~l~~~~~~~~~~~~~  318 (409)
                      +   ++++.++.          ....++-++|+|.++       .-+          .+++.+|.+-+  -+-+..+++.
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er--LpRPk~csed  343 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER--LPRPKYCSED  343 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc--CCCCCCChHH
Confidence            4   33333222          124556666766652       111          23344443222  3446678889


Q ss_pred             HHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          319 VLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       319 l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      +++++..||..+|.+|||+..+.+.
T Consensus       344 IY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  344 IYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             HHHHHHHhccCCccccccHHHHHHh
Confidence            9999999999999999999999743

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=6.6e-31  Score=248.37  Aligned_cols=181  Identities=23%  Similarity=0.342  Sum_probs=144.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++|+..+.||+|+||.||+|...  ++.||+|++....  ....+.+.+|+.++++++||||+++++++.. ....++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-KRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-CCEEEEEE
Confidence            46888899999999999999986  8899999986442  2234568899999999999999999999987 67899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++++|..++..   ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        80 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          80 EYCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             eccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            99999988887742   345899999999999999999999   899999999999999999999999999999875443


Q ss_pred             c----eeeecccc---c----cCCCcHHHHHHhhhccCcHHHHhh
Q 048535          269 Q----VMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLD  302 (409)
Q Consensus       269 ~----~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~  302 (409)
                      .    ...+...+   +    ...++...|+|+++  ..+++++.
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG--~i~~~l~~  196 (286)
T cd07847         154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIG--CVFAELLT  196 (286)
T ss_pred             cccccCcccccccCCHHHHhCCCCcCchhhhHHHH--HHHHHHHh
Confidence            2    11111111   1    12346678999985  23444443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=7.1e-31  Score=245.21  Aligned_cols=226  Identities=23%  Similarity=0.422  Sum_probs=174.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      .++|+..+.||+|+||.||++... +..+|+|.+... ....+.|.+|+.++++++|+||+++++.+..  ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEe
Confidence            467889999999999999999876 677999988754 3345679999999999999999999998875  568999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV  270 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  270 (409)
                      +++|+|.+++... ....+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            9999999999653 2346889999999999999999999   88999999999999999999999999999976543221


Q ss_pred             e--ee------cccc---ccCCCcHHHHHHhhhccCcHHHHhh-HHhh--------------h--cCCCCHHHHHHHHHH
Q 048535          271 M--SG------RRPI---EEGKRNLVDRMWSLTERSELLSVLD-ERLK--------------A--KGGYADEVVEKVLHL  322 (409)
Q Consensus       271 ~--~g------~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~~l~--------------~--~~~~~~~~~~~l~~l  322 (409)
                      .  .+      ..+.   ....++...|+|+++.  .+++++. ....              .  ..+.+......+.++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~--~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI--LLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI  235 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHH--HHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHH
Confidence            1  01      1111   1234456778998741  1222221 1110              0  011223345678999


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHhc
Q 048535          323 GLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      +.+||+.+|++||++.++.+.|+.
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         236 MMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHHcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=8.6e-31  Score=247.08  Aligned_cols=221  Identities=26%  Similarity=0.365  Sum_probs=173.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ..|+..+.||+|+||.||+|.+.  +..||+|.+... .......+.+|+.++++++||||+++++++.+ ....++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEe
Confidence            35677889999999999999986  789999998754 34556789999999999999999999999987 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+++..    ..+++.++..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          83 YLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             cCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            9999999999843    35899999999999999999999   8999999999999999999999999999997654322


Q ss_pred             e----eeec---ccc---ccCCCcHHHHHHhhhccCcHHHHhhHHhhh----------------cCCCCHHHHHHHHHHH
Q 048535          270 V----MSGR---RPI---EEGKRNLVDRMWSLTERSELLSVLDERLKA----------------KGGYADEVVEKVLHLG  323 (409)
Q Consensus       270 ~----~~g~---~p~---~~~~~~~~~~vws~~~~~~~~~~~~~~l~~----------------~~~~~~~~~~~l~~l~  323 (409)
                      .    ..+.   .+.   .....+...|+|+++  ..+++++......                ...........+.+++
T Consensus       156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG--~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (277)
T cd06640         156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLG--ITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFI  233 (277)
T ss_pred             cccccccCcccccCHhHhccCCCccHHHHHHHH--HHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHH
Confidence            1    1111   111   123456788999974  1222222211110                1223345667889999


Q ss_pred             HHccCcCCCCCCCHHHHHHH
Q 048535          324 LLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~~  343 (409)
                      .+||+.+|++||++.++++.
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         234 DACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             HHHcccCcccCcCHHHHHhC
Confidence            99999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=6.5e-31  Score=246.80  Aligned_cols=220  Identities=20%  Similarity=0.326  Sum_probs=160.2

Q ss_pred             ceeecCCceEEEEEEEC----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCC
Q 048535          119 NVIGLGGNGKVYKGQLL----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMEN  193 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~  193 (409)
                      ++||+|+||.||+|...    ...+++|.+... .....+.|.+|+.+++.++||||+++++.|.+ ....++||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~   79 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-AIPYLLVFEYCEL   79 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-CCccEEEEecCCC
Confidence            36999999999999764    235677877654 33456789999999999999999999999987 6778999999999


Q ss_pred             CCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---
Q 048535          194 GSLDKWIFECDE-SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---  269 (409)
Q Consensus       194 gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---  269 (409)
                      |+|.+++..... ....++..+..++.||+.||+|||   +.+++||||||+|||++.++.+||+|||++.......   
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            999999975322 234677788899999999999999   8999999999999999999999999999986422111   


Q ss_pred             ---eeeeccc---cc----------cCCCcHHHHHHhhhccCcHHHH----------------hhHHhhh------cCCC
Q 048535          270 ---VMSGRRP---IE----------EGKRNLVDRMWSLTERSELLSV----------------LDERLKA------KGGY  311 (409)
Q Consensus       270 ---~~~g~~p---~~----------~~~~~~~~~vws~~~~~~~~~~----------------~~~~l~~------~~~~  311 (409)
                         ...+...   .+          ...++...|+|+++.  .++++                +...+..      .+..
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~--~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGV--TLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL  234 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHH--HHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence               1111111   11          012345678888731  11111                1111110      0111


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 048535          312 ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       312 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                      .......+.+++..|| .+|++||+++++++.|.
T Consensus       235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2224556788999999 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=5.2e-31  Score=245.18  Aligned_cols=224  Identities=25%  Similarity=0.393  Sum_probs=172.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      .+|+..+.||+|+||.||+|.+. +..+|+|.+..... ....|.+|++++++++|||++++++++.. ....++||||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTE-RSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEcc-CCceEEEEEcC
Confidence            46778899999999999999887 88899999875422 23578899999999999999999999876 66789999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM  271 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  271 (409)
                      ++|+|.+++...  ...+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||+++........
T Consensus        82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          82 EHGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            999999998642  245899999999999999999999   889999999999999999999999999998765332211


Q ss_pred             e--------eccccc---cCCCcHHHHHHhhhccCcHHHHh----------------hHHhhh-cCCCCHHHHHHHHHHH
Q 048535          272 S--------GRRPIE---EGKRNLVDRMWSLTERSELLSVL----------------DERLKA-KGGYADEVVEKVLHLG  323 (409)
Q Consensus       272 ~--------g~~p~~---~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~~-~~~~~~~~~~~l~~l~  323 (409)
                      +        +..+.+   ...++..+|+|+++.  .+++++                ...... ....+......+.+++
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~--~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGV--LMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELM  234 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHH--HHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence            0        111111   244566789998741  112211                111000 0011222356789999


Q ss_pred             HHccCcCCCCCCCHHHHHHHHh
Q 048535          324 LLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                      .+||+.+|++|||+.++++.|.
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         235 QHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             HHHcccChhhCCCHHHHHHhhC
Confidence            9999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.97  E-value=4.4e-31  Score=255.45  Aligned_cols=167  Identities=23%  Similarity=0.335  Sum_probs=137.4

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||+|...  ++.||+|+++..   .....+.+.+|+.++.++ +||||+++++++.. .+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-TSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-CCEEEEEEeCCC
Confidence            46999999999999987  789999999754   233456788999999888 69999999998876 678999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC-Cc--
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH-GQ--  269 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~-~~--  269 (409)
                      +|+|.+++..   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.... ..  
T Consensus        80 ~~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  153 (327)
T cd05617          80 GGDLMFHMQR---QRKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT  153 (327)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence            9999998853   346999999999999999999999   89999999999999999999999999999975321 11  


Q ss_pred             -eeeecccc------ccCCCcHHHHHHhhh
Q 048535          270 -VMSGRRPI------EEGKRNLVDRMWSLT  292 (409)
Q Consensus       270 -~~~g~~p~------~~~~~~~~~~vws~~  292 (409)
                       ...|...+      ....++..+|+|+++
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  183 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALG  183 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhH
Confidence             12233222      124566788999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=6.2e-31  Score=247.03  Aligned_cols=228  Identities=25%  Similarity=0.470  Sum_probs=171.2

Q ss_pred             CCccceeecCCceEEEEEEEC-----CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC-----
Q 048535          115 FSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE-----  182 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  182 (409)
                      |.+.+.||+|+||.||+|.+.     +..||||++...  .....+++.+|+.++++++||||+++++++.....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999864     578999998754  34556789999999999999999999998864221     


Q ss_pred             eEEEEEEeCCCCCHHHHHhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 048535          183 SLILIYDYMENGSLDKWIFEC---DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDF  259 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF  259 (409)
                      ..++++||+++|+|.+++...   .....+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            247899999999999887532   12235889999999999999999999   889999999999999999999999999


Q ss_pred             cCcccccCCcee-e---eccc-----c---ccCCCcHHHHHHhhhccCcHHHHhh----------------HHhhh-cCC
Q 048535          260 GLAKMHHHGQVM-S---GRRP-----I---EEGKRNLVDRMWSLTERSELLSVLD----------------ERLKA-KGG  310 (409)
Q Consensus       260 Gla~~~~~~~~~-~---g~~p-----~---~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~~-~~~  310 (409)
                      |+++........ .   ...+     .   .....+..+|+|+++  ..+++++.                ..... ...
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG--~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFG--VTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLK  235 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHH--HHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence            999865432211 0   0001     1   123346678999974  12222221                00000 011


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       311 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      .+......+.+++.+||+.+|++|||+.++++.|+++
T Consensus       236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1223456889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.4e-31  Score=250.99  Aligned_cols=223  Identities=26%  Similarity=0.384  Sum_probs=168.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|++.+.||.|+||.||+|...  +..||+|.+........+.|.+|++++++++||||+++++++.. +...++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEEee
Confidence            467888999999999999999986  88999999987766677889999999999999999999999987 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (280)
T cd06611          83 FCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL  157 (280)
T ss_pred             ccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence            99999999998643  246999999999999999999999   8999999999999999999999999999986543221


Q ss_pred             ----eeeecccc-----------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhc------------------CCCCHHHH
Q 048535          270 ----VMSGRRPI-----------EEGKRNLVDRMWSLTERSELLSVLDERLKAK------------------GGYADEVV  316 (409)
Q Consensus       270 ----~~~g~~p~-----------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~------------------~~~~~~~~  316 (409)
                          ...|...+           ....++..+|+|+++  ..+++++.......                  ...+....
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (280)
T cd06611         158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLG--ITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWS  235 (280)
T ss_pred             cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHH--HHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCC
Confidence                11111111           112245568899874  12222222211100                  01122234


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+.+++..||+.+|.+||++.++++
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         236 SSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhc
Confidence            45666777777777777777776654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=9.4e-31  Score=248.69  Aligned_cols=222  Identities=23%  Similarity=0.324  Sum_probs=168.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      +.|++.+.||+|+||.||+|...  +..||+|.+........+.+.+|+.++++++||||+++++.+.. ++..++||||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   90 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-DGKLWIMIEF   90 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-CCeEEEEEec
Confidence            56888999999999999999986  78999999987777777889999999999999999999999887 6789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc-
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ-  269 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-  269 (409)
                      +++++|..++...  ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++....... 
T Consensus        91 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          91 CPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence            9999999887542  245899999999999999999999   8999999999999999999999999999987532211 


Q ss_pred             ---eeeecccc-----------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh---------------c---CCCCHHHHH
Q 048535          270 ---VMSGRRPI-----------EEGKRNLVDRMWSLTERSELLSVLDERLKA---------------K---GGYADEVVE  317 (409)
Q Consensus       270 ---~~~g~~p~-----------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~---------------~---~~~~~~~~~  317 (409)
                         ...+...+           ....++..+|+|+++  ..+++++......               .   ...+.....
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG--~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG--ITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSM  243 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHH--HHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCH
Confidence               11111111           112245678999874  1222222211110               0   011223345


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+.+++.+||+.||++||++.++++
T Consensus       244 ~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         244 EFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhc
Confidence            6777788888888888888877754

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.6e-31  Score=263.40  Aligned_cols=263  Identities=18%  Similarity=0.190  Sum_probs=191.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC----CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL----GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ..+|.+.+.||+|+||.||++...    +..||+|.+...     +.+.+|+++|++++||||+++++++.. ....+++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW-KSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee-CCEEEEE
Confidence            457999999999999999999764    577999998643     234689999999999999999999886 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+. ++|.+++.   ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       165 ~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        165 MPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             ehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99996 58999883   3456999999999999999999999   89999999999999999999999999999976543


Q ss_pred             Cc------eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCC
Q 048535          268 GQ------VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRP  335 (409)
Q Consensus       268 ~~------~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  335 (409)
                      ..      ...|...+      ....++...|+|+++  ..+++++.......+.........+.. +..|++..|...|
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG--vil~el~~g~~pf~~~~~~~~~~~l~~-i~~~~~~~~~~~~  314 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAG--LVLFEMSVKNVTLFGKQVKSSSSQLRS-IIRCMQVHPLEFP  314 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHH--HHHHHHHHCCCCCCCCCCCCcHHHHHH-HHHHhccCccccC
Confidence            21      11222221      124566789999997  456666655544322222223333333 4456677676655


Q ss_pred             C--HHHHHHHHhcCc---CCC-CCC-------CCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          336 T--IRQVLKMLEGQT---EGT-GLE-------DEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       336 t--~~evl~~L~~~~---~~~-~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      .  ...+.+.+....   ..+ ..+       .+....+++.+|+..+|.+|.+..+++.||||...+
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence            3  222333332221   111 111       011235789999999999999999999999998654

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=6.7e-31  Score=244.97  Aligned_cols=223  Identities=25%  Similarity=0.337  Sum_probs=174.3

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|+..+.||+|+||.||+|...  ++.+|+|.+........+.+.+|+.++++++||||+++++++.. ....+++||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l~~e   80 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-RDKLWIVME   80 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-CCEEEEEEe
Confidence            467888999999999999999986  78899999987655567889999999999999999999999887 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++++|.+++...  ...+++.++..++.|++.||.|||   +.+|+|+||||+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          81 YCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            99999999998642  246899999999999999999999   8999999999999999999999999999987654321


Q ss_pred             ----eeeeccc---cc---cC---CCcHHHHHHhhhccCcHHHHhhHHhh---------------h-----cCCCCHHHH
Q 048535          270 ----VMSGRRP---IE---EG---KRNLVDRMWSLTERSELLSVLDERLK---------------A-----KGGYADEVV  316 (409)
Q Consensus       270 ----~~~g~~p---~~---~~---~~~~~~~vws~~~~~~~~~~~~~~l~---------------~-----~~~~~~~~~  316 (409)
                          ...+...   .+   ..   ..+..+|+|+++.  .+++++.....               .     .........
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~--~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGI--TAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWS  233 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHH--HHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhh
Confidence                1111111   11   12   4566789998731  11221111100               0     001123445


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+.+++.+||+.+|.+|||+.+++.
T Consensus       234 ~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         234 PVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            67899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.3e-31  Score=257.81  Aligned_cols=268  Identities=19%  Similarity=0.280  Sum_probs=182.2

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-----
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-----  180 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----  180 (409)
                      ...++|+..+.||+|+||.||+|...  ++.||||.+...  .....+.+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578999999999999999999876  789999999754  223446688999999999999999999987532     


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEeccc
Q 048535          181 KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG  260 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG  260 (409)
                      ....++++|++ +++|.+++.    ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCc
Confidence            13578999988 779998873    245999999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCc-eeeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCC
Q 048535          261 LAKMHHHGQ-VMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEAN  332 (409)
Q Consensus       261 la~~~~~~~-~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~  332 (409)
                      +++...... ...|...+   +    ...++...|+|+++  ..+++++............+....+...   .-...+.
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG--~il~el~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~  238 (343)
T cd07878         164 LARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG--CIMAELLKGKALFPGNDYIDQLKRIMEV---VGTPSPE  238 (343)
T ss_pred             cceecCCCcCCccccccccCchHhcCCccCCchhhhHhHH--HHHHHHHHCCCCCCCCCHHHHHHHHHHH---hCCCCHH
Confidence            998754422 11122211   1    13456789999996  3455555443322111111111111111   1111100


Q ss_pred             --CCCCHHHHHHHHhcCcCCCCC-------CCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          333 --SRPTIRQVLKMLEGQTEGTGL-------EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       333 --~RPt~~evl~~L~~~~~~~~~-------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                        .+.+.....+.++.....+..       .......+++.+|+..+|.+|++..+++.||||....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence              000001111111111111100       0011236899999999999999999999999998754

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=6.6e-31  Score=246.03  Aligned_cols=220  Identities=24%  Similarity=0.374  Sum_probs=167.8

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh---------HHHHHHHHHHHHhccCCCCceeeEeeEEEccCC
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE---------HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  182 (409)
                      +|.....||+|+||.||+|...  ++.||+|.+.....         ...+.+.+|+.++++++||||+++++++.+ ..
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD-AD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CC
Confidence            3667889999999999999875  78999998864321         123568899999999999999999999887 67


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..+++|||+++++|.+++..   ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCC
Confidence            88999999999999999953   346899999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCc----------eeeecccc---c---cCCCcHHHHHHhhhccCcHHHHhhH----------------HhhhcCC
Q 048535          263 KMHHHGQ----------VMSGRRPI---E---EGKRNLVDRMWSLTERSELLSVLDE----------------RLKAKGG  310 (409)
Q Consensus       263 ~~~~~~~----------~~~g~~p~---~---~~~~~~~~~vws~~~~~~~~~~~~~----------------~l~~~~~  310 (409)
                      +......          ...|...+   +   ...++..+|+|+++  ..+++++..                .......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  231 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLG--CLVVEMLTGKHPFPDCTQLQAIFKIGENASPE  231 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHH--HHHHHHhhCCCCCCCccHHHHHHHHhccCCCc
Confidence            8665211          01111111   1   13345567888873  111111111                0111123


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       311 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+......+.+++.+||+.||.+||++.|+++
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         232 IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            34455677889999999999999999988875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=6.1e-31  Score=250.52  Aligned_cols=221  Identities=27%  Similarity=0.325  Sum_probs=169.1

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh-----HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE-----HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      +|+..+.||+|+||.||+|...  ++.||||.++....     .....+..|++++++++|+||+++++++.+ .+..++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEE
Confidence            4777889999999999999986  88999999975532     234567789999999999999999999987 778999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+ +|+|.+++....  ..+++..+..++.||++||.|||   +.+|+|+||||+|||++.++.+||+|||+++...
T Consensus        80 v~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             EEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            99999 899999995422  36999999999999999999999   8999999999999999999999999999998764


Q ss_pred             CCce-ee---e---ccccc----cCCCcHHHHHHhhhccCcHHHHhhHH---------------hhhc------------
Q 048535          267 HGQV-MS---G---RRPIE----EGKRNLVDRMWSLTERSELLSVLDER---------------LKAK------------  308 (409)
Q Consensus       267 ~~~~-~~---g---~~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~---------------l~~~------------  308 (409)
                      .... ..   +   ..+.+    ...++...|+|+++.  .+++++...               ....            
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~--il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         154 SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGC--IFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             CCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHH--HHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence            4310 00   0   11111    123467789998741  122221110               0000            


Q ss_pred             -----------CCC-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          309 -----------GGY-----ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       309 -----------~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                                 ...     .......+.+++.+||+.||++|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                       000     01224578899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=7.8e-31  Score=247.91  Aligned_cols=220  Identities=25%  Similarity=0.355  Sum_probs=166.7

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      |++.+.||+|+||.||+|...  +..+|+|.+........+.+.+|+++++.++||||+++++++.. .+..++||||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-CCEEEEEEEecC
Confidence            566788999999999999987  78899999977666677889999999999999999999999987 678999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---  269 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---  269 (409)
                      +|+|..++..  ....+++..+..++.|+++||.|||   +.+++||||||+|||++.++.+||+|||++.......   
T Consensus        86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~  160 (282)
T cd06643          86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  160 (282)
T ss_pred             CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence            9999998854  2346899999999999999999999   8999999999999999999999999999987543211   


Q ss_pred             -eeeecccc-----------ccCCCcHHHHHHhhhccCcHHHHhh---------------HHhhh---cCCCCHHHHHHH
Q 048535          270 -VMSGRRPI-----------EEGKRNLVDRMWSLTERSELLSVLD---------------ERLKA---KGGYADEVVEKV  319 (409)
Q Consensus       270 -~~~g~~p~-----------~~~~~~~~~~vws~~~~~~~~~~~~---------------~~l~~---~~~~~~~~~~~l  319 (409)
                       ...+...+           ....++..+|+|+++  ..+++++.               .....   ....+......+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG--vil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG--ITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEF  238 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHH--HHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHH
Confidence             11111111           112244568888873  11111111               11110   011122344567


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHH
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+++.+||+.||.+|||+.++++
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         239 KDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            88888888888888888887764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=3.7e-31  Score=250.40  Aligned_cols=235  Identities=21%  Similarity=0.268  Sum_probs=175.2

Q ss_pred             ccHHHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEc
Q 048535          103 VSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKK  179 (409)
Q Consensus       103 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  179 (409)
                      +.++.+..++++|++.+.||+|+||.||++...  ++.+|+|.+.... .....+.+|+.+++++ +||||+++++++..
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            456677778899999999999999999999886  7899999986432 2235688899999999 79999999998852


Q ss_pred             ----cCCeEEEEEEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcE
Q 048535          180 ----EKESLILIYDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNA  254 (409)
Q Consensus       180 ----~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~  254 (409)
                          .++..++||||+++|+|.+++... .....+++..+..++.|+++||.|||   +.+|+||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence                245689999999999999988642 23346899999999999999999999   8999999999999999999999


Q ss_pred             EEecccCcccccCCc----eeeeccc---cc--------cCCCcHHHHHHhhhccCcHHHHhhHHhh-------------
Q 048535          255 RLGDFGLAKMHHHGQ----VMSGRRP---IE--------EGKRNLVDRMWSLTERSELLSVLDERLK-------------  306 (409)
Q Consensus       255 kl~DFGla~~~~~~~----~~~g~~p---~~--------~~~~~~~~~vws~~~~~~~~~~~~~~l~-------------  306 (409)
                      ||+|||+++......    ...|...   .+        ...++..+|+|+++.  .++++......             
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv--i~~el~~g~~p~~~~~~~~~~~~~  241 (286)
T cd06638         164 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI--TAIELGDGDPPLADLHPMRALFKI  241 (286)
T ss_pred             EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHH--HHHHHhcCCCCCCCCchhHHHhhc
Confidence            999999997654321    1112111   11        122456788888731  11111111100             


Q ss_pred             --hc---CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          307 --AK---GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       307 --~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                        ..   ...+......+.+++.+||+.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence              00   00111234568899999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=7.3e-31  Score=244.59  Aligned_cols=228  Identities=24%  Similarity=0.353  Sum_probs=174.8

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIY  188 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~~lv~  188 (409)
                      +|+..+.||.|+||.||++...  +..||+|.+...  .....+.+.+|+.++++++||||+++++++... ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999886  789999998654  344567789999999999999999999987642 45689999


Q ss_pred             EeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          189 DYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGW--ESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       189 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      ||+++++|.+++... .....+++..++.++.|++.||.|||..+  +.+++|+||||+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653 22457999999999999999999999554  678999999999999999999999999999876


Q ss_pred             cCCce----eeecc---c---cccCCCcHHHHHHhhhccCcHHHHhhH---------------Hhhh-cCCCCHHHHHHH
Q 048535          266 HHGQV----MSGRR---P---IEEGKRNLVDRMWSLTERSELLSVLDE---------------RLKA-KGGYADEVVEKV  319 (409)
Q Consensus       266 ~~~~~----~~g~~---p---~~~~~~~~~~~vws~~~~~~~~~~~~~---------------~l~~-~~~~~~~~~~~l  319 (409)
                      .....    ..|..   +   ......+...|+|+++.  .+++++..               .... ....+......+
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~--il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGC--LIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL  238 (265)
T ss_pred             cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHH--HHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHH
Confidence            54331    11111   1   11234566789998731  11111111               1110 122344556788


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHHH
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      .+++.+|++.+|++|||+.+|++.
T Consensus       239 ~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         239 NEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHHHHHHccCCcccCCCHHHHhhC
Confidence            999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=1.9e-30  Score=254.22  Aligned_cols=266  Identities=18%  Similarity=0.234  Sum_probs=180.8

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-----
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-----  181 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  181 (409)
                      ..++|+..+.||+|+||.||++...  |..||+|.+...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999999886  899999999643  3344567889999999999999999999886422     


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      ...|+||||+++ +|.+.+.     ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCC
Confidence            357999999976 6777663     24788999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCcee---eecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCC---------------HHHHH
Q 048535          262 AKMHHHGQVM---SGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYA---------------DEVVE  317 (409)
Q Consensus       262 a~~~~~~~~~---~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~---------------~~~~~  317 (409)
                      ++........   .|...+      ....++...|+|+++  ..+++++.......+...               .+...
T Consensus       170 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG--~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         170 ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG--CIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             ccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            9765332211   111111      123456678999986  345555554433222111               11111


Q ss_pred             HHHHHHHHccCcCCCCCC-CHHHHHHHHhc--CcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          318 KVLHLGLLCAHPEANSRP-TIRQVLKMLEG--QTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      .+...........|..+. +..++......  ...... .......+++.+|+..+|.+|++.++++.|||+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDK-LKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhcccccccccccccc-ccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence            111111112222222111 11111110000  000000 00122379999999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=4.6e-31  Score=247.76  Aligned_cols=226  Identities=24%  Similarity=0.366  Sum_probs=166.6

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEcc-----C
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKE-----K  181 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-----~  181 (409)
                      .+++.|+..+.||+|+||.||+|...  ++.||+|.+.... .....+.+|+.++.++ +|+||+++++++...     .
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45677888999999999999999886  7899999986543 3345788999999998 799999999998752     2


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      ...+++|||+++|+|.+++... ....+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence            4589999999999999998653 2346899999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCc----eeeecc---ccc--------cCCCcHHHHHHhhhccCcHHHHhhHHhhhc-----------------C
Q 048535          262 AKMHHHGQ----VMSGRR---PIE--------EGKRNLVDRMWSLTERSELLSVLDERLKAK-----------------G  309 (409)
Q Consensus       262 a~~~~~~~----~~~g~~---p~~--------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~-----------------~  309 (409)
                      ++......    ...|..   +.+        ...++...|+|+++  ..+++++.......                 .
T Consensus       158 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG--v~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~  235 (272)
T cd06637         158 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG--ITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR  235 (272)
T ss_pred             ceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHH--HHHHHHHhCCCCccccCHHHHHHHHhcCCCCC
Confidence            97653221    111211   111        12355678999874  22233322211100                 0


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          310 GYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       310 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ......+..+.+++.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            011123346677777777777777777777754

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.97  E-value=4.8e-31  Score=277.58  Aligned_cols=230  Identities=20%  Similarity=0.252  Sum_probs=175.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|++.+.||+|+||.||+|...  ++.||+|+++..   .....++|.+|++++++++||||+++++++.+ ++..++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-GDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-CCEEEEE
Confidence            57889999999999999999986  899999999754   23345679999999999999999999999987 6789999


Q ss_pred             EEeCCCCCHHHHHhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 048535          188 YDYMENGSLDKWIFECD--------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDF  259 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF  259 (409)
                      |||+++|+|.+++....        ....+++..+++++.||++||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEec
Confidence            99999999999986421        1234677888999999999999999   899999999999999999999999999


Q ss_pred             cCcccccCCc----------------------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcC--
Q 048535          260 GLAKMHHHGQ----------------------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKG--  309 (409)
Q Consensus       260 Gla~~~~~~~----------------------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~--  309 (409)
                      |+++......                      ...|...+.      ...++..+|+|+++  ..+++++....+...  
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLG--VILyELLTG~~PF~~~~  235 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALG--VILYQMLTLSFPYRRKK  235 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHH--HHHHHHHHCCCCCCCcc
Confidence            9998652110                      011222221      24467788999985  233333332211100  


Q ss_pred             --------------C--CCHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHhcCc
Q 048535          310 --------------G--YADEVVEKVLHLGLLCAHPEANSRP-TIRQVLKMLEGQT  348 (409)
Q Consensus       310 --------------~--~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~  348 (409)
                                    .  .....+..+.+++.+|++.||++|| +++++.+.|+...
T Consensus       236 ~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l  291 (932)
T PRK13184        236 GRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL  291 (932)
T ss_pred             hhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                          0  0113345688999999999999996 5677777776543

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=1.8e-31  Score=257.88  Aligned_cols=219  Identities=21%  Similarity=0.251  Sum_probs=162.6

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHH-HhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVS-SLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||+|...  |+.||+|++...   .......+..|.. +++.++||||+++++++.. .+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-TEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-CCEEEEEEcCCC
Confidence            46999999999999986  899999999654   2233455666665 4677899999999999887 778999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC----
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG----  268 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~----  268 (409)
                      +|+|..++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||+++.....    
T Consensus        80 ~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  153 (325)
T cd05604          80 GGELFFHLQR---ERSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT  153 (325)
T ss_pred             CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence            9999998853   346899999999999999999999   899999999999999999999999999998753211    


Q ss_pred             ceeeecccc------ccCCCcHHHHHHhhhcc-------------CcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCc
Q 048535          269 QVMSGRRPI------EEGKRNLVDRMWSLTER-------------SELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHP  329 (409)
Q Consensus       269 ~~~~g~~p~------~~~~~~~~~~vws~~~~-------------~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~  329 (409)
                      ....|...+      ....++...|+|+++..             ....++.+..+.............+.+++.+|++.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~  233 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEK  233 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhcc
Confidence            112222221      12345667889987411             11222222222211222233456678899999999


Q ss_pred             CCCCCCCHHHHHHHH
Q 048535          330 EANSRPTIRQVLKML  344 (409)
Q Consensus       330 dP~~RPt~~evl~~L  344 (409)
                      ||.+||++++.++.+
T Consensus       234 ~p~~R~~~~~~~~~i  248 (325)
T cd05604         234 DRQRRLGAKEDFLEI  248 (325)
T ss_pred             CHHhcCCCCCCHHHH
Confidence            999999987544443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=5.5e-31  Score=249.65  Aligned_cols=217  Identities=22%  Similarity=0.318  Sum_probs=163.1

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      |+..+.||+|+||+||+|...  ++.||+|.+....   ......+.+|++++++++|+||+++.+.+.. ++..+++||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-KDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-CCEEEEEEE
Confidence            667789999999999999986  8899999986542   2234567889999999999999999998887 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          81 IMNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             eccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            99999999988643 2346999999999999999999999   8999999999999999999999999999997653322


Q ss_pred             e---eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh-------------------cCCCCHHHHHHHHH
Q 048535          270 V---MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKA-------------------KGGYADEVVEKVLH  321 (409)
Q Consensus       270 ~---~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~-------------------~~~~~~~~~~~l~~  321 (409)
                      .   ..|...+      ....++...|+|+++  ..+++++......                   ...++......+.+
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG--~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLG--CLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKS  234 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHH
Confidence            1   1111111      123456667888873  1122222211110                   11223334556778


Q ss_pred             HHHHccCcCCCCCCCHH
Q 048535          322 LGLLCAHPEANSRPTIR  338 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~  338 (409)
                      ++..||+.||++||++.
T Consensus       235 li~~~l~~~P~~R~~~~  251 (285)
T cd05632         235 ICKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             HHHHHccCCHhHcCCCc
Confidence            88888888888888843

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=4.1e-31  Score=247.71  Aligned_cols=222  Identities=26%  Similarity=0.450  Sum_probs=169.1

Q ss_pred             ceeecCCceEEEEEEEC--C------cEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          119 NVIGLGGNGKVYKGQLL--G------VEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +.||+|+||.||+|+..  .      ..+|+|.+.... ......+.+|+.+++.++||||+++++++.. ....++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-NEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-CCCeEEEEe
Confidence            36899999999999875  2      579999986542 3456789999999999999999999999987 667899999


Q ss_pred             eCCCCCHHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC-----cEEEeccc
Q 048535          190 YMENGSLDKWIFECD----ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM-----NARLGDFG  260 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-----~~kl~DFG  260 (409)
                      |+++|+|.+++....    ....+++.+++.++.|++.||.|||   +.+++|+||||+||+++.+.     .+||+|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence            999999999996531    2235889999999999999999999   88999999999999999877     89999999


Q ss_pred             CcccccCCcee---------eecccc---ccCCCcHHHHHHhhhccCcHHHHhh-HHh--------------h--hcCCC
Q 048535          261 LAKMHHHGQVM---------SGRRPI---EEGKRNLVDRMWSLTERSELLSVLD-ERL--------------K--AKGGY  311 (409)
Q Consensus       261 la~~~~~~~~~---------~g~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~~l--------------~--~~~~~  311 (409)
                      +++........         ....+.   .....+...|+|+++  ..+++++. ...              .  .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG--~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFG--VLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK  234 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHH--HHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCC
Confidence            99765332211         011111   124456678888874  12222221 100              0  00122


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          312 ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       312 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      +...+..+.+++.+||+.+|.+||++.++++.|++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            34456788999999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=4.8e-31  Score=247.12  Aligned_cols=221  Identities=24%  Similarity=0.342  Sum_probs=168.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      ++|+..+.||+|+||.||+|...  ++.||+|.++.........+.+|+.+++.++||||+++++.+.. .+..++||||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-RDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEEEEEec
Confidence            46777889999999999999886  88999999987655556678899999999999999999999887 7789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc-
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ-  269 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-  269 (409)
                      +++|+|.+++..   ...+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++....... 
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            999999999853   346899999999999999999999   8899999999999999999999999999987543211 


Q ss_pred             ---eeeeccc---cc------cCCCcHHHHHHhhhccCcHHHHhhHHhhh------------------cCCC--CHHHHH
Q 048535          270 ---VMSGRRP---IE------EGKRNLVDRMWSLTERSELLSVLDERLKA------------------KGGY--ADEVVE  317 (409)
Q Consensus       270 ---~~~g~~p---~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~------------------~~~~--~~~~~~  317 (409)
                         ...|...   .+      ...++..+|+|+++  ..++++.......                  ....  ......
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG--~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVG--ITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSN  239 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHH--HHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCH
Confidence               1112211   11      22355678999974  1222221111100                  0000  012234


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+.+++.+||+.+|++|||+.++++
T Consensus       240 ~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         240 SFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HHHHHHHHHccCCchhCcCHHHHhc
Confidence            5778888999999999999888865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=2.5e-31  Score=251.69  Aligned_cols=224  Identities=22%  Similarity=0.374  Sum_probs=170.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|+..+.||+|+||+||++...  ++.||+|.+... .....+.+.+|+++++.++||||+++++++.. ....++|||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   83 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-ENNICMCME   83 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-CCEEEEEEe
Confidence            46777899999999999999987  889999998654 34456789999999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+++..   ...+++.....++.|++.||.|||+  ..+++||||||+||++++++.++|+|||++.......
T Consensus        84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~  158 (284)
T cd06620          84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI  158 (284)
T ss_pred             cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence            9999999999854   3468999999999999999999994  3689999999999999999999999999987543211


Q ss_pred             --eeeecccc------ccCCCcHHHHHHhhhccCcHHHHh--------------------------hHHhhh-cCCCC-H
Q 048535          270 --VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVL--------------------------DERLKA-KGGYA-D  313 (409)
Q Consensus       270 --~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~--------------------------~~~l~~-~~~~~-~  313 (409)
                        ...|...+      .....+...|+|+++.  .+++++                          ...... ....+ .
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~--~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGI--SIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS  236 (284)
T ss_pred             cCccccCcccCCHHHHccCCCCccchHHHHHH--HHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence              11222211      1234456788888731  122222                          111110 01111 1


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQVLKML  344 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L  344 (409)
                      .....+.+++.+||+.||++|||+.|++++.
T Consensus       237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             hcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            2455788899999999999999999998763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=263.05  Aligned_cols=218  Identities=22%  Similarity=0.298  Sum_probs=172.1

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  184 (409)
                      ..++|...++||+|.||.|+++..+  ++.+|||.++++   ...+.+..+.|.+++... +||.+++++..|.. .+++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT-~~~l  444 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT-KEHL  444 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-CCeE
Confidence            4478999999999999999999998  788999999877   445667788899998877 69999999998877 8899


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      |.||||+.||++..+.    ....+++..+.-+++.|+.||+|||   +++||+||||.+|||||.+|.+||+||||++.
T Consensus       445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe  517 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE  517 (694)
T ss_pred             EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccc
Confidence            9999999999965544    3357999999999999999999999   89999999999999999999999999999986


Q ss_pred             cc-C---Cceeeeccccc------cCCCcHHHHHHhhh-------------ccCcHHHHhhHHhhhcCCCCHHHHHHHHH
Q 048535          265 HH-H---GQVMSGRRPIE------EGKRNLVDRMWSLT-------------ERSELLSVLDERLKAKGGYADEVVEKVLH  321 (409)
Q Consensus       265 ~~-~---~~~~~g~~p~~------~~~~~~~~~vws~~-------------~~~~~~~~~~~~l~~~~~~~~~~~~~l~~  321 (409)
                      .- .   ....+|.+-+.      ...|+...|.|+++             ...+-.++.|..+.....+|...+.+...
T Consensus       518 ~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~  597 (694)
T KOG0694|consen  518 GMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIA  597 (694)
T ss_pred             cCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHH
Confidence            43 1   22566766543      36788889999984             12233344444444444455555556666


Q ss_pred             HHHHccCcCCCCCCC
Q 048535          322 LGLLCAHPEANSRPT  336 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt  336 (409)
                      ++.+.+..||++|--
T Consensus       598 il~~ll~k~p~kRLG  612 (694)
T KOG0694|consen  598 IMRRLLRKNPEKRLG  612 (694)
T ss_pred             HHHHHhccCcccccC
Confidence            666666666666643

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.97  E-value=3.3e-31  Score=256.00  Aligned_cols=221  Identities=21%  Similarity=0.258  Sum_probs=162.5

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHH-HhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVS-SLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||+|...  ++.||+|++....   ......+..|.. +++.++||||+++++++.. .+..++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-CCeEEEEEeCCC
Confidence            46999999999999987  7889999997532   222334555554 5678899999999999887 678999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---  269 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---  269 (409)
                      +|+|.+++..   ...+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+++......   
T Consensus        80 ~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~  153 (325)
T cd05602          80 GGELFYHLQR---ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT  153 (325)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence            9999999953   345888899999999999999999   8999999999999999999999999999997532211   


Q ss_pred             -eeeeccccc------cCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCc
Q 048535          270 -VMSGRRPIE------EGKRNLVDRMWSLTE-------------RSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHP  329 (409)
Q Consensus       270 -~~~g~~p~~------~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~  329 (409)
                       ...|...+.      ...++...|+|+++.             .....+..+................+.+++.+|++.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~  233 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQK  233 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHccc
Confidence             122222221      234556778888731             111122222222222233344566789999999999


Q ss_pred             CCCCCCCHHHHHHHHhc
Q 048535          330 EANSRPTIRQVLKMLEG  346 (409)
Q Consensus       330 dP~~RPt~~evl~~L~~  346 (409)
                      ||.+||++.+.+..+.+
T Consensus       234 ~p~~R~~~~~~~~~i~~  250 (325)
T cd05602         234 DRTKRLGAKDDFMEIKN  250 (325)
T ss_pred             CHHHCCCCCCCHHHHhc
Confidence            99999998865554443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=2e-30  Score=254.55  Aligned_cols=263  Identities=19%  Similarity=0.239  Sum_probs=181.6

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-----C
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-----K  181 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~  181 (409)
                      ..++|+..+.||+|+||.||++...  ++.||||++...  .....+.+.+|+.+++.++||||+++++++...     .
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999986  889999999753  334456788999999999999999999987542     2


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      ...|+||||+++ +|.+++.     ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999975 7887773     24789999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCcee---eecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCC---------------HHHHH
Q 048535          262 AKMHHHGQVM---SGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYA---------------DEVVE  317 (409)
Q Consensus       262 a~~~~~~~~~---~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~---------------~~~~~  317 (409)
                      ++........   .|...+      ....++...|+|+++  ..+++++...........               .+...
T Consensus       173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG--~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG--CIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             ccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHH--HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9875443211   122111      124456789999986  345555544433221111               11111


Q ss_pred             HHHHHHHHccCcCCCCCCCHH-----HHHHHHh-cCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          318 KVLHLGLLCAHPEANSRPTIR-----QVLKMLE-GQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~-----evl~~L~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      .+...+....    .+||...     ++..... ...............+++.+|+..+|.+|+++.+++.||||..
T Consensus       251 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         251 KLQPTVRTYV----ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             hhhHHHHHHH----hhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence            1111111111    2222221     1110000 0000000001122378999999999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=6.3e-31  Score=258.67  Aligned_cols=191  Identities=20%  Similarity=0.200  Sum_probs=152.9

Q ss_pred             HHHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEc
Q 048535          105 YQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK  179 (409)
Q Consensus       105 ~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  179 (409)
                      +.++....++|+..+.||+|+||.||++...  ++.||+|.+...   .....+.+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            4455566789999999999999999999987  789999998642   22334568899999999999999999999887


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 048535          180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDF  259 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF  259 (409)
                       ....++||||+++|+|.+++..    ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus       115 -~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 -DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             -CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeC
Confidence             7789999999999999999853    34888899999999999999999   899999999999999999999999999


Q ss_pred             cCcccccCCc-----eeeecccccc----------CCCcHHHHHHhhhccCcHHHHhhHHh
Q 048535          260 GLAKMHHHGQ-----VMSGRRPIEE----------GKRNLVDRMWSLTERSELLSVLDERL  305 (409)
Q Consensus       260 Gla~~~~~~~-----~~~g~~p~~~----------~~~~~~~~vws~~~~~~~~~~~~~~l  305 (409)
                      |+++......     ...|...+..          ..++...|+|+++  ..+++++....
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlG--vilyell~G~~  245 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG--VFLYEMLVGDT  245 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehh--HHHHHHHhCCC
Confidence            9998654322     1123222211          1255678999986  34555554433

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=3.9e-31  Score=254.28  Aligned_cols=261  Identities=21%  Similarity=0.297  Sum_probs=172.6

Q ss_pred             cceeecCCceEEEEEEEC----CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeEEEEEEeCC
Q 048535          118 ENVIGLGGNGKVYKGQLL----GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYME  192 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~~lv~E~~~  192 (409)
                      .++||+|+||.||+|...    ++.||+|.+....  ....+.+|+.++++++||||+++++++... ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999864    5789999986542  224577899999999999999999988642 456889999996


Q ss_pred             CCCHHHHHhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee----CCCCcEEEecccCc
Q 048535          193 NGSLDKWIFECD------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL----DKKMNARLGDFGLA  262 (409)
Q Consensus       193 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----~~~~~~kl~DFGla  262 (409)
                      + +|.+++....      ....+++..+..++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|||+|
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 8988875321      2235899999999999999999999   8999999999999999    45678999999999


Q ss_pred             ccccCCc-------eeeec---cccc---c-CCCcHHHHHHhhhccCcHHHHhhHHhhhcCC---------CCHHHHHHH
Q 048535          263 KMHHHGQ-------VMSGR---RPIE---E-GKRNLVDRMWSLTERSELLSVLDERLKAKGG---------YADEVVEKV  319 (409)
Q Consensus       263 ~~~~~~~-------~~~g~---~p~~---~-~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~---------~~~~~~~~l  319 (409)
                      +......       ...|.   .+.+   . ..++...|+|+++  ..+++++.........         ........+
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG--~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG--CIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  237 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHH--HHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence            8754321       11111   1222   1 3356789999986  3455555443321110         111222222


Q ss_pred             HHHHHHccCcCCCCC---CCHHHHHHHHhcC----------cCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          320 LHLGLLCAHPEANSR---PTIRQVLKMLEGQ----------TEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~R---Pt~~evl~~L~~~----------~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      ..+...+...+....   |......+.+...          .+......+....+++.+|+..||.+|+|+++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            222211111111111   1111111111110          001111122235799999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-30  Score=250.29  Aligned_cols=149  Identities=28%  Similarity=0.339  Sum_probs=132.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh---HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE---HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||+|...  ++.||+|.+.....   ...+.+..|+++++.++||||+++++.+.. ....++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEE
Confidence            46888899999999999999986  79999999976522   345678999999999999999999999887 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      |||+.+++|.+++... ....+++..+..++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||++....
T Consensus        80 ~e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          80 MDYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EEecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            9999999999998642 3356899999999999999999999   8999999999999999999999999999987543

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=1.2e-30  Score=242.45  Aligned_cols=221  Identities=24%  Similarity=0.351  Sum_probs=172.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|+..+.||+|+||.||+|...  +..+|+|.++....  .+++.+|++++++++||||+++++++.. ....++++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK-NTDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec-CCcEEEEEe
Confidence            367888999999999999999987  78999999975433  6789999999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++++|.+++...  ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus        79 ~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          79 YCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             cCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            99999999998542  346899999999999999999999   8899999999999999999999999999998654322


Q ss_pred             ----eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh------------------cCCCCHHHHHHHHH
Q 048535          270 ----VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKA------------------KGGYADEVVEKVLH  321 (409)
Q Consensus       270 ----~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~------------------~~~~~~~~~~~l~~  321 (409)
                          ...|...+      ....++...|+|+++  ..+++++......                  ....+......+.+
T Consensus       154 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (256)
T cd06612         154 AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLG--ITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFND  231 (256)
T ss_pred             cccccccCCccccCHHHHhcCCCCchhhHHHHH--HHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHH
Confidence                11111111      123445678999874  1222222211110                  00112234457888


Q ss_pred             HHHHccCcCCCCCCCHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ++.+||+.||++|||+.|+++
T Consensus       232 ~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         232 FVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             HHHHHHhcChhhCcCHHHHhc
Confidence            999999999999999998875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=1e-30  Score=252.82  Aligned_cols=142  Identities=22%  Similarity=0.235  Sum_probs=124.2

Q ss_pred             ccceeecC--CceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          117 EENVIGLG--GNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       117 ~~~~lG~G--~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      ..++||+|  +||+||++...  |+.||+|+++..  .....+.+.+|+++++.++||||+++++++.. ++..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCEEEEEEec
Confidence            35789999  78999999887  899999999754  23344567789999999999999999999987 6789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      +++|+|.+++.... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++++|||.+.
T Consensus        81 ~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          81 MAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             cCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhh
Confidence            99999999996432 235899999999999999999999   8999999999999999999999999998654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=5.3e-31  Score=249.87  Aligned_cols=173  Identities=25%  Similarity=0.396  Sum_probs=141.1

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      |+..+.||+|+||.||++...  ++.||+|.+....   ......+.+|+.++++++|+||+++++.+.+ .+..++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e   80 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLT   80 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-CCEEEEEEE
Confidence            677789999999999999987  8899999986542   2234567889999999999999999999887 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            99999999998643 2345899999999999999999999   8999999999999999999999999999997654322


Q ss_pred             ee---eecccc------ccCCCcHHHHHHhhh
Q 048535          270 VM---SGRRPI------EEGKRNLVDRMWSLT  292 (409)
Q Consensus       270 ~~---~g~~p~------~~~~~~~~~~vws~~  292 (409)
                      ..   .|...+      ....++...|+|+++
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG  188 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALG  188 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHH
Confidence            11   111111      123456678899885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=2e-30  Score=247.55  Aligned_cols=265  Identities=23%  Similarity=0.331  Sum_probs=185.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|...+.||+|+||.||+|...  ++.||+|.++... ......+.+|+.++++++||||+++++++.. ....++|||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv~e   84 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFE   84 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-CCeEEEEEe
Confidence            56888999999999999999886  7899999997542 2334567889999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |++ ++|.+++...  ...+++..+..++.|+++||.|||   +.+|+|+||||+|||+++++.+||+|||+++......
T Consensus        85 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          85 YLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             ccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            997 5999988643  345889999999999999999999   8999999999999999999999999999997643221


Q ss_pred             e-------eeeccccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCC-CCCH
Q 048535          270 V-------MSGRRPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANS-RPTI  337 (409)
Q Consensus       270 ~-------~~g~~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~-RPt~  337 (409)
                      .       .....+.+    ...++..+|+|+++  ..+++++............    +....+..++...+.. .|.+
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG--~~l~el~tg~~~f~~~~~~----~~~~~~~~~~~~~~~~~~~~~  232 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVG--CIFYEMSTGRPLFPGSTVE----EQLHFIFRILGTPTEETWPGI  232 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHH--HHHHHHHhCCCCCCCCCHH----HHHHHHHHHcCCCChhhchhh
Confidence            0       01111111    12356788999996  4556666654432222112    2222223332222111 1111


Q ss_pred             HHHHHHHhcCcCCCC----------CCCCCcchhHHhhhcccCCCCcccccccCCCCCccccccc
Q 048535          338 RQVLKMLEGQTEGTG----------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKN  392 (409)
Q Consensus       338 ~evl~~L~~~~~~~~----------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~  392 (409)
                      ..-.. ... ...+.          ..-+....+++.+|+..+|.+|+++++++.||||......
T Consensus       233 ~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~  295 (301)
T cd07873         233 LSNEE-FKS-YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER  295 (301)
T ss_pred             hcccc-ccc-cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence            00000 000 00000          0011123689999999999999999999999999877643

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=8.9e-31  Score=249.72  Aligned_cols=220  Identities=23%  Similarity=0.359  Sum_probs=171.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      ++|+..+.||.|+||.||+|...  ++.||+|.+........+.+.+|+.+++.++||||+++++++.. ....++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-GDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-CceEEEEEEe
Confidence            56888999999999999999875  89999999976655556788999999999999999999999987 6789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV  270 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  270 (409)
                      +++|+|.+++..    ..+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            999999999843    35899999999999999999999   89999999999999999999999999999876543221


Q ss_pred             ----eeecc---ccc---cCCCcHHHHHHhhhccCcHHHHhhHHhhh------------------cCCCCHHHHHHHHHH
Q 048535          271 ----MSGRR---PIE---EGKRNLVDRMWSLTERSELLSVLDERLKA------------------KGGYADEVVEKVLHL  322 (409)
Q Consensus       271 ----~~g~~---p~~---~~~~~~~~~vws~~~~~~~~~~~~~~l~~------------------~~~~~~~~~~~l~~l  322 (409)
                          ..|..   +.+   ....+..+|+|+++  ..+++++......                  ....+......+.++
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG--vil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  248 (296)
T cd06655         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG--IMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF  248 (296)
T ss_pred             cCCCcCCCccccCcchhcCCCCCchhhHHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence                11111   111   23356778999873  1111111111100                  011233345678889


Q ss_pred             HHHccCcCCCCCCCHHHHHH
Q 048535          323 GLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +.+||+.||.+|||+.++++
T Consensus       249 i~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         249 LNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             HHHHhhcChhhCCCHHHHhh
Confidence            99999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-32  Score=264.38  Aligned_cols=224  Identities=26%  Similarity=0.338  Sum_probs=181.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      +-|...+.||.|+||.||-+++.  .+.||||++...   +....++++.|+..|.+++|||+|.+-|+|.. ....|||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWLV  104 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWLV  104 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHHH
Confidence            34666788999999999999987  788999999765   33456789999999999999999999999887 6788999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||||-| |-.+.+.-.  +.++.+.++..|+.+.++||+|||   +.+.||||||+.||||++.|.+||+|||.|....+
T Consensus       105 MEYClG-SAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P  178 (948)
T KOG0577|consen  105 MEYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP  178 (948)
T ss_pred             HHHHhc-cHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence            999954 877777543  347999999999999999999999   89999999999999999999999999999998887


Q ss_pred             Cceeeecccc---------ccCCCcHHHHHHhhhccCcHH-------------HHhhHHhhhc--CCCCHHHHHHHHHHH
Q 048535          268 GQVMSGRRPI---------EEGKRNLVDRMWSLTERSELL-------------SVLDERLKAK--GGYADEVVEKVLHLG  323 (409)
Q Consensus       268 ~~~~~g~~p~---------~~~~~~~~~~vws~~~~~~~~-------------~~~~~~l~~~--~~~~~~~~~~l~~l~  323 (409)
                      ...+.|.+.+         +.+.|+-..|||+++-.+.-.             ..+.......  .-...+++..+..++
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv  258 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV  258 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence            7666666543         347888899999995443211             1111111100  112457888999999


Q ss_pred             HHccCcCCCCCCCHHHHHHH
Q 048535          324 LLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ..|++.-|.+|||..++++.
T Consensus       259 d~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  259 DSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             HHHHhhCcccCCcHHHHhhc
Confidence            99999999999999998763

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.8e-30  Score=251.57  Aligned_cols=183  Identities=26%  Similarity=0.254  Sum_probs=146.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|++.+.||+|+||.||++...  ++.||+|++...   .....+.|.+|+.++..++|+||+++++++.+ ++..++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-ENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-CCeEEEE
Confidence            47889999999999999999986  889999999642   22334568899999999999999999999887 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++...  ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        80 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             EecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            9999999999999642  345899999999999999999999   89999999999999999999999999999876543


Q ss_pred             Cc-----eeeecccccc-----------CCCcHHHHHHhhhccCcHHHHhhH
Q 048535          268 GQ-----VMSGRRPIEE-----------GKRNLVDRMWSLTERSELLSVLDE  303 (409)
Q Consensus       268 ~~-----~~~g~~p~~~-----------~~~~~~~~vws~~~~~~~~~~~~~  303 (409)
                      ..     ...|...+..           ..++...|+|+++  ..+++++..
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG--~~l~el~~g  204 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLG--VCMYEMLYG  204 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhh--hHHHHHhhC
Confidence            22     1223222211           2245567899885  344455443

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=2.4e-31  Score=260.06  Aligned_cols=266  Identities=18%  Similarity=0.233  Sum_probs=182.6

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC----
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK----  181 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----  181 (409)
                      ...++|+..+.||+|+||.||++...  ++.||||++...  .......+.+|+.+++.++||||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34578999999999999999999876  889999999754  3344567889999999999999999999886422    


Q ss_pred             -CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEeccc
Q 048535          182 -ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG  260 (409)
Q Consensus       182 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG  260 (409)
                       ...++||||+++ +|.+++.     ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCc
Confidence             357999999975 7777763     24889999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCce---eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCc--
Q 048535          261 LAKMHHHGQV---MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHP--  329 (409)
Q Consensus       261 la~~~~~~~~---~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~--  329 (409)
                      +++.......   ..|...+      ....++...|+|+++  ..+++++.......+..   ....+..++......  
T Consensus       165 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG--~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~~  239 (355)
T cd07874         165 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG--CIMGEMVRHKILFPGRD---YIDQWNKVIEQLGTPCP  239 (355)
T ss_pred             ccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHH--HHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCCH
Confidence            9987544321   1122221      123456789999996  34555555443322111   111122222211111  


Q ss_pred             --CCCCCCCHHHHHHHHhcC-------------cCCCC---CCCCCcchhHHhhhcccCCCCcccccccCCCCCcccc
Q 048535          330 --EANSRPTIRQVLKMLEGQ-------------TEGTG---LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEI  389 (409)
Q Consensus       330 --dP~~RPt~~evl~~L~~~-------------~~~~~---~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~  389 (409)
                        ....+|+....++.....             .....   ........+++.+|+..+|.+|+++.+++.||||...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence              111122222211110000             00000   0001123689999999999999999999999999743

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=4.5e-31  Score=249.69  Aligned_cols=173  Identities=25%  Similarity=0.376  Sum_probs=141.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++|+..+.||+|+||.||+|.+.  ++.||+|.+...  .....+.+.+|+++++.++||||+++++++.. +...++||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEE
Confidence            46888899999999999999986  889999998643  22235678899999999999999999999986 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++++|.++...   ...+++.++..++.|+++||+|||   +.+++|+||+|+||++++++.+||+|||++......
T Consensus        80 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          80 EFVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             ecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            99999999887743   235899999999999999999999   789999999999999999999999999998765432


Q ss_pred             ce----eeecc---ccc----cCCCcHHHHHHhhh
Q 048535          269 QV----MSGRR---PIE----EGKRNLVDRMWSLT  292 (409)
Q Consensus       269 ~~----~~g~~---p~~----~~~~~~~~~vws~~  292 (409)
                      ..    ..+..   +.+    ....+..+|+|+++
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  188 (286)
T cd07846         154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVG  188 (286)
T ss_pred             ccccCcccceeeccCcHHhccccccCchHhHHHHH
Confidence            21    11111   111    12345678999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=1.5e-30  Score=243.47  Aligned_cols=220  Identities=26%  Similarity=0.396  Sum_probs=166.1

Q ss_pred             CCCccceeecCCceEEEEEEEC-CcEEEEEEeccCC------hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDS------EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      +|+..+.||+|+||.||+|... ++.+|+|.+....      ......+.+|++++++++|+||+++++++.+ ....++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-DNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-CCeEEE
Confidence            4778899999999999999876 8889999986431      2234568899999999999999999999987 678999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      +|||+++|+|.+++..   ...+++..+..++.|++.||+|||   +.+|+|+||||+||++++++.+||+|||+++...
T Consensus        80 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          80 FMEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            9999999999999954   245889999999999999999999   8899999999999999999999999999987542


Q ss_pred             CCc----------eeeecc---ccc---cCCCcHHHHHHhhhccCcHHHHhhHHhh------------------hcCCCC
Q 048535          267 HGQ----------VMSGRR---PIE---EGKRNLVDRMWSLTERSELLSVLDERLK------------------AKGGYA  312 (409)
Q Consensus       267 ~~~----------~~~g~~---p~~---~~~~~~~~~vws~~~~~~~~~~~~~~l~------------------~~~~~~  312 (409)
                      ...          ...|..   |.+   ...++...|+|+++  ..+++++....+                  .....+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG--~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIG--CTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP  231 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHH--HHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCC
Confidence            110          011111   111   23346778999973  111222111111                  001223


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ......+.+++.+||+.+|++||++.++++
T Consensus       232 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         232 DSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            334556778888888888888888887764

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=9.1e-31  Score=243.17  Aligned_cols=223  Identities=27%  Similarity=0.484  Sum_probs=172.7

Q ss_pred             CCccceeecCCceEEEEEEEC--C----cEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--G----VEVALKRISLDSEH-GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~----~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      |++.+.||.|+||.||++...  +    ..||+|.+...... ..+.+..|+.++..++|+||+++++++.+ .+..+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-EEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCeeEEE
Confidence            456789999999999999987  3    78999999766433 56789999999999999999999999987 5789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++++|.+++..... ..+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||+++....
T Consensus        80 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             EeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            999999999999964321 22899999999999999999999   89999999999999999999999999999987654


Q ss_pred             Cceeee---c-----ccc---ccCCCcHHHHHHhhhccCcHHHHhh----------------HHhh-hcCCCCHHHHHHH
Q 048535          268 GQVMSG---R-----RPI---EEGKRNLVDRMWSLTERSELLSVLD----------------ERLK-AKGGYADEVVEKV  319 (409)
Q Consensus       268 ~~~~~g---~-----~p~---~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~-~~~~~~~~~~~~l  319 (409)
                      ......   .     .+.   ....++..+|+|+++.  .+.+++.                .... .....+...+..+
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~--i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGV--LLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEI  233 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHH--HHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHH
Confidence            421111   0     011   1244567789998741  1111111                1100 0012223356788


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHHHH
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLKML  344 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~~L  344 (409)
                      .+++.+||+.||++|||+.|+++.|
T Consensus       234 ~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      234 YKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHHHHHCcCChhhCcCHHHHHhhC
Confidence            9999999999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=1.9e-30  Score=241.37  Aligned_cols=224  Identities=23%  Similarity=0.344  Sum_probs=171.9

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|+..+.||+|+||.||++...  ++.||+|.+...  .....+++.+|+.++++++||||+++++++.. .+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEe
Confidence            4788899999999999999886  889999998643  34455689999999999999999999999876 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++++|.+++... ....+++.++..++.|++.||.|||   +.+++|+||+|+|||++.++.++|+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          80 YCEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             cCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            99999999998653 2345899999999999999999999   8999999999999999999999999999997654322


Q ss_pred             e----eeeccc---c---ccCCCcHHHHHHhhh-------------ccCcHHHHhhHHhhhc-CCCCHHHHHHHHHHHHH
Q 048535          270 V----MSGRRP---I---EEGKRNLVDRMWSLT-------------ERSELLSVLDERLKAK-GGYADEVVEKVLHLGLL  325 (409)
Q Consensus       270 ~----~~g~~p---~---~~~~~~~~~~vws~~-------------~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~l~~~  325 (409)
                      .    ..|...   .   .....+...|+|+++             ......+.++..+... ...+......+.+++.+
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  235 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ  235 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH
Confidence            1    111111   1   113344567888863             1112222222222211 12334456678899999


Q ss_pred             ccCcCCCCCCCHHHHHH
Q 048535          326 CAHPEANSRPTIRQVLK  342 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~  342 (409)
                      ||+.+|++||++.+|++
T Consensus       236 ~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         236 LFKRNPRDRPSVNSILE  252 (256)
T ss_pred             HhhCChhhCcCHHHHhh
Confidence            99999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=2.7e-31  Score=247.17  Aligned_cols=219  Identities=27%  Similarity=0.402  Sum_probs=166.8

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHH--HHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGM--REFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~--~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      |+..+.||+|+||+||++...  ++.||+|.+........  ....+|+.++++++||||+++++++.+ ....++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccc
Confidence            456789999999999999998  67899999987644332  344669999999999999999999987 7789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC-Cc
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH-GQ  269 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~-~~  269 (409)
                      +++++|.+++.   ....+++..+..++.|+++||.|||   +.+|+|+||||+||+++.++.++|+|||.+..... ..
T Consensus        80 ~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~  153 (260)
T PF00069_consen   80 CPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE  153 (260)
T ss_dssp             ETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred             ccccccccccc---ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            99999999996   2356899999999999999999999   78999999999999999999999999999975311 11


Q ss_pred             ---eeeec---ccc---c-cCCCcHHHHHHhhhccCcHHHHhhHHhhhc----------------------CCCCHHHHH
Q 048535          270 ---VMSGR---RPI---E-EGKRNLVDRMWSLTERSELLSVLDERLKAK----------------------GGYADEVVE  317 (409)
Q Consensus       270 ---~~~g~---~p~---~-~~~~~~~~~vws~~~~~~~~~~~~~~l~~~----------------------~~~~~~~~~  317 (409)
                         ...+.   .+.   . ....+...|+|+++.  .+.+++.......                      .........
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~--il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGI--ILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSE  231 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHH--HHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHH
T ss_pred             cccccccccccccccccccccccccccccccccc--ccccccccccccccccchhhhhhhhhcccccccccccccchhHH
Confidence               11111   111   1 245678899998841  2222222211100                      000001126


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+.+++..||+.||++|||+.++++
T Consensus       232 ~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  232 ELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhc
Confidence            7888999999999999999988875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=4.1e-32  Score=245.85  Aligned_cols=269  Identities=22%  Similarity=0.330  Sum_probs=193.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC------CcEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL------GVEVALKRISLDSE--HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  183 (409)
                      ...|+....||+|.||.||++.-.      .+.+|+|+++....  .-.....+|+.+++.++||||+.+..++...+..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            356888999999999999999654      24699999976522  2234577999999999999999999988876778


Q ss_pred             EEEEEEeCCCCCHHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC----CcEEEe
Q 048535          184 LILIYDYMENGSLDKWIFEC--DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK----MNARLG  257 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~----~~~kl~  257 (409)
                      +++++||.+. +|.+.|+-+  .....++...+..|+.||+.|+.|||   ++=|+||||||.|||+..+    |.+||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEee
Confidence            9999999998 999988643  23357899999999999999999999   7889999999999999888    899999


Q ss_pred             cccCcccccCCc---------eee-ecc-c---cccCCCcHHHHHHhhhccCcHHHHhhH---------HhhhcCCCCHH
Q 048535          258 DFGLAKMHHHGQ---------VMS-GRR-P---IEEGKRNLVDRMWSLTERSELLSVLDE---------RLKAKGGYADE  314 (409)
Q Consensus       258 DFGla~~~~~~~---------~~~-g~~-p---~~~~~~~~~~~vws~~~~~~~~~~~~~---------~l~~~~~~~~~  314 (409)
                      |||+||.+...-         ++| =.+ |   .....|+...|+|+++  +...+++.-         .+....++..+
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiG--CIfaElLtl~PlF~g~E~k~~~~~Pfq~d  256 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIG--CIFAELLTLEPLFKGREEKIKTKNPFQHD  256 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHH--HHHHHHHccCccccchhhhcccCCCchHH
Confidence            999999876532         111 011 1   1235678889999986  333333321         12222234444


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCH------HHHHHHHhcCcCCC----------CCCCCCcchhHHhhhcccCCCCccccc
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTI------RQVLKMLEGQTEGT----------GLEDEGMNVHLLKRIGTRAMTSSWKFA  378 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~------~evl~~L~~~~~~~----------~~~~~~~~~~~l~~~~~~~~~~~~~~~  378 (409)
                      .+.++.+++   -.+.-++=|++      +..+..++...-..          ...++ ...++|.+|+++||.+|+++.
T Consensus       257 Ql~rIf~vL---G~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~-~a~~LL~klL~yDP~kRIta~  332 (438)
T KOG0666|consen  257 QLDRIFEVL---GTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDP-SALDLLQKLLTYDPIKRITAE  332 (438)
T ss_pred             HHHHHHHHc---CCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCc-hHHHHHHHHhccCchhhccHH
Confidence            555555543   33333333443      34444444221111          11222 268999999999999999999


Q ss_pred             ccCCCCCccccc
Q 048535          379 GSRGHPTFNEIN  390 (409)
Q Consensus       379 ~~~~hp~~~~~~  390 (409)
                      +++.|++|.+.+
T Consensus       333 qAleh~yF~~d~  344 (438)
T KOG0666|consen  333 QALEHPYFTEDP  344 (438)
T ss_pred             HHhcccccccCC
Confidence            999999999864

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=2.1e-30  Score=248.08  Aligned_cols=225  Identities=17%  Similarity=0.230  Sum_probs=170.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||++...  ++.||+|.+....   ......+.+|+.+++.++||||+++++.+.. ++..++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEE
Confidence            46888999999999999999987  7899999987552   2345678899999999999999999999886 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++..   ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        80 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          80 MEYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            999999999999954   346899999999999999999999   89999999999999999999999999999874211


Q ss_pred             Cc-------------------eeee---ccccc---cCCCcHHHHHHhhhccCcHHHH---------------hhHHhhh
Q 048535          268 GQ-------------------VMSG---RRPIE---EGKRNLVDRMWSLTERSELLSV---------------LDERLKA  307 (409)
Q Consensus       268 ~~-------------------~~~g---~~p~~---~~~~~~~~~vws~~~~~~~~~~---------------~~~~l~~  307 (409)
                      ..                   ...|   ..+.+   ...++...|+|+++  ..++++               .......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~vl~el~~g~~pf~~~~~~~~~~~~~~~  231 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG--IILYEFLVGCVPFFGDTPEELFGQVISD  231 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            00                   0011   11111   23456678899873  112222               2211111


Q ss_pred             cCCC---CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          308 KGGY---ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       308 ~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      ....   ....+..+.+++.+||+.||++||++.++.+.|+.
T Consensus       232 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         232 DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            0011   11345668899999999999999998777776654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=1.7e-30  Score=246.16  Aligned_cols=263  Identities=22%  Similarity=0.314  Sum_probs=173.9

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccC---CCCceeeEeeEEEcc----CC
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRL---KHRNLVGLRGWCKKE----KE  182 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~----~~  182 (409)
                      +|+..+.||+|+||.||+|...  ++.||+|.++...  ......+.+|+.+++.+   +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999987  8899999987542  12223456777777655   799999999988642    24


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..+++|||+++ +|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence            58999999985 8999886532 345899999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCce---eeec---ccc---ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCC
Q 048535          263 KMHHHGQV---MSGR---RPI---EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANS  333 (409)
Q Consensus       263 ~~~~~~~~---~~g~---~p~---~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  333 (409)
                      +.......   ..|.   .+.   ....++..+|+|+++  ..+++++................++..   ..-...+..
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG--~~l~~l~~g~~~f~~~~~~~~~~~~~~---~~~~~~~~~  230 (288)
T cd07863         156 RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVG--CIFAEMFRRKPLFCGNSEADQLGKIFD---LIGLPPEDD  230 (288)
T ss_pred             ccccCcccCCCccccccccCchHhhCCCCCCcchhhhHH--HHHHHHHhCCcCcCCCCHHHHHHHHHH---HhCCCChhh
Confidence            87543221   1111   111   124566788999996  344555433222111112222222222   111111111


Q ss_pred             CCCHHHHHH-HHhcCc----CCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          334 RPTIRQVLK-MLEGQT----EGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       334 RPt~~evl~-~L~~~~----~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      .|.-..+.. .+....    ....+.-+....+++.+|+..+|.+|++..+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            111000000 000000    00000112234899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=2.4e-30  Score=247.88  Aligned_cols=223  Identities=24%  Similarity=0.358  Sum_probs=171.4

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .+.|+..+.||+|+||.||+|...  ++.||+|.+...   .....+.+.+|+++++.++||||++++++|.+ .+..++
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-~~~~~l   92 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-EHTAWL   92 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-CCeEEE
Confidence            456888899999999999999986  899999998643   33445678999999999999999999999987 678899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||++ |+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||+|+||++++++.+||+|||++....
T Consensus        93 v~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          93 VMEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             EHHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            999997 5887777532  346899999999999999999999   8999999999999999999999999999997665


Q ss_pred             CCceeeeccc---cc------cCCCcHHHHHHhhhccCcHHHHhhHHhh----------------hcCC-CCHHHHHHHH
Q 048535          267 HGQVMSGRRP---IE------EGKRNLVDRMWSLTERSELLSVLDERLK----------------AKGG-YADEVVEKVL  320 (409)
Q Consensus       267 ~~~~~~g~~p---~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~----------------~~~~-~~~~~~~~l~  320 (409)
                      ......+...   .+      ...++..+|+|+++  ..+++++.....                .... ....+...+.
T Consensus       167 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G--~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (307)
T cd06607         167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG--ITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR  244 (307)
T ss_pred             CCCCccCCccccCceeeeccCCCCCCcccchHHHH--HHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence            4332222211   11      13345678888874  122222221110                0011 1234566789


Q ss_pred             HHHHHccCcCCCCCCCHHHHHHH
Q 048535          321 HLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       321 ~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      +++.+||+.+|++||++.+++..
T Consensus       245 ~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         245 NFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHHHHHhcCChhhCcCHHHHhcC
Confidence            99999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=3.6e-30  Score=242.79  Aligned_cols=220  Identities=26%  Similarity=0.374  Sum_probs=170.2

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      -|+..+.||+|+||.||+|...  +..||+|.+... .....+.+.+|+.++.+++||||+++++++.. ++..++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-CCeEEEEEEe
Confidence            3667889999999999999875  789999998654 33445678999999999999999999999987 6789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV  270 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  270 (409)
                      +++|+|.+++..    ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++.......
T Consensus        84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            999999999842    35899999999999999999999   89999999999999999999999999999876543211


Q ss_pred             ----eeec---cccc---cCCCcHHHHHHhhhccCcHHHHhhHHhhh----------------cCCCCHHHHHHHHHHHH
Q 048535          271 ----MSGR---RPIE---EGKRNLVDRMWSLTERSELLSVLDERLKA----------------KGGYADEVVEKVLHLGL  324 (409)
Q Consensus       271 ----~~g~---~p~~---~~~~~~~~~vws~~~~~~~~~~~~~~l~~----------------~~~~~~~~~~~l~~l~~  324 (409)
                          ..+.   .+.+   ....+...|+|+++.  .+++++......                ...........+.+++.
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~--~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI--TAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE  234 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHH--HHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHH
Confidence                1111   1111   133456788998741  112221111110                01122334567889999


Q ss_pred             HccCcCCCCCCCHHHHHHH
Q 048535          325 LCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       325 ~Cl~~dP~~RPt~~evl~~  343 (409)
                      +||+.+|.+||++.++++.
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         235 ACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             HHccCChhhCcCHHHHHhC
Confidence            9999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=2e-30  Score=246.32  Aligned_cols=220  Identities=22%  Similarity=0.246  Sum_probs=168.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||++...  ++.||+|.+...   .....+.+.+|++++++++||||+++++++.. ....++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-DSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCeEEEE
Confidence            46888999999999999999986  799999998653   23345678999999999999999999999887 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+|+||+|+|||++.++.+||+|||+++....
T Consensus        80 ~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          80 MEYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            999999999999954   356899999999999999999999   89999999999999999999999999999987654


Q ss_pred             Cc-eeeeccc------cccCCCcHHHHHHhhhccCcHHHHhhH---------------HhhhcCCCCHHHHHHHHHHHHH
Q 048535          268 GQ-VMSGRRP------IEEGKRNLVDRMWSLTERSELLSVLDE---------------RLKAKGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       268 ~~-~~~g~~p------~~~~~~~~~~~vws~~~~~~~~~~~~~---------------~l~~~~~~~~~~~~~l~~l~~~  325 (409)
                      .. ...|...      ......+...|+|+++  ..+++++..               ........+......+.+++.+
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  231 (290)
T cd05580         154 RTYTLCGTPEYLAPEIILSKGYGKAVDWWALG--ILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRN  231 (290)
T ss_pred             CCCCCCCCccccChhhhcCCCCCccccHHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHH
Confidence            32 1112111      1123345567888874  112222211               1111122333445677888889


Q ss_pred             ccCcCCCCCC-----CHHHHH
Q 048535          326 CAHPEANSRP-----TIRQVL  341 (409)
Q Consensus       326 Cl~~dP~~RP-----t~~evl  341 (409)
                      ||+.||.+||     +++|++
T Consensus       232 ~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         232 LLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             HccCCHHHccCcccCCHHHHH
Confidence            9999999998     555554

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=3.4e-30  Score=241.57  Aligned_cols=227  Identities=22%  Similarity=0.358  Sum_probs=171.0

Q ss_pred             CCCccceeecCCceEEEEEEEC---CcEEEEEEeccC----------ChHHHHHHHHHHHHhcc-CCCCceeeEeeEEEc
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL---GVEVALKRISLD----------SEHGMREFLAEVSSLGR-LKHRNLVGLRGWCKK  179 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~  179 (409)
                      +|+..+.||+|+||.||+|...   ++.+|+|.+...          ......++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4788899999999999999986   578999988532          22345668889998875 799999999999987


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEec
Q 048535          180 EKESLILIYDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGD  258 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D  258 (409)
                       ++..+++|||+++++|.+++... .....+++..+..++.|++.||.|||+  ..+++|+||||+||+++.++.+||+|
T Consensus        81 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 -NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             -CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence             77899999999999999988542 234568999999999999999999993  26799999999999999999999999


Q ss_pred             ccCcccccCCc---eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHH---------------hhhc-CC-CC
Q 048535          259 FGLAKMHHHGQ---VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDER---------------LKAK-GG-YA  312 (409)
Q Consensus       259 FGla~~~~~~~---~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~---------------l~~~-~~-~~  312 (409)
                      ||++.......   ...|...+      ....++...|+|+++  ..+++++...               .... .+ ..
T Consensus       158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG--~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  235 (269)
T cd08528         158 FGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFG--CILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE  235 (269)
T ss_pred             ccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHH--HHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCc
Confidence            99998755432   11121111      123356678999873  1111111111               0000 01 11


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                      ......+.+++.+||+.||++||++.|+..+++
T Consensus       236 ~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         236 GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            134567899999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-30  Score=243.83  Aligned_cols=220  Identities=25%  Similarity=0.350  Sum_probs=169.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|+..+.||.|+||.||+|...  ++.||+|.+.... ......+.+|+.+++.++|+||+++++++.+ ....++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-GSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-CCeEEEEEE
Confidence            36788899999999999999986  8899999997653 4455678999999999999999999999887 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++++|.+++..    ..+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||+++......
T Consensus        80 ~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          80 YCGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eeCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            9999999999953    27899999999999999999999   8999999999999999999999999999998765431


Q ss_pred             ----eeeec---cccc---cCCCcHHHHHHhhhccCcHHHHhhHHhhh----------------cCCCCHH-HHHHHHHH
Q 048535          270 ----VMSGR---RPIE---EGKRNLVDRMWSLTERSELLSVLDERLKA----------------KGGYADE-VVEKVLHL  322 (409)
Q Consensus       270 ----~~~g~---~p~~---~~~~~~~~~vws~~~~~~~~~~~~~~l~~----------------~~~~~~~-~~~~l~~l  322 (409)
                          ...|.   .+.+   ...++..+|+|+++  ..+++++......                ....... ....+.++
T Consensus       153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG--~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (274)
T cd06609         153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLG--ITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDF  230 (274)
T ss_pred             cccccccCCccccChhhhccCCCCchhhHHHHH--HHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHH
Confidence                11111   1111   23456788999974  1222222211110                0111111 34567788


Q ss_pred             HHHccCcCCCCCCCHHHHHH
Q 048535          323 GLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +.+||+.+|++|||++++++
T Consensus       231 l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         231 VSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             HHHHhhCChhhCcCHHHHhh
Confidence            88888888888888888865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=2e-30  Score=251.36  Aligned_cols=184  Identities=24%  Similarity=0.250  Sum_probs=146.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||++...  ++.+|+|.+...   .......+.+|+.++..++|+||+++++++.+ .+..++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-ENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCEEEEE
Confidence            47888999999999999999987  788999998642   22334558899999999999999999998887 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        80 ~ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             EeccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            9999999999999642  246899999999999999999999   89999999999999999999999999999875432


Q ss_pred             Cc-----eeeecccc---c--------cCCCcHHHHHHhhhccCcHHHHhhHH
Q 048535          268 GQ-----VMSGRRPI---E--------EGKRNLVDRMWSLTERSELLSVLDER  304 (409)
Q Consensus       268 ~~-----~~~g~~p~---~--------~~~~~~~~~vws~~~~~~~~~~~~~~  304 (409)
                      ..     ...|...+   +        ...++..+|+|+++  ..+++++...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlG--vil~ell~g~  205 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLG--VCMYEMLYGE  205 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeH--HHHHHHhcCC
Confidence            21     11222221   1        12345677888886  3445554433

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=3.8e-30  Score=239.18  Aligned_cols=220  Identities=25%  Similarity=0.420  Sum_probs=169.2

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-----hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-----EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      +|+..+.||+|+||.||+|...  +..|++|.+....     .+..+.+.+|+.++++++|+||+++++++.. ....++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-EDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-CCeEEE
Confidence            4677889999999999999986  8899999986542     3356789999999999999999999999887 678999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ++||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++....
T Consensus        80 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          80 FLELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999999954   245899999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCc---eeeecc---c---cccCC-CcHHHHHHhhhccCcHHHHhhHHh-----------------hhcCCCCHHHHHHH
Q 048535          267 HGQ---VMSGRR---P---IEEGK-RNLVDRMWSLTERSELLSVLDERL-----------------KAKGGYADEVVEKV  319 (409)
Q Consensus       267 ~~~---~~~g~~---p---~~~~~-~~~~~~vws~~~~~~~~~~~~~~l-----------------~~~~~~~~~~~~~l  319 (409)
                      ...   ...|..   +   ..... .+...|+|+++.  .+++++....                 ......+......+
T Consensus       154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~--~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (258)
T cd06632         154 EFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGC--TVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEA  231 (258)
T ss_pred             ccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHH--HHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHH
Confidence            332   111111   1   11122 566788998731  1111111100                 00112333445678


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHH
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+++.+||+.+|++||++.++++
T Consensus       232 ~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         232 KDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhc
Confidence            88999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=6.1e-31  Score=248.62  Aligned_cols=261  Identities=24%  Similarity=0.304  Sum_probs=182.9

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|+..+.||+|+||.||+|...  |+.||+|.++...  ......+.+|++++++++||||+++++++.+ ....++++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-DKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-CCceEEEEe
Confidence            4778899999999999999986  8899999997542  2233567889999999999999999999887 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |++ ++|.+++...  ...+++..+..++.||++||.|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        80 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          80 YCD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             cCC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            997 4888887542  345899999999999999999999   8999999999999999999999999999998654321


Q ss_pred             e----eeec---cccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 048535          270 V----MSGR---RPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIR  338 (409)
Q Consensus       270 ~----~~g~---~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  338 (409)
                      -    ..+.   .+.+    ...++...|+|+++  ..+++++....+......  ....+..+...+-..++..-|.+.
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG--~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG--CIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPGVS  229 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHH--HHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHHhh
Confidence            0    0011   1111    12346789999996  445555544332111111  112233333333333333333333


Q ss_pred             HHHHHHhcCcCCCC--------CCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          339 QVLKMLEGQTEGTG--------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       339 evl~~L~~~~~~~~--------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      ++..... ....+.        +.-.....+++.+|+..+|.+|.+.++++.||||
T Consensus       230 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         230 KLPDYKP-YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             hcccccc-cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            3222110 000000        0011223689999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=4e-30  Score=243.88  Aligned_cols=225  Identities=28%  Similarity=0.373  Sum_probs=167.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~~lv~  188 (409)
                      ++|...+.||.|++|.||++...  ++.+|+|.+... .......+.+|++++++++||||++++++|... ...+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46788899999999999999986  789999999754 334557799999999999999999999988653 34689999


Q ss_pred             EeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          189 DYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       189 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||+++++|.+++... .....+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999987532 23456899999999999999999999   89999999999999999999999999999875432


Q ss_pred             Cc--eeeecc---c---cccCCCcHHHHHHhhhccCcHHHHhhHHhhhc---------------------------CCCC
Q 048535          268 GQ--VMSGRR---P---IEEGKRNLVDRMWSLTERSELLSVLDERLKAK---------------------------GGYA  312 (409)
Q Consensus       268 ~~--~~~g~~---p---~~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~---------------------------~~~~  312 (409)
                      ..  ...+..   +   .....++...|+|+++  ..+++++.......                           ....
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd06621         158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLG--LTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG  235 (287)
T ss_pred             cccccccCCccccCHHHhcCCCCCchhhHHHHH--HHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCC
Confidence            21  111111   1   1123456678899874  11122221111100                           0000


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ......+.+++.+||+.+|++|||+.|+++
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            123456778888888888888888888776

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=3.5e-30  Score=241.33  Aligned_cols=148  Identities=28%  Similarity=0.481  Sum_probs=129.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-----ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-----SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESL  184 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~  184 (409)
                      .+|+..+.||+|+||.||+|...  +..||+|.+...     .......+.+|+.++++++||||+++++++... ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888999999999999999875  889999998643     223456788999999999999999999988653 3578


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++++||+++++|.+++..   ...+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999999954   335899999999999999999999   89999999999999999999999999999975


Q ss_pred             cc
Q 048535          265 HH  266 (409)
Q Consensus       265 ~~  266 (409)
                      ..
T Consensus       156 ~~  157 (266)
T cd06651         156 LQ  157 (266)
T ss_pred             cc
Confidence            43

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=2.3e-30  Score=245.79  Aligned_cols=234  Identities=23%  Similarity=0.265  Sum_probs=172.0

Q ss_pred             ccHHHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEc
Q 048535          103 VSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKK  179 (409)
Q Consensus       103 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  179 (409)
                      ++++++..++++|+..+.||+|+||.||++...  ++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            455667778899999999999999999999986  8899999986432 2235678899999999 89999999999875


Q ss_pred             cC----CeEEEEEEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcE
Q 048535          180 EK----ESLILIYDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNA  254 (409)
Q Consensus       180 ~~----~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~  254 (409)
                      .+    ...++||||+++|+|.+++... .....+++..+..++.|++.||.|||   +.+++||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            32    3589999999999999988542 12346899999999999999999999   8999999999999999999999


Q ss_pred             EEecccCcccccCCc----eeeecc---cccc--------CCCcHHHHHHhhhccCcHHHHhhHHhh-------------
Q 048535          255 RLGDFGLAKMHHHGQ----VMSGRR---PIEE--------GKRNLVDRMWSLTERSELLSVLDERLK-------------  306 (409)
Q Consensus       255 kl~DFGla~~~~~~~----~~~g~~---p~~~--------~~~~~~~~vws~~~~~~~~~~~~~~l~-------------  306 (409)
                      ||+|||+++......    ...|..   +.+.        ...+..+|+|+++  ..+++++.....             
T Consensus       168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG--vi~~el~~g~~p~~~~~~~~~~~~~  245 (291)
T cd06639         168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLG--ITAIELGDGDPPLFDMHPVKTLFKI  245 (291)
T ss_pred             EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHH--HHHHHHhhCCCCCCCCcHHHHHHHH
Confidence            999999988654322    111111   1110        1135678899874  112222211111             


Q ss_pred             --hc---CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          307 --AK---GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       307 --~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                        ..   ...+......+.+++.+||+.+|++||++.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         246 PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             hcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence              00   0112233446777888888888888888888765

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=4.2e-30  Score=240.12  Aligned_cols=224  Identities=25%  Similarity=0.379  Sum_probs=168.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|+..+.||.|+||+||+|...  +..+|+|++... .....+.+.+|+++++.++|+||+++++.+.. .+..+++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-GDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-CCEEEEEEe
Confidence            47889999999999999999975  789999999754 23356789999999999999999999998887 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++++|.+++........+++..+..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            9999999999965433356899999999999999999999   8999999999999999999999999999987654322


Q ss_pred             e--------eeecccc---c---cC-CCcHHHHHHhhhccCcHHHHhhHHhhhc----------------CCCC-----H
Q 048535          270 V--------MSGRRPI---E---EG-KRNLVDRMWSLTERSELLSVLDERLKAK----------------GGYA-----D  313 (409)
Q Consensus       270 ~--------~~g~~p~---~---~~-~~~~~~~vws~~~~~~~~~~~~~~l~~~----------------~~~~-----~  313 (409)
                      .        ..|...+   +   .. ..+..+|+|+++  ..+++++.......                ....     .
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG--~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFG--ITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK  234 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHh--HHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccc
Confidence            1        1122211   1   11 345667888873  12222222211100                0000     1


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .....+.+++..||+.||++|||+.++++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            33456677777888888888888777764

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=2e-30  Score=274.15  Aligned_cols=232  Identities=20%  Similarity=0.260  Sum_probs=173.4

Q ss_pred             HHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCe
Q 048535          109 HAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KES  183 (409)
Q Consensus       109 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~  183 (409)
                      ....++|.+.+.||+|+||+||++...  +..||+|.+...  .......|..|+.+|++|+|||||+++++|... ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            344578999999999999999999987  788999998754  344567899999999999999999999988643 456


Q ss_pred             EEEEEEeCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCceeecCCCCCCeeeCCC-------
Q 048535          184 LILIYDYMENGSLDKWIFECD-ESIALSWEQRIKVLKDVASGILYLYEGW----ESKVLHRDIKASNVLLDKK-------  251 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~ivHrDlKp~NILl~~~-------  251 (409)
                      +||||||+++|+|.++|.... ....+++..++.|+.||+.||.|||...    ..+||||||||+||||+.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999996532 2346999999999999999999999421    1469999999999999642       


Q ss_pred             ----------CcEEEecccCcccccCCc---eeeeccccc--------cCCCcHHHHHHhhhccCcHHHHhhHHhh----
Q 048535          252 ----------MNARLGDFGLAKMHHHGQ---VMSGRRPIE--------EGKRNLVDRMWSLTERSELLSVLDERLK----  306 (409)
Q Consensus       252 ----------~~~kl~DFGla~~~~~~~---~~~g~~p~~--------~~~~~~~~~vws~~~~~~~~~~~~~~l~----  306 (409)
                                ..+||+|||+++......   ...|...+.        ...++..+|+|+++  ..+++++....+    
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG--~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG--CIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHH--HHHHHHHHCCCCCCcC
Confidence                      348999999998754322   112222221        12356788999984  222222221111    


Q ss_pred             -----------hcCCCC-HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          307 -----------AKGGYA-DEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       307 -----------~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                                 .....+ ......+.+|+..||+.+|.+||++.|+++
T Consensus       247 ~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence                       101111 223467899999999999999999999984

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=2.5e-30  Score=244.43  Aligned_cols=262  Identities=23%  Similarity=0.297  Sum_probs=176.6

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|+..+.||.|++|.||+|...  ++.||||.++...  ......+.+|++++++++||||+++++++.+ ....++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-CCcEEEEee
Confidence            4788899999999999999986  8899999987542  2234578899999999999999999999886 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |++ ++|.+++... ....+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||+++......
T Consensus        80 ~~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          80 FLH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             ccc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            996 6899988653 2356899999999999999999999   8999999999999999999999999999987653321


Q ss_pred             e-------eeeccccc---c-CCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 048535          270 V-------MSGRRPIE---E-GKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIR  338 (409)
Q Consensus       270 ~-------~~g~~p~~---~-~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  338 (409)
                      .       ..+..+.+   . ...+...|+|+++  ..+++++...........   ...+.++...--......-|...
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG--~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG--CIFAEMVTRRALFPGDSE---IDQLFRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHH--HHHHHHHHCCCCCCCCCH---HHHHHHHHHHhCCCChhhhhhhh
Confidence            0       00111111   1 2235679999986  345555554433211111   11222222111111111111111


Q ss_pred             HHHHHHhcCcCCC-------CCCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          339 QVLKMLEGQTEGT-------GLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       339 evl~~L~~~~~~~-------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      ++-+.-.......       .+.-+....+++.+|+..+|.+|.+..+++.||||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            1111100000000       00001122578888888888888888888888887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=5e-30  Score=243.47  Aligned_cols=264  Identities=22%  Similarity=0.283  Sum_probs=178.1

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++++|...+.||+|+||.||+|...  +..||+|.+.... ......+.+|+.+++.++|+||+++++++.. +...++|
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv   81 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTFV   81 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEEEE
Confidence            4678999999999999999999876  8899999997543 2223467899999999999999999999887 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||++ ++|.+++...  ...+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++++||+|||+++....
T Consensus        82 ~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          82 FEYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             Eeccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            99996 6888777542  245788899999999999999999   88999999999999999999999999999875432


Q ss_pred             Cc----eeee---ccccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCc-CCCCCC
Q 048535          268 GQ----VMSG---RRPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHP-EANSRP  335 (409)
Q Consensus       268 ~~----~~~g---~~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~-dP~~RP  335 (409)
                      ..    ...+   ..+.+    ...++...|+|+++  ..+++++........  .....+.+.+. ..++.. .+...|
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG--~~l~~l~~g~~~f~~--~~~~~~~~~~~-~~~~~~~~~~~~~  230 (291)
T cd07870         156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAG--CIFIEMLQGQPAFPG--VSDVFEQLEKI-WTVLGVPTEDTWP  230 (291)
T ss_pred             CCCCCCCccccccccCCceeecCCCCCcHHHHHHHH--HHHHHHHhCCCCCCC--chhHHHHHHHH-HHHcCCCChhhhh
Confidence            11    0001   11111    12346678999986  345555544332111  11111222221 111111 111101


Q ss_pred             CHHHHHHHHhcCcC----------CCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          336 TIRQVLKMLEGQTE----------GTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       336 t~~evl~~L~~~~~----------~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      ....+-+.......          ...........+++.+|+..+|.+|+++.+++.||||
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            11000000000000          0000111233689999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=7.4e-31  Score=257.13  Aligned_cols=225  Identities=23%  Similarity=0.315  Sum_probs=182.4

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      .-...|.+.+.||+|.|+.|.+|+..  +..||+|.+...  +....+.+.+|+++|+.++|||||+++.+... ...+|
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~~ly  131 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EATLY  131 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-cceeE
Confidence            34577899999999999999999987  999999999765  44455669999999999999999999999887 77899


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +||||+.+|.+++|+..   ...+.+..+..++.|+..|++|||   ++.|+|||||++||||+.++++||+|||++..+
T Consensus       132 lV~eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~  205 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFF  205 (596)
T ss_pred             EEEEeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceee
Confidence            99999999999999964   345667888999999999999999   899999999999999999999999999999988


Q ss_pred             cCCc---eeeecccccc-------CCCcHHHHHHhhhccCcHHHHhhHHhhhc---------------CCCCHHHHHHHH
Q 048535          266 HHGQ---VMSGRRPIEE-------GKRNLVDRMWSLTERSELLSVLDERLKAK---------------GGYADEVVEKVL  320 (409)
Q Consensus       266 ~~~~---~~~g~~p~~~-------~~~~~~~~vws~~~~~~~~~~~~~~l~~~---------------~~~~~~~~~~l~  320 (409)
                      ..+.   ..+|.+|+..       .......|+|+++.  .++.++...|++.               -..+.-....+.
T Consensus       206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgv--vly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce  283 (596)
T KOG0586|consen  206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGV--VLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCE  283 (596)
T ss_pred             cccccccccCCCCCccChHhhcCcccCCcceehhhhhh--hheeeeecccccCCcccccccchheeeeecccceeechhH
Confidence            7654   4567777643       22345678999842  2333333333322               223334455788


Q ss_pred             HHHHHccCcCCCCCCCHHHHHHH
Q 048535          321 HLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       321 ~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      +++.+.+-.+|.+|++++++.+.
T Consensus       284 ~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  284 DLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             HHHHHhhccCccccCCHHHhhhh
Confidence            89999999999999999998753

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=4.8e-30  Score=238.39  Aligned_cols=224  Identities=21%  Similarity=0.326  Sum_probs=169.8

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|+..+.||+|+||.||++...  ++.+|+|.+...  .....+.+.+|++++++++||||+++++.+.. .+..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEe
Confidence            4778899999999999999886  889999998654  33456789999999999999999999998876 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC-CcEEEecccCcccccCC
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK-MNARLGDFGLAKMHHHG  268 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFGla~~~~~~  268 (409)
                      |+++++|.+++... ....+++..+..++.|+++||.|||   +++++|+||||+||+++++ +.+||+|||+++.....
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          80 YAPGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             cCCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            99999999999653 2345899999999999999999999   8999999999999999865 46899999999865432


Q ss_pred             c---eeeeccc---c---ccCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhh-cCCCCHHHHHHHHHHHHH
Q 048535          269 Q---VMSGRRP---I---EEGKRNLVDRMWSLTE-------------RSELLSVLDERLKA-KGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       269 ~---~~~g~~p---~---~~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~-~~~~~~~~~~~l~~l~~~  325 (409)
                      .   ...|...   .   .....+...|+|+++.             .............. ....+......+.+++.+
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  235 (256)
T cd08220         156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS  235 (256)
T ss_pred             ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence            2   1111111   1   1133455678888731             01111111111110 112233456678999999


Q ss_pred             ccCcCCCCCCCHHHHHH
Q 048535          326 CAHPEANSRPTIRQVLK  342 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~  342 (409)
                      ||+.+|++|||+.|+++
T Consensus       236 ~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         236 MLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HccCChhhCCCHHHHhh
Confidence            99999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=2.8e-30  Score=244.08  Aligned_cols=262  Identities=20%  Similarity=0.290  Sum_probs=188.5

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|++.+.||+|+||.||+|...  +..||+|++....  ......+.+|+.++++++||||+++++++.. ....++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCeeEEEec
Confidence            4778899999999999999986  8899999997653  3445679999999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+ +++|.+++....  ..+++.++..++.|+++||.|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            99 999999986432  56999999999999999999999   8999999999999999999999999999998765432


Q ss_pred             e-----eeec---cccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 048535          270 V-----MSGR---RPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI  337 (409)
Q Consensus       270 ~-----~~g~---~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  337 (409)
                      .     ..|.   .+.+    ...++...|+|+++  ..+++++.........   .....+..+....-.+.+...|..
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG--~~l~~l~tg~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVG--CIFAELLNGSPLFPGE---NDIEQLAIVFRTLGTPNEETWPGL  228 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHH--HHHHHHHcCCcCcCCC---CHHHHHHHHHHHcCCCChHHHhhc
Confidence            0     0111   1111    12346789999986  3445555442221111   112233333333434444444444


Q ss_pred             HHHHHHHhcCcCCCC--------CCCCCcchhHHhhhcccCCCCcccccccCCCCCcc
Q 048535          338 RQVLKMLEGQTEGTG--------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFN  387 (409)
Q Consensus       338 ~evl~~L~~~~~~~~--------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~  387 (409)
                      .++............        +..+..-.+++.+|+..+|.+|++..+++.||||+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            333222111000000        00112337899999999999999999999999985

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-30  Score=245.24  Aligned_cols=173  Identities=25%  Similarity=0.372  Sum_probs=141.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++|+..+.||+|+||.||+|...  ++.||+|.++..  .....+.+.+|++++++++|+||+++++++.. ++..+++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEE
Confidence            36888999999999999999986  789999998654  23345778999999999999999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||++++.+..+..   ....+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||++......
T Consensus        80 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          80 EYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             ecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            9999877776653   2345899999999999999999999   899999999999999999999999999998875543


Q ss_pred             ce-----eeec---cccc---cC-CCcHHHHHHhhh
Q 048535          269 QV-----MSGR---RPIE---EG-KRNLVDRMWSLT  292 (409)
Q Consensus       269 ~~-----~~g~---~p~~---~~-~~~~~~~vws~~  292 (409)
                      ..     ..+.   .+.+   .. .++...|+|+++
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG  189 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIG  189 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHH
Confidence            21     1111   1111   12 456788999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=2.8e-30  Score=241.78  Aligned_cols=220  Identities=20%  Similarity=0.362  Sum_probs=166.3

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC------hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS------EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      +|+..+.||+|+||.||+|...  ++.||+|.+....      ....+.+.+|+.++++++|+||+++++++.+ .+..+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-DSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-CCeEE
Confidence            4788899999999999999875  8899999996432      2235678999999999999999999999987 67899


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC-cEEEecccCccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM-NARLGDFGLAKM  264 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~  264 (409)
                      +||||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++ .+||+|||++..
T Consensus        80 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          80 LFVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            99999999999999954   346899999999999999999999   89999999999999998776 599999999876


Q ss_pred             ccCCc--------eeeec---cccc---cCCCcHHHHHHhhhccCcHHHHhhHHhh--------------------hcCC
Q 048535          265 HHHGQ--------VMSGR---RPIE---EGKRNLVDRMWSLTERSELLSVLDERLK--------------------AKGG  310 (409)
Q Consensus       265 ~~~~~--------~~~g~---~p~~---~~~~~~~~~vws~~~~~~~~~~~~~~l~--------------------~~~~  310 (409)
                      .....        ...|.   .+.+   ...++...|+|+++  ..+++++.....                    ....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG--~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVG--CVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS  231 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHH--HHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCC
Confidence            54321        01111   1111   13445667888873  111111111110                    1123


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       311 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+......+.+++.+|++.+|++|||+.++++
T Consensus       232 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         232 IPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            34445567788888888888888888888764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=1.2e-30  Score=248.26  Aligned_cols=219  Identities=22%  Similarity=0.287  Sum_probs=165.7

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      |.....||+|+||.||++...  +..||||.+........+.+.+|+.++++++|+||+++++.+.. .+..++||||++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~lv~e~~~  102 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-GDELWVVMEFLE  102 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-CCeEEEEEeCCC
Confidence            333467999999999999875  88999999976655666789999999999999999999999887 678999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---  269 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---  269 (409)
                      +++|.+++..    ..+++..+..++.||+.||.|||   +.+|+||||||+||++++++.+||+|||++.......   
T Consensus       103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~  175 (292)
T cd06658         103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR  175 (292)
T ss_pred             CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence            9999998842    35899999999999999999999   8899999999999999999999999999987543211   


Q ss_pred             -eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhc----------------C--CCCHHHHHHHHHHHH
Q 048535          270 -VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAK----------------G--GYADEVVEKVLHLGL  324 (409)
Q Consensus       270 -~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~----------------~--~~~~~~~~~l~~l~~  324 (409)
                       ...|...+      ....++...|+|+++  ..+++++.......                .  .........+.+++.
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG--vil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  253 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLG--IMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD  253 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHH
Confidence             11122111      113456778999974  11222222111100                0  111123446777888


Q ss_pred             HccCcCCCCCCCHHHHHHH
Q 048535          325 LCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       325 ~Cl~~dP~~RPt~~evl~~  343 (409)
                      .||+.||++|||+.++++.
T Consensus       254 ~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         254 LMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHccCChhHCcCHHHHhhC
Confidence            8888888888888888763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=4.2e-30  Score=243.89  Aligned_cols=263  Identities=24%  Similarity=0.356  Sum_probs=179.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE-HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|+..+.||+|++|.||+|...  ++.||+|.+..... .....+.+|++++++++|+||+++++++.+ ....++|||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   83 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-KKTLTLVFE   83 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-CCeEEEEEe
Confidence            67888999999999999999986  88999999865422 223457789999999999999999999887 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++ +|.+++....  ..+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          84 YLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            9985 9999986532  36899999999999999999999   8999999999999999999999999999987543211


Q ss_pred             ------e-eeeccccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 048535          270 ------V-MSGRRPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIR  338 (409)
Q Consensus       270 ------~-~~g~~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  338 (409)
                            . .....+.+    ...++...|+|+++  ..+++++..........  .....+..+....-...+...|...
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG--~il~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVG--CIFYEMATGRPLFPGST--DVEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHH--HHHHHHHhCCCCCCCCc--cHHHHHHHHHHhcCCCChhhhhhhh
Confidence                  0 00111111    12356678999986  34555554433221111  1111122121111111222222221


Q ss_pred             HHHHHHhcCcC----------CCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          339 QVLKMLEGQTE----------GTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       339 evl~~L~~~~~----------~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      ...........          .+.........+++.+|+..+|..|.+..+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            11111100000          0011111233689999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-30  Score=254.10  Aligned_cols=219  Identities=22%  Similarity=0.343  Sum_probs=178.6

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCCH
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSL  196 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gsL  196 (409)
                      -.||+|.||+||-|++.  ...+|||.+...+....+-+..|+.+.++|+|.|||+++|.|.+ ++.+-|.||-.|||||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCcH
Confidence            36999999999999987  66789999988877777889999999999999999999999877 7788899999999999


Q ss_pred             HHHHhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC-CCcEEEecccCcccccC----Cc
Q 048535          197 DKWIFECDESIAL--SWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK-KMNARLGDFGLAKMHHH----GQ  269 (409)
Q Consensus       197 ~~~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DFGla~~~~~----~~  269 (409)
                      .++|+..=  +++  ++...-.+.+||++||.|||   ++.|||||||-+|||++. .|.+||+|||.++.+..    .+
T Consensus       660 SsLLrskW--GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  660 SSLLRSKW--GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             HHHHHhcc--CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence            99996532  345  78888899999999999999   899999999999999965 68899999998876532    33


Q ss_pred             eeeeccccc--------cCCCcHHHHHHhhhccC--------------cHH-HHhh-HHhhhcCCCCHHHHHHHHHHHHH
Q 048535          270 VMSGRRPIE--------EGKRNLVDRMWSLTERS--------------ELL-SVLD-ERLKAKGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       270 ~~~g~~p~~--------~~~~~~~~~vws~~~~~--------------~~~-~~~~-~~l~~~~~~~~~~~~~l~~l~~~  325 (409)
                      ..||..-+.        .-.|...+|+|+++...              ... .++. +..+..++.|.+...+...++++
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filr  814 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILR  814 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence            555654332        24577889999995321              111 1111 12233467889999999999999


Q ss_pred             ccCcCCCCCCCHHHHHHH
Q 048535          326 CAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~~  343 (409)
                      |+.+||.+||+++++++.
T Consensus       815 cFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  815 CFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             HcCCCcccCccHHHhccC
Confidence            999999999999999863

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.97  E-value=1e-32  Score=248.62  Aligned_cols=219  Identities=26%  Similarity=0.357  Sum_probs=178.7

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      -|++..+||+|+||.||++.++  |+.+|||.+..++  +.+++..|+.+|.+++.|++|++||.+.. ...+|+|||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK-~sDLWIVMEYC  110 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFK-HSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhcc-CCceEeehhhc
Confidence            3667789999999999999987  9999999998654  56889999999999999999999998887 67899999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc--
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ--  269 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~--  269 (409)
                      ..|++.+.++.  .+.+|++.++..++.+.++||+|||   ...-||||||+.||||+.+|.+||+|||.|..+....  
T Consensus       111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK  185 (502)
T KOG0574|consen  111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK  185 (502)
T ss_pred             CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence            99999999975  3457999999999999999999999   8899999999999999999999999999997665422  


Q ss_pred             --eeeeccc------cccCCCcHHHHHHhhhccCcHHHHhhHHh------------------hhcCCCCHHHHHHHHHHH
Q 048535          270 --VMSGRRP------IEEGKRNLVDRMWSLTERSELLSVLDERL------------------KAKGGYADEVVEKVLHLG  323 (409)
Q Consensus       270 --~~~g~~p------~~~~~~~~~~~vws~~~~~~~~~~~~~~l------------------~~~~~~~~~~~~~l~~l~  323 (409)
                        .+.|.+-      ++.-.|+...|+|+++-..  .++...+.                  +..-.-++.++.++.+++
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITa--IEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi  263 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITA--IEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI  263 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchh--hhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence              2233332      2345688999999995321  11111110                  000123567889999999


Q ss_pred             HHccCcCCCCCCCHHHHHH
Q 048535          324 LLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..|+-.+|++|-|+-++++
T Consensus       264 ~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  264 RSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HHHhcCCHHHHHHHHHHhh
Confidence            9999999999999998875

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=2.7e-30  Score=244.14  Aligned_cols=234  Identities=24%  Similarity=0.356  Sum_probs=174.1

Q ss_pred             cccHHHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEE
Q 048535          102 RVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCK  178 (409)
Q Consensus       102 ~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  178 (409)
                      ..++.++..+.+.|+..+.||+|+||.||+|...  ++.+|+|.+.... ....++..|+.++.++ +|+||+++++++.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           5 DIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            3466677778899999999999999999999986  7899999986543 3346788999999998 7999999999885


Q ss_pred             c-----cCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc
Q 048535          179 K-----EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN  253 (409)
Q Consensus       179 ~-----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~  253 (409)
                      .     .....+++|||+++|+|.+++... ....+++..+..++.|++.||.|||   +.+|+|+||||+||++++++.
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~  159 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCC
Confidence            3     135789999999999999998653 2345889999999999999999999   899999999999999999999


Q ss_pred             EEEecccCcccccCC----ceeeeccc---cc--------cCCCcHHHHHHhhhccCcHHHHhhHHhhhc----------
Q 048535          254 ARLGDFGLAKMHHHG----QVMSGRRP---IE--------EGKRNLVDRMWSLTERSELLSVLDERLKAK----------  308 (409)
Q Consensus       254 ~kl~DFGla~~~~~~----~~~~g~~p---~~--------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~----------  308 (409)
                      ++|+|||+++.....    ....|...   .+        ...++...|+|+++  ..+++++.......          
T Consensus       160 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG--~~l~el~~g~~p~~~~~~~~~~~~  237 (282)
T cd06636         160 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG--ITAIEMAEGAPPLCDMHPMRALFL  237 (282)
T ss_pred             EEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHH--HHHHHHHhCCCCccccCHHhhhhh
Confidence            999999998754321    11112111   11        12345568899874  12222222111100          


Q ss_pred             -------CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          309 -------GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       309 -------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                             ..........+.+++.+||+.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                   0011124457788888888888888888888764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=5.6e-30  Score=238.86  Aligned_cols=221  Identities=24%  Similarity=0.388  Sum_probs=171.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE-HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|+..+.||+|++|.||++...  ++.||+|++..... ...+.+.+|+..+.+++|+||+++++++.. ....++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-EGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-CCeEEEEEE
Confidence            46888899999999999999987  89999999976643 456789999999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE-SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      |+++++|.+++...   ..+++..+..++.|+++||+|||   + .+++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          80 YMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             ecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            99999999999542   56899999999999999999999   8 99999999999999999999999999999876433


Q ss_pred             cee----eeccc------cccCCCcHHHHHHhhhccCcHHHHhhHH------------------hhh-cCCCCHH-HHHH
Q 048535          269 QVM----SGRRP------IEEGKRNLVDRMWSLTERSELLSVLDER------------------LKA-KGGYADE-VVEK  318 (409)
Q Consensus       269 ~~~----~g~~p------~~~~~~~~~~~vws~~~~~~~~~~~~~~------------------l~~-~~~~~~~-~~~~  318 (409)
                      ...    .+...      .....++...|+|+++  ..+++++...                  ... ....+.. .+..
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG--~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (264)
T cd06623         154 LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLG--LTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPE  231 (264)
T ss_pred             CCcccceeecccccCHhhhCCCCCCchhhHHHHH--HHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHH
Confidence            211    11111      1123456678899874  1122222211                  110 0112222 4567


Q ss_pred             HHHHHHHccCcCCCCCCCHHHHHH
Q 048535          319 VLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       319 l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +.+++..||+.+|++|||+.++++
T Consensus       232 l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         232 FRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             HHHHHHHHccCChhhCCCHHHHHh
Confidence            888888888888888888888876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=7.2e-30  Score=241.18  Aligned_cols=262  Identities=26%  Similarity=0.357  Sum_probs=179.4

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      +|+..+.||.|++|.||+|+..  |..||||.++... ......+.+|+.++++++||||+++++++.+ .+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-ENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-CCcEEEEEec
Confidence            5788899999999999999986  8899999997653 2234567889999999999999999999987 6788999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc-
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ-  269 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-  269 (409)
                      +++ +|.+++........+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++...... 
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            985 89998865443456899999999999999999999   8899999999999999999999999999997543211 


Q ss_pred             -----eee-eccccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 048535          270 -----VMS-GRRPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQ  339 (409)
Q Consensus       270 -----~~~-g~~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e  339 (409)
                           ..+ ...+.+    ...++..+|+|+++  ..+++++............+....   +...+-.+.+...+...+
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG--~~l~~l~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  230 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVG--CIMAEMITGRPLFPGTNNEDQLLK---IFRIMGTPTESTWPGISQ  230 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCCcHHHHHH---HHHHhCCCChhhHHHHhc
Confidence                 000 011111    12346788999985  344555544333222222222222   222221111111000000


Q ss_pred             HHHHHhcCcCC--------CCCCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          340 VLKMLEGQTEG--------TGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       340 vl~~L~~~~~~--------~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      . ..+......        ..+.-+....+++.+|+..+|.+|++.++++.||||
T Consensus       231 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         231 L-PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             C-chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            0 000000000        000012234788999999999999999999999997

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.4e-30  Score=244.23  Aligned_cols=148  Identities=22%  Similarity=0.247  Sum_probs=132.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      +.|+..+.||+|.-|+||++.+.  +..+|+|++.+.   ..+...+...|-+||+.++||.+..||+.+.. +...|++
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-~~~~cl~  155 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-DKYSCLV  155 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-cceeEEE
Confidence            45667789999999999999998  478999999765   33445667889999999999999999999987 7889999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      ||||+||+|..+.++. ....+++..+..++.+|+-||+|||   -.|||.|||||+||||-++|.+.|+||.|+...
T Consensus       156 meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            9999999999988764 4567999999999999999999999   899999999999999999999999999998654

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=3e-30  Score=241.17  Aligned_cols=224  Identities=24%  Similarity=0.380  Sum_probs=168.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|+..+.||+|+||.||++...  ++.||+|.+... .....+++.+|++++++++||||+++++++.. ....++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-NGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-CCEEEEEEE
Confidence            36777889999999999999997  889999998765 34456789999999999999999999999987 688999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE-SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      |+++++|.+++....  ..+++..+..++.|++.||+|||   + .+++|+||||+||++++++.+||+|||++......
T Consensus        80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          80 YMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             ecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            999999999996432  56899999999999999999999   7 99999999999999999999999999998754321


Q ss_pred             c--eeeecc---c---cccCCCcHHHHHHhhhcc------------------CcHHHHhhHHhhhc-CCCCHH-HHHHHH
Q 048535          269 Q--VMSGRR---P---IEEGKRNLVDRMWSLTER------------------SELLSVLDERLKAK-GGYADE-VVEKVL  320 (409)
Q Consensus       269 ~--~~~g~~---p---~~~~~~~~~~~vws~~~~------------------~~~~~~~~~~l~~~-~~~~~~-~~~~l~  320 (409)
                      .  ...+..   +   .....++...|+|+++..                  ....+.+....... ...+.. ....+.
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (265)
T cd06605         155 LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ  234 (265)
T ss_pred             HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence            1  011111   1   112345667889887410                  01111222111110 111222 455677


Q ss_pred             HHHHHccCcCCCCCCCHHHHHH
Q 048535          321 HLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       321 ~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +++..||..||++|||+.+++.
T Consensus       235 ~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         235 DFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHHHHHcCCCchhCcCHHHHhh
Confidence            8888888888888888888764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=7.2e-30  Score=238.96  Aligned_cols=221  Identities=24%  Similarity=0.361  Sum_probs=165.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-----ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-----SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESL  184 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~  184 (409)
                      ++|+..+.||+|+||.||+|...  ++.||+|.+...     .....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57888999999999999999986  889999998532     223456788999999999999999999987653 3468


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      +++|||+++|+|.+++...   ..+++....+++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            8999999999999998542   35789999999999999999999   89999999999999999999999999999975


Q ss_pred             ccCC-------ceeeecccc---c---cCCCcHHHHHHhhhccCcHHHHhhHHhh-----------------hcCCCCHH
Q 048535          265 HHHG-------QVMSGRRPI---E---EGKRNLVDRMWSLTERSELLSVLDERLK-----------------AKGGYADE  314 (409)
Q Consensus       265 ~~~~-------~~~~g~~p~---~---~~~~~~~~~vws~~~~~~~~~~~~~~l~-----------------~~~~~~~~  314 (409)
                      ....       ...+|...+   +   ....+..+|+|+++.  .+++++.....                 ..+..+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~--il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGC--TVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH  233 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHH--HHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchh
Confidence            4321       111222111   1   233456788998741  12222211110                 01223344


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ....+.+++.+|+. +|++||+++|+++
T Consensus       234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         234 VSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             hCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            55667778888874 8888888888765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=7e-30  Score=238.37  Aligned_cols=220  Identities=27%  Similarity=0.393  Sum_probs=166.0

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE--HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|+..+.||+|+||.||+|...  ++.||+|.++....  ...+.+.+|+.++++++|+||+++++++.. .+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-REKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-CCEEEEEEe
Confidence            4778899999999999999875  88999999976533  467889999999999999999999998876 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||   +.+|+|+||||+||++++++.+||+|||++.......
T Consensus        80 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          80 YCSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             cCCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            9999999999953   345889999999999999999999   8999999999999999999999999999998754322


Q ss_pred             eee--------eccc---cc---cC---CCcHHHHHHhhhccCcHHHHhhHHhhh-----------------cCCCCHH-
Q 048535          270 VMS--------GRRP---IE---EG---KRNLVDRMWSLTERSELLSVLDERLKA-----------------KGGYADE-  314 (409)
Q Consensus       270 ~~~--------g~~p---~~---~~---~~~~~~~vws~~~~~~~~~~~~~~l~~-----------------~~~~~~~-  314 (409)
                      ...        +...   .+   ..   ......|+|+++  ..+++++......                 ....+.. 
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G--~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  231 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLG--CVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSL  231 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHH--HHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCccc
Confidence            111        1111   11   11   145667888874  1122222111110                 0111111 


Q ss_pred             -HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 -VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 -~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                       ....+.+++.+||+.+|++|||+.+++.
T Consensus       232 ~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         232 QLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             2456677888888888888888887754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=3.9e-30  Score=242.88  Aligned_cols=223  Identities=21%  Similarity=0.346  Sum_probs=160.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHH-hccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSS-LGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++|++.+.||+|+||.||++...  |+.||+|+++... .....++..|+.. ++.++||||+++++++.. ++..+++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-EGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-CCcEEEEh
Confidence            46888999999999999999986  8999999997552 2334456667765 566799999999999987 67899999


Q ss_pred             EeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          189 DYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWES-KVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       189 E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||++ |+|.+++... .....+++..+..++.|++.||+|||   ++ +++||||||+|||++.++.+||+|||+++...
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            9997 6898887643 23356899999999999999999999   65 89999999999999999999999999998654


Q ss_pred             CCce---eeecccc---cc-------CCCcHHHHHHhhhccCcHHHHhhHHhhh-----------------cCCCC-HHH
Q 048535          267 HGQV---MSGRRPI---EE-------GKRNLVDRMWSLTERSELLSVLDERLKA-----------------KGGYA-DEV  315 (409)
Q Consensus       267 ~~~~---~~g~~p~---~~-------~~~~~~~~vws~~~~~~~~~~~~~~l~~-----------------~~~~~-~~~  315 (409)
                      ....   ..|..++   +.       ..++...|+|+++  ..+++++....+.                 ....+ ...
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG--~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLG--ITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF  233 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhH--HHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence            3211   1121111   10       2234567888874  1122222211110                 01111 123


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +..+.+++.+||+.+|.+|||+.++++
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            456777777777777888877777764

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=7.1e-30  Score=247.40  Aligned_cols=149  Identities=24%  Similarity=0.234  Sum_probs=131.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|++.+.||+|+||.||+++..  ++.||+|.+...   .......+.+|..++..++|+||+++++++.+ .+..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence            47889999999999999999987  788999998643   22334568889999999999999999999887 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++...  ...+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        80 ~Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          80 MDYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             EeCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            9999999999999652  246899999999999999999999   89999999999999999999999999999976543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=5.3e-30  Score=245.82  Aligned_cols=267  Identities=23%  Similarity=0.302  Sum_probs=187.2

Q ss_pred             CCCccceeecCCceEEEEEEEC----CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL----GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLI  185 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~~  185 (409)
                      +|+..+.||+|+||.||+|...    +..||+|.+....   ....+.+.+|+.++++++||||+++++++.+. ....+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999984    6899999997632   33446778999999999999999999999873 16799


Q ss_pred             EEEEeCCCCCHHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC----CCcEEEecc
Q 048535          186 LIYDYMENGSLDKWIFECD--ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK----KMNARLGDF  259 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~----~~~~kl~DF  259 (409)
                      +||||+++ +|.+++....  ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 7777764322  2236899999999999999999999   899999999999999999    899999999


Q ss_pred             cCcccccCCce-------eeec---cccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCC------HHHHHHH
Q 048535          260 GLAKMHHHGQV-------MSGR---RPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYA------DEVVEKV  319 (409)
Q Consensus       260 Gla~~~~~~~~-------~~g~---~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~------~~~~~~l  319 (409)
                      |+++.......       ..+.   .+.+    ...++..+|+|+++  ..+++++...........      ......+
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG--~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~  234 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG--CIFAELLTLEPIFKGREAKIKKSNPFQRDQL  234 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHH--HHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence            99986543211       0111   1111    12356778999986  344555443332211111      1122344


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHHHHh---cCcCCCCC------------CCCCcchhHHhhhcccCCCCcccccccCCCC
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLKMLE---GQTEGTGL------------EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHP  384 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~~L~---~~~~~~~~------------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp  384 (409)
                      ..+...+-..++..++.+.+..+...   ........            .......+++.+|+..+|..|.++++++.||
T Consensus       235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~  314 (316)
T cd07842         235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP  314 (316)
T ss_pred             HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCC
Confidence            55555555556665554444432222   11100000            1112236899999999999999999999999


Q ss_pred             Cc
Q 048535          385 TF  386 (409)
Q Consensus       385 ~~  386 (409)
                      ||
T Consensus       315 ~f  316 (316)
T cd07842         315 YF  316 (316)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.5e-30  Score=249.34  Aligned_cols=215  Identities=21%  Similarity=0.234  Sum_probs=157.6

Q ss_pred             eecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC---CCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          121 IGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL---KHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       121 lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      ||+|+||+||+|...  ++.||||++...   .......+..|..++...   +||||+++++++.. ....++||||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-DSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-CCeEEEEEcCCC
Confidence            799999999999986  899999999643   122334556677777655   79999999998887 678999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---  269 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---  269 (409)
                      +|+|.+++..   ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......   
T Consensus        80 ~g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~  153 (330)
T cd05586          80 GGELFWHLQK---EGRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT  153 (330)
T ss_pred             CChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence            9999999853   346899999999999999999999   8999999999999999999999999999987532211   


Q ss_pred             -eeeecccc---c----cCCCcHHHHHHhhhcc-------------CcHHHHhhHHhhhcCCCC-HHHHHHHHHHHHHcc
Q 048535          270 -VMSGRRPI---E----EGKRNLVDRMWSLTER-------------SELLSVLDERLKAKGGYA-DEVVEKVLHLGLLCA  327 (409)
Q Consensus       270 -~~~g~~p~---~----~~~~~~~~~vws~~~~-------------~~~~~~~~~~l~~~~~~~-~~~~~~l~~l~~~Cl  327 (409)
                       ...|...+   +    ...++...|+|+++..             ....+............+ ......+.+++.+||
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L  233 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLL  233 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHc
Confidence             12232222   1    1235677899998411             111122221111111112 123567789999999


Q ss_pred             CcCCCCCCC----HHHHHH
Q 048535          328 HPEANSRPT----IRQVLK  342 (409)
Q Consensus       328 ~~dP~~RPt----~~evl~  342 (409)
                      +.||.+||+    +.++++
T Consensus       234 ~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         234 NRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             CCCHHHCCCCCCCHHHHhc
Confidence            999999995    555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8e-30  Score=240.11  Aligned_cols=219  Identities=26%  Similarity=0.396  Sum_probs=167.7

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCC---CCceeeEeeEEEccCCeEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLK---HRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .|+..+.||+|+||.||+|.+.  ++.||+|.++.. ......++.+|+.++++++   |||++++++++.. +...++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-GPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-CCEEEEE
Confidence            4777889999999999999985  899999998754 3445567889999999986   9999999999886 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++++|.+++..    ..+++..+..++.|++.||.|||   +.+|+|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          81 MEYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             EecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999999843    36899999999999999999999   89999999999999999999999999999976543


Q ss_pred             Cc----eeeecc---ccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhh----------------cCCCCH-HHHHHH
Q 048535          268 GQ----VMSGRR---PIE----EGKRNLVDRMWSLTERSELLSVLDERLKA----------------KGGYAD-EVVEKV  319 (409)
Q Consensus       268 ~~----~~~g~~---p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~----------------~~~~~~-~~~~~l  319 (409)
                      ..    ...|..   +.+    ...++...|+|+++  ..+++++....+.                ...... .....+
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG--~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (277)
T cd06917         154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLG--ITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLL  231 (277)
T ss_pred             CccccccccCCcceeCHHHhccCCccccchhHHHHH--HHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHH
Confidence            32    111111   111    12235678888874  1222222211110                011111 145578


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHH
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+++.+||+.||++||++.++++
T Consensus       232 ~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         232 REFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             HHHHHHHcCCCcccCcCHHHHhh
Confidence            88999999999999999999876

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=1.2e-29  Score=243.81  Aligned_cols=261  Identities=21%  Similarity=0.259  Sum_probs=171.0

Q ss_pred             cceeecCCceEEEEEEEC----CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEc-cCCeEEEEEEeCC
Q 048535          118 ENVIGLGGNGKVYKGQLL----GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK-EKESLILIYDYME  192 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~~lv~E~~~  192 (409)
                      ..+||+|+||.||+|+..    +..||+|.+....  ....+.+|+.++++++||||+++++++.. .+...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            367999999999999875    4789999986542  22457889999999999999999998864 2457899999997


Q ss_pred             CCCHHHHHhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee----CCCCcEEEecccCc
Q 048535          193 NGSLDKWIFEC------DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL----DKKMNARLGDFGLA  262 (409)
Q Consensus       193 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----~~~~~~kl~DFGla  262 (409)
                      + +|.+++...      .....+++..+..++.|++.||.|||   +.+|+||||||+|||+    +.++++||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 888877422      12235889999999999999999999   8999999999999999    56678999999999


Q ss_pred             ccccCCc-------eeeec---cccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCC------HHHHHHHHHH
Q 048535          263 KMHHHGQ-------VMSGR---RPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYA------DEVVEKVLHL  322 (409)
Q Consensus       263 ~~~~~~~-------~~~g~---~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~------~~~~~~l~~l  322 (409)
                      +......       ...|.   .+.+    ...++...|+|+++  ..+++++...........      ......+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG--~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG--CIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHH--HHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            8754321       11111   1222    13357789999996  345555554332211000      0001111122


Q ss_pred             HHHccCcCCCC------CCCHHHHHHHHh----------cCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          323 GLLCAHPEANS------RPTIRQVLKMLE----------GQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       323 ~~~Cl~~dP~~------RPt~~evl~~L~----------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      ...+-......      .|..........          ...+......+....+++.+|+..+|.+|+|+++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            11111111111      011111111100          00011111122234689999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=4.4e-30  Score=245.01  Aligned_cols=217  Identities=22%  Similarity=0.287  Sum_probs=166.0

Q ss_pred             ccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCC
Q 048535          117 EENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENG  194 (409)
Q Consensus       117 ~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~g  194 (409)
                      ....||+|+||.||++...  ++.||+|.+........+.+.+|+.++..++||||+++++++.. ++..+++|||++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~iv~e~~~~~  103 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-GEELWVLMEFLQGG  103 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-CCeEEEEEecCCCC
Confidence            3457999999999999885  89999999976544556778899999999999999999999887 67899999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc----e
Q 048535          195 SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ----V  270 (409)
Q Consensus       195 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~----~  270 (409)
                      +|.+++..    ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.......    .
T Consensus       104 ~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659         104 ALTDIVSQ----TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             CHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence            99998732    35899999999999999999999   8999999999999999999999999999987543221    1


Q ss_pred             eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhc------------------CCCCHHHHHHHHHHHHHc
Q 048535          271 MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAK------------------GGYADEVVEKVLHLGLLC  326 (409)
Q Consensus       271 ~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~------------------~~~~~~~~~~l~~l~~~C  326 (409)
                      ..|...+      ....++...|+|+++  ..+++++.......                  ..........+.+++.+|
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG--~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~  254 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTEVDIWSLG--IMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM  254 (297)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence            1222211      123456778999974  22222222211100                  001112345678888999


Q ss_pred             cCcCCCCCCCHHHHHHH
Q 048535          327 AHPEANSRPTIRQVLKM  343 (409)
Q Consensus       327 l~~dP~~RPt~~evl~~  343 (409)
                      |+.+|++||++.++++.
T Consensus       255 l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         255 LTREPQERATAQELLDH  271 (297)
T ss_pred             hcCCcccCcCHHHHhhC
Confidence            99999999999988873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=7.3e-30  Score=242.60  Aligned_cols=260  Identities=22%  Similarity=0.277  Sum_probs=172.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCC----e
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKE----S  183 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~----~  183 (409)
                      ++|+..+.||+|+||.||+|...  ++.||+|.++...  ......+.+|+.+++++ +||||+++++++.....    .
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999986  8899999986542  22345788999999999 56999999998876322    3


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC-CCcEEEeccc
Q 048535          184 LILIYDYMENGSLDKWIFECDE--SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK-KMNARLGDFG  260 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DFG  260 (409)
                      .|+||||+++ +|.+++.....  ...+++..+..++.||++||.|||   +.+|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999986 89998864322  246899999999999999999999   899999999999999998 8899999999


Q ss_pred             CcccccCCce----eee---ccccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCc
Q 048535          261 LAKMHHHGQV----MSG---RRPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHP  329 (409)
Q Consensus       261 la~~~~~~~~----~~g---~~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~  329 (409)
                      +++.......    ..+   ..+.+    ...++...|+|+++  ..+++++.........   .....+.++....  .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG--~~l~~l~~g~~~~~~~---~~~~~~~~~~~~~--~  229 (295)
T cd07837         157 LGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVG--CIFAEMSRKQPLFPGD---SELQQLLHIFKLL--G  229 (295)
T ss_pred             cceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHH--HHHHHHHcCCCCCCCC---CHHHHHHHHHHHh--C
Confidence            9875432110    000   11111    12346678999985  3344444433221111   1222223322211  1


Q ss_pred             CCCCCC--CHHHHHH----------HHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCcc
Q 048535          330 EANSRP--TIRQVLK----------MLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFN  387 (409)
Q Consensus       330 dP~~RP--t~~evl~----------~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~  387 (409)
                      .|..+.  ...++..          .+...  .+  .-...-.+++.+|+..+|.+|.+..+++.||||+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRA--VP--DLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CCChhhCcchhhccchhhcCcccchhHHHh--cc--ccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            111110  0000000          00000  01  1122346778888888888888888888888874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=5e-31  Score=273.93  Aligned_cols=227  Identities=26%  Similarity=0.373  Sum_probs=168.7

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEc-------
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK-------  179 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-------  179 (409)
                      +-..+|+..+.||+||||.||+++.+  |+.+|||+|... +......+.+|+.+|++|+|||||+++..+.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            45578888999999999999999988  999999999866 44456678999999999999999999865432       


Q ss_pred             --------------------------------------------------------------------------------
Q 048535          180 --------------------------------------------------------------------------------  179 (409)
Q Consensus       180 --------------------------------------------------------------------------------  179 (409)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------cC-------CeEEEEEEeCCCCCHHHHHhcCCCCCCC-CHHHHHHHHHHHHHHHHH
Q 048535          180 ------------------------EK-------ESLILIYDYMENGSLDKWIFECDESIAL-SWEQRIKVLKDVASGILY  227 (409)
Q Consensus       180 ------------------------~~-------~~~~lv~E~~~~gsL~~~l~~~~~~~~l-~~~~~~~i~~~ia~gL~y  227 (409)
                                              +.       ..+||-||||+...|+++++++.   .. .....++++++|++||.|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHH
Confidence                                    00       24789999999988888885432   22 467788999999999999


Q ss_pred             HHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc----C-------Cc--------eee---ecccc------c-
Q 048535          228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH----H-------GQ--------VMS---GRRPI------E-  278 (409)
Q Consensus       228 LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~----~-------~~--------~~~---g~~p~------~-  278 (409)
                      +|   +.+||||||||.||+||++..+||+|||+|+...    .       .+        -.|   |+.-+      . 
T Consensus       713 IH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99   8999999999999999999999999999998722    0       00        011   11111      1 


Q ss_pred             c--CCCcHHHHHHhhhc-----------cCcHHHHh----hHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 048535          279 E--GKRNLVDRMWSLTE-----------RSELLSVL----DERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVL  341 (409)
Q Consensus       279 ~--~~~~~~~~vws~~~-----------~~~~~~~~----~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl  341 (409)
                      .  ..|+.+.|+++++-           ..+-..++    ++.++...++.......-.+++.++++.||++|||+.|++
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL  869 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL  869 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence            1  35778888888731           01111111    2222222233445556668899999999999999999998


Q ss_pred             H
Q 048535          342 K  342 (409)
Q Consensus       342 ~  342 (409)
                      +
T Consensus       870 ~  870 (1351)
T KOG1035|consen  870 N  870 (1351)
T ss_pred             h
Confidence            6

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-31  Score=258.69  Aligned_cols=224  Identities=24%  Similarity=0.321  Sum_probs=179.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      +.|.++..||.|+||.||++..+  +...|.|++...+....++|+-|++||..++||+||++++.|+. .+.+++..||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-enkLwiliEF  110 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-ENKLWILIEF  110 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cCceEEEEee
Confidence            44666788999999999999887  56678999988888889999999999999999999999998877 6789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC--
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG--  268 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~--  268 (409)
                      |.||-++..+.+.  ...|++.++.-++.|++.||.|||   +++|||||||+.|||++-+|.++|+|||.+......  
T Consensus       111 C~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  111 CGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             cCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence            9999999988654  357999999999999999999999   899999999999999999999999999998543211  


Q ss_pred             --ceeeeccc-----------cccCCCcHHHHHHhhhccC-------------cHHHHhhHHhhhcC---CCCHHHHHHH
Q 048535          269 --QVMSGRRP-----------IEEGKRNLVDRMWSLTERS-------------ELLSVLDERLKAKG---GYADEVVEKV  319 (409)
Q Consensus       269 --~~~~g~~p-----------~~~~~~~~~~~vws~~~~~-------------~~~~~~~~~l~~~~---~~~~~~~~~l  319 (409)
                        ....|.+.           +....|+..+|+|+++-.-             ....++-...+..+   -.|..+...+
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence              12222222           2346788999999995221             11112222211111   1355678889


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHH
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+++..|+..||..||++.++++
T Consensus       266 ~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHHHHHHhcCCccCCCHHHHhh
Confidence            99999999999999999999875

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.5e-30  Score=240.21  Aligned_cols=227  Identities=26%  Similarity=0.358  Sum_probs=171.1

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEcc-----C
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKE-----K  181 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-----~  181 (409)
                      .++++|+..+.||+|+||.||+|...  ++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++...     .
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35688999999999999999999986  78899999876543 346789999999999 799999999998752     2


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEeccc
Q 048535          182 ESLILIYDYMENGSLDKWIFECD-ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG  260 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG  260 (409)
                      ...++||||+++++|.+++.... ....+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence            34899999999999999986432 2356899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCc----eeeecccc---c--------cCCCcHHHHHHhhhccCcHHHHhhHHhhh------------------
Q 048535          261 LAKMHHHGQ----VMSGRRPI---E--------EGKRNLVDRMWSLTERSELLSVLDERLKA------------------  307 (409)
Q Consensus       261 la~~~~~~~----~~~g~~p~---~--------~~~~~~~~~vws~~~~~~~~~~~~~~l~~------------------  307 (409)
                      ++.......    ...|...+   +        ...++..+|+|+++  ..+++++......                  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  236 (275)
T cd06608         159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG--ITAIELADGKPPLCDMHPMRALFKIPRNPPP  236 (275)
T ss_pred             cceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhH--HHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence            987543211    01111111   1        12345568899874  1122222111110                  


Q ss_pred             cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          308 KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       308 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ....+......+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            00112234567889999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=9.2e-30  Score=242.31  Aligned_cols=233  Identities=22%  Similarity=0.324  Sum_probs=176.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|...+.||+|+||.||++...  +..||+|.+........+.+.+|+.++++++||||+++++++.. .+..++|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e   96 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-GDELWVVME   96 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-CCcEEEEEe
Confidence            367888999999999999999875  78899999876555556788999999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+++..    ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        97 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             cCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            9999999999843    35789999999999999999999   8999999999999999999999999999887544322


Q ss_pred             ----eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh----------------cC--CCCHHHHHHHHH
Q 048535          270 ----VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKA----------------KG--GYADEVVEKVLH  321 (409)
Q Consensus       270 ----~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~----------------~~--~~~~~~~~~l~~  321 (409)
                          ...|...+      .....+...|+|+++  ..+++++......                ..  ..+......+.+
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG--~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  247 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG--IMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD  247 (293)
T ss_pred             cccccccCChhhcCchhhccCCCCchhhHHHHH--HHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHH
Confidence                11121111      113345678888873  1112221111100                00  112234557889


Q ss_pred             HHHHccCcCCCCCCCHHHHHHH--HhcCcCCCCCC
Q 048535          322 LGLLCAHPEANSRPTIRQVLKM--LEGQTEGTGLE  354 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~~~~~  354 (409)
                      ++.+||+.+|++||++.+++..  ++.......++
T Consensus       248 li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~  282 (293)
T cd06647         248 FLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLT  282 (293)
T ss_pred             HHHHHccCChhhCcCHHHHhcCHHHhcCccccccc
Confidence            9999999999999999999865  44444444333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=1.1e-29  Score=238.63  Aligned_cols=220  Identities=25%  Similarity=0.381  Sum_probs=163.7

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC----------hHHHHHHHHHHHHhccCCCCceeeEeeEEEccC
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS----------EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK  181 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  181 (409)
                      +|...+.||+|+||.||+|...  ++.||+|.++...          ....+.+.+|+.++++++|||++++++++.. .
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-E   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-C
Confidence            4667889999999999999875  8899999886421          1123468889999999999999999999887 6


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      +..++||||+++|+|.+++...   ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccc
Confidence            7899999999999999999543   46899999999999999999999   88999999999999999999999999999


Q ss_pred             cccccCCc------eeeeccc---cc---c--CCCcHHHHHHhhhccCcHHHHhhHHh----------------h-hcCC
Q 048535          262 AKMHHHGQ------VMSGRRP---IE---E--GKRNLVDRMWSLTERSELLSVLDERL----------------K-AKGG  310 (409)
Q Consensus       262 a~~~~~~~------~~~g~~p---~~---~--~~~~~~~~vws~~~~~~~~~~~~~~l----------------~-~~~~  310 (409)
                      ++......      ...|...   .+   .  ..++...|+|+++.  .+++++....                . ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~--~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  232 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGC--VVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPP  232 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHH--HHHHHHhCCCCCcCcchHHHHHHhhccccCCc
Confidence            97643211      1111111   11   1  12456678888631  1111111100                0 0011


Q ss_pred             ----CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          311 ----YADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       311 ----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                          ........+.+++..||+.+|++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         233 IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence                11233567888888999999999999888875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-29  Score=233.71  Aligned_cols=220  Identities=31%  Similarity=0.456  Sum_probs=170.1

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE--HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|+..+.||+|++|.||++...  ++.||+|.+.....  .....+.+|++++++++|||++++++++.+ .+..+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-SDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEEEEEEe
Confidence            4778899999999999999886  78999999976643  456789999999999999999999999887 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++.......
T Consensus        80 ~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          80 YAENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             cCCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999999854   256999999999999999999999   8999999999999999999999999999998765432


Q ss_pred             e----eeecc---cc---ccCCCcHHHHHHhhhccCcHHHHhhHHh----------------hhcCCCCHHHHHHHHHHH
Q 048535          270 V----MSGRR---PI---EEGKRNLVDRMWSLTERSELLSVLDERL----------------KAKGGYADEVVEKVLHLG  323 (409)
Q Consensus       270 ~----~~g~~---p~---~~~~~~~~~~vws~~~~~~~~~~~~~~l----------------~~~~~~~~~~~~~l~~l~  323 (409)
                      .    ..+..   +.   .....+...|+|+++.  .+++++....                ......+......+.+++
T Consensus       154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~--~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  231 (254)
T cd06627         154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGC--TVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFL  231 (254)
T ss_pred             ccccccccchhhcCHhhhcCCCCCcchhHHHHHH--HHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence            1    11111   11   1122345678887641  1222221111                111222334456788899


Q ss_pred             HHccCcCCCCCCCHHHHHH
Q 048535          324 LLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+||+.+|++|||+.+++.
T Consensus       232 ~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         232 MQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HHHHhCChhhCcCHHHHhc
Confidence            9999999999999988874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=8.9e-30  Score=236.73  Aligned_cols=222  Identities=24%  Similarity=0.343  Sum_probs=164.9

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|+..+.||+|+||.||+|...  |..||+|.+...  .....+.+.+|+.++++++|+||+++++.+.. ....++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEe
Confidence            4778899999999999999987  789999998654  22345678899999999999999999998877 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC-cEEEecccCcccccCC
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM-NARLGDFGLAKMHHHG  268 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~  268 (409)
                      |+++++|.+++... ....+++..+..++.|+++||.|||   +.+++|+||||+||++++++ .+||+|||.+......
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          80 YCDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             cCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            99999999999653 2335899999999999999999999   89999999999999999885 4699999999765433


Q ss_pred             ce----eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh----------------cCCCCHHHHHHHHHH
Q 048535          269 QV----MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKA----------------KGGYADEVVEKVLHL  322 (409)
Q Consensus       269 ~~----~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~----------------~~~~~~~~~~~l~~l  322 (409)
                      ..    ..|...+      .....+...|+|+++  ..+++++......                ...........+.++
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLG--CVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSL  233 (257)
T ss_pred             cccccccCCCccccCHHHHcCCCCCchhhHHHHH--HHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHH
Confidence            21    1111111      123455678999874  1112222111110                011122234467777


Q ss_pred             HHHccCcCCCCCCCHHHHHH
Q 048535          323 GLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +.+||+.+|++|||+.|+++
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             HHHHhccChhhCcCHHHHhh
Confidence            78888888888888877765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.8e-30  Score=254.76  Aligned_cols=221  Identities=19%  Similarity=0.339  Sum_probs=171.7

Q ss_pred             CccceeecCCceEEEEEEEC--CcEEEEEEeccC----ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-CeEEEEE
Q 048535          116 SEENVIGLGGNGKVYKGQLL--GVEVALKRISLD----SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-ESLILIY  188 (409)
Q Consensus       116 ~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~~lv~  188 (409)
                      +...+||+|+|-+||+|.+.  |..||.-.++..    ++...++|..|+++|+.|+|||||+++.++.+.. ..+.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34567999999999999987  888887655432    5666789999999999999999999999988743 3477899


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC-CcEEEecccCcccccC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK-MNARLGDFGLAKMHHH  267 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFGla~~~~~  267 (409)
                      |.+..|+|+.|+.+.   ..++...+.+|++||++||.|||+. .++|||||||.+||+|+.+ |.+||+|+|||.....
T Consensus       123 EL~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            999999999999654   4588899999999999999999986 7899999999999999764 8899999999988765


Q ss_pred             Cc--eeeecccccc-----CCCcHHHHHHhhhccCcHHHHhhHHhhhc-------------CCCCHH-----HHHHHHHH
Q 048535          268 GQ--VMSGRRPIEE-----GKRNLVDRMWSLTERSELLSVLDERLKAK-------------GGYADE-----VVEKVLHL  322 (409)
Q Consensus       268 ~~--~~~g~~p~~~-----~~~~~~~~vws~~~~~~~~~~~~~~l~~~-------------~~~~~~-----~~~~l~~l  322 (409)
                      ..  .+-|.+-+..     ..|+...||++++  ..+++++....+..             ....+.     ..+++.++
T Consensus       199 s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFG--MCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~f  276 (632)
T KOG0584|consen  199 SHAKSVIGTPEFMAPEMYEENYNELVDVYAFG--MCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREF  276 (632)
T ss_pred             cccceeccCccccChHHHhhhcchhhhhhhhh--HHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHH
Confidence            43  3456555432     6677888888874  22222222211100             111111     13578999


Q ss_pred             HHHccCcCCCCCCCHHHHHHH
Q 048535          323 GLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      +.+|+.. .++|||+.|+++.
T Consensus       277 IekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  277 IEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             HHHHhcC-chhccCHHHHhhC
Confidence            9999999 9999999999963

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=8e-30  Score=243.12  Aligned_cols=265  Identities=25%  Similarity=0.348  Sum_probs=196.3

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccC----
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK----  181 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----  181 (409)
                      ...++|++.+.||+|+||.||+|...  ++.||+|.++...  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999986  8899999997542  223356788999999999999999999887532    


Q ss_pred             -----CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEE
Q 048535          182 -----ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARL  256 (409)
Q Consensus       182 -----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl  256 (409)
                           ...++|+||+++ +|.+++...  ...+++..+..++.|++.||+|||   +.+|+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEe
Confidence                 378999999986 787777532  346899999999999999999999   899999999999999999999999


Q ss_pred             ecccCcccccCCce--e---eec---cccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHH
Q 048535          257 GDFGLAKMHHHGQV--M---SGR---RPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGL  324 (409)
Q Consensus       257 ~DFGla~~~~~~~~--~---~g~---~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~  324 (409)
                      +|||++........  .   .+.   .+.+    ....+...|+|+++  ..+++++......   ...+....+..+..
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG--~~~~el~~g~~~~---~~~~~~~~~~~~~~  232 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG--CILGELFTKKPIF---QANQELAQLELISR  232 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHH--HHHHHHHhCCCCC---CCCChHHHHHHHHH
Confidence            99999986543220  0   011   1111    12345678999986  3455555543322   12234455666777


Q ss_pred             HccCcCCCCCCCHHHHHHHHh---------cCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          325 LCAHPEANSRPTIRQVLKMLE---------GQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       325 ~Cl~~dP~~RPt~~evl~~L~---------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      .|....|..+|.+.+....-.         ...+.... -+..-.+++.+|+..+|..|.++.+++.||||
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSF-IPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             HhCCCChhhcccccccccccccccccccccchhhhcCC-CCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            888888888887765432210         00000000 12234799999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-30  Score=266.38  Aligned_cols=235  Identities=25%  Similarity=0.415  Sum_probs=185.6

Q ss_pred             HHHHhCCCCccceeecCCceEEEEEEEC---------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeE
Q 048535          108 IHAATKGFSEENVIGLGGNGKVYKGQLL---------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGW  176 (409)
Q Consensus       108 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~  176 (409)
                      ++...++..+.+.||+|.||.|++|...         ...||||.++.. ...+.+.+..|+++|+.+ +|+||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            4444556667779999999999999865         246999999865 446678899999999999 79999999999


Q ss_pred             EEccCCeEEEEEEeCCCCCHHHHHhcCC------C-----C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q 048535          177 CKKEKESLILIYDYMENGSLDKWIFECD------E-----S--IALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKA  243 (409)
Q Consensus       177 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~------~-----~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp  243 (409)
                      |.. ++..++|+||+..|+|.+||+..+      .     .  ..++....+.++.|||.||+||+   +.++|||||.+
T Consensus       371 ~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa  446 (609)
T KOG0200|consen  371 CTQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA  446 (609)
T ss_pred             ecc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence            998 788999999999999999998654      0     0  23899999999999999999999   89999999999


Q ss_pred             CCeeeCCCCcEEEecccCcccccCCceee---e--ccccc--------cCCCcHHHHHHhhhcc-------------C-c
Q 048535          244 SNVLLDKKMNARLGDFGLAKMHHHGQVMS---G--RRPIE--------EGKRNLVDRMWSLTER-------------S-E  296 (409)
Q Consensus       244 ~NILl~~~~~~kl~DFGla~~~~~~~~~~---g--~~p~~--------~~~~~~~~~vws~~~~-------------~-~  296 (409)
                      +|||++.+..+||+|||+||.........   +  +.|..        ...++..+|+|+++--             + .
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99999999999999999999755543221   1  13432        2567888999998310             0 0


Q ss_pred             -HHHHhhHHhhh--cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          297 -LLSVLDERLKA--KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       297 -~~~~~~~~l~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                       ..+++. .++.  ..+.|..+..++.++++.||+.+|++||++.++++.++..
T Consensus       527 ~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 PTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             cHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence             111211 1211  1245566778899999999999999999999999999874

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=7.9e-30  Score=260.09  Aligned_cols=270  Identities=18%  Similarity=0.216  Sum_probs=178.7

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC---CcEEEEE------------------EeccCChHHHHHHHHHHHHhccCCCC
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL---GVEVALK------------------RISLDSEHGMREFLAEVSSLGRLKHR  168 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~---~~~vAvK------------------~~~~~~~~~~~~~~~E~~~l~~l~H~  168 (409)
                      ...++|++.+.||+|+||+||+|..+   +..++.|                  .+. ........+.+|+.+|++++||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence            34578999999999999999998764   2222222                  111 1223345688999999999999


Q ss_pred             ceeeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 048535          169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDE--SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNV  246 (409)
Q Consensus       169 niv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NI  246 (409)
                      |||++++++.. .+..|+|+|++. ++|.+++.....  .......+...++.||+.||.|||   +++|+||||||+||
T Consensus       224 nIv~l~~~~~~-~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NI  298 (501)
T PHA03210        224 NILKIEEILRS-EANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENI  298 (501)
T ss_pred             CcCcEeEEEEE-CCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHE
Confidence            99999999987 678899999995 588888754211  122345677889999999999999   89999999999999


Q ss_pred             eeCCCCcEEEecccCcccccCCc-----eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCC---CC
Q 048535          247 LLDKKMNARLGDFGLAKMHHHGQ-----VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGG---YA  312 (409)
Q Consensus       247 Ll~~~~~~kl~DFGla~~~~~~~-----~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~---~~  312 (409)
                      |++.++.+||+|||+++......     ...|...+      ....++...|+|+++  ..+++++...+.....   .+
T Consensus       299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG--vil~ell~~~~~p~~~~~~~~  376 (501)
T PHA03210        299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCG--LILLDMLSHDFCPIGDGGGKP  376 (501)
T ss_pred             EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHH--HHHHHHHHCCCCCccCCCCCH
Confidence            99999999999999998764322     11232222      124567889999997  4566666544321111   11


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC--C-CC-------CCCCCcchhHHhhhcccCCCCcccccccCC
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE--G-TG-------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRG  382 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~--~-~~-------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  382 (409)
                      .....++......|...-|..   ..++.+.+....-  . ..       ...+....+++.+|+..||.+|.++.+++.
T Consensus       377 ~~~~~~~~~~~~~~~~~~p~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        377 GKQLLKIIDSLSVCDEEFPDP---PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHHHhcccChhhcCCc---HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            222222333222333222221   1223333221110  0 00       001112356788999999999999999999


Q ss_pred             CCCccccc
Q 048535          383 HPTFNEIN  390 (409)
Q Consensus       383 hp~~~~~~  390 (409)
                      ||||+...
T Consensus       454 hp~f~~~~  461 (501)
T PHA03210        454 LPLFSAEE  461 (501)
T ss_pred             ChhhhcCC
Confidence            99998654

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=3e-29  Score=231.48  Aligned_cols=221  Identities=29%  Similarity=0.430  Sum_probs=172.9

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      +|+..+.||+|++|.||++...  +..+++|++........+.+.+|++.+++++|+|++++++++.. ....++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-KDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEecC
Confidence            4777899999999999999987  88999999987655566789999999999999999999999887 67899999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc--
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ--  269 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~--  269 (409)
                      ++++|.+++....  ..+++..+..++.|++.||.|||   ..+++|+||+|+||++++++.++|+|||.+.......  
T Consensus        80 ~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  154 (253)
T cd05122          80 SGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR  154 (253)
T ss_pred             CCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccccccc
Confidence            9999999986432  46899999999999999999999   8999999999999999999999999999998765542  


Q ss_pred             -eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh----------------cCCCCHH--HHHHHHHHHH
Q 048535          270 -VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKA----------------KGGYADE--VVEKVLHLGL  324 (409)
Q Consensus       270 -~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~----------------~~~~~~~--~~~~l~~l~~  324 (409)
                       ...+...+      .....+...|+|+++  ..+++++......                .......  ....+.+++.
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  232 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLG--ITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLK  232 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHH--HHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHH
Confidence             22222111      112345668888874  1122222211110                0111111  2567899999


Q ss_pred             HccCcCCCCCCCHHHHHH
Q 048535          325 LCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       325 ~Cl~~dP~~RPt~~evl~  342 (409)
                      +||+.||++|||+.++++
T Consensus       233 ~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         233 KCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             HHccCChhhCCCHHHHhc
Confidence            999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=9e-30  Score=241.98  Aligned_cols=263  Identities=22%  Similarity=0.285  Sum_probs=185.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-CeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-ESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~~lv  187 (409)
                      ++|+..+.||+|+||.||+|...  ++.+|+|.++...  ......+.+|+.++++++||||+++++++.... ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888899999999999999987  7899999997542  222345778999999999999999999887622 789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++ +|.+++....  ..+++..+..++.|++.||+|||   +.+++|+||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999975 9999886432  36899999999999999999999   88999999999999999999999999999986544


Q ss_pred             Cc----eeeec---cccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCC
Q 048535          268 GQ----VMSGR---RPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPT  336 (409)
Q Consensus       268 ~~----~~~g~---~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt  336 (409)
                      ..    ...+.   .+.+    ....+..+|+|+++  ..+++++...........   ...+.++...|..+.+...|.
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG--~~l~~l~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~~  233 (293)
T cd07843         159 PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVG--CIFAELLTKKPLFPGKSE---IDQLNKIFKLLGTPTEKIWPG  233 (293)
T ss_pred             CccccccccccccccCchhhcCCccccchhhHHHHH--HHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCchHHHHH
Confidence            31    00111   1111    11235678999986  345555554333222112   223344445555444444333


Q ss_pred             HHHHHHHHhcCc----------CCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          337 IRQVLKMLEGQT----------EGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       337 ~~evl~~L~~~~----------~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      ..++...-....          ..+.........+++.+|+..+|.+|++..+++.||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            322221110000          00000012234689999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=3.4e-29  Score=241.09  Aligned_cols=228  Identities=25%  Similarity=0.337  Sum_probs=173.0

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .|+..+.||+|+||.||++...  +..||+|.+...   .......+.+|++++++++|||++++++++.+ ....++||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~  104 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-EHTAWLVM  104 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCeEEEEE
Confidence            3677889999999999999986  889999998643   33445678999999999999999999999987 67889999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++ +|.+++...  ...+++.++..++.|++.||.|||   +.+|+||||+|+||+++.++.+||+|||++......
T Consensus       105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            99974 888877532  346899999999999999999999   899999999999999999999999999998766543


Q ss_pred             ceeeecccc---c------cCCCcHHHHHHhhhccCcHHHHhhH---------------Hhhh--cCCCCHHHHHHHHHH
Q 048535          269 QVMSGRRPI---E------EGKRNLVDRMWSLTERSELLSVLDE---------------RLKA--KGGYADEVVEKVLHL  322 (409)
Q Consensus       269 ~~~~g~~p~---~------~~~~~~~~~vws~~~~~~~~~~~~~---------------~l~~--~~~~~~~~~~~l~~l  322 (409)
                      ....|...+   +      ...++...|+|+++.  .+++++..               ....  ...........+.++
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGv--il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  256 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI--TCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF  256 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHH--HHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence            322222211   1      133556778888731  11121111               1110  011123455678999


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          323 GLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      +.+||+.+|.+||++.++++.+--....
T Consensus       257 i~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         257 VDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             HHHHccCCcccCcCHHHHHhChhhhccC
Confidence            9999999999999999999865544433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.7e-30  Score=244.58  Aligned_cols=226  Identities=22%  Similarity=0.313  Sum_probs=180.3

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ..-|+.++.||+|-|+.|-++++.  |..||||++.+.  +.-....+.+|++.|+.++|||||++|.+... ...+|||
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT-QTKlyLi   95 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT-QTKLYLI   95 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc-cceEEEE
Confidence            355788899999999999999875  999999999765  33345678899999999999999999998876 7899999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC-CCCcEEEecccCccccc
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD-KKMNARLGDFGLAKMHH  266 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~kl~DFGla~~~~  266 (409)
                      +|.-++|+|++||.++..  .+.+....+++.||+.|+.|+|   +..+|||||||+||.+- .-|-+||+|||++..+.
T Consensus        96 LELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             EEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            999999999999977543  5899999999999999999999   88999999999999885 45789999999998887


Q ss_pred             CCc---eeeecccccc------CCC-cHHHHHHhhhc-----------------cCcHHHHhhHHhhhcCCCCHHHHHHH
Q 048535          267 HGQ---VMSGRRPIEE------GKR-NLVDRMWSLTE-----------------RSELLSVLDERLKAKGGYADEVVEKV  319 (409)
Q Consensus       267 ~~~---~~~g~~p~~~------~~~-~~~~~vws~~~-----------------~~~~~~~~~~~l~~~~~~~~~~~~~l  319 (409)
                      .++   ..+|...+..      +.| ....|+|+++.                 .+.+..++|...    ..|.....++
T Consensus       171 PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY----tvPshvS~eC  246 (864)
T KOG4717|consen  171 PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY----TVPSHVSKEC  246 (864)
T ss_pred             CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc----cCchhhhHHH
Confidence            775   3445544432      333 35679999831                 111222333222    3466778889


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHHH--HhcC
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLKM--LEGQ  347 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~~--L~~~  347 (409)
                      .+|+..|+..||.+|.+.+|++..  |+..
T Consensus       247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~  276 (864)
T KOG4717|consen  247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAG  276 (864)
T ss_pred             HHHHHHHHhcCchhhccHHHHhccccccCC
Confidence            999999999999999999998753  4443

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=4.9e-30  Score=239.05  Aligned_cols=147  Identities=29%  Similarity=0.356  Sum_probs=132.0

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      +|+..+.||.|+||.||+|...  ++.||+|.+...   .....+.+.+|++++++++||||+++++.+.. ....++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEE
Confidence            4788899999999999999987  899999999754   23456789999999999999999999998876 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||+++++|.+++..   ...+++..+..++.|+++||.|||   +.+++|+||||+||++++++.++|+|||++.....
T Consensus        80 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~  152 (258)
T cd05578          80 DLLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP  152 (258)
T ss_pred             eCCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence            99999999999954   257899999999999999999999   88999999999999999999999999999876544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=9.8e-30  Score=236.98  Aligned_cols=139  Identities=25%  Similarity=0.384  Sum_probs=124.9

Q ss_pred             eecCCceEEEEEEEC--CcEEEEEEeccCCh---HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCC
Q 048535          121 IGLGGNGKVYKGQLL--GVEVALKRISLDSE---HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS  195 (409)
Q Consensus       121 lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gs  195 (409)
                      ||+|+||.||+++..  ++.+|+|.+.....   ...+.+.+|++++++++||||+++++.+.. ....+++|||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence            689999999999997  89999999975532   456678999999999999999999998876 778999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          196 LDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       196 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      |.+++...   ..+++..+..++.|+++||+|||   +.+++|+||+|+||++++++.+||+|||++....
T Consensus        80 L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~  144 (265)
T cd05579          80 LASLLENV---GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGL  144 (265)
T ss_pred             HHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence            99999642   36899999999999999999999   8999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-29  Score=245.53  Aligned_cols=147  Identities=31%  Similarity=0.471  Sum_probs=127.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC----CeE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK----ESL  184 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~  184 (409)
                      +++|++.+.||+|+||.||+|...  |+.||+|.+... .......+.+|+.++++++||||+++++++....    ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            478999999999999999999886  899999998643 3334567889999999999999999999876422    357


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++++||+++ +|.+++.    ...+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999975 8888873    246999999999999999999999   89999999999999999999999999999976


Q ss_pred             cc
Q 048535          265 HH  266 (409)
Q Consensus       265 ~~  266 (409)
                      ..
T Consensus       156 ~~  157 (336)
T cd07849         156 AD  157 (336)
T ss_pred             cc
Confidence            54

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=2.9e-29  Score=237.03  Aligned_cols=181  Identities=28%  Similarity=0.401  Sum_probs=142.8

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      |+..+.||.|++|.||+|...  |..||+|++....  ......+.+|++++++++|||++++++++.+ .+..+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-ENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-CCeEEEEEec
Confidence            567889999999999999986  8999999997542  2234578899999999999999999999987 6789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV  270 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  270 (409)
                      ++ ++|.+++.... ...+++..+..++.|+++||+|||   +++++|+||+|+||+++.++.++|+|||+++.......
T Consensus        80 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          80 LD-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             cC-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            95 69999986432 236899999999999999999999   78999999999999999999999999999976532210


Q ss_pred             -------eeeccccc---c-CCCcHHHHHHhhhccCcHHHHhhH
Q 048535          271 -------MSGRRPIE---E-GKRNLVDRMWSLTERSELLSVLDE  303 (409)
Q Consensus       271 -------~~g~~p~~---~-~~~~~~~~vws~~~~~~~~~~~~~  303 (409)
                             .....+.+   . ..++..+|+|+++  ..+++++..
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG--~~l~~l~~g  196 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIG--CIFAEMVNR  196 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHH--HHHHHHHhC
Confidence                   00011111   1 2346679999985  234444443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=3.4e-29  Score=233.90  Aligned_cols=165  Identities=25%  Similarity=0.313  Sum_probs=136.4

Q ss_pred             eecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCC
Q 048535          121 IGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS  195 (409)
Q Consensus       121 lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gs  195 (409)
                      ||.|+||.||++...  ++.||+|.+....   ....+.+.+|+.++++++||||+++++++.+ +...++++||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCc
Confidence            699999999999998  8999999996542   2345679999999999999999999999887 678999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---eee
Q 048535          196 LDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---VMS  272 (409)
Q Consensus       196 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---~~~  272 (409)
                      |.+++..   ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||+++......   ...
T Consensus        80 L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~  153 (262)
T cd05572          80 LWTILRD---RGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC  153 (262)
T ss_pred             HHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccccccc
Confidence            9999954   345899999999999999999999   8999999999999999999999999999998765431   111


Q ss_pred             ecc---c---cccCCCcHHHHHHhhh
Q 048535          273 GRR---P---IEEGKRNLVDRMWSLT  292 (409)
Q Consensus       273 g~~---p---~~~~~~~~~~~vws~~  292 (409)
                      |..   +   .....++...|+|+++
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG  179 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLG  179 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhH
Confidence            111   1   1123345667888874

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=1.4e-29  Score=245.15  Aligned_cols=178  Identities=22%  Similarity=0.369  Sum_probs=143.3

Q ss_pred             HHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC
Q 048535          107 EIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       107 ~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  182 (409)
                      ++...+++|+..+.||.|+||.||++...  ++.||+|++...  .....+.+.+|++++++++||||+++++++.....
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            34557889999999999999999999876  889999988543  23345678899999999999999999999876566


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..++++||+ +++|.+++..    ..+++.....++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||++
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccc
Confidence            789999998 5699988842    35788889999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCc-eeee---ccccc---c-CCCcHHHHHHhhh
Q 048535          263 KMHHHGQ-VMSG---RRPIE---E-GKRNLVDRMWSLT  292 (409)
Q Consensus       263 ~~~~~~~-~~~g---~~p~~---~-~~~~~~~~vws~~  292 (409)
                      +...... ...+   ..+.+   . ..++...|+|+++
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  193 (328)
T cd07856         156 RIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAG  193 (328)
T ss_pred             cccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHH
Confidence            7654321 0011   11111   1 3456789999974

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=2.6e-29  Score=238.21  Aligned_cols=219  Identities=21%  Similarity=0.271  Sum_probs=164.6

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      .|...+.||+|++|.||++...  ++.+++|++........+.+.+|+.+++.++||||+++++++.. .+..++++||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-GDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-CCeEEEEEecc
Confidence            3555679999999999999875  78999999876655556778999999999999999999999886 67899999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc--
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ--  269 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~--  269 (409)
                      ++++|.+++..    ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++.......  
T Consensus        99 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~  171 (285)
T cd06648          99 EGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR  171 (285)
T ss_pred             CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence            99999999853    45899999999999999999999   8999999999999999999999999999887543221  


Q ss_pred             --eeeeccc---cc---cCCCcHHHHHHhhhccCcHHHHhhHH---------------hhhc---CCCCHHHHHHHHHHH
Q 048535          270 --VMSGRRP---IE---EGKRNLVDRMWSLTERSELLSVLDER---------------LKAK---GGYADEVVEKVLHLG  323 (409)
Q Consensus       270 --~~~g~~p---~~---~~~~~~~~~vws~~~~~~~~~~~~~~---------------l~~~---~~~~~~~~~~l~~l~  323 (409)
                        ...|...   .+   ...++...|+|+++  ..+++++...               ....   ..........+.+++
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG--v~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLG--IMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFL  249 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHH--HHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHH
Confidence              0111111   11   12345667888874  1112221111               1000   001112345678888


Q ss_pred             HHccCcCCCCCCCHHHHHH
Q 048535          324 LLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+||+.+|++|||+.++++
T Consensus       250 ~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         250 DRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             HHHcccChhhCcCHHHHcc
Confidence            8888888888888888775

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=4.4e-29  Score=231.34  Aligned_cols=220  Identities=23%  Similarity=0.373  Sum_probs=172.8

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccC--CeEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK--ESLILI  187 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~--~~~~lv  187 (409)
                      +|+..+.||+|++|.||+|...  ++.|++|.+....  ....+.+.+|+.++++++||||+++++.+.. .  ...+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERD-EEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEec-CCCCeEEEE
Confidence            4777899999999999999987  8899999997653  3556789999999999999999999999887 5  689999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      +||+++++|.+++...   ..+++..+..++.|+++||.|||   +.+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          80 LEYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            9999999999999543   37999999999999999999999   89999999999999999999999999999987654


Q ss_pred             Cce------eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhh------------------hcCCCCHHHHH
Q 048535          268 GQV------MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLK------------------AKGGYADEVVE  317 (409)
Q Consensus       268 ~~~------~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~------------------~~~~~~~~~~~  317 (409)
                      ...      ..+...+      .....+...|+|+++.  .+++++.....                  .....+.....
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~--il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGC--TVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSE  231 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHH--HHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCH
Confidence            321      1111111      1123566788888741  12222221110                  11223444567


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+.+++.+|++.||++||++.++++
T Consensus       232 ~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         232 EAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             HHHHHHHHhCcCChhhCCCHHHHhh
Confidence            8889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=6.7e-29  Score=234.15  Aligned_cols=171  Identities=22%  Similarity=0.266  Sum_probs=134.6

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCC-CCceeeEeeEEEcc-CCeEEEEEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKE-KESLILIYD  189 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~-~~~~~lv~E  189 (409)
                      |+..+.||+|+||.||+|...  +..||+|+++.. .........+|+.++.++. |+||+++++++.+. .+..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567789999999999999986  889999998754 2222234567999999985 99999999999863 167899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |++ |+|.+++...  ...+++..+..++.|++.||.|||   +.+++||||||+||+++. +.+||+|||+++......
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 5888888542  246899999999999999999999   899999999999999999 999999999998654322


Q ss_pred             e---eeecc---ccc----cCCCcHHHHHHhhh
Q 048535          270 V---MSGRR---PIE----EGKRNLVDRMWSLT  292 (409)
Q Consensus       270 ~---~~g~~---p~~----~~~~~~~~~vws~~  292 (409)
                      .   ..+..   +.+    ....+..+|+|+++
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  186 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVG  186 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHH
Confidence            1   11111   111    12346678999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=3.7e-29  Score=239.78  Aligned_cols=267  Identities=24%  Similarity=0.276  Sum_probs=185.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeEeeEEEccC-CeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE--HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-ESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~~l  186 (409)
                      .++|+..+.||+|+||.||+|...  |+.||+|.++....  .....+.+|+.++++++|+||+++++++.... +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467999999999999999999986  89999999975422  22335678999999999999999999987533 56899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+.+ +|.+++...  ...+++.++..++.|+++||.|||   +.+++||||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 898888543  256899999999999999999999   8999999999999999999999999999998754


Q ss_pred             CCc-eee------eccccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCC
Q 048535          267 HGQ-VMS------GRRPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRP  335 (409)
Q Consensus       267 ~~~-~~~------g~~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  335 (409)
                      ... ..+      ...+.+    ...++...|+|+++  ..+++++.........   .....+..+...+-.......|
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG--~il~el~~g~~~f~~~---~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVG--CILAELLAHKPLLPGK---SEIEQLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             CccCCCCcccccccccChhhhcCCCCcCchHHHHHHH--HHHHHHHhCCCCCCCC---CHHHHHHHHHHhcCCCChhhch
Confidence            321 000      011111    12356789999996  4455555544322111   1122233333333223333333


Q ss_pred             CHHHHHHHHhcCcCCCC---------CCCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          336 TIRQVLKMLEGQTEGTG---------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       336 t~~evl~~L~~~~~~~~---------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ...++-. .........         ........+++.+|+..+|.+|++..+++.||||....
T Consensus       235 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         235 GFSDLPL-VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             hhhcccc-cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence            2222111 000000000         00122237899999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=1.6e-29  Score=245.54  Aligned_cols=227  Identities=22%  Similarity=0.288  Sum_probs=169.3

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC----Ce
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK----ES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~  183 (409)
                      .++|...+.||+|+||.||+|...  ++.||||.+...  .......+.+|+.+++.++|+||+++++++....    ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457889999999999999999986  899999998653  3334567788999999999999999999886422    34


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      .++||||+. ++|.+++..   ...+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 699998843   356999999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCc----eeeeccc---cc----cCCCcHHHHHHhhhccCcHHHHhhHHhhh-------------------------
Q 048535          264 MHHHGQ----VMSGRRP---IE----EGKRNLVDRMWSLTERSELLSVLDERLKA-------------------------  307 (409)
Q Consensus       264 ~~~~~~----~~~g~~p---~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~-------------------------  307 (409)
                      ......    ...+...   .+    ....+...|+|+++.  .+++++......                         
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~--il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGC--IFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHH--HHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            654331    1111111   11    123556788888731  111111110000                         


Q ss_pred             ----------------cC-----CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HhcC
Q 048535          308 ----------------KG-----GYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKM--LEGQ  347 (409)
Q Consensus       308 ----------------~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~  347 (409)
                                      ..     .........+.+++.+||+.+|++|||++++++.  ++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                            00     0011234667899999999999999999999876  5443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.96  E-value=4.2e-29  Score=235.52  Aligned_cols=212  Identities=24%  Similarity=0.319  Sum_probs=157.3

Q ss_pred             eecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCC
Q 048535          121 IGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS  195 (409)
Q Consensus       121 lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gs  195 (409)
                      ||+|+||+||++...  |+.||+|.+....   ......+..|++++++++||||+++++++.. .+..|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-KDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-CCeEEEEEecCCCCc
Confidence            699999999999876  8999999986432   2234567889999999999999999999887 678999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee---e
Q 048535          196 LDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM---S  272 (409)
Q Consensus       196 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~---~  272 (409)
                      |.+++.... ...+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||++.........   .
T Consensus        80 L~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  155 (277)
T cd05577          80 LKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA  155 (277)
T ss_pred             HHHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence            999996532 246899999999999999999999   899999999999999999999999999998765432111   1


Q ss_pred             ec---ccc---ccCCCcHHHHHHhhhccCcHHHHhhHHhhh-------------------cCCCCHHHHHHHHHHHHHcc
Q 048535          273 GR---RPI---EEGKRNLVDRMWSLTERSELLSVLDERLKA-------------------KGGYADEVVEKVLHLGLLCA  327 (409)
Q Consensus       273 g~---~p~---~~~~~~~~~~vws~~~~~~~~~~~~~~l~~-------------------~~~~~~~~~~~l~~l~~~Cl  327 (409)
                      +.   .+.   ....++...|+|+++  ..+++++......                   ....+......+.+++.+||
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  233 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALG--CTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL  233 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHH--HHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHc
Confidence            11   111   123356678999874  1222332222111                   11122233456677777777


Q ss_pred             CcCCCCCCCHHH
Q 048535          328 HPEANSRPTIRQ  339 (409)
Q Consensus       328 ~~dP~~RPt~~e  339 (409)
                      +.||++||++++
T Consensus       234 ~~~p~~R~~~~~  245 (277)
T cd05577         234 QKDPEKRLGCRG  245 (277)
T ss_pred             cCChhHccCCCc
Confidence            777777774444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.96  E-value=6.1e-29  Score=235.45  Aligned_cols=224  Identities=24%  Similarity=0.366  Sum_probs=172.3

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ..++.|+..+.||+|+||.||+|.+.  +..||+|.+..... ..+.+.+|++++++++|+|++++++.+.. ....+++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv   93 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-GDELWVV   93 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-CCEEEEE
Confidence            45677888899999999999999997  88999999976544 56778999999999999999999999987 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      +||+++++|.+++....  ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        94 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  168 (286)
T cd06614          94 MEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK  168 (286)
T ss_pred             EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence            99999999999996532  36999999999999999999999   89999999999999999999999999998865433


Q ss_pred             Cc----eeeec---ccc---ccCCCcHHHHHHhhhccCcHHHHhhHH---------------hh-hcC--CCCHHHHHHH
Q 048535          268 GQ----VMSGR---RPI---EEGKRNLVDRMWSLTERSELLSVLDER---------------LK-AKG--GYADEVVEKV  319 (409)
Q Consensus       268 ~~----~~~g~---~p~---~~~~~~~~~~vws~~~~~~~~~~~~~~---------------l~-~~~--~~~~~~~~~l  319 (409)
                      ..    ...+.   .+.   ....++...|+|+++.  .+++++...               .. ...  .........+
T Consensus       169 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGv--il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  246 (286)
T cd06614         169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGI--MCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEF  246 (286)
T ss_pred             chhhhccccCCcccCCHhHhcCCCCCCccccHHHHH--HHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHH
Confidence            21    11111   111   1123455678887641  111111110               00 000  1112245678


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHH
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+++.+||+.+|.+|||+.++++
T Consensus       247 ~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         247 KDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             HHHHHHHhccChhhCcCHHHHhh
Confidence            89999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=1.2e-28  Score=240.88  Aligned_cols=266  Identities=19%  Similarity=0.233  Sum_probs=179.9

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-----
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-----  181 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  181 (409)
                      ..++|+..+.||+|+||.||+|...  ++.||+|.+...  .......+.+|+.++++++||||+++++++....     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4588999999999999999999986  899999998643  3344567889999999999999999999886422     


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      ...++||||+++ +|.+++..     .+++..+..++.|++.||+|||   ..+|+||||||+|||++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence            357999999965 89888742     2889999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCcee---eecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcC---------------CCCHHHHH
Q 048535          262 AKMHHHGQVM---SGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKG---------------GYADEVVE  317 (409)
Q Consensus       262 a~~~~~~~~~---~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~---------------~~~~~~~~  317 (409)
                      ++........   .+...+      ....++...|+|+++  ..+++++........               ..+.+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG--~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         165 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG--CIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             ceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHH--HHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9876543211   111111      123456778999985  334444433322111               11111111


Q ss_pred             HHHHHHHHccCcCCCCCC-CHHHHHHHHhcCcCCCC--CCCCCcchhHHhhhcccCCCCcccccccCCCCCcc
Q 048535          318 KVLHLGLLCAHPEANSRP-TIRQVLKMLEGQTEGTG--LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFN  387 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~  387 (409)
                      .+........+..|..++ ...++............  ........+++.+|+..+|.+|++..+++.|||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~  315 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN  315 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence            111111111121221111 12222111100000000  01111237899999999999999999999999886

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.96  E-value=2.4e-29  Score=236.69  Aligned_cols=148  Identities=27%  Similarity=0.376  Sum_probs=131.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCC-CCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|...+.||+|+||.||+|...  +..||+|++...   .....+.+.+|+.++++++ ||||+++++++.. .+..++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEE
Confidence            46888999999999999999986  899999998653   2334567889999999998 9999999998876 678999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++....
T Consensus        80 v~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          80 VLEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EEcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            9999999999999954   336999999999999999999999   8999999999999999999999999999987654


Q ss_pred             C
Q 048535          267 H  267 (409)
Q Consensus       267 ~  267 (409)
                      .
T Consensus       154 ~  154 (280)
T cd05581         154 P  154 (280)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=3.1e-29  Score=243.36  Aligned_cols=148  Identities=28%  Similarity=0.409  Sum_probs=128.3

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEcc-CCeE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKE-KESL  184 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~-~~~~  184 (409)
                      ..++|+..+.||+|+||.||+|.+.  ++.+|+|++...  .......+.+|+.+++++ +||||+++++++... ....
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567888999999999999999986  789999998542  334456678899999999 999999999988653 3468


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++||||++ ++|.+++..    ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 599999843    26889999999999999999999   89999999999999999999999999999986


Q ss_pred             cc
Q 048535          265 HH  266 (409)
Q Consensus       265 ~~  266 (409)
                      ..
T Consensus       157 ~~  158 (337)
T cd07852         157 LS  158 (337)
T ss_pred             cc
Confidence            54

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=4.2e-29  Score=237.72  Aligned_cols=215  Identities=21%  Similarity=0.266  Sum_probs=159.5

Q ss_pred             cceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCC
Q 048535          118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS  195 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gs  195 (409)
                      ...||+|+||.||++...  +..||+|++..........+.+|+.+++.++|+||+++++++.. .+..++||||+++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~  103 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEGGA  103 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-CCEEEEEEecCCCCc
Confidence            367999999999999885  88999999876555566779999999999999999999999987 678999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc----ee
Q 048535          196 LDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ----VM  271 (409)
Q Consensus       196 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~----~~  271 (409)
                      |.+++..    ..+++.....++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.......    ..
T Consensus       104 L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657         104 LTDIVTH----TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence            9998732    35899999999999999999999   8899999999999999999999999999986543221    11


Q ss_pred             eecc---cc---ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcC------------------CCCHHHHHHHHHHHHHcc
Q 048535          272 SGRR---PI---EEGKRNLVDRMWSLTERSELLSVLDERLKAKG------------------GYADEVVEKVLHLGLLCA  327 (409)
Q Consensus       272 ~g~~---p~---~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~------------------~~~~~~~~~l~~l~~~Cl  327 (409)
                      .|..   +.   ....++...|+|+++  ..+++++........                  .........+.+++.+||
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slG--vil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  254 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLG--IMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLL  254 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHH
Confidence            2211   11   123446778999984  222333322111000                  011122344556666666


Q ss_pred             CcCCCCCCCHHHHHH
Q 048535          328 HPEANSRPTIRQVLK  342 (409)
Q Consensus       328 ~~dP~~RPt~~evl~  342 (409)
                      +.+|.+||++.++++
T Consensus       255 ~~~P~~R~~~~~ll~  269 (292)
T cd06657         255 VRDPAQRATAAELLK  269 (292)
T ss_pred             hCCcccCcCHHHHhc
Confidence            666666666666654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.96  E-value=4.7e-29  Score=231.54  Aligned_cols=225  Identities=20%  Similarity=0.301  Sum_probs=171.9

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|++.+.||+|+||.||++...  ++.+|+|.+...  .......+.+|+.++++++|+||+++++++.+ ....++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-GNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-CCEEEEEeh
Confidence            4778899999999999999876  789999998754  34456678899999999999999999999887 678999999


Q ss_pred             eCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          190 YMENGSLDKWIFECD-ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      |+++++|.+++.... ....+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.+||+|||+++.....
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            999999999986521 2356899999999999999999999   899999999999999999999999999999876543


Q ss_pred             cee--eec------cccccCCCcHHHHHHhhhcc-------------CcHHHHhhHHhh-hcCCCCHHHHHHHHHHHHHc
Q 048535          269 QVM--SGR------RPIEEGKRNLVDRMWSLTER-------------SELLSVLDERLK-AKGGYADEVVEKVLHLGLLC  326 (409)
Q Consensus       269 ~~~--~g~------~p~~~~~~~~~~~vws~~~~-------------~~~~~~~~~~l~-~~~~~~~~~~~~l~~l~~~C  326 (409)
                      ...  .+.      .......++...|+|+++.-             ....+....... .....+......+.+++.+|
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSM  236 (256)
T ss_pred             CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHH
Confidence            100  011      01112334556888887310             111111111111 01223345667899999999


Q ss_pred             cCcCCCCCCCHHHHHH
Q 048535          327 AHPEANSRPTIRQVLK  342 (409)
Q Consensus       327 l~~dP~~RPt~~evl~  342 (409)
                      |+.+|++|||+.++++
T Consensus       237 l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         237 LQVKPKLRPNCDKILA  252 (256)
T ss_pred             cCCCcccCCCHHHHhc
Confidence            9999999999999976

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=4.2e-29  Score=233.03  Aligned_cols=167  Identities=23%  Similarity=0.301  Sum_probs=132.5

Q ss_pred             ceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHh-ccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSL-GRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||+|...  ++.||+|.++...   ......+..|..++ ...+|+|++++++++.. ++..++|+||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEeccC
Confidence            56899999999999986  8899999996542   22233455565544 45589999999999987 678999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCceee
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS  272 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~  272 (409)
                      +++|.+++..   ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||+++.........
T Consensus        81 ~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  154 (260)
T cd05611          81 GGDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV  154 (260)
T ss_pred             CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCC
Confidence            9999999954   346899999999999999999999   8999999999999999999999999999998654332222


Q ss_pred             ecccc------ccCCCcHHHHHHhhh
Q 048535          273 GRRPI------EEGKRNLVDRMWSLT  292 (409)
Q Consensus       273 g~~p~------~~~~~~~~~~vws~~  292 (409)
                      |...+      ....++...|+|+++
T Consensus       155 ~~~~y~~pe~~~~~~~~~~~Dv~slG  180 (260)
T cd05611         155 GTPDYLAPETILGVGDDKMSDWWSLG  180 (260)
T ss_pred             CCcCccChhhhcCCCCcchhhhHHHH
Confidence            22211      123356778999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.96  E-value=1.2e-28  Score=228.57  Aligned_cols=225  Identities=28%  Similarity=0.383  Sum_probs=170.9

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|+..+.||.|+||.||++...  +..||+|++...  .....+.+.+|+++++.++|||++++++.+.. ....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-KGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-CCEEEEEEE
Confidence            4778899999999999999987  899999999765  23566789999999999999999999999887 688999999


Q ss_pred             eCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          190 YMENGSLDKWIFECD-ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      |+++++|.+++.... ....+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999999996532 1357999999999999999999999   889999999999999999999999999999876543


Q ss_pred             ce----eeecc---cc---ccCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhh-cCCCCHHHHHHHHHHHH
Q 048535          269 QV----MSGRR---PI---EEGKRNLVDRMWSLTE-------------RSELLSVLDERLKA-KGGYADEVVEKVLHLGL  324 (409)
Q Consensus       269 ~~----~~g~~---p~---~~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~-~~~~~~~~~~~l~~l~~  324 (409)
                      ..    ..|..   +.   .....+...|+|+++.             .....++....... ....+......+.+++.
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS  236 (258)
T ss_pred             cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            21    11111   11   1233455678888631             11111111111110 01222234467788888


Q ss_pred             HccCcCCCCCCCHHHHHH
Q 048535          325 LCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       325 ~Cl~~dP~~RPt~~evl~  342 (409)
                      +||+.+|++|||+.++++
T Consensus       237 ~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         237 SLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HHcCCChhhCcCHHHHhc
Confidence            888888888888888875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=5.6e-29  Score=234.95  Aligned_cols=147  Identities=25%  Similarity=0.400  Sum_probs=127.6

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHHhccCC-CCceeeEeeEEEccCCeEEEEEEe
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      |++.+.||+|+||.||+|...  ++.||+|++.... ........+|+..+++++ |+||+++++++.+ ++..++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEec
Confidence            567789999999999999986  7889999986542 222334567999999998 9999999999987 7789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      + +|+|.+++.... ...+++..+..++.|++.||.|||   +++++|+||||+||++++++.++|+|||+++....
T Consensus        80 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          80 M-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             C-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            9 889999986532 346899999999999999999999   89999999999999999999999999999986544

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=8.2e-29  Score=234.12  Aligned_cols=166  Identities=24%  Similarity=0.279  Sum_probs=129.0

Q ss_pred             eeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhc---cCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          120 VIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLG---RLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       120 ~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~---~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      .||+|+||.||++...  ++.+|+|.+....   ......+.+|..++.   ..+||||+.+++++.. .+..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-PDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-CCeEEEEEecC
Confidence            4899999999999986  8899999986541   122233445554433   4479999999998887 67889999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc--
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ--  269 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~--  269 (409)
                      ++|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||++.......  
T Consensus        80 ~~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~  153 (279)
T cd05633          80 NGGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH  153 (279)
T ss_pred             CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCcc
Confidence            99999999853   346999999999999999999999   8999999999999999999999999999987543221  


Q ss_pred             eeeecccc---c----cCCCcHHHHHHhhh
Q 048535          270 VMSGRRPI---E----EGKRNLVDRMWSLT  292 (409)
Q Consensus       270 ~~~g~~p~---~----~~~~~~~~~vws~~  292 (409)
                      ...|..++   +    ...++..+|+|+++
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  183 (279)
T cd05633         154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLG  183 (279)
T ss_pred             CcCCCcCccCHHHhcCCCCCCchhhhHHHH
Confidence            11122221   1    12356778999984

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.96  E-value=1.6e-29  Score=245.23  Aligned_cols=148  Identities=28%  Similarity=0.433  Sum_probs=128.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc---CCeE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE---KESL  184 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---~~~~  184 (409)
                      ..+|+..+.||+|+||.||+|...  ++.||+|++...  .....+.+.+|+.+|++++||||+++++++...   ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368888999999999999999886  899999998754  223456788999999999999999999987532   3468


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++||||+. |+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||+++.
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 599998843   345999999999999999999999   89999999999999999999999999999976


Q ss_pred             cc
Q 048535          265 HH  266 (409)
Q Consensus       265 ~~  266 (409)
                      ..
T Consensus       157 ~~  158 (334)
T cd07855         157 LS  158 (334)
T ss_pred             ec
Confidence            53

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=1.5e-28  Score=230.80  Aligned_cols=248  Identities=17%  Similarity=0.152  Sum_probs=171.0

Q ss_pred             HHHHHHhCCCCcccee--ecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEcc
Q 048535          106 QEIHAATKGFSEENVI--GLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKE  180 (409)
Q Consensus       106 ~~l~~~~~~f~~~~~l--G~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  180 (409)
                      .+.....++|++.+.+  |+|+||.||++...  +..+|+|.+.......     .|+.....+ +||||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~-   80 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT-   80 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec-
Confidence            3444555677777776  99999999999986  7889999986542111     122222222 79999999999987 


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC-cEEEecc
Q 048535          181 KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM-NARLGDF  259 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DF  259 (409)
                      .+..++||||+++|+|.+++...   ..+++.++..++.|+++||.|||   +.+++||||||+||+++.++ .++|+||
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence            67899999999999999999542   37999999999999999999999   88999999999999999998 9999999


Q ss_pred             cCcccccCCceeeeccc---c---ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCC
Q 048535          260 GLAKMHHHGQVMSGRRP---I---EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANS  333 (409)
Q Consensus       260 Gla~~~~~~~~~~g~~p---~---~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  333 (409)
                      |+++.........|...   .   ....++...|+|+++  ..+++++....+......                    +
T Consensus       155 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG--~il~~l~~g~~p~~~~~~--------------------~  212 (267)
T PHA03390        155 GLCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVG--VLTYELLTGKHPFKEDED--------------------E  212 (267)
T ss_pred             ccceecCCCccCCCCCcccChhhhcCCCCCchhhHHHHH--HHHHHHHHCCCCCCCCCc--------------------c
Confidence            99987654432222221   1   124456778999985  334444443322111000                    0


Q ss_pred             CCCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCccc-ccccCCCCCccc
Q 048535          334 RPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWK-FAGSRGHPTFNE  388 (409)
Q Consensus       334 RPt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~hp~~~~  388 (409)
                      -+...++..........+. ..+....+++.+|++.+|.+|++ +++++.||||..
T Consensus       213 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        213 ELDLESLLKRQQKKLPFIK-NVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             hhhHHHHHHhhcccCCccc-ccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            0111222222211111111 11122378899999999999986 589999999863

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.96  E-value=3.4e-29  Score=242.18  Aligned_cols=278  Identities=21%  Similarity=0.259  Sum_probs=195.2

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccC----CeEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK----ESLI  185 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~~  185 (409)
                      +|++.+.||+|+||.||+|...  ++.||+|.+....  ....+.+.+|+.+++.++|+||+++++++....    ...|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999986  7899999997542  445578999999999999999999999987633    3689


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      ++|||+++ +|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999984 89999853   347999999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCce----e---eecc---ccc---cC-CCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCC
Q 048535          266 HHGQV----M---SGRR---PIE---EG-KRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEA  331 (409)
Q Consensus       266 ~~~~~----~---~g~~---p~~---~~-~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP  331 (409)
                      .....    .   .+..   +.+   .. ..+..+|+|+++  ..+++++............    +....+..++...+
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG--~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~~  227 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVG--CIFAELLTRKPLFPGRDYI----DQLNLIVEVLGTPS  227 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHH--HHHHHHHcCCCCcCCCCHH----HHHHHHHHhcCCCC
Confidence            54320    1   1111   111   12 456778999986  3445555443332222111    22222222222222


Q ss_pred             CC---CCCHHHHHHHHhcCcCCCCC-------CCCCcchhHHhhhcccCCCCcccccccCCCCCccccccccCCCCCCcc
Q 048535          332 NS---RPTIRQVLKMLEGQTEGTGL-------EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNRSSSPSLNA  401 (409)
Q Consensus       332 ~~---RPt~~evl~~L~~~~~~~~~-------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~~~~s~~~~~  401 (409)
                      .+   +.......+.+.........       ..+....+++.+|+..+|..|.+..+++.||||..+.......+...+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~  307 (330)
T cd07834         228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPP  307 (330)
T ss_pred             hhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCc
Confidence            11   11222222232221111110       011223689999999999999999999999999998877666666665


Q ss_pred             ccc
Q 048535          402 SDV  404 (409)
Q Consensus       402 ~~~  404 (409)
                      .++
T Consensus       308 ~~~  310 (330)
T cd07834         308 FDF  310 (330)
T ss_pred             ccc
Confidence            554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=9.6e-29  Score=236.29  Aligned_cols=262  Identities=23%  Similarity=0.342  Sum_probs=181.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccC------
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK------  181 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  181 (409)
                      .++|+..+.||+|+||.||+|...  ++.||||.+....  ......+.+|+.++++++||||++++++|....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            357899999999999999999986  8999999986442  222345678999999999999999999987532      


Q ss_pred             -CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEeccc
Q 048535          182 -ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG  260 (409)
Q Consensus       182 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG  260 (409)
                       ...++||||+.+ +|.+++..  ....+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCC
Confidence             346999999975 88888854  2236899999999999999999999   8899999999999999999999999999


Q ss_pred             CcccccCCce-----e---ee---cccccc----CCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHH
Q 048535          261 LAKMHHHGQV-----M---SG---RRPIEE----GKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       261 la~~~~~~~~-----~---~g---~~p~~~----~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~  325 (409)
                      ++........     .   .+   ..+.+.    ...+..+|+|+++  ..+++++............   ..+..+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG--~~l~el~t~~~~~~~~~~~---~~~~~~~~~  239 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG--CIMAEMWTRSPIMQGNTEQ---HQLTLISQL  239 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHH--HHHHHHHhCCCCCCCCCHH---HHHHHHHHH
Confidence            9976533210     0   01   111111    1245678999986  3455555443322222111   222223333


Q ss_pred             ccCcCCCCCCCHHHHHHHHhcCcCCCC------------CCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          326 CAHPEANSRPTIRQVLKMLEGQTEGTG------------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~~L~~~~~~~~------------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      |-...|...|....... .+.. ..+.            ........+++.+|+..+|.+|++.++++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         240 CGSITPEVWPGVDKLEL-FKKM-ELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hCCCChhhcccccchhh-hhhc-cCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            44444444444322111 1100 0000            0011223689999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.96  E-value=1.1e-28  Score=238.64  Aligned_cols=139  Identities=22%  Similarity=0.256  Sum_probs=122.1

Q ss_pred             ceeecC--CceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLG--GNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G--~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      ..||+|  +||+||++.+.  |+.||+|.+...  .....+.+.+|+.+++.++||||+++++++.. ++..++|+||++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-GSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-CCceEEEEeccc
Confidence            456776  99999999985  899999998754  33445788999999999999999999999987 678899999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      +|+|.+++.... ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||.+
T Consensus        83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~  148 (328)
T cd08226          83 YGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHL  148 (328)
T ss_pred             CCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHH
Confidence            999999986532 235899999999999999999999   899999999999999999999999999854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.96  E-value=7.9e-29  Score=233.97  Aligned_cols=260  Identities=25%  Similarity=0.353  Sum_probs=191.4

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeEEEEEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYD  189 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~~lv~E  189 (409)
                      |++.+.||+|+||.||+|...  ++.+|+|.+...  .......+.+|++++++++|+|++++++++... .+..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999987  789999999765  233456788999999999999999999999873 278999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++ +|.+++...  ...+++..+..++.|+++||+|||   +.+++|+||||+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9985 999988542  246899999999999999999999   7899999999999999999999999999998664432


Q ss_pred             --eeee------ccccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 048535          270 --VMSG------RRPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI  337 (409)
Q Consensus       270 --~~~g------~~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  337 (409)
                        ..++      ..+.+    ...++...|+|+++  ..+++++........   ......+..+...|-..++..+|..
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG--~~l~el~t~~~p~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVG--CILAELFLGKPIFQG---STELEQLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHH--HHHHHHHhCCCCCCC---CChHHHHHHHHHHhCCCchhhcccc
Confidence              0111      11111    12356789999986  345555554433211   1223344555566777777777776


Q ss_pred             HHHHHHHhcCcCCCC----------CCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          338 RQVLKMLEGQTEGTG----------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       338 ~evl~~L~~~~~~~~----------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      .++..... ......          ...+....+++.+|+..+|.+|.+..+++.||||
T Consensus       230 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         230 SKLPWFEN-LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccchhhhh-ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            65422111 000000          0002234788999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=3.3e-29  Score=237.37  Aligned_cols=222  Identities=26%  Similarity=0.358  Sum_probs=159.4

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCC-CCceeeEeeEEEccCCeEEEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      +|...+.||+|+||.||++...  ++.||+|.+... .......+.+|+.++.++. |+||+++++++.. ....+++||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~~~~~~e   83 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGDCWICME   83 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCcEEEEEe
Confidence            4556688999999999999986  899999999754 2345567899999999995 9999999999887 667889999


Q ss_pred             eCCCCCHHHHH---hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          190 YMENGSLDKWI---FECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       190 ~~~~gsL~~~l---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      |++. +|.++.   .. .....+++..+..++.|++.||+|||+  ..+++||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~~-~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMDI-SLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             cccC-CHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9865 655443   22 123569999999999999999999994  3589999999999999999999999999997643


Q ss_pred             CCc---eeeeccccc------c---CCCcHHHHHHhhhccCcHHHHhhHHhhhc---------------------CCCCH
Q 048535          267 HGQ---VMSGRRPIE------E---GKRNLVDRMWSLTERSELLSVLDERLKAK---------------------GGYAD  313 (409)
Q Consensus       267 ~~~---~~~g~~p~~------~---~~~~~~~~vws~~~~~~~~~~~~~~l~~~---------------------~~~~~  313 (409)
                      ...   ...|..++.      .   ..++..+|+|+++  ..+++++....+..                     .....
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG--~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd06616         160 DSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLG--ITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER  237 (288)
T ss_pred             cCCccccccCccCccCHHHhccccccCCcchhhhhHHH--HHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence            321   112222211      1   1456678999874  11222221111100                     01111


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .....+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         238 EFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            24456777777788888888888777765

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.96  E-value=6.4e-29  Score=235.53  Aligned_cols=223  Identities=21%  Similarity=0.250  Sum_probs=163.8

Q ss_pred             CCCccceeecCCceEEEEEEEC-----CcEEEEEEeccCC----hHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCe
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLDS----EHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  183 (409)
                      +|+..+.||+|+||.||++...     ++.||||.++...    ....+.+.+|+.++.++ +||||+++++.+.. +..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCE
Confidence            4777899999999999998753     6789999987432    23346788999999999 69999999998876 678


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      .++||||+++|+|.+++..   ...+++..+..++.|+++||.|||   +.+++||||||+||+++.++.++|+|||+++
T Consensus        80 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            8999999999999999853   346899999999999999999999   8999999999999999999999999999987


Q ss_pred             cccCCc-----eeeeccccc------cC--CCcHHHHHHhhhccCcHHHHhhHHh-------------------hhcCCC
Q 048535          264 MHHHGQ-----VMSGRRPIE------EG--KRNLVDRMWSLTERSELLSVLDERL-------------------KAKGGY  311 (409)
Q Consensus       264 ~~~~~~-----~~~g~~p~~------~~--~~~~~~~vws~~~~~~~~~~~~~~l-------------------~~~~~~  311 (409)
                      ......     ...|...+.      ..  ..+...|+|+++.  .+++++....                   ......
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~--il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGV--LTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF  231 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHH--HHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC
Confidence            643321     111221111      11  1356778888741  1222222111                   111122


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 048535          312 ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       312 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                      +......+.+++.+||+.||++|||+.++.+.|+
T Consensus       232 ~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         232 PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            2233456677777888888888888777766554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.3e-28  Score=239.89  Aligned_cols=278  Identities=19%  Similarity=0.275  Sum_probs=189.0

Q ss_pred             ccccHHHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeE
Q 048535          101 HRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGW  176 (409)
Q Consensus       101 ~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~  176 (409)
                      ++....++...+++|+..+.||+|+||.||+|...  ++.||+|++...  .....+.+.+|+.++++++||||++++++
T Consensus         5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~   84 (345)
T cd07877           5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV   84 (345)
T ss_pred             hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence            34455677788899999999999999999999875  889999999753  23345678899999999999999999998


Q ss_pred             EEcc-----CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC
Q 048535          177 CKKE-----KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK  251 (409)
Q Consensus       177 ~~~~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~  251 (409)
                      +...     ....+++++++ +++|.+++..    ..+++..+..++.|+++||+|||   +.+|+||||||+||+++++
T Consensus        85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~  156 (345)
T cd07877          85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNED  156 (345)
T ss_pred             eeecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCC
Confidence            7642     13467888877 7799988742    35899999999999999999999   8999999999999999999


Q ss_pred             CcEEEecccCcccccCCce-eeecc---ccc---c-CCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHH
Q 048535          252 MNARLGDFGLAKMHHHGQV-MSGRR---PIE---E-GKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLG  323 (409)
Q Consensus       252 ~~~kl~DFGla~~~~~~~~-~~g~~---p~~---~-~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~  323 (409)
                      +.+||+|||+++....... ..+..   +.+   . ..++...|+|+++  ..+++++...........   ...+..+.
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG--~il~el~~g~~pf~~~~~---~~~~~~~~  231 (345)
T cd07877         157 CELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG--CIMAELLTGRTLFPGTDH---IDQLKLIL  231 (345)
T ss_pred             CCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHH--HHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence            9999999999986543321 11111   111   1 2346678999986  344555544332211111   11122221


Q ss_pred             HHccCcCCCCCC-----CHHHHHHHHhcCcCCCC----CCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          324 LLCAHPEANSRP-----TIRQVLKMLEGQTEGTG----LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       324 ~~Cl~~dP~~RP-----t~~evl~~L~~~~~~~~----~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      .......|..-+     ..+...+.+....+..-    ...+....+++.+|+..+|.+|++..+++.||||.+...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~  308 (345)
T cd07877         232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  308 (345)
T ss_pred             HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence            111111110000     11112222221111000    011223479999999999999999999999999997553

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.96  E-value=9.4e-29  Score=237.31  Aligned_cols=144  Identities=21%  Similarity=0.195  Sum_probs=124.8

Q ss_pred             ccceeecCCceEEEEEEECCcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCC
Q 048535          117 EENVIGLGGNGKVYKGQLLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENG  194 (409)
Q Consensus       117 ~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~g  194 (409)
                      +.+.+|.|+++.||++...++.||||+++..  .....+.+.+|+.+++.++|+||+++++++.+ .+..+++|||+++|
T Consensus         6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-DSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-CCeEEEEEeccCCC
Confidence            3455666777777777777999999999754  44566789999999999999999999999887 67899999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          195 SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       195 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +|.+++.... ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||.+...
T Consensus        85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~  151 (314)
T cd08216          85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM  151 (314)
T ss_pred             CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceee
Confidence            9999996532 235889999999999999999999   899999999999999999999999999988654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.96  E-value=2e-28  Score=232.76  Aligned_cols=267  Identities=21%  Similarity=0.294  Sum_probs=180.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++|+..+.||+|++|.||+|...  ++.||+|.+....  ....+.+.+|++++++++||||+++++++.+ ....++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-CCeEEEEE
Confidence            56888999999999999999986  8899999986542  2334678899999999999999999999987 67899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC-CCcEEEecccCcccccC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK-KMNARLGDFGLAKMHHH  267 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DFGla~~~~~  267 (409)
                      ||++ ++|.+++... ....+++..+..++.||+.||+|||   +++++||||||+||+++. ++.+||+|||+++....
T Consensus        81 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         81 EYLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             eccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            9996 5888887542 2334688889999999999999999   889999999999999985 55799999999976432


Q ss_pred             Cce----ee---eccccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCC-C
Q 048535          268 GQV----MS---GRRPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSR-P  335 (409)
Q Consensus       268 ~~~----~~---g~~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-P  335 (409)
                      ...    ..   ...+.+    ...++...|+|+++  ..+++++...........   ...+.++. .++...+..+ +
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG--~i~~~l~tg~~pf~~~~~---~~~~~~~~-~~~~~~~~~~~~  229 (294)
T PLN00009        156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVG--CIFAEMVNQKPLFPGDSE---IDELFKIF-RILGTPNEETWP  229 (294)
T ss_pred             CccccccCceeecccCHHHHhCCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCCH---HHHHHHHH-HHhCCCChhhcc
Confidence            210    00   111111    12356789999986  345555554333211111   12222221 1221111111 1


Q ss_pred             CHHHHHHHHhcCcCCC-------CCCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          336 TIRQVLKMLEGQTEGT-------GLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       336 t~~evl~~L~~~~~~~-------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      ....+-..........       .+.......+++.+|+..+|..|.+..+++.||||.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~  292 (294)
T PLN00009        230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD  292 (294)
T ss_pred             ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence            1111111000000000       0111222468899999999999999999999999998764

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.4e-28  Score=239.62  Aligned_cols=270  Identities=19%  Similarity=0.277  Sum_probs=182.6

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-----
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-----  181 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----  181 (409)
                      ..++|+..+.||+|+||.||++...  +..||||++...  .......+.+|+.++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            4678999999999999999999876  899999998543  2334467889999999999999999999887532     


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      ...++||||+ +++|.+++..    ..+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            2468999999 6799988842    46899999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCce-eeeccc---cc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCC-
Q 048535          262 AKMHHHGQV-MSGRRP---IE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEAN-  332 (409)
Q Consensus       262 a~~~~~~~~-~~g~~p---~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~-  332 (409)
                      ++....... ..+...   .+    ....+...|+|+++  ..+++++...........   ...+.++.. +....|. 
T Consensus       165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG--~ll~~l~~g~~pf~~~~~---~~~~~~~~~-~~~~~~~~  238 (343)
T cd07880         165 ARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVG--CIMAEMLTGKPLFKGHDH---LDQLMEIMK-VTGTPSKE  238 (343)
T ss_pred             ccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCCH---HHHHHHHHH-hcCCCCHH
Confidence            986543321 111111   11    12356778999985  334444443322111111   111222111 1111000 


Q ss_pred             --CC---CCHHHHHHHHhcCcCC----CCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccccccccC
Q 048535          333 --SR---PTIRQVLKMLEGQTEG----TGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNRS  394 (409)
Q Consensus       333 --~R---Pt~~evl~~L~~~~~~----~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~~~  394 (409)
                        ++   .........+......    ....-.....+++.+|+..+|.+|++..+++.||||........
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~  309 (343)
T cd07880         239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPED  309 (343)
T ss_pred             HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccc
Confidence              00   0011111111111000    00011122478999999999999999999999999998764433

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=3.7e-28  Score=233.46  Aligned_cols=220  Identities=25%  Similarity=0.355  Sum_probs=165.5

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      |...+.||+|+||.||+|+..  +..||+|.+...   .....+.+.+|++++++++|||++++++++.+ ....++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-EHTAWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEEe
Confidence            555678999999999999985  889999998643   33445678899999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |++ |+|.+++..  ....+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.......
T Consensus       102 ~~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~  175 (313)
T cd06633         102 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN  175 (313)
T ss_pred             cCC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCC
Confidence            996 588887754  2346899999999999999999999   8899999999999999999999999999987644332


Q ss_pred             eeeecccc---c------cCCCcHHHHHHhhhccCcHHHHhhHHh---------------hh--cCCCCHHHHHHHHHHH
Q 048535          270 VMSGRRPI---E------EGKRNLVDRMWSLTERSELLSVLDERL---------------KA--KGGYADEVVEKVLHLG  323 (409)
Q Consensus       270 ~~~g~~p~---~------~~~~~~~~~vws~~~~~~~~~~~~~~l---------------~~--~~~~~~~~~~~l~~l~  323 (409)
                      ...|...+   +      ...++..+|+|+++.  .++++.....               ..  ...........+.+++
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGv--il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  253 (313)
T cd06633         176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI--TCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV  253 (313)
T ss_pred             CccccccccChhhccccCCCCCCchhhHHHHHH--HHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence            22222211   1      133566789998741  1222211111               00  0011122345688899


Q ss_pred             HHccCcCCCCCCCHHHHHHH
Q 048535          324 LLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~~  343 (409)
                      .+||+.+|.+||++.++++.
T Consensus       254 ~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         254 DYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             HHHccCChhhCcCHHHHhcC
Confidence            99999999999999988853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=1.4e-28  Score=233.39  Aligned_cols=147  Identities=26%  Similarity=0.312  Sum_probs=128.4

Q ss_pred             CCCccceeecCCceEEEEEEE-----CCcEEEEEEeccCC----hHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCe
Q 048535          114 GFSEENVIGLGGNGKVYKGQL-----LGVEVALKRISLDS----EHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  183 (409)
                      +|+..+.||+|+||.||++..     .|..||+|+++...    ....+.+.+|+.++.++ +|+||+++++++.. +..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCe
Confidence            477889999999999999986     37889999997532    22346788999999999 69999999998876 678


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      .++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++
T Consensus        80 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          80 LHLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            8999999999999999954   346889999999999999999999   8999999999999999999999999999998


Q ss_pred             cccC
Q 048535          264 MHHH  267 (409)
Q Consensus       264 ~~~~  267 (409)
                      ....
T Consensus       154 ~~~~  157 (290)
T cd05613         154 EFHE  157 (290)
T ss_pred             eccc
Confidence            6543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.96  E-value=1.6e-28  Score=235.53  Aligned_cols=223  Identities=26%  Similarity=0.368  Sum_probs=169.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      +.|+..+.||+|+||.||+|...  +..+|+|.+...   .....+++.+|+++++.++|+|++++++++.. ....++|
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   93 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV   93 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCeeEEE
Confidence            34666788999999999999986  788999998642   33445678899999999999999999999987 6788999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+. |+|.+++...  ...+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          94 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            99996 5888877542  345899999999999999999999   89999999999999999999999999999987654


Q ss_pred             Cceeeecccc---c------cCCCcHHHHHHhhhccCcHHHHhhHH---------------hhhc--CCCCHHHHHHHHH
Q 048535          268 GQVMSGRRPI---E------EGKRNLVDRMWSLTERSELLSVLDER---------------LKAK--GGYADEVVEKVLH  321 (409)
Q Consensus       268 ~~~~~g~~p~---~------~~~~~~~~~vws~~~~~~~~~~~~~~---------------l~~~--~~~~~~~~~~l~~  321 (409)
                      .....|...+   +      ....+...|+|+++.  .+++++...               ....  ..........+.+
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~--il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (308)
T cd06634         168 ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI--TCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  245 (308)
T ss_pred             cccccCCccccCHHHHhhcccCCCCcccchHHHHH--HHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence            4323222211   1      123455678888731  111111111               1000  0112245567899


Q ss_pred             HHHHccCcCCCCCCCHHHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLKML  344 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~~L  344 (409)
                      ++.+||+.+|++||++.++++..
T Consensus       246 li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         246 FVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             HHHHHhhCCcccCCCHHHHhhCc
Confidence            99999999999999999998763

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=2.9e-28  Score=237.13  Aligned_cols=227  Identities=21%  Similarity=0.307  Sum_probs=167.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-----C
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-----E  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~  182 (409)
                      .++|...+.||+|+||.||+|...  ++.||+|++...  .......+.+|+.++++++||||+++++++....     .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999975  899999998643  2233456889999999999999999999886422     3


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..++|+||+.. +|.+++.     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999975 8877651     25899999999999999999999   889999999999999999999999999999


Q ss_pred             ccccCCce-eeec---cccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhc--------------------------
Q 048535          263 KMHHHGQV-MSGR---RPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAK--------------------------  308 (409)
Q Consensus       263 ~~~~~~~~-~~g~---~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~--------------------------  308 (409)
                      +....... ..+.   .+.+    ...++..+|+|+++.  .+++++.......                          
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGv--il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         165 RHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGC--IMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             cCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHH--HHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            86543210 1111   1112    123567789998731  1111111100000                          


Q ss_pred             ------------CCCC--------HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HhcCcC
Q 048535          309 ------------GGYA--------DEVVEKVLHLGLLCAHPEANSRPTIRQVLKM--LEGQTE  349 (409)
Q Consensus       309 ------------~~~~--------~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~  349 (409)
                                  ...+        ......+.+++.+||+.||++||++.+++..  +++...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                        0000        0123457899999999999999999999854  655543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.96  E-value=1.6e-28  Score=231.51  Aligned_cols=171  Identities=28%  Similarity=0.386  Sum_probs=139.6

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      |+..+.||+|++|.||+|...  ++.+|+|.++...  ......+.+|+.++++++|+||+++++++.. +...++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-KGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-CCCEEEEEec
Confidence            566789999999999999986  8899999987542  2345678899999999999999999999887 6789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc-
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ-  269 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-  269 (409)
                      +++ +|.+++...  ...+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.+||+|||.+....... 
T Consensus        80 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          80 MDT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             cCC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            976 898888542  246899999999999999999999   8999999999999999999999999999997665432 


Q ss_pred             e---eeecc---ccc---cC-CCcHHHHHHhhh
Q 048535          270 V---MSGRR---PIE---EG-KRNLVDRMWSLT  292 (409)
Q Consensus       270 ~---~~g~~---p~~---~~-~~~~~~~vws~~  292 (409)
                      .   ..+..   +.+   .. ..+...|+|+++
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG  186 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVG  186 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHH
Confidence            0   01111   111   12 456778999984

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.1e-28  Score=227.92  Aligned_cols=221  Identities=25%  Similarity=0.383  Sum_probs=162.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-----ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-----SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESL  184 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~  184 (409)
                      .+|+..+.||+|+||.||+|...  ++.||+|.+...     .......+.+|++++++++|+||+++++++.+. ....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57888999999999999999976  889999987532     234456789999999999999999999988653 3468


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++++||+++++|.+++..   ...+++.....++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999999853   235889999999999999999999   89999999999999999999999999999976


Q ss_pred             ccCCc-------eeeecc---ccc---cCCCcHHHHHHhhhccCcHHHHhhHH---------------hh--hcCCCCHH
Q 048535          265 HHHGQ-------VMSGRR---PIE---EGKRNLVDRMWSLTERSELLSVLDER---------------LK--AKGGYADE  314 (409)
Q Consensus       265 ~~~~~-------~~~g~~---p~~---~~~~~~~~~vws~~~~~~~~~~~~~~---------------l~--~~~~~~~~  314 (409)
                      .....       ...|..   +.+   ....+..+|+|+++  ..+++++...               ..  .....+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~  233 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVA--CTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG  233 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHH--HHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcc
Confidence            43210       111211   111   12345667888873  1122222111               10  01223444


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+.+.+++.+||+ +|..|||+.+++.
T Consensus       234 ~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         234 VSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             cCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            55667777777777 4577777776654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.96  E-value=1.2e-28  Score=238.97  Aligned_cols=269  Identities=20%  Similarity=0.228  Sum_probs=181.6

Q ss_pred             CCCC-ccceeecCCceEEEEEEEC--CcEEEEEEeccCChHH--------------HHHHHHHHHHhccCCCCceeeEee
Q 048535          113 KGFS-EENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHG--------------MREFLAEVSSLGRLKHRNLVGLRG  175 (409)
Q Consensus       113 ~~f~-~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~g  175 (409)
                      ++|. ..+.||+|+||.||+|...  ++.||||.++......              ...+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 3577999999999999976  8999999986542111              124779999999999999999999


Q ss_pred             EEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEE
Q 048535          176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNAR  255 (409)
Q Consensus       176 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k  255 (409)
                      ++.. .+..++||||++ |+|.+++..   ...+++.....++.|++.||.|||   +.+|+|+||||+||+++.++.+|
T Consensus        88 ~~~~-~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         88 VYVE-GDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEec-CCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEE
Confidence            9987 678999999997 599999843   346899999999999999999999   89999999999999999999999


Q ss_pred             EecccCcccccCCc---------------eee---e---ccccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCC
Q 048535          256 LGDFGLAKMHHHGQ---------------VMS---G---RRPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGG  310 (409)
Q Consensus       256 l~DFGla~~~~~~~---------------~~~---g---~~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~  310 (409)
                      |+|||+++......               ..+   +   ..+.+    ...++...|+|+++  ..+++++.........
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG--~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG--CIFAELLTGKPLFPGE  237 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCC
Confidence            99999997654111               000   0   11111    12346789999996  4455665543332222


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCC------CCCCCCcchhHHhhhcccCCCCcccccccCCCC
Q 048535          311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGT------GLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHP  384 (409)
Q Consensus       311 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp  384 (409)
                      ...+.   +..+...+-.+.+..=|....+-...+.....+      .......-.+++.+|+..+|.+|+++++++.||
T Consensus       238 ~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        238 NEIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             CHHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            22222   222222222211111111111100000000000      001112346899999999999999999999999


Q ss_pred             CccccccccC
Q 048535          385 TFNEINKNRS  394 (409)
Q Consensus       385 ~~~~~~~~~~  394 (409)
                      ||....+.-.
T Consensus       315 ~~~~~~~~~~  324 (335)
T PTZ00024        315 YFKSDPLPCD  324 (335)
T ss_pred             ccCCCCCCCC
Confidence            9987665443

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.96  E-value=3.5e-28  Score=229.71  Aligned_cols=147  Identities=29%  Similarity=0.522  Sum_probs=124.1

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccC---CCCceeeEeeEEEccCCe----
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRL---KHRNLVGLRGWCKKEKES----  183 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~~~~----  183 (409)
                      |++.+.||+|+||.||+|+..  ++.||+|+++..  .......+.+|+.+++++   +|||++++++++.. .+.    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~-~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHG-PRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEee-ccCCCCc
Confidence            567889999999999999987  799999999744  222234567788777655   69999999999986 344    


Q ss_pred             -EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          184 -LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       184 -~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                       .+++|||+++ +|.+++.... ...+++..+..++.|+++||.|||   +.+++|+||||+||+++.++.+||+|||++
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcc
Confidence             8999999975 8999886532 235899999999999999999999   889999999999999999999999999999


Q ss_pred             ccccC
Q 048535          263 KMHHH  267 (409)
Q Consensus       263 ~~~~~  267 (409)
                      .....
T Consensus       155 ~~~~~  159 (287)
T cd07838         155 RIYSF  159 (287)
T ss_pred             eeccC
Confidence            87644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=251.52  Aligned_cols=189  Identities=25%  Similarity=0.397  Sum_probs=154.8

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-----CeEEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-----ESLIL  186 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~~l  186 (409)
                      +...+.||+|+||.||+|+.+  |+.||||.++.. .....+...+|+++|++++|+|||++++.-.+..     ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            344578999999999999977  999999999865 3445667889999999999999999998655422     24679


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee--CCCCc--EEEecccCc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL--DKKMN--ARLGDFGLA  262 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl--~~~~~--~kl~DFGla  262 (409)
                      |||||.+|||+..|.+-.+...|++.+.+.+..+++.||.|||   +++|+||||||.||++  ..+|+  -||+|||+|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999987767778999999999999999999999   8999999999999999  34454  699999999


Q ss_pred             ccccCCceee---ecccc------c-cCCCcHHHHHHhhhccCcHHHHhhHHhhhc
Q 048535          263 KMHHHGQVMS---GRRPI------E-EGKRNLVDRMWSLTERSELLSVLDERLKAK  308 (409)
Q Consensus       263 ~~~~~~~~~~---g~~p~------~-~~~~~~~~~vws~~~~~~~~~~~~~~l~~~  308 (409)
                      |..+.+..++   |..-+      + ...|+...|.|+++  ..++..+.+.+++.
T Consensus       172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~G--vtlY~caTG~lPF~  225 (732)
T KOG4250|consen  172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFG--VTLYECATGELPFI  225 (732)
T ss_pred             ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhh--hHHHHHhccCCCCC
Confidence            9998877433   33221      2 25667778999997  56777777776543

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.96  E-value=1.8e-28  Score=233.61  Aligned_cols=223  Identities=22%  Similarity=0.348  Sum_probs=163.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++|+..+.||+|+||.||+|.+.  ++.||||.++.. ......++..|+.++.+. .||||+++++++.+ ....+++|
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~   93 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-DSDVFICM   93 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-CCeEEEEe
Confidence            66788899999999999999997  899999999754 233456677888877777 59999999999987 67899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++ +|.+++...  ...+++..+..++.|+++||+|||+  ..+|+||||+|+||++++++.+||+|||++......
T Consensus        94 e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          94 ELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            99854 787776542  2368999999999999999999993  258999999999999999999999999999765432


Q ss_pred             cee---eecc---ccc-------cCCCcHHHHHHhhhccCcHHHHhh----------------HHhhhc-C--CCCHHHH
Q 048535          269 QVM---SGRR---PIE-------EGKRNLVDRMWSLTERSELLSVLD----------------ERLKAK-G--GYADEVV  316 (409)
Q Consensus       269 ~~~---~g~~---p~~-------~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~~~-~--~~~~~~~  316 (409)
                      ...   .+..   +.+       ....+...|+|+++  ..+++++.                ..+... .  .......
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG--~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (296)
T cd06618         169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLG--ISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS  246 (296)
T ss_pred             CcccCCCCCccccCHhhcCCCCCccccccchhHHHHH--HHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCC
Confidence            111   1111   111       12245678999874  11222221                111100 0  0111235


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      .++.+++.+||+.||.+||++.++++.
T Consensus       247 ~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         247 PDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            567888889999999999998888754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=3.9e-28  Score=231.26  Aligned_cols=225  Identities=16%  Similarity=0.170  Sum_probs=155.9

Q ss_pred             hCCCCccceeecCCceEEEEEEECC-----cEEEEEEeccCChHH-----------HHHHHHHHHHhccCCCCceeeEee
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-----------MREFLAEVSSLGRLKHRNLVGLRG  175 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l~g  175 (409)
                      .++|++.+.||+|+||.||+|...+     ..+|+|.........           ......+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3679999999999999999999762     356676643322111           112234455667789999999999


Q ss_pred             EEEccCC---eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC
Q 048535          176 WCKKEKE---SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM  252 (409)
Q Consensus       176 ~~~~~~~---~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~  252 (409)
                      ++.....   ..++++|++.. ++.+.+..   ....++..+..++.|++.||+|||   +.+|+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence            7654322   34678887754 67766632   223678889999999999999999   89999999999999999999


Q ss_pred             cEEEecccCcccccCCc-----------eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhc-------
Q 048535          253 NARLGDFGLAKMHHHGQ-----------VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAK-------  308 (409)
Q Consensus       253 ~~kl~DFGla~~~~~~~-----------~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~-------  308 (409)
                      .+||+|||+|+......           ...|...+      ....++..+|+|+++  ..+++++....+..       
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG--~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLG--YCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHH--HHHHHHHhCCCCCCccccchH
Confidence            99999999998653211           11222222      124467889999983  11222221111110       


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 048535          309 ----------------GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       309 ----------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                                      ..........+.+++..||+.+|++||++.++++.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 LIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence                            0011223567889999999999999999999998763

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.2e-28  Score=239.98  Aligned_cols=184  Identities=22%  Similarity=0.330  Sum_probs=144.0

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC---
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE---  182 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---  182 (409)
                      ...++|+..+.||+|+||.||+|...  +..||+|++...  .....+.+.+|+.++++++||||+++++++.....   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999986  789999998643  33345678889999999999999999987765222   


Q ss_pred             --eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEeccc
Q 048535          183 --SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG  260 (409)
Q Consensus       183 --~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG  260 (409)
                        ..++|+||+ +++|.+++..    ..+++..+..++.|+++||.|||   +.+|+||||||+||++++++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccc
Confidence              389999999 5699999843    46999999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCc-eeeecc---ccc----cCCCcHHHHHHhhhccCcHHHHhhH
Q 048535          261 LAKMHHHGQ-VMSGRR---PIE----EGKRNLVDRMWSLTERSELLSVLDE  303 (409)
Q Consensus       261 la~~~~~~~-~~~g~~---p~~----~~~~~~~~~vws~~~~~~~~~~~~~  303 (409)
                      ++....... ...+..   +.+    ....+...|+|+++  ..+++++..
T Consensus       164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG--v~l~elltg  212 (343)
T cd07851         164 LARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG--CIMAELLTG  212 (343)
T ss_pred             ccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHH--HHHHHHHhC
Confidence            998654321 011111   111    12456778999985  334444443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.96  E-value=2.9e-28  Score=237.20  Aligned_cols=264  Identities=20%  Similarity=0.266  Sum_probs=174.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC---------
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK---------  181 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---------  181 (409)
                      .+|...+.||.|+||.||+|...  ++.||+|.+........+.+.+|++++++++||||+++++++....         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            67889999999999999999986  8899999997765566678899999999999999999998765422         


Q ss_pred             ----CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC-CCcEEE
Q 048535          182 ----ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK-KMNARL  256 (409)
Q Consensus       182 ----~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kl  256 (409)
                          ...++||||++ ++|.+++..    ..+++..+..++.|++.||.|||   +.+|+||||||+||+++. ++.+||
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEE
Confidence                35789999997 599988842    35899999999999999999999   899999999999999974 567899


Q ss_pred             ecccCcccccCCce-------eeeccc---cc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHH
Q 048535          257 GDFGLAKMHHHGQV-------MSGRRP---IE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHL  322 (409)
Q Consensus       257 ~DFGla~~~~~~~~-------~~g~~p---~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l  322 (409)
                      +|||+++.......       ..+...   .+    ...++..+|+|+++  ..+++++..........+   ...+..+
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlG--vil~el~~g~~pf~~~~~---~~~~~~~  231 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG--CIFAEMLTGKPLFAGAHE---LEQMQLI  231 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHH--HHHHHHHhCCCCCCCCCH---HHHHHHH
Confidence            99999976532110       011111   11    12345678999986  344555444433211111   1112222


Q ss_pred             HHHccCcCCCCCCCHHHHH-HHHh-cCcCCC------CCCCCCcchhHHhhhcccCCCCcccccccCCCCCcccc
Q 048535          323 GLLCAHPEANSRPTIRQVL-KMLE-GQTEGT------GLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEI  389 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl-~~L~-~~~~~~------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~  389 (409)
                      ....--.++.+++...... ..+. ......      .+.......+++.+|+..+|.+|++..+++.||||+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence            1111111111111110000 0000 000000      00011223578888888888888888888888888754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.96  E-value=2.6e-28  Score=233.37  Aligned_cols=264  Identities=25%  Similarity=0.336  Sum_probs=183.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccC------
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK------  181 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~------  181 (409)
                      .++|+..+.||+|+||.||+|...  ++.||+|++....  ......+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999986  8899999986542  222345778999999999999999999876432      


Q ss_pred             -CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEeccc
Q 048535          182 -ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG  260 (409)
Q Consensus       182 -~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG  260 (409)
                       ..+++|+||+.+ +|.+.+..  ....+++..+..++.|+++||+|||   +.+|+|+||||+|||+++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCc
Confidence             247999999975 78777753  2346999999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCcee---------------eec---cccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHH
Q 048535          261 LAKMHHHGQVM---------------SGR---RPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEK  318 (409)
Q Consensus       261 la~~~~~~~~~---------------~g~---~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~  318 (409)
                      +++........               .+.   .+.+    ...++...|+|+++  ..+++++.......+..   ....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG--~il~el~~g~~~~~~~~---~~~~  235 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG--CVFAEMFTRRPILQGKS---DIDQ  235 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHH--HHHHHHHhCCCCCCCCC---HHHH
Confidence            99865432210               011   1111    12346678999996  44555555433221111   1223


Q ss_pred             HHHHHHHccCcCCCCCCCHHHHHHHHhcCc--CCCC------CCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          319 VLHLGLLCAHPEANSRPTIRQVLKMLEGQT--EGTG------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       319 l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~--~~~~------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      ...+...|-...|...|....+-.......  ..+.      ......-.+++.+|+..+|.+|++..+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            334444455544444443322221110000  0000      0001123689999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=4.3e-28  Score=226.17  Aligned_cols=224  Identities=21%  Similarity=0.310  Sum_probs=161.8

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-----ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-----SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      +|.+.+.||+|+||.||++...  +..+++|.++..     ......++..|+.++++++||||+++++++.+ ....++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-RDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-CCceEE
Confidence            4778899999999999999886  445556655421     22334467789999999999999999999876 667899


Q ss_pred             EEEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          187 IYDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      ||||+++++|.+++... .....+++..+..++.|++.||.|||   +.+++|+||||+||++++ +.+||+|||+++..
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeec
Confidence            99999999999988642 23356999999999999999999999   899999999999999975 56999999998765


Q ss_pred             cCCce----eeecc---c---cccCCCcHHHHHHhhhcc-------------CcHHHHhhHHhhh-cCCCCHHHHHHHHH
Q 048535          266 HHGQV----MSGRR---P---IEEGKRNLVDRMWSLTER-------------SELLSVLDERLKA-KGGYADEVVEKVLH  321 (409)
Q Consensus       266 ~~~~~----~~g~~---p---~~~~~~~~~~~vws~~~~-------------~~~~~~~~~~l~~-~~~~~~~~~~~l~~  321 (409)
                      .....    ..|..   +   .....++...|+|+++.-             ............. ....+......+.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (260)
T cd08222         156 MGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS  235 (260)
T ss_pred             CCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHH
Confidence            43221    11111   1   111334556888887311             1111111111110 12233455667888


Q ss_pred             HHHHccCcCCCCCCCHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ++.+||+.+|++||++.|+++
T Consensus       236 li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         236 IMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHHHHhcCChhhCcCHHHHhh
Confidence            888999999999999888875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=6.3e-29  Score=225.88  Aligned_cols=263  Identities=19%  Similarity=0.274  Sum_probs=188.7

Q ss_pred             ccHHHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEc
Q 048535          103 VSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKK  179 (409)
Q Consensus       103 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  179 (409)
                      -+|+++...|     .+.||+|+|+.|-.+...  |.++|||++.+.....+.+..+|++++.+. .|+||++++.||.+
T Consensus        73 g~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   73 GKFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             chHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            3577887777     578999999999988765  999999999887777788999999999999 69999999999988


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC---cEEE
Q 048535          180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM---NARL  256 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~~kl  256 (409)
                       +.+.|||||-|.||+|...|.+   ...+++.++.++..+|+.||.|||   .++|.||||||+|||-.+..   -+||
T Consensus       148 -d~~FYLVfEKm~GGplLshI~~---~~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKi  220 (463)
T KOG0607|consen  148 -DTRFYLVFEKMRGGPLLSHIQK---RKHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKI  220 (463)
T ss_pred             -cceEEEEEecccCchHHHHHHH---hhhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceee
Confidence             7889999999999999999964   356999999999999999999999   89999999999999996544   3899


Q ss_pred             ecccCcccccCCc---------eee--ecccc-----------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHH
Q 048535          257 GDFGLAKMHHHGQ---------VMS--GRRPI-----------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADE  314 (409)
Q Consensus       257 ~DFGla~~~~~~~---------~~~--g~~p~-----------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~  314 (409)
                      |||.|..-.....         ++|  |...+           +...|+...|.|+++.  .++-++....++.+     
T Consensus       221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGv--IlYImLsGYpPFvG-----  293 (463)
T KOG0607|consen  221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGV--ILYIMLSGYPPFVG-----  293 (463)
T ss_pred             eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHH--HHHHHHhCCCCccC-----
Confidence            9999876433221         221  11111           0133455567788752  22222222222111     


Q ss_pred             HHHHHHHHHHHccCcCCCCC-----CCHHHHHHHHhc-CcCCCCCCCCC---cchhHHhhhcccCCCCcccccccCCCCC
Q 048535          315 VVEKVLHLGLLCAHPEANSR-----PTIRQVLKMLEG-QTEGTGLEDEG---MNVHLLKRIGTRAMTSSWKFAGSRGHPT  385 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~R-----Pt~~evl~~L~~-~~~~~~~~~~~---~~~~~l~~~~~~~~~~~~~~~~~~~hp~  385 (409)
                                .|-+..--+|     -.-..+.+.+++ --+.|+..=..   ...|+...++..++..|.+..+.++|||
T Consensus       294 ----------~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw  363 (463)
T KOG0607|consen  294 ----------HCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW  363 (463)
T ss_pred             ----------ccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence                      1222122222     222333344432 33443322111   2378899999999999999999999999


Q ss_pred             ccccccccC
Q 048535          386 FNEINKNRS  394 (409)
Q Consensus       386 ~~~~~~~~~  394 (409)
                      +..+...-.
T Consensus       364 ~~~~~~eka  372 (463)
T KOG0607|consen  364 VQRCAPEKA  372 (463)
T ss_pred             ccccchhcc
Confidence            998775543

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.96  E-value=7.5e-28  Score=222.80  Aligned_cols=210  Identities=23%  Similarity=0.258  Sum_probs=158.4

Q ss_pred             eecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCC
Q 048535          121 IGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS  195 (409)
Q Consensus       121 lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gs  195 (409)
                      ||+|+||.||++...  ++.+|+|.+....   ......+..|+.++++++||||+++++.+.. +...+++|||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence            699999999999986  8899999987542   2345688999999999999999999998876 778999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc----ee
Q 048535          196 LDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ----VM  271 (409)
Q Consensus       196 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~----~~  271 (409)
                      |.+++..   ...+++..+..++.|+++||.|||   +.+++|+||||+||+++.++.++|+|||++.......    ..
T Consensus        80 L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (250)
T cd05123          80 LFSHLSK---EGRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF  153 (250)
T ss_pred             HHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence            9999953   336899999999999999999999   8999999999999999999999999999997654421    11


Q ss_pred             eecc---cc---ccCCCcHHHHHHhhhccCcHHHHhhHH---------------hhhcCCCCHHHHHHHHHHHHHccCcC
Q 048535          272 SGRR---PI---EEGKRNLVDRMWSLTERSELLSVLDER---------------LKAKGGYADEVVEKVLHLGLLCAHPE  330 (409)
Q Consensus       272 ~g~~---p~---~~~~~~~~~~vws~~~~~~~~~~~~~~---------------l~~~~~~~~~~~~~l~~l~~~Cl~~d  330 (409)
                      .+..   +.   .....+...|+|+++  ..+++++...               .......+......+.+++.+||..|
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG--~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~  231 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLG--VLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKD  231 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHH--HHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCC
Confidence            1111   11   112345668888874  1122222211               11112233333556777888888888


Q ss_pred             CCCCCCHHH
Q 048535          331 ANSRPTIRQ  339 (409)
Q Consensus       331 P~~RPt~~e  339 (409)
                      |++|||+.+
T Consensus       232 p~~R~~~~~  240 (250)
T cd05123         232 PTKRLGSGG  240 (250)
T ss_pred             HhhCCCccc
Confidence            888888743

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=8.5e-28  Score=226.99  Aligned_cols=166  Identities=23%  Similarity=0.253  Sum_probs=128.7

Q ss_pred             eeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHH---HhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          120 VIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVS---SLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       120 ~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~---~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      .||+|+||.||++...  ++.||+|.+....   ......+..|..   .++..+||||+++++++.+ .+..++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-CCEEEEEEecC
Confidence            4899999999999875  7899999986542   122223444443   4445689999999998887 67899999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc--
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ--  269 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~--  269 (409)
                      ++|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++......  
T Consensus        80 ~g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~  153 (278)
T cd05606          80 NGGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH  153 (278)
T ss_pred             CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCc
Confidence            99999998843   346999999999999999999999   8999999999999999999999999999987543211  


Q ss_pred             eeeeccccc-------cCCCcHHHHHHhhh
Q 048535          270 VMSGRRPIE-------EGKRNLVDRMWSLT  292 (409)
Q Consensus       270 ~~~g~~p~~-------~~~~~~~~~vws~~  292 (409)
                      ...|...+.       ...++...|+|+++
T Consensus       154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G  183 (278)
T cd05606         154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLG  183 (278)
T ss_pred             CcCCCcCCcCcHHhcCCCCCCcccchHhHH
Confidence            122322221       11345668999874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=4e-28  Score=228.71  Aligned_cols=146  Identities=32%  Similarity=0.468  Sum_probs=128.6

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      |+..+.||+|+||.||+|+..  ++.||+|.+....  ....+.+..|+.++++++|+|++++++++.+ ....++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-ERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-CCceEEEecC
Confidence            556788999999999999987  8999999997652  3344678899999999999999999999887 6789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ++ ++|.+++....  ..+++..+..++.|++.||.|||   +.+|+||||+|+||++++++.+||+|||+++....
T Consensus        80 ~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          80 CD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             cC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            98 59999996532  46999999999999999999999   88999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-28  Score=228.11  Aligned_cols=238  Identities=18%  Similarity=0.274  Sum_probs=188.3

Q ss_pred             HHHHHHHhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeE
Q 048535          105 YQEIHAATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGW  176 (409)
Q Consensus       105 ~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~  176 (409)
                      .+++.....+++....+-+|.||.||+|.|.       .+.|-+|.++.. ++-+...|+.|...+..+.|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3456666677888889999999999999775       345788888655 56677889999999999999999999999


Q ss_pred             EEccCCeEEEEEEeCCCCCHHHHHh-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC
Q 048535          177 CKKEKESLILIYDYMENGSLDKWIF-----ECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK  251 (409)
Q Consensus       177 ~~~~~~~~~lv~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~  251 (409)
                      +.++....+++|.++.-|+|..||.     +....+.++..+.+.++.|++.||+|||   ..+|||.||.++|++||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhh
Confidence            9987888999999999999999998     3344566888899999999999999999   8999999999999999999


Q ss_pred             CcEEEecccCcccccCCceee----eccccc--------cCCCcHHHHHHhhhcc--------------CcHHHH---hh
Q 048535          252 MNARLGDFGLAKMHHHGQVMS----GRRPIE--------EGKRNLVDRMWSLTER--------------SELLSV---LD  302 (409)
Q Consensus       252 ~~~kl~DFGla~~~~~~~~~~----g~~p~~--------~~~~~~~~~vws~~~~--------------~~~~~~---~~  302 (409)
                      .++||+|=.++|.+-..++-+    ..+|..        ...++..+|+|+++..              -+..++   +.
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            999999999999765444221    123332        3567778888887311              111111   11


Q ss_pred             HHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          303 ERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       303 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      ...+  -..|.++++++..++.-||...|++||+++|++.-|.+.
T Consensus       513 dGyR--laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  513 DGYR--LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ccce--ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence            1111  234567788999999999999999999999999988653

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=4.2e-30  Score=226.74  Aligned_cols=265  Identities=24%  Similarity=0.375  Sum_probs=193.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-------C
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-------K  181 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------~  181 (409)
                      ..|....+||+|.||.||+++..  |+.||+|++-.+.  ...-..-++|+.+|..|+|+|++.++..|...       .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34555678999999999999887  7889998874432  22234567899999999999999999888631       2


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      ..+|+||.+|+. +|.-.|..  ....++..++.+++.++..||.|+|   ...|+|||+||.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccc
Confidence            358999999988 99988843  4467999999999999999999999   89999999999999999999999999999


Q ss_pred             cccccCCcee-----------eeccccc----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHc
Q 048535          262 AKMHHHGQVM-----------SGRRPIE----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLC  326 (409)
Q Consensus       262 a~~~~~~~~~-----------~g~~p~~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~C  326 (409)
                      |+.+...+-.           --.+|.+    ...|....|+|...  +.+.++.....-..++   .....+.-+-..|
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAg--CimaeMwtrspimqgn---teqqql~~Is~Lc  245 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAG--CIMAEMWTRSPIMQGN---TEQQQLHLISQLC  245 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHH--HHHHHHHccCccccCC---hHHHHHHHHHHHh
Confidence            9876544311           1122222    24566778899775  3333433322211121   2233455566678


Q ss_pred             cCcCCCCCCCHHHH--HHHHhcC-------------cCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          327 AHPEANSRPTIRQV--LKMLEGQ-------------TEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       327 l~~dP~~RPt~~ev--l~~L~~~-------------~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      -+..|+-=|.+..+  .+.++-.             ..  +...+....|++++++..||.+|+.++++++|-||-...
T Consensus       246 Gs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~k--p~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  246 GSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLK--PYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             ccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcc--cccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence            88888888887754  2333111             11  111123458999999999999999999999999987643

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=2.3e-27  Score=229.87  Aligned_cols=146  Identities=25%  Similarity=0.336  Sum_probs=123.7

Q ss_pred             CCCccceeecCCceEEEEEEEC----CcEEEEEEeccC--ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEc---cCCe
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL----GVEVALKRISLD--SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKK---EKES  183 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~---~~~~  183 (409)
                      +|+..+.||+|+||.||++...    +..||+|.+...  .....+.+.+|+++++++ +||||+++++.+..   ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999986    568999998643  223356788999999999 59999999987542   1245


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      .++++||+. ++|.+++.   ....+++..+..++.||+.||.|||   +.+|+||||||+|||+++++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            788999986 59999884   3456899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccc
Q 048535          264 MHH  266 (409)
Q Consensus       264 ~~~  266 (409)
                      ...
T Consensus       154 ~~~  156 (332)
T cd07857         154 GFS  156 (332)
T ss_pred             ecc
Confidence            654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1e-27  Score=241.31  Aligned_cols=153  Identities=22%  Similarity=0.321  Sum_probs=121.8

Q ss_pred             HhCCCCccceeecCCceEEEEEEE------------------CCcEEEEEEeccCChHHHHHHH--------------HH
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQL------------------LGVEVALKRISLDSEHGMREFL--------------AE  158 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~------------------~~~~vAvK~~~~~~~~~~~~~~--------------~E  158 (409)
                      ..++|++.++||+|+||.||+|..                  .++.||||++........++|.              .|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                  1467999999765433333343              46


Q ss_pred             HHHhccCCCCce-----eeEeeEEEcc-------CCeEEEEEEeCCCCCHHHHHhcCCC---------------------
Q 048535          159 VSSLGRLKHRNL-----VGLRGWCKKE-------KESLILIYDYMENGSLDKWIFECDE---------------------  205 (409)
Q Consensus       159 ~~~l~~l~H~ni-----v~l~g~~~~~-------~~~~~lv~E~~~~gsL~~~l~~~~~---------------------  205 (409)
                      +.++.+++|.|+     ++++++|...       .+..+|||||+++|+|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766654     6778877531       3468999999999999999864211                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          206 SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       206 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ...++|..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~  360 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMC  360 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence            123567889999999999999999   8899999999999999999999999999997653

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.3e-28  Score=231.30  Aligned_cols=251  Identities=22%  Similarity=0.274  Sum_probs=185.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .+.|..-++||+||||.||-++..  |+.+|.|.+...   ..+.....++|-.+|.+++.+.||.+--.|.. .+.+|+
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT-kd~LCl  262 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET-KDALCL  262 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-CCceEE
Confidence            356888899999999999988876  999999998654   23344567899999999999999998766665 889999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      |+..|.||+|.-+|.... ...+++..++.++.+|+.||++||   ..+||.|||||+|||||+.|+++|+|+|||..+.
T Consensus       263 VLtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            999999999998887643 357999999999999999999999   8999999999999999999999999999999998


Q ss_pred             CCceeeecccc---------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 048535          267 HGQVMSGRRPI---------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI  337 (409)
Q Consensus       267 ~~~~~~g~~p~---------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  337 (409)
                      .++...|+...         ..+.|++..|.|+++  ..+++++...-++..    . -+++                .-
T Consensus       339 ~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lG--CllYemi~G~sPFr~----~-KeKv----------------k~  395 (591)
T KOG0986|consen  339 EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLG--CLLYEMIAGHSPFRQ----R-KEKV----------------KR  395 (591)
T ss_pred             CCCccccccCcccccCHHHHcCCcccCCccHHHHH--hHHHHHHcccCchhh----h-hhhh----------------hH
Confidence            88866664322         236688899999997  566666654432110    0 0000                01


Q ss_pred             HHHHHHHhc-CcCCCCCCCCCcchhHHhhhcccCCCCccc-----ccccCCCCCcccccc
Q 048535          338 RQVLKMLEG-QTEGTGLEDEGMNVHLLKRIGTRAMTSSWK-----FAGSRGHPTFNEINK  391 (409)
Q Consensus       338 ~evl~~L~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-----~~~~~~hp~~~~~~~  391 (409)
                      +||-++..+ ..+.++ .-.....++...++..+|.+|..     ++++..||+|+.++-
T Consensus       396 eEvdrr~~~~~~ey~~-kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw  454 (591)
T KOG0986|consen  396 EEVDRRTLEDPEEYSD-KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW  454 (591)
T ss_pred             HHHHHHHhcchhhccc-ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence            122222111 111111 11112356666666666666665     458889999999884

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=2.8e-27  Score=243.36  Aligned_cols=260  Identities=17%  Similarity=0.170  Sum_probs=158.4

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEE-----Ec
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC-----KK  179 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~-----~~  179 (409)
                      ..++|+..+.||+|+||.||+|++.      +..||+|++......  +.+..|  .+....+.+++.++..+     ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4678999999999999999999985      478999998643221  111111  11222222222222111     12


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q 048535          180 EKESLILIYDYMENGSLDKWIFECDES-----------------IALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIK  242 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK  242 (409)
                      .....++||||+++++|.+++......                 .......+..++.|++.||.|||   +.+|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            356789999999999999998643210                 01123345679999999999999   8999999999


Q ss_pred             CCCeeeCC-CCcEEEecccCcccccCCc-----eeeecccc---c-------------------------cCCCcHHHHH
Q 048535          243 ASNVLLDK-KMNARLGDFGLAKMHHHGQ-----VMSGRRPI---E-------------------------EGKRNLVDRM  288 (409)
Q Consensus       243 p~NILl~~-~~~~kl~DFGla~~~~~~~-----~~~g~~p~---~-------------------------~~~~~~~~~v  288 (409)
                      |+|||++. ++.+||+|||+|+....+.     ...+...+   +                         ...+....|+
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 5789999999998643221     01111100   0                         0012223499


Q ss_pred             HhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccC--------cCCCCCCCHHHHHHHHhcCcCCCCCCCCCcch
Q 048535          289 WSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAH--------PEANSRPTIRQVLKMLEGQTEGTGLEDEGMNV  360 (409)
Q Consensus       289 ws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~--------~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~  360 (409)
                      |+++  ..+++++-+.+.     .......+...+..|-.        ..+..+|...+..+.+.        .+.....
T Consensus       363 wSlG--viL~el~~~~~~-----~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--------~~~~~~~  427 (566)
T PLN03225        363 YSAG--LIFLQMAFPNLR-----SDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLD--------LDGGAGW  427 (566)
T ss_pred             HHHH--HHHHHHHhCcCC-----CchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhcc--------ccchHHH
Confidence            9986  345665543322     11222223333222211        11112222222211110        0112235


Q ss_pred             hHHhhhcccCCCCcccccccCCCCCccccccc
Q 048535          361 HLLKRIGTRAMTSSWKFAGSRGHPTFNEINKN  392 (409)
Q Consensus       361 ~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~  392 (409)
                      +++.+|+..+|.+|+++.+++.||||...+..
T Consensus       428 dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~~  459 (566)
T PLN03225        428 ELLKSMMRFKGRQRISAKAALAHPYFDREGLL  459 (566)
T ss_pred             HHHHHHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence            89999999999999999999999999876643

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-28  Score=253.10  Aligned_cols=252  Identities=23%  Similarity=0.218  Sum_probs=189.8

Q ss_pred             cHHHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEE
Q 048535          104 SYQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCK  178 (409)
Q Consensus       104 ~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  178 (409)
                      ...++....++|.+.+.||+|+||.|..++.+  ++.+|.|+++..   ......-|..|-.+|..-+.+.|++++-.|.
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            34567777899999999999999999999997  788999999763   2334567899999999999999999998888


Q ss_pred             ccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEec
Q 048535          179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGD  258 (409)
Q Consensus       179 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D  258 (409)
                      + ..++|+|||||+||+|-.++.+..   .+++..+..++..|+-||.-||   +.|+|||||||+|||||.+|.+||+|
T Consensus       146 D-~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLAD  218 (1317)
T KOG0612|consen  146 D-ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLAD  218 (1317)
T ss_pred             C-ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeecc
Confidence            7 789999999999999999995432   6999999999999999999999   89999999999999999999999999


Q ss_pred             ccCccccc-CCcee----eeccccc-----------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHH
Q 048535          259 FGLAKMHH-HGQVM----SGRRPIE-----------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHL  322 (409)
Q Consensus       259 FGla~~~~-~~~~~----~g~~p~~-----------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l  322 (409)
                      ||.+-.+. .+.+.    .|++-+-           .+.|+.-.|.|+++  --+++++-+.-   +-|.+..+...-+|
T Consensus       219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlG--V~~YEMlyG~T---PFYadslveTY~KI  293 (1317)
T KOG0612|consen  219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLG--VFMYEMLYGET---PFYADSLVETYGKI  293 (1317)
T ss_pred             chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhH--HHHHHHHcCCC---cchHHHHHHHHHHH
Confidence            99876655 44322    2333221           14567778899987  34566665543   23455555656666


Q ss_pred             HHH--ccCcC--CCCCCCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCccc---ccccCCCCCccccc
Q 048535          323 GLL--CAHPE--ANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWK---FAGSRGHPTFNEIN  390 (409)
Q Consensus       323 ~~~--Cl~~d--P~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~---~~~~~~hp~~~~~~  390 (409)
                      +..  |++.-  +.-=+.+                      .+++.+++. ++..|.+   ..++.+||||.+++
T Consensus       294 m~hk~~l~FP~~~~VSeea----------------------kdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~  345 (1317)
T KOG0612|consen  294 MNHKESLSFPDETDVSEEA----------------------KDLIEALLC-DREVRLGRNGIEDIKNHPFFEGID  345 (1317)
T ss_pred             hchhhhcCCCcccccCHHH----------------------HHHHHHHhc-ChhhhcccccHHHHHhCccccCCC
Confidence            544  44332  1111222                      344444432 2333444   88999999999987

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.95  E-value=4.2e-28  Score=216.38  Aligned_cols=222  Identities=20%  Similarity=0.306  Sum_probs=171.2

Q ss_pred             CccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          116 SEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       116 ~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      +....||.|..|.|++++..  |...|||.+... +....++++..+.++.+- +.|.||+.+|||.. +...++.||.|
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-n~dV~IcMelM  173 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-NTDVFICMELM  173 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-CchHHHHHHHH
Confidence            44577999999999999998  799999999765 556678889999887766 59999999999998 66788999998


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce-
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV-  270 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~-  270 (409)
                      .. .+..++..  -.+++++..+-++...+.+||.||-+  .++|+|||+||+|||+|+.|++|+||||++..+..+.. 
T Consensus       174 s~-C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  174 ST-CAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             HH-HHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence            55 66676654  34579999999999999999999997  78999999999999999999999999999976654431 


Q ss_pred             --eeecc---------ccccCCCcHHHHHHhhhcc--------------CcHHHHhhHHhhhcC---CCCHHHHHHHHHH
Q 048535          271 --MSGRR---------PIEEGKRNLVDRMWSLTER--------------SELLSVLDERLKAKG---GYADEVVEKVLHL  322 (409)
Q Consensus       271 --~~g~~---------p~~~~~~~~~~~vws~~~~--------------~~~~~~~~~~l~~~~---~~~~~~~~~l~~l  322 (409)
                        -.|-.         |.....|+..+|||+++-.              ..-.+++...+...+   +.....+..+.++
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~f  328 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSF  328 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHH
Confidence              11211         1223678999999998321              112233333333211   1122356788999


Q ss_pred             HHHccCcCCCCCCCHHHHHHH
Q 048535          323 GLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      +..||..|+.+||...++++.
T Consensus       329 v~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  329 VKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             HHHHhhcCcccCcchHHHhcC
Confidence            999999999999999998763

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=9e-28  Score=232.13  Aligned_cols=221  Identities=21%  Similarity=0.289  Sum_probs=166.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccC--ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLD--SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ..|++.+.||+||.+.||++... .+.+|+|++...  +.+....|.+|+..|.+| .|.+||++++|-.. ++.+|+||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceEEEEe
Confidence            45888899999999999999987 677888887644  667788999999999999 69999999999887 78999999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||=+. +|.++|.... .....| .+..+..|++.++.++|   ..+|||.||||.|.|+- .|.+||+|||.|..+..+
T Consensus       440 E~Gd~-DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  440 ECGDI-DLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             ecccc-cHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence            98755 9999996532 222334 78889999999999999   89999999999999994 578999999999987665


Q ss_pred             c------eeeeccccc------------c-----CCCcHHHHHHhhhccCcHHHHhhHHhhhc--------------C--
Q 048535          269 Q------VMSGRRPIE------------E-----GKRNLVDRMWSLTERSELLSVLDERLKAK--------------G--  309 (409)
Q Consensus       269 ~------~~~g~~p~~------------~-----~~~~~~~~vws~~~~~~~~~~~~~~l~~~--------------~--  309 (409)
                      +      .-.|...+.            .     -..+-.+|||+++  +.+++++..+.++.              +  
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLG--CILYqMvYgktPf~~~~n~~aKl~aI~~P~~  590 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLG--CILYQMVYGKTPFGQIINQIAKLHAITDPNH  590 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhh--hHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence            4      111222111            0     1245678999996  44454443321110              0  


Q ss_pred             --CCCHH-HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          310 --GYADE-VVEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       310 --~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                        +|+.- ...++.+++..||+.||.+|||+.++++.
T Consensus       591 ~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  591 EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence              11111 11238889999999999999999998863

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-27  Score=229.46  Aligned_cols=218  Identities=22%  Similarity=0.301  Sum_probs=166.9

Q ss_pred             cceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCC
Q 048535          118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMEN  193 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~  193 (409)
                      .+.||+|.||+||-|+.+  |+.||||++.+.  ..++..++.+|+.+|.+++||.||.+.-.|.. .++.++|||-+ +
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-~ervFVVMEKl-~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-PERVFVVMEKL-H  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-CceEEEEehhh-c
Confidence            478999999999999987  999999999654  34455788999999999999999999988887 78999999999 5


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC---CcEEEecccCcccccCCc-
Q 048535          194 GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK---MNARLGDFGLAKMHHHGQ-  269 (409)
Q Consensus       194 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kl~DFGla~~~~~~~-  269 (409)
                      |+..+.|... ..+.|++.....++.||+.||.|||   -++|+|+||||+||||.+.   -.+||||||+||++.... 
T Consensus       647 GDMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF  722 (888)
T KOG4236|consen  647 GDMLEMILSS-EKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF  722 (888)
T ss_pred             chHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence            5888877653 4567999999999999999999999   8999999999999999654   359999999999987654 


Q ss_pred             --eeeeccccc------cCCCcHHHHHHhhh--------------ccCcHHHH-hhHHhhhcCCCCHHHHHHHHHHHHHc
Q 048535          270 --VMSGRRPIE------EGKRNLVDRMWSLT--------------ERSELLSV-LDERLKAKGGYADEVVEKVLHLGLLC  326 (409)
Q Consensus       270 --~~~g~~p~~------~~~~~~~~~vws~~--------------~~~~~~~~-~~~~l~~~~~~~~~~~~~l~~l~~~C  326 (409)
                        .+.|.+.+-      ...|+-.-|+|+.+              ..+++.+- -+.....++....+.....++++...
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~L  802 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNL  802 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence              344555443      24566667899872              11222222 12222222344456666777777777


Q ss_pred             cCcCCCCCCCHHHHH
Q 048535          327 AHPEANSRPTIRQVL  341 (409)
Q Consensus       327 l~~dP~~RPt~~evl  341 (409)
                      ++..-.+|-|..+.+
T Consensus       803 LqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  803 LQVKMRKRYSVDKSL  817 (888)
T ss_pred             HHHHHHHhcchHhhc
Confidence            777777777776654

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=219.34  Aligned_cols=223  Identities=24%  Similarity=0.339  Sum_probs=168.4

Q ss_pred             CccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          116 SEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       116 ~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      +....||.|+||+|+|-.++  |+..|||+++.. .....++++.|.+...+- +.||||+++|.+.. .+..|+.||.|
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-EGdcWiCMELM  145 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-EGDCWICMELM  145 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-CCceeeeHHHH
Confidence            34578999999999999887  999999999866 446678899999876555 89999999999987 67789999999


Q ss_pred             CCCCHHHH---HhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          192 ENGSLDKW---IFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       192 ~~gsL~~~---l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      +- ||+.+   ++. ..+..+++..+-+|....++||.||-+  ...|||||+||+|||||..|.+||||||.+..+..+
T Consensus       146 d~-SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  146 DI-SLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             hh-hHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence            66 76654   333 234468999999999999999999997  688999999999999999999999999998765433


Q ss_pred             c---eeeeccccc--------cCCCcHHHHHHhhhcc-----------CcHHHHhhHHhhh-cCC-----CCH---HHHH
Q 048535          269 Q---VMSGRRPIE--------EGKRNLVDRMWSLTER-----------SELLSVLDERLKA-KGG-----YAD---EVVE  317 (409)
Q Consensus       269 ~---~~~g~~p~~--------~~~~~~~~~vws~~~~-----------~~~~~~~~~~l~~-~~~-----~~~---~~~~  317 (409)
                      -   .-.|-+|+.        ...|+..+|+||++-.           ..+..+++..-.. .++     .+.   +...
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~  301 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSF  301 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCH
Confidence            2   223444432        2358899999999311           1122222221100 011     112   2456


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      .+..++..|+-.|-++||...++.++
T Consensus       302 ~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  302 SMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             HHHHHHHHHhhcccccCcchhhhhcC
Confidence            78899999999999999999998764

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=4.3e-27  Score=238.00  Aligned_cols=236  Identities=24%  Similarity=0.330  Sum_probs=183.7

Q ss_pred             ccHHHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEc
Q 048535          103 VSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKK  179 (409)
Q Consensus       103 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  179 (409)
                      +.++.+-..+.-|.+.+.||.|.+|.||+++..  ++.+|+|+...... ..++...|.++|+.. +|||++.++|++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            345555567788999999999999999999876  88899999876533 235677899999888 89999999999863


Q ss_pred             ----cCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEE
Q 048535          180 ----EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNAR  255 (409)
Q Consensus       180 ----~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k  255 (409)
                          .++.+|||||||.+||.-++++... ...+.|..+.-|+..++.||.+||   .+.++|||||-.|||++.++.+|
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEE
Confidence                2467999999999999999997654 668999999999999999999999   89999999999999999999999


Q ss_pred             EecccCcccccCCc----eeeecccc-----------ccCCCcHHHHHHhhhccCcH--------HHH-----hhHHhhh
Q 048535          256 LGDFGLAKMHHHGQ----VMSGRRPI-----------EEGKRNLVDRMWSLTERSEL--------LSV-----LDERLKA  307 (409)
Q Consensus       256 l~DFGla~~~~~~~----~~~g~~p~-----------~~~~~~~~~~vws~~~~~~~--------~~~-----~~~~l~~  307 (409)
                      |+|||++...+.+.    ...|.+-.           ....|+...|+|+++-...-        .++     +-...+.
T Consensus       164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN  243 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN  243 (953)
T ss_pred             EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC
Confidence            99999998766432    12222211           12456778899999532111        111     1011110


Q ss_pred             ---cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          308 ---KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       308 ---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                         ...-+..+.+++.+++..|+..|-.+||++.++++.
T Consensus       244 PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  244 PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence               012356788999999999999999999999998753

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-28  Score=255.74  Aligned_cols=226  Identities=26%  Similarity=0.317  Sum_probs=177.2

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .+-+++....||.|.||.||.|...  |...|+|.++..  .....+...+|+.+|..++|||+|+++|+-.. ++..+|
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-Rekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-REKVYI 1311 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-HHHHHH
Confidence            3456778899999999999999876  899999998755  33345667899999999999999999998887 778999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      .||||++|+|.+.+..   +...++.....+..|++.|++|||   +.+||||||||.||+|+.+|.+|++|||.|....
T Consensus      1312 FMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEec
Confidence            9999999999999843   344677777888999999999999   8999999999999999999999999999998765


Q ss_pred             CCc--------eeeecccccc---------CCCcHHHHHHhhhcc-------CcH-------HHHh-hHHhhhcCCCCHH
Q 048535          267 HGQ--------VMSGRRPIEE---------GKRNLVDRMWSLTER-------SEL-------LSVL-DERLKAKGGYADE  314 (409)
Q Consensus       267 ~~~--------~~~g~~p~~~---------~~~~~~~~vws~~~~-------~~~-------~~~~-~~~l~~~~~~~~~  314 (409)
                      ...        -+.|.+.+..         ....-++|+|+++.-       ...       ++++ .-.....+.+|..
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ 1465 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER 1465 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh
Confidence            432        2233333221         233456899998311       111       1111 1122233667788


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ...+-.+++.+|++.||+.|-++.|+++.
T Consensus      1466 ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1466 LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            88889999999999999999988888765

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.95  E-value=4.3e-27  Score=216.96  Aligned_cols=200  Identities=19%  Similarity=0.119  Sum_probs=145.8

Q ss_pred             CCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCCHHHHHh
Q 048535          124 GGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIF  201 (409)
Q Consensus       124 G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~  201 (409)
                      |.||.||++...  ++.||+|.++...     .+.+|...+....||||+++++++.+ ....++||||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheec-CCeEEEEEecCCCCCHHHHHH
Confidence            899999999986  8999999997543     23345555566679999999999887 678999999999999999985


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee----eecccc
Q 048535          202 ECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM----SGRRPI  277 (409)
Q Consensus       202 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~----~g~~p~  277 (409)
                      .   ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++|||++.........    ....+.
T Consensus        78 ~---~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aP  151 (237)
T cd05576          78 K---FLNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAP  151 (237)
T ss_pred             H---hcCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCC
Confidence            4   235899999999999999999999   899999999999999999999999999987655432100    001111


Q ss_pred             c---cCCCcHHHHHHhhhccCcHHHHhhHHhhh-----------cCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 048535          278 E---EGKRNLVDRMWSLTERSELLSVLDERLKA-----------KGGYADEVVEKVLHLGLLCAHPEANSRPTI  337 (409)
Q Consensus       278 ~---~~~~~~~~~vws~~~~~~~~~~~~~~l~~-----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  337 (409)
                      +   ...++...|+|+++  ..+++++......           ....+......+.+++.+|++.||++||++
T Consensus       152 E~~~~~~~~~~~DvwslG--~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         152 EVGGISEETEACDWWSLG--AILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cccCCCCCCchhhHHHHH--HHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            1   23456678999985  2233333221100           001222334556677777777777777765

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.95  E-value=6.2e-28  Score=217.79  Aligned_cols=233  Identities=23%  Similarity=0.260  Sum_probs=170.8

Q ss_pred             HhCCCCcc-ceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEc---cCCe
Q 048535          111 ATKGFSEE-NVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKK---EKES  183 (409)
Q Consensus       111 ~~~~f~~~-~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~---~~~~  183 (409)
                      .|++|++. ++||-|-.|.|..+..+  ++.+|+|++...     ....+|+++.-.. .|||||+++++|..   ....
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45667654 67999999999999887  899999998633     3445788876655 79999999998863   2346


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC---CCcEEEeccc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK---KMNARLGDFG  260 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kl~DFG  260 (409)
                      +.+|||.|+||.|.+.+.+. ..+.+++.++-.|+.||+.|+.|||   +.+|.||||||+|+|...   |..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccc
Confidence            88999999999999999763 4567999999999999999999999   899999999999999965   4568999999


Q ss_pred             CcccccCCc-eeeec-ccc-------ccCCCcHHHHHHhhhccC----------------cH-----HHHhhHHhhhcCC
Q 048535          261 LAKMHHHGQ-VMSGR-RPI-------EEGKRNLVDRMWSLTERS----------------EL-----LSVLDERLKAKGG  310 (409)
Q Consensus       261 la~~~~~~~-~~~g~-~p~-------~~~~~~~~~~vws~~~~~----------------~~-----~~~~~~~l~~~~~  310 (409)
                      +|+...... +.|.- .|+       ....|+...|+|+++..-                .+     ..+......++.+
T Consensus       210 FAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p  289 (400)
T KOG0604|consen  210 FAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP  289 (400)
T ss_pred             cccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence            999866332 22211 111       124566667788873110                00     1111122222233


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HhcCcCCCC
Q 048535          311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKM--LEGQTEGTG  352 (409)
Q Consensus       311 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~~~  352 (409)
                      ...+.++...++++..|.-+|.+|-|+.++++.  +......|.
T Consensus       290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~  333 (400)
T KOG0604|consen  290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQ  333 (400)
T ss_pred             hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCC
Confidence            345667788899999999999999999998863  444444443

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=7e-28  Score=219.55  Aligned_cols=245  Identities=20%  Similarity=0.249  Sum_probs=188.3

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      -++|+..++||+|.||.|.+++-+  ++.+|+|+++++   .......-+.|-++|+..+||.+..+--.|.. ..++|.
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt-~drlCF  245 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT-QDRLCF  245 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc-CceEEE
Confidence            367889999999999999999887  899999999876   33344556789999999999999887666665 789999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||..||.|.-+|.   ....+++.....+-..|+.||.|||   +++||.||||.+|.|||.+|.+||+||||++..-
T Consensus       246 VMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhcc
Confidence            999999999998884   3456899999999999999999999   8999999999999999999999999999998643


Q ss_pred             C----Cceeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCC
Q 048535          267 H----GQVMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPT  336 (409)
Q Consensus       267 ~----~~~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt  336 (409)
                      .    ....+|.+.+      +...|.-..|.|-++  -..++++..+++.    ....-..+.+|++.|=-.-|..   
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~G--VVMYEMmCGRLPF----yn~dh~kLFeLIl~ed~kFPr~---  390 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVG--VVMYEMMCGRLPF----YNKDHEKLFELILMEDLKFPRT---  390 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhh--HHHHHHHhccCcc----cccchhHHHHHHHhhhccCCcc---
Confidence            2    2255666543      345677777888876  4567888888753    3333456677766553333321   


Q ss_pred             HHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCccc-----ccccCCCCCccccc
Q 048535          337 IRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWK-----FAGSRGHPTFNEIN  390 (409)
Q Consensus       337 ~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-----~~~~~~hp~~~~~~  390 (409)
                                       -.+ ....+|..++..||.+|..     ..+++.|+||..|+
T Consensus       391 -----------------ls~-eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  391 -----------------LSP-EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             -----------------CCH-HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence                             111 1245666666666766665     45888999998887

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.94  E-value=6.2e-27  Score=217.79  Aligned_cols=269  Identities=19%  Similarity=0.216  Sum_probs=186.1

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC-C-Cc----eeeEeeEEEccCC
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-H-RN----LVGLRGWCKKEKE  182 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-~n----iv~l~g~~~~~~~  182 (409)
                      .+++|.+.+.+|+|.||.|-.+.+.  +..||||+++.- ....+.-+-|+++|.++. + ||    +|++.+||.- .+
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy-rg  164 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY-RG  164 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc-cC
Confidence            4788999999999999999999987  788999999743 344566778999999993 2 33    7888888877 78


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC------------
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK------------  250 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~------------  250 (409)
                      +.|||+|.+ |-|++++|.++ +-.+++...+..|+.|++++++|||   +.+++|-||||+|||+.+            
T Consensus       165 hiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCc
Confidence            999999998 55999999763 4567999999999999999999999   899999999999999932            


Q ss_pred             --------CCcEEEecccCcccccCCc--eeeecccc-----ccCCCcHHHHHHhhhcc--------------C--cHHH
Q 048535          251 --------KMNARLGDFGLAKMHHHGQ--VMSGRRPI-----EEGKRNLVDRMWSLTER--------------S--ELLS  299 (409)
Q Consensus       251 --------~~~~kl~DFGla~~~~~~~--~~~g~~p~-----~~~~~~~~~~vws~~~~--------------~--~~~~  299 (409)
                              +..+||.|||.|.......  +++.+..-     -.-.++...|+||++.-              .  +-..
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLa  319 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLA  319 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHH
Confidence                    2348999999998765443  33333221     12467888999998411              0  1112


Q ss_pred             HhhHHhhhcCCCCHHHHHHH---HHHHHHccCcC--CCCC--CCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCC
Q 048535          300 VLDERLKAKGGYADEVVEKV---LHLGLLCAHPE--ANSR--PTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMT  372 (409)
Q Consensus       300 ~~~~~l~~~~~~~~~~~~~l---~~l~~~Cl~~d--P~~R--Pt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~  372 (409)
                      ++...+   +++|...+.+.   .-+-..|++++  -..|  -...+..+-|+...... ......-+||+++|+..||+
T Consensus       320 MMerIl---Gp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~-d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  320 MMERIL---GPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQD-DLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHhh---CCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccC-cHHHhHHHHHHHHHHccCcc
Confidence            333222   34444433322   11112233321  1111  11111122222222211 12222348999999999999


Q ss_pred             CcccccccCCCCCccccc
Q 048535          373 SSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       373 ~~~~~~~~~~hp~~~~~~  390 (409)
                      +|+|+.+++.||||+...
T Consensus       396 ~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  396 RRITLREALSHPFFARLT  413 (415)
T ss_pred             ccccHHHHhcCHHhhcCC
Confidence            999999999999998643

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=6.4e-28  Score=215.15  Aligned_cols=261  Identities=20%  Similarity=0.298  Sum_probs=192.9

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC----CeEEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK----ESLIL  186 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~~l  186 (409)
                      .+..+-||-|+||.||-.++.  |+.||.|++..-  +-...+.+.+|+.+|..++|.|++..++......    +++|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            344678999999999999987  999999998643  2334578999999999999999999888664311    24688


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ++|.|.. +|.+.|   -..+.++.+.+.-+..||++||.|||   +.+|.||||||.|.|+++|...||||||+||..+
T Consensus       135 ~TELmQS-DLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  135 LTELMQS-DLHKII---VSPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHh-hhhhee---ccCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc
Confidence            9999866 898888   45678999999999999999999999   8999999999999999999999999999999876


Q ss_pred             CCc-------eeeec-cc----cccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCC
Q 048535          267 HGQ-------VMSGR-RP----IEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSR  334 (409)
Q Consensus       267 ~~~-------~~~g~-~p----~~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R  334 (409)
                      .++       ++|.. +.    .....|+-..|+|+.+  ....+++..++.+....+.+..+-+.++.         --
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVG--CIFaELLgRrILFQAq~PiqQL~lItdLL---------GT  276 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVG--CIFAELLQRKILFQAAGPIEQLQMIIDLL---------GT  276 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhh--HHHHHHHhhhhhhhccChHHHHHHHHHHh---------CC
Confidence            543       11110 00    1123456677899987  55667777776655555656655555553         34


Q ss_pred             CCHHHHHHHHhc--------CcCCCCCC----------CCCcchhHHhhhcccCCCCcccccccCCCCCcccccccc
Q 048535          335 PTIRQVLKMLEG--------QTEGTGLE----------DEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNR  393 (409)
Q Consensus       335 Pt~~evl~~L~~--------~~~~~~~~----------~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~~  393 (409)
                      ||++..-..-|+        -.+.|..+          ......+++..++..+|.+|++.++++.|++..+.....
T Consensus       277 Ps~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~  353 (449)
T KOG0664|consen  277 PSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRF  353 (449)
T ss_pred             CcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceee
Confidence            666655443333        22222111          011237899999999999999999999999888766443

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=8e-27  Score=220.12  Aligned_cols=222  Identities=23%  Similarity=0.301  Sum_probs=166.3

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-------ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-------SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      +|-...+||+|||+.||++.+.  .+-||||+-...       .....+...+|.++.+.|+||.||++++|+.-+.+.+
T Consensus       464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF  543 (775)
T KOG1151|consen  464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF  543 (775)
T ss_pred             HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence            4555678999999999999876  788999987543       1112345678999999999999999999998767889


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC---CCCcEEEecccC
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD---KKMNARLGDFGL  261 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~---~~~~~kl~DFGl  261 (409)
                      |-|+|||+|.+|+-||..   ...+++.++..|+.||+.||.||.+. ..+|||-||||.||||-   .-|.+||+||||
T Consensus       544 CTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  544 CTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             eeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            999999999999999953   45689999999999999999999976 78999999999999994   357899999999


Q ss_pred             cccccCCc------------------------eeeeccccccCCCcHHHHHHhhhcc--------------CcHHHHhhH
Q 048535          262 AKMHHHGQ------------------------VMSGRRPIEEGKRNLVDRMWSLTER--------------SELLSVLDE  303 (409)
Q Consensus       262 a~~~~~~~------------------------~~~g~~p~~~~~~~~~~~vws~~~~--------------~~~~~~~~~  303 (409)
                      +++++.+.                        .+.|+.   +...+-+.|||+++..              ..-.+++..
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgke---PPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe  696 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKE---PPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE  696 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCC---CCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence            99887543                        112222   2345667789987311              001111111


Q ss_pred             H--hhh-c--CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          304 R--LKA-K--GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       304 ~--l~~-~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .  +.. .  -+..+....+...++.+|++..-++|-...++..
T Consensus       697 NTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  697 NTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            0  100 0  1112344567889999999999999988777643

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.93  E-value=1.8e-25  Score=204.67  Aligned_cols=211  Identities=27%  Similarity=0.361  Sum_probs=160.8

Q ss_pred             CceEEEEEEEC--CcEEEEEEeccCChHH-HHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCCHHHHHh
Q 048535          125 GNGKVYKGQLL--GVEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIF  201 (409)
Q Consensus       125 ~fg~Vy~~~~~--~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~  201 (409)
                      +||.||+|...  ++.+|+|++....... .+.+.+|++.+++++|+||+++++++.. ....++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-EDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-CCEEEEEEeCCCCCCHHHHHH
Confidence            58999999997  6999999997664433 6789999999999999999999999987 678999999999999999985


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---eeeecc---
Q 048535          202 ECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---VMSGRR---  275 (409)
Q Consensus       202 ~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---~~~g~~---  275 (409)
                      ..   ..+++..+..++.++++++.|||   +.+++|+||+|+||++++++.++|+|||++.......   ...+..   
T Consensus        80 ~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  153 (244)
T smart00220       80 KR---GRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM  153 (244)
T ss_pred             hc---cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence            42   23899999999999999999999   7899999999999999999999999999998765531   111111   


Q ss_pred             ccc---cCCCcHHHHHHhhhcc--------------CcHHHHhhHHhhhcCCCCHH---HHHHHHHHHHHccCcCCCCCC
Q 048535          276 PIE---EGKRNLVDRMWSLTER--------------SELLSVLDERLKAKGGYADE---VVEKVLHLGLLCAHPEANSRP  335 (409)
Q Consensus       276 p~~---~~~~~~~~~vws~~~~--------------~~~~~~~~~~l~~~~~~~~~---~~~~l~~l~~~Cl~~dP~~RP  335 (409)
                      +.+   ....+...|+|+++.-              .......+............   ....+.+++.+||..+|++||
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence            111   1334557888887311              11111111111110111111   556789999999999999999


Q ss_pred             CHHHHHH
Q 048535          336 TIRQVLK  342 (409)
Q Consensus       336 t~~evl~  342 (409)
                      ++.++++
T Consensus       234 ~~~~~~~  240 (244)
T smart00220      234 TAEEALQ  240 (244)
T ss_pred             CHHHHhh
Confidence            9999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.93  E-value=7.3e-25  Score=195.53  Aligned_cols=199  Identities=30%  Similarity=0.489  Sum_probs=162.1

Q ss_pred             eecCCceEEEEEEEC--CcEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCCHH
Q 048535          121 IGLGGNGKVYKGQLL--GVEVALKRISLDSEH-GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLD  197 (409)
Q Consensus       121 lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gsL~  197 (409)
                      ||+|++|.||++...  ++.+++|++...... ..+.+.+|+..++.++|++++++++++.. ....++++||+++++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-ENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-CCeEEEEEecCCCCcHH
Confidence            689999999999998  899999999766432 45679999999999999999999999987 57899999999999999


Q ss_pred             HHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC-CCcEEEecccCcccccCCc----eee
Q 048535          198 KWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK-KMNARLGDFGLAKMHHHGQ----VMS  272 (409)
Q Consensus       198 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DFGla~~~~~~~----~~~  272 (409)
                      +++....  ..+++..+..++.+++++|.|||   ..+++|+||+|.||+++. ++.++|+|||.+.......    ...
T Consensus        80 ~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (215)
T cd00180          80 DLLKENE--GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV  154 (215)
T ss_pred             HHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence            9995421  46899999999999999999999   789999999999999999 8999999999998665432    001


Q ss_pred             ecc---ccc---cC-CCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          273 GRR---PIE---EG-KRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       273 g~~---p~~---~~-~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      +..   +.+   .. ..+...|+|+++.  .+.++                ..+.+++..|++.||++||++.++++.
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~--~~~~l----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGV--ILYEL----------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHH--HHHHH----------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            111   111   12 4456678888751  22222                678999999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-26  Score=197.35  Aligned_cols=181  Identities=21%  Similarity=0.327  Sum_probs=148.8

Q ss_pred             HHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCe
Q 048535          108 IHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       108 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  183 (409)
                      +....++......||+|++|.|-+-++.  |...|+|+++.. ..+..++.++|+.+..+. .+|.+|.++|.... ...
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-egd  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-EGD  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-ccc
Confidence            3445566666789999999998777765  999999999866 455667889999976655 89999999998877 678


Q ss_pred             EEEEEEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          184 LILIYDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      .++.||.|.. ||+.+-.+. .....+++..+-+|+..+.+||.|||+  ...+||||+||+||||+.+|++||||||.+
T Consensus       120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccc
Confidence            9999999966 888775432 455679999999999999999999997  689999999999999999999999999999


Q ss_pred             ccccCCc---eeeecccccc----------CCCcHHHHHHhhh
Q 048535          263 KMHHHGQ---VMSGRRPIEE----------GKRNLVDRMWSLT  292 (409)
Q Consensus       263 ~~~~~~~---~~~g~~p~~~----------~~~~~~~~vws~~  292 (409)
                      ..+.++-   +-+|-.|+..          ..|+..+|+|++.
T Consensus       197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLG  239 (282)
T KOG0984|consen  197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLG  239 (282)
T ss_pred             eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhh
Confidence            8776543   3445555432          4688999999997

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.93  E-value=7.9e-27  Score=203.47  Aligned_cols=269  Identities=19%  Similarity=0.280  Sum_probs=187.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeEeeEEEccC-CeEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKEK-ESLILI  187 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~~lv  187 (409)
                      .++|++.+++|+|.|+.||.|...  .++++||.++.-   ..+.+.+|+.+|..|. ||||+++++...+.. ....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            467888999999999999999864  889999999743   3467889999999996 999999999887632 346799


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC-CcEEEecccCccccc
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK-MNARLGDFGLAKMHH  266 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFGla~~~~  266 (409)
                      +||+.+.+...+.      ..++-..+..++.++++||.|+|   +.||+|||+||.|++||.. -..+|+|.|||.+..
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999998877765      34777888999999999999999   9999999999999999875 459999999999988


Q ss_pred             CCceee---------eccc-cccCCCcHHHHHHhhhccCcHHHHhhHH-hhhcCCCCHHHHHHHHHHH------HHccCc
Q 048535          267 HGQVMS---------GRRP-IEEGKRNLVDRMWSLTERSELLSVLDER-LKAKGGYADEVVEKVLHLG------LLCAHP  329 (409)
Q Consensus       267 ~~~~~~---------g~~p-~~~~~~~~~~~vws~~~~~~~~~~~~~~-l~~~~~~~~~~~~~l~~l~------~~Cl~~  329 (409)
                      .+.-..         |..- .+...|+..-|+||++  +-+..++-.+ .-+.+....+..-++.++.      .-.-..
T Consensus       185 p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~G--cmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  185 PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG--CMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             CCceeeeeeehhhcCCchheeechhccccHHHHHHH--HHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            765221         2111 1224566777999996  3333333221 1111222333322222211      000011


Q ss_pred             CCCCCCCHHHHHHHHhcC-----cC--CCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccccccccCC
Q 048535          330 EANSRPTIRQVLKMLEGQ-----TE--GTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNRSS  395 (409)
Q Consensus       330 dP~~RPt~~evl~~L~~~-----~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~~~~  395 (409)
                      .-.--|.+.+++..-..-     ..  ...+. .....|++.+++.+|...|.|+.+++.||||..+....++
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~-~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~  334 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLV-SPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESS  334 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccC-ChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhc
Confidence            112234455555433221     11  11111 1134899999999999999999999999999987754443

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.93  E-value=3.2e-25  Score=233.32  Aligned_cols=147  Identities=25%  Similarity=0.346  Sum_probs=132.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||+++..   .......+..|+.++..++||||+++++++.. ....|+|
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEEEE
Confidence            67889999999999999999998  899999999753   23445678899999999999999999998876 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      |||+++|+|.+++..   ...+++..++.++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++...
T Consensus        83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~  155 (669)
T cd05610          83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL  155 (669)
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence            999999999999954   245889999999999999999999   7899999999999999999999999999998653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=228.32  Aligned_cols=251  Identities=22%  Similarity=0.282  Sum_probs=192.5

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ....+|.....+|.|.||.|||+++.  ++..|+|.++........-..+|+-+++..+|||||.++|.+.. ...+++.
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-~dklwic   90 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-RDKLWIC   90 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-hcCcEEE
Confidence            34577888999999999999999987  89999999998876777788899999999999999999999887 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||||.+|+|++.-+   ..+++++.++..+++...+||.|||   +.+-+|||||-.|||+++.|.+|++|||.+..+..
T Consensus        91 MEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh
Confidence            99999999998763   4568999999999999999999999   89999999999999999999999999999876543


Q ss_pred             Cc----eeeeccccc---------cCCCcHHHHHHhhhccCcHHH----------------HhhHHhhhc--CCCCHHHH
Q 048535          268 GQ----VMSGRRPIE---------EGKRNLVDRMWSLTERSELLS----------------VLDERLKAK--GGYADEVV  316 (409)
Q Consensus       268 ~~----~~~g~~p~~---------~~~~~~~~~vws~~~~~~~~~----------------~~~~~l~~~--~~~~~~~~  316 (409)
                      .-    -.-|++...         .+.|+...|+|.......-..                ++.......  ..-...+.
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws  244 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWS  244 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccch
Confidence            21    222333221         267888899998853322111                111100000  01223567


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCC
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAM  371 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~  371 (409)
                      +.+-++++.|+-.+|++|||+..+++  ......+  -+....+++|++..+.++
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~--h~fvs~~--l~~rl~~eLLdK~n~P~~  295 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQ--HPFVSQT--LSRRLAIELLDKVNNPNP  295 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhhee--ceeeccc--hhhHHHHHHHHHccCCCC
Confidence            78899999999999999999998876  2222222  223345677777766653

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1.4e-25  Score=219.53  Aligned_cols=154  Identities=22%  Similarity=0.320  Sum_probs=131.8

Q ss_pred             cHHHHHHHh---CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEee
Q 048535          104 SYQEIHAAT---KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRG  175 (409)
Q Consensus       104 ~~~~l~~~~---~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g  175 (409)
                      .|..|+++.   .-|..++.||-|+||+|.++...  ...+|.|.+++.+   ..+......|-.||...+++.||+|+-
T Consensus       617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy  696 (1034)
T KOG0608|consen  617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY  696 (1034)
T ss_pred             hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence            444555443   45888899999999999998765  6779999997653   233445678999999999999999998


Q ss_pred             EEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEE
Q 048535          176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNAR  255 (409)
Q Consensus       176 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k  255 (409)
                      .|.+ ++.+|+||||++||++-.+|..   .+-+.+..+..++.++..|+++.|   ..++|||||||+|||||.+|.+|
T Consensus       697 SFQD-kdnLYFVMdYIPGGDmMSLLIr---mgIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIK  769 (1034)
T KOG0608|consen  697 SFQD-KDNLYFVMDYIPGGDMMSLLIR---MGIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIK  769 (1034)
T ss_pred             Eecc-CCceEEEEeccCCccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCcee
Confidence            8887 8899999999999999999853   356888889999999999999999   89999999999999999999999


Q ss_pred             EecccCccc
Q 048535          256 LGDFGLAKM  264 (409)
Q Consensus       256 l~DFGla~~  264 (409)
                      |+||||+.-
T Consensus       770 LTDFGLCTG  778 (1034)
T KOG0608|consen  770 LTDFGLCTG  778 (1034)
T ss_pred             eeecccccc
Confidence            999999864

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-25  Score=220.93  Aligned_cols=217  Identities=19%  Similarity=0.189  Sum_probs=162.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++.|.....+|.|+|+.|-.+...  ++..+||++....    .+-.+|+.++... +||||+++.+.+.+ +.+.|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~-~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYED-GKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecC-Cceeeeee
Confidence            567888888999999999999887  8889999997552    2234678777666 89999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee-CCCCcEEEecccCcccccC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL-DKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl-~~~~~~kl~DFGla~~~~~  267 (409)
                      |++.+|-|.+.+...    +....++..|+.+|+.|+.|||   ++++|||||||+|||+ ++.++++|+|||.++....
T Consensus       396 e~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER  468 (612)
T ss_pred             hhccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence            999999888877432    2223778889999999999999   8999999999999999 6899999999999998766


Q ss_pred             Cc----eeeeccc---cccCCCcHHHHHHhhhccCcHHHHhhHHhhh--------------cCCCCHHHHHHHHHHHHHc
Q 048535          268 GQ----VMSGRRP---IEEGKRNLVDRMWSLTERSELLSVLDERLKA--------------KGGYADEVVEKVLHLGLLC  326 (409)
Q Consensus       268 ~~----~~~g~~p---~~~~~~~~~~~vws~~~~~~~~~~~~~~l~~--------------~~~~~~~~~~~l~~l~~~C  326 (409)
                      .-    +..+..+   .....++...|+|+++  .-+++++.+....              .+.+....+....+|+.+|
T Consensus       469 ~~~tp~~t~~y~APEvl~~~~yt~acD~WSLG--vlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~L  546 (612)
T KOG0603|consen  469 SCDTPALTLQYVAPEVLAIQEYTEACDWWSLG--VLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQL  546 (612)
T ss_pred             hhcccchhhcccChhhhccCCCCcchhhHHHH--HHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHHh
Confidence            51    1111111   1235678899999984  2233333222111              1334455666777777777


Q ss_pred             cCcCCCCCCCHHHHHH
Q 048535          327 AHPEANSRPTIRQVLK  342 (409)
Q Consensus       327 l~~dP~~RPt~~evl~  342 (409)
                      |+.||.+||+|.++..
T Consensus       547 L~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  547 LQVDPALRLGADEIGA  562 (612)
T ss_pred             ccCChhhCcChhhhcc
Confidence            7777777777777754

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=6.2e-26  Score=217.80  Aligned_cols=268  Identities=19%  Similarity=0.209  Sum_probs=191.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC------CCceeeEeeEEEccCCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK------HRNLVGLRGWCKKEKES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~g~~~~~~~~  183 (409)
                      -..|.+....|+|-|++|.+|.+.  |..||||+|... .-..+.=+.|+++|++|+      --|+++++..|.. .++
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h-knH  508 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH-KNH  508 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh-cce
Confidence            466888888999999999999987  889999999865 233355678999999995      3478999888877 789


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC-cEEEecccCc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM-NARLGDFGLA  262 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla  262 (409)
                      +|||+|-+.- +|.+.|.....+..|....+..++.|+.-||..|-   ..+|+|.||||.|||+++.. .+||||||.|
T Consensus       509 LClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccc
Confidence            9999998855 99999988777788999999999999999999999   89999999999999998865 5899999999


Q ss_pred             ccccCCcee---ee-----ccccccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHH------------
Q 048535          263 KMHHHGQVM---SG-----RRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHL------------  322 (409)
Q Consensus       263 ~~~~~~~~~---~g-----~~p~~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l------------  322 (409)
                      ......++.   ..     ..-+-.-.|+..-|+|+.+  +.++++....+.+++.....+..-++++            
T Consensus       585 ~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvg--ctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg  662 (752)
T KOG0670|consen  585 SFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVG--CTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG  662 (752)
T ss_pred             cccccccccHHHHHHhccCcceeecCcccCCccceeec--eeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence            877655411   01     1111224566777899986  4555555554444333333322211111            


Q ss_pred             --H-----HHc----cCcCC-----------CCCCCHHHHHHHHhcCcCCCCCCCCC--cchhHHhhhcccCCCCccccc
Q 048535          323 --G-----LLC----AHPEA-----------NSRPTIRQVLKMLEGQTEGTGLEDEG--MNVHLLKRIGTRAMTSSWKFA  378 (409)
Q Consensus       323 --~-----~~C----l~~dP-----------~~RPt~~evl~~L~~~~~~~~~~~~~--~~~~~l~~~~~~~~~~~~~~~  378 (409)
                        .     ..|    .+.|+           .--|| +++...|.+....+...+..  ...+||.+|+.-+|.+|+++.
T Consensus       663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPt-kdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n  741 (752)
T KOG0670|consen  663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPT-KDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN  741 (752)
T ss_pred             chhhhhcccccceEEEeccccccceeEEEecccCcc-hhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence              0     001    11111           11132 45555565543333322221  237999999999999999999


Q ss_pred             ccCCCCCccc
Q 048535          379 GSRGHPTFNE  388 (409)
Q Consensus       379 ~~~~hp~~~~  388 (409)
                      +++.||||++
T Consensus       742 qAL~HpFi~~  751 (752)
T KOG0670|consen  742 QALKHPFITE  751 (752)
T ss_pred             HHhcCCcccC
Confidence            9999999974

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=2.8e-25  Score=202.51  Aligned_cols=263  Identities=19%  Similarity=0.256  Sum_probs=182.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-----C
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-----E  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~  182 (409)
                      ..+|...+.+|.|.- .|.-+.+.  +++||+|+....  .....++..+|..++..++|+||++++.++....     .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356667778888887 66666655  899999998543  3334567789999999999999999999887422     3


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..|+|||||.. +|.+.+.     ..++-..+..+..|++.|+.|||   +.+|+||||||+||++..++.+||.|||+|
T Consensus        95 e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhh
Confidence            58999999966 9999885     24777888999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCceeeec-------cc--cccCCCcHHHHHHhhhccCcHHHHhhHHh---------------hhcCCCCHHHHHH
Q 048535          263 KMHHHGQVMSGR-------RP--IEEGKRNLVDRMWSLTERSELLSVLDERL---------------KAKGGYADEVVEK  318 (409)
Q Consensus       263 ~~~~~~~~~~g~-------~p--~~~~~~~~~~~vws~~~~~~~~~~~~~~l---------------~~~~~~~~~~~~~  318 (409)
                      +....+-.+|..       .|  .-...+....|+|+.+  +...+++...+               ...+..++....+
T Consensus       166 r~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvG--ci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  166 RTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG--CIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             cccCcccccCchhheeeccCchheeccCCcccchhhhhh--hHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            977665222211       01  0113366778999985  22333322222               2223445555555


Q ss_pred             HHHHHHHccCcCCCCC-CCHHHHHHH--HhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCcc
Q 048535          319 VLHLGLLCAHPEANSR-PTIRQVLKM--LEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFN  387 (409)
Q Consensus       319 l~~l~~~Cl~~dP~~R-Pt~~evl~~--L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~  387 (409)
                      +...+..-....|+.- -++.+.+.-  .....+.+ ..+..+.+|++.+|+..+|.+|++.+++++||+++
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~-~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGS-KLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCC-ccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence            5555554444222111 122222110  01111111 23334569999999999999999999999999775

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.91  E-value=1.4e-24  Score=218.98  Aligned_cols=217  Identities=26%  Similarity=0.350  Sum_probs=151.4

Q ss_pred             CCccceeecCCceE-EEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          115 FSEENVIGLGGNGK-VYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       115 f~~~~~lG~G~fg~-Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      |...+.+|.|+.|+ ||+|.+.|+.||||++-.+.   ..-..+|+..|+.- +|||||++++.-.+ ++..||..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d-~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQD-RQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccC-CceEEEEehHhh
Confidence            55567899999875 79999999999999985432   23456899999888 79999999986665 788999999996


Q ss_pred             CCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC---C--CcEEEecccCccccc
Q 048535          193 NGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK---K--MNARLGDFGLAKMHH  266 (409)
Q Consensus       193 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~--~~~kl~DFGla~~~~  266 (409)
                      . +|.+++... .......-...+.+..|++.||++||   +.+||||||||.||||+.   +  .+++|+|||+++...
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            6 999999652 11111111345678899999999999   899999999999999976   3  469999999999887


Q ss_pred             CCce-------eeeccccc------cCCCcHHHHHHhhhcc------------CcHHHHhhHHhhhc-----CCCCHHHH
Q 048535          267 HGQV-------MSGRRPIE------EGKRNLVDRMWSLTER------------SELLSVLDERLKAK-----GGYADEVV  316 (409)
Q Consensus       267 ~~~~-------~~g~~p~~------~~~~~~~~~vws~~~~------------~~~~~~~~~~l~~~-----~~~~~~~~  316 (409)
                      .++-       .+|.....      ........|+.+++.-            ++.++--...+...     -....++ 
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~-  741 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDC-  741 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchH-
Confidence            6541       11211111      1222335566666211            11111100111100     0011122 


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVL  341 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl  341 (409)
                       +..+|+.++++++|..||++.+|+
T Consensus       742 -eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  742 -EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             -HHHHHHHHhcCCCcccCCCHHHHh
Confidence             778999999999999999999997

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=4.3e-24  Score=206.70  Aligned_cols=142  Identities=18%  Similarity=0.152  Sum_probs=114.5

Q ss_pred             HHHhCCCCccceeecCCceEEEEEEEC---CcEEEEEEeccC-----ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc
Q 048535          109 HAATKGFSEENVIGLGGNGKVYKGQLL---GVEVALKRISLD-----SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE  180 (409)
Q Consensus       109 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  180 (409)
                      ....++|+..+.||+|+||+||+|.+.   ++.||||++...     .....+.|.+|+++|++++|+|+++.+..    
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----   89 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----   89 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----
Confidence            345678999999999999999999874   677899987532     22345679999999999999999853322    


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCC-CCCCeeeCCCCcEEEecc
Q 048535          181 KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDI-KASNVLLDKKMNARLGDF  259 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-Kp~NILl~~~~~~kl~DF  259 (409)
                      .+..++||||+++++|.. +.   ..   .   ...++.|+++||.|||   +.+|+|||| ||+|||++.++.+||+||
T Consensus        90 ~~~~~LVmE~~~G~~L~~-~~---~~---~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHL-AR---PH---G---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             cCCcEEEEEccCCCCHHH-hC---cc---c---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEEC
Confidence            235799999999999973 21   11   1   1467889999999999   899999999 999999999999999999


Q ss_pred             cCcccccC
Q 048535          260 GLAKMHHH  267 (409)
Q Consensus       260 Gla~~~~~  267 (409)
                      |+|+....
T Consensus       157 GlA~~~~~  164 (365)
T PRK09188        157 QLASVFRR  164 (365)
T ss_pred             ccceeccc
Confidence            99986543

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4e-24  Score=200.46  Aligned_cols=216  Identities=18%  Similarity=0.253  Sum_probs=165.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~  185 (409)
                      ..+|.....||+|+||.|.++..+  .+.+|||+++.+   ...+.+--+.|-++|... +-|.+++++.++.. -+++|
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT-mDRLy  426 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT-MDRLY  426 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh-hhhee
Confidence            357888999999999999999988  467999999876   223344456677888776 56788999987776 78899


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      .||||+.||+|--.+.   .-+.+.+..+..++.+||-||-|||   +++||.||||..|||||.+|.+||+|||+++..
T Consensus       427 FVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccc
Confidence            9999999999988774   3456888899999999999999999   899999999999999999999999999999864


Q ss_pred             cCCc----eeeeccccc------cCCCcHHHHHHhhh-------------ccCcHHHHhhHHhhhcCCCCHHHHHHHHHH
Q 048535          266 HHGQ----VMSGRRPIE------EGKRNLVDRMWSLT-------------ERSELLSVLDERLKAKGGYADEVVEKVLHL  322 (409)
Q Consensus       266 ~~~~----~~~g~~p~~------~~~~~~~~~vws~~-------------~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l  322 (409)
                      -.+.    ..+|.+-+-      ...|....|.|++.             +.++-.++..........++...+.+...+
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~i  580 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAI  580 (683)
T ss_pred             ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHH
Confidence            4332    455655432      25677888899873             112222333333333334566666677777


Q ss_pred             HHHccCcCCCCC
Q 048535          323 GLLCAHPEANSR  334 (409)
Q Consensus       323 ~~~Cl~~dP~~R  334 (409)
                      ....+...|.+|
T Consensus       581 ckg~ltK~P~kR  592 (683)
T KOG0696|consen  581 CKGLLTKHPGKR  592 (683)
T ss_pred             HHHHhhcCCccc
Confidence            777777788777

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.90  E-value=6.3e-24  Score=200.21  Aligned_cols=270  Identities=24%  Similarity=0.286  Sum_probs=187.3

Q ss_pred             HHHHHhCCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEcc
Q 048535          107 EIHAATKGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKE  180 (409)
Q Consensus       107 ~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  180 (409)
                      .+....+.|..+++||.|.|++||++++.     .+.||+|.+...+.  .....+|+++|..+ .+.||+++.+++.. 
T Consensus        30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rn-  106 (418)
T KOG1167|consen   30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRN-  106 (418)
T ss_pred             hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhcc-
Confidence            34455678999999999999999999764     57899999975532  24588999999999 69999999998876 


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC-CcEEEecc
Q 048535          181 KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK-MNARLGDF  259 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DF  259 (409)
                      ++...+|+||++.-.-.++..      .++..++..++..+..||.++|   .++||||||||+|+|.+.. +.-.|.||
T Consensus       107 nd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDF  177 (418)
T KOG1167|consen  107 NDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDF  177 (418)
T ss_pred             CCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEec
Confidence            778999999999999999883      3778899999999999999999   8999999999999999764 56789999


Q ss_pred             cCcccccCCc-----------------------------------ee-------------eecccc---c----cCCCcH
Q 048535          260 GLAKMHHHGQ-----------------------------------VM-------------SGRRPI---E----EGKRNL  284 (409)
Q Consensus       260 Gla~~~~~~~-----------------------------------~~-------------~g~~p~---~----~~~~~~  284 (409)
                      |||...+...                                   ..             .|.+.+   +    ....+.
T Consensus       178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt  257 (418)
T KOG1167|consen  178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT  257 (418)
T ss_pred             hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence            9997321100                                   00             011111   0    133456


Q ss_pred             HHHHHhhhccCcHHHHhhHHhhhcC---C----------CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc-CC
Q 048535          285 VDRMWSLTERSELLSVLDERLKAKG---G----------YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT-EG  350 (409)
Q Consensus       285 ~~~vws~~~~~~~~~~~~~~l~~~~---~----------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~-~~  350 (409)
                      ..|+|+.+.  .+..++..+.++-.   +          +-...+.++..+--+-+-..+..+|++.++..-.+... +.
T Consensus       258 aiDiws~GV--I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~  335 (418)
T KOG1167|consen  258 AIDIWSAGV--ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES  335 (418)
T ss_pred             ccceeeccc--eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence            678888742  12222222221100   0          11112222222222211223366899988887666552 21


Q ss_pred             CCCCC-------------CCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          351 TGLED-------------EGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       351 ~~~~~-------------~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      -...+             +....|+|.++++.+|.+|++.++++.||||++.+
T Consensus       336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence            11100             11348999999999999999999999999999654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.5e-23  Score=186.59  Aligned_cols=140  Identities=19%  Similarity=0.207  Sum_probs=108.0

Q ss_pred             cceeecCCceEEEEEEEC-CcEEEEEEeccCChH--H-------HHH-----------------HHHHHHHhccCCCCce
Q 048535          118 ENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEH--G-------MRE-----------------FLAEVSSLGRLKHRNL  170 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni  170 (409)
                      ...||+|+||.||+|... |+.||||+++.....  .       ...                 ...|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            467999999999999986 999999999754211  1       112                 2349999999988776


Q ss_pred             eeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC
Q 048535          171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK  250 (409)
Q Consensus       171 v~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~  250 (409)
                      .....+...   ..+|||||++++++.....   ....+++.....++.|++.+|.|||+  +.+|+||||||+|||++ 
T Consensus        82 ~~p~~~~~~---~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILLK---SHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEec---CCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE-
Confidence            443332222   2379999999987765532   22468899999999999999999932  78999999999999998 


Q ss_pred             CCcEEEecccCccccc
Q 048535          251 KMNARLGDFGLAKMHH  266 (409)
Q Consensus       251 ~~~~kl~DFGla~~~~  266 (409)
                      ++.++|+|||+|....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.7e-24  Score=207.51  Aligned_cols=214  Identities=17%  Similarity=0.200  Sum_probs=166.7

Q ss_pred             CCCCccceeecCCceEEEEEEECCcE--EEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLLGVE--VALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~~~~--vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .+++....||-||||.|=+....++.  +|+|.+++.   +..+.+....|-.+|...+.|.||++|..|.+ ...+|+.
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-~kyvYmL  498 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-SKYVYML  498 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-chhhhhh
Confidence            45566778999999999999888544  899988765   44556778899999999999999999999987 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||-|-||.|...|+   ..+.++......++..+.+|++|||   +++||.|||||+|+|||.+|-+||.|||+|+....
T Consensus       499 mEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  499 MEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             HHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            99999999999994   4567899999999999999999999   89999999999999999999999999999999877


Q ss_pred             Cc---eeeecccccc------CCCcHHHHHHhhhccCcHHHHhhHHhhhc-----------------CCCCHHHHHHHHH
Q 048535          268 GQ---VMSGRRPIEE------GKRNLVDRMWSLTERSELLSVLDERLKAK-----------------GGYADEVVEKVLH  321 (409)
Q Consensus       268 ~~---~~~g~~p~~~------~~~~~~~~vws~~~~~~~~~~~~~~l~~~-----------------~~~~~~~~~~l~~  321 (409)
                      +.   ..+|.+.+-.      ...+...|.|+++  --+++++....++.                 -.+|........+
T Consensus       573 g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLG--Ili~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~  650 (732)
T KOG0614|consen  573 GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALG--ILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATD  650 (732)
T ss_pred             CCceeeecCCcccccchhhhccCcchhhHHHHHH--HHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHH
Confidence            65   5566665432      3456788999984  12222222222111                 1234444455566


Q ss_pred             HHHHccCcCCCCCC
Q 048535          322 LGLLCAHPEANSRP  335 (409)
Q Consensus       322 l~~~Cl~~dP~~RP  335 (409)
                      ++.+.+..+|.+|-
T Consensus       651 Lik~LCr~~P~ERL  664 (732)
T KOG0614|consen  651 LIKKLCRDNPTERL  664 (732)
T ss_pred             HHHHHHhcCcHhhh
Confidence            66666666676664

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.89  E-value=3.2e-23  Score=201.54  Aligned_cols=173  Identities=25%  Similarity=0.341  Sum_probs=139.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh--------HHHHHHHHHHHHhccCC---CCceeeEeeEEEc
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE--------HGMREFLAEVSSLGRLK---HRNLVGLRGWCKK  179 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~  179 (409)
                      .+|...+.+|.|+||.|++|.++  ...|+||.+.++..        ...-..-.|+.+|..++   |+||++++++|.+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35788899999999999999998  67899999975411        11123457999999997   9999999999988


Q ss_pred             cCCeEEEEEEeC-CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEec
Q 048535          180 EKESLILIYDYM-ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGD  258 (409)
Q Consensus       180 ~~~~~~lv~E~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D  258 (409)
                       ++.+||+||-- ++-+|.++|   .-+..+++.++.-|+.||+.|+++||   +.+|||||||-+|+.++.+|-+||+|
T Consensus       641 -dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  641 -DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             -CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEee
Confidence             78899999965 456899999   44567999999999999999999999   99999999999999999999999999


Q ss_pred             ccCcccccCCc--eeeecccccc------CCC-cHHHHHHhhh
Q 048535          259 FGLAKMHHHGQ--VMSGRRPIEE------GKR-NLVDRMWSLT  292 (409)
Q Consensus       259 FGla~~~~~~~--~~~g~~p~~~------~~~-~~~~~vws~~  292 (409)
                      ||.|.....+.  +..|..-+..      ..| ....|+|.++
T Consensus       714 fgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalg  756 (772)
T KOG1152|consen  714 FGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALG  756 (772)
T ss_pred             ccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhh
Confidence            99998766543  3333322211      111 3457899874

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=2.7e-22  Score=178.79  Aligned_cols=139  Identities=19%  Similarity=0.214  Sum_probs=110.7

Q ss_pred             cceeecCCceEEEEEEEC-CcEEEEEEeccCChH--------------------------HHHHHHHHHHHhccCCCCce
Q 048535          118 ENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEH--------------------------GMREFLAEVSSLGRLKHRNL  170 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~H~ni  170 (409)
                      ...||+|+||.||+|... |+.||||+++.....                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            468999999999999987 999999999754210                          01224578999999999987


Q ss_pred             eeEeeEEEccCCeEEEEEEeCCCCCHHHH-HhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CceeecCCCCCCeee
Q 048535          171 VGLRGWCKKEKESLILIYDYMENGSLDKW-IFECDESIALSWEQRIKVLKDVASGILYLYEGWE-SKVLHRDIKASNVLL  248 (409)
Q Consensus       171 v~l~g~~~~~~~~~~lv~E~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlKp~NILl  248 (409)
                      .....+...   ..++||||++++++... +.    ...++......++.|++.+|.+||   . .+|+||||||+|||+
T Consensus        82 ~~p~~~~~~---~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll  151 (190)
T cd05145          82 PVPEPILLK---KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILY  151 (190)
T ss_pred             CCceEEEec---CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEE
Confidence            544444332   23799999998865443 42    235788899999999999999999   6 899999999999999


Q ss_pred             CCCCcEEEecccCcccccC
Q 048535          249 DKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       249 ~~~~~~kl~DFGla~~~~~  267 (409)
                      + ++.++|+|||+|+....
T Consensus       152 ~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-CCCEEEEEcccceecCC
Confidence            8 88999999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=2.3e-21  Score=185.54  Aligned_cols=133  Identities=23%  Similarity=0.293  Sum_probs=113.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC-----CC---ceeeEeeEEEcc-
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-----HR---NLVGLRGWCKKE-  180 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H~---niv~l~g~~~~~-  180 (409)
                      ..+|.+.++||-|-|++||++.+.  .+.||+|+.+.. ....+..+.||++|++++     |+   +||+|++.|... 
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            367889999999999999999998  678999998743 445567889999999983     33   599999999743 


Q ss_pred             --CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC
Q 048535          181 --KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD  249 (409)
Q Consensus       181 --~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~  249 (409)
                        +.++|+|+|++ |-+|..+|... ..+.++...+.+|+.||+.||.|||.  ..+|||-||||+|||+.
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeee
Confidence              45799999999 55999999764 44569999999999999999999998  56999999999999994

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3.3e-22  Score=178.62  Aligned_cols=147  Identities=20%  Similarity=0.342  Sum_probs=124.4

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .+.|.+.+.||+|.||.+-+++++  .+.+++|-+... ....++|.+|...--.| .|.||+.-++...+..+....++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            356888999999999999999998  678999998654 23457899999876666 69999998887666567788999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee-CC-CCcEEEecccCccccc
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL-DK-KMNARLGDFGLAKMHH  266 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl-~~-~~~~kl~DFGla~~~~  266 (409)
                      ||+|.|+|.+-+.    ...+.+....+++.|++.|+.|+|   +.++||||||.+|||| +. ..++||||||+.+..+
T Consensus       102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999998773    345888889999999999999999   9999999999999999 33 3479999999997644

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.87  E-value=4.6e-21  Score=173.86  Aligned_cols=148  Identities=33%  Similarity=0.492  Sum_probs=131.4

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEH-GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      |...+.||+|++|.||++...  ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++.. ....++++||+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-PEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-CCceEEEEecc
Confidence            556788999999999999987  689999999876544 67789999999999999999999999886 67889999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ++++|.+++.....  .+++..+..++.+++.++.|||   +.+++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       80 EGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             CCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            99999999964321  1899999999999999999999   789999999999999999999999999999876543

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=9.9e-22  Score=176.79  Aligned_cols=138  Identities=16%  Similarity=0.235  Sum_probs=107.3

Q ss_pred             CCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccC-----CCCceeeEeeEEEccC--Ce-EEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRL-----KHRNLVGLRGWCKKEK--ES-LIL  186 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~g~~~~~~--~~-~~l  186 (409)
                      +...+.||+|+||.||.....+.. +||++........+.+.+|+.+++.+     +||||++++|++.++.  +. ..+
T Consensus         4 L~~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             cCCcceecCCCceEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            345688999999999962222444 69998765444567899999999999     5799999999998743  23 337


Q ss_pred             EEEe--CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCceeecCCCCCCeeeCC----CCcEEEecc
Q 048535          187 IYDY--MENGSLDKWIFECDESIALSWEQRIKVLKDVASGI-LYLYEGWESKVLHRDIKASNVLLDK----KMNARLGDF  259 (409)
Q Consensus       187 v~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDlKp~NILl~~----~~~~kl~DF  259 (409)
                      |+||  +++|+|.+++.+    ..+++.  ..++.|++.++ +|||   +.+|+||||||+|||++.    +..++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  668999999943    235555  35678888888 9999   899999999999999974    347999995


Q ss_pred             cCc
Q 048535          260 GLA  262 (409)
Q Consensus       260 Gla  262 (409)
                      +-+
T Consensus       154 ~G~  156 (210)
T PRK10345        154 IGE  156 (210)
T ss_pred             CCC
Confidence            444

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=1.2e-21  Score=179.64  Aligned_cols=174  Identities=22%  Similarity=0.302  Sum_probs=145.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~  185 (409)
                      .++|.....||+|+|+.|.++++.  .+.+|+|+++++   ...+..-...|-.+..+. +||.+|.+..+|.. ...++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt-esrlf  327 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT-ESRLF  327 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc-cceEE
Confidence            367889999999999999999987  788999999764   344455566777777776 89999999998876 77899


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      .|.||.++|+|--++.   ....++++.+..+..+|+-||.|||   +.+||.||||..|+|||..|.+||+|+|+.+.-
T Consensus       328 fvieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcC
Confidence            9999999999976663   4456999999999999999999999   899999999999999999999999999999853


Q ss_pred             cC----Cceeeeccccc------cCCCcHHHHHHhhh
Q 048535          266 HH----GQVMSGRRPIE------EGKRNLVDRMWSLT  292 (409)
Q Consensus       266 ~~----~~~~~g~~p~~------~~~~~~~~~vws~~  292 (409)
                      -.    ....+|.+.+-      .+.|.+..|.|.+.
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalg  438 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALG  438 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCceehHHHHH
Confidence            22    22556665542      36788888999884

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=7.2e-20  Score=165.67  Aligned_cols=134  Identities=20%  Similarity=0.337  Sum_probs=113.0

Q ss_pred             ceeecCCceEEEEEEECCcEEEEEEeccCCh--------HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          119 NVIGLGGNGKVYKGQLLGVEVALKRISLDSE--------HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      +.||+|++|.||+|.+.|..|++|.......        .....+.+|++++..++|+|+.....++.. ....+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-PENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-CCCCEEEEEE
Confidence            5799999999999999999999998654311        112467899999999999998777666655 4567899999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      +++++|.+++...      .+ .+..++.+++.+|.+||   +.+++|+|++|.|||++ ++.++|+|||+++.
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998431      22 78899999999999999   89999999999999999 78899999999875

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.82  E-value=1.1e-19  Score=187.05  Aligned_cols=139  Identities=19%  Similarity=0.280  Sum_probs=114.3

Q ss_pred             HhCCCCccceeecCCceEEEEEEECCcEEEEEEeccC--C------hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD--S------EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~--~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  182 (409)
                      ....|...+.||+|+||+||+|.+.+..+++|+....  .      ....+.+.+|++++.+++|+|++....++.. ..
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD-PE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe-CC
Confidence            3455667899999999999999998666666553211  1      1123568899999999999999887777765 45


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..++||||+++++|.+++.           ....++.|++++|.|||   +.+++||||||+|||+ +++.++|+|||++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence            6789999999999999883           35679999999999999   8999999999999999 6778999999999


Q ss_pred             ccc
Q 048535          263 KMH  265 (409)
Q Consensus       263 ~~~  265 (409)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            864

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=9.8e-20  Score=164.69  Aligned_cols=163  Identities=13%  Similarity=0.118  Sum_probs=125.9

Q ss_pred             HhCCCCccceeecCCceEEEEEEECCcEEEEEEeccCCh---HHHHH------HHHHHHHhccCCCCceeeEeeEEEcc-
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSE---HGMRE------FLAEVSSLGRLKHRNLVGLRGWCKKE-  180 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~---~~~~~------~~~E~~~l~~l~H~niv~l~g~~~~~-  180 (409)
                      ..++|+..+.||.|+||.||+....+..+|+|.+.....   .....      +.+|+..+.+++|++|..+.+++... 
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            468899999999999999999777677899999975422   22222      67999999999999999998886532 


Q ss_pred             ------CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcE
Q 048535          181 ------KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNA  254 (409)
Q Consensus       181 ------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~  254 (409)
                            .+..+|+|||++|.+|.++..       ++.    ....+++.+|..+|   ..+++|||+||+||+++.++ +
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-E
Confidence                  235789999999999988741       222    34569999999999   89999999999999999988 9


Q ss_pred             EEecccCcccccCCc---eeeeccccccCCCcHHHHHHhhhc
Q 048535          255 RLGDFGLAKMHHHGQ---VMSGRRPIEEGKRNLVDRMWSLTE  293 (409)
Q Consensus       255 kl~DFGla~~~~~~~---~~~g~~p~~~~~~~~~~~vws~~~  293 (409)
                      +|+|||..+......   ++.-.     ..+....|+|+++-
T Consensus       174 ~liDfg~~~~~~e~~a~d~~vle-----r~y~~~~di~~lg~  210 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAKDRIDLE-----RHYGIKNEIKDLGY  210 (232)
T ss_pred             EEEECCCcccccchhhHHHHHHH-----hHhcccccccceeE
Confidence            999999987654322   11111     12335678898863

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=7.3e-20  Score=168.40  Aligned_cols=141  Identities=17%  Similarity=0.204  Sum_probs=110.2

Q ss_pred             CCCccceeecCCceEEEEEE-E-C-CcEEEEEEeccCChH------------------------HHHHHHHHHHHhccCC
Q 048535          114 GFSEENVIGLGGNGKVYKGQ-L-L-GVEVALKRISLDSEH------------------------GMREFLAEVSSLGRLK  166 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~-~-~-~~~vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  166 (409)
                      .|++.+.||+|+||.||+|. . . |+.||+|+++.....                        ....+..|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47888999999999999998 3 3 899999998753210                        1123568999999997


Q ss_pred             CCc--eeeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-eeecCCCC
Q 048535          167 HRN--LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLHRDIKA  243 (409)
Q Consensus       167 H~n--iv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDlKp  243 (409)
                      +.+  +.+++++     ...++||||+++++|..+..   ....+...+...++.|++.+|.|||   ..+ |+||||||
T Consensus       109 ~~~i~~p~~~~~-----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW-----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe-----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCCh
Confidence            533  3444442     13479999999988876542   2234566677899999999999999   888 99999999


Q ss_pred             CCeeeCCCCcEEEecccCccccc
Q 048535          244 SNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       244 ~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      +||+++ +++++|+|||+|....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999999 8899999999997644

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.4e-19  Score=158.01  Aligned_cols=133  Identities=15%  Similarity=0.109  Sum_probs=107.7

Q ss_pred             CccceeecCCceEEEEEEECCcEEEEEEeccCCh----HHHHHHHHHHHHhccCC-CCceeeEeeEEEccCCeEEEEEEe
Q 048535          116 SEENVIGLGGNGKVYKGQLLGVEVALKRISLDSE----HGMREFLAEVSSLGRLK-HRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       116 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      .....|++|+||+||.+...+.+++.+.+.....    -....|.+|+++|++|. |+++.+++++     +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEEee
Confidence            3467899999999998877889999888865422    11235889999999994 5889999885     235899999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCC-CCCCeeeCCCCcEEEecccCccccc
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDI-KASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl-Kp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      +.|.+|.+.+..          ....++.|++++|.++|   +.+|+|||| ||+|||++.++.++|+|||+|....
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence            999999765411          11357789999999999   899999999 7999999999999999999997543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=1.4e-19  Score=162.34  Aligned_cols=131  Identities=21%  Similarity=0.324  Sum_probs=106.3

Q ss_pred             eeecCCceEEEEEEECCcEEEEEEeccCC--------hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          120 VIGLGGNGKVYKGQLLGVEVALKRISLDS--------EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       120 ~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      .||+|+||.||+|.+.+..|++|......        .....++.+|++++..++|+++.....++.. ....++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-PDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-CCCCEEEEEEE
Confidence            48999999999999889999999865321        1123567899999999988876544444444 44568999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      ++++|.+++...   ..       .++.+++.+|.+||   +.+++|+|++|.||+++ ++.+++.|||+++..
T Consensus        80 ~g~~l~~~~~~~---~~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEG---ND-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhc---HH-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999987431   11       78999999999999   89999999999999999 789999999998763

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=3.7e-19  Score=159.61  Aligned_cols=143  Identities=21%  Similarity=0.247  Sum_probs=111.4

Q ss_pred             HHHHHhCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCCh----------------------HHHHHHHHHHHHhc
Q 048535          107 EIHAATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSE----------------------HGMREFLAEVSSLG  163 (409)
Q Consensus       107 ~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~----------------------~~~~~~~~E~~~l~  163 (409)
                      ++......|...+.||+|+||.||++... |+.||||+++....                      .....+..|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            44444444778899999999999999986 99999998764320                      01123678899999


Q ss_pred             cCCCCc--eeeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCC
Q 048535          164 RLKHRN--LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDI  241 (409)
Q Consensus       164 ~l~H~n--iv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl  241 (409)
                      ++.|++  +.+.++.     ...++||||+++++|.+...         ......++.+++.++.++|   ..+|+||||
T Consensus        89 ~l~~~~i~v~~~~~~-----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh---~~gi~H~Dl  151 (198)
T cd05144          89 ALYEEGFPVPKPIDW-----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAY---KHGIIHGDL  151 (198)
T ss_pred             HHHHcCCCCCceeec-----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHH---HCCCCcCCC
Confidence            998874  4444442     34589999999999977541         0234678899999999999   799999999


Q ss_pred             CCCCeeeCCCCcEEEecccCccccc
Q 048535          242 KASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       242 Kp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||+||++++++.++|+|||++....
T Consensus       152 ~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         152 SEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999996544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.79  E-value=4.1e-20  Score=165.33  Aligned_cols=222  Identities=22%  Similarity=0.387  Sum_probs=163.0

Q ss_pred             cceeecCCceEEEEEEECCcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCC
Q 048535          118 ENVIGLGGNGKVYKGQLLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS  195 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gs  195 (409)
                      .-+|.+...|+.|+|+|.|..+++|++...  +....++|..|.-.|+-+.||||+.++|.|.. ..++.++..|||.||
T Consensus       195 ~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-ppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-PPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-CCCceEeeeeccchH
Confidence            456788889999999999999999988654  34445789999999999999999999999998 678999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEe--cccCcccccCCcee--
Q 048535          196 LDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLG--DFGLAKMHHHGQVM--  271 (409)
Q Consensus       196 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~--DFGla~~~~~~~~~--  271 (409)
                      |+..|++. ....++-.++++++.++|+|++|||+. ++-|..--|.+..+++|++.+++|+  |--++-.. .+...  
T Consensus       274 lynvlhe~-t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe-~gr~y~p  350 (448)
T KOG0195|consen  274 LYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-VGRAYSP  350 (448)
T ss_pred             HHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec-cccccCc
Confidence            99999874 445678889999999999999999975 4556666789999999999998874  32211110 01100  


Q ss_pred             ---e----eccccccCCCcHHHHHHhh-------hccCcH----------HHHhhHHhhhcCCCCHHHHHHHHHHHHHcc
Q 048535          272 ---S----GRRPIEEGKRNLVDRMWSL-------TERSEL----------LSVLDERLKAKGGYADEVVEKVLHLGLLCA  327 (409)
Q Consensus       272 ---~----g~~p~~~~~~~~~~~vws~-------~~~~~~----------~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl  327 (409)
                         +    .+.|-  +..--..|+|++       ..++..          ..+.-+.++  ...++..+..+.+|+.-|.
T Consensus       351 awmspealqrkpe--d~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr--v~ippgis~hm~klm~icm  426 (448)
T KOG0195|consen  351 AWMSPEALQRKPE--DLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR--VHIPPGISRHMNKLMNICM  426 (448)
T ss_pred             ccCCHHHHhcCch--hcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc--ccCCCCccHHHHHHHHHHh
Confidence               0    01111  122234455555       222211          011122233  3466777788899999999


Q ss_pred             CcCCCCCCCHHHHHHHHhcC
Q 048535          328 HPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~  347 (409)
                      +.||.+||.+..++-.|+++
T Consensus       427 nedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  427 NEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             cCCCCcCCCcceehhhHHHh
Confidence            99999999999999998865

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.78  E-value=1.8e-19  Score=193.96  Aligned_cols=171  Identities=13%  Similarity=0.187  Sum_probs=114.2

Q ss_pred             cCCC-CceeeEeeEEEcc------CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 048535          164 RLKH-RNLVGLRGWCKKE------KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV  236 (409)
Q Consensus       164 ~l~H-~niv~l~g~~~~~------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  236 (409)
                      .++| +||.+++++|...      ...++.++||+ +++|.++|..  ....+++.+++.++.||++||.|||   +++|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH---~~gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAH---SQGI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            4556 6888888887211      23567788988 5599999953  2346999999999999999999999   8999


Q ss_pred             eecCCCCCCeeeCC-------------------CCcEEEecccCcccccCC---------c-----------eeee---c
Q 048535          237 LHRDIKASNVLLDK-------------------KMNARLGDFGLAKMHHHG---------Q-----------VMSG---R  274 (409)
Q Consensus       237 vHrDlKp~NILl~~-------------------~~~~kl~DFGla~~~~~~---------~-----------~~~g---~  274 (409)
                      +||||||+||||+.                   ++.+||+|||+++.....         .           ...|   +
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   455677777777642210         0           0001   1


Q ss_pred             ccc---ccCCCcHHHHHHhhhccCcHHHHhhHHh------------h--hcCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 048535          275 RPI---EEGKRNLVDRMWSLTERSELLSVLDERL------------K--AKGGYADEVVEKVLHLGLLCAHPEANSRPTI  337 (409)
Q Consensus       275 ~p~---~~~~~~~~~~vws~~~~~~~~~~~~~~l------------~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  337 (409)
                      .+.   ....++...|+|+++.  .+++++.+..            .  ..++...........++.+||+.+|.+||||
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGv--iL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~  259 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGV--LLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSM  259 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHH--HHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcCh
Confidence            111   1245678899999841  2233221110            0  0011111123456788899999999999999


Q ss_pred             HHHHH
Q 048535          338 RQVLK  342 (409)
Q Consensus       338 ~evl~  342 (409)
                      .|+++
T Consensus       260 ~eil~  264 (793)
T PLN00181        260 SELLQ  264 (793)
T ss_pred             HHHhh
Confidence            99986

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.77  E-value=7.6e-18  Score=162.56  Aligned_cols=145  Identities=21%  Similarity=0.230  Sum_probs=119.9

Q ss_pred             CCCccceeecCCceEEEEEEECC---cEEEEEEeccCChHHHHHHHHHHHHhccCCC----CceeeEeeEEEccCCeEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLLG---VEVALKRISLDSEHGMREFLAEVSSLGRLKH----RNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~~---~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~g~~~~~~~~~~l  186 (409)
                      +|.+.+.||+|+||.||++....   ..+|+|............+..|+.++..+..    +++.++++.........++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            79999999999999999999873   4688888765433222267789999888863    5788888877422567889


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC-----CcEEEecccC
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK-----MNARLGDFGL  261 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-----~~~kl~DFGl  261 (409)
                      ||+.+ |.||.++..... ...++..+.++|+.|++.+|.+||   +.+++||||||.|++++..     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 669999775543 567999999999999999999999   8999999999999999865     4589999999


Q ss_pred             cc
Q 048535          262 AK  263 (409)
Q Consensus       262 a~  263 (409)
                      |+
T Consensus       174 ar  175 (322)
T KOG1164|consen  174 AR  175 (322)
T ss_pred             Cc
Confidence            98

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.75  E-value=1.5e-17  Score=141.07  Aligned_cols=136  Identities=18%  Similarity=0.115  Sum_probs=114.8

Q ss_pred             ccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCC--CceeeEeeEEEccCCeEEEEEEeCCCC
Q 048535          117 EENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKH--RNLVGLRGWCKKEKESLILIYDYMENG  194 (409)
Q Consensus       117 ~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~~lv~E~~~~g  194 (409)
                      +.+.||+|.++.||++...+..+++|.......  ...+.+|+.++..++|  .++.+++++... .+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGES-DGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCccEEEEEecCCe
Confidence            357899999999999999888999999865533  4678899999999976  588898887765 56789999999987


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          195 SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       195 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      ++..+          +......++.+++++|.+||.....+++|+|++|+|||++..+.+++.|||+++..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            77543          55677788999999999999544468999999999999999899999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=2.1e-17  Score=152.39  Aligned_cols=137  Identities=23%  Similarity=0.223  Sum_probs=108.6

Q ss_pred             cceee-cCCceEEEEEEECCcEEEEEEeccCC-------------hHHHHHHHHHHHHhccCCCCce--eeEeeEEEccC
Q 048535          118 ENVIG-LGGNGKVYKGQLLGVEVALKRISLDS-------------EHGMREFLAEVSSLGRLKHRNL--VGLRGWCKKEK  181 (409)
Q Consensus       118 ~~~lG-~G~fg~Vy~~~~~~~~vAvK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~g~~~~~~  181 (409)
                      ...|| .||.|+||.....+..++||.+....             ......+.+|++++.+|+|++|  ++.+++.....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            46788 89999999999989999999885321             1223567889999999998875  67777654422


Q ss_pred             Ce---EEEEEEeCCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEe
Q 048535          182 ES---LILIYDYMEN-GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLG  257 (409)
Q Consensus       182 ~~---~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~  257 (409)
                      ..   .++||||+++ .+|.+++..    ..++..    .+.+++.+|.+||   +.+|+||||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEE
Confidence            22   3599999997 699998843    235543    3578999999999   8999999999999999998999999


Q ss_pred             cccCcccc
Q 048535          258 DFGLAKMH  265 (409)
Q Consensus       258 DFGla~~~  265 (409)
                      |||.++..
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99998763

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.74  E-value=5e-17  Score=143.42  Aligned_cols=147  Identities=27%  Similarity=0.360  Sum_probs=118.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCC-ceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHR-NLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~~lv~  188 (409)
                      ...|...+.||+|+||.+|.|...  |..||||.-+....  ..++..|..+.+.|+|- .|..+.-|..+ ...-.+||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e-~~ynvlVM   90 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTE-KDYNVLVM   90 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccc-cccceeee
Confidence            367999999999999999999876  99999999764422  24567888888888753 44444444444 66778999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC---CcEEEecccCcccc
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK---MNARLGDFGLAKMH  265 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kl~DFGla~~~  265 (409)
                      +.+ |.||.+++.-+.  ..++..+.+-++-|++.-++|+|   .+++|||||||+|.|..-+   ..+.++|||||+.+
T Consensus        91 dLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhh
Confidence            988 779999875443  35888999999999999999999   8999999999999999644   35889999999875


Q ss_pred             cC
Q 048535          266 HH  267 (409)
Q Consensus       266 ~~  267 (409)
                      ..
T Consensus       165 ~d  166 (341)
T KOG1163|consen  165 RD  166 (341)
T ss_pred             cc
Confidence            43

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=2.3e-17  Score=146.30  Aligned_cols=135  Identities=19%  Similarity=0.238  Sum_probs=97.9

Q ss_pred             cceeecCCceEEEEEEEC-CcEEEEEEeccCCh--HHHHHH----------------------HHHHHHhccCCCCc--e
Q 048535          118 ENVIGLGGNGKVYKGQLL-GVEVALKRISLDSE--HGMREF----------------------LAEVSSLGRLKHRN--L  170 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~--~~~~~~----------------------~~E~~~l~~l~H~n--i  170 (409)
                      .+.||+|+||.||+|... ++.||||+++....  .....+                      ..|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999999988 99999999875421  111111                      35666666664433  3


Q ss_pred             eeEeeEEEccCCeEEEEEEeCCCCCHHH-HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CceeecCCCCCCeee
Q 048535          171 VGLRGWCKKEKESLILIYDYMENGSLDK-WIFECDESIALSWEQRIKVLKDVASGILYLYEGWE-SKVLHRDIKASNVLL  248 (409)
Q Consensus       171 v~l~g~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlKp~NILl  248 (409)
                      .+.++.     ...++||||++++++.. .+...    ... .....++.+++.++.++|   . .+|+|+||||+||++
T Consensus        82 ~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili  148 (187)
T cd05119          82 PKPIDL-----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILV  148 (187)
T ss_pred             CceEec-----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEE
Confidence            444432     23589999999965432 12110    011 567889999999999999   6 999999999999999


Q ss_pred             CCCCcEEEecccCccccc
Q 048535          249 DKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       249 ~~~~~~kl~DFGla~~~~  266 (409)
                      + ++.++|+|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.71  E-value=5.2e-17  Score=149.38  Aligned_cols=147  Identities=24%  Similarity=0.298  Sum_probs=118.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      -.|.+.++||+|+||..+.|+..  ++.||||.-...+.  ..++..|.+..+.| ..++|...+-|-.+ +-.-.||+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqe-G~~NiLVid  104 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQE-GKYNILVID  104 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccc-cchhhhhhh
Confidence            46899999999999999999875  99999998754432  24566788888777 46778776643333 555679999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC-----cEEEecccCccc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM-----NARLGDFGLAKM  264 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-----~~kl~DFGla~~  264 (409)
                      .+ |.||.+++.-+.  ..++..++..+|.|++.-++|+|   ++.+|.|||||+|.||..-+     .+.|.|||+|+.
T Consensus       105 LL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            88 679988775433  45899999999999999999999   89999999999999997543     489999999998


Q ss_pred             ccCC
Q 048535          265 HHHG  268 (409)
Q Consensus       265 ~~~~  268 (409)
                      +...
T Consensus       179 YrDp  182 (449)
T KOG1165|consen  179 YRDP  182 (449)
T ss_pred             hcCc
Confidence            7554

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=4.9e-18  Score=174.93  Aligned_cols=169  Identities=20%  Similarity=0.229  Sum_probs=125.2

Q ss_pred             CccceeecCCceEEEEEEEC--CcEEEEEEec-----cCChHH-HHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          116 SEENVIGLGGNGKVYKGQLL--GVEVALKRIS-----LDSEHG-MREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       116 ~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~-----~~~~~~-~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .....+|.|++|.|+.....  .+..+.|..+     ...... ...+..|+.+-..+.|||++..+..+.+ ....+-.
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~-~~~~~~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE-IDGILQS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh-cccchhh
Confidence            35678999999987776654  3434444332     222222 2237778888899999999888777665 3334445


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||||++ +|..++..   ...++..++-.++.|+..|+.|||   ..+|.|||||++|++++.++.+||+|||.+.....
T Consensus       400 mE~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~  472 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRY  472 (601)
T ss_pred             hhcccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeecc
Confidence            999999 99999943   346888999999999999999999   89999999999999999999999999999976543


Q ss_pred             Cc--------eeeecccccc-------CCCcHHHHHHhhh
Q 048535          268 GQ--------VMSGRRPIEE-------GKRNLVDRMWSLT  292 (409)
Q Consensus       268 ~~--------~~~g~~p~~~-------~~~~~~~~vws~~  292 (409)
                      +.        -+.|..|+..       .......|+|+..
T Consensus       473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~  512 (601)
T KOG0590|consen  473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCG  512 (601)
T ss_pred             CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhcc
Confidence            21        3456666322       2234667899873

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.69  E-value=5.3e-16  Score=146.92  Aligned_cols=224  Identities=25%  Similarity=0.339  Sum_probs=161.7

Q ss_pred             CCccceeecCCceEEEEEEECCcEEEEEEeccCCh---HHHHHHHHHHHHhccCCCC-ceeeEeeEEEccCCeEEEEEEe
Q 048535          115 FSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSE---HGMREFLAEVSSLGRLKHR-NLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~-niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      |...+.||.|+||.||++... ..+++|.+.....   .....|.+|+.++..+.|+ |++++.+.+.. ....+++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEEec
Confidence            566788999999999999998 8899999976522   2467899999999999888 79999999865 5567999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC-cEEEecccCcccccCCc
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM-NARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~~  269 (409)
                      +.++++.+++........+.......++.|++.++.|+|   ..+++|||+||+||+++... .++++|||+++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999977743211126889999999999999999999   88899999999999999988 79999999998544321


Q ss_pred             ----------eeeeccccc------c---CCCcHHHHHHhhhcc-------------Cc----HHHHhhHHhhhcCC---
Q 048535          270 ----------VMSGRRPIE------E---GKRNLVDRMWSLTER-------------SE----LLSVLDERLKAKGG---  310 (409)
Q Consensus       270 ----------~~~g~~p~~------~---~~~~~~~~vws~~~~-------------~~----~~~~~~~~l~~~~~---  310 (409)
                                ...|...+.      .   .......|+|+++..             ..    .....+........   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA  236 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccc
Confidence                      122222221      1   245677889966300             00    01111111100000   


Q ss_pred             --CCHH----HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          311 --YADE----VVEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       311 --~~~~----~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                        ....    ....+.+++..|+..+|..|.++.+....
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              0111    11467788888999999999988877653

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.62  E-value=1.6e-15  Score=150.07  Aligned_cols=184  Identities=24%  Similarity=0.343  Sum_probs=131.3

Q ss_pred             hccCCCCceeeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCC
Q 048535          162 LGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDI  241 (409)
Q Consensus       162 l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl  241 (409)
                      |+.+.|.|+.+++|.+.+ ++..++|.+||..|+|.+.+..  ....++|.-...+.++|+.||.|||+  +.--.|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~-~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVD-GPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEec-CCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeee
Confidence            467899999999999998 5889999999999999999964  45679999999999999999999995  333399999


Q ss_pred             CCCCeeeCCCCcEEEecccCcccccC------------------Cceeeeccc--------cccCCCcHHHHHHhhhcc-
Q 048535          242 KASNVLLDKKMNARLGDFGLAKMHHH------------------GQVMSGRRP--------IEEGKRNLVDRMWSLTER-  294 (409)
Q Consensus       242 Kp~NILl~~~~~~kl~DFGla~~~~~------------------~~~~~g~~p--------~~~~~~~~~~~vws~~~~-  294 (409)
                      +++|+++|..+.+||+|||+......                  .+++.+...        ...+.|++..-+.++..+ 
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999999887632                  112222111        112334444333333111 


Q ss_pred             ---------CcHHHHhhHHhh-----hcCCCC-H-HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          295 ---------SELLSVLDERLK-----AKGGYA-D-EVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       295 ---------~~~~~~~~~~l~-----~~~~~~-~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                               ....+++.....     ..+... . +..+.+..++..||..+|.+||+++++-..++.....
T Consensus       156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             CccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence                     111122222111     001111 1 3444789999999999999999999999988876554

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=1.6e-15  Score=160.11  Aligned_cols=146  Identities=23%  Similarity=0.239  Sum_probs=109.3

Q ss_pred             HHHhCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCC---CCceeeEeeEEEccCCeE
Q 048535          109 HAATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLK---HRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       109 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~  184 (409)
                      ..-...|.+.++||+|+||.||+|... |+.||+|+-+....-   +|.--.+++.+|+   -+.|..+...+.. .+.-
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~-~~~S  769 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVF-QNAS  769 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHcc-CCcc
Confidence            334456788899999999999999987 999999997654321   1212222333343   1223333333332 3455


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC-------CCcEEEe
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK-------KMNARLG  257 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-------~~~~kl~  257 (409)
                      +||+||.+.|+|.+++.   ....++|...+.++.|++.-++.||   ..+|||+||||+|.||..       +..++|+
T Consensus       770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEE
Confidence            79999999999999994   5667999999999999999999999   899999999999999932       3458999


Q ss_pred             cccCccc
Q 048535          258 DFGLAKM  264 (409)
Q Consensus       258 DFGla~~  264 (409)
                      |||.|-.
T Consensus       844 DfG~siD  850 (974)
T KOG1166|consen  844 DFGRSID  850 (974)
T ss_pred             eccccee
Confidence            9999853

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.61  E-value=3.1e-15  Score=149.52  Aligned_cols=142  Identities=17%  Similarity=0.206  Sum_probs=101.6

Q ss_pred             cceeecCCceEEEEEEEC-CcEEEEEEeccCChHHH----------------------------------------HHHH
Q 048535          118 ENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGM----------------------------------------REFL  156 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~----------------------------------------~~~~  156 (409)
                      .+.||.|++|.||+|++. |+.||||+.+.......                                        -+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            367999999999999997 99999999875421110                                        0255


Q ss_pred             HHHHHhccCC----CCceeeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHhc
Q 048535          157 AEVSSLGRLK----HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVAS-GILYLYEG  231 (409)
Q Consensus       157 ~E~~~l~~l~----H~niv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~  231 (409)
                      +|+..+.+++    |.+-+.+-..+.+.....+|||||++|++|.++......  ..   .+..++.++++ .+..+|  
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~--  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVL--  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHH--
Confidence            5666666552    333334333343323456899999999999887643111  12   23456666666 467888  


Q ss_pred             CCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       232 ~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                       ..+++|+|+||.||+++.+++++++|||++.....
T Consensus       275 -~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 -RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             -hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence             79999999999999999999999999999977653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.60  E-value=7.5e-15  Score=128.65  Aligned_cols=137  Identities=18%  Similarity=0.098  Sum_probs=96.2

Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCceeee
Q 048535          194 GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSG  273 (409)
Q Consensus       194 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~g  273 (409)
                      |||.+++...  ...+++.++..++.|++.||.|||   +.+      ||+|||++.++.+|+  ||+++....... .|
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~-~g   66 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQS-RV   66 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccccC-CC
Confidence            7999999642  346999999999999999999999   454      999999999999999  999987654321 22


Q ss_pred             cccc------ccCCCcHHHHHHhhhccCcHHHHhhHHh----------------hhcC-------CCCHHHHH--HHHHH
Q 048535          274 RRPI------EEGKRNLVDRMWSLTERSELLSVLDERL----------------KAKG-------GYADEVVE--KVLHL  322 (409)
Q Consensus       274 ~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l----------------~~~~-------~~~~~~~~--~l~~l  322 (409)
                      ...+      ....++...|+|+++  ..+++++....                ....       ........  .+.++
T Consensus        67 ~~~y~aPE~~~~~~~~~~~DiwSlG--~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEKADIYSLG--ITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF  144 (176)
T ss_pred             cccccChHHhcCCCCcchhhHHHHH--HHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence            2222      124567789999984  11222221111                0000       01122223  58999


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHhc
Q 048535          323 GLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      +.+||+.||.+|||+.|+++.+..
T Consensus       145 i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      145 MRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHHHhcccccccCHHHHHHHHHH
Confidence            999999999999999999988754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.60  E-value=3.5e-15  Score=140.33  Aligned_cols=172  Identities=18%  Similarity=0.247  Sum_probs=114.3

Q ss_pred             CCCceeeEeeEEEc--------------------------cCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHH
Q 048535          166 KHRNLVGLRGWCKK--------------------------EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLK  219 (409)
Q Consensus       166 ~H~niv~l~g~~~~--------------------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  219 (409)
                      +|||||+++++|.+                          .+..+|+||.-++. +|++|+-.    ...+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc----CCCchHHHHHHHH
Confidence            59999999998764                          12368999998876 99999943    3456667777999


Q ss_pred             HHHHHHHHHHhcCCCceeecCCCCCCeee--CCCCc--EEEecccCcccccCC---------c-------------eeee
Q 048535          220 DVASGILYLYEGWESKVLHRDIKASNVLL--DKKMN--ARLGDFGLAKMHHHG---------Q-------------VMSG  273 (409)
Q Consensus       220 ~ia~gL~yLH~~~~~~ivHrDlKp~NILl--~~~~~--~kl~DFGla~~~~~~---------~-------------~~~g  273 (409)
                      |+++|+.|||   .++|.|||+|++|||+  |+|..  ..|+|||++---+..         +             +.+.
T Consensus       349 QlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999   8999999999999999  45543  689999987432210         0             1111


Q ss_pred             ccccccCCCcHHHHHHhhhc--------cCcHHH----HhhHH---hhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 048535          274 RRPIEEGKRNLVDRMWSLTE--------RSELLS----VLDER---LKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIR  338 (409)
Q Consensus       274 ~~p~~~~~~~~~~~vws~~~--------~~~~~~----~~~~~---l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  338 (409)
                      .+.........+.|.|....        ...++.    .++.+   -...+..++.++..+.+++...++.||++||+..
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence            11111111224567776521        111111    11110   0111334556677889999999999999999988


Q ss_pred             HHHHHHh
Q 048535          339 QVLKMLE  345 (409)
Q Consensus       339 evl~~L~  345 (409)
                      -..+.|+
T Consensus       506 iAANvl~  512 (598)
T KOG4158|consen  506 IAANVLN  512 (598)
T ss_pred             HHHhHHH
Confidence            7766664

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.50  E-value=4.3e-13  Score=125.19  Aligned_cols=213  Identities=19%  Similarity=0.211  Sum_probs=127.4

Q ss_pred             CCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCC----------CceeeEeeEEE-
Q 048535          115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKH----------RNLVGLRGWCK-  178 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H----------~niv~l~g~~~-  178 (409)
                      +...+.||.|+++.||.+++.  ++++|||.+...   .....+++.+|.-....+.+          -.++--++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            345688999999999999998  799999998543   33456778888766665432          11221111111 


Q ss_pred             --------ccC--C-----eEEEEEEeCCCCCHHHHHhc---CC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeec
Q 048535          179 --------KEK--E-----SLILIYDYMENGSLDKWIFE---CD-ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR  239 (409)
Q Consensus       179 --------~~~--~-----~~~lv~E~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr  239 (409)
                              ...  .     +.+++|+-+. +||.+++..   .. ....+....++.+..|+++.+++||   ..+++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence                    100  1     3467788774 488887532   11 1223555667788899999999999   8999999


Q ss_pred             CCCCCCeeeCCCCcEEEecccCcccccCCcee----eecccc-----------ccCCCcHHHHHHhhhccCcHHHHhhHH
Q 048535          240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQVM----SGRRPI-----------EEGKRNLVDRMWSLTERSELLSVLDER  304 (409)
Q Consensus       240 DlKp~NILl~~~~~~kl~DFGla~~~~~~~~~----~g~~p~-----------~~~~~~~~~~vws~~~~~~~~~~~~~~  304 (409)
                      ||||+|++++.+|.++|+||+...........    .+..|.           ..-.++...|.|.++  -.++.+....
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG--~~ly~lWC~~  247 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLG--ITLYSLWCGR  247 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHH--HHHHHHHHSS
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHH--HHHHHHHHcc
Confidence            99999999999999999999876554332111    011111           112357778888873  1122221111


Q ss_pred             hhh------------cCCCCHHHHHHHHHHHHHccCcCCCCC
Q 048535          305 LKA------------KGGYADEVVEKVLHLGLLCAHPEANSR  334 (409)
Q Consensus       305 l~~------------~~~~~~~~~~~l~~l~~~Cl~~dP~~R  334 (409)
                      ++.            -..+. +.++.+..|+...++.||.+|
T Consensus       248 lPf~~~~~~~~~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            110            02334 788889999999999999988

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=1.2e-13  Score=120.15  Aligned_cols=128  Identities=20%  Similarity=0.135  Sum_probs=96.9

Q ss_pred             cceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCcee-eEeeEEEccCCeEEEEEEeCCCCCH
Q 048535          118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV-GLRGWCKKEKESLILIYDYMENGSL  196 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~~lv~E~~~~gsL  196 (409)
                      .+.|+.|.++.||+++..+..|++|....... ....+..|+.++..+.+.+++ +++.+..   ...++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~---~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP---ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC---CCCeEEEEecCCCcc
Confidence            35689999999999999899999999865432 123467899999988665554 4554332   234799999999887


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-----eeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          197 DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-----VLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       197 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      .+.-        .   ....++.+++++|+.||   ..+     ++|+|++|.||+++ ++.+++.|||.+..
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5420        1   11245678999999999   555     59999999999999 66899999999865

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.46  E-value=4.3e-13  Score=136.02  Aligned_cols=145  Identities=12%  Similarity=0.130  Sum_probs=96.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHH----------------------------------H----
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHG----------------------------------M----  152 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~----------------------------------~----  152 (409)
                      ..|+. +.||+|++|+||+|+++  |+.||||+.+..-...                                  .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45766 78999999999999986  8999999997541110                                  0    


Q ss_pred             --HHHHHHHHHhccCC----CCceeeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCC---CCCCHHHHHHHHHHHHH
Q 048535          153 --REFLAEVSSLGRLK----HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDES---IALSWEQRIKVLKDVAS  223 (409)
Q Consensus       153 --~~~~~E~~~l~~l~----H~niv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~ia~  223 (409)
                        -+|.+|+..+.+++    +.+.+.+-.++.+-....+|||||++|+++.++-.-...+   ..+.......++.|   
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q---  275 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ---  275 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence              12455665555552    4444444444433344568999999999998752111111   01222222222233   


Q ss_pred             HHHHHHhcCCCceeecCCCCCCeeeCCCC----cEEEecccCcccccCC
Q 048535          224 GILYLYEGWESKVLHRDIKASNVLLDKKM----NARLGDFGLAKMHHHG  268 (409)
Q Consensus       224 gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kl~DFGla~~~~~~  268 (409)
                          +.   ..+++|+|+||.||+++.++    ++++.|||++...+..
T Consensus       276 ----if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        276 ----VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             ----HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                33   57999999999999999988    9999999999876543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.45  E-value=4.9e-14  Score=146.94  Aligned_cols=223  Identities=15%  Similarity=0.139  Sum_probs=150.7

Q ss_pred             CCCccceeecCCceEEEEEEECCcEEEEEEeccCC-hHHHHHHHHHHHH--hccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          114 GFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDS-EHGMREFLAEVSS--LGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~~--l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      ++...+.||++.|=.|.+|+++...|+||++-... .-..+.|.++++-  ...++|||++++.-+-.. ....|||=+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t-~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT-DKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh-hHHHHHHHHH
Confidence            57778899999999999999994459999985443 3334444444433  445589999998776544 4456788888


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc--cCC
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH--HHG  268 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~--~~~  268 (409)
                      ..+ +|++.|   ..+..+...+..-|+.|++.||..+|   ..+|+|+|||.+||||+.-.-+.|+||.--|..  ..+
T Consensus       103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            866 999988   33455777888889999999999999   899999999999999999888999999876532  111


Q ss_pred             c----------------eee--------eccccccC-C-CcHHHHHHhhhccCcHHHHhhH---------Hh--hhcCCC
Q 048535          269 Q----------------VMS--------GRRPIEEG-K-RNLVDRMWSLTERSELLSVLDE---------RL--KAKGGY  311 (409)
Q Consensus       269 ~----------------~~~--------g~~p~~~~-~-~~~~~~vws~~~~~~~~~~~~~---------~l--~~~~~~  311 (409)
                      .                ++.        |......+ . -....|+++++  +.+.+++.+         -+  +.....
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~G--CViaELf~Eg~PlF~LSQL~aYr~~~~~  253 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAG--CVIAELFLEGRPLFTLSQLLAYRSGNAD  253 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhh--HHHHHHHhcCCCcccHHHHHhHhccCcc
Confidence            0                000        11111111 1 23455666653  222222211         00  000122


Q ss_pred             CHHH-H-----HHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          312 ADEV-V-----EKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       312 ~~~~-~-----~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      ..+. +     ..+++++..|++.||++|-++++.++.-.+
T Consensus       254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            2221 1     247889999999999999999999987444

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.45  E-value=2.1e-14  Score=142.66  Aligned_cols=211  Identities=21%  Similarity=0.173  Sum_probs=156.5

Q ss_pred             eeecCCceEEEEEE-----ECCcEEEEEEeccCCh--HHHHHHHHHHHHhccCC-CCceeeEeeEEEccCCeEEEEEEeC
Q 048535          120 VIGLGGNGKVYKGQ-----LLGVEVALKRISLDSE--HGMREFLAEVSSLGRLK-HRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       120 ~lG~G~fg~Vy~~~-----~~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      .+|+|.||.|+++.     ..|..+|.|.++....  ........|..++..++ ||.+|++.-.+.. +...+++++|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-DGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-ccchhHhhhhc
Confidence            37999999998743     2377789988865421  11124556788888886 9999999877766 78899999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM  271 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  271 (409)
                      .+|+|...+.   ....+++.....+...++-|++++|   +.+|+|||+|++||+++.+|.+|+.|||+++..-..+..
T Consensus        80 rgg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   80 RGGDLFTRLS---KEVMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             ccchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            9999998884   3445777778888899999999999   899999999999999999999999999999987666655


Q ss_pred             eecccccc----CCCcHHHHHHhhhcc---------CcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 048535          272 SGRRPIEE----GKRNLVDRMWSLTER---------SELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI  337 (409)
Q Consensus       272 ~g~~p~~~----~~~~~~~~vws~~~~---------~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  337 (409)
                      +|..-+..    .......|.|++..-         .--.+.+...++.....+.+......++.......+|.+|--.
T Consensus       154 cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  154 CGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGGDTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCchHHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            65544332    224455677875211         0001344444444456677777777888888888888888644

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.34  E-value=1e-11  Score=110.13  Aligned_cols=135  Identities=16%  Similarity=0.141  Sum_probs=98.1

Q ss_pred             ceeecCCceEEEEEEEC--------CcEEEEEEeccCC------------h----------HHHHHHH----HHHHHhcc
Q 048535          119 NVIGLGGNGKVYKGQLL--------GVEVALKRISLDS------------E----------HGMREFL----AEVSSLGR  164 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--------~~~vAvK~~~~~~------------~----------~~~~~~~----~E~~~l~~  164 (409)
                      ..||.|--+.||.|...        +..+|||+.+...            .          ...+.+.    +|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            56899999999999765        3689999986320            0          0122233    79999999


Q ss_pred             CCC--CceeeEeeEEEccCCeEEEEEEeCCCCCHHH-HHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCceeecC
Q 048535          165 LKH--RNLVGLRGWCKKEKESLILIYDYMENGSLDK-WIFECDESIALSWEQRIKVLKDVASGILYL-YEGWESKVLHRD  240 (409)
Q Consensus       165 l~H--~niv~l~g~~~~~~~~~~lv~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivHrD  240 (409)
                      +..  -++.+.+++     ..-+|||||+.++.+.. .+.    ...++..+...+..+++.+|..| |   ..+|+|+|
T Consensus        83 l~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGD  150 (197)
T cd05146          83 MQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHAD  150 (197)
T ss_pred             HHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence            843  456666653     23478999998754422 231    12355566778889999999999 7   78999999


Q ss_pred             CCCCCeeeCCCCcEEEecccCccccc
Q 048535          241 IKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       241 lKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      |++.|||++ ++.+.|+|||.|-..+
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999997 4679999999886544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.34  E-value=1.8e-13  Score=133.61  Aligned_cols=150  Identities=21%  Similarity=0.306  Sum_probs=101.8

Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      .+||.|++|...+|.+||...+.....++.....++.|++.|++|      ++.+|||+||.||....+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            378999999999999999766666678899999999999999998      68899999999999999999999999998


Q ss_pred             ccccCCc----------eeeeccc------cccCCCcHHHHHHhhhccCcHHHHhh-----------HHhhhcCCCCHHH
Q 048535          263 KMHHHGQ----------VMSGRRP------IEEGKRNLVDRMWSLTERSELLSVLD-----------ERLKAKGGYADEV  315 (409)
Q Consensus       263 ~~~~~~~----------~~~g~~p------~~~~~~~~~~~vws~~~~~~~~~~~~-----------~~l~~~~~~~~~~  315 (409)
                      .......          --.|..-      +....|+...|+++++-  .+.+++.           -.-...+.+++..
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGl--il~EL~~~f~T~~er~~t~~d~r~g~ip~~~  481 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGL--ILAELLIQFSTQFERIATLTDIRDGIIPPEF  481 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHH--HHHHHHHHhccHHHHHHhhhhhhcCCCChHH
Confidence            6554432          0111111      11245666667666521  0111100           0000112333222


Q ss_pred             ---HHHHHHHHHHccCcCCCCCCCHHHH
Q 048535          316 ---VEKVLHLGLLCAHPEANSRPTIRQV  340 (409)
Q Consensus       316 ---~~~l~~l~~~Cl~~dP~~RPt~~ev  340 (409)
                         .++=..+.++.+.+.|.+||++.++
T Consensus       482 ~~d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  482 LQDYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence               1234578889999999999955443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.29  E-value=3.3e-11  Score=103.74  Aligned_cols=133  Identities=19%  Similarity=0.285  Sum_probs=98.8

Q ss_pred             ceeecCCceEEEEEEECCcEEEEEEeccC---Ch-----HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          119 NVIGLGGNGKVYKGQLLGVEVALKRISLD---SE-----HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~---~~-----~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      ..+++|+-+.+|.+.+.|.++.+|.-...   .+     -....-.+|+.++.+++--.|.-..=+..+ .....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-PDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-CCCCEEEEEE
Confidence            35789999999999988878777764322   11     123457789999998854433222223333 4566799999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      +++-.|.+++...          ...++..+-.-+.-||   ..+|+|+||.++||++..+. +.++||||+....
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~  142 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD  142 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence            9999999998432          2456777777788899   89999999999999997765 9999999998643

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.28  E-value=6.6e-11  Score=101.45  Aligned_cols=144  Identities=17%  Similarity=0.229  Sum_probs=105.0

Q ss_pred             ccceeecCCceEEEEEEECCcEEEEEEeccC--------ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          117 EENVIGLGGNGKVYKGQLLGVEVALKRISLD--------SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       117 ~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~--------~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ....|-+|+-+.|+++.+.|+...||.-...        ..-..++..+|+++|.+++--.|.-..=++.+ ...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D-~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID-TYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe-cCCCeEEE
Confidence            4678999999999999999999888864322        12234667899999998854343222223333 33446899


Q ss_pred             EeCCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC---cEEEecccCccc
Q 048535          189 DYMEN-GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM---NARLGDFGLAKM  264 (409)
Q Consensus       189 E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~~kl~DFGla~~  264 (409)
                      ||+++ .++.+++....... ........++.+|-+.+.-||   .+.|+|+||..+||+|..++   .+.+.|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 47888887643332 222333678889999999999   89999999999999997665   368999999865


Q ss_pred             c
Q 048535          265 H  265 (409)
Q Consensus       265 ~  265 (409)
                      .
T Consensus       166 s  166 (229)
T KOG3087|consen  166 S  166 (229)
T ss_pred             c
Confidence            4

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.27  E-value=3.9e-11  Score=108.89  Aligned_cols=143  Identities=17%  Similarity=0.185  Sum_probs=110.5

Q ss_pred             ceeecCCceEEEEEEEC-CcEEEEEEeccCCh-HHHHHHHHHHHHhccCCC--CceeeEeeEEEccC--CeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL-GVEVALKRISLDSE-HGMREFLAEVSSLGRLKH--RNLVGLRGWCKKEK--ESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~--~~~~lv~E~~~  192 (409)
                      +.|+.|.++.||+++.. |..+++|....... .....+..|+++++.+.+  .++.+++.+.....  +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999887 48999999865422 134578899999999965  34566777665421  25689999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW----------------------------------------  232 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------  232 (409)
                      +.++.+.+..    ..++..+...++.+++++|.+||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9888775521    35778888889999999999998521                                        


Q ss_pred             -------------CCceeecCCCCCCeeeCC--CCcEEEecccCcccc
Q 048535          233 -------------ESKVLHRDIKASNVLLDK--KMNARLGDFGLAKMH  265 (409)
Q Consensus       233 -------------~~~ivHrDlKp~NILl~~--~~~~kl~DFGla~~~  265 (409)
                                   ...++|+|+.|.|||++.  ++.+.|.||+.+...
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                         245799999999999998  566899999988653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.13  E-value=1.9e-09  Score=100.81  Aligned_cols=142  Identities=15%  Similarity=0.105  Sum_probs=102.9

Q ss_pred             ceeecCCceEEEEEEECCcEEEEEEeccCChH-HHH----------HHHHHHHHhccCCCCc--eeeEeeEEEcc----C
Q 048535          119 NVIGLGGNGKVYKGQLLGVEVALKRISLDSEH-GMR----------EFLAEVSSLGRLKHRN--LVGLRGWCKKE----K  181 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~-~~~----------~~~~E~~~l~~l~H~n--iv~l~g~~~~~----~  181 (409)
                      +.+-......|++..+.|+.+.||........ ..+          .+.+|...+.++..-+  +.+.+++....    .
T Consensus        28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            44444444567788888999999987543211 111          3778999888884333  34455554321    2


Q ss_pred             CeEEEEEEeCCCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC-------CCc
Q 048535          182 ESLILIYDYMENG-SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK-------KMN  253 (409)
Q Consensus       182 ~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-------~~~  253 (409)
                      ...+||||++++- +|.+++.... ....+...+..++.+++..+.-||   ..+|+|+|++++|||++.       +..
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            2478999999986 8999985321 234566778899999999999999   899999999999999975       467


Q ss_pred             EEEecccCccc
Q 048535          254 ARLGDFGLAKM  264 (409)
Q Consensus       254 ~kl~DFGla~~  264 (409)
                      +.|+||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.10  E-value=1.6e-10  Score=120.92  Aligned_cols=180  Identities=17%  Similarity=0.212  Sum_probs=110.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ..+|..++.|-.|+||.||..+++  .+++|.| ++.++-     +++-  ++.....|                +.|  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~np----------------fvv--  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNP----------------FVV--  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCc----------------cee--
Confidence            468999999999999999999887  7788884 432211     1110  12222222                223  


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC-
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG-  268 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~-  268 (409)
                          ||-...+.   ..+.++-.        ++.+++|||   ..+|+|||+||+|.||+.-|.+|++|||+++..-.. 
T Consensus       136 ----gDc~tllk---~~g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ----GDCATLLK---NIGPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ----chhhhhcc---cCCCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                44444442   22334432        378999999   899999999999999999999999999998753211 


Q ss_pred             ------------------ceeeecccccc------CCCcHHHHHHhhhc-------------cCcHHHHhhHHhhhcCCC
Q 048535          269 ------------------QVMSGRRPIEE------GKRNLVDRMWSLTE-------------RSELLSVLDERLKAKGGY  311 (409)
Q Consensus       269 ------------------~~~~g~~p~~~------~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~~~~~  311 (409)
                                        +-++|.+-+..      ..|....|.|.+..             .....+++..-+.....+
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w  277 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  277 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence                              12333333221      34555667787731             111122222222111111


Q ss_pred             ---CHHHHHHHHHHHHHccCcCCCCCC
Q 048535          312 ---ADEVVEKVLHLGLLCAHPEANSRP  335 (409)
Q Consensus       312 ---~~~~~~~l~~l~~~Cl~~dP~~RP  335 (409)
                         ++....+..+++.+.++.+|..|-
T Consensus       278 pE~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  278 PEEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             cccCcCCCHHHHHHHHHHHHhChHhhc
Confidence               233455778888888888998884

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.06  E-value=1.2e-11  Score=127.79  Aligned_cols=152  Identities=29%  Similarity=0.322  Sum_probs=121.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC---CcEEEEEEeccCC--hHHHHHHHHHHHHhccCC-CCceeeEeeEEEccCCeEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL---GVEVALKRISLDS--EHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~  185 (409)
                      ...|...+.||+|+|+.|-.....   ...+|+|.+....  .........|..+-..+. |+|++++++...+ .+..+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-PRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-Ccccc
Confidence            355677788999999999887664   4567787776442  233344556888888886 9999999998876 77889


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC-cEEEecccCccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM-NARLGDFGLAKM  264 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~  264 (409)
                      +.+||..+|++.+.+... .....+....-.+..|+..++.|+|.  ..++.|||+||+|.+++..+ ..|++|||+|..
T Consensus        98 ~~~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             cccCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            999999999999887321 11245666778899999999999995  57899999999999999999 999999999987


Q ss_pred             ccC
Q 048535          265 HHH  267 (409)
Q Consensus       265 ~~~  267 (409)
                      +..
T Consensus       175 ~~~  177 (601)
T KOG0590|consen  175 YRN  177 (601)
T ss_pred             ccc
Confidence            655

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.03  E-value=2.1e-10  Score=114.22  Aligned_cols=222  Identities=19%  Similarity=0.218  Sum_probs=153.8

Q ss_pred             CCCCccceeec--CCceEEEEEEE--C--CcEEEEEEec--cCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCe
Q 048535          113 KGFSEENVIGL--GGNGKVYKGQL--L--GVEVALKRIS--LDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       113 ~~f~~~~~lG~--G~fg~Vy~~~~--~--~~~vAvK~~~--~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  183 (409)
                      +.|...+.+|.  |.+|.||.+..  .  +..+|+|+-+  ...+.....=.+|+...+++ .|+|.++.+..+.. .+.
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~-~~~  192 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG-SGI  192 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc-CCc
Confidence            45667788999  99999999887  4  7889999843  33334444455788888888 59999998877766 778


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCceeecCCCCCCeeeCCC-CcEEEec
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVAS----GILYLYEGWESKVLHRDIKASNVLLDKK-MNARLGD  258 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl~D  258 (409)
                      .++-+|+|. .+|.++.+..  ...++......+..+..+    ||.++|   ...++|-|+||.||+...+ ...+++|
T Consensus       193 lfiqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             ceeeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCC
Confidence            899999986 6999888643  223666777777888888    999999   8999999999999999999 8899999


Q ss_pred             ccCcccccCCceeee----cc----------ccccCCCcHHHHHHhhhcc-------------C--cHHHHhhHHhhhcC
Q 048535          259 FGLAKMHHHGQVMSG----RR----------PIEEGKRNLVDRMWSLTER-------------S--ELLSVLDERLKAKG  309 (409)
Q Consensus       259 FGla~~~~~~~~~~g----~~----------p~~~~~~~~~~~vws~~~~-------------~--~~~~~~~~~l~~~~  309 (409)
                      ||+...+..+.+..-    +.          ....+.+...+|+.++...             +  .-+.-++.... ..
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i-p~  345 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI-PL  345 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC-ch
Confidence            999887765541110    11          1112455666777665311             0  00011111110 01


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          310 GYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       310 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ++......++.....++++.+|-.|++.+.+.+
T Consensus       346 e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  346 EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            112222335555888899999999999888764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=2.6e-09  Score=94.30  Aligned_cols=125  Identities=22%  Similarity=0.270  Sum_probs=81.3

Q ss_pred             EEEEEEEC-CcEEEEEEeccCC-------------h-------------HHHHHHHHHHHHhccCCCC--ceeeEeeEEE
Q 048535          128 KVYKGQLL-GVEVALKRISLDS-------------E-------------HGMREFLAEVSSLGRLKHR--NLVGLRGWCK  178 (409)
Q Consensus       128 ~Vy~~~~~-~~~vAvK~~~~~~-------------~-------------~~~~~~~~E~~~l~~l~H~--niv~l~g~~~  178 (409)
                      .||.|... |..+|||..+...             .             .......+|.+.|.++..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            48999986 8899999986420             0             0123467899999999755  456666542 


Q ss_pred             ccCCeEEEEEEeCC--CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCceeecCCCCCCeeeCCCCcEE
Q 048535          179 KEKESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVASGILY-LYEGWESKVLHRDIKASNVLLDKKMNAR  255 (409)
Q Consensus       179 ~~~~~~~lv~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivHrDlKp~NILl~~~~~~k  255 (409)
                        .  -+|||||++  +..+..+. ..    .++......++.+++..+.. +|   ..+|+|+||.+.|||++++ .+.
T Consensus        80 --~--~~ivME~I~~~G~~~~~l~-~~----~~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 --R--NVIVMEYIGEDGVPLPRLK-DV----DLSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             --T--TEEEEE--EETTEEGGCHH-HC----GGGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEE
T ss_pred             --C--CEEEEEecCCCccchhhHH-hc----cccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEE
Confidence              2  269999998  54554433 11    12234456677788886666 46   8999999999999999888 899


Q ss_pred             EecccCccccc
Q 048535          256 LGDFGLAKMHH  266 (409)
Q Consensus       256 l~DFGla~~~~  266 (409)
                      |+|||.|....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.93  E-value=1.1e-09  Score=101.58  Aligned_cols=97  Identities=23%  Similarity=0.410  Sum_probs=80.9

Q ss_pred             HhccCCCCceeeEeeEEEcc----CCeEEEEEEeCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 048535          161 SLGRLKHRNLVGLRGWCKKE----KESLILIYDYMENGSLDKWIFECD-ESIALSWEQRIKVLKDVASGILYLYEGWESK  235 (409)
Q Consensus       161 ~l~~l~H~niv~l~g~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  235 (409)
                      -|-++.|.|||+++.|+.+.    ..+..+++|||..|+|.++|++.. ....+......+|+.||..||.|||.. +++
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence            34556799999999988652    345788999999999999997642 234578888899999999999999964 899


Q ss_pred             eeecCCCCCCeeeCCCCcEEEec
Q 048535          236 VLHRDIKASNVLLDKKMNARLGD  258 (409)
Q Consensus       236 ivHrDlKp~NILl~~~~~~kl~D  258 (409)
                      |+|+++..+-|++..++-+||+-
T Consensus       199 iihgnlTc~tifiq~ngLIkig~  221 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGS  221 (458)
T ss_pred             cccCCcchhheeecCCceEEecc
Confidence            99999999999999998888753

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.91  E-value=2.3e-08  Score=100.92  Aligned_cols=120  Identities=17%  Similarity=0.238  Sum_probs=97.7

Q ss_pred             CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHH
Q 048535          136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI  215 (409)
Q Consensus       136 ~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~  215 (409)
                      +.+|.|...+...........+-++.|+.++||||++++..+.. .+..|||+|-+.  .|..++.+      +......
T Consensus        37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-~~~~ylvTErV~--Pl~~~lk~------l~~~~v~  107 (690)
T KOG1243|consen   37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-EGTLYLVTERVR--PLETVLKE------LGKEEVC  107 (690)
T ss_pred             CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-cCceEEEeeccc--cHHHHHHH------hHHHHHH
Confidence            78888888876655444556778889999999999999998876 678999999763  46666643      2344555


Q ss_pred             HHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          216 KVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       216 ~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      --+.||+.||.|||+  +.+++|++|.-..|+++..|..||++|-++....
T Consensus       108 ~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~  156 (690)
T KOG1243|consen  108 LGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS  156 (690)
T ss_pred             HHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence            577899999999997  7899999999999999999999999998875443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.87  E-value=1.2e-09  Score=108.72  Aligned_cols=148  Identities=21%  Similarity=0.188  Sum_probs=116.5

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC---CcEEEEEEeccCChHHH--HHHHHHHHHhccC-CCCceeeEeeEEEccCCe
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL---GVEVALKRISLDSEHGM--REFLAEVSSLGRL-KHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~--~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  183 (409)
                      ..+.+|.....||.|.|+.|+.....   +..+++|.+........  ..-+.|+.+...+ .|.++++.+..+.. ...
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-LRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-ccc
Confidence            34567888999999999999988755   77899999875522221  2224566666666 58888887665655 456


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC-CcEEEecccCc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK-MNARLGDFGLA  262 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFGla  262 (409)
                      .|+--|||.++++...+   .-...+.+..++++..|++.++.++|   ++.++|+|+||+||++..+ +..+++|||++
T Consensus       341 ~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccc
Confidence            77999999999987765   23346788889999999999999999   8999999999999999886 78899999998


Q ss_pred             cc
Q 048535          263 KM  264 (409)
Q Consensus       263 ~~  264 (409)
                      ..
T Consensus       415 t~  416 (524)
T KOG0601|consen  415 TR  416 (524)
T ss_pred             cc
Confidence            64

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.85  E-value=3.8e-08  Score=96.61  Aligned_cols=141  Identities=20%  Similarity=0.280  Sum_probs=110.9

Q ss_pred             CceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEc---cCCeEEEEEEeCCC-CCHHH
Q 048535          125 GNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK---EKESLILIYDYMEN-GSLDK  198 (409)
Q Consensus       125 ~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---~~~~~~lv~E~~~~-gsL~~  198 (409)
                      .-.+.|++...  |..|++|++..+..+.......=++.++++.|+|||++..++..   .+..+++||+|.|+ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            34678999876  99999999954433333334456788999999999999988762   24568999999997 57877


Q ss_pred             HHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          199 WIFECD------------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       199 ~l~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      +-....            .+...++..++.++.|+..||.++|   +.|..-+-|.+.+||++.+.+++|+.-|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            654321            2234788999999999999999999   7899999999999999999999998888877655


Q ss_pred             CC
Q 048535          267 HG  268 (409)
Q Consensus       267 ~~  268 (409)
                      .+
T Consensus       445 ~d  446 (655)
T KOG3741|consen  445 ED  446 (655)
T ss_pred             CC
Confidence            44

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=4.8e-08  Score=88.06  Aligned_cols=107  Identities=21%  Similarity=0.256  Sum_probs=83.0

Q ss_pred             HHHHHHHHHhccCCCCc--eeeEeeEEEccC---CeEEEEEEeCCCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHH
Q 048535          153 REFLAEVSSLGRLKHRN--LVGLRGWCKKEK---ESLILIYDYMENG-SLDKWIFECDESIALSWEQRIKVLKDVASGIL  226 (409)
Q Consensus       153 ~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~---~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~  226 (409)
                      ....+|...+..|..-.  +.+.+++.....   ...++|+|++++. +|.+++....   ..+......++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~---~~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE---QLDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc---ccchhhHHHHHHHHHHHHH
Confidence            45778888887774333  455666554421   2458999999984 7999985421   2666778899999999999


Q ss_pred             HHHhcCCCceeecCCCCCCeeeCCCC---cEEEecccCcccc
Q 048535          227 YLYEGWESKVLHRDIKASNVLLDKKM---NARLGDFGLAKMH  265 (409)
Q Consensus       227 yLH~~~~~~ivHrDlKp~NILl~~~~---~~kl~DFGla~~~  265 (409)
                      -||   ..+|+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       133 ~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999   89999999999999998887   7999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.74  E-value=2.2e-07  Score=82.85  Aligned_cols=140  Identities=17%  Similarity=0.150  Sum_probs=105.9

Q ss_pred             eeecCCceEEEEEEECCcEEEEEEeccC---C---hHHHHHHHHHHHHhccCCCC--ceeeEeeEEEcc----CCeEEEE
Q 048535          120 VIGLGGNGKVYKGQLLGVEVALKRISLD---S---EHGMREFLAEVSSLGRLKHR--NLVGLRGWCKKE----KESLILI  187 (409)
Q Consensus       120 ~lG~G~fg~Vy~~~~~~~~vAvK~~~~~---~---~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~----~~~~~lv  187 (409)
                      --|+||.+-|++-.+.|..+=+|+-...   +   +.....|.+|...|.+|..-  .+.+.. ++...    .-..+||
T Consensus        25 N~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         25 NYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            3577999999998888888889987522   1   33567899999999998533  244444 33211    1246899


Q ss_pred             EEeCCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc--EEEecccCccc
Q 048535          188 YDYMEN-GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN--ARLGDFGLAKM  264 (409)
Q Consensus       188 ~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~--~kl~DFGla~~  264 (409)
                      +|-+++ -||.+++.+. ...+.+...+..++.++++.+.-||   +.++.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997764 5899988542 2234677888899999999999999   899999999999999986666  99999987654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.73  E-value=6e-08  Score=88.62  Aligned_cols=132  Identities=21%  Similarity=0.267  Sum_probs=94.0

Q ss_pred             CCccceeecCCceEEEEEEEC-CcEEEEEEeccCCh----------------------HHHHHHHHHHHHhccCCCC--c
Q 048535          115 FSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSE----------------------HGMREFLAEVSSLGRLKHR--N  169 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~--n  169 (409)
                      ..+.+.||-|--+.||.|... |.++|||.=+....                      -.+....+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            445689999999999999998 99999997543210                      1123457899999999654  6


Q ss_pred             eeeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC
Q 048535          170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD  249 (409)
Q Consensus       170 iv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~  249 (409)
                      |.+.+++     +...+||||+++-.|...=        ++....-.++..|++-+.-.-   ..+|||+|+.+=||+++
T Consensus       173 VP~P~~~-----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~  236 (304)
T COG0478         173 VPKPIAW-----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVT  236 (304)
T ss_pred             CCCcccc-----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEe
Confidence            7777763     3457999999996665421        112222233344444443333   58899999999999999


Q ss_pred             CCCcEEEecccCc
Q 048535          250 KKMNARLGDFGLA  262 (409)
Q Consensus       250 ~~~~~kl~DFGla  262 (409)
                      +||.+.++||=-+
T Consensus       237 ~dg~~~vIDwPQ~  249 (304)
T COG0478         237 EDGDIVVIDWPQA  249 (304)
T ss_pred             cCCCEEEEeCccc
Confidence            9999999999654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.60  E-value=3.6e-07  Score=92.57  Aligned_cols=141  Identities=14%  Similarity=0.174  Sum_probs=93.7

Q ss_pred             ceeecCCceEEEEEEEC-CcEEEEEEeccCChHH------------------------------HH----------HHHH
Q 048535          119 NVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHG------------------------------MR----------EFLA  157 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~------------------------------~~----------~~~~  157 (409)
                      +-|+.++-|+||+|+++ |+.||||+.+.+-...                              .+          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            67999999999999999 9999999987541110                              01          2445


Q ss_pred             HHHHhccCC-----CCceeeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHH-HHHHHhc
Q 048535          158 EVSSLGRLK-----HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASG-ILYLYEG  231 (409)
Q Consensus       158 E~~~l~~l~-----H~niv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~  231 (409)
                      |...+.+++     .+++ ++=..+.+-.+.-.|+|||++|-.+.+...-..  ...+...   ++..++++ +..+-  
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~--  282 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLL--  282 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHH--
Confidence            666666552     3333 332333332345679999999988888742211  2344332   33333332 12222  


Q ss_pred             CCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       232 ~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                       ..++.|.|..|.||+++.+++..+-|||+....+..
T Consensus       283 -~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         283 -RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             -hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence             468999999999999999999999999998776554

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.52  E-value=1.7e-06  Score=79.12  Aligned_cols=139  Identities=18%  Similarity=0.162  Sum_probs=83.6

Q ss_pred             ceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCc--eeeEeeEEEccCCeEEEEEEeCCCCC-
Q 048535          119 NVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN--LVGLRGWCKKEKESLILIYDYMENGS-  195 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~~lv~E~~~~gs-  195 (409)
                      ..||+|..+.||+.  .+..+++|......  ......+|.++++.+..-.  +.+.+++... .+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVED-GGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEec-CCeeeeeeeecCCccc
Confidence            56899999999984  35567888876533  2244678999998885433  3556666655 556788999999863 


Q ss_pred             HHHH---------------------HhcCCCCCCCCHHHHH-HHHH----------HHHH-HHHHHHhc-CCCceeecCC
Q 048535          196 LDKW---------------------IFECDESIALSWEQRI-KVLK----------DVAS-GILYLYEG-WESKVLHRDI  241 (409)
Q Consensus       196 L~~~---------------------l~~~~~~~~l~~~~~~-~i~~----------~ia~-gL~yLH~~-~~~~ivHrDl  241 (409)
                      +...                     ||..... ..+..... ++..          ++.+ ...+|... ....++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            2211                     1111000 11111100 0000          0011 11222211 1345789999


Q ss_pred             CCCCeeeCCCCcEEEecccCccc
Q 048535          242 KASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       242 Kp~NILl~~~~~~kl~DFGla~~  264 (409)
                      .|.||++++++ +.|.||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999888 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.45  E-value=4.2e-06  Score=76.13  Aligned_cols=145  Identities=15%  Similarity=0.135  Sum_probs=86.8

Q ss_pred             cceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCC--ceeeEeeEEEcc--CCeEEEEEEeCCC
Q 048535          118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHR--NLVGLRGWCKKE--KESLILIYDYMEN  193 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~~~~--~~~~~lv~E~~~~  193 (409)
                      .+.|+.|..+.||+....+..+++|.....  .....+..|..++..+...  .+.+++.++...  ....+++|+++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            367899999999999998789999997644  4456778899988888433  345666644321  3357899999999


Q ss_pred             CCHHH----------------HH---hcCC-CCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 048535          194 GSLDK----------------WI---FECD-ESIALSWEQ---------RIKV------------LKDVAS-GILYLYE-  230 (409)
Q Consensus       194 gsL~~----------------~l---~~~~-~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~-  230 (409)
                      ..+..                .+   +... ......+..         ....            ...+.+ .+..++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            88777                11   1110 111111110         0000            111222 2333332 


Q ss_pred             ---cCCCceeecCCCCCCeeeC-CCCcEEEecccCccc
Q 048535          231 ---GWESKVLHRDIKASNVLLD-KKMNARLGDFGLAKM  264 (409)
Q Consensus       231 ---~~~~~ivHrDlKp~NILl~-~~~~~kl~DFGla~~  264 (409)
                         .....++|+|+.|.|||++ +++.+-|.||+.+..
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence               1257799999999999999 666668999998864

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.43  E-value=7.9e-07  Score=78.78  Aligned_cols=105  Identities=20%  Similarity=0.202  Sum_probs=82.9

Q ss_pred             HHHHHhccCCC-CceeeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc
Q 048535          157 AEVSSLGRLKH-RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK  235 (409)
Q Consensus       157 ~E~~~l~~l~H-~niv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  235 (409)
                      .|.-+|+.+++ +++.+++|+|-.     +++.||.+.+++...-.....-..-+|..+.+||.++++.+.+|++.....
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~-----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR-----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC-----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            58888888866 699999999953     579999998766421000011124689999999999999999999766567


Q ss_pred             eeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          236 VLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       236 ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      +.-.|++++|+-+++++++|+.|...+-...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            8889999999999999999999998775543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.41  E-value=5.7e-06  Score=74.19  Aligned_cols=139  Identities=16%  Similarity=0.170  Sum_probs=94.3

Q ss_pred             HhCCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHH---------HHHHHHhccCCC---CceeeEeeEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREF---------LAEVSSLGRLKH---RNLVGLRGWCK  178 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~---------~~E~~~l~~l~H---~niv~l~g~~~  178 (409)
                      ..++|...+.+-......|.+-...|..+.+|..+.......+.|         .+++..+.+++.   -..+.++.+..
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            457788888888888888888888899999999876533222222         233443333322   22222222221


Q ss_pred             cc----CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcE
Q 048535          179 KE----KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNA  254 (409)
Q Consensus       179 ~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~  254 (409)
                      ..    ....+++|||++|-.|.++.       .++.    .++..+++++.-||   ..|+.|+|..|.|+++++++ +
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-E
Confidence            10    23456899999998886653       1222    24566778899999   89999999999999998655 9


Q ss_pred             EEecccCccc
Q 048535          255 RLGDFGLAKM  264 (409)
Q Consensus       255 kl~DFGla~~  264 (409)
                      ++.||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.39  E-value=4.5e-06  Score=75.71  Aligned_cols=153  Identities=17%  Similarity=0.197  Sum_probs=103.3

Q ss_pred             cccHHHHHHHhCCCCccceee---cCCceEEEEEEEC-CcEEEEEEeccCChHH-------------------HH-----
Q 048535          102 RVSYQEIHAATKGFSEENVIG---LGGNGKVYKGQLL-GVEVALKRISLDSEHG-------------------MR-----  153 (409)
Q Consensus       102 ~~~~~~l~~~~~~f~~~~~lG---~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~-------------------~~-----  153 (409)
                      ..++..+.....+..+....|   +|--+.||+|... +..+|||+.+......                   .+     
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            456667777766666665555   5666789999876 8999999997542111                   01     


Q ss_pred             HHHHHHHHhccCC--CCceeeEeeEEEccCCeEEEEEEeCCCCC-HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 048535          154 EFLAEVSSLGRLK--HRNLVGLRGWCKKEKESLILIYDYMENGS-LDKWIFECDESIALSWEQRIKVLKDVASGILYLYE  230 (409)
Q Consensus       154 ~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~~lv~E~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~  230 (409)
                      -..+|..-|.++.  +-.+.+-+++..     -.|||||+.... -.-.|.    ...+...+...+..++++.+.-|-.
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~-----nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~  184 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFRN-----NVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYK  184 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeecC-----CeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHH
Confidence            1245777787773  344455555332     268999997641 111121    1223444677788888888888873


Q ss_pred             cCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       231 ~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                        ..++||+||..=|||+. ++.+.|+|||-|-...
T Consensus       185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         185 --EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             --hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence              48999999999999999 8899999999886544

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.34  E-value=3e-06  Score=72.82  Aligned_cols=130  Identities=22%  Similarity=0.273  Sum_probs=90.6

Q ss_pred             CccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCcee-eEeeEEEccCCeEEEEEEeCCCC
Q 048535          116 SEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV-GLRGWCKKEKESLILIYDYMENG  194 (409)
Q Consensus       116 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~~lv~E~~~~g  194 (409)
                      ...+.||+|.+|.||+|.+.|..+|+|+-+.+++  +..+..|+++|..+.-.++. +++.|-.     -++.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~-----~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE-----DFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech-----hhhhhhhhcCc
Confidence            4457899999999999999999999999876544  46788999999999877764 3444332     23569999998


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCC--CCeeeCCCCcEEEecccCccccc
Q 048535          195 SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKA--SNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       195 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp--~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      .|.+.-..      .+-..+.    .+++. +|.=+  ..+|-|..|.-  .||++++ ..+.|+||.-|+...
T Consensus        98 ~L~~~~~~------~~rk~l~----~vlE~-a~~LD--~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~k~  157 (201)
T COG2112          98 PLGKLEIG------GDRKHLL----RVLEK-AYKLD--RLGIEHGELSRPWKNVLVND-RDVYIIDFDSATFKK  157 (201)
T ss_pred             chhhhhhc------ccHHHHH----HHHHH-HHHHH--HhccchhhhcCCceeEEecC-CcEEEEEccchhhcc
Confidence            88876521      1222333    33444 23222  56787877753  4555554 489999999987543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.30  E-value=9e-06  Score=75.14  Aligned_cols=140  Identities=14%  Similarity=0.079  Sum_probs=84.5

Q ss_pred             eecCCc-eEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeEeeEEEccCCeEEEEEEeCCCCCHHH
Q 048535          121 IGLGGN-GKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKEKESLILIYDYMENGSLDK  198 (409)
Q Consensus       121 lG~G~f-g~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~lv~E~~~~gsL~~  198 (409)
                      |-.|.+ ..||+....+..+.||......   ...+.+|++++..+. +--+.+++++... .+..++|||+++|.+|.+
T Consensus         6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSD-DGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEec-CCccEEEEEeeCCccHhH
Confidence            444544 7899988777788888876443   235668898888883 4335567776655 456789999999977764


Q ss_pred             HH-------------------hcCCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----cC
Q 048535          199 WI-------------------FECDE-SIALS--WEQRIKVLK--------------------DVASGILYLYE----GW  232 (409)
Q Consensus       199 ~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~~  232 (409)
                      ..                   +.... ..+..  .........                    .+...+..|-.    ..
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            32                   11110 00111  000000000                    01111122211    01


Q ss_pred             CCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       233 ~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ...++|+|+.|.|||++.+....|.||+.|..
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            35699999999999999987788999998864

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.28  E-value=9.2e-06  Score=71.99  Aligned_cols=126  Identities=23%  Similarity=0.336  Sum_probs=92.8

Q ss_pred             CCCCccceeecCCc-eEEEEEEECCcEEEEEEecc---CCh------------------HHHHHHHHHHHHhccCC---C
Q 048535          113 KGFSEENVIGLGGN-GKVYKGQLLGVEVALKRISL---DSE------------------HGMREFLAEVSSLGRLK---H  167 (409)
Q Consensus       113 ~~f~~~~~lG~G~f-g~Vy~~~~~~~~vAvK~~~~---~~~------------------~~~~~~~~E~~~l~~l~---H  167 (409)
                      .+++..+.||.|.- |.||+.+..|+.+|+|.++.   ...                  .....|..|.+..++|+   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            78888999999999 99999999999999999431   100                  12245889999988884   4


Q ss_pred             Cce--eeEeeEEEcc-----------------CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 048535          168 RNL--VGLRGWCKKE-----------------KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL  228 (409)
Q Consensus       168 ~ni--v~l~g~~~~~-----------------~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL  228 (409)
                      .++  |+.+||..-.                 .....||.||.+...            .++..    -+.+|.+-|..+
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~~~  180 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLKIL  180 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHHHH
Confidence            456  9999988421                 112467888876632            22322    344566777889


Q ss_pred             HhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       229 H~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      |   ..+|+-+|+|+.|..     .-||+|||.+
T Consensus       181 ~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 H---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             H---HCCeeeccCcccccc-----CCEEEecccC
Confidence            9   899999999999975     3589999965

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.24  E-value=5.9e-06  Score=83.64  Aligned_cols=142  Identities=20%  Similarity=0.208  Sum_probs=91.4

Q ss_pred             ceeecCCceEEEEEEEC-CcEEEEEEeccCChHH-------------------------------------HHHHHHHHH
Q 048535          119 NVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHG-------------------------------------MREFLAEVS  160 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~-------------------------------------~~~~~~E~~  160 (409)
                      +.||.-+.|.||+|+++ |+.||||+-+.+-.+.                                     .-+|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            67999999999999998 9999999986541111                                     012555665


Q ss_pred             HhccC----CCCc---eeeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 048535          161 SLGRL----KHRN---LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE  233 (409)
Q Consensus       161 ~l~~l----~H~n---iv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  233 (409)
                      -..++    .|-+   =|.+=.++.+-.....|+||||+|..+.+.-.-  ....++...+..-+.   ++  |++....
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~---~~--~~~qIf~  319 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLV---EA--YLEQIFK  319 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHH---HH--HHHHHHh
Confidence            54443    3555   122223333323467899999999877654321  122355554333333   32  2222224


Q ss_pred             CceeecCCCCCCeeeCC----CCcEEEecccCcccccC
Q 048535          234 SKVLHRDIKASNVLLDK----KMNARLGDFGLAKMHHH  267 (409)
Q Consensus       234 ~~ivHrDlKp~NILl~~----~~~~kl~DFGla~~~~~  267 (409)
                      .|++|+|=.|.||+++.    ++++.+-|||+.....+
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            67999999999999984    67899999999876654

>PLN02876 acyl-CoA dehydrogenase

Probab=98.21  E-value=1.9e-05  Score=85.78  Aligned_cols=78  Identities=14%  Similarity=0.209  Sum_probs=57.0

Q ss_pred             cceeecCCceEEEEEEECC----cEEEEEEeccCC-hHHHHHHHHHHHHhccCC-CCce--eeEeeEEEccC--CeEEEE
Q 048535          118 ENVIGLGGNGKVYKGQLLG----VEVALKRISLDS-EHGMREFLAEVSSLGRLK-HRNL--VGLRGWCKKEK--ESLILI  187 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~~----~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~g~~~~~~--~~~~lv  187 (409)
                      .+.++.|.++.+|+....+    ..+++|+..... ......+.+|+++|+.+. |.++  .+++++|.+..  +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            4678999999999987763    467888765432 123356889999999995 6665  77888876521  457899


Q ss_pred             EEeCCCCC
Q 048535          188 YDYMENGS  195 (409)
Q Consensus       188 ~E~~~~gs  195 (409)
                      |||+++..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998754

>PRK10593 hypothetical protein; Provisional

Probab=98.00  E-value=9.2e-05  Score=70.62  Aligned_cols=79  Identities=13%  Similarity=-0.049  Sum_probs=57.4

Q ss_pred             CccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCC---CceeeEeeEEEcc--CCeEEEEEEe
Q 048535          116 SEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKH---RNLVGLRGWCKKE--KESLILIYDY  190 (409)
Q Consensus       116 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~--~~~~~lv~E~  190 (409)
                      ...+.||.|..+.||+-...+..+.+|..+...  ....|..|.+.|+.|.-   -.+.+++++|..+  .+..+||||+
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGNPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCCEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            335679999999999987765567777754311  22578899999988843   3577888877542  3568999999


Q ss_pred             CCCCCH
Q 048535          191 MENGSL  196 (409)
Q Consensus       191 ~~~gsL  196 (409)
                      ++++++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998765

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.00  E-value=0.00013  Score=65.08  Aligned_cols=134  Identities=19%  Similarity=0.340  Sum_probs=89.5

Q ss_pred             CccceeecCCceEEEEEEECCcEEEEEEeccCC----------------hHHHHHHHHHHHHhccCC------CCceeeE
Q 048535          116 SEENVIGLGGNGKVYKGQLLGVEVALKRISLDS----------------EHGMREFLAEVSSLGRLK------HRNLVGL  173 (409)
Q Consensus       116 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l  173 (409)
                      +....||+|+.=.||.--. .....||+.....                ....+++.+|+.....+.      +.+|.++
T Consensus         4 ~~~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCCcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            3456799999999986333 3446788876554                122456667776655554      7889999


Q ss_pred             eeEEEccCCeEEEEEEeCCC------CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCee
Q 048535          174 RGWCKKEKESLILIYDYMEN------GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVL  247 (409)
Q Consensus       174 ~g~~~~~~~~~~lv~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NIL  247 (409)
                      +|+..+ +...-+|+|.+.+      -+|.+++.+    ..++. ...+.+.+.   ..||-   +..|+.+|++|.||+
T Consensus        83 ~G~veT-~~G~Glv~e~I~d~dG~~s~TL~~~l~~----~~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   83 YGFVET-NLGLGLVVELIRDADGNISPTLEDYLKE----GGLTE-ELRQALDEF---KRYLL---DHHIVIRDLNPHNIV  150 (199)
T ss_pred             eEEEec-CCceEEEEEEEECCCCCcCccHHHHHHc----CCccH-HHHHHHHHH---HHHHH---HcCCeecCCCcccEE
Confidence            999987 5556788888753      257888832    23555 334343333   45566   678999999999999


Q ss_pred             eCCCC----cEEEec-ccCc
Q 048535          248 LDKKM----NARLGD-FGLA  262 (409)
Q Consensus       248 l~~~~----~~kl~D-FGla  262 (409)
                      +....    .+.|.| ||-.
T Consensus       151 ~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  151 VQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             EEecCCCceEEEEEeCCCCc
Confidence            95432    477777 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=97.94  E-value=4.1e-06  Score=88.72  Aligned_cols=271  Identities=17%  Similarity=0.139  Sum_probs=150.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .++|.+.+-+-+|.++.++.+.-.  |...+.|......   ..+.+....+-.++-..+||-++...--+.. ....+|
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~-rsP~~L  881 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPC-RSPLPL  881 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCC-CCCcch
Confidence            355666677888999998876554  4444444433221   1112222233333333345666655443222 567899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      +++|+.+++|...|+..   ...+..........+.++++|||   ...+.|||++|.|+|+..++..+++|||+.....
T Consensus       882 ~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccc
Confidence            99999999999998643   35666666777888999999999   6779999999999999999999999999554322


Q ss_pred             CCceeeec-----------cccccCCCcHHHH-----HHhhhccCcH-HHHhhHHhhhcCCCCHHHHHHHHHHHHHccCc
Q 048535          267 HGQVMSGR-----------RPIEEGKRNLVDR-----MWSLTERSEL-LSVLDERLKAKGGYADEVVEKVLHLGLLCAHP  329 (409)
Q Consensus       267 ~~~~~~g~-----------~p~~~~~~~~~~~-----vws~~~~~~~-~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~  329 (409)
                      --.-.++.           .+.......+..+     .-.......+ .+..-.+-.  +. ..++...-..+....+-.
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h--gs-~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH--GS-AADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC--CC-cchhhhhhhhhhhhhcCC
Confidence            11001111           0000000111111     0000000000 000000000  11 111111112222233344


Q ss_pred             CCCCCCCHHHHHHHH-hcCcCCCCCCCCCc--chhHHhhhcccCCCCccccc---ccCCCCCccccccc
Q 048535          330 EANSRPTIRQVLKML-EGQTEGTGLEDEGM--NVHLLKRIGTRAMTSSWKFA---GSRGHPTFNEINKN  392 (409)
Q Consensus       330 dP~~RPt~~evl~~L-~~~~~~~~~~~~~~--~~~~l~~~~~~~~~~~~~~~---~~~~hp~~~~~~~~  392 (409)
                      -|.+=++-+++.+-+ .+....+.-+....  .-++..+.+..++.+|....   +.-.||+|..++-.
T Consensus      1033 pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~ 1101 (1205)
T KOG0606|consen 1033 PPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWE 1101 (1205)
T ss_pred             CCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcc
Confidence            555666777776543 33333333332222  25777888889999999866   88899999987743

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.90  E-value=9e-05  Score=68.09  Aligned_cols=74  Identities=15%  Similarity=0.165  Sum_probs=44.9

Q ss_pred             ceeecCCce-EEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCC---ceeeEeeEEEccC--CeEEEEEEeCC
Q 048535          119 NVIGLGGNG-KVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHR---NLVGLRGWCKKEK--ESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg-~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~--~~~~lv~E~~~  192 (409)
                      +.|+.|+.. .||+.   +..+.+|..+...  ....+.+|.++|..+...   -+.++++......  ...+++||+++
T Consensus         3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc---CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            567777766 48874   3457777755322  235788899998877422   2334444332211  23578999999


Q ss_pred             CCCHH
Q 048535          193 NGSLD  197 (409)
Q Consensus       193 ~gsL~  197 (409)
                      |.++.
T Consensus        78 G~~l~   82 (235)
T cd05155          78 GETAT   82 (235)
T ss_pred             CCCCC
Confidence            87663

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.80  E-value=0.00012  Score=68.21  Aligned_cols=139  Identities=14%  Similarity=0.051  Sum_probs=79.7

Q ss_pred             eecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeEeeEEEccCCeEEEEEEeCCCCCHHHH
Q 048535          121 IGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL-VGLRGWCKKEKESLILIYDYMENGSLDKW  199 (409)
Q Consensus       121 lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~lv~E~~~~gsL~~~  199 (409)
                      +..|-.+.+|+....+..+++|..........-...+|.++++.+....+ .++++.+   .  -++||||++|..+..-
T Consensus         4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~---~--~~~v~e~i~G~~~~~~   78 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN---E--HWLLVEWLEGEVITLD   78 (256)
T ss_pred             CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe---C--CEEEEEeccCcccccc
Confidence            45677889999887788899987654322111134678888888854333 3344332   1  2589999998665321


Q ss_pred             -----------------HhcCCC-CCCCCHHH-HHHHHHHH---------HHHHHHHHhc-----CCCceeecCCCCCCe
Q 048535          200 -----------------IFECDE-SIALSWEQ-RIKVLKDV---------ASGILYLYEG-----WESKVLHRDIKASNV  246 (409)
Q Consensus       200 -----------------l~~~~~-~~~l~~~~-~~~i~~~i---------a~gL~yLH~~-----~~~~ivHrDlKp~NI  246 (409)
                                       ||.... ..+++... ...+..++         ..-+..+-..     ....++|+|+.|.||
T Consensus        79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni  158 (256)
T TIGR02721        79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL  158 (256)
T ss_pred             cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence                             121111 11222221 11211111         1111112111     124689999999999


Q ss_pred             eeCCCCcEEEecccCcccc
Q 048535          247 LLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       247 Ll~~~~~~kl~DFGla~~~  265 (409)
                      |+++++ +.|.||..|..-
T Consensus       159 l~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       159 VVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             EEeCCC-CEEEeccccCcC
Confidence            999877 789999988653

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.67  E-value=0.00066  Score=67.00  Aligned_cols=75  Identities=15%  Similarity=0.092  Sum_probs=53.0

Q ss_pred             cceeecCCceEEEEEEEC-C-cEEEEEEeccC------C-hHHHHHHHHHHHHhccCC---CCceeeEeeEEEccCCeEE
Q 048535          118 ENVIGLGGNGKVYKGQLL-G-VEVALKRISLD------S-EHGMREFLAEVSSLGRLK---HRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~-~-~~vAvK~~~~~------~-~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~~  185 (409)
                      .+.||.|.+..||+.... | +.|.||.-...      . +-..+++..|.+.|..+.   -.++.+++.+.   ....+
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D---~~~~~  107 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD---EELAV  107 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC---CCCCE
Confidence            367999999999999988 4 48999985411      1 223456777888888762   24566777653   34567


Q ss_pred             EEEEeCCCCC
Q 048535          186 LIYDYMENGS  195 (409)
Q Consensus       186 lv~E~~~~gs  195 (409)
                      +||||+++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            9999998743

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.65  E-value=0.00051  Score=62.93  Aligned_cols=140  Identities=16%  Similarity=0.132  Sum_probs=80.8

Q ss_pred             ceeecCCceEEEEEEEC---CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeEeeEEEccCCeEEEEEEeCCCC
Q 048535          119 NVIGLGGNGKVYKGQLL---GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL-VGLRGWCKKEKESLILIYDYMENG  194 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~lv~E~~~~g  194 (409)
                      +.|..|-...+|+....   +..|.+|........ .-...+|+.++..+...++ .++++.+.  .   .++|||++|.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~---~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--N---GLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C---cEEEEeeCCC
Confidence            56778888999998876   578999977543221 1123468888888843333 44444332  2   3799999986


Q ss_pred             CHHHH-----------------HhcCCCCC--------CC-CHHHHHHHHHH----------------------HH---H
Q 048535          195 SLDKW-----------------IFECDESI--------AL-SWEQRIKVLKD----------------------VA---S  223 (409)
Q Consensus       195 sL~~~-----------------l~~~~~~~--------~l-~~~~~~~i~~~----------------------ia---~  223 (409)
                      ++...                 +|......        .. .+..+..+...                      +.   .
T Consensus        78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  157 (235)
T cd05157          78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS  157 (235)
T ss_pred             cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence            65311                 11111110        11 12222222111                      11   1


Q ss_pred             HHH-HHHhc-CCCceeecCCCCCCeeeCC-CCcEEEecccCccc
Q 048535          224 GIL-YLYEG-WESKVLHRDIKASNVLLDK-KMNARLGDFGLAKM  264 (409)
Q Consensus       224 gL~-yLH~~-~~~~ivHrDlKp~NILl~~-~~~~kl~DFGla~~  264 (409)
                      .|. .+-.. ....++|+|+.+.|||++. +..+.|.||..|..
T Consensus       158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            111 11110 1357999999999999998 57899999998864

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK05231 homoserine kinase; Provisional

Probab=97.61  E-value=0.0012  Score=63.56  Aligned_cols=158  Identities=17%  Similarity=0.126  Sum_probs=83.2

Q ss_pred             cHHHHHHHhCCCCc-----cceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccC-----CCCceeeE
Q 048535          104 SYQEIHAATKGFSE-----ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRL-----KHRNLVGL  173 (409)
Q Consensus       104 ~~~~l~~~~~~f~~-----~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l  173 (409)
                      +.+++......|..     .+.|+.|....+|+....+..+++|+......   .....|+.++..|     .-|.+++-
T Consensus         8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~   84 (319)
T PRK05231          8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVAR   84 (319)
T ss_pred             CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeC
Confidence            34444444444543     34566777789999887756789998762222   2233344444444     23333321


Q ss_pred             e-e-EEEccCCeEEEEEEeCCCCCHH-----------HH---HhcCCC--------CCCCCH-HHHHHH-----------
Q 048535          174 R-G-WCKKEKESLILIYDYMENGSLD-----------KW---IFECDE--------SIALSW-EQRIKV-----------  217 (409)
Q Consensus       174 ~-g-~~~~~~~~~~lv~E~~~~gsL~-----------~~---l~~~~~--------~~~l~~-~~~~~i-----------  217 (409)
                      . | .+....+..++++||++|..+.           +.   +|....        ...+.| .....-           
T Consensus        85 ~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (319)
T PRK05231         85 RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAA  164 (319)
T ss_pred             CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHH
Confidence            1 1 0111145678999999986431           11   111110        011212 111111           


Q ss_pred             -HHH-HHHHHHHHHh----cCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          218 -LKD-VASGILYLYE----GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       218 -~~~-ia~gL~yLH~----~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                       ..+ +...++.+..    ....+++|+|+.|.|||++.+...-|.||+.+..
T Consensus       165 ~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        165 LLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             HHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence             111 1112223321    1246899999999999998766568999998854

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.59  E-value=0.0007  Score=64.34  Aligned_cols=144  Identities=15%  Similarity=0.090  Sum_probs=86.4

Q ss_pred             cceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCc--eeeEeeE-----EEccCCeEEEEEEe
Q 048535          118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN--LVGLRGW-----CKKEKESLILIYDY  190 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~-----~~~~~~~~~lv~E~  190 (409)
                      .+.|..|....+|+....+..+++|+....   .......|++++..+.+.+  +.+++..     .....+..+++++|
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~   95 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF   95 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence            456777887899998777778999987642   2345667788777774332  4444331     11113456899999


Q ss_pred             CCCCCHHH-----------H---HhcC----CCC----CCCCHHHHH----------HHHHHHHHHHHHHHh----cCCC
Q 048535          191 MENGSLDK-----------W---IFEC----DES----IALSWEQRI----------KVLKDVASGILYLYE----GWES  234 (409)
Q Consensus       191 ~~~gsL~~-----------~---l~~~----~~~----~~l~~~~~~----------~i~~~ia~gL~yLH~----~~~~  234 (409)
                      ++|..+..           .   +|..    ...    ....|....          .....+..++.++..    ....
T Consensus        96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~  175 (296)
T cd05153          96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR  175 (296)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence            99866432           0   1111    000    111222211          011123334444442    1235


Q ss_pred             ceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          235 KVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       235 ~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      .++|+|+.|.|||++++..+.|.||+.+..
T Consensus       176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         176 GVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            799999999999999987778999998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.40  E-value=0.0028  Score=60.65  Aligned_cols=145  Identities=14%  Similarity=0.066  Sum_probs=83.0

Q ss_pred             cceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCC--ceeeEeeEE-----EccCCeEEEEEEe
Q 048535          118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHR--NLVGLRGWC-----KKEKESLILIYDY  190 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~~-----~~~~~~~~lv~E~  190 (409)
                      .+.++.|....+|+....+..+.+|+......  ......|++++..|...  .+.+++...     ....+..++++||
T Consensus        27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~  104 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF  104 (307)
T ss_pred             ccccCCccccceEEEEeCCCcEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence            45577777789999877655788898754311  23344566666666322  233443311     1123567899999


Q ss_pred             CCCCCHH-----------HH---HhcCCCC------C---CCCHHHHHH------------HHHHHHHHHHHHHh----c
Q 048535          191 MENGSLD-----------KW---IFECDES------I---ALSWEQRIK------------VLKDVASGILYLYE----G  231 (409)
Q Consensus       191 ~~~gsL~-----------~~---l~~~~~~------~---~l~~~~~~~------------i~~~ia~gL~yLH~----~  231 (409)
                      ++|..+.           ..   +|.....      .   .-.|.....            ....+.+.++++..    .
T Consensus       105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~  184 (307)
T TIGR00938       105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD  184 (307)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            9885432           11   1211010      0   011211110            11223345555542    2


Q ss_pred             CCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       232 ~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ...+++|+|+.+.||+++.++...|.||+.+..
T Consensus       185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            357899999999999999887778999998754

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.29  E-value=0.0016  Score=62.06  Aligned_cols=141  Identities=25%  Similarity=0.270  Sum_probs=82.6

Q ss_pred             ceeecCCceEEEEEEEC--------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeEeeEEEccCCeEEEEEE
Q 048535          119 NVIGLGGNGKVYKGQLL--------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL-VGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~lv~E  189 (409)
                      +.+..|-...+|+....        ++.+++|+...... ......+|.+++..+....+ .++++++.  +   .+|+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~---~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP--N---GRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC--C---Cchhh
Confidence            45666777789988765        37899999754422 22345678888887743333 34555443  2   25899


Q ss_pred             eCCCCCHHHH-----------------HhcCCCCC--------CCCHHHHHH--------------------------HH
Q 048535          190 YMENGSLDKW-----------------IFECDESI--------ALSWEQRIK--------------------------VL  218 (409)
Q Consensus       190 ~~~~gsL~~~-----------------l~~~~~~~--------~l~~~~~~~--------------------------i~  218 (409)
                      |++|..+...                 +|......        +.-|.....                          +.
T Consensus        78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (302)
T cd05156          78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL  157 (302)
T ss_pred             eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence            9988765431                 11111110        011111111                          11


Q ss_pred             HHHHHHHHHHHh------cCCCceeecCCCCCCeeeCCC----CcEEEecccCcccc
Q 048535          219 KDVASGILYLYE------GWESKVLHRDIKASNVLLDKK----MNARLGDFGLAKMH  265 (409)
Q Consensus       219 ~~ia~gL~yLH~------~~~~~ivHrDlKp~NILl~~~----~~~kl~DFGla~~~  265 (409)
                      ..+..-+.+|-.      .....++|+|+.+.|||++++    +.++++||..|...
T Consensus       158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            122223334431      135679999999999999985    78999999998653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.12  E-value=0.0054  Score=58.60  Aligned_cols=131  Identities=14%  Similarity=0.153  Sum_probs=78.8

Q ss_pred             eEEEEEEECCcEEEEEEecc--CChHHHHHHHHHHHHhccCCC--CceeeEeeEEEccC-CeEEEEEEeCCCCCHHHHHh
Q 048535          127 GKVYKGQLLGVEVALKRISL--DSEHGMREFLAEVSSLGRLKH--RNLVGLRGWCKKEK-ESLILIYDYMENGSLDKWIF  201 (409)
Q Consensus       127 g~Vy~~~~~~~~vAvK~~~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~-~~~~lv~E~~~~gsL~~~l~  201 (409)
                      -.+|.....++++.+. ...  ..........+|..+|+.+.-  --+-+.++.|.++. +..+.||+|++|..+.+.+.
T Consensus        39 n~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~  117 (321)
T COG3173          39 NDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALP  117 (321)
T ss_pred             cceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCC
Confidence            3445544447778887 331  223344556678888877742  23445677787644 46789999998843322221


Q ss_pred             cCCCCCCCCHHHHHHHH-HHHHHHHHHHHh--------------------------------------------------
Q 048535          202 ECDESIALSWEQRIKVL-KDVASGILYLYE--------------------------------------------------  230 (409)
Q Consensus       202 ~~~~~~~l~~~~~~~i~-~~ia~gL~yLH~--------------------------------------------------  230 (409)
                      .    ....    .+++ ..+++.|.-||.                                                  
T Consensus       118 ~----~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~  189 (321)
T COG3173         118 P----ESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEA  189 (321)
T ss_pred             c----ccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHh
Confidence            0    0000    1111 133333333332                                                  


Q ss_pred             c-----CCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          231 G-----WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       231 ~-----~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      .     ....++|+|+.+.|++++.+...=|.||+++..-+
T Consensus       190 ~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         190 NRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             cCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            1     13569999999999999998889999999997644

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.97  E-value=0.0094  Score=56.19  Aligned_cols=32  Identities=25%  Similarity=0.455  Sum_probs=26.7

Q ss_pred             CceeecCCCCCCeeeCCCCc-EEEecccCcccc
Q 048535          234 SKVLHRDIKASNVLLDKKMN-ARLGDFGLAKMH  265 (409)
Q Consensus       234 ~~ivHrDlKp~NILl~~~~~-~kl~DFGla~~~  265 (409)
                      ..++|+|+.|.|||++++++ .-|.||+.+..-
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            45899999999999997555 469999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=96.92  E-value=0.0017  Score=69.06  Aligned_cols=64  Identities=14%  Similarity=0.111  Sum_probs=38.5

Q ss_pred             eecCCCCC-CeeeCCCCcEEEecccCcccccCCc------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhh
Q 048535          237 LHRDIKAS-NVLLDKKMNARLGDFGLAKMHHHGQ------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLD  302 (409)
Q Consensus       237 vHrDlKp~-NILl~~~~~~kl~DFGla~~~~~~~------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~  302 (409)
                      .|++.+|. |++++.+...++.|||.++....+.      ...|...+.      ...++...|+|+++  ..+++++.
T Consensus       499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG--~il~Ellt  575 (669)
T cd05610         499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALG--VCLFEFLT  575 (669)
T ss_pred             CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHHH--HHHHHHHH
Confidence            34555555 6677777778899999987754332      123333322      24467789999985  33444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PLN02236 choline kinase

Probab=96.87  E-value=0.0082  Score=58.51  Aligned_cols=140  Identities=16%  Similarity=0.181  Sum_probs=80.6

Q ss_pred             ceeecCCceEEEEEEEC------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeEeeEEEccCCeEEEEEEeC
Q 048535          119 NVIGLGGNGKVYKGQLL------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL-VGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~lv~E~~  191 (409)
                      ..|-.|-...+|+....      ++.|.+|........... -.+|..++..+..-++ .++++.+.  ++   .|+||+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~--~g---~v~efi  115 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFP--NG---RVEEFI  115 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEEC--Cc---eEEEee
Confidence            34445667788887753      367889887654322222 2578888888854444 34555543  22   589999


Q ss_pred             CCCCHHHH-----------------HhcCCC---CCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh
Q 048535          192 ENGSLDKW-----------------IFECDE---SIALSWEQRIKVLKDV-----------------ASGILYL----YE  230 (409)
Q Consensus       192 ~~gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~~i-----------------a~gL~yL----H~  230 (409)
                      ++.+|..-                 +|....   .....|....++..++                 ...+..|    ..
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87665421                 121111   1112233333332221                 1112222    11


Q ss_pred             -cCCCceeecCCCCCCeeeCC-CCcEEEecccCccc
Q 048535          231 -GWESKVLHRDIKASNVLLDK-KMNARLGDFGLAKM  264 (409)
Q Consensus       231 -~~~~~ivHrDlKp~NILl~~-~~~~kl~DFGla~~  264 (409)
                       .....++|+|+++.|||+++ ++.+.+.||..|..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             12457899999999999986 46799999998865

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.80  E-value=0.0016  Score=61.55  Aligned_cols=129  Identities=16%  Similarity=0.135  Sum_probs=90.0

Q ss_pred             CCccceeecCCceEEEEEEEC-CcEEEEEEeccCCh-----H-----------------HHHHHHHHHHHhccCC-CC-c
Q 048535          115 FSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSE-----H-----------------GMREFLAEVSSLGRLK-HR-N  169 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~-----~-----------------~~~~~~~E~~~l~~l~-H~-n  169 (409)
                      +...+.||-|--+.||.+-.. |.+.++|.-+....     .                 .+-...+|...|+.|. |. -
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            577899999999999999888 88888886442200     0                 0123467888888883 32 2


Q ss_pred             eeeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC
Q 048535          170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD  249 (409)
Q Consensus       170 iv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~  249 (409)
                      |.+.++     .+..++|||++.+-.|.+.-+      ..+..++..-+.++   +.-|.   ..++||+|..-=||+++
T Consensus       174 VPkpiD-----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~---Iv~la---~~GlIHgDFNEFNimv~  236 (465)
T KOG2268|consen  174 VPKPID-----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGL---IVRLA---NHGLIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCccc-----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHH---HHHHH---HcCceecccchheeEEe
Confidence            444554     345689999998877765431      22334444333333   33444   78999999999999999


Q ss_pred             CCCcEEEeccc
Q 048535          250 KKMNARLGDFG  260 (409)
Q Consensus       250 ~~~~~kl~DFG  260 (409)
                      +++.++++||=
T Consensus       237 dd~~i~vIDFP  247 (465)
T KOG2268|consen  237 DDDKIVVIDFP  247 (465)
T ss_pred             cCCCEEEeech
Confidence            99999999995

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.76  E-value=0.031  Score=55.24  Aligned_cols=80  Identities=15%  Similarity=0.064  Sum_probs=53.3

Q ss_pred             cceeecCCceEEEEEEECCcEEEEEEeccC----Ch---HHHHHHHHHHHHhccCC---CCceeeEeeEEEccCCeEEEE
Q 048535          118 ENVIGLGGNGKVYKGQLLGVEVALKRISLD----SE---HGMREFLAEVSSLGRLK---HRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~----~~---~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .+.||.|....||+....+..+.||+-...    ..   ....+-..|.+.|+.+.   ..++.+++.++.+   ..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded---~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT---MALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC---CCEEE
Confidence            567899999999998877777999987521    11   12333344566666553   3467788887753   35789


Q ss_pred             EEeCCC--CCHHHHH
Q 048535          188 YDYMEN--GSLDKWI  200 (409)
Q Consensus       188 ~E~~~~--gsL~~~l  200 (409)
                      |||+++  ..+.+.+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999977  3454443

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=96.69  E-value=0.0014  Score=67.25  Aligned_cols=47  Identities=21%  Similarity=0.442  Sum_probs=40.7

Q ss_pred             HHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       219 ~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      .+++.||.|+|.  +.++||++|.|++|.++.++..||+.|+.+-....
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~  152 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANG  152 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCC
Confidence            345599999997  78999999999999999999999999998755433

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.58  E-value=0.025  Score=54.92  Aligned_cols=79  Identities=13%  Similarity=0.007  Sum_probs=50.3

Q ss_pred             ceeecCCceEEEEEEECC--cEEEEEEeccC-------ChHHHHHHHHHHHHhccCC--CC-ceeeEeeEEEccCCeEEE
Q 048535          119 NVIGLGGNGKVYKGQLLG--VEVALKRISLD-------SEHGMREFLAEVSSLGRLK--HR-NLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~~--~~vAvK~~~~~-------~~~~~~~~~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~~l  186 (409)
                      ++||.|....||++...+  +.|+||.-..-       -+-...+..-|.+.|+...  -| .+.+++.+  + .....+
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D-~e~~~~   77 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--D-TEMAVT   77 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--c-ccccee
Confidence            358999999999999873  68999986321       1223345556777776652  34 34455543  2 445668


Q ss_pred             EEEeCCCC-CHHHHH
Q 048535          187 IYDYMENG-SLDKWI  200 (409)
Q Consensus       187 v~E~~~~g-sL~~~l  200 (409)
                      |||+++.. .|++.|
T Consensus        78 vMEdL~~~~ilR~~L   92 (370)
T TIGR01767        78 VMEDLSHHKIARKGL   92 (370)
T ss_pred             hHhhCccchHHHHHH
Confidence            99999653 344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.56  E-value=0.013  Score=56.55  Aligned_cols=142  Identities=18%  Similarity=0.236  Sum_probs=95.9

Q ss_pred             ccceeecCCceEEEEEEEC-CcEEEEEEeccC-----C-------------------hHH-H-HHHHHHHHHhccCCCCc
Q 048535          117 EENVIGLGGNGKVYKGQLL-GVEVALKRISLD-----S-------------------EHG-M-REFLAEVSSLGRLKHRN  169 (409)
Q Consensus       117 ~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~-----~-------------------~~~-~-~~~~~E~~~l~~l~H~n  169 (409)
                      +..+|..|--+.||.++-. |..+|||+.+..     +                   +.. . --...|++-|.+|+...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            3457888999999999887 999999998632     0                   000 0 11245788888876544


Q ss_pred             eeeEeeEEEccCCeEEEEEEeCCCCCH-HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee
Q 048535          170 LVGLRGWCKKEKESLILIYDYMENGSL-DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL  248 (409)
Q Consensus       170 iv~l~g~~~~~~~~~~lv~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl  248 (409)
                      |.-.--...  . ...|||+|+..... .-.|    ....++...+..+-.|++.-|.-|.+  ..++||.||.-=|+|+
T Consensus       228 IP~PePIlL--k-~hVLVM~FlGrdgw~aPkL----Kd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  228 IPCPEPILL--K-NHVLVMEFLGRDGWAAPKL----KDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCceee--e-cceEeeeeccCCCCcCccc----ccccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheE
Confidence            321111111  1 23689999964221 1122    23457777888888899999988886  6789999999999999


Q ss_pred             CCCCcEEEecccCcccccCC
Q 048535          249 DKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       249 ~~~~~~kl~DFGla~~~~~~  268 (409)
                      . +|.+.|+|-+-+-..+++
T Consensus       299 h-dG~lyiIDVSQSVE~DHP  317 (520)
T KOG2270|consen  299 H-DGKLYIIDVSQSVEHDHP  317 (520)
T ss_pred             E-CCEEEEEEccccccCCCh
Confidence            5 567999998877655443

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.56  E-value=0.018  Score=54.50  Aligned_cols=75  Identities=19%  Similarity=0.256  Sum_probs=46.9

Q ss_pred             CccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCC---CCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          116 SEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLK---HRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       116 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +..+.++.|....+|+....++.+-||.-..   .....|..|.+-|+.|.   --.+.+.+++... .+..+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~-~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY-DDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEETTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE--SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEECCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee-cCCceEEEEeec
Confidence            3456789999999999887789999998762   22356778888887773   3446778887765 445589999998


Q ss_pred             CC
Q 048535          193 NG  194 (409)
Q Consensus       193 ~g  194 (409)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.48  E-value=0.017  Score=51.98  Aligned_cols=116  Identities=15%  Similarity=0.119  Sum_probs=73.0

Q ss_pred             CceEEEEEEECCcEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcC
Q 048535          125 GNGKVYKGQLLGVEVALKRISLDSEH-GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC  203 (409)
Q Consensus       125 ~fg~Vy~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~  203 (409)
                      +..+.-.+...--+..+|+++.-.-. ...-|..+.+++.+++  .|+++..   +.....-++.|+|-.-..       
T Consensus        74 gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N---Dn~~~yGvIlE~Cy~~~i-------  141 (308)
T PF07387_consen   74 GNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN---DNNYKYGVILERCYKIKI-------  141 (308)
T ss_pred             CceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec---CCCceeEEEEeeccCccc-------
Confidence            34444444444223456666533222 3355778888888775  4677662   334567789999844111       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          204 DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       204 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                           ++   .-.|..+ .++|.-.|++ ..+.+|+|..|+|||-|.+|.+||.|=+.-
T Consensus       142 -----~~---~N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 -----NF---SNFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             -----ch---hHHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence                 11   1112222 4667788865 678999999999999999999999997643

The function of this family is unknown.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=96.46  E-value=0.0094  Score=64.86  Aligned_cols=187  Identities=17%  Similarity=0.189  Sum_probs=112.2

Q ss_pred             HHHHHHHHHHhccCCCCceeeEeeEEEccCC---eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 048535          152 MREFLAEVSSLGRLKHRNLVGLRGWCKKEKE---SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL  228 (409)
Q Consensus       152 ~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL  228 (409)
                      .....-|...+.++.|+|++.+++|-.....   ...+..|+|..-++...+.   ....++....+.+..+..+||.|+
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHH
Confidence            3344567788899999999999998765322   1234567888888888774   345688889999999999999999


Q ss_pred             HhcCCCceeecCCCCC---CeeeCCCCcEEEe--cccCcccccCCc-----eeeecc----cccc--CCCcHHHHHHhhh
Q 048535          229 YEGWESKVLHRDIKAS---NVLLDKKMNARLG--DFGLAKMHHHGQ-----VMSGRR----PIEE--GKRNLVDRMWSLT  292 (409)
Q Consensus       229 H~~~~~~ivHrDlKp~---NILl~~~~~~kl~--DFGla~~~~~~~-----~~~g~~----p~~~--~~~~~~~~vws~~  292 (409)
                      |   +....|.=+..+   +--.+.++...++  ||+.++......     +..+..    +...  .......++|.+.
T Consensus       303 h---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  303 H---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             H---HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHH
Confidence            9   454444444444   3344555666766  888887655432     111111    1111  2223445777763


Q ss_pred             ccCcHH-HH--hhHHhhhcCC-CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 048535          293 ERSELL-SV--LDERLKAKGG-YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKML  344 (409)
Q Consensus       293 ~~~~~~-~~--~~~~l~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L  344 (409)
                      ....-. ..  +......... .+........+....|+..++++|+++.+++...
T Consensus       380 ll~~~~~~~~~i~~~~~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             HHHhhhhhcCcccccccchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            211000 00  0000000000 0111111567778899999999999999998764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=96.35  E-value=0.00042  Score=70.46  Aligned_cols=135  Identities=19%  Similarity=0.071  Sum_probs=91.8

Q ss_pred             cceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCc-eeeEeeEEEccCCeEEEEEEeCCCC-
Q 048535          118 ENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN-LVGLRGWCKKEKESLILIYDYMENG-  194 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~~lv~E~~~~g-  194 (409)
                      -+.+++|+++.+||.+-. .+....+.+...     ....-++++|.+++||| .++.++-+.. ....+++++++.+| 
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~-E~~~~i~~~i~s~~r  320 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDG-EDYLWIPMRICSTGR  320 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCc-ccccchhhhhhcCCc
Confidence            356889999999998766 333335555432     34456889999999999 6776665554 56788999999887 


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          195 SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       195 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      +-..-..  .....+...+...+.+.-+++|+|||   +..-+|||    ||+..+ +..|..||+.+..+...
T Consensus       321 s~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~  384 (829)
T KOG0576|consen  321 SSALEMT--VSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT  384 (829)
T ss_pred             cccccCC--hhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCcc
Confidence            2221110  11122344445556677788999999   55568999    887765 57899999988765543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.33  E-value=0.075  Score=50.71  Aligned_cols=31  Identities=23%  Similarity=0.307  Sum_probs=26.5

Q ss_pred             CCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       233 ~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ..+++|+|+.+.||+++. +.+.|.||+.+..
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            367999999999999987 5689999997653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.10  E-value=0.064  Score=51.37  Aligned_cols=32  Identities=19%  Similarity=0.312  Sum_probs=28.9

Q ss_pred             CCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       233 ~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ..+++|+|+.+.|+|++.++.+.+.||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999999999999998865

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.93  E-value=0.039  Score=53.45  Aligned_cols=141  Identities=16%  Similarity=0.214  Sum_probs=79.3

Q ss_pred             ceeecCCceEEEEEEECC-----cEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL-VGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~~-----~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.|..|-...+|+....+     ..|.+|........ .-.-.+|..+++.+..-++ .++++++ . .+   +|.+|++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~-~-~G---~i~~fi~   93 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVF-G-NG---MIQSFIN   93 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEe-C-Cc---Eeehhhc
Confidence            445557777888887653     27888887544321 1123478888888865444 3556554 2 22   5899997


Q ss_pred             CCCHHH-----------------HHhcCCC---CCCCCHHHHHHHHHHH----------------------HHHHHHHHh
Q 048535          193 NGSLDK-----------------WIFECDE---SIALSWEQRIKVLKDV----------------------ASGILYLYE  230 (409)
Q Consensus       193 ~gsL~~-----------------~l~~~~~---~~~l~~~~~~~i~~~i----------------------a~gL~yLH~  230 (409)
                      +-.|..                 .+|...-   ...-.|..+.++..++                      .+-+..+..
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            765421                 0122110   1111233333332221                      111111111


Q ss_pred             -----cCCCceeecCCCCCCeeeCC-CCcEEEecccCcccc
Q 048535          231 -----GWESKVLHRDIKASNVLLDK-KMNARLGDFGLAKMH  265 (409)
Q Consensus       231 -----~~~~~ivHrDlKp~NILl~~-~~~~kl~DFGla~~~  265 (409)
                           ....-.+|.|+-+.|||+++ ++.++++||..|...
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence                 11235899999999999975 578999999988653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=95.91  E-value=0.19  Score=49.37  Aligned_cols=137  Identities=15%  Similarity=0.189  Sum_probs=84.0

Q ss_pred             ccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEE------ccCCeEEEEEE
Q 048535          117 EENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCK------KEKESLILIYD  189 (409)
Q Consensus       117 ~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~------~~~~~~~lv~E  189 (409)
                      ....||+|+-+.+|-----+..|| |+..........+   -++.|.+. .||-+-.-+.|=.      +.....-+.|.
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d~VA-KIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRDQVA-KIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CCccccCCccceeeecchhhchhh-eeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            457799999999995332233333 5544332222122   23334444 5665433122110      11222556677


Q ss_pred             eCCCCC-HHHHHhc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEeccc
Q 048535          190 YMENGS-LDKWIFE---CDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG  260 (409)
Q Consensus       190 ~~~~gs-L~~~l~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG  260 (409)
                      .+++-. ...++..   ...-....|.-.+++++.+|.+.+-||   ..+.+-+|+.++|+|+++++.+.|.|=.
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccc
Confidence            666532 2222221   122335789999999999999999999   7899999999999999999888887743

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.72  E-value=0.21  Score=45.36  Aligned_cols=75  Identities=16%  Similarity=0.186  Sum_probs=51.6

Q ss_pred             ceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCC---CceeeEeeEEEccCCeEEEEEEeCCCCC
Q 048535          119 NVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKH---RNLVGLRGWCKKEKESLILIYDYMENGS  195 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~g~~~~~~~~~~lv~E~~~~gs  195 (409)
                      +.+.-|.--..|...+...++-||+=   .......|..|+.-|..|.-   -++.+++.+-.+ ....|+|+||++-|.
T Consensus        22 ~~v~gG~inea~~v~dg~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~-~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRDGTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGAS-RDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeecCCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCC-CCeeEEEEeeccCCC
Confidence            44555555566666666788888874   33445678888887777643   345666665555 678899999999876


Q ss_pred             HH
Q 048535          196 LD  197 (409)
Q Consensus       196 L~  197 (409)
                      +.
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            65

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.71  E-value=0.046  Score=53.84  Aligned_cols=80  Identities=11%  Similarity=0.006  Sum_probs=52.3

Q ss_pred             cceeecCCceEEEEEEEC--CcEEEEEEeccC------ChHHHHHHHHHHHHhccCC--CC-ceeeEeeEEEccCCeEEE
Q 048535          118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLD------SEHGMREFLAEVSSLGRLK--HR-NLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~------~~~~~~~~~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~~l  186 (409)
                      .+.||.|.-..||++...  ++.|+||.-..-      -+-..++..-|.++|+...  -| .+.+++.+  + .....+
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D-~e~~~~  110 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--D-SVMNCC  110 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--C-cHHhhH
Confidence            468999999999999985  678999975321      1223456667777777662  34 34556543  2 345678


Q ss_pred             EEEeCCCC-CHHHHH
Q 048535          187 IYDYMENG-SLDKWI  200 (409)
Q Consensus       187 v~E~~~~g-sL~~~l  200 (409)
                      |||+++.. .|++.|
T Consensus       111 vMEdL~~~~ilR~~L  125 (409)
T PRK12396        111 VMEDLSDHTILRTAL  125 (409)
T ss_pred             HHHhCcccHHHHHHH
Confidence            99999653 344444

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.51  E-value=0.061  Score=51.92  Aligned_cols=76  Identities=21%  Similarity=0.209  Sum_probs=57.2

Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEeccc
Q 048535          181 KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG  260 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG  260 (409)
                      ....|++|++- |++|.-       ...-.|++.+.++.+-+.-+.-+..  .-+.=|||+.-.||||+ +|++.|+||-
T Consensus       298 ~~y~yl~~kdh-gt~is~-------ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         298 TLYLYLHFKDH-GTPISI-------IKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             ceEEEEEEecC-Cceeee-------eecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEee
Confidence            44566777764 445432       1235688899999887777766664  56789999999999999 9999999999


Q ss_pred             CcccccC
Q 048535          261 LAKMHHH  267 (409)
Q Consensus       261 la~~~~~  267 (409)
                      ++|.-..
T Consensus       367 lsRl~~~  373 (488)
T COG5072         367 LSRLSYS  373 (488)
T ss_pred             eeecccC
Confidence            9996443

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.49  E-value=0.12  Score=49.93  Aligned_cols=141  Identities=17%  Similarity=0.216  Sum_probs=80.7

Q ss_pred             eeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCce---ee---Eee----EEEccCCeEEEEEE
Q 048535          120 VIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL---VG---LRG----WCKKEKESLILIYD  189 (409)
Q Consensus       120 ~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni---v~---l~g----~~~~~~~~~~lv~E  189 (409)
                      .|.+ .-..+|+....+..+++|.....  ....+...|...|..|.-.+|   ++   +-|    .... ....+-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~-~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSG-GPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccC-CceeEEEEE
Confidence            3444 44578988887555689988765  233455667777776632111   11   111    1111 136788999


Q ss_pred             eCCCCCHHH-H--------------HhcC----C----C-CCCCCHHH-------------HHHHHHHHHHHHHHHHhc-
Q 048535          190 YMENGSLDK-W--------------IFEC----D----E-SIALSWEQ-------------RIKVLKDVASGILYLYEG-  231 (409)
Q Consensus       190 ~~~~gsL~~-~--------------l~~~----~----~-~~~l~~~~-------------~~~i~~~ia~gL~yLH~~-  231 (409)
                      |++|..+.. .              +|..    .    . .....|..             -.....++...+..+... 
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999977762 1              1110    0    0 01233431             011233444444444432 


Q ss_pred             ---CCCc---eeecCCCCCCeeeCCCCc-EEEecccCccc
Q 048535          232 ---WESK---VLHRDIKASNVLLDKKMN-ARLGDFGLAKM  264 (409)
Q Consensus       232 ---~~~~---ivHrDlKp~NILl~~~~~-~kl~DFGla~~  264 (409)
                         ....   +||+|+-|.||+++.+.. +.+.|||-+..
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence               1233   999999999999999875 89999998753

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.26  E-value=0.05  Score=53.28  Aligned_cols=62  Identities=21%  Similarity=0.202  Sum_probs=45.9

Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK  250 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~  250 (409)
                      ...|+-+|+++-++..++..    ...++....+++.-.++|+.-+--  --+.+|.|+.|.||++--
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~----~~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKW----KSQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             cceeeeeccccccHHhhhhc----ccChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEe
Confidence            35677789999999999843    234556667777777777755543  468999999999999943

>PRK06148 hypothetical protein; Provisional

Probab=95.08  E-value=0.49  Score=52.88  Aligned_cols=142  Identities=18%  Similarity=0.218  Sum_probs=77.2

Q ss_pred             ceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccC-------CCCceeeEe-e----EEEccCC--e
Q 048535          119 NVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRL-------KHRNLVGLR-G----WCKKEKE--S  183 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-------~H~niv~l~-g----~~~~~~~--~  183 (409)
                      +.|+ |..-.+|+.... |..+++|+.+.....  .....|...|..|       .-|.+++-. |    ......+  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4454 345678887766 778999999754222  2333444555433       234444322 1    1111112  4


Q ss_pred             EEEEEEeCCCCCHHHH-----------------Hhc----CC---CCCCCCHHH-----------------HHHHHHHHH
Q 048535          184 LILIYDYMENGSLDKW-----------------IFE----CD---ESIALSWEQ-----------------RIKVLKDVA  222 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~-----------------l~~----~~---~~~~l~~~~-----------------~~~i~~~ia  222 (409)
                      .+-+++|++|..+.+.                 ++.    ..   ....+.|..                 ...++.++.
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            6778999999777541                 110    00   011233321                 112222332


Q ss_pred             HHHH-----HHHhcCCCceeecCCCCCCeeeCCCC--cEE-EecccCccc
Q 048535          223 SGIL-----YLYEGWESKVLHRDIKASNVLLDKKM--NAR-LGDFGLAKM  264 (409)
Q Consensus       223 ~gL~-----yLH~~~~~~ivHrDlKp~NILl~~~~--~~k-l~DFGla~~  264 (409)
                      +...     .+. .....+||.|+.+.|||++.+.  ++. |.|||-+..
T Consensus       188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            2221     122 2256799999999999999875  555 999998754

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.66  E-value=1.1  Score=43.31  Aligned_cols=30  Identities=27%  Similarity=0.343  Sum_probs=25.2

Q ss_pred             CCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       233 ~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ..+++|+|+-+.|||++ + .+.|.||+-+..
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            45789999999999995 4 578999998754

>PTZ00384 choline kinase; Provisional

Probab=94.54  E-value=0.34  Score=47.89  Aligned_cols=73  Identities=16%  Similarity=0.208  Sum_probs=42.8

Q ss_pred             ceeecCCceEEEEEEECC---cE-----EEEEEeccCChHHHHHHHHHHHHhccCCCCcee-eEeeEEEccCCeEEEEEE
Q 048535          119 NVIGLGGNGKVYKGQLLG---VE-----VALKRISLDSEHGMREFLAEVSSLGRLKHRNLV-GLRGWCKKEKESLILIYD  189 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~~---~~-----vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~~lv~E  189 (409)
                      +.|..|-...+|++...+   ..     |.+......... .-.-.+|+.+++.+...++- ++++.+..     ++++|
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l-~IdR~~E~~i~~~Ls~~glgP~l~~~f~~-----g~l~e  129 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSL-VIDNDLQYNIAKLLGDNNFGPKIIGRFGD-----FTIQE  129 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCce-EeccHHHHHHHHHHHhCCCCCeEEEecCC-----EEEEE
Confidence            455567788899887652   12     444432211111 11224688999998665554 45554421     58999


Q ss_pred             eCCCCCHH
Q 048535          190 YMENGSLD  197 (409)
Q Consensus       190 ~~~~gsL~  197 (409)
                      |++|-.|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99987653

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=94.33  E-value=0.032  Score=35.44  Aligned_cols=31  Identities=19%  Similarity=0.145  Sum_probs=17.2

Q ss_pred             ccceeEehhhHHHHHHHHHHHHHHhhhhhcc
Q 048535           51 RSKGFILGVSVGGLLIMGCGVVVYMVCLKRK   81 (409)
Q Consensus        51 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~r~   81 (409)
                      .+..+.+|+++..+++++++.+++++++||+
T Consensus         9 ~~vaIa~~VvVPV~vI~~vl~~~l~~~~rR~   39 (40)
T PF08693_consen    9 NTVAIAVGVVVPVGVIIIVLGAFLFFWYRRK   39 (40)
T ss_pred             ceEEEEEEEEechHHHHHHHHHHhheEEecc
Confidence            3455666666666665555545454444443

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>PTZ00296 choline kinase; Provisional

Probab=94.00  E-value=0.42  Score=48.16  Aligned_cols=140  Identities=14%  Similarity=0.124  Sum_probs=78.4

Q ss_pred             cceeecCCceEEEEEEEC----------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCcee-eEeeEEEccCCeEEE
Q 048535          118 ENVIGLGGNGKVYKGQLL----------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV-GLRGWCKKEKESLIL  186 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~----------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~g~~~~~~~~~~l  186 (409)
                      .+.|..|-.-.+|+....          ++.|.+++.-.....-. .-..|..++..+...+|- ++++.+.  +   ..
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~--g---g~  183 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS--G---GR  183 (442)
T ss_pred             EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC--C---CE
Confidence            355666777788887754          35788887754432222 234677777777544443 4555442  2   35


Q ss_pred             EEEeCCCCCHHH--H---------------HhcCCCC---------CCCCHHHHHHHHHHHH------------------
Q 048535          187 IYDYMENGSLDK--W---------------IFECDES---------IALSWEQRIKVLKDVA------------------  222 (409)
Q Consensus       187 v~E~~~~gsL~~--~---------------l~~~~~~---------~~l~~~~~~~i~~~ia------------------  222 (409)
                      |.||+++-.|..  +               +|.....         .+..|..+.++...+.                  
T Consensus       184 I~efi~g~~l~~~dl~~~~~~~~iA~~L~~lH~~~~~~~~~~~f~~~p~~f~~i~~~~~~~~~~~~~~~~~~~~~~l~~e  263 (442)
T PTZ00296        184 IEEWLYGDPLRIDDLKNPSILIGIANVLGKFHTLSRKRHLPEHWDRTPCIFKMMEKWKNQLSKYKNIEKYQRDIHKYIKE  263 (442)
T ss_pred             EEEeeCCccCCHHHcCCHHHHHHHHHHHHHHhcccccccCchhccCCCcHHHHHHHHHHHHHhhccchHhHhhHHHHHHH
Confidence            799999864431  1               1221100         0112333333322211                  


Q ss_pred             --HHHHHHH-------hcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          223 --SGILYLY-------EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       223 --~gL~yLH-------~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                        .-..++.       ......++|.|+-+.|||.++++ ++++||-.|..
T Consensus       264 ~~~l~~~l~~~~~l~~~~~~~VfCHNDl~~~NiL~~~~~-l~LIDfEYAg~  313 (442)
T PTZ00296        264 SEKFIKFMKVYSKSDNLANDIVFCHNDLQENNIINTNKC-LRLIDFEYSGY  313 (442)
T ss_pred             HHHHHHHHHhhcccccccCCeeEEeCCCCccceeecCCC-EEEEeeccccc
Confidence              1122332       11135689999999999986554 99999988864

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	409
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-34
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-33
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-25
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-25
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-23
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-23
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-23
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-15
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		9e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-13
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-13
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-13
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		6e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-11
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-11
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-11
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-11
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-11
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-11
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-11
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-11
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-11
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-11
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-11
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-11
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		7e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-10
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-10
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-10
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-10
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-10
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		8e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		9e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		9e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-09
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-09
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-09
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-09
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-09
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-09
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		8e-09
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-09
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-09
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-09
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		9e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-09
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-09
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-08
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-08
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		3e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-08
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		3e-08
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-08
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-08
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		5e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-08
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-08
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		8e-08
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		9e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		9e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-07
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-07
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-07
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-07
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-07
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-07
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-07
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-07
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-07
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		4e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-07
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-07
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-07
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-07
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-07
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		6e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		7e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-06
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-06
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-06
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-06
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-06
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-06
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-06
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-06
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-06
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-06
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-06
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		7e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		8e-06
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		9e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		9e-06
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		9e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-05
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-05
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-05
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-05
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-05
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-05
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-05
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-05
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-05
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-05
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-05
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-05
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		4e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-05
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-05
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-05
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-05
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-05
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-05
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		9e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-04
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-04
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-04
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-04
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-04
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-04
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-04
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-04
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-04
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-04
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-04
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-04
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-04
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-04
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-04
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-04
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-04
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-04
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-04
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-04
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-04
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-04
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-04
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-04
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-04
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-04
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-04
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		3e-04
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-04
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-04
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-04
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-04
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-04
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-04
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-04
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		4e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-04
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-04
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-04
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-04
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-04
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-04
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		7e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-04
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-04
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		7e-04
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-04
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-04
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-04
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-04
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 100/309 (32%), Positives = 158/309 (51%), Gaps = 52/309 (16%)
Query: 87  DVEETEDWELEYWP-HRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRI 144
           DV   ED E+      R S +E+  A+  FS +N++G GG GKVYKG+L  G  VA+KR+
Sbjct: 11  DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 70
Query: 145 SLDSEHGMR-EFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC 203
             +   G   +F  EV  +    HRNL+ LRG+C    E L L+Y YM NGS+   + E 
Sbjct: 71  KEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRER 129
Query: 204 DES-IALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
            ES   L W +R ++    A G+ YL++  + K++HRD+KA+N+LLD++  A +GDFGLA
Sbjct: 130 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 189
Query: 263 KMHHHG---------------------------------------QVMSGRRPIE----- 278
           K+  +                                        ++++G+R  +     
Sbjct: 190 KLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 249
Query: 279 -EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI 337
            +    L+D +  L +  +L +++D  L  +G Y DE VE+++ + LLC       RP +
Sbjct: 250 NDDDVMLLDWVKGLLKEKKLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKM 307
Query: 338 RQVLKMLEG 346
            +V++MLEG
Sbjct: 308 SEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 99/309 (32%), Positives = 159/309 (51%), Gaps = 52/309 (16%)
Query: 87  DVEETEDWELEYWP-HRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRI 144
           DV   ED E+      R S +E+  A+  F  +N++G GG GKVYKG+L  G  VA+KR+
Sbjct: 3   DVPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRL 62
Query: 145 SLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC 203
             + ++ G  +F  EV  +    HRNL+ LRG+C    E L L+Y YM NGS+   + E 
Sbjct: 63  KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRER 121
Query: 204 DES-IALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
            ES   L W +R ++    A G+ YL++  + K++HRD+KA+N+LLD++  A +GDFGLA
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181
Query: 263 KMHHHG---------------------------------------QVMSGRRPIEEGKRN 283
           K+  +                                        ++++G+R  +  +  
Sbjct: 182 KLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241
Query: 284 ------LVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI 337
                 L+D +  L +  +L +++D  L  +G Y DE VE+++ + LLC       RP +
Sbjct: 242 NDDDVMLLDWVKGLLKEKKLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKM 299
Query: 338 RQVLKMLEG 346
            +V++MLEG
Sbjct: 300 SEVVRMLEG 308

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  111 bits (278), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 66/175 (37%), Positives = 109/175 (62%), Gaps = 6/175 (3%)
Query: 91  TEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSE 149
           +  + + +  +RV   ++  AT  F  + +IG G  GKVYKG L  G +VALKR + +S 
Sbjct: 17  SSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS 76
Query: 150 HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECD-ESIA 208
            G+ EF  E+ +L   +H +LV L G+C  E+  +ILIY YMENG+L + ++  D  +++
Sbjct: 77  QGIEEFETEIETLSFCRHPHLVSLIGFC-DERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 209 LSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +SWEQR+++    A G+ YL+      ++HRD+K+ N+LLD+    ++ DFG++K
Sbjct: 136 MSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK 187

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 66/175 (37%), Positives = 109/175 (62%), Gaps = 6/175 (3%)
Query: 91  TEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSE 149
           +  + + +  +RV   ++  AT  F  + +IG G  GKVYKG L  G +VALKR + +S 
Sbjct: 17  SSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS 76
Query: 150 HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECD-ESIA 208
            G+ EF  E+ +L   +H +LV L G+C  E+  +ILIY YMENG+L + ++  D  +++
Sbjct: 77  QGIEEFETEIETLSFCRHPHLVSLIGFC-DERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 209 LSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +SWEQR+++    A G+ YL+      ++HRD+K+ N+LLD+    ++ DFG++K
Sbjct: 136 MSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK 187

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 62/173 (35%), Positives = 97/173 (56%), Gaps = 14/173 (8%)
Query: 101 HRVSYQEIHAATKGFSEE------NVIGLGGNGKVYKGQLLGVEVALKRIS----LDSEH 150
           H  S+ E+   T  F E       N +G GG G VYKG +    VA+K+++    + +E 
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 72
Query: 151 GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALS 210
             ++F  E+  + + +H NLV L G+   + + L L+Y YM NGSL   +   D +  LS
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGF-SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           W  R K+ +  A+GI +L+E      +HRDIK++N+LLD+   A++ DFGLA+
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 62/173 (35%), Positives = 97/173 (56%), Gaps = 14/173 (8%)
Query: 101 HRVSYQEIHAATKGFSEE------NVIGLGGNGKVYKGQLLGVEVALKRIS----LDSEH 150
           H  S+ E+   T  F E       N +G GG G VYKG +    VA+K+++    + +E 
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 72
Query: 151 GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALS 210
             ++F  E+  + + +H NLV L G+   + + L L+Y YM NGSL   +   D +  LS
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGF-SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           W  R K+ +  A+GI +L+E      +HRDIK++N+LLD+   A++ DFGLA+
Sbjct: 132 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 62/173 (35%), Positives = 97/173 (56%), Gaps = 14/173 (8%)
Query: 101 HRVSYQEIHAATKGFSEE------NVIGLGGNGKVYKGQLLGVEVALKRIS----LDSEH 150
           H  S+ E+   T  F E       N +G GG G VYKG +    VA+K+++    + +E 
Sbjct: 7   HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 66
Query: 151 GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALS 210
             ++F  E+  + + +H NLV L G+   + + L L+Y YM NGSL   +   D +  LS
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGF-SSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 125
Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           W  R K+ +  A+GI +L+E      +HRDIK++N+LLD+   A++ DFGLA+
Sbjct: 126 WHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 175

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 61/173 (35%), Positives = 93/173 (53%), Gaps = 14/173 (8%)
Query: 101 HRVSYQEIHAATKGFSEE------NVIGLGGNGKVYKGQLLGVEVALKR----ISLDSEH 150
           H  S+ E+   T  F E       N  G GG G VYKG +    VA+K+    + + +E 
Sbjct: 4   HSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEE 63
Query: 151 GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALS 210
             ++F  E+    + +H NLV L G+   + + L L+Y Y  NGSL   +   D +  LS
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGF-SSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLS 122
Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           W  R K+ +  A+GI +L+E      +HRDIK++N+LLD+   A++ DFGLA+
Sbjct: 123 WHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 172

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 92/165 (55%), Gaps = 15/165 (9%)
Query: 107 EIHAATKGFSEENVIGLGGNGKVYKGQLLG------VEVALKRISLDSEHGMR-EFLAEV 159
           EIH +    + + VIG G  G+VYKG L        V VA+K +        R +FL E 
Sbjct: 40  EIHPSC--VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 97
Query: 160 SSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLK 219
             +G+  H N++ L G   K K  +++I +YMENG+LDK++ E D   ++   Q + +L+
Sbjct: 98  GIMGQFSHHNIIRLEGVISKYK-PMMIITEYMENGALDKFLREKDGEFSVL--QLVGMLR 154
Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            +A+G+ YL        +HRD+ A N+L++  +  ++ DFGL+++
Sbjct: 155 GIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 102/186 (54%), Gaps = 23/186 (12%)
Query: 95  ELEYWPHRVSYQEIHAATKGFSEE---------NVIGLGGNGKVYKGQLL-----GVEVA 140
           E +++    +Y+E   A + F+ E          +IG G +G+V  G+L       V VA
Sbjct: 22  EPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVA 81
Query: 141 LKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKW 199
           +K +    +E   R+FL+E S +G+  H N++ L G   + + ++I + +YMENGSLD +
Sbjct: 82  IKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI-VTEYMENGSLDTF 140
Query: 200 IFECDESIALSWEQRIKVLKDVASGILYLYE-GWESKVLHRDIKASNVLLDKKMNARLGD 258
           +   D    +   Q + +L+ V +G+ YL + G+    +HRD+ A NVL+D  +  ++ D
Sbjct: 141 LRTHDGQFTIM--QLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSD 194
Query: 259 FGLAKM 264
           FGL+++
Sbjct: 195 FGLSRV 200

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 102/186 (54%), Gaps = 23/186 (12%)
Query: 95  ELEYWPHRVSYQEIHAATKGFSEE---------NVIGLGGNGKVYKGQLL-----GVEVA 140
           E +++    +Y+E   A + F+ E          +IG G +G+V  G+L       V VA
Sbjct: 22  EPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVA 81
Query: 141 LKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKW 199
           +K +    +E   R+FL+E S +G+  H N++ L G   + + ++I + +YMENGSLD +
Sbjct: 82  IKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI-VTEYMENGSLDTF 140
Query: 200 IFECDESIALSWEQRIKVLKDVASGILYLYE-GWESKVLHRDIKASNVLLDKKMNARLGD 258
           +   D    +   Q + +L+ V +G+ YL + G+    +HRD+ A NVL+D  +  ++ D
Sbjct: 141 LRTHDGQFTIM--QLVGMLRGVGAGMRYLSDLGY----VHRDLAARNVLVDSNLVCKVSD 194
Query: 259 FGLAKM 264
           FGL+++
Sbjct: 195 FGLSRV 200

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 96/175 (54%), Gaps = 19/175 (10%)
Query: 102 RVSYQEIHAATKGFSEEN-----VIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEH 150
           R S Q +H   K     N     V+G G  G+V  G+L       + VA+K + +  +E 
Sbjct: 17  RGSTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK 76
Query: 151 GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALS 210
             R+FL E S +G+  H N++ L G   K K  +I + +YMENGSLD ++ + D    + 
Sbjct: 77  QRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI-VTEYMENGSLDSFLRKHDAQFTVI 135
Query: 211 WEQRIKVLKDVASGILYLYE-GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
             Q + +L+ +ASG+ YL + G+    +HRD+ A N+L++  +  ++ DFGL+++
Sbjct: 136 --QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRV 184

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/179 (32%), Positives = 96/179 (53%), Gaps = 21/179 (11%)
Query: 100 PHRV--SYQEIHAATKGFSEEN-----VIGLGGNGKVYKGQLL-----GVEVALKRISLD 147
           PH      Q +H   K     N     V+G G  G+V  G+L       + VA+K + + 
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 148 -SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDES 206
            +E   R+FL E S +G+  H N++ L G   K K  +I + +YMENGSLD ++ + D  
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI-VTEYMENGSLDSFLRKHDAQ 143
Query: 207 IALSWEQRIKVLKDVASGILYLYE-GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
             +   Q + +L+ +ASG+ YL + G+    +HRD+ A N+L++  +  ++ DFGLA++
Sbjct: 144 FTVI--QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLARV 196

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/173 (32%), Positives = 95/173 (54%), Gaps = 19/173 (10%)
Query: 104 SYQEIHAATKGFSEEN-----VIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGM 152
           S Q +H   K     N     V+G G  G+V  G+L       + VA+K + +  +E   
Sbjct: 2   STQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 61
Query: 153 REFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWE 212
           R+FL E S +G+  H N++ L G   K K  +I + +YMENGSLD ++ + D    +   
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI-VTEYMENGSLDSFLRKHDAQFTVI-- 118
Query: 213 QRIKVLKDVASGILYLYE-GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           Q + +L+ +ASG+ YL + G+    +HRD+ A N+L++  +  ++ DFGL+++
Sbjct: 119 QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRV 167

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 83/146 (56%), Gaps = 4/146 (2%)
Query: 121 IGLGGNGKVYKGQLLGVEVALKRISLDSEHGMR--EFLAEVSSLGRLKHRNLVGLRGWCK 178
           IG G  G V++ +  G +VA+K +     H  R  EFL EV+ + RL+H N+V   G   
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG-AV 103
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLH 238
            +  +L ++ +Y+  GSL + + +      L   +R+ +  DVA G+ YL+      ++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVH 162
Query: 239 RDIKASNVLLDKKMNARLGDFGLAKM 264
           RD+K+ N+L+DKK   ++ DFGL+++
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 94/178 (52%), Gaps = 19/178 (10%)
Query: 100 PHRV--SYQEIHAATKGFSEEN-----VIGLGGNGKVYKGQLL-----GVEVALKRISLD 147
           PH      Q +H   K     N     V+G G  G+V  G+L       + VA+K + + 
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 148 -SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDES 206
            +E   R+FL E S +G+  H N++ L G   K K  +I + +YMENGSLD ++ + D  
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI-VTEYMENGSLDSFLRKHDAQ 143
Query: 207 IALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
             +   Q + +L+ +ASG+ YL    +   +HRD+ A N+L++  +  ++ DFGL+++
Sbjct: 144 FTVI--QLVGMLRGIASGMKYLS---DMGFVHRDLAARNILINSNLVCKVSDFGLSRV 196

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 96/179 (53%), Gaps = 21/179 (11%)
Query: 100 PHRV--SYQEIHAATKGFSEEN-----VIGLGGNGKVYKGQLL-----GVEVALKRISLD 147
           PH      Q +H   K     N     V+G G  G+V  G+L       + VA+K + + 
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 148 -SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDES 206
            +E   R+FL E S +G+  H N++ L G   K K  +I + +YMENGSLD ++ + D  
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI-VTEYMENGSLDSFLRKHDAQ 143
Query: 207 IALSWEQRIKVLKDVASGILYLYE-GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
             +   Q + +L+ +ASG+ YL + G+    +HRD+ A N+L++  +  ++ DFGL+++
Sbjct: 144 FTVI--QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRV 196

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 96/179 (53%), Gaps = 21/179 (11%)
Query: 100 PHRV--SYQEIHAATKGFSEEN-----VIGLGGNGKVYKGQLL-----GVEVALKRISLD 147
           PH      Q +H   K     N     V+G G  G+V  G+L       + VA+K + + 
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 148 -SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDES 206
            +E   R+FL E S +G+  H N++ L G   K K  +I + +YMENGSLD ++ + D  
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI-VTEYMENGSLDSFLRKHDAQ 143
Query: 207 IALSWEQRIKVLKDVASGILYLYE-GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
             +   Q + +L+ +ASG+ YL + G+    +HRD+ A N+L++  +  ++ DFGL+++
Sbjct: 144 FTVI--QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRV 196

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 94/171 (54%), Gaps = 19/171 (11%)
Query: 106 QEIHAATKGFSEEN-----VIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMRE 154
           Q +H   K     N     V+G G  G+V  G+L       + VA+K + +  +E   R+
Sbjct: 33  QTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 155 FLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR 214
           FL E S +G+  H N++ L G   K K  +I + +YMENGSLD ++ + D    +   Q 
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI-VTEYMENGSLDSFLRKHDAQFTVI--QL 149
Query: 215 IKVLKDVASGILYLYE-GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           + +L+ +ASG+ YL + G+    +HRD+ A N+L++  +  ++ DFGL+++
Sbjct: 150 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRV 196

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 94/171 (54%), Gaps = 19/171 (11%)
Query: 106 QEIHAATKGFSEEN-----VIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMRE 154
           Q +H   K     N     V+G G  G+V  G+L       + VA+K + +  +E   R+
Sbjct: 33  QTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 155 FLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR 214
           FL E S +G+  H N++ L G   K K  +I + +YMENGSLD ++ + D    +   Q 
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI-VTEYMENGSLDSFLRKHDAQFTVI--QL 149
Query: 215 IKVLKDVASGILYLYE-GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           + +L+ +ASG+ YL + G+    +HRD+ A N+L++  +  ++ DFGL+++
Sbjct: 150 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRV 196

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/171 (32%), Positives = 94/171 (54%), Gaps = 19/171 (11%)
Query: 106 QEIHAATKGFSEEN-----VIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMRE 154
           Q +H   K     N     V+G G  G+V  G+L       + VA+K + +  +E   R+
Sbjct: 31  QTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 90
Query: 155 FLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR 214
           FL E S +G+  H N++ L G   K K  +I + +YMENGSLD ++ + D    +   Q 
Sbjct: 91  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI-VTEYMENGSLDSFLRKHDAQFTVI--QL 147
Query: 215 IKVLKDVASGILYLYE-GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           + +L+ +ASG+ YL + G+    +HRD+ A N+L++  +  ++ DFGL+++
Sbjct: 148 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRV 194

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 95/179 (53%), Gaps = 21/179 (11%)
Query: 100 PHRV--SYQEIHAATKGFSEEN-----VIGLGGNGKVYKGQLL-----GVEVALKRISLD 147
           PH      Q +H   K     N     V+G G  G+V  G+L       + VA+K + + 
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 148 -SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDES 206
            +E   R+FL E S +G+  H N++ L G   K K  +I + +YMENGSLD ++ + D  
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI-VTEYMENGSLDSFLRKHDAQ 143
Query: 207 IALSWEQRIKVLKDVASGILYLYE-GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
             +   Q + +L+ +ASG+ YL + G+    +HRD+ A N+L++  +  ++ DFGL ++
Sbjct: 144 FTVI--QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRV 196

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 88/170 (51%), Gaps = 21/170 (12%)
Query: 118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSS----LGRLKHRNLVGL 173
           E +IG+GG GKVY+   +G EVA+K    D +  + + +  V         LKH N++ L
Sbjct: 12  EEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIF--ECDESIALSWEQRIKVLKDVASGILYLYEG 231
           RG C KE  +L L+ ++   G L++ +        I ++W  +I      A G+ YL++ 
Sbjct: 72  RGVCLKEP-NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMNYLHDE 124
Query: 232 WESKVLHRDIKASNVLLDKKMN--------ARLGDFGLAKMHHHGQVMSG 273
               ++HRD+K+SN+L+ +K+          ++ DFGLA+  H    MS 
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA 174

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 83/146 (56%), Gaps = 4/146 (2%)
Query: 121 IGLGGNGKVYKGQLLGVEVALKRISLDSEHGMR--EFLAEVSSLGRLKHRNLVGLRGWCK 178
           IG G  G V++ +  G +VA+K +     H  R  EFL EV+ + RL+H N+V   G   
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG-AV 103
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLH 238
            +  +L ++ +Y+  GSL + + +      L   +R+ +  DVA G+ YL+      ++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVH 162
Query: 239 RDIKASNVLLDKKMNARLGDFGLAKM 264
           R++K+ N+L+DKK   ++ DFGL+++
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL 188

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 101/181 (55%), Gaps = 25/181 (13%)
Query: 100 PHRVSYQEIHAATKGFSEE---------NVIGLGGNGKVYKGQL-----LGVEVALKRIS 145
           PH  +Y++ + A   F++E          VIG G  G+V  G+L       + VA+K + 
Sbjct: 2   PH--TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLK 59
Query: 146 LD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECD 204
           +  +E   R+FL E S +G+  H N++ L G   K K  +I + +YMENGSLD ++ + D
Sbjct: 60  VGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMI-VTEYMENGSLDTFLKKND 118
Query: 205 ESIALSWEQRIKVLKDVASGILYLYE-GWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               +   Q + +L+ +++G+ YL + G+    +HRD+ A N+L++  +  ++ DFGL++
Sbjct: 119 GQFTVI--QLVGMLRGISAGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR 172
Query: 264 M 264
           +
Sbjct: 173 V 173

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 103/191 (53%), Gaps = 23/191 (12%)
Query: 83  KKMKDVEETEDWELEYWPHRVSYQ---EIHAATKGFSEENVIGLGGNGKVYKGQL----- 134
           K   D E  ED      P+R  +Q   E+ A+      E VIG G  G+V  G+L     
Sbjct: 18  KTYIDPETYED------PNRAVHQFAKELDASC--IKIERVIGAGEFGEVCSGRLKLPGK 69
Query: 135 LGVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMEN 193
             V VA+K + +  +E   R+FL E S +G+  H N+V L G   + K  +I+I ++MEN
Sbjct: 70  RDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVI-EFMEN 128
Query: 194 GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN 253
           G+LD ++ + D    +   Q + +L+ +A+G+ YL    +   +HRD+ A N+L++  + 
Sbjct: 129 GALDAFLRKHDGQFTVI--QLVGMLRGIAAGMRYLA---DMGYVHRDLAARNILVNSNLV 183
Query: 254 ARLGDFGLAKM 264
            ++ DFGL+++
Sbjct: 184 CKVSDFGLSRV 194

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 94/173 (54%), Gaps = 19/173 (10%)
Query: 104 SYQEIHAATKGFSEEN-----VIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGM 152
           S Q +H   K     N     V+G G  G+V  G+L       + VA+K + +  +E   
Sbjct: 2   STQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR 61
Query: 153 REFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWE 212
           R+FL E S +G+  H N++ L G   K K  +I + + MENGSLD ++ + D    +   
Sbjct: 62  RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI-VTEXMENGSLDSFLRKHDAQFTVI-- 118
Query: 213 QRIKVLKDVASGILYLYE-GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           Q + +L+ +ASG+ YL + G+    +HRD+ A N+L++  +  ++ DFGL+++
Sbjct: 119 QLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRV 167

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 93/178 (52%), Gaps = 19/178 (10%)
Query: 100 PHRV--SYQEIHAATKGFSEEN-----VIGLGGNGKVYKGQLL-----GVEVALKRISLD 147
           PH      Q +H   K     N     V+G G  G+V  G+L       + VA+K + + 
Sbjct: 25  PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 148 -SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDES 206
            +E   R+FL E S +G+  H N++ L G   K K  +I + + MENGSLD ++ + D  
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI-VTEXMENGSLDSFLRKHDAQ 143
Query: 207 IALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
             +   Q + +L+ +ASG+ YL    +   +HRD+ A N+L++  +  ++ DFGL+++
Sbjct: 144 FTVI--QLVGMLRGIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRV 196

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 86/153 (56%), Gaps = 12/153 (7%)
Query: 118 ENVIGLGGNGKVYKGQL-----LGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKHRNLV 171
           E VIG G  G+V  G L       + VA+K + S  +E   R+FL+E S +G+  H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G   K    +I I ++MENGSLD ++ + D    +   Q + +L+ +A+G+ YL + 
Sbjct: 98  HLEGVVTKSTPVMI-ITEFMENGSLDSFLRQNDGQFTVI--QLVGMLRGIAAGMKYLAD- 153
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                +HRD+ A N+L++  +  ++ DFGL++ 
Sbjct: 154 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 184

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 93/171 (54%), Gaps = 19/171 (11%)
Query: 106 QEIHAATKGFSEEN-----VIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMRE 154
           Q +H   K     N     V+G G  G+V  G+L       + VA+K + +  +E   R+
Sbjct: 33  QTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 155 FLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR 214
           FL E S +G+  H N++ L G   K K  +I + + MENGSLD ++ + D    +   Q 
Sbjct: 93  FLGEASIMGQFDHPNIIRLEGVVTKSKPVMI-VTEXMENGSLDSFLRKHDAQFTVI--QL 149
Query: 215 IKVLKDVASGILYLYE-GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           + +L+ +ASG+ YL + G+    +HRD+ A N+L++  +  ++ DFGL+++
Sbjct: 150 VGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRV 196

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 98/176 (55%), Gaps = 21/176 (11%)
Query: 104 SYQEIHAATKGFSEE---------NVIGLGGNGKVYKGQL-----LGVEVALKRISLD-S 148
           ++++ + A + F++E          VIG+G  G+V  G+L       + VA+K +    +
Sbjct: 11  TFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYT 70
Query: 149 EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA 208
           +   R+FL+E S +G+  H N++ L G   K K  +I I +YMENGSLD ++ + D    
Sbjct: 71  DKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMI-ITEYMENGSLDAFLRKNDGRFT 129
Query: 209 LSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           +   Q + +L+ + SG+ YL +      +HRD+ A N+L++  +  ++ DFG++++
Sbjct: 130 VI--QLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDFGMSRV 180

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 88/153 (57%), Gaps = 12/153 (7%)
Query: 118 ENVIGLGGNGKVYKGQL-----LGVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
           E VIG+G  G+V  G+L       + VA+K +    ++   R+FL+E S +G+  H N++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G   K K  +I I +YMENGSLD ++ + D    +   Q + +L+ + SG+ YL + 
Sbjct: 79  HLEGVVTKCKPVMI-ITEYMENGSLDAFLRKNDGRFTVI--QLVGMLRGIGSGMKYLSD- 134
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                +HRD+ A N+L++  +  ++ DFG++++
Sbjct: 135 --MSYVHRDLAARNILVNSNLVCKVSDFGMSRV 165

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 118 ENVIGLGGNGKVYKGQLLGVE-----VALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
           E VIG G  G+V +G+L         VA+K +    +E   REFL+E S +G+ +H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G        +IL  ++MENG+LD ++   D    +   Q + +L+ +ASG+ YL E 
Sbjct: 81  RLEGVVTNSMPVMILT-EFMENGALDSFLRLNDGQFTVI--QLVGMLRGIASGMRYLAE- 136
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                +HRD+ A N+L++  +  ++ DFGL++ 
Sbjct: 137 --MSYVHRDLAARNILVNSNLVCKVSDFGLSRF 167

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 88/153 (57%), Gaps = 12/153 (7%)
Query: 118 ENVIGLGGNGKVYKGQL-----LGVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
           E VIG+G  G+V  G+L       + VA+K +    ++   R+FL+E S +G+  H N++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G   K K  +I I +YMENGSLD ++ + D    +   Q + +L+ + SG+ YL + 
Sbjct: 73  HLEGVVTKCKPVMI-ITEYMENGSLDAFLRKNDGRFTVI--QLVGMLRGIGSGMKYLSD- 128
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                +HRD+ A N+L++  +  ++ DFG++++
Sbjct: 129 --MSYVHRDLAARNILVNSNLVCKVSDFGMSRV 159

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 118 ENVIGLGGNGKVYKGQLLGVE-----VALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
           E VIG G  G+V +G+L         VA+K +    +E   REFL+E S +G+ +H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G        +IL  ++MENG+LD ++   D    +   Q + +L+ +ASG+ YL E 
Sbjct: 79  RLEGVVTNSMPVMILT-EFMENGALDSFLRLNDGQFTVI--QLVGMLRGIASGMRYLAE- 134
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                +HRD+ A N+L++  +  ++ DFGL++ 
Sbjct: 135 --MSYVHRDLAARNILVNSNLVCKVSDFGLSRF 165

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 79/250 (31%), Positives = 115/250 (46%), Gaps = 30/250 (12%)
Query: 119 NVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
             IG G  G V  G   G +VA+K I  D+    + FLAE S + +L+H NLV L G   
Sbjct: 199 QTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLH 238
           +EK  L ++ +YM  GSL  ++     S+ L  +  +K   DV   + YL EG  +  +H
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL-EG--NNFVH 312
Query: 239 RDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIE--------EGKRNLVDRMWS 290
           RD+ A NVL+ +   A++ DFGL K     Q  +G+ P++        E K +    +WS
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWS 371
Query: 291 ----LTERSELLSVLDERLKAKG-------GY----ADEVVEKVLHLGLLCAHPEANSRP 335
               L E      V   R+  K        GY     D     V  +   C H +A +RP
Sbjct: 372 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRP 431
Query: 336 TIRQVLKMLE 345
           T  Q+ + LE
Sbjct: 432 TFLQLREQLE 441

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 85/153 (55%), Gaps = 12/153 (7%)
Query: 118 ENVIGLGGNGKVYKGQL-----LGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKHRNLV 171
           E VIG G  G+V  G L       + VA+K + S  +E   R+FL+E S +G+  H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G   K    +I I ++MENGSLD ++ + D    +   Q + +L+ +A+G+ YL   
Sbjct: 72  HLEGVVTKSTPVMI-ITEFMENGSLDSFLRQNDGQFTVI--QLVGMLRGIAAGMKYLA-- 126
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            +   +HR + A N+L++  +  ++ DFGL++ 
Sbjct: 127 -DMNYVHRALAARNILVNSNLVCKVSDFGLSRF 158

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 87/168 (51%), Gaps = 27/168 (16%)
Query: 110 AATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREF-LAEVSSLGRLK 166
           +++  F +   +G G    VYKG  +  GV VALK + LDSE G     + E+S +  LK
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWI-----------FECDESIALSWEQRI 215
           H N+V L      E + L L++++M+N  L K++            E +      W+   
Sbjct: 62  HENIVRLYDVIHTENK-LTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQ--- 116
Query: 216 KVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
                +  G+ + +E   +K+LHRD+K  N+L++K+   +LGDFGLA+
Sbjct: 117 -----LLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLAR 156

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 114/250 (45%), Gaps = 30/250 (12%)
Query: 119 NVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
             IG G  G V  G   G +VA+K I  D+    + FLAE S + +L+H NLV L G   
Sbjct: 27  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLH 238
           +EK  L ++ +YM  GSL  ++     S+ L  +  +K   DV   + YL EG  +  +H
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL-EG--NNFVH 140
Query: 239 RDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIE--------EGKRNLVDRMWS 290
           RD+ A NVL+ +   A++ DFGL K     Q  +G+ P++        E K +    +WS
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWS 199
Query: 291 ----LTERSELLSVLDERLKAKG-------GY----ADEVVEKVLHLGLLCAHPEANSRP 335
               L E      V   R+  K        GY     D     V  +   C H +A  RP
Sbjct: 200 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRP 259
Query: 336 TIRQVLKMLE 345
           +  Q+ + LE
Sbjct: 260 SFLQLREQLE 269

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/160 (35%), Positives = 85/160 (53%), Gaps = 7/160 (4%)
Query: 119 NVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
             IG G  G V  G   G +VA+K I  D+    + FLAE S + +L+H NLV L G   
Sbjct: 18  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLH 238
           +EK  L ++ +YM  GSL  ++     S+ L  +  +K   DV   + YL EG  +  +H
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL-EG--NNFVH 131
Query: 239 RDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIE 278
           RD+ A NVL+ +   A++ DFGL K     Q  +G+ P++
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVK 170

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 78/250 (31%), Positives = 114/250 (45%), Gaps = 30/250 (12%)
Query: 119 NVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
             IG G  G V  G   G +VA+K I  D+    + FLAE S + +L+H NLV L G   
Sbjct: 12  QTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLH 238
           +EK  L ++ +YM  GSL  ++     S+ L  +  +K   DV   + YL EG  +  +H
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL-EG--NNFVH 125
Query: 239 RDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIE--------EGKRNLVDRMWS 290
           RD+ A NVL+ +   A++ DFGL K     Q  +G+ P++        E K +    +WS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKKFSTKSDVWS 184
Query: 291 ----LTERSELLSVLDERLKAKG-------GY----ADEVVEKVLHLGLLCAHPEANSRP 335
               L E      V   R+  K        GY     D     V  +   C H +A  RP
Sbjct: 185 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRP 244
Query: 336 TIRQVLKMLE 345
           +  Q+ + LE
Sbjct: 245 SFLQLREQLE 254

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 122/261 (46%), Gaps = 39/261 (14%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +   S      FLAE + + +L+H+ LV  R +   
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV--RLYAVV 77
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + +I +YMENGSL  ++ +    I L+  + + +   +A G+ ++ E      +HR
Sbjct: 78  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133
Query: 240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS---GRRPIEEGKRNLVDRMWSLTERSE 296
           D++A+N+L+   ++ ++ DFGLA++    +  +    + PI+      ++   + T +S+
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAIN-YGTFTIKSD 192
Query: 297 LLS--------VLDERLKAKG------------GY----ADEVVEKVLHLGLLCAHPEAN 332
           + S        V   R+   G            GY     D   E++  L  LC      
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPE 252
Query: 333 SRPT---IRQVLKMLEGQTEG 350
            RPT   +R VL+     TEG
Sbjct: 253 DRPTFDYLRSVLEDFFTATEG 273

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 122/261 (46%), Gaps = 39/261 (14%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +   S      FLAE + + +L+H+ LV  R +   
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV--RLYAVV 87
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + +I +YMENGSL  ++ +    I L+  + + +   +A G+ ++ E      +HR
Sbjct: 88  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 143
Query: 240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS---GRRPIEEGKRNLVDRMWSLTERSE 296
           D++A+N+L+   ++ ++ DFGLA++    +  +    + PI+      ++   + T +S+
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN-YGTFTIKSD 202
Query: 297 LLS--------VLDERLKAKG------------GY----ADEVVEKVLHLGLLCAHPEAN 332
           + S        V   R+   G            GY     D   E++  L  LC      
Sbjct: 203 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPE 262
Query: 333 SRPT---IRQVLKMLEGQTEG 350
            RPT   +R VL+     TEG
Sbjct: 263 DRPTFDYLRSVLEDFFTATEG 283

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 122/261 (46%), Gaps = 39/261 (14%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +   S      FLAE + + +L+H+ LV  R +   
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV--RLYAVV 85
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + +I +YMENGSL  ++ +    I L+  + + +   +A G+ ++ E      +HR
Sbjct: 86  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 141
Query: 240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS---GRRPIEEGKRNLVDRMWSLTERSE 296
           D++A+N+L+   ++ ++ DFGLA++    +  +    + PI+      ++   + T +S+
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN-YGTFTIKSD 200
Query: 297 LLS--------VLDERLKAKG------------GY----ADEVVEKVLHLGLLCAHPEAN 332
           + S        V   R+   G            GY     D   E++  L  LC      
Sbjct: 201 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPE 260
Query: 333 SRPT---IRQVLKMLEGQTEG 350
            RPT   +R VL+     TEG
Sbjct: 261 DRPTFDYLRSVLEDFFTATEG 281

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 122/261 (46%), Gaps = 39/261 (14%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +   S      FLAE + + +L+H+ LV  R +   
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV--RLYAVV 83
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + +I +YMENGSL  ++ +    I L+  + + +   +A G+ ++ E      +HR
Sbjct: 84  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 139
Query: 240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS---GRRPIEEGKRNLVDRMWSLTERSE 296
           D++A+N+L+   ++ ++ DFGLA++    +  +    + PI+      ++   + T +S+
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN-YGTFTIKSD 198
Query: 297 LLS--------VLDERLKAKG------------GY----ADEVVEKVLHLGLLCAHPEAN 332
           + S        V   R+   G            GY     D   E++  L  LC      
Sbjct: 199 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPE 258
Query: 333 SRPT---IRQVLKMLEGQTEG 350
            RPT   +R VL+     TEG
Sbjct: 259 DRPTFDYLRSVLEDFFTATEG 279

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 122/261 (46%), Gaps = 39/261 (14%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +   S      FLAE + + +L+H+ LV  R +   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV--RLYAVV 77
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + +I +YMENGSL  ++ +    I L+  + + +   +A G+ ++ E      +HR
Sbjct: 78  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133
Query: 240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS---GRRPIEEGKRNLVDRMWSLTERSE 296
           D++A+N+L+   ++ ++ DFGLA++    +  +    + PI+      ++   + T +S+
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN-YGTFTIKSD 192
Query: 297 LLS--------VLDERLKAKG------------GY----ADEVVEKVLHLGLLCAHPEAN 332
           + S        V   R+   G            GY     D   E++  L  LC      
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPE 252
Query: 333 SRPT---IRQVLKMLEGQTEG 350
            RPT   +R VL+     TEG
Sbjct: 253 DRPTFDYLRSVLEDFFTATEG 273

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 122/261 (46%), Gaps = 39/261 (14%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +   S      FLAE + + +L+H+ LV  R +   
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV--RLYAVV 86
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + +I +YMENGSL  ++ +    I L+  + + +   +A G+ ++ E      +HR
Sbjct: 87  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 142
Query: 240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS---GRRPIEEGKRNLVDRMWSLTERSE 296
           D++A+N+L+   ++ ++ DFGLA++    +  +    + PI+      ++   + T +S+
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAIN-YGTFTIKSD 201
Query: 297 LLS--------VLDERLKAKG------------GY----ADEVVEKVLHLGLLCAHPEAN 332
           + S        V   R+   G            GY     D   E++  L  LC      
Sbjct: 202 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPE 261
Query: 333 SRPT---IRQVLKMLEGQTEG 350
            RPT   +R VL+     TEG
Sbjct: 262 DRPTFDYLRSVLEDFFTATEG 282

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 75/147 (51%), Gaps = 8/147 (5%)
Query: 120 VIGLGGNGKVYK--GQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
           V+G G  G+  K   +  G  + +K +    E   R FL EV  +  L+H N++   G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
            K+K  L  I +Y++ G+L   I   D      W QR+   KD+ASG+ YL+      ++
Sbjct: 77  YKDKR-LNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAKDIASGMAYLHS---MNII 130
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HRD+ + N L+ +  N  + DFGLA++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARL 157

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/147 (36%), Positives = 81/147 (55%), Gaps = 12/147 (8%)
Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVGLRGWC 177
           +G G    VYKG+  L    VALK I L+ E G     + EVS L  LKH N+V L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGILYLYEGWESKV 236
             EK SL L+++Y++   L +++ +C   I +     +K+ L  +  G+ Y +     KV
Sbjct: 70  HTEK-SLTLVFEYLDK-DLKQYLDDCGNIINM---HNVKLFLFQLLRGLAYCHR---QKV 121
Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAK 263
           LHRD+K  N+L++++   +L DFGLA+
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ YL     
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLAS--- 150
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 83/145 (57%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +   S      FLAE + + +L+H+ LV  R +   
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV--RLYAVV 72
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + +I +YMENGSL  ++ +    I L+  + + +   +A G+ ++ E      +HR
Sbjct: 73  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 128
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+   ++ ++ DFGLA++
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARL 153

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ YL     
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLAS--- 149
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 83/145 (57%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +   S      FLAE + + +L+H+ LV  R +   
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV--RLYAVV 83
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + +I +YMENGSL  ++ +    I L+  + + +   +A G+ ++ E      +HR
Sbjct: 84  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 139
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+   ++ ++ DFGLA++
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARL 164

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 83/145 (57%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +   S      FLAE + + +L+H+ LV  R +   
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV--RLYAVV 82
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + +I +YMENGSL  ++ +    I L+  + + +   +A G+ ++ E      +HR
Sbjct: 83  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 138
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+   ++ ++ DFGLA++
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARL 163

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ YL     
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLAS--- 170
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 200

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ YL     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLAS--- 151
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ YL     
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLAS--- 146
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 83/145 (57%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +   S      FLAE + + +L+H+ LV  R +   
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV--RLYAVV 79
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + +I +YMENGSL  ++ +    I L+  + + +   +A G+ ++ E      +HR
Sbjct: 80  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 135
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+   ++ ++ DFGLA++
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARL 160

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ YL     
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLAS--- 169
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 199

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ YL     
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLAS--- 150
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 180

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 83/145 (57%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +   S      FLAE + + +L+H+ LV  R +   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV--RLYAVV 77
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + +I +YMENGSL  ++ +    I L+  + + +   +A G+ ++ E      +HR
Sbjct: 78  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+   ++ ++ DFGLA++
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARL 158

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ YL     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLAS--- 151
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ YL     
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLAS--- 148
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 178

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ YL     
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKYLAS--- 143
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 173

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 83/145 (57%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +   S      FLAE + + +L+H+ LV  R +   
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV--RLYAVV 77
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + +I +YMENGSL  ++ +    I L+  + + +   +A G+ ++ E      +HR
Sbjct: 78  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 133
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+   ++ ++ DFGLA++
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARL 158

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 83/145 (57%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +   S      FLAE + + +L+H+ LV  R +   
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV--RLYAVV 78
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + +I +YMENGSL  ++ +    I L+  + + +   +A G+ ++ E      +HR
Sbjct: 79  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 134
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+   ++ ++ DFGLA++
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARL 159

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 83/160 (51%), Gaps = 21/160 (13%)
Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           +G G  GKV+  +          + VA+K +   S++  ++F  E   L  L+H ++V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWI----------FECDESIALSWEQRIKVLKDVAS 223
            G C  E + LI++++YM++G L+K++           E +    L+  Q + + + +A+
Sbjct: 81  YGVCV-EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           G++YL        +HRD+   N L+ + +  ++GDFG+++
Sbjct: 140 GMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSR 176

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 13/163 (7%)
Query: 101 HRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVS 160
           H + Y+EI         E V+G G  G V K +    +VA+K+I  +SE   + F+ E+ 
Sbjct: 4   HMIDYKEIEV-------EEVVGRGAFGVVCKAKWRAKDVAIKQIESESER--KAFIVELR 54
Query: 161 SLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD 220
            L R+ H N+V L G C      + L+ +Y E GSL   +   +     +    +     
Sbjct: 55  QLSRVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 111
Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNA-RLGDFGLA 262
            + G+ YL+      ++HRD+K  N+LL       ++ DFG A
Sbjct: 112 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 154

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ +L     
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLAS--- 156
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 186

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ +L     
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLAS--- 210
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 44/270 (16%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E    I+I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 78  REPPFYIII-EFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLEKKNFI 131
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM-------HHHGQVM----SGRRPIEEGKRNLVD 286
           HRD+ A N L+ +    ++ DFGL+++        H G       +    +   K ++  
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 287 RMWSL-----------------TERSELLSVL--DERLKAKGGYADEVVEKVLHLGLLCA 327
            +W+                   + S++  +L  D R++   G      EKV  L   C 
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEG----CPEKVYELMRACW 247
Query: 328 HPEANSRPTIRQVLKMLEGQTEGTGLEDEG 357
               + RP+  ++ +  E   + + + DEG
Sbjct: 248 QWNPSDRPSFAEIHQAFETMFQESSISDEG 277

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ +L     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLAS--- 151
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ +L     
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLAS--- 152
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ +L     
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLAS--- 149
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 179

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 13/163 (7%)
Query: 101 HRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVS 160
           H + Y+EI         E V+G G  G V K +    +VA+K+I  +SE   + F+ E+ 
Sbjct: 3   HMIDYKEIEV-------EEVVGRGAFGVVCKAKWRAKDVAIKQIESESER--KAFIVELR 53
Query: 161 SLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD 220
            L R+ H N+V L G C      + L+ +Y E GSL   +   +     +    +     
Sbjct: 54  QLSRVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110
Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNA-RLGDFGLA 262
            + G+ YL+      ++HRD+K  N+LL       ++ DFG A
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ +L     
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLAS--- 151
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 181

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 79/150 (52%), Gaps = 11/150 (7%)
Query: 120 VIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGL 173
           VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++ L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C + + S +++  YM++G L  +I   +E+   + +  I     VA G+ +L     
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLAS--- 152
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            K +HRD+ A N +LD+K   ++ DFGLA+
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLAR 182

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 83/145 (57%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +   S      FLAE + + +L+H+ LV  R +   
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV--RLYAVV 73
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + +I +YMENGSL  ++ +    I L+  + + +   +A G+ ++ E      +HR
Sbjct: 74  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHR 129
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           +++A+N+L+   ++ ++ DFGLA++
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARL 154

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 85/164 (51%), Gaps = 14/164 (8%)
Query: 107 EIHAATKGFSEENVIGLGGNGKVYKGQLLGVE--VALKRISL----DSEHGM-REFLAEV 159
           ++ +  K + + + +G G    VYK +       VA+K+I L    +++ G+ R  L E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 160 SSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLK 219
             L  L H N++GL       K ++ L++D+ME    D  +   D S+ L+       + 
Sbjct: 64  KLLQELSHPNIIGLLD-AFGHKSNISLVFDFMET---DLEVIIKDNSLVLTPSHIKAYML 119
Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               G+ YL++ W   +LHRD+K +N+LLD+    +L DFGLAK
Sbjct: 120 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 77/150 (51%), Gaps = 17/150 (11%)
Query: 124 GGNGKVYKGQLLGVEVALKRISL-DSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE 182
           G  G V+K QLL   VA+K   + D +    E+  EV SL  +KH N++   G  K+   
Sbjct: 35  GRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKRGTS 92
Query: 183 ---SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE-------GW 232
               L LI  + E GSL  ++    ++  +SW +   + + +A G+ YL+E       G 
Sbjct: 93  VDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           +  + HRDIK+ NVLL   + A + DFGLA
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLA 178

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 86/168 (51%), Gaps = 10/168 (5%)
Query: 100 PHRVSYQEIHAATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLA 157
           P   +Y +        + ++ +G G  G+VY+G  +   + VA+K +  D+   + EFL 
Sbjct: 5   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 63
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV 217
           E + +  +KH NLV L G C +E    I+I ++M  G+L  ++ EC+       E    V
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIII-EFMTYGNLLDYLRECNRQ-----EVNAVV 117
Query: 218 LKDVASGILYLYEGWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           L  +A+ I    E  E K  +HRD+ A N L+ +    ++ DFGL+++
Sbjct: 118 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 82/159 (51%), Gaps = 10/159 (6%)
Query: 105 YQEIHAATKGFSEENVIGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLG 163
           Y EI A+    S    IG G  G VYKG+  G V V + ++   +    + F  EV+ L 
Sbjct: 30  YWEIEASEVMLSTR--IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLR 87
Query: 164 RLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           + +H N++   G+  K+  +L ++  + E  SL K +   +    +   Q I + +  A 
Sbjct: 88  KTRHVNILLFMGYMTKD--NLAIVTQWCEGSSLYKHLHVQETKFQMF--QLIDIARQTAQ 143
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           G+ YL+      ++HRD+K++N+ L + +  ++GDFGLA
Sbjct: 144 GMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLA 179

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 79/147 (53%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E    I+I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 81  REPPFYIII-EFMTYGNLLDYLRECNRQ-----EVNAVVLLYMATQISSAMEYLEKKNFI 134
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HRD+ A N L+ +    ++ DFGL+++
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRL 161

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 79/147 (53%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E    I+I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 80  REPPFYIII-EFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HRD+ A N L+ +    ++ DFGL+++
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 79/147 (53%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E    I+I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 80  REPPFYIII-EFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HRD+ A N L+ +    ++ DFGL+++
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 78/148 (52%), Gaps = 12/148 (8%)
Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISL---DSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
           +G GG   VY  +  +L ++VA+K I +   + E  ++ F  EV +  +L H+N+V +  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
              +E +   L+ +Y+E  +L ++I   +    LS +  I     +  GI +     + +
Sbjct: 79  -VDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKH---AHDMR 131
Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAK 263
           ++HRDIK  N+L+D     ++ DFG+AK
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAK 159

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 10/168 (5%)
Query: 100 PHRVSYQEIHAATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLA 157
           P   +Y +        + ++ +G G  G+VY+G  +   + VA+K +  D+   + EFL 
Sbjct: 5   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 63
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV 217
           E + +  +KH NLV L G C +E     +I ++M  G+L  ++ EC+       E    V
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQ-----EVNAVV 117
Query: 218 LKDVASGILYLYEGWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           L  +A+ I    E  E K  +HRD+ A N L+ +    ++ DFGL+++
Sbjct: 118 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 10/168 (5%)
Query: 100 PHRVSYQEIHAATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLA 157
           P   +Y +        + ++ +G G  G+VY+G  +   + VA+K +  D+   + EFL 
Sbjct: 5   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 63
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV 217
           E + +  +KH NLV L G C +E     +I ++M  G+L  ++ EC+       E    V
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQ-----EVNAVV 117
Query: 218 LKDVASGILYLYEGWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           L  +A+ I    E  E K  +HRD+ A N L+ +    ++ DFGL+++
Sbjct: 118 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 10/168 (5%)
Query: 100 PHRVSYQEIHAATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLA 157
           P   +Y +        + ++ +G G  G+VY+G  +   + VA+K +  D+   + EFL 
Sbjct: 5   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 63
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV 217
           E + +  +KH NLV L G C +E     +I ++M  G+L  ++ EC+       E    V
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQ-----EVNAVV 117
Query: 218 LKDVASGILYLYEGWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           L  +A+ I    E  E K  +HRD+ A N L+ +    ++ DFGL+++
Sbjct: 118 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 85/168 (50%), Gaps = 10/168 (5%)
Query: 100 PHRVSYQEIHAATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLA 157
           P   +Y +        + ++ +G G  G+VY+G  +   + VA+K +  D+   + EFL 
Sbjct: 5   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 63
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV 217
           E + +  +KH NLV L G C +E     +I ++M  G+L  ++ EC+       E    V
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQ-----EVSAVV 117
Query: 218 LKDVASGILYLYEGWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           L  +A+ I    E  E K  +HRD+ A N L+ +    ++ DFGL+++
Sbjct: 118 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 165

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 118/270 (43%), Gaps = 46/270 (17%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E     +I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 82  REP-PFYIITEFMTYGNLLDYLRECNRQ-----EVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM---HHHGQVMSGRRPIE--------EGKRNLVD 286
           HRD+ A N L+ +    ++ DFGL+++     +      + PI+          K ++  
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 287 RMWS--------------------LTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLC 326
            +W+                    L++  ELL   D R++   G      EKV  L   C
Sbjct: 196 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DYRMERPEG----CPEKVYELMRAC 250
Query: 327 AHPEANSRPTIRQVLKMLEGQTEGTGLEDE 356
                + RP+  ++ +  E   + + + DE
Sbjct: 251 WQWNPSDRPSFAEIHQAFETMFQESSISDE 280

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 118/270 (43%), Gaps = 46/270 (17%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E     +I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 81  REP-PFYIITEFMTYGNLLDYLRECNRQ-----EVNAVVLLYMATQISSAMEYLEKKNFI 134
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM---HHHGQVMSGRRPIE--------EGKRNLVD 286
           HRD+ A N L+ +    ++ DFGL+++     +      + PI+          K ++  
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 287 RMWS--------------------LTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLC 326
            +W+                    L++  ELL   D R++   G      EKV  L   C
Sbjct: 195 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-DYRMERPEG----CPEKVYELMRAC 249
Query: 327 AHPEANSRPTIRQVLKMLEGQTEGTGLEDE 356
                + RP+  ++ +  E   + + + DE
Sbjct: 250 WQWNPSDRPSFAEIHQAFETMFQESSISDE 279

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 24/180 (13%)
Query: 118 ENVIGLGGNGKVYKGQL----LGVEVALKRIS-LDSEHGMREFLAEVSSLGRL-KHRNLV 171
           ++VIG G  G+V K ++    L ++ A+KR+    S+   R+F  E+  L +L  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKW-----IFECDESIA--------LSWEQRIKVL 218
            L G C+  +  L L  +Y  +G+L  +     + E D + A        LS +Q +   
Sbjct: 80  NLLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 138
Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH-HGQVMSGRRPI 277
            DVA G+ YL +    + +HRD+ A N+L+ +   A++ DFGL++    + +   GR P+
Sbjct: 139 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 195

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E     +I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 84  REP-PFYIITEFMTYGNLLDYLRECNRQ-----EVNAVVLLYMATQISSAMEYLEKKNFI 137
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HRD+ A N L+ +    ++ DFGL+++
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRL 164

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 24/180 (13%)
Query: 118 ENVIGLGGNGKVYKGQL----LGVEVALKRIS-LDSEHGMREFLAEVSSLGRL-KHRNLV 171
           ++VIG G  G+V K ++    L ++ A+KR+    S+   R+F  E+  L +L  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKW-----IFECDESIA--------LSWEQRIKVL 218
            L G C+  +  L L  +Y  +G+L  +     + E D + A        LS +Q +   
Sbjct: 90  NLLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH-HGQVMSGRRPI 277
            DVA G+ YL +    + +HRD+ A N+L+ +   A++ DFGL++    + +   GR P+
Sbjct: 149 ADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 205

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E     +I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 80  REP-PFYIITEFMTYGNLLDYLRECNRQ-----EVNAVVLLYMATQISSAMEYLEKKNFI 133
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HRD+ A N L+ +    ++ DFGL+++
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 10/145 (6%)
Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  GKVYK Q     V  A K I   SE  + +++ E+  L    H N+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVL-KDVASGILYLYEGWESKVL 237
            E    ILI ++   G++D  + E +  +    E +I+V+ K     + YL++   +K++
Sbjct: 105 YENNLWILI-EFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHD---NKII 157
Query: 238 HRDIKASNVLLDKKMNARLGDFGLA 262
           HRD+KA N+L     + +L DFG++
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 10/145 (6%)
Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  GKVYK Q     V  A K I   SE  + +++ E+  L    H N+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVL-KDVASGILYLYEGWESKVL 237
            E    ILI ++   G++D  + E +  +    E +I+V+ K     + YL++   +K++
Sbjct: 105 YENNLWILI-EFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHD---NKII 157
Query: 238 HRDIKASNVLLDKKMNARLGDFGLA 262
           HRD+KA N+L     + +L DFG++
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E     +I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 80  REP-PFYIITEFMTYGNLLDYLRECNRQ-----EVNAVVLLYMATQISSAMEYLEKKNFI 133
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HRD+ A N L+ +    ++ DFGL+++
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E     +I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 82  REP-PFYIITEFMTYGNLLDYLRECNRQ-----EVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HRD+ A N L+ +    ++ DFGL+++
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRL 162

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E     +I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 93  REP-PFYIITEFMTYGNLLDYLRECNRQ-----EVNAVVLLYMATQISSAMEYLEKKNFI 146
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HRD+ A N L+ +    ++ DFGL+++
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRL 173

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 10/145 (6%)
Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  GKVYK Q     V  A K I   SE  + +++ E+  L    H N+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVL-KDVASGILYLYEGWESKVL 237
            E    ILI ++   G++D  + E +  +    E +I+V+ K     + YL++   +K++
Sbjct: 105 YENNLWILI-EFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHD---NKII 157
Query: 238 HRDIKASNVLLDKKMNARLGDFGLA 262
           HRD+KA N+L     + +L DFG++
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E     +I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 78  REP-PFYIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLEKKNFI 131
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HRD+ A N L+ +    ++ DFGL+++
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRL 158

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E     +I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 80  REP-PFYIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HRD+ A N L+ +    ++ DFGL+++
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +Y+  G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL  ++ +  E I       IK+L+    +  G+ YL      + +HRD+   N+L++ +
Sbjct: 117 SLRDYLQKHKERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 168
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 169 NRVKIGDFGLTKV 181

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 83/164 (50%), Gaps = 20/164 (12%)
Query: 118 ENVIGLGGNGKVYKGQLLGVE--VALKRISLDSEHG-------MREFLAEVSSLGRLKHR 168
           E  IG GG G V+KG+L+  +  VA+K + L    G        +EF  EV  +  L H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L G          ++ +++  G L   +   D++  + W  +++++ D+A GI Y+
Sbjct: 84  NIVKLYGLMHNPPR---MVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 229 YEGWESKVLHRDIKASNVLL-----DKKMNARLGDFGLAKMHHH 267
            +     ++HRD+++ N+ L     +  + A++ DFGL++   H
Sbjct: 139 -QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH 181

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +Y+  G
Sbjct: 70  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL  ++ +  E I       IK+L+    +  G+ YL      + +HRD+   N+L++ +
Sbjct: 130 SLRDYLQKHKERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 181
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 182 NRVKIGDFGLTKV 194

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 78/156 (50%), Gaps = 10/156 (6%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G V  G+  G  +VA+K I  +      EF+ E   +  L H  LV L G C K
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLH 238
           ++  + +I +YM NG L  ++ E         +Q +++ KDV   + YL    ESK  LH
Sbjct: 76  QR-PIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYL----ESKQFLH 128
Query: 239 RDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGR 274
           RD+ A N L++ +   ++ DFGL++     +  S R
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSR 164

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +Y+  G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL  ++ +  E I       IK+L+    +  G+ YL      + +HRD+   N+L++ +
Sbjct: 117 SLRDYLQKHKERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 168
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 169 NRVKIGDFGLTKV 181

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E     +I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 82  REP-PFYIITEFMTYGNLLDYLRECNRQ-----EVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HRD+ A N L+ +    ++ DFGL+++
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRL 162

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E     +I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 80  REP-PFYIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLEKKNFI 133
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HRD+ A N L+ +    ++ DFGL+++
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRL 160

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 10/145 (6%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G V  G+  G  +VA+K I  +      EF+ E   +  L H  LV L G C K
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLH 238
           ++  + +I +YM NG L  ++ E         +Q +++ KDV   + YL    ESK  LH
Sbjct: 91  QR-PIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYL----ESKQFLH 143
Query: 239 RDIKASNVLLDKKMNARLGDFGLAK 263
           RD+ A N L++ +   ++ DFGL++
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSR 168

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +Y+  G
Sbjct: 37  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 96
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL  ++ +  E I       IK+L+    +  G+ YL      + +HRD+   N+L++ +
Sbjct: 97  SLRDYLQKHKERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 148
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 149 NRVKIGDFGLTKV 161

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +Y+  G
Sbjct: 46  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 105
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL  ++ +  E I       IK+L+    +  G+ YL      + +HRD+   N+L++ +
Sbjct: 106 SLRDYLQKHKERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 157
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 158 NRVKIGDFGLTKV 170

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 10/145 (6%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G V  G+  G  +VA+K I  +      EF+ E   +  L H  LV L G C K
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLH 238
           ++  + +I +YM NG L  ++ E         +Q +++ KDV   + YL    ESK  LH
Sbjct: 91  QR-PIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYL----ESKQFLH 143
Query: 239 RDIKASNVLLDKKMNARLGDFGLAK 263
           RD+ A N L++ +   ++ DFGL++
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSR 168

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +Y+  G
Sbjct: 44  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 103
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL  ++ +  E I       IK+L+    +  G+ YL      + +HRD+   N+L++ +
Sbjct: 104 SLRDYLQKHKERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 155
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 156 NRVKIGDFGLTKV 168

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +Y+  G
Sbjct: 45  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 104
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL  ++ +  E I       IK+L+    +  G+ YL      + +HRD+   N+L++ +
Sbjct: 105 SLRDYLQKHKERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 156
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 157 NRVKIGDFGLTKV 169

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +Y+  G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL  ++ +  E I       IK+L+    +  G+ YL      + +HRD+   N+L++ +
Sbjct: 102 SLRDYLQKHKERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 153
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 154 NRVKIGDFGLTKV 166

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +Y+  G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL  ++ +  E I       IK+L+    +  G+ YL      + +HRD+   N+L++ +
Sbjct: 99  SLRDYLQKHKERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 150
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 151 NRVKIGDFGLTKV 163

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 10/145 (6%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G V  G+  G  +VA+K I  +      EF+ E   +  L H  LV L G C K
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLH 238
           ++  + +I +YM NG L  ++ E         +Q +++ KDV   + YL    ESK  LH
Sbjct: 71  QR-PIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYL----ESKQFLH 123
Query: 239 RDIKASNVLLDKKMNARLGDFGLAK 263
           RD+ A N L++ +   ++ DFGL++
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSR 148

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +Y+  G
Sbjct: 43  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 102
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL  ++ +  E I       IK+L+    +  G+ YL      + +HRD+   N+L++ +
Sbjct: 103 SLRDYLQKHKERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 154
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 155 NRVKIGDFGLTKV 167

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +Y+  G
Sbjct: 38  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 97
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL  ++ +  E I       IK+L+    +  G+ YL      + +HRD+   N+L++ +
Sbjct: 98  SLRDYLQKHKERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 149
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 150 NRVKIGDFGLTKV 162

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +Y+  G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL  ++ +  E I       IK+L+    +  G+ YL      + +HRD+   N+L++ +
Sbjct: 99  SLRDYLQKHKERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 150
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 151 NRVKIGDFGLTKV 163

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +Y+  G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL  ++ +  E I       IK+L+    +  G+ YL      + +HRD+   N+L++ +
Sbjct: 99  SLRDYLQKHKERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 150
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 151 NRVKIGDFGLTKV 163

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E     +I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 78  REP-PFYIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLEKKNFI 131
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HRD+ A N L+ +    ++ DFGL+++
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRL 158

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 10/145 (6%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G V  G+  G  +VA+K I  +      EF+ E   +  L H  LV L G C K
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLH 238
           ++  + +I +YM NG L  ++ E         +Q +++ KDV   + YL    ESK  LH
Sbjct: 82  QR-PIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYL----ESKQFLH 134
Query: 239 RDIKASNVLLDKKMNARLGDFGLAK 263
           RD+ A N L++ +   ++ DFGL++
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSR 159

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 10/145 (6%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G V  G+  G  +VA+K I  +      EF+ E   +  L H  LV L G C K
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLH 238
           ++  + +I +YM NG L  ++ E         +Q +++ KDV   + YL    ESK  LH
Sbjct: 75  QR-PIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYL----ESKQFLH 127
Query: 239 RDIKASNVLLDKKMNARLGDFGLAK 263
           RD+ A N L++ +   ++ DFGL++
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSR 152

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/145 (33%), Positives = 75/145 (51%), Gaps = 10/145 (6%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G V  G+  G  +VA+K I  +      EF+ E   +  L H  LV L G C K
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLH 238
           ++  + +I +YM NG L  ++ E         +Q +++ KDV   + YL    ESK  LH
Sbjct: 76  QR-PIFIITEYMANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYL----ESKQFLH 128
Query: 239 RDIKASNVLLDKKMNARLGDFGLAK 263
           RD+ A N L++ +   ++ DFGL++
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSR 153

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E     +I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 326 REP-PFYIITEFMTYGNLLDYLRECNRQ-----EVNAVVLLYMATQISSAMEYLEKKNFI 379
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HR++ A N L+ +    ++ DFGL+++
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRL 406

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 85/154 (55%), Gaps = 17/154 (11%)
Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLA--EVSSLGRLKHRNLVGLRGW 176
           IG G  G+V+K +    G +VALK++ +++E       A  E+  L  LKH N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 177 CKKE-------KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           C+ +       K S+ L++D+ E+   D      +  +  +  +  +V++ + +G+ Y++
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               +K+LHRD+KA+NVL+ +    +L DFGLA+
Sbjct: 143 R---NKILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 75/145 (51%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G VYKG+  G V V +  ++  +   ++ F  EV  L + +H N++   G+  K
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +  L ++  + E  SL   +   +    +  ++ I + +  A G+ YL+      ++HR
Sbjct: 80  PQ--LAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHA---KSIIHR 132
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D+K++N+ L +    ++GDFGLA +
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATV 157

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 75/145 (51%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G VYKG+  G V V +  ++  +   ++ F  EV  L + +H N++   G+  K
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +  L ++  + E  SL   +   +    +   + I + +  A G+ YL+      ++HR
Sbjct: 78  PQ--LAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KSIIHR 130
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D+K++N+ L + +  ++GDFGLA +
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATV 155

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY+G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
           +E     +I ++M  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 287 REP-PFYIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAMEYLEKKNFI 340
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HR++ A N L+ +    ++ DFGL+++
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRL 367

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 85/154 (55%), Gaps = 17/154 (11%)
Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLA--EVSSLGRLKHRNLVGLRGW 176
           IG G  G+V+K +    G +VALK++ +++E       A  E+  L  LKH N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 177 CKKE-------KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           C+ +       K S+ L++D+ E+   D      +  +  +  +  +V++ + +G+ Y++
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               +K+LHRD+KA+NVL+ +    +L DFGLA+
Sbjct: 143 R---NKILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 8/143 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G VYKG+  G V V +  ++  +   ++ F  EV  L + +H N++   G+  K
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +  L ++  + E  SL   +   +    +  ++ I + +  A G+ YL+      ++HR
Sbjct: 92  PQ--LAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHA---KSIIHR 144
Query: 240 DIKASNVLLDKKMNARLGDFGLA 262
           D+K++N+ L +    ++GDFGLA
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 75/145 (51%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G VYKG+  G V V +  ++  +   ++ F  EV  L + +H N++   G+  K
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +  L ++  + E  SL   +   +    +   + I + +  A G+ YL+      ++HR
Sbjct: 81  PQ--LAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KSIIHR 133
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D+K++N+ L + +  ++GDFGLA +
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATV 158

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 75/145 (51%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G VYKG+  G V V +  ++  +   ++ F  EV  L + +H N++   G+  K
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +  L ++  + E  SL   +   +    +   + I + +  A G+ YL+      ++HR
Sbjct: 81  PQ--LAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KSIIHR 133
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D+K++N+ L + +  ++GDFGLA +
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATV 158

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 71/133 (53%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +Y+  G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL  ++    E I       IK+L+    +  G+ YL      + +HRD+   N+L++ +
Sbjct: 102 SLRDYLQAHAERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 153
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 154 NRVKIGDFGLTKV 166

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 73/133 (54%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +++  G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYG 101
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL +++ +  E I       IK+L+    +  G+ YL      + +HRD+   N+L++ +
Sbjct: 102 SLREYLQKHKERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENE 153
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 154 NRVKIGDFGLTKV 166

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 76/147 (51%), Gaps = 10/147 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G+VY G  +   + VA+K +  D+   + EFL E + +  +KH NLV L G C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VL 237
            E     ++ +YM  G+L  ++ EC+       E    VL  +A+ I    E  E K  +
Sbjct: 99  LEP-PFYIVTEYMPYGNLLDYLRECNRE-----EVTAVVLLYMATQISSAMEYLEKKNFI 152
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKM 264
           HRD+ A N L+ +    ++ DFGL+++
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRL 179

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 75/145 (51%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G VYKG+  G V V +  ++  +   ++ F  EV  L + +H N++   G+  K
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +  L ++  + E  SL   +   +    +   + I + +  A G+ YL+      ++HR
Sbjct: 76  PQ--LAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KSIIHR 128
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D+K++N+ L + +  ++GDFGLA +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATV 153

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 8/143 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G VYKG+  G V V +  ++  +   ++ F  EV  L + +H N++   G+  K
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +  L ++  + E  SL   +   +    +   + I + +  A G+ YL+      ++HR
Sbjct: 96  PQ--LAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KSIIHR 148
Query: 240 DIKASNVLLDKKMNARLGDFGLA 262
           D+K++N+ L + +  ++GDFGLA
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLA 171

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 8/143 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G VYKG+  G V V +  ++  +   ++ F  EV  L + +H N++   G+  K
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +  L ++  + E  SL   +   +    +   + I + +  A G+ YL+      ++HR
Sbjct: 76  PQ--LAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KSIIHR 128
Query: 240 DIKASNVLLDKKMNARLGDFGLA 262
           D+K++N+ L + +  ++GDFGLA
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLA 151

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 8/143 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G VYKG+  G V V +  ++  +   ++ F  EV  L + +H N++   G+  K
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +  L ++  + E  SL   +   +    +   + I + +  A G+ YL+      ++HR
Sbjct: 104 PQ--LAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KSIIHR 156
Query: 240 DIKASNVLLDKKMNARLGDFGLA 262
           D+K++N+ L + +  ++GDFGLA
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 8/143 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G VYKG+  G V V +  ++  +   ++ F  EV  L + +H N++   G+  K
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +  L ++  + E  SL   +   +    +   + I + +  A G+ YL+      ++HR
Sbjct: 104 PQ--LAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KSIIHR 156
Query: 240 DIKASNVLLDKKMNARLGDFGLA 262
           D+K++N+ L + +  ++GDFGLA
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLA 179

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 93/180 (51%), Gaps = 24/180 (13%)
Query: 118 ENVIGLGGNGKVYKGQL----LGVEVALKRIS-LDSEHGMREFLAEVSSLGRL-KHRNLV 171
           ++VIG G  G+V K ++    L ++ A+KR+    S+   R+F  E+  L +L  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKW-----IFECDESIA--------LSWEQRIKVL 218
            L G C+  +  L L  +Y  +G+L  +     + E D + A        LS +Q +   
Sbjct: 87  NLLGACE-HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 145
Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH-HGQVMSGRRPI 277
            DVA G+ YL +    + +HR++ A N+L+ +   A++ DFGL++    + +   GR P+
Sbjct: 146 ADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 202

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 115/267 (43%), Gaps = 47/267 (17%)
Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           F E  +IG GG G+V+K +  + G    +KR+  ++E   RE    V +L +L H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68
Query: 173 LRG-W--------------CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV 217
             G W               + + + L +  ++ + G+L++WI E      L     +++
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127
Query: 218 LKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL-AKMHHHGQ------- 269
            + +  G+ Y++     K+++RD+K SN+ L      ++GDFGL   + + G+       
Sbjct: 128 FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGT 184
Query: 270 --VMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYAD----------EVVE 317
              MS  +   +     VD        +ELL V D   +    + D          +  E
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKE 244
Query: 318 KVLHLGLLCAHPEANSRPTIRQVLKML 344
           K L   LL   PE   RP   ++L+ L
Sbjct: 245 KTLLQKLLSKKPE--DRPNTSEILRTL 269

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 8/143 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G VYKG+  G V V +  ++  +   ++ F  EV  L + +H N++   G+  K
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +  L ++  + E  SL   +   +    +   + I + +  A G+ YL+      ++HR
Sbjct: 103 PQ--LAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KSIIHR 155
Query: 240 DIKASNVLLDKKMNARLGDFGLA 262
           D+K++N+ L + +  ++GDFGLA
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLA 178

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G+VY+GQ+ G       ++VA+K +  + SE    +FL E   + +L H+N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYL 228
             G   +     IL+ + M  G L  ++ E      +  +L+    + V +D+A G  YL
Sbjct: 113 CIGVSLQSLPRFILL-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 229 YEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAK 263
               E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 172 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 83/166 (50%), Gaps = 20/166 (12%)
Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           F E  V+G G  G+V K +  L     A+K+I   +E  +   L+EV  L  L H+ +V 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 173 L-------RGWCK-----KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD 220
                   R + K     K+K +L +  +Y ENG+L   I    E++    ++  ++ + 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQ 124
Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH 266
           +   + Y++      ++HRD+K  N+ +D+  N ++GDFGLAK  H
Sbjct: 125 ILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G+VY+GQ+ G       ++VA+K +  + SE    +FL E   + +L H+N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYL 228
             G   +     IL+ + M  G L  ++ E      +  +L+    + V +D+A G  YL
Sbjct: 99  CIGVSLQSLPRFILL-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 229 YEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAK 263
               E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 158 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 85/154 (55%), Gaps = 17/154 (11%)
Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLA--EVSSLGRLKHRNLVGLRGW 176
           IG G  G+V+K +    G +VALK++ +++E       A  E+  L  LKH N+V L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 177 CKKE-------KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           C+ +       K S+ L++D+ E+   D      +  +  +  +  +V++ + +G+ Y++
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               +K+LHRD+KA+NVL+ +    +L DFGLA+
Sbjct: 142 R---NKILHRDMKAANVLITRDGVLKLADFGLAR 172

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 27/179 (15%)
Query: 106 QEIHAATKGFSEENVIGLGGNGKVYKGQLLGVE-------VALKRISLDSEHGMRE-FLA 157
           +EI  +   F EE  +G    GKVYKG L G         VA+K +   +E  +RE F  
Sbjct: 21  KEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 78
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIF-----------ECDES 206
           E     RL+H N+V L G   K+ + L +I+ Y  +G L +++            + D +
Sbjct: 79  EAMLRARLQHPNVVCLLGVVTKD-QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 207 I--ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +  AL     + ++  +A+G+ YL       V+H+D+   NVL+  K+N ++ D GL +
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFR 193

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 118 ENVIGLGGNGKVYKGQLLGVE--VALKRISLDSEHG-------MREFLAEVSSLGRLKHR 168
           E  IG GG G V+KG+L+  +  VA+K + L    G        +EF  EV  +  L H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L G          ++ +++  G L   +   D++  + W  +++++ D+A GI Y+
Sbjct: 84  NIVKLYGLMHNPPR---MVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 229 YEGWESKVLHRDIKASNVLL-----DKKMNARLGDFGLAKMHHH 267
            +     ++HRD+++ N+ L     +  + A++ DFG ++   H
Sbjct: 139 -QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH 181

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 85/154 (55%), Gaps = 17/154 (11%)
Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLA--EVSSLGRLKHRNLVGLRGW 176
           IG G  G+V+K +    G +VALK++ +++E       A  E+  L  LKH N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 177 CKKE-------KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           C+ +       K S+ L++D+ E+   D      +  +  +  +  +V++ + +G+ Y++
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEH---DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               +K+LHRD+KA+NVL+ +    +L DFGLA+
Sbjct: 143 R---NKILHRDMKAANVLITRDGVLKLADFGLAR 173

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 72/133 (54%), Gaps = 12/133 (9%)
Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMENG 194
           G  VA+K++   +E  +R+F  E+  L  L+H N+V  +G C    + +L LI +Y+  G
Sbjct: 40  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 99
Query: 195 SLDKWIFECDESIALSWEQRIKVLK---DVASGILYLYEGWESKVLHRDIKASNVLLDKK 251
           SL  ++ +  E I       IK+L+    +  G+ YL      + +HR++   N+L++ +
Sbjct: 100 SLRDYLQKHKERI-----DHIKLLQYTSQICKGMEYL---GTKRYIHRNLATRNILVENE 151
Query: 252 MNARLGDFGLAKM 264
              ++GDFGL K+
Sbjct: 152 NRVKIGDFGLTKV 164

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 98/197 (49%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E    I    E+++   KD+ 
Sbjct: 103 IINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-TFKDLV 160
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGR 274
           S    L  G E     K +HRD+ A NVL+ +    R+ DFGLA+    + ++ +  +GR
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGR 220
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 221 LPVKWMAPEALFDRVYT 237

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 27/179 (15%)
Query: 106 QEIHAATKGFSEENVIGLGGNGKVYKGQLLGVE-------VALKRISLDSEHGMRE-FLA 157
           +EI  +   F EE  +G    GKVYKG L G         VA+K +   +E  +RE F  
Sbjct: 4   KEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 61
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIF-----------ECDES 206
           E     RL+H N+V L G   K+ + L +I+ Y  +G L +++            + D +
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKD-QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 207 I--ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +  AL     + ++  +A+G+ YL       V+H+D+   NVL+  K+N ++ D GL +
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFR 176

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 82/164 (50%), Gaps = 20/164 (12%)
Query: 118 ENVIGLGGNGKVYKGQLLGVE--VALKRISLDSEHG-------MREFLAEVSSLGRLKHR 168
           E  IG GG G V+KG+L+  +  VA+K + L    G        +EF  EV  +  L H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L G          ++ +++  G L   +   D++  + W  +++++ D+A GI Y+
Sbjct: 84  NIVKLYGLMHNPPR---MVMEFVPCGDLYHRLL--DKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 229 YEGWESKVLHRDIKASNVLL-----DKKMNARLGDFGLAKMHHH 267
            +     ++HRD+++ N+ L     +  + A++ DF L++   H
Sbjct: 139 -QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH 181

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 16/157 (10%)
Query: 121 IGLGGNGKVYKGQLLGVEVALKRI------SLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
           +G  G  KV K +L G +VA+K +      SLD    +R    E+ +L   +H +++ L 
Sbjct: 26  VGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR---EIQNLKLFRHPHIIKLY 82
Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
                  + + ++ +Y+  G L  +I  C        E R ++ + + SG+ Y +     
Sbjct: 83  QVISTPSD-IFMVMEYVSGGELFDYI--CKNGRLDEKESR-RLFQQILSGVDYCHRHM-- 136
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
            V+HRD+K  NVLLD  MNA++ DFGL+ M   G+ +
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 172

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G+VY+GQ+ G       ++VA+K +  + SE    +FL E   + +  H+N+V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYL 228
             G   +     IL+ + M  G L  ++ E      +  +L+    + V +D+A G  YL
Sbjct: 139 CIGVSLQSLPRFILL-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 229 YEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAK 263
               E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 198 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G+VY+GQ+ G       ++VA+K +  + SE    +FL E   + +  H+N+V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYL 228
             G   +     IL+ + M  G L  ++ E      +  +L+    + V +D+A G  YL
Sbjct: 90  CIGVSLQSLPRFILL-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 148
Query: 229 YEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAK 263
               E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 149 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G+VY+GQ+ G       ++VA+K +  + SE    +FL E   + +  H+N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYL 228
             G   +     IL+ + M  G L  ++ E      +  +L+    + V +D+A G  YL
Sbjct: 98  CIGVSLQSLPRFILL-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 229 YEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAK 263
               E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 157 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G+VY+GQ+ G       ++VA+K +  + SE    +FL E   + +  H+N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYL 228
             G   +     IL+ + M  G L  ++ E      +  +L+    + V +D+A G  YL
Sbjct: 99  CIGVSLQSLPRFILL-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 229 YEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAK 263
               E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 158 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G+VY+GQ+ G       ++VA+K +  + SE    +FL E   + +  H+N+V 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYL 228
             G   +     IL+ + M  G L  ++ E      +  +L+    + V +D+A G  YL
Sbjct: 116 CIGVSLQSLPRFILL-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 174
Query: 229 YEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAK 263
               E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 175 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G+VY+GQ+ G       ++VA+K +  + SE    +FL E   + +  H+N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYL 228
             G   +     IL+ + M  G L  ++ E      +  +L+    + V +D+A G  YL
Sbjct: 98  CIGVSLQSLPRFILM-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 229 YEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAK 263
               E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 157 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G+VY+GQ+ G       ++VA+K +  + SE    +FL E   + +  H+N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYL 228
             G   +     IL+ + M  G L  ++ E      +  +L+    + V +D+A G  YL
Sbjct: 99  CIGVSLQSLPRFILL-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 229 YEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAK 263
               E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 158 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G+VY+GQ+ G       ++VA+K +  + SE    +FL E   + +  H+N+V 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYL 228
             G   +     IL+ + M  G L  ++ E      +  +L+    + V +D+A G  YL
Sbjct: 115 CIGVSLQSLPRFILL-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 173
Query: 229 YEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAK 263
               E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 174 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G+VY+GQ+ G       ++VA+K +  + SE    +FL E   + +  H+N+V 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYL 228
             G   +     IL+ + M  G L  ++ E      +  +L+    + V +D+A G  YL
Sbjct: 125 CIGVSLQSLPRFILL-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 229 YEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAK 263
               E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 184 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G+VY+GQ+ G       ++VA+K +  + SE    +FL E   + +  H+N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYL 228
             G   +     IL+ + M  G L  ++ E      +  +L+    + V +D+A G  YL
Sbjct: 113 CIGVSLQSLPRFILM-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 229 YEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAK 263
               E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 172 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 73/143 (51%), Gaps = 8/143 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G VYKG+  G V V +  ++  +   ++ F  EV  L + +H N++   G+   
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +  L ++  + E  SL   +   +    +  ++ I + +  A G+ YL+      ++HR
Sbjct: 92  PQ--LAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHA---KSIIHR 144
Query: 240 DIKASNVLLDKKMNARLGDFGLA 262
           D+K++N+ L +    ++GDFGLA
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLA 167

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G+VY+GQ+ G       ++VA+K +  + SE    +FL E   + +  H+N+V 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYL 228
             G   +     IL+ + M  G L  ++ E      +  +L+    + V +D+A G  YL
Sbjct: 105 CIGVSLQSLPRFILL-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 163
Query: 229 YEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAK 263
               E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 164 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 119 NVIGLGGNGKVYKG--QLLGVEVALK---RISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           + +G+G  GKV  G  QL G +VA+K   R  + S   + +   E+ +L   +H +++ L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
                   +   ++ +Y+  G L  +I  C        E R ++ + + S + Y +    
Sbjct: 77  YQVISTPTD-FFMVMEYVSGGELFDYI--CKHGRVEEMEAR-RLFQQILSAVDYCHR--- 129
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
             V+HRD+K  NVLLD  MNA++ DFGL+ M   G+ +
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 98/197 (49%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E    I    E+++   KD+ 
Sbjct: 103 IINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-TFKDLV 160
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGR 274
           S    L  G E     K +HRD+ A NVL+ +    ++ DFGLA+    + ++ +  +GR
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 221 LPVKWMAPEALFDRVYT 237

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLG-------VEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G+VY+GQ+ G       ++VA+K +  + SE    +FL E   + +  H+N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYL 228
             G   +     IL+ + M  G L  ++ E      +  +L+    + V +D+A G  YL
Sbjct: 113 CIGVSLQSLPRFILL-ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 229 YEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAK 263
               E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 172 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 15/154 (9%)
Query: 121 IGLGGNGKVYKGQLLGVEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G+V++G+  G EVA+K  S   E    RE  AE+     L+H N++G      K
Sbjct: 50  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 107
Query: 180 EK---ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE---GWE 233
           +      L L+ DY E+GSL    F+      ++ E  IK+    ASG+ +L+    G +
Sbjct: 108 DNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 234 SK--VLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
            K  + HRD+K+ N+L+ K     + D GLA  H
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 197

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 82/158 (51%), Gaps = 26/158 (16%)
Query: 120 VIGLGGNGKVYKG------QLLGVEVALKRISLDSEHGMR---EFLAEVSSLGRLKHRNL 170
           V+G G  G VYKG      + + + VA+K   L+   G +   EF+ E   +  + H +L
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETVKIPVAIK--ILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVASGIL 226
           V L G C     ++ L+   M +G L +++ E  ++I     L+W  +I      A G++
Sbjct: 103 VRLLGVCLSP--TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMM 154
Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           YL E    +++HRD+ A NVL+    + ++ DFGLA++
Sbjct: 155 YLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARL 189

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 119 NVIGLGGNGKVYKG--QLLGVEVALK---RISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           + +G+G  GKV  G  QL G +VA+K   R  + S   + +   E+ +L   +H +++ L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
                   +   ++ +Y+  G L  +I  C        E R ++ + + S + Y +    
Sbjct: 77  YQVISTPTD-FFMVMEYVSGGELFDYI--CKHGRVEEMEAR-RLFQQILSAVDYCHR--- 129
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
             V+HRD+K  NVLLD  MNA++ DFGL+ M   G+ +
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL 167

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 15/154 (9%)
Query: 121 IGLGGNGKVYKGQLLGVEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G+V++G+  G EVA+K  S   E    RE  AE+     L+H N++G      K
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 94
Query: 180 EK---ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE---GWE 233
           +      L L+ DY E+GSL    F+      ++ E  IK+    ASG+ +L+    G +
Sbjct: 95  DNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 234 SK--VLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
            K  + HRD+K+ N+L+ K     + D GLA  H
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 184

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 98/197 (49%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E    I    E+++   KD+ 
Sbjct: 149 IINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-TFKDLV 206
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGR 274
           S    L  G E     K +HRD+ A NVL+ +    ++ DFGLA+    + ++ +  +GR
Sbjct: 207 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 267 LPVKWMAPEALFDRVYT 283

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 15/154 (9%)
Query: 121 IGLGGNGKVYKGQLLGVEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G+V++G+  G EVA+K  S   E    RE  AE+     L+H N++G      K
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 69
Query: 180 EK---ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE---GWE 233
           +      L L+ DY E+GSL    F+      ++ E  IK+    ASG+ +L+    G +
Sbjct: 70  DNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 234 SK--VLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
            K  + HRD+K+ N+L+ K     + D GLA  H
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 159

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 15/154 (9%)
Query: 121 IGLGGNGKVYKGQLLGVEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G+V++G+  G EVA+K  S   E    RE  AE+     L+H N++G      K
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 74
Query: 180 EK---ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE---GWE 233
           +      L L+ DY E+GSL    F+      ++ E  IK+    ASG+ +L+    G +
Sbjct: 75  DNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 234 SK--VLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
            K  + HRD+K+ N+L+ K     + D GLA  H
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 164

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 15/154 (9%)
Query: 121 IGLGGNGKVYKGQLLGVEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G+V++G+  G EVA+K  S   E    RE  AE+     L+H N++G      K
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 71
Query: 180 EK---ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE---GWE 233
           +      L L+ DY E+GSL    F+      ++ E  IK+    ASG+ +L+    G +
Sbjct: 72  DNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 234 SK--VLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
            K  + HRD+K+ N+L+ K     + D GLA  H
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 161

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G VYKG+  G V V +  ++  +   ++ F  EV  L + +H N++   G+   
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +  L ++  + E  SL   +   +    +   + I + +  A G+ YL+      ++HR
Sbjct: 76  PQ--LAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHA---KSIIHR 128
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D+K++N+ L + +  ++GDFGLA +
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATV 153

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 78/154 (50%), Gaps = 15/154 (9%)
Query: 121 IGLGGNGKVYKGQLLGVEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G+V++G+  G EVA+K  S   E    RE  AE+     L+H N++G      K
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADNK 68
Query: 180 EK---ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE---GWE 233
           +      L L+ DY E+GSL    F+      ++ E  IK+    ASG+ +L+    G +
Sbjct: 69  DNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 234 SK--VLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
            K  + HRD+K+ N+L+ K     + D GLA  H
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 81/156 (51%), Gaps = 22/156 (14%)
Query: 120 VIGLGGNGKVYKG------QLLGVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVG 172
           V+G G  G VYKG      + + + VA+K ++  +      EF+ E   +  + H +LV 
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVASGILYL 228
           L G C     ++ L+   M +G L +++ E  ++I     L+W  +I      A G++YL
Sbjct: 82  LLGVCLSP--TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 133
Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            E    +++HRD+ A NVL+    + ++ DFGLA++
Sbjct: 134 EE---RRLVHRDLAARNVLVKSPNHVKITDFGLARL 166

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 81/149 (54%), Gaps = 16/149 (10%)
Query: 121 IGLGGNGKVYKGQL-LGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHRNLVGLRGWC 177
           IG G  G VYK Q   G   ALK+I L+ E  G+    + E+S L  LKH N+V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 178 KKEKESLILIYDYMENGSLDKWIFECD---ESIALSWEQRIKVLKDVASGILYLYEGWES 234
             +K  L+L++++++   L K +  C+   ES+          L  + +GI Y ++    
Sbjct: 70  HTKKR-LVLVFEHLDQ-DLKKLLDVCEGGLESVTAK-----SFLLQLLNGIAYCHD---R 119
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +VLHRD+K  N+L++++   ++ DFGLA+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 81/149 (54%), Gaps = 16/149 (10%)
Query: 121 IGLGGNGKVYKGQL-LGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHRNLVGLRGWC 177
           IG G  G VYK Q   G   ALK+I L+ E  G+    + E+S L  LKH N+V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 178 KKEKESLILIYDYMENGSLDKWIFECD---ESIALSWEQRIKVLKDVASGILYLYEGWES 234
             +K  L+L++++++   L K +  C+   ES+          L  + +GI Y ++    
Sbjct: 70  HTKKR-LVLVFEHLDQ-DLKKLLDVCEGGLESVTAK-----SFLLQLLNGIAYCHD---R 119
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +VLHRD+K  N+L++++   ++ DFGLA+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 98/197 (49%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E    I    E+++   KD+ 
Sbjct: 103 IITLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-TFKDLV 160
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGR 274
           S    L  G E     K +HRD+ A NVL+ +    ++ DFGLA+    + ++ +  +GR
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 221 LPVKWMAPEALFDRVYT 237

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 97/197 (49%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E    I    E+++   KD+ 
Sbjct: 103 IINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-TFKDLV 160
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGR 274
           S    L  G E     K +HRD+ A NVL+ +    ++ DFGLA+    + ++    +GR
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGR 220
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 221 LPVKWMAPEALFDRVYT 237

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 81/149 (54%), Gaps = 16/149 (10%)
Query: 121 IGLGGNGKVYKGQL-LGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHRNLVGLRGWC 177
           IG G  G VYK Q   G   ALK+I L+ E  G+    + E+S L  LKH N+V L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 178 KKEKESLILIYDYMENGSLDKWIFECD---ESIALSWEQRIKVLKDVASGILYLYEGWES 234
             +K  L+L++++++   L K +  C+   ES+          L  + +GI Y ++    
Sbjct: 70  HTKKR-LVLVFEHLDQ-DLKKLLDVCEGGLESVTAK-----SFLLQLLNGIAYCHD---R 119
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +VLHRD+K  N+L++++   ++ DFGLA+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLAR 148

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 121 IGLGGNGKVYKGQLLGVE-VALKRISLDSEHGMRE--FLAEVSSLGRLKHRNLVGLRGWC 177
           IG G  G V+ G  L  + VA+K I    E  M E  F+ E   + +L H  LV L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
             E+  + L++++ME+G L  ++    +    + E  + +  DV  G+ YL E   + V+
Sbjct: 72  L-EQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEE---ASVI 125
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
           HRD+ A N L+ +    ++ DFG+ +     Q  S
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 160

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 98/197 (49%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E    I    E+++   KD+ 
Sbjct: 90  IINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-TFKDLV 147
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGR 274
           S    L  G E     K +HRD+ A NVL+ +    ++ DFGLA+    + ++ +  +GR
Sbjct: 148 SCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 207
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 208 LPVKWMAPEALFDRVYT 224

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 98/197 (49%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E    I    E+++   KD+ 
Sbjct: 95  IINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-TFKDLV 152
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGR 274
           S    L  G E     K +HRD+ A NVL+ +    ++ DFGLA+    + ++ +  +GR
Sbjct: 153 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 212
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 213 LPVKWMAPEALFDRVYT 229

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 98/197 (49%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E    I    E+++   KD+ 
Sbjct: 92  IINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-TFKDLV 149
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGR 274
           S    L  G E     K +HRD+ A NVL+ +    ++ DFGLA+    + ++ +  +GR
Sbjct: 150 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 209
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 210 LPVKWMAPEALFDRVYT 226

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 77/163 (47%), Gaps = 17/163 (10%)
Query: 120 VIGLGGNGKVYKGQL-----LGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVG 172
           ++G G  G V +G L       ++VA+K + LD  S+  + EFL+E + +    H N++ 
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 173 LRGWCKKEKESLI----LIYDYMENGSLDKWIFECDESIA---LSWEQRIKVLKDVASGI 225
           L G C +     I    +I  +M+ G L  ++           +  +  +K + D+A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
            YL        LHRD+ A N +L   M   + DFGL+K  + G
Sbjct: 161 EYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG 200

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 98/197 (49%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E    I    E+++   KD+ 
Sbjct: 103 IIHLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-TFKDLV 160
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGR 274
           S    L  G E     K +HRD+ A NVL+ +    ++ DFGLA+    + ++ +  +GR
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 221 LPVKWMAPEALFDRVYT 237

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 12/156 (7%)
Query: 121 IGLGGNGKVYKGQLLGVE-VALKRISLDSEHGMRE--FLAEVSSLGRLKHRNLVGLRGWC 177
           IG G  G V+ G  L  + VA+K I    E  M E  F+ E   + +L H  LV L G C
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
             E+  + L++++ME+G L  ++    +    + E  + +  DV  G+ YL E   + V+
Sbjct: 70  L-EQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 123
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSG 273
           HRD+ A N L+ +    ++ DFG+ +     Q  S 
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 121 IGLGGNGKVYKGQLLGVE-VALKRISLDSEHGMRE--FLAEVSSLGRLKHRNLVGLRGWC 177
           IG G  G V+ G  L  + VA+K I    E  M E  F+ E   + +L H  LV L G C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
             E+  + L++++ME+G L  ++    +    + E  + +  DV  G+ YL E   + V+
Sbjct: 72  L-EQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 125
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
           HRD+ A N L+ +    ++ DFG+ +     Q  S
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 160

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 121 IGLGGNGKVYKGQLLGVE-VALKRISLDSEHGMRE--FLAEVSSLGRLKHRNLVGLRGWC 177
           IG G  G V+ G  L  + VA+K I    E  M E  F+ E   + +L H  LV L G C
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK---EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
             E+  + L++++ME+G L  ++    +    + E  + +  DV  G+ YL E   + V+
Sbjct: 92  L-EQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 145
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
           HRD+ A N L+ +    ++ DFG+ +     Q  S
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 180

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 33/199 (16%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI---------FECDES----IALSWEQRIK 216
           ++ L G C ++   L +I +Y   G+L +++         F  + S      LS +  + 
Sbjct: 96  IINLLGACTQDG-PLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVS 154
Query: 217 VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH----GQVMS 272
               VA G+ YL      K +HRD+ A NVL+ +    ++ DFGLA+  HH     +  +
Sbjct: 155 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTN 211
Query: 273 GRRPIE-EGKRNLVDRMWS 290
           GR P++      L DR+++
Sbjct: 212 GRLPVKWMAPEALFDRIYT 230

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/147 (34%), Positives = 81/147 (55%), Gaps = 12/147 (8%)
Query: 121 IGLGGNGKVYKGQ-LLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHRNLVGLRGWC 177
           +G G  G VYK +   G  VALKRI LD+E  G+    + E+S L  L H N+V L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGILYLYEGWESKV 236
             E+  L L++++ME   L K +   DE+     + +IK+ L  +  G+ + ++    ++
Sbjct: 89  HSER-CLTLVFEFMEK-DLKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRI 140
Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAK 263
           LHRD+K  N+L++     +L DFGLA+
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLAR 167

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 97/197 (49%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I  Y   G+L +++        E    I    E+++   KD+ 
Sbjct: 103 IINLLGACTQDG-PLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-TFKDLV 160
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGR 274
           S    L  G E     K +HRD+ A NVL+ +    ++ DFGLA+    + ++ +  +GR
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 221 LPVKWMAPEALFDRVYT 237

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 12/155 (7%)
Query: 121 IGLGGNGKVYKGQLLGVE-VALKRISLDSEHGMRE--FLAEVSSLGRLKHRNLVGLRGWC 177
           IG G  G V+ G  L  + VA+K I    E  M E  F+ E   + +L H  LV L G C
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
             E+  + L++++ME+G L  ++    +    + E  + +  DV  G+ YL E   + V+
Sbjct: 75  L-EQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 128
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
           HRD+ A N L+ +    ++ DFG+ +     Q  S
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           F E  V+G G  G+V K +  L     A+K+I   +E  +   L+EV  L  L H+ +V 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 173 L-------RGWCK-----KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD 220
                   R + K     K+K +L +  +Y EN +L   I    E++    ++  ++ + 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHS--ENLNQQRDEYWRLFRQ 124
Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH 266
           +   + Y++      ++HRD+K  N+ +D+  N ++GDFGLAK  H
Sbjct: 125 ILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 85/160 (53%), Gaps = 14/160 (8%)
Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEH--GMREFLA-EVSSLGRLKHRN 169
           F   N++G G    VY+ + +  G+EVA+K I   + +  GM + +  EV    +LKH +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           ++ L  + + +   + L+ +   NG +++++   +     S  +    +  + +G+LYL+
Sbjct: 73  ILELYNYFE-DSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIITGMLYLH 129
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLA---KMHH 266
                 +LHRD+  SN+LL + MN ++ DFGLA   KM H
Sbjct: 130 S---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/147 (34%), Positives = 81/147 (55%), Gaps = 12/147 (8%)
Query: 121 IGLGGNGKVYKGQ-LLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHRNLVGLRGWC 177
           +G G  G VYK +   G  VALKRI LD+E  G+    + E+S L  L H N+V L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGILYLYEGWESKV 236
             E+  L L++++ME   L K +   DE+     + +IK+ L  +  G+ + ++    ++
Sbjct: 89  HSER-CLTLVFEFMEK-DLKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCHQ---HRI 140
Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAK 263
           LHRD+K  N+L++     +L DFGLA+
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLAR 167

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  GKVYK +    G   A K I   SE  + +++ E+  L    H  +V L G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVL-KDVASGILYLYEGWESKVL 237
            + +  I+I ++   G++D  + E D  +    E +I+V+ + +   + +L+     +++
Sbjct: 79  HDGKLWIMI-EFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHS---KRII 131
Query: 238 HRDIKASNVLLDKKMNARLGDFGLA 262
           HRD+KA NVL+  + + RL DFG++
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVS 156

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 97/197 (49%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I  Y   G+L +++        E    I    E+++   KD+ 
Sbjct: 103 IINLLGACTQDG-PLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-TFKDLV 160
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGR 274
           S    L  G E     K +HRD+ A NVL+ +    ++ DFGLA+    + ++ +  +GR
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 221 LPVKWMAPEALFDRVYT 237

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 76/145 (52%), Gaps = 10/145 (6%)
Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  GKVYK +    G   A K I   SE  + +++ E+  L    H  +V L G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVL-KDVASGILYLYEGWESKVL 237
            + +  I+I ++   G++D  + E D  +    E +I+V+ + +   + +L+     +++
Sbjct: 87  HDGKLWIMI-EFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHS---KRII 139
Query: 238 HRDIKASNVLLDKKMNARLGDFGLA 262
           HRD+KA NVL+  + + RL DFG++
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVS 164

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      L  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 144
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 145 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 178

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      L  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 145
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 146 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 179

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      L  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 136
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 137 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 170

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      L  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 144 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 81/153 (52%), Gaps = 17/153 (11%)
Query: 121 IGLGGNGKV------YKGQLLGVEVALKRISLDSEHG---MREFLAEVSSLGRLKHRNLV 171
           +G G  GKV       +G   G +VA+K  SL  E G   + +   E+  L  L H N+V
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVK--SLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 172 GLRGWCKKEKESLI-LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
             +G C ++  + I LI +++ +GSL +++ +    I L  +Q++K    +  G+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINL--KQQLKYAVQICKGMDYL-- 142
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               + +HRD+ A NVL++ +   ++GDFGL K
Sbjct: 143 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      L  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 144 IHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARV 177

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      L  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 138 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 171

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      L  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 144 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      L  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 144
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 145 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 178

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      L  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 137
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 138 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 171

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      L  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 144 IHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARV 177

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 23/162 (14%)
Query: 121 IGLGGNGKVYKGQ---LLGVE----VALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           +G G  GKV+  +   LL  +    VA+K +   SE   ++F  E   L  L+H+++V  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWI---------FECDESIA---LSWEQRIKVLKDV 221
            G C  E   L+++++YM +G L++++             E +A   L   Q + V   V
Sbjct: 109 FGVCT-EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 222 ASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           A+G++YL        +HRD+   N L+ + +  ++GDFG+++
Sbjct: 168 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/137 (31%), Positives = 75/137 (54%), Gaps = 11/137 (8%)
Query: 131 KGQLLGVEVALKRISLDSEHG---MREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI-L 186
           +G   G +VA+K  SL  E G   + +   E+  L  L H N+V  +G C ++  + I L
Sbjct: 33  EGDNTGEQVAVK--SLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 90
Query: 187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNV 246
           I +++ +GSL +++ +    I L  +Q++K    +  G+ YL      + +HRD+ A NV
Sbjct: 91  IMEFLPSGSLKEYLPKNKNKINL--KQQLKYAVQICKGMDYL---GSRQYVHRDLAARNV 145
Query: 247 LLDKKMNARLGDFGLAK 263
           L++ +   ++GDFGL K
Sbjct: 146 LVESEHQVKIGDFGLTK 162

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 75/145 (51%), Gaps = 10/145 (6%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G V  G+  G  +VA+K I  +      EF  E  ++ +L H  LV   G C K
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES-KVLH 238
           E   + ++ +Y+ NG L  ++    + +  S  Q +++  DV  G+ +L    ES + +H
Sbjct: 75  EY-PIYIVTEYISNGCLLNYLRSHGKGLEPS--QLLEMCYDVCEGMAFL----ESHQFIH 127
Query: 239 RDIKASNVLLDKKMNARLGDFGLAK 263
           RD+ A N L+D+ +  ++ DFG+ +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTR 152

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 99/197 (50%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E   + + + E+++   KD+ 
Sbjct: 137 IINLLGACTQDG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS-KDLV 194
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH----GQVMSGR 274
           S    +  G E     K +HRD+ A NVL+ +    ++ DFGLA+  HH     +  +GR
Sbjct: 195 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 254
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 255 LPVKWMAPEALFDRIYT 271

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 82/166 (49%), Gaps = 20/166 (12%)
Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           F E  V+G G  G+V K +  L     A+K+I   +E  +   L+EV  L  L H+ +V 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 173 L-------RGWCK-----KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD 220
                   R + K     K+K +L +  +Y EN +L   I    E++    ++  ++ + 
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHS--ENLNQQRDEYWRLFRQ 124
Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH 266
           +   + Y++      ++HR++K  N+ +D+  N ++GDFGLAK  H
Sbjct: 125 ILEALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVH 167

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 99/198 (50%), Gaps = 31/198 (15%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSW--------EQRIKVLKDV 221
           ++ L G C ++   L +I +Y   G+L +++ +  E   L +        E+++   KD+
Sbjct: 96  IINLLGACTQDG-PLYVIVEYASKGNLREYL-QAREPPGLEYSYNPSHNPEEQLSS-KDL 152
Query: 222 ASGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH----GQVMSG 273
            S    +  G E     K +HRD+ A NVL+ +    ++ DFGLA+  HH     +  +G
Sbjct: 153 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 274 RRPIE-EGKRNLVDRMWS 290
           R P++      L DR+++
Sbjct: 213 RLPVKWMAPEALFDRIYT 230

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/280 (23%), Positives = 115/280 (41%), Gaps = 60/280 (21%)
Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           F E  +IG GG G+V+K +  + G    ++R+  ++E   R    EV +L +L H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIVH 69
Query: 173 LRG-W---------------------------CKKEKESLILIYDYMENGSLDKWIFECD 204
             G W                            + + + L +  ++ + G+L++WI E  
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKR 128
Query: 205 ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL-AK 263
               L     +++ + +  G+ Y++     K++HRD+K SN+ L      ++GDFGL   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 264 MHHHGQ---------VMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYAD- 313
           + + G+          MS  +   +     VD        +ELL V D   +    + D 
Sbjct: 186 LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL 245
Query: 314 ---------EVVEKVLHLGLLCAHPEANSRPTIRQVLKML 344
                    +  EK L   LL   PE   RP   ++L+ L
Sbjct: 246 RDGIISDIFDKKEKTLLQKLLSKKPE--DRPNTSEILRTL 283

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 23/162 (14%)
Query: 121 IGLGGNGKVYKGQ---LLGVE----VALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           +G G  GKV+  +   LL  +    VA+K +   SE   ++F  E   L  L+H+++V  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWI---------FECDESIA---LSWEQRIKVLKDV 221
            G C  E   L+++++YM +G L++++             E +A   L   Q + V   V
Sbjct: 80  FGVCT-EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 222 ASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           A+G++YL        +HRD+   N L+ + +  ++GDFG+++
Sbjct: 139 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR 177

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      L  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  +   LS +     L  +  G+ Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKCQHLSNDHICYFLYQILRGLKY 143
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 144 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/162 (27%), Positives = 82/162 (50%), Gaps = 23/162 (14%)
Query: 121 IGLGGNGKVYKGQ---LLGVE----VALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           +G G  GKV+  +   LL  +    VA+K +   SE   ++F  E   L  L+H+++V  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWI---------FECDESIA---LSWEQRIKVLKDV 221
            G C  E   L+++++YM +G L++++             E +A   L   Q + V   V
Sbjct: 86  FGVCT-EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 222 ASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           A+G++YL        +HRD+   N L+ + +  ++GDFG+++
Sbjct: 145 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR 183

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 99/197 (50%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E   + + + E+++   KD+ 
Sbjct: 96  IINLLGACTQDG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS-KDLV 153
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH----GQVMSGR 274
           S    +  G E     K +HRD+ A NVL+ +    ++ DFGLA+  HH     +  +GR
Sbjct: 154 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 213
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 214 LPVKWMAPEALFDRIYT 230

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E    I    E+++   KD+ 
Sbjct: 103 IINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM-TFKDLV 160
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGR 274
           S    L  G E     K +HRD+ A NVL+ +    ++ DFGLA+    +    +  +GR
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGR 220
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 221 LPVKWMAPEALFDRVYT 237

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E    I    E+++   KD+ 
Sbjct: 103 IINLLGACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM-TFKDLV 160
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGR 274
           S    L  G E     K +HRD+ A NVL+ +    ++ DFGLA+    +    +  +GR
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGR 220
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 221 LPVKWMAPEALFDRVYT 237

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 99/197 (50%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E   + + + E+++   KD+ 
Sbjct: 89  IINLLGACTQDG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS-KDLV 146
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH----GQVMSGR 274
           S    +  G E     K +HRD+ A NVL+ +    ++ DFGLA+  HH     +  +GR
Sbjct: 147 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 206
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 207 LPVKWMAPEALFDRIYT 223

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 99/197 (50%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E   + + + E+++   KD+ 
Sbjct: 85  IINLLGACTQDG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS-KDLV 142
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH----GQVMSGR 274
           S    +  G E     K +HRD+ A NVL+ +    ++ DFGLA+  HH     +  +GR
Sbjct: 143 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 202
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 203 LPVKWMAPEALFDRIYT 219

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           +++   IG G  G V      +    VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 172 GLRGWCKKEK----ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+R   +         + ++ D ME       +++  +S  LS +     L  +  G+ Y
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETD-----LYKLLKSQQLSNDHICYFLYQILRGLKY 159
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+L++   + ++ DFGLA++
Sbjct: 160 IHS---ANVLHRDLKPSNLLINTTCDLKICDFGLARI 193

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 99/197 (50%), Gaps = 29/197 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWI-------FECDESIALSWEQRIKVLKDVA 222
           ++ L G C ++   L +I +Y   G+L +++        E   + + + E+++   KD+ 
Sbjct: 88  IINLLGACTQDG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS-KDLV 145
Query: 223 SGILYLYEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH----GQVMSGR 274
           S    +  G E     K +HRD+ A NVL+ +    ++ DFGLA+  HH     +  +GR
Sbjct: 146 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGR 205
Query: 275 RPIE-EGKRNLVDRMWS 290
            P++      L DR+++
Sbjct: 206 LPVKWMAPEALFDRIYT 222

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 96/199 (48%), Gaps = 33/199 (16%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFE--------C-----DESIALSWEQRIK 216
           ++ L G C ++   L +I +Y   G+L +++          C     +    LS +  + 
Sbjct: 81  IINLLGACTQDG-PLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 139
Query: 217 VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH----GQVMS 272
               VA G+ YL      K +HRD+ A NVL+ +    ++ DFGLA+  HH     +  +
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 273 GRRPIE-EGKRNLVDRMWS 290
           GR P++      L DR+++
Sbjct: 197 GRLPVKWMAPEALFDRIYT 215

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 78/163 (47%), Gaps = 24/163 (14%)
Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           +G G  GKV+  +   +        VA+K +   +    ++F  E   L  L+H ++V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFE--CDESI-----------ALSWEQRIKVLKD 220
            G C  + + LI++++YM++G L+K++     D  I            L   Q + +   
Sbjct: 83  YGVCG-DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +ASG++YL        +HRD+   N L+   +  ++GDFG+++
Sbjct: 142 IASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSR 181

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 112/252 (44%), Gaps = 34/252 (13%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 331
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 387
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM---HHHGQVMSGRRPIE--------EGKRNLVDRM 288
           D++A+N+L+ + +  ++ DFGLA++   + +      + PI+         G+  +   +
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 289 WS----LTE-----RSELLSVLDERL--KAKGGY----ADEVVEKVLHLGLLCAHPEANS 333
           WS    LTE     R     +++  +  + + GY      E  E +  L   C   E   
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEE 507
Query: 334 RPTIRQVLKMLE 345
           RPT   +   LE
Sbjct: 508 RPTFEYLQAFLE 519

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      L  V VA+++IS  + +   +  L E+  L R +H N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 143
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 144 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 96/199 (48%), Gaps = 33/199 (16%)
Query: 121 IGLGGNGKVYKGQLLGVE---------VALKRISLD-SEHGMREFLAEVSSLGRL-KHRN 169
           +G G  G+V   + +G++         VA+K +  D +E  + + ++E+  +  + KH+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFE--------C-----DESIALSWEQRIK 216
           ++ L G C ++   L +I +Y   G+L +++          C     +    LS +  + 
Sbjct: 96  IINLLGACTQDG-PLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 154
Query: 217 VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH----GQVMS 272
               VA G+ YL      K +HRD+ A NVL+ +    ++ DFGLA+  HH     +  +
Sbjct: 155 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 211
Query: 273 GRRPIE-EGKRNLVDRMWS 290
           GR P++      L DR+++
Sbjct: 212 GRLPVKWMAPEALFDRIYT 230

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      +  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 140 IHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARV 173

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      +  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 160 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 193

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      +  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 140 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 173

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      +  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 140 IHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARV 173

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      +  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 140 IHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARV 173

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      +  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 142 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 175

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 121 IGLGGNGK--VYKGQLLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           IG G  GK  + K    G +  +K I++   S     E   EV+ L  +KH N+V  R  
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
            + E  SL ++ DY E G L K I    + +    +Q +     +   + ++++    K+
Sbjct: 92  FE-ENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHD---RKI 146
Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAKM 264
           LHRDIK+ N+ L K    +LGDFG+A++
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARV 174

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRI--SLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
            IG G  G V   +  L G +VA+K+I  + D     +  L E+  L   KH N++ ++ 
Sbjct: 62  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 176 WCKK-----EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
             +      E +S+ ++ D ME+  L + I     S  L+ E     L  +  G+ Y++ 
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMES-DLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHS 177
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
              ++V+HRD+K SN+L+++    ++GDFG+A+
Sbjct: 178 ---AQVIHRDLKPSNLLVNENCELKIGDFGMAR 207

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      +  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 147
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 148 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 181

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 81/157 (51%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      +  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 139
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 140 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 173

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 82/172 (47%), Gaps = 33/172 (19%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           IG G  G+V++ +  G+        VA+K +  ++   M+ +F  E + +    + N+V 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFE------CDES---------------IALSW 211
           L G C   K  + L+++YM  G L++++        C  S                 LS 
Sbjct: 115 LLGVCAVGK-PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 212 EQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +++ + + VA+G+ YL E    K +HRD+   N L+ + M  ++ DFGL++
Sbjct: 174 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 16/153 (10%)
Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRI--SLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
            IG G  G V   +  L G +VA+K+I  + D     +  L E+  L   KH N++ ++ 
Sbjct: 61  TIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 176 WCKK-----EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
             +      E +S+ ++ D ME+  L + I     S  L+ E     L  +  G+ Y++ 
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMES-DLHQII---HSSQPLTLEHVRYFLYQLLRGLKYMHS 176
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
              ++V+HRD+K SN+L+++    ++GDFG+A+
Sbjct: 177 ---AQVIHRDLKPSNLLVNENCELKIGDFGMAR 206

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 21/158 (13%)
Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRI---SLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
            IG G   KV   +  L G EVA+K I    L+S   +++   EV  +  L H N+V L 
Sbjct: 14  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVLNHPNIVKLF 72
Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSW----EQRIKVLKDVASGILYLYE 230
              + EK +L L+ +Y   G +       D  +A  W    E R K  + + S + Y ++
Sbjct: 73  EVIETEK-TLYLVMEYASGGEV------FDYLVAHGWMKEKEARAK-FRQIVSAVQYCHQ 124
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
            +   ++HRD+KA N+LLD  MN ++ DFG +     G
Sbjct: 125 KF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG 159

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 112/252 (44%), Gaps = 34/252 (13%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS---GRRPIE--------EGKRNLVDRM 288
           D++A+N+L+ + +  ++ DFGLA++    +  +    + PI+         G+  +   +
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 289 WS----LTE-----RSELLSVLDERL--KAKGGY----ADEVVEKVLHLGLLCAHPEANS 333
           WS    LTE     R     +++  +  + + GY      E  E +  L   C   E   
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEE 424
Query: 334 RPTIRQVLKMLE 345
           RPT   +   LE
Sbjct: 425 RPTFEYLQAFLE 436

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 112/252 (44%), Gaps = 34/252 (13%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS---GRRPIE--------EGKRNLVDRM 288
           D++A+N+L+ + +  ++ DFGLA++    +  +    + PI+         G+  +   +
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 289 WS----LTE-----RSELLSVLDERL--KAKGGY----ADEVVEKVLHLGLLCAHPEANS 333
           WS    LTE     R     +++  +  + + GY      E  E +  L   C   E   
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEE 424
Query: 334 RPTIRQVLKMLE 345
           RPT   +   LE
Sbjct: 425 RPTFEYLQAFLE 436

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L+++++    L K++    ++ AL+       L  + S + 
Sbjct: 64  HPNIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLF 113
Query: 227 YLYEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            L +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L+++++    L K++    ++ AL+       L  + S + 
Sbjct: 63  HPNIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLF 112
Query: 227 YLYEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            L +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 113 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 12/155 (7%)
Query: 121 IGLGGNGKVYKGQLLGVE-VALKRISLDSEHGMRE--FLAEVSSLGRLKHRNLVGLRGWC 177
           IG G  G V+ G  L  + VA+K I    E  M E  F+ E   + +L H  LV L G C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
             E+  + L+ ++ME+G L  ++    +    + E  + +  DV  G+ YL E   + V+
Sbjct: 73  L-EQAPICLVTEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 126
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
           HRD+ A N L+ +    ++ DFG+ +     Q  S
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L+++++    L K++    ++ AL+       L  + S + 
Sbjct: 62  HPNIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLF 111
Query: 227 YLYEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            L +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 112 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 18/159 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHR 168
           + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L      E + L L+++++    L K++    ++ AL+       L  + S +  L
Sbjct: 67  NIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLFQL 116
Query: 229 YEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 117 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L+++++    L K++    ++ AL+       L  + S + 
Sbjct: 64  HPNIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLF 113
Query: 227 YLYEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            L +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 18/159 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHR 168
           + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L      E + L L+++++    L K++    ++ AL+       L  + S +  L
Sbjct: 62  NIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLFQL 111
Query: 229 YEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L+++++    L K++    ++ AL+       L  + S + 
Sbjct: 61  HPNIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLF 110
Query: 227 YLYEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            L +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L+++++    L K++    ++ AL+       L  + S + 
Sbjct: 61  HPNIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLF 110
Query: 227 YLYEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            L +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 18/159 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHR 168
           + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L      E + L L+++++    L K++    ++ AL+       L  + S +  L
Sbjct: 70  NIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLFQL 119
Query: 229 YEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 120 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L+++++    L K++    ++ AL+       L  + S + 
Sbjct: 65  HPNIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLF 114
Query: 227 YLYEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            L +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 115 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 155

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L+++++    L K++    ++ AL+       L  + S + 
Sbjct: 63  HPNIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLF 112
Query: 227 YLYEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            L +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 113 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 18/159 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHR 168
           + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L      E + L L+++++    L K++    ++ AL+       L  + S +  L
Sbjct: 64  NIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLFQL 113
Query: 229 YEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 114 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 18/159 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHR 168
           + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L      E + L L+++++    L K++    ++ AL+       L  + S +  L
Sbjct: 63  NIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLFQL 112
Query: 229 YEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L+++++    L K++    ++ AL+       L  + S + 
Sbjct: 61  HPNIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLF 110
Query: 227 YLYEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            L +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 18/159 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHR 168
           + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L      E + L L+++++    L K++    ++ AL+       L  + S +  L
Sbjct: 70  NIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLFQL 119
Query: 229 YEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 120 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 158

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 18/159 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHR 168
           + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L      E + L L+++++    L K++    ++ AL+       L  + S +  L
Sbjct: 62  NIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLFQL 111
Query: 229 YEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 18/159 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHR 168
           + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L      E + L L+++++    L K++    ++ AL+       L  + S +  L
Sbjct: 63  NIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLFQL 112
Query: 229 YEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 18/159 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHR 168
           + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L      E + L L+++++    L K++    ++ AL+       L  + S +  L
Sbjct: 62  NIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLFQL 111
Query: 229 YEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 78/157 (49%), Gaps = 10/157 (6%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L+++++     D         I L   +    L  +  G+ 
Sbjct: 61  HPNIVKLLDVIHTENK-LYLVFEFLHQDLKDFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           + +     +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 118 FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLAR 151

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L+++++    L K++    ++ AL+       L  + S + 
Sbjct: 62  HPNIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLF 111
Query: 227 YLYEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            L +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 112 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 152

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 25/159 (15%)
Query: 118 ENVIGLGGNGKVYKGQLLG-----VEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLV 171
           + VIG G  G VY G+ +      ++ A+K +S  +E    E FL E   +  L H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD-------VASG 224
            L G     +    ++  YM +G L ++I            QR   +KD       VA G
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFI---------RSPQRNPTVKDLISFGLQVARG 136
Query: 225 ILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           + YL E    K +HRD+ A N +LD+    ++ DFGLA+
Sbjct: 137 MEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 18/159 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHR 168
           + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L      E + L L+++++    L K++    ++ AL+       L  + S +  L
Sbjct: 63  NIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLFQL 112
Query: 229 YEGWE----SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 113 LQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 18/159 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHR 168
           + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L      E + L L+++++    L K++    ++ AL+       L  + S +  L
Sbjct: 62  NIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLFQL 111
Query: 229 YEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 18/159 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHR 168
           + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L      E + L L+++++    L K++    ++ AL+       L  + S +  L
Sbjct: 63  NIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLFQL 112
Query: 229 YEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L+++++    L K++    ++ AL+       L  + S + 
Sbjct: 63  HPNIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLF 112
Query: 227 YLYEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            L +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 113 QLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLAR 153

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L+++++    L K++    ++ AL+       L  + S + 
Sbjct: 62  HPNIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLF 111
Query: 227 YLYEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            L +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 112 QLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 75
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 76  SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 131
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+ + +  ++ DFGLA++
Sbjct: 132 DLRAANILVGENLVCKVADFGLARL 156

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 72
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 73  SEEPIXIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 128
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+ + +  ++ DFGLA++
Sbjct: 129 DLRAANILVGENLVCKVADFGLARL 153

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 12/158 (7%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLD-KWIFECDESIALSWEQRIKVLKDVASGI 225
           H N+V L      E + L L+++++   S+D K   +      +        L  +  G+
Sbjct: 64  HPNIVKLLDVIHTENK-LYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            + +     +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 120 AFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLAR 154

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L+++++    L K++    ++ AL+       L  + S + 
Sbjct: 61  HPNIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLF 110
Query: 227 YLYEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            L +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 10/157 (6%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L+++++      K   +      +        L  +  G+ 
Sbjct: 64  HPNIVKLLDVIHTENK-LYLVFEFLHQDL--KTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           + +     +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 121 FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 12/158 (7%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLD-KWIFECDESIALSWEQRIKVLKDVASGI 225
           H N+V L      E + L L+++++   S+D K   +      +        L  +  G+
Sbjct: 62  HPNIVKLLDVIHTENK-LYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGL 117
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            + +     +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 118 AFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLAR 152

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 77/145 (53%), Gaps = 7/145 (4%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G      +VA+K +   +   ++ FL E + +  L+H  LV L     +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
           E E + +I +YM  GSL  ++ + DE   +   + I     +A G+ Y+        +HR
Sbjct: 80  E-EPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 134
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+NVL+ + +  ++ DFGLA++
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARV 159

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 12/158 (7%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLD-KWIFECDESIALSWEQRIKVLKDVASGI 225
           H N+V L      E + L L+++++   S+D K   +      +        L  +  G+
Sbjct: 64  HPNIVKLLDVIHTENK-LYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGL 119
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            + +     +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 120 AFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 94/182 (51%), Gaps = 16/182 (8%)
Query: 90  ETEDWELEYW-PHRVSYQEIHAATKGFS-EENVIGLGGNGKVYKG--QLLGVEVALKRIS 145
           +TE +E  Y  P  +  +E++   K  + E+  +G G  G V KG  Q+  V   +    
Sbjct: 345 DTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKI 404
Query: 146 LDSEHG----MREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIF 201
           L +E        E LAE + + +L +  +V + G C  E ES +L+ +  E G L+K++ 
Sbjct: 405 LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYL- 461
Query: 202 ECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL 261
              ++  +  +  I+++  V+ G+ YL E   S  +HRD+ A NVLL  +  A++ DFGL
Sbjct: 462 --QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGL 516
Query: 262 AK 263
           +K
Sbjct: 517 SK 518

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 85/161 (52%), Gaps = 18/161 (11%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N+V L      E + L L++++++   L K++    ++ AL+       L  + S + 
Sbjct: 64  HPNIVKLLDVIHTENK-LYLVFEHVDQ-DLKKFM----DASALTGIP----LPLIKSYLF 113
Query: 227 YLYEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            L +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 114 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 154

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 12/158 (7%)
Query: 111 ATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLK 166
           + + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLD-KWIFECDESIALSWEQRIKVLKDVASGI 225
           H N+V L      E + L L+++++   S+D K   +      +        L  +  G+
Sbjct: 63  HPNIVKLLDVIHTENK-LYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGL 118
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            + +     +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 119 AFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR 153

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 79
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHR 135
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+ + +  ++ DFGLA++
Sbjct: 136 DLRAANILVGENLVCKVADFGLARL 160

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 77/145 (53%), Gaps = 7/145 (4%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G      +VA+K +   +   ++ FL E + +  L+H  LV L     K
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
           E E + +I ++M  GSL  ++ + DE   +   + I     +A G+ Y+        +HR
Sbjct: 79  E-EPIYIITEFMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHR 133
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+NVL+ + +  ++ DFGLA++
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARV 158

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 68/130 (52%), Gaps = 9/130 (6%)
Query: 136 GVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGLRGWCKKEKE-SLILIYDYMEN 193
           G  VA+K +  D     R  +  E+  L  L H +++  +G C+ + E SL L+ +Y+  
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 194 GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN 253
           GSL  ++     SI L+  Q +   + +  G+ YL+       +HR++ A NVLLD    
Sbjct: 103 GSLRDYLPR--HSIGLA--QLLLFAQQICEGMAYLHS---QHYIHRNLAARNVLLDNDRL 155
Query: 254 ARLGDFGLAK 263
            ++GDFGLAK
Sbjct: 156 VKIGDFGLAK 165

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 79
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHR 135
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+ + +  ++ DFGLA++
Sbjct: 136 DLRAANILVGENLVCKVADFGLARL 160

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+ + +  ++ DFGLA++
Sbjct: 139 DLRAANILVGENLVCKVADFGLARL 163

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 112/252 (44%), Gaps = 34/252 (13%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 248
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 304
Query: 240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS---GRRPIE--------EGKRNLVDRM 288
           D++A+N+L+ + +  ++ DFGLA++    +  +    + PI+         G+  +   +
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 289 WS----LTE-----RSELLSVLDERL--KAKGGY----ADEVVEKVLHLGLLCAHPEANS 333
           WS    LTE     R     +++  +  + + GY      E  E +  L   C   E   
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEE 424
Query: 334 RPTIRQVLKMLE 345
           RPT   +   LE
Sbjct: 425 RPTFEYLQAFLE 436

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 68/130 (52%), Gaps = 9/130 (6%)
Query: 136 GVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGLRGWCKKEKE-SLILIYDYMEN 193
           G  VA+K +  D     R  +  E+  L  L H +++  +G C+ + E SL L+ +Y+  
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 194 GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN 253
           GSL  ++     SI L+  Q +   + +  G+ YL+       +HR++ A NVLLD    
Sbjct: 103 GSLRDYLPR--HSIGLA--QLLLFAQQICEGMAYLHA---QHYIHRNLAARNVLLDNDRL 155
Query: 254 ARLGDFGLAK 263
            ++GDFGLAK
Sbjct: 156 VKIGDFGLAK 165

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 71
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 72  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 127
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+ + +  ++ DFGLA++
Sbjct: 128 DLRAANILVGENLVCKVADFGLARL 152

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+ + +  ++ DFGLA++
Sbjct: 139 DLRAANILVGENLVCKVADFGLARL 163

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+ + +  ++ DFGLA++
Sbjct: 139 DLRAANILVGENLVCKVADFGLARL 163

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 67/130 (51%), Gaps = 9/130 (6%)
Query: 136 GVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDYMEN 193
           G  VA+K +  D+    R  +  E+  L  L H +++  +G C+     SL L+ +Y+  
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 194 GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN 253
           GSL  ++     SI L+  Q +   + +  G+ YL+       +HRD+ A NVLLD    
Sbjct: 120 GSLRDYLPR--HSIGLA--QLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRL 172
Query: 254 ARLGDFGLAK 263
            ++GDFGLAK
Sbjct: 173 VKIGDFGLAK 182

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 83  SEEPIYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+ + +  ++ DFGLA++
Sbjct: 139 DLRAANILVGENLVCKVADFGLARL 163

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 73
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 74  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 129
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+ + +  ++ DFGLA++
Sbjct: 130 DLRAANILVGENLVCKVADFGLARL 154

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 121 IGLGGNGKV------YKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
           +G G  GKV        GQ + +++  K++   S+   R    E+S L  L+H +++ L 
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 70
Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
              K  K+ +I++ +Y  N   D +I + D+   +S ++  +  + + S + Y +     
Sbjct: 71  DVIK-SKDEIIMVIEYAGNELFD-YIVQRDK---MSEQEARRFFQQIISAVEYCHR---H 122
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
           K++HRD+K  N+LLD+ +N ++ DFGL+ +   G  +
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 159

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 121 IGLGGNGKV------YKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
           +G G  GKV        GQ + +++  K++   S+   R    E+S L  L+H +++ L 
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 80
Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
              K  K+ +I++ +Y  N   D +I + D+   +S ++  +  + + S + Y +     
Sbjct: 81  DVIK-SKDEIIMVIEYAGNELFD-YIVQRDK---MSEQEARRFFQQIISAVEYCHR---H 132
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
           K++HRD+K  N+LLD+ +N ++ DFGL+ +   G  +
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 169

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 121 IGLGGNGKV------YKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
           +G G  GKV        GQ + +++  K++   S+   R    E+S L  L+H +++ L 
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 79
Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
              K  K+ +I++ +Y  N   D +I + D+   +S ++  +  + + S + Y +     
Sbjct: 80  DVIK-SKDEIIMVIEYAGNELFD-YIVQRDK---MSEQEARRFFQQIISAVEYCHR---H 131
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
           K++HRD+K  N+LLD+ +N ++ DFGL+ +   G  +
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 168

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 16/150 (10%)
Query: 124 GGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE- 182
           G  G V+K QL+   VA+K   L  +   +    E+ S   +KH NL+      K+    
Sbjct: 26  GRFGCVWKAQLMNDFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSNL 84
Query: 183 --SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE--------GW 232
              L LI  + + GSL  ++    +   ++W +   V + ++ G+ YL+E        G 
Sbjct: 85  EVELWLITAFHDKGSLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGH 140
Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           +  + HRD K+ NVLL   + A L DFGLA
Sbjct: 141 KPSIAHRDFKSKNVLLKSDLTAVLADFGLA 170

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 82/157 (52%), Gaps = 15/157 (9%)
Query: 121 IGLGGNGKV------YKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
           +G G  GKV        GQ + +++  K++   S+   R    E+S L  L+H +++ L 
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGR-IEREISYLRLLRHPHIIKLY 74
Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
              K  K+ +I++ +Y  N   D +I + D+   +S ++  +  + + S + Y +     
Sbjct: 75  DVIK-SKDEIIMVIEYAGNELFD-YIVQRDK---MSEQEARRFFQQIISAVEYCHR---H 126
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
           K++HRD+K  N+LLD+ +N ++ DFGL+ +   G  +
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL 163

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 8/148 (5%)
Query: 118 ENVIGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           E  +G G  G+V+        +VA+K +   S   +  FLAE + +  L+H  LV L   
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
             KE   + +I ++M  GSL  ++ + DE       + I     +A G+ ++ +      
Sbjct: 79  VTKE--PIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNY 132
Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAKM 264
           +HRD++A+N+L+   +  ++ DFGLA++
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARV 160

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 8/148 (5%)
Query: 118 ENVIGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           E  +G G  G+V+        +VA+K +   S   +  FLAE + +  L+H  LV L   
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
             KE   + +I ++M  GSL  ++ + DE       + I     +A G+ ++ +      
Sbjct: 246 VTKE--PIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNY 299
Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAKM 264
           +HRD++A+N+L+   +  ++ DFGLA++
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARV 327

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 62/119 (52%), Gaps = 4/119 (3%)
Query: 155 FLAEVSSLGRLKHRNLVGLRG-WCKKEKESLILIYDYMENGSLDKWIFE-CDESIALSWE 212
            ++EV+ L  LKH N+V        +   +L ++ +Y E G L   I +   E   L  E
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 213 QRIKVLKDVASGILYLYEGWES--KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
             ++V+  +   +   +   +    VLHRD+K +NV LD K N +LGDFGLA++ +H +
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDE 170

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G  +VA+K +   +      FL E   + +LKH  LV L  +   
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQL--YAVV 73
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ +  E  AL     + +   VA+G+ Y+        +HR
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHR 129
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++++N+L+   +  ++ DFGLA++
Sbjct: 130 DLRSANILVGNGLICKIADFGLARL 154

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +++H  LV L  +   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQL--YAVV 82
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+ + +  ++ DFGLA++
Sbjct: 139 DLRAANILVGENLVCKVADFGLARL 163

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 10/155 (6%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHR 168
           + F +   IG G  G VYK   +L G  VALK+I LD+E  G+    + E+S L  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L      E + L L+++++      K   +      +        L  +  G+ + 
Sbjct: 62  NIVKLLDVIHTENK-LYLVFEHVHQDL--KTFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +     +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 119 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 8/148 (5%)
Query: 118 ENVIGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           E  +G G  G+V+        +VA+K +   S   +  FLAE + +  L+H  LV L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
             KE   + +I ++M  GSL  ++ + DE       + I     +A G+ ++ +      
Sbjct: 252 VTKE--PIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNY 305
Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAKM 264
           +HRD++A+N+L+   +  ++ DFGLA++
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARV 333

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 45/262 (17%)
Query: 121 IGLGGNGKVYKG---------QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
           +G G   K++KG         QL   EV LK +     +    F    S + +L H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
              G C    E+ IL+ ++++ GSLD ++ +    I + W  +++V K +A+ + +L   
Sbjct: 76  LNYGVCVCGDEN-ILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLE-- 130
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG--------QVMSGRRP------I 277
            E+ ++H ++ A N+LL ++ + + G+    K+   G         ++  R P      I
Sbjct: 131 -ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECI 189
Query: 278 EEGKR-NLVDRMWSLTER--------SELLSVLDERLKAKGGYADE---VVEKVLHLGLL 325
           E  K  NL    WS             + LS LD + K +  Y D       K   L  L
Sbjct: 190 ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRHQLPAPKAAELANL 248
Query: 326 ---CAHPEANSRPTIRQVLKML 344
              C   E + RP+ R +++ L
Sbjct: 249 INNCMDYEPDHRPSFRAIIRDL 270

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 73/147 (49%), Gaps = 11/147 (7%)
Query: 121 IGLGGNGKVYKGQLLGVE--VALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           IG G  G V+K +       VALKR+ LD   E      L E+  L  LKH+N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
              +K+ L L++++ +   L K+   C+    L  E     L  +  G+ + +      V
Sbjct: 70  LHSDKK-LTLVFEFCDQ-DLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHS---RNV 122
Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAK 263
           LHRD+K  N+L+++    +L DFGLA+
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLAR 149

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 122/284 (42%), Gaps = 52/284 (18%)
Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHG-MREFLAEVSSLGRLKHR-NLV 171
           +G G  G+V +    G++       VA+K +   + H   R  ++E+  L  + H  N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWI---------FECDESIA---LSWEQRIKVLK 219
            L G C K    L++I ++ + G+L  ++         ++  E +    L+ E  I    
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK--MHHHGQVMSG--RR 275
            VA G+ +L      K +HRD+ A N+LL +K   ++ DFGLA+        V  G  R 
Sbjct: 156 QVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 276 PIE-EGKRNLVDRMWSLTERS--------ELLSV---------LDE----RLK--AKGGY 311
           P++      + DR++++            E+ S+         +DE    RLK   +   
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 272
Query: 312 ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLED 355
            D    ++    L C H E + RPT  ++++ L    +    +D
Sbjct: 273 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 13/153 (8%)
Query: 121 IGLGGNGKVYKGQLLG----VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           IG G  G+V+ G+L      V V   R +L  +   + FL E   L +  H N+V L G 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 180
Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
           C  +K+ + ++ + ++ G  D   F   E   L  +  ++++ D A+G+ YL    ESK 
Sbjct: 181 CT-QKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL----ESKC 233
Query: 237 -LHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
            +HRD+ A N L+ +K   ++ DFG+++    G
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 94/182 (51%), Gaps = 16/182 (8%)
Query: 90  ETEDWELEYW-PHRVSYQEIHAATKGFS-EENVIGLGGNGKVYKG--QLLGVEVALKRIS 145
           +TE +E  Y  P  +  +E++   K  + E+  +G G  G V KG  Q+  V   +    
Sbjct: 2   DTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKI 61
Query: 146 LDSEHG----MREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIF 201
           L +E        E LAE + + +L +  +V + G C  E ES +L+ +  E G L+K++ 
Sbjct: 62  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYL- 118
Query: 202 ECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL 261
              ++  +  +  I+++  V+ G+ YL E   S  +HRD+ A NVLL  +  A++ DFGL
Sbjct: 119 --QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 262 AK 263
           +K
Sbjct: 174 SK 175

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 94/182 (51%), Gaps = 16/182 (8%)
Query: 90  ETEDWELEYW-PHRVSYQEIHAATKGFS-EENVIGLGGNGKVYKG--QLLGVEVALKRIS 145
           +TE +E  Y  P  +  +E++   K  + E+  +G G  G V KG  Q+  V   +    
Sbjct: 2   DTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKI 61
Query: 146 LDSEHG----MREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIF 201
           L +E        E LAE + + +L +  +V + G C  E ES +L+ +  E G L+K++ 
Sbjct: 62  LKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYL- 118
Query: 202 ECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL 261
              ++  +  +  I+++  V+ G+ YL E   S  +HRD+ A NVLL  +  A++ DFGL
Sbjct: 119 --QQNRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 262 AK 263
           +K
Sbjct: 174 SK 175

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 61/117 (52%), Gaps = 4/117 (3%)
Query: 155 FLAEVSSLGRLKHRNLVGLRG-WCKKEKESLILIYDYMENGSLDKWIFE-CDESIALSWE 212
            ++EV+ L  LKH N+V        +   +L ++ +Y E G L   I +   E   L  E
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 213 QRIKVLKDVASGILYLYEGWES--KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
             ++V+  +   +   +   +    VLHRD+K +NV LD K N +LGDFGLA++ +H
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 61/117 (52%), Gaps = 4/117 (3%)
Query: 155 FLAEVSSLGRLKHRNLVGLRG-WCKKEKESLILIYDYMENGSLDKWIFE-CDESIALSWE 212
            ++EV+ L  LKH N+V        +   +L ++ +Y E G L   I +   E   L  E
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 213 QRIKVLKDVASGILYLYEGWES--KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
             ++V+  +   +   +   +    VLHRD+K +NV LD K N +LGDFGLA++ +H
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 75/145 (51%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D+ A+N+L+ + +  ++ DFGLA++
Sbjct: 139 DLAAANILVGENLVCKVADFGLARL 163

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 78/153 (50%), Gaps = 13/153 (8%)
Query: 121 IGLGGNGKVYKGQLLG----VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           IG G  G+V+ G+L      V V   R +L  +   + FL E   L +  H N+V L G 
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 180
Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
           C  +K+ + ++ + ++ G  D   F   E   L  +  ++++ D A+G+ YL    ESK 
Sbjct: 181 CT-QKQPIYIVMELVQGG--DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL----ESKC 233
Query: 237 -LHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
            +HRD+ A N L+ +K   ++ DFG+++    G
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 81/168 (48%), Gaps = 22/168 (13%)
Query: 110 AATKGFSEE----NVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLG 163
           AA K F ++    +VIG G +  V +   +  G E A+K + + +E    E L EV    
Sbjct: 87  AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREAT 146
Query: 164 RLK---------HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR 214
           R +         H +++ L     +    + L++D M  G L  ++    E +ALS ++ 
Sbjct: 147 RRETHILRQVAGHPHIITLID-SYESSSFMFLVFDLMRKGELFDYL---TEKVALSEKET 202
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             +++ +   + +L+    + ++HRD+K  N+LLD  M  RL DFG +
Sbjct: 203 RSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFS 247

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 82/178 (46%), Gaps = 18/178 (10%)
Query: 106 QEIHAATKGFSEENVIGLGGNGKVYKGQLLG-----VEVALKRISLD--SEHGMREFLAE 158
           +++    + F+   ++G G  G V + QL       V+VA+K +  D  +   + EFL E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 159 VSSLGRLKHRNL-----VGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALS 210
            + +    H ++     V LR   K      ++I  +M++G L  ++      +    L 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
            +  ++ + D+A G+ YL        +HRD+ A N +L + M   + DFGL++  + G
Sbjct: 136 LQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG 190

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 82/159 (51%), Gaps = 18/159 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHR 168
           + F +   IG G  G VYK   +L G  VAL +I LD+E  G+    + E+S L  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L      E + L L+++++    L K++    ++ AL+       L  + S +  L
Sbjct: 63  NIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLFQL 112
Query: 229 YEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 113 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 82/159 (51%), Gaps = 18/159 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSE-HGMREF-LAEVSSLGRLKHR 168
           + F +   IG G  G VYK   +L G  VAL +I LD+E  G+    + E+S L  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N+V L      E + L L+++++    L K++    ++ AL+       L  + S +  L
Sbjct: 62  NIVKLLDVIHTENK-LYLVFEFLHQ-DLKKFM----DASALTGIP----LPLIKSYLFQL 111
Query: 229 YEGW----ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +G       +VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 112 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 88/171 (51%), Gaps = 15/171 (8%)
Query: 100 PHRVSYQEIHAATKGFS-EENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHG----M 152
           P  +  +E++   K  + E+  +G G  G V KG  Q+  V   +    L +E       
Sbjct: 355 PEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 414
Query: 153 REFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWE 212
            E LAE + + +L +  +V + G C  E ES +L+ +  E G L+K++    ++  +  +
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDK 469
Query: 213 QRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             I+++  V+ G+ YL E   S  +HRD+ A NVLL  +  A++ DFGL+K
Sbjct: 470 NIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 517

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 75/145 (51%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  G L  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 83  SEEPIYIVMEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+ + +  ++ DFGLA++
Sbjct: 139 DLRAANILVGENLVCKVADFGLARL 163

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      +  V VA+K+IS  + +   +  L E+  L   +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 142 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 175

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 116 SEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           S+  ++G G  G+V+K +    G+++A K I         E   E+S + +L H NL+ L
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
                + K  ++L+ +Y++ G L   I   DES  L+    I  +K +  GI ++++ + 
Sbjct: 152 YD-AFESKNDIVLVMEYVDGGELFDRII--DESYNLTELDTILFMKQICEGIRHMHQMY- 207
Query: 234 SKVLHRDIKASNVLL---DKKMNARLGDFGLAKMH 265
             +LH D+K  N+L    D K   ++ DFGLA+ +
Sbjct: 208 --ILHLDLKPENILCVNRDAK-QIKIIDFGLARRY 239

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 73/149 (48%), Gaps = 11/149 (7%)
Query: 118 ENVIGLGGNGKVYKGQ--LLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGL 173
           +  IG G   KV   +  L G EVA+K I     +   +++   EV  +  L H N+V L
Sbjct: 20  QKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
               + EK +L L+ +Y   G +  ++           E R K  + + S + Y ++ + 
Sbjct: 80  FEVIETEK-TLYLVMEYASGGEVFDYL--VAHGRMKEKEARAK-FRQIVSAVQYCHQKY- 134
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             ++HRD+KA N+LLD  MN ++ DFG +
Sbjct: 135 --IVHRDLKAENLLLDGDMNIKIADFGFS 161

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 75/145 (51%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L  +   
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--YAVV 82
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  G L  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 83  SEEPIYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 138
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+ + +  ++ DFGLA++
Sbjct: 139 DLRAANILVGENLVCKVADFGLARL 163

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 13/154 (8%)
Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRI---SLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
            IG G   KV   +  L G EVA+K I    L+S   +++   EV  +  L H N+V L 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVLNHPNIVKLF 79
Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
              + EK +L L+ +Y   G +  ++           E R K  + + S + Y ++ +  
Sbjct: 80  EVIETEK-TLYLVMEYASGGEVFDYL--VAHGRMKEKEARAK-FRQIVSAVQYCHQKF-- 133
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
            ++HRD+KA N+LLD  MN ++ DFG +     G
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG 166

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 13/159 (8%)
Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRI---SLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
            IG G   KV   +  L G EVA+K I    L+S   +++   EV  +  L H N+V L 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVLNHPNIVKLF 79
Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
              + EK +L L+ +Y   G +  ++           E R K  + + S + Y ++ +  
Sbjct: 80  EVIETEK-TLYLVMEYASGGEVFDYL--VAHGRMKEKEARAK-FRQIVSAVQYCHQKF-- 133
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSG 273
            ++HRD+KA N+LLD  MN ++ DFG +     G  +  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA 171

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 74/148 (50%), Gaps = 13/148 (8%)
Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRI---SLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
            IG G   KV   +  L G EVA+K I    L+S   +++   EV  +  L H N+V L 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIMKVLNHPNIVKLF 79
Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
              + EK +L L+ +Y   G +  ++           E R K  + + S + Y ++ +  
Sbjct: 80  EVIETEK-TLYLVMEYASGGEVFDYL--VAHGRMKEKEARAK-FRQIVSAVQYCHQKF-- 133
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLA 262
            ++HRD+KA N+LLD  MN ++ DFG +
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 121 IGLGGNGKVYKGQLLGV-EVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           +G G  G+V+ G   G   VA+K +          FL E   + +L+H  LV L  +   
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQL--YAVV 249
Query: 180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            +E + ++ +YM  GSL  ++ + +    L   Q + +   +ASG+ Y+        +HR
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 305
Query: 240 DIKASNVLLDKKMNARLGDFGLAKM 264
           D++A+N+L+ + +  ++ DFGL ++
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRL 330

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 50/235 (21%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKE-SLILIYDYMENGSLDKWIFECDESIALSWEQRIK 216
           E+  L  L H ++V  +G C+ + E S+ L+ +Y+  GSL  ++      + L+  Q + 
Sbjct: 60  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPR--HCVGLA--QLLL 115
Query: 217 VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM----HHHGQVM- 271
             + +  G+ YL+       +HR + A NVLLD     ++GDFGLAK     H + +V  
Sbjct: 116 FAQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 172
Query: 272 SGRRPI--------EEGKRNLVDRMWSL-TERSELLSVLDERLKAKGGYAD--------- 313
            G  P+        +E K      +WS      ELL+  D        + +         
Sbjct: 173 DGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQM 232
Query: 314 ------EVVEK-------------VLHLGLLCAHPEANSRPTIRQVLKMLEGQTE 349
                 E++E+             + HL   C   EA+ RPT + ++ +L+   E
Sbjct: 233 TVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQE 287

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 79/152 (51%), Gaps = 17/152 (11%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLD-SEHGMR-EFLAEVSSLGRLKHRNLVGLRGW 176
           +G G  G+VYK    +    VA+KRI L+  E G+    + EVS L  L+HRN++ L+  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS- 100
Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
                  L LI++Y EN  L K++   D++  +S       L  + +G+ + +     + 
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVNFCH---SRRC 153
Query: 237 LHRDIKASNVLL-----DKKMNARLGDFGLAK 263
           LHRD+K  N+LL      +    ++GDFGLA+
Sbjct: 154 LHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 50/235 (21%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKE-SLILIYDYMENGSLDKWIFECDESIALSWEQRIK 216
           E+  L  L H ++V  +G C+ + E S+ L+ +Y+  GSL  ++      + L+  Q + 
Sbjct: 61  EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPR--HCVGLA--QLLL 116
Query: 217 VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM----HHHGQVM- 271
             + +  G+ YL+       +HR + A NVLLD     ++GDFGLAK     H + +V  
Sbjct: 117 FAQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 173
Query: 272 SGRRPI--------EEGKRNLVDRMWSL-TERSELLSVLDERLKAKGGYAD--------- 313
            G  P+        +E K      +WS      ELL+  D        + +         
Sbjct: 174 DGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQM 233
Query: 314 ------EVVEK-------------VLHLGLLCAHPEANSRPTIRQVLKMLEGQTE 349
                 E++E+             + HL   C   EA+ RPT + ++ +L+   E
Sbjct: 234 TVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQE 288

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 121 IGLGGNGKVYK--GQLLGVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGLR--- 174
           +G GG G V +   Q  G +VA+K+   +     RE +  E+  + +L H N+V  R   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 175 -GWCKKEKESL-ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
            G  K     L +L  +Y E G L K++ + +    L       +L D++S + YL+   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138
Query: 233 ESKVLHRDIKASNVLLD---KKMNARLGDFGLAKMHHHGQVMS 272
           E++++HRD+K  N++L    +++  ++ D G AK    G++ +
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 82/163 (50%), Gaps = 14/163 (8%)
Query: 121 IGLGGNGKVYK--GQLLGVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGLR--- 174
           +G GG G V +   Q  G +VA+K+   +     RE +  E+  + +L H N+V  R   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 175 -GWCKKEKESL-ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
            G  K     L +L  +Y E G L K++ + +    L       +L D++S + YL+   
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 139
Query: 233 ESKVLHRDIKASNVLLD---KKMNARLGDFGLAKMHHHGQVMS 272
           E++++HRD+K  N++L    +++  ++ D G AK    G++ +
Sbjct: 140 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 182

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 19/177 (10%)
Query: 120 VIGLGGNGKVYKGQLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
            +G G  G+V++G   G  VA+K  S  D +   RE   E+ +   L+H N++G      
Sbjct: 44  CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 101
Query: 179 KEKES---LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY------ 229
             + S   L LI  Y E GSL  ++    +   L     ++++  +ASG+ +L+      
Sbjct: 102 TSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 157
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH--GQVMSGRRPIEEGKRNL 284
           +G +  + HRD+K+ N+L+ K     + D GLA MH     Q+  G  P    KR +
Sbjct: 158 QG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 213

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 107/261 (40%), Gaps = 39/261 (14%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRIS---LDSEHGMREFLAEVSSLGRLKHR 168
            F  E  IG G   +VY+   L  GV VALK++    L       + + E+  L +L H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILY 227
           N++       ++ E L ++ +  + G L + I    +   L  E+ + K    + S + +
Sbjct: 93  NVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH------HGQV-----MSGRRP 276
           ++     +V+HRDIK +NV +      +LGD GL +         H  V     MS  R 
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER- 207
Query: 277 IEEGKRNLVDRMWSL---------------TERSELLSVLD--ERLKAKGGYADEVVEKV 319
           I E   N    +WSL                ++  L S+    E+       +D   E++
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267
Query: 320 LHLGLLCAHPEANSRPTIRQV 340
             L  +C +P+   RP +  V
Sbjct: 268 RQLVNMCINPDPEKRPDVTYV 288

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 80/157 (50%), Gaps = 15/157 (9%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      +  V VA+K+IS  + +   +  L E+  L   +H N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 172 GL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           G+    R    ++ + + ++ D ME       +++  ++  LS +     L  +  G+ Y
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICYFLYQILRGLKY 141
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 142 IHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARV 175

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 88/171 (51%), Gaps = 15/171 (8%)
Query: 100 PHRVSYQEIHAATKGFS-EENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHG----M 152
           P  +  +E++   K  + E+  +G G  G V KG  Q+  V   +    L +E       
Sbjct: 11  PEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 70
Query: 153 REFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWE 212
            E LAE + + +L +  +V + G C  E ES +L+ +  E G L+K++    ++  +  +
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDK 125
Query: 213 QRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             I+++  V+ G+ YL E   S  +HRD+ A NVLL  +  A++ DFGL+K
Sbjct: 126 NIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 173

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 19/177 (10%)
Query: 120 VIGLGGNGKVYKGQLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
            +G G  G+V++G   G  VA+K  S  D +   RE   E+ +   L+H N++G      
Sbjct: 15  CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 179 KEKES---LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY------ 229
             + S   L LI  Y E GSL  ++    +   L     ++++  +ASG+ +L+      
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH--GQVMSGRRPIEEGKRNL 284
           +G +  + HRD+K+ N+L+ K     + D GLA MH     Q+  G  P    KR +
Sbjct: 129 QG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 11/147 (7%)
Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRG 175
            IG G   KV   +  L G EVA+K I     +   +++   EV  +  L H N+V L  
Sbjct: 19  TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
             + EK +L LI +Y   G +  ++           E R K  + + S + Y ++    +
Sbjct: 79  VIETEK-TLYLIMEYASGGEVFDYL--VAHGRMKEKEARSK-FRQIVSAVQYCHQ---KR 131
Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLA 262
           ++HRD+KA N+LLD  MN ++ DFG +
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFS 158

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 81/144 (56%), Gaps = 10/144 (6%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
           +G G  G VYK   +  G  VA+K++ ++S+  ++E + E+S + +    ++V   G   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLH 238
           K  + L ++ +Y   GS+   I   +++  L+ ++   +L+    G+ YL+     + +H
Sbjct: 95  KNTD-LWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEYLHF---MRKIH 148
Query: 239 RDIKASNVLLDKKMNARLGDFGLA 262
           RDIKA N+LL+ + +A+L DFG+A
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVA 172

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 121/285 (42%), Gaps = 53/285 (18%)
Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHG-MREFLAEVSSLGRLKHR-NLV 171
           +G G  G+V +    G++       VA+K +   + H   R  ++E+  L  + H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIF----------ECDESIA---LSWEQRIKVL 218
            L G C K    L++I ++ + G+L  ++           E  E +    L+ E  I   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA----KMHHHGQVMSGR 274
             VA G+ +L      K +HRD+ A N+LL +K   ++ DFGLA    K   + +    R
Sbjct: 157 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 275 RPIE-EGKRNLVDRMWSLTERS--------ELLSV---------LDE----RLK--AKGG 310
            P++      + DR++++            E+ S+         +DE    RLK   +  
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 273
Query: 311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLED 355
             D    ++    L C H E + RPT  ++++ L    +    +D
Sbjct: 274 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 318

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 19/177 (10%)
Query: 120 VIGLGGNGKVYKGQLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCK 178
            +G G  G+V++G   G  VA+K  S  D +   RE   E+ +   L+H N++G      
Sbjct: 15  CVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIASDM 72
Query: 179 KEKES---LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY------ 229
             + S   L LI  Y E GSL  ++    +   L     ++++  +ASG+ +L+      
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH--GQVMSGRRPIEEGKRNL 284
           +G +  + HRD+K+ N+L+ K     + D GLA MH     Q+  G  P    KR +
Sbjct: 129 QG-KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C      LI+    M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 81  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 132
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 133 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 170

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C      LI+    M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 80  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 132 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 11/147 (7%)
Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRG 175
            IG G   KV   +  L G EVA+K I     +   +++   EV  +  L H N+V L  
Sbjct: 22  TIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
             + EK +L LI +Y   G +  ++           E R K  + + S + Y ++    +
Sbjct: 82  VIETEK-TLYLIMEYASGGEVFDYL--VAHGRMKEKEARSK-FRQIVSAVQYCHQ---KR 134
Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLA 262
           ++HRD+KA N+LLD  MN ++ DFG +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFS 161

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C      LI+    M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 79  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 131 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 168

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C      LI+    M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 78  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 129
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 130 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 167

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 84
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 134
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 135 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 185

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 95
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 145
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 146 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 196

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 64/123 (52%), Gaps = 10/123 (8%)
Query: 143 RISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSL---DKW 199
           +IS+ S++   +F  E+  +  +K+   +   G      E  I IY+YMEN S+   D++
Sbjct: 80  KISIKSKYD--DFKNELQIITDIKNEYCLTCEGIITNYDEVYI-IYEYMENDSILKFDEY 136
Query: 200 IFECDESIALSWEQRIKVLKDVASGIL--YLYEGWESKVLHRDIKASNVLLDKKMNARLG 257
            F  D++        I+V+K +   +L  + Y   E  + HRD+K SN+L+DK    +L 
Sbjct: 137 FFVLDKNYTCFIP--IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLS 194
Query: 258 DFG 260
           DFG
Sbjct: 195 DFG 197

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 110
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 160
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 112
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 162
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 163 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 213

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C      LI+    M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 77  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 110
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 160
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 89
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 139
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 140 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 190

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 80  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 132 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 88
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 138
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 104
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 154
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 155 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 205

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 83  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 134
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 135 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 172

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 80  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 132 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 87/166 (52%), Gaps = 19/166 (11%)
Query: 121 IGLGGNGKVYKGQLL---GVEVALKRISLDS-EHGM-----REFLAEVSSLGRLKHRNLV 171
           IG G  GKV+K + L   G  VALKR+ + + E GM     RE +A +  L   +H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFEHPNVV 77
Query: 172 GLRGWC---KKEKES-LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
            L   C   + ++E+ L L++++++   L  ++ +  E   +  E    ++  +  G+ +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDF 135
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSG 273
           L+     +V+HRD+K  N+L+      +L DFGLA+++     ++ 
Sbjct: 136 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 126
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 84  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 136 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 126
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 126
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C      LI+    M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 78  PHVCRLLGICLTSTVQLIM--QLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AK 129
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 130 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 167

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 87  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 138
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 139 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 176

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 28/187 (14%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRI------SLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +G G  G V+K   +  G  VA+K+I      S D++   RE +      G   H N+V 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG---HENIVN 73
Query: 173 LRGWCKKEKE-SLILIYDYME---NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           L    + + +  + L++DYME   +  +   I E      + + Q IKV+K       YL
Sbjct: 74  LLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY-QLIKVIK-------YL 125
Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRP--IEEGKRNLVD 286
           + G    +LHRD+K SN+LL+ + + ++ DFGL++   + + ++   P  I E   N  D
Sbjct: 126 HSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 287 RMWSLTE 293
               LT+
Sbjct: 183 DQPILTD 189

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 77
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 127
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 128 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 178

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 88
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 138
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 139 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 13/148 (8%)
Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRI---SLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
            IG G   KV   +  L G EVA++ I    L+S   +++   EV  +  L H N+V L 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSS-SLQKLFREVRIMKVLNHPNIVKLF 79
Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
              + EK +L L+ +Y   G +  ++           E R K  + + S + Y ++ +  
Sbjct: 80  EVIETEK-TLYLVMEYASGGEVFDYL--VAHGRMKEKEARAK-FRQIVSAVQYCHQKF-- 133
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLA 262
            ++HRD+KA N+LLD  MN ++ DFG +
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 12/148 (8%)
Query: 121 IGLGGNGKV----YKGQLLGVEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGLRG 175
           +G G  G V    Y+ +   ++VA+K +   +E     E + E   + +L +  +V L G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
            C  + E+L+L+ +    G L K++    E I +S     ++L  V+ G+ YL E     
Sbjct: 78  VC--QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEE---KN 130
Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +HRD+ A NVLL  +  A++ DFGL+K
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSK 158

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 79  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 131 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 168

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 81
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 131
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 132 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 182

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 77  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 102 PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 153
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 154 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 191

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 74  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AE 125
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 126 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 163

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 80  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 131
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 132 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 169

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 74/148 (50%), Gaps = 13/148 (8%)
Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRI---SLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
            IG G   KV   +  L G EVA++ I    L+S   +++   EV  +  L H N+V L 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSS-SLQKLFREVRIMKVLNHPNIVKLF 79
Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
              + EK +L L+ +Y   G +  ++           E R K  + + S + Y ++ +  
Sbjct: 80  EVIETEK-TLYLVMEYASGGEVFDYL--VAHGRMKEKEARAK-FRQIVSAVQYCHQKF-- 133
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLA 262
            ++HRD+KA N+LLD  MN ++ DFG +
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 114
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 164
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 165 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 215

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 155
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 205
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 206 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 256

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 11/147 (7%)
Query: 121 IGLGGNGKVYKGQLLGVE--VALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           IG G  G V+K +       VALKR+ LD   E      L E+  L  LKH+N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
              +K+ L L++++ +   L K+   C+    L  E     L  +  G+ + +      V
Sbjct: 70  LHSDKK-LTLVFEFCDQ-DLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHS---RNV 122
Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAK 263
           LHRD+K  N+L+++    +L +FGLA+
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLAR 149

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 87/166 (52%), Gaps = 19/166 (11%)
Query: 121 IGLGGNGKVYKGQLL---GVEVALKRISLDS-EHGM-----REFLAEVSSLGRLKHRNLV 171
           IG G  GKV+K + L   G  VALKR+ + + E GM     RE +A +  L   +H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFEHPNVV 77
Query: 172 GLRGWC---KKEKES-LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
            L   C   + ++E+ L L++++++   L  ++ +  E   +  E    ++  +  G+ +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDF 135
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSG 273
           L+     +V+HRD+K  N+L+      +L DFGLA+++     ++ 
Sbjct: 136 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 77  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 67/283 (23%), Positives = 118/283 (41%), Gaps = 51/283 (18%)
Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHG-MREFLAEVSSLGRLKHR-NLV 171
           +G G  G+V +    G++       VA+K +   + H   R  ++E+  L  + H  N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA-----------LSWEQRIKVLKD 220
            L G C K    L++I ++ + G+L  ++                   L+ E  I     
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK--MHHHGQVMSG--RRP 276
           VA G+ +L      K +HRD+ A N+LL +K   ++ DFGLA+        V  G  R P
Sbjct: 157 VAKGMEFLAS---RKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 277 IE-EGKRNLVDRMWSLTERS--------ELLSV---------LDE----RLK--AKGGYA 312
           ++      + DR++++            E+ S+         +DE    RLK   +    
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP 273
Query: 313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLED 355
           D    ++    L C H E + RPT  ++++ L    +    +D
Sbjct: 274 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 77  PHVCRLLGICLTS--TVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 87/166 (52%), Gaps = 19/166 (11%)
Query: 121 IGLGGNGKVYKGQLL---GVEVALKRISLDS-EHGM-----REFLAEVSSLGRLKHRNLV 171
           IG G  GKV+K + L   G  VALKR+ + + E GM     RE +A +  L   +H N+V
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFEHPNVV 77
Query: 172 GLRGWC---KKEKES-LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
            L   C   + ++E+ L L++++++   L  ++ +  E   +  E    ++  +  G+ +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDF 135
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSG 273
           L+     +V+HRD+K  N+L+      +L DFGLA+++     ++ 
Sbjct: 136 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 178

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 78/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 80
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 130
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 131 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 181

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 115/270 (42%), Gaps = 49/270 (18%)
Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHG-MREFLAEVSSLGRLKHR-NLV 171
           +G G  G+V +    G++       VA+K +   + H   R  ++E+  L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA---------LSWEQRIKVLKDVA 222
            L G C K    L++I ++ + G+L  ++                 L+ E  I     VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA----KMHHHGQVMSGRRPIE 278
            G+ +L      K +HRD+ A N+LL +K   ++ DFGLA    K   + +    R P++
Sbjct: 155 KGMEFLAS---RKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 279 -EGKRNLVDRMWSLTERS--------ELLSV---------LDE----RLK--AKGGYADE 314
                 + DR++++            E+ S+         +DE    RLK   +    D 
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRAPDY 271
Query: 315 VVEKVLHLGLLCAHPEANSRPTIRQVLKML 344
              ++    L C H E + RPT  ++++ L
Sbjct: 272 TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 71  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 122
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 113/262 (43%), Gaps = 45/262 (17%)
Query: 121 IGLGGNGKVYKG---------QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
           +G G   K++KG         QL   EV LK +     +    F    S + +L H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
              G C    E+ IL+ ++++ GSLD ++ +    I + W  +++V K +A  + +L   
Sbjct: 76  LNYGVCFCGDEN-ILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLE-- 130
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG--------QVMSGRRP------I 277
            E+ ++H ++ A N+LL ++ + + G+    K+   G         ++  R P      I
Sbjct: 131 -ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECI 189
Query: 278 EEGKR-NLVDRMWSLTER--------SELLSVLDERLKAKGGYADE---VVEKVLHLGLL 325
           E  K  NL    WS             + LS LD + K +  Y D       K   L  L
Sbjct: 190 ENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ-FYEDRHQLPAPKAAELANL 248
Query: 326 ---CAHPEANSRPTIRQVLKML 344
              C   E + RP+ R +++ L
Sbjct: 249 INNCMDYEPDHRPSFRAIIRDL 270

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 115/281 (40%), Gaps = 58/281 (20%)
Query: 120 VIGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMRE-FLAEVSSLGRL-KHRNL 170
            +G G  GKV +    G+       +VA+K +   +    +E  ++E+  +  L +H N+
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKW------IFECDESIA-----LSWEQRIKVLK 219
           V L G C      L+ I +Y   G L  +      + E D + A     LS    +    
Sbjct: 113 VNLLGACTHGGPVLV-ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSS 171
Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK--MHHHGQVMSG--RR 275
            VA G+ +L        +HRD+ A NVLL     A++GDFGLA+  M+    ++ G  R 
Sbjct: 172 QVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 276 PIE-EGKRNLVDRMWSLTERS--------ELLS------------------VLDERLKAK 308
           P++     ++ D ++++            E+ S                  V D    A+
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ 288
Query: 309 GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE 349
             +A + +  ++     C   E   RPT +Q+   L+ Q +
Sbjct: 289 PAFAPKNIYSIMQ---ACWALEPTHRPTFQQICSFLQEQAQ 326

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 19/166 (11%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            LR +     E   ++Y    N  LD ++ E    +A  +  R K    V    LY+Y+ 
Sbjct: 77  RLRYFFYSSGEKKDVVY---LNLVLD-YVPETVYRVARHYS-RAKQTLPVIYVKLYMYQL 131
Query: 232 WES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 12/148 (8%)
Query: 121 IGLGGNGKV----YKGQLLGVEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGLRG 175
           +G G  G V    Y+ +   ++VA+K +   +E     E + E   + +L +  +V L G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
            C  + E+L+L+ +    G L K++    E I +S     ++L  V+ G+ YL E     
Sbjct: 404 VC--QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMGMKYLEE---KN 456
Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +HR++ A NVLL  +  A++ DFGL+K
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSK 484

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 64/110 (58%), Gaps = 8/110 (7%)
Query: 154 EFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQ 213
           E LAE + + +L +  +V + G C  E ES +L+ +  E G L+K++    ++  +  + 
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 112
Query: 214 RIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            I+++  V+ G+ YL E   S  +HRD+ A NVLL  +  A++ DFGL+K
Sbjct: 113 IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 159

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 64/110 (58%), Gaps = 8/110 (7%)
Query: 154 EFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQ 213
           E LAE + + +L +  +V + G C  E ES +L+ +  E G L+K++    ++  +  + 
Sbjct: 58  ELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 112
Query: 214 RIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            I+++  V+ G+ YL E   S  +HRD+ A NVLL  +  A++ DFGL+K
Sbjct: 113 IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 159

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 12/158 (7%)
Query: 120 VIGLGGNGKVYKGQLLGVEVALKRISL--DSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
           +IG G  G+VY G+  G EVA++ I +  D+E  ++ F  EV +  + +H N+V   G C
Sbjct: 40  LIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
                 L +I    +  +L   +   D  I L   +  ++ +++  G+ YL+      +L
Sbjct: 99  MSPPH-LAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGIL 152
Query: 238 HRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRR 275
           H+D+K+ NV  D      + DFGL  +   G + +GRR
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSI--SGVLQAGRR 187

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 64/110 (58%), Gaps = 8/110 (7%)
Query: 154 EFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQ 213
           E LAE + + +L +  +V + G C  E ES +L+ +  E G L+K++    ++  +  + 
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 118
Query: 214 RIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            I+++  V+ G+ YL E   S  +HRD+ A NVLL  +  A++ DFGL+K
Sbjct: 119 IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 165

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 10/164 (6%)
Query: 115 FSEENVIGLGGNGKVYKGQL-----LGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN 169
           F +  V+G GG G+V+  Q+     L     L +  L    G +  + E   L ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR-IKVLKDVASGILYL 228
           +V L  +  + K  L L+   M  G +   I+  DE      E R I     + SG+ +L
Sbjct: 247 IVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
           ++     +++RD+K  NVLLD   N R+ D GLA     GQ  +
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 10/164 (6%)
Query: 115 FSEENVIGLGGNGKVYKGQL-----LGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN 169
           F +  V+G GG G+V+  Q+     L     L +  L    G +  + E   L ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR-IKVLKDVASGILYL 228
           +V L  +  + K  L L+   M  G +   I+  DE      E R I     + SG+ +L
Sbjct: 247 IVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
           ++     +++RD+K  NVLLD   N R+ D GLA     GQ  +
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 10/164 (6%)
Query: 115 FSEENVIGLGGNGKVYKGQL-----LGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN 169
           F +  V+G GG G+V+  Q+     L     L +  L    G +  + E   L ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR-IKVLKDVASGILYL 228
           +V L  +  + K  L L+   M  G +   I+  DE      E R I     + SG+ +L
Sbjct: 247 IVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
           ++     +++RD+K  NVLLD   N R+ D GLA     GQ  +
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 64/110 (58%), Gaps = 8/110 (7%)
Query: 154 EFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQ 213
           E LAE + + +L +  +V + G C  E ES +L+ +  E G L+K++    ++  +  + 
Sbjct: 52  ELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 106
Query: 214 RIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            I+++  V+ G+ YL E   S  +HRD+ A NVLL  +  A++ DFGL+K
Sbjct: 107 IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 153

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 10/164 (6%)
Query: 115 FSEENVIGLGGNGKVYKGQL-----LGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN 169
           F +  V+G GG G+V+  Q+     L     L +  L    G +  + E   L ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR-IKVLKDVASGILYL 228
           +V L  +  + K  L L+   M  G +   I+  DE      E R I     + SG+ +L
Sbjct: 247 IVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
           ++     +++RD+K  NVLLD   N R+ D GLA     GQ  +
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 115/270 (42%), Gaps = 49/270 (18%)
Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHG-MREFLAEVSSLGRLKHR-NLV 171
           +G G  G+V +    G++       VA+K +   + H   R  ++E+  L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA---------LSWEQRIKVLKDVA 222
            L G C K    L++I ++ + G+L  ++                 L+ E  I     VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA----KMHHHGQVMSGRRPIE 278
            G+ +L      K +HRD+ A N+LL +K   ++ DFGLA    K   + +    R P++
Sbjct: 155 KGMEFLAS---RKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 279 -EGKRNLVDRMWSLTERS--------ELLSV---------LDE----RLK--AKGGYADE 314
                 + DR++++            E+ S+         +DE    RLK   +    D 
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDY 271
Query: 315 VVEKVLHLGLLCAHPEANSRPTIRQVLKML 344
              ++    L C H E + RPT  ++++ L
Sbjct: 272 TTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 118/285 (41%), Gaps = 53/285 (18%)
Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHG-MREFLAEVSSLGRLKHR-NLV 171
           +G G  G+V +    G++       VA+K +   + H   R  ++E+  L  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA-------------LSWEQRIKVL 218
            L G C K    L++I ++ + G+L  ++                     L+ E  I   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA----KMHHHGQVMSGR 274
             VA G+ +L      K +HRD+ A N+LL +K   ++ DFGLA    K   + +    R
Sbjct: 146 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 275 RPIE-EGKRNLVDRMWSLTERS--------ELLSV---------LDE----RLK--AKGG 310
            P++      + DR++++            E+ S+         +DE    RLK   +  
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 262
Query: 311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLED 355
             D    ++    L C H E + RPT  ++++ L    +    +D
Sbjct: 263 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 307

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 64/110 (58%), Gaps = 8/110 (7%)
Query: 154 EFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQ 213
           E LAE + + +L +  +V + G C  E ES +L+ +  E G L+K++    ++  +  + 
Sbjct: 54  ELLAEANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 108
Query: 214 RIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            I+++  V+ G+ YL E   S  +HRD+ A NVLL  +  A++ DFGL+K
Sbjct: 109 IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 155

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 118/285 (41%), Gaps = 53/285 (18%)
Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHG-MREFLAEVSSLGRLKHR-NLV 171
           +G G  G+V +    G++       VA+K +   + H   R  ++E+  L  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA-------------LSWEQRIKVL 218
            L G C K    L++I ++ + G+L  ++                     L+ E  I   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA----KMHHHGQVMSGR 274
             VA G+ +L      K +HRD+ A N+LL +K   ++ DFGLA    K   + +    R
Sbjct: 146 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 275 RPIE-EGKRNLVDRMWSLTERS--------ELLSV---------LDE----RLK--AKGG 310
            P++      + DR++++            E+ S+         +DE    RLK   +  
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 262
Query: 311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLED 355
             D    ++    L C H E + RPT  ++++ L    +    +D
Sbjct: 263 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 307

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 118/285 (41%), Gaps = 53/285 (18%)
Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHG-MREFLAEVSSLGRLKHR-NLV 171
           +G G  G+V +    G++       VA+K +   + H   R  ++E+  L  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA-------------LSWEQRIKVL 218
            L G C K    L++I ++ + G+L  ++                     L+ E  I   
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK--MHHHGQVMSG--R 274
             VA G+ +L      K +HRD+ A N+LL +K   ++ DFGLA+        V  G  R
Sbjct: 146 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 275 RPIE-EGKRNLVDRMWSLTERS--------ELLSV---------LDE----RLK--AKGG 310
            P++      + DR++++            E+ S+         +DE    RLK   +  
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 262
Query: 311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLED 355
             D    ++    L C H E + RPT  ++++ L    +    +D
Sbjct: 263 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 307

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 118/285 (41%), Gaps = 53/285 (18%)
Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHG-MREFLAEVSSLGRLKHR-NLV 171
           +G G  G+V +    G++       VA+K +   + H   R  ++E+  L  + H  N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA-------------LSWEQRIKVL 218
            L G C K    L++I ++ + G+L  ++                     L+ E  I   
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA----KMHHHGQVMSGR 274
             VA G+ +L      K +HRD+ A N+LL +K   ++ DFGLA    K   + +    R
Sbjct: 192 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 275 RPIE-EGKRNLVDRMWSLTERS--------ELLSV---------LDE----RLK--AKGG 310
            P++      + DR++++            E+ S+         +DE    RLK   +  
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 308
Query: 311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLED 355
             D    ++    L C H E + RPT  ++++ L    +    +D
Sbjct: 309 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 353

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/156 (26%), Positives = 78/156 (50%), Gaps = 13/156 (8%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V      +  V VA+K+IS  + +   +  L E+  L R +H N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 172 GLRGWCKK---EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           G+    +    E+   + +  ++    L K +    ++  LS +     L  +  G+ Y+
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLL----KTQHLSNDHICYFLYQILRGLKYI 160
Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           +    + VLHRD+K SN+LL+   + ++ DFGLA++
Sbjct: 161 HS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARV 193

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/285 (23%), Positives = 118/285 (41%), Gaps = 53/285 (18%)
Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHG-MREFLAEVSSLGRLKHR-NLV 171
           +G G  G+V +    G++       VA+K +   + H   R  ++E+  L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA-------------LSWEQRIKVL 218
            L G C K    L++I ++ + G+L  ++                     L+ E  I   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA----KMHHHGQVMSGR 274
             VA G+ +L      K +HRD+ A N+LL +K   ++ DFGLA    K   + +    R
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 275 RPIE-EGKRNLVDRMWSLTERS--------ELLSV---------LDE----RLK--AKGG 310
            P++      + DR++++            E+ S+         +DE    RLK   +  
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 271
Query: 311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLED 355
             D    ++    L C H E + RPT  ++++ L    +    +D
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 118/285 (41%), Gaps = 53/285 (18%)
Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHG-MREFLAEVSSLGRLKHR-NLV 171
           +G G  G+V +    G++       VA+K +   + H   R  ++E+  L  + H  N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA-------------LSWEQRIKVL 218
            L G C K    L++I ++ + G+L  ++                     L+ E  I   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK--MHHHGQVMSG--R 274
             VA G+ +L      K +HRD+ A N+LL +K   ++ DFGLA+        V  G  R
Sbjct: 146 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 275 RPIE-EGKRNLVDRMWSLTERS--------ELLSV---------LDE----RLK--AKGG 310
            P++      + DR++++            E+ S+         +DE    RLK   +  
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 262
Query: 311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLED 355
             D    ++    L C H E + RPT  ++++ L    +    +D
Sbjct: 263 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 307

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 118/285 (41%), Gaps = 53/285 (18%)
Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHG-MREFLAEVSSLGRLKHR-NLV 171
           +G G  G+V +    G++       VA+K +   + H   R  ++E+  L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA-------------LSWEQRIKVL 218
            L G C K    L++I ++ + G+L  ++                     L+ E  I   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK--MHHHGQVMSG--R 274
             VA G+ +L      K +HRD+ A N+LL +K   ++ DFGLA+        V  G  R
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 275 RPIE-EGKRNLVDRMWSLTERS--------ELLSV---------LDE----RLK--AKGG 310
            P++      + DR++++            E+ S+         +DE    RLK   +  
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 271
Query: 311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLED 355
             D    ++    L C H E + RPT  ++++ L    +    +D
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 86/170 (50%), Gaps = 25/170 (14%)
Query: 108 IHAATKGFSE----ENVIGLGGNGKVY--KGQLLGVEVALKRIS---LDSEHGMREFLAE 158
           +  +T  FS+    + V+G G  G+V   K ++ G E A+K IS   +  +      L E
Sbjct: 23  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 82
Query: 159 VSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA---LSWEQRI 215
           V  L +L H N++ L  + + +K    L+ +    G L       DE I+    S     
Sbjct: 83  VQLLKQLDHPNIMKLYEFFE-DKGYFYLVGEVYTGGEL------FDEIISRKRFSEVDAA 135
Query: 216 KVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK---MNARLGDFGLA 262
           ++++ V SGI Y+++   +K++HRD+K  N+LL+ K    N R+ DFGL+
Sbjct: 136 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 182

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 118/285 (41%), Gaps = 53/285 (18%)
Query: 121 IGLGGNGKVYKGQLLGVE-------VALKRISLDSEHG-MREFLAEVSSLGRLKHR-NLV 171
           +G G  G+V +    G++       VA+K +   + H   R  ++E+  L  + H  N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA-------------LSWEQRIKVL 218
            L G C K    L++I ++ + G+L  ++                     L+ E  I   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK--MHHHGQVMSG--R 274
             VA G+ +L      K +HRD+ A N+LL +K   ++ DFGLA+        V  G  R
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 275 RPIE-EGKRNLVDRMWSLTERS--------ELLSV---------LDE----RLK--AKGG 310
            P++      + DR++++            E+ S+         +DE    RLK   +  
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 271
Query: 311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLED 355
             D    ++    L C H E + RPT  ++++ L    +    +D
Sbjct: 272 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 65/281 (23%), Positives = 115/281 (40%), Gaps = 58/281 (20%)
Query: 120 VIGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMRE-FLAEVSSLGRL-KHRNL 170
            +G G  GKV +    G+       +VA+K +   +    +E  ++E+  +  L +H N+
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKW------IFECDESIAL-----SWEQRIKVLK 219
           V L G C      L+ I +Y   G L  +      + E D + A+     S    +    
Sbjct: 113 VNLLGACTHGGPVLV-ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK--MHHHGQVMSG--RR 275
            VA G+ +L        +HRD+ A NVLL     A++GDFGLA+  M+    ++ G  R 
Sbjct: 172 QVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 276 PIE-EGKRNLVDRMWSLTERS--------ELLS------------------VLDERLKAK 308
           P++     ++ D ++++            E+ S                  V D    A+
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ 288
Query: 309 GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE 349
             +A + +  ++     C   E   RPT +Q+   L+ Q +
Sbjct: 289 PAFAPKNIYSIMQ---ACWALEPTHRPTFQQICSFLQEQAQ 326

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 86/170 (50%), Gaps = 25/170 (14%)
Query: 108 IHAATKGFSE----ENVIGLGGNGKVY--KGQLLGVEVALKRIS---LDSEHGMREFLAE 158
           +  +T  FS+    + V+G G  G+V   K ++ G E A+K IS   +  +      L E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 159 VSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA---LSWEQRI 215
           V  L +L H N++ L  + + +K    L+ +    G L       DE I+    S     
Sbjct: 77  VQLLKQLDHPNIMKLYEFFE-DKGYFYLVGEVYTGGEL------FDEIISRKRFSEVDAA 129
Query: 216 KVLKDVASGILYLYEGWESKVLHRDIKASNVLLD---KKMNARLGDFGLA 262
           ++++ V SGI Y+++   +K++HRD+K  N+LL+   K  N R+ DFGL+
Sbjct: 130 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 86/170 (50%), Gaps = 25/170 (14%)
Query: 108 IHAATKGFSE----ENVIGLGGNGKVY--KGQLLGVEVALKRIS---LDSEHGMREFLAE 158
           +  +T  FS+    + V+G G  G+V   K ++ G E A+K IS   +  +      L E
Sbjct: 40  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 99
Query: 159 VSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA---LSWEQRI 215
           V  L +L H N++ L  + + +K    L+ +    G L       DE I+    S     
Sbjct: 100 VQLLKQLDHPNIMKLYEFFE-DKGYFYLVGEVYTGGEL------FDEIISRKRFSEVDAA 152
Query: 216 KVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK---MNARLGDFGLA 262
           ++++ V SGI Y+++   +K++HRD+K  N+LL+ K    N R+ DFGL+
Sbjct: 153 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 199

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 86/170 (50%), Gaps = 25/170 (14%)
Query: 108 IHAATKGFSE----ENVIGLGGNGKVY--KGQLLGVEVALKRIS---LDSEHGMREFLAE 158
           +  +T  FS+    + V+G G  G+V   K ++ G E A+K IS   +  +      L E
Sbjct: 41  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 100
Query: 159 VSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA---LSWEQRI 215
           V  L +L H N++ L  + + +K    L+ +    G L       DE I+    S     
Sbjct: 101 VQLLKQLDHPNIMKLYEFFE-DKGYFYLVGEVYTGGEL------FDEIISRKRFSEVDAA 153
Query: 216 KVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK---MNARLGDFGLA 262
           ++++ V SGI Y+++   +K++HRD+K  N+LL+ K    N R+ DFGL+
Sbjct: 154 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 200

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 13/149 (8%)
Query: 120 VIGLGGNGKVYK--GQLLGVEVALKRISLDSEHGMREFLA--EVSSLGRLKHRNLVGLRG 175
           ++G G  G V K   +  G  VA+K+     +  M + +A  E+  L +L+H NLV L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 176 WCKKEKESLILIYDYMENGSLDKW-IFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
            CKK+K    L+++++++  LD   +F       L ++   K L  + +GI + +     
Sbjct: 92  VCKKKKR-WYLVFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHS---H 143
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            ++HRDIK  N+L+ +    +L DFG A+
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFAR 172

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 17/152 (11%)
Query: 121 IGLGGNGKVYKGQLLGVEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLVGLRGWCKK 179
           IG G  G+V+ G+  G +VA+K      E    RE   E+     ++H N++G      K
Sbjct: 45  IGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAADIK 102
Query: 180 EKES---LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY------E 230
              S   L LI DY ENGSL  ++    +S  L  +  +K+     SG+ +L+      +
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           G +  + HRD+K+ N+L+ K     + D GLA
Sbjct: 159 G-KPAIAHRDLKSKNILVKKNGTCCIADLGLA 189

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G   GV        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA-------LSWEQRIKVLKDVASGI 225
           L G   + + +L+ I + M  G L  ++     ++A        S  + I++  ++A G+
Sbjct: 93  LLGVVSQGQPTLV-IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            YL     +K +HRD+ A N ++ +    ++GDFG+ +
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+  G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C      LI+    M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 84  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 136 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 120 VIGLGGNGKVYKGQLLGVEVALKRIS-LDSEHGMREFLAEVSSLGRLKHRNLVGLRG--- 175
            +G G  G+V++G   G  VA+K  S  D +   RE   E+ +   L+H N++G      
Sbjct: 15  CVGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRE--TEIYNTVLLRHDNILGFIASDM 72
Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY------ 229
             +     L LI  Y E+GSL    ++  +   L     +++    A G+ +L+      
Sbjct: 73  TSRNSSTQLWLITHYHEHGSL----YDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGT 128
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
           +G +  + HRD K+ NVL+   +   + D GLA MH  G
Sbjct: 129 QG-KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQG 166

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G   GV        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA-------LSWEQRIKVLKDVASGI 225
           L G   + + +L+ I + M  G L  ++     ++A        S  + I++  ++A G+
Sbjct: 83  LLGVVSQGQPTLV-IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            YL     +K +HRD+ A N ++ +    ++GDFG+ +
Sbjct: 142 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 176

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 58/108 (53%), Gaps = 8/108 (7%)
Query: 156 LAEVSSLGRLK-HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR 214
           L EV  L ++  H N++ L+    +      L++D M+ G L  ++    E + LS ++ 
Sbjct: 71  LKEVDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKET 126
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
            K+++ +   I  L++     ++HRD+K  N+LLD  MN +L DFG +
Sbjct: 127 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 58/108 (53%), Gaps = 8/108 (7%)
Query: 156 LAEVSSLGRLK-HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR 214
           L EV  L ++  H N++ L+    +      L++D M+ G L  ++    E + LS ++ 
Sbjct: 71  LKEVDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKET 126
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
            K+++ +   I  L++     ++HRD+K  N+LLD  MN +L DFG +
Sbjct: 127 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+  G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 84  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 136 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 173

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+  G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 77  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C      LI+    M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 81  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 132
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFG AK+
Sbjct: 133 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKL 170

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+  +    S    +E L E   +  + +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 111 PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 162
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 163 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 200

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C      LI+    M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 79  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFG AK+
Sbjct: 131 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKL 168

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C      LI+    M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 79  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFG AK+
Sbjct: 131 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKL 168

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 58/108 (53%), Gaps = 8/108 (7%)
Query: 156 LAEVSSLGRLK-HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR 214
           L EV  L ++  H N++ L+    +      L++D M+ G L  ++    E + LS ++ 
Sbjct: 58  LKEVDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKET 113
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
            K+++ +   I  L++     ++HRD+K  N+LLD  MN +L DFG +
Sbjct: 114 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 158

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 13/159 (8%)
Query: 120 VIGLGGNGKVYKGQ--LLGVEVALK---RISLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
            IG G   KV   +  L G EVA+K   +  L+S   +++   EV     L H N+V L 
Sbjct: 21  TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSS-SLQKLFREVRIXKVLNHPNIVKLF 79
Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
              + EK +L L+ +Y   G +  ++           E R K  + + S + Y ++ +  
Sbjct: 80  EVIETEK-TLYLVXEYASGGEVFDYL--VAHGRXKEKEARAK-FRQIVSAVQYCHQKF-- 133
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSG 273
            ++HRD+KA N+LLD   N ++ DFG +     G  +  
Sbjct: 134 -IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA 171

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 84  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 135
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFG AK+
Sbjct: 136 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKL 173

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 79  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 130
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFG AK+
Sbjct: 131 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKL 168

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 10/157 (6%)
Query: 120 VIGLGGNGKVYKGQLLGV--EVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLRGW 176
           V+  GG   VY+ Q +G   E ALKR+  + E   R  + EV  + +L  H N+V     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 177 CKKEKE------SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
               KE      +  L+   +  G L +++ + +    LS +  +K+       + +++ 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
             +  ++HRD+K  N+LL  +   +L DFG A    H
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH 190

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 115 FSEENVIGLGGNGKVYKG------QLLGVEVALKRI-SLDSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG      + + + VA+K +    S    +E L E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA----LSWEQRIKVLKDVAS 223
            ++  L G C     ++ LI   M  G L  ++ E  ++I     L+W  +I      A 
Sbjct: 77  PHVCRLLGICLTS--TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 128
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           G+ YL +    +++HRD+ A NVL+    + ++ DFG AK+
Sbjct: 129 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKL 166

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G   GV        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWI------FECDESIAL-SWEQRIKVLKDVASGI 225
           L G   + + +L+ I + M  G L  ++       E +  +A  S  + I++  ++A G+
Sbjct: 87  LLGVVSQGQPTLV-IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            YL     +K +HRD+ A N ++ +    ++GDFG+ +
Sbjct: 146 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G   GV        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWI------FECDESIAL-SWEQRIKVLKDVASGI 225
           L G   + + +L+ I + M  G L  ++       E +  +A  S  + I++  ++A G+
Sbjct: 78  LLGVVSQGQPTLV-IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            YL     +K +HRD+ A N ++ +    ++GDFG+ +
Sbjct: 137 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 171

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G   GV        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWI------FECDESIAL-SWEQRIKVLKDVASGI 225
           L G   + + +L+ I + M  G L  ++       E +  +A  S  + I++  ++A G+
Sbjct: 86  LLGVVSQGQPTLV-IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            YL     +K +HRD+ A N ++ +    ++GDFG+ +
Sbjct: 145 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 113/267 (42%), Gaps = 46/267 (17%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G    +        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESI-------ALSWEQRIKVLKDVASGI 225
           L G   K + +L+++ + M +G L  ++                + ++ I++  ++A G+
Sbjct: 86  LLGVVSKGQPTLVVM-ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGRRPI---- 277
            YL      K +HR++ A N ++      ++GDFG+ +      ++ +   G  P+    
Sbjct: 145 AYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 201
Query: 278 ----EEGKRNLVDRMWSL-TERSELLSVLDE-----------RLKAKGGYADE---VVEK 318
               ++G       MWS      E+ S+ ++           +    GGY D+     E+
Sbjct: 202 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 261
Query: 319 VLHLGLLCAHPEANSRPTIRQVLKMLE 345
           V  L  +C     N RPT  +++ +L+
Sbjct: 262 VTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 78/151 (51%), Gaps = 9/151 (5%)
Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLV 171
           F   + +G G  G V K Q    G+ +A K I L+ +  +R + + E+  L       +V
Sbjct: 18  FERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 77
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
           G  G    + E  I + ++M+ GSLD+ +    E+  +  E   KV   V  G+ YL E 
Sbjct: 78  GFYGAFYSDGEISICM-EHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLRE- 132
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
            + +++HRD+K SN+L++ +   +L DFG++
Sbjct: 133 -KHQIMHRDVKPSNILVNSRGEIKLCDFGVS 162

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G   GV        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWI------FECDESIAL-SWEQRIKVLKDVASGI 225
           L G   + + +L+ I + M  G L  ++       E +  +A  S  + I++  ++A G+
Sbjct: 80  LLGVVSQGQPTLV-IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            YL     +K +HRD+ A N ++ +    ++GDFG+ +
Sbjct: 139 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 173

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 113/267 (42%), Gaps = 46/267 (17%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G    +        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESI-------ALSWEQRIKVLKDVASGI 225
           L G   K + +L+++ + M +G L  ++                + ++ I++  ++A G+
Sbjct: 85  LLGVVSKGQPTLVVM-ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGRRPI---- 277
            YL      K +HR++ A N ++      ++GDFG+ +      ++ +   G  P+    
Sbjct: 144 AYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 278 ----EEGKRNLVDRMWSL-TERSELLSVLDE-----------RLKAKGGYADE---VVEK 318
               ++G       MWS      E+ S+ ++           +    GGY D+     E+
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 319 VLHLGLLCAHPEANSRPTIRQVLKMLE 345
           V  L  +C     N RPT  +++ +L+
Sbjct: 261 VTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G   GV        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWI------FECDESIAL-SWEQRIKVLKDVASGI 225
           L G   + + +L+ I + M  G L  ++       E +  +A  S  + I++  ++A G+
Sbjct: 87  LLGVVSQGQPTLV-IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            YL     +K +HRD+ A N ++ +    ++GDFG+ +
Sbjct: 146 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 180

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G   GV        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWI------FECDESIAL-SWEQRIKVLKDVASGI 225
           L G   + + +L+ I + M  G L  ++       E +  +A  S  + I++  ++A G+
Sbjct: 84  LLGVVSQGQPTLV-IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 142
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            YL     +K +HRD+ A N ++ +    ++GDFG+ +
Sbjct: 143 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 177

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 80/152 (52%), Gaps = 11/152 (7%)
Query: 115 FSEENVIGLGGNGKVYK--GQLLGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLV 171
           F + + +G G  G V+K   +  G+ +A K I L+ +  +R + + E+  L       +V
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 129
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYLYE 230
           G  G    + E  I + ++M+ GSLD+ +    +      EQ + KV   V  G+ YL E
Sbjct: 130 GFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE 184
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             + K++HRD+K SN+L++ +   +L DFG++
Sbjct: 185 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 214

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G   GV        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWI------FECDESIAL-SWEQRIKVLKDVASGI 225
           L G   + + +L+ I + M  G L  ++       E +  +A  S  + I++  ++A G+
Sbjct: 93  LLGVVSQGQPTLV-IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            YL     +K +HRD+ A N ++ +    ++GDFG+ +
Sbjct: 152 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISL---DSEHGMREFLAEVSSLGRLKH 167
           K FS+   IG G  G VY  + +     VA+K++S     S    ++ + EV  L +L+H
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
            N +  RG C   + +  L+ +Y    + D  + E  +   L   +   V      G+ Y
Sbjct: 114 PNTIQYRG-CYLREHTAWLVMEYCLGSASD--LLEVHKK-PLQEVEIAAVTHGALQGLAY 169
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           L+      ++HRD+KA N+LL +    +LGDFG A +
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 61/118 (51%), Gaps = 22/118 (18%)
Query: 154 EFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIF------ECDESI 207
           E   E+S L  L H N++ L    + +K+   L+ ++ E G L + I       ECD + 
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFE-DKKYFYLVTEFYEGGELFEQIINRHKFDECDAA- 149
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK---MNARLGDFGLA 262
                    ++K + SGI YL++     ++HRDIK  N+LL+ K   +N ++ DFGL+
Sbjct: 150 --------NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G   GV        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWI------FECDESIAL-SWEQRIKVLKDVASGI 225
           L G   + + +L+ I + M  G L  ++       E +  +A  S  + I++  ++A G+
Sbjct: 86  LLGVVSQGQPTLV-IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            YL     +K +HRD+ A N ++ +    ++GDFG+ +
Sbjct: 145 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 179

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 20/141 (14%)
Query: 132 GQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDY 190
           G   G  VA+K++        R+F  E+  L  L    +V  RG      ++SL L+ +Y
Sbjct: 36  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 95
Query: 191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY---LYEGWE----SKVLHRDIKA 243
           + +G L  ++            QR +   D +  +LY   + +G E     + +HRD+ A
Sbjct: 96  LPSGCLRDFL------------QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAA 143
Query: 244 SNVLLDKKMNARLGDFGLAKM 264
            N+L++ + + ++ DFGLAK+
Sbjct: 144 RNILVESEAHVKIADFGLAKL 164

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 20/141 (14%)
Query: 132 GQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDY 190
           G   G  VA+K++        R+F  E+  L  L    +V  RG      ++SL L+ +Y
Sbjct: 35  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 94
Query: 191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY---LYEGWE----SKVLHRDIKA 243
           + +G L  ++            QR +   D +  +LY   + +G E     + +HRD+ A
Sbjct: 95  LPSGCLRDFL------------QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAA 142
Query: 244 SNVLLDKKMNARLGDFGLAKM 264
            N+L++ + + ++ DFGLAK+
Sbjct: 143 RNILVESEAHVKIADFGLAKL 163

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 80/152 (52%), Gaps = 11/152 (7%)
Query: 115 FSEENVIGLGGNGKVYK--GQLLGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLV 171
           F + + +G G  G V+K   +  G+ +A K I L+ +  +R + + E+  L       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYLYE 230
           G  G    + E  I + ++M+ GSLD+ +    +      EQ + KV   V  G+ YL E
Sbjct: 68  GFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             + K++HRD+K SN+L++ +   +L DFG++
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 78/158 (49%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G   GV        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 114
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWI------FECDESIAL-SWEQRIKVLKDVASGI 225
           L G   + + +L+++ + M  G L  ++       E +  +A  S  + I++  ++A G+
Sbjct: 115 LLGVVSQGQPTLVIM-ELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            YL     +K +HRD+ A N ++ +    ++GDFG+ +
Sbjct: 174 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 208

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/267 (22%), Positives = 110/267 (41%), Gaps = 46/267 (17%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G    +        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESI-------ALSWEQRIKVLKDVASGI 225
           L G   K + +L+++ + M +G L  ++                + ++ I++  ++A G+
Sbjct: 85  LLGVVSKGQPTLVVM-ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM----SGRRPI---- 277
            YL      K +HRD+ A N ++      ++GDFG+ +             G  P+    
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 278 ----EEGKRNLVDRMWSL-TERSELLSVLDE-----------RLKAKGGYADE---VVEK 318
               ++G       MWS      E+ S+ ++           +    GGY D+     E+
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 319 VLHLGLLCAHPEANSRPTIRQVLKMLE 345
           V  L  +C     N RPT  +++ +L+
Sbjct: 261 VTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 80/152 (52%), Gaps = 11/152 (7%)
Query: 115 FSEENVIGLGGNGKVYK--GQLLGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLV 171
           F + + +G G  G V+K   +  G+ +A K I L+ +  +R + + E+  L       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYLYE 230
           G  G    + E  I + ++M+ GSLD+ +    +      EQ + KV   V  G+ YL E
Sbjct: 68  GFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             + K++HRD+K SN+L++ +   +L DFG++
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISL---DSEHGMREFLAEVSSLGRLKH 167
           K FS+   IG G  G VY  + +     VA+K++S     S    ++ + EV  L +L+H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
            N +  RG C   + +  L+ +Y    + D  + E  +   L   +   V      G+ Y
Sbjct: 75  PNTIQYRG-CYLREHTAWLVMEYCLGSASD--LLEVHKK-PLQEVEIAAVTHGALQGLAY 130
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           L+      ++HRD+KA N+LL +    +LGDFG A +
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 20/141 (14%)
Query: 132 GQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDY 190
           G   G  VA+K++        R+F  E+  L  L    +V  RG      ++SL L+ +Y
Sbjct: 48  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107
Query: 191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY---LYEGWE----SKVLHRDIKA 243
           + +G L  ++            QR +   D +  +LY   + +G E     + +HRD+ A
Sbjct: 108 LPSGCLRDFL------------QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAA 155
Query: 244 SNVLLDKKMNARLGDFGLAKM 264
            N+L++ + + ++ DFGLAK+
Sbjct: 156 RNILVESEAHVKIADFGLAKL 176

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 92/186 (49%), Gaps = 12/186 (6%)
Query: 82  GKKMKDVEETEDWELEYWPHRVSYQEI-HAATKGFSEENVIGLGGNGKVYK--GQLLGVE 138
           GKK++++E  E             Q++       F + + +G G  G V+K   +  G+ 
Sbjct: 1   GKKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 139 VALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLD 197
           +A K I L+ +  +R + + E+  L       +VG  G    + E  I + ++M+ GSLD
Sbjct: 61  MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLD 119
Query: 198 KWIFECDESIALSWEQRI-KVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARL 256
           + +    +      EQ + KV   V  G+ YL E  + K++HRD+K SN+L++ +   +L
Sbjct: 120 QVL----KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKL 173
Query: 257 GDFGLA 262
            DFG++
Sbjct: 174 CDFGVS 179

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 80/152 (52%), Gaps = 11/152 (7%)
Query: 115 FSEENVIGLGGNGKVYK--GQLLGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLV 171
           F + + +G G  G V+K   +  G+ +A K I L+ +  +R + + E+  L       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYLYE 230
           G  G    + E  I + ++M+ GSLD+ +    +      EQ + KV   V  G+ YL E
Sbjct: 68  GFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             + K++HRD+K SN+L++ +   +L DFG++
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 83/176 (47%), Gaps = 22/176 (12%)
Query: 111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMR-EFLAEVSSLGRLK 166
           AT  +     IG+G  G VYK +    G  VALK + + + E G+    + EV+ L RL+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 167 ---HRNLVGLRGWCKKEKES----LILIYDYMENG---SLDKWIFECDESIALSWEQRIK 216
              H N+V L   C   +      + L++++++      LDK          L  E    
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-----PPPGLPAETIKD 116
Query: 217 VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
           +++    G+ +L+      ++HRD+K  N+L+      +L DFGLA+++ +   ++
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALA 169

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 21/156 (13%)
Query: 120 VIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAE--VSSLGRLKHRNL----VGL 173
           +IG G  G VYKG L    VA+K  S  +      F+ E  +  +  ++H N+    VG 
Sbjct: 20  LIGRGRYGAVYKGSLDERPVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIVGD 76
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALS-WEQRIKVLKDVASGILYLY--- 229
                  +   +L+ +Y  NGSL K++     S+  S W    ++   V  G+ YL+   
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVSSCRLAHSVTRGLAYLHTEL 131
Query: 230 ---EGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
              + ++  + HRD+ + NVL+       + DFGL+
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 80/152 (52%), Gaps = 11/152 (7%)
Query: 115 FSEENVIGLGGNGKVYK--GQLLGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLV 171
           F + + +G G  G V+K   +  G+ +A K I L+ +  +R + + E+  L       +V
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYLYE 230
           G  G    + E  I + ++M+ GSLD+ +    +      EQ + KV   V  G+ YL E
Sbjct: 71  GFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE 125
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             + K++HRD+K SN+L++ +   +L DFG++
Sbjct: 126 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 155

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 25/170 (14%)
Query: 108 IHAATKGFSE----ENVIGLGGNGKVY--KGQLLGVEVALKRIS---LDSEHGMREFLAE 158
           +  +T  FS+    + V+G G  G+V   K ++ G E A+K IS   +  +      L E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 159 VSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA---LSWEQRI 215
           V  L +L H N+  L  + + +K    L+ +    G L       DE I+    S     
Sbjct: 77  VQLLKQLDHPNIXKLYEFFE-DKGYFYLVGEVYTGGEL------FDEIISRKRFSEVDAA 129
Query: 216 KVLKDVASGILYLYEGWESKVLHRDIKASNVLLD---KKMNARLGDFGLA 262
           ++++ V SGI Y ++   +K++HRD+K  N+LL+   K  N R+ DFGL+
Sbjct: 130 RIIRQVLSGITYXHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++        RE    +  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIV 76
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 126
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 77/171 (45%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++        RE    +  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIV 76
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+          E    +A  +  R K    V    L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYS-RAKQTLPVIYVKL 126
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 112/267 (41%), Gaps = 46/267 (17%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G    +        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESI-------ALSWEQRIKVLKDVASGI 225
           L G   K + +L+++ + M +G L  ++                + ++ I++  ++A G+
Sbjct: 85  LLGVVSKGQPTLVVM-ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGRRPI---- 277
            YL      K +HRD+ A N ++      ++GDFG+ +      ++ +   G  P+    
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 278 ----EEGKRNLVDRMWSL-TERSELLSVLDE-----------RLKAKGGYADE---VVEK 318
               ++G       MWS      E+ S+ ++           +    GGY D+     E+
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 319 VLHLGLLCAHPEANSRPTIRQVLKMLE 345
           V  L  +C       RPT  +++ +L+
Sbjct: 261 VTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 115/277 (41%), Gaps = 54/277 (19%)
Query: 120 VIGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMRE-FLAEVSSLGRL-KHRNL 170
            +G G  GKV +    G+       +VA+K +   +    +E  ++E+  +  L +H N+
Sbjct: 45  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 104
Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD-------VAS 223
           V L G C      L+ I +Y   G L  ++    E+     + R   L+D       VA 
Sbjct: 105 VNLLGACTHGGPVLV-ITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 163
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK--MHHHGQVMSG--RRPIE- 278
           G+ +L        +HRD+ A NVLL     A++GDFGLA+  M+    ++ G  R P++ 
Sbjct: 164 GMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 220
Query: 279 EGKRNLVDRMWSLTERS--------ELLS------------------VLDERLKAKGGYA 312
               ++ D ++++            E+ S                  V D    A+  +A
Sbjct: 221 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFA 280
Query: 313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE 349
            + +  ++     C   E   RPT +Q+   L+ Q +
Sbjct: 281 PKNIYSIMQ---ACWALEPTHRPTFQQICSFLQEQAQ 314

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 112/267 (41%), Gaps = 46/267 (17%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G    +        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESI-------ALSWEQRIKVLKDVASGI 225
           L G   K + +L+++ + M +G L  ++                + ++ I++  ++A G+
Sbjct: 85  LLGVVSKGQPTLVVM-ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGRRPI---- 277
            YL      K +HRD+ A N ++      ++GDFG+ +      ++ +   G  P+    
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMA 200
Query: 278 ----EEGKRNLVDRMWSL-TERSELLSVLDE-----------RLKAKGGYADE---VVEK 318
               ++G       MWS      E+ S+ ++           +    GGY D+     E+
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 319 VLHLGLLCAHPEANSRPTIRQVLKMLE 345
           V  L  +C       RPT  +++ +L+
Sbjct: 261 VTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 80/152 (52%), Gaps = 11/152 (7%)
Query: 115 FSEENVIGLGGNGKVYK--GQLLGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLV 171
           F + + +G G  G V+K   +  G+ +A K I L+ +  +R + + E+  L       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYLYE 230
           G  G    + E  I + ++M+ GSLD+ +    +      EQ + KV   V  G+ YL E
Sbjct: 68  GFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             + K++HRD+K SN+L++ +   +L DFG++
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 80/152 (52%), Gaps = 11/152 (7%)
Query: 115 FSEENVIGLGGNGKVYK--GQLLGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLV 171
           F + + +G G  G V+K   +  G+ +A K I L+ +  +R + + E+  L       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYLYE 230
           G  G    + E  I + ++M+ GSLD+ +    +      EQ + KV   V  G+ YL E
Sbjct: 68  GFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             + K++HRD+K SN+L++ +   +L DFG++
Sbjct: 123 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 22/175 (12%)
Query: 111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMR-EFLAEVSSLGRLK 166
           AT  +     IG+G  G VYK +    G  VALK + + + E G+    + EV+ L RL+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 167 ---HRNLVGLRGWCKKEKES----LILIYDYMENG---SLDKWIFECDESIALSWEQRIK 216
              H N+V L   C   +      + L++++++      LDK          L  E    
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-----PPPGLPAETIKD 116
Query: 217 VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
           +++    G+ +L+      ++HRD+K  N+L+      +L DFGLA+++ +   +
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 168

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 22/175 (12%)
Query: 111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMR-EFLAEVSSLGRLK 166
           AT  +     IG+G  G VYK +    G  VALK + + + E G+    + EV+ L RL+
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 167 ---HRNLVGLRGWCKKEKES----LILIYDYMENG---SLDKWIFECDESIALSWEQRIK 216
              H N+V L   C   +      + L++++++      LDK          L  E    
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-----PPPGLPAETIKD 116
Query: 217 VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
           +++    G+ +L+      ++HRD+K  N+L+      +L DFGLA+++ +   +
Sbjct: 117 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 168

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 112/267 (41%), Gaps = 46/267 (17%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G    +        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESI-------ALSWEQRIKVLKDVASGI 225
           L G   K + +L+++ + M +G L  ++                + ++ I++  ++A G+
Sbjct: 84  LLGVVSKGQPTLVVM-ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK----MHHHGQVMSGRRPI---- 277
            YL      K +HRD+ A N ++      ++GDFG+ +      ++ +   G  P+    
Sbjct: 143 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 278 ----EEGKRNLVDRMWSL-TERSELLSVLDE-----------RLKAKGGYADE---VVEK 318
               ++G       MWS      E+ S+ ++           +    GGY D+     E+
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 259
Query: 319 VLHLGLLCAHPEANSRPTIRQVLKMLE 345
           V  L  +C       RPT  +++ +L+
Sbjct: 260 VTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 80/152 (52%), Gaps = 11/152 (7%)
Query: 115 FSEENVIGLGGNGKVYK--GQLLGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLV 171
           F + + +G G  G V+K   +  G+ +A K I L+ +  +R + + E+  L       +V
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYLYE 230
           G  G    + E  I + ++M+ GSLD+ +    +      EQ + KV   V  G+ YL E
Sbjct: 87  GFYGAFYSDGEISICM-EHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLRE 141
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             + K++HRD+K SN+L++ +   +L DFG++
Sbjct: 142 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 171

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 122/284 (42%), Gaps = 64/284 (22%)
Query: 120 VIGLGGNGKVYKGQLLGVE-------VALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
            +G G  GKV K     ++       VA+K +  + S   +R+ L+E + L ++ H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFEC---------------------DESIALS 210
            L G C ++   L+LI +Y + GSL  ++ E                       +  AL+
Sbjct: 90  KLYGACSQDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH---- 266
               I     ++ G+ YL E    K++HRD+ A N+L+ +    ++ DFGL++  +    
Sbjct: 149 MGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 267 HGQVMSGRRPIE-EGKRNLVDRMWSLTERSELLS------------------VLDERL-- 305
           + +   GR P++     +L D ++  T +S++ S                  +  ERL  
Sbjct: 206 YVKRSQGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN 263
Query: 306 KAKGGY----ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE 345
             K G+     D   E++  L L C   E + RP    + K LE
Sbjct: 264 LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 47
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 48  CPENIKK---EICINAMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 100
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 268 GQ 269
Sbjct: 158 NN 159

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 115/277 (41%), Gaps = 54/277 (19%)
Query: 120 VIGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMRE-FLAEVSSLGRL-KHRNL 170
            +G G  GKV +    G+       +VA+K +   +    +E  ++E+  +  L +H N+
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD-------VAS 223
           V L G C      L+ I +Y   G L  ++    E+     + R   L+D       VA 
Sbjct: 113 VNLLGACTHGGPVLV-ITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQ 171
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK--MHHHGQVMSG--RRPIE- 278
           G+ +L        +HRD+ A NVLL     A++GDFGLA+  M+    ++ G  R P++ 
Sbjct: 172 GMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 228
Query: 279 EGKRNLVDRMWSLTERS--------ELLS------------------VLDERLKAKGGYA 312
               ++ D ++++            E+ S                  V D    A+  +A
Sbjct: 229 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFA 288
Query: 313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE 349
            + +  ++     C   E   RPT +Q+   L+ Q +
Sbjct: 289 PKNIYSIMQ---ACWALEPTHRPTFQQICSFLQEQAQ 322

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 81/179 (45%), Gaps = 25/179 (13%)
Query: 111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLA-----EVSSLG 163
           AT  +     IG+G  G VYK +    G  VALK + + +  G    L      EV+ L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 164 RLK---HRNLVGLRGWCKKEKES----LILIYDYMENG---SLDKWIFECDESIALSWEQ 213
           RL+   H N+V L   C   +      + L++++++      LDK          L  E 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-----PPPGLPAET 121
Query: 214 RIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
              +++    G+ +L+      ++HRD+K  N+L+      +L DFGLA+++ +   ++
Sbjct: 122 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALT 177

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G   GV        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWI------FECDESIAL-SWEQRIKVLKDVASGI 225
           L G   + + +L+ I + M  G L  ++       E +  +A  S  + I++  ++A G+
Sbjct: 80  LLGVVSQGQPTLV-IMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            YL     +K +HRD+ A N  + +    ++GDFG+ +
Sbjct: 139 AYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTR 173

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 31/173 (17%)
Query: 118 ENVIGLGGNGKV-YKGQLLGVEVALKRISLD-SEHGMRE--FLAEVSSLGRLKHRNLVGL 173
           E ++G G +G V ++G   G  VA+KR+ +D  +  + E   L E        H N++  
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD-----HPNVI-- 72
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFE---CDESIALSWE-QRIKVLKDVASGILYLY 229
           R +C +  +  + I   + N +L   +      DE++ L  E   I +L+ +ASG+ +L+
Sbjct: 73  RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 230 EGWESKVLHRDIKASNVLL--------DKKMNAR-----LGDFGLAKMHHHGQ 269
                K++HRD+K  N+L+        D++  A      + DFGL K    GQ
Sbjct: 133 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 31/173 (17%)
Query: 118 ENVIGLGGNGKV-YKGQLLGVEVALKRISLD-SEHGMRE--FLAEVSSLGRLKHRNLVGL 173
           E ++G G +G V ++G   G  VA+KR+ +D  +  + E   L E        H N++  
Sbjct: 38  EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD-----HPNVI-- 90
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFE---CDESIALSWE-QRIKVLKDVASGILYLY 229
           R +C +  +  + I   + N +L   +      DE++ L  E   I +L+ +ASG+ +L+
Sbjct: 91  RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 230 EGWESKVLHRDIKASNVLL--------DKKMNAR-----LGDFGLAKMHHHGQ 269
                K++HRD+K  N+L+        D++  A      + DFGL K    GQ
Sbjct: 151 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 47
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 48  CPENIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 100
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 268 GQ 269
Sbjct: 158 NN 159

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 47
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 48  CPENIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 100
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 268 GQ 269
Sbjct: 158 NN 159

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 47
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 48  CPENIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 100
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 268 GQ 269
Sbjct: 158 NN 159

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 47
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 48  CPENIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 100
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 268 GQ 269
Sbjct: 158 NN 159

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 31/173 (17%)
Query: 118 ENVIGLGGNGKV-YKGQLLGVEVALKRISLD-SEHGMRE--FLAEVSSLGRLKHRNLVGL 173
           E ++G G +G V ++G   G  VA+KR+ +D  +  + E   L E        H N++  
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD-----HPNVI-- 72
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFE---CDESIALSWE-QRIKVLKDVASGILYLY 229
           R +C +  +  + I   + N +L   +      DE++ L  E   I +L+ +ASG+ +L+
Sbjct: 73  RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 230 EGWESKVLHRDIKASNVLL--------DKKMNAR-----LGDFGLAKMHHHGQ 269
                K++HRD+K  N+L+        D++  A      + DFGL K    GQ
Sbjct: 133 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 83/173 (47%), Gaps = 31/173 (17%)
Query: 118 ENVIGLGGNGKV-YKGQLLGVEVALKRISLD-SEHGMRE--FLAEVSSLGRLKHRNLVGL 173
           E ++G G +G V ++G   G  VA+KR+ +D  +  + E   L E        H N++  
Sbjct: 38  EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD-----HPNVI-- 90
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFE---CDESIALSWE-QRIKVLKDVASGILYLY 229
           R +C +  +  + I   + N +L   +      DE++ L  E   I +L+ +ASG+ +L+
Sbjct: 91  RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 230 EGWESKVLHRDIKASNVLL--------DKKMNAR-----LGDFGLAKMHHHGQ 269
                K++HRD+K  N+L+        D++  A      + DFGL K    GQ
Sbjct: 151 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 200

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 46
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 47  CPENIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 99
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 268 GQ 269
Sbjct: 157 NN 158

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 118 ENVIGLGGNGKVYKGQLLGVE--VALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLR 174
           + VIG G    V        +  VA+KRI+L+  +  M E L E+ ++ +  H N+V   
Sbjct: 15  QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 74
Query: 175 GWCKKEKESLILIYDYMENGS-LD--KWIFECDE--SIALSWEQRIKVLKDVASGILYLY 229
                 K+ L L+   +  GS LD  K I    E  S  L       +L++V  G+ YL+
Sbjct: 75  T-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 133
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           +  +   +HRD+KA N+LL +  + ++ DFG++
Sbjct: 134 KNGQ---IHRDVKAGNILLGEDGSVQIADFGVS 163

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 120/284 (42%), Gaps = 64/284 (22%)
Query: 120 VIGLGGNGKVYKGQLLGVE-------VALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
            +G G  GKV K     ++       VA+K +  + S   +R+ L+E + L ++ H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFEC---------------------DESIALS 210
            L G C ++   L+LI +Y + GSL  ++ E                       +  AL+
Sbjct: 90  KLYGACSQDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV 270
               I     ++ G+ YL E    K++HRD+ A N+L+ +    ++ DFGL++  +    
Sbjct: 149 MGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 271 M----SGRRPIE-EGKRNLVDRMWSLTERSELLS------------------VLDERL-- 305
                 GR P++     +L D ++  T +S++ S                  +  ERL  
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN 263
Query: 306 KAKGGY----ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE 345
             K G+     D   E++  L L C   E + RP    + K LE
Sbjct: 264 LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 76/171 (44%), Gaps = 29/171 (16%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +++  VIG G  G VY+ +L   G  VA+K++        RE    +  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRE----LQIMRKLDHCNIV 76
Query: 172 GLRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
            LR +      KK++  L L+ DY+               +A  +  R K    V    L
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVY---------RVARHYS-RAKQTLPVIYVKL 126
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+ + S        + HRDIK  N+LLD      +L DFG AK    G+
Sbjct: 127 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 118 ENVIGLGGNGKVYKGQLLGVE--VALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLR 174
           + VIG G    V        +  VA+KRI+L+  +  M E L E+ ++ +  H N+V   
Sbjct: 20  QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 175 GWCKKEKESLILIYDYMENGS-LD--KWIFECDE--SIALSWEQRIKVLKDVASGILYLY 229
                 K+ L L+   +  GS LD  K I    E  S  L       +L++V  G+ YL+
Sbjct: 80  T-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH 138
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           +  +   +HRD+KA N+LL +  + ++ DFG++
Sbjct: 139 KNGQ---IHRDVKAGNILLGEDGSVQIADFGVS 168

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 21/160 (13%)
Query: 121 IGLGGNGKV-----YKGQLLGVEVALKRISLD----SEHGMREFLAEVSSLGRLKHRNLV 171
           +G G  GKV     YK Q    +VALK IS      S+  MR    E+S L  L+H +++
Sbjct: 17  LGEGSFGKVKLATHYKTQQ---KVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHII 72
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L        + ++++ +Y   G L  +I E      ++ ++  +  + +   I Y +  
Sbjct: 73  KLYDVITTPTD-IVMVIEY-AGGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHR- 126
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
              K++HRD+K  N+LLD  +N ++ DFGL+ +   G  +
Sbjct: 127 --HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL 164

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +C ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 87  ERDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 144
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 145 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 186

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 16/170 (9%)
Query: 107 EIHAATKGFSEENVIGLGGNGKVYKG-QLLGVEVALKRIS-----------LDSEHGMRE 154
           E+HA    ++ +  I  G  G V  G    G+ VA+KR+            L      + 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 155 FLAEVSSLGRLKHRNLVGLRG-WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQ 213
            L E+  L    H N++GLR  +   E+ ++  +Y   E    D      D+ I +S + 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 214 RIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               +  +  G+  L+E   + V+HRD+   N+LL    +  + DF LA+
Sbjct: 136 IQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAR 182

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 16/170 (9%)
Query: 107 EIHAATKGFSEENVIGLGGNGKVYKG-QLLGVEVALKRIS-----------LDSEHGMRE 154
           E+HA    ++ +  I  G  G V  G    G+ VA+KR+            L      + 
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 155 FLAEVSSLGRLKHRNLVGLRG-WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQ 213
            L E+  L    H N++GLR  +   E+ ++  +Y   E    D      D+ I +S + 
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 214 RIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               +  +  G+  L+E   + V+HRD+   N+LL    +  + DF LA+
Sbjct: 136 IQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAR 182

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 74/160 (46%), Gaps = 24/160 (15%)
Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV------G 172
           +G GGNG V+          VA+K+I L     ++  L E+  + RL H N+V      G
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 173 LRGW-------CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGI 225
             G           E  S+ ++ +YME       +    E   L  E     +  +  G+
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLLEEHARLFMYQLLRGL 133
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKK-MNARLGDFGLAKM 264
            Y++    + VLHRD+K +N+ ++ + +  ++GDFGLA++
Sbjct: 134 KYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 47
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 48  CPENIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 100
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 268 GQ 269
Sbjct: 158 NN 159

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 46
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 47  CPENIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 99
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 268 GQ 269
Sbjct: 157 NN 158

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 46
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 47  CPENIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 99
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 268 GQ 269
Sbjct: 157 NN 158

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 76/179 (42%), Gaps = 25/179 (13%)
Query: 91  TEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEH 150
            EDW+L       +Y E+  A    +EE V                V++   + ++D   
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVDCPE 48
Query: 151 GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALS 210
            +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I + 
Sbjct: 49  NIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDIGMP 101
Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
                +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +  
Sbjct: 102 EPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 113 KGFSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           K ++    IG G +G VY       G EVA+++++L  +      + E+  +   K+ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 171 VG-LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           V  L  +   ++  L ++ +Y+  GSL   + E      +   Q   V ++    + +L+
Sbjct: 81  VNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH 134
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
               ++V+HRDIK+ N+LL    + +L DFG  
Sbjct: 135 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFC 164

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 113 KGFSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           K ++    IG G +G VY       G EVA+++++L  +      + E+  +   K+ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 171 VG-LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           V  L  +   ++  L ++ +Y+  GSL   + E      +   Q   V ++    + +L+
Sbjct: 80  VNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH 133
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
               ++V+HRDIK+ N+LL    + +L DFG  
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 46
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 47  CPENIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 99
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 268 GQ 269
Sbjct: 157 NN 158

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 113 KGFSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           K ++    IG G +G VY       G EVA+++++L  +      + E+  +   K+ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 171 VG-LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           V  L  +   ++  L ++ +Y+  GSL   + E      +   Q   V ++    + +L+
Sbjct: 80  VNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH 133
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
               ++V+HRDIK+ N+LL    + +L DFG  
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 46
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 47  CPENIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 99
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 268 GQ 269
Sbjct: 157 NN 158

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/153 (25%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 113 KGFSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           K ++    IG G +G VY       G EVA+++++L  +      + E+  +   K+ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 171 VG-LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           V  L  +   ++  L ++ +Y+  GSL   + E      +   Q   V ++    + +L+
Sbjct: 80  VNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH 133
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
               ++V+HRDIK+ N+LL    + +L DFG  
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 46
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 47  CPENIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 99
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 268 GQ 269
Sbjct: 157 NN 158

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 46
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 47  CPENIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 99
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 268 GQ 269
Sbjct: 157 NN 158

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 47
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 48  CPENIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 100
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 268 GQ 269
Sbjct: 158 NN 159

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 46
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 47  CPENIKK---EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDI 99
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 268 GQ 269
Sbjct: 157 NN 158

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 46
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 47  CPENIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 99
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 268 GQ 269
Sbjct: 157 NN 158

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 46
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 47  CPENIKK---EIXINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 99
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 268 GQ 269
Sbjct: 157 NN 158

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 26/159 (16%)
Query: 119 NVIGLGGNGKVYKG------QLLGVEVALKRISLDSEHGMREFLA---EVSSLGRLKHRN 169
            V+G G  G V+KG      + + + V +K I  + + G + F A    + ++G L H +
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFE----CDESIALSWEQRIKVLKDVASGI 225
           +V L G C     SL L+  Y+  GSL   + +        + L+W  +I      A G+
Sbjct: 77  IVRLLGLCPGS--SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGM 128
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            YL E     ++HR++ A NVLL      ++ DFG+A +
Sbjct: 129 YYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADL 164

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 57/112 (50%), Gaps = 8/112 (7%)
Query: 152 MREFLAEVSSLGRLKHRNLVGLRGWCKKEKES-LILIYDYMENGSLDKWIFECDESIALS 210
           + +   E++ L +L H N+V L        E  L ++++ +  G     + E      LS
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP----VMEVPTLKPLS 135
Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
            +Q     +D+  GI YL+     K++HRDIK SN+L+ +  + ++ DFG++
Sbjct: 136 EDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS 184

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 46
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 47  CPENIKK---EIXINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDI 99
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 268 GQ 269
Sbjct: 157 NN 158

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 26/159 (16%)
Query: 119 NVIGLGGNGKVYKG------QLLGVEVALKRISLDSEHGMREFLA---EVSSLGRLKHRN 169
            V+G G  G V+KG      + + + V +K I  + + G + F A    + ++G L H +
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAIGSLDHAH 94
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFE----CDESIALSWEQRIKVLKDVASGI 225
           +V L G C     SL L+  Y+  GSL   + +        + L+W  +I      A G+
Sbjct: 95  IVRLLGLCPGS--SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGM 146
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            YL E     ++HR++ A NVLL      ++ DFG+A +
Sbjct: 147 YYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADL 182

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 109/267 (40%), Gaps = 46/267 (17%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G    +        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESI-------ALSWEQRIKVLKDVASGI 225
           L G   K + +L+++ + M +G L  ++                + ++ I++  ++A G+
Sbjct: 85  LLGVVSKGQPTLVVM-ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM----SGRRPI---- 277
            YL      K +HRD+ A N ++      ++GDFG+ +             G  P+    
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 278 ----EEGKRNLVDRMWSL-TERSELLSVLDE-----------RLKAKGGYADE---VVEK 318
               ++G       MWS      E+ S+ ++           +    GGY D+     E+
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 260
Query: 319 VLHLGLLCAHPEANSRPTIRQVLKMLE 345
           V  L  +C       RPT  +++ +L+
Sbjct: 261 VTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 30/175 (17%)
Query: 120 VIGLGGNGKVYKGQLLGVE-----VALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGL 173
            IG G  G V++G  +  E     VA+K     +   +RE FL E  ++ +  H ++V L
Sbjct: 45  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 104
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE--- 230
            G   +    +I     ME  +L +           S+ Q  K   D+AS ILY Y+   
Sbjct: 105 IGVITENPVWII-----MELCTLGE---------LRSFLQVRKYSLDLASLILYAYQLST 150
Query: 231 ---GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKMHH---HGQVMSGRRPIE 278
                ESK  +HRDI A NVL+      +LGDFGL++      + +   G+ PI+
Sbjct: 151 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 205

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 30/175 (17%)
Query: 120 VIGLGGNGKVYKGQLLGVE-----VALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGL 173
            IG G  G V++G  +  E     VA+K     +   +RE FL E  ++ +  H ++V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE--- 230
            G   +    +I     ME  +L +           S+ Q  K   D+AS ILY Y+   
Sbjct: 77  IGVITENPVWII-----MELCTLGE---------LRSFLQVRKFSLDLASLILYAYQLST 122
Query: 231 ---GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKMHH---HGQVMSGRRPIE 278
                ESK  +HRDI A NVL+      +LGDFGL++      + +   G+ PI+
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +Y E+  A    +EE V                V++   + ++D
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 47
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 48  CPENIKK---EIXINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRI---EPDI 100
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 101 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 157
Query: 268 GQ 269
Sbjct: 158 NN 159

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 79/160 (49%), Gaps = 25/160 (15%)
Query: 119 NVIGLGGNGKVYKGQ------LLGVEVALKRISL--DSEHGMREFLAEVSSLGRLKHRNL 170
           +++G G    V++G+      L  ++V    IS     +  MREF      L +L H+N+
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKV-FNNISFLRPVDVQMREF----EVLKKLNHKNI 69
Query: 171 VGLRGWCKKEKESL---ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           V L  +  +E+ +    +LI ++   GSL   + E   +  L   + + VL+DV  G+ +
Sbjct: 70  VKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 228 LYEGWESKVLHRDIKASNVLL----DKKMNARLGDFGLAK 263
           L    E+ ++HR+IK  N++     D +   +L DFG A+
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 79/175 (45%), Gaps = 30/175 (17%)
Query: 120 VIGLGGNGKVYKGQLLGVE-----VALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGL 173
            IG G  G V++G  +  E     VA+K     +   +RE FL E  ++ +  H ++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE--- 230
            G   +    + +I +    G L  ++            Q  K   D+AS ILY Y+   
Sbjct: 457 IGVITEN--PVWIIMELCTLGELRSFL------------QVRKFSLDLASLILYAYQLST 502
Query: 231 ---GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKMHH---HGQVMSGRRPIE 278
                ESK  +HRDI A NVL+      +LGDFGL++      + +   G+ PI+
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 73/157 (46%), Gaps = 27/157 (17%)
Query: 120 VIGLGGNGKVYKGQLLGVE-----VALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGL 173
            IG G  G V++G  +  E     VA+K     +   +RE FL E  ++ +  H ++V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE--- 230
            G   +       ++  ME  +L +           S+ Q  K   D+AS ILY Y+   
Sbjct: 77  IGVITENP-----VWIIMELCTLGE---------LRSFLQVRKFSLDLASLILYAYQLST 122
Query: 231 ---GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
                ESK  +HRDI A NVL+      +LGDFGL++
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 159

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 30/175 (17%)
Query: 120 VIGLGGNGKVYKGQLLGVE-----VALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGL 173
            IG G  G V++G  +  E     VA+K     +   +RE FL E  ++ +  H ++V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE--- 230
            G   +    +I     ME  +L +           S+ Q  K   D+AS ILY Y+   
Sbjct: 77  IGVITENPVWII-----MELCTLGE---------LRSFLQVRKYSLDLASLILYAYQLST 122
Query: 231 ---GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKMHH---HGQVMSGRRPIE 278
                ESK  +HRDI A NVL+      +LGDFGL++      + +   G+ PI+
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 30/175 (17%)
Query: 120 VIGLGGNGKVYKGQLLGVE-----VALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGL 173
            IG G  G V++G  +  E     VA+K     +   +RE FL E  ++ +  H ++V L
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE--- 230
            G   +    +I     ME  +L +           S+ Q  K   D+AS ILY Y+   
Sbjct: 77  IGVITENPVWII-----MELCTLGE---------LRSFLQVRKYSLDLASLILYAYQLST 122
Query: 231 ---GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKMHH---HGQVMSGRRPIE 278
                ESK  +HRDI A NVL+      +LGDFGL++      + +   G+ PI+
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/267 (21%), Positives = 109/267 (40%), Gaps = 46/267 (17%)
Query: 121 IGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVG 172
           +G G  G VY+G    +        VA+K ++  +    R EFL E S +      ++V 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESI-------ALSWEQRIKVLKDVASGI 225
           L G   K + +L+++ + M +G L  ++                + ++ I++  ++A G+
Sbjct: 82  LLGVVSKGQPTLVVM-ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM----SGRRPI---- 277
            YL      K +HRD+ A N ++      ++GDFG+ +             G  P+    
Sbjct: 141 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 278 ----EEGKRNLVDRMWSL-TERSELLSVLDE-----------RLKAKGGYADE---VVEK 318
               ++G       MWS      E+ S+ ++           +    GGY D+     E+
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER 257
Query: 319 VLHLGLLCAHPEANSRPTIRQVLKMLE 345
           V  L  +C       RPT  +++ +L+
Sbjct: 258 VTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 30/175 (17%)
Query: 120 VIGLGGNGKVYKGQLLGVE-----VALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGL 173
            IG G  G V++G  +  E     VA+K     +   +RE FL E  ++ +  H ++V L
Sbjct: 19  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 78
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE--- 230
            G   +    +I     ME  +L +           S+ Q  K   D+AS ILY Y+   
Sbjct: 79  IGVITENPVWII-----MELCTLGE---------LRSFLQVRKYSLDLASLILYAYQLST 124
Query: 231 ---GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKMHH---HGQVMSGRRPIE 278
                ESK  +HRDI A NVL+      +LGDFGL++      + +   G+ PI+
Sbjct: 125 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 179

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 30/175 (17%)
Query: 120 VIGLGGNGKVYKGQLLGVE-----VALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGL 173
            IG G  G V++G  +  E     VA+K     +   +RE FL E  ++ +  H ++V L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE--- 230
            G   +    +I     ME  +L +           S+ Q  K   D+AS ILY Y+   
Sbjct: 74  IGVITENPVWII-----MELCTLGE---------LRSFLQVRKYSLDLASLILYAYQLST 119
Query: 231 ---GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKMHH---HGQVMSGRRPIE 278
                ESK  +HRDI A NVL+      +LGDFGL++      + +   G+ PI+
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 30/175 (17%)
Query: 120 VIGLGGNGKVYKGQLLGVE-----VALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGL 173
            IG G  G V++G  +  E     VA+K     +   +RE FL E  ++ +  H ++V L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE--- 230
            G   +    +I     ME  +L +           S+ Q  K   D+AS ILY Y+   
Sbjct: 82  IGVITENPVWII-----MELCTLGE---------LRSFLQVRKYSLDLASLILYAYQLST 127
Query: 231 ---GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKMHH---HGQVMSGRRPIE 278
                ESK  +HRDI A NVL+      +LGDFGL++      + +   G+ PI+
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 79/175 (45%), Gaps = 30/175 (17%)
Query: 120 VIGLGGNGKVYKGQLLGVE-----VALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGL 173
            IG G  G V++G  +  E     VA+K     +   +RE FL E  ++ +  H ++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE--- 230
            G   +    + +I +    G L  ++            Q  K   D+AS ILY Y+   
Sbjct: 457 IGVITEN--PVWIIMELCTLGELRSFL------------QVRKFSLDLASLILYAYQLST 502
Query: 231 ---GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKMHH---HGQVMSGRRPIE 278
                ESK  +HRDI A NVL+      +LGDFGL++      + +   G+ PI+
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 30/175 (17%)
Query: 120 VIGLGGNGKVYKGQLLGVE-----VALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGL 173
            IG G  G V++G  +  E     VA+K     +   +RE FL E  ++ +  H ++V L
Sbjct: 20  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 79
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE--- 230
            G   +    +I     ME  +L +           S+ Q  K   D+AS ILY Y+   
Sbjct: 80  IGVITENPVWII-----MELCTLGE---------LRSFLQVRKYSLDLASLILYAYQLST 125
Query: 231 ---GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKMHH---HGQVMSGRRPIE 278
                ESK  +HRDI A NVL+      +LGDFGL++      + +   G+ PI+
Sbjct: 126 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 180

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 66/141 (46%), Gaps = 20/141 (14%)
Query: 132 GQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYDY 190
           G   G  VA+K++        R+F  E+  L  L    +V  RG      +  L L+ +Y
Sbjct: 32  GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEY 91
Query: 191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY---LYEGWE----SKVLHRDIKA 243
           + +G L  ++            QR +   D +  +LY   + +G E     + +HRD+ A
Sbjct: 92  LPSGCLRDFL------------QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAA 139
Query: 244 SNVLLDKKMNARLGDFGLAKM 264
            N+L++ + + ++ DFGLAK+
Sbjct: 140 RNILVESEAHVKIADFGLAKL 160

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 125 GNGKVYKGQLLGVEV-ALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES 183
           G      G+ + V V  LK   L     M +F+ EV+++  L HRNL+ L G        
Sbjct: 37  GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--P 94
Query: 184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLHRDIK 242
           + ++ +    GSL   + +      L    R  V   VA G+ YL    ESK  +HRD+ 
Sbjct: 95  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL----ESKRFIHRDLA 148
Query: 243 ASNVLLDKKMNARLGDFGLAK 263
           A N+LL  +   ++GDFGL +
Sbjct: 149 ARNLLLATRDLVKIGDFGLMR 169

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 79/160 (49%), Gaps = 25/160 (15%)
Query: 119 NVIGLGGNGKVYKGQ------LLGVEVALKRISL--DSEHGMREFLAEVSSLGRLKHRNL 170
           +++G G    V++G+      L  ++V    IS     +  MREF      L +L H+N+
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKV-FNNISFLRPVDVQMREF----EVLKKLNHKNI 69
Query: 171 VGLRGWCKKEKESL---ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           V L  +  +E+ +    +LI ++   GSL   + E   +  L   + + VL+DV  G+ +
Sbjct: 70  VKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 228 LYEGWESKVLHRDIKASNVLL----DKKMNARLGDFGLAK 263
           L    E+ ++HR+IK  N++     D +   +L DFG A+
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 125 GNGKVYKGQLLGVEV-ALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES 183
           G      G+ + V V  LK   L     M +F+ EV+++  L HRNL+ L G        
Sbjct: 37  GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--P 94
Query: 184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLHRDIK 242
           + ++ +    GSL   + +      L    R  V   VA G+ YL    ESK  +HRD+ 
Sbjct: 95  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL----ESKRFIHRDLA 148
Query: 243 ASNVLLDKKMNARLGDFGLAK 263
           A N+LL  +   ++GDFGL +
Sbjct: 149 ARNLLLATRDLVKIGDFGLMR 169

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 125 GNGKVYKGQLLGVEV-ALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES 183
           G      G+ + V V  LK   L     M +F+ EV+++  L HRNL+ L G        
Sbjct: 27  GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--P 84
Query: 184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLHRDIK 242
           + ++ +    GSL   + +      L    R  V   VA G+ YL    ESK  +HRD+ 
Sbjct: 85  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL----ESKRFIHRDLA 138
Query: 243 ASNVLLDKKMNARLGDFGLAK 263
           A N+LL  +   ++GDFGL +
Sbjct: 139 ARNLLLATRDLVKIGDFGLMR 159

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 125 GNGKVYKGQLLGVEV-ALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES 183
           G      G+ + V V  LK   L     M +F+ EV+++  L HRNL+ L G        
Sbjct: 27  GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--P 84
Query: 184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLHRDIK 242
           + ++ +    GSL   + +      L    R  V   VA G+ YL    ESK  +HRD+ 
Sbjct: 85  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL----ESKRFIHRDLA 138
Query: 243 ASNVLLDKKMNARLGDFGLAK 263
           A N+LL  +   ++GDFGL +
Sbjct: 139 ARNLLLATRDLVKIGDFGLMR 159

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K + +   IG G  G V      +LG+ VA+K++S    +  H  R +  E+  L  + H
Sbjct: 22  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNH 80
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++ L      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 81  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-----HMELDHERMSYLLYQMLC 135
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 136 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 172

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 119/284 (41%), Gaps = 64/284 (22%)
Query: 120 VIGLGGNGKVYKGQLLGVE-------VALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
            +G G  GKV K     ++       VA+K +  + S   +R+ L+E + L ++ H +++
Sbjct: 30  TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFEC---------------------DESIALS 210
            L G C ++   L+LI +Y + GSL  ++ E                       +  AL+
Sbjct: 90  KLYGACSQDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV 270
               I     ++ G+ YL E     ++HRD+ A N+L+ +    ++ DFGL++  +    
Sbjct: 149 MGDLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 271 M----SGRRPIE-EGKRNLVDRMWSLTERSELLS------------------VLDERL-- 305
                 GR P++     +L D ++  T +S++ S                  +  ERL  
Sbjct: 206 XVKRSQGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN 263
Query: 306 KAKGGY----ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE 345
             K G+     D   E++  L L C   E + RP    + K LE
Sbjct: 264 LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 125 GNGKVYKGQLLGVEV-ALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES 183
           G      G+ + V V  LK   L     M +F+ EV+++  L HRNL+ L G        
Sbjct: 31  GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--P 88
Query: 184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLHRDIK 242
           + ++ +    GSL   + +      L    R  V   VA G+ YL    ESK  +HRD+ 
Sbjct: 89  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL----ESKRFIHRDLA 142
Query: 243 ASNVLLDKKMNARLGDFGLAK 263
           A N+LL  +   ++GDFGL +
Sbjct: 143 ARNLLLATRDLVKIGDFGLMR 163

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 125 GNGKVYKGQLLGVEV-ALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES 183
           G      G+ + V V  LK   L     M +F+ EV+++  L HRNL+ L G        
Sbjct: 31  GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--P 88
Query: 184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLHRDIK 242
           + ++ +    GSL   + +      L    R  V   VA G+ YL    ESK  +HRD+ 
Sbjct: 89  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL----ESKRFIHRDLA 142
Query: 243 ASNVLLDKKMNARLGDFGLAK 263
           A N+LL  +   ++GDFGL +
Sbjct: 143 ARNLLLATRDLVKIGDFGLMR 163

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 74/164 (45%), Gaps = 19/164 (11%)
Query: 109 HAATKGFSEENVIGLGGNGKV----YKGQ--LLGVEVALKRISL---DSEHGMREFLAEV 159
           HA    F    VIG G  GKV    +K +     V+V  K+  L   + +H M E     
Sbjct: 34  HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE---RN 90
Query: 160 SSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLK 219
             L  +KH  LVGL  +  +  + L  + DY+  G L  +     E   L    R     
Sbjct: 91  VLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYA-A 146
Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           ++AS + YL+      +++RD+K  N+LLD + +  L DFGL K
Sbjct: 147 EIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK 187

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 114 GFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           GF++   I      +V+ G+++   + LK       H   +   E+S    L H+++VG 
Sbjct: 53  GFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQHVVGF 106
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G+ + + + + ++ +     SL +         AL+  +    L+ +  G  YL+    
Sbjct: 107 HGFFE-DNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHR--- 159
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLA-KMHHHGQ 269
           ++V+HRD+K  N+ L++ +  ++GDFGLA K+ + G+
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 11/151 (7%)
Query: 115 FSEENVIGLGGNGKVYKGQLLGVE--VALKRISLDSEHGMREFLA-EVSSLGRLKHRNLV 171
           F++   IG G  G+V+KG     +  VA+K I L+      E +  E++ L +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
              G   K+ + L +I +Y+  GS      +  E   L   Q   +L+++  G+ YL+  
Sbjct: 84  KYYGSYLKDTK-LWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS- 137
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
              K +HRDIKA+NVLL +    +L DFG+A
Sbjct: 138 --EKKIHRDIKAANVLLSEHGEVKLADFGVA 166

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 114 GFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           GF++   I      +V+ G+++   + LK       H   +   E+S    L H+++VG 
Sbjct: 33  GFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQHVVGF 86
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G+ + + + + ++ +     SL +         AL+  +    L+ +  G  YL+    
Sbjct: 87  HGFFE-DNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHR--- 139
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLA-KMHHHGQ 269
           ++V+HRD+K  N+ L++ +  ++GDFGLA K+ + G+
Sbjct: 140 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 176

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 66/141 (46%), Gaps = 10/141 (7%)
Query: 125 GNGKVYKGQLLGVEV-ALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES 183
           G      G+ + V V  LK   L     M +F+ EV+++  L HRNL+ L G        
Sbjct: 27  GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--P 84
Query: 184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLHRDIK 242
           + ++ +    GSL   + +      L    R  V   VA G+ YL    ESK  +HRD+ 
Sbjct: 85  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL----ESKRFIHRDLA 138
Query: 243 ASNVLLDKKMNARLGDFGLAK 263
           A N+LL  +   ++GDFGL +
Sbjct: 139 ARNLLLATRDLVKIGDFGLMR 159

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 114 GFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           GF++   I      +V+ G+++   + LK       H   +   E+S    L H+++VG 
Sbjct: 29  GFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQHVVGF 82
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G+ + + + + ++ +     SL +         AL+  +    L+ +  G  YL+    
Sbjct: 83  HGFFE-DNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHR--- 135
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLA-KMHHHGQ 269
           ++V+HRD+K  N+ L++ +  ++GDFGLA K+ + G+
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 172

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 114 GFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           GF++   I      +V+ G+++   + LK       H   +   E+S    L H+++VG 
Sbjct: 29  GFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQHVVGF 82
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G+ + + + + ++ +     SL +         AL+  +    L+ +  G  YL+    
Sbjct: 83  HGFFE-DNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHR--- 135
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLA-KMHHHGQ 269
           ++V+HRD+K  N+ L++ +  ++GDFGLA K+ + G+
Sbjct: 136 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 172

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 114 GFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           GF++   I      +V+ G+++   + LK       H   +   E+S    L H+++VG 
Sbjct: 51  GFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQHVVGF 104
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G+ + + + + ++ +     SL +         AL+  +    L+ +  G  YL+    
Sbjct: 105 HGFFE-DNDFVFVVLELCRRRSLLEL---HKRRKALTEPEARYYLRQIVLGCQYLHR--- 157
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLA-KMHHHGQ 269
           ++V+HRD+K  N+ L++ +  ++GDFGLA K+ + G+
Sbjct: 158 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 194

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 78/160 (48%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K + +   IG G  G V      +LG+ VA+K++S    +  H  R +  E+  L  + H
Sbjct: 24  KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNH 82
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++ L      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-----HMELDHERMSYLLYQMLC 137
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 78/157 (49%), Gaps = 14/157 (8%)
Query: 114 GFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           GF++   I      +V+ G+++   + LK       H   +   E+S    L H+++VG 
Sbjct: 27  GFAKCFEISDADTKEVFAGKIVPKSLLLK------PHQREKMSMEISIHRSLAHQHVVGF 80
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G+ + + + + ++ +     SL +         AL+  +    L+ +  G  YL+    
Sbjct: 81  HGFFE-DNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIVLGCQYLHR--- 133
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLA-KMHHHGQ 269
           ++V+HRD+K  N+ L++ +  ++GDFGLA K+ + G+
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLA-EVSSLGRLKHRNLV 171
           F++   IG G  G+V+KG        VA+K I L+      E +  E++ L +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
              G   K+ + L +I +Y+  GS      +  E   L   Q   +L+++  G+ YL+  
Sbjct: 69  KYYGSYLKDTK-LWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS- 122
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
              K +HRDIKA+NVLL +    +L DFG+A
Sbjct: 123 --EKKIHRDIKAANVLLSEHGEVKLADFGVA 151

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLA-EVSSLGRLKHRNLV 171
           F++   IG G  G+V+KG        VA+K I L+      E +  E++ L +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
              G   K+ + L +I +Y+  GS      +  E   L   Q   +L+++  G+ YL+  
Sbjct: 69  KYYGSYLKDTK-LWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS- 122
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
              K +HRDIKA+NVLL +    +L DFG+A
Sbjct: 123 --EKKIHRDIKAANVLLSEHGEVKLADFGVA 151

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 11/151 (7%)
Query: 115 FSEENVIGLGGNGKVYKGQLLGVE--VALKRISLDSEHGMREFLA-EVSSLGRLKHRNLV 171
           F++   IG G  G+V+KG     +  VA+K I L+      E +  E++ L +     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
              G   K+ + L +I +Y+  GS      +  E   L   Q   +L+++  G+ YL+  
Sbjct: 89  KYYGSYLKDTK-LWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHS- 142
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
              K +HRDIKA+NVLL +    +L DFG+A
Sbjct: 143 --EKKIHRDIKAANVLLSEHGEVKLADFGVA 171

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 113 KGFSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           K ++    IG G +G VY       G EVA+++++L  +      + E+  +   K+ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 171 VG-LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           V  L  +   ++  L ++ +Y+  GSL   + E      +   Q   V ++    + +L+
Sbjct: 81  VNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLH 134
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
               ++V+HR+IK+ N+LL    + +L DFG  
Sbjct: 135 S---NQVIHRNIKSDNILLGMDGSVKLTDFGFC 164

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 113 KGFSEENVIGLGGNGKVY--KGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           K F    V+G G   +V+  K +L G   ALK I             E++ L ++KH N+
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68
Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFE----CDESIALSWEQRIKVLKDVASGIL 226
           V L     +      L+   +  G L   I E     ++  +L       V++ V S + 
Sbjct: 69  VTLED-IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-------VIQQVLSAVK 120
Query: 227 YLYEGWESKVLHRDIKASNVL-LDKKMNAR--LGDFGLAKMHHHGQVMS 272
           YL+E   + ++HRD+K  N+L L  + N++  + DFGL+KM  +G +MS
Sbjct: 121 YLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMS 165

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 19/153 (12%)
Query: 120 VIGLGGNGKVY------KGQLLGVEVALKRISL---DSEHGMREFLAEVSSLGRLKHRNL 170
           V+G G  GKV        G L  V+V  K + L   D E  M E    + SL R  H  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE--KRILSLAR-NHPFL 86
Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
             L   C +  + L  + +++  G L   +F   +S      +      ++ S +++L++
Sbjct: 87  TQLF-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
                +++RD+K  NVLLD + + +L DFG+ K
Sbjct: 143 ---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 115 FSEENVIGLGGNGKVY--KGQLLGVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLV 171
           F     +G GG G V+  K ++     A+KRI L +    RE  + EV +L +L+H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 172 G-LRGWCKKE-----KESLILIYDYME-----NGSLDKW------IFECDESIALSWEQR 214
                W +K      + S   +Y Y++       +L  W      I E + S+ L     
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH---- 122
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             +   +A  + +L+      ++HRD+K SN+        ++GDFGL 
Sbjct: 123 --IFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 79/155 (50%), Gaps = 21/155 (13%)
Query: 120 VIGLGGNGKVYKG------QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKH-RNLVG 172
           ++G G  G+VYKG      QL  ++V    ++ D E  +++   E++ L +  H RN+  
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIKQ---EINMLKKYSHHRNIAT 85
Query: 173 LRG-WCKKEK----ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
             G + KK      + L L+ ++   GS+   I +  +   L  E    + +++  G+ +
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSH 144
Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           L++    KV+HRDIK  NVLL +    +L DFG++
Sbjct: 145 LHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 19/155 (12%)
Query: 112 TKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
           T  F   ++I    NG+ Y  ++L  E+ ++   ++  +  R  L+ V+      H  ++
Sbjct: 16  TGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT------HPFII 69
Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK--VLKDVASGILYLY 229
            + G   ++ + + +I DY+E G L            L   QR    V K  A+ +    
Sbjct: 70  RMWG-TFQDAQQIFMIMDYIEGGELFS---------LLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 230 EGWESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
           E   SK +++RD+K  N+LLDK  + ++ DFG AK
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK 154

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 30/171 (17%)
Query: 114 GFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
            ++   VIG G  G V++ +L+   EVA+K++  D     RE    +  +  +KH N+V 
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE----LQIMRIVKHPNVVD 96
Query: 173 LRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIA-LSWEQRIKVLKDVASGIL 226
           L+ +      KK++  L L+ +Y+      + ++      A L     + ++K      L
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIK------L 145
Query: 227 YLYEGWES-------KVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQ 269
           Y+Y+   S        + HRDIK  N+LLD      +L DFG AK+   G+
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 25/167 (14%)
Query: 121 IGLGGNGKVY--KGQLLGVEVALKRI---SLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
           +G G  G+V   K +L G E A+K I   S+ +       L EV+ L +L H N++ L  
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 176 WCKKEKESLILIYDYMENGSLDKWIF-----ECDESIALSWEQRIKVLKDVASGILYLYE 230
           + + ++   +++  Y      D+ I      E D ++         ++K V SG  YL++
Sbjct: 89  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---------IMKQVLSGTTYLHK 139
Query: 231 GWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAKMHHHGQVMSGR 274
                ++HRD+K  N+LL+ K      ++ DFGL+     G  M  R
Sbjct: 140 ---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER 183

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 64/283 (22%), Positives = 114/283 (40%), Gaps = 60/283 (21%)
Query: 120 VIGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMRE-FLAEVSSLGRL-KHRNL 170
            +G G  GKV +    G+       +VA+K +   +    +E  ++E+  +  L +H N+
Sbjct: 53  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWI---------FECDESI----ALSWEQRIKV 217
           V L G C      L+ I +Y   G L  ++         +  + S      LS    +  
Sbjct: 113 VNLLGACTHGGPVLV-ITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHF 171
Query: 218 LKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK--MHHHGQVMSG-- 273
              VA G+ +L        +HRD+ A NVLL     A++GDFGLA+  M+    ++ G  
Sbjct: 172 SSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 228
Query: 274 RRPIE-EGKRNLVDRMWSLTERS--------ELLS------------------VLDERLK 306
           R P++     ++ D ++++            E+ S                  V D    
Sbjct: 229 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 288
Query: 307 AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE 349
           A+  +A + +  ++     C   E   RPT +Q+   L+ Q +
Sbjct: 289 AQPAFAPKNIYSIMQ---ACWALEPTHRPTFQQICSFLQEQAQ 328

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 75/155 (48%), Gaps = 25/155 (16%)
Query: 121 IGLGGNGKVYK------GQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
           IG G  G V+K      GQ++ ++  L+  S D     +  L E+  L +LKH NLV L 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLE--SEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 175 GWCKKEKESLILIYDYMENG---SLDKWIFECDESI--ALSWEQRIKVLKDVASGILYLY 229
              ++ K  L L+++Y ++     LD++     E +  +++W+            + + +
Sbjct: 69  EVFRR-KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQAVNFCH 119
Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           +      +HRD+K  N+L+ K    +L DFG A++
Sbjct: 120 K---HNCIHRDVKPENILITKHSVIKLCDFGFARL 151

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 25/167 (14%)
Query: 121 IGLGGNGKVY--KGQLLGVEVALKRI---SLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
           +G G  G+V   K +L G E A+K I   S+ +       L EV+ L +L H N++ L  
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 176 WCKKEKESLILIYDYMENGSLDKWIF-----ECDESIALSWEQRIKVLKDVASGILYLYE 230
           + + ++   +++  Y      D+ I      E D ++         ++K V SG  YL++
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---------IMKQVLSGTTYLHK 122
Query: 231 GWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAKMHHHGQVMSGR 274
                ++HRD+K  N+LL+ K      ++ DFGL+     G  M  R
Sbjct: 123 ---HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKER 166

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 13/175 (7%)
Query: 119 NVIGLGGNGKVYKG--QLLGVEVALKRI--SLDSEHGMREFLAEVSSLGRLKHRNLVG-L 173
           ++IG G  G V +   +L    VA+K+I    +     +  L E++ L RL H ++V  L
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 174 RGWCKKEKESLILIYDYMENGSLD-KWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
                K+ E    +Y  +E    D K +F     + L+      +L ++  G+ Y++   
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAG 176
Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPI--EEGKRNLV 285
              +LHRD+K +N L+++  + ++ DFGLA+   + +  + + PI   E   NLV
Sbjct: 177 ---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 15/156 (9%)
Query: 114 GFSEENVIGLGGNGK-VYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
            F  ++V+G G  G  VY+G     +VA+KRI  +       F      L R    +   
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC----FSFADREVQLLRESDEHPNV 80
Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
           +R +C ++      I   +   +L +++ + D   A    + I +L+   SG+ +L+   
Sbjct: 81  IRYFCTEKDRQFQYIAIELCAATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 233 ESKVLHRDIKASNVLLDK-----KMNARLGDFGLAK 263
              ++HRD+K  N+L+       K+ A + DFGL K
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 107 EIHAATKG-FSEENVIGLGGNGKVYKGQL-----LGVEVALKRISLDSEHGMREFLAEVS 160
           E    TK  F +  V+G GG G+V   Q+     +     L++  +    G    L E  
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 161 SLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD 220
            L ++  R +V L  +  + K++L L+   M  G L   I+   ++      + +    +
Sbjct: 237 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQA-GFPEARAVFYAAE 294
Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGR 274
           +  G+  L+     ++++RD+K  N+LLD   + R+ D GLA     GQ + GR
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 345

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 76/182 (41%), Gaps = 25/182 (13%)
Query: 88  VEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD 147
           V   EDW+L       +  E+  A    +EE V                V++   + ++D
Sbjct: 2   VPFVEDWDLVQTLGEGAAGEVQLAVNRVTEEAV---------------AVKIVDMKRAVD 46
Query: 148 SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI 207
               +++   E+     L H N+V   G  ++E     L  +Y   G L   I   +  I
Sbjct: 47  CPENIKK---EICINKMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRI---EPDI 99
Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            +      +    + +G++YL+      + HRDIK  N+LLD++ N ++ DFGLA +  +
Sbjct: 100 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 156
Query: 268 GQ 269
Sbjct: 157 NN 158

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 11/174 (6%)
Query: 107 EIHAATKG-FSEENVIGLGGNGKVYKGQL-----LGVEVALKRISLDSEHGMREFLAEVS 160
           E    TK  F +  V+G GG G+V   Q+     +     L++  +    G    L E  
Sbjct: 177 ERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ 236
Query: 161 SLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD 220
            L ++  R +V L  +  + K++L L+   M  G L   I+   ++      + +    +
Sbjct: 237 ILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQA-GFPEARAVFYAAE 294
Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGR 274
           +  G+  L+     ++++RD+K  N+LLD   + R+ D GLA     GQ + GR
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 345

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/290 (21%), Positives = 113/290 (38%), Gaps = 67/290 (23%)
Query: 120 VIGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMRE-FLAEVSSLGRL-KHRNL 170
            +G G  GKV +    G+       +VA+K +   +    +E  ++E+  +  L +H N+
Sbjct: 38  TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 97
Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI--------------------ALS 210
           V L G C      L+ I +Y   G L  ++    E++                     L 
Sbjct: 98  VNLLGACTHGGPVLV-ITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLE 156
Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK--MHHHG 268
               +     VA G+ +L        +HRD+ A NVLL     A++GDFGLA+  M+   
Sbjct: 157 LRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 213
Query: 269 QVMSG--RRPIE-EGKRNLVDRMWSLTERS--------ELLS------------------ 299
            ++ G  R P++     ++ D ++++            E+ S                  
Sbjct: 214 YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 273
Query: 300 VLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE 349
           V D    A+  +A + +  ++     C   E   RPT +Q+   L+ Q +
Sbjct: 274 VKDGYQMAQPAFAPKNIYSIMQ---ACWALEPTHRPTFQQICSFLQEQAQ 320

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 82  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 139
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 140 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 181

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 83  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 140
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 141 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 182

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 85  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 142
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 143 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 184

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 82  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTA- 139
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 140 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 181

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 82  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 139
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 140 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 181

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 83  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 140
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 141 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 182

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 82  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 139
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 140 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 181

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 80  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 137
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 138 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 179

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 82  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 139
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 140 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 181

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 80  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 137
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 138 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 179

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 80  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 137
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 138 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 179

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 80  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 137
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 138 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 179

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 82  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 139
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 140 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 181

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 95/223 (42%), Gaps = 52/223 (23%)
Query: 115 FSEEN-----VIGLGGNGKVYKGQLLGV-------EVALKRISLDSEHGMRE-FLAEVSS 161
           F  EN     V+G G  GKV      G+       +VA+K +   ++   RE  ++E+  
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 162 LGRL-KHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWI-------------------F 201
           + +L  H N+V L G C      + LI++Y   G L  ++                    
Sbjct: 102 MTQLGSHENIVNLLGACTLSG-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 202 ECDESI-ALSWEQRIKVLKDVASGILYLYEGWESK-VLHRDIKASNVLLDKKMNARLGDF 259
           E +E +  L++E  +     VA G+ +L    E K  +HRD+ A NVL+      ++ DF
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFL----EFKSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 260 GLAK--MHHHGQVMSG--RRPIE--------EGKRNLVDRMWS 290
           GLA+  M     V+ G  R P++        EG   +   +WS
Sbjct: 217 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 259

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 27/159 (16%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLA-EVSSLGRLKHRNLV 171
           F++   IG G  G+V+KG        VA+K I L+      E +  E++ L +     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 172 GLRG-WCKKEKESLILIY-------DYMENGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
              G + K  K  +I+ Y       D +  G  D++             Q   +LK++  
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEF-------------QIATMLKEILK 131
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           G+ YL+     K +HRDIKA+NVLL ++ + +L DFG+A
Sbjct: 132 GLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVA 167

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 15/111 (13%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 60  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 117
Query: 215 IKVLKDVASGILYLY-EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+ +G    ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 118 -----EIVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKV 159

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 15/111 (13%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 59  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 116
Query: 215 IKVLKDVASGILYLY-EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+ +G    ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 117 -----EIVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKV 158

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 11/161 (6%)
Query: 109 HAATKGFS-EENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRL 165
           +A T  +   + V+GLG NGKV +   +  G + ALK +  DS    +E      + G  
Sbjct: 24  YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-YDSPKARQEVDHHWQASGGP 82
Query: 166 KHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGI 225
               ++ +       K  L++I + ME G L   I E  +  A +  +  ++++D+ + I
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ-AFTEREAAEIMRDIGTAI 141
Query: 226 LYLYEGWESKVLHRDIKASNVLL---DKKMNARLGDFGLAK 263
            +L+      + HRD+K  N+L    +K    +L DFG AK
Sbjct: 142 QFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 57  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 114
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 115 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 156

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 11/161 (6%)
Query: 109 HAATKGFS-EENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRL 165
           +A T  +   + V+GLG NGKV +   +  G + ALK +  DS    +E      + G  
Sbjct: 5   YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-YDSPKARQEVDHHWQASGGP 63
Query: 166 KHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGI 225
               ++ +       K  L++I + ME G L   I E  +  A +  +  ++++D+ + I
Sbjct: 64  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ-AFTEREAAEIMRDIGTAI 122
Query: 226 LYLYEGWESKVLHRDIKASNVLL---DKKMNARLGDFGLAK 263
            +L+      + HRD+K  N+L    +K    +L DFG AK
Sbjct: 123 QFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 160

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 15/111 (13%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 58  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 115
Query: 215 IKVLKDVASGILYLY-EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+ +G    ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 116 -----EIVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKV 157

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 17/153 (11%)
Query: 120 VIGLGGNGKVYKGQLLGVE--VALKRISLDSEH--GMREFLAEVSSLGRLKHRNLVGLRG 175
           +IG G  G VY       E  VA+K+++   E     +  L E++ L RLK   ++ L  
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYD 92
Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY---LYEGW 232
                   LI+  D ++   L   +   D  +   ++  I + ++    ILY   L E +
Sbjct: 93  --------LIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 233 --ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             ES ++HRD+K +N LL++  + ++ DFGLA+
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 79  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 136
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 137 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 178

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 64  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 121
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 122 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 163

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQR 214
           E   + RL H   V L  +  ++ E L     Y +NG L K+I +    DE+    +   
Sbjct: 79  ERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA- 136
Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                ++ S + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK+
Sbjct: 137 -----EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKV 178

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 18/172 (10%)
Query: 101 HRVSYQEIHAATKGFSEENVIGLGGNGKVY---------KGQLLGVEVALKRISLDSEHG 151
           H V      A    F    V+G G  GKV+          G L  ++V LK+ +L     
Sbjct: 16  HHVKAGSEKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKV-LKKATLKVRDR 74
Query: 152 MREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSW 211
           +R  + E   L  + H  +V L  +  + +  L LI D++  G L        + +  + 
Sbjct: 75  VRTKM-ERDILADVNHPFVVKLH-YAFQTEGKLYLILDFLRGGDL---FTRLSKEVMFTE 129
Query: 212 EQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           E     L ++A G+ +L+      +++RD+K  N+LLD++ + +L DFGL+K
Sbjct: 130 EDVKFYLAELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 178

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 12/157 (7%)
Query: 109 HAATKGFSEENVIGLGGNGKVY-----KGQLLGVEVALKRISLDSEHGMREFLAEVSSLG 163
           H     F     +G G  G VY     K   +     L +  ++ E    +   E+    
Sbjct: 19  HFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQA 78
Query: 164 RLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
            L H N++ L  +   ++  + LI +Y   G L K   E  +S     ++   +++++A 
Sbjct: 79  HLHHPNILRLYNYFY-DRRRIYLILEYAPRGELYK---ELQKSCTFDEQRTATIMEELAD 134
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG 260
            ++Y +     KV+HRDIK  N+LL  K   ++ DFG
Sbjct: 135 ALMYCHG---KKVIHRDIKPENLLLGLKGELKIADFG 168

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K +     IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNH 82
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++GL      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI-----QMELDHERMSYLLYQMLC 137
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 21/154 (13%)
Query: 120 VIGLGGNGKVYKGQLLG--VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
           V+G G  G VY G+ L   V +A+K I        +    E++    LKH+N+V   G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 178 KKEKESLILIYDYMENGSLD-----KW--IFECDESIALSWEQRIKVLKDVASGILYLYE 230
             E   + +  + +  GSL      KW  + + +++I    +Q       +  G+ YL++
Sbjct: 89  S-ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-------ILEGLKYLHD 140
Query: 231 GWESKVLHRDIKASNVLLDKKMNA-RLGDFGLAK 263
              ++++HRDIK  NVL++      ++ DFG +K
Sbjct: 141 ---NQIVHRDIKGDNVLINTYSGVLKISDFGTSK 171

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K +     IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNH 82
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++GL      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI-----QMELDHERMSYLLYQMLC 137
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 21/154 (13%)
Query: 120 VIGLGGNGKVYKGQLLG--VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
           V+G G  G VY G+ L   V +A+K I        +    E++    LKH+N+V   G  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-S 73
Query: 178 KKEKESLILIYDYMENGSLD-----KW--IFECDESIALSWEQRIKVLKDVASGILYLYE 230
             E   + +  + +  GSL      KW  + + +++I    +Q       +  G+ YL++
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-------ILEGLKYLHD 126
Query: 231 GWESKVLHRDIKASNVLLDKKMNA-RLGDFGLAK 263
              ++++HRDIK  NVL++      ++ DFG +K
Sbjct: 127 ---NQIVHRDIKGDNVLINTYSGVLKISDFGTSK 157

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K +     IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNH 82
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++GL      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI-----QMELDHERMSYLLYQMLC 137
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K +     IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H
Sbjct: 24  KRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNH 82
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++GL      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI-----QMELDHERMSYLLYQMLV 137
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 13/152 (8%)
Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLA-EVSSLGRLKHRNLV 171
           F++ + IG G  G+VYKG        VA+K I L+      E +  E++ L +     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 172 GLRG-WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
              G + K  K  L +I +Y+  GS      +  +   L       +L+++  G+ YL+ 
Sbjct: 81  RYFGSYLKSTK--LWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHS 134
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
               + +HRDIKA+NVLL ++ + +L DFG+A
Sbjct: 135 ---ERKIHRDIKAANVLLSEQGDVKLADFGVA 163

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 121 IGLGGNGKV---YKGQLLGVEVALKRISLDSE---HGMREFLAEVSSLGRLKHRNLVGL- 173
           +G G  G V   Y  +L   +VA+K++S   +   H  R +  E+  L  LKH N++GL 
Sbjct: 28  VGSGAYGSVCSAYDARLRQ-KVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGLL 85
Query: 174 ---RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
                    E  S + +   +    L+  I +C    ALS E    ++  +  G+ Y++ 
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNN-IVKCQ---ALSDEHVQFLVYQLLRGLKYIHS 141
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
              + ++HRD+K SNV +++    R+ DFGLA+
Sbjct: 142 ---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 20/165 (12%)
Query: 120 VIGLGGNGKVYK--GQLLGVEVALKRISLDSEHG--MREFLAEVSSLGRLKHRNLVGLRG 175
           ++G G  G+V K   ++   E A+K I+  S         L EV  L +L H N++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIA---LSWEQRIKVLKDVASGILYLYEGW 232
             + +  S  ++ +    G L       DE I     S     +++K V SGI Y+++  
Sbjct: 89  ILE-DSSSFYIVGELYTGGEL------FDEIIKRKRFSEHDAARIIKQVFSGITYMHK-- 139
Query: 233 ESKVLHRDIKASNVLL---DKKMNARLGDFGLAKMHHHGQVMSGR 274
              ++HRD+K  N+LL   +K  + ++ DFGL+        M  R
Sbjct: 140 -HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K +     IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNH 82
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++GL      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 137
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K +     IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNH 82
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++GL      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI-----QMELDHERMSYLLYQMLV 137
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 121 IGLGGNGKV---YKGQLLGVEVALKRISLDSE---HGMREFLAEVSSLGRLKHRNLVGL- 173
           +G G  G V   Y  +L   +VA+K++S   +   H  R +  E+  L  LKH N++GL 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ-KVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGLL 93
Query: 174 ---RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
                    E  S + +   +    L+  I +C    ALS E    ++  +  G+ Y++ 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNN-IVKCQ---ALSDEHVQFLVYQLLRGLKYIHS 149
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
              + ++HRD+K SNV +++    R+ DFGLA+
Sbjct: 150 ---AGIIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K +     IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H
Sbjct: 29  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNH 87
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++GL      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 88  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 142
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 143 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 179

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K +     IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H
Sbjct: 26  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNH 84
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++GL      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 85  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 139
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 140 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 176

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K +     IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H
Sbjct: 18  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNH 76
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++GL      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 77  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 131
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 132 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 168

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K +     IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNH 82
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++GL      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 137
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 20/165 (12%)
Query: 120 VIGLGGNGKVYK--GQLLGVEVALKRISLDSEHG--MREFLAEVSSLGRLKHRNLVGLRG 175
           ++G G  G+V K   ++   E A+K I+  S         L EV  L +L H N++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIA---LSWEQRIKVLKDVASGILYLYEGW 232
             + +  S  ++ +    G L       DE I     S     +++K V SGI Y+++  
Sbjct: 89  ILE-DSSSFYIVGELYTGGEL------FDEIIKRKRFSEHDAARIIKQVFSGITYMHK-- 139
Query: 233 ESKVLHRDIKASNVLLDKK---MNARLGDFGLAKMHHHGQVMSGR 274
              ++HRD+K  N+LL+ K    + ++ DFGL+        M  R
Sbjct: 140 -HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 100 PHRVSYQEIHAATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRI-SLDSEHGMREFL 156
           P R+ Y      +  F  ++++G G  G V     +  G  VA+K+I   D        L
Sbjct: 2   PKRIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 157 AEVSSLGRLKHRNLVGLRGWCKK---EKESLILIYDYMENGSLDKWI---FECDESIALS 210
            E+  L   KH N++ +    +    E  + + I   +    L + I      D+ I   
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF 117
Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
             Q ++ +K V  G         S V+HRD+K SN+L++   + ++ DFGLA++
Sbjct: 118 IYQTLRAVK-VLHG---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K +     IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNH 82
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++GL      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 137
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K +     IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKVVNH 82
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++GL      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVI-----QMELDHERMSYLLYQMLV 137
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLAR 174

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/152 (21%), Positives = 71/152 (46%), Gaps = 14/152 (9%)
Query: 120 VIGLGGNGKVYKGQLL------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           ++G GG  +V+  + L       V+V    ++ D    +R F  E  +   L H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAV 77
Query: 174 RGWCKKEKESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
               + E  +  L Y  ME  +G   + I   +    ++ ++ I+V+ D    + + ++ 
Sbjct: 78  YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN 135
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               ++HRD+K +N+++      ++ DFG+A+
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIAR 164

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/149 (22%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 114 GFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           GF++   I      +V+ G+++   + LK       H   +   E++    L + ++VG 
Sbjct: 54  GFAKCYEITDMDTKEVFAGKVVPKSMLLK------PHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G+ + +      +Y  +E       +       A++  +    ++    G+ YL+    
Sbjct: 108 HGFFEDDD----FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN--- 160
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           ++V+HRD+K  N+ L+  M+ ++GDFGLA
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 81/167 (48%), Gaps = 26/167 (15%)
Query: 121 IGLGGNGKVY--KGQLLGVEVALK--RISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           +G G  G+V   + ++  VE A+K  R +  S     + L EV+ L  L H N++ L  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 177 CKKEKESLILIYDYMENGSLDKWIF------ECDESIALSWEQRIKVLKDVASGILYLYE 230
            + +K +  L+ +  + G L   I       E D ++         ++K V SG+ YL++
Sbjct: 105 FE-DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---------IIKQVLSGVTYLHK 154
Query: 231 GWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAKMHHHGQVMSGR 274
                ++HRD+K  N+LL+ K      ++ DFGL+ +  + + M  R
Sbjct: 155 ---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER 198

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K +     IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNH 82
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++GL      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 137
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 100 PHRVSYQEIHAATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRI-SLDSEHGMREFL 156
           P R+ Y      +  F  ++++G G  G V     +  G  VA+K+I   D        L
Sbjct: 2   PKRIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 157 AEVSSLGRLKHRNLVGLRGWCKK---EKESLILIYDYMENGSLDKWI---FECDESIALS 210
            E+  L   KH N++ +    +    E  + + I   +    L + I      D+ I   
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF 117
Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
             Q ++ +K V  G         S V+HRD+K SN+L++   + ++ DFGLA++
Sbjct: 118 IYQTLRAVK-VLHG---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K +     IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H
Sbjct: 25  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNH 83
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++GL      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 138
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 139 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 20/165 (12%)
Query: 120 VIGLGGNGKVYK--GQLLGVEVALKRISLDSEHG--MREFLAEVSSLGRLKHRNLVGLRG 175
           ++G G  G+V K   ++   E A+K I+  S         L EV  L +L H N++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIA---LSWEQRIKVLKDVASGILYLYEGW 232
             + +  S  ++ +    G L       DE I     S     +++K V SGI Y+++  
Sbjct: 89  ILE-DSSSFYIVGELYTGGEL------FDEIIKRKRFSEHDAARIIKQVFSGITYMHK-- 139
Query: 233 ESKVLHRDIKASNVLLDKK---MNARLGDFGLAKMHHHGQVMSGR 274
              ++HRD+K  N+LL+ K    + ++ DFGL+        M  R
Sbjct: 140 -HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 39/178 (21%), Positives = 79/178 (44%), Gaps = 26/178 (14%)
Query: 125 GNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL 184
             G+V+  + +     L + ++ +E         +S + +L H  L+ L     ++K  +
Sbjct: 74  ATGRVFVAKFINTPYPLDKYTVKNE---------ISIMNQLHHPKLINLHD-AFEDKYEM 123
Query: 185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKAS 244
           +LI +++  G L   I    E   +S  + I  ++    G+ +++E     ++H DIK  
Sbjct: 124 VLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPE 178
Query: 245 NVLLDKKM--NARLGDFGLA-KMHHHGQVMSGRRPIEEGKRNLVDR--------MWSL 291
           N++ + K   + ++ DFGLA K++    V       E     +VDR        MW++
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAI 236

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 76/160 (47%), Gaps = 18/160 (11%)
Query: 113 KGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKH 167
           K +     IG G  G V      +L   VA+K++S    +  H  R +  E+  +  + H
Sbjct: 24  KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNH 82
Query: 168 RNLVGLRGWCKKEK--ESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           +N++GL      +K  E    +Y  ME  + +L + I      + L  E+   +L  +  
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI-----QMELDHERMSYLLYQMLC 137
Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           GI +L+    + ++HRD+K SN+++      ++ DFGLA+
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/149 (22%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 114 GFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           GF++   I      +V+ G+++   + LK       H   +   E++    L + ++VG 
Sbjct: 38  GFAKCYEITDMDTKEVFAGKVVPKSMLLK------PHQKEKMSTEIAIHKSLDNPHVVGF 91
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G+ + +      +Y  +E       +       A++  +    ++    G+ YL+    
Sbjct: 92  HGFFEDDD----FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN--- 144
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           ++V+HRD+K  N+ L+  M+ ++GDFGLA
Sbjct: 145 NRVIHRDLKLGNLFLNDDMDVKIGDFGLA 173

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 76/174 (43%), Gaps = 23/174 (13%)
Query: 100 PHRVSYQEIHAATKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRI-SLDSEHGMREFL 156
           P R+ Y      +  F  ++++G G  G V     +  G  VA+K+I   D        L
Sbjct: 2   PKRIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL 57
Query: 157 AEVSSLGRLKHRNLVGLRGWCKK---EKESLILIYDYMENGSLDKWI---FECDESIALS 210
            E+  L   KH N++ +    +    E  + + I   +    L + I      D+ I   
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF 117
Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
             Q ++ +K V  G         S V+HRD+K SN+L++   + ++ DFGLA++
Sbjct: 118 IYQTLRAVK-VLHG---------SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 33/149 (22%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 114 GFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           GF++   I      +V+ G+++   + LK       H   +   E++    L + ++VG 
Sbjct: 54  GFAKCYEITDMDTKEVFAGKVVPKSMLLK------PHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G+ + +      +Y  +E       +       A++  +    ++    G+ YL+    
Sbjct: 108 HGFFEDDD----FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN--- 160
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           ++V+HRD+K  N+ L+  M+ ++GDFGLA
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/152 (22%), Positives = 71/152 (46%), Gaps = 14/152 (9%)
Query: 120 VIGLGGNGKVYKGQLL------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           ++G GG  +V+  + L       V+V    ++ D    +R F  E  +   L H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAV 77
Query: 174 RGWCKKEKESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
               + E  +  L Y  ME  +G   + I   +    ++ ++ I+V+ D    + + ++ 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN 135
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               ++HRD+K +N+L+      ++ DFG+A+
Sbjct: 136 G---IIHRDVKPANILISATNAVKVVDFGIAR 164

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/149 (22%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 114 GFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           GF++   I      +V+ G+++   + LK       H   +   E++    L + ++VG 
Sbjct: 54  GFAKCYEITDMDTKEVFAGKVVPKSMLLK------PHQKEKMSTEIAIHKSLDNPHVVGF 107
Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G+ + +      +Y  +E       +       A++  +    ++    G+ YL+    
Sbjct: 108 HGFFEDDD----FVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN--- 160
Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           ++V+HRD+K  N+ L+  M+ ++GDFGLA
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 76/159 (47%), Gaps = 17/159 (10%)
Query: 114 GFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS--LDSEHGMREFLAEVSSLGRLKHRN 169
            +  +++IG G  G VY    +     VA+K+++   +     +  L E++ L RLK   
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY-- 227
           ++ L          LI+  D ++   L   +   D  +   ++  I + +     ILY  
Sbjct: 89  IIRLHD--------LIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNL 140
Query: 228 -LYEGW--ESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            L E +  ES ++HRD+K +N LL++  + ++ DFGLA+
Sbjct: 141 LLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLAR 179

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 120 VIGLGGNGKVYK---------GQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           V+G GG GKV++         G++  ++V  K + + +        AE + L  +KH  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
           V L  +  +    L LI +Y+  G L     + +       +     L +++  + +L++
Sbjct: 84  VDLI-YAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
                +++RD+K  N++L+ + + +L DFGL K   H
Sbjct: 140 ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 120 VIGLGGNGKVYK---------GQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           V+G GG GKV++         G++  ++V  K + + +        AE + L  +KH  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
           V L  +  +    L LI +Y+  G L     + +       +     L +++  + +L++
Sbjct: 84  VDLI-YAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
                +++RD+K  N++L+ + + +L DFGL K   H
Sbjct: 140 ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH 173

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/146 (23%), Positives = 69/146 (47%), Gaps = 14/146 (9%)
Query: 121 IGLGGNGKVYKGQ------LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
           +G G  G VY  +      ++ ++V  K   L+ E    +   E+     L+H N++ + 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKS-QLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
            +   +++ + L+ ++   G L K   E  +      ++    ++++A  + Y +E    
Sbjct: 81  NYFH-DRKRIYLMLEFAPRGELYK---ELQKHGRFDEQRSATFMEELADALHYCHE---R 133
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFG 260
           KV+HRDIK  N+L+  K   ++ DFG
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFG 159

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 121 IGLGGNGKV---YKGQLLGVEVALKRISLDSE---HGMREFLAEVSSLGRLKHRNLVGL- 173
           +G G  G V   Y  +L   +VA+K++S   +   H  R +  E+  L  LKH N++GL 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ-KVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGLL 93
Query: 174 ---RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
                    E  S + +   +    L+  +    +S ALS E    ++  +  G+ Y++ 
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIV----KSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
              + ++HRD+K SNV +++    R+ DFGLA+
Sbjct: 150 ---AGIIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 10/165 (6%)
Query: 110 AATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN 169
           A +  F  E+ +G G    VY+ +  G +       L      +    E+  L RL H N
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPN 109
Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           ++ L+   +   E + L+ + +  G L   I E       S       +K +   + YL+
Sbjct: 110 IIKLKEIFETPTE-ISLVLELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLH 165
Query: 230 EGWESKVLHRDIKASNVLLDKK---MNARLGDFGLAKMHHHGQVM 271
           E   + ++HRD+K  N+L          ++ DFGL+K+  H  +M
Sbjct: 166 E---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM 207

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/152 (21%), Positives = 71/152 (46%), Gaps = 14/152 (9%)
Query: 120 VIGLGGNGKVYKGQLL------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           ++G GG  +V+  + L       V+V    ++ D    +R F  E  +   L H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAV 77
Query: 174 RGWCKKEKESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
               + E  +  L Y  ME  +G   + I   +    ++ ++ I+V+ D    + + ++ 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN 135
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               ++HRD+K +N+++      ++ DFG+A+
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIAR 164

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/146 (23%), Positives = 69/146 (47%), Gaps = 14/146 (9%)
Query: 121 IGLGGNGKVYKGQ------LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
           +G G  G VY  +      ++ ++V  K   L+ E    +   E+     L+H N++ + 
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKS-QLEKEGVEHQLRREIEIQSHLRHPNILRMY 81
Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
            +   +++ + L+ ++   G L K   E  +      ++    ++++A  + Y +E    
Sbjct: 82  NYFH-DRKRIYLMLEFAPRGELYK---ELQKHGRFDEQRSATFMEELADALHYCHE---R 134
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFG 260
           KV+HRDIK  N+L+  K   ++ DFG
Sbjct: 135 KVIHRDIKPENLLMGYKGELKIADFG 160

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 16/28 (57%), Positives = 23/28 (82%)
Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLA 262
           K++HRDIK SN+LLD+  N +L DFG++
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGIS 173

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 89/203 (43%), Gaps = 26/203 (12%)
Query: 75  MVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKG-- 132
           M  +++KG   +DV +T  WEL                K +     +G G  G V     
Sbjct: 20  MSLIRKKGFYKQDVNKTA-WEL---------------PKTYVSPTHVGSGAYGSVCSAID 63
Query: 133 QLLGVEVALKRIS--LDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY 190
           +  G +VA+K++S    SE   +    E+  L  ++H N++GL         SL   YD+
Sbjct: 64  KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD-VFTPASSLRNFYDF 122
Query: 191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK 250
                  +   +    +  S E+   ++  +  G+ Y++    + V+HRD+K  N+ +++
Sbjct: 123 YLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNE 179
Query: 251 KMNARLGDFGLAKMHHHGQVMSG 273
               ++ DFGLA+  H    M+G
Sbjct: 180 DCELKILDFGLAR--HADAEMTG 200

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/152 (21%), Positives = 71/152 (46%), Gaps = 14/152 (9%)
Query: 120 VIGLGGNGKVYKGQLL------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           ++G GG  +V+  + L       V+V    ++ D    +R F  E  +   L H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAV 77
Query: 174 RGWCKKEKESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
               + E  +  L Y  ME  +G   + I   +    ++ ++ I+V+ D    + + ++ 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN 135
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               ++HRD+K +N+++      ++ DFG+A+
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIAR 164

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 65/144 (45%), Gaps = 13/144 (9%)
Query: 132 GQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM 191
           G+L  V+   K+     E  +     E++ L ++KH N+V L     +    L L+   +
Sbjct: 47  GKLFAVKCIPKKALKGKESSIEN---EIAVLRKIKHENIVALED-IYESPNHLYLVMQLV 102
Query: 192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL--- 248
             G L   I E       + +    +++ V   + YL+      ++HRD+K  N+L    
Sbjct: 103 SGGELFDRIVE---KGFYTEKDASTLIRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQ 156
Query: 249 DKKMNARLGDFGLAKMHHHGQVMS 272
           D++    + DFGL+KM   G VMS
Sbjct: 157 DEESKIMISDFGLSKMEGKGDVMS 180

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 33/152 (21%), Positives = 71/152 (46%), Gaps = 14/152 (9%)
Query: 120 VIGLGGNGKVYKGQLL------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           ++G GG  +V+  + L       V+V    ++ D    +R F  E  +   L H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAV 77
Query: 174 RGWCKKEKESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
               + E  +  L Y  ME  +G   + I   +    ++ ++ I+V+ D    + + ++ 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN 135
Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               ++HRD+K +N+++      ++ DFG+A+
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIAR 164

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	409
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-90
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-82
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-81
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-46
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-41
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-38
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-38
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-37
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-35
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-35
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-34
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-34
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-33
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-32
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-32
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-32
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-32
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-30
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-25
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-25
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-24
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-24
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-24
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-24
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-24
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-24
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-24
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-24
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-24
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-24
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-23
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-23
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-23
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-22
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-22
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-22
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-22
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-22
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-22
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-22
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-22
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-22
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-22
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-21
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-21
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-21
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-21
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-21
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-21
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-21
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	6e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	7e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-21
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-20
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-20
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-20
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-20
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-20
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-19
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-19
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-19
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-19
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-19
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	4e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-19
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-19
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-19
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-19
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-18
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-18
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-18
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-18
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-18
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-18
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-18
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-17
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-17
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-17
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-17
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-17
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-17
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-17
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-16
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-16
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-16
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-16
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-16
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-16
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-16
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-16
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-15
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-15
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-15
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-15
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-15
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-15
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-15
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	7e-15
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-14
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-14
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-13
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-13
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-13
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-13
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-13
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-13
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-13
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-13
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-13
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-13
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-13
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	5e-13
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-13
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	6e-13
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-12
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-12
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-12
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-12
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-12
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-12
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-12
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-12
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-12
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	5e-12
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-12
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-12
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-12
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-11
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-11
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-11
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-11
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-11
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-11
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-11
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-11
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-11
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-11
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-11
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-11
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-11
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-11
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	6e-11
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-11
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-11
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-10
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-10
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-10
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-10
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-10
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-10
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-10
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-10
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-09
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-09
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-09
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-09
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-09
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-09
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-09
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-09
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-08
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-08
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-08
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-08
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-08
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-08
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-07
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-07
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	3e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-05
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-06
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	1e-06
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	2e-06
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	2e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-06
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	3e-06
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	5e-06
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	5e-06
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-06
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-06
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-05
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	2e-05
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-05
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-05
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-05
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-05
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-05
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-05
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-05
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-05
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	5e-05
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	6e-05
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	8e-05
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	9e-05
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	1e-04
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	2e-04
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	2e-04
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	2e-04
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	2e-04
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	2e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-04
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	3e-04
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	3e-04
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	3e-04
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	4e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-04
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	6e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  274 bits (703), Expect = 3e-90
 Identities = 100/309 (32%), Positives = 156/309 (50%), Gaps = 52/309 (16%)

Query: 87  DVEETEDWELEY-WPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRI 144
           DV   ED E+      R S +E+  A+  FS +N++G GG GKVYKG+L  G  VA+KR+
Sbjct: 3   DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62

Query: 145 SLDSEHGM-REFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC 203
             +   G   +F  EV  +    HRNL+ LRG+C    E  +L+Y YM NGS+   + E 
Sbjct: 63  KEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE-RLLVYPYMANGSVASCLRER 121

Query: 204 DES-IALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
            ES   L W +R ++    A G+ YL++  + K++HRD+KA+N+LLD++  A +GDFGLA
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181

Query: 263 KMHHHGQ------VM---------------------------------SGRRPIE----- 278
           K+  +        V                                  +G+R  +     
Sbjct: 182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241

Query: 279 -EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI 337
            +    L+D +  L +  +L +++D  L  +G Y DE VE+++ + LLC       RP +
Sbjct: 242 NDDDVMLLDWVKGLLKEKKLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKM 299

Query: 338 RQVLKMLEG 346
            +V++MLEG
Sbjct: 300 SEVVRMLEG 308

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  254 bits (650), Expect = 3e-82
 Identities = 84/312 (26%), Positives = 137/312 (43%), Gaps = 52/312 (16%)

Query: 81  KGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL-GVEV 139
           K     +   +  + + +  +RV   ++  AT  F  + +IG G  GKVYKG L  G +V
Sbjct: 7   KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66

Query: 140 ALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKW 199
           ALKR + +S  G+ EF  E+ +L   +H +LV L G+C  E+  +ILIY YMENG+L + 
Sbjct: 67  ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-DERNEMILIYKYMENGNLKRH 125

Query: 200 IFECDE-SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGD 258
           ++  D  ++++SWEQR+++    A G+ YL+      ++HRD+K+ N+LLD+    ++ D
Sbjct: 126 LYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITD 182

Query: 259 FGLAKMHHHG-------QVM---------------------------------SGRRPI- 277
           FG++K             V                                    R  I 
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242

Query: 278 ---EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSR 334
                   NL +         +L  ++D  L        E + K     + C    +  R
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNL--ADKIRPESLRKFGDTAVKCLALSSEDR 300

Query: 335 PTIRQVLKMLEG 346
           P++  VL  LE 
Sbjct: 301 PSMGDVLWKLEY 312

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  250 bits (641), Expect = 4e-81
 Identities = 79/301 (26%), Positives = 134/301 (44%), Gaps = 59/301 (19%)

Query: 100 PHRVSYQEIHAATKGFSEE------NVIGLGGNGKVYKGQLLGVEVALKRIS----LDSE 149
            H  S+ E+   T  F E       N +G GG G VYKG +    VA+K+++    + +E
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71

Query: 150 HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIAL 209
              ++F  E+  + + +H NLV L G+     + L L+Y YM NGSL   +   D +  L
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-LCLVYVYMPNGSLLDRLSCLDGTPPL 130

Query: 210 SWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
           SW  R K+ +  A+GI +L+E      +HRDIK++N+LLD+   A++ DFGLA+      
Sbjct: 131 SWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 270 -------VM--------------------------------SGRRPIEEGK--RNLVDRM 288
                  ++                                +G   ++E +  + L+D  
Sbjct: 188 QTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247

Query: 289 WS-LTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ 347
                E   +   +D+++          VE +  +   C H + N RP I++V ++L+  
Sbjct: 248 EEIEDEEKTIEDYIDKKM---NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

Query: 348 T 348
           T
Sbjct: 305 T 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  161 bits (410), Expect = 1e-46
 Identities = 61/305 (20%), Positives = 107/305 (35%), Gaps = 68/305 (22%)

Query: 104 SYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLG 163
             + ++  +       V   G  G V+K QLL   VA+K   +  +    +   EV SL 
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSW-QNEYEVYSLP 73

Query: 164 RLKHRNLVGLRGWCKKEKES---LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD 220
            +KH N++   G  K+       L LI  + E GSL  ++        +SW +   + + 
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIAET 129

Query: 221 VASGILYLYE-------GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---- 269
           +A G+ YL+E       G +  + HRDIK+ NVLL   + A + DFGLA     G+    
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 270 -----------------------------------------VMSGRRPI----EEGKRNL 284
                                                    + S         +E     
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249

Query: 285 VDRMW---SLTERSELLSVLDERLKAKGGYA-DEVVEKVLHLGLLCAHPEANSRPTIRQV 340
            + +    SL +  E++    +R   +  +     +  +      C   +A +R +   V
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309

Query: 341 LKMLE 345
            + + 
Sbjct: 310 GERIT 314

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  147 bits (374), Expect = 2e-41
 Identities = 48/196 (24%), Positives = 96/196 (48%), Gaps = 18/196 (9%)

Query: 79  KRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVE 138
             +    +   + +D +       + + +++        +  IG G  G V++ +  G +
Sbjct: 17  TTENLYFQGAMDGDDMD-------IPWCDLN-------IKEKIGAGSFGTVHRAEWHGSD 62

Query: 139 VALKRISLDSEHG--MREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSL 196
           VA+K +     H   + EFL EV+ + RL+H N+V   G   +   +L ++ +Y+  GSL
Sbjct: 63  VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSL 121

Query: 197 DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARL 256
            + + +      L   +R+ +  DVA G+ YL       ++HR++K+ N+L+DKK   ++
Sbjct: 122 YRLLHKSGAREQLDERRRLSMAYDVAKGMNYL-HNRNPPIVHRNLKSPNLLVDKKYTVKV 180

Query: 257 GDFGLAKMHHHGQVMS 272
            DFGL+++     + S
Sbjct: 181 CDFGLSRLKASTFLSS 196

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  139 bits (351), Expect = 4e-38
 Identities = 38/178 (21%), Positives = 70/178 (39%), Gaps = 15/178 (8%)

Query: 104 SYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLG 163
           +  E            +IG G  G VYKG L    VA+K  S  +          +  + 
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINE-KNIYRVP 62

Query: 164 RLKHRNLVGLRGWCKK----EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLK 219
            ++H N+       ++     +   +L+ +Y  NGSL K++          W    ++  
Sbjct: 63  LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAH 118

Query: 220 DVASGILYL------YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
            V  G+ YL       + ++  + HRD+ + NVL+       + DFGL+      +++
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  138 bits (349), Expect = 7e-38
 Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 14/167 (8%)

Query: 104 SYQEIHAATKGFSE---ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVS 160
           S   I      + E   E V+G G  G V K +    +VA+K+I  +SE   + F+ E+ 
Sbjct: 1   SLHMID-----YKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESE--RKAFIVELR 53

Query: 161 SLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD 220
            L R+ H N+V L G C      + L+ +Y E GSL   +   +     +    +     
Sbjct: 54  QLSRVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110

Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMN-ARLGDFGLAKMHH 266
            + G+ YL+      ++HRD+K  N+LL       ++ DFG A    
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  136 bits (344), Expect = 1e-37
 Identities = 34/157 (21%), Positives = 67/157 (42%), Gaps = 5/157 (3%)

Query: 118 ENVIGLGGNGKVYKGQLLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRG 175
              +    +G+++KG+  G ++ +K + +   S    R+F  E   L    H N++ + G
Sbjct: 15  LTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 176 WCKKE-KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
            C+        LI  +M  GSL   + E   +  +   Q +K   D+A G+ +L    E 
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMAFL-HTLEP 132

Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
            +    + + +V++D+ M AR+    +         M
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM 169

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  132 bits (333), Expect = 1e-35
 Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 8/149 (5%)

Query: 118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
             V+G G  G+  K      G  + +K +    E   R FL EV  +  L+H N++   G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
              K+K  L  I +Y++ G+L   I          W QR+   KD+ASG+ YL+      
Sbjct: 75  VLYKDKR-LNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLH---SMN 128

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           ++HRD+ + N L+ +  N  + DFGLA++
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARL 157

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  130 bits (329), Expect = 2e-35
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 17/168 (10%)

Query: 118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEH----GMREFLAEVSSLGRLKHRNLVGL 173
           E +IG+GG GKVY+   +G EVA+K    D +      +     E      LKH N++ L
Sbjct: 12  EEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
           RG C KE  +L L+ ++   G L++ +        +  +  +     +A G+ YL++   
Sbjct: 72  RGVCLKE-PNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 234 SKVLHRDIKASNVLLDKKMNAR--------LGDFGLAKMHHHGQVMSG 273
             ++HRD+K+SN+L+ +K+           + DFGLA+  H    MS 
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA 174

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  128 bits (324), Expect = 1e-34
 Identities = 58/301 (19%), Positives = 115/301 (38%), Gaps = 64/301 (21%)

Query: 87  DVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRI 144
           +  ++    L          EI         E  IG GG G V+KG+L+     VA+K +
Sbjct: 7   EFPKSRLPTLADN-------EIE-------YEKQIGKGGFGLVHKGRLVKDKSVVAIKSL 52

Query: 145 SLDSEHG-------MREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLD 197
            L    G        +EF  EV  +  L H N+V L G          ++ +++  G L 
Sbjct: 53  ILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP---PRMVMEFVPCGDLY 109

Query: 198 KWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK-----M 252
             +   D++  + W  +++++ D+A GI Y+ +     ++HRD+++ N+ L        +
Sbjct: 110 HRLL--DKAHPIKWSVKLRLMLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPV 166

Query: 253 NARLGDFGLAKMHHHGQVMSGRR-------P-IEEGKRNLVDR----------MWSLTER 294
            A++ DFGL++   H   +SG         P     +                ++++   
Sbjct: 167 CAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

Query: 295 SE------LLSVLDERLKAKGGY----ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKML 344
                      +    +  + G      ++   ++ ++  LC   +   RP    ++K L
Sbjct: 225 EGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

Query: 345 E 345
            
Sbjct: 285 S 285

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  126 bits (318), Expect = 2e-33
 Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 15/163 (9%)

Query: 118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGM-REFLAEVSSLGRLKHRNLVGLRGW 176
              +G G  G+V++G   G  VA+K  S   E    RE   E+ +   L+H N++G    
Sbjct: 13  LECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIAS 70

Query: 177 CKKEKES---LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL----- 228
               + S   L LI  Y E GSL  ++    +   L     ++++  +ASG+ +L     
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
               +  + HRD+K+ N+L+ K     + D GLA MH      
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  122 bits (308), Expect = 3e-32
 Identities = 44/181 (24%), Positives = 82/181 (45%), Gaps = 24/181 (13%)

Query: 89  EETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD- 147
           +  +DWE       +   +I            IG G  G VYKG+  G +VA+K +++  
Sbjct: 14  DAADDWE-------IPDGQIT-------VGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA 58

Query: 148 -SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDES 206
            +   ++ F  EV  L + +H N++   G+    +  L ++  + E  SL   +      
Sbjct: 59  PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ--LAIVTQWCEGSSLYHHLH--ASE 114

Query: 207 IALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH 266
                ++ I + +  A G+ YL+      ++HRD+K++N+ L +    ++GDFGLA    
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171

Query: 267 H 267
            
Sbjct: 172 R 172

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  122 bits (309), Expect = 4e-32
 Identities = 44/183 (24%), Positives = 83/183 (45%), Gaps = 24/183 (13%)

Query: 92  EDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISL--DSE 149
           ++W+       + ++++           +IG G  G+VY G+  G EVA++ I +  D+E
Sbjct: 26  QEWD-------IPFEQLE-------IGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNE 70

Query: 150 HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIAL 209
             ++ F  EV +  + +H N+V   G C      L +I    +  +L   +   D  I L
Sbjct: 71  DQLKAFKREVMAYRQTRHENVVLFMGACMSP-PHLAIITSLCKGRTLYSVVR--DAKIVL 127

Query: 210 SWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
              +  ++ +++  G+ YL+      +LH+D+K+ NV  D      + DFGL  +    Q
Sbjct: 128 DVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQ 183

Query: 270 VMS 272
              
Sbjct: 184 AGR 186

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  122 bits (309), Expect = 6e-32
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 13/159 (8%)

Query: 118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
              IG G  G+V+ G+  G +VA+K     +E        E+     ++H N++G     
Sbjct: 42  VKQIGKGRYGEVWMGKWRGEKVAVKVFF-TTEEASWFRETEIYQTVLMRHENILGFIAAD 100

Query: 178 KKEKES---LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL-----Y 229
            K   S   L LI DY ENGSL  ++    +S  L  +  +K+     SG+ +L      
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
              +  + HRD+K+ N+L+ K     + D GLA      
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  119 bits (300), Expect = 1e-30
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 17/165 (10%)

Query: 118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAE--VSSLGRLKHRNLVGLRG 175
           +  IG G  G+V++G+  G EVA+K  S       R +  E  +     L+H N++G   
Sbjct: 47  QESIGKGRFGEVWRGKWRGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103

Query: 176 WCKKEKES---LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
              K+  +   L L+ DY E+GSL  ++        ++ E  IK+    ASG+ +L+   
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 233 ES-----KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
                   + HRD+K+ N+L+ K     + D GLA  H       
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  105 bits (265), Expect = 3e-26
 Identities = 56/161 (34%), Positives = 81/161 (50%), Gaps = 9/161 (5%)

Query: 118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
              IG G  G V  G   G +VA+K I  D+    + FLAE S + +L+H NLV L G  
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-V 236
            +EK  L ++ +YM  GSL  ++     S  L  +  +K   DV   + YL    E    
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL----EGNNF 138

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPI 277
           +HRD+ A NVL+ +   A++ DFGL K     Q  +G+ P+
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPV 178

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  103 bits (260), Expect = 2e-25
 Identities = 35/164 (21%), Positives = 63/164 (38%), Gaps = 17/164 (10%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISL-DSEHGMREFLAEVSSLGRLKHRNLV 171
           F     +G GG G V++ +  +     A+KRI L + E    + + EV +L +L+H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 172 GLRGWC-----------KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD 220
                               K  L +        +L  W+              + +   
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126

Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           +A  + +L+      ++HRD+K SN+        ++GDFGL   
Sbjct: 127 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 167

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  106 bits (266), Expect = 2e-25
 Identities = 53/147 (36%), Positives = 75/147 (51%), Gaps = 8/147 (5%)

Query: 118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
              IG G  G V  G   G +VA+K I  D+    + FLAE S + +L+H NLV L G  
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-V 236
            +EK  L ++ +YM  GSL  ++     S  L  +  +K   DV   + YL    E    
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL----EGNNF 310

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAK 263
           +HRD+ A NVL+ +   A++ DFGL K
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK 337

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  102 bits (257), Expect = 5e-25
 Identities = 64/279 (22%), Positives = 113/279 (40%), Gaps = 71/279 (25%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           F E  +IG GG G+V+K +  + G    +KR+  ++E   RE    V +L +L H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68

Query: 173 LRG---------------WCKKEKESLILIYDYMENGSLDKWIFEC-----DESIALSWE 212
             G                 + + + L +  ++ + G+L++WI +      D+ +AL   
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL- 127

Query: 213 QRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV-- 270
                 + +  G+ Y++     K+++RD+K SN+ L      ++GDFGL     +     
Sbjct: 128 -----FEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179

Query: 271 --------MSGRRP-IEEGKR--NLVDRMWSL--------------TERSELLSVLDERL 305
                   MS   P     +     VD +++L               E S+  + L    
Sbjct: 180 RSKGTLRYMS---PEQISSQDYGKEVD-LYALGLILAELLHVCDTAFETSKFFTDL-RDG 234

Query: 306 KAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKML 344
                +  +  EK L   LL   PE   RP   ++L+ L
Sbjct: 235 IISDIFDKK--EKTLLQKLLSKKPE--DRPNTSEILRTL 269

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  102 bits (256), Expect = 1e-24
 Identities = 37/164 (22%), Positives = 63/164 (38%), Gaps = 9/164 (5%)

Query: 106 QEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLG 163
             +    K +     +G GG   V   + L  G   ALKRI    +    E   E     
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81

Query: 164 RLKHRNLVGLRGWCKKEKES---LILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLK 219
              H N++ L  +C +E+ +     L+  + + G+L   I    +      E +I  +L 
Sbjct: 82  LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141

Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +  G+  ++        HRD+K +N+LL  +    L D G   
Sbjct: 142 GICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  102 bits (257), Expect = 1e-24
 Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 19/154 (12%)

Query: 120 VIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRG 175
            IG G  GK    +    G +  +K I++   S     E   EV+ L  +KH N+V  R 
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFEC-----DESIALSWEQRIKVLKDVASGILYLYE 230
              +E  SL ++ DY E G L K I         E   L W         +   + ++++
Sbjct: 91  -SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVHD 143

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
               K+LHRDIK+ N+ L K    +LGDFG+A++
Sbjct: 144 ---RKILHRDIKSQNIFLTKDGTVQLGDFGIARV 174

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  101 bits (253), Expect = 1e-24
 Identities = 52/255 (20%), Positives = 95/255 (37%), Gaps = 37/255 (14%)

Query: 120 VIGLGGNGKVYKG--QLLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRG 175
            IG G    VYKG      VEVA   +     ++   + F  E   L  L+H N+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 176 -W--CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
            W    K K+ ++L+ + M +G+L  ++        +  +      + +  G+ +L+   
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR- 148

Query: 233 ESKVLHRDIKASNVLLDKKM-NARLGDFGLAKMHHHGQVMSGRR------P--IEEGKRN 283
              ++HRD+K  N+ +     + ++GD GLA +       +         P   EE    
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDE 208

Query: 284 LVDRMWSL--------TER---SELLSVLDERLKAKGGYADEVVEKVLHLGL-----LCA 327
            VD +++         T     SE  +      +   G      +KV    +      C 
Sbjct: 209 SVD-VYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267

Query: 328 HPEANSRPTIRQVLK 342
               + R +I+ +L 
Sbjct: 268 RQNKDERYSIKDLLN 282

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  104 bits (261), Expect = 2e-24
 Identities = 50/242 (20%), Positives = 90/242 (37%), Gaps = 21/242 (8%)

Query: 29  SIGDALVTTHLPSFELPKDSVFRSKGFILGVSVGGLLIMGCGVVVYMVCLKRKGKKMKDV 88
           S          P+      ++   +  I  ++  G       +                 
Sbjct: 257 SSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFE 316

Query: 89  EETED-WELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLG----VEVALKR 143
               D  EL+                    +  +G G  G V +G        ++VA+K 
Sbjct: 317 SPFSDPEELK----DKKLFLKRDNLL--IADIELGCGNFGSVRQGVYRMRKKQIDVAIKV 370

Query: 144 ISLDSEHGMR-EFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFE 202
           +   +E     E + E   + +L +  +V L G C  + E+L+L+ +    G L K++  
Sbjct: 371 LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVG 428

Query: 203 CDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLHRDIKASNVLLDKKMNARLGDFGL 261
             E   +      ++L  V+ G+ YL    E K  +HR++ A NVLL  +  A++ DFGL
Sbjct: 429 KREE--IPVSNVAELLHQVSMGMKYL----EEKNFVHRNLAARNVLLVNRHYAKISDFGL 482

Query: 262 AK 263
           +K
Sbjct: 483 SK 484

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  101 bits (253), Expect = 3e-24
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 10/156 (6%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRN 169
           F  E  IG G   +VY+   L  GV VALK++ +          + + E+  L +L H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYL 228
           ++        E   L ++ +  + G L + I    +   L  E+ + K    + S + ++
Sbjct: 94  VIKYYASFI-EDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           +     +V+HRDIK +NV +      +LGD GL + 
Sbjct: 153 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF 185

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  100 bits (252), Expect = 3e-24
 Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 25/182 (13%)

Query: 89  EETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLG-----VEVALKR 143
           +  +   +      V + E            VIG G  G VY G LL      +  A+K 
Sbjct: 13  QAVQHVVIGPSSLIVHFNE------------VIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60

Query: 144 ISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFE 202
           ++       + +FL E   +    H N++ L G C + + S +++  YM++G L  +I  
Sbjct: 61  LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120

Query: 203 CDESIALSWEQRIKVLKDVASGILYLYEGWES-KVLHRDIKASNVLLDKKMNARLGDFGL 261
              +   + +  I     VA G+ YL     S K +HRD+ A N +LD+K   ++ DFGL
Sbjct: 121 ETHN--PTVKDLIGFGLQVAKGMKYL----ASKKFVHRDLAARNCMLDEKFTVKVADFGL 174

Query: 262 AK 263
           A+
Sbjct: 175 AR 176

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  100 bits (252), Expect = 4e-24
 Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 16/155 (10%)

Query: 118 ENVIGLGGNGKVYKGQLLG------VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNL 170
             V+G G  G VYKG  +       + VA+K +    S    +E L E   +  + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
             L G C     ++ LI   M  G L  ++ E  ++I    +  +     +A G+ YL  
Sbjct: 80  CRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYL-- 133

Query: 231 GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKM 264
             E + ++HRD+ A NVL+    + ++ DFGLAK+
Sbjct: 134 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 99.6 bits (249), Expect = 5e-24
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 14/153 (9%)

Query: 117 EENVIGLGGNGKVYKGQLLG----VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
            +  +G G  G V +G        ++VA+K +     +    E + E   + +L +  +V
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G C  + E+L+L+ +    G L K++    E   +      ++L  V+ G+ YL   
Sbjct: 74  RLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL--- 126

Query: 232 WESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
            E K  +HRD+ A NVLL  +  A++ DFGL+K
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 99.6 bits (249), Expect = 6e-24
 Identities = 46/154 (29%), Positives = 77/154 (50%), Gaps = 16/154 (10%)

Query: 117 EENVIGLGGNGKVYKGQLLG----VEVALK--RISLDSEHGMREFLAEVSSLGRLKHRNL 170
           E+  +G G  G V KG          VA+K  +   +      E LAE + + +L +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
           V + G C  E ES +L+ +  E G L+K++ +      +  +  I+++  V+ G+ YL  
Sbjct: 81  VRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYL-- 133

Query: 231 GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
             E    +HRD+ A NVLL  +  A++ DFGL+K
Sbjct: 134 --EESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  100 bits (252), Expect = 7e-24
 Identities = 51/184 (27%), Positives = 82/184 (44%), Gaps = 29/184 (15%)

Query: 89  EETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLG-----VEVA--- 140
           +  +   +      V + E            VIG G  G VY G LL      +  A   
Sbjct: 77  QAVQHVVIGPSSLIVHFNE------------VIGRGHFGCVYHGTLLDNDGKKIHCAVKS 124

Query: 141 LKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWI 200
           L RI+   E  + +FL E   +    H N++ L G C + + S +++  YM++G L  +I
Sbjct: 125 LNRITDIGE--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182

Query: 201 FECDESIALSWEQRIKVLKDVASGILYLYEGWES-KVLHRDIKASNVLLDKKMNARLGDF 259
                +  +  +  I     VA G+ +L     S K +HRD+ A N +LD+K   ++ DF
Sbjct: 183 RNETHNPTV--KDLIGFGLQVAKGMKFL----ASKKFVHRDLAARNCMLDEKFTVKVADF 236

Query: 260 GLAK 263
           GLA+
Sbjct: 237 GLAR 240

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 99.7 bits (249), Expect = 7e-24
 Identities = 45/187 (24%), Positives = 75/187 (40%), Gaps = 28/187 (14%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           F E  V+G G  G+V K +  L     A+K+I    E  +   L+EV  L  L H+ +V 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66

Query: 173 LRG-WCKKE-----------KESLILIYDYMENGSLDKWI----FECDESIALSWEQRIK 216
               W ++            K +L +  +Y ENG+L   I                    
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL----- 121

Query: 217 VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRP 276
             + +   + Y++      ++HRD+K  N+ +D+  N ++GDFGLAK  H    +     
Sbjct: 122 -FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 277 IEEGKRN 283
                 +
Sbjct: 178 QNLPGSS 184

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 8/160 (5%)

Query: 120 VIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRG 175
            IG G  G+  K +    G  +  K +     +E   +  ++EV+ L  LKH N+V    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 176 -WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYLYE--G 231
               +   +L ++ +Y E G L   I +  +      E+ + +V+  +   +   +    
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
               VLHRD+K +NV LD K N +LGDFGLA++ +H    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 46/156 (29%), Positives = 70/156 (44%), Gaps = 17/156 (10%)

Query: 118 ENVIGLGGNGKVYKGQLLG-----VEVA---LKRISLDSEHGMREFLAEVSSLGRLKHRN 169
              +G G  G V +G+        V VA   LK   L     M +F+ EV+++  L HRN
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           L+ L G        + ++ +    GSL   + +      L      +    VA G+ YL 
Sbjct: 83  LIRLYGVV--LTPPMKMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYL- 137

Query: 230 EGWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKM 264
              ESK  +HRD+ A N+LL  +   ++GDFGL + 
Sbjct: 138 ---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 16/194 (8%)

Query: 77  CLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLG 136
             + K  + +   E   +E      R   +EI A       E +IG G +G+V  G+L  
Sbjct: 15  YFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEA--SRIHIEKIIGSGDSGEVCYGRLRV 72

Query: 137 -----VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY 190
                V VA+K +    +E   R+FL+E S +G+  H N++ L G   +     +++ +Y
Sbjct: 73  PGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG-RLAMIVTEY 131

Query: 191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK-VLHRDIKASNVLLD 249
           MENGSLD ++   D     +  Q + +L+ V +G+ YL         +HRD+ A NVL+D
Sbjct: 132 MENGSLDTFLRTHDGQ--FTIMQLVGMLRGVGAGMRYL----SDLGYVHRDLAARNVLVD 185

Query: 250 KKMNARLGDFGLAK 263
             +  ++ DFGL++
Sbjct: 186 SNLVCKVSDFGLSR 199

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 97.0 bits (242), Expect = 5e-23
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 14/154 (9%)

Query: 118 ENVIGLGGNGKVYKGQLLG------VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
              +G G  G V   +           VA+K++   +E  +R+F  E+  L  L+H N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 172 GLRGWC-KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
             +G C    + +L LI +Y+  GSL  ++ +  E I     + ++    +  G+ YL  
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICKGMEYL-- 130

Query: 231 GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
              +K  +HRD+   N+L++ +   ++GDFGL K
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTK 162

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 97.1 bits (242), Expect = 8e-23
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 14/154 (9%)

Query: 118 ENVIGLGGNGKVYKGQLLG------VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
              +G G  G V   +           VA+K++   +E  +R+F  E+  L  L+H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 172 GLRGWC-KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
             +G C    + +L LI +Y+  GSL  ++ +  E I     + ++    +  G+ YL  
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICKGMEYL-- 161

Query: 231 GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
              +K  +HRD+   N+L++ +   ++GDFGL K
Sbjct: 162 --GTKRYIHRDLATRNILVENENRVKIGDFGLTK 193

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 16/154 (10%)

Query: 118 ENVIGLGGNGKVYKGQLLG------VEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNL 170
             V+G G  G VYKG  +       + VA+K +   +     +E L E   +  + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
             L G C     ++ LI   M  G L  ++ E  ++I    +  +     +A G+ YL  
Sbjct: 80  CRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYL-- 133

Query: 231 GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
             E + ++HRD+ A NVL+    + ++ DFGLAK
Sbjct: 134 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 15/155 (9%)

Query: 118 ENVIGLGGNGKVYKGQLL------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNL 170
              +G G  GKV   +        G +VA+K +  +   + + +   E+  L  L H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 171 VGLRGWC-KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           V  +G C +     + LI +++ +GSL +++ +    I L   Q++K    +  G+ YL 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLK--QQLKYAVQICKGMDYL- 142

Query: 230 EGWESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
               S+  +HRD+ A NVL++ +   ++GDFGL K
Sbjct: 143 ---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 95.0 bits (237), Expect = 2e-22
 Identities = 50/148 (33%), Positives = 74/148 (50%), Gaps = 10/148 (6%)

Query: 118 ENVIGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
              +G G  G V  G+  G  +VA+K I   S     EF+ E   +  L H  LV L G 
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK- 235
           C K++   I I +YM NG L  ++ E         +Q +++ KDV   + YL    ESK 
Sbjct: 88  CTKQRPIFI-ITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYL----ESKQ 140

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAK 263
            LHRD+ A N L++ +   ++ DFGL++
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSR 168

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 11/150 (7%)

Query: 118 ENVIGLGGNGKVYKGQLLG--VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLR 174
              IG G  G+V+ G+L      VA+K            +FL E   L +  H N+V L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
           G C +++   I + + ++ G    ++        L  +  ++++ D A+G+ YL    ES
Sbjct: 179 GVCTQKQPIYI-VMELVQGGDFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYL----ES 231

Query: 235 K-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
           K  +HRD+ A N L+ +K   ++ DFG+++
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSR 261

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 94.6 bits (236), Expect = 3e-22
 Identities = 46/152 (30%), Positives = 81/152 (53%), Gaps = 10/152 (6%)

Query: 118 ENVIGLGGNGKVYKGQLLG--VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
           ++ +G G  G+VY+G      + VA+K +  D+   + EFL E + +  +KH NLV L G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
            C +E    I I ++M  G+L  ++ EC+    +S    + +   ++S + YL    E K
Sbjct: 77  VCTREPPFYI-ITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL----EKK 130

Query: 236 -VLHRDIKASNVLLDKKMNARLGDFGLAKMHH 266
             +HRD+ A N L+ +    ++ DFGL+++  
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 96.3 bits (240), Expect = 3e-22
 Identities = 50/154 (32%), Positives = 86/154 (55%), Gaps = 14/154 (9%)

Query: 118 ENVIGLGGNGKVYKGQLLG-----VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
           + V+G G  G+V  G+L       + VA+K + +  +E   R+FL E S +G+  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G   K K  +I+  +YMENGSLD ++ + D     +  Q + +L+ +ASG+ YL   
Sbjct: 110 RLEGVVTKSKPVMIVT-EYMENGSLDSFLRKHDAQ--FTVIQLVGMLRGIASGMKYL--- 163

Query: 232 WESK-VLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                 +HRD+ A N+L++  +  ++ DFGL ++
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 94.6 bits (236), Expect = 4e-22
 Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 15/153 (9%)

Query: 118 ENVIGLGGNGKVYKGQLLG-----VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
             ++G G  G+VY+G         + VA+K    D +     +F++E   +  L H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G    E+E   +I +    G L  ++     S+ +     +     +   + YL   
Sbjct: 77  KLIGII--EEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQICKAMAYL--- 129

Query: 232 WESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
            ES   +HRDI   N+L+      +LGDFGL++
Sbjct: 130 -ESINCVHRDIAVRNILVASPECVKLGDFGLSR 161

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 96.7 bits (241), Expect = 4e-22
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 10/148 (6%)

Query: 118 ENVIGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           E  +G G  G+V+        +VA+K +   S   +  FLAE + +  L+H  LV L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK- 235
               KE + +I ++M  GSL  ++   + S      + I     +A G+ ++    E + 
Sbjct: 252 V--TKEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI----EQRN 304

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +HRD++A+N+L+   +  ++ DFGLA+
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLAR 332

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 94.2 bits (235), Expect = 4e-22
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 15/153 (9%)

Query: 118 ENVIGLGGNGKVYKGQLLG-----VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
              IG G  G V++G  +      + VA+K      S+    +FL E  ++ +  H ++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G     +  + +I +    G L  ++     S+ L+    I     +++ + YL   
Sbjct: 80  KLIGVI--TENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYL--- 132

Query: 232 WESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
            ESK  +HRDI A NVL+      +LGDFGL++
Sbjct: 133 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 94.3 bits (235), Expect = 4e-22
 Identities = 37/164 (22%), Positives = 76/164 (46%), Gaps = 25/164 (15%)

Query: 118 ENVIGLGGNGKVYKGQLLG---------VEVALKRISLDSEHGMREFLAEVSSLGRLKHR 168
              +G G   K++KG              EV LK +     +    F    S + +L H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           +LV   G C    E+++ + ++++ GSLD ++ +    I + W+  ++V K +A+ + +L
Sbjct: 73  HLVLNYGVCVCGDENIL-VQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFL 129

Query: 229 YEGWESK-VLHRDIKASNVLLDKKMNAR--------LGDFGLAK 263
               E   ++H ++ A N+LL ++ + +        L D G++ 
Sbjct: 130 ----EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 95.1 bits (237), Expect = 5e-22
 Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 14/154 (9%)

Query: 118 ENVIGLGGNGKVYKGQLLG------VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLV 171
            + +G G  G V   +           VA+K++        R+F  E+  L  L    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 172 GLRGWCKKEK-ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
             RG       +SL L+ +Y+ +G L  ++      +  S  + +     +  G+ YL  
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYL-- 143

Query: 231 GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
              S+  +HRD+ A N+L++ + + ++ DFGLAK
Sbjct: 144 --GSRRCVHRDLAARNILVESEAHVKIADFGLAK 175

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 93.8 bits (234), Expect = 5e-22
 Identities = 41/148 (27%), Positives = 70/148 (47%), Gaps = 10/148 (6%)

Query: 118 ENVIGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
              IG G  G V+ G  L   +VA+K I   +     +F+ E   + +L H  LV L G 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK- 235
           C ++    + + ++ME+G L  ++         + E  + +  DV  G+ YL    E   
Sbjct: 72  CLEQAPICL-VTEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYL----EEAC 124

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAK 263
           V+HRD+ A N L+ +    ++ DFG+ +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTR 152

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 94.7 bits (236), Expect = 7e-22
 Identities = 52/155 (33%), Positives = 88/155 (56%), Gaps = 15/155 (9%)

Query: 118 ENVIGLGGNGKVYKGQLLG------VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNL 170
           + VIG G  G+VYKG L        V VA+K +    +E    +FL E   +G+  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
           + L G   K  + +++I +YMENG+LDK++ E D     S  Q + +L+ +A+G+ YL  
Sbjct: 109 IRLEGVISKY-KPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKYL-- 163

Query: 231 GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAKM 264
              +   +HRD+ A N+L++  +  ++ DFGL+++
Sbjct: 164 --ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 96.5 bits (240), Expect = 8e-22
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 10/154 (6%)

Query: 118 ENVIGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           E  +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAV 330

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK- 235
             +E   + ++ +YM  GSL  ++        L   Q + +   +ASG+ Y+    E   
Sbjct: 331 VSEE--PIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYV----ERMN 383

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
            +HRD++A+N+L+ + +  ++ DFGLA++    +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 96.0 bits (239), Expect = 8e-22
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 10/154 (6%)

Query: 118 ENVIGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           E  +G G  G+V+ G   G   VA+K +   +      FL E   + +L+H  LV L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAV 247

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK- 235
             +E   + ++ +YM  GSL  ++        L   Q + +   +ASG+ Y+    E   
Sbjct: 248 VSEE--PIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYV----ERMN 300

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
            +HRD++A+N+L+ + +  ++ DFGLA++    +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 93.5 bits (233), Expect = 9e-22
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 17/156 (10%)

Query: 117 EENVIGLGGNGKVYKGQLLG-----VEVA---LKRISLDSEHGMREFLAEVSSLGRLKHR 168
            + VIG G  G VY G+ +      ++ A   L RI+   +  +  FL E   +  L H 
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ--VEAFLREGLLMRGLNHP 82

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
           N++ L G     +    ++  YM +G L ++I     +  +     I     VA G+ YL
Sbjct: 83  NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK--DLISFGLQVARGMEYL 140

Query: 229 YEGWES-KVLHRDIKASNVLLDKKMNARLGDFGLAK 263
                  K +HRD+ A N +LD+    ++ DFGLA+
Sbjct: 141 ----AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 93.0 bits (232), Expect = 9e-22
 Identities = 45/148 (30%), Positives = 72/148 (48%), Gaps = 10/148 (6%)

Query: 118 ENVIGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
              +G G  G V  G+  G  +VA+K I   S     EF  E  ++ +L H  LV   G 
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK- 235
           C KE    I + +Y+ NG L  ++    +   L   Q +++  DV  G+ +L    ES  
Sbjct: 72  CSKEYPIYI-VTEYISNGCLLNYLRSHGKG--LEPSQLLEMCYDVCEGMAFL----ESHQ 124

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +HRD+ A N L+D+ +  ++ DFG+ +
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTR 152

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 41/154 (26%), Positives = 69/154 (44%), Gaps = 16/154 (10%)

Query: 118 ENVIGLGGNGKVYKGQLLG------VEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNL 170
             V+G G  G V+KG  +       + V +K I   S     +     + ++G L H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
           V L G C     SL L+  Y+  GSL   + +   ++    +  +     +A G+ YL  
Sbjct: 78  VRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYL-- 131

Query: 231 GWESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
             E   ++HR++ A NVLL      ++ DFG+A 
Sbjct: 132 --EEHGMVHRNLAARNVLLKSPSQVQVADFGVAD 163

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 40/157 (25%), Positives = 66/157 (42%), Gaps = 16/157 (10%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLD--SEHGMREFLAEVSSLGRL-KHRN 169
           F   + +G G  G+V+K +    G   A+KR              LAEV S  ++ +H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118

Query: 170 LVGLRG-WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGILY 227
            V L   W  +E   L L  +     SL +       S+    E ++   L+D    + +
Sbjct: 119 CVRLEQAW--EEGGILYLQTELCG-PSLQQHCEAWGASLP---EAQVWGYLRDTLLALAH 172

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           L+      ++H D+K +N+ L  +   +LGDFGL   
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 43/148 (29%), Positives = 80/148 (54%), Gaps = 10/148 (6%)

Query: 118 ENVIGLGGNGKVYKGQLLG-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
              +G G  G+V+ G   G  +VA+K +   S      FLAE + + +L+H+ LV L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK- 235
               +E + +I +YMENGSL  ++        L+  + + +   +A G+ ++    E + 
Sbjct: 77  V--TQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI----EERN 129

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAK 263
            +HRD++A+N+L+   ++ ++ DFGLA+
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLAR 157

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 46/190 (24%), Positives = 84/190 (44%), Gaps = 33/190 (17%)

Query: 89  EETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLG-----VEVALKR 143
            + ED  ++   + +   +            ++G G  G V +G L       ++VA+K 
Sbjct: 24  NKLEDVVID--RNLLILGK------------ILGEGEFGSVMEGNLKQEDGTSLKVAVKT 69

Query: 144 ISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE----KESLILIYDYMENGSLD 197
           + LD  S+  + EFL+E + +    H N++ L G C +         ++I  +M+ G L 
Sbjct: 70  MKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLH 129

Query: 198 KWIFEC---DESIALSWEQRIKVLKDVASGILYLYEGWES-KVLHRDIKASNVLLDKKMN 253
            ++           +  +  +K + D+A G+ YL     +   LHRD+ A N +L   M 
Sbjct: 130 TYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL----SNRNFLHRDLAARNCMLRDDMT 185

Query: 254 ARLGDFGLAK 263
             + DFGL+K
Sbjct: 186 VCVADFGLSK 195

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 19/153 (12%)

Query: 120 VIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
           V+G G  G VY G+ L   V +A+K I        +    E++    LKH+N+V   G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG-S 87

Query: 178 KKEKESLILIYDYMENGSLDKWI------FECDESIALSWEQRIKVLKDVASGILYLYEG 231
             E   + +  + +  GSL   +       + +E     +       K +  G+ YL++ 
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY------TKQILEGLKYLHD- 140

Query: 232 WESKVLHRDIKASNVLLDKKM-NARLGDFGLAK 263
             ++++HRDIK  NVL++      ++ DFG +K
Sbjct: 141 --NQIVHRDIKGDNVLINTYSGVLKISDFGTSK 171

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 94.5 bits (235), Expect = 3e-21
 Identities = 45/152 (29%), Positives = 81/152 (53%), Gaps = 10/152 (6%)

Query: 118 ENVIGLGGNGKVYKGQLLG--VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
           ++ +G G  G+VY+G      + VA+K +  D+   + EFL E + +  +KH NLV L G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
            C +E    I I ++M  G+L  ++ EC+    +S    + +   ++S + YL    E K
Sbjct: 284 VCTREPPFYI-ITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYL----EKK 337

Query: 236 -VLHRDIKASNVLLDKKMNARLGDFGLAKMHH 266
             +HR++ A N L+ +    ++ DFGL+++  
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 92.4 bits (230), Expect = 4e-21
 Identities = 42/191 (21%), Positives = 81/191 (42%), Gaps = 34/191 (17%)

Query: 89  EETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLG-----VEVALK- 142
           E+ ED  +     + +               ++G G  G V + QL       V+VA+K 
Sbjct: 13  EKLEDVLIP--EQQFTLGR------------MLGKGEFGSVREAQLKQEDGSFVKVAVKM 58

Query: 143 -RISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-----KESLILIYDYMENGSL 196
            +  + +   + EFL E + +    H ++  L G   +          ++I  +M++G L
Sbjct: 59  LKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDL 118

Query: 197 DKWIFEC---DESIALSWEQRIKVLKDVASGILYLYEGWES-KVLHRDIKASNVLLDKKM 252
             ++      +    L  +  ++ + D+A G+ YL     S   +HRD+ A N +L + M
Sbjct: 119 HAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYL----SSRNFIHRDLAARNCMLAEDM 174

Query: 253 NARLGDFGLAK 263
              + DFGL++
Sbjct: 175 TVCVADFGLSR 185

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 94.2 bits (234), Expect = 5e-21
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 15/153 (9%)

Query: 118 ENVIGLGGNGKVYKGQLLG-----VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
              IG G  G V++G  +      + VA+K      S+    +FL E  ++ +  H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G     +  + +I +    G L  ++     S+ L+    I     +++ + YL   
Sbjct: 455 KLIGVI--TENPVWIIMELCTLGELRSFLQVRKFSLDLA--SLILYAYQLSTALAYL--- 507

Query: 232 WESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
            ESK  +HRDI A NVL+      +LGDFGL++
Sbjct: 508 -ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 91.2 bits (227), Expect = 5e-21
 Identities = 46/185 (24%), Positives = 72/185 (38%), Gaps = 31/185 (16%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLD--SEHGMREFLAEVSSLGRL-KHRN 169
           F E   IG G  G V+K    L G   A+KR           +  L EV +   L +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 170 LVGLRG-WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGILY 227
           +V     W   E + +++  +Y   GSL   I E    ++   E  +K  L  V  G+ Y
Sbjct: 73  VVRYFSAW--AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130

Query: 228 LYEGWESKVLHRDIKASNVLLDK-------------------KMNARLGDFGLAKMHHHG 268
           ++      ++H DIK SN+ + +                   K+  ++GD G        
Sbjct: 131 IHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP 187

Query: 269 QVMSG 273
           QV  G
Sbjct: 188 QVEEG 192

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 91.5 bits (228), Expect = 6e-21
 Identities = 54/162 (33%), Positives = 81/162 (50%), Gaps = 27/162 (16%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHG-----MREFLAEVSSLGRLKH 167
           F +   +G G    VYKG     GV VALK + LDSE G     +RE    +S +  LKH
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKH 62

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVAS---- 223
            N+V L       +  L L++++M+N  L K++    +S  +    R   L  V      
Sbjct: 63  ENIVRLYDVIH-TENKLTLVFEFMDN-DLKKYM----DSRTVGNTPRGLELNLVKYFQWQ 116

Query: 224 ---GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
              G+ + +E     +LHRD+K  N+L++K+   +LGDFGLA
Sbjct: 117 LLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 91.5 bits (228), Expect = 7e-21
 Identities = 50/157 (31%), Positives = 83/157 (52%), Gaps = 20/157 (12%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHG-----MREFLAEVSSLGRLKH 167
           + + + +G G    VYKG+       VALK I L+ E G     +RE    VS L  LKH
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKH 59

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGIL 226
            N+V L       ++SL L+++Y++   L +++ +C   I +     +K+ L  +  G+ 
Sbjct: 60  ANIVTLHDIIH-TEKSLTLVFEYLDK-DLKQYLDDCGNIINMH---NVKLFLFQLLRGLA 114

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           Y +      VLHRD+K  N+L++++   +L DFGLA+
Sbjct: 115 YCHRQK---VLHRDLKPQNLLINERGELKLADFGLAR 148

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 91.2 bits (227), Expect = 8e-21
 Identities = 42/151 (27%), Positives = 76/151 (50%), Gaps = 10/151 (6%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +     +G G  GKVYK +    G   A K I   SE  + +++ E+  L    H  +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGILYLYEG 231
           L G    + +  I+I ++   G++D  + E D  +    E +I+ V + +   + +L+  
Sbjct: 81  LLGAYYHDGKLWIMI-EFCPGGAVDAIMLELDRGLT---EPQIQVVCRQMLEALNFLHS- 135

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
              +++HRD+KA NVL+  + + RL DFG++
Sbjct: 136 --KRIIHRDLKAGNVLMTLEGDIRLADFGVS 164

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 90.0 bits (224), Expect = 1e-20
 Identities = 46/167 (27%), Positives = 72/167 (43%), Gaps = 27/167 (16%)

Query: 118 ENVIGLGGNGKVYKGQLLG-------VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRN 169
              +G    GKVYKG L G         VA+K +          EF  E     RL+H N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKW-------------IFECDESIALSWEQRIK 216
           +V L G   K+ + L +I+ Y  +G L ++               +     AL     + 
Sbjct: 74  VVCLLGVVTKD-QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 217 VLKDVASGILYLYEGWES-KVLHRDIKASNVLLDKKMNARLGDFGLA 262
           ++  +A+G+ YL     S  V+H+D+   NVL+  K+N ++ D GL 
Sbjct: 133 LVAQIAAGMEYL----SSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 41/164 (25%), Positives = 77/164 (46%), Gaps = 23/164 (14%)

Query: 118 ENVIGLGGNGKVYKGQLLGVE-------VALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           +  +G G  GKV+  +   +        VA+K +   SE   ++F  E   L  L+H+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKW------------IFECDESIALSWEQRIKVL 218
           V   G C +    L+++++YM +G L+++              E      L   Q + V 
Sbjct: 106 VRFFGVCTEG-RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             VA+G++YL        +HRD+   N L+ + +  ++GDFG++
Sbjct: 165 SQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 46/162 (28%), Positives = 82/162 (50%), Gaps = 31/162 (19%)

Query: 119 NVIGLGGNGKVYKGQLL--GVEVALKRISLDSEH------GMREFLAEVSSLGRLKHRNL 170
             IG G  G+V+K +    G +VALK++ +++E        +RE    +  L  LKH N+
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE----IKILQLLKHENV 78

Query: 171 VGLRG-------WCKKEKESLILIYDYMEN---GSLDKWIFECDESIALSWEQRIKVLKD 220
           V L            + K S+ L++D+ E+   G L       +  +  +  +  +V++ 
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------NVLVKFTLSEIKRVMQM 132

Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           + +G+ Y++      +LHRD+KA+NVL+ +    +L DFGLA
Sbjct: 133 LLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 89.5 bits (223), Expect = 2e-20
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 21/158 (13%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEH------GMREFLAEVSSLGRLK 166
           + +   IG G  G V+K +       VALKR+ LD +        +RE    +  L  LK
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKELK 59

Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGI 225
           H+N+V L        + L L++++ +   L K+   C+  +       +K  L  +  G+
Sbjct: 60  HKNIVRLHD-VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPE---IVKSFLFQLLKGL 114

Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            + +      VLHRD+K  N+L+++    +L +FGLA+
Sbjct: 115 GFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 29/168 (17%)

Query: 118 ENVIGLGGNGKVYKGQLLG----VEVA---LKRISLDSEHGMREFLAEVSSLGRL-KHRN 169
           ++VIG G  G+V K ++      ++ A   +K  +   +H  R+F  E+  L +L  H N
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPN 87

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKW-------------IFECDESIALSWEQRIK 216
           ++ L G C+     L L  +Y  +G+L  +                   +  LS +Q + 
Sbjct: 88  IINLLGACEHR-GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146

Query: 217 VLKDVASGILYLYEGWESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
              DVA G+ YL      K  +HRD+ A N+L+ +   A++ DFGL++
Sbjct: 147 FAADVARGMDYL----SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 21/157 (13%)

Query: 118 ENVIGLGGNGKVYKGQL------LGVEVALKRISLDSEHG---MREFLAEVSSLGRLKHR 168
              +G G  GKV            G  VA+K  +L ++ G      +  E+  L  L H 
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK--ALKADAGPQHRSGWKQEIDILRTLYHE 93

Query: 169 NLVGLRGWC-KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           +++  +G C      SL L+ +Y+  GSL  ++       ++   Q +   + +  G+ Y
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAY 149

Query: 228 LYEGWESK-VLHRDIKASNVLLDKKMNARLGDFGLAK 263
           L     ++  +HRD+ A NVLLD     ++GDFGLAK
Sbjct: 150 L----HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 89.4 bits (222), Expect = 4e-20
 Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 11/161 (6%)

Query: 120 VIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLA-EVSSLGRLKHRNLVGLRG- 175
           ++G G    V++G  +  G   A+K  +  S     +    E   L +L H+N+V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
             +      +LI ++   GSL   + E   +  L   + + VL+DV  G+ +L    E+ 
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RENG 132

Query: 236 VLHRDIKASNVLL----DKKMNARLGDFGLAKMHHHGQVMS 272
           ++HR+IK  N++     D +   +L DFG A+     +   
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 89.2 bits (222), Expect = 5e-20
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 20/157 (12%)

Query: 115 FSEENVIGLGGNGKVYKGQ-LLGVEVALKRISLDSEH------GMREFLAEVSSLGRLKH 167
           + +   +G G  G VYK +   G  VALKRI LD+E        +RE    +S L  L H
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE----ISLLKELHH 78

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGIL 226
            N+V L       +  L L++++ME   L K + E    +  S   +IK  L  +  G+ 
Sbjct: 79  PNIVSLID-VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS---QIKIYLYQLLRGVA 133

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           + ++     +LHRD+K  N+L++     +L DFGLA+
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 88.5 bits (220), Expect = 6e-20
 Identities = 44/178 (24%), Positives = 83/178 (46%), Gaps = 19/178 (10%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLV 171
           +  + VIG G    V          +VA+KRI+L+  +  M E L E+ ++ +  H N+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 172 GLRG-WCKKEKESLILIYDYMENGSLD---KWIFECDESIALSWEQRI--KVLKDVASGI 225
                +  K++  L L+   +  GS+    K I    E  +   ++     +L++V  G+
Sbjct: 77  SYYTSFVVKDE--LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIEEGKRN 283
            YL++   +  +HRD+KA N+LL +  + ++ DFG++       + +G        R 
Sbjct: 135 EYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS-----AFLATGGDITRNKVRK 184

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 88.4 bits (220), Expect = 7e-20
 Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 20/158 (12%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEH------GMREFLAEVSSLGRLK 166
           F +   IG G  G VYK +  L G  VALK+I LD+E        +RE    +S L  L 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELN 60

Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLD-KWIFECDESIALSWEQRIKVLKDVASGI 225
           H N+V L       +  L L+++++     D K   +      +        L  +  G+
Sbjct: 61  HPNIVKLLDVIH-TENKLYLVFEFLH---QDLKKFMDASALTGIPLPLIKSYLFQLLQGL 116

Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            + +      VLHRD+K  N+L++ +   +L DFGLA+
Sbjct: 117 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 88.8 bits (221), Expect = 7e-20
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 16/157 (10%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMRE---FLA--EVSSLGRLKH 167
           + + + +G G    VYK +       VA+K+I L      ++     A  E+  L  L H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGIL 226
            N++GL       K ++ L++D+ME   L+  I +    +       IK  +     G+ 
Sbjct: 72  PNIIGLLD-AFGHKSNISLVFDFMET-DLEVIIKDNSLVLT---PSHIKAYMLMTLQGLE 126

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           YL++ W   +LHRD+K +N+LLD+    +L DFGLAK
Sbjct: 127 YLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 89.5 bits (222), Expect = 7e-20
 Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 11/161 (6%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLA-EVSSLGRLKHRNLVGLRG- 175
           ++G G    V++G+    G   A+K  +  S     +    E   L +L H+N+V L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
             +      +LI ++   GSL   + E   +  L   + + VL+DV  G+ +L    E+ 
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL---RENG 132

Query: 236 VLHRDIKASNVLL----DKKMNARLGDFGLAKMHHHGQVMS 272
           ++HR+IK  N++     D +   +L DFG A+     +   
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV 173

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 88.5 bits (220), Expect = 7e-20
 Identities = 43/195 (22%), Positives = 79/195 (40%), Gaps = 37/195 (18%)

Query: 86  KDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVE------- 138
            DV   ++WE+     +++                +G G  G VY+G   GV        
Sbjct: 12  ADVYVPDEWEVA--REKITMSR------------ELGQGSFGMVYEGVAKGVVKDEPETR 57

Query: 139 VA---LKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS 195
           VA   +   +   E    EFL E S +      ++V L G   +  +  ++I + M  G 
Sbjct: 58  VAIKTVNEAASMRER--IEFLNEASVMKEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGD 114

Query: 196 LDKWIFEC-------DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL 248
           L  ++                S  + I++  ++A G+ YL     +K +HRD+ A N ++
Sbjct: 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMV 171

Query: 249 DKKMNARLGDFGLAK 263
            +    ++GDFG+ +
Sbjct: 172 AEDFTVKIGDFGMTR 186

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 21/164 (12%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEH-GMREF----LAEVSSLGRLK- 166
           +     IG+G  G VYK +    G  VALK + + +   G        + EV+ L RL+ 
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70

Query: 167 --HRNLVGLR----GWCKKEKESLILIYDYMENGSLD-KWIFECDESIALSWEQRIKVLK 219
             H N+V L           +  + L++++++    D +   +      L  E    +++
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD---QDLRTYLDKAPPPGLPAETIKDLMR 127

Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
               G+ +L+      ++HRD+K  N+L+      +L DFGLA+
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 87.2 bits (217), Expect = 1e-19
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 20/157 (12%)

Query: 115 FSEENVIGLGGNGKVYKGQ-LLGVEVALKRISLDSEH------GMREFLAEVSSLGRLKH 167
           +     IG G  G VYK Q   G   ALK+I L+ E        +RE    +S L  LKH
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIRE----ISILKELKH 59

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGIL 226
            N+V L       K+ L+L++++++   L K +  C+  +        K  L  + +GI 
Sbjct: 60  SNIVKLYDVIH-TKKRLVLVFEHLDQ-DLKKLLDVCEGGLESV---TAKSFLLQLLNGIA 114

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           Y ++     VLHRD+K  N+L++++   ++ DFGLA+
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLAR 148

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 40/149 (26%), Positives = 75/149 (50%), Gaps = 13/149 (8%)

Query: 119 NVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLA--EVSSLGRLKHRNLVGLR 174
            ++G G  G V K +    G  VA+K+     +  M + +A  E+  L +L+H NLV L 
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGILYLYEGWE 233
             CKK+K    L+++++++ ++   +      +     Q ++  L  + +GI + +    
Sbjct: 91  EVCKKKK-RWYLVFEFVDH-TILDDLELFPNGLD---YQVVQKYLFQIINGIGFCHSHN- 144

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             ++HRDIK  N+L+ +    +L DFG A
Sbjct: 145 --IIHRDIKPENILVSQSGVVKLCDFGFA 171

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 89.4 bits (221), Expect = 2e-19
 Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 14/164 (8%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLA-EVSSLGRLKHRNLVGLR-- 174
            +G GG G V +      G +VA+K+   +     RE    E+  + +L H N+V  R  
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 175 ---GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
                     +  +L  +Y E G L K++ + +    L       +L D++S + YL   
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL--- 137

Query: 232 WESKVLHRDIKASNVLLDKK---MNARLGDFGLAKMHHHGQVMS 272
            E++++HRD+K  N++L      +  ++ D G AK    G++ +
Sbjct: 138 HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT 181

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 40/166 (24%), Positives = 76/166 (45%), Gaps = 26/166 (15%)

Query: 118 ENVIGLGGNGKVYKGQLLG-------VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL 170
           +  +G G  GKV+  +          + VA+K +   +    ++F  E   L  L+H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFEC-------------DESIALSWEQRIKV 217
           V   G C    + LI++++YM++G L+K++                     L   Q + +
Sbjct: 80  VKFYGVCGDG-DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 218 LKDVASGILYLYEGWES-KVLHRDIKASNVLLDKKMNARLGDFGLA 262
              +ASG++YL     S   +HRD+   N L+   +  ++GDFG++
Sbjct: 139 ASQIASGMVYL----ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 19/161 (11%)

Query: 118 ENVIGLGGNGKVYKGQLLG-------VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRN 169
              +G G  G+VY+GQ+ G       ++VA+K +    SE    +FL E   + +  H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGI 225
           +V   G   +      ++ + M  G L  ++ E      +  +L+    + V +D+A G 
Sbjct: 95  IVRCIGVSLQS-LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 226 LYLYEGWESKVLHRDIKASNVLLDKK---MNARLGDFGLAK 263
            YL    E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 154 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 87.1 bits (216), Expect = 3e-19
 Identities = 41/160 (25%), Positives = 71/160 (44%), Gaps = 10/160 (6%)

Query: 118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLR 174
             V+  GG   VY+ Q +  G E ALKR+  + E   R  + EV  + +L  H N+V   
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92

Query: 175 GWCKKEKESL------ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
                 KE         L+   +  G L +++ + +    LS +  +K+       + ++
Sbjct: 93  SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
           +   +  ++HRD+K  N+LL  +   +L DFG A    H 
Sbjct: 153 HRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 86.1 bits (214), Expect = 4e-19
 Identities = 37/149 (24%), Positives = 71/149 (47%), Gaps = 13/149 (8%)

Query: 119 NVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLA--EVSSLGRLKHRNLVGLR 174
             IG G  G V+K +    G  VA+K+     +  + + +A  E+  L +LKH NLV L 
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68

Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGILYLYEGWE 233
              ++++  L L+++Y ++ ++   +      +    E  +K +       + + ++   
Sbjct: 69  EVFRRKR-RLHLVFEYCDH-TVLHELDRYQRGVP---EHLVKSITWQTLQAVNFCHKHN- 122

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLA 262
              +HRD+K  N+L+ K    +L DFG A
Sbjct: 123 --CIHRDVKPENILITKHSVIKLCDFGFA 149

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 87.1 bits (216), Expect = 5e-19
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 19/161 (11%)

Query: 118 ENVIGLGGNGKVYKGQLLG-------VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRN 169
              +G G  G+VY+GQ+ G       ++VA+K +    SE    +FL E   + +  H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGI 225
           +V   G   +      ++ + M  G L  ++ E      +  +L+    + V +D+A G 
Sbjct: 136 IVRCIGVSLQS-LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 226 LYLYEGWESKVLHRDIKASNVLLDKK---MNARLGDFGLAK 263
            YL    E+  +HRDI A N LL        A++GDFG+A+
Sbjct: 195 QYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 86.1 bits (214), Expect = 6e-19
 Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 25/162 (15%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEH------GMREFLAEVSSLGRLK 166
           +     +G G  G+VYK    +    VA+KRI L+ E        +RE    VS L  L+
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE----VSLLKELQ 91

Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           HRN++ L+         L LI++Y EN  L K++   D++  +S       L  + +G+ 
Sbjct: 92  HRNIIELKSVIH-HNHRLHLIFEYAEN-DLKKYM---DKNPDVSMRVIKSFLYQLINGVN 146

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNAR-----LGDFGLAK 263
           + +       LHRD+K  N+LL     +      +GDFGLA+
Sbjct: 147 FCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 85.7 bits (213), Expect = 7e-19
 Identities = 41/166 (24%), Positives = 72/166 (43%), Gaps = 27/166 (16%)

Query: 115 FSEENVIGLGGNGKVYKG---QLLGVEVALKRISLDSEH------GMREFLAEVSSLGRL 165
           +     IG G  GKV+K    +  G  VALKR+ + +         +RE    V+ L  L
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE----VAVLRHL 68

Query: 166 K---HRNLVGLR----GWCKKEKESLILIYDYMENGSLD-KWIFECDESIALSWEQRIKV 217
           +   H N+V L           +  L L++++++    D     +      +  E    +
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD---QDLTTYLDKVPEPGVPTETIKDM 125

Query: 218 LKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +  +  G+ +L+      V+HRD+K  N+L+      +L DFGLA+
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 85.8 bits (213), Expect = 7e-19
 Identities = 71/298 (23%), Positives = 114/298 (38%), Gaps = 75/298 (25%)

Query: 119 NVIGLGGNGKVYKGQLLGVE-------VA---LKRISLDSEHGMREFLAEVSSLGRL-KH 167
             +G G  G+V +    G++       VA   LK  +  SE   R  ++E+  L  +  H
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGHH 90

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSL-------------DKWIFECDESIALSWEQR 214
            N+V L G C K    L++I ++ + G+L              K   E      L+ E  
Sbjct: 91  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150

Query: 215 IKVLKDVASGILYLYEGWES-KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM-- 271
           I     VA G+ +L     S K +HRD+ A N+LL +K   ++ DFGLA+  +       
Sbjct: 151 ICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206

Query: 272 --SGRRPI-----EEGKRNLVDRM-------WS------------------LTERSELLS 299
               R P+     E     + DR+       WS                  +    E   
Sbjct: 207 KGDARLPLKWMAPET----IFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262

Query: 300 VLDE--RLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLED 355
            L E  R++A      E+ +      L C H E + RPT  ++++ L    +    +D
Sbjct: 263 RLKEGTRMRAPDYTTPEMYQ----TMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQD 316

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 85.9 bits (213), Expect = 8e-19
 Identities = 50/192 (26%), Positives = 81/192 (42%), Gaps = 25/192 (13%)

Query: 78  LKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL-- 135
           L+R G + +D E     E          +E+H  T        +G G  G+V++ +    
Sbjct: 27  LQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ----PRVGRGSFGEVHRMKDKQT 82

Query: 136 GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS 195
           G + A+K++ L+        + E+ +   L    +V L G   +E   + +  + +E GS
Sbjct: 83  GFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYG-AVREGPWVNIFMELLEGGS 136

Query: 196 LDKWIFEC---DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK- 251
           L + I +     E  AL        L     G+ YL+     ++LH D+KA NVLL    
Sbjct: 137 LGQLIKQMGCLPEDRALY------YLGQALEGLEYLHT---RRILHGDVKADNVLLSSDG 187

Query: 252 MNARLGDFGLAK 263
             A L DFG A 
Sbjct: 188 SRAALCDFGHAL 199

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 85.5 bits (212), Expect = 8e-19
 Identities = 44/151 (29%), Positives = 80/151 (52%), Gaps = 12/151 (7%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           F     +G G  G VYK      G  VA+K++ ++S+  ++E + E+S + +    ++V 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-VLKDVASGILYLYEG 231
             G   K  + L ++ +Y   GS+   I   ++++    E  I  +L+    G+ YL+  
Sbjct: 89  YYGSYFKNTD-LWIVMEYCGAGSVSDIIRLRNKTLT---EDEIATILQSTLKGLEYLHF- 143

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
              + +HRDIKA N+LL+ + +A+L DFG+A
Sbjct: 144 --MRKIHRDIKAGNILLNTEGHAKLADFGVA 172

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 83.9 bits (208), Expect = 2e-18
 Identities = 38/150 (25%), Positives = 71/150 (47%), Gaps = 10/150 (6%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           ++    IG G +G VY    +  G EVA+++++L  +      + E+  +   K+ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
                    E L ++ +Y+  GSL   + E      +   Q   V ++    + +L+   
Sbjct: 82  YLDSYLVGDE-LWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS-- 134

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
            ++V+HRDIK+ N+LL    + +L DFG  
Sbjct: 135 -NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 40/156 (25%), Positives = 76/156 (48%), Gaps = 13/156 (8%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLV 171
           F    ++G G  G+VYKG+ +  G   A+K + +  +    E   E++ L +   HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIA 84

Query: 172 G-----LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
                 ++       + L L+ ++   GS+   + +  +   L  E    + +++  G+ 
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLS 143

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           +L++    KV+HRDIK  NVLL +    +L DFG++
Sbjct: 144 HLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 33/169 (19%), Positives = 73/169 (43%), Gaps = 18/169 (10%)

Query: 113 KGFSEENVIGLGGNGKVYKGQ-LLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRN 169
           + +S    IG GG+ KV++         A+K ++L+      +  +  E++ L +L+  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 170 L--VGLRGWCKKEKESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVASGI 225
              + L  +   ++     IY  ME  N  L+ W+    +  ++   +R    K++   +
Sbjct: 69  DKIIRLYDYEITDQY----IYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAV 121

Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGR 274
             +++     ++H D+K +N L+      +L DFG+A           +
Sbjct: 122 HTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVK 166

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 33/169 (19%), Positives = 73/169 (43%), Gaps = 18/169 (10%)

Query: 113 KGFSEENVIGLGGNGKVYKGQ-LLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRN 169
           + +S    IG GG+ KV++         A+K ++L+      +  +  E++ L +L+  +
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 170 L--VGLRGWCKKEKESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVASGI 225
              + L  +   ++     IY  ME  N  L+ W+    +  ++   +R    K++   +
Sbjct: 116 DKIIRLYDYEITDQY----IYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAV 168

Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGR 274
             +++     ++H D+K +N L+      +L DFG+A           +
Sbjct: 169 HTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK 213

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 10/150 (6%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
                 IG G  G V   +    G +VA+K + L  +        EV  +   +H N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
           +       +E L ++ ++++ G+L   + +      L+ EQ   V + V   + YL+   
Sbjct: 107 MYKSYLVGEE-LWVLMEFLQGGALTDIVSQVR----LNEEQIATVCEAVLQALAYLHA-- 159

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
              V+HRDIK+ ++LL      +L DFG  
Sbjct: 160 -QGVIHRDIKSDSILLTLDGRVKLSDFGFC 188

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 82.8 bits (205), Expect = 5e-18
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 17/154 (11%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLV 171
           F++   IG G  G+V+KG        VA+K I L+  E  + +   E++ L +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFEC--DES-IALSWEQRIKVLKDVASGILYL 228
              G    +   L +I +Y+  GS    +     DE+ IA        +L+++  G+ YL
Sbjct: 84  KYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT-------ILREILKGLDYL 135

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           +     K +HRDIKA+NVLL +    +L DFG+A
Sbjct: 136 HS---EKKIHRDIKAANVLLSEHGEVKLADFGVA 166

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 19/158 (12%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMRE-FLAEVSSLGRLKHRNLVGLRG 175
           +G GG  K ++          A K +      +   RE    E+S    L H+++VG  G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQRIKVLKDVASGILYLYEGW 232
              ++ + + ++ +     SL +         E      E R   L+ +  G  YL+   
Sbjct: 109 -FFEDNDFVFVVLELCRRRSLLELHKRRKALTE-----PEAR-YYLRQIVLGCQYLHR-- 159

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLA-KMHHHGQ 269
            ++V+HRD+K  N+ L++ +  ++GDFGLA K+ + G+
Sbjct: 160 -NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 82.2 bits (204), Expect = 9e-18
 Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 19/158 (12%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMRE-FLAEVSSLGRLKHRNLVGLRG 175
           +G GG  K ++          A K +      +   RE    E+S    L H+++VG  G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQRIKVLKDVASGILYLYEGW 232
              ++ + + ++ +     SL +         E      E R   L+ +  G  YL+   
Sbjct: 83  -FFEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----EAR-YYLRQIVLGCQYLHR-- 133

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLA-KMHHHGQ 269
            ++V+HRD+K  N+ L++ +  ++GDFGLA K+ + G+
Sbjct: 134 -NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 49/221 (22%), Positives = 88/221 (39%), Gaps = 44/221 (19%)

Query: 68  GCGVVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNG 127
                         G    ++ E   WEL     R+   +             +G G  G
Sbjct: 38  IPTTENLYFQGMLAGVSEYELPEDPRWELP--RDRLVLGK------------PLGEGAFG 83

Query: 128 KVYKGQLLG---------VEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGW 176
           +V   + +G          +VA+K +  D +E  + + ++E+  +  + KH+N++ L G 
Sbjct: 84  QVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143

Query: 177 CKKEKESLILIYDYMENGSL-------------DKWIFECDESIALSWEQRIKVLKDVAS 223
           C ++   L +I +Y   G+L               +    +    LS +  +     VA 
Sbjct: 144 CTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 202

Query: 224 GILYLYEGWES-KVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           G+ YL     S K +HRD+ A NVL+ +    ++ DFGLA+
Sbjct: 203 GMEYL----ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 46/209 (22%), Positives = 84/209 (40%), Gaps = 45/209 (21%)

Query: 84  KMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLG------- 136
           +M  +   +   LEY  + + Y               IG G  G+V++ +  G       
Sbjct: 30  RMPLLLNPKLLSLEYPRNNIEYVR------------DIGEGAFGRVFQARAPGLLPYEPF 77

Query: 137 VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS 195
             VA+K +  + S     +F  E + +    + N+V L G C    + + L+++YM  G 
Sbjct: 78  TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-KPMCLLFEYMAYGD 136

Query: 196 L---------------------DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
           L                      +          LS  +++ + + VA+G+ YL E    
Sbjct: 137 LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---R 193

Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           K +HRD+   N L+ + M  ++ DFGL++
Sbjct: 194 KFVHRDLATRNCLVGENMVVKIADFGLSR 222

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 32/164 (19%), Positives = 70/164 (42%), Gaps = 18/164 (10%)

Query: 119 NVIGLGGNGKVYKGQ-LLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNL--VGL 173
             IG GG+ KV++         A+K ++L+      +  +  E++ L +L+  +   + L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 174 RGWCKKEKESLILIYDYME--NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
             +   ++     IY  ME  N  L+ W+    +  ++   +R    K++   +  +++ 
Sbjct: 94  YDYEITDQY----IYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ- 145

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRR 275
               ++H D+K +N L+      +L DFG+A           + 
Sbjct: 146 --HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKD 186

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 11/152 (7%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLV 171
           F + + +G G  G V+K      G+ +A K I L+       + + E+  L       +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYLYE 230
           G  G    + E  I + ++M+ GSLD+ + +    I    EQ + KV   V  G+ YL E
Sbjct: 95  GFYGAFYSDGEISICM-EHMDGGSLDQ-VLKKAGRIP---EQILGKVSIAVIKGLTYLRE 149

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             + K++HRD+K SN+L++ +   +L DFG++
Sbjct: 150 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 44/204 (21%), Positives = 89/204 (43%), Gaps = 40/204 (19%)

Query: 84  KMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLG------- 136
            + + E  ED + E+   +++  +             +G G  G+V   + +G       
Sbjct: 18  GVSEYELPEDPKWEFPRDKLTLGK------------PLGEGAFGQVVMAEAVGIDKDKPK 65

Query: 137 --VEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYME 192
             V VA+K +  D +E  + + ++E+  +  + KH+N++ L G C ++   L +I +Y  
Sbjct: 66  EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYAS 124

Query: 193 NGSL-------------DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR 239
            G+L               +         ++++  +     +A G+ YL      K +HR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHR 181

Query: 240 DIKASNVLLDKKMNARLGDFGLAK 263
           D+ A NVL+ +    ++ DFGLA+
Sbjct: 182 DLAARNVLVTENNVMKIADFGLAR 205

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 47/209 (22%), Positives = 83/209 (39%), Gaps = 53/209 (25%)

Query: 87  DVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLG-------VEV 139
            + E   WE       +   +             +G G  GKV K              V
Sbjct: 11  KILEDPKWEFP--RKNLVLGK------------TLGEGEFGKVVKATAFHLKGRAGYTTV 56

Query: 140 A---LKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSL 196
           A   LK  +  SE  +R+ L+E + L ++ H +++ L G C ++   L+LI +Y + GSL
Sbjct: 57  AVKMLKENASPSE--LRDLLSEFNVLKQVNHPHVIKLYGACSQD-GPLLLIVEYAKYGSL 113

Query: 197 ---------------------DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES- 234
                                +    +  +  AL+    I     ++ G+ YL       
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL----AEM 169

Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           K++HRD+ A N+L+ +    ++ DFGL++
Sbjct: 170 KLVHRDLAARNILVAEGRKMKISDFGLSR 198

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 12/153 (7%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHG---MREFLAEVSSLGRLKHRN 169
           FS+   IG G  G VY  + +     VA+K++S   +      ++ + EV  L +L+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
            +  RG   +E     L+ +Y    + D  + E  +   L   +   V      G+ YL+
Sbjct: 116 TIQYRGCYLREHT-AWLVMEYCLGSASD--LLEVHKKP-LQEVEIAAVTHGALQGLAYLH 171

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
                 ++HRD+KA N+LL +    +LGDFG A
Sbjct: 172 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 80.9 bits (200), Expect = 6e-17
 Identities = 42/204 (20%), Positives = 87/204 (42%), Gaps = 48/204 (23%)

Query: 87  DVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVE-------- 138
           ++ E   WE      +++  +             +G G  G+V   + +G++        
Sbjct: 69  ELPEDPKWEFP--RDKLTLGK------------PLGEGCFGQVVMAEAVGIDKDKPKEAV 114

Query: 139 -VA---LKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYMEN 193
            VA   LK  + + +  + + ++E+  +  + KH+N++ L G C ++   L +I +Y   
Sbjct: 115 TVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASK 171

Query: 194 GSL-------------DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES-KVLHR 239
           G+L               +         ++++  +     +A G+ YL     S K +HR
Sbjct: 172 GNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL----ASQKCIHR 227

Query: 240 DIKASNVLLDKKMNARLGDFGLAK 263
           D+ A NVL+ +    ++ DFGLA+
Sbjct: 228 DLAARNVLVTENNVMKIADFGLAR 251

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 41/152 (26%), Positives = 66/152 (43%), Gaps = 10/152 (6%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRL-KHRNL 170
             +   IG G  G V K      G  +A+KRI     E   ++ L ++  + R      +
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI--KVLKDVASGILYL 228
           V   G   +E +   +  + M + S DK+       +     + I  K+       + +L
Sbjct: 84  VQFYGALFREGD-CWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFG 260
            E    K++HRDIK SN+LLD+  N +L DFG
Sbjct: 142 KE--NLKIIHRDIKPSNILLDRSGNIKLCDFG 171

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 46/171 (26%), Positives = 76/171 (44%), Gaps = 27/171 (15%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVR 111

Query: 173 LR-----GWCKKEKESLILIYDYMENGSLDKWIFECDES-IALSWEQRIK-----VLKDV 221
           LR        KK++  L L+ DY+   ++ +       +   L     +K     + +  
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFR-- 167

Query: 222 ASGILYLYEGWESKVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQVM 271
              + Y++      + HRDIK  N+LLD      +L DFG AK    G+  
Sbjct: 168 --SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 45/168 (26%), Positives = 69/168 (41%), Gaps = 30/168 (17%)

Query: 118 ENVIGLGGNGKVYKGQLLG-------VEVA---LKRISLDSEHGMREFLAEVSSLGRL-K 166
              +G G  GKV +    G       ++VA   LK  +   E      ++E+  +  L +
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE--KEALMSELKIMSHLGQ 108

Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSL-----------DKWIFECDESIALSWEQRI 215
           H N+V L G C      +++I +Y   G L           +        +   S    +
Sbjct: 109 HENIVNLLGACTHG-GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 216 KVLKDVASGILYLYEGWESK-VLHRDIKASNVLLDKKMNARLGDFGLA 262
                VA G+ +L     SK  +HRD+ A NVLL     A++GDFGLA
Sbjct: 168 HFSSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 43/174 (24%), Positives = 70/174 (40%), Gaps = 33/174 (18%)

Query: 118 ENVIGLGGNGKVYKGQLLG-------VEVALKRISLD-SEHGMREFLAEVSSLGRL-KHR 168
             V+G G  GKV      G       ++VA+K +            ++E+  + +L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSL--------------------DKWIFECDESIA 208
           N+V L G C      + LI++Y   G L                     K + E ++   
Sbjct: 110 NIVNLLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168

Query: 209 LSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           L++E  +     VA G+ +L        +HRD+ A NVL+      ++ DFGLA
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLA 219

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 78.8 bits (195), Expect = 1e-16
 Identities = 49/221 (22%), Positives = 80/221 (36%), Gaps = 48/221 (21%)

Query: 86  KDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLG-------VE 138
             +     WE     +R+S+ +             +G G  GKV +    G       + 
Sbjct: 10  TQLPYDHKWEFP--RNRLSFGK------------TLGAGAFGKVVEATAYGLIKSDAAMT 55

Query: 139 VALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYMENGSL 196
           VA+K +            ++E+  L  L  H N+V L G C       ++I +Y   G L
Sbjct: 56  VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-GPTLVITEYCCYGDL 114

Query: 197 ---------------DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES-KVLHRD 240
                                 D+ +AL  E  +     VA G+ +L     S   +HRD
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL----ASKNCIHRD 170

Query: 241 IKASNVLLDKKMNARLGDFGLAKMHHHGQVM----SGRRPI 277
           + A N+LL      ++ DFGLA+   +        + R P+
Sbjct: 171 LAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 24/169 (14%)

Query: 115 FSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
           ++   VIG G  G V++ +L+   EVA+K++  D     R    E+  +  +KH N+V L
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDL 97

Query: 174 R-----GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-----LKDVAS 223
           +        KK++  L L+ +Y+   ++ +      +         IK+     L+    
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLR---- 152

Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQVM 271
            + Y++      + HRDIK  N+LLD      +L DFG AK+   G+  
Sbjct: 153 SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 34/160 (21%), Positives = 57/160 (35%), Gaps = 23/160 (14%)

Query: 115 FSEENVIGLGGN--GKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHR 168
           +    VIG G      V   +    G  V ++RI+L+  S   +     E+       H 
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLD---KWIFEC--DES-IALSWEQRIKVLKDVA 222
           N+V  R         L ++  +M  GS        F    +E  IA        +L+ V 
Sbjct: 87  NIVPYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-------ILQGVL 138

Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
             + Y++       +HR +KAS++L+       L      
Sbjct: 139 KALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSN 175

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 35/167 (20%), Positives = 67/167 (40%), Gaps = 25/167 (14%)

Query: 120 VIGLGGNGKVYKGQLLGVEVALKRIS----------------LDSEHGMREFLA-EVSSL 162
            +  G   K+   +      ALK+                    S     +    E+  +
Sbjct: 38  TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 163 GRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWI-----FECDESIALSWEQRIKV 217
             +K+   +   G      E + +IY+YMEN S+ K+       + + +  +  +    +
Sbjct: 98  TDIKNEYCLTCEGIITNYDE-VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156

Query: 218 LKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
           +K V +   Y++   E  + HRD+K SN+L+DK    +L DFG ++ 
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 78.3 bits (193), Expect = 4e-16
 Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 21/157 (13%)

Query: 121 IGLGGNGKVYKGQLL----GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           +G G  G VYK +        + ALK+I             E++ L  LKH N++ L+  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKV 86

Query: 177 C-KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI------KVLKDVASGILYLY 229
                   + L++DY E+  L   I     S A     ++       +L  +  GI YL+
Sbjct: 87  FLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 230 EGWESKVLHRDIKASNVLLDKKMNAR----LGDFGLA 262
             W   VLHRD+K +N+L+  +   R    + D G A
Sbjct: 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 179

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 76.5 bits (189), Expect = 6e-16
 Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 9/153 (5%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVS-SLGRLKHRNL 170
                 +G G  G V K + +  G  +A+KRI         +  L ++  S+  +     
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYLY 229
           V   G   +E +  I + + M + SLDK+  +  +      E  + K+   +   + +L+
Sbjct: 69  VTFYGALFREGDVWICM-ELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
              +  V+HRD+K SNVL++     ++ DFG++
Sbjct: 127 S--KLSVIHRDVKPSNVLINALGQVKMCDFGIS 157

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 76.0 bits (188), Expect = 8e-16
 Identities = 39/156 (25%), Positives = 77/156 (49%), Gaps = 29/156 (18%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALK---RISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
           +G G    VY+ + +  G+EVA+K   + ++     ++    EV    +LKH +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD---------VASGIL 226
           + +     + L+ +   NG +++++           + R+K   +         + +G+L
Sbjct: 79  YFEDSNY-VYLVLEMCHNGEMNRYL-----------KNRVKPFSENEARHFMHQIITGML 126

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           YL+      +LHRD+  SN+LL + MN ++ DFGLA
Sbjct: 127 YLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLA 159

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 39/162 (24%), Positives = 74/162 (45%), Gaps = 17/162 (10%)

Query: 115 FSEENVIGLGGNGK-VYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVG 172
           F  ++V+G G  G  VY+G     +VA+KRI  +          EV  L    +H N++ 
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIR 82

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
                +K+++   +  +     +L +++    +  A    + I +L+   SG+ +L+   
Sbjct: 83  YFC-TEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136

Query: 233 ESKVLHRDIKASNVLLDKK-----MNARLGDFGLAKMHHHGQ 269
              ++HRD+K  N+L+        + A + DFGL K    G+
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 33/153 (21%), Positives = 67/153 (43%), Gaps = 12/153 (7%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRL-KHRNL 170
                 +G G  G+V+K +    G  +A+K++     +   +  L ++  + +      +
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-KVLKDVASGILYLY 229
           V   G      + + +  + M     +K        I    E+ + K+   +   + YL 
Sbjct: 87  VQCFGTFITNTD-VFIAMELM-GTCAEKLKKRMQGPIP---ERILGKMTVAIVKALYYLK 141

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           E  +  V+HRD+K SN+LLD++   +L DFG++
Sbjct: 142 E--KHGVIHRDVKPSNILLDERGQIKLCDFGIS 172

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 39/200 (19%), Positives = 84/200 (42%), Gaps = 14/200 (7%)

Query: 79  KRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQ--LLG 136
           K  G K+ D ++  +   + +  +    +  +    +     +G G  G V++      G
Sbjct: 17  KYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATG 76

Query: 137 VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSL 196
                K I+            E+S + +L H  L+ L     ++K  ++LI +++  G L
Sbjct: 77  RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-EDKYEMVLILEFLSGGEL 135

Query: 197 DKWIFE--CDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNA 254
               F+    E   +S  + I  ++    G+ +++   E  ++H DIK  N++ + K  +
Sbjct: 136 ----FDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKAS 188

Query: 255 RL--GDFGLAKMHHHGQVMS 272
            +   DFGLA   +  +++ 
Sbjct: 189 SVKIIDFGLATKLNPDEIVK 208

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 40/182 (21%), Positives = 71/182 (39%), Gaps = 31/182 (17%)

Query: 115 FSEENVIGLGGNGKV-YKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVG 172
              E ++G G +G V ++G   G  VA+KR+ +D          E+  L     H N++ 
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIR 73

Query: 173 LRGWCKKEKESLILIYDYME--NGSLDKWI----FECDESIALSWEQRIKVLKDVASGIL 226
                  ++     +Y  +E  N +L   +       +          I +L+ +ASG+ 
Sbjct: 74  YYCSETTDRF----LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 227 YLYEGWESKVLHRDIKASNVLLDKK-------------MNARLGDFGLAKMHHHGQVMSG 273
           +L+     K++HRD+K  N+L+                +   + DFGL K    GQ    
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 274 RR 275
             
Sbjct: 187 TN 188

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 75.3 bits (186), Expect = 2e-15
 Identities = 36/154 (23%), Positives = 66/154 (42%), Gaps = 18/154 (11%)

Query: 119 NVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMRE-FLAEVSSLGRLKHRNLVGL 173
             +G G  G VY  +       +ALK +      + G+      EV     L+H N++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQRIKVLKDVASGILYLYE 230
            G+   +   + LI +Y   G++ + + +    DE            + ++A+ + Y + 
Sbjct: 75  YGYFH-DATRVYLILEYAPLGTVYRELQKLSKFDEQRTA------TYITELANALSYCHS 127

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
               +V+HRDIK  N+LL      ++ DFG +  
Sbjct: 128 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVH 158

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 44/179 (24%), Positives = 71/179 (39%), Gaps = 31/179 (17%)

Query: 112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN 169
              F  E + G G  G V  G+    G+ VA+K++  D     RE L  +  L  L H N
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80

Query: 170 LVGLR------GWCKKEKESLILIYDYMENGSLDKWI-FECDESIALSWEQRIKVLKDVA 222
           +V L+      G   +    L ++ +Y+ + +L +         +A      IK      
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL-IK------ 132

Query: 223 SGILYLYE---------GWESKVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHGQVM 271
              ++L++              V HRDIK  NVL+++     +L DFG AK     +  
Sbjct: 133 ---VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 75.6 bits (186), Expect = 6e-15
 Identities = 41/204 (20%), Positives = 80/204 (39%), Gaps = 18/204 (8%)

Query: 79  KRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSE----ENVIGLGGNGKVYKGQ- 133
            +  +    V    D  +     +   Q +        +       +G G  G V++   
Sbjct: 119 GKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTE 178

Query: 134 -LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME 192
              G   A K +    E        E+ ++  L+H  LV L     ++   +++IY++M 
Sbjct: 179 RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-EDDNEMVMIYEFMS 237

Query: 193 NGSLDKWIFE--CDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK 250
            G L    FE   DE   +S ++ ++ ++ V  G+ +++   E+  +H D+K  N++   
Sbjct: 238 GGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTT 290

Query: 251 KMNARL--GDFGLAKMHHHGQVMS 272
           K +  L   DFGL       Q + 
Sbjct: 291 KRSNELKLIDFGLTAHLDPKQSVK 314

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 73.4 bits (181), Expect = 7e-15
 Identities = 37/153 (24%), Positives = 68/153 (44%), Gaps = 18/153 (11%)

Query: 120 VIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLA-EVSSLGRLKHRNLVGLR 174
            +G G  G VY  +       +ALK +      + G+   L  E+     L+H N++ + 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQRIKVLKDVASGILYLYEG 231
            +    K  + L+ ++   G L K + +    DE  + ++ + +      A  + Y +E 
Sbjct: 81  NYFHDRKR-IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL------ADALHYCHE- 132

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
              KV+HRDIK  N+L+  K   ++ DFG +  
Sbjct: 133 --RKVIHRDIKPENLLMGYKGELKIADFGWSVH 163

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 74.1 bits (182), Expect = 7e-15
 Identities = 34/236 (14%), Positives = 66/236 (27%), Gaps = 44/236 (18%)

Query: 145 SLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECD 204
            L S   M     ++  +     +N VG        K  L +        +L  W+    
Sbjct: 98  PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQ-PSSPKVYLYIQMQLCRKENLKDWMNRRC 156

Query: 205 ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
                     + +   +A  + +L+      ++HRD+K SN+        ++GDFGL   
Sbjct: 157 SLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213

Query: 265 HHHGQVMSGRRPIEEGKRNL-----------------------VDRMWSL---------- 291
               +                                      VD ++SL          
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD-IFSLGLILFELLYS 272

Query: 292 ----TERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKM 343
                ER  +++ +               E ++   +L   P    RP    +++ 
Sbjct: 273 FSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPT--ERPEATDIIEN 326

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 43/164 (26%), Positives = 81/164 (49%), Gaps = 14/164 (8%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
            S+  ++G G  G+V+K +    G+++A K I         E   E+S + +L H NL+ 
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFE--CDESIALSWEQRIKVLKDVASGILYLYE 230
           L     + K  ++L+ +Y++ G L    F+   DES  L+    I  +K +  GI +++ 
Sbjct: 151 LYD-AFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMH- 204

Query: 231 GWESKVLHRDIKASNVLLDKKMNARL--GDFGLAKMHHHGQVMS 272
             +  +LH D+K  N+L   +   ++   DFGLA+ +   + + 
Sbjct: 205 --QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 19/177 (10%), Positives = 38/177 (21%), Gaps = 36/177 (20%)

Query: 120 VIGLGGNGKVYKG--QLLGVEVALKRI---SLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
            + +G    V+         + ALK     + +S   +        +  RL   +    R
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 175 GWCKKEKESLIL----------------------IYDYME--NGSLDKWIFECDESIA-- 208
              +    S  +                          M   +  L+      D      
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 209 --LSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
                     +   +      L       ++H      N+ +       LGD     
Sbjct: 189 GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 62/287 (21%), Positives = 107/287 (37%), Gaps = 48/287 (16%)

Query: 118 ENVIGLGGNGKVYKGQLL--GVEVALKRIS---LDSEHGMREFLAEVSSLGRLKHRNLVG 172
           + V+G G  G+V   +    G E A+K IS   +  +      L EV  L +L H N++ 
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
           L  + + +K    L+ +    G L   I         S     ++++ V SGI Y+++  
Sbjct: 91  LYEFFE-DKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHK-- 144

Query: 233 ESKVLHRDIKASNVLL-DKKMNARL--GDFGLAKMHHHGQVMSGR---------RPIEEG 280
            +K++HRD+K  N+LL  K  +A +   DFGL+      + M  +           +   
Sbjct: 145 -NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT 203

Query: 281 KRNLVDRMWSL-----------------TERSELLSVLDERLKAKGGYADEVVEKVLHL- 322
                D +WS                   E   L  V   +   +     +V E    L 
Sbjct: 204 YDEKCD-VWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLI 262

Query: 323 -GLLCAHPEANSRPTIRQVLKM--LEGQTEGTGLEDEGMNVHLLKRI 366
             +L   P  + R + R  L    ++  T+     D     + +  I
Sbjct: 263 RKMLTYVP--SMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNI 307

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 36/162 (22%), Positives = 74/162 (45%), Gaps = 11/162 (6%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGLRGW 176
            +G G  G V+  +    G+E  +K I+ D      E   AE+  L  L H N++ +   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 177 CKKEKESLILIYDYMENGSL-DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
            + +  ++ ++ +  E G L ++ +       ALS     +++K + + + Y +      
Sbjct: 89  FE-DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QH 144

Query: 236 VLHRDIKASNVLL-DKKMNARL--GDFGLAKMHHHGQVMSGR 274
           V+H+D+K  N+L  D   ++ +   DFGLA++    +  +  
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA 186

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 70.9 bits (173), Expect = 1e-13
 Identities = 31/287 (10%), Positives = 71/287 (24%), Gaps = 72/287 (25%)

Query: 120 VIGLGGNGKVYKG--QLLGVEVALKRISLD---SEHGMREFLAEVSSLGRL--------- 165
           V+G        +   Q  G    +           + +++   EV  L  L         
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 166 -------------KHRNLVGLRGWCKKEKESLILIY------DYMENGSLDKWIFE-CDE 205
                        K      +      E++  +L              +  + +      
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 206 SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
             +L    R+++   V   +  L+      ++H  ++  +++LD++    L  F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 266 HH-----------------GQVMSGRRPIEEGKRNLVDRMWSL-------------TERS 295
                               +++   +          D  W+L                 
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFD-TWTLGLAIYWIWCADLPNTDD 320

Query: 296 ELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK 342
             L   +   ++       V  + L  G L    E   R    Q ++
Sbjct: 321 AALGGSEWIFRSCKNIPQPV--RALLEGFLRYPKED--RLLPLQAME 363

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 27/191 (14%), Positives = 58/191 (30%), Gaps = 27/191 (14%)

Query: 107 EIHAATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLDSEHGMREFLAEV 159
           E    +K     +++G G   +VY+             +  LK     +          +
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118

Query: 160 SSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWI--FECDESIALSWEQRIKV 217
             L        +         +   +L+ +    G+L   I  ++      +     I  
Sbjct: 119 ERLKPSMQHMFMKFYS-AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 218 LKDVASGILYLYEGWESKVLHRDIKASNVLL-----------DKKMNARLGDFGLA---K 263
              +   I  ++   + +++H DIK  N +L           D      L D G +   K
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 264 MHHHGQVMSGR 274
           +   G + + +
Sbjct: 235 LFPKGTIFTAK 245

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 69.5 bits (171), Expect = 2e-13
 Identities = 40/163 (24%), Positives = 66/163 (40%), Gaps = 18/163 (11%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
            IG G  G+V         +  A K+I       +  F  E+  +  L H N++ L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 178 KKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQRIKVLKDVASGILYLYEGWES 234
            ++   + L+ +    G L + +       ES A       +++KDV S + Y +   + 
Sbjct: 76  -EDNTDIYLVMELCTGGELFERVVHKRVFRESDAA------RIMKDVLSAVAYCH---KL 125

Query: 235 KVLHRDIKASNVLL---DKKMNARLGDFGLAKMHHHGQVMSGR 274
            V HRD+K  N L          +L DFGLA     G++M  +
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 168

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 38/164 (23%), Positives = 66/164 (40%), Gaps = 38/164 (23%)

Query: 118 ENVIGLGGNGKVYKGQ--LLGVEVALK--RISLDSEHGMRE-FLAEVSSLGRLKHRNLVG 172
             ++G GG G VY+ +  +    VALK    +L S+   R     E  + GRL+  ++V 
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 173 LRGWCKKEKESLILIYDY----------ME--NG-SLDKWIFECDESIALSWEQRIKVLK 219
                         I+D+          M   NG  L   +        L+  + + +++
Sbjct: 99  --------------IHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVR 141

Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            + S +   +    +   HRD+K  N+L+     A L DFG+A 
Sbjct: 142 QIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIAS 182

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 58/283 (20%), Positives = 104/283 (36%), Gaps = 61/283 (21%)

Query: 111 ATKGFSEE----NVIGLGGNGKVYKGQ--LLGVEVALKRIS---------LDSEHGMREF 155
           +T GF E      ++G G +  V +        E A+K I           + +      
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 156 LAEVSSLGRLK-HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR 214
           L EV  L ++  H N++ L+   +       L++D M+ G L  ++ E    + LS ++ 
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYE-TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKET 126

Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSG- 273
            K+++ +   I  L++     ++HRD+K  N+LLD  MN +L DFG +     G+ +   
Sbjct: 127 RKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 183

Query: 274 ------------RRPIEEGKRNL---VDRMWSL-----------------TERSELLSVL 301
                          + +        VD MWS                   +   L  ++
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVD-MWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242

Query: 302 DERLKAKGGYADEVVEKVLHL--GLLCAHPEANSRPTIRQVLK 342
               +      D+  + V  L    L   P+   R T  + L 
Sbjct: 243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQ--KRYTAEEALA 283

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 58/287 (20%), Positives = 110/287 (38%), Gaps = 48/287 (16%)

Query: 118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGL 173
              +G G  G+V   +     VE A+K I     S     + L EV+ L  L H N++ L
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
             + + +K +  L+ +  + G L   I    +    +      ++K V SG+ YL++   
Sbjct: 102 YDFFE-DKRNYYLVMECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHK--- 154

Query: 234 SKVLHRDIKASNVLL-DKKMNARL--GDFGLAKMHHHGQVMSGR---------RPIEEGK 281
             ++HRD+K  N+LL  K+ +A +   DFGL+ +  + + M  R           + +  
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKY 214

Query: 282 RNLVDRMWSL-----------------TERSELLSVLDERLKAKGGYADEVVEKVLHL-- 322
               D +WS+                 T++  L  V   +          V E    L  
Sbjct: 215 DEKCD-VWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIK 273

Query: 323 GLLCAHPEANSRPTIRQVLK---MLEGQTEGTGLEDEGMNVHLLKRI 366
            +L        R + +Q L+   + E  ++     +     + ++ +
Sbjct: 274 QMLQFDS--QRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENM 318

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 70.1 bits (172), Expect = 3e-13
 Identities = 66/315 (20%), Positives = 110/315 (34%), Gaps = 66/315 (20%)

Query: 101 HRVSYQEIHAATKGFSE----ENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGM 152
           H  S +E       F+E      ++G G  G+V K +      E A+K I+         
Sbjct: 6   HHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65

Query: 153 REFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECD---ESIAL 209
              L EV  L +L H N++ L    + +  S  ++ +    G L   I +     E  A 
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILE-DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA 124

Query: 210 SWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL-DKKMNARL--GDFGLAKMHH 266
                 +++K V SGI Y+++     ++HRD+K  N+LL  K+ +  +   DFGL+    
Sbjct: 125 ------RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175

Query: 267 HGQVMSG-------------RRPIEEGKRNLVDRMWSL-----------------TERSE 296
               M               R   +E      D +WS                   E   
Sbjct: 176 QNTKMKDRIGTAYYIAPEVLRGTYDEK----CD-VWSAGVILYILLSGTPPFYGKNEYDI 230

Query: 297 LLSVLDERLKAKGGYADEVVEKVLHL--GLLCAHPEANSRPTIRQVLK---MLEGQTEGT 351
           L  V   +          + +    L   +L  HP  + R T  Q L+   + +  +E  
Sbjct: 231 LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHP--SLRITATQCLEHPWIQKYSSETP 288

Query: 352 GLEDEGMNVHLLKRI 366
            + D       +  I
Sbjct: 289 TISDLPSLESAMTNI 303

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 68.4 bits (168), Expect = 4e-13
 Identities = 42/175 (24%), Positives = 74/175 (42%), Gaps = 44/175 (25%)

Query: 121 IGLGGNGKVYKGQ--LLGVEVALK--RISLDSEHGMRE-FLAEVSSLGRLKHRNLVGLRG 175
           +G GG   VY  +  +L ++VA+K   I    +    + F  EV +  +L H+N+V    
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS--- 75

Query: 176 WCKKEKESLILIYDY----------ME--NG-SLDKWIFECDESIALSWEQRIKVLKDVA 222
                      + D           ME   G +L ++I   +    LS +  I     + 
Sbjct: 76  -----------MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQIL 121

Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK------MHHHGQVM 271
            GI + ++    +++HRDIK  N+L+D     ++ DFG+AK      +     V+
Sbjct: 122 DGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL 173

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 58/298 (19%), Positives = 101/298 (33%), Gaps = 60/298 (20%)

Query: 118 ENVIGLGGNGKVYKGQLL--GVEVALKRIS-------------LDSEHGMREFLAEVSSL 162
              +G G  G+V   +      E A+K I               + E    E   E+S L
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 163 GRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVA 222
             L H N++ L    + +K+   L+ ++ E G L + I    +           ++K + 
Sbjct: 101 KSLDHPNIIKLFDVFE-DKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQIL 156

Query: 223 SGILYLYEGWESKVLHRDIKASNVLL-DKKMNARL--GDFGLAKMHHHGQVMSGRR---- 275
           SGI YL++     ++HRDIK  N+LL +K     +   DFGL+        +  R     
Sbjct: 157 SGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAY 213

Query: 276 ---PIEEGKRN---LVDRMWSL-----------------TERSELLSVLDERLKAKGGYA 312
              P E  K+      D +WS                   ++  +  V   +        
Sbjct: 214 YIAP-EVLKKKYNEKCD-VWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271

Query: 313 DEVVEKVLHL--GLLCAHPEANSRPTIRQVLKM--LEGQTEGTGLEDEGMNVHLLKRI 366
             + ++   L   +L      N R T  + L    ++         D+      L  +
Sbjct: 272 KNISDEAKELIKLMLTYDY--NKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNM 327

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 69.3 bits (170), Expect = 5e-13
 Identities = 54/272 (19%), Positives = 94/272 (34%), Gaps = 63/272 (23%)

Query: 120 VIGLGGNGKVYKG--QLLGVEVALKRIS--------LDSEHGMREFLAEVSSLGRLKHRN 169
            +G G  G+V     +    +VA++ IS                    E+  L +L H  
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQRIKVLKDVASGIL 226
           ++ ++ +   + E   ++ + ME G L   +       E+              +   + 
Sbjct: 202 IIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK------LYFYQMLLAVQ 253

Query: 227 YLYEGWESKVLHRDIKASNVLL---DKKMNARLGDFGLAKMHHHGQVMSG---------- 273
           YL+E   + ++HRD+K  NVLL   ++    ++ DFG +K+     +M            
Sbjct: 254 YLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310

Query: 274 ---RRPIEEGKRNLVDRMWSL------------------TERSELLSVLDERLKAKGGYA 312
                    G    VD  WSL                  T+ S    +   +        
Sbjct: 311 EVLVSVGTAGYNRAVD-CWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369

Query: 313 DEVVEKVLHL--GLLCAHPEANSRPTIRQVLK 342
            EV EK L L   LL   P+  +R T  + L+
Sbjct: 370 AEVSEKALDLVKKLLVVDPK--ARFTTEEALR 399

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 47/159 (29%), Positives = 73/159 (45%), Gaps = 17/159 (10%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
           IG G   KV      L G EVA+K I     +   +++   EV  +  L H N+V L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 177 CKKEKESLILIYDYMENGSLDKWIFE---CDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            + EK  L LI +Y   G +  ++       E  A S  ++I       S + Y ++   
Sbjct: 83  IETEKT-LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI------VSAVQYCHQ--- 132

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
            +++HRD+KA N+LLD  MN ++ DFG +     G  + 
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 68.1 bits (167), Expect = 6e-13
 Identities = 40/180 (22%), Positives = 71/180 (39%), Gaps = 36/180 (20%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRIS-------------------------LDSEHGMR 153
           IG G  G V     +      A+K +S                              G  
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 154 EFLA-EVSSLGRLKHRNLVGLRG-WCKKEKESLILIYDYMENGSLDKWIFECDESIALSW 211
           E +  E++ L +L H N+V L        ++ L ++++ +  G +     E      LS 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLSE 136

Query: 212 EQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM 271
           +Q     +D+  GI YL+     K++HRDIK SN+L+ +  + ++ DFG++        +
Sbjct: 137 DQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 21/190 (11%), Positives = 52/190 (27%), Gaps = 37/190 (19%)

Query: 120 VIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMRE----------------------- 154
           V+G        +   Q  G    +                                    
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 155 -----FLAEVSSLGRLKHRNLVGLRGWCKKEKE-SLILIYDYME--NGSLDKWIFE-CDE 205
                F+     +   + + ++ +R   +     S   +Y  M+    +  + +      
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 206 SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
             +L    R+++   V   +  L+      ++H  ++  +++LD++    L  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 266 HHGQVMSGRR 275
               V S  R
Sbjct: 257 GARVVSSVSR 266

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 34/167 (20%), Positives = 73/167 (43%), Gaps = 22/167 (13%)

Query: 121 IGLGGNGKVYKGQ--LLGVEVALK--RISLDSEHGMRE-FLAEVSSLGRLKHRNLVGLRG 175
           +G GG  +V+  +      +VA+K  R  L  +      F  E  +   L H  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79

Query: 176 WCKKEKESLILIYDYME--NG-SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
             + E  +  L Y  ME  +G +L   +        ++ ++ I+V+ D    + + ++  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSHQ-- 134

Query: 233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAK--------MHHHGQVM 271
            + ++HRD+K +N+++      ++ DFG+A+        +     V+
Sbjct: 135 -NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 34/160 (21%), Positives = 66/160 (41%), Gaps = 18/160 (11%)

Query: 120 VIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLA-EVSSLGRLKHRNLVGL 173
           ++G G  GKV +          A+K +    L         +  E+  L RL+H+N++ L
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 174 RG-WCKKEKESLILIYDYMENGSLDKWIFECDESIA---LSWEQRIKVLKDVASGILYLY 229
                 +EK+ + ++ +Y   G  +  + +   S+        Q       +  G+ YL+
Sbjct: 72  VDVLYNEEKQKMYMVMEYCVCGMQE--MLD---SVPEKRFPVCQAHGYFCQLIDGLEYLH 126

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
                 ++H+DIK  N+LL      ++   G+A+  H   
Sbjct: 127 S---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 53/281 (18%), Positives = 97/281 (34%), Gaps = 80/281 (28%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRISL--------DSEHGMREFLAEVSSLGRLK-HR 168
           VIG G +  V +      G E A+K + +          E        E   L ++  H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI------------K 216
           +++ L    +     + L++D M  G L    F+            +             
Sbjct: 161 HIITLIDSYE-SSSFMFLVFDLMRKGEL----FD-----------YLTEKVALSEKETRS 204

Query: 217 VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSG--- 273
           +++ +   + +L+    + ++HRD+K  N+LLD  M  RL DFG +     G+ +     
Sbjct: 205 IMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCG 261

Query: 274 ----------RRPIEEGKRNL---VDRMWSL-----------------TERSELLSVLDE 303
                     +  ++E        VD +W+                   +   L  +++ 
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVD-LWACGVILFTLLAGSPPFWHRRQILMLRMIMEG 320

Query: 304 RLKAKGGYADEVVEKVLHL--GLLCAHPEANSRPTIRQVLK 342
           + +      D+    V  L   LL   PEA  R T  Q L+
Sbjct: 321 QYQFSSPEWDDRSSTVKDLISRLLQVDPEA--RLTAEQALQ 359

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 66.9 bits (164), Expect = 1e-12
 Identities = 36/169 (21%), Positives = 66/169 (39%), Gaps = 27/169 (15%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRIS-------LDSEHGMRE-FLAEVSSLGRLKHRN 169
            +G G  G+V          +VA+K IS          E         E+  L +L H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESIALSWEQRIKVLKDVASGIL 226
           ++ ++ +   + E   ++ + ME G L   +       E+              +   + 
Sbjct: 77  IIKIKNFF--DAEDYYIVLELMEGGELFDKVVGNKRLKEATC------KLYFYQMLLAVQ 128

Query: 227 YLYEGWESKVLHRDIKASNVLLDKK---MNARLGDFGLAKMHHHGQVMS 272
           YL+E   + ++HRD+K  NVLL  +      ++ DFG +K+     +M 
Sbjct: 129 YLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 174

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 33/175 (18%), Positives = 64/175 (36%), Gaps = 46/175 (26%)

Query: 120 VIGLGGNGKVYKG---QLLGVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLVGLRG 175
            I  GG G +Y      + G  V LK +    +   +   +AE   L  + H ++V    
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ--- 143

Query: 176 WCKKEKESLILIYDY---------------ME--NG-SLDKWIFECDESIALSWEQRIKV 217
                      I+++               ME   G SL +   +      L   + I  
Sbjct: 144 -----------IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAY 187

Query: 218 LKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK-MHHHGQVM 271
           L ++   + YL+      +++ D+K  N++L ++   +L D G    ++  G + 
Sbjct: 188 LLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY 238

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 21/162 (12%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRIS-------LDSEHGMREFLAEVSSLGRLKHR-- 168
           ++G GG G VY G      + VA+K +         +  +G R  + EV  L ++     
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFS 108

Query: 169 NLVGLRGWCKKEKESLILIYDYMEN-GSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
            ++ L  W ++  +S +LI +  E    L  +I E     AL  E        V   + +
Sbjct: 109 GVIRLLDWFER-PDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRH 164

Query: 228 LYEGWESKVLHRDIKASNVLLD-KKMNARLGDFGLAKMHHHG 268
            +      VLHRDIK  N+L+D  +   +L DFG   +    
Sbjct: 165 CHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 203

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 42/167 (25%), Positives = 72/167 (43%), Gaps = 25/167 (14%)

Query: 118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLR 174
           E+V+G G + +V     L    E A+K I     H       EV  L + + HRN++ L 
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 175 GWCKKEKESLILIYDYMENGSL-----DKWIF-ECDESIALSWEQRIKVLKDVASGILYL 228
            + + E++   L+++ M  GS+      +  F E + S          V++DVAS + +L
Sbjct: 78  EFFE-EEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS---------VVVQDVASALDFL 127

Query: 229 YEGWESKVLHRDIKASNVLL-DKKMNA--RLGDFGLAKMHHHGQVMS 272
           +      + HRD+K  N+L       +  ++ DF L          S
Sbjct: 128 HN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 42/172 (24%), Positives = 72/172 (41%), Gaps = 34/172 (19%)

Query: 118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLR 174
             V+GLG NGKV +        + ALK +  D     RE    V    R  +  ++V + 
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARRE----VELHWRASQCPHIVRIV 121

Query: 175 GWC---KKEKESLILIYDYMENGSL--------DKWIFECDESIALSWEQRIKVLKDVAS 223
                    ++ L+++ + ++ G L        D+   E + S         +++K +  
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS---------EIMKSIGE 172

Query: 224 GILYLYEGWESKVLHRDIKASNVLL-DKKMNA--RLGDFGLAKMHHHGQVMS 272
            I YL+      + HRD+K  N+L   K+ NA  +L DFG AK       ++
Sbjct: 173 AIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 221

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 65.7 bits (161), Expect = 4e-12
 Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 18/160 (11%)

Query: 118 ENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
             V+G G   +V+    +L G   ALK I             E++ L ++KH N+V L  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECD---ESIALSWEQRIKVLKDVASGILYLYEGW 232
              +      L+   +  G L   I E     E  A        V++ V S + YL+   
Sbjct: 74  IY-ESTTHYYLVMQLVSGGELFDRILERGVYTEKDA------SLVIQQVLSAVKYLH--- 123

Query: 233 ESKVLHRDIKASNVLL-DKKMNARL--GDFGLAKMHHHGQ 269
           E+ ++HRD+K  N+L    + N+++   DFGL+KM  +G 
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 40/163 (24%), Positives = 68/163 (41%), Gaps = 20/163 (12%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
            +G G    VY+ +        ALK +    +  +     E+  L RL H N++ L+   
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI--VRTEIGVLLRLSHPNIIKLKEIF 117

Query: 178 KKEKESLILIYDYMENGSLDKWIFECD---ESIALSWEQRIKVLKDVASGILYLYEGWES 234
           +     + L+ + +  G L   I E     E  A         +K +   + YL+E   +
Sbjct: 118 E-TPTEISLVLELVTGGELFDRIVEKGYYSERDA------ADAVKQILEAVAYLHE---N 167

Query: 235 KVLHRDIKASNVLL-DKKMNARL--GDFGLAKMHHHGQVMSGR 274
            ++HRD+K  N+L      +A L   DFGL+K+  H  +M   
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV 210

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 42/185 (22%), Positives = 75/185 (40%), Gaps = 35/185 (18%)

Query: 106 QEIHAATKGFSEE----NVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEV 159
           Q++H  +  F++       IG+G      +       +E A+K I         E    +
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----I 66

Query: 160 SSLGRL-KHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIF------ECDESIALSWE 212
             L R  +H N++ L+     + + + ++ + M+ G L   I       E + S      
Sbjct: 67  EILLRYGQHPNIITLKDVYD-DGKYVYVVTELMKGGELLDKILRQKFFSEREAS------ 119

Query: 213 QRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL-DKKMNA---RLGDFGLAK-MHHH 267
               VL  +   + YL+      V+HRD+K SN+L  D+  N    R+ DFG AK +   
Sbjct: 120 ---AVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173

Query: 268 GQVMS 272
             ++ 
Sbjct: 174 NGLLM 178

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 46/210 (21%), Positives = 84/210 (40%), Gaps = 37/210 (17%)

Query: 120 VIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGM--REFLAEVSSLGRLKHRNLVGL-- 173
           +IG G  G V +   +L    VA+K+I    E  +  +  L E++ L RL H ++V +  
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119

Query: 174 --RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-----VLKDVASGIL 226
                  ++ + L ++ +  ++    K        + L+ E  IK     +L     G+ 
Sbjct: 120 IVIPKDVEKFDELYVVLEIADS-DFKKLF---RTPVYLT-ELHIKTLLYNLLV----GVK 170

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIEEGKRNLVD 286
           Y++      +LHRD+K +N L+++  + ++ DFGLA            R ++  +     
Sbjct: 171 YVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA------------RTVDYPENGNSQ 215

Query: 287 RMWSLTERSELLSVLDERLKAKGGYADEVV 316
              S  E    L         K      VV
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVV 245

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 64.9 bits (159), Expect = 7e-12
 Identities = 28/159 (17%), Positives = 63/159 (39%), Gaps = 15/159 (9%)

Query: 120 VIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
            +G G  G V++            K + +           E+S L   +HRN++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 178 KKEKESLILIYDYMENGSLDKWIFE--CDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
           +   E L++I++++    +    FE     +  L+  + +  +  V   + +L+      
Sbjct: 71  E-SMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHS---HN 122

Query: 236 VLHRDIKASNVLLDKKMNARL--GDFGLAKMHHHGQVMS 272
           + H DI+  N++   + ++ +   +FG A+    G    
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 64.1 bits (157), Expect = 9e-12
 Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 26/161 (16%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDS--EHGMREFLA-EVSSLGRLKHRNLVGLRG 175
           +G+G  GKV  G  QL G +VA+K ++        +   +  E+ +L   +H +++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76

Query: 176 WCKKE----KESLILIYDYMENGSLDKWIFE---CDESIALSWEQRIKVLKDVASGILYL 228
               +         ++ +Y+  G L  +I +    +E  A    Q+I       S + Y 
Sbjct: 77  ---YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI------LSAVDYC 127

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
           +      V+HRD+K  NVLLD  MNA++ DFGL+ M   G+
Sbjct: 128 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 64.1 bits (157), Expect = 1e-11
 Identities = 41/177 (23%), Positives = 72/177 (40%), Gaps = 24/177 (13%)

Query: 112 TKGFSEE----NVIGLGGNGKVYKGQ--LLGVEVALKRI--SLDSEHGMREFLAEVSSLG 163
           +  FS+       +G G    V +      G+E A K I     S    ++   E     
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 164 RLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECD---ESIALSWEQRIKVLKD 220
           +L+H N+V L    + E+    L++D +  G L + I   +   E+ A         ++ 
Sbjct: 61  KLQHPNIVRLHDSIQ-EESFHYLVFDLVTGGELFEDIVAREFYSEADA------SHCIQQ 113

Query: 221 VASGILYLYEGWESKVLHRDIKASNVLLDKKMNA---RLGDFGLAKMHHHGQVMSGR 274
           +   I Y +    + ++HR++K  N+LL  K      +L DFGLA   +  +   G 
Sbjct: 114 ILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 64.6 bits (158), Expect = 1e-11
 Identities = 41/167 (24%), Positives = 71/167 (42%), Gaps = 16/167 (9%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRIS---LDSEHGMRE--FLAEVSSLGRLKHRNLVG 172
           VIG G    V +      G + A+K +      S  G+       E S    LKH ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 173 LRGWCKKEKESLILIYDYMENGSL-DKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
           L          L +++++M+   L  + +   D     S       ++ +   + Y ++ 
Sbjct: 91  LLETYS-SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD- 148

Query: 232 WESKVLHRDIKASNVLL-DKKMNA--RLGDFGLAK-MHHHGQVMSGR 274
             + ++HRD+K   VLL  K+ +A  +LG FG+A  +   G V  GR
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 63.8 bits (156), Expect = 1e-11
 Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 12/153 (7%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLA-EVSSLGRLKHRNLVGLRGWC 177
           +G G  G+V     ++    VA+K + +       E +  E+     L H N+V   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73

Query: 178 KKEKESLILIYDYMENGSL-DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
           ++E     L  +Y   G L D+        I +      +    + +G++YL+      +
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
            HRDIK  N+LLD++ N ++ DFGLA +  +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 44/165 (26%), Positives = 77/165 (46%), Gaps = 20/165 (12%)

Query: 118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLR 174
           + V+GLG NGKV +      G + ALK +  DS    +E    V    +     ++V + 
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQE----VDHHWQASGGPHIVCIL 88

Query: 175 GWC---KKEKESLILIYDYMENGSL-DKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
                    K  L++I + ME G L  + I E  +  A +  +  ++++D+ + I +L+ 
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSR-IQERGDQ-AFTEREAAEIMRDIGTAIQFLHS 146

Query: 231 GWESKVLHRDIKASNVLL-DKKMNA--RLGDFGLAKMHHHGQVMS 272
                + HRD+K  N+L   K+ +A  +L DFG AK      + +
Sbjct: 147 ---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT 188

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 41/173 (23%), Positives = 68/173 (39%), Gaps = 41/173 (23%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRI--SLDSEHGMREFLA----EVSSLGRL----KH 167
           ++G GG G V+ G      ++VA+K I  +                EV+ L ++     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 168 RNLVGLRGWCKKEKESLILI----------YDY-MENGSLDKWIFECDESIALSWEQRIK 216
             ++ L  W +  +E  +L+          +DY  E G L        E  +     R  
Sbjct: 98  PGVIRLLDWFET-QEGFMLVLERPLPAQDLFDYITEKGPLG-------EGPS-----R-C 143

Query: 217 VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNA-RLGDFGLAKMHHHG 268
               V + I + +      V+HRDIK  N+L+D +    +L DFG   + H  
Sbjct: 144 FFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE 193

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 36/168 (21%), Positives = 69/168 (41%), Gaps = 29/168 (17%)

Query: 118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLR 174
           +  +G G      K          A+K IS   E   ++   E+++L   + H N+V L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72

Query: 175 GWCKKEKESLILIYDYMENGSL-----DKWIF-ECDESIALSWEQRIKVLKDVASGILYL 228
                ++    L+ + +  G L      K  F E + S          +++ + S + ++
Sbjct: 73  EVFH-DQLHTFLVMELLNGGELFERIKKKKHFSETEAS---------YIMRKLVSAVSHM 122

Query: 229 YEGWESKVLHRDIKASNVLL-DKKMNA--RLGDFGLAK-MHHHGQVMS 272
           ++     V+HRD+K  N+L  D+  N   ++ DFG A+      Q + 
Sbjct: 123 HD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 45/161 (27%), Positives = 78/161 (48%), Gaps = 26/161 (16%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDS--EHGMREFLA-EVSSLGRLKHRNLVGLRG 175
           +G+G  GKV  G  +L G +VA+K ++        +   +  E+ +L   +H +++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81

Query: 176 WCKKE----KESLILIYDYMENGSLDKWIFE---CDESIALSWEQRIKVLKDVASGILYL 228
               +       + ++ +Y+  G L  +I +    DE  +    Q+I       SG+ Y 
Sbjct: 82  ---YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI------LSGVDYC 132

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
           +      V+HRD+K  NVLLD  MNA++ DFGL+ M   G+
Sbjct: 133 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 12/153 (7%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLA-EVSSLGRLKHRNLVGLRGWC 177
           +G G  G+V     ++    VA+K + +       E +  E+     L H N+V   G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-H 73

Query: 178 KKEKESLILIYDYMENGSL-DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
           ++E     L  +Y   G L D+        I +      +    + +G++YL+      +
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
            HRDIK  N+LLD++ N ++ DFGLA +  +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 42/166 (25%), Positives = 69/166 (41%), Gaps = 21/166 (12%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRIS------LDSEHGMREFLAEVSSLGRLKHRNLV 171
            +G G    V K +    G+E A K I               E   EVS L ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFE-CDESIALSWEQRIKVLKDVASGILYLYE 230
            L    +  +  ++LI + +  G L    F+   +  +LS E+    +K +  G+ YL+ 
Sbjct: 79  TLHDVYE-NRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT 133

Query: 231 GWESKVLHRDIKASNVLL----DKKMNARLGDFGLAKMHHHGQVMS 272
               K+ H D+K  N++L        + +L DFGLA     G    
Sbjct: 134 ---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 63.0 bits (154), Expect = 2e-11
 Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 26/190 (13%)

Query: 100 PHRVSYQEIHAATKGFSEE----NVIGLGGNGKVYKGQ--LLGVEVALKRIS---LDSEH 150
            H  S +E       F+E      ++G G  G+V K +  +   E A+K I+     ++ 
Sbjct: 5   HHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64

Query: 151 GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---DESI 207
                L EV  L +L H N++ L    + +  S  ++ +    G L   I +     E  
Sbjct: 65  -TSTILREVELLKKLDHPNIMKLFEILE-DSSSFYIVGELYTGGELFDEIIKRKRFSEHD 122

Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL---DKKMNARLGDFGLAKM 264
           A       +++K V SGI Y+++     ++HRD+K  N+LL   +K  + ++ DFGL+  
Sbjct: 123 AA------RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173

Query: 265 HHHGQVMSGR 274
                 M  R
Sbjct: 174 FQQNTKMKDR 183

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 32/196 (16%), Positives = 59/196 (30%), Gaps = 50/196 (25%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRIS-----LDSEHGMREFLAEVSSLGRLKHRNLVG 172
            IG G  G V            A+K ++       +   +     EV  + +L H N+  
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 173 LRGWCKKEKESLILIYDYMENGSL------------------------------------ 196
           L    + +++ + L+ +    G L                                    
Sbjct: 93  LYEVYE-DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAIN 151

Query: 197 -DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNAR 255
                F          +    +++ + S + YL+      + HRDIK  N L     +  
Sbjct: 152 GSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFE 208

Query: 256 L--GDFGLAKMHHHGQ 269
           +   DFGL+K  +   
Sbjct: 209 IKLVDFGLSKEFYKLN 224

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 36/165 (21%), Positives = 73/165 (44%), Gaps = 29/165 (17%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLRGWC 177
           +G G   +V++        +V +K +    +   ++   E+  L  L+   N++ L    
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100

Query: 178 K-KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-----VLKDVASGILYLYEG 231
           K     +  L+++++ N    +          L+ +  I+     +LK     + Y +  
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQ------TLT-DYDIRFYMYEILK----ALDYCH-- 147

Query: 232 WESK-VLHRDIKASNVLLD-KKMNARLGDFGLAKMHHHGQVMSGR 274
             S  ++HRD+K  NV++D +    RL D+GLA+ +H GQ  + R
Sbjct: 148 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 190

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 63.0 bits (154), Expect = 3e-11
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 21/166 (12%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRIS------LDSEHGMREFLAEVSSLGRLKHRNLV 171
            +G G    V K +    G+E A K I               E   EVS L ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFE-CDESIALSWEQRIKVLKDVASGILYLYE 230
            L    +  +  ++LI + +  G L    F+   +  +LS E+    +K +  G+ YL+ 
Sbjct: 79  TLHDVYE-NRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT 133

Query: 231 GWESKVLHRDIKASNVLL-DKKMNA---RLGDFGLAKMHHHGQVMS 272
               K+ H D+K  N++L DK +     +L DFGLA     G    
Sbjct: 134 ---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 62.6 bits (153), Expect = 4e-11
 Identities = 42/166 (25%), Positives = 70/166 (42%), Gaps = 21/166 (12%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRI------SLDSEHGMREFLAEVSSLGRLKHRNLV 171
            +G G    V K +    G E A K I      S        E   EV+ L  ++H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFE-CDESIALSWEQRIKVLKDVASGILYLYE 230
            L    +  K  ++LI + +  G L    F+   E  +L+ ++  + LK +  G+ YL+ 
Sbjct: 72  TLHDIFE-NKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLHS 126

Query: 231 GWESKVLHRDIKASNVLLDKKMNA----RLGDFGLAKMHHHGQVMS 272
               ++ H D+K  N++L  K       +L DFG+A     G    
Sbjct: 127 ---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK 169

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 62.3 bits (152), Expect = 6e-11
 Identities = 38/165 (23%), Positives = 67/165 (40%), Gaps = 20/165 (12%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRI--SLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
            +G G    V +      G+E A K I     S    ++   E     +L+H N+V L  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIA---LSWEQRIKVLKDVASGILYLYEGW 232
             + E+    L++D +  G L       ++ +A    S       ++ +   I Y +   
Sbjct: 96  SIQ-EESFHYLVFDLVTGGEL------FEDIVAREFYSEADASHCIQQILESIAYCHS-- 146

Query: 233 ESKVLHRDIKASNVLL-DKKMNARL--GDFGLAKMHHHGQVMSGR 274
            + ++HR++K  N+LL  K   A +   DFGLA   +  +   G 
Sbjct: 147 -NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 190

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 61.7 bits (150), Expect = 9e-11
 Identities = 33/173 (19%), Positives = 67/173 (38%), Gaps = 38/173 (21%)

Query: 121 IGLGGNGKVYKGQ--LLGVEVALKRIS---LDSEHGMREFLA-----EVSSLGRLKHRNL 170
           +G G  G V+         EV +K I    +  +  + +        E++ L R++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 171 VGLRGWCKKEKESLILI----------YDY-MENGSLDKWIFECDESIALSWEQRIKVLK 219
           + +    + +     L+          + +   +  LD       E +A        + +
Sbjct: 92  IKVLDIFENQGF-FQLVMEKHGSGLDLFAFIDRHPRLD-------EPLA------SYIFR 137

Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
            + S + YL       ++HRDIK  N+++ +    +L DFG A     G++  
Sbjct: 138 QLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY 187

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 10/155 (6%)

Query: 115 FSEENVIGLGGNGKVYKGQLLGVEV--ALKRISLD---SEHGMREFLAEVSSLGRLKHRN 169
           F +  V+G GG G+V+  Q+       A K+++        G +  + E   L ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGILYL 228
           +V L  +  + K  L L+   M  G +   I+  DE      E R       + SG+ +L
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           ++     +++RD+K  NVLLD   N R+ D GLA 
Sbjct: 306 HQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAV 337

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 12/166 (7%)

Query: 115 FSEENVIGLGGNGKVYKGQLLGVEV--ALKRISLD---SEHGMREFLAEVSSLGRLKHRN 169
           F +  V+G GG G+V   Q+       A K++         G    L E   L ++  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGILYL 228
           +V L  +  + K++L L+   M  G L   I+   ++     E R      ++  G+  L
Sbjct: 246 VVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP--EARAVFYAAEICCGLEDL 302

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGR 274
           +     ++++RD+K  N+LLD   + R+ D GLA     GQ + GR
Sbjct: 303 HR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR 345

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 41/165 (24%), Positives = 70/165 (42%), Gaps = 29/165 (17%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRISLD--SEHGMREFLA-EVSSLGRLKHRNLVGLRG 175
           +G G  GKV          +VALK IS     +  M   +  E+S L  L+H +++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 176 -WCKKEKESLIL------IYDY-MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
                    +++      ++DY +E   +        E     + Q+I         I Y
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRMT-------EDEGRRFFQQI------ICAIEY 123

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
            +     K++HRD+K  N+LLD  +N ++ DFGL+ +   G  + 
Sbjct: 124 CHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 21/168 (12%)

Query: 118 ENVIGLGGNGKVYKGQ--LLGVEVALKRI------SLDSEHGMREFLAEVSSLGRLKHRN 169
              +G G    V K +    G++ A K I      S        +   EVS L  ++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFE-CDESIALSWEQRIKVLKDVASGILYL 228
           ++ L    +  K  +ILI + +  G L    F+   E  +L+ E+  + LK + +G+ YL
Sbjct: 76  VITLHEVYE-NKTDVILILELVAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYL 130

Query: 229 YEGWESKVLHRDIKASNVLL----DKKMNARLGDFGLAKMHHHGQVMS 272
           +     ++ H D+K  N++L      K   ++ DFGLA     G    
Sbjct: 131 HS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK 175

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 20/154 (12%)

Query: 120 VIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGW 176
           V+GLG NGKV +        + ALK +  D     RE    V    R  +  ++V +   
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARRE----VELHWRASQCPHIVRIVDV 79

Query: 177 C---KKEKESLILIYDYMENGSL-DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
                  ++ L+++ + ++ G L  + I +  +  A +  +  +++K +   I YL+   
Sbjct: 80  YENLYAGRKCLLIVMECLDGGELFSR-IQDRGDQ-AFTEREASEIMKSIGEAIQYLHS-- 135

Query: 233 ESKVLHRDIKASNVLL-DKKMNA--RLGDFGLAK 263
              + HRD+K  N+L   K+ NA  +L DFG AK
Sbjct: 136 -INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 42/169 (24%), Positives = 63/169 (37%), Gaps = 27/169 (15%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMRE--FLAEVSSLGRLKHRNLVGLRG 175
            +G G    V +    L G E A   I+              E      LKH N+V L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 176 WCKKEKESLILIYDYMENGSLDKWIF------ECDESIALSWEQRIKVLKDVASGILYLY 229
               E+    LI+D +  G L + I       E D S           ++ +   +L+ +
Sbjct: 78  SIS-EEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---------HCIQQILEAVLHCH 127

Query: 230 EGWESKVLHRDIKASNVLL-DKKMNARL--GDFGLAK-MHHHGQVMSGR 274
           +     V+HR++K  N+LL  K   A +   DFGLA  +    Q   G 
Sbjct: 128 Q---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 173

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 59.6 bits (145), Expect = 5e-10
 Identities = 36/164 (21%), Positives = 67/164 (40%), Gaps = 15/164 (9%)

Query: 120 VIGLGGNGKVYKGQ--LLGVEVALKRI--SLDSEHGMREFLAEVSSLGRLKHR-NLVGLR 174
            +G G    V +      G E A K +      +    E L E++ L   K    ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 175 GWCKKEKESLILIYDYMENGSL-DKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
              +     +ILI +Y   G +    + E  E   +S    I+++K +  G+ YL++   
Sbjct: 96  EVYE-NTSEIILILEYAAGGEIFSLCLPELAEM--VSENDVIRLIKQILEGVYYLHQ--- 149

Query: 234 SKVLHRDIKASNVLL-DKKMNARL--GDFGLAKMHHHGQVMSGR 274
           + ++H D+K  N+LL        +   DFG+++   H   +   
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI 193

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 38/200 (19%), Positives = 69/200 (34%), Gaps = 47/200 (23%)

Query: 112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN 169
           +K +S    +G G  G V +   +  G   ALK++  D  +  RE    +  +  L H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61

Query: 170 LVGLR------GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI-------- 215
           ++ L       G  + +       ++ +   +           +  S  + +        
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 216 ----KVLKDVAS-------------------GILYLYEGWESKVLHRDIKASNVLLDKKM 252
               KVLK                        + +++      + HRDIK  N+L++ K 
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKD 178

Query: 253 NA-RLGDFGLAKMHHHGQVM 271
           N  +L DFG AK     +  
Sbjct: 179 NTLKLCDFGSAKKLIPSEPS 198

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 19/148 (12%), Positives = 49/148 (33%), Gaps = 14/148 (9%)

Query: 120 VIGLGGNGKVYKG--QLLGVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLR 174
             G     + ++     L  +VAL  +       +  ++E L+    L R+    +  + 
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
                 +   +++ +++  GSL +         + S    I+ ++ +A+     +    +
Sbjct: 98  DVVH-TRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHR---A 148

Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLA 262
            V       S V +    +  L      
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATM 176

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 43/169 (25%), Positives = 76/169 (44%), Gaps = 34/169 (20%)

Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           + +   +G GGNG V+          VA+K+I L     ++  L E+  + RL H N+V 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72

Query: 173 LR-------------GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK--- 216
           +                   E  S+ ++ +YME   L   +    E   L  E+  +   
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL----EQGPLL-EEHARLFM 126

Query: 217 --VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK-MNARLGDFGLA 262
             +L+    G+ Y++      VLHRD+K +N+ ++ + +  ++GDFGLA
Sbjct: 127 YQLLR----GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLA 168

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.0 bits (139), Expect = 2e-09
 Identities = 33/195 (16%), Positives = 58/195 (29%), Gaps = 44/195 (22%)

Query: 111 ATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSE--------HGMREFLAEVSSL 162
            T+       IG G  G+V++       VA+K I+++              E L E+   
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 163 GRL---------KHRNLVGLRGWCK---KEKESLILIYDYM--ENGSLDK---------- 198
             L         +    +GL             L+  +D+     GS +           
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137

Query: 199 -WIFECDE---------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL 248
             + E +          +   S      +L  + + +         +  HRD+   NVLL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLL 195

Query: 249 DKKMNARLGDFGLAK 263
            K    +L      K
Sbjct: 196 KKTSLKKLHYTLNGK 210

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 49/255 (19%), Positives = 94/255 (36%), Gaps = 29/255 (11%)

Query: 29  SIGDALVTTHLPSF--ELPKDSVFRSKGFILGVSVGGLLIMGCGVVVYMVCLKRKGKKMK 86
            I D  +   L +      K ++   +G ++   V   L       +  +C   +G   +
Sbjct: 107 EIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPY---IEEICQNLRGDVFQ 163

Query: 87  DVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEV--ALKRI 144
              E++ +        V     H     FS   +IG GG G+VY  +        A+K +
Sbjct: 164 KFIESDKFTRFCQWKNVELNI-HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL 222

Query: 145 SLDS-------EHGM--REFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS 195
                         +  R  L+ VS+        +V +  +     + L  I D M  G 
Sbjct: 223 DKKRIKMKQGETLALNERIMLSLVSTG---DCPFIVCMS-YAFHTPDKLSFILDLMNGGD 278

Query: 196 LDKWIFECDESIALSWEQRIKV-LKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNA 254
           L   + +         E  ++    ++  G+ +++      V++RD+K +N+LLD+  + 
Sbjct: 279 LHYHLSQHGVFS----EADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHV 331

Query: 255 RLGDFGLAKMHHHGQ 269
           R+ D GLA      +
Sbjct: 332 RISDLGLACDFSKKK 346

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 57.2 bits (139), Expect = 2e-09
 Identities = 40/160 (25%), Positives = 68/160 (42%), Gaps = 34/160 (21%)

Query: 120 VIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMRE-----FLAEVSSLGRLKHRNLVG 172
           ++G G    V   + L    E A+K   L+  H ++E        E   + RL H   V 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIK--ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94

Query: 173 LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD---------VAS 223
           L  +  ++ E L     Y +NG L            L + ++I    +         + S
Sbjct: 95  LY-FTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIVS 141

Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            + YL+      ++HRD+K  N+LL++ M+ ++ DFG AK
Sbjct: 142 ALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAK 178

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 38/174 (21%), Positives = 75/174 (43%), Gaps = 24/174 (13%)

Query: 112 TKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLK 166
            K +     IG G  G V      +L   VA+K++S    +  H  R    E+  +  + 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVN 119

Query: 167 HRNLVGLR-----GWCKKEKESLILIYDYMENGSLDKWIFE--CDESIALSWEQRIKVLK 219
           H+N++ L          +E + + L+ + M+  +L + I      E ++    Q +  +K
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIK 178

Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSG 273
                  +L     + ++HRD+K SN+++      ++ DFGLA+      +M+ 
Sbjct: 179 -------HL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 222

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 41/203 (20%), Positives = 83/203 (40%), Gaps = 24/203 (11%)

Query: 71  VVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVY 130
           + +Y  C     ++ K++ E  +W     P     +++    + F    VIG G  G+V 
Sbjct: 35  ICLYDECNNSPLRREKNILEYLEW---AKPFTSKVKQMRLHREDFEILKVIGRGAFGEVA 91

Query: 131 ------KGQLLGVEVALKRISL---DSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK 181
                   ++  +++  K   L   ++      F  E   L     + +  L  +  ++ 
Sbjct: 92  VVKLKNADKVFAMKILNKWEMLKRAETAC----FREERDVLVNGDSKWITTLH-YAFQDD 146

Query: 182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGILYLYEGWESKVLHRD 240
            +L L+ DY   G L   + + ++ +    E+  +  L ++   I  +++      +HRD
Sbjct: 147 NNLYLVMDYYVGGDLLTLLSKFEDRLP---EEMARFYLAEMVIAIDSVHQ---LHYVHRD 200

Query: 241 IKASNVLLDKKMNARLGDFGLAK 263
           IK  N+L+D   + RL DFG   
Sbjct: 201 IKPDNILMDMNGHIRLADFGSCL 223

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 42/163 (25%), Positives = 63/163 (38%), Gaps = 32/163 (19%)

Query: 121 IGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
           IG G  G       +L    VA+K I       E+  RE    + +   L+H N+V    
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRF-- 81

Query: 176 WCKKE----KESLILIYDYMENGSLDKWIFE---CDESIALSWEQRIKVLKDVASGILYL 228
              KE       L +I +Y   G L + I       E  A  + Q++       SG+ Y 
Sbjct: 82  ---KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL------LSGVSYC 132

Query: 229 YEGWESKVLHRDIKASNVLLDKK--MNARLGDFGLAKMHHHGQ 269
           +     ++ HRD+K  N LLD       ++ DFG +K      
Sbjct: 133 HS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 56.5 bits (137), Expect = 5e-09
 Identities = 48/179 (26%), Positives = 84/179 (46%), Gaps = 37/179 (20%)

Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS-----LDSEHGMREFLAEVSSLGRLKH 167
           ++  + IG G  G V      L  V VA+K+IS        +  +RE    +  L R +H
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE----IKILLRFRH 84

Query: 168 RNLVGL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-----VL 218
            N++G+    R    ++ + + ++ D ME   L K +    ++  LS    I      +L
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL----KTQHLS-NDHICYFLYQIL 138

Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM----HHHGQVMSG 273
           +    G+ Y+     + VLHRD+K SN+LL+   + ++ DFGLA++    H H   ++ 
Sbjct: 139 R----GLKYI---HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 56.3 bits (136), Expect = 6e-09
 Identities = 48/213 (22%), Positives = 81/213 (38%), Gaps = 25/213 (11%)

Query: 71  VVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVY 130
           + V+      +  + K V +   W     P  V  +E+      F    VIG G   +V 
Sbjct: 22  LGVHQELGASELAQDKYVADFLQW---AEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVA 78

Query: 131 ------KGQLLGVEVALKRISL---DSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK 181
                  GQ+  +++  K   L   +       F  E   L     R +  L  +  +++
Sbjct: 79  VVKMKQTGQVYAMKIMNKWDMLKRGEVSC----FREERDVLVNGDRRWITQLH-FAFQDE 133

Query: 182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV-LKDVASGILYLYEGWESKVLHRD 240
             L L+ +Y   G L   + +  E I     +  +  L ++   I  ++       +HRD
Sbjct: 134 NYLYLVMEYYVGGDLLTLLSKFGERIP---AEMARFYLAEIVMAIDSVHR---LGYVHRD 187

Query: 241 IKASNVLLDKKMNARLGDFGLAK-MHHHGQVMS 272
           IK  N+LLD+  + RL DFG    +   G V S
Sbjct: 188 IKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 54.2 bits (131), Expect = 3e-08
 Identities = 40/166 (24%), Positives = 75/166 (45%), Gaps = 28/166 (16%)

Query: 112 TKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS--LDSEHGMREFLAEVSSLGRLKH 167
            K +     +G G  G V     +  G +VA+K++S    SE   +    E+  L  ++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 168 RNLVGLR-----GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-----V 217
            N++GL          +      L+  +M+   L K +      +  S E++I+     +
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-----GLKFS-EEKIQYLVYQM 135

Query: 218 LKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           LK    G+ Y+     + V+HRD+K  N+ +++    ++ DFGLA+
Sbjct: 136 LK----GLKYI---HSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 54.3 bits (131), Expect = 3e-08
 Identities = 35/165 (21%), Positives = 74/165 (44%), Gaps = 27/165 (16%)

Query: 112 TKGFSEENVIGLGGNGKVYK--GQLLGVEVALKRISLDSEHGM--REFLAEVSSLGRLKH 167
            + +   + +G G  G V        G+ VA+K++S   +  +  +    E+  L  +KH
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 168 RNLVGLR-----GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-----V 217
            N++GL          +E   + L+   M    L+  +    +   L+ +  ++     +
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV----KCQKLT-DDHVQFLIYQI 141

Query: 218 LKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           L+    G+ Y+     + ++HRD+K SN+ +++    ++ DFGLA
Sbjct: 142 LR----GLKYI---HSADIIHRDLKPSNLAVNEDCELKILDFGLA 179

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 39/174 (22%), Positives = 76/174 (43%), Gaps = 45/174 (25%)

Query: 112 TKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRIS------LDSEHGMREFLAEVSSLG 163
              +  +++IG G  G VY    +     VA+K+++      +D +  +RE    ++ L 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE----ITILN 80

Query: 164 RLKHRNLVGLRGWCK----KEKESLILIYDYMENGSLDKWIFECD------ESIALSWEQ 213
           RLK   ++ L          + + L ++ +  +           D        I L+ E+
Sbjct: 81  RLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD----------SDLKKLFKTPIFLT-EE 129

Query: 214 RIK-----VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
            IK     +L     G  +++E     ++HRD+K +N LL++  + ++ DFGLA
Sbjct: 130 HIKTILYNLLL----GENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 53.5 bits (129), Expect = 4e-08
 Identities = 45/190 (23%), Positives = 75/190 (39%), Gaps = 32/190 (16%)

Query: 105 YQEIHAATKGFSEENVIGLGGNGKVYKGQ-LLGVEVALKRIS--LDSEHGMREF------ 155
             E+HA    ++ +  I  G  G V  G    G+ VA+KR+   +     +         
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 156 ---LAEVSSLGRLKHRNLVGL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIA 208
              L E+  L    H N++GL      + +     L L+ + M    L + I   D+ I 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH--DQRIV 130

Query: 209 LSWEQRIK-----VLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +S  Q I+     +L     G+  L+E     V+HRD+   N+LL    +  + DF LA+
Sbjct: 131 IS-PQHIQYFMYHILL----GLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR 182

Query: 264 MHHHGQVMSG 273
                   + 
Sbjct: 183 EDTADANKTH 192

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 38/210 (18%), Positives = 72/210 (34%), Gaps = 40/210 (19%)

Query: 71  VVVYMVCLKRKGKKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVY 130
             +         +K K+++        Y       +++    + +    VIG G  G+V 
Sbjct: 30  DALVYDLDFPALRKNKNIDNFLSR---YKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQ 86

Query: 131 --KGQLLGVEVALKRIS-------LDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK 181
             + +      A+K +S        DS      F  E   +       +V L  +  ++ 
Sbjct: 87  LVRHKSTRKVYAMKLLSKFEMIKRSDSAF----FWEERDIMAFANSPWVVQLF-YAFQDD 141

Query: 182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVA--------SGILYLYEGWE 233
             L ++ +YM  G L            ++      V +  A          +  ++    
Sbjct: 142 RYLYMVMEYMPGGDL------------VNLMSNYDVPEKWARFYTAEVVLALDAIHS--- 186

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
              +HRD+K  N+LLDK  + +L DFG   
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 53.2 bits (128), Expect = 7e-08
 Identities = 39/174 (22%), Positives = 77/174 (44%), Gaps = 30/174 (17%)

Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS---LDSEHGMREFLAEVSSLGRLKHRN 169
           +     IG G  G V      +L   VA+K++S    +  H  R    E+  +  + H+N
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVNHKN 85

Query: 170 LVGLR-----GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-----VLK 219
           ++GL          +E + + ++ + M+  +L + I      + L   +R+      +L 
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI-----QMELD-HERMSYLLYQMLC 138

Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSG 273
               GI +L     + ++HRD+K SN+++      ++ DFGLA+      +M+ 
Sbjct: 139 ----GIKHL---HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 185

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 51.9 bits (125), Expect = 2e-07
 Identities = 33/153 (21%), Positives = 66/153 (43%), Gaps = 17/153 (11%)

Query: 119 NVIGLGGNGKVYKG--QLLGVEVALKRIS--LDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
             +G G  G V        G +VA+K++     SE   +    E+  L  ++H N++GL 
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90

Query: 175 -----GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
                     +     L+  +M    L K +    +   L  ++   ++  +  G+ Y+ 
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGT-DLGKLM----KHEKLGEDRIQFLVYQMLKGLRYI- 144

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
               + ++HRD+K  N+ +++    ++ DFGLA
Sbjct: 145 --HAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 40/164 (24%), Positives = 73/164 (44%), Gaps = 27/164 (16%)

Query: 112 TKGFSEENVIGLGGNGKVYKG--QLLGVEVALKRISL--DSEHGMREFLAEVSSLGRLKH 167
           +  F  ++++G G  G V     +  G  VA+K+I         +R  L E+  L   KH
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKH 68

Query: 168 RNLVGL----RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-----VL 218
            N++ +    R    +    + +I + M+   L + I     +  LS +  I+      L
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI----STQMLS-DDHIQYFIYQTL 122

Query: 219 KDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
           +     +  L+      V+HRD+K SN+L++   + ++ DFGLA
Sbjct: 123 R----AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52

 Score = 46.0 bits (109), Expect = 3e-07
 Identities = 11/26 (42%), Positives = 18/26 (69%)

Query: 1  MHVGFSAGTGQLVESHKILAWSFSNS 26
          + +GFSA TG    +H++L+WSF + 
Sbjct: 20 VRIGFSATTGAEYAAHEVLSWSFHSE 45

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 23/79 (29%), Positives = 35/79 (44%), Gaps = 7/79 (8%)

Query: 203 CDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
                 L+ E  I     VA G+ +L      K +HRD+ A N+LL +K   ++ DFGLA
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA 240

Query: 263 KMHHHGQVM----SGRRPI 277
           +  +           R P+
Sbjct: 241 RDIYKDPDYVRKGDARLPL 259

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 23/107 (21%), Positives = 43/107 (40%), Gaps = 13/107 (12%)

Query: 118 ENVIGLGGNGKVYKGQLLGVEVA----------LKRISLDSEHGMREFLAEVSSLGRL-K 166
              +G G  G+V +    G++            LK  +  SE   R  ++E+  L  +  
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALMSELKILIHIGH 84

Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQ 213
           H N+V L G C K    L++I ++ + G+L  ++            +
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK 131

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 49.6 bits (119), Expect = 8e-07
 Identities = 37/164 (22%), Positives = 70/164 (42%), Gaps = 24/164 (14%)

Query: 120 VIGLGGNGKVYKGQLLGVEV--ALKRISLDSEHGMREF---LAEVSSLGRLKHRNLVGLR 174
            IG G  GKV   Q    +   A+K ++        E      E+  +  L+H  LV L 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 175 GWCKKEKESLILIYDYMENGSL-----DKWIFECDESIALSWEQRIKV-LKDVASGILYL 228
               +++E + ++ D +  G L         F+         E+ +K+ + ++   + YL
Sbjct: 82  Y-SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK---------EETVKLFICELVMALDYL 131

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
                 +++HRD+K  N+LLD+  +  + DF +A M      ++
Sbjct: 132 QN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 32/163 (19%)

Query: 115 FSEENVIGLGGNGKVYKG--QLLGVEVALKRIS------LDSEHGMREFLAEVSSLGRLK 166
           +     +G G  G V+K   +  G  VA+K+I        D++   RE    +  L  L 
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE----IMILTELS 66

Query: 167 -HRNLVGLRGWCKKEK-ESLILIYDYMENGSLDKWIFECDESIALSWEQRIK-----VLK 219
            H N+V L    + +    + L++DYME   L   I     +  L      +     ++K
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVI----RANILE-PVHKQYVVYQLIK 120

Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA 262
                I YL+ G    +LHRD+K SN+LL+ + + ++ DFGL+
Sbjct: 121 ----VIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253

 Score = 48.2 bits (114), Expect = 1e-06
 Identities = 17/48 (35%), Positives = 27/48 (56%), Gaps = 2/48 (4%)

Query: 1   MHVGFSAGTGQLV--ESHKILAWSFSNSNFSIGDALVTTHLPSFELPK 46
           + +GFSA TG  +  ESH +L+WSF+++       +    L SF L +
Sbjct: 204 VRIGFSAATGLDIPGESHDVLSWSFASNLPHASSNIDPLDLTSFVLHE 251

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234

 Score = 47.5 bits (112), Expect = 2e-06
 Identities = 13/29 (44%), Positives = 19/29 (65%), Gaps = 1/29 (3%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNSNFS 29
           + +GFSA TG    +H++L+WSF  S  S
Sbjct: 207 VRIGFSATTGAEYAAHEVLSWSFH-SELS 234

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232

 Score = 47.4 bits (112), Expect = 2e-06
 Identities = 9/27 (33%), Positives = 15/27 (55%), Gaps = 1/27 (3%)

Query: 1   MHVGFSAGTGQL-VESHKILAWSFSNS 26
           +  GFSA       + H I +WSF+++
Sbjct: 202 VKFGFSASGSLGGRQIHLIRSWSFTST 228

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 39/156 (25%), Positives = 65/156 (41%), Gaps = 25/156 (16%)

Query: 120 VIGLGGNGKVY------KGQLLGVEVALKRISL---DSEHGMRE--FLAEVSSLGRLKHR 168
           V+G G  GKV         +L  V++  K + +   D E  M E   LA        K  
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-----KPP 402

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLK-DVASGILY 227
            L  L   C +  + L  + +Y+  G L   I +         E        ++A G+ +
Sbjct: 403 FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK----EPHAVFYAAEIAIGLFF 457

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           L       +++RD+K  NV+LD + + ++ DFG+ K
Sbjct: 458 LQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 490

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133

 Score = 45.5 bits (107), Expect = 3e-06
 Identities = 12/26 (46%), Positives = 18/26 (69%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNS 26
           + VG SA TGQ  E + + +WSF++S
Sbjct: 88  VRVGLSASTGQDKERNTVHSWSFTSS 113

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261

 Score = 46.7 bits (110), Expect = 5e-06
 Identities = 10/26 (38%), Positives = 20/26 (76%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNS 26
           + VGFSA +G+  ++H + +WSF+++
Sbjct: 220 VRVGFSAASGEQFQTHNLESWSFTST 245

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240

 Score = 46.4 bits (109), Expect = 5e-06
 Identities = 15/26 (57%), Positives = 20/26 (76%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNS 26
           + VGFSA TGQ  +++ ILAWSF +S
Sbjct: 208 VRVGFSATTGQYTQTNNILAWSFRSS 233

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 46.8 bits (112), Expect = 7e-06
 Identities = 37/159 (23%), Positives = 69/159 (43%), Gaps = 32/159 (20%)

Query: 120 VIGLGGNGKVY------KGQLLGVEVALKRISL---DSEHGMREFLAEVSSLGRLKHRNL 170
           ++G G  GKV        G+   +++  K + +   +  H +     E   L   +H  L
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----TESRVLQNTRHPFL 67

Query: 171 VGLRGWCKKEKESLILIYDYMENGSL-----DKWIFECDESIALSWEQRIKV-LKDVASG 224
             L+ +  +  + L  + +Y   G L      + +F          E+R +    ++ S 
Sbjct: 68  TALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFT---------EERARFYGAEIVSA 117

Query: 225 ILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           + YL+      V++RDIK  N++LDK  + ++ DFGL K
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 47.0 bits (112), Expect = 7e-06
 Identities = 38/161 (23%), Positives = 68/161 (42%), Gaps = 31/161 (19%)

Query: 120 VIGLGGNGKVY------KGQLLGVEVALKRISL---DSEHGMREFLAEVSSLGRLKHRNL 170
           ++G G  GKV        G+   +++  K + +   +  H +     E   L   +H  L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL----TENRVLQNSRHPFL 210

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV------LKDVASG 224
             L+ +  +  + L  + +Y   G L    F       LS E+            ++ S 
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGEL---FFH------LSRERVFSEDRARFYGAEIVSA 260

Query: 225 ILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
           + YL+   E  V++RD+K  N++LDK  + ++ DFGL K  
Sbjct: 261 LDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 46.1 bits (110), Expect = 9e-06
 Identities = 41/203 (20%), Positives = 77/203 (37%), Gaps = 39/203 (19%)

Query: 80  RKGKKMKDVEETEDWELEYWPHRVSYQEIHAAT-KGFSEENVIGLGGNGKVYKGQLLGVE 138
           +KG + + V+E      E +  +      + A    F     +G G  G+V   +     
Sbjct: 7   KKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESG 66

Query: 139 --VALKRISLDS-------EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD 189
              A+K +           EH +     E   L  +    LV L  +  K+  +L ++ +
Sbjct: 67  NHYAMKILDKQKVVKLKQIEHTL----NEKRILQAVNFPFLVKLE-FSFKDNSNLYMVME 121

Query: 190 YMENGSLDKWIFECDESIALSWEQRIKVLKD---------VASGILYLYEGWESKVLHRD 240
           Y+  G +    F        S  +RI    +         +     YL+      +++RD
Sbjct: 122 YVAGGEM----F--------SHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRD 166

Query: 241 IKASNVLLDKKMNARLGDFGLAK 263
           +K  N+L+D++   ++ DFG AK
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAK 189

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 40/197 (20%), Positives = 76/197 (38%), Gaps = 40/197 (20%)

Query: 89  EETEDWELEYWPHRVSYQEIHAATKGFSEEN-----VIGLGGNGKVY------KGQLLGV 137
           +      +E     ++ +E   A+     ++     VIG G   KV         ++  +
Sbjct: 23  QGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAM 82

Query: 138 EVALKRISL---DSEHGMRE--FLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME 192
            V  K +     D +    E     + S      H  LVGL   C + +  L  + +Y+ 
Sbjct: 83  RVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHPFLVGLH-SCFQTESRLFFVIEYVN 136

Query: 193 NGSL-----DKWIFECDESIALSWEQRIKV-LKDVASGILYLYEGWESKVLHRDIKASNV 246
            G L      +             E+  +    +++  + YL+E     +++RD+K  NV
Sbjct: 137 GGDLMFHMQRQRKLP---------EEHARFYSAEISLALNYLHE---RGIIYRDLKLDNV 184

Query: 247 LLDKKMNARLGDFGLAK 263
           LLD + + +L D+G+ K
Sbjct: 185 LLDSEGHIKLTDYGMCK 201

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252

 Score = 45.1 bits (106), Expect = 2e-05
 Identities = 18/49 (36%), Positives = 26/49 (53%), Gaps = 4/49 (8%)

Query: 1   MHVGFSAGTG---QLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPK 46
           + VGFSA TG     VE++ +L+WSF+ S  S        +L +  L K
Sbjct: 203 VSVGFSATTGINKGNVETNDVLSWSFA-SKLSDETTSEGLNLANLVLNK 250

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 35/161 (21%)

Query: 120 VIGLGGNGKVY------KGQLLGVEVALKRISL---DSEHGMRE--FLAEVSSLGRLKHR 168
           VIG G   KV         ++  ++V  K +     D +    E     + S      H 
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-----NHP 70

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSL-----DKWIFECDESIALSWEQRIKV-LKDVA 222
            LVGL   C + +  L  + +Y+  G L      +             E+  +    +++
Sbjct: 71  FLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLP---------EEHARFYSAEIS 120

Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             + YL+E     +++RD+K  NVLLD + + +L D+G+ K
Sbjct: 121 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 44.9 bits (107), Expect = 3e-05
 Identities = 46/161 (28%), Positives = 71/161 (44%), Gaps = 35/161 (21%)

Query: 120 VIGLGGNGKVY------KGQLLGVEVALKRISL---DSEHGM--REFLAEVSSLGRLKHR 168
           VIG G  GKV       +     V+V  K+  L   + +H M  R  L +      +KH 
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK-----NVKHP 99

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSL-----DKWIFECDESIALSWEQRIKV-LKDVA 222
            LVGL  +  +  + L  + DY+  G L      +  F          E R +    ++A
Sbjct: 100 FLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFL---------EPRARFYAAEIA 149

Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           S + YL+      +++RD+K  N+LLD + +  L DFGL K
Sbjct: 150 SALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK 187

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 34/157 (21%), Positives = 61/157 (38%), Gaps = 29/157 (18%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG--- 175
           IG G  G++  G+ L     VA+K   + S                  ++ L    G   
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-------YKQLGSGDGIPQ 69

Query: 176 --WCKKEKESLILIYDYMENG-SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
             +     +   ++ + +  G SL+     CD + +L      K +  +A  ++   E  
Sbjct: 70  VYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL------KTVLMIAIQLISRMEYV 121

Query: 233 ESK-VLHRDIKASNVLLDKKMNAR-----LGDFGLAK 263
            SK +++RD+K  N L+ +  N       + DF LAK
Sbjct: 122 HSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 44.9 bits (107), Expect = 3e-05
 Identities = 42/161 (26%), Positives = 69/161 (42%), Gaps = 35/161 (21%)

Query: 120 VIGLGGNGKVY------KGQLLGVEVALKRISL---DSEHGMRE--FLAEVSSLGRLKHR 168
           V+G G  GKV        G L  V+V  K + L   D E  M E   L+         H 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-----NHP 84

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSL-----DKWIFECDESIALSWEQRIKV-LKDVA 222
            L  L   C +  + L  + +++  G L         F+         E R +    ++ 
Sbjct: 85  FLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---------EARARFYAAEII 134

Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           S +++L++     +++RD+K  NVLLD + + +L DFG+ K
Sbjct: 135 SALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK 172

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 44.4 bits (106), Expect = 3e-05
 Identities = 35/162 (21%), Positives = 66/162 (40%), Gaps = 38/162 (23%)

Query: 120 VIGLGGNGKVYKGQLLGVE--VALKRISLDS-------EHGMREFLAEVSSLGRLKHRNL 170
            +G G  G+V+  +        A+K +  +        EH       E   L  + H  +
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN----DERLMLSIVTHPFI 68

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKD---------V 221
           + +     ++ + + +I DY+E G L    F        S  ++ +   +         V
Sbjct: 69  IRMW-GTFQDAQQIFMIMDYIEGGEL----F--------SLLRKSQRFPNPVAKFYAAEV 115

Query: 222 ASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
              + YL+      +++RD+K  N+LLDK  + ++ DFG AK
Sbjct: 116 CLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK 154

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 34/161 (21%)

Query: 120 VIGLGGNGKVY---------KGQLLGVEVALKR--ISLDSEHGMREFLAEVSSLGRLKHR 168
           V+G G  GKV+           QL  ++V  K      D          E   L  + H 
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK----MERDILVEVNHP 86

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSL-----DKWIFECDESIALSWEQRIKV-LKDVA 222
            +V L  +  + +  L LI D++  G L      + +F          E+ +K  L ++A
Sbjct: 87  FIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFT---------EEDVKFYLAELA 136

Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
             + +L+      +++RD+K  N+LLD++ + +L DFGL+K
Sbjct: 137 LALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 39/161 (24%), Positives = 65/161 (40%), Gaps = 35/161 (21%)

Query: 120 VIGLGGNGKVY------KGQLLGVEVALKRISL---DSEHGMRE--FLAEVSSLGRLKHR 168
           V+G G  GKV         +L  V++  K + +   D E  M E   LA        K  
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-----KPP 81

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSL-----DKWIFECDESIALSWEQRIKV-LKDVA 222
            L  L   C +  + L  + +Y+  G L         F+         E        ++A
Sbjct: 82  FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK---------EPHAVFYAAEIA 131

Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
            G+ +L       +++RD+K  NV+LD + + ++ DFG+ K
Sbjct: 132 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK 169

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 38/164 (23%)

Query: 120 VIGLGGNGKVY---------KGQLLGVEVALKRISL-----DSEHGMREFLAEVSSLGRL 165
           V+G GG GKV+          G++  ++V LK+  +     D+ H      AE + L  +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKV-LKKAMIVRNAKDTAHTK----AERNILEEV 78

Query: 166 KHRNLVGLRGWCKKEKESLILIYDYMENGSL-----DKWIFECDESIALSWEQRIKV-LK 219
           KH  +V L  +  +    L LI +Y+  G L      + IF          E      L 
Sbjct: 79  KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFM---------EDTACFYLA 128

Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           +++  + +L++     +++RD+K  N++L+ + + +L DFGL K
Sbjct: 129 EISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 44.1 bits (105), Expect = 4e-05
 Identities = 37/164 (22%), Positives = 65/164 (39%), Gaps = 41/164 (25%)

Query: 120 VIGLGGNGKVY------KGQLLGVEVALKRISL---DSEHGMRE--FLAEVSSLGRLKHR 168
           ++G G  GKV+        Q   ++   K + L   D E  M E   L+        +H 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-----EHP 78

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLK--------- 219
            L  +     + KE+L  + +Y+  G L   I            Q               
Sbjct: 79  FLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI------------QSCHKFDLSRATFYAA 125

Query: 220 DVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK 263
           ++  G+ +L+      +++RD+K  N+LLDK  + ++ DFG+ K
Sbjct: 126 EIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223

 Score = 43.2 bits (101), Expect = 5e-05
 Identities = 14/35 (40%), Positives = 22/35 (62%), Gaps = 3/35 (8%)

Query: 1   MHVGFSAGTGQL---VESHKILAWSFSNSNFSIGD 32
           + VGFSA +G      E+H +L+WSFS+   ++ D
Sbjct: 175 VSVGFSATSGAYQWSYETHDVLSWSFSSKFINLKD 209

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253

 Score = 43.2 bits (101), Expect = 6e-05
 Identities = 14/49 (28%), Positives = 23/49 (46%), Gaps = 4/49 (8%)

Query: 1   MHVGFSAGTG---QLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPK 46
           + +GFSA TG      E+H +L+WSF+ S            + S+ +  
Sbjct: 204 VSIGFSATTGLSEGYTETHDVLSWSFA-SKLPDDSTTEPLDIASYLVRN 251

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233

 Score = 42.8 bits (100), Expect = 8e-05
 Identities = 14/32 (43%), Positives = 22/32 (68%), Gaps = 4/32 (12%)

Query: 1   MHVGFSAGTG---QLVESHKILAWSFSNSNFS 29
           + VGFSA TG    +VE+H I++WSF+  + +
Sbjct: 203 VRVGFSATTGLNAGVVETHDIVSWSFA-VSLA 233

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242

 Score = 42.9 bits (100), Expect = 9e-05
 Identities = 13/34 (38%), Positives = 19/34 (55%), Gaps = 3/34 (8%)

Query: 1   MHVGFSAGTGQLV--ESHKILAWSFSNSNFSIGD 32
           + VGFS G G     E+H +L+W F+ SN    +
Sbjct: 210 VSVGFSGGVGNAAEFETHDVLSWYFT-SNLEANN 242

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257

 Score = 42.5 bits (99), Expect = 1e-04
 Identities = 14/50 (28%), Positives = 23/50 (46%), Gaps = 5/50 (10%)

Query: 1   MHVGFSAGTGQL-VESHKILAWSFSNSNFSIGDALVTTHLPSFELPKDSV 49
           + VG SA TG     +  IL+W FS++  S   ++     P   + +  V
Sbjct: 212 VRVGISASTGNNQFLTVYILSWRFSSNLQS--TSVKAAMEPE--ITRTVV 257

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242

 Score = 42.0 bits (98), Expect = 2e-04
 Identities = 9/27 (33%), Positives = 16/27 (59%), Gaps = 1/27 (3%)

Query: 1   MHVGFSAGTGQ-LVESHKILAWSFSNS 26
           + VGFS  T      +H++L W F+++
Sbjct: 210 VSVGFSGSTYIGRQATHEVLNWYFTST 236

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234

 Score = 41.7 bits (97), Expect = 2e-04
 Identities = 12/27 (44%), Positives = 17/27 (62%), Gaps = 1/27 (3%)

Query: 1   MHVGFSAGT-GQLVESHKILAWSFSNS 26
           + VGFSA T     E H I +WSF+++
Sbjct: 200 VSVGFSATTWNPERERHDIYSWSFTST 226

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243

 Score = 41.7 bits (97), Expect = 2e-04
 Identities = 11/26 (42%), Positives = 16/26 (61%), Gaps = 1/26 (3%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNS 26
           + +GFSAG G   E   IL+W F ++
Sbjct: 213 VRIGFSAGVG-YDEVTYILSWHFFST 237

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240

 Score = 41.7 bits (97), Expect = 2e-04
 Identities = 12/29 (41%), Positives = 18/29 (62%), Gaps = 3/29 (10%)

Query: 1   MHVGFSAGTG---QLVESHKILAWSFSNS 26
           + VGFS  +G      E+H +L+WSFS+ 
Sbjct: 198 VSVGFSPTSGLTEDTTETHDVLSWSFSSK 226

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238

 Score = 41.7 bits (97), Expect = 2e-04
 Identities = 14/35 (40%), Positives = 23/35 (65%), Gaps = 4/35 (11%)

Query: 1   MHVGFSAGTG---QLVESHKILAWSFSNSNFSIGD 32
           ++VG SA TG     VE+H+I++WSF+ S+    +
Sbjct: 205 VNVGLSATTGYQKNAVETHEIISWSFT-SSLQETN 238

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 27/156 (17%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG--- 175
           IG G  G +Y G  +  G EVA+K   + ++H      +++       ++ + G  G   
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-------YKMMQGGVGIPT 69

Query: 176 --WCKKEKESLILIYDYMENG-SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
             WC  E +  +++ + +  G SL+     C    +L      K +  +A  ++   E  
Sbjct: 70  IRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSL------KTVLLLADQMISRIEYI 121

Query: 233 ESK-VLHRDIKASNVLLDKKMNA---RLGDFGLAKM 264
            SK  +HRD+K  N L+          + DFGLAK 
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 32/162 (19%), Positives = 65/162 (40%), Gaps = 37/162 (22%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG--- 175
           IG G  G +++G  L    +VA+K     S+                 ++ L G  G   
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT-------YKLLAGCTGIPN 70

Query: 176 --WCKKEKESLILIYDYMENG-SLDKWIFECD-----ESIALSWEQRIKVLKDVASGILY 227
             +  +E    +L+ D +  G SL+  +  C      +++A++ +Q +  ++ +      
Sbjct: 71  VYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---- 124

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNAR-----LGDFGLAKM 264
                   +++RDIK  N L+ +  +       + DFG+ K 
Sbjct: 125 ------KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239

 Score = 41.3 bits (96), Expect = 3e-04
 Identities = 14/28 (50%), Positives = 21/28 (75%), Gaps = 2/28 (7%)

Query: 1   MHVGFSAGTGQ--LVESHKILAWSFSNS 26
           + VGFSA TG    VE+H +L+WSF+++
Sbjct: 211 VRVGFSAATGYPTEVETHDVLSWSFTST 238

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251

 Score = 41.3 bits (96), Expect = 3e-04
 Identities = 12/29 (41%), Positives = 19/29 (65%), Gaps = 3/29 (10%)

Query: 1   MHVGFSAGTGQ---LVESHKILAWSFSNS 26
           + VGFSA TG     +E+H + +WSF++ 
Sbjct: 208 VRVGFSAATGASGGKIETHDVFSWSFASK 236

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237

 Score = 40.9 bits (95), Expect = 3e-04
 Identities = 11/29 (37%), Positives = 19/29 (65%), Gaps = 3/29 (10%)

Query: 1   MHVGFSAGTG---QLVESHKILAWSFSNS 26
           +  GFSA TG     V+++ +L+WSF ++
Sbjct: 206 VRFGFSATTGIDKGYVQTNDVLSWSFESN 234

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226

 Score = 40.9 bits (95), Expect = 4e-04
 Identities = 16/31 (51%), Positives = 22/31 (70%), Gaps = 4/31 (12%)

Query: 1   MHVGFSAGTG---QLVESHKILAWSFSNSNF 28
           + VGFSA +G   +  E+H +L+WSFS SNF
Sbjct: 196 VSVGFSATSGSKKETTETHNVLSWSFS-SNF 225

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.8 bits (97), Expect = 4e-04
 Identities = 66/496 (13%), Positives = 144/496 (29%), Gaps = 152/496 (30%)

Query: 16  HKILAWSFSNSNFSIGDALVTTHLPSF----------ELPKDSVFRSKGF--ILGVS--- 60
           H  + +      +   D +++    +F          ++PK S+   +    I+      
Sbjct: 4   HHHMDFETGEHQYQYKD-ILSVFEDAFVDNFDCKDVQDMPK-SILSKEEIDHIIMSKDAV 61

Query: 61  VGGLLIMGCGVVVYMVCLKRKGKK-----MKDVEETE-DWELEYW--------------- 99
            G L +           L  K ++     +++V      + +                  
Sbjct: 62  SGTLRLFWT--------LLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI 113

Query: 100 --------------PHRVS----YQEIHAATKGF-SEENVI--GLGGNGKVYKGQLLGVE 138
                          + VS    Y ++  A       +NV+  G+ G+GK      + ++
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK----TWVALD 169

Query: 139 VALKR------------ISLDSEHGMREFLAEVSSL---------GRLKHRNLVGLR-GW 176
           V L              ++L + +     L  +  L          R  H + + LR   
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229

Query: 177 CKKEKESLILIYDYMENGSL-------DKWIFE-----C-------DESIA--LSWEQRI 215
            + E   L+    Y     L       +   +      C        + +   LS     
Sbjct: 230 IQAELRRLLKSKPYEN--CLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTT 287

Query: 216 KV-LKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGR 274
            + L   +     L    E K           LL K ++ R  D     +  + + +S  
Sbjct: 288 HISLDHHSMT---LTPD-EVK----------SLLLKYLDCRPQDLPREVLTTNPRRLSI- 332

Query: 275 RPIEEGKRNLVDRM--WSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEAN 332
             I E  R+ +     W      +L ++++  L        E  +    L +    P + 
Sbjct: 333 --IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVL--EPAEYRKMFDRLSVF---PPSA 385

Query: 333 SRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRG-HPTFNEINK 391
             PT   +L ++          D  + V+ L +    ++        +      + E+  
Sbjct: 386 HIPT--ILLSLIWFDVIK---SDVMVVVNKLHK---YSLVEKQPKESTISIPSIYLELKV 437

Query: 392 NRSSSPSLNASDVLLE 407
              +  +L+ S  +++
Sbjct: 438 KLENEYALHRS--IVD 451

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 44/155 (28%), Positives = 70/155 (45%), Gaps = 27/155 (17%)

Query: 121 IGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG--- 175
           IG G  G++Y G  +    EVA+K  ++ ++H    + +++       +R L G  G   
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKI-------YRILQGGTGIPN 67

Query: 176 --WCKKEKESLILIYDYMENG-SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW 232
             W   E +  +L+ D +  G SL+     C   ++L      K +  +A  ++   E  
Sbjct: 68  VRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSL------KTVLMLADQMINRVEFV 119

Query: 233 ESK-VLHRDIKASNVLLDKKMNAR---LGDFGLAK 263
            SK  LHRDIK  N L+     A    + DFGLAK
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239

 Score = 40.2 bits (93), Expect = 6e-04
 Identities = 10/32 (31%), Positives = 16/32 (50%), Gaps = 4/32 (12%)

Query: 1   MHVGFSAGTG---QLVESHKILAWSFSNSNFS 29
           + VG S  TG      E+H + +WSF  ++  
Sbjct: 208 VDVGLSGATGAQRDAAETHDVYSWSFQ-ASLP 238

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 38/168 (22%), Positives = 59/168 (35%), Gaps = 33/168 (19%)

Query: 121 IGLGGNGKVYKGQLL-------GVEVALKRIS-----LDSEHGMREFLAEVSSLGRLKHR 168
           IG GG G +Y   +             +K        L +E    +  A+   + +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 169 NLVGLRG-----WC----KKEKESLILIYDYMENG-SLDKWIFECDESIALSWEQRIKVL 218
             +   G           K  K    +I D    G  L K      +  +        VL
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRK-----TVL 155

Query: 219 KDVASGILYLYEGWESK-VLHRDIKASNVLLDKKMNAR--LGDFGLAK 263
           + ++  IL + E       +H DIKASN+LL+ K   +  L D+GLA 
Sbjct: 156 Q-LSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	409
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.98
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.98
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.98
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.98
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.91
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.5
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.3
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.26
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.82
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.72
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.69
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	98.62
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.61
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.56
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.55
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.41
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.2
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.09
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	98.05
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.02
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.87
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.69
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.57
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	97.54
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.44
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.3
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.19
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.18
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.94
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.9
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.86
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.47
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.39
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	95.63
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	95.28
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	95.13
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.87
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	94.3
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	94.26
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	93.1
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.95
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	92.77
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	92.77
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	92.29
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	92.26
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	91.94
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	91.71
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	91.35
3niz_A	311	Rhodanese family protein; structural genomics, str	91.31
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	90.57
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	90.53
3o0g_A	292	Cell division protein kinase 5; kinase activator c	90.36
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	90.03
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	89.91
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	89.75
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	89.69
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	89.61
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	89.55
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	89.53
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	89.39
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	89.25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	89.16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	89.1
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	88.93
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	88.87
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	88.75
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	88.68
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	88.62
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	88.57
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	88.31
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	88.25
3rp9_A	458	Mitogen-activated protein kinase; structural genom	88.23
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	88.19
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	88.12
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	88.11
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	87.67
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	87.52
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	87.39
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	87.1
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	87.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	86.99
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	86.78
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	86.76
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	86.68
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	86.61
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	86.57
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	86.55
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	86.53
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	86.42
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	86.41
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	86.33
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	86.22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	86.11
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	85.99
3fme_A	290	Dual specificity mitogen-activated protein kinase;	85.98
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	85.96
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	85.93
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	85.87
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	85.78
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	85.67
2k9y_A	41	Ephrin type-A receptor 2; receptor tyrosine kinase	85.66
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	85.53
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	85.29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	85.28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	85.28
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	85.2
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	84.92
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	84.86
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	84.31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	84.19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	84.03
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	84.01
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	83.94
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	83.93
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	83.9
3bhy_A	283	Death-associated protein kinase 3; death associate	83.85
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	83.67
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	83.41
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	83.16
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	83.11
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	82.77
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	82.29
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	82.03
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	81.9
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	81.89
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	81.86
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	81.83
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	81.62
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	81.58
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	80.51
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	80.47
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	80.35
2l8s_A	54	Integrin alpha-1; transmembrane region, detergent	80.32
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	80.25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	80.22
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	80.18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	80.14

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.8e-48  Score=372.47  Aligned_cols=235  Identities=22%  Similarity=0.338  Sum_probs=184.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      ++|...++||+|+||+||+|++.       ++.||||+++..+....++|.+|+++|++++|||||+++|+|.+ .+.++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-GRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEE
Confidence            45667789999999999999874       57899999987777778899999999999999999999999987 67899


Q ss_pred             EEEEeCCCCCHHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc
Q 048535          186 LIYDYMENGSLDKWIFECDE------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN  253 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~  253 (409)
                      ||||||++|+|.++|+....            ..+++|.++++|+.|||+||+|||   +++||||||||+||||++++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCc
Confidence            99999999999999975421            246999999999999999999999   789999999999999999999


Q ss_pred             EEEecccCcccccCCc------eeeecccc------ccCCCcHHHHHHhhh-------c-------cCcHHHHhhHHhhh
Q 048535          254 ARLGDFGLAKMHHHGQ------VMSGRRPI------EEGKRNLVDRMWSLT-------E-------RSELLSVLDERLKA  307 (409)
Q Consensus       254 ~kl~DFGla~~~~~~~------~~~g~~p~------~~~~~~~~~~vws~~-------~-------~~~~~~~~~~~l~~  307 (409)
                      +||+|||+|+......      ...|...+      ....++..+|||+++       .       .....++++.....
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g  276 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG  276 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999998764432      11222222      236688999999983       1       01112222222111


Q ss_pred             -cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCC
Q 048535          308 -KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGT  351 (409)
Q Consensus       308 -~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  351 (409)
                       ..+.+..+++++.+|+.+||+.||++||||+||++.|+.+.+.|
T Consensus       277 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          277 RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence             13455667788999999999999999999999999999877654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.1e-48  Score=369.47  Aligned_cols=231  Identities=23%  Similarity=0.403  Sum_probs=186.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      ++|...+.||+|+||+||+|++.       +..||||+++..+....++|.+|+++|++++|||||+++|+|.+ ++.++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCEEE
Confidence            56778899999999999999874       57899999987777778899999999999999999999999987 67899


Q ss_pred             EEEEeCCCCCHHHHHhcC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEE
Q 048535          186 LIYDYMENGSLDKWIFEC----------DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNAR  255 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~k  255 (409)
                      ||||||++|||.++|+..          .....++|.++++|+.|||+||+|||   +++||||||||+||||++++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEE
Confidence            999999999999999753          22356999999999999999999999   79999999999999999999999


Q ss_pred             EecccCcccccCCce------eeeccccc------cCCCcHHHHHHhhhccCcHHH----------------HhhHHhhh
Q 048535          256 LGDFGLAKMHHHGQV------MSGRRPIE------EGKRNLVDRMWSLTERSELLS----------------VLDERLKA  307 (409)
Q Consensus       256 l~DFGla~~~~~~~~------~~g~~p~~------~~~~~~~~~vws~~~~~~~~~----------------~~~~~l~~  307 (409)
                      |+|||+|+.......      ..|...+.      ...++..+|+|+++  ..+++                ++......
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~G--vvl~Ellt~G~~Pf~~~~~~~~~~~i~~~  246 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG--VVLWEIFTYGKQPWYQLSNNEVIECITQG  246 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHH--HHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence            999999987644321      12322221      26788999999983  11222                22221111


Q ss_pred             -cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          308 -KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       308 -~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                       ..+.+..+++++.+|+.+||+.||++||||+||++.|+++.+
T Consensus       247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence             124455677889999999999999999999999999987654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-47  Score=365.79  Aligned_cols=228  Identities=25%  Similarity=0.338  Sum_probs=181.3

Q ss_pred             CCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      +++..++||+|+||+||+|++.       ++.||||+++.. .....++|.+|+.+|++++|||||+++|+|.+ ++.++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~~  105 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-DQPLS  105 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-CCEEE
Confidence            4566789999999999999973       578999999754 33446789999999999999999999999987 67789


Q ss_pred             EEEEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC
Q 048535          186 LIYDYMENGSLDKWIFECDE-------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM  252 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~  252 (409)
                      ||||||++|||.++|.....             ...++|.++++|+.|||+||+|||   +++||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            99999999999999965321             246999999999999999999999   78999999999999999999


Q ss_pred             cEEEecccCcccccCCc------eeeecccc------ccCCCcHHHHHHhhhccCcHHHHh----------------hHH
Q 048535          253 NARLGDFGLAKMHHHGQ------VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVL----------------DER  304 (409)
Q Consensus       253 ~~kl~DFGla~~~~~~~------~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~----------------~~~  304 (409)
                      ++||+|||+|+......      ...|...+      ..+.++..+|||+++  ..+++++                ...
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfG--vvl~El~t~g~~Pf~~~~~~~~~~~i  260 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG--VVLWEVFSYGLQPYCGYSNQDVVEMI  260 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTTCCTTTTCCHHHHHHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHH--HHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            99999999998764332      11222222      136788999999983  1222222                111


Q ss_pred             hh-hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          305 LK-AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       305 l~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      .. ...+.+..++..+.+|+.+||+.||++||||.||++.|+..
T Consensus       261 ~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          261 RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            11 11234566778899999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=355.57  Aligned_cols=227  Identities=24%  Similarity=0.377  Sum_probs=179.6

Q ss_pred             hCCCCccceeecCCceEEEEEEECCcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .+++...++||+|+||+||+|++.+ .||||+++..  +....+.|.+|+.+|++++|||||+++|+|.+  +.++||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEEEEEE
Confidence            3667888999999999999998875 5999999744  45667889999999999999999999998864  46899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      ||++|+|.++|+..  ...++|.+++.|+.|||+||+|||   +++||||||||+||||++++++||+|||+|+......
T Consensus       112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            99999999999753  346999999999999999999999   7899999999999999999999999999998754321


Q ss_pred             ------eeeeccccc---------cCCCcHHHHHHhhhccCcHHHHhhHHhhh---------------------cCCCCH
Q 048535          270 ------VMSGRRPIE---------EGKRNLVDRMWSLTERSELLSVLDERLKA---------------------KGGYAD  313 (409)
Q Consensus       270 ------~~~g~~p~~---------~~~~~~~~~vws~~~~~~~~~~~~~~l~~---------------------~~~~~~  313 (409)
                            ..+|...+.         .+.++..+|||+++  ..+++++....++                     ....+.
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~G--vvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~  264 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYG--IVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYK  264 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHH--HHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCT
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHH--HHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccc
Confidence                  223444332         23578999999983  1222222211110                     012334


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      .++..+.+|+.+||+.||++||||.||++.|+.+.
T Consensus       265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          265 NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             TSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            56678999999999999999999999999987653

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.9e-47  Score=362.91  Aligned_cols=244  Identities=20%  Similarity=0.240  Sum_probs=185.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|++.+.||+|+||+||+|+..  |+.||||+++..   .....+.+.+|+++|++++|||||++++++.+ .+.+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEE
Confidence            46999999999999999999987  899999999754   23345779999999999999999999999987 7889999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||||++|+|.+++..   ...+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus       111 mEy~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          111 LSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            999999999999964   346999999999999999999999   89999999999999999999999999999997643


Q ss_pred             Cc------eeeecccccc------CCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCC
Q 048535          268 GQ------VMSGRRPIEE------GKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRP  335 (409)
Q Consensus       268 ~~------~~~g~~p~~~------~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  335 (409)
                      ..      ..+|...+..      ..++...|+|+++  ..+++++....++.+....    ++..-+..          
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlG--vilyeml~G~~PF~~~~~~----~~~~~i~~----------  248 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALG--CIIYQLVAGLPPFRAGNEG----LIFAKIIK----------  248 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHH--HHHHHHHHSSCSSCCSSHH----HHHHHHHH----------
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCCHH----HHHHHHHc----------
Confidence            21      3456655532      5678999999996  4455555554433221111    11111111          


Q ss_pred             CHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccc------cCCCCCccccc
Q 048535          336 TIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAG------SRGHPTFNEIN  390 (409)
Q Consensus       336 t~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~------~~~hp~~~~~~  390 (409)
                                +....+..- .....+++.+|+..||.+|+++++      ++.||||++++
T Consensus       249 ----------~~~~~p~~~-s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          249 ----------LEYDFPEKF-FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             ----------TCCCCCTTC-CHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             ----------CCCCCCccc-CHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence                      111111111 112356777777777777777666      47899999886

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.9e-46  Score=359.98  Aligned_cols=221  Identities=20%  Similarity=0.243  Sum_probs=178.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .+.|+..++||+|+||.||+|++.  |+.||||+++.+..     +.+|+.+|++++|||||++++++.+ ++.+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~-~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVRE-GPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEe
Confidence            356778889999999999999987  89999999975422     2479999999999999999999987 788999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC-cEEEecccCcccccCC
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM-NARLGDFGLAKMHHHG  268 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~  268 (409)
                      ||++|+|.++|..   ...+++.++..++.||+.||+|||   +++||||||||+||||+.++ .+||+|||+|+.....
T Consensus       131 y~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          131 LLEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            9999999999964   346999999999999999999999   89999999999999999998 5999999999976543


Q ss_pred             c---------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhc------------------CCCCHHH
Q 048535          269 Q---------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAK------------------GGYADEV  315 (409)
Q Consensus       269 ~---------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~------------------~~~~~~~  315 (409)
                      .         .++|...+.      ...++...|+|+++  ..+++++....++.                  ...+..+
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlG--vilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  282 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSC--CMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSC  282 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHH--HHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTS
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHH--HHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccC
Confidence            2         234555443      25678899999984  22333332221110                  1234456


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      +..+.+++.+||+.||++|||+.|+++.|..
T Consensus       283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          283 APLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            6789999999999999999999999998764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.7e-46  Score=362.56  Aligned_cols=239  Identities=24%  Similarity=0.343  Sum_probs=189.2

Q ss_pred             HHHHHHhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCC-CceeeEeeE
Q 048535          106 QEIHAATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKH-RNLVGLRGW  176 (409)
Q Consensus       106 ~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H-~niv~l~g~  176 (409)
                      .+++...++|++.+.||+|+||.||+|.+.       ++.||||+++.. .....+.|.+|+.+|.+++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            455566788999999999999999999875       257999999765 34556789999999999965 899999999


Q ss_pred             EEccCCeEEEEEEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCC
Q 048535          177 CKKEKESLILIYDYMENGSLDKWIFECDE-------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKA  243 (409)
Q Consensus       177 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp  243 (409)
                      |.+.++.++||||||++|+|.++|+....             ...++|.+++.++.|||+||+|||   +++||||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCc
Confidence            98756678999999999999999975321             345899999999999999999999   89999999999


Q ss_pred             CCeeeCCCCcEEEecccCcccccCCc--e----eeeccccc------cCCCcHHHHHHhhhccCcHHHHh----------
Q 048535          244 SNVLLDKKMNARLGDFGLAKMHHHGQ--V----MSGRRPIE------EGKRNLVDRMWSLTERSELLSVL----------  301 (409)
Q Consensus       244 ~NILl~~~~~~kl~DFGla~~~~~~~--~----~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~----------  301 (409)
                      +|||+++++.+||+|||+|+....+.  .    ..|...+.      ...++..+|||+++  ..+++++          
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~G--v~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG--VLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHTTTSCCSSTTC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehH--HHHHHHHhCCCCCCCCC
Confidence            99999999999999999999764432  1    12222221      36788999999983  1112211          


Q ss_pred             ------hHHhhh--cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          302 ------DERLKA--KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       302 ------~~~l~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                            ...+..  ....+..+++++.+++.+||+.||++||||.|+++.|+++.+
T Consensus       292 ~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq  347 (353)
T 4ase_A          292 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  347 (353)
T ss_dssp             CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence                  111110  133455567789999999999999999999999999987643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.2e-45  Score=356.08  Aligned_cols=225  Identities=24%  Similarity=0.333  Sum_probs=179.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++|++.+.||+|+||+||+|+..  |+.||||+++..  .....+.|.+|+.+|++|+|||||++++++.+ ++.+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-~~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEE
Confidence            68999999999999999999987  899999999754  45567789999999999999999999999987 78899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      |||++|+|.++|... ....+++.++..|+.||+.||+|||   +++||||||||+||||+.++.+||+|||+|+.....
T Consensus       103 Ey~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             ECCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             eCCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            999999999999753 3456899999999999999999999   899999999999999999999999999999977543


Q ss_pred             c----eeeeccccc------cCCCcHHHHHHhhh-------------ccCcHHHHhhHHhhhc-CCCCHHHHHHHHHHHH
Q 048535          269 Q----VMSGRRPIE------EGKRNLVDRMWSLT-------------ERSELLSVLDERLKAK-GGYADEVVEKVLHLGL  324 (409)
Q Consensus       269 ~----~~~g~~p~~------~~~~~~~~~vws~~-------------~~~~~~~~~~~~l~~~-~~~~~~~~~~l~~l~~  324 (409)
                      .    ..+|...+.      ...|+...|+|+++             ......+++...+... ...+...+..+.+|+.
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~  258 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS  258 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence            2    233554442      25688999999983             1222333333333211 2334456678999999


Q ss_pred             HccCcCCCCCCCHHHHHH
Q 048535          325 LCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       325 ~Cl~~dP~~RPt~~evl~  342 (409)
                      +||+.||++|||+.|+++
T Consensus       259 ~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          259 QLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             HHTCSSGGGSCCHHHHHT
T ss_pred             HHccCChhHCcCHHHHhc
Confidence            999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.8e-45  Score=350.69  Aligned_cols=230  Identities=23%  Similarity=0.294  Sum_probs=175.2

Q ss_pred             CCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC---eEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE---SLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---~~~lv~E  189 (409)
                      ++|...+.||+|+||+||+|++.|+.||||+++..... ...+..|+..+.+++|||||+++|+|.++..   .+|||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            45677899999999999999999999999999754322 2234457777788999999999999986432   5899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG-----WESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ||++|+|.++|+.    ..++|..+.+++.|+++||+|||+.     +.++||||||||+||||+.++++||+|||+|+.
T Consensus        82 y~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            9999999999964    3599999999999999999999943     134999999999999999999999999999987


Q ss_pred             ccCCc--------eeeecccccc------------CCCcHHHHHHhhhccCcHHHHhhHH--------------------
Q 048535          265 HHHGQ--------VMSGRRPIEE------------GKRNLVDRMWSLTERSELLSVLDER--------------------  304 (409)
Q Consensus       265 ~~~~~--------~~~g~~p~~~------------~~~~~~~~vws~~~~~~~~~~~~~~--------------------  304 (409)
                      .....        ...|...+..            ..++..+|||+++  ..+++++...                    
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~G--vvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG--LVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH--HHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHH--HHHHHHHHCCCCCCccccccccchhccccc
Confidence            65432        1223333321            1356689999984  2233332210                    


Q ss_pred             ---------h-h--hcCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          305 ---------L-K--AKGGYA-----DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       305 ---------l-~--~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                               . .  ..+..+     .+....+.+|+.+||+.||++||||.||++.|+++.+
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~  297 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence                     0 0  001122     2456678999999999999999999999999987653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.5e-45  Score=350.44  Aligned_cols=246  Identities=20%  Similarity=0.221  Sum_probs=192.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      +.|+..++||+|+||.||+|++.  |+.||||+++.......+.+.+|+.+|++++|||||++++++.+ .+.+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeC
Confidence            56888999999999999999997  89999999976654455678999999999999999999999987 7889999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc-
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ-  269 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-  269 (409)
                      |++|+|.+++..    ..+++.++..++.||+.||+|||   +++||||||||+||||+.++.+||+|||+|+...... 
T Consensus       153 ~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  225 (346)
T 4fih_A          153 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  225 (346)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred             CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence            999999999954    35999999999999999999999   8999999999999999999999999999998765432 


Q ss_pred             ---eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 048535          270 ---VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQV  340 (409)
Q Consensus       270 ---~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev  340 (409)
                         ..+|...+.      ...|+...|+|+++  ..+++++....++.+..    ..++...+.......+.   ..   
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlG--vilyeml~G~~PF~~~~----~~~~~~~i~~~~~~~~~---~~---  293 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLG--IMVIEMVDGEPPYFNEP----PLKAMKMIRDNLPPRLK---NL---  293 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHH--HHHHHHHHSSCTTTTSC----HHHHHHHHHHSSCCCCS---CG---
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHH--HHHHHHHHCCCCCCCcC----HHHHHHHHHcCCCCCCC---cc---
Confidence               334555443      35688999999998  55677766554432211    11222222221111000   00   


Q ss_pred             HHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          341 LKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       341 l~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                                ..  -.....+++.+|+..||.+|+++++++.||||++..
T Consensus       294 ----------~~--~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          294 ----------HK--VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             ----------GG--SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ----------cc--CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence                      00  011237899999999999999999999999998754

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.6e-44  Score=336.56  Aligned_cols=183  Identities=26%  Similarity=0.407  Sum_probs=142.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|++.+.||+|+||+||+|...  |+.||||+++..   .....+.+.+|+.+|++++|||||++++++.+ .+.+|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-KDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEE
Confidence            68999999999999999999986  899999999754   23345679999999999999999999999987 7889999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||| +|+|.+++..   ...+++.++..++.||+.||+|||   +++|+||||||+|||+++++++||+|||+|+....
T Consensus        92 mEy~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             EECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             EeCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9999 6799999964   346999999999999999999999   89999999999999999999999999999987654


Q ss_pred             Cc---eeeecccccc------CC-CcHHHHHHhhhccCcHHHHhhHHh
Q 048535          268 GQ---VMSGRRPIEE------GK-RNLVDRMWSLTERSELLSVLDERL  305 (409)
Q Consensus       268 ~~---~~~g~~p~~~------~~-~~~~~~vws~~~~~~~~~~~~~~l  305 (409)
                      ..   ..+|...+..      .. ++...|+|+++  ..+++++....
T Consensus       165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlG--vily~lltg~~  210 (275)
T 3hyh_A          165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG--VILYVMLCRRL  210 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHH--HHHHHHHHSSC
T ss_pred             CCccCCeeECcccCChhhhcCCCCCCChhhhHHHH--HHHHHHHHCCC
Confidence            43   2345544422      23 35789999996  34455554443

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5.2e-44  Score=337.20  Aligned_cols=241  Identities=18%  Similarity=0.279  Sum_probs=184.2

Q ss_pred             CccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc---CCeEEEEE
Q 048535          116 SEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE---KESLILIY  188 (409)
Q Consensus       116 ~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---~~~~~lv~  188 (409)
                      +..++||+|+||+||+|.+.  +..||+|++...  .....+.|.+|+++|++++|||||+++++|.+.   ...+||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999987  889999999644  445567899999999999999999999998642   34589999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeeeCC-CCcEEEecccCcccc
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK--VLHRDIKASNVLLDK-KMNARLGDFGLAKMH  265 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlKp~NILl~~-~~~~kl~DFGla~~~  265 (409)
                      |||++|+|.+++..   ...+++..+..++.||+.||+|||   +++  ||||||||+||||+. ++.+||+|||+|+..
T Consensus       109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            99999999999964   346999999999999999999999   666  999999999999984 799999999999875


Q ss_pred             cCCc--eeeeccccc-----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 048535          266 HHGQ--VMSGRRPIE-----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIR  338 (409)
Q Consensus       266 ~~~~--~~~g~~p~~-----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  338 (409)
                      ....  ..+|.+.+.     .+.++...|+|+++  ..+++++....++...                        .+..
T Consensus       183 ~~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlG--vilyelltg~~Pf~~~------------------------~~~~  236 (290)
T 3fpq_A          183 RASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFG--MCMLEMATSEYPYSEC------------------------QNAA  236 (290)
T ss_dssp             CTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHH--HHHHHHHHSSCTTTTC------------------------SSHH
T ss_pred             CCCccCCcccCccccCHHHcCCCCCcHHHHHHHH--HHHHHHHHCCCCCCCC------------------------CcHH
Confidence            5432  334554432     25688999999998  4566666654432111                        1222


Q ss_pred             HHHHHHhcCcCCCCCCCC--CcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          339 QVLKMLEGQTEGTGLEDE--GMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       339 evl~~L~~~~~~~~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      ++.+.+......+..+..  ....+++.+|+..+|..|+|+++++.||||++
T Consensus       237 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          237 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            233332221111111111  12368999999999999999999999999975

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.5e-45  Score=348.09  Aligned_cols=244  Identities=20%  Similarity=0.241  Sum_probs=178.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      ++|++.+.||+|+||+||+|+..     ++.||||+++..  .......+.+|+++|++++|||||++++++.+ ++.+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-EGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-TTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEE
Confidence            56899999999999999999873     678999999754  22233468899999999999999999999987 78899


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      ||||||++|+|.+++..   ...+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus       103 ivmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            99999999999999964   346999999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCc----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCC
Q 048535          266 HHGQ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRP  335 (409)
Q Consensus       266 ~~~~----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  335 (409)
                      ....    ..+|...+.      ...++...|+|+++  ..+++++....++.+...    .++...+..+         
T Consensus       177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlG--vilyemltG~~PF~~~~~----~~~~~~i~~~---------  241 (304)
T 3ubd_A          177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG--VLMFEMLTGTLPFQGKDR----KETMTMILKA---------  241 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHH--HHHHHHHHSSCSSCCSSH----HHHHHHHHHC---------
T ss_pred             cCCCccccccccCcccCCHHHhccCCCCCCCcccchH--HHHHHHHhCCCCCCCcCH----HHHHHHHHcC---------
Confidence            3322    334555443      25678899999997  455666655444322111    1111111111         


Q ss_pred             CHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccc-----cccCCCCCccccc
Q 048535          336 TIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKF-----AGSRGHPTFNEIN  390 (409)
Q Consensus       336 t~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-----~~~~~hp~~~~~~  390 (409)
                                 ....|..- +....+++.+|+..+|.+|+++     ++++.||||++++
T Consensus       242 -----------~~~~p~~~-s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          242 -----------KLGMPQFL-SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             -----------CCCCCTTS-CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             -----------CCCCCCcC-CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence                       11111111 1123677888888888888874     5889999999886

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.9e-44  Score=351.53  Aligned_cols=247  Identities=20%  Similarity=0.217  Sum_probs=194.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .+.|+..++||+|+||.||+|++.  |+.||||++........+.+.+|+.+|++++|||||++++++.+ .+.+|||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~iVmE  228 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVME  228 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-CCEEEEEEe
Confidence            356999999999999999999997  89999999986655555678999999999999999999999987 788999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      ||++|+|.+++..    ..+++.++..++.||+.||+|||   +++||||||||+||||+.++.+||+|||+|+......
T Consensus       229 y~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          229 FLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             CCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             CCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            9999999999954    35999999999999999999999   8999999999999999999999999999998765432


Q ss_pred             ----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 048535          270 ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQ  339 (409)
Q Consensus       270 ----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e  339 (409)
                          ..+|...+.      ...|+...|+|+++  ..+++++.....+.+..    ..++...+..........      
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlG--vilyeml~G~~PF~~~~----~~~~~~~i~~~~~~~~~~------  369 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG--IMVIEMVDGEPPYFNEP----PLKAMKMIRDNLPPRLKN------  369 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHH--HHHHHHHHSSCTTTTSC----HHHHHHHHHHSCCCCCSC------
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHH--HHHHHHHHCCCCCCCcC----HHHHHHHHHcCCCCCCcc------
Confidence                345655543      35688999999998  55677776655432211    112222222211111000      


Q ss_pred             HHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          340 VLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       340 vl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                                ....  .....+++.+|+..||.+|+++++++.||||+...
T Consensus       370 ----------~~~~--s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          370 ----------LHKV--SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             ----------TTSS--CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             ----------cccC--CHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence                      0000  11237899999999999999999999999998754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.2e-44  Score=338.52  Aligned_cols=225  Identities=19%  Similarity=0.265  Sum_probs=162.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC-------
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE-------  182 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-------  182 (409)
                      ++|+..+.||+|+||+||+|+..  |+.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45888999999999999999987  899999999755 34456789999999999999999999999875332       


Q ss_pred             ----eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEec
Q 048535          183 ----SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGD  258 (409)
Q Consensus       183 ----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D  258 (409)
                          .+|+|||||++|+|.+++.........++..++.++.||++||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                37999999999999999976444445677889999999999999999   89999999999999999999999999


Q ss_pred             ccCcccccCCc----------------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHH-----------h
Q 048535          259 FGLAKMHHHGQ----------------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDER-----------L  305 (409)
Q Consensus       259 FGla~~~~~~~----------------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~-----------l  305 (409)
                      ||+|+......                ..+|.+.+.      ...++...|+|+++  ..+++++.+-           .
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlG--vilyell~Pf~~~~~~~~~~~~  239 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLG--LILFELLYPFSTQMERVRTLTD  239 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHH--HHHHHHHSCCSSHHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHH--HHHHHHccCCCCccHHHHHHHH
Confidence            99998765432                123544442      25678999999996  2344443100           0


Q ss_pred             hhcCCCCH---HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          306 KAKGGYAD---EVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       306 ~~~~~~~~---~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .....+++   ...+...+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00012222   12233455666666666666666666543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=333.34  Aligned_cols=266  Identities=21%  Similarity=0.310  Sum_probs=197.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-----CCe
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-----KES  183 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  183 (409)
                      ++|++.+.||+|+||+||+|++.  |+.||||+++..  .....+.+.+|+.+|++++|||||++++++...     .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57899999999999999999987  899999999754  345567899999999999999999999987532     357


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      +|||||||+ |+|.+++.   ....+++..+..++.||+.||.|||   +++||||||||+|||++.++.+||+|||+|+
T Consensus       134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceee
Confidence            999999996 68999994   3457999999999999999999999   8999999999999999999999999999998


Q ss_pred             cccCCc--------eeeecccccc-------CCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccC
Q 048535          264 MHHHGQ--------VMSGRRPIEE-------GKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAH  328 (409)
Q Consensus       264 ~~~~~~--------~~~g~~p~~~-------~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~  328 (409)
                      ......        ...|.+.+..       ..++...|+|+++  ..+++++.....+.+..   ....+..+...+..
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG--~il~ell~G~~pF~g~~---~~~~l~~I~~~~g~  281 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVG--CIFGEMLARRQLFPGKN---YVHQLQLIMMVLGT  281 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHH--HHHHHHHHTSCSSCCSS---HHHHHHHHHHHHCC
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhH--HHHHHHHHCCCCCCCCC---HHHHHHHHHHhcCC
Confidence            754321        2345444322       3468899999998  56777777665443322   22233334444444


Q ss_pred             cCCCCCC--CHHHHHHHHhcCcCCCCCC-------CCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          329 PEANSRP--TIRQVLKMLEGQTEGTGLE-------DEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       329 ~dP~~RP--t~~evl~~L~~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      +.+..-+  ....+...+.........+       -.....|++.+|+..||.+|+|+++++.||||++..
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence            3333222  1222223333322211110       112347999999999999999999999999999764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.3e-41  Score=326.51  Aligned_cols=265  Identities=21%  Similarity=0.288  Sum_probs=192.0

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCe
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~  183 (409)
                      ...+.|++.+.||+|+||+||+|+.+     ++.||+|++.....  ..++.+|+++|+.+ +|||||++++++.+ .+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-~~~   94 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRK-NDH   94 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEE-TTE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEE-CCE
Confidence            34678999999999999999999863     57899999865432  35678999999998 79999999999987 789


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC-CcEEEecccCc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK-MNARLGDFGLA  262 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFGla  262 (409)
                      +|+|||||++|+|.+++.      .+++.++..++.|++.||+|||   +++|+||||||+|||++.+ +.+||+|||+|
T Consensus        95 ~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            999999999999999982      4899999999999999999999   8999999999999999877 79999999999


Q ss_pred             ccccCCc--------------------------------eeeecccccc-------CCCcHHHHHHhhhccCcHHHHhhH
Q 048535          263 KMHHHGQ--------------------------------VMSGRRPIEE-------GKRNLVDRMWSLTERSELLSVLDE  303 (409)
Q Consensus       263 ~~~~~~~--------------------------------~~~g~~p~~~-------~~~~~~~~vws~~~~~~~~~~~~~  303 (409)
                      +......                                ...|.+.+..       ..++...|+|+++  ..+++++..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG--~il~ell~G  243 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAG--VIFLSLLSG  243 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHH--HHHHHHHHT
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhH--HHHHHHHHC
Confidence            8654321                                1124443321       3478899999997  567777776


Q ss_pred             HhhhcCCCCHHHHHHHHHHHHHcc----------------CcCCCCCCCHHHHHHHHhcCcCCCC---------------
Q 048535          304 RLKAKGGYADEVVEKVLHLGLLCA----------------HPEANSRPTIRQVLKMLEGQTEGTG---------------  352 (409)
Q Consensus       304 ~l~~~~~~~~~~~~~l~~l~~~Cl----------------~~dP~~RPt~~evl~~L~~~~~~~~---------------  352 (409)
                      ..+.....++  ...+..+...+-                ...........++.+.+.+......               
T Consensus       244 ~~Pf~~~~~~--~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  321 (361)
T 4f9c_A          244 RYPFYKASDD--LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG  321 (361)
T ss_dssp             CSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred             CCCCCCCCCH--HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence            6543222221  122222221110                0011112234444444433211100               


Q ss_pred             -CCCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          353 -LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       353 -~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                       ..-.....|++.+|+..||.+|+|+++++.||||++++
T Consensus       322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          322 WNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             cccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence             00112247999999999999999999999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.5e-40  Score=336.47  Aligned_cols=247  Identities=19%  Similarity=0.193  Sum_probs=181.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC------hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS------EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      ++|++.+.||+|+||.||+|+..  |+.||||+++...      .........++.+++.++|||||++++++.+ .+.+
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~-~~~l  267 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKL  267 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-CCEE
Confidence            67999999999999999999997  8999999996431      1112233445778888999999999999987 7899


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      |||||||+||+|.++|..   ...+++..+..++.||+.||+|||   +++||||||||+||||+.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999964   346999999999999999999999   89999999999999999999999999999987


Q ss_pred             ccCCc--eeeecccccc-------CCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCC
Q 048535          265 HHHGQ--VMSGRRPIEE-------GKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRP  335 (409)
Q Consensus       265 ~~~~~--~~~g~~p~~~-------~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  335 (409)
                      .....  ..+|.+.+..       ..|+...|+|+++  ..+++++....++.+....+. .++...+            
T Consensus       342 ~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLG--vilYEmLtG~~PF~~~~~~~~-~~i~~~i------------  406 (689)
T 3v5w_A          342 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLG--CMLFKLLRGHSPFRQHKTKDK-HEIDRMT------------  406 (689)
T ss_dssp             CSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHH--HHHHHHHHSSCTTCGGGCCCH-HHHHHHH------------
T ss_pred             cCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCChHHH-HHHHHhh------------
Confidence            65543  3456554432       3578999999997  455666655443221100000 0111111            


Q ss_pred             CHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccc-----cccCCCCCccccc
Q 048535          336 TIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKF-----AGSRGHPTFNEIN  390 (409)
Q Consensus       336 t~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-----~~~~~hp~~~~~~  390 (409)
                              +......+..- .....+++.+|+..+|.+|+++     ++++.||||++++
T Consensus       407 --------~~~~~~~p~~~-S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id  457 (689)
T 3v5w_A          407 --------LTMAVELPDSF-SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  457 (689)
T ss_dssp             --------HHCCCCCCTTS-CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred             --------cCCCCCCCccC-CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence                    11111111111 1123677777777777777763     6788888888776

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.1e-38  Score=328.62  Aligned_cols=225  Identities=21%  Similarity=0.302  Sum_probs=183.3

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|++.+.||+|+||.||+|...  |+.||+|++........+.+.+|+.+|+.++|||||++++++.+ ...+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEe
Confidence            367999999999999999999987  89999999987766677889999999999999999999999987 789999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC--CcEEEecccCcccccC
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK--MNARLGDFGLAKMHHH  267 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~--~~~kl~DFGla~~~~~  267 (409)
                      ||++|+|.++|..  ....+++.++..++.||+.||.|||   +++|+||||||+|||++.+  +.+||+|||+|+....
T Consensus       235 ~~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          235 FMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             ecCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            9999999999953  3346999999999999999999999   8999999999999999864  7899999999998766


Q ss_pred             Cc---eeeeccccc------cCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhhcCCCC----HHHHHHHHH
Q 048535          268 GQ---VMSGRRPIE------EGKRNLVDRMWSLTE-------------RSELLSVLDERLKAKGGYA----DEVVEKVLH  321 (409)
Q Consensus       268 ~~---~~~g~~p~~------~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~~~~~~----~~~~~~l~~  321 (409)
                      ..   ..+|...+.      ...++...|+|+++.             .....+.+.........++    ...+..+.+
T Consensus       310 ~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d  389 (573)
T 3uto_A          310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  389 (573)
T ss_dssp             TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred             CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            54   234554432      356789999999841             1112222222222111111    234567899


Q ss_pred             HHHHccCcCCCCCCCHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      |+.+||+.||.+|||+.|+++
T Consensus       390 li~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          390 FIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999987

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.7e-39  Score=306.67  Aligned_cols=246  Identities=22%  Similarity=0.346  Sum_probs=182.2

Q ss_pred             cHHHHHHHhCCCCccceeecCCceEEEEEEECCcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC
Q 048535          104 SYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK  181 (409)
Q Consensus       104 ~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  181 (409)
                      ...++....++|++.+.||+|+||.||+|+..+..||||++...  .....+.|.+|+.++++++||||+++++++.+ .
T Consensus        28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~  106 (309)
T 3p86_A           28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-P  106 (309)
T ss_dssp             ----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-T
T ss_pred             CcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-C
Confidence            33344445678899999999999999999999999999999755  34556789999999999999999999999987 6


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeeeCCCCcEEEecc
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK--VLHRDIKASNVLLDKKMNARLGDF  259 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlKp~NILl~~~~~~kl~DF  259 (409)
                      +..++||||+++|+|.+++........+++..+..++.|++.||+|||   +.+  |+||||||+|||++.++.+||+||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCC
Confidence            778999999999999999975433335999999999999999999999   788  999999999999999999999999


Q ss_pred             cCcccccCCc----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhh-----------------hcCCCC
Q 048535          260 GLAKMHHHGQ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLK-----------------AKGGYA  312 (409)
Q Consensus       260 Gla~~~~~~~----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~-----------------~~~~~~  312 (409)
                      |+++......    ...|...+.      ...++..+|+|+++  ..+++++.....                 .....+
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~  261 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG--VILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP  261 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTCCCCTTHHHHHHH--HHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred             CCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence            9998654332    122222221      24456788999984  122222221111                 112334


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLED  355 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~  355 (409)
                      ......+.+++.+||+.||.+|||+.++++.|+...+...+++
T Consensus       262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~  304 (309)
T 3p86_A          262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP  304 (309)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence            4556778999999999999999999999999998876654443

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.9e-38  Score=304.58  Aligned_cols=246  Identities=36%  Similarity=0.639  Sum_probs=195.6

Q ss_pred             CccccHHHHHHHhCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCCh-HHHHHHHHHHHHhccCCCCceeeEeeEE
Q 048535          100 PHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSE-HGMREFLAEVSSLGRLKHRNLVGLRGWC  177 (409)
Q Consensus       100 ~~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~g~~  177 (409)
                      ...+++.++...+++|+..+.||+|+||.||+|... ++.||||++..... .....+.+|+.++++++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            357899999999999999999999999999999876 89999999976532 2234689999999999999999999999


Q ss_pred             EccCCeEEEEEEeCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEE
Q 048535          178 KKEKESLILIYDYMENGSLDKWIFECD-ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARL  256 (409)
Q Consensus       178 ~~~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl  256 (409)
                      .. ....++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+..+|+||||||+|||++.++.+||
T Consensus        97 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           97 MT-PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             CC-SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             ec-CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            87 667899999999999999997643 2345999999999999999999999533339999999999999999999999


Q ss_pred             ecccCcccccCCce-----eeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhh-------------------
Q 048535          257 GDFGLAKMHHHGQV-----MSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLK-------------------  306 (409)
Q Consensus       257 ~DFGla~~~~~~~~-----~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~-------------------  306 (409)
                      +|||+++.......     ..|...+.      ...++..+|+|+++  ..+++++.....                   
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYG--VMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHH--HHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHH--HHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            99999987643221     11222221      24567889999984  122222221110                   


Q ss_pred             ---------------hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          307 ---------------AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       307 ---------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                                     ....++......+.+++.+||+.||.+|||+.|+++.|++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence                           012456778889999999999999999999999999998754

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.4e-38  Score=305.18  Aligned_cols=244  Identities=34%  Similarity=0.567  Sum_probs=194.7

Q ss_pred             ccccHHHHHHHhCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEc
Q 048535          101 HRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK  179 (409)
Q Consensus       101 ~~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  179 (409)
                      .++++.++...+++|+..+.||+|+||.||+|.+. ++.||||++........+.+.+|+.++++++||||+++++++.+
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            34555666778899999999999999999999987 89999999987766667889999999999999999999999886


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEec
Q 048535          180 EKESLILIYDYMENGSLDKWIFECD-ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGD  258 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D  258 (409)
                       .+..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus       107 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          107 -RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             -TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECC
T ss_pred             -CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEee
Confidence             678899999999999999996532 2236999999999999999999999   79999999999999999999999999


Q ss_pred             ccCcccccCCc------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhh--------------------
Q 048535          259 FGLAKMHHHGQ------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLK--------------------  306 (409)
Q Consensus       259 FGla~~~~~~~------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~--------------------  306 (409)
                      ||+++......      ...|...+.      ...++...|+|+++  ..+++++.....                    
T Consensus       183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  260 (321)
T 2qkw_B          183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFG--VVLFEVLCARSAIVQSLPREMVNLAEWAVESH  260 (321)
T ss_dssp             CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHH--HHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred             cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHH--HHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence            99998643211      122332221      25567889999984  122222211100                    


Q ss_pred             ------------hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          307 ------------AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       307 ------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                                  ............+.+++.+||+.||++|||+.|+++.|+...+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence                        01234577888999999999999999999999999999876543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.8e-37  Score=295.15  Aligned_cols=242  Identities=33%  Similarity=0.538  Sum_probs=195.1

Q ss_pred             ccccHHHHHHHhCCCCcc------ceeecCCceEEEEEEECCcEEEEEEeccC----ChHHHHHHHHHHHHhccCCCCce
Q 048535          101 HRVSYQEIHAATKGFSEE------NVIGLGGNGKVYKGQLLGVEVALKRISLD----SEHGMREFLAEVSSLGRLKHRNL  170 (409)
Q Consensus       101 ~~~~~~~l~~~~~~f~~~------~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~H~ni  170 (409)
                      ..+++.++..++++|...      +.||+|+||.||+|...++.||||++...    .....+.+.+|+.++++++||||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   92 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL   92 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence            578999999999999887      89999999999999999999999998643    23456789999999999999999


Q ss_pred             eeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC
Q 048535          171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK  250 (409)
Q Consensus       171 v~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~  250 (409)
                      +++++++.+ .+..++||||+++|+|.+++........+++..+..++.|++.||.|||   +.+|+||||||+|||++.
T Consensus        93 ~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~~  168 (307)
T 2nru_A           93 VELLGFSSD-GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDE  168 (307)
T ss_dssp             CCEEEEECS-SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECT
T ss_pred             EEEEEEEec-CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEcC
Confidence            999999987 6778999999999999999975444557999999999999999999999   789999999999999999


Q ss_pred             CCcEEEecccCcccccCCc------eeeeccccc-----cCCCcHHHHHHhhhccCcHHHHhhHH---------------
Q 048535          251 KMNARLGDFGLAKMHHHGQ------VMSGRRPIE-----EGKRNLVDRMWSLTERSELLSVLDER---------------  304 (409)
Q Consensus       251 ~~~~kl~DFGla~~~~~~~------~~~g~~p~~-----~~~~~~~~~vws~~~~~~~~~~~~~~---------------  304 (409)
                      ++.+||+|||+++......      ...|...+.     .+.++...|+|+++.  .+++++...               
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~--il~~l~~g~~p~~~~~~~~~~~~~  246 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGV--VLLEIITGLPAVDEHREPQLLLDI  246 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHH--HHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHH--HHHHHHHCCCCcccCcchHHHHHH
Confidence            9999999999998654321      112222221     134567889999831  111111110               


Q ss_pred             ---h------------hhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          305 ---L------------KAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       305 ---l------------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                         +            ......+......+.+++.+||+.||.+|||+.++++.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence               0            0012345667788999999999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.6e-38  Score=298.00  Aligned_cols=228  Identities=23%  Similarity=0.361  Sum_probs=184.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      ++|...+.||+|+||+||+|.+.  ++.||+|++........+.|.+|++++++++||||+++++++.+ .+..++||||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~   88 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRLNFITEY   88 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-CCeeEEEEEe
Confidence            56888899999999999999987  89999999977777778899999999999999999999999987 7789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV  270 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  270 (409)
                      +++|+|.+++...  ...+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999999753  346999999999999999999999   79999999999999999999999999999987643321


Q ss_pred             ------------------eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhc------------------
Q 048535          271 ------------------MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAK------------------  308 (409)
Q Consensus       271 ------------------~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~------------------  308 (409)
                                        ..|...+      ....++..+|+|+++  ..+++++.......                  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  241 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFG--IVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD  241 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHH--HHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHH--HHHHHHhcCCCCCcchhhhHHHHhhhhhcccc
Confidence                              1222222      124567889999985  23344432211100                  


Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          309 GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       309 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      ...+..++..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       242 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          242 RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            0112333456889999999999999999999999998764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9e-38  Score=300.44  Aligned_cols=232  Identities=27%  Similarity=0.457  Sum_probs=183.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|++.+.||+|+||.||+|.+.     +..||||.++.. .....+.|.+|+.++++++||||+++++++.+ .+..++
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l  127 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-GRLAMI  127 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-GGCCEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCccEE
Confidence            46777899999999999999985     456999999765 45566789999999999999999999999987 677899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            99999999999999643  346999999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCc----eeee------ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HHh---------------h-hcCCCCHHHH
Q 048535          267 HGQ----VMSG------RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ERL---------------K-AKGGYADEVV  316 (409)
Q Consensus       267 ~~~----~~~g------~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~l---------------~-~~~~~~~~~~  316 (409)
                      ...    ..++      ..+.+   ...++...|+|+++  ..+++++. ...               . .....+..++
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG--~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFG--VVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCP  280 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHH--HHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHH--HHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcC
Confidence            432    1111      11111   14567889999984  22333322 111               1 0122344556


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCCC
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTG  352 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~  352 (409)
                      ..+.+++..||+.||++|||+.|+++.|+.+...+.
T Consensus       281 ~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            788999999999999999999999999998765543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2.2e-37  Score=298.26  Aligned_cols=222  Identities=24%  Similarity=0.359  Sum_probs=176.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .++|+..+.||+|+||.||+|.+.  |+.||||++...  .....+.+.+|+.+|+.++||||+++++++.. .+..++|
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv   92 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKTLYLI   92 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEE
Confidence            467999999999999999999985  899999999654  44566789999999999999999999999987 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++...   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            9999999999999643   45999999999999999999999   79999999999999999999999999999987654


Q ss_pred             Cc---eeeecccccc------CC-CcHHHHHHhhhccCcHHHHhhH---------------HhhhcCCCCHHHHHHHHHH
Q 048535          268 GQ---VMSGRRPIEE------GK-RNLVDRMWSLTERSELLSVLDE---------------RLKAKGGYADEVVEKVLHL  322 (409)
Q Consensus       268 ~~---~~~g~~p~~~------~~-~~~~~~vws~~~~~~~~~~~~~---------------~l~~~~~~~~~~~~~l~~l  322 (409)
                      +.   ...|...+..      .. .+...|+|+++  ..+++++..               ........+......+.++
T Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG--~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  244 (328)
T 3fe3_A          167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG--VILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL  244 (328)
T ss_dssp             SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             CCccccccCCcceeCcccccCCCcCCchhhhhhhH--HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            32   2223333321      22 34789999985  223333332               2222222333345567788


Q ss_pred             HHHccCcCCCCCCCHHHHHH
Q 048535          323 GLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +.+||+.||.+|||+.|+++
T Consensus       245 i~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          245 LKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HHHHCCSSTTTSCCHHHHTT
T ss_pred             HHHHCCCChhHCcCHHHHhc
Confidence            88888888888888888875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.1e-37  Score=294.00  Aligned_cols=221  Identities=21%  Similarity=0.326  Sum_probs=174.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|+..+.||+|+||+||+|...  ++.||||++........+.+.+|+.++++++||||+++++++.. .+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-CCEEEEEEE
Confidence            468999999999999999999876  89999999976655556778999999999999999999999987 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+++..    ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        98 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            9999999999954    25899999999999999999999   7899999999999999999999999999998765432


Q ss_pred             ----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhc------------------CCCCHHHHHHHHH
Q 048535          270 ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAK------------------GGYADEVVEKVLH  321 (409)
Q Consensus       270 ----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~------------------~~~~~~~~~~l~~  321 (409)
                          ...|...+.      ...++...|+|+++  ..+++++.......                  ...+......+.+
T Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (297)
T 3fxz_A          171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG--IMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD  248 (297)
T ss_dssp             CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHH--HHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHH
T ss_pred             cccCCccCCcCccChhhhcCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHH
Confidence                122322221      24567889999985  23333333222111                  1122334455677


Q ss_pred             HHHHccCcCCCCCCCHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ++.+||+.||++|||+.|+++
T Consensus       249 li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          249 FLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHccCChhHCcCHHHHhh
Confidence            777788888888888777764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.5e-37  Score=296.82  Aligned_cols=227  Identities=26%  Similarity=0.316  Sum_probs=177.1

Q ss_pred             hCCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC---CeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK---ESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---~~~~lv~  188 (409)
                      .++|+..+.||+|+||.||+|++.++.||||++.... .....+..|+.++++++||||+++++++....   ..+++||
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEECCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            4678899999999999999999999999999997543 33455677999999999999999999998643   2479999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------ceeecCCCCCCeeeCCCCcEEEec
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES----------KVLHRDIKASNVLLDKKMNARLGD  258 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------~ivHrDlKp~NILl~~~~~~kl~D  258 (409)
                      ||+++|+|.+++..    ..+++..+..++.|++.||.|||   +.          +|+||||||+|||++.++.+||+|
T Consensus       102 e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D  174 (322)
T 3soc_A          102 AFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD  174 (322)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred             ecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence            99999999999954    34999999999999999999999   77          999999999999999999999999


Q ss_pred             ccCcccccCCce------eeecccccc-----------CCCcHHHHHHhhhccCcHHHHhhHHhhhc-------------
Q 048535          259 FGLAKMHHHGQV------MSGRRPIEE-----------GKRNLVDRMWSLTERSELLSVLDERLKAK-------------  308 (409)
Q Consensus       259 FGla~~~~~~~~------~~g~~p~~~-----------~~~~~~~~vws~~~~~~~~~~~~~~l~~~-------------  308 (409)
                      ||+|+.......      ..|...+..           ..++...|+|+++  ..+++++.......             
T Consensus       175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG--~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG--LVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHH--HHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHH--HHHHHHHhCCCCCCCCcchhccchhhh
Confidence            999976543321      122222211           1334567999984  22333332211100             


Q ss_pred             --------------------CCC-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          309 --------------------GGY-----ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       309 --------------------~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                                          +..     .......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~  317 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ  317 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                                000     1234556999999999999999999999999998754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.4e-37  Score=305.16  Aligned_cols=229  Identities=22%  Similarity=0.366  Sum_probs=182.4

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .++|...+.||+|+||.||+|.+.  ++.||||.++.. .....+.|.+|+.+|++++||||+++++++.. .+..++||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~  191 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVM  191 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-SSSCEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-CCCcEEEE
Confidence            467888999999999999999997  899999999755 34455679999999999999999999999986 67789999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++|+|.+++...  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....+
T Consensus       192 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~  266 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG  266 (377)
T ss_dssp             ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred             EcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence            999999999999642  345899999999999999999999   799999999999999999999999999999875543


Q ss_pred             ceee------e---ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HH--------------hh--hcCCCCHHHHHHH
Q 048535          269 QVMS------G---RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ER--------------LK--AKGGYADEVVEKV  319 (409)
Q Consensus       269 ~~~~------g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~--------------l~--~~~~~~~~~~~~l  319 (409)
                      ....      +   ..+.+   ...++..+|+|+++  ..+++++. ..              +.  .....+..++..+
T Consensus       267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG--~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  344 (377)
T 3cbl_A          267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFG--ILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV  344 (377)
T ss_dssp             EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHH--HHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            2111      1   11111   25567889999984  12222222 10              10  0122344456788


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      .+++.+||+.||++|||+.++++.|+.+.
T Consensus       345 ~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          345 FRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            99999999999999999999999998653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=5.9e-37  Score=307.72  Aligned_cols=229  Identities=31%  Similarity=0.388  Sum_probs=182.4

Q ss_pred             hCCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      .++|+..+.||+|+||.||+|.+.++.||||+++...  ..+.|.+|+.+|++++||||+++++++.+..+..++||||+
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            4678888999999999999999999999999997653  45789999999999999999999999887556799999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM  271 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  271 (409)
                      ++|+|.+++... ....+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++........
T Consensus       270 ~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  345 (450)
T 1k9a_A          270 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT  345 (450)
T ss_dssp             TTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccC
Confidence            999999999763 2334799999999999999999999   799999999999999999999999999999865432211


Q ss_pred             -eecccc------ccCCCcHHHHHHhhhccCcHHHHhh-HH--------------h-h-hcCCCCHHHHHHHHHHHHHcc
Q 048535          272 -SGRRPI------EEGKRNLVDRMWSLTERSELLSVLD-ER--------------L-K-AKGGYADEVVEKVLHLGLLCA  327 (409)
Q Consensus       272 -~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~-~~--------------l-~-~~~~~~~~~~~~l~~l~~~Cl  327 (409)
                       .+...+      ....++..+|+|+++  ..+++++. ..              + . .....+..++..+.+++.+||
T Consensus       346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG--~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl  423 (450)
T 1k9a_A          346 GKLPVKWTAPEALREKKFSTKSDVWSFG--ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCW  423 (450)
T ss_dssp             -CCCTTTSCHHHHHSSCCCHHHHHHHHH--HHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             CCCCcceeCHHHhcCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHc
Confidence             111111      125578899999984  22223222 11              1 0 012334556678999999999


Q ss_pred             CcCCCCCCCHHHHHHHHhcCc
Q 048535          328 HPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~~  348 (409)
                      +.||++|||+.++++.|+.+.
T Consensus       424 ~~dp~~Rpt~~~l~~~L~~i~  444 (450)
T 1k9a_A          424 HLDAATRPTFLQLREQLEHIR  444 (450)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCChhHCcCHHHHHHHHHHHH
Confidence            999999999999999998654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.8e-37  Score=292.33  Aligned_cols=235  Identities=22%  Similarity=0.344  Sum_probs=183.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC--C-------cEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCe
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--G-------VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~-------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  183 (409)
                      ++|...+.||+|+||.||+|...  +       ..||+|.+........+.+.+|+.++++++||||+++++++.+ .+.
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~   86 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC-GDE   86 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC-TTC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe-CCC
Confidence            56888899999999999999876  3       5799999977666677889999999999999999999999987 677


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc--------EE
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN--------AR  255 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~--------~k  255 (409)
                      .++||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceee
Confidence            89999999999999999653  334999999999999999999999   899999999999999998887        99


Q ss_pred             EecccCcccccCCceeeecccccc-------CCCcHHHHHHhhhccCcHHHHhhHHh---------------hhcCCCCH
Q 048535          256 LGDFGLAKMHHHGQVMSGRRPIEE-------GKRNLVDRMWSLTERSELLSVLDERL---------------KAKGGYAD  313 (409)
Q Consensus       256 l~DFGla~~~~~~~~~~g~~p~~~-------~~~~~~~~vws~~~~~~~~~~~~~~l---------------~~~~~~~~  313 (409)
                      |+|||+++.........|..++..       ..++...|+|+++  ..+++++....               ......+.
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG--~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  239 (289)
T 4fvq_A          162 LSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFG--TTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA  239 (289)
T ss_dssp             ECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHH--HHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred             eccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHH--HHHHHHHcCCCCCccccchHHHHHHhhccCCCCC
Confidence            999999987655443333333221       4467889999985  22333333111               11112222


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLED  355 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~  355 (409)
                      .....+.+++.+||+.||++|||+.|+++.|+.+......++
T Consensus       240 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~  281 (289)
T 4fvq_A          240 PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR  281 (289)
T ss_dssp             CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-------
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCC
Confidence            234568899999999999999999999999999877655443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2e-37  Score=293.24  Aligned_cols=230  Identities=23%  Similarity=0.421  Sum_probs=179.9

Q ss_pred             hCCCCccceeecCCceEEEEEEE------CCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQL------LGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESL  184 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~  184 (409)
                      .++|+..+.||+|+||.||+|++      .++.||||++........+.|.+|+.++++++||||+++++++... ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            36788899999999999999985      2789999999877777778899999999999999999999998642 3458


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999999653  345999999999999999999999   79999999999999999999999999999987


Q ss_pred             ccCCcee-------ee---ccccc---cCCCcHHHHHHhhhccCcHHHHhhH----------------------------
Q 048535          265 HHHGQVM-------SG---RRPIE---EGKRNLVDRMWSLTERSELLSVLDE----------------------------  303 (409)
Q Consensus       265 ~~~~~~~-------~g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~~----------------------------  303 (409)
                      .......       .+   ..+.+   ...++...|+|+++  ..+++++..                            
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFG--VVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHH--HHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            6543210       01   11111   25568899999984  122222221                            


Q ss_pred             --Hhh--hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          304 --RLK--AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       304 --~l~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                        .+.  .....+..++..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence              000  011233445678999999999999999999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1e-36  Score=292.59  Aligned_cols=234  Identities=21%  Similarity=0.270  Sum_probs=182.7

Q ss_pred             CCccccHHHHHHHhCC----------CCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC
Q 048535           99 WPHRVSYQEIHAATKG----------FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK  166 (409)
Q Consensus        99 ~~~~~~~~~l~~~~~~----------f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~  166 (409)
                      .+..++++++..+++.          |+..+.||+|+||.||+|+..  |+.||||++........+.+.+|+.++++++
T Consensus        21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  100 (321)
T 2c30_A           21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ  100 (321)
T ss_dssp             ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred             cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence            3456888999888865          666789999999999999986  8999999998766556678999999999999


Q ss_pred             CCceeeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 048535          167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNV  246 (409)
Q Consensus       167 H~niv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NI  246 (409)
                      ||||+++++++.. .+..++||||+++|+|.+++..    ..+++..+..++.|++.||.|||   +.+|+||||||+||
T Consensus       101 h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NI  172 (321)
T 2c30_A          101 HFNVVEMYKSYLV-GEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSI  172 (321)
T ss_dssp             CTTBCCEEEEEEE-TTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred             CCCcceEEEEEEE-CCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHE
Confidence            9999999999987 6789999999999999999842    46999999999999999999999   78999999999999


Q ss_pred             eeCCCCcEEEecccCcccccCCc----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhc--------
Q 048535          247 LLDKKMNARLGDFGLAKMHHHGQ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAK--------  308 (409)
Q Consensus       247 Ll~~~~~~kl~DFGla~~~~~~~----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~--------  308 (409)
                      |++.++.+||+|||+++......    ...|...+.      ...++...|+|+++  ..+++++.......        
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG--~il~el~~g~~pf~~~~~~~~~  250 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLG--IMVIEMVDGEPPYFSDSPVQAM  250 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHH--HHHHHHHHSSCTTTTSCHHHHH
T ss_pred             EECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHH--HHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999998754321    122322221      24567789999984  22233332211110        


Q ss_pred             -------C---CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          309 -------G---GYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       309 -------~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                             .   .........+.+++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          251 KRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             HHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   0   111233456788888999999999999988876

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.2e-37  Score=301.12  Aligned_cols=231  Identities=21%  Similarity=0.367  Sum_probs=182.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC---------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEcc
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL---------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKE  180 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  180 (409)
                      .++|++.+.||+|+||.||+|++.         +..||||+++.. .....+.+.+|+.+++++ +||||++++++|.+ 
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  158 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-  158 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence            467888999999999999999863         457999999765 445667899999999999 89999999999987 


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCee
Q 048535          181 KESLILIYDYMENGSLDKWIFECDE-------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVL  247 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NIL  247 (409)
                      .+..|+||||+++|+|.+++.....             ...+++..++.++.||+.||.|||   +.+|+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEE
Confidence            6789999999999999999976431             235899999999999999999999   799999999999999


Q ss_pred             eCCCCcEEEecccCcccccCCce------eee---cccc---ccCCCcHHHHHHhhhccCcHHHHhh-HH----------
Q 048535          248 LDKKMNARLGDFGLAKMHHHGQV------MSG---RRPI---EEGKRNLVDRMWSLTERSELLSVLD-ER----------  304 (409)
Q Consensus       248 l~~~~~~kl~DFGla~~~~~~~~------~~g---~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~~----------  304 (409)
                      ++.++.+||+|||+++.......      ..+   ..+.   ....++...|+|+++  ..+++++. ..          
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG--~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG--VLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHH--HHHHHHHTTSCCSSTTCCGGG
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHH--HHHHHHHcCCCCCCCCCCHHH
Confidence            99999999999999986543221      111   1111   125578899999984  22333322 11          


Q ss_pred             ----h-h-hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          305 ----L-K-AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       305 ----l-~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                          + . .....+..+...+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il  363 (370)
T 2psq_A          314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  363 (370)
T ss_dssp             HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                1 0 012334455668999999999999999999999999998754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.3e-37  Score=301.39  Aligned_cols=230  Identities=27%  Similarity=0.485  Sum_probs=175.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|++.+.||+|+||.||+|++.     +..||||+++.. .....+.|.+|+.++++++||||+++++++.+ ....++
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l  123 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-SKPVMI  123 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCceEE
Confidence            57899999999999999999875     567999999765 45566789999999999999999999999987 678899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++...  ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999643  346999999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCce-----eee-----ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHHHH
Q 048535          267 HGQV-----MSG-----RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADEVV  316 (409)
Q Consensus       267 ~~~~-----~~g-----~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~~~  316 (409)
                      ....     ..+     ..+.+   ...++..+|+|+++  ..+++++. .....                ....+..++
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG--~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~  276 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYG--IVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCP  276 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCB
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence            4320     111     11111   25577889999984  22233222 11100                122334456


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      ..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       277 ~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          277 AALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            7789999999999999999999999999876543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-36  Score=287.84  Aligned_cols=234  Identities=21%  Similarity=0.329  Sum_probs=182.7

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .++|++.+.||+|+||.||+|...  ++.||+|.+...   .....+.|.+|+.++++++||||+++++++.+ .+..++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~l   88 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-DDCYYL   88 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-SSEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-CCeEEE
Confidence            367889999999999999999987  899999998543   34556789999999999999999999999987 778999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++...   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        89 v~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999999642   46999999999999999999999   7899999999999999999999999999998764


Q ss_pred             CCc-----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcC--------------------CCCHHH
Q 048535          267 HGQ-----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKG--------------------GYADEV  315 (409)
Q Consensus       267 ~~~-----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~--------------------~~~~~~  315 (409)
                      ...     ...|...+.      ...++...|+|+++  ..+++++....+..+                    ......
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIG--IVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI  240 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHH--HHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTS
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHH--HHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCC
Confidence            432     112322221      24456778999984  223333322211100                    011224


Q ss_pred             HHHHHHHHHHccCcCCCCCC-CHHHHHHHHhcCcCCCCCC
Q 048535          316 VEKVLHLGLLCAHPEANSRP-TIRQVLKMLEGQTEGTGLE  354 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~~~~~~  354 (409)
                      +..+.+++.+||+.||.+|| +++++.+.|+.........
T Consensus       241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~  280 (294)
T 4eqm_A          241 PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN  280 (294)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred             CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence            46789999999999999998 9999999999876554433

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.4e-37  Score=298.83  Aligned_cols=240  Identities=23%  Similarity=0.317  Sum_probs=187.8

Q ss_pred             cHHHHHHHhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEe
Q 048535          104 SYQEIHAATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLR  174 (409)
Q Consensus       104 ~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~  174 (409)
                      ...++....++|++.+.||+|+||.||+|.+.       ++.||||+++.. .....+.+.+|++++.++ +||||++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~   92 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   92 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            34455566789999999999999999999853       578999999765 444567899999999999 899999999


Q ss_pred             eEEEccCCeEEEEEEeCCCCCHHHHHhcCCC-------------------------------------------------
Q 048535          175 GWCKKEKESLILIYDYMENGSLDKWIFECDE-------------------------------------------------  205 (409)
Q Consensus       175 g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------------------------------------------------  205 (409)
                      +++.+.....++||||+++|+|.+++.....                                                 
T Consensus        93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (359)
T 3vhe_A           93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS  172 (359)
T ss_dssp             EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred             eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence            9998756668999999999999999975432                                                 


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc--
Q 048535          206 --------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ--  269 (409)
Q Consensus       206 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~--  269 (409)
                                    ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......  
T Consensus       173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             -----------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred             cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence                          122899999999999999999999   7899999999999999999999999999998654322  


Q ss_pred             ----eeeecccc---c---cCCCcHHHHHHhhhccCcHHHHhh-HHhhh-----------------cCCCCHHHHHHHHH
Q 048535          270 ----VMSGRRPI---E---EGKRNLVDRMWSLTERSELLSVLD-ERLKA-----------------KGGYADEVVEKVLH  321 (409)
Q Consensus       270 ----~~~g~~p~---~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~~-----------------~~~~~~~~~~~l~~  321 (409)
                          ...|...+   +   ...++...|+|+++  ..+++++. .....                 ....+......+.+
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG--~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  327 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG--VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ  327 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred             hhccccCCCceeEChhhhcCCCCCchhhhhhHH--HHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence                11121111   1   25678899999984  22333332 11110                 12233345567899


Q ss_pred             HHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          322 LGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      ++..||+.||.+|||+.|+++.|+.+.
T Consensus       328 li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          328 TMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            999999999999999999999998654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.5e-37  Score=311.00  Aligned_cols=230  Identities=23%  Similarity=0.418  Sum_probs=185.4

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ..++|+..+.||+|+||.||+|.+.  +..||||.++... ...++|.+|+.+|++++|||||+++++|.. ....++||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~  295 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIIT  295 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEec-CCcEEEEE
Confidence            4456778899999999999999998  8899999997653 245789999999999999999999999987 67789999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++|+|.+++... ....+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       296 E~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          296 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            999999999999764 3346999999999999999999999   799999999999999999999999999999876543


Q ss_pred             ceee--e------ccccc---cCCCcHHHHHHhhhccCcHHHHhh-------------------HHhhhcCCCCHHHHHH
Q 048535          269 QVMS--G------RRPIE---EGKRNLVDRMWSLTERSELLSVLD-------------------ERLKAKGGYADEVVEK  318 (409)
Q Consensus       269 ~~~~--g------~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-------------------~~l~~~~~~~~~~~~~  318 (409)
                      ....  +      ..+.+   ...++..+|+|+++  ..+++++.                   ....  ...+..++..
T Consensus       372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG--~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  447 (495)
T 1opk_A          372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG--VLLWEIATYGMSPYPGIDLSQVYELLEKDYR--MERPEGCPEK  447 (495)
T ss_dssp             CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHH--HHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTCCHH
T ss_pred             ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHH--HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHH
Confidence            3211  1      11111   24567889999984  12222221                   1111  2334456678


Q ss_pred             HHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          319 VLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       319 l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      +.+|+.+||+.||++|||+.++++.|+.....
T Consensus       448 l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          448 VYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             HHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            89999999999999999999999999987644

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.4e-36  Score=291.33  Aligned_cols=224  Identities=19%  Similarity=0.287  Sum_probs=173.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC------
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE------  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~------  182 (409)
                      .++|+..+.||+|+||.||+|+..  ++.||||+++.. .....+.+.+|+.+|++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457888999999999999999997  899999999754 34456789999999999999999999999865322      


Q ss_pred             --------------------------------------------------eEEEEEEeCCCCCHHHHHhcCCCCCCCCHH
Q 048535          183 --------------------------------------------------SLILIYDYMENGSLDKWIFECDESIALSWE  212 (409)
Q Consensus       183 --------------------------------------------------~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~  212 (409)
                                                                        ..++|||||++|+|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              389999999999999999876555567888


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc----------------eeeeccc
Q 048535          213 QRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ----------------VMSGRRP  276 (409)
Q Consensus       213 ~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~----------------~~~g~~p  276 (409)
                      .+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......                ...|...
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999   7999999999999999999999999999998765432                0112222


Q ss_pred             cc------cCCCcHHHHHHhhhccCcHHHHhh-------------HHhhhcCCCC---HHHHHHHHHHHHHccCcCCCCC
Q 048535          277 IE------EGKRNLVDRMWSLTERSELLSVLD-------------ERLKAKGGYA---DEVVEKVLHLGLLCAHPEANSR  334 (409)
Q Consensus       277 ~~------~~~~~~~~~vws~~~~~~~~~~~~-------------~~l~~~~~~~---~~~~~~l~~l~~~Cl~~dP~~R  334 (409)
                      +.      ...++...|+|+++  ..+++++.             ....  ...+   ......+.+++.+||+.||++|
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG--~il~el~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R  317 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLG--LILFELLYSFSTQMERVRIITDVRN--LKFPLLFTQKYPQEHMMVQDMLSPSPTER  317 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHH--HHHHHHHSCCCCHHHHHHHHHHHHT--TCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred             ccChHHhcCCCCcchhhHHHHH--HHHHHHHHcCCChhHHHHHHHHhhc--cCCCcccccCChhHHHHHHHHccCCCCcC
Confidence            21      24567889999984  12222221             1111  2222   2334567888899999999999


Q ss_pred             CCHHHHHH
Q 048535          335 PTIRQVLK  342 (409)
Q Consensus       335 Pt~~evl~  342 (409)
                      ||+.|+++
T Consensus       318 ps~~~~l~  325 (332)
T 3qd2_B          318 PEATDIIE  325 (332)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHhh
Confidence            99888875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.4e-37  Score=309.85  Aligned_cols=236  Identities=22%  Similarity=0.381  Sum_probs=185.8

Q ss_pred             HHHHhCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          108 IHAATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       108 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      +....++|+..+.||+|+||.||+|.+. +..||||+++... ...+.|.+|+.+|++++|||||++++++.  .+..++
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~l  259 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYI  259 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEE
Confidence            3445677888999999999999999998 7889999997653 34678999999999999999999999986  456899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++... ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       260 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            99999999999999642 2235899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCcee--e---e---cccc---ccCCCcHHHHHHhhhccCcHHHHhh-HH---------------hh-hcCCCCHHHHHH
Q 048535          267 HGQVM--S---G---RRPI---EEGKRNLVDRMWSLTERSELLSVLD-ER---------------LK-AKGGYADEVVEK  318 (409)
Q Consensus       267 ~~~~~--~---g---~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~~---------------l~-~~~~~~~~~~~~  318 (409)
                      .....  .   +   ..+.   ....++..+|+|+++  ..+++++. ..               .. ...+.+..++..
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG--~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~  413 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFG--ILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE  413 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHH--HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            42211  0   1   1111   125678899999984  12222222 11               11 012234455678


Q ss_pred             HHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCCC
Q 048535          319 VLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTG  352 (409)
Q Consensus       319 l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~  352 (409)
                      +.+++.+||+.||++|||+.++++.|+.......
T Consensus       414 l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~  447 (454)
T 1qcf_A          414 LYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE  447 (454)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence            9999999999999999999999999998865443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.8e-37  Score=306.63  Aligned_cols=195  Identities=22%  Similarity=0.216  Sum_probs=158.4

Q ss_pred             ccHHHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh---HHHHHHHHHHHHhccCCCCceeeEeeEE
Q 048535          103 VSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE---HGMREFLAEVSSLGRLKHRNLVGLRGWC  177 (409)
Q Consensus       103 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~g~~  177 (409)
                      ..+.++...+++|+..+.||+|+||.||+|+..  ++.||+|+++....   .....+.+|..++..++||||++++++|
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345666677889999999999999999999997  78999999965321   1223488999999999999999999999


Q ss_pred             EccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEe
Q 048535          178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLG  257 (409)
Q Consensus       178 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~  257 (409)
                      .+ .+.+|+|||||++|+|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus       144 ~~-~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          144 QD-DNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             EC-SSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             ee-CCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEc
Confidence            87 78899999999999999999642  346999999999999999999999   8999999999999999999999999


Q ss_pred             cccCcccccCCce-----eeeccccc-----------cCCCcHHHHHHhhhccCcHHHHhhHHh
Q 048535          258 DFGLAKMHHHGQV-----MSGRRPIE-----------EGKRNLVDRMWSLTERSELLSVLDERL  305 (409)
Q Consensus       258 DFGla~~~~~~~~-----~~g~~p~~-----------~~~~~~~~~vws~~~~~~~~~~~~~~l  305 (409)
                      |||+|+.......     ..|...+.           ...++...|+|+++  ..+++++....
T Consensus       218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlG--vil~elltG~~  279 (437)
T 4aw2_A          218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG--VCMYEMLYGET  279 (437)
T ss_dssp             CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHH--HHHHHHHHSSC
T ss_pred             chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHH--HHHHHHHhCCC
Confidence            9999976544321     23333221           23467789999996  34555554443

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.4e-36  Score=287.71  Aligned_cols=227  Identities=23%  Similarity=0.334  Sum_probs=173.6

Q ss_pred             hCCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhcc--CCCCceeeEeeEEEcc---CCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGR--LKHRNLVGLRGWCKKE---KESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~---~~~~~l  186 (409)
                      .++|+..+.||+|+||+||+|++.++.||||++....   ...+..|.+++..  ++||||+++++++...   ....++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            4679999999999999999999999999999996542   3455666666655  7999999999987642   345899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW-----ESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      ||||+++|+|.+++.    ...+++..+..++.|++.||+|||...     +++|+||||||+|||++.++.+||+|||+
T Consensus        84 v~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  159 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL  159 (301)
T ss_dssp             EECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             ehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence            999999999999993    346999999999999999999999421     57999999999999999999999999999


Q ss_pred             cccccCCce--------eeecccccc------C------CCcHHHHHHhhhccCcHHHHhhH------------------
Q 048535          262 AKMHHHGQV--------MSGRRPIEE------G------KRNLVDRMWSLTERSELLSVLDE------------------  303 (409)
Q Consensus       262 a~~~~~~~~--------~~g~~p~~~------~------~~~~~~~vws~~~~~~~~~~~~~------------------  303 (409)
                      |+.......        ..|...+..      .      .++...|+|+++  ..+++++..                  
T Consensus       160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG--~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG--LVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHH--HHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHH--HHHHHHHhhhcCccccccccccccccC
Confidence            976544321        122222211      1      334688999985  223333322                  


Q ss_pred             -----------Hhhh---cCCC-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          304 -----------RLKA---KGGY-----ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       304 -----------~l~~---~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                                 ....   ....     +......+.+++.+||+.||++|||+.|+++.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          238 PNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence                       0000   0111     124567899999999999999999999999999853

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-36  Score=293.45  Aligned_cols=236  Identities=22%  Similarity=0.380  Sum_probs=185.9

Q ss_pred             HHHhCCCCccceeecCCceEEEEEEECC-------cEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc
Q 048535          109 HAATKGFSEENVIGLGGNGKVYKGQLLG-------VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE  180 (409)
Q Consensus       109 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  180 (409)
                      ....++|+..+.||+|+||.||+|+..+       +.||||+++.. .....+.|.+|+.++++++||||+++++++.+ 
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-  121 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-  121 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-
Confidence            3446789999999999999999999863       78999999765 44556789999999999999999999999987 


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeec
Q 048535          181 KESLILIYDYMENGSLDKWIFECDE---------------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHR  239 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr  239 (409)
                      .+..++||||+++|+|.+++.....                     ...+++.+++.++.||++||.|||   +.+|+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence            6788999999999999999976321                     256999999999999999999999   7899999


Q ss_pred             CCCCCCeeeCCCCcEEEecccCcccccCCce------eeec---cccc---cCCCcHHHHHHhhhccCcHHHHhh-HH--
Q 048535          240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQV------MSGR---RPIE---EGKRNLVDRMWSLTERSELLSVLD-ER--  304 (409)
Q Consensus       240 DlKp~NILl~~~~~~kl~DFGla~~~~~~~~------~~g~---~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~--  304 (409)
                      ||||+|||++.++.+||+|||+++.......      ..+.   .+.+   ...++..+|+|+++  ..+++++. ..  
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG--~il~el~t~g~~p  276 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG--VVLWEIFSYGLQP  276 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTTCCT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHH--HHHHHHHhcCCCc
Confidence            9999999999999999999999976533221      1111   1111   24577889999984  22222222 11  


Q ss_pred             -------------hhh-cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          305 -------------LKA-KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       305 -------------l~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                                   ... ....+...+..+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             TTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence                         110 0123344556889999999999999999999999999987654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.1e-36  Score=288.99  Aligned_cols=268  Identities=22%  Similarity=0.284  Sum_probs=201.3

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .++|+..+.||+|+||+||+|... ++.||+|++...  .....+.+.+|+.++++++||||+++++++.+ ....++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-ERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-SSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-CCEEEEEE
Confidence            477899999999999999999997 899999999754  22335678999999999999999999999987 67899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++ +|.+++..  ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99985 88888864  3345999999999999999999999   799999999999999999999999999999876432


Q ss_pred             c----eeeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 048535          269 Q----VMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI  337 (409)
Q Consensus       269 ~----~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  337 (409)
                      .    ...|...+   +    ...++...|+|+++  ..+++++.......+....+.   +..+...+-..+|...|..
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG--~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          173 VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIG--CIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHH--HHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGG
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHH--HHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhh
Confidence            1    11122111   1    13467899999997  456666665544333223333   3444445566677766666


Q ss_pred             HHHHHHHhcCcCCCCCC--------CCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          338 RQVLKMLEGQTEGTGLE--------DEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       338 ~evl~~L~~~~~~~~~~--------~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      .++....+.........        -.....+++.+|+..+|.+|+++++++.||||++++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence            55544433322211111        0112368999999999999999999999999998874

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.4e-36  Score=280.69  Aligned_cols=230  Identities=24%  Similarity=0.386  Sum_probs=181.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      .++|+..+.||+|+||.||+|.+. +..||+|+++.... ..+++.+|+.++.+++||||+++++++.+ ....++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK-EYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCceEEEEEc
Confidence            467888999999999999999988 67899999976532 34678999999999999999999999976 6789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV  270 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  270 (409)
                      +++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  159 (268)
T 3sxs_A           85 ISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY  159 (268)
T ss_dssp             CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred             cCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence            9999999999653  345999999999999999999999   78999999999999999999999999999987655432


Q ss_pred             ee--e------ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHHHHHHHHHH
Q 048535          271 MS--G------RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADEVVEKVLHL  322 (409)
Q Consensus       271 ~~--g------~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~~~~~l~~l  322 (409)
                      ..  +      ..+.+   ...++..+|+|+++  ..+++++. ...+.                ....+......+.++
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  237 (268)
T 3sxs_A          160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFG--ILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQI  237 (268)
T ss_dssp             EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHH--HHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             hcccCCCcCcccCCHHHHhccCCchhhhhHHHH--HHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHH
Confidence            11  1      11111   13456778999985  22333332 11111                011223345678999


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          323 GLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      +..||+.||++|||+.|+++.|+.+.+.
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          238 MYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            9999999999999999999999987643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-36  Score=283.20  Aligned_cols=227  Identities=23%  Similarity=0.358  Sum_probs=180.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      ++|+..+.||+|+||.||+|.+. +..||+|++..... ..+++.+|+.++++++||||+++++++.+ .+..++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCceEEEEEeC
Confidence            56888899999999999999996 88899999976532 33679999999999999999999999987 67799999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce-
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV-  270 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~-  270 (409)
                      ++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            999999999643  346899999999999999999999   89999999999999999999999999999986543221 


Q ss_pred             ----eee---ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HH---------------hhh-cCCCCHHHHHHHHHHH
Q 048535          271 ----MSG---RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ER---------------LKA-KGGYADEVVEKVLHLG  323 (409)
Q Consensus       271 ----~~g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~---------------l~~-~~~~~~~~~~~l~~l~  323 (409)
                          ..+   ..+.+   ...++..+|+|+++  ..+++++. ..               ... ....+......+.+++
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG--VLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM  240 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHH--HHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHH
Confidence                111   11111   25577889999984  22233222 11               110 1122333456788999


Q ss_pred             HHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          324 LLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      ..||+.||++|||+.|+++.|+++.
T Consensus       241 ~~~l~~~p~~Rps~~~ll~~l~~l~  265 (269)
T 4hcu_A          241 NHCWRERPEDRPAFSRLLRQLAEIA  265 (269)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHccCCcccCcCHHHHHHHHHHHH
Confidence            9999999999999999999998754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.4e-36  Score=280.43  Aligned_cols=229  Identities=20%  Similarity=0.319  Sum_probs=180.4

Q ss_pred             CCCCccceeecCCceEEEEEEECCcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~~lv~E  189 (409)
                      ++|+..+.||+|+||.||+|++.++.||||++...  .....+.|.+|+.++++++||||+++++++.+. ....++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   89 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH   89 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence            57888999999999999999999999999999765  445567899999999999999999999999863 267899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK--VLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |+++|+|.+++... ....+++..+..++.|++.||.|||   +.+  |+||||||+|||++.++.++|+|||++.....
T Consensus        90 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           90 WMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             CCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             ccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            99999999999753 3336999999999999999999999   777  99999999999999999999999988765443


Q ss_pred             Cceeeeccccc---------cCCCcHHHHHHhhhccCcHHHHhhHHhh-----------------hcCCCCHHHHHHHHH
Q 048535          268 GQVMSGRRPIE---------EGKRNLVDRMWSLTERSELLSVLDERLK-----------------AKGGYADEVVEKVLH  321 (409)
Q Consensus       268 ~~~~~g~~p~~---------~~~~~~~~~vws~~~~~~~~~~~~~~l~-----------------~~~~~~~~~~~~l~~  321 (409)
                      ... .|...+.         ...++..+|+|+++  ..+++++.....                 .....+......+.+
T Consensus       166 ~~~-~~t~~y~aPE~~~~~~~~~~~~~~Di~slG--~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (271)
T 3kmu_A          166 PGR-MYAPAWVAPEALQKKPEDTNRRSADMWSFA--VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSK  242 (271)
T ss_dssp             TTC-BSCGGGSCHHHHHSCGGGSCHHHHHHHHHH--HHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHH
T ss_pred             cCc-cCCccccChhhhccCCCCCCCchhhHHHHH--HHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence            221 1222111         12234478999984  122222221111                 012334455678899


Q ss_pred             HHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          322 LGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      ++..||+.||++|||+.|+++.|+.+.
T Consensus       243 li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          243 LMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            999999999999999999999998754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-35  Score=284.63  Aligned_cols=225  Identities=17%  Similarity=0.236  Sum_probs=178.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|++.+.||+|+||.||+|...  ++.||+|.+.... .....+.+|+.+++.++||||+++++++.+ .+..++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES-MEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEec-CCEEEEEEE
Confidence            467899999999999999999987  8899999997543 345678899999999999999999999987 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC--CCcEEEecccCcccccC
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK--KMNARLGDFGLAKMHHH  267 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~--~~~~kl~DFGla~~~~~  267 (409)
                      |+++|+|.+++..  ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.  ++.+||+|||+++....
T Consensus        82 ~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             eCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            9999999999953  2346999999999999999999999   799999999999999987  78999999999988765


Q ss_pred             Cce---eeeccccc------cCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhhcCCCCH----HHHHHHHH
Q 048535          268 GQV---MSGRRPIE------EGKRNLVDRMWSLTE-------------RSELLSVLDERLKAKGGYAD----EVVEKVLH  321 (409)
Q Consensus       268 ~~~---~~g~~p~~------~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~~~~~~~----~~~~~l~~  321 (409)
                      +..   ..|...+.      ...++...|+|+++.             .....+.+.........++.    ..+..+.+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T 1tki_A          157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence            432   22332221      234678999999841             11112222222222222232    23567899


Q ss_pred             HHHHccCcCCCCCCCHHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ++.+||+.||.+|||+.|+++.
T Consensus       237 li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          237 FVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHcCCChhHCcCHHHHhcC
Confidence            9999999999999999999973

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-36  Score=292.91  Aligned_cols=228  Identities=23%  Similarity=0.352  Sum_probs=175.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC--Cc----EEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GV----EVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      ++|+..+.||+|+||.||+|.+.  ++    +||+|.+... .....+.|.+|+.++++++||||++++++|.+  +..+
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~   92 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQ   92 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES--SSEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec--CCeE
Confidence            56888999999999999999975  33    4689988644 33456789999999999999999999999986  3478


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +|+||+++|+|.+++...  ...+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus        93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            999999999999999763  346999999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCce------eee---ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHHHH
Q 048535          266 HHGQV------MSG---RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADEVV  316 (409)
Q Consensus       266 ~~~~~------~~g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~~~  316 (409)
                      .....      ..+   ..+.+   ...++..+|+|+++  ..+++++. .....                ....+....
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG--~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG--VTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT  245 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBC
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhH--HHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCC
Confidence            44321      111   11111   25578899999984  22233322 11110                122344456


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      ..+.+++.+||+.||.+|||+.|+++.|+....
T Consensus       246 ~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          246 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             HHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            678999999999999999999999999987654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.7e-36  Score=281.68  Aligned_cols=226  Identities=27%  Similarity=0.431  Sum_probs=169.6

Q ss_pred             hCCCCccceeecCCceEEEEEEECCcEEEEEEeccCC----hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDS----EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .++|+..+.||+|+||.||+|.+.+..||||++....    ....+.+.+|+.+++.++||||+++++++.+ .+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-EPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-C--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-CCceEEE
Confidence            3678889999999999999999999999999997542    2235678999999999999999999999987 6778999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc---eeecCCCCCCeeeCC--------CCcEEE
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK---VLHRDIKASNVLLDK--------KMNARL  256 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~---ivHrDlKp~NILl~~--------~~~~kl  256 (409)
                      |||+++|+|.+++.    ...+++..+..++.|++.||.|||   +.+   |+||||||+|||++.        ++.+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl  157 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI  157 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence            99999999999993    346999999999999999999999   566   999999999999986        678999


Q ss_pred             ecccCcccccCCce--eeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhh-----------------cCCC
Q 048535          257 GDFGLAKMHHHGQV--MSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKA-----------------KGGY  311 (409)
Q Consensus       257 ~DFGla~~~~~~~~--~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~-----------------~~~~  311 (409)
                      +|||+++.......  ..|...+.      ...++...|+|+++  ..+++++......                 ....
T Consensus       158 ~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (271)
T 3dtc_A          158 TDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYG--VLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI  235 (271)
T ss_dssp             CCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHH--HHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred             ccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHH--HHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence            99999986544321  12222221      24567889999984  2222322221111                 1123


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          312 ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       312 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      +......+.+++.+||+.||.+|||+.|+++.|+.+
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            344556789999999999999999999999999853

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.2e-36  Score=283.82  Aligned_cols=174  Identities=22%  Similarity=0.343  Sum_probs=142.7

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .++|++.+.||+|+||.||+|...  +..||+|++....   ......+.+|+.++++++||||+++++++.+ ....++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   86 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYL   86 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-CCEEEE
Confidence            467888999999999999999987  7789999996432   2234678999999999999999999999987 678999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++...   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            99999999999999643   45899999999999999999999   8999999999999999999999999999986654


Q ss_pred             CCc--eeeecccc------ccCCCcHHHHHHhhh
Q 048535          267 HGQ--VMSGRRPI------EEGKRNLVDRMWSLT  292 (409)
Q Consensus       267 ~~~--~~~g~~p~------~~~~~~~~~~vws~~  292 (409)
                      ...  ...|...+      ....++...|+|+++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  194 (279)
T 3fdn_A          161 SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLG  194 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHH
T ss_pred             cccccccCCCCCccCHhHhccCCCCccchhHhHH
Confidence            332  11222221      123456678999885

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.2e-35  Score=287.87  Aligned_cols=224  Identities=25%  Similarity=0.294  Sum_probs=177.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh------HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE------HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  183 (409)
                      .+.|++.+.||+|+||.||+|...  |+.||+|.++....      ...+.+.+|+.+|++++||||+++++++.+ ...
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~   89 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN-RTD   89 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe-CCE
Confidence            467899999999999999999987  89999999975422      135779999999999999999999999987 778


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC----cEEEecc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM----NARLGDF  259 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kl~DF  259 (409)
                      .++||||+++|+|.+++.   ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            999999999999999994   3457999999999999999999999   79999999999999998877    7999999


Q ss_pred             cCcccccCCc---eeeeccccc------cCCCcHHHHHHhhhcc-------------CcHHHHhhHHhhhcCCCCHH---
Q 048535          260 GLAKMHHHGQ---VMSGRRPIE------EGKRNLVDRMWSLTER-------------SELLSVLDERLKAKGGYADE---  314 (409)
Q Consensus       260 Gla~~~~~~~---~~~g~~p~~------~~~~~~~~~vws~~~~-------------~~~~~~~~~~l~~~~~~~~~---  314 (409)
                      |+++......   ...|...+.      ...++...|+|+++.-             ....+.+.........++..   
T Consensus       164 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (361)
T 2yab_A          164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS  243 (361)
T ss_dssp             SSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             CCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence            9998765542   122333222      2457788999998411             11122222222211223322   


Q ss_pred             -HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 -VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 -~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                       ....+.+++..||+.||.+|||+.|+++
T Consensus       244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          244 QTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             3457889999999999999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7e-37  Score=293.24  Aligned_cols=239  Identities=21%  Similarity=0.392  Sum_probs=173.1

Q ss_pred             HHHhCCCCccceeecCCceEEEEEEEC--C---cEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC
Q 048535          109 HAATKGFSEENVIGLGGNGKVYKGQLL--G---VEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK  181 (409)
Q Consensus       109 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~---~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~  181 (409)
                      ....++|+..+.||+|+||.||+|.+.  +   ..||||+++..  .....+.+.+|+.++++++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            344578999999999999999999886  2   27999999765  4455688999999999999999999999998632


Q ss_pred             C-----eEEEEEEeCCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc
Q 048535          182 E-----SLILIYDYMENGSLDKWIFECD---ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN  253 (409)
Q Consensus       182 ~-----~~~lv~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~  253 (409)
                      .     ..++||||+++|+|.+++....   ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCC
Confidence            2     1389999999999999986432   2235999999999999999999999   789999999999999999999


Q ss_pred             EEEecccCcccccCCcee------ee---cccc---ccCCCcHHHHHHhhhccCcHHHHhh-HHhhh-------------
Q 048535          254 ARLGDFGLAKMHHHGQVM------SG---RRPI---EEGKRNLVDRMWSLTERSELLSVLD-ERLKA-------------  307 (409)
Q Consensus       254 ~kl~DFGla~~~~~~~~~------~g---~~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~~l~~-------------  307 (409)
                      +||+|||+++........      .+   ..+.   ....++..+|+|+++  ..+++++. .....             
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~ell~~g~~p~~~~~~~~~~~~~~  253 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFG--VTMWEIMTRGQTPYAGIENAEIYNYLI  253 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHH--HHHHHHHhCCCCCccccChHHHHHHHh
Confidence            999999999876443211      11   1111   124578899999984  22333322 11110             


Q ss_pred             ---cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCCC
Q 048535          308 ---KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTG  352 (409)
Q Consensus       308 ---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~  352 (409)
                         ....+...+..+.+++.+||+.||++|||+.++++.|+++...+.
T Consensus       254 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          254 GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence               123344556789999999999999999999999999998765443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3e-36  Score=284.93  Aligned_cols=263  Identities=22%  Similarity=0.290  Sum_probs=195.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++|+..+.||+|+||+||+|...  ++.||||++...  .....+.+.+|+.++++++||||+++++++.+ .+..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-CCEEEEEE
Confidence            57888999999999999999996  889999999754  33445788999999999999999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++ +|.+++...  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~-~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             ECCSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             ecCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            99986 666666442  346999999999999999999999   789999999999999999999999999999876432


Q ss_pred             c----eeeecccc---c---c-CCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 048535          269 Q----VMSGRRPI---E---E-GKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI  337 (409)
Q Consensus       269 ~----~~~g~~p~---~---~-~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  337 (409)
                      .    ...|...+   +   . ..++...|+|+++  ..+++++........  .......+..+...+-.+.+...|.+
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG--~il~~l~~~~~p~~~--~~~~~~~~~~i~~~~~~~~~~~~~~~  230 (292)
T 3o0g_A          155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG--CIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHH--HHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred             cccccCCccccCCcChHHHcCCCCcCchHHHHHHH--HHHHHHHHcCCCCcC--CCCHHHHHHHHHHHhCCCChhhhhhh
Confidence            2    11111111   1   1 2368899999997  445565544332111  12223344555555666666666665


Q ss_pred             HHHHHHHhcCcCCCCC-----------CCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          338 RQVLKMLEGQTEGTGL-----------EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       338 ~evl~~L~~~~~~~~~-----------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      .+....    ...+..           ..+....+++.+|+..+|.+|+++++++.||||+++.
T Consensus       231 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          231 TKLPDY----KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             GGSTTC----CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccc----cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            543211    111110           0111236899999999999999999999999998753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-36  Score=286.60  Aligned_cols=233  Identities=20%  Similarity=0.259  Sum_probs=182.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-CeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-ESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~~lv~  188 (409)
                      ++|.+.+.||+|+||.||+|...  ++.||||++.... ....+.+.+|++++++++||||+++++++.... ...++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            56888999999999999999998  8999999997542 334577889999999999999999999987633 3789999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee----CCCCcEEEecccCccc
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL----DKKMNARLGDFGLAKM  264 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----~~~~~~kl~DFGla~~  264 (409)
                      ||+++|+|.+++........+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            99999999999976544445999999999999999999999   7899999999999999    8888899999999987


Q ss_pred             ccCCce---eeecccc---c-----------cCCCcHHHHHHhhhcc-----------------CcHHHHhhHHhhhc--
Q 048535          265 HHHGQV---MSGRRPI---E-----------EGKRNLVDRMWSLTER-----------------SELLSVLDERLKAK--  308 (409)
Q Consensus       265 ~~~~~~---~~g~~p~---~-----------~~~~~~~~~vws~~~~-----------------~~~~~~~~~~l~~~--  308 (409)
                      ......   ..|...+   +           ...++...|+|+++..                 ....+++...+...  
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~  245 (319)
T 4euu_A          166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (319)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred             cCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence            654431   1122211   1           2456778999998310                 11111221111111  


Q ss_pred             -----------------------CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          309 -----------------------GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       309 -----------------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                                             ..........+.+++.+||+.||++|||++|+++...+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence                                   1334677788999999999999999999999999887543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=298.48  Aligned_cols=233  Identities=23%  Similarity=0.358  Sum_probs=183.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC---------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEcc
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL---------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKE  180 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  180 (409)
                      .++|.+.+.||+|+||.||+|++.         +..||||+++.. .....+.+.+|+++++++ +||||+++++++.+ 
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  146 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-  146 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc-
Confidence            467888999999999999999864         357999999765 455667899999999999 99999999999987 


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCee
Q 048535          181 KESLILIYDYMENGSLDKWIFECDE-------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVL  247 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NIL  247 (409)
                      .+..++||||+++|+|.+++.....             ...+++..+..++.|++.||.|||   +.+|+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEE
Confidence            6778999999999999999976431             235999999999999999999999   789999999999999


Q ss_pred             eCCCCcEEEecccCcccccCCc------eeeec---ccc---ccCCCcHHHHHHhhhccCcHHHHhh-H-----------
Q 048535          248 LDKKMNARLGDFGLAKMHHHGQ------VMSGR---RPI---EEGKRNLVDRMWSLTERSELLSVLD-E-----------  303 (409)
Q Consensus       248 l~~~~~~kl~DFGla~~~~~~~------~~~g~---~p~---~~~~~~~~~~vws~~~~~~~~~~~~-~-----------  303 (409)
                      ++.++.+||+|||+|+......      ...+.   .+.   ....++..+|+|+++  ..+++++. .           
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG--~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG--VLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHH--HHHHHHHTTSCCSSTTCCHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHH--HHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999998654322      11111   111   124567889999984  22222222 1           


Q ss_pred             ----Hhhh-cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          304 ----RLKA-KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       304 ----~l~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                          .... ....+......+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                1110 1223334556789999999999999999999999999876543

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.1e-36  Score=290.66  Aligned_cols=223  Identities=23%  Similarity=0.287  Sum_probs=173.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .++|++.+.||+|+||.||+|...  ++.||||++.... ....+.+.+|+.+++.++||||+++++++.+ .+..++||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEE
Confidence            368899999999999999999987  8999999997553 2334678899999999999999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++|+|.+++.   ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        85 e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EcCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            9999999999984   3456999999999999999999999   899999999999999999999999999999865422


Q ss_pred             c------eeeeccccc------cCC-CcHHHHHHhhhccCcHHHHhhHHhhhc------------------CCCCHHHHH
Q 048535          269 Q------VMSGRRPIE------EGK-RNLVDRMWSLTERSELLSVLDERLKAK------------------GGYADEVVE  317 (409)
Q Consensus       269 ~------~~~g~~p~~------~~~-~~~~~~vws~~~~~~~~~~~~~~l~~~------------------~~~~~~~~~  317 (409)
                      .      ...|...+.      ... ++...|+|+++  ..+++++.......                  .........
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG--~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG--IVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS  236 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHH--HHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCH
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHH--HHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCH
Confidence            1      122332221      122 36789999984  22333332222110                  011123456


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      .+.+++.+||+.||++|||+.|+++.
T Consensus       237 ~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          237 APLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhhC
Confidence            78899999999999999999999764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.7e-36  Score=291.78  Aligned_cols=175  Identities=21%  Similarity=0.300  Sum_probs=144.9

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  184 (409)
                      ..++|+..+.||+|+||.||+|+..  ++.||||+++..   .....+.+.+|..++..+ +||||+++++++.+ .+.+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~   99 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-PDRL   99 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-CCEE
Confidence            3478999999999999999999987  899999999754   233456788999999988 79999999999987 7789


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      |+||||+++|+|.+++...   ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       100 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence            9999999999999999642   46999999999999999999999   78999999999999999999999999999986


Q ss_pred             ccCCc----eeeecccccc------CCCcHHHHHHhhh
Q 048535          265 HHHGQ----VMSGRRPIEE------GKRNLVDRMWSLT  292 (409)
Q Consensus       265 ~~~~~----~~~g~~p~~~------~~~~~~~~vws~~  292 (409)
                      .....    ..+|...+..      ..++...|+|+++
T Consensus       174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  211 (353)
T 3txo_A          174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMG  211 (353)
T ss_dssp             SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHH
T ss_pred             cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcch
Confidence            43221    2234333321      3456788999985

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.2e-36  Score=285.03  Aligned_cols=231  Identities=27%  Similarity=0.413  Sum_probs=182.3

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  183 (409)
                      .++|...+.||+|+||.||+|...       +..||||++... .....+.+.+|+.++++++||||+++++++.+ .+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~  100 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-DGP  100 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec-CCc
Confidence            467888999999999999999873       478999999765 45566789999999999999999999999987 677


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q 048535          184 LILIYDYMENGSLDKWIFECDE---------------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIK  242 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK  242 (409)
                      .++||||+++|+|.+++.....                     ...+++..+..++.|+++||.|||   +.+|+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccc
Confidence            8999999999999999976432                     234899999999999999999999   7899999999


Q ss_pred             CCCeeeCCCCcEEEecccCcccccCCcee------eecccc---c---cCCCcHHHHHHhhhccCcHHHHhh-HH-----
Q 048535          243 ASNVLLDKKMNARLGDFGLAKMHHHGQVM------SGRRPI---E---EGKRNLVDRMWSLTERSELLSVLD-ER-----  304 (409)
Q Consensus       243 p~NILl~~~~~~kl~DFGla~~~~~~~~~------~g~~p~---~---~~~~~~~~~vws~~~~~~~~~~~~-~~-----  304 (409)
                      |+|||++.++.+||+|||+++........      .+...+   +   ...++..+|+|+++  ..+++++. ..     
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG--VLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHH--HHHHHHHTTSCCSSTT
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHH--HHHHHHHhCCCCCCCC
Confidence            99999999999999999999876443211      111111   1   24467889999984  22233322 11     


Q ss_pred             ---------hh--hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          305 ---------LK--AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       305 ---------l~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                               +.  .....+......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~  310 (314)
T 2ivs_A          256 IPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM  310 (314)
T ss_dssp             CCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                     10  012234455678899999999999999999999999998653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.3e-36  Score=289.06  Aligned_cols=223  Identities=19%  Similarity=0.250  Sum_probs=177.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||+|+..  |+.||+|+++..   .......+.+|+.+|++++||||+++++++.+ .+..++|
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~lv   83 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-CCEEEEE
Confidence            57888999999999999999987  899999999754   22345678899999999999999999999987 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            999999999999954   346899999999999999999999   78999999999999999999999999999986432


Q ss_pred             C----ceeeeccccc------cCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhhcCCCCHHHHHHHHHHHH
Q 048535          268 G----QVMSGRRPIE------EGKRNLVDRMWSLTE-------------RSELLSVLDERLKAKGGYADEVVEKVLHLGL  324 (409)
Q Consensus       268 ~----~~~~g~~p~~------~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~  324 (409)
                      .    ....|...+.      ...++...|+|+++.             .....++....+.....++......+.+++.
T Consensus       158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  237 (337)
T 1o6l_A          158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA  237 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            1    1233433221      245678899999841             1112222222222223344455678899999


Q ss_pred             HccCcCCCCCC-----CHHHHHH
Q 048535          325 LCAHPEANSRP-----TIRQVLK  342 (409)
Q Consensus       325 ~Cl~~dP~~RP-----t~~evl~  342 (409)
                      +||+.||++||     ++.|+++
T Consensus       238 ~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          238 GLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHhhcCHHHhcCCCCCCHHHHHc
Confidence            99999999999     8999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2e-36  Score=304.03  Aligned_cols=234  Identities=24%  Similarity=0.374  Sum_probs=180.9

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ...++|+..+.||+|+||.||+|.+. +..||||+++... ...+.|.+|+.+|++++||||+++++++.+  +..++||
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~  257 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVT  257 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEE
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEe
Confidence            34567888999999999999999998 5789999997653 234689999999999999999999999865  5688999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++|+|.+++... ....+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            999999999999542 2235899999999999999999999   799999999999999999999999999999876543


Q ss_pred             cee-----eecccc---c---cCCCcHHHHHHhhhccCcHHHHhh----------------HHhhh-cCCCCHHHHHHHH
Q 048535          269 QVM-----SGRRPI---E---EGKRNLVDRMWSLTERSELLSVLD----------------ERLKA-KGGYADEVVEKVL  320 (409)
Q Consensus       269 ~~~-----~g~~p~---~---~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~~-~~~~~~~~~~~l~  320 (409)
                      ...     .+...+   +   ...++..+|+|+++  ..+++++.                ..... ..+.+..++..+.
T Consensus       334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG--~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  411 (452)
T 1fmk_A          334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG--ILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH  411 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred             ceecccCCcccccccCHhHHhcCCCCccccHHhHH--HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            211     111111   1   25678899999984  12222222                11110 1233445667889


Q ss_pred             HHHHHccCcCCCCCCCHHHHHHHHhcCcCCCC
Q 048535          321 HLGLLCAHPEANSRPTIRQVLKMLEGQTEGTG  352 (409)
Q Consensus       321 ~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~  352 (409)
                      +++.+||+.||++|||+.++++.|+.......
T Consensus       412 ~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          412 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            99999999999999999999999998865543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4e-36  Score=287.81  Aligned_cols=276  Identities=24%  Similarity=0.320  Sum_probs=180.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .++|+..+.||+|+||.||+|...  ++.||+|+++... ....+.+.+|+.++++++||||+++++++.+ .+..++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEEE
Confidence            468999999999999999999986  8999999997553 2334678899999999999999999999987 67899999


Q ss_pred             EeCCCCCHHHHHhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          189 DYMENGSLDKWIFEC---DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       189 E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      ||++ |+|.+++...   .....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 5999998643   12245899999999999999999999   789999999999999999999999999999875


Q ss_pred             cCCc----eeeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCC
Q 048535          266 HHGQ----VMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSR  334 (409)
Q Consensus       266 ~~~~----~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R  334 (409)
                      ....    ...|...+   +    ...++...|+|+++  ..+++++.......+....+.   +..+...+-..++...
T Consensus       159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG--~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~  233 (317)
T 2pmi_A          159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCG--CILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLW  233 (317)
T ss_dssp             TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHH--HHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTC
T ss_pred             CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHh
Confidence            4321    11122111   1    13467899999997  456666665544322222222   2233333333333222


Q ss_pred             CCHHH---------------HHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccccccccCCCCCC
Q 048535          335 PTIRQ---------------VLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNRSSSPSL  399 (409)
Q Consensus       335 Pt~~e---------------vl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~~~~s~~~  399 (409)
                      |+...               +.+.+.....   ...+..-.+++.+|+..+|.+|+++++++.||||++........+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~  310 (317)
T 2pmi_A          234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTK---EPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASMGGSR  310 (317)
T ss_dssp             GGGGGCTTCCTTCCCCCCCCSHHHHGGGCS---SCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--------
T ss_pred             hhhhhhhhcccccccccchhHHHhhccccc---ccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhccccc
Confidence            22211               1111111100   01112347999999999999999999999999999877655555554


Q ss_pred             c
Q 048535          400 N  400 (409)
Q Consensus       400 ~  400 (409)
                      +
T Consensus       311 ~  311 (317)
T 2pmi_A          311 S  311 (317)
T ss_dssp             -
T ss_pred             c
Confidence            4

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=6.6e-37  Score=292.46  Aligned_cols=221  Identities=23%  Similarity=0.267  Sum_probs=168.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..++||+|+||+||+|.+.  ++.||||++...  .......+..|+..+.++ +||||++++++|.+ .+..++|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-~~~~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-GGILYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-CCEEEEE
Confidence            67999999999999999999997  899999998653  344455667777766665 99999999999987 7889999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+ +|+|.+++...  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 66999998653  346999999999999999999999   78999999999999999999999999999987654


Q ss_pred             Cc---eeeecccc---c--cCCCcHHHHHHhhhccCcHHHHhhHHhh----------hcCCCCH----HHHHHHHHHHHH
Q 048535          268 GQ---VMSGRRPI---E--EGKRNLVDRMWSLTERSELLSVLDERLK----------AKGGYAD----EVVEKVLHLGLL  325 (409)
Q Consensus       268 ~~---~~~g~~p~---~--~~~~~~~~~vws~~~~~~~~~~~~~~l~----------~~~~~~~----~~~~~l~~l~~~  325 (409)
                      ..   ...|...+   +  .+.++...|+|+++  ..+++++.....          .....+.    .....+.+++.+
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG--~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  287 (311)
T 3p1a_A          210 AGAGEVQEGDPRYMAPELLQGSYGTAADVFSLG--LTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVM  287 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGTCCSTHHHHHHHH--HHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHH
T ss_pred             CCCCcccCCCccccCHhHhcCCCCchhhHHHHH--HHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHH
Confidence            32   11222221   1  24567889999985  223333322100          0011111    224568888889


Q ss_pred             ccCcCCCCCCCHHHHHH
Q 048535          326 CAHPEANSRPTIRQVLK  342 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~  342 (409)
                      ||+.||++|||+.|+++
T Consensus       288 ~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          288 MLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HSCSSTTTSCCHHHHHT
T ss_pred             HcCCChhhCcCHHHHHh
Confidence            99999999999888875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-35  Score=284.02  Aligned_cols=173  Identities=23%  Similarity=0.295  Sum_probs=147.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||+++..  |+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.+ ....++|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-CCEEEEE
Confidence            67888999999999999999987  8999999997542   2345678899999999999999999999987 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999999964   346899999999999999999999   89999999999999999999999999999987654


Q ss_pred             Cc-eeeeccccc------cCCCcHHHHHHhhh
Q 048535          268 GQ-VMSGRRPIE------EGKRNLVDRMWSLT  292 (409)
Q Consensus       268 ~~-~~~g~~p~~------~~~~~~~~~vws~~  292 (409)
                      .. ...|...+.      ...++...|+|+++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  190 (318)
T 1fot_A          159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFG  190 (318)
T ss_dssp             CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHH
T ss_pred             ccccccCCccccCHhHhcCCCCCcccchhhhH
Confidence            32 223333221      24567788999985

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-36  Score=294.93  Aligned_cols=232  Identities=26%  Similarity=0.378  Sum_probs=180.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  183 (409)
                      .++|+..+.||+|+||.||+|.+.       ++.||||+++.. .......+.+|+.++++++||||+++++++.+ ...
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~  148 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLP  148 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCC
Confidence            367888999999999999999953       568999999754 45556789999999999999999999999987 667


Q ss_pred             EEEEEEeCCCCCHHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC---cEEE
Q 048535          184 LILIYDYMENGSLDKWIFECD----ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM---NARL  256 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~~kl  256 (409)
                      .++||||+++|+|.+++....    ....+++..++.++.||+.||+|||   +.+|+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEE
Confidence            899999999999999997542    2245999999999999999999999   89999999999999999555   5999


Q ss_pred             ecccCcccccCCc------eeeec---cccc---cCCCcHHHHHHhhhccCcHHHHhh-H---------------Hhhh-
Q 048535          257 GDFGLAKMHHHGQ------VMSGR---RPIE---EGKRNLVDRMWSLTERSELLSVLD-E---------------RLKA-  307 (409)
Q Consensus       257 ~DFGla~~~~~~~------~~~g~---~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~---------------~l~~-  307 (409)
                      +|||+|+......      ...|.   .+.+   ...++...|+|+++  ..+++++. .               .... 
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG--~il~ellt~g~~pf~~~~~~~~~~~i~~~~  303 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG--VLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  303 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999997542111      11111   1111   25678899999984  22333332 1               1110 


Q ss_pred             cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          308 KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       308 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      ....+......+.+++.+||+.||++|||+.++++.|+....
T Consensus       304 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          304 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            122334455678999999999999999999999999987543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-35  Score=281.88  Aligned_cols=221  Identities=23%  Similarity=0.303  Sum_probs=175.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh------HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE------HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      +.|+..+.||+|+||.||+|...  ++.||+|.+.....      ...+.+.+|+.+|++++||||+++++++.+ ....
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~   89 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTDV   89 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEE
Confidence            56888999999999999999987  89999999975422      135789999999999999999999999987 7789


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC----cEEEeccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM----NARLGDFG  260 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kl~DFG  260 (409)
                      ++||||+++|+|.+++.   ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999994   3456999999999999999999999   79999999999999999887    79999999


Q ss_pred             CcccccCCc---eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHh---------------hhcCCCCH---
Q 048535          261 LAKMHHHGQ---VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERL---------------KAKGGYAD---  313 (409)
Q Consensus       261 la~~~~~~~---~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l---------------~~~~~~~~---  313 (409)
                      +++......   ...|...+.      ...++...|+|+++  ..+++++....               ......+.   
T Consensus       164 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (326)
T 2y0a_A          164 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG--VITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF  241 (326)
T ss_dssp             TCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHH--HHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred             CCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHH--HHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence            998765432   122332221      24567889999984  22222222211               11112222   


Q ss_pred             -HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          314 -EVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       314 -~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                       .....+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             22456789999999999999999999987

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-36  Score=289.47  Aligned_cols=236  Identities=23%  Similarity=0.335  Sum_probs=181.0

Q ss_pred             HHHhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEc
Q 048535          109 HAATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKK  179 (409)
Q Consensus       109 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  179 (409)
                      ....++|...+.||+|+||.||+|.+.       +..||||.+... .....+.+.+|+.++.++ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            345678999999999999999999972       568999999754 334457899999999999 99999999999987


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCceeec
Q 048535          180 EKESLILIYDYMENGSLDKWIFECDES--------------------IALSWEQRIKVLKDVASGILYLYEGWESKVLHR  239 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr  239 (409)
                       .+..++||||+++|+|.+++......                    ..+++..+..++.|++.||.|||   +.+|+||
T Consensus       121 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~  196 (344)
T 1rjb_A          121 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR  196 (344)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred             -CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence             67889999999999999999754321                    34899999999999999999999   7999999


Q ss_pred             CCCCCCeeeCCCCcEEEecccCcccccCCc--ee----eec---cccc---cCCCcHHHHHHhhhccCcHHHHhh-HHhh
Q 048535          240 DIKASNVLLDKKMNARLGDFGLAKMHHHGQ--VM----SGR---RPIE---EGKRNLVDRMWSLTERSELLSVLD-ERLK  306 (409)
Q Consensus       240 DlKp~NILl~~~~~~kl~DFGla~~~~~~~--~~----~g~---~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~  306 (409)
                      ||||+|||++.++.+||+|||+++......  ..    .|.   .+.+   ...++...|+|+++  ..+++++. ...+
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG--~il~el~t~g~~p  274 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG--ILLWEIFSLGVNP  274 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHTTTSCCS
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHH--HHHHHHHcCCCCC
Confidence            999999999999999999999998654332  11    111   1111   25678889999984  22233322 1110


Q ss_pred             h-----------------cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          307 A-----------------KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       307 ~-----------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      .                 ....+......+.+++.+||+.||.+|||+.++++.|+.....
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          275 YPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             STTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             cccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            0                 1223334566889999999999999999999999999886544

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.7e-36  Score=284.52  Aligned_cols=230  Identities=23%  Similarity=0.337  Sum_probs=174.7

Q ss_pred             CCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      ++|+..+.||+|+||.||+|.+.++.||||.+...  ...+.|.+|+.++++++||||+++++++.+   ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEEEEcCC
Confidence            56788899999999999999999999999999643  345789999999999999999999998764   3689999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc-EEEecccCcccccCCc-e
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN-ARLGDFGLAKMHHHGQ-V  270 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~-~kl~DFGla~~~~~~~-~  270 (409)
                      +|+|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||+++...... .
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~  162 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN  162 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccccc
Confidence            9999999976443345889999999999999999999432389999999999999998886 7999999997654321 1


Q ss_pred             eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh------------------cCCCCHHHHHHHHHHHHHc
Q 048535          271 MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKA------------------KGGYADEVVEKVLHLGLLC  326 (409)
Q Consensus       271 ~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~------------------~~~~~~~~~~~l~~l~~~C  326 (409)
                      ..|...+      ....++...|+|+++  ..+++++......                  ........+..+.+++.+|
T Consensus       163 ~~gt~~y~aPE~~~~~~~~~~~Di~slG--~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  240 (307)
T 2eva_A          163 NKGSAAWMAPEVFEGSNYSEKCDVFSWG--IILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRC  240 (307)
T ss_dssp             --CCTTSSCHHHHTCCCCCTHHHHHHHH--HHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHH
T ss_pred             CCCCCceEChhhhCCCCCCcHHHHHHHH--HHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHH
Confidence            1222222      124567889999984  2222322221110                  1122334456789999999


Q ss_pred             cCcCCCCCCCHHHHHHHHhcCcC
Q 048535          327 AHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       327 l~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      |+.||++|||+.++++.|+.+.+
T Consensus       241 l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          241 WSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             hcCChhhCcCHHHHHHHHHHHHH
Confidence            99999999999999999987654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-35  Score=286.95  Aligned_cols=247  Identities=22%  Similarity=0.290  Sum_probs=180.2

Q ss_pred             HHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCC
Q 048535          109 HAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       109 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~  182 (409)
                      ....++|...+.||+|+||.||+|+..  ++.||+|+++...   ....+.+..|..++..+ +||||+++++++.+ ..
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-~~   91 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KE   91 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SS
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-CC
Confidence            345688999999999999999999987  8999999997542   23456688899999877 99999999999987 77


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..|+||||+++|+|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence            89999999999999999964   246999999999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCc----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCC
Q 048535          263 KMHHHGQ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEAN  332 (409)
Q Consensus       263 ~~~~~~~----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~  332 (409)
                      +......    ...|...+.      ...++...|+|+++  ..+++++.........                      
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~ell~g~~Pf~~~----------------------  221 (345)
T 1xjd_A          166 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFG--VLLYEMLIGQSPFHGQ----------------------  221 (345)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHH--HHHHHHHHSSCSSCCS----------------------
T ss_pred             hhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHH--HHHHHHhcCCCCCCCC----------------------
Confidence            8643221    223333322      24567889999996  3444544433221111                      


Q ss_pred             CCCCHHHHHHHHhcC-cCCCCCCCCCcchhHHhhhcccCCCCccccc-ccCCCCCccccc
Q 048535          333 SRPTIRQVLKMLEGQ-TEGTGLEDEGMNVHLLKRIGTRAMTSSWKFA-GSRGHPTFNEIN  390 (409)
Q Consensus       333 ~RPt~~evl~~L~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~hp~~~~~~  390 (409)
                         +..++.+.+... ...+. .-+....+++.+|+..+|.+|.+.. +++.||||++++
T Consensus       222 ---~~~~~~~~i~~~~~~~p~-~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          222 ---DEEELFHSIRMDNPFYPR-WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             ---SHHHHHHHHHHCCCCCCT-TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             ---CHHHHHHHHHhCCCCCCc-ccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence               111121111111 11111 0112236777778888888888776 777888887765

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.1e-36  Score=289.94  Aligned_cols=235  Identities=23%  Similarity=0.366  Sum_probs=182.3

Q ss_pred             HHHHhCCCCccceeecCCceEEEEEEEC--C-----cEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEE
Q 048535          108 IHAATKGFSEENVIGLGGNGKVYKGQLL--G-----VEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCK  178 (409)
Q Consensus       108 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~-----~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~  178 (409)
                      +....++|+..+.||+|+||.||+|...  +     ..||+|.+... .....+.+.+|+.+++++ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3445678999999999999999999985  2     47999999765 345567899999999999 8999999999998


Q ss_pred             ccCCeEEEEEEeCCCCCHHHHHhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCee
Q 048535          179 KEKESLILIYDYMENGSLDKWIFECD-----------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVL  247 (409)
Q Consensus       179 ~~~~~~~lv~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NIL  247 (409)
                      . .+..++||||+++|+|.+++....           ....+++..+..++.|++.||.|||   +.+|+||||||+|||
T Consensus       121 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          121 H-GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL  196 (333)
T ss_dssp             S-SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCE
T ss_pred             c-CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEE
Confidence            7 678899999999999999986431           1245899999999999999999999   789999999999999


Q ss_pred             eCCCCcEEEecccCcccccCCc--ee----ee---ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HH----------
Q 048535          248 LDKKMNARLGDFGLAKMHHHGQ--VM----SG---RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ER----------  304 (409)
Q Consensus       248 l~~~~~~kl~DFGla~~~~~~~--~~----~g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~----------  304 (409)
                      ++.++.+||+|||+++......  ..    .|   ..+.+   ...++...|+|+++  ..+++++. ..          
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~el~t~g~~p~~~~~~~~  274 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG--ILLWEIFSLGLNPYPGILVNS  274 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHH--HHHHHHTTTSCCSSTTCCSSH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHH--HHHHHHHcCCCCCCcccchhH
Confidence            9999999999999998654322  11    11   11111   25577889999984  22222222 11          


Q ss_pred             -----hh--hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          305 -----LK--AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       305 -----l~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                           +.  .....+...+..+.+++..||+.||.+|||+.|+++.|+...
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          275 KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence                 00  001223334567899999999999999999999999998643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.5e-36  Score=279.89  Aligned_cols=228  Identities=20%  Similarity=0.282  Sum_probs=171.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      .++|+..+.||+|+||.||+|.+.     +..||+|.+... .....+.+.+|+.++++++||||+++++++.  .+..+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~   91 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVW   91 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc--cCccE
Confidence            467888999999999999999885     456999998764 4455678999999999999999999999985  45688


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccccccc
Confidence            999999999999999653  346999999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCcee-----ee---ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HHh---------------h-hcCCCCHHHHH
Q 048535          266 HHGQVM-----SG---RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ERL---------------K-AKGGYADEVVE  317 (409)
Q Consensus       266 ~~~~~~-----~g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~l---------------~-~~~~~~~~~~~  317 (409)
                      ......     .+   ..+.+   ...++...|+|+++  ..+++++. ...               . .....+...+.
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (281)
T 1mp8_A          167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG--VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  244 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHH--HHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             CcccccccccCCCcccccChhhcccCCCCCccCchHHH--HHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            543211     11   11111   24567889999984  12222221 110               0 01223445567


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      .+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       245 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          245 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            7899999999999999999999999998653

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.5e-36  Score=284.56  Aligned_cols=228  Identities=23%  Similarity=0.404  Sum_probs=176.5

Q ss_pred             CCCCccceeecCCceEEEEEEE------CCcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-CeE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQL------LGVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-ESL  184 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~  184 (409)
                      +.|+..+.||+|+||.||+|++      .++.||+|++... .....+.+.+|+.++++++||||+++++++.... ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4578889999999999999984      2889999999754 3344578999999999999999999999998632 568


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++||||+++|+|.+++....  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccc
Confidence            99999999999999996532  45999999999999999999999   89999999999999999999999999999987


Q ss_pred             ccCCcee-------eec---cccc---cCCCcHHHHHHhhhccCcHHHHhhH----------------------------
Q 048535          265 HHHGQVM-------SGR---RPIE---EGKRNLVDRMWSLTERSELLSVLDE----------------------------  303 (409)
Q Consensus       265 ~~~~~~~-------~g~---~p~~---~~~~~~~~~vws~~~~~~~~~~~~~----------------------------  303 (409)
                      .......       .|.   .+.+   ...++..+|+|+++  ..+++++..                            
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFG--VTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHH--HHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHH--HHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            6543311       111   1111   24567789999984  122222210                            


Q ss_pred             -Hhh--hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          304 -RLK--AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       304 -~l~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                       .+.  .....+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence             010  01123344556789999999999999999999999999864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-35  Score=285.82  Aligned_cols=231  Identities=25%  Similarity=0.325  Sum_probs=174.7

Q ss_pred             HHHhCCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhcc--CCCCceeeEeeEEEccC---Ce
Q 048535          109 HAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGR--LKHRNLVGLRGWCKKEK---ES  183 (409)
Q Consensus       109 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~---~~  183 (409)
                      ....++|++.+.||+|+||.||+|++.++.||||++....   ...+..|.+++..  ++||||+++++++....   ..
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             cccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            3455789999999999999999999999999999996442   2344455555554  49999999999988732   67


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC--------ceeecCCCCCCeeeCCCCcEE
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES--------KVLHRDIKASNVLLDKKMNAR  255 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~--------~ivHrDlKp~NILl~~~~~~k  255 (409)
                      .++||||+++|+|.+++..    ..+++..+..++.|++.||.|||   +.        +|+||||||+|||++.++.+|
T Consensus       110 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             eEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence            8999999999999999954    35999999999999999999999   66        999999999999999999999


Q ss_pred             EecccCcccccCCce--------eeecccccc------CCC------cHHHHHHhhhccCcHHHHhhH------------
Q 048535          256 LGDFGLAKMHHHGQV--------MSGRRPIEE------GKR------NLVDRMWSLTERSELLSVLDE------------  303 (409)
Q Consensus       256 l~DFGla~~~~~~~~--------~~g~~p~~~------~~~------~~~~~vws~~~~~~~~~~~~~------------  303 (409)
                      |+|||+++.......        ..|...+..      ...      ...+|+|+++  ..+++++..            
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG--~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG--LILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHH--HHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHH--HHHHHHHhccCcccccccccc
Confidence            999999976543221        122222211      111      1248999985  223333222            


Q ss_pred             -----------------Hhh---hcCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCC
Q 048535          304 -----------------RLK---AKGGYA-----DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGT  351 (409)
Q Consensus       304 -----------------~l~---~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  351 (409)
                                       ...   .....+     ..+...+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence                             000   001122     266778999999999999999999999999998876543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.5e-36  Score=283.38  Aligned_cols=231  Identities=24%  Similarity=0.398  Sum_probs=184.7

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ...++|+..+.||+|+||.||+|.+.  +..||+|.+.... ...+.+.+|+.++++++||||+++++++.+ .+..++|
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v   87 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYII   87 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCEEEE
Confidence            34577888999999999999999998  8899999997543 345789999999999999999999999987 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        88 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           88 TEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            9999999999999763 3456999999999999999999999   78999999999999999999999999999987654


Q ss_pred             Ccee-----ee---ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HH--------------hh--hcCCCCHHHHHHH
Q 048535          268 GQVM-----SG---RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ER--------------LK--AKGGYADEVVEKV  319 (409)
Q Consensus       268 ~~~~-----~g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~--------------l~--~~~~~~~~~~~~l  319 (409)
                      ....     .+   ..+.+   ...++..+|+|+++  ..+++++. ..              +.  .....+...+..+
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (288)
T 3kfa_A          164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFG--VLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV  241 (288)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CccccccCCccccCcCChhhhccCCCCchhhHHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHH
Confidence            3311     11   11111   25567889999984  12222222 11              10  0122344456788


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      .+++..||+.||.+|||+.++++.|+...
T Consensus       242 ~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          242 YELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence            99999999999999999999999998654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.1e-35  Score=279.57  Aligned_cols=230  Identities=26%  Similarity=0.401  Sum_probs=180.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ..|+..+.||+|+||.||+|.+.     ...||+|.+... .....+.+.+|+.++++++||||+++++++....+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            45778899999999999999875     235899999754 445667899999999999999999999998766678899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++..  ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECccccccccc
Confidence            9999999999999964  3456899999999999999999999   7999999999999999999999999999998654


Q ss_pred             CCce--------eeec---ccc---ccCCCcHHHHHHhhhccCcHHHHhhHH----------------hhh-cCCCCHHH
Q 048535          267 HGQV--------MSGR---RPI---EEGKRNLVDRMWSLTERSELLSVLDER----------------LKA-KGGYADEV  315 (409)
Q Consensus       267 ~~~~--------~~g~---~p~---~~~~~~~~~~vws~~~~~~~~~~~~~~----------------l~~-~~~~~~~~  315 (409)
                      ....        ..|.   .+.   ....++...|+|+++  ..+++++...                ... ....+...
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG--VLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC  257 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHH--HHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccC
Confidence            4321        1111   111   124567889999984  2233332211                100 01123334


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      +..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       258 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          258 PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            5678999999999999999999999999987643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.5e-36  Score=288.07  Aligned_cols=239  Identities=21%  Similarity=0.357  Sum_probs=186.2

Q ss_pred             HHHHHHHhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeE
Q 048535          105 YQEIHAATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGW  176 (409)
Q Consensus       105 ~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~  176 (409)
                      .+++....++|+..+.||+|+||.||+|.+.       ++.||||.+... .......+.+|+.++++++||||++++++
T Consensus        17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            3344556688999999999999999999864       578999999755 34456679999999999999999999999


Q ss_pred             EEccCCeEEEEEEeCCCCCHHHHHhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC
Q 048535          177 CKKEKESLILIYDYMENGSLDKWIFECD-------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD  249 (409)
Q Consensus       177 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~  249 (409)
                      +.+ .+..++||||+++|+|.+++....       ....+++..+..++.|++.||.|||   +.+|+||||||+|||++
T Consensus        97 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~  172 (322)
T 1p4o_A           97 VSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVA  172 (322)
T ss_dssp             ECS-SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEEC
T ss_pred             Ecc-CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEc
Confidence            987 677899999999999999986421       1245799999999999999999999   78999999999999999


Q ss_pred             CCCcEEEecccCcccccCCcee------eec---cccc---cCCCcHHHHHHhhhccCcHHHHhh-HH------------
Q 048535          250 KKMNARLGDFGLAKMHHHGQVM------SGR---RPIE---EGKRNLVDRMWSLTERSELLSVLD-ER------------  304 (409)
Q Consensus       250 ~~~~~kl~DFGla~~~~~~~~~------~g~---~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~------------  304 (409)
                      .++.+||+|||+++........      .|.   .+.+   ...++...|+|+++  ..+++++. ..            
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~el~~~g~~p~~~~~~~~~~  250 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG--VVLWEIATLAEQPYQGLSNEQVL  250 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHH--HHHHHHHhcCCCccccCCHHHHH
Confidence            9999999999999865433211      111   1111   25577889999984  22233322 11            


Q ss_pred             ---hhh-cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          305 ---LKA-KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       305 ---l~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                         ... ....+......+.+++.+||+.||.+|||+.|+++.|++...
T Consensus       251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          251 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence               110 012334455678999999999999999999999999987654

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.8e-36  Score=281.37  Aligned_cols=229  Identities=26%  Similarity=0.387  Sum_probs=178.0

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ..++|+..+.||+|+||.||+|.+. +..||+|++..... ..+++.+|++++.+++||||+++++++.+ ....++|||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   99 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITE   99 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEec-CCCeEEEEe
Confidence            3467888999999999999999988 67899999976532 23678999999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A          100 YMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             CCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            99999999999642  346999999999999999999999   7999999999999999999999999999998654322


Q ss_pred             e-----eee---ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHHHHHHHHH
Q 048535          270 V-----MSG---RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADEVVEKVLH  321 (409)
Q Consensus       270 ~-----~~g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~~~~~l~~  321 (409)
                      .     ..+   ..+.+   ...++...|+|+++  ..+++++. .....                ....+......+.+
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG--~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  252 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG--VLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT  252 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHH--HHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccCCccCcccCCHHHhccCCCCchhhHHHHH--HHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHH
Confidence            1     011   11111   24567889999984  22333332 11110                01223334567889


Q ss_pred             HHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          322 LGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      ++.+||+.||.+|||+.|+++.|+.+.
T Consensus       253 li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          253 IMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHHHHHHHHh
Confidence            999999999999999999999998654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-36  Score=292.13  Aligned_cols=229  Identities=26%  Similarity=0.405  Sum_probs=172.2

Q ss_pred             CCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .|+..+.||+|+||.||+|++.     +..||||.++.. .....+.|.+|+.++++++||||++++++|....+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            3566789999999999999874     246899999654 4456788999999999999999999999987656678999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++..  ....+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999964  3346899999999999999999999   78999999999999999999999999999986543


Q ss_pred             Ccee-----e---e---ccccc---cCCCcHHHHHHhhhccCcHHHHhhH-H---------------hhh-cCCCCHHHH
Q 048535          268 GQVM-----S---G---RRPIE---EGKRNLVDRMWSLTERSELLSVLDE-R---------------LKA-KGGYADEVV  316 (409)
Q Consensus       268 ~~~~-----~---g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~~-~---------------l~~-~~~~~~~~~  316 (409)
                      ....     +   +   ..+.+   ...++...|+|+++  ..+++++.. .               ... ....+..++
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG--~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~  322 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG--VLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP  322 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCC
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHH--HHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence            2210     1   1   11111   25678899999984  223333221 0               000 012233455


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      ..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus       323 ~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          323 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            678999999999999999999999999987643

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.3e-35  Score=277.45  Aligned_cols=228  Identities=22%  Similarity=0.408  Sum_probs=172.0

Q ss_pred             hCCCCccceeecCCceEEEEEEECCcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|+..+.||+|+||.||+|++.+ .||+|+++..  .....+.|.+|+.++++++||||+++++++.  ....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc--CCccEEEEE
Confidence            4679999999999999999998765 4999999754  4556678999999999999999999999764  456889999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++++|.+++..  ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            9999999999954  2356999999999999999999999   7899999999999999999999999999997654211


Q ss_pred             ------eeeeccccc---------cCCCcHHHHHHhhhccCcHHHHhhHHhhhc---------------------CCCCH
Q 048535          270 ------VMSGRRPIE---------EGKRNLVDRMWSLTERSELLSVLDERLKAK---------------------GGYAD  313 (409)
Q Consensus       270 ------~~~g~~p~~---------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~---------------------~~~~~  313 (409)
                            ...|...+.         ...++...|+|+++  ..+++++.......                     .....
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG--~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG--IVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS  252 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHH--HHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHH--HHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence                  112222211         24467789999984  12222222111110                     01123


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      .++..+.+++.+||+.||.+|||+.++++.|+++.+
T Consensus       253 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          253 NCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            455778999999999999999999999999998654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-36  Score=287.32  Aligned_cols=230  Identities=27%  Similarity=0.457  Sum_probs=175.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      ++|+..+.||+|+||.||+|.+.      +..||||.++.. .......+.+|+.++++++||||+++++++.. .+..+
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~  122 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMM  122 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-CCCcE
Confidence            45666799999999999999875      235999999765 44556789999999999999999999999986 67899


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            999999999999999653  346999999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCce----ee---e---cccc---ccCCCcHHHHHHhhhccCcHHHHhh----------------HHhhh-cCCCCHHH
Q 048535          266 HHGQV----MS---G---RRPI---EEGKRNLVDRMWSLTERSELLSVLD----------------ERLKA-KGGYADEV  315 (409)
Q Consensus       266 ~~~~~----~~---g---~~p~---~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~~-~~~~~~~~  315 (409)
                      .....    ..   +   ..+.   ....++...|+|+++  ..+++++.                ..... ....+...
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  275 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFG--IVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDC  275 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHH--HHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHH--HHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccC
Confidence            43220    00   0   1111   125567889999984  12222221                11110 12233445


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      ...+.+++.+||+.||++||++.++++.|+.....
T Consensus       276 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          276 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            66789999999999999999999999999876543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9.9e-36  Score=279.46  Aligned_cols=225  Identities=21%  Similarity=0.273  Sum_probs=170.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .++|+..+.||+|+||.||+|...  ++.||+|++...  .......+.+|+..+.++ +||||+++++++.+ .+..++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-~~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-DDHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-TTEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEE
Confidence            467889999999999999999997  899999999754  344567889999999999 99999999999987 778999


Q ss_pred             EEEeCCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC--------------
Q 048535          187 IYDYMENGSLDKWIFECDE-SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK--------------  251 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~--------------  251 (409)
                      ||||+++|+|.+++..... ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999965311 246899999999999999999999   7899999999999999844              


Q ss_pred             -----CcEEEecccCcccccCCceeeecccccc-------CCCcHHHHHHhhhccCcHHHHhhHHhh-------------
Q 048535          252 -----MNARLGDFGLAKMHHHGQVMSGRRPIEE-------GKRNLVDRMWSLTERSELLSVLDERLK-------------  306 (409)
Q Consensus       252 -----~~~kl~DFGla~~~~~~~~~~g~~p~~~-------~~~~~~~~vws~~~~~~~~~~~~~~l~-------------  306 (409)
                           ..+||+|||+++.........|...+..       ..++...|+|+++  ..+++++.....             
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG--~il~~l~~~~~~~~~~~~~~~~~~~  243 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALA--LTVVCAAGAEPLPRNGDQWHEIRQG  243 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHH--HHHHHHTTCCCCCSSSHHHHHHHTT
T ss_pred             ccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHH--HHHHHHhcCCCCCcchhHHHHHHcC
Confidence                 4799999999988766554444443321       2445789999984  122222211100             


Q ss_pred             hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          307 AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       307 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .....+......+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          244 RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            001222333456677777777777777777776654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.8e-35  Score=294.69  Aligned_cols=223  Identities=22%  Similarity=0.212  Sum_probs=175.1

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ..++|+..+.||+|+||.||+|...  |+.||+|++...  .....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~l   87 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-EGHHYL   87 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-SSEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-CCEEEE
Confidence            4567999999999999999999986  899999999755  33456779999999999999999999999987 788999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC---CCCcEEEecccCcc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD---KKMNARLGDFGLAK  263 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~---~~~~~kl~DFGla~  263 (409)
                      |||||++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++   .++.+||+|||+|+
T Consensus        88 v~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            9999999999999964   346999999999999999999999   78999999999999998   46789999999998


Q ss_pred             cccCCce----eeeccccc------cCCCcHHHHHHhhhccCcHHHHh---------------hHHhhhcC----CCCHH
Q 048535          264 MHHHGQV----MSGRRPIE------EGKRNLVDRMWSLTERSELLSVL---------------DERLKAKG----GYADE  314 (409)
Q Consensus       264 ~~~~~~~----~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~---------------~~~l~~~~----~~~~~  314 (409)
                      .......    ..|...+.      ...++...|+|+++  ..+++++               ........    +....
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlG--vilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (444)
T 3soa_A          162 EVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACG--VILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDT  239 (444)
T ss_dssp             CCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHH--HHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred             EecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHH--HHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccccc
Confidence            7654321    22333221      24578899999984  1222222               21111111    11124


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ....+.+++.+||+.||++|||+.|+++
T Consensus       240 ~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          240 VTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            4667889999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.6e-35  Score=297.07  Aligned_cols=221  Identities=23%  Similarity=0.338  Sum_probs=177.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|...+.||+|+||.||+|...  |+.||||++....   ......+.+|+.+++.++||||+++++++.. ....++|
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lv   94 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-PSDIFMV   94 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEE
Confidence            67888999999999999999987  8999999996542   1235678999999999999999999999987 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++.   ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999994   3456999999999999999999999   89999999999999999999999999999987655


Q ss_pred             Cce---eeecccccc------CC-CcHHHHHHhhhccCcHHHHhhH---------------HhhhcCCCCHHHHHHHHHH
Q 048535          268 GQV---MSGRRPIEE------GK-RNLVDRMWSLTERSELLSVLDE---------------RLKAKGGYADEVVEKVLHL  322 (409)
Q Consensus       268 ~~~---~~g~~p~~~------~~-~~~~~~vws~~~~~~~~~~~~~---------------~l~~~~~~~~~~~~~l~~l  322 (409)
                      +..   .+|...+..      .. .+...|+|+++  ..+++++..               ........+......+.++
T Consensus       169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG--vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L  246 (476)
T 2y94_A          169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSG--VILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISL  246 (476)
T ss_dssp             TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHH--HHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred             cccccccCCCcCeEChhhccCCCCCCCcceehhhH--HHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHH
Confidence            432   223333221      22 36789999984  222333222               2211122233345678999


Q ss_pred             HHHccCcCCCCCCCHHHHHH
Q 048535          323 GLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +.+||+.||++|||+.|+++
T Consensus       247 i~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          247 LKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHcCCCchhCcCHHHHHh
Confidence            99999999999999999997

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.9e-35  Score=278.44  Aligned_cols=226  Identities=24%  Similarity=0.435  Sum_probs=176.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChH---H----HHHHHHHHHHhccCCCCceeeEeeEEEccCC
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEH---G----MREFLAEVSSLGRLKHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~---~----~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  182 (409)
                      .++|+..+.||+|+||.||+|.+.  ++.||+|++......   .    .+.+.+|+.++++++||||+++++++.+ ..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN-PP   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT-TT
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC-CC
Confidence            367888999999999999999996  899999999654211   1    1678999999999999999999999865 33


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeeeCCCCc-----EE
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK--VLHRDIKASNVLLDKKMN-----AR  255 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlKp~NILl~~~~~-----~k  255 (409)
                        ++||||+++|+|.+++..  ....+++..+..++.|++.||.|||   +.+  |+||||||+|||++.++.     +|
T Consensus        97 --~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             --eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence              699999999999998865  3356999999999999999999999   778  999999999999988776     99


Q ss_pred             EecccCcccccCCce-eeeccc---cc-----cCCCcHHHHHHhhhccCcHHHHhhHHhh-------------------h
Q 048535          256 LGDFGLAKMHHHGQV-MSGRRP---IE-----EGKRNLVDRMWSLTERSELLSVLDERLK-------------------A  307 (409)
Q Consensus       256 l~DFGla~~~~~~~~-~~g~~p---~~-----~~~~~~~~~vws~~~~~~~~~~~~~~l~-------------------~  307 (409)
                      |+|||+++....... ..|...   .+     ...++...|+|+++  ..+++++.....                   .
T Consensus       170 l~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG--~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          170 VADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFA--MILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             ECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHH--HHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             eCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHH--HHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            999999986544321 112211   11     23357889999984  122222221111                   1


Q ss_pred             cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          308 KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       308 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      ....+......+.+++..||+.||++|||+.|+++.|+++
T Consensus       248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            1233445567899999999999999999999999999863

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.8e-35  Score=287.41  Aligned_cols=223  Identities=17%  Similarity=0.219  Sum_probs=178.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||+++..  |+.||+|++....   ....+.+.+|+.+|+.++||||+++++++.+ ....|+|
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv  119 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEEEE
Confidence            57888999999999999999987  8999999996542   2345678999999999999999999999987 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence            9999999999999643   35999999999999999999999   89999999999999999999999999999987654


Q ss_pred             Cc-eeeeccccc------cCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHcc
Q 048535          268 GQ-VMSGRRPIE------EGKRNLVDRMWSLTE-------------RSELLSVLDERLKAKGGYADEVVEKVLHLGLLCA  327 (409)
Q Consensus       268 ~~-~~~g~~p~~------~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl  327 (409)
                      .. ...|...+.      ...++...|+|+++.             .....++..........++......+.+++.+||
T Consensus       194 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL  273 (350)
T 1rdq_E          194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL  273 (350)
T ss_dssp             CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHS
T ss_pred             CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence            32 233443332      245678899999841             1112222222222223344455677899999999


Q ss_pred             CcCCCCCCC-----HHHHHH
Q 048535          328 HPEANSRPT-----IRQVLK  342 (409)
Q Consensus       328 ~~dP~~RPt-----~~evl~  342 (409)
                      +.||.+||+     ++|+++
T Consensus       274 ~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          274 QVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CSCTTTCTTSSTTTTHHHHT
T ss_pred             hcCHHhccCCccCCHHHHHh
Confidence            999999998     777764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.6e-35  Score=282.13  Aligned_cols=232  Identities=22%  Similarity=0.339  Sum_probs=182.8

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccC
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEK  181 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  181 (409)
                      ..++|+..+.||+|+||.||+|++.       ++.||||++... .....+.+.+|+.+++++ +||||+++++++.. .
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~   99 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-G   99 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec-C
Confidence            3467888999999999999999862       578999999765 334567899999999999 99999999999987 6


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 048535          182 ESLILIYDYMENGSLDKWIFECDE---------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNV  246 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NI  246 (409)
                      +..++||||+++|+|.+++.....               ...+++..+..++.|++.||.|||   +.+|+||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceE
Confidence            778999999999999999976432               125899999999999999999999   78999999999999


Q ss_pred             eeCCCCcEEEecccCcccccCCce--e----ee---ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HHhhh------
Q 048535          247 LLDKKMNARLGDFGLAKMHHHGQV--M----SG---RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ERLKA------  307 (409)
Q Consensus       247 Ll~~~~~~kl~DFGla~~~~~~~~--~----~g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~~------  307 (409)
                      |++.++.+||+|||+++.......  .    .|   ..+.+   ...++...|+|+++  ..+++++. .....      
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG--IFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTTCCSSTTCCSS
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHH--HHHHHHHhCCCCCCCcccch
Confidence            999999999999999987654321  1    11   11111   25577889999984  22333332 11110      


Q ss_pred             -----------cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          308 -----------KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       308 -----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                                 ....+...+..+.+++.+||+.||.+|||+.|+++.|++..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                       01223345567899999999999999999999999998754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7e-36  Score=287.03  Aligned_cols=231  Identities=22%  Similarity=0.331  Sum_probs=182.1

Q ss_pred             CCCCccceeecCCceEEEEEEE------CCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEc-cCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQL------LGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK-EKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~~  185 (409)
                      ++|+..+.||+|+||.||+|++      .++.||||++........+.+.+|++++++++||||+++++++.. .....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            6788899999999999999985      278999999987777777889999999999999999999998874 245689


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +||||+++|+|.+++...  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence            999999999999999653  235999999999999999999999   799999999999999999999999999999876


Q ss_pred             cCCcee-------eec---cccc---cCCCcHHHHHHhhhccCcHHHHhhHHh---------------------------
Q 048535          266 HHGQVM-------SGR---RPIE---EGKRNLVDRMWSLTERSELLSVLDERL---------------------------  305 (409)
Q Consensus       266 ~~~~~~-------~g~---~p~~---~~~~~~~~~vws~~~~~~~~~~~~~~l---------------------------  305 (409)
                      ......       .|.   .+.+   ...++...|+|+++  ..+++++....                           
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFG--VVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHH--HHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHH--HHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            543210       111   1111   24457889999984  12222222100                           


Q ss_pred             --h--hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          306 --K--AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       306 --~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                        .  .....+......+.+++.+||+.||++|||+.|+++.|+.....
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence              0  01123334556789999999999999999999999999987543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.1e-36  Score=292.17  Aligned_cols=226  Identities=22%  Similarity=0.261  Sum_probs=167.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHH-hccCCCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSS-LGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|+..+.||+|+||.||+|+..  ++.||+|+++...   ......+..|..+ ++.++||||+++++++.+ .+.+|+
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-~~~~~l  116 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYF  116 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-CCEEEE
Confidence            57889999999999999999997  7899999997542   2344567788887 577899999999999987 778999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            9999999999999964   346899999999999999999999   8999999999999999999999999999998633


Q ss_pred             CC----ceeeeccccc------cCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhhcCCCCHHHHHHHHHHH
Q 048535          267 HG----QVMSGRRPIE------EGKRNLVDRMWSLTE-------------RSELLSVLDERLKAKGGYADEVVEKVLHLG  323 (409)
Q Consensus       267 ~~----~~~~g~~p~~------~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~  323 (409)
                      ..    ...+|...+.      ...++...|+|+++.             .....++....+.....++......+.+++
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL  270 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence            21    1223333322      245678899999841             112222222223222233444556788899


Q ss_pred             HHccCcCCCCCCCHHHHHHHHh
Q 048535          324 LLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                      .+||+.||.+||++.+.++.+.
T Consensus       271 ~~lL~~dp~~R~~~~~~~~~i~  292 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAKDDFMEIK  292 (373)
T ss_dssp             HHHTCSSGGGSTTTTTTHHHHH
T ss_pred             HHHcccCHHhCCCCCCCHHHHh
Confidence            9999999999999865544443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.9e-35  Score=281.08  Aligned_cols=235  Identities=22%  Similarity=0.213  Sum_probs=181.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc---CCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE---KESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---~~~~~l  186 (409)
                      .++|+..+.||+|+||.||++...  ++.||||++........+.+.+|+.++++++||||+++++++...   ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            467899999999999999999985  899999999777677778899999999999999999999998732   347899


Q ss_pred             EEEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          187 IYDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      ||||+++|+|.+++... .....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999998653 23456999999999999999999999   789999999999999999999999999998764


Q ss_pred             cCCc-------------e---eeecccccc------CCCcHHHHHHhhhccCcHHHHhhHHhh-----------------
Q 048535          266 HHGQ-------------V---MSGRRPIEE------GKRNLVDRMWSLTERSELLSVLDERLK-----------------  306 (409)
Q Consensus       266 ~~~~-------------~---~~g~~p~~~------~~~~~~~~vws~~~~~~~~~~~~~~l~-----------------  306 (409)
                      ....             .   ..+..+.+.      ..++...|+|+++  ..+++++.....                 
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG--~il~el~~g~~p~~~~~~~~~~~~~~~~~  262 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG--CVLYAMMFGEGPYDMVFQKGDSVALAVQN  262 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHH--HHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHH--HHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence            3211             0   001111111      1246789999984  122222211110                 


Q ss_pred             -hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCC
Q 048535          307 -AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGT  351 (409)
Q Consensus       307 -~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  351 (409)
                       ...+........+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence             001122344567899999999999999999999999999876543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.5e-35  Score=287.12  Aligned_cols=224  Identities=19%  Similarity=0.253  Sum_probs=179.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|++.+.||+|+||.||+|...  ++.||+|.+..........+.+|+.+|++++||||+++++++.+ ....++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-CCEEEEEEE
Confidence            467999999999999999999987  88999999987766666789999999999999999999999987 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC--CCcEEEecccCcccccC
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK--KMNARLGDFGLAKMHHH  267 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~--~~~~kl~DFGla~~~~~  267 (409)
                      |+++|+|.+++..  ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.  ++.+||+|||+++....
T Consensus       129 ~~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          129 FLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            9999999999954  2346999999999999999999999   799999999999999974  47799999999987765


Q ss_pred             Cc---eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhH---------------Hhhh----cCCCCHHHHHHH
Q 048535          268 GQ---VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDE---------------RLKA----KGGYADEVVEKV  319 (409)
Q Consensus       268 ~~---~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~---------------~l~~----~~~~~~~~~~~l  319 (409)
                      ..   ...|...+.      ...++...|+|+++  ..+++++..               ....    ...........+
T Consensus       204 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG--~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  281 (387)
T 1kob_A          204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIG--VLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEA  281 (387)
T ss_dssp             TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHH--HHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHH
T ss_pred             CcceeeeccCCCccCchhccCCCCCCcccEeeHh--HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHH
Confidence            43   223333222      24578899999984  122222221               1111    011122345678


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHHH
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      .+++.+||+.||++|||+.|+++.
T Consensus       282 ~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          282 KDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHcCCChhHCcCHHHHhhC
Confidence            999999999999999999999874

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.2e-35  Score=292.97  Aligned_cols=183  Identities=21%  Similarity=0.311  Sum_probs=148.7

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~  185 (409)
                      .++|+..+.||+|+||.||+|+..  ++.||+|+++..   .....+.+..|..++.++ +|||||++++++.+ ...++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~~  129 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLF  129 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-CCEEE
Confidence            367899999999999999999987  789999999754   223345688999999887 89999999999987 77899


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +||||+++|+|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       130 lV~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            99999999999999964   246999999999999999999999   899999999999999999999999999999863


Q ss_pred             cCC----ceeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhH
Q 048535          266 HHG----QVMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDE  303 (409)
Q Consensus       266 ~~~----~~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~  303 (409)
                      ...    ...+|...+.      ...++...|+|+++  ..+++++..
T Consensus       204 ~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslG--vllyell~G  249 (396)
T 4dc2_A          204 LRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG--VLMFEMMAG  249 (396)
T ss_dssp             CCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHH--HHHHHHHHS
T ss_pred             ccCCCccccccCCcccCCchhhcCCCCChHHHHHHHH--HHHHHHHhC
Confidence            221    1233433322      25578899999986  334444443

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.6e-35  Score=286.54  Aligned_cols=224  Identities=22%  Similarity=0.274  Sum_probs=177.8

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ..++|+..+.||+|+||.||+|...  ++.||+|++...  .....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~l  105 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYL  105 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEE
Confidence            3467999999999999999999987  899999999754  34556789999999999999999999999987 778999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC---cEEEecccCcc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM---NARLGDFGLAK  263 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~~kl~DFGla~  263 (409)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++   .+||+|||+++
T Consensus       106 v~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             EECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             EEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            9999999999999943   456999999999999999999999   78999999999999998654   59999999998


Q ss_pred             cccCCce---eeeccccc------cCCCcHHHHHHhhhccCcHHHHhh---------------HHhhhcCCCC----HHH
Q 048535          264 MHHHGQV---MSGRRPIE------EGKRNLVDRMWSLTERSELLSVLD---------------ERLKAKGGYA----DEV  315 (409)
Q Consensus       264 ~~~~~~~---~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~---------------~~l~~~~~~~----~~~  315 (409)
                      .......   ..|...+.      ...++...|+|+++  ..+++++.               ........++    ...
T Consensus       180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  257 (362)
T 2bdw_A          180 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG--VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV  257 (362)
T ss_dssp             CCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGS
T ss_pred             EecCCcccccCCCCccccCHHHHccCCCCchhhHHHHH--HHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCC
Confidence            7654432   22333222      24577889999984  12222222               1111111111    234


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ...+.+++.+||+.||++|||+.|+++.
T Consensus       258 ~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          258 TPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            5678999999999999999999999864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.9e-35  Score=290.91  Aligned_cols=149  Identities=21%  Similarity=0.221  Sum_probs=134.5

Q ss_pred             hCCCCccceeecC--CceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          112 TKGFSEENVIGLG--GNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       112 ~~~f~~~~~lG~G--~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      .++|++.+.||+|  +||.||+|+..  ++.||||++...  .....+.+.+|+.++++++|||||++++++.+ .+..+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~  102 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELW  102 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-CCEEE
Confidence            3678899999999  99999999997  899999999754  34556778899999999999999999999987 77899


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +|||||++|+|.+++... ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus       103 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            999999999999999763 2346999999999999999999999   799999999999999999999999999998654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-35  Score=279.28  Aligned_cols=174  Identities=23%  Similarity=0.359  Sum_probs=139.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh--------------------------HHHHHHHHHHHHhc
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE--------------------------HGMREFLAEVSSLG  163 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--------------------------~~~~~~~~E~~~l~  163 (409)
                      .++|+..+.||+|+||.||+|...  ++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367899999999999999999986  88999999965421                          12356899999999


Q ss_pred             cCCCCceeeEeeEEEcc-CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCC
Q 048535          164 RLKHRNLVGLRGWCKKE-KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIK  242 (409)
Q Consensus       164 ~l~H~niv~l~g~~~~~-~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlK  242 (409)
                      +++||||+++++++.+. ....++||||+++|+|.+++    ....+++..+..++.|++.||.|||   +.+|+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCC
Confidence            99999999999998753 46789999999999998865    3346999999999999999999999   7899999999


Q ss_pred             CCCeeeCCCCcEEEecccCcccccCCce----eeecccc---cc---CC---CcHHHHHHhhh
Q 048535          243 ASNVLLDKKMNARLGDFGLAKMHHHGQV----MSGRRPI---EE---GK---RNLVDRMWSLT  292 (409)
Q Consensus       243 p~NILl~~~~~~kl~DFGla~~~~~~~~----~~g~~p~---~~---~~---~~~~~~vws~~  292 (409)
                      |+|||++.++.+||+|||+++.......    ..|...+   +.   ..   ++...|+|+++
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG  227 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMG  227 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHH
T ss_pred             HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHH
Confidence            9999999999999999999987654321    1122221   11   11   36788999985

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.7e-35  Score=283.51  Aligned_cols=225  Identities=28%  Similarity=0.416  Sum_probs=177.8

Q ss_pred             CCccceeecCCceEEEEEEEC------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeEEE
Q 048535          115 FSEENVIGLGGNGKVYKGQLL------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLIL  186 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~~l  186 (409)
                      |+..+.||+|+||.||++.+.      ++.||||+++.. .....+.+.+|++++++++||||+++++++.+. ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            488899999999999998752      788999999765 345567899999999999999999999999864 357899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++..    ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999954    34999999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCcee-------eec---ccc---ccCCCcHHHHHHhhhccCcHHHHhhHH-----------------------------
Q 048535          267 HGQVM-------SGR---RPI---EEGKRNLVDRMWSLTERSELLSVLDER-----------------------------  304 (409)
Q Consensus       267 ~~~~~-------~g~---~p~---~~~~~~~~~~vws~~~~~~~~~~~~~~-----------------------------  304 (409)
                      .....       .|.   .+.   ....++...|+|+++  ..+++++...                             
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFG--VTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHH--HHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHH--HHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            43211       111   111   124566788999984  1222222110                             


Q ss_pred             hh--hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          305 LK--AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       305 l~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      +.  .....+...+..+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            00  012233445678999999999999999999999999998654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=7.1e-36  Score=286.96  Aligned_cols=229  Identities=23%  Similarity=0.322  Sum_probs=177.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--Cc----EEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GV----EVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      ++|+..+.||+|+||.||+|.+.  ++    +||+|.+... .....+.+.+|+.++++++||||+++++++..  +..+
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~   90 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--SSLQ   90 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--SSEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CccE
Confidence            57888999999999999999986  33    4888888544 22334567899999999999999999998864  5688


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            999999999999999643  346899999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCc------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhh-HHhhhc----------------CCCCHHHH
Q 048535          266 HHGQ------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLD-ERLKAK----------------GGYADEVV  316 (409)
Q Consensus       266 ~~~~------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~-~~l~~~----------------~~~~~~~~  316 (409)
                      ....      ...|...+.      ...++..+|+|+++  ..+++++. ......                ...+....
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYG--VTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICT  243 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBC
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhH--HHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCc
Confidence            4432      111111111      25678899999985  23334333 221111                12223344


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      ..+.+++.+||+.||.+|||+.++++.|+.....
T Consensus       244 ~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          244 IDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            5678899999999999999999999999876543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.9e-36  Score=281.55  Aligned_cols=266  Identities=24%  Similarity=0.315  Sum_probs=192.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCCh--HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSE--HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|+..+.||+|+||.||+|... ++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+ .+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-CCeEEEEEE
Confidence            56888999999999999999987 89999999975532  234678899999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++ +|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CCSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ecCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            9986 999998643  346899999999999999999999   7899999999999999999999999999998654321


Q ss_pred             ----eeeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 048535          270 ----VMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIR  338 (409)
Q Consensus       270 ----~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  338 (409)
                          ...|...+   +    ...++...|+|+++  ..+++++.........   .....+..+...+-...+...|...
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG--~il~~l~~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVG--CIFAEMVNGTPLFPGV---SEADQLMRIFRILGTPNSKNWPNVT  229 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHH--HHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCC---CHHHHHHHHHHHHCCCChhhchhhh
Confidence                11122111   1    13467899999997  4566666554432221   1223344444444455555555544


Q ss_pred             HHHHHHhcCcCCCCC-------CCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          339 QVLKMLEGQTEGTGL-------EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       339 evl~~L~~~~~~~~~-------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      +....-.........       .-+....+++.+|+..+|.+|+++++++.||||++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~n  288 (288)
T 1ob3_A          230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKENN  288 (288)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC--
T ss_pred             cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcC
Confidence            332211111100000       0011226899999999999999999999999998753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.9e-35  Score=289.05  Aligned_cols=215  Identities=22%  Similarity=0.322  Sum_probs=166.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|++.+.||+|+||.||++...  ++.||+|++...   .....+.+.+|+.+|++++|||||++++++.+ ....++|
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lv   93 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-EEDMFMV   93 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEE
Confidence            57888999999999999999987  889999999643   22345678999999999999999999999987 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus        94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999999953   346999999999999999999999   89999999999999999999999999999987654


Q ss_pred             Cc---eeeeccccc---------cCCCcHHHHHHhhhccCcHHHHhhHHhhh------------------cCCCCHHHHH
Q 048535          268 GQ---VMSGRRPIE---------EGKRNLVDRMWSLTERSELLSVLDERLKA------------------KGGYADEVVE  317 (409)
Q Consensus       268 ~~---~~~g~~p~~---------~~~~~~~~~vws~~~~~~~~~~~~~~l~~------------------~~~~~~~~~~  317 (409)
                      ..   ...|...+.         ...++...|+|+++  ..+++++......                  ...++.....
T Consensus       168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG--~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~  245 (384)
T 4fr4_A          168 ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG--VTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ  245 (384)
T ss_dssp             TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHH--HHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             CCceeccCCCccccCCeeeccCCCCCCCccceeechH--HHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCH
Confidence            32   223333221         12367889999985  2334443322221                  1223333445


Q ss_pred             HHHHHHHHccCcCCCCCCC
Q 048535          318 KVLHLGLLCAHPEANSRPT  336 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt  336 (409)
                      .+.+++.+||+.||.+||+
T Consensus       246 ~~~~li~~lL~~dP~~R~s  264 (384)
T 4fr4_A          246 EMVSLLKKLLEPNPDQRFS  264 (384)
T ss_dssp             HHHHHHHHHSCSSGGGSCC
T ss_pred             HHHHHHHHHhcCCHhHhcc
Confidence            5566666666666666666

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.2e-35  Score=284.27  Aligned_cols=182  Identities=22%  Similarity=0.316  Sum_probs=150.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|+..+.||+|+||.||+|+..  ++.||+|+++..   .....+.+.+|..++.++ +||||+++++++.+ ....|+
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~l   87 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFF   87 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-CCEEEE
Confidence            56888999999999999999987  889999999754   344567788999999988 89999999999987 778999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            9999999999999964   246999999999999999999999   7899999999999999999999999999998632


Q ss_pred             CC----ceeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhH
Q 048535          267 HG----QVMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDE  303 (409)
Q Consensus       267 ~~----~~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~  303 (409)
                      ..    ....|...+.      ...++...|+|+++  ..+++++..
T Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~ell~g  206 (345)
T 3a8x_A          162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALG--VLMFEMMAG  206 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHH--HHHHHHHHS
T ss_pred             CCCCcccccCCCccccCccccCCCCCChHHhHHHHH--HHHHHHHhC
Confidence            21    1223333221      24567889999986  334444443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-35  Score=279.30  Aligned_cols=229  Identities=24%  Similarity=0.322  Sum_probs=178.2

Q ss_pred             CCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .|...+.||+|+||.||+|.+.     +..||+|.+... .....+.+.+|+.++++++||||+++++++.+.....++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3555689999999999999874     237999999754 4456678999999999999999999999998755556899


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+.+|+|.+++..  ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999965  3456899999999999999999999   78999999999999999999999999999986543


Q ss_pred             Cce--------eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHH----------------hh-hcCCCCHHHH
Q 048535          268 GQV--------MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDER----------------LK-AKGGYADEVV  316 (409)
Q Consensus       268 ~~~--------~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~----------------l~-~~~~~~~~~~  316 (409)
                      ...        ..+...+      ....++..+|+|+++  ..+++++...                .. .....+....
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFG--VLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCP  254 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHH--HHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCC
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHH--HHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccch
Confidence            221        1111111      124567889999984  2223322211                00 0122333455


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      ..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus       255 ~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          255 DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            678999999999999999999999999987643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.9e-36  Score=308.00  Aligned_cols=234  Identities=24%  Similarity=0.365  Sum_probs=182.7

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ..++|+..+.||+|+||.||+|.+. +..||||+++... ...+.|.+|+.+|++++||||+++++++.+  +..+||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~e  341 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTE  341 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEeee
Confidence            3456777889999999999999998 5789999997653 234689999999999999999999999865  56899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+++... ....+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......
T Consensus       342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            99999999999542 2235899999999999999999999   7999999999999999999999999999998765322


Q ss_pred             ee--e---e---cccc---ccCCCcHHHHHHhhhccCcHHHHhh----------------HHhhh-cCCCCHHHHHHHHH
Q 048535          270 VM--S---G---RRPI---EEGKRNLVDRMWSLTERSELLSVLD----------------ERLKA-KGGYADEVVEKVLH  321 (409)
Q Consensus       270 ~~--~---g---~~p~---~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~~-~~~~~~~~~~~l~~  321 (409)
                      ..  .   +   ..+.   ....++...|+|+++  ..+++++.                ..... ....+..+...+.+
T Consensus       418 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG--v~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  495 (535)
T 2h8h_A          418 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFG--ILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  495 (535)
T ss_dssp             HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHH--HHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             eecccCCcCcccccCHHHhccCCCCchhhHHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            10  0   1   1111   125678889999984  12222222                11110 11234455677899


Q ss_pred             HHHHccCcCCCCCCCHHHHHHHHhcCcCCCCC
Q 048535          322 LGLLCAHPEANSRPTIRQVLKMLEGQTEGTGL  353 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~  353 (409)
                      |+.+||+.||++|||+.++++.|+.......+
T Consensus       496 li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  527 (535)
T 2h8h_A          496 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  527 (535)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence            99999999999999999999999988755443

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.4e-36  Score=279.67  Aligned_cols=229  Identities=31%  Similarity=0.383  Sum_probs=174.4

Q ss_pred             hCCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      .++|+..+.||+|+||.||+|...++.||||.++...  ..+.+.+|+.++++++||||+++++++.+..+..++||||+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            4678889999999999999999999999999997543  45679999999999999999999999876556789999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce-
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV-  270 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~-  270 (409)
                      ++|+|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....... 
T Consensus        98 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  173 (278)
T 1byg_A           98 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT  173 (278)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccccC
Confidence            999999999642 2224899999999999999999999   78999999999999999999999999999986543321 


Q ss_pred             eeecccc---c---cCCCcHHHHHHhhhccCcHHHHhh-HH--------------h-h-hcCCCCHHHHHHHHHHHHHcc
Q 048535          271 MSGRRPI---E---EGKRNLVDRMWSLTERSELLSVLD-ER--------------L-K-AKGGYADEVVEKVLHLGLLCA  327 (409)
Q Consensus       271 ~~g~~p~---~---~~~~~~~~~vws~~~~~~~~~~~~-~~--------------l-~-~~~~~~~~~~~~l~~l~~~Cl  327 (409)
                      ..+...+   +   ...++...|+|+++  ..+++++. ..              + . .....+...+..+.+++..||
T Consensus       174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  251 (278)
T 1byg_A          174 GKLPVKWTAPEALREKKFSTKSDVWSFG--ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCW  251 (278)
T ss_dssp             --CCTTTSCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             CCccccccCHHHhCCCCCCchhcHHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHh
Confidence            1111111   1   24567889999984  22222221 11              1 0 012234455678899999999


Q ss_pred             CcCCCCCCCHHHHHHHHhcCc
Q 048535          328 HPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~~  348 (409)
                      +.||++|||+.|+++.|+.+.
T Consensus       252 ~~~p~~Rps~~~l~~~L~~i~  272 (278)
T 1byg_A          252 HLDAAMRPSFLQLREQLEHIK  272 (278)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCChhhCCCHHHHHHHHHHHH
Confidence            999999999999999998653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.9e-35  Score=286.19  Aligned_cols=177  Identities=26%  Similarity=0.376  Sum_probs=143.0

Q ss_pred             cceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCCC
Q 048535          118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGS  195 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~gs  195 (409)
                      .+.||+|+||.||+|...  |+.||+|+++.......+.+.+|+.+|++++||||+++++++.+ .+..++||||+++|+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-KNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeCCCCCc
Confidence            568999999999999986  89999999987766677889999999999999999999999987 678999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee--CCCCcEEEecccCcccccCCce---
Q 048535          196 LDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL--DKKMNARLGDFGLAKMHHHGQV---  270 (409)
Q Consensus       196 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl--~~~~~~kl~DFGla~~~~~~~~---  270 (409)
                      |.+++..  ....+++..+..++.||+.||.|||   +.+|+||||||+|||+  +.++.+||+|||+++.......   
T Consensus       173 L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~  247 (373)
T 2x4f_A          173 LFDRIID--ESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV  247 (373)
T ss_dssp             EHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred             HHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence            9999864  2346999999999999999999999   7899999999999999  6678999999999987654331   


Q ss_pred             eeeccccc------cCCCcHHHHHHhhhccCcHHHHhh
Q 048535          271 MSGRRPIE------EGKRNLVDRMWSLTERSELLSVLD  302 (409)
Q Consensus       271 ~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~  302 (409)
                      ..|...+.      ...++...|+|+++  ..+++++.
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~ellt  283 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVG--VIAYMLLS  283 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHH--HHHHHHHH
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHH--HHHHHHHh
Confidence            12332221      25567899999985  33444443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=285.86  Aligned_cols=236  Identities=21%  Similarity=0.258  Sum_probs=182.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeEeeEEE-------ccC
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLRGWCK-------KEK  181 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~-------~~~  181 (409)
                      ..+|+..+.||+|+||.||+|.+.  ++.||||++........+.+.+|+.++.++. ||||+++++++.       ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            357888999999999999999985  8999999997776677788999999999995 999999999984       224


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeeeCCCCcEEEecc
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK--VLHRDIKASNVLLDKKMNARLGDF  259 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlKp~NILl~~~~~~kl~DF  259 (409)
                      ...++||||++ |+|.+++........+++..+..++.||+.||.|||   +.+  |+||||||+|||++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            45899999996 699999865444557999999999999999999999   777  999999999999999999999999


Q ss_pred             cCcccccCCce----------------eeeccc---c------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhc------
Q 048535          260 GLAKMHHHGQV----------------MSGRRP---I------EEGKRNLVDRMWSLTERSELLSVLDERLKAK------  308 (409)
Q Consensus       260 Gla~~~~~~~~----------------~~g~~p---~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~------  308 (409)
                      |+++.......                ..|...   .      ....++...|+|+++  ..+++++.......      
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG--~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG--CILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHH--HHHHHHHHSSCCC-------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHH--HHHHHHHhCCCCCcchhHHH
Confidence            99987654211                112111   1      123457799999985  23344433221110      


Q ss_pred             -------CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCCCC
Q 048535          309 -------GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGL  353 (409)
Q Consensus       309 -------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~~  353 (409)
                             ..........+.+++..||+.||.+|||+.|+++.|+........
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~  312 (337)
T 3ll6_A          261 IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV  312 (337)
T ss_dssp             -----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred             hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence                   011112234578899999999999999999999999887654433

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.9e-35  Score=277.74  Aligned_cols=184  Identities=22%  Similarity=0.298  Sum_probs=149.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++|+..+.||+|+||.||+|...  ++.||+|++...  .....+.+.+|+.++++++||||+++++++.+ .+..++||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   81 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-KRRLHLVF   81 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-CCeEEEEE
Confidence            67889999999999999999997  899999998654  33445778899999999999999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            99999999998853   346999999999999999999999   789999999999999999999999999999876532


Q ss_pred             c----eeeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHHh
Q 048535          269 Q----VMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDERL  305 (409)
Q Consensus       269 ~----~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~l  305 (409)
                      .    ...|...+   +    ...++...|+|+++  ..+++++....
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG--~il~~l~~g~~  201 (311)
T 4agu_A          156 SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIG--CVFAELLSGVP  201 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHH--HHHHHHHHSSC
T ss_pred             ccccCCCcCCccccChHHHhcCCCCCcchhhHHHH--HHHHHHHhCCC
Confidence            2    11122111   1    14467889999996  34555555433

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.6e-35  Score=283.04  Aligned_cols=233  Identities=21%  Similarity=0.375  Sum_probs=182.2

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC---------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEc
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL---------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKK  179 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  179 (409)
                      ..++|...+.||+|+||.||+|.+.         +..||||+++.. .....+.+.+|+.+++++ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3477889999999999999999873         567999999765 445667899999999999 99999999999987


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 048535          180 EKESLILIYDYMENGSLDKWIFECDE-------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNV  246 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NI  246 (409)
                       .+..++||||+++|+|.+++.....             ...+++..+..++.|++.||.|||   +.+|+||||||+||
T Consensus       113 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          113 -DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV  188 (334)
T ss_dssp             -SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred             -CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceE
Confidence             6788999999999999999975421             234899999999999999999999   78999999999999


Q ss_pred             eeCCCCcEEEecccCcccccCCcee------eec---cccc---cCCCcHHHHHHhhhccCcHHHHhh-H----------
Q 048535          247 LLDKKMNARLGDFGLAKMHHHGQVM------SGR---RPIE---EGKRNLVDRMWSLTERSELLSVLD-E----------  303 (409)
Q Consensus       247 Ll~~~~~~kl~DFGla~~~~~~~~~------~g~---~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~----------  303 (409)
                      |++.++.+||+|||+++........      .+.   .+.+   ...++...|+|+++  ..+++++. .          
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~ellt~g~~p~~~~~~~  266 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG--VLMWEIFTLGGSPYPGIPVE  266 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHH--HHHHHHHTTSCCSSTTCCHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHH--HHHHHHHhCCCCCcCcCCHH
Confidence            9999999999999999876543211      111   1111   24567889999984  22233222 1          


Q ss_pred             -----Hhhh-cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          304 -----RLKA-KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       304 -----~l~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                           .... ....+......+.+++.+||+.||.+|||+.|+++.|+++..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~  318 (334)
T 2pvf_A          267 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT  318 (334)
T ss_dssp             HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                 1110 122334455678999999999999999999999999987653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4.1e-36  Score=290.25  Aligned_cols=220  Identities=23%  Similarity=0.309  Sum_probs=176.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|.+.+.||+|+||.||+|...  ++.||||++....   ......+.+|+.+++.++||||+++++++.. ....++|
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv   87 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-PTDIVMV   87 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEE
Confidence            67889999999999999999985  8999999996431   1223578899999999999999999999987 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+ +|+|.+++...   ..+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus        88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 67999998642   46999999999999999999999   78999999999999999999999999999987655


Q ss_pred             Cce---eeeccccc------cCC-CcHHHHHHhhhccCcHHHHhhHHhhhc---------------CCCCHHHHHHHHHH
Q 048535          268 GQV---MSGRRPIE------EGK-RNLVDRMWSLTERSELLSVLDERLKAK---------------GGYADEVVEKVLHL  322 (409)
Q Consensus       268 ~~~---~~g~~p~~------~~~-~~~~~~vws~~~~~~~~~~~~~~l~~~---------------~~~~~~~~~~l~~l  322 (409)
                      +..   ..|...+.      ... .+...|+|+++  ..+++++....+..               ...+...+..+.++
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG--~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  238 (336)
T 3h4j_B          161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCG--IVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSL  238 (336)
T ss_dssp             SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHH--HHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHH
T ss_pred             CcccccccCCcCcCCHHHHcCCCCCCCccchhHHH--HHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence            431   22322221      122 25789999985  33444444332211               12234456778999


Q ss_pred             HHHccCcCCCCCCCHHHHHH
Q 048535          323 GLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +.+||+.||.+|||+.|+++
T Consensus       239 i~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          239 IRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             HHTTSCSSGGGSCCHHHHTT
T ss_pred             HHHHcCCChhHCcCHHHHHh
Confidence            99999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.1e-35  Score=281.60  Aligned_cols=240  Identities=23%  Similarity=0.317  Sum_probs=186.5

Q ss_pred             cHHHHHHHhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEe
Q 048535          104 SYQEIHAATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLR  174 (409)
Q Consensus       104 ~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~  174 (409)
                      ...++....++|++.+.||+|+||.||+|.+.       ++.||||++... .....+.+.+|+.++.++ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            34455556788999999999999999999852       578999999765 344567899999999999 799999999


Q ss_pred             eEEEccCCeEEEEEEeCCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCC
Q 048535          175 GWCKKEKESLILIYDYMENGSLDKWIFECDE-------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDI  241 (409)
Q Consensus       175 g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl  241 (409)
                      +++...+...++||||+++|+|.+++.....             ...+++..+..++.|++.||.|||   +.+|+||||
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~di  174 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDL  174 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccC
Confidence            9998755668999999999999999975432             123899999999999999999999   789999999


Q ss_pred             CCCCeeeCCCCcEEEecccCcccccCCc------eeeecccc---c---cCCCcHHHHHHhhhccCcHHHHhh-HHhhh-
Q 048535          242 KASNVLLDKKMNARLGDFGLAKMHHHGQ------VMSGRRPI---E---EGKRNLVDRMWSLTERSELLSVLD-ERLKA-  307 (409)
Q Consensus       242 Kp~NILl~~~~~~kl~DFGla~~~~~~~------~~~g~~p~---~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~~-  307 (409)
                      ||+|||++.++.+||+|||+++......      ...|...+   +   ...++...|+|+++  ..+++++. ..... 
T Consensus       175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~t~g~~p~~  252 (316)
T 2xir_A          175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG--VLLWEIFSLGASPYP  252 (316)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCSST
T ss_pred             ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHH--HHHHHHHhCCCCCCc
Confidence            9999999999999999999998654322      11111111   1   25577899999984  22333332 11110 


Q ss_pred             ----------------cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          308 ----------------KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       308 ----------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                                      ....+......+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                            01223334567899999999999999999999999998754

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=9.5e-35  Score=282.33  Aligned_cols=224  Identities=21%  Similarity=0.257  Sum_probs=175.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-----hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-----EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      +.|++.+.||+|+||.||+|...  ++.||||++....     ....+.+.+|+.+++.++||||+++++++.+ .+..+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~  102 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-DGMLY  102 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEE
Confidence            56888999999999999999987  8999999986431     1235779999999999999999999999987 78899


Q ss_pred             EEEEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc---EEEecccC
Q 048535          186 LIYDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGL  261 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~kl~DFGl  261 (409)
                      +|||||++|+|.+++... .....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999888543 22345899999999999999999999   799999999999999987655   99999999


Q ss_pred             cccccCCce----eeeccccc------cCCCcHHHHHHhhhccCcHHHHhh--------------HHhhhcCCCCH----
Q 048535          262 AKMHHHGQV----MSGRRPIE------EGKRNLVDRMWSLTERSELLSVLD--------------ERLKAKGGYAD----  313 (409)
Q Consensus       262 a~~~~~~~~----~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~--------------~~l~~~~~~~~----  313 (409)
                      ++.......    ..|...+.      ...++...|+|+++  ..+++++.              .........+.    
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCG--VILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHH--HHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHH--HHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccc
Confidence            987654332    12322221      24567889999984  12222222              12221112222    


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .....+.+++.+||+.||++|||+.|+++
T Consensus       258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            23467899999999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.5e-35  Score=274.39  Aligned_cols=221  Identities=23%  Similarity=0.260  Sum_probs=168.7

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|+..+.||+|+||.||+|...  +..||+|++........+.+.+|++++++++||||+++++++.+ ....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-NTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeEEEEEe
Confidence            467889999999999999999987  77899999976655556789999999999999999999999987 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee---CCCCcEEEecccCccccc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL---DKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kl~DFGla~~~~  266 (409)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++...
T Consensus        87 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            9999999999864   345899999999999999999999   8999999999999999   788999999999998765


Q ss_pred             CCce---eeeccccc-----cCCCcHHHHHHhhhccCcHHHHhhHHhhh---------------cCCCCH----HHHHHH
Q 048535          267 HGQV---MSGRRPIE-----EGKRNLVDRMWSLTERSELLSVLDERLKA---------------KGGYAD----EVVEKV  319 (409)
Q Consensus       267 ~~~~---~~g~~p~~-----~~~~~~~~~vws~~~~~~~~~~~~~~l~~---------------~~~~~~----~~~~~l  319 (409)
                      ....   ..|...+.     .+.++...|+|+++  ..+++++......               ....+.    .....+
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG--~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (277)
T 3f3z_A          161 PGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAG--VMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQA  238 (277)
T ss_dssp             TTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHH
T ss_pred             CccchhccCCCCCccChHHhcccCCchhhehhHH--HHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHH
Confidence            4331   12222221     13467788999985  2233333322111               111222    123456


Q ss_pred             HHHHHHccCcCCCCCCCHHHHH
Q 048535          320 LHLGLLCAHPEANSRPTIRQVL  341 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl  341 (409)
                      .+++.+||+.||++|||+.|++
T Consensus       239 ~~li~~~l~~dp~~R~s~~~~l  260 (277)
T 3f3z_A          239 ESLIRRLLTKSPKQRITSLQAL  260 (277)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHT
T ss_pred             HHHHHHHccCChhhCcCHHHHh
Confidence            6666666666666666666654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.9e-35  Score=287.07  Aligned_cols=222  Identities=26%  Similarity=0.363  Sum_probs=175.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      +.|+..+.||+|+||.||+|...  ++.||||++...   .....+.+.+|+.++++++||||+++++++.+ .+..++|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv  132 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV  132 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCeEEEE
Confidence            45888899999999999999975  899999999754   23445679999999999999999999999987 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||++ |+|.+++...  ...+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 6888888542  346999999999999999999999   78999999999999999999999999999987665


Q ss_pred             Cceeeeccccc---------cCCCcHHHHHHhhhccCcHHHHhhHHh---------------hhc--CCCCHHHHHHHHH
Q 048535          268 GQVMSGRRPIE---------EGKRNLVDRMWSLTERSELLSVLDERL---------------KAK--GGYADEVVEKVLH  321 (409)
Q Consensus       268 ~~~~~g~~p~~---------~~~~~~~~~vws~~~~~~~~~~~~~~l---------------~~~--~~~~~~~~~~l~~  321 (409)
                      .....|...+.         ...++...|+|+++  ..+++++....               ...  ..........+.+
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG--~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  284 (348)
T 1u5q_A          207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG--ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  284 (348)
T ss_dssp             BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHH--HHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHH
T ss_pred             CCcccCCcceeCHhhhccccCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence            44344433321         24567789999984  22222222111               100  1112234567889


Q ss_pred             HHHHccCcCCCCCCCHHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ++.+||+.||++|||+.++++.
T Consensus       285 li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          285 FVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHHHHcccChhhCcCHHHHhhC
Confidence            9999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=3.6e-35  Score=285.13  Aligned_cols=221  Identities=23%  Similarity=0.265  Sum_probs=156.5

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ..+.|+..+.||+|+||.||+|...  ++.||||+++...  ..+.+.+|+.++++++||||+++++++.+ ....++||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~  127 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET-PTEISLVL  127 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec-CCeEEEEE
Confidence            3467889999999999999999997  7889999997543  34678899999999999999999999987 67899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC---CCcEEEecccCcccc
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK---KMNARLGDFGLAKMH  265 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kl~DFGla~~~  265 (409)
                      ||+++|+|.+++..   ...+++.++..++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++..
T Consensus       128 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          128 ELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999999999953   456999999999999999999999   789999999999999975   889999999999876


Q ss_pred             cCCc---eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcC--------------------CCCHHHH
Q 048535          266 HHGQ---VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKG--------------------GYADEVV  316 (409)
Q Consensus       266 ~~~~---~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~--------------------~~~~~~~  316 (409)
                      ....   ...|...+.      ...++...|+|+++  ..+++++........                    +......
T Consensus       202 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  279 (349)
T 2w4o_A          202 EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVG--IITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS  279 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHH--HHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred             CcccccccccCCCCccCHHHhcCCCCCcccchHHHH--HHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence            5432   122332221      24567889999985  223333322211111                    1112334


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+.+++.+||+.||++|||+.|+++
T Consensus       280 ~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          280 LNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhc
Confidence            45666777777777777777777665

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.8e-35  Score=296.64  Aligned_cols=222  Identities=19%  Similarity=0.252  Sum_probs=160.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .++|+..+.||+|+||.||+|...  ++.||||++...   .......+.+|+.++++++||||+++++++.+ .+..++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~l  225 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCF  225 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-TTEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-CCEEEE
Confidence            367899999999999999999987  899999999753   33445678899999999999999999999987 778999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE-SKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||+|||   + .+|+||||||+|||++.++.+||+|||+|+..
T Consensus       226 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            9999999999999954   346999999999999999999999   6 89999999999999999999999999999864


Q ss_pred             cCCc----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhh---------------hcCCCCHHHHHHHH
Q 048535          266 HHGQ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLK---------------AKGGYADEVVEKVL  320 (409)
Q Consensus       266 ~~~~----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~---------------~~~~~~~~~~~~l~  320 (409)
                      ....    ...|...+.      ...++...|+|+++  ..+++++....+               ....++......+.
T Consensus       300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  377 (446)
T 4ejn_A          300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG--VVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAK  377 (446)
T ss_dssp             CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             cCCCcccccccCCccccCHhhcCCCCCCCccchhhhH--HHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Confidence            3221    122332221      25577899999985  233333332222               11222333445566


Q ss_pred             HHHHHccCcCCCCCC-----CHHHHHH
Q 048535          321 HLGLLCAHPEANSRP-----TIRQVLK  342 (409)
Q Consensus       321 ~l~~~Cl~~dP~~RP-----t~~evl~  342 (409)
                      +++.+||+.||.+||     |++|+++
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            666666666666666     6666553

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.8e-36  Score=297.15  Aligned_cols=180  Identities=20%  Similarity=0.213  Sum_probs=150.1

Q ss_pred             HHHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEc
Q 048535          105 YQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKK  179 (409)
Q Consensus       105 ~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  179 (409)
                      +.++....++|+..+.||+|+||.||+|+..  ++.||+|+++...   ....+.+.+|+.+++.++|||||++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            4455566789999999999999999999997  8899999996431   1122458899999999999999999999987


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 048535          180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDF  259 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF  259 (409)
                       ...+|+|||||++|+|.+++..    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+||
T Consensus       141 -~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DF  212 (410)
T 3v8s_A          141 -DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADF  212 (410)
T ss_dssp             -SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEecc
Confidence             7889999999999999999954    35899999999999999999999   799999999999999999999999999


Q ss_pred             cCcccccCCc-----eeeecccccc----------CCCcHHHHHHhhh
Q 048535          260 GLAKMHHHGQ-----VMSGRRPIEE----------GKRNLVDRMWSLT  292 (409)
Q Consensus       260 Gla~~~~~~~-----~~~g~~p~~~----------~~~~~~~~vws~~  292 (409)
                      |+|+......     ...|...+..          ..++...|+|+++
T Consensus       213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlG  260 (410)
T 3v8s_A          213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG  260 (410)
T ss_dssp             TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHH
T ss_pred             ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecch
Confidence            9998765443     2234333321          1267889999985

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.8e-35  Score=282.57  Aligned_cols=225  Identities=21%  Similarity=0.307  Sum_probs=169.7

Q ss_pred             hCCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHH--HHHhccCCCCceeeEeeEEEc----cCCeEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAE--VSSLGRLKHRNLVGLRGWCKK----EKESLI  185 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E--~~~l~~l~H~niv~l~g~~~~----~~~~~~  185 (409)
                      .++|+..+.||+|+||.||+|+..++.||||++.....   ..+..|  +..+..++||||+++++++..    .....+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            36788999999999999999999999999999975432   334444  444556899999999986542    233578


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------ceeecCCCCCCeeeCCCCcEEE
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES---------KVLHRDIKASNVLLDKKMNARL  256 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~---------~ivHrDlKp~NILl~~~~~~kl  256 (409)
                      +||||+++|+|.+++..    ...++..+..++.|+++||.|||   +.         +|+||||||+|||++.++.+||
T Consensus        89 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEE
T ss_pred             EEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEE
Confidence            99999999999999954    23589999999999999999999   67         9999999999999999999999


Q ss_pred             ecccCcccccCCce------------eeecccccc-------------CCCcHHHHHHhhhccCcHHHHhhHHhhh----
Q 048535          257 GDFGLAKMHHHGQV------------MSGRRPIEE-------------GKRNLVDRMWSLTERSELLSVLDERLKA----  307 (409)
Q Consensus       257 ~DFGla~~~~~~~~------------~~g~~p~~~-------------~~~~~~~~vws~~~~~~~~~~~~~~l~~----  307 (409)
                      +|||+++.......            ..|...+..             ..++...|+|+++  ..+++++......    
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG--~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG--LIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHH--HHHHHHHTTBGGGSTTS
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHH--HHHHHHHhcCCcCCCcc
Confidence            99999987643221            112222211             1234678999985  2333333221100    


Q ss_pred             -------------------------------cCCC------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          308 -------------------------------KGGY------ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       308 -------------------------------~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                                                     ....      .......+.+++.+||+.||++|||+.|+++.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence                                           0111      1235567999999999999999999999999998765

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-35  Score=290.91  Aligned_cols=232  Identities=20%  Similarity=0.262  Sum_probs=181.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-CeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-ESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~~lv~  188 (409)
                      ++|.+.+.||+|+||.||+|.+.  ++.||||++.... ....+.+.+|++++++++||||+++++++.... ...++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            56888999999999999999997  8999999997542 334577889999999999999999999988633 3689999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee----CCCCcEEEecccCccc
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL----DKKMNARLGDFGLAKM  264 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----~~~~~~kl~DFGla~~  264 (409)
                      ||+++|+|.+++........+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++.
T Consensus        89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            99999999999965443445999999999999999999999   7899999999999999    7888899999999987


Q ss_pred             ccCCce---eeecccccc--------------CCCcHHHHHHhhhccCcHHH-------------------HhhHHhhhc
Q 048535          265 HHHGQV---MSGRRPIEE--------------GKRNLVDRMWSLTERSELLS-------------------VLDERLKAK  308 (409)
Q Consensus       265 ~~~~~~---~~g~~p~~~--------------~~~~~~~~vws~~~~~~~~~-------------------~~~~~l~~~  308 (409)
                      ......   ..|...+..              ..++...|+|+++  ..+++                   .+...+...
T Consensus       166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG--~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG--VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             CCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHH--HHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             ccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHH--HHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            654331   122222211              2345678999983  11222                   222221110


Q ss_pred             -------------------------CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          309 -------------------------GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       309 -------------------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                                               ..........+.+++.+||+.||++|||+.|+++.++.+..
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence                                     12336677889999999999999999999999998876543

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.7e-35  Score=281.95  Aligned_cols=234  Identities=23%  Similarity=0.361  Sum_probs=175.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .++|++.+.||+|+||.||+|...  ++.||||++...   .......+.+|+.++++++||||+++++++.. .+..++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~l  109 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNI  109 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCcEEE
Confidence            357889999999999999999986  899999999753   44566789999999999999999999999987 678999


Q ss_pred             EEEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          187 IYDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      ||||+++|+|.+++... .....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            99999999999998642 12456899999999999999999999   789999999999999999999999999999865


Q ss_pred             cCCc----eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh-------------------cCCCCHHHH
Q 048535          266 HHGQ----VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKA-------------------KGGYADEVV  316 (409)
Q Consensus       266 ~~~~----~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~-------------------~~~~~~~~~  316 (409)
                      ....    ...|...+      ....++...|+|+++  ..+++++......                   .........
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLG--CLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS  264 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHH--HHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSC
T ss_pred             cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHH--HHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccC
Confidence            4322    11122211      124567889999984  1122222111100                   001113345


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCC
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGT  351 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  351 (409)
                      ..+.+++.+||+.||++|||+.++++.|+.+.+..
T Consensus       265 ~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          265 EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            67899999999999999999999999998875443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.6e-35  Score=280.24  Aligned_cols=228  Identities=24%  Similarity=0.416  Sum_probs=179.4

Q ss_pred             CCCCccceeecCCceEEEEEEE------CCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-CeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQL------LGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-ESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~------~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-~~~~  185 (409)
                      ++|+..+.||+|+||.||+|.+      .++.||||++........+.+.+|+.++++++||||+++++++.... ...+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            5688889999999999999985      28899999998776677788999999999999999999999987532 3689


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       121 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            999999999999999753  245999999999999999999999   799999999999999999999999999999876


Q ss_pred             cCCcee-------eec---cccc---cCCCcHHHHHHhhhccCcHHHHhhH-----------------------------
Q 048535          266 HHGQVM-------SGR---RPIE---EGKRNLVDRMWSLTERSELLSVLDE-----------------------------  303 (409)
Q Consensus       266 ~~~~~~-------~g~---~p~~---~~~~~~~~~vws~~~~~~~~~~~~~-----------------------------  303 (409)
                      ......       .+.   .+.+   ...++...|+|+++.  .+++++..                             
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~--il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGV--VLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHH--HHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHH--HHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            543211       111   1111   144678899999831  12222110                             


Q ss_pred             -Hhhh--cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          304 -RLKA--KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       304 -~l~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                       .+..  ....+...+..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             0100  1123344557889999999999999999999999999865

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.6e-35  Score=279.47  Aligned_cols=228  Identities=17%  Similarity=0.241  Sum_probs=171.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC---e
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE---S  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---~  183 (409)
                      .++|++.+.||+|+||.||+|...  ++.||||+++..   .......+.+|+.++++++||||+++++++.....   .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            467899999999999999999986  899999999764   34455689999999999999999999999875322   3


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      .++||||+++|+|.+++...   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            58999999999999999642   46999999999999999999999   7899999999999999999999999999998


Q ss_pred             cccCCc-------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhc--------------CCCCH---
Q 048535          264 MHHHGQ-------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAK--------------GGYAD---  313 (409)
Q Consensus       264 ~~~~~~-------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~--------------~~~~~---  313 (409)
                      ......       ...|...+.      ...++...|+|+++  ..+++++.......              ...+.   
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG--CVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR  242 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHH--HHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHH--HHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence            654321       112222221      24567889999984  22333332221110              11111   


Q ss_pred             --HHHHHHHHHHHHccCcCCCCCCCHHHHH-HHHhcC
Q 048535          314 --EVVEKVLHLGLLCAHPEANSRPTIRQVL-KMLEGQ  347 (409)
Q Consensus       314 --~~~~~l~~l~~~Cl~~dP~~RPt~~evl-~~L~~~  347 (409)
                        ..+..+.+++.+||+.||++||++.+++ ..|...
T Consensus       243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence              1345789999999999999999766555 445443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.4e-35  Score=275.00  Aligned_cols=176  Identities=23%  Similarity=0.349  Sum_probs=143.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|...+.||+|+||.||++...  +..||+|++... .....+.+.+|++++++++||||+++++++.+ ....++|||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e  100 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-YHNMYIVME  100 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-CCeEEEEEE
Confidence            56888999999999999999987  889999999755 23346789999999999999999999999987 778999999


Q ss_pred             eCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee---CCCCcEEEecccCcccc
Q 048535          190 YMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL---DKKMNARLGDFGLAKMH  265 (409)
Q Consensus       190 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kl~DFGla~~~  265 (409)
                      |+++|+|.+++... .....+++..+..++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++..
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999998643 12356999999999999999999999   7999999999999999   45678999999999875


Q ss_pred             cCCc---eeeeccccc-----cCCCcHHHHHHhhh
Q 048535          266 HHGQ---VMSGRRPIE-----EGKRNLVDRMWSLT  292 (409)
Q Consensus       266 ~~~~---~~~g~~p~~-----~~~~~~~~~vws~~  292 (409)
                      ....   ...|...+.     ...++...|+|+++
T Consensus       178 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG  212 (285)
T 3is5_A          178 KSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAG  212 (285)
T ss_dssp             ---------CTTGGGCCHHHHTTCCCHHHHHHHHH
T ss_pred             CCcccCcCcccccCcCChHHhccCCCcccCeehHH
Confidence            5432   112222211     24567889999985

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.9e-35  Score=285.42  Aligned_cols=272  Identities=19%  Similarity=0.163  Sum_probs=192.6

Q ss_pred             cccHHHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC-----CCceeeEe
Q 048535          102 RVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-----HRNLVGLR  174 (409)
Q Consensus       102 ~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~  174 (409)
                      .+++++.....++|++.+.||+|+||.||+|+..  ++.||||+++.. ....+.+..|+.+++.++     ||||++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            4555666666789999999999999999999995  889999999743 344567788999999886     99999999


Q ss_pred             eEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC----
Q 048535          175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK----  250 (409)
Q Consensus       175 g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~----  250 (409)
                      +++.. .+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.    
T Consensus       103 ~~~~~-~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          103 GKFMY-YDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEE-TTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCC
T ss_pred             ceeeE-CCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccc
Confidence            99987 67899999999 88999999763 2345999999999999999999999   899999999999999975    


Q ss_pred             ---------------------CCcEEEecccCcccccCCc-eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhh
Q 048535          251 ---------------------KMNARLGDFGLAKMHHHGQ-VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLD  302 (409)
Q Consensus       251 ---------------------~~~~kl~DFGla~~~~~~~-~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~  302 (409)
                                           ++.+||+|||+|+...... ...|...+      ....++...|+|+++  ..+++++.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~ell~  254 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFG--CVLAELYT  254 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHH--HHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHH--HHHHHHHH
Confidence                                 7889999999998654322 12222222      124567889999996  44555555


Q ss_pred             HHhhhcCCCCHHHHHHHHHHHHHccCcC--------------------------CCCCCCHHHHHHHHhcCcCCCCCCCC
Q 048535          303 ERLKAKGGYADEVVEKVLHLGLLCAHPE--------------------------ANSRPTIRQVLKMLEGQTEGTGLEDE  356 (409)
Q Consensus       303 ~~l~~~~~~~~~~~~~l~~l~~~Cl~~d--------------------------P~~RPt~~evl~~L~~~~~~~~~~~~  356 (409)
                      ...........+.    ...+.......                          |........ ...+....+.......
T Consensus       255 g~~pf~~~~~~~~----~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~  329 (360)
T 3llt_A          255 GSLLFRTHEHMEH----LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINS-IKHVKKCLPLYKIIKH  329 (360)
T ss_dssp             SSCSCCCSSHHHH----HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHH-HHHHHTCCCHHHHCCC
T ss_pred             CCCCCCCCcHHHH----HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhh-hhhhhhcccccccchH
Confidence            4443222111111    11111111111                          222222222 1222222211111223


Q ss_pred             CcchhHHhhhcccCCCCcccccccCCCCCcc
Q 048535          357 GMNVHLLKRIGTRAMTSSWKFAGSRGHPTFN  387 (409)
Q Consensus       357 ~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~  387 (409)
                      ..-.+++.+|+..+|.+|+++++++.||||+
T Consensus       330 ~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          330 ELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            4557888888888888888888888888884

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.2e-35  Score=282.39  Aligned_cols=273  Identities=22%  Similarity=0.304  Sum_probs=194.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChH-HHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEH-GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|...+.||+|+||.||+|...  ++.||+|++...... ....+.+|+.++++++||||+++++++.. .+..++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-SSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-CCEEEEEec
Confidence            56888999999999999999987  889999999754322 22246689999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |++ |+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           81 YLD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CCS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             ccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            997 5999998653  346899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             e----eeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 048535          270 V----MSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIR  338 (409)
Q Consensus       270 ~----~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  338 (409)
                      .    ..|...+   +    ...++...|+|+++  ..+++++.......+...   ...+..+...+-.+.+...|...
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG--~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~  229 (324)
T 3mtl_A          155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVG--CIFYEMATGRPLFPGSTV---EEQLHFIFRILGTPTEETWPGIL  229 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHH--HHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             cccccccCcccccChhhhcCCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCChHhchhhh
Confidence            1    1111111   1    14467889999997  456666665543322222   22334444445555555555443


Q ss_pred             HHHHHHhcCcCCCC--------CCCCCcchhHHhhhcccCCCCcccccccCCCCCccccccccCCCC
Q 048535          339 QVLKMLEGQTEGTG--------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNRSSSP  397 (409)
Q Consensus       339 evl~~L~~~~~~~~--------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~~~~s~  397 (409)
                      ..-..-.-......        +.-+....+++.+|+..+|.+|+++++++.||||.++.......+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~  296 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLP  296 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSC
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCC
Confidence            32221111100000        001122379999999999999999999999999999876554433

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-35  Score=304.39  Aligned_cols=219  Identities=24%  Similarity=0.376  Sum_probs=173.1

Q ss_pred             eeecCCceEEEEEEEC----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCCCC
Q 048535          120 VIGLGGNGKVYKGQLL----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENG  194 (409)
Q Consensus       120 ~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~~g  194 (409)
                      .||+|+||.||+|.+.    +..||||+++.. .....++|.+|+.+|++++|||||+++++|..  +..++|||||++|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~E~~~~g  420 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGG  420 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEEEECCTTC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEEEEeCCCC
Confidence            7999999999999874    567999999765 33456889999999999999999999999975  4689999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc-----
Q 048535          195 SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ-----  269 (409)
Q Consensus       195 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-----  269 (409)
                      +|.+++..  ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......     
T Consensus       421 ~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          421 PLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             BHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             cHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            99999964  2456999999999999999999999   7899999999999999999999999999998764332     


Q ss_pred             eeeeccc--c---c---cCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHHHHHHHHHHHH
Q 048535          270 VMSGRRP--I---E---EGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADEVVEKVLHLGL  324 (409)
Q Consensus       270 ~~~g~~p--~---~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~~~~~l~~l~~  324 (409)
                      ...+..+  +   +   ...++..+|+|+++  ..+++++. .....                ....+..++..+.+++.
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlG--v~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  573 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYG--VTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMS  573 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHH--HHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence            1111111  1   1   25678899999984  22333332 11110                12334456678999999


Q ss_pred             HccCcCCCCCCCHHHHHHHHhcC
Q 048535          325 LCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       325 ~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      .||+.||++|||+.++++.|+..
T Consensus       574 ~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          574 DCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             HTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHHHHHHH
Confidence            99999999999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.5e-34  Score=271.72  Aligned_cols=222  Identities=22%  Similarity=0.255  Sum_probs=176.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .++|++.+.||+|+||.||+|...  ++.||+|++...  .....+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-CCEEEEE
Confidence            478999999999999999999987  889999999654  44556788999999999999999999999987 7788999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc---EEEecccCccc
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAKM  264 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~kl~DFGla~~  264 (409)
                      |||+++|+|.+++...   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.   +||+|||++..
T Consensus        84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~  157 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  157 (284)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence            9999999999988542   46999999999999999999999   789999999999999987655   99999999987


Q ss_pred             ccCCce---eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHH---------------hhhcC----CCCHHHH
Q 048535          265 HHHGQV---MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDER---------------LKAKG----GYADEVV  316 (409)
Q Consensus       265 ~~~~~~---~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~---------------l~~~~----~~~~~~~  316 (409)
                      ......   ..|...+      ....++...|+|+++  ..+++++...               .....    .......
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T 3kk8_A          158 VNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG--VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT  235 (284)
T ss_dssp             CCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             cccCccccCCCCCcCCcCchhhcCCCCCcccchHHHH--HHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccC
Confidence            654432   1222222      124567889999984  1222222211               11101    1112345


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          236 PEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhc
Confidence            67899999999999999999999987

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.7e-35  Score=272.47  Aligned_cols=227  Identities=23%  Similarity=0.350  Sum_probs=179.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      ++|+..+.||+|+||.||+|.+. +..||+|.+..... ..+.+.+|++++++++||||+++++++.+ .+..++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCeEEEEeCC
Confidence            56888899999999999999997 78899999976532 33678999999999999999999999987 67789999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce-
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV-  270 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~-  270 (409)
                      ++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            999999999653  346899999999999999999999   78999999999999999999999999999986543221 


Q ss_pred             ----eee---ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHHHHHHHHHHH
Q 048535          271 ----MSG---RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADEVVEKVLHLG  323 (409)
Q Consensus       271 ----~~g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~~~~~l~~l~  323 (409)
                          ..+   ..+.+   ...++..+|+|+++  ..+++++. .....                ....+......+.+++
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  238 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFG--VLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM  238 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhH--HHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHH
Confidence                111   11111   24567889999984  22233322 11110                0112333456789999


Q ss_pred             HHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          324 LLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      .+||+.||++|||+.++++.|+++.
T Consensus       239 ~~~l~~~p~~Rps~~~ll~~L~~l~  263 (267)
T 3t9t_A          239 NHCWRERPEDRPAFSRLLRQLAEIA  263 (267)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHH
Confidence            9999999999999999999998754

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-34  Score=273.39  Aligned_cols=227  Identities=22%  Similarity=0.323  Sum_probs=178.6

Q ss_pred             CCCCccc-eeecCCceEEEEEEEC----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEEN-VIGLGGNGKVYKGQLL----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~-~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|.+.+ .||+|+||.||+|.+.    +..||||+++.. .....+.+.+|+.++++++||||+++++++.  .+..++
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~l   86 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALML   86 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec--CCCcEE
Confidence            4455555 8999999999999863    778999999765 4456778999999999999999999999994  456899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++..  ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            9999999999999954  3346999999999999999999999   7899999999999999999999999999998764


Q ss_pred             CCcee-------eeccccc------cCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHHHH
Q 048535          267 HGQVM-------SGRRPIE------EGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADEVV  316 (409)
Q Consensus       267 ~~~~~-------~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~~~  316 (409)
                      .....       .|...+.      ...++..+|+|+++  ..+++++. .....                ....+...+
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~  239 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG--VTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP  239 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHH--HHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHH--HHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcC
Confidence            33211       0111111      14567889999984  22233332 11110                123344556


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      ..+.+++..||+.||++|||+.++++.|+...
T Consensus       240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            78999999999999999999999999998754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.6e-35  Score=277.14  Aligned_cols=237  Identities=22%  Similarity=0.402  Sum_probs=175.7

Q ss_pred             HHHHHhCCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEc
Q 048535          107 EIHAATKGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK  179 (409)
Q Consensus       107 ~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  179 (409)
                      ++....++|...+.||+|+||.||+|...     +..||+|.++..  .....+.+.+|+.++++++||||+++++++.+
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  107 (313)
T 3brb_A           28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE  107 (313)
T ss_dssp             TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred             hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence            33344577888999999999999999875     347999999754  44556789999999999999999999999976


Q ss_pred             cCC----eEEEEEEeCCCCCHHHHHhcC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC
Q 048535          180 EKE----SLILIYDYMENGSLDKWIFEC---DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM  252 (409)
Q Consensus       180 ~~~----~~~lv~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~  252 (409)
                      ...    ..++||||+++|+|.+++...   .....+++..+..++.|+++||.|||   +.+|+||||||+|||++.++
T Consensus       108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTS
T ss_pred             ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCC
Confidence            332    359999999999999998542   23356999999999999999999999   89999999999999999999


Q ss_pred             cEEEecccCcccccCCc------eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhh----------------HH
Q 048535          253 NARLGDFGLAKMHHHGQ------VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLD----------------ER  304 (409)
Q Consensus       253 ~~kl~DFGla~~~~~~~------~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~----------------~~  304 (409)
                      .+||+|||+++......      ...+...+      ....++..+|+|+++  ..+++++.                ..
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~el~~~g~~p~~~~~~~~~~~~~  262 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG--VTMWEIATRGMTPYPGVQNHEMYDYL  262 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHH--HHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHH--HHHHHHHhcCCCCCccCCHHHHHHHH
Confidence            99999999998754332      11111111      124567889999984  22222222                11


Q ss_pred             hhh-cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          305 LKA-KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       305 l~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      ... ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       263 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          263 LHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             HTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            110 12233445578999999999999999999999999998754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.2e-35  Score=280.86  Aligned_cols=224  Identities=23%  Similarity=0.262  Sum_probs=165.5

Q ss_pred             hCCCCccceeecCCceEEEEEEE-----CCcEEEEEEeccCC----hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQL-----LGVEVALKRISLDS----EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  182 (409)
                      .++|+..+.||+|+||.||+++.     .++.||+|+++...    ......+.+|+.+|++++||||+++++++.. .+
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-GG   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC-SS
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc-CC
Confidence            36788999999999999999987     28899999997542    2344568899999999999999999999987 67


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..++||||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            89999999999999999964   346899999999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCc----eeeeccccc------cCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhhcCCCCHHHHHHH
Q 048535          263 KMHHHGQ----VMSGRRPIE------EGKRNLVDRMWSLTE-------------RSELLSVLDERLKAKGGYADEVVEKV  319 (409)
Q Consensus       263 ~~~~~~~----~~~g~~p~~------~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~~~~~~~~~~~~l  319 (409)
                      +......    ...|...+.      ...++...|+|+++.             .....+.+...+......+......+
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~  248 (327)
T 3a62_A          169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA  248 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred             cccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence            8643221    112222221      245678899999841             11112222222222233444455678


Q ss_pred             HHHHHHccCcCCCCCC-----CHHHHHH
Q 048535          320 LHLGLLCAHPEANSRP-----TIRQVLK  342 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RP-----t~~evl~  342 (409)
                      .+++.+||+.||++||     ++.|+++
T Consensus       249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          249 RDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             HHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            8999999999999998     6677765

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-34  Score=285.24  Aligned_cols=267  Identities=22%  Similarity=0.291  Sum_probs=184.7

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCC-CCceeeEeeEEEcc-CCeE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKE-KESL  184 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~-~~~~  184 (409)
                      ..++|+..+.||+|+||.||+|.+.  ++.||||++...  .....+.+.+|+.++.++. ||||+++++++... ...+
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4578999999999999999999987  899999998643  4556678899999999997 99999999999753 3468


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      |+|||||+ |+|.+++..    ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus        87 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  158 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRS  158 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence            99999998 599999954    36899999999999999999999   89999999999999999999999999999986


Q ss_pred             ccCCc-------------------------eeeeccccc-------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCC
Q 048535          265 HHHGQ-------------------------VMSGRRPIE-------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYA  312 (409)
Q Consensus       265 ~~~~~-------------------------~~~g~~p~~-------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~  312 (409)
                      .....                         ...|...+.       ...++...|+|+++  ..+++++.......+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG--~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG--CILGEILCGKPIFPGSST  236 (388)
T ss_dssp             SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHH--HHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHH--HHHHHHHhCCCCCCCCCH
Confidence            53211                         112222221       24578899999997  456666665443322222


Q ss_pred             HHHHHHHHHHHHHccCcCC-----CCCCCHHHHHHHHhcCcCC--------------------CCCCCCCcchhHHhhhc
Q 048535          313 DEVVEKVLHLGLLCAHPEA-----NSRPTIRQVLKMLEGQTEG--------------------TGLEDEGMNVHLLKRIG  367 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP-----~~RPt~~evl~~L~~~~~~--------------------~~~~~~~~~~~~l~~~~  367 (409)
                      .+....+..   .+-.+.+     ...|-....++.+......                    +.........+++.+|+
T Consensus       237 ~~~~~~i~~---~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L  313 (388)
T 3oz6_A          237 MNQLERIIG---VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL  313 (388)
T ss_dssp             HHHHHHHHH---HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred             HHHHHHHHH---hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence            222222222   1111110     0123333333333221100                    00011223479999999


Q ss_pred             ccCCCCcccccccCCCCCccccc
Q 048535          368 TRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       368 ~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ..+|.+|+++++++.||||+...
T Consensus       314 ~~dP~~R~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          314 QFNPNKRISANDALKHPFVSIFH  336 (388)
T ss_dssp             CSSGGGSCCHHHHTTSTTTTTTC
T ss_pred             ccCcccCCCHHHHhCCHHHHHhc
Confidence            99999999999999999998764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3e-34  Score=270.96  Aligned_cols=224  Identities=21%  Similarity=0.320  Sum_probs=171.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      ++|.....||+|+||.||+|...  ++.||||.+........+.+.+|+.++++++||||+++++++.. .+..++||||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~  100 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-NGFIKIFMEQ  100 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-CCcEEEEEEe
Confidence            34555679999999999999986  88999999987666667889999999999999999999999987 6789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC-CCcEEEecccCcccccCCc
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK-KMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DFGla~~~~~~~  269 (409)
                      +++|+|.+++........+++..+..++.|++.||.|||   +.+|+||||||+|||++. ++.+||+|||+++......
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            999999999976544456789999999999999999999   789999999999999987 8999999999998754321


Q ss_pred             ----eeeecccccc--------CCCcHHHHHHhhhccCcHHHHhhHHh------------------hhcCCCCHHHHHHH
Q 048535          270 ----VMSGRRPIEE--------GKRNLVDRMWSLTERSELLSVLDERL------------------KAKGGYADEVVEKV  319 (409)
Q Consensus       270 ----~~~g~~p~~~--------~~~~~~~~vws~~~~~~~~~~~~~~l------------------~~~~~~~~~~~~~l  319 (409)
                          ...|...+..        ..++...|+|+++  ..+++++....                  ......+......+
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLG--CTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA  255 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHH--HHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHH
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHH--HHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHH
Confidence                1122222211        1257889999984  12222222111                  11123334455677


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHH
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+++.+||+.||++|||+.|+++
T Consensus       256 ~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          256 KAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHccCChhhCCCHHHHhc
Confidence            78888888888888888888764

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.1e-35  Score=276.30  Aligned_cols=226  Identities=26%  Similarity=0.349  Sum_probs=176.4

Q ss_pred             hCCCCccc-eeecCCceEEEEEEEC----CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          112 TKGFSEEN-VIGLGGNGKVYKGQLL----GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       112 ~~~f~~~~-~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      .++|.+.+ .||+|+||.||+|.+.    ++.||||+++..  .....+.+.+|+.++++++||||+++++++.  .+..
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~   92 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESW   92 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSSE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC--CCCc
Confidence            45677777 9999999999999653    688999999754  2334678999999999999999999999984  5678


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             EEEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            999999999999999965   245999999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCcee-------eecccc---c---cCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHH
Q 048535          265 HHHGQVM-------SGRRPI---E---EGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADE  314 (409)
Q Consensus       265 ~~~~~~~-------~g~~p~---~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~  314 (409)
                      .......       .+...+   +   ...++...|+|+++  ..+++++. .....                ....+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  244 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG--VLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG  244 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHH--HHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHH--HHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            6543211       111111   1   24457789999984  22333332 11110                1223344


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      .+..+.+++.+||+.||.+|||+.++++.|++.
T Consensus       245 ~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          245 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            567899999999999999999999999999865

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=8.1e-35  Score=280.08  Aligned_cols=227  Identities=18%  Similarity=0.207  Sum_probs=177.7

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .++|+..+.||+|+||.||+|...  ++.||||++.....  .+.+.+|+.+++++ +||||+++++++.. ....++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccEEEE
Confidence            367889999999999999999975  89999999875432  24688999999999 99999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc-----EEEecccCcc
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN-----ARLGDFGLAK  263 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~-----~kl~DFGla~  263 (409)
                      ||+ +|+|.+++...  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.     +||+|||+++
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           85 ELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            999 99999999753  346999999999999999999999   789999999999999999887     9999999998


Q ss_pred             cccCCc-----------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcC-----------------
Q 048535          264 MHHHGQ-----------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKG-----------------  309 (409)
Q Consensus       264 ~~~~~~-----------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~-----------------  309 (409)
                      ......           ...|...+.      ...++..+|+|+++  ..+++++........                 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALG--HMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH--HHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHH--HHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence            754322           222333222      24568899999984  223333322222111                 


Q ss_pred             -CCCHHH----HHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          310 -GYADEV----VEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       310 -~~~~~~----~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                       ..+...    .+.+.+++..||+.||.+||++.++++.|+....
T Consensus       237 ~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~  281 (330)
T 2izr_A          237 RATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFD  281 (330)
T ss_dssp             HHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             ccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence             011110    1278999999999999999999999999986543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-35  Score=282.48  Aligned_cols=230  Identities=23%  Similarity=0.343  Sum_probs=175.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--Cc----EEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GV----EVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      .++|+..+.||+|+||.||+|.+.  ++    +||+|.+... .....+.+.+|+.++++++||||+++++++..  +..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~   91 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STV   91 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES--SSE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec--CCc
Confidence            367889999999999999999985  43    4688887544 34456789999999999999999999999986  347


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++|+||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        92 ~~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             eEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            8999999999999999753  346999999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCce------eee---ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHHH
Q 048535          265 HHHGQV------MSG---RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADEV  315 (409)
Q Consensus       265 ~~~~~~------~~g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~~  315 (409)
                      ......      ..+   ..+.+   ...++...|+|+++  ..+++++. .....                ....+...
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG--~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  244 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG--VTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC  244 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTB
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHH--HHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccC
Confidence            643321      111   11111   25578899999984  22333332 11110                12233445


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      ...+.+++.+||+.||.+|||+.|+++.|+.....
T Consensus       245 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          245 TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            66789999999999999999999999999876543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8e-35  Score=283.06  Aligned_cols=225  Identities=17%  Similarity=0.235  Sum_probs=177.2

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  184 (409)
                      ..++|+..+.||+|+||.||+|+..  ++.||+|+++..   .....+.+..|..++..+ +||||+++++++.+ .+..
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~   96 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRL   96 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-SSEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-CCEE
Confidence            3478999999999999999999997  788999999754   223456788999999988 89999999999987 7789


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      |+||||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        97 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            9999999999999999642   46999999999999999999999   78999999999999999999999999999986


Q ss_pred             ccCCc----eeeeccccc------cCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhhcCCCCHHHHHHHHH
Q 048535          265 HHHGQ----VMSGRRPIE------EGKRNLVDRMWSLTE-------------RSELLSVLDERLKAKGGYADEVVEKVLH  321 (409)
Q Consensus       265 ~~~~~----~~~g~~p~~------~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~~~~~~~~~~~~l~~  321 (409)
                      .....    ..+|...+.      ...++...|+|+++.             .....++....+.....++......+.+
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  250 (353)
T 2i0e_A          171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA  250 (353)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            43211    223333322      245678899999841             1122222333333223445556678899


Q ss_pred             HHHHccCcCCCCCCC-----HHHHHH
Q 048535          322 LGLLCAHPEANSRPT-----IRQVLK  342 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt-----~~evl~  342 (409)
                      ++.+||+.||.+||+     ++++++
T Consensus       251 li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          251 ICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            999999999999995     567664

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.2e-35  Score=275.35  Aligned_cols=228  Identities=20%  Similarity=0.291  Sum_probs=177.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      .++|...+.||+|+||.||+|.+.     +..||+|.+... .....+.|.+|+.++++++||||+++++++.+  +..+
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~   88 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--EPTW   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS--SSCE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCE
Confidence            467888999999999999999875     235999999765 44566789999999999999999999999864  4568


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence            999999999999999653  345899999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCce-----eee---ccccc---cCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHHHHH
Q 048535          266 HHGQV-----MSG---RRPIE---EGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADEVVE  317 (409)
Q Consensus       266 ~~~~~-----~~g---~~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~~~~  317 (409)
                      .....     ..+   ..+.+   ...++...|+|+++  ..+++++. .....                ....+.....
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (281)
T 3cc6_A          164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFA--VCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPP  241 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCH
T ss_pred             ccccccccccCCCCcceeCchhhccCCCCchhccHHHH--HHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCH
Confidence            54321     111   11111   25567889999984  22333332 11110                1122334556


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      .+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          242 VLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence            7899999999999999999999999998653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7e-35  Score=273.38  Aligned_cols=229  Identities=26%  Similarity=0.424  Sum_probs=179.3

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ..++|+..+.||+|+||.||+|... +..||+|.+.... ...+.+.+|++++++++||||+++++++.+  +..++|||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e   87 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITE   87 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC--CCcEEEEe
Confidence            3467888999999999999999988 6789999997543 235679999999999999999999998864  45889999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+++|+|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++......
T Consensus        88 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           88 YMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             CCTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             cCCCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            99999999999532 1226999999999999999999999   7999999999999999999999999999998765443


Q ss_pred             eee-----ecccc---c---cCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHHHHHHHHH
Q 048535          270 VMS-----GRRPI---E---EGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADEVVEKVLH  321 (409)
Q Consensus       270 ~~~-----g~~p~---~---~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~~~~~l~~  321 (409)
                      ...     +...+   +   ...++..+|+|+++  ..+++++. .....                ....+......+.+
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  241 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG--ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ  241 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHH--HHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cccccCCCCccCccChhhhccCCCCchhhhHHHH--HHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHH
Confidence            211     11111   1   14567789999984  22233332 11110                01223344567899


Q ss_pred             HHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          322 LGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      ++..||+.||++|||+.++++.|+...
T Consensus       242 li~~~l~~~p~~Rps~~~l~~~l~~~~  268 (279)
T 1qpc_A          242 LMRLCWKERPEDRPTFDYLRSVLEDFF  268 (279)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhccChhhCCCHHHHHHHHHHHH
Confidence            999999999999999999999998754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.7e-34  Score=271.09  Aligned_cols=220  Identities=20%  Similarity=0.321  Sum_probs=163.5

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc---CCeEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE---KESLIL  186 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---~~~~~l  186 (409)
                      .|...+.||+|+||.||+|...  +..||+|.+...  .....+.+.+|+.++++++||||+++++++...   ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            4677789999999999999987  788999999754  455667899999999999999999999988642   356899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeeeC-CCCcEEEecccCcc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK--VLHRDIKASNVLLD-KKMNARLGDFGLAK  263 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlKp~NILl~-~~~~~kl~DFGla~  263 (409)
                      ||||+++|+|.+++...   ..+++..+..++.|++.||.|||   +.+  |+||||||+|||++ .++.+||+|||++.
T Consensus       107 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            99999999999999642   46899999999999999999999   777  99999999999997 78999999999997


Q ss_pred             cccCCc--eeeeccccc-----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCC------------------CCHHHHHH
Q 048535          264 MHHHGQ--VMSGRRPIE-----EGKRNLVDRMWSLTERSELLSVLDERLKAKGG------------------YADEVVEK  318 (409)
Q Consensus       264 ~~~~~~--~~~g~~p~~-----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~------------------~~~~~~~~  318 (409)
                      ......  ...|...+.     .+.++...|+|+++  ..+++++.........                  .+......
T Consensus       181 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG--~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (290)
T 1t4h_A          181 LKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFG--MCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             GCCTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHH--HHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             cccccccccccCCcCcCCHHHHhccCCCcchHHHHH--HHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence            654432  112222211     24567889999985  2333333322211110                  01111234


Q ss_pred             HHHHHHHccCcCCCCCCCHHHHH
Q 048535          319 VLHLGLLCAHPEANSRPTIRQVL  341 (409)
Q Consensus       319 l~~l~~~Cl~~dP~~RPt~~evl  341 (409)
                      +.+++..||+.||.+|||+.|++
T Consensus       259 l~~li~~~l~~dp~~Rps~~ell  281 (290)
T 1t4h_A          259 VKEIIEGCIRQNKDERYSIKDLL  281 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHHccCChhhCCCHHHHh
Confidence            55666666666666666666554

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1e-34  Score=274.53  Aligned_cols=227  Identities=18%  Similarity=0.203  Sum_probs=178.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .++|+..+.||+|+||.||+|...  ++.||||++....  ..+.+.+|+.++.++ +|+|++++++++.. ....++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC-CceeEEEE
Confidence            367899999999999999999975  8999999986542  224578899999999 89999999999886 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc-----EEEecccCcc
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN-----ARLGDFGLAK  263 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~-----~kl~DFGla~  263 (409)
                      ||+ +|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.     +||+|||+++
T Consensus        86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            999 99999999753  345999999999999999999999   899999999999999988776     9999999998


Q ss_pred             cccCCc-----------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCC----------------
Q 048535          264 MHHHGQ-----------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGG----------------  310 (409)
Q Consensus       264 ~~~~~~-----------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~----------------  310 (409)
                      ......           ...|...+.      ...++..+|+|+++  ..+++++....+....                
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALG--HVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH--HHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHH--HHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            765432           112222221      24568899999984  2223333222211110                


Q ss_pred             --CC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          311 --YA-----DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       311 --~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                        .+     ...+..+.+++..||+.||++|||++++++.|+++.+
T Consensus       238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence              01     1234578999999999999999999999999987654

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-35  Score=284.74  Aligned_cols=230  Identities=18%  Similarity=0.182  Sum_probs=171.5

Q ss_pred             HHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-----ChHHHHHHHHHHHHhccCCCCceeeEeeEEEc
Q 048535          107 EIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-----SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK  179 (409)
Q Consensus       107 ~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  179 (409)
                      ++....++|+..+.||+|+||.||+|...  ++.||+|++...     .....+.+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            34566788999999999999999999987  889999998643     23456789999999999999999999999987


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCC-------------------------------------CCCCCCHHHHHHHHHHHH
Q 048535          180 EKESLILIYDYMENGSLDKWIFECD-------------------------------------ESIALSWEQRIKVLKDVA  222 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia  222 (409)
                       .+..++||||+++|+|.+++....                                     ....+++..+..++.|++
T Consensus       100 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A          100 -EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             -SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             -CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence             778999999999999999984210                                     012346778889999999


Q ss_pred             HHHHHHHhcCCCceeecCCCCCCeeeCCCC--cEEEecccCcccccCCc--------eeeeccccc--------cCCCcH
Q 048535          223 SGILYLYEGWESKVLHRDIKASNVLLDKKM--NARLGDFGLAKMHHHGQ--------VMSGRRPIE--------EGKRNL  284 (409)
Q Consensus       223 ~gL~yLH~~~~~~ivHrDlKp~NILl~~~~--~~kl~DFGla~~~~~~~--------~~~g~~p~~--------~~~~~~  284 (409)
                      .||+|||   +.+|+||||||+|||++.++  .+||+|||+++......        ...|...+.        ...++.
T Consensus       179 ~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          179 SALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            9999999   78999999999999998776  89999999998653211        112222211        145677


Q ss_pred             HHHHHhhhccCcHHHHhhHHhhhc---------------CCC----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          285 VDRMWSLTERSELLSVLDERLKAK---------------GGY----ADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       285 ~~~vws~~~~~~~~~~~~~~l~~~---------------~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+|+|+++  ..+++++.......               ...    .......+.+++.+||+.||.+|||+.|+++
T Consensus       256 ~~DiwslG--~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          256 KCDAWSAG--VLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHH--HHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            89999984  22333332222110               000    1123456778888888888888888888875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1e-34  Score=274.42  Aligned_cols=222  Identities=21%  Similarity=0.334  Sum_probs=172.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .++|...+.||+|+||.||++...  ++.||+|.+...   .....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l   92 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFV   92 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-CCEEEE
Confidence            357888999999999999999997  889999998654   34556789999999999999999999999987 778999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++++|.+++..   ...+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        93 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           93 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             EEECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            9999999999999854   246899999999999999999999   7899999999999999999999999999998754


Q ss_pred             CCc----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhh---------------hcCCCCHHHHHHHHH
Q 048535          267 HGQ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLK---------------AKGGYADEVVEKVLH  321 (409)
Q Consensus       267 ~~~----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~---------------~~~~~~~~~~~~l~~  321 (409)
                      ...    ...|...+.      ...++...|+|+++  ..+++++.....               .....+......+.+
T Consensus       167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (294)
T 2rku_A          167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG--CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS  244 (294)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHH--HHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHH
T ss_pred             cCccccccccCCCCcCCcchhccCCCCchhhHHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHH
Confidence            321    122222221      23467789999984  223333322111               111223334456677


Q ss_pred             HHHHccCcCCCCCCCHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ++.+||+.||++|||+.|+++
T Consensus       245 li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          245 LIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHHHcccChhhCcCHHHHhh
Confidence            777788888888888777765

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-35  Score=292.70  Aligned_cols=184  Identities=23%  Similarity=0.243  Sum_probs=153.3

Q ss_pred             ccHHHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEE
Q 048535          103 VSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWC  177 (409)
Q Consensus       103 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~  177 (409)
                      +.++++....++|+..+.||+|+||.||+++..  ++.||+|+++...   ....+.+.+|..++.+++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            445566667789999999999999999999986  8999999997532   22234588999999999999999999999


Q ss_pred             EccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEe
Q 048535          178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLG  257 (409)
Q Consensus       178 ~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~  257 (409)
                      .+ .+.+|+||||+++|+|.+++...  ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus       131 ~~-~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          131 QD-ENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             EC-SSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             ee-CCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEe
Confidence            87 77899999999999999999653  236999999999999999999999   7999999999999999999999999


Q ss_pred             cccCcccccCCc-----eeeeccccc-------------cCCCcHHHHHHhhh
Q 048535          258 DFGLAKMHHHGQ-----VMSGRRPIE-------------EGKRNLVDRMWSLT  292 (409)
Q Consensus       258 DFGla~~~~~~~-----~~~g~~p~~-------------~~~~~~~~~vws~~  292 (409)
                      |||+++......     ...|...+.             ...++...|+|+++
T Consensus       205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlG  257 (412)
T 2vd5_A          205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG  257 (412)
T ss_dssp             CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHH
T ss_pred             echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHh
Confidence            999998765432     123333322             13467889999984

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1e-34  Score=283.15  Aligned_cols=222  Identities=21%  Similarity=0.236  Sum_probs=168.4

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|+..+.||+|+||.||++...  ++.||||++..... ..+.+.+|+.++++++||||+++++++.+ ....++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEee-CCEEEEEEE
Confidence            467999999999999999999997  89999999975432 23568899999999999999999999987 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc--EEEecccCcccccC
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN--ARLGDFGLAKMHHH  267 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~--~kl~DFGla~~~~~  267 (409)
                      |+++|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.  +||+|||+|+....
T Consensus        97 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           97 YASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            9999999999954   246999999999999999999999   899999999999999987765  99999999985332


Q ss_pred             Cc---eeeeccccc------cCCC-cHHHHHHhhhccCcHHHHhhH-------------------HhhhcCCCCH--HHH
Q 048535          268 GQ---VMSGRRPIE------EGKR-NLVDRMWSLTERSELLSVLDE-------------------RLKAKGGYAD--EVV  316 (409)
Q Consensus       268 ~~---~~~g~~p~~------~~~~-~~~~~vws~~~~~~~~~~~~~-------------------~l~~~~~~~~--~~~  316 (409)
                      ..   ...|...+.      ...+ ...+|+|+++  ..+++++..                   .+......+.  ...
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG--~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  248 (361)
T 3uc3_A          171 HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCG--VTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS  248 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHH--HHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred             cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhH--HHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence            21   122332221      1233 3448999984  222222222                   1111111111  235


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ..+.+++.+||+.||++|||+.|+++.
T Consensus       249 ~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            678899999999999999999999864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.5e-35  Score=279.45  Aligned_cols=232  Identities=26%  Similarity=0.389  Sum_probs=177.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcE--EEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVE--VALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~--vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|+..+.||+|+||.||+|...  +..  ||+|.++.. .....+.+.+|+++++++ +||||+++++++.+ .+..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~l  103 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYL  103 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-CCceEE
Confidence            67888999999999999999986  554  599998754 334556799999999999 99999999999987 778999


Q ss_pred             EEEeCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc
Q 048535          187 IYDYMENGSLDKWIFECD-------------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN  253 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~  253 (409)
                      ||||+++|+|.+++....             ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCe
Confidence            999999999999996532             1246999999999999999999999   899999999999999999999


Q ss_pred             EEEecccCcccccCCc---eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhh-HH--------------hhh--
Q 048535          254 ARLGDFGLAKMHHHGQ---VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLD-ER--------------LKA--  307 (409)
Q Consensus       254 ~kl~DFGla~~~~~~~---~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~-~~--------------l~~--  307 (409)
                      +||+|||+++......   ...+...+.      ...++...|+|+++  ..+++++. ..              +..  
T Consensus       181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~ellt~g~~pf~~~~~~~~~~~~~~~~  258 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG--VLLWEIVSLGGTPYCGMTCAELYEKLPQGY  258 (327)
T ss_dssp             EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHH--HHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             EEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHH--HHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence            9999999997433211   111111111      24457889999984  22333332 11              110  


Q ss_pred             cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          308 KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       308 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      ....+......+.+++.+||+.||.+|||+.|+++.|+.+.+.
T Consensus       259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            1123344556789999999999999999999999999876543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.7e-35  Score=277.19  Aligned_cols=228  Identities=24%  Similarity=0.326  Sum_probs=176.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|...+.||+|+||.||+++..  |+.||+|.++.......+.+.+|+.++++++||||+++++++.+ ....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-TTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-CCEEEEEEE
Confidence            467888999999999999999987  89999999986654455678999999999999999999999987 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee---CCCCcEEEecccCccccc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL---DKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kl~DFGla~~~~  266 (409)
                      |+++|+|.+++...   ..+++..+..++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++...
T Consensus        87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            99999999998542   46899999999999999999999   7899999999999999   788999999999998654


Q ss_pred             CCc--eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhH---------------Hhhh----cCCCCHHHHHHH
Q 048535          267 HGQ--VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDE---------------RLKA----KGGYADEVVEKV  319 (409)
Q Consensus       267 ~~~--~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~---------------~l~~----~~~~~~~~~~~l  319 (409)
                      ...  ...|...+      ....++...|+|+++  ..+++++..               ....    ...........+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (304)
T 2jam_A          161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIG--VITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA  238 (304)
T ss_dssp             CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHH--HHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred             CCccccccCCCCccChHHhccCCCCchhhHHHHH--HHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence            322  11122111      224567899999984  122222211               1110    111223445778


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHH--HHhcCc
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLK--MLEGQT  348 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~  348 (409)
                      .+++.+||+.||++|||+.|+++  .+++..
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          239 KDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            99999999999999999999987  455543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4e-35  Score=274.93  Aligned_cols=222  Identities=24%  Similarity=0.398  Sum_probs=160.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .++|++.+.||+|+||.||+|+..  ++.||||.+....   ....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   88 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-SNYVYL   88 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-SSEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-CCeEEE
Confidence            357888999999999999999985  8999999996442   1224678999999999999999999999987 778999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++..  ....+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        89 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            9999999999999964  2356999999999999999999999   7899999999999999999999999999998754


Q ss_pred             CCc----eeeecccc---c---cCCCcHHHHHHhhhccCcHHHHhhHHhhhcC---------------CCCHHHHHHHHH
Q 048535          267 HGQ----VMSGRRPI---E---EGKRNLVDRMWSLTERSELLSVLDERLKAKG---------------GYADEVVEKVLH  321 (409)
Q Consensus       267 ~~~----~~~g~~p~---~---~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~---------------~~~~~~~~~l~~  321 (409)
                      ...    ...|...+   +   ...++..+|+|+++  ..+++++........               ..+......+.+
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (278)
T 3cok_A          164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLG--CMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKD  241 (278)
T ss_dssp             ----------------------------CTHHHHHH--HHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHH
T ss_pred             CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHH--HHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHH
Confidence            321    11222211   1   13345667999985  334444433222111               112222344555


Q ss_pred             HHHHccCcCCCCCCCHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVL  341 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl  341 (409)
                      ++.+||+.||++|||+.+++
T Consensus       242 li~~~l~~dp~~Rps~~~~l  261 (278)
T 3cok_A          242 LIHQLLRRNPADRLSLSSVL  261 (278)
T ss_dssp             HHHHHSCSSGGGSCCHHHHT
T ss_pred             HHHHHcccCHhhCCCHHHHh
Confidence            66666666666666655554

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.6e-35  Score=284.47  Aligned_cols=270  Identities=19%  Similarity=0.238  Sum_probs=190.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .++|+..+.||+|+||.||+|...  +..||+|++... .....+.+.+|+.++++++||||+++++++.. .+..++||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~  110 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM  110 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-CCEEEEEE
Confidence            357888999999999999999997  899999999765 44556789999999999999999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES-KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||+++|+|.+++...   ..+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||+++....
T Consensus       111 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             CCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             ECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999999643   35899999999999999999999   54 899999999999999999999999999975422


Q ss_pred             C--ceeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHH----------------H
Q 048535          268 G--QVMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHL----------------G  323 (409)
Q Consensus       268 ~--~~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l----------------~  323 (409)
                      .  ....|...+      ....++...|+|+++  ..+++++......... ...........                .
T Consensus       185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMG--LSLVEMAVGRYPIPPP-DAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             HC----CCCCTTCCHHHHTTCCCSHHHHHHHHH--HHHHHHHHTSCCSSCC-CHHHHHHHHC------------------
T ss_pred             ccccCCCCCCCeECHHHHcCCCCCchhhHHHHH--HHHHHHHhCCCCCCCC-CHHHHHHHhcccccccCCCCCCCcccCC
Confidence            1  112222222      124578899999996  3455555544332211 11111111000                0


Q ss_pred             H--HccCcCCCCCCCHHHHHHHHhcCcCC--CCCCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          324 L--LCAHPEANSRPTIRQVLKMLEGQTEG--TGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       324 ~--~Cl~~dP~~RPt~~evl~~L~~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      .  .-+..+....-+..++++.+......  +...-+..-.+++.+|+..+|..|.++++++.||||+..+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  333 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  333 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence            0  00111122222344555544433221  11222445678888888888888888888888888877553

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1e-34  Score=280.19  Aligned_cols=222  Identities=21%  Similarity=0.340  Sum_probs=176.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .++|...+.||+|+||.||++...  ++.||+|++...   .....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l  118 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFV  118 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEE
Confidence            367888999999999999999987  789999998654   34566789999999999999999999999987 678999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++++|.+++..   ...+++.++..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       119 v~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          119 VLELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             EECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            9999999999999854   246999999999999999999999   7899999999999999999999999999998754


Q ss_pred             CCc----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHH---------------hhhcCCCCHHHHHHHHH
Q 048535          267 HGQ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDER---------------LKAKGGYADEVVEKVLH  321 (409)
Q Consensus       267 ~~~----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~---------------l~~~~~~~~~~~~~l~~  321 (409)
                      ...    ...|...+.      ...++...|+|+++  ..+++++...               .......+......+.+
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (335)
T 2owb_A          193 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIG--CIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAAS  270 (335)
T ss_dssp             STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHH--HHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred             cCcccccccCCCccccCHHHhccCCCCchhhHHHHH--HHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHH
Confidence            321    122222221      24467789999984  1222222211               11112233344567888


Q ss_pred             HHHHccCcCCCCCCCHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ++.+||+.||++|||+.|+++
T Consensus       271 li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          271 LIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGG
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.8e-35  Score=304.74  Aligned_cols=219  Identities=26%  Similarity=0.370  Sum_probs=172.7

Q ss_pred             ceeecCCceEEEEEEEC----CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL----GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      +.||+|+||.||+|.+.    ++.||||+++..  .....++|.+|+.+|++++|||||+++++|..  +..++|||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEEEccC
Confidence            47999999999999763    578999999764  33446789999999999999999999999964  45889999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce--
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV--  270 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~--  270 (409)
                      +|+|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.......  
T Consensus       453 ~g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          453 LGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             TEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            9999999964   346999999999999999999999   78999999999999999999999999999987654321  


Q ss_pred             ---eeec--ccc------ccCCCcHHHHHHhhhccCcHHHHhh-HHhhh----------------cCCCCHHHHHHHHHH
Q 048535          271 ---MSGR--RPI------EEGKRNLVDRMWSLTERSELLSVLD-ERLKA----------------KGGYADEVVEKVLHL  322 (409)
Q Consensus       271 ---~~g~--~p~------~~~~~~~~~~vws~~~~~~~~~~~~-~~l~~----------------~~~~~~~~~~~l~~l  322 (409)
                         ..+.  ..+      ....++..+|+|+++  ..+++++. .....                ....+..++..+.++
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlG--v~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  604 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG--VLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL  604 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence               1111  111      124678899999984  22333322 11110                123345566789999


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          323 GLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      +..||+.||++|||+.++++.|+..
T Consensus       605 i~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          605 MNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            9999999999999999999999753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=3.6e-34  Score=274.47  Aligned_cols=222  Identities=25%  Similarity=0.307  Sum_probs=174.3

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh------HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE------HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  183 (409)
                      .++|++.+.||+|+||.||+|...  ++.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+ ...
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~   89 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-RTD   89 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCE
Confidence            356889999999999999999987  89999999975421      135789999999999999999999999987 778


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC----cEEEecc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM----NARLGDF  259 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kl~DF  259 (409)
                      .++||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            9999999999999999953   346899999999999999999999   78999999999999999888    7999999


Q ss_pred             cCcccccCCce---eeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHH---------------hhhcCCCCHH-
Q 048535          260 GLAKMHHHGQV---MSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDER---------------LKAKGGYADE-  314 (409)
Q Consensus       260 Gla~~~~~~~~---~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~---------------l~~~~~~~~~-  314 (409)
                      |+++.......   ..|...+.      ...++...|+|+++  ..+++++...               .......+.. 
T Consensus       164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  241 (321)
T 2a2a_A          164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG--VITYILLSGASPFLGDTKQETLANITSVSYDFDEEF  241 (321)
T ss_dssp             TTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHH--HHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred             ccceecCccccccccCCCCCccCcccccCCCCCCccccHHHH--HHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh
Confidence            99987654321   12222221      24567889999984  2222322221               1111122222 


Q ss_pred             ---HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 ---VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ---~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                         ....+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          242 FSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               2356788999999999999999998886

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.6e-34  Score=270.37  Aligned_cols=222  Identities=23%  Similarity=0.327  Sum_probs=170.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .++|.+.+.||+|+||.||+|...  ++.||||.+....   ....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   88 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-PTDFFM   88 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CCeEEE
Confidence            367889999999999999999987  8999999996542   2235678999999999999999999999987 678999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++++|.+++...   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             EEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            99999999999999643   35899999999999999999999   7899999999999999999999999999998765


Q ss_pred             CCce---eeecccc---c---cCC-CcHHHHHHhhhccCcHHHHhhHH---------------hhhcCCCCHHHHHHHHH
Q 048535          267 HGQV---MSGRRPI---E---EGK-RNLVDRMWSLTERSELLSVLDER---------------LKAKGGYADEVVEKVLH  321 (409)
Q Consensus       267 ~~~~---~~g~~p~---~---~~~-~~~~~~vws~~~~~~~~~~~~~~---------------l~~~~~~~~~~~~~l~~  321 (409)
                      ....   ..|...+   +   ... .+...|+|+++  ..+++++...               .......+......+.+
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG--~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  240 (276)
T 2h6d_A          163 DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCG--VILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT  240 (276)
T ss_dssp             C-------------CCTGGGTTSCCCHHHHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             CCcceecccCCccccCHHHHcCCCCCCccchHHHHH--HHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence            4321   1121111   1   122 25789999984  1222222221               11111223334456778


Q ss_pred             HHHHccCcCCCCCCCHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ++.+||+.||++|||+.|+++
T Consensus       241 li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          241 LLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhhCCCHHHHHh
Confidence            888888888888888888876

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.1e-35  Score=284.03  Aligned_cols=232  Identities=18%  Similarity=0.159  Sum_probs=174.5

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccCChHHH-----------HHHHHHHHHhccCCCCceee
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLDSEHGM-----------REFLAEVSSLGRLKHRNLVG  172 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~  172 (409)
                      ..++|++.+.||+|+||.||+|.+.       ++.||||++........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            3568999999999999999999885       36799999876542211           23456777888899999999


Q ss_pred             EeeEEEcc---CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC
Q 048535          173 LRGWCKKE---KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD  249 (409)
Q Consensus       173 l~g~~~~~---~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~  249 (409)
                      +++++...   ....++||||+ +|+|.+++...  ...+++..+..++.||+.||.|||   +.+|+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEe
Confidence            99998763   14589999999 99999999653  356999999999999999999999   78999999999999999


Q ss_pred             --CCCcEEEecccCcccccCCc-----------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcC-
Q 048535          250 --KKMNARLGDFGLAKMHHHGQ-----------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKG-  309 (409)
Q Consensus       250 --~~~~~kl~DFGla~~~~~~~-----------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~-  309 (409)
                        .++.+||+|||+|+......           ...|...+.      ...++..+|+|+++  ..+++++....+... 
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILG--YCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHH--HHHHHHHHSCCTTGGG
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHH--HHHHHHHhCCCCcccc
Confidence              88999999999998754322           111332221      24578899999984  222333222211110 


Q ss_pred             ----------------CC---------CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          310 ----------------GY---------ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       310 ----------------~~---------~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                                      ..         ....+..+.+++..||+.||.+||++.++++.|+.....
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          265 LKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             TTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence                            00         011245788999999999999999999999999876543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.9e-35  Score=284.16  Aligned_cols=224  Identities=21%  Similarity=0.283  Sum_probs=177.4

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh--------HHHHHHHHHHHHhccCCCCceeeEeeEEEcc
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE--------HGMREFLAEVSSLGRLKHRNLVGLRGWCKKE  180 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  180 (409)
                      ..++|+..+.||+|+||.||+|...  ++.||||++.....        ...+.+.+|+.++++++||||+++++++.+ 
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-  100 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-  100 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            3567999999999999999999986  89999999975421        133467789999999999999999999987 


Q ss_pred             CCeEEEEEEeCCCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 048535          181 KESLILIYDYMENG-SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDF  259 (409)
Q Consensus       181 ~~~~~lv~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF  259 (409)
                      .+..++||||+.+| +|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeec
Confidence            77899999999877 99999954   346999999999999999999999   789999999999999999999999999


Q ss_pred             cCcccccCCce---eeeccccc------cCC-CcHHHHHHhhhccCcHHHHhhHHhh---------hcCCCCHHHHHHHH
Q 048535          260 GLAKMHHHGQV---MSGRRPIE------EGK-RNLVDRMWSLTERSELLSVLDERLK---------AKGGYADEVVEKVL  320 (409)
Q Consensus       260 Gla~~~~~~~~---~~g~~p~~------~~~-~~~~~~vws~~~~~~~~~~~~~~l~---------~~~~~~~~~~~~l~  320 (409)
                      |+++.......   ..|...+.      ... ++...|+|+++  ..+++++.....         .....+......+.
T Consensus       175 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG--~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~  252 (335)
T 3dls_A          175 GSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLG--VTLYTLVFEENPFCELEETVEAAIHPPYLVSKELM  252 (335)
T ss_dssp             TTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHH--HHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHH
T ss_pred             ccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHH--HHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHH
Confidence            99987655432   22333222      123 37788999985  233444332211         11112223456789


Q ss_pred             HHHHHccCcCCCCCCCHHHHHHH
Q 048535          321 HLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       321 ~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      +++..||+.||++|||+.|+++.
T Consensus       253 ~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          253 SLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             HHHHHHccCChhhCcCHHHHhcC
Confidence            99999999999999999999874

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.1e-34  Score=289.63  Aligned_cols=149  Identities=26%  Similarity=0.408  Sum_probs=132.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC----Ce
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK----ES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~  183 (409)
                      .++|.+.+.||+|+||.||+|...  ++.||||++...  .....+.+.+|+.+|++++||||+++++++....    ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            478999999999999999999987  889999999753  4455678999999999999999999999987632    56


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      .|+||||++ |+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999997 599999953   356999999999999999999999   7899999999999999999999999999998


Q ss_pred             cccC
Q 048535          264 MHHH  267 (409)
Q Consensus       264 ~~~~  267 (409)
                      ....
T Consensus       178 ~~~~  181 (432)
T 3n9x_A          178 TINS  181 (432)
T ss_dssp             EC--
T ss_pred             cccc
Confidence            7643

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.4e-35  Score=273.43  Aligned_cols=231  Identities=23%  Similarity=0.383  Sum_probs=179.1

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEc---------
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK---------  179 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~---------  179 (409)
                      ..++|+..+.||+|+||.||+|...  ++.||+|++....    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3467889999999999999999997  8999999997654    346789999999999999999998753         


Q ss_pred             ------cCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc
Q 048535          180 ------EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN  253 (409)
Q Consensus       180 ------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~  253 (409)
                            .....++||||+++|+|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCC
Confidence                  134589999999999999999653 2346999999999999999999999   789999999999999999999


Q ss_pred             EEEecccCcccccCCce---eeeccccc------cCCCcHHHHHHhhhccCcHHHHhh------------HHhhhcCCCC
Q 048535          254 ARLGDFGLAKMHHHGQV---MSGRRPIE------EGKRNLVDRMWSLTERSELLSVLD------------ERLKAKGGYA  312 (409)
Q Consensus       254 ~kl~DFGla~~~~~~~~---~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~------------~~l~~~~~~~  312 (409)
                      +||+|||+++.......   ..|...+.      ...++...|+|+++.  .+++++.            ..+. ....+
T Consensus       161 ~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~--il~~l~~~~~~~~~~~~~~~~~~-~~~~~  237 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGL--ILAELLHVCDTAFETSKFFTDLR-DGIIS  237 (284)
T ss_dssp             EEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHH--HHHHHHSCCSSHHHHHHHHHHHH-TTCCC
T ss_pred             EEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHH--HHHHHHhcCCcchhHHHHHHHhh-ccccc
Confidence            99999999987654321   11222221      244677899999841  2222221            1111 12233


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCCC
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTG  352 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~  352 (409)
                      ......+.+++.+||+.||.+|||+.|+++.|+.....+.
T Consensus       238 ~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          238 DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            3445678899999999999999999999999987765544

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-34  Score=291.41  Aligned_cols=148  Identities=23%  Similarity=0.372  Sum_probs=123.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc----CCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE----KES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----~~~  183 (409)
                      .++|++.+.||+|+||.||+|...  ++.||||++...  .....+.+.+|+.+|++++|||||++++++...    ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367999999999999999999887  899999999653  445567899999999999999999999998542    256


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      +|+||||+. |+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+
T Consensus       132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccch
Confidence            899999985 699999953   356999999999999999999999   7899999999999999999999999999998


Q ss_pred             ccc
Q 048535          264 MHH  266 (409)
Q Consensus       264 ~~~  266 (409)
                      ...
T Consensus       205 ~~~  207 (458)
T 3rp9_A          205 TVD  207 (458)
T ss_dssp             CTT
T ss_pred             hcc
Confidence            764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.4e-35  Score=280.27  Aligned_cols=232  Identities=17%  Similarity=0.185  Sum_probs=173.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .++|++.+.||+|+||.||+|...  ++.||+|++...   .....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~l  111 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-DGQLYV  111 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-CCeEEE
Confidence            478999999999999999999986  889999999754   33345789999999999999999999999987 778999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++++|.+++...   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            99999999999999642   46999999999999999999999   7899999999999999999999999999997654


Q ss_pred             CCc-----eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhH--------------Hhhhc----CCCCHHHHH
Q 048535          267 HGQ-----VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDE--------------RLKAK----GGYADEVVE  317 (409)
Q Consensus       267 ~~~-----~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~--------------~l~~~----~~~~~~~~~  317 (409)
                      ...     ...|...+      ....++...|+|+++  ..+++++..              .+...    ...+...+.
T Consensus       186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T 2h34_A          186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALT--CVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPV  263 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHH--HHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCT
T ss_pred             ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHH--HHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCH
Confidence            432     11122111      123345567899873  112222221              11100    112233456


Q ss_pred             HHHHHHHHccCcCCCCCC-CHHHHHHHHhcCcCCCC
Q 048535          318 KVLHLGLLCAHPEANSRP-TIRQVLKMLEGQTEGTG  352 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~~~~  352 (409)
                      .+.+++.+||+.||++|| |++++++.|+.......
T Consensus       264 ~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          264 AFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             HHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            788999999999999999 99999999998766544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.4e-34  Score=296.39  Aligned_cols=251  Identities=21%  Similarity=0.302  Sum_probs=182.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .++|+..+.||+|+||.||+|...  |+.||+|++...   .......+.+|+.+|++++|||||++++++.+ .+.+|+
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~l  261 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCL  261 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-CCEEEE
Confidence            356888999999999999999986  899999999653   12334668899999999999999999999987 778999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+++|+|.+++... ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus       262 VmEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            99999999999999653 2345999999999999999999999   7899999999999999999999999999998775


Q ss_pred             CCcee---eeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 048535          267 HGQVM---SGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI  337 (409)
Q Consensus       267 ~~~~~---~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  337 (409)
                      .+...   .|...+.      ...++...|+|+++  ..+++++.........                     ....+.
T Consensus       338 ~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLG--vilyeLltG~~PF~~~---------------------~~~~~~  394 (576)
T 2acx_A          338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALG--CLLYEMIAGQSPFQQR---------------------KKKIKR  394 (576)
T ss_dssp             TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHH--HHHHHHHHSSCSSSCS---------------------SSCCCH
T ss_pred             cCccccccCCCccccCHHHHcCCCCCccchHHHHH--HHHHHHHhCCCCCccc---------------------ccchhH
Confidence            54322   2333222      24567889999996  3445554433321110                     001122


Q ss_pred             HHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcc-----cccccCCCCCccccc
Q 048535          338 RQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSW-----KFAGSRGHPTFNEIN  390 (409)
Q Consensus       338 ~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-----~~~~~~~hp~~~~~~  390 (409)
                      .++.+.+..........-.....+++.+|+..+|.+|+     +.++++.||||+.++
T Consensus       395 ~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~  452 (576)
T 2acx_A          395 EEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN  452 (576)
T ss_dssp             HHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred             HHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence            22322222211110011112236777777777777777     556788888888765

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.4e-34  Score=272.15  Aligned_cols=221  Identities=19%  Similarity=0.247  Sum_probs=166.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|+..+.||+|+||.||+|...  ++.||+|++....   ....+.+.+|++++++++||||+++++++.+ .+..++|
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   92 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-RKRIYLM   92 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-CCEEEEE
Confidence            57888999999999999999987  7889999996432   2234678999999999999999999999987 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++...   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999999643   35899999999999999999999   89999999999999999999999999999976543


Q ss_pred             Cc--eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhh---------------hcCCCCHHHHHHHHHHHH
Q 048535          268 GQ--VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLK---------------AKGGYADEVVEKVLHLGL  324 (409)
Q Consensus       268 ~~--~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~---------------~~~~~~~~~~~~l~~l~~  324 (409)
                      ..  ...|...+.      ...++...|+|+++  ..+++++.....               ....++......+.+++.
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  244 (284)
T 2vgo_A          167 LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAG--VLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLIS  244 (284)
T ss_dssp             SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHH--HHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred             cccccccCCCCcCCHHHhccCCCCcccchhhHH--HHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHH
Confidence            21  122222221      23456778999985  223333322211               111222233345566666


Q ss_pred             HccCcCCCCCCCHHHHHH
Q 048535          325 LCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       325 ~Cl~~dP~~RPt~~evl~  342 (409)
                      +||+.||.+|||+.|+++
T Consensus       245 ~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          245 KLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             HHSCSSGGGSCCHHHHHT
T ss_pred             HHhhcCHhhCCCHHHHhh
Confidence            666666666666666653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.9e-35  Score=277.60  Aligned_cols=147  Identities=25%  Similarity=0.365  Sum_probs=129.3

Q ss_pred             CCCCcc-ceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEE-NVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~-~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      +.|.+. +.||+|+||.||+|...  ++.||||++........+.+.+|++++.++ +||||+++++++.+ .+..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-EDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEEEEEE
Confidence            567764 78999999999999976  899999999766555567899999999985 79999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc---EEEecccCcccc
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN---ARLGDFGLAKMH  265 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~kl~DFGla~~~  265 (409)
                      ||+++|+|.+++...   ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.   +||+|||+++..
T Consensus        91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            999999999999653   46899999999999999999999   789999999999999998776   999999999765


Q ss_pred             c
Q 048535          266 H  266 (409)
Q Consensus       266 ~  266 (409)
                      .
T Consensus       165 ~  165 (316)
T 2ac3_A          165 K  165 (316)
T ss_dssp             -
T ss_pred             c
Confidence            3

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.7e-35  Score=281.81  Aligned_cols=270  Identities=22%  Similarity=0.297  Sum_probs=187.1

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      ...++|+..+.||+|+||+||+|...  ++.||||+++...  ....+.+.+|+.++++++||||+++++++.+ ....+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~  109 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-NHRLH  109 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-TTEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-CCEEE
Confidence            34568999999999999999999886  8999999997553  2335678899999999999999999999987 77899


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee-----CCCCcEEEeccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL-----DKKMNARLGDFG  260 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl-----~~~~~~kl~DFG  260 (409)
                      +||||+++ +|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||+     +.++.+||+|||
T Consensus       110 lv~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            99999985 999999643   35999999999999999999999   7899999999999999     455569999999


Q ss_pred             CcccccCCc----eeeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCc
Q 048535          261 LAKMHHHGQ----VMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHP  329 (409)
Q Consensus       261 la~~~~~~~----~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~  329 (409)
                      +++......    ...|...+   +    ...++...|+|+++  ..+++++.........   .....+..+...+-.+
T Consensus       183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG--~il~ell~g~~pf~~~---~~~~~~~~~~~~~~~~  257 (329)
T 3gbz_A          183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIA--CIWAEMLMKTPLFPGD---SEIDQLFKIFEVLGLP  257 (329)
T ss_dssp             HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHH--HHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCC
T ss_pred             CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHH--HHHHHHHHCCCCcCCC---CHHHHHHHHHHHhCCC
Confidence            998654321    11122111   1    13468899999997  4566666544432222   1222334444433333


Q ss_pred             CCCCCCCHHHHHHHHhcCcCCCC--------CCCCCcchhHHhhhcccCCCCcccccccCCCCCccccccc
Q 048535          330 EANSRPTIRQVLKMLEGQTEGTG--------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKN  392 (409)
Q Consensus       330 dP~~RPt~~evl~~L~~~~~~~~--------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~  392 (409)
                      ++...|.....-...+.......        ........+++.+|+..+|.+|+++++++.||||++++..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  328 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD  328 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence            33333332211110000000000        0011223689999999999999999999999999988754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-34  Score=292.16  Aligned_cols=263  Identities=19%  Similarity=0.247  Sum_probs=185.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-----C
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-----E  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~  182 (409)
                      .++|+..+.||+|+||.||+|...  ++.||||++...  .....+.+.+|+.+|+.++||||+++++++....     .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999999987  899999999754  4455678999999999999999999999986532     4


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..|+||||+++ +|.+.+.     ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|
T Consensus       141 ~~~lv~E~~~~-~l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            68999999976 5777763     24899999999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCce---eeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCC
Q 048535          263 KMHHHGQV---MSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANS  333 (409)
Q Consensus       263 ~~~~~~~~---~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  333 (409)
                      +.......   ..|...+.      ...++...|+|+++  ..+++++.....+.+..   ....+..++..+-.+.|..
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG--~il~ell~g~~pF~g~~---~~~~~~~i~~~lg~p~~~~  286 (464)
T 3ttj_A          212 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG--CIMGEMVRHKILFPGRD---YIDQWNKVIEQLGTPCPEF  286 (464)
T ss_dssp             -----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHH--HHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCSCCHHH
T ss_pred             eecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHH--HHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCCHHH
Confidence            87665432   22222221      24567889999997  45666666554433222   2223333333333322211


Q ss_pred             CCCH-HHHHHHHhcCcCCCCCCC-------------------CCcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          334 RPTI-RQVLKMLEGQTEGTGLED-------------------EGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       334 RPt~-~evl~~L~~~~~~~~~~~-------------------~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      -... ..+.+.+++.........                   .....+++.+|+..+|.+|+++++++.||||+.
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence            1110 111222222111111000                   112478999999999999999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1e-34  Score=272.17  Aligned_cols=230  Identities=24%  Similarity=0.317  Sum_probs=176.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEc-cCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK-EKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~~l  186 (409)
                      .++|+..+.||+|+||.||+|...  ++.||+|.+...  .....+.+.+|+.++++++||||+++++++.+ .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            367888999999999999999986  899999999754  34556789999999999999999999998753 3567999


Q ss_pred             EEEeCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc-----eeecCCCCCCeeeCCCCcEEEeccc
Q 048535          187 IYDYMENGSLDKWIFECD-ESIALSWEQRIKVLKDVASGILYLYEGWESK-----VLHRDIKASNVLLDKKMNARLGDFG  260 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-----ivHrDlKp~NILl~~~~~~kl~DFG  260 (409)
                      ||||+++|+|.+++.... ....+++..+..++.|++.||.|||   +.+     |+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999996532 2345999999999999999999999   566     9999999999999999999999999


Q ss_pred             CcccccCCc----eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhH---------------Hhhh-cCCCCHH
Q 048535          261 LAKMHHHGQ----VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDE---------------RLKA-KGGYADE  314 (409)
Q Consensus       261 la~~~~~~~----~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~---------------~l~~-~~~~~~~  314 (409)
                      +++......    ...|...+      ....++..+|+|+++  ..+++++..               .... ....+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  239 (279)
T 2w5a_A          162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG--CLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  239 (279)
T ss_dssp             HHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             hheeeccccccccccCCCccccChHHhccCCCCchhhHHHHH--HHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence            998765432    11122111      124567889999984  112222211               1110 0123334


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      ....+.+++.+||+.||++|||+.|+++.+..
T Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          240 YSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            55678999999999999999999999986654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.6e-34  Score=278.66  Aligned_cols=238  Identities=22%  Similarity=0.310  Sum_probs=181.4

Q ss_pred             cHHHHHHHhCCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhcc--CCCCceeeEeeEEEccC
Q 048535          104 SYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGR--LKHRNLVGLRGWCKKEK  181 (409)
Q Consensus       104 ~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~g~~~~~~  181 (409)
                      ++.--....++|+..+.||+|+||.||+|++.++.||||++...   ..+.+.+|++++..  ++||||+++++++....
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~  109 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN  109 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence            33333455678999999999999999999999999999999643   33567888888877  79999999999998743


Q ss_pred             ---CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCceeecCCCCCCeeeCCCCc
Q 048535          182 ---ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW-----ESKVLHRDIKASNVLLDKKMN  253 (409)
Q Consensus       182 ---~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDlKp~NILl~~~~~  253 (409)
                         ...++||||+++|+|.+++..    ..+++..+..++.|++.||.|||...     +.+|+||||||+|||++.++.
T Consensus       110 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~  185 (342)
T 1b6c_B          110 GTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  185 (342)
T ss_dssp             SSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC
T ss_pred             CccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC
Confidence               278999999999999999954    35899999999999999999999321     478999999999999999999


Q ss_pred             EEEecccCcccccCCce--------eeecccccc------C------CCcHHHHHHhhhccCcHHHHhhH----------
Q 048535          254 ARLGDFGLAKMHHHGQV--------MSGRRPIEE------G------KRNLVDRMWSLTERSELLSVLDE----------  303 (409)
Q Consensus       254 ~kl~DFGla~~~~~~~~--------~~g~~p~~~------~------~~~~~~~vws~~~~~~~~~~~~~----------  303 (409)
                      +||+|||+++.......        ..|...+..      .      .++...|+|+++  ..+++++..          
T Consensus       186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG--~il~el~tg~~~~~~~~~~  263 (342)
T 1b6c_B          186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG--LVFWEIARRCSIGGIHEDY  263 (342)
T ss_dssp             EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHH--HHHHHHHTTBCBTTBCCCC
T ss_pred             EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHH--HHHHHHHhccCcCCccccc
Confidence            99999999986554321        112222211      1      123678999984  222222221          


Q ss_pred             -------------------Hh-h--hcCCCC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          304 -------------------RL-K--AKGGYA-----DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       304 -------------------~l-~--~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                                         .+ .  .....+     ......+.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus       264 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence                               00 0  001122     25667899999999999999999999999999876543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.8e-34  Score=272.58  Aligned_cols=230  Identities=20%  Similarity=0.273  Sum_probs=178.4

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|+..+.||+|+||.||+|+..  ++.||||++.....  .+.+.+|+.+++.++|+|++..++++.......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            478999999999999999999975  89999999875432  24688999999999999988877777666788999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee---CCCCcEEEecccCccccc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL---DKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kl~DFGla~~~~  266 (409)
                      |+ +|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 89999999643  346999999999999999999999   8999999999999999   478899999999998755


Q ss_pred             CCc-----------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcC------------------CC
Q 048535          267 HGQ-----------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKG------------------GY  311 (409)
Q Consensus       267 ~~~-----------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~------------------~~  311 (409)
                      ...           ...|...+.      ...++..+|+|+++  ..+++++....+...                  ..
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG--YVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH--HHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHH--HHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            432           122222221      24567899999984  222222222211100                  00


Q ss_pred             C-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCCC
Q 048535          312 A-----DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGT  351 (409)
Q Consensus       312 ~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~  351 (409)
                      +     ...+..+.+++.+||+.||++|||+.++++.|+......
T Consensus       238 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          238 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            1     123467899999999999999999999999998765433

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-34  Score=287.23  Aligned_cols=223  Identities=23%  Similarity=0.293  Sum_probs=166.0

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--------hHHHHHHHHHHHHhccCCCCceeeEeeEEEc
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--------EHGMREFLAEVSSLGRLKHRNLVGLRGWCKK  179 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~  179 (409)
                      ...++|...+.||+|+||.||+|...  ++.||||++....        ......+.+|+.+|++++||||+++++++..
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            45688999999999999999999987  7899999996531        1122358899999999999999999999854


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC---CcEEE
Q 048535          180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK---MNARL  256 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kl  256 (409)
                        +..++||||+++|+|.+++.   ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.+   +.+||
T Consensus       212 --~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          212 --EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             --SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             --CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEE
Confidence              56899999999999999984   3457999999999999999999999   7899999999999999654   45999


Q ss_pred             ecccCcccccCCc---eeeecccc---c------cCCCcHHHHHHhhhccCcHHHHhhHHhhhc----------------
Q 048535          257 GDFGLAKMHHHGQ---VMSGRRPI---E------EGKRNLVDRMWSLTERSELLSVLDERLKAK----------------  308 (409)
Q Consensus       257 ~DFGla~~~~~~~---~~~g~~p~---~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~----------------  308 (409)
                      +|||+|+......   ...|...+   +      ...++...|+|+++  ..+++++.......                
T Consensus       284 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG--~il~~lltg~~pf~~~~~~~~~~~~i~~~~  361 (419)
T 3i6u_A          284 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG--VILFICLSGYPPFSEHRTQVSLKDQITSGK  361 (419)
T ss_dssp             CCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHH--HHHHHHHHSSCSSCCCSSSCCHHHHHHTTC
T ss_pred             eecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHH--HHHHHHHHCCCCCCCCcchHHHHHHHhcCC
Confidence            9999998765443   12233222   2      13457789999985  22333333222110                


Q ss_pred             CCCCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          309 GGYAD----EVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       309 ~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .....    .....+.+++.+||+.||++|||+.|+++
T Consensus       362 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          362 YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            11111    12456778888888888888888887765

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3e-34  Score=273.19  Aligned_cols=268  Identities=21%  Similarity=0.256  Sum_probs=179.3

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-----hHHHHHHHHHHHHhccC---CCCceeeEeeEEEcc
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-----EHGMREFLAEVSSLGRL---KHRNLVGLRGWCKKE  180 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~~  180 (409)
                      .+++|++.+.||+|+||+||+|+..  ++.||||++....     ......+.+|+.+++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            4678999999999999999999975  8999999996432     11124566777777766   499999999999863


Q ss_pred             CC----eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEE
Q 048535          181 KE----SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARL  256 (409)
Q Consensus       181 ~~----~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl  256 (409)
                      ..    ..++||||++ |+|.+++... ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEE
Confidence            32    5899999997 5999999753 2335999999999999999999999   789999999999999999999999


Q ss_pred             ecccCcccccCCce---eeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHcc
Q 048535          257 GDFGLAKMHHHGQV---MSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCA  327 (409)
Q Consensus       257 ~DFGla~~~~~~~~---~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl  327 (409)
                      +|||+++.......   ..|...+.      ...++...|+|+++  ..+++++............+.   +..+...+-
T Consensus       162 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~  236 (308)
T 3g33_A          162 ADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVG--CIFAEMFRRKPLFCGNSEADQ---LGKIFDLIG  236 (308)
T ss_dssp             CSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHH--HHHHHTTTSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred             eeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHH--HHHHHHHhCCCCCCCCCHHHH---HHHHHHHhC
Confidence            99999987654332   12222221      24567789999997  345565554433222222222   222222222


Q ss_pred             CcCCCCCCCHHHHHHHHhcCcCCC--------CCCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          328 HPEANSRPTIRQVLKMLEGQTEGT--------GLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~~~~~--------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      ...+..-|....+.   +......        .+.......+++.+|+..+|.+|+++++++.||||...+.
T Consensus       237 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~  305 (308)
T 3g33_A          237 LPPEDDWPRDVSLP---RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG  305 (308)
T ss_dssp             CCCTTTSCSSCSSC---GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred             CCChhhccchhhcc---ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence            22211111100000   0000000        0001122368999999999999999999999999987654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=280.63  Aligned_cols=221  Identities=18%  Similarity=0.279  Sum_probs=170.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCC--CceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLD--SEHGMREFLAEVSSLGRLKH--RNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~~l  186 (409)
                      .+.|++.+.||+|+||.||++... ++.||||++...  .....+.+.+|+.+|.+++|  |||+++++++.+ ....++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-CCEEEE
Confidence            356888999999999999999887 889999999754  44556789999999999976  999999999987 778999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||| +.+|+|.+++..   ...+++.++..++.|++.||.|||   +.+|+||||||+|||++ ++.+||+|||+++...
T Consensus        87 v~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEe-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            999 567899999965   346999999999999999999999   78999999999999997 6789999999998764


Q ss_pred             CCc------eeeeccccc-----------------cCCCcHHHHHHhhhccCcHHHHhhHHhhh----------------
Q 048535          267 HGQ------VMSGRRPIE-----------------EGKRNLVDRMWSLTERSELLSVLDERLKA----------------  307 (409)
Q Consensus       267 ~~~------~~~g~~p~~-----------------~~~~~~~~~vws~~~~~~~~~~~~~~l~~----------------  307 (409)
                      ...      ...|...+.                 ...++...|+|+++  ..+++++....+.                
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG--~il~ell~g~~pf~~~~~~~~~~~~~~~~  236 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG--CILYYMTYGKTPFQQIINQISKLHAIIDP  236 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHH--HHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHH--HHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence            332      112222221                 14567789999984  2233332222111                


Q ss_pred             --cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          308 --KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       308 --~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                        ...++......+.+++..||+.||.+|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence              012233334578899999999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-34  Score=269.72  Aligned_cols=174  Identities=25%  Similarity=0.377  Sum_probs=145.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .++|++.+.||+|+||.||+|...  ++.||||.+... .....+.+.+|+.+++.++||||+++++++.+ .+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   84 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFL   84 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-CCEEEEEE
Confidence            367889999999999999999987  899999999654 33455789999999999999999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++|+|.+++.   ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           85 EYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             ECCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             EecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            9999999999984   3456999999999999999999999   799999999999999999999999999999765322


Q ss_pred             c------eeeecccc---c---cCC-CcHHHHHHhhh
Q 048535          269 Q------VMSGRRPI---E---EGK-RNLVDRMWSLT  292 (409)
Q Consensus       269 ~------~~~g~~p~---~---~~~-~~~~~~vws~~  292 (409)
                      .      ...|...+   +   ... .+...|+|+++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  195 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG  195 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHH
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHH
Confidence            1      11122211   1   122 36789999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.5e-34  Score=271.38  Aligned_cols=229  Identities=20%  Similarity=0.276  Sum_probs=175.0

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ..++|+..+.||+|+||.||+|+..  ++.||||++.....  ...+.+|+.+++.++|+|++..++++.......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            4578999999999999999999975  89999998764422  2457899999999999998888887766678899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee---CCCCcEEEecccCcccc
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL---DKKMNARLGDFGLAKMH  265 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kl~DFGla~~~  265 (409)
                      ||+ +|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 99999999643  346999999999999999999999   7899999999999999   78899999999999876


Q ss_pred             cCCc-----------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcC------------------C
Q 048535          266 HHGQ-----------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKG------------------G  310 (409)
Q Consensus       266 ~~~~-----------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~------------------~  310 (409)
                      ....           ...|...+.      ...++..+|+|+++  ..+++++....+...                  .
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG--YVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHH--HHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHH--HHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            5432           122322221      24567899999984  222333222211110                  0


Q ss_pred             CC-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          311 YA-----DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       311 ~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      .+     ...+..+.+++..||+.||++|||+.++++.|++..+
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            11     1124678999999999999999999999999987654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.1e-34  Score=271.29  Aligned_cols=223  Identities=25%  Similarity=0.392  Sum_probs=169.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc---------
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE---------  180 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---------  180 (409)
                      .++|+..+.||+|+||.||+|...  ++.||||++... ....+.+.+|+.++++++||||+++++++.+.         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            467889999999999999999986  899999999643 44567899999999999999999999988642         


Q ss_pred             ---CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEe
Q 048535          181 ---KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLG  257 (409)
Q Consensus       181 ---~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~  257 (409)
                         ....++||||+++|+|.+++...  ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEe
Confidence               34689999999999999999753  346889999999999999999999   7899999999999999999999999


Q ss_pred             cccCcccccCCc------------------eeeeccccc-------cCCCcHHHHHHhhhccCcHHHHhh----------
Q 048535          258 DFGLAKMHHHGQ------------------VMSGRRPIE-------EGKRNLVDRMWSLTERSELLSVLD----------  302 (409)
Q Consensus       258 DFGla~~~~~~~------------------~~~g~~p~~-------~~~~~~~~~vws~~~~~~~~~~~~----------  302 (409)
                      |||+++......                  ...|...+.       ...++...|+|+++  ..+++++.          
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG--~il~~l~~p~~~~~~~~~  236 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLG--IIFFEMIYPFSTGMERVN  236 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHH--HHHHHHHSCCSSHHHHHH
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHH--HHHHHHHhccCCchhHHH
Confidence            999998654221                  111222111       13567889999985  22233221          


Q ss_pred             ---HH----hhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          303 ---ER----LKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       303 ---~~----l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                         ..    ......++......+.+++.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence               00    00112233344456777888888888888888888775

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3e-34  Score=271.00  Aligned_cols=209  Identities=12%  Similarity=0.097  Sum_probs=171.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|++.+.||+|+||.||+|.+.  ++.||||++...   .....+.|.+|+.++.+++||||+++++++.+ .+..|+|
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~lv  109 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-RAGGLVV  109 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-CCcEEEE
Confidence            67999999999999999999997  899999999755   24456789999999999999999999999987 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++++|.+++..    . ....++.+++.|++.||+|||   +.+|+||||||+|||++.++.+||+++|...    
T Consensus       110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~~----  177 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATMP----  177 (286)
T ss_dssp             EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCCT----
T ss_pred             EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEeccccC----
Confidence            999999999999932    1 356678999999999999999   8999999999999999999999999776542    


Q ss_pred             CceeeeccccccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCC----------------------CCHHHHHHHHHHHHH
Q 048535          268 GQVMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGG----------------------YADEVVEKVLHLGLL  325 (409)
Q Consensus       268 ~~~~~g~~p~~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~----------------------~~~~~~~~l~~l~~~  325 (409)
                                   .++...|+|+++  ..+++++.......+.                      .....+..+.+++.+
T Consensus       178 -------------~~~~~~Di~slG--~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  242 (286)
T 3uqc_A          178 -------------DANPQDDIRGIG--ASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR  242 (286)
T ss_dssp             -------------TCCHHHHHHHHH--HHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHH
T ss_pred             -------------CCCchhHHHHHH--HHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHH
Confidence                         356788999885  3344444333221110                      012345678999999


Q ss_pred             ccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          326 CAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      ||+.||++| |+.|+++.|+.....
T Consensus       243 ~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          243 SVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             HHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             HcccCCccC-CHHHHHHHHHHHhcc
Confidence            999999999 999999999876543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.7e-34  Score=270.04  Aligned_cols=222  Identities=26%  Similarity=0.367  Sum_probs=174.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .+.|+..+.||+|+||.||+|...  ++.||||++... .....+.+.+|+.++++++||||+++++++.+ ....++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   99 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIM   99 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEE
Confidence            356888999999999999999986  889999999755 23456789999999999999999999999987 67899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++++|.+++.    ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       100 e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          100 EYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             ECCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             EeCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            9999999999994    246999999999999999999999   789999999999999999999999999999876543


Q ss_pred             ce----eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh----------------cCCCCHHHHHHHHHH
Q 048535          269 QV----MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKA----------------KGGYADEVVEKVLHL  322 (409)
Q Consensus       269 ~~----~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~----------------~~~~~~~~~~~l~~l  322 (409)
                      ..    ..|...+      ....++...|+|+++  ..+++++......                ....+......+.++
T Consensus       173 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  250 (303)
T 3a7i_A          173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG--ITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEF  250 (303)
T ss_dssp             BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHH--HHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHH
T ss_pred             ccccCccCCCcCccCHHHHhcCCCCchhhhHHHH--HHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHH
Confidence            21    1122211      124566789999984  2223332221110                012222344567888


Q ss_pred             HHHccCcCCCCCCCHHHHHHH
Q 048535          323 GLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      +..||+.||.+|||+.|+++.
T Consensus       251 i~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          251 VEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             HHHHCCSSGGGSCCHHHHTTC
T ss_pred             HHHHcCCChhhCcCHHHHhhC
Confidence            899999999999999988763

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-35  Score=291.34  Aligned_cols=224  Identities=13%  Similarity=0.120  Sum_probs=165.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHH---HHhccCCCCceeeEe-------eE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEV---SSLGRLKHRNLVGLR-------GW  176 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------g~  176 (409)
                      .++|+..+.||+|+||.||+|++.  |+.||||++...   .....+.|.+|+   .+|++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467888999999999999999975  899999999743   444567899999   556666899999998       66


Q ss_pred             EEccCC----------------eEEEEEEeCCCCCHHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 048535          177 CKKEKE----------------SLILIYDYMENGSLDKWIFECD----ESIALSWEQRIKVLKDVASGILYLYEGWESKV  236 (409)
Q Consensus       177 ~~~~~~----------------~~~lv~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  236 (409)
                      +.+.+.                ..++||||+ +|+|.+++....    ....+++..+..++.||+.||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            554211                378999999 679999996431    1223556889999999999999999   7899


Q ss_pred             eecCCCCCCeeeCCCCcEEEecccCcccccCCc-eeeecccccc------C-----------CCcHHHHHHhhhccCcHH
Q 048535          237 LHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ-VMSGRRPIEE------G-----------KRNLVDRMWSLTERSELL  298 (409)
Q Consensus       237 vHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-~~~g~~p~~~------~-----------~~~~~~~vws~~~~~~~~  298 (409)
                      +||||||+|||++.++.+||+|||+|+...... ...| ..+..      .           .++...|+|+++  ..++
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG--~il~  304 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG--LVIY  304 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH--HHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH--HHHH
Confidence            999999999999999999999999998654321 2223 22211      2           578899999996  3344


Q ss_pred             HHhhHHhhhcC-----------CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          299 SVLDERLKAKG-----------GYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       299 ~~~~~~l~~~~-----------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +++....+...           ......+..+.+++.+||+.||++|||+.|+++
T Consensus       305 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            44443222110           001123456778888888888888888888764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.1e-34  Score=281.00  Aligned_cols=265  Identities=20%  Similarity=0.255  Sum_probs=188.6

Q ss_pred             HHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-----
Q 048535          108 IHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-----  180 (409)
Q Consensus       108 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----  180 (409)
                      +....++|+..+.||+|+||.||+|...  |+.||||++..+..    ...+|+.+|+.++||||+++++++...     
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            3456788999999999999999999986  89999999965422    233799999999999999999998542     


Q ss_pred             --------------------------------CCeEEEEEEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHH
Q 048535          181 --------------------------------KESLILIYDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILY  227 (409)
Q Consensus       181 --------------------------------~~~~~lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~y  227 (409)
                                                      ....++||||+++ +|.+.+... .....+++..+..++.||++||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            2348899999984 888777532 234579999999999999999999


Q ss_pred             HHhcCCCceeecCCCCCCeeeC-CCCcEEEecccCcccccCCce---eeecccc---c----cCCCcHHHHHHhhhccCc
Q 048535          228 LYEGWESKVLHRDIKASNVLLD-KKMNARLGDFGLAKMHHHGQV---MSGRRPI---E----EGKRNLVDRMWSLTERSE  296 (409)
Q Consensus       228 LH~~~~~~ivHrDlKp~NILl~-~~~~~kl~DFGla~~~~~~~~---~~g~~p~---~----~~~~~~~~~vws~~~~~~  296 (409)
                      ||   +.+|+||||||+|||++ .++.+||+|||+|+.......   ..|...+   +    ...++...|+|+++  ..
T Consensus       157 LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG--~i  231 (383)
T 3eb0_A          157 IH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG--CV  231 (383)
T ss_dssp             HH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH--HH
T ss_pred             HH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHH--HH
Confidence            99   89999999999999997 688999999999987544321   1222111   1    13478899999997  45


Q ss_pred             HHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC--CCC-----------CCCCcchhHH
Q 048535          297 LLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG--TGL-----------EDEGMNVHLL  363 (409)
Q Consensus       297 ~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~--~~~-----------~~~~~~~~~l  363 (409)
                      +++++.......+....+.   +..++..+      ..|+..++..+-....+.  +..           ..+....+++
T Consensus       232 l~ell~g~~pf~~~~~~~~---~~~i~~~~------g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  302 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQ---LVRIIQIM------GTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLL  302 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHH---HHHHHHHH------CCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHH
T ss_pred             HHHHHhCCCCCCCCChHHH---HHHHHHHh------CCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHH
Confidence            6666665544333222233   33333322      245555555443221111  100           0112247999


Q ss_pred             hhhcccCCCCcccccccCCCCCcccccc
Q 048535          364 KRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      .+|+..+|.+|+++.+++.||||+++..
T Consensus       303 ~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          303 EQILRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             HHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             HHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence            9999999999999999999999998753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3.7e-34  Score=277.38  Aligned_cols=229  Identities=15%  Similarity=0.126  Sum_probs=169.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccCChH-----------HHHHHHHHHHHhccCCCCceeeEee
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLDSEH-----------GMREFLAEVSSLGRLKHRNLVGLRG  175 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~g  175 (409)
                      .++|.+.+.||+|+||.||+|...     +..||+|++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367889999999999999999984     578999999765321           1134678899999999999999999


Q ss_pred             EEEcc---CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC
Q 048535          176 WCKKE---KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM  252 (409)
Q Consensus       176 ~~~~~---~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~  252 (409)
                      ++...   ....++||||+ +|+|.+++..   ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCC
Confidence            98763   46789999999 9999999954   237999999999999999999999   78999999999999999887


Q ss_pred             --cEEEecccCcccccCCc-----------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhh------
Q 048535          253 --NARLGDFGLAKMHHHGQ-----------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKA------  307 (409)
Q Consensus       253 --~~kl~DFGla~~~~~~~-----------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~------  307 (409)
                        .+||+|||+|+......           ...|...+.      ...++..+|+|+++  ..+++++......      
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILG--YCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHH--HHHHHHHHSSCTTGGGTTC
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHH--HHHHHHHhCCCCccccccc
Confidence              99999999998654321           112222221      24568899999984  1222222211111      


Q ss_pred             -----------cCCCCH---------HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          308 -----------KGGYAD---------EVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       308 -----------~~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                                 ....+.         ..+..+.+++..||+.||++|||+.++++.|+....
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          267 PVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             cHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence                       011222         233478999999999999999999999999987653

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.7e-34  Score=289.03  Aligned_cols=225  Identities=24%  Similarity=0.297  Sum_probs=173.4

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh-------------HHHHHHHHHHHHhccCCCCceeeEee
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE-------------HGMREFLAEVSSLGRLKHRNLVGLRG  175 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~g  175 (409)
                      ..++|.+.+.||+|+||+||+|...  ++.||+|++.....             ...+.+.+|+.+|++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999987  78999999975421             23567899999999999999999999


Q ss_pred             EEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC---
Q 048535          176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM---  252 (409)
Q Consensus       176 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---  252 (409)
                      ++.+ ....++|||||++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++   
T Consensus       114 ~~~~-~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          114 VFED-KKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEC-SSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCS
T ss_pred             EEEc-CCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCc
Confidence            9987 7789999999999999999864   246999999999999999999999   78999999999999998775   


Q ss_pred             cEEEecccCcccccCCce---eeeccccc-----cCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhhcCCC
Q 048535          253 NARLGDFGLAKMHHHGQV---MSGRRPIE-----EGKRNLVDRMWSLTE-------------RSELLSVLDERLKAKGGY  311 (409)
Q Consensus       253 ~~kl~DFGla~~~~~~~~---~~g~~p~~-----~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~~~~~  311 (409)
                      .+||+|||+|+.......   ..|...+.     ...++...|+|+++.             .....+++.........+
T Consensus       187 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  266 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF  266 (504)
T ss_dssp             SEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             cEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            699999999987654431   12222221     245678899999841             111122222222211112


Q ss_pred             CH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          312 AD----EVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       312 ~~----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +.    ..+..+.+++.+||+.||.+|||+.|+++
T Consensus       267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            21    23467899999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.8e-34  Score=277.15  Aligned_cols=232  Identities=26%  Similarity=0.377  Sum_probs=177.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  183 (409)
                      .++|+..+.||+|+||.||+|++.       +..||||.+... .......+.+|+.++++++||||+++++++.+ ...
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~  107 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLP  107 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC-CCC
Confidence            478999999999999999999842       678999999754 45566789999999999999999999999987 667


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC---CCcEEE
Q 048535          184 LILIYDYMENGSLDKWIFECDE----SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK---KMNARL  256 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kl  256 (409)
                      .++||||+++|+|.+++.....    ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEE
Confidence            8999999999999999976422    145899999999999999999999   789999999999999984   446999


Q ss_pred             ecccCcccccCCce------eeec---cccc---cCCCcHHHHHHhhhccCcHHHHhh-HH---------------hhh-
Q 048535          257 GDFGLAKMHHHGQV------MSGR---RPIE---EGKRNLVDRMWSLTERSELLSVLD-ER---------------LKA-  307 (409)
Q Consensus       257 ~DFGla~~~~~~~~------~~g~---~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~~---------------l~~-  307 (409)
                      +|||+++.......      ..|.   .+.+   ...++...|+|+++  ..+++++. ..               ... 
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~ellt~g~~p~~~~~~~~~~~~~~~~~  262 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG--VLLWEIFSLGYMPYPSKSNQEVLEFVTSGG  262 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHH--HHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence            99999975433221      1111   1111   25567899999984  22233322 11               110 


Q ss_pred             cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          308 KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       308 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      ....+......+.+++.+||+.||.+|||+.++++.|+....
T Consensus       263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            112233445678999999999999999999999999986543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.5e-34  Score=267.66  Aligned_cols=221  Identities=24%  Similarity=0.306  Sum_probs=166.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh------HHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE------HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      ++|+..+.||+|+||.||+|...  ++.||+|.+.....      ...+.+.+|+.++++++||||+++++++.+ ....
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   83 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-KTDV   83 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-CCeE
Confidence            56888999999999999999997  89999999975421      135789999999999999999999999987 6789


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC----cEEEeccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM----NARLGDFG  260 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kl~DFG  260 (409)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            999999999999999954   346999999999999999999999   78999999999999998877    79999999


Q ss_pred             CcccccCCce---eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhc---------------CCCCHH--
Q 048535          261 LAKMHHHGQV---MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAK---------------GGYADE--  314 (409)
Q Consensus       261 la~~~~~~~~---~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~---------------~~~~~~--  314 (409)
                      +++.......   ..|...+      ....++...|+|+++  ..+++++.......               ...+..  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T 3bhy_A          158 IAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG--VITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF  235 (283)
T ss_dssp             TCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHH--HHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred             cceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHH--HHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhc
Confidence            9987654321   1122211      124567789999985  22333332221110               111111  


Q ss_pred             --HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 --VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 --~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                        ....+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             TTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence              2345666777777777777777777664

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2e-34  Score=277.38  Aligned_cols=262  Identities=20%  Similarity=0.229  Sum_probs=182.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++|+..+.||+|+||.||+|...  ++.||||++...  .....+.+.+|+.++++++||||+++++++.+ .+..++||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~  103 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-KKRWYLVF  103 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-CCEEEEEE
Confidence            67888999999999999999997  899999998654  33445678899999999999999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999999988743   346999999999999999999999   789999999999999999999999999999765432


Q ss_pred             c----eeeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 048535          269 Q----VMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI  337 (409)
Q Consensus       269 ~----~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  337 (409)
                      .    ...|...+   +    ...++...|+|+++  ..+++++............   ..+..++..+-...|    ..
T Consensus       178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~----~~  248 (331)
T 4aaa_A          178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIG--CLVTEMFMGEPLFPGDSDI---DQLYHIMMCLGNLIP----RH  248 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHH--HHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCH----HH
T ss_pred             ccccCCCcCCccccCcccccCCCCcchHHHHHHHH--HHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCCh----hh
Confidence            1    11122211   1    12567889999996  4456665544332221111   122222221111110    01


Q ss_pred             HHHHHHHhc--CcCCC-----------CCCCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          338 RQVLKMLEG--QTEGT-----------GLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       338 ~evl~~L~~--~~~~~-----------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      .+....-..  ....+           .+.-+..-.+++.+|+..+|.+|.++++++.||||+..+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  314 (331)
T 4aaa_A          249 QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG  314 (331)
T ss_dssp             HHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred             hhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence            111100000  00000           011234457888888898999999999999999987654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-33  Score=267.37  Aligned_cols=229  Identities=19%  Similarity=0.241  Sum_probs=174.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC----hHHHHHHHHHHHHhccCCCCceeeEeeEEEc-cCCeE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS----EHGMREFLAEVSSLGRLKHRNLVGLRGWCKK-EKESL  184 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~  184 (409)
                      .++|++.+.||+|+||.||++...  ++.||+|++....    ....+.+.+|+.++++++||||+++++++.. .....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            478999999999999999999986  8899999997542    2345789999999999999999999999853 24578


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++||||+++| |.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999886 77777653 3456999999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCc------eeeecccccc--------CCCcHHHHHHhhhccCcHHHHhhH---------------HhhhcCCCCHHH
Q 048535          265 HHHGQ------VMSGRRPIEE--------GKRNLVDRMWSLTERSELLSVLDE---------------RLKAKGGYADEV  315 (409)
Q Consensus       265 ~~~~~------~~~g~~p~~~--------~~~~~~~~vws~~~~~~~~~~~~~---------------~l~~~~~~~~~~  315 (409)
                      .....      ...|...+..        ...+...|+|+++  ..+++++..               ........+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG--~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  236 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAG--VTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDC  236 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHH--HHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSS
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHH--HHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCcc
Confidence            54211      1112222111        1236789999984  122222221               111112233344


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHH--HhcC
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKM--LEGQ  347 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~  347 (409)
                      ...+.+++.+||+.||.+|||+.|+++.  +++.
T Consensus       237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence            5678899999999999999999999964  5543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.9e-34  Score=289.19  Aligned_cols=222  Identities=25%  Similarity=0.325  Sum_probs=170.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .+.|+..+.||+|+||.||+|+..  +..||+|++....  ......+.+|+.+++.++||||+++++++.+ ....++|
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv  114 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYLV  114 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEE
Confidence            456889999999999999999997  8899999997542  2335678999999999999999999999987 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC---CcEEEecccCccc
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK---MNARLGDFGLAKM  264 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kl~DFGla~~  264 (409)
                      ||||++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.+   +.+||+|||+|+.
T Consensus       115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            9999999999988542   46999999999999999999999   7899999999999999764   4599999999987


Q ss_pred             ccCCce---eeeccccc-----cCCCcHHHHHHhhhccCcHHHHhh---------------HHhhhcCCC----CHHHHH
Q 048535          265 HHHGQV---MSGRRPIE-----EGKRNLVDRMWSLTERSELLSVLD---------------ERLKAKGGY----ADEVVE  317 (409)
Q Consensus       265 ~~~~~~---~~g~~p~~-----~~~~~~~~~vws~~~~~~~~~~~~---------------~~l~~~~~~----~~~~~~  317 (409)
                      ......   ..|...+.     ...++...|+|+++  ..+++++.               ........+    ....+.
T Consensus       189 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG--~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  266 (494)
T 3lij_A          189 FENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIG--VILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE  266 (494)
T ss_dssp             CBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred             CCCCccccccCCCcCeeCHHHHcccCCCchhHHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence            654432   12222221     24577889999984  12222222               211111111    123456


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+.+++.+||+.||.+|||+.|+++
T Consensus       267 ~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          267 GAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHHCCCChhhCccHHHHhc
Confidence            7889999999999999999999884

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.9e-34  Score=282.03  Aligned_cols=220  Identities=18%  Similarity=0.273  Sum_probs=170.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccC--ChHHHHHHHHHHHHhccCC--CCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLD--SEHGMREFLAEVSSLGRLK--HRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~~~~lv  187 (409)
                      +.|++.+.||+|+||.||+|... ++.||||++...  .....+.+.+|+.+|++++  ||||+++++++.. .+..++|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-CCEEEEE
Confidence            45889999999999999999987 889999999654  4456678999999999996  5999999999987 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      || +.+|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++....
T Consensus       135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 5688999999653   36899999999999999999999   89999999999999995 58899999999987643


Q ss_pred             Cc------eeeecccccc-----------------CCCcHHHHHHhhhccCcHHHHhhHHhhh-----------------
Q 048535          268 GQ------VMSGRRPIEE-----------------GKRNLVDRMWSLTERSELLSVLDERLKA-----------------  307 (409)
Q Consensus       268 ~~------~~~g~~p~~~-----------------~~~~~~~~vws~~~~~~~~~~~~~~l~~-----------------  307 (409)
                      ..      ...|...+..                 ..++...|+|+++  ..+++++....+.                 
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlG--vil~ell~G~~Pf~~~~~~~~~~~~~~~~~  284 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG--CILYYMTYGKTPFQQIINQISKLHAIIDPN  284 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHH--HHHHHHHHSSCTTTTCCCHHHHHHHHHCTT
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHH--HHHHHHHHCCCcchhhhHHHHHHHHHhCcc
Confidence            32      1123322211                 2577889999984  2222222211110                 


Q ss_pred             -cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          308 -KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       308 -~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                       ...++......+.+++.+||+.||.+|||+.|+++.
T Consensus       285 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence             012222234578899999999999999999999864

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=9.9e-34  Score=272.27  Aligned_cols=245  Identities=17%  Similarity=0.192  Sum_probs=175.3

Q ss_pred             cceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeEeeEEEccCCeEEEEEEeCCCC
Q 048535          118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKEKESLILIYDYMENG  194 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~lv~E~~~~g  194 (409)
                      .+.||+|+||.||+|...  ++.||||++...   ....+.+|+.+++.+. ||||+++++++.+ ....++||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD-QLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-CCEEEEEEEccCCC
Confidence            478999999999999997  899999999643   3456789999999996 9999999999987 77899999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC---cEEEecccCcccccCCc--
Q 048535          195 SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM---NARLGDFGLAKMHHHGQ--  269 (409)
Q Consensus       195 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~---~~kl~DFGla~~~~~~~--  269 (409)
                      +|.+++..   ...+++.++..++.|++.||.|||   +.+|+||||||+|||++.++   .+||+|||+++......  
T Consensus        92 ~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           92 ELFERIKK---KKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             BHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            99999965   346999999999999999999999   89999999999999997765   89999999998654332  


Q ss_pred             --eeeecc---cc---ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 048535          270 --VMSGRR---PI---EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVL  341 (409)
Q Consensus       270 --~~~g~~---p~---~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl  341 (409)
                        ...|..   +.   ....++...|+|+++  ..+++++.....    +.....              .....+..+++
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG--~il~~ll~g~~p----f~~~~~--------------~~~~~~~~~~~  225 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLG--VILYTMLSGQVP----FQSHDR--------------SLTCTSAVEIM  225 (325)
T ss_dssp             ------------------CCCCHHHHHHHHH--HHHHHHHHSSCT----TC---------------------CCCHHHHH
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHH--HHHHHHHhCCCC----CCCCcc--------------ccccccHHHHH
Confidence              111111   11   124567889999997  345555543332    111100              01112334444


Q ss_pred             HHHhcCcCCCCC----CCCCcchhHHhhhcccCCCCcccccccCCCCCccccccc
Q 048535          342 KMLEGQTEGTGL----EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKN  392 (409)
Q Consensus       342 ~~L~~~~~~~~~----~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~  392 (409)
                      +.+.........    .-+....+++.+|+..+|..|++.++++.||||.+..+.
T Consensus       226 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~  280 (325)
T 3kn6_A          226 KKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL  280 (325)
T ss_dssp             HHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred             HHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence            444332111110    011223678888999999999999999999999875543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.9e-34  Score=272.25  Aligned_cols=183  Identities=24%  Similarity=0.386  Sum_probs=142.7

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEc----------
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK----------  179 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~----------  179 (409)
                      .++|+..+.||+|+||.||+|...  ++.||+|++........+.+.+|+.++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            367888999999999999999997  89999999987777778889999999999999999999998743          


Q ss_pred             ---cCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC-CCCcEE
Q 048535          180 ---EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD-KKMNAR  255 (409)
Q Consensus       180 ---~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~k  255 (409)
                         .....++||||++ |+|.+++.    ...+++..+..++.|++.||+|||   +.+|+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEE
Confidence               2467899999998 59999994    346899999999999999999999   78999999999999997 567999


Q ss_pred             EecccCcccccCCce-------eeecc---ccc----cCCCcHHHHHHhhhccCcHHHHhhHH
Q 048535          256 LGDFGLAKMHHHGQV-------MSGRR---PIE----EGKRNLVDRMWSLTERSELLSVLDER  304 (409)
Q Consensus       256 l~DFGla~~~~~~~~-------~~g~~---p~~----~~~~~~~~~vws~~~~~~~~~~~~~~  304 (409)
                      |+|||+++.......       ..+..   +.+    ...++...|+|+++  ..+++++...
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG--~il~el~~g~  222 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG--CIFAEMLTGK  222 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHH--HHHHHHHHSS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHH--HHHHHHHhCC
Confidence            999999987643210       00111   111    24567889999996  3455555443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.9e-34  Score=282.90  Aligned_cols=220  Identities=23%  Similarity=0.245  Sum_probs=165.6

Q ss_pred             CCCCcc-ceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhcc-CCCCceeeEeeEEEc---cCCeEE
Q 048535          113 KGFSEE-NVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGR-LKHRNLVGLRGWCKK---EKESLI  185 (409)
Q Consensus       113 ~~f~~~-~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~-l~H~niv~l~g~~~~---~~~~~~  185 (409)
                      ++|... +.||+|+||.||+|...  ++.||||+++..     ..+.+|+.++.+ .+||||+++++++..   +...+|
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456655 68999999999999987  889999999643     356788888744 589999999998763   245689


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC---CCcEEEecccCc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK---KMNARLGDFGLA  262 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kl~DFGla  262 (409)
                      +|||||++|+|.+++... ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            999999999999999753 2346999999999999999999999   789999999999999998   788999999999


Q ss_pred             ccccCCc---eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhh-----------------------cCC
Q 048535          263 KMHHHGQ---VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKA-----------------------KGG  310 (409)
Q Consensus       263 ~~~~~~~---~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~-----------------------~~~  310 (409)
                      +......   ...|...+      ....++...|+|+++  ..+++++......                       ...
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~  289 (400)
T 1nxk_A          212 KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP  289 (400)
T ss_dssp             EECC-----------CTTCCGGGSCCCCSSSHHHHHHHH--HHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTT
T ss_pred             cccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHH--HHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCc
Confidence            8765432   11222211      235677889999984  2223332221110                       001


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       311 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ........+.+++.+||+.||++|||+.|+++.
T Consensus       290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            112456678999999999999999999999974

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.6e-34  Score=289.61  Aligned_cols=185  Identities=25%  Similarity=0.382  Sum_probs=152.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|...+.||+|+||.||+|+..  |+.||+|++....   ....+.+.+|+.+|++++||||+++++++.+ ...+|+|
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~lV  263 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDLCLV  263 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-CCEEEEE
Confidence            56888899999999999999986  8999999996542   2335678999999999999999999999887 7789999


Q ss_pred             EEeCCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          188 YDYMENGSLDKWIFECD-ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      |||+++|+|.+++.... ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999997542 2346999999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCce----eeeccccc------cCCCcHHHHHHhhhccCcHHHHhhH
Q 048535          267 HGQV----MSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDE  303 (409)
Q Consensus       267 ~~~~----~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~  303 (409)
                      ....    ..|...+.      ...++...|+|+++  ..+++++..
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlG--vilyelltG  385 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALG--VTLYEMIAA  385 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHH--HHHHHHHHS
T ss_pred             CCCcccccccCCccccChhhhcCCCCChHHhcCcch--HHHHHHHhC
Confidence            4321    23433332      24578899999986  334444443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.6e-34  Score=277.06  Aligned_cols=228  Identities=21%  Similarity=0.317  Sum_probs=171.5

Q ss_pred             HHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--------hHHHHHHHHHHHHhccC-CCCceeeEe
Q 048535          106 QEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--------EHGMREFLAEVSSLGRL-KHRNLVGLR  174 (409)
Q Consensus       106 ~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l-~H~niv~l~  174 (409)
                      .......++|+..+.||+|+||.||+|.+.  |+.||||+++...        ....+.+.+|+.+++++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344455678999999999999999999986  8999999986542        12245688999999999 899999999


Q ss_pred             eEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcE
Q 048535          175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNA  254 (409)
Q Consensus       175 g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~  254 (409)
                      +++.. ....++||||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+
T Consensus       167 ~~~~~-~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          167 DSYES-SSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEB-SSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred             EEEee-CCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCE
Confidence            99987 7789999999999999999964   346999999999999999999999   7899999999999999999999


Q ss_pred             EEecccCcccccCCce---eeeccccc------------cCCCcHHHHHHhhhccCcHHHHhhHHhhhc-----------
Q 048535          255 RLGDFGLAKMHHHGQV---MSGRRPIE------------EGKRNLVDRMWSLTERSELLSVLDERLKAK-----------  308 (409)
Q Consensus       255 kl~DFGla~~~~~~~~---~~g~~p~~------------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~-----------  308 (409)
                      ||+|||++........   ..|...+.            ...++...|+|+++  ..+++++.......           
T Consensus       240 kl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG--~il~ell~g~~pf~~~~~~~~~~~i  317 (365)
T 2y7j_A          240 RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG--VILFTLLAGSPPFWHRRQILMLRMI  317 (365)
T ss_dssp             EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             EEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHH--HHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            9999999987654321   22222221            12356789999985  23333333222110           


Q ss_pred             ----CCCCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          309 ----GGYAD----EVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       309 ----~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                          ...+.    .....+.+++.+||+.||++|||+.|+++
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          318 MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                11111    11234666777777777777777776654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=6.2e-34  Score=288.45  Aligned_cols=227  Identities=23%  Similarity=0.290  Sum_probs=176.7

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .++|++.+.||+|+||+||+|...  ++.||||++...  .......+.+|+.+|++++||||+++++++.+ ....++|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv   99 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYIV   99 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-CCEEEEE
Confidence            467999999999999999999987  899999999643  22345778999999999999999999999987 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC---CCCcEEEecccCccc
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD---KKMNARLGDFGLAKM  264 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~---~~~~~kl~DFGla~~  264 (409)
                      ||||++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++   .++.+||+|||+|+.
T Consensus       100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999999998643   46999999999999999999999   78999999999999995   456799999999987


Q ss_pred             ccCCcee---eeccccc-----cCCCcHHHHHHhhhccCcHHHHhh---------------HHhhhcCC----CCHHHHH
Q 048535          265 HHHGQVM---SGRRPIE-----EGKRNLVDRMWSLTERSELLSVLD---------------ERLKAKGG----YADEVVE  317 (409)
Q Consensus       265 ~~~~~~~---~g~~p~~-----~~~~~~~~~vws~~~~~~~~~~~~---------------~~l~~~~~----~~~~~~~  317 (409)
                      .......   .|...+.     .+.++...|+|+++  ..+++++.               ........    .....+.
T Consensus       174 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG--~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  251 (486)
T 3mwu_A          174 FQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAG--VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD  251 (486)
T ss_dssp             BCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCH
T ss_pred             CCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCH
Confidence            6543311   1222211     24578899999984  12222222               21111111    1123456


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHHH--HhcC
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLKM--LEGQ  347 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~  347 (409)
                      .+.+++.+||+.||.+|||+.|+++.  +++.
T Consensus       252 ~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~  283 (486)
T 3mwu_A          252 DAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (486)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence            78999999999999999999999974  4443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.2e-34  Score=289.49  Aligned_cols=222  Identities=27%  Similarity=0.322  Sum_probs=174.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      .++|+..+.||+|+||.||+|...  ++.||||++...   .....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l  103 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGYFYL  103 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEE
Confidence            356888999999999999999987  899999999644   23456789999999999999999999999987 788999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee---CCCCcEEEecccCcc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL---DKKMNARLGDFGLAK  263 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kl~DFGla~  263 (409)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||+|+
T Consensus       104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999999854   346999999999999999999999   7899999999999999   567899999999998


Q ss_pred             cccCCce---eeeccccc-----cCCCcHHHHHHhhhccCcHHHHhhH---------------HhhhcCC----CCHHHH
Q 048535          264 MHHHGQV---MSGRRPIE-----EGKRNLVDRMWSLTERSELLSVLDE---------------RLKAKGG----YADEVV  316 (409)
Q Consensus       264 ~~~~~~~---~~g~~p~~-----~~~~~~~~~vws~~~~~~~~~~~~~---------------~l~~~~~----~~~~~~  316 (409)
                      .......   ..|...+.     .+.++...|+|+++  ..+++++..               .......    .....+
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG--~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  255 (484)
T 3nyv_A          178 HFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTG--VILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS  255 (484)
T ss_dssp             HBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSC
T ss_pred             EcccccccccCCCCccccCceeecCCCCCcceeHHHH--HHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCC
Confidence            7654431   11222221     14577889999984  122222222               1111111    112345


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+.+++.+||+.||.+|||+.|+++
T Consensus       256 ~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          256 ESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            67888999999999999999999885

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=8.7e-34  Score=268.30  Aligned_cols=175  Identities=26%  Similarity=0.400  Sum_probs=146.0

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---------hHHHHHHHHHHHHhccCC-CCceeeEeeEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---------EHGMREFLAEVSSLGRLK-HRNLVGLRGWCK  178 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~  178 (409)
                      ..++|+..+.||+|+||.||+|...  ++.||||++....         ....+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578999999999999999999996  8999999996542         223567889999999995 999999999998


Q ss_pred             ccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEec
Q 048535          179 KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGD  258 (409)
Q Consensus       179 ~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D  258 (409)
                      . ....++||||+++|+|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus        95 ~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           95 T-NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             C-SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             c-CCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEec
Confidence            7 7789999999999999999964   346999999999999999999999   78999999999999999999999999


Q ss_pred             ccCcccccCCce---eeecccc---c---------cCCCcHHHHHHhhh
Q 048535          259 FGLAKMHHHGQV---MSGRRPI---E---------EGKRNLVDRMWSLT  292 (409)
Q Consensus       259 FGla~~~~~~~~---~~g~~p~---~---------~~~~~~~~~vws~~  292 (409)
                      ||+++.......   ..|...+   +         ...++...|+|+++
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG  216 (298)
T 1phk_A          168 FGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG  216 (298)
T ss_dssp             CTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHH
T ss_pred             ccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHH
Confidence            999987654321   1122111   1         23456789999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-33  Score=276.04  Aligned_cols=182  Identities=20%  Similarity=0.314  Sum_probs=141.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-----C
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-----E  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~  182 (409)
                      .++|+..+.||+|+||.||+|...  |+.||||++...  .....+.+.+|+.+|++++||||+++++++....     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467899999999999999999986  899999999543  4445678999999999999999999999987632     3


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..|+||||+ +++|.+++..    ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            469999999 7899999954    35899999999999999999999   799999999999999999999999999999


Q ss_pred             ccccCCc-eeeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhH
Q 048535          263 KMHHHGQ-VMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDE  303 (409)
Q Consensus       263 ~~~~~~~-~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~  303 (409)
                      +...... ...|...+   +    ...++...|+|+++  ..+++++..
T Consensus       176 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG--~il~ell~g  222 (367)
T 1cm8_A          176 RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVG--CIMAEMITG  222 (367)
T ss_dssp             EECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHH--HHHHHHHHS
T ss_pred             cccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHH--HHHHHHHhC
Confidence            8764321 11122211   1    14567889999985  334444443

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-33  Score=275.10  Aligned_cols=270  Identities=21%  Similarity=0.297  Sum_probs=183.8

Q ss_pred             ccHHHHHHHhCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccC-----------ChHHHHHHHHHHHHhccCCCCce
Q 048535          103 VSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLD-----------SEHGMREFLAEVSSLGRLKHRNL  170 (409)
Q Consensus       103 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~-----------~~~~~~~~~~E~~~l~~l~H~ni  170 (409)
                      ....++....++|+..+.||+|+||.||+|... ++.||||++...           .....+.+.+|+.++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            346788889999999999999999999999887 899999998543           12234789999999999999999


Q ss_pred             eeEeeEEEcc----CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 048535          171 VGLRGWCKKE----KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNV  246 (409)
Q Consensus       171 v~l~g~~~~~----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NI  246 (409)
                      +++++++...    ....++||||++ |+|.+++..  ....+++..+..++.|++.||.|||   +.+|+||||||+||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NI  165 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNI  165 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHE
Confidence            9999998542    336899999998 589888864  3446999999999999999999999   78999999999999


Q ss_pred             eeCCCCcEEEecccCcccccCCc---eeeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHH
Q 048535          247 LLDKKMNARLGDFGLAKMHHHGQ---VMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVV  316 (409)
Q Consensus       247 Ll~~~~~~kl~DFGla~~~~~~~---~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~  316 (409)
                      |++.++.+||+|||+++......   ...|...+   +    ...++...|+|+++  ..+++++.......+....+..
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG--~il~~l~~g~~pf~~~~~~~~~  243 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAG--CVMAEMFNRKALFRGSTFYNQL  243 (362)
T ss_dssp             EECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHH--HHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHH--HHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999997544332   11222211   1    14567889999996  3455555544432222222222


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHH--------HHHhcCcCCCC--------CCCCCcchhHHhhhcccCCCCccccccc
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVL--------KMLEGQTEGTG--------LEDEGMNVHLLKRIGTRAMTSSWKFAGS  380 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl--------~~L~~~~~~~~--------~~~~~~~~~~l~~~~~~~~~~~~~~~~~  380 (409)
                      ..   +...+.      +|...++.        +.+........        +..+..-.+++.+|+..+|.+|+++.++
T Consensus       244 ~~---i~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  314 (362)
T 3pg1_A          244 NK---IVEVVG------TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA  314 (362)
T ss_dssp             HH---HHHHHC------CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             HH---HHHHcC------CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence            22   222111      12222211        11111111000        0001123577888888888888888888


Q ss_pred             CCCCCcccc
Q 048535          381 RGHPTFNEI  389 (409)
Q Consensus       381 ~~hp~~~~~  389 (409)
                      +.||||+.+
T Consensus       315 l~hp~f~~~  323 (362)
T 3pg1_A          315 LRHPYFESL  323 (362)
T ss_dssp             HTSGGGTTT
T ss_pred             HcCchhhhc
Confidence            888888765

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.4e-34  Score=278.37  Aligned_cols=176  Identities=22%  Similarity=0.323  Sum_probs=145.0

Q ss_pred             hCCCCccceeecCCceEEEEEEECCcEEEEEEeccCChH-----------------HHHHHHHHHHHhccCCCCceeeEe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEH-----------------GMREFLAEVSSLGRLKHRNLVGLR  174 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~-----------------~~~~~~~E~~~l~~l~H~niv~l~  174 (409)
                      .++|.+.+.||+|+||.||+|...++.||||++......                 ..+.+.+|+.++++++||||++++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            468999999999999999999999999999999644211                 127899999999999999999999


Q ss_pred             eEEEccCCeEEEEEEeCCCCCHHHH------HhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CceeecCCCCCCee
Q 048535          175 GWCKKEKESLILIYDYMENGSLDKW------IFECDESIALSWEQRIKVLKDVASGILYLYEGWE-SKVLHRDIKASNVL  247 (409)
Q Consensus       175 g~~~~~~~~~~lv~E~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDlKp~NIL  247 (409)
                      +++.+ .+..++||||+++|+|.++      +.. .....+++..+..++.|++.||.|||   + .+|+||||||+|||
T Consensus       110 ~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          110 GIITN-YDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNIL  184 (348)
T ss_dssp             EEEES-SSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEE
T ss_pred             EEEee-CCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEE
Confidence            99987 6789999999999999998      532 12467999999999999999999999   6 89999999999999


Q ss_pred             eCCCCcEEEecccCcccccCCce--eeeccc---cc---cC-CCcH-HHHHHhhh
Q 048535          248 LDKKMNARLGDFGLAKMHHHGQV--MSGRRP---IE---EG-KRNL-VDRMWSLT  292 (409)
Q Consensus       248 l~~~~~~kl~DFGla~~~~~~~~--~~g~~p---~~---~~-~~~~-~~~vws~~  292 (409)
                      ++.++.+||+|||+++.......  ..|...   .+   .. .++. ..|+|+++
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG  239 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLG  239 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHH
T ss_pred             EcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHH
Confidence            99999999999999987544321  111111   11   12 3344 89999985

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.2e-33  Score=296.70  Aligned_cols=184  Identities=21%  Similarity=0.279  Sum_probs=150.4

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~  184 (409)
                      ..++|+..+.||+|+||.||+|+..  ++.||||+++..   .....+.+..|..++..+ +||||+++++++.+ .+.+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~~~  417 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRL  417 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SSEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CCEE
Confidence            3467899999999999999999987  788999999753   223456788999999988 79999999998876 7789


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      |+||||+++|+|.+++...   ..+++..+..++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+|+.
T Consensus       418 ~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            9999999999999999643   46999999999999999999999   79999999999999999999999999999986


Q ss_pred             ccCCc----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhH
Q 048535          265 HHHGQ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDE  303 (409)
Q Consensus       265 ~~~~~----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~  303 (409)
                      .....    ...|...+.      ...++...|+|+++  ..+++++..
T Consensus       492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlG--vilyelltG  538 (674)
T 3pfq_A          492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFG--VLLYEMLAG  538 (674)
T ss_dssp             CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHH--HHHHHHHHS
T ss_pred             cccCCcccccccCCCcccCHhhhcCCCCCccceEechH--HHHHHHHcC
Confidence            43221    223333332      25678899999986  334444443

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-34  Score=280.97  Aligned_cols=226  Identities=15%  Similarity=0.145  Sum_probs=174.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC----------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceee----------
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL----------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG----------  172 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~----------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~----------  172 (409)
                      ++|++.+.||+|+||.||+|+..          ++.||+|.+...     +.+.+|+.++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            67899999999999999999885          578999999754     45789999999999999988          


Q ss_pred             -----EeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCee
Q 048535          173 -----LRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVL  247 (409)
Q Consensus       173 -----l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NIL  247 (409)
                           +++++.......++||||+ +|+|.+++... ....+++..+..++.||+.||.|||   +.+|+||||||+|||
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl  191 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIF  191 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEE
Confidence                 6777776567899999999 99999999753 2357999999999999999999999   789999999999999


Q ss_pred             eCCCC--cEEEecccCcccccCCce-----------eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhc
Q 048535          248 LDKKM--NARLGDFGLAKMHHHGQV-----------MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAK  308 (409)
Q Consensus       248 l~~~~--~~kl~DFGla~~~~~~~~-----------~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~  308 (409)
                      ++.++  .+||+|||+++.......           ..|...+      ....++..+|+|+++  ..+++++.......
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~il~el~~g~~pf~  269 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLG--YCMLKWLYGFLPWT  269 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHH--HHHHHHHHSCCTTG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHH--HHHHHHHhCCCCcc
Confidence            99998  899999999986543221           1122221      124568899999984  12222222111110


Q ss_pred             --------------------CCCC------HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          309 --------------------GGYA------DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       309 --------------------~~~~------~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                                          ....      ......+.+++.+||+.||++|||+.++++.|+++.+.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          270 NCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             GGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence                                0000      11246789999999999999999999999999876543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4e-34  Score=270.92  Aligned_cols=179  Identities=26%  Similarity=0.408  Sum_probs=131.2

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ...++|+..+.||+|+||.||+|...  ++.||||++.... ....+.+.+|+.++++++||||+++++++.. .+..++
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   90 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-KDELWL   90 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-SSCEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-cCCcEE
Confidence            34578999999999999999999875  8899999997542 3445678999999999999999999999987 678999


Q ss_pred             EEEeCCCCCHHHHHhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          187 IYDYMENGSLDKWIFEC-----DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      ||||+++|+|.+++...     .....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999998631     12356999999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCc---------eeeecccccc-------CCCcHHHHHHhhh
Q 048535          262 AKMHHHGQ---------VMSGRRPIEE-------GKRNLVDRMWSLT  292 (409)
Q Consensus       262 a~~~~~~~---------~~~g~~p~~~-------~~~~~~~~vws~~  292 (409)
                      ++......         ...|...+..       ..++...|+|+++
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  214 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG  214 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHH
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHH
Confidence            97654321         1122222211       2356788999985

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.6e-33  Score=267.28  Aligned_cols=216  Identities=24%  Similarity=0.275  Sum_probs=169.4

Q ss_pred             CCCCcc-ceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHh-ccCCCCceeeEeeEEEc---cCCeEE
Q 048535          113 KGFSEE-NVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSL-GRLKHRNLVGLRGWCKK---EKESLI  185 (409)
Q Consensus       113 ~~f~~~-~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~g~~~~---~~~~~~  185 (409)
                      ++|... +.||+|+||.||+|...  ++.||+|+++..     ..+.+|+.++ +.++||||+++++++..   .....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            556666 77999999999999986  899999999643     4567888888 55699999999998864   245689


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC---CCcEEEecccCc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK---KMNARLGDFGLA  262 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kl~DFGla  262 (409)
                      +||||+++|+|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            999999999999999763 3346999999999999999999999   899999999999999998   788999999999


Q ss_pred             ccccCCceeeeccccccCCCcHHHHHHhhhccCcHHHHhhHHhhhc-------------------CCCC----HHHHHHH
Q 048535          263 KMHHHGQVMSGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAK-------------------GGYA----DEVVEKV  319 (409)
Q Consensus       263 ~~~~~~~~~~g~~p~~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~-------------------~~~~----~~~~~~l  319 (409)
                      +....            ..++...|+|+++  ..+++++.......                   ...+    ......+
T Consensus       168 ~~~~~------------~~~~~~~DiwslG--~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (299)
T 3m2w_A          168 KETTG------------EKYDKSCDMWSLG--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV  233 (299)
T ss_dssp             EECTT------------CGGGGHHHHHHHH--HHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHH
T ss_pred             ccccc------------ccCCchhhHHHHH--HHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHH
Confidence            76542            3456788999985  23344433222110                   0111    1235678


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHH--HHhcCcCCC
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLK--MLEGQTEGT  351 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~~  351 (409)
                      .+++.+||+.||++|||+.|+++  .+.+....+
T Consensus       234 ~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~  267 (299)
T 3m2w_A          234 KMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP  267 (299)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred             HHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence            99999999999999999999987  355444333

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-34  Score=281.55  Aligned_cols=222  Identities=22%  Similarity=0.257  Sum_probs=168.8

Q ss_pred             hCCCCccceeecCCceEEEEEEE-----CCcEEEEEEeccCC----hHHHHHHHHHHHHhccC-CCCceeeEeeEEEccC
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQL-----LGVEVALKRISLDS----EHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEK  181 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  181 (409)
                      .++|+..+.||+|+||.||+|+.     .++.||||+++...    ....+.+.+|+.++.++ +||||+++++++.. .
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~  131 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-E  131 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-T
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-C
Confidence            36789999999999999999998     38899999986431    22345677899999999 69999999999987 6


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      ...++||||+++|+|.+++...   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             ceEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence            7899999999999999999642   46999999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCc-----eeeeccccc--------cCCCcHHHHHHhhhccCcHHHHhh-------------------HHhhhcC
Q 048535          262 AKMHHHGQ-----VMSGRRPIE--------EGKRNLVDRMWSLTERSELLSVLD-------------------ERLKAKG  309 (409)
Q Consensus       262 a~~~~~~~-----~~~g~~p~~--------~~~~~~~~~vws~~~~~~~~~~~~-------------------~~l~~~~  309 (409)
                      ++......     ...|...+.        ...++...|+|+++  ..+++++.                   .......
T Consensus       206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG--~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  283 (355)
T 1vzo_A          206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG--VLMYELLTGASPFTVDGEKNSQAEISRRILKSEP  283 (355)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHH--HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC
T ss_pred             CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHH--HHHHHHHHCCCCCccCCccchHHHHHHHHhccCC
Confidence            98653221     112222221        12356788999984  22222222                   2222223


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 048535          310 GYADEVVEKVLHLGLLCAHPEANSRP-----TIRQVLK  342 (409)
Q Consensus       310 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  342 (409)
                      .++......+.+++.+||+.||.+||     |+.|+++
T Consensus       284 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          284 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence            34444556677788888888888888     6666654

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.5e-34  Score=270.89  Aligned_cols=229  Identities=23%  Similarity=0.321  Sum_probs=170.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC---C--cEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL---G--VEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~---~--~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  183 (409)
                      .++|+..+.||+|+||.||+|++.   +  ..||||+++..   .....+.+.+|+.++++++||||+++++++.. . .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-~   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P-P   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-S
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc-C-C
Confidence            367888999999999999999864   2  36999999754   33456789999999999999999999999876 3 4


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      .++||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             ceeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccc
Confidence            78999999999999999653  246899999999999999999999   7899999999999999999999999999998


Q ss_pred             cccCCce-------eeec---cccc---cCCCcHHHHHHhhhccCcHHHHhh-H---------------Hhhh--cCCCC
Q 048535          264 MHHHGQV-------MSGR---RPIE---EGKRNLVDRMWSLTERSELLSVLD-E---------------RLKA--KGGYA  312 (409)
Q Consensus       264 ~~~~~~~-------~~g~---~p~~---~~~~~~~~~vws~~~~~~~~~~~~-~---------------~l~~--~~~~~  312 (409)
                      .......       ..+.   .+.+   ...++...|+|+++  ..+++++. .               ....  ....+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  247 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG--VTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP  247 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHH--HHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHH--HHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCC
Confidence            7654321       1111   1111   24467889999984  22233322 1               1110  11223


Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      ...+..+.+++.+||+.||++|||+.++++.|++...
T Consensus       248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            3455778999999999999999999999999987653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.6e-33  Score=269.41  Aligned_cols=260  Identities=15%  Similarity=0.208  Sum_probs=189.5

Q ss_pred             cccHHHHHHHhCCCCcc-ceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccC-CCCceeeEee
Q 048535          102 RVSYQEIHAATKGFSEE-NVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRL-KHRNLVGLRG  175 (409)
Q Consensus       102 ~~~~~~l~~~~~~f~~~-~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~g  175 (409)
                      .+.++......+.|.+. +.||+|+||.||+|...  ++.||+|++...  .......+.+|+.++.++ +||||+++++
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~   96 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE   96 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            34455555666777777 88999999999999987  899999999754  233467899999999999 5699999999


Q ss_pred             EEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC---CC
Q 048535          176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK---KM  252 (409)
Q Consensus       176 ~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~  252 (409)
                      ++.+ ....++||||+++|+|.+++... ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.   ++
T Consensus        97 ~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           97 VYEN-TSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEEC-SSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBC
T ss_pred             EEEe-CCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCC
Confidence            9987 77899999999999999998542 2356999999999999999999999   789999999999999988   78


Q ss_pred             cEEEecccCcccccCCce---eeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHH
Q 048535          253 NARLGDFGLAKMHHHGQV---MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLG  323 (409)
Q Consensus       253 ~~kl~DFGla~~~~~~~~---~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~  323 (409)
                      .+||+|||+++.......   ..|...+      ....++...|+|+++  ..+++++........              
T Consensus       172 ~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~~ll~g~~pf~~--------------  235 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIG--IIAYMLLTHTSPFVG--------------  235 (327)
T ss_dssp             CEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHH--HHHHHHHHSSCSSCC--------------
T ss_pred             cEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHH--HHHHHHHhCCCCCCC--------------
Confidence            999999999987654321   1222222      124567789999997  344555544332211              


Q ss_pred             HHccCcCCCCCCCHHHHHHHHhcC-cCCCCC---CCCCcchhHHhhhcccCCCCcccccccCCCCCcccccccc
Q 048535          324 LLCAHPEANSRPTIRQVLKMLEGQ-TEGTGL---EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNR  393 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~~L~~~-~~~~~~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~~  393 (409)
                                 .+..+....+... ...+..   .-+..-.+++.+|+..+|..|.++++++.||||+.++...
T Consensus       236 -----------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~  298 (327)
T 3lm5_A          236 -----------EDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFEN  298 (327)
T ss_dssp             -----------SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTC
T ss_pred             -----------CCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccc
Confidence                       1112221111111 111110   1112236889999999999999999999999998876443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-34  Score=276.69  Aligned_cols=268  Identities=23%  Similarity=0.275  Sum_probs=182.7

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChH-----HHHHHHHHHHHhccCCCCceeeEeeEEEccCC
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEH-----GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE  182 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~  182 (409)
                      ...++|+..+.||+|+||.||+|...  |+.||||++......     ..+.+.+|+.++++++||||+++++++.+ ..
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~   85 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KS   85 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TT
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-CC
Confidence            44578999999999999999999987  899999999754211     12468899999999999999999999987 67


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..++||||+++ +|.+++..  ....+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence            88999999986 89998854  3346899999999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCc----eeeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCC
Q 048535          263 KMHHHGQ----VMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEA  331 (409)
Q Consensus       263 ~~~~~~~----~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP  331 (409)
                      +......    ...|...+   +    ...++...|+|+++  ..+++++.......+   ......+..+...+-.+.+
T Consensus       160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG--~il~ell~g~~~~~~---~~~~~~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVG--CILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTE  234 (346)
T ss_dssp             STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHH--HHHHHHHHSSCSSCC---SSHHHHHHHHHHHHCCCCT
T ss_pred             eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHH--HHHHHHHHCCCCCCC---CCHHHHHHHHHHHcCCCCh
Confidence            8764322    11122211   1    13467899999997  345555543322111   1222334444444545555


Q ss_pred             CCCCCHHHHHHHHhcCcCCCCCC-------CCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          332 NSRPTIRQVLKMLEGQTEGTGLE-------DEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       332 ~~RPt~~evl~~L~~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ...|.+..+.+.+.. ...+..+       ....-.+++.+|+..+|.+|+++++++.||||+...
T Consensus       235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTF-KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             TTSSSTTSSTTCCCC-CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             hhhhhhccCcccccc-cccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence            444443222111100 0000000       011236778888888888888888888888887654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.6e-33  Score=270.53  Aligned_cols=266  Identities=18%  Similarity=0.234  Sum_probs=187.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeEeeEEEcc-CCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKE-KESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~-~~~~~lv~  188 (409)
                      ++|+..+.||+|+||.||+|...  ++.||||+++...   .+.+.+|+.++++++ ||||+++++++.+. ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            67889999999999999999886  8999999997543   367889999999996 99999999998863 35689999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC-cEEEecccCcccccC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM-NARLGDFGLAKMHHH  267 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~~~~  267 (409)
                      ||+++++|.+++.      .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+|+....
T Consensus       113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            9999999999983      3899999999999999999999   89999999999999999776 899999999987654


Q ss_pred             Cce---eeeccccc-------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCH-HHHHHHHH------HHHHccCcC
Q 048535          268 GQV---MSGRRPIE-------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYAD-EVVEKVLH------LGLLCAHPE  330 (409)
Q Consensus       268 ~~~---~~g~~p~~-------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~-~~~~~l~~------l~~~Cl~~d  330 (409)
                      ...   ..|...+.       ...++...|+|+++  ..+++++............ +....+..      +...+-...
T Consensus       184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG--~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG--CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHH--HHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCccccccccccccChhhhcCCCcCCchhhHHHHH--HHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            321   12222111       14578899999997  4455655544332111111 11111111      111111222


Q ss_pred             CCCCCCHHHHHHHHhc-----Cc-CCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccccccc
Q 048535          331 ANSRPTIRQVLKMLEG-----QT-EGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKN  392 (409)
Q Consensus       331 P~~RPt~~evl~~L~~-----~~-~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~  392 (409)
                      ....|...+.+..-..     .. ......-...-.+++.+|+..+|.+|+++++++.||||+++.+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~  329 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  329 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence            3333433333221100     00 00011123345899999999999999999999999999988753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.7e-34  Score=268.37  Aligned_cols=176  Identities=22%  Similarity=0.319  Sum_probs=132.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChH-HHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEH-GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~-~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .++|+..+.||+|+||.||+|...  ++.||+|+++.. ... ..+.+.++...++.++||||+++++++.+ .+..++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-~~~~~lv   84 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-EGDVWIC   84 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSSEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-cCCEEEE
Confidence            467889999999999999999985  899999999755 222 23344555556888999999999999987 6789999


Q ss_pred             EEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          188 YDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWES-KVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      |||+++ +|.+++... .....+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999975 888877532 23457999999999999999999999   66 9999999999999999999999999999865


Q ss_pred             cCCc---eeeecccc----------ccCCCcHHHHHHhhh
Q 048535          266 HHGQ---VMSGRRPI----------EEGKRNLVDRMWSLT  292 (409)
Q Consensus       266 ~~~~---~~~g~~p~----------~~~~~~~~~~vws~~  292 (409)
                      ....   ...|...+          ....++...|+|+++
T Consensus       161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG  200 (290)
T 3fme_A          161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLG  200 (290)
T ss_dssp             ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHH
T ss_pred             cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHH
Confidence            4432   11222221          123467889999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.6e-33  Score=275.75  Aligned_cols=172  Identities=23%  Similarity=0.338  Sum_probs=137.3

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-----C
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-----E  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~  182 (409)
                      .++|+..+.||+|+||.||+|...  ++.||||++...  .....+.+.+|+.+++.++||||+++++++....     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            478999999999999999999986  899999999753  4455678899999999999999999999997633     2


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..++||||+++ +|.+++.     ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence            78999999975 8888884     24899999999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCce---eeeccccc------cCCCcHHHHHHhhh
Q 048535          263 KMHHHGQV---MSGRRPIE------EGKRNLVDRMWSLT  292 (409)
Q Consensus       263 ~~~~~~~~---~~g~~p~~------~~~~~~~~~vws~~  292 (409)
                      +.......   ..|...+.      ...++...|+|+++
T Consensus       175 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  213 (371)
T 2xrw_A          175 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG  213 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHH
T ss_pred             cccccccccCCceecCCccCHHHhcCCCCCchHhHHHHH
Confidence            87654321   12222221      24467789999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.6e-33  Score=274.81  Aligned_cols=183  Identities=27%  Similarity=0.391  Sum_probs=148.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC----CeE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK----ESL  184 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~----~~~  184 (409)
                      .++|+..+.||+|+||.||+|...  ++.||||++... .....+.+.+|+.++.+++||||+++++++....    ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999999987  889999999754 3445578999999999999999999999987532    468


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++||||+++ +|.+++..    ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            999999974 99999854    35999999999999999999999   79999999999999999999999999999987


Q ss_pred             ccCCce-------eeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHH
Q 048535          265 HHHGQV-------MSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDER  304 (409)
Q Consensus       265 ~~~~~~-------~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~  304 (409)
                      ......       ..|...+   +    ...++...|+|+++  ..+++++...
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG--~il~ell~g~  229 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG--CILAEMLSNR  229 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHH--HHHHHHHHSS
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHH--HHHHHHHHCC
Confidence            653321       1222221   1    23467889999985  3344444433

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.6e-33  Score=271.57  Aligned_cols=264  Identities=20%  Similarity=0.255  Sum_probs=189.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc----CCeE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE----KESL  184 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----~~~~  184 (409)
                      .++|+..+.||+|+||.||+|...  |+.||||++... .......+.+|+.++++++||||+++++++...    ....
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            478999999999999999999987  899999999754 444567789999999999999999999987652    2578


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++||||++ |+|.+++..    ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 599999854    35999999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCce--------------eeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHH
Q 048535          265 HHHGQV--------------MSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLG  323 (409)
Q Consensus       265 ~~~~~~--------------~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~  323 (409)
                      ......              ..|...+   +    ...++...|+|+++  ..+++++.......+.....   .+..+.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~~---~~~~~~  236 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG--CILAELFLRRPIFPGRDYRH---QLLLIF  236 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHH--HHHHHHHHSSCSCCCSSHHH---HHHHHH
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHH--HHHHHHHhCCCCCCCCCcHH---HHHHHH
Confidence            653210              1122211   1    24578899999997  44566665443322221111   222222


Q ss_pred             HHccCcCC------CCCCCHHHHHHHHhcCcCCCCC-------CCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          324 LLCAHPEA------NSRPTIRQVLKMLEGQTEGTGL-------EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       324 ~~Cl~~dP------~~RPt~~evl~~L~~~~~~~~~-------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ..+-.+..      ...+...+..   ......+..       .-+....+++.+|+..+|.+|+++++++.||||+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          237 GIIGTPHSDNDLRCIESPRAREYI---KSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             HHHCCCCSTTTTTTCCCHHHHHHH---HTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHhCCCchhccccccccchhhHHh---hcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence            22211111      1112223332   222211111       1112236899999999999999999999999998866


Q ss_pred             c
Q 048535          391 K  391 (409)
Q Consensus       391 ~  391 (409)
                      .
T Consensus       314 ~  314 (353)
T 2b9h_A          314 D  314 (353)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.9e-34  Score=271.76  Aligned_cols=222  Identities=23%  Similarity=0.303  Sum_probs=169.1

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--------hHHHHHHHHHHHHhccCCCCceeeEeeEEEcc
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--------EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE  180 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~  180 (409)
                      ..++|.+.+.||+|+||.||+|...  ++.||||.+....        ......+.+|++++++++||||+++++++.. 
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   86 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-   86 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence            3467899999999999999999987  7899999996532        1223458899999999999999999999875 


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc---EEEe
Q 048535          181 KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN---ARLG  257 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~kl~  257 (409)
                       +..++||||+++|+|.+++.   ....+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.   +||+
T Consensus        87 -~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           87 -EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             -SSEEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             -CceEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEc
Confidence             34899999999999999984   3457999999999999999999999   789999999999999987664   9999


Q ss_pred             cccCcccccCCce---eeecccc---c------cCCCcHHHHHHhhhccCcHHHHhhHHhhh----------------cC
Q 048535          258 DFGLAKMHHHGQV---MSGRRPI---E------EGKRNLVDRMWSLTERSELLSVLDERLKA----------------KG  309 (409)
Q Consensus       258 DFGla~~~~~~~~---~~g~~p~---~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~----------------~~  309 (409)
                      |||+++.......   ..|...+   +      ...++...|+|+++  ..+++++......                ..
T Consensus       160 Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          160 DFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG--VILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             CCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHH--HHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             cCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHH--HHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            9999987655431   1122211   1      24467789999984  1222222221110                01


Q ss_pred             CCCH----HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          310 GYAD----EVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       310 ~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ....    .....+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          238 NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1111    23467899999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.4e-34  Score=274.87  Aligned_cols=266  Identities=22%  Similarity=0.332  Sum_probs=193.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-------C
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-------K  181 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------~  181 (409)
                      ++|+..+.||+|+||.||+|+..  ++.||||++....  ......+.+|+.++++++||||+++++++...       .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            67899999999999999999986  8999999986542  22345788999999999999999999998763       3


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccC
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGL  261 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl  261 (409)
                      +..++||||+++ +|.+.+...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence            468999999986 888877542  346999999999999999999999   78999999999999999999999999999


Q ss_pred             cccccCCc--------eeeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHc
Q 048535          262 AKMHHHGQ--------VMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLC  326 (409)
Q Consensus       262 a~~~~~~~--------~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~C  326 (409)
                      |+......        ...|...+   +    ...++...|+|+++  ..+++++.......+.   .....+..+...|
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG--~il~ell~g~~pf~~~---~~~~~~~~i~~~~  245 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG--CIMAEMWTRSPIMQGN---TEQHQLALISQLC  245 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHH--HHHHHHHHSSCSCCCS---SHHHHHHHHHHHH
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHH--HHHHHHHhCCCCCCCC---ChHHHHHHHHHHh
Confidence            98654211        11111111   1    13467899999997  4566666654432222   2223344555566


Q ss_pred             cCcCCCCCCCHHHHHHHHhcCcCCCCCC-----------CCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          327 AHPEANSRPTIRQVLKMLEGQTEGTGLE-----------DEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       327 l~~dP~~RPt~~evl~~L~~~~~~~~~~-----------~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ....|...|.....- ..+.........           .+....+++.+|+..+|.+|+++++++.||||.+..
T Consensus       246 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          246 GSITPEVWPNVDNYE-LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             CCCCTTTSTTGGGCG-GGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             CCCChhhccccccch-hhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            666666666543221 011110000000           011236899999999999999999999999998644

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.7e-34  Score=275.03  Aligned_cols=220  Identities=24%  Similarity=0.305  Sum_probs=168.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .++|+..+.||+|+||.||+|...  ++.||||++.....    .+.+|++++.++ +||||+++++++.+ ....|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDD-GKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEc-CCEEEEEE
Confidence            467899999999999999999987  88999999975432    245788888888 79999999999987 78899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC----CcEEEecccCccc
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK----MNARLGDFGLAKM  264 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~----~~~kl~DFGla~~  264 (409)
                      ||+++|+|.+++..   ...+++..+..++.||+.||.|||   +.+|+||||||+|||+.++    +.+||+|||+++.
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999999954   346999999999999999999999   7899999999999998443    3599999999987


Q ss_pred             ccCCc----eeeecccccc------CCCcHHHHHHhhhcc----------------CcHHHHhhHHhhhc----CCCCHH
Q 048535          265 HHHGQ----VMSGRRPIEE------GKRNLVDRMWSLTER----------------SELLSVLDERLKAK----GGYADE  314 (409)
Q Consensus       265 ~~~~~----~~~g~~p~~~------~~~~~~~~vws~~~~----------------~~~~~~~~~~l~~~----~~~~~~  314 (409)
                      .....    ...|...+..      ..++...|+|+++..                ....+++.......    ......
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            64432    1122222211      235678899998310                11112222211111    112234


Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ....+.+++.+||+.||++|||+.|+++
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            5677899999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.7e-33  Score=275.35  Aligned_cols=186  Identities=21%  Similarity=0.289  Sum_probs=146.4

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC--------CCceeeEeeEEEc--
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK--------HRNLVGLRGWCKK--  179 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~g~~~~--  179 (409)
                      .++|++.+.||+|+||.||+|...  ++.||||+++.. ....+.+.+|+.++++++        |+||+++++++..  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            477999999999999999999886  889999999744 445677899999999985        8889999998872  


Q ss_pred             -cCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCeeeCCCC-----
Q 048535          180 -EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES-KVLHRDIKASNVLLDKKM-----  252 (409)
Q Consensus       180 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlKp~NILl~~~~-----  252 (409)
                       .....++||||+ +|+|.+++... ....+++..+..++.||+.||.|||   ++ +|+||||||+|||++.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhh
Confidence             245789999999 56777776543 2356999999999999999999999   67 999999999999999775     


Q ss_pred             --------------------------------------------cEEEecccCcccccCCc-eeeeccccc------cCC
Q 048535          253 --------------------------------------------NARLGDFGLAKMHHHGQ-VMSGRRPIE------EGK  281 (409)
Q Consensus       253 --------------------------------------------~~kl~DFGla~~~~~~~-~~~g~~p~~------~~~  281 (409)
                                                                  .+||+|||+|+...... ...|...+.      ...
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~  269 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSG  269 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSC
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCC
Confidence                                                        79999999998654321 112222221      244


Q ss_pred             CcHHHHHHhhhccCcHHHHhhHHh
Q 048535          282 RNLVDRMWSLTERSELLSVLDERL  305 (409)
Q Consensus       282 ~~~~~~vws~~~~~~~~~~~~~~l  305 (409)
                      ++...|+|+++  ..+++++....
T Consensus       270 ~~~~~DiwslG--~il~elltg~~  291 (397)
T 1wak_A          270 YNTPADIWSTA--CMAFELATGDY  291 (397)
T ss_dssp             CCTHHHHHHHH--HHHHHHHHSSC
T ss_pred             CCcHHHHHHHH--HHHHHHhhCCC
Confidence            67889999996  34555554433

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=9.5e-34  Score=276.98  Aligned_cols=266  Identities=19%  Similarity=0.256  Sum_probs=176.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-----CC
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-----KE  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~  182 (409)
                      .++|+..+.||+|+||.||+|...  |+.||||++...  .....+.+.+|+.+++.++||||+++++++...     ..
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999999986  899999999653  445567899999999999999999999998652     24


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..++|+||+ +++|.+++..    ..+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 6799998843    46999999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCc-eeeeccccc-------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCC-
Q 048535          263 KMHHHGQ-VMSGRRPIE-------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANS-  333 (409)
Q Consensus       263 ~~~~~~~-~~~g~~p~~-------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~-  333 (409)
                      +...... ...|...+.       ...++...|+|+++  ..+++++.......+....+.   +..+...+-.+.++. 
T Consensus       180 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG--~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          180 RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG--CIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGAELL  254 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHH--HHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHH
T ss_pred             ccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHH--HHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHH
Confidence            8754321 112222211       14567889999997  456666665544322222222   222222222211110 


Q ss_pred             -CCCHHHHHHHHhcCcCCCCCC-------CCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          334 -RPTIRQVLKMLEGQTEGTGLE-------DEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       334 -RPt~~evl~~L~~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                       +-.-....+.++.....+...       ......+++.+|+..+|.+|+++.+++.||||+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence             011111222233222222111       112347999999999999999999999999999764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.9e-34  Score=275.55  Aligned_cols=235  Identities=23%  Similarity=0.338  Sum_probs=175.1

Q ss_pred             HHHHHHhCCCCccceeecCCceEEEEEEECCcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCe
Q 048535          106 QEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       106 ~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  183 (409)
                      +++....++|+..+.||+|+||.||+|.+.+. ||+|.++..  .....+.+.+|+.++++++||||+++++++.+ .+.
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~-~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~  103 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-PPH  103 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESSS-EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-SSC
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcCe-EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CCc
Confidence            33444567899999999999999999998764 999999754  22334568899999999999999999999987 677


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      .++||||+++++|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++ ++.+||+|||+++
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             eEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence            99999999999999999542  346899999999999999999999   78999999999999998 6799999999987


Q ss_pred             cccCCc---------eeeeccccc---------------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcC----------
Q 048535          264 MHHHGQ---------VMSGRRPIE---------------EGKRNLVDRMWSLTERSELLSVLDERLKAKG----------  309 (409)
Q Consensus       264 ~~~~~~---------~~~g~~p~~---------------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~----------  309 (409)
                      ......         ...|...+.               ...++...|+|+++  ..+++++........          
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG--~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG--TIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHH--HHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHH--HHHHHHHhCCCCCCCCCHHHHHHHh
Confidence            543211         111221111               12367899999984  223333322211100          


Q ss_pred             -------CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          310 -------GYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       310 -------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                             .........+.+++..||+.||++|||+.++++.|+.+.+.
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence                   01112345688999999999999999999999999987654

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.1e-33  Score=283.58  Aligned_cols=226  Identities=21%  Similarity=0.278  Sum_probs=172.7

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|++.+.||+|+||.||+|++.  ++.||||++.....  ..++..|+++++.++|++.+..+.++.......+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            467999999999999999999986  89999999865432  23578999999999875544444444444778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee---CCCCcEEEecccCccccc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL---DKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl---~~~~~~kl~DFGla~~~~  266 (409)
                      |+ +|+|.+++...  ...+++..++.|+.||+.||.|||   +.+|+||||||+||||   +.++.+||+|||+++...
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999999643  346999999999999999999999   7899999999999999   688999999999998765


Q ss_pred             CCc-----------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCC------------------
Q 048535          267 HGQ-----------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGY------------------  311 (409)
Q Consensus       267 ~~~-----------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~------------------  311 (409)
                      ...           ...|...+.      ...++...|+|+++  ..+++++.....+....                  
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlG--vil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLG--YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH--HHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHH--HHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence            432           222332221      24567889999985  23333333222211100                  


Q ss_pred             C-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          312 A-----DEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       312 ~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      .     .....++.+++..||+.||++||++.+|++.|+.+
T Consensus       236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            0     11235789999999999999999999999998765

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.9e-33  Score=266.89  Aligned_cols=222  Identities=25%  Similarity=0.348  Sum_probs=168.7

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ..+.|+..+.||+|+||.||+|...  |+.||+|.+....  ..+.+.+|+.++++++||||+++++++.. .+..++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK-NTDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEe
Confidence            4577999999999999999999987  8999999997543  34678999999999999999999999987 67899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++.+||+|||+++.....
T Consensus       104 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999999999998632  346899999999999999999999   799999999999999999999999999999765433


Q ss_pred             c----eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhc------------------CCCCHHHHHHHH
Q 048535          269 Q----VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAK------------------GGYADEVVEKVL  320 (409)
Q Consensus       269 ~----~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~------------------~~~~~~~~~~l~  320 (409)
                      .    ...|...+      ....++...|+|+++  ..+++++.......                  ...+......+.
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  256 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLG--ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT  256 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHH--HHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             ccccCccCCCCCccChhhcCCCCCCccccHHHHH--HHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHH
Confidence            1    11222211      123456778999984  22233222211100                  011223356788


Q ss_pred             HHHHHccCcCCCCCCCHHHHHH
Q 048535          321 HLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       321 ~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +++.+||+.||.+|||+.++++
T Consensus       257 ~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          257 DFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHccCChhhCcCHHHHHh
Confidence            8999999999999999999876

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.2e-33  Score=277.35  Aligned_cols=264  Identities=19%  Similarity=0.205  Sum_probs=183.4

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC------CCCceeeEeeEEEccCCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL------KHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~g~~~~~~~~  183 (409)
                      ..+|++.+.||+|+||.||+|...  ++.||||+++.. ....+.+.+|+.+++.+      +|+||+++++++.. ...
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-~~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-RNH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-TTE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-CCe
Confidence            467899999999999999999987  789999999754 33446677888887776      57799999999987 688


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc--EEEecccC
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN--ARLGDFGL  261 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~--~kl~DFGl  261 (409)
                      .++||||+. |+|.+++... ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.  +||+|||+
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            999999996 6999999763 3345999999999999999999999   789999999999999999987  99999999


Q ss_pred             cccccCCc-eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCC-
Q 048535          262 AKMHHHGQ-VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANS-  333 (409)
Q Consensus       262 a~~~~~~~-~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~-  333 (409)
                      |+...... ...|...+.      ...++...|+|+++  ..+++++.......+....+....+.++    +...|.. 
T Consensus       249 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG--~il~elltG~~pf~~~~~~~~l~~i~~~----~~~p~~~~  322 (429)
T 3kvw_A          249 SCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLG--CILAELLTGYPLLPGEDEGDQLACMIEL----LGMPSQKL  322 (429)
T ss_dssp             CEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHH----HCCCCHHH
T ss_pred             ceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHH--HHHHHHHhCCCCCCCCCHHHHHHHHHHH----cCCCCHHH
Confidence            97654332 112222221      24578899999997  4566666654433222222222222221    1111100 


Q ss_pred             --------------------------------------------CCCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhccc
Q 048535          334 --------------------------------------------RPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTR  369 (409)
Q Consensus       334 --------------------------------------------RPt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~  369 (409)
                                                                  .|...+....+.+       ..+....+++.+|+..
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-------~~~~~~~dli~~~L~~  395 (429)
T 3kvw_A          323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG-------CDDPLFLDFLKQCLEW  395 (429)
T ss_dssp             HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTT-------CCCHHHHHHHHHHTCS
T ss_pred             HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccc-------cchHHHHHHHHHHCCC
Confidence                                                        0000000010000       0011237999999999


Q ss_pred             CCCCcccccccCCCCCccccccccCC
Q 048535          370 AMTSSWKFAGSRGHPTFNEINKNRSS  395 (409)
Q Consensus       370 ~~~~~~~~~~~~~hp~~~~~~~~~~~  395 (409)
                      +|.+|+|+++++.||||.......++
T Consensus       396 dP~~Rpta~e~L~Hpw~~~~~~~~~~  421 (429)
T 3kvw_A          396 DPAVRMTPGQALRHPWLRRRLPKPPT  421 (429)
T ss_dssp             STTTSCCHHHHHTSTTTC--------
T ss_pred             ChhhCCCHHHHhCChhhccCCCCCCc
Confidence            99999999999999999986544433

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.4e-33  Score=278.48  Aligned_cols=263  Identities=20%  Similarity=0.246  Sum_probs=184.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC-----eEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE-----SLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----~~~l  186 (409)
                      .+|+..+.||+|+||.||+|+.. +..||+|++.....    ...+|+.+++.++||||+++++++.....     ..++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            46888999999999999999997 66799999864422    12369999999999999999999865322     3789


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC-CCCcEEEecccCcccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD-KKMNARLGDFGLAKMH  265 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~kl~DFGla~~~  265 (409)
                      ||||++++.+............+++..+..++.||++||+|||   +.+|+||||||+|||++ .++.+||+|||+|+..
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            9999987544433322223457999999999999999999999   79999999999999999 7999999999999876


Q ss_pred             cCCce---eeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCC
Q 048535          266 HHGQV---MSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRP  335 (409)
Q Consensus       266 ~~~~~---~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  335 (409)
                      ..+..   ..|...+   +    ...++...|+|+++  ..+++++.......+....+.   +..++...      ..|
T Consensus       193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG--~il~ell~g~~pf~~~~~~~~---l~~i~~~~------g~p  261 (394)
T 4e7w_A          193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTG--CVMAELMQGQPLFPGESGIDQ---LVEIIKVL------GTP  261 (394)
T ss_dssp             CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHH--HHHHHHHHSSCSSCCSSHHHH---HHHHHHHH------CCC
T ss_pred             cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCCHHHH---HHHHHHHh------CCC
Confidence            44321   1122211   1    13478899999997  456666665544333222222   22332221      134


Q ss_pred             CHHHHHHHHhcCcC--CCC-----------CCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccccc
Q 048535          336 TIRQVLKMLEGQTE--GTG-----------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNR  393 (409)
Q Consensus       336 t~~evl~~L~~~~~--~~~-----------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~~  393 (409)
                      +..++..+-.+..+  .+.           ...+....+++.+|+..+|.+|+++.+++.||||+++....
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  332 (394)
T 4e7w_A          262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE  332 (394)
T ss_dssp             CHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred             CHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence            44444333221111  000           00112347999999999999999999999999999876443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.1e-33  Score=263.51  Aligned_cols=248  Identities=21%  Similarity=0.280  Sum_probs=180.4

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ..+.|++.+.||+|+||.||+|...  ++.||+|.+........+.+.+|+.++++++||||+++++++.. .+..++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-DGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-C-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-CCeEEEEE
Confidence            3477899999999999999999997  88999999987666667889999999999999999999999987 67899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC-
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH-  267 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~-  267 (409)
                      ||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++..... 
T Consensus        96 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           96 EFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             ECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999998653  345999999999999999999999   78999999999999999999999999999754211 


Q ss_pred             ---Cceeeecccc-----------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCC
Q 048535          268 ---GQVMSGRRPI-----------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANS  333 (409)
Q Consensus       268 ---~~~~~g~~p~-----------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  333 (409)
                         .....|...+           ....++...|+|+++  ..+++++......                         .
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG--~il~~l~~g~~p~-------------------------~  223 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG--ITLIEMAQIEPPH-------------------------H  223 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHH--HHHHHHHHSSCTT-------------------------T
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHH--HHHHHHhcCCCCC-------------------------c
Confidence               1111122111           123456788999986  3344444332221                         1


Q ss_pred             CCCHHHHHH-HHhcCcCCCCCCC--CCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          334 RPTIRQVLK-MLEGQTEGTGLED--EGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       334 RPt~~evl~-~L~~~~~~~~~~~--~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      -.+..+.+. ...........+.  +..-.+++.+|+..+|..|.+..+++.||||+.+..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          224 ELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             TSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             cCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            111111111 1111111100011  112368899999999999999999999999988763

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-33  Score=294.71  Aligned_cols=229  Identities=20%  Similarity=0.281  Sum_probs=179.3

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      ..++|+..+.||+|+||.||+|.+.     +..||||.++.. .....+.|.+|+.++++++||||+++++++.+  +..
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~  465 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPV  465 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--Cce
Confidence            3466788899999999999999985     467999998754 44556789999999999999999999999853  568


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++||||+++|+|.+++...  ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence            9999999999999999653  346899999999999999999999   78999999999999999999999999999987


Q ss_pred             ccCCcee-----eecccc---c---cCCCcHHHHHHhhhccCcHHHHhh-H---------------Hhh-hcCCCCHHHH
Q 048535          265 HHHGQVM-----SGRRPI---E---EGKRNLVDRMWSLTERSELLSVLD-E---------------RLK-AKGGYADEVV  316 (409)
Q Consensus       265 ~~~~~~~-----~g~~p~---~---~~~~~~~~~vws~~~~~~~~~~~~-~---------------~l~-~~~~~~~~~~  316 (409)
                      .......     .+...+   +   ...++...|+|+++  ..+++++. .               ... .....+..++
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG--~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  618 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG--VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP  618 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCC
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHH--HHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence            6543311     111111   1   24577889999984  12222221 1               111 0122344556


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      ..+.+++.+||+.||++|||+.++++.|+.+.
T Consensus       619 ~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          619 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            78899999999999999999999999998653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.3e-34  Score=271.70  Aligned_cols=233  Identities=23%  Similarity=0.351  Sum_probs=173.7

Q ss_pred             ccHHHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEc
Q 048535          103 VSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKK  179 (409)
Q Consensus       103 ~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~  179 (409)
                      +++.++....++|+..+.||+|+||.||+|.+.  ++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            344455566788999999999999999999995  8999999997543 2346788999999999 89999999999976


Q ss_pred             c-----CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcE
Q 048535          180 E-----KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNA  254 (409)
Q Consensus       180 ~-----~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~  254 (409)
                      .     ....++||||+++|+|.+++... ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCE
Confidence            3     35789999999999999999753 2356899999999999999999999   7899999999999999999999


Q ss_pred             EEecccCcccccCCc----eeeeccccc-----------cCCCcHHHHHHhhhccCcHHHHhhHHhhhc-----------
Q 048535          255 RLGDFGLAKMHHHGQ----VMSGRRPIE-----------EGKRNLVDRMWSLTERSELLSVLDERLKAK-----------  308 (409)
Q Consensus       255 kl~DFGla~~~~~~~----~~~g~~p~~-----------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~-----------  308 (409)
                      ||+|||++.......    ...|...+.           ...++...|+|+++  ..+++++.......           
T Consensus       169 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG--~il~~l~~g~~p~~~~~~~~~~~~~  246 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG--ITAIEMAEGAPPLCDMHPMRALFLI  246 (326)
T ss_dssp             EECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHH--HHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             EEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHH--HHHHHHHhCCCCCCCCcHHHHHHHh
Confidence            999999998654321    112222111           23456678999984  22333332211110           


Q ss_pred             ------CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          309 ------GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       309 ------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                            ..........+.+++.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                  0011223457888999999999999999999886

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.4e-33  Score=278.99  Aligned_cols=260  Identities=24%  Similarity=0.272  Sum_probs=184.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-----CCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-----KESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~~  185 (409)
                      .+|+..+.||+|+||.||+|++.  ++.||||++....    +.+.+|+++|++++|||||++++++...     ...++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            35788899999999999999996  8999999996542    1234799999999999999999988642     12367


Q ss_pred             EEEEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC-CcEEEecccCcc
Q 048535          186 LIYDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK-MNARLGDFGLAK  263 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFGla~  263 (409)
                      +||||+++ +|.+.+... .....+++..+..++.||++||.|||   +.+|+||||||+|||++.+ +.+||+|||+|+
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999986 676665421 23457999999999999999999999   8999999999999999965 568999999998


Q ss_pred             cccCCc---eeeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCC
Q 048535          264 MHHHGQ---VMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANS  333 (409)
Q Consensus       264 ~~~~~~---~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~  333 (409)
                      ....+.   ...|...+   +    ...++...|+|+++  ..+++++.....+.+....+   .+.+++...      .
T Consensus       206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG--~il~ell~G~~pf~~~~~~~---~l~~i~~~l------g  274 (420)
T 1j1b_A          206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG--CVLAELLLGQPIFPGDSGVD---QLVEIIKVL------G  274 (420)
T ss_dssp             ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHH--HHHHHHHHSSCSSCCSSHHH---HHHHHHHHH------C
T ss_pred             hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHH--HHHHHHHhCCCCCCCCCHHH---HHHHHHHHh------C
Confidence            754332   11222211   1    13578899999997  45677776554433322222   233333222      2


Q ss_pred             CCCHHHHHHHHhcCcCC--CC-----------CCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          334 RPTIRQVLKMLEGQTEG--TG-----------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       334 RPt~~evl~~L~~~~~~--~~-----------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      .|+..++..+-....+.  +.           ...+....+++.+|+..+|.+|++..+++.||||+++..
T Consensus       275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence            34555554432221111  10           011123479999999999999999999999999988753

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=8.4e-34  Score=277.56  Aligned_cols=183  Identities=11%  Similarity=0.059  Sum_probs=130.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHH---HhccCCCCceeeEe-------eE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVS---SLGRLKHRNLVGLR-------GW  176 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~---~l~~l~H~niv~l~-------g~  176 (409)
                      ...|+..+.||+|+||.||+|.+.  ++.||||++....   ....+.+.+|+.   .|+. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            345888999999999999999986  8999999998653   244566778854   5555 799988755       44


Q ss_pred             EEccC----------------CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 048535          177 CKKEK----------------ESLILIYDYMENGSLDKWIFECDESIALSWEQR------IKVLKDVASGILYLYEGWES  234 (409)
Q Consensus       177 ~~~~~----------------~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~  234 (409)
                      +...+                ...++|||||+ |+|.+++...  ...+.+..+      ..++.||+.||+|||   +.
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~  213 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQ---SK  213 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHH---HC
Confidence            43211                34899999999 8999999753  223455556      788899999999999   89


Q ss_pred             ceeecCCCCCCeeeCCCCcEEEecccCcccccCCc-eeeecccc---c---c--CCCcHHHHHHhhhccCcHHHHhhH
Q 048535          235 KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ-VMSGRRPI---E---E--GKRNLVDRMWSLTERSELLSVLDE  303 (409)
Q Consensus       235 ~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-~~~g~~p~---~---~--~~~~~~~~vws~~~~~~~~~~~~~  303 (409)
                      +|+||||||+|||++.++.+||+|||+|+...... ...+...+   +   .  ..++...|+|+++  ..+++++..
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG--~il~elltg  289 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLG--LSIYRVWCL  289 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHH--HHHHHHHHS
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHH--HHHHHHHhC
Confidence            99999999999999999999999999998765433 11111111   1   1  3568899999996  344555443

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.6e-33  Score=272.39  Aligned_cols=231  Identities=14%  Similarity=0.117  Sum_probs=176.4

Q ss_pred             HHhCCCCccceeecCCceEEEEEE-----EC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC---CCceeeEeeEEEc
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQ-----LL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK---HRNLVGLRGWCKK  179 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~-----~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~  179 (409)
                      ...++|.+.+.||+|+||.||+|.     ..  ++.||||+++....   .++..|+.++..++   |+||+++++++..
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            345778999999999999999994     22  88999999976543   45667777777765   9999999999987


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC-------
Q 048535          180 EKESLILIYDYMENGSLDKWIFECD--ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK-------  250 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-------  250 (409)
                       .+..++|||||++|+|.+++....  ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.       
T Consensus       139 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          139 -QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             -SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC--
T ss_pred             -CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccc
Confidence             678899999999999999996421  3456999999999999999999999   899999999999999998       


Q ss_pred             ----CCcEEEecccCccccc---CCce---eeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcC-----
Q 048535          251 ----KMNARLGDFGLAKMHH---HGQV---MSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKG-----  309 (409)
Q Consensus       251 ----~~~~kl~DFGla~~~~---~~~~---~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~-----  309 (409)
                          ++.+||+|||+|+...   ....   ..|...+.      ...++...|+|+++  ..+++++........     
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG--~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVA--ATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHH--HHHHHHHHSSCCCEEEETTE
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHH--HHHHHHHhCCCccccCCCCc
Confidence                8999999999997543   2221   12332221      24578899999996  345555544321100     


Q ss_pred             -----CC-CHHHHHHHHHHHHHccCcCCCCC-CCHHHHHHHHhcCcC
Q 048535          310 -----GY-ADEVVEKVLHLGLLCAHPEANSR-PTIRQVLKMLEGQTE  349 (409)
Q Consensus       310 -----~~-~~~~~~~l~~l~~~Cl~~dP~~R-Pt~~evl~~L~~~~~  349 (409)
                           .+ .....+.+.+++..|++.+|.+| |+++++.+.|++..+
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~  339 (365)
T 3e7e_A          293 CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ  339 (365)
T ss_dssp             EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred             eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence                 00 00124567789999999999998 678888888877654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.3e-33  Score=261.93  Aligned_cols=223  Identities=24%  Similarity=0.308  Sum_probs=170.2

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ..++|++.+.||+|+||.||+|...  ++.||+|++...  .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   98 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYI   98 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-CCeEEE
Confidence            4568999999999999999999986  899999999654  23456789999999999999999999999987 678999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC---CcEEEecccCcc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK---MNARLGDFGLAK  263 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~---~~~kl~DFGla~  263 (409)
                      ||||+++++|.+++...   ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.+   +.+||+|||+++
T Consensus        99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            99999999999988542   36899999999999999999999   7899999999999999764   469999999998


Q ss_pred             cccCCcee---eeccccc-----cCCCcHHHHHHhhhccCcHHHHhhHHh---------------hhcCCCC----HHHH
Q 048535          264 MHHHGQVM---SGRRPIE-----EGKRNLVDRMWSLTERSELLSVLDERL---------------KAKGGYA----DEVV  316 (409)
Q Consensus       264 ~~~~~~~~---~g~~p~~-----~~~~~~~~~vws~~~~~~~~~~~~~~l---------------~~~~~~~----~~~~  316 (409)
                      ........   .|...+.     .+.++...|+|+++  ..+++++....               ......+    ...+
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG--~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 2wei_A          173 CFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAG--VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS  250 (287)
T ss_dssp             TBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred             eecCCCccccccCcccccChHHhcCCCCCchhhHhHH--HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence            76543211   1111111     13467789999984  22222222111               1000000    2234


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+.+++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          251 DDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHhc
Confidence            56778888888888888888888876

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1e-32  Score=269.98  Aligned_cols=182  Identities=24%  Similarity=0.344  Sum_probs=142.4

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC-----
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE-----  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  182 (409)
                      .++|...+.||+|+||.||+|...  |+.||||++...  .....+.+.+|+.++++++||||+++++++.....     
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468889999999999999999987  899999999754  44456789999999999999999999999976322     


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..++||||++ |+|.+++.     ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence            2389999997 59988872     24999999999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCc-eeeecccc---c---c-CCCcHHHHHHhhhccCcHHHHhhHH
Q 048535          263 KMHHHGQ-VMSGRRPI---E---E-GKRNLVDRMWSLTERSELLSVLDER  304 (409)
Q Consensus       263 ~~~~~~~-~~~g~~p~---~---~-~~~~~~~~vws~~~~~~~~~~~~~~  304 (409)
                      +...... ...|...+   +   . ..++...|+|+++  ..+++++...
T Consensus       192 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG--~il~el~~g~  239 (371)
T 4exu_A          192 RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVG--CIMAEMLTGK  239 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHH--HHHHHHHHSS
T ss_pred             cccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHH--HHHHHHHhCC
Confidence            8654322 11122111   1   1 3567789999985  3344444433

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.2e-32  Score=267.68  Aligned_cols=275  Identities=22%  Similarity=0.255  Sum_probs=180.3

Q ss_pred             HHHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC-
Q 048535          106 QEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE-  182 (409)
Q Consensus       106 ~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-  182 (409)
                      .......++|++.+.||+|+||.||+|...  ++.||||++.... .....+.+|+..+..++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            345567789999999999999999999987  8999999986542 223456788888999999999999999865222 


Q ss_pred             -----eEEEEEEeCCCCCHHHHHhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC-CCcEE
Q 048535          183 -----SLILIYDYMENGSLDKWIFE-CDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK-KMNAR  255 (409)
Q Consensus       183 -----~~~lv~E~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-~~~~k  255 (409)
                           ..++||||+++ +|.+.+.. ......+++..+..++.|++.||.|||.+ +.+|+||||||+|||++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEE
Confidence                 27899999987 55544432 13455789999999999999999999943 689999999999999997 89999


Q ss_pred             EecccCcccccCCce---eeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHH
Q 048535          256 LGDFGLAKMHHHGQV---MSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       256 l~DFGla~~~~~~~~---~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~  325 (409)
                      |+|||+++.......   ..|...+   +    ...++...|+|+++  ..+++++...............   ..+...
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG--~il~ell~g~~pf~~~~~~~~~---~~~~~~  247 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVG--CIFAEMMLGEPIFRGDNSAGQL---HEIVRV  247 (360)
T ss_dssp             ECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHH--HHHHHHHHSSCSSCCSSHHHHH---HHHHHH
T ss_pred             EeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHH--HHHHHHHhCCCCcCCCChHHHH---HHHHHH
Confidence            999999987654331   1122211   1    13368899999997  4566666554433222222222   222221


Q ss_pred             ccCcCCCCCCCHHHHHHHHhcCc-----------------CCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          326 CAHPEANSRPTIRQVLKMLEGQT-----------------EGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~~L~~~~-----------------~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      ..      .|. .+.+..+....                 ..........-.+++.+|+..+|.+|+++.+++.||||++
T Consensus       248 ~~------~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  320 (360)
T 3e3p_A          248 LG------CPS-REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE  320 (360)
T ss_dssp             HC------CCC-HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred             cC------CCC-HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence            11      111 11222211100                 0000111123478999999999999999999999999999


Q ss_pred             cccccCC
Q 048535          389 INKNRSS  395 (409)
Q Consensus       389 ~~~~~~~  395 (409)
                      +......
T Consensus       321 ~~~~~~~  327 (360)
T 3e3p_A          321 LHDPATK  327 (360)
T ss_dssp             GGCTTCC
T ss_pred             cCCcccc
Confidence            8754443

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7e-33  Score=265.46  Aligned_cols=187  Identities=25%  Similarity=0.376  Sum_probs=145.8

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC---CcEEEEEEeccCC--hHHHHHHHHHHHHhccC---CCCceeeEeeEEEc---
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL---GVEVALKRISLDS--EHGMREFLAEVSSLGRL---KHRNLVGLRGWCKK---  179 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~---  179 (409)
                      ..++|++.+.||+|+||.||+|...   ++.||+|++....  ......+.+|+.+++.+   +||||+++++++..   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999983   7889999996432  11223566777777666   89999999999872   


Q ss_pred             -cCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEec
Q 048535          180 -EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGD  258 (409)
Q Consensus       180 -~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~D  258 (409)
                       .....++||||++ |+|.+++.... ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEec
Confidence             2457899999998 69999997642 345999999999999999999999   78999999999999999999999999


Q ss_pred             ccCcccccCCc---eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHH
Q 048535          259 FGLAKMHHHGQ---VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDER  304 (409)
Q Consensus       259 FGla~~~~~~~---~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~  304 (409)
                      ||+++......   ...|...+      ....++...|+|+++  ..+++++...
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~  216 (326)
T 1blx_A          164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG--CIFAEMFRRK  216 (326)
T ss_dssp             CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHH--HHHHHHHHSS
T ss_pred             CcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHH--HHHHHHHcCC
Confidence            99998755322   11222221      124567889999996  3455555443

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4e-32  Score=260.87  Aligned_cols=184  Identities=18%  Similarity=0.270  Sum_probs=148.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC---CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCc------eeeEeeEEEccCC
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL---GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN------LVGLRGWCKKEKE  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~  182 (409)
                      .++|++.+.||+|+||.||+|...   ++.||||+++.. ....+.+.+|+.+++.++|+|      ++++++++.. .+
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-~~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-HG   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-TT
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-CC
Confidence            467899999999999999999873   789999999754 344577889999999887665      9999999987 67


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC------------
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK------------  250 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~------------  250 (409)
                      ..++||||+ +++|.+++... ....+++..+..++.|++.||+|||   +.+|+||||||+|||++.            
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             cEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            899999999 88999999753 3346899999999999999999999   789999999999999987            


Q ss_pred             -------CCcEEEecccCcccccCCc-eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHH
Q 048535          251 -------KMNARLGDFGLAKMHHHGQ-VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDER  304 (409)
Q Consensus       251 -------~~~~kl~DFGla~~~~~~~-~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~  304 (409)
                             ++.+||+|||+++...... ...|...+.      ...++...|+|+++  ..+++++...
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~il~el~~g~  231 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIG--CILIEYYLGF  231 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHH--HHHHHHHHSS
T ss_pred             cccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHH--HHHHHHHhCC
Confidence                   6689999999998754432 122222221      24567889999996  3455555443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.7e-33  Score=268.63  Aligned_cols=230  Identities=18%  Similarity=0.284  Sum_probs=170.9

Q ss_pred             cccHHHHHHHhCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccC--ChHHHHHHHHHHHHhccCC--CCceeeEeeE
Q 048535          102 RVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLD--SEHGMREFLAEVSSLGRLK--HRNLVGLRGW  176 (409)
Q Consensus       102 ~~~~~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~g~  176 (409)
                      .+.++.+....++|++.+.||+|+||.||++... ++.||||++...  .....+.+.+|+.++.+++  ||||++++++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            3444444455678999999999999999999987 889999999754  4456678999999999996  5999999999


Q ss_pred             EEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEE
Q 048535          177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARL  256 (409)
Q Consensus       177 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl  256 (409)
                      +.. .+..++||| +.+|+|.+++..   ...+++..+..++.|+++||.|||   +.+|+||||||+|||+++ +.+||
T Consensus        97 ~~~-~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL  167 (313)
T 3cek_A           97 EIT-DQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKL  167 (313)
T ss_dssp             EEC-SSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEE
T ss_pred             eec-CCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEE
Confidence            987 678999999 668899999964   246899999999999999999999   789999999999999964 88999


Q ss_pred             ecccCcccccCCc------eeeeccccc-----------------cCCCcHHHHHHhhhccCcHHHHhhHHhhhc-----
Q 048535          257 GDFGLAKMHHHGQ------VMSGRRPIE-----------------EGKRNLVDRMWSLTERSELLSVLDERLKAK-----  308 (409)
Q Consensus       257 ~DFGla~~~~~~~------~~~g~~p~~-----------------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~-----  308 (409)
                      +|||+++......      ...|...+.                 ...++...|+|+++  ..+++++.......     
T Consensus       168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG--~il~el~~g~~pf~~~~~~  245 (313)
T 3cek_A          168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG--CILYYMTYGKTPFQQIINQ  245 (313)
T ss_dssp             CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHH--HHHHHHHHSSCTTTTCCSH
T ss_pred             eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHH--HHHHHHHhCCCchhhHHHH
Confidence            9999998754322      111222211                 12567889999984  22222222211100     


Q ss_pred             -------------CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          309 -------------GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       309 -------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                                   ..++......+.+++.+||+.||.+|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          246 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence                         1122223456788888999999999999988875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.6e-32  Score=268.05  Aligned_cols=274  Identities=19%  Similarity=0.193  Sum_probs=187.9

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC-CC-----ceeeEeeEEEccC
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-HR-----NLVGLRGWCKKEK  181 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~g~~~~~~  181 (409)
                      ...++|++.+.||+|+||.||+|...  ++.||||+++.. .....++..|+.++..++ |+     +|+++++++.. .
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-~  128 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-R  128 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-T
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-C
Confidence            34678999999999999999999987  889999999754 344567788998888874 44     49999999987 6


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC--CCCcEEEecc
Q 048535          182 ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD--KKMNARLGDF  259 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~--~~~~~kl~DF  259 (409)
                      +..++||||++ |+|.+++.... ...+++..+..++.|++.||.|||.. ..+|+||||||+|||++  .++.+||+||
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             CceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            78999999996 59999997642 34599999999999999999999942 47899999999999995  4778999999


Q ss_pred             cCcccccCCc-eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHH--------
Q 048535          260 GLAKMHHHGQ-VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGL--------  324 (409)
Q Consensus       260 Gla~~~~~~~-~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~--------  324 (409)
                      |+|+...... ...|...+.      ...++...|+|+++  ..+++++.......+....+....+.....        
T Consensus       206 G~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG--~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  283 (382)
T 2vx3_A          206 GSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLG--CILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD  283 (382)
T ss_dssp             TTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             cCceecccccccccCCccccChHHHcCCCCCcHHHHHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9998765422 122222221      24577899999997  456666665544322222222222222110        


Q ss_pred             ------HccCcCC---------------CCCCCHHHHHHHHhcCcCCCCCCCC----------CcchhHHhhhcccCCCC
Q 048535          325 ------LCAHPEA---------------NSRPTIRQVLKMLEGQTEGTGLEDE----------GMNVHLLKRIGTRAMTS  373 (409)
Q Consensus       325 ------~Cl~~dP---------------~~RPt~~evl~~L~~~~~~~~~~~~----------~~~~~~l~~~~~~~~~~  373 (409)
                            .++..-|               ..+|....+.+.+......+.....          ....+++.+|+..+|.+
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  363 (382)
T 2vx3_A          284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT  363 (382)
T ss_dssp             TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred             hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence                  0000000               0112222233333221111110000          12369999999999999


Q ss_pred             cccccccCCCCCccccc
Q 048535          374 SWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       374 ~~~~~~~~~hp~~~~~~  390 (409)
                      |+|+++++.||||++..
T Consensus       364 Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          364 RIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             SCCHHHHTTSGGGCC--
T ss_pred             CCCHHHHhcCcccccCC
Confidence            99999999999998754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-33  Score=267.69  Aligned_cols=226  Identities=25%  Similarity=0.374  Sum_probs=165.7

Q ss_pred             HHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh------HHHHHHHHHHHHhccC----CCCceeeEee
Q 048535          108 IHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE------HGMREFLAEVSSLGRL----KHRNLVGLRG  175 (409)
Q Consensus       108 l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~g  175 (409)
                      .....++|+..+.||+|+||.||+|...  ++.||||++.....      .....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3445678999999999999999999885  88999999975422      1233466799999888    8999999999


Q ss_pred             EEEccCCeEEEEEEe-CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC-CCCc
Q 048535          176 WCKKEKESLILIYDY-MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD-KKMN  253 (409)
Q Consensus       176 ~~~~~~~~~~lv~E~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~  253 (409)
                      ++.. .+..++|||| +++++|.+++..   ...+++..+..++.|++.||.|||   +.+|+||||||+|||++ .++.
T Consensus       106 ~~~~-~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          106 WFET-QEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EC------CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTE
T ss_pred             EEec-CCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCe
Confidence            9887 6678899999 789999999965   246999999999999999999999   78999999999999999 8899


Q ss_pred             EEEecccCcccccCCce--eeeccccc-------cCCCcHHHHHHhhhccCcHHHHhhHHhh---------hcCCCCHHH
Q 048535          254 ARLGDFGLAKMHHHGQV--MSGRRPIE-------EGKRNLVDRMWSLTERSELLSVLDERLK---------AKGGYADEV  315 (409)
Q Consensus       254 ~kl~DFGla~~~~~~~~--~~g~~p~~-------~~~~~~~~~vws~~~~~~~~~~~~~~l~---------~~~~~~~~~  315 (409)
                      +||+|||+++.......  ..|...+.       ........|+|+++  ..+++++.....         .....+...
T Consensus       179 ~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  256 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLG--ILLYDMVCGDIPFERDQEILEAELHFPAHV  256 (312)
T ss_dssp             EEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHH--HHHHHHHHSSCSCCSHHHHHHTCCCCCTTS
T ss_pred             EEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHH--HHHHHHHHCCCCCCChHHHhhhccCCcccC
Confidence            99999999987654331  11222211       12234578999985  223333332211         112233445


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ...+.+++.+||+.||++|||+.|+++
T Consensus       257 ~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          257 SPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            567889999999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.4e-32  Score=267.00  Aligned_cols=181  Identities=24%  Similarity=0.333  Sum_probs=142.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC-----
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE-----  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~-----  182 (409)
                      .++|...+.||+|+||.||+|...  |+.||||++...  .....+.+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367888999999999999999986  899999999654  34456789999999999999999999999976322     


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..++||||++ |+|.+++.     ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence            3599999997 59988872     24999999999999999999999   789999999999999999999999999999


Q ss_pred             ccccCCc-eeeecccc---c----cCCCcHHHHHHhhhccCcHHHHhhH
Q 048535          263 KMHHHGQ-VMSGRRPI---E----EGKRNLVDRMWSLTERSELLSVLDE  303 (409)
Q Consensus       263 ~~~~~~~-~~~g~~p~---~----~~~~~~~~~vws~~~~~~~~~~~~~  303 (409)
                      +...... ...|...+   +    ...++...|+|+++  ..+++++..
T Consensus       174 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG--~il~el~~g  220 (353)
T 3coi_A          174 RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVG--CIMAEMLTG  220 (353)
T ss_dssp             TC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHH--HHHHHHHHS
T ss_pred             cCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHH--HHHHHHHhC
Confidence            8754322 11122211   1    13467789999985  334444443

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.4e-32  Score=263.90  Aligned_cols=224  Identities=25%  Similarity=0.333  Sum_probs=165.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHH-HhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVS-SLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~-~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .++|+..+.||+|+||.||+|...  ++.||||++... ......++..|+. +++.++||||+++++++.. .+..++|
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-~~~~~lv   99 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-EGDCWIC   99 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-CCceEEE
Confidence            367888999999999999999997  899999999765 3344556667776 7788899999999999987 6789999


Q ss_pred             EEeCCCCCHHHHHhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          188 YDYMENGSLDKWIFEC--DESIALSWEQRIKVLKDVASGILYLYEGWES-KVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      |||+++ +|.+++...  .....+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            999986 888877521  12456999999999999999999999   66 999999999999999999999999999987


Q ss_pred             ccCCce---eeecccc---c-------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcC-----------------C----
Q 048535          265 HHHGQV---MSGRRPI---E-------EGKRNLVDRMWSLTERSELLSVLDERLKAKG-----------------G----  310 (409)
Q Consensus       265 ~~~~~~---~~g~~p~---~-------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~-----------------~----  310 (409)
                      ......   ..|...+   +       ...++...|+|+++  ..+++++........                 .    
T Consensus       176 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3aln_A          176 LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLG--ITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS  253 (327)
T ss_dssp             ------------------------------CCSHHHHHHHH--HHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCC
T ss_pred             cccccccccCCCCccccCceeeccccCcCCCCchhhHHHHH--HHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCc
Confidence            543321   1122111   1       13356789999984  233333332211100                 0    


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       311 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ........+.+++.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            01124567889999999999999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.9e-32  Score=262.11  Aligned_cols=268  Identities=17%  Similarity=0.179  Sum_probs=182.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--C-cEEEEEEeccCChHHHHHHHHHHHHhccCCCCc------eeeEeeEEEccCC
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--G-VEVALKRISLDSEHGMREFLAEVSSLGRLKHRN------LVGLRGWCKKEKE  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~-~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~g~~~~~~~  182 (409)
                      .++|++.+.||+|+||.||+|...  + +.||+|+++.. ....+.+.+|+.++++++|+|      ++.+++++.. .+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-~~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-HG   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-TT
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-CC
Confidence            478999999999999999999986  4 78999999754 345577889999999997766      8999998887 67


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee--------------
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL--------------  248 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl--------------  248 (409)
                      ..++||||+ +|+|.+++... ....+++..+..++.||+.||.|||   +.+|+||||||+|||+              
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccc
Confidence            899999999 66888877653 3346999999999999999999999   8999999999999999              


Q ss_pred             -----CCCCcEEEecccCcccccCCc-eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHH
Q 048535          249 -----DKKMNARLGDFGLAKMHHHGQ-VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVV  316 (409)
Q Consensus       249 -----~~~~~~kl~DFGla~~~~~~~-~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~  316 (409)
                           +.++.+||+|||+++...... ...|...+.      ...++..+|+|+++  ..+++++............+..
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG--~il~el~~g~~pf~~~~~~~~~  248 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIG--CILFEYYRGFTLFQTHENREHL  248 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHH--HHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHH--HHHHHHHhCCCCCCCCCHHHHH
Confidence                 567899999999998654332 122322221      24567889999996  4455555544332211111111


Q ss_pred             HHHHHHHHHccCcCCC--------------------CCCCHHHHHHHHhcC-c--CCCCCCCCCcchhHHhhhcccCCCC
Q 048535          317 EKVLHLGLLCAHPEAN--------------------SRPTIRQVLKMLEGQ-T--EGTGLEDEGMNVHLLKRIGTRAMTS  373 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~--------------------~RPt~~evl~~L~~~-~--~~~~~~~~~~~~~~l~~~~~~~~~~  373 (409)
                      .    .+...+...|.                    ..+.....+...... .  ..........-.+++.+|+..+|.+
T Consensus       249 ~----~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          249 V----MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             H----HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             H----HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            1    11111111111                    000000111100000 0  0001111224577888888888888


Q ss_pred             cccccccCCCCCccccccc
Q 048535          374 SWKFAGSRGHPTFNEINKN  392 (409)
Q Consensus       374 ~~~~~~~~~hp~~~~~~~~  392 (409)
                      |++.++++.||||++++..
T Consensus       325 Rpt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          325 RITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             SCCHHHHTTSGGGGGCCHH
T ss_pred             CcCHHHHhcChhhcCCChh
Confidence            8888888899999987643

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.98  E-value=2.2e-32  Score=266.94  Aligned_cols=175  Identities=17%  Similarity=0.248  Sum_probs=141.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC-----------CCceeeEeeEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-----------HRNLVGLRGWCK  178 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~  178 (409)
                      .++|.+.+.||+|+||.||+|...  ++.||||++... ....+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            367899999999999999999986  899999999753 344567889999999886           899999999987


Q ss_pred             ccC---CeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCeeeC-----
Q 048535          179 KEK---ESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES-KVLHRDIKASNVLLD-----  249 (409)
Q Consensus       179 ~~~---~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlKp~NILl~-----  249 (409)
                      ...   ...++||||+ +++|.+++.... ...+++..+..++.||+.||+|||   +. +|+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCC
Confidence            532   2689999999 889999997632 345999999999999999999999   66 999999999999994     


Q ss_pred             -CCCcEEEecccCcccccCCc-eeeeccccc------cCCCcHHHHHHhhh
Q 048535          250 -KKMNARLGDFGLAKMHHHGQ-VMSGRRPIE------EGKRNLVDRMWSLT  292 (409)
Q Consensus       250 -~~~~~kl~DFGla~~~~~~~-~~~g~~p~~------~~~~~~~~~vws~~  292 (409)
                       .++.+||+|||+++...... ...|...+.      ...++..+|+|+++
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG  222 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTA  222 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHH
T ss_pred             cCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHH
Confidence             44589999999998765432 112222221      24567889999984

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.98  E-value=1.3e-32  Score=272.18  Aligned_cols=265  Identities=21%  Similarity=0.293  Sum_probs=174.2

Q ss_pred             CCc-cceeecCCceEEEEEEEC----CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEc-cCCeEEEEE
Q 048535          115 FSE-ENVIGLGGNGKVYKGQLL----GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK-EKESLILIY  188 (409)
Q Consensus       115 f~~-~~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-~~~~~~lv~  188 (409)
                      |.. .++||+|+||.||+|...    ++.||||++.....  ...+.+|+.+|++++||||+++++++.. .....++||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            444 458999999999999965    67899999975432  2468899999999999999999999864 356799999


Q ss_pred             EeCCCCCHHHHHhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee----CCCCcEEEec
Q 048535          189 DYMENGSLDKWIFEC------DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL----DKKMNARLGD  258 (409)
Q Consensus       189 E~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl----~~~~~~kl~D  258 (409)
                      ||+++ +|.+++...      .....+++..+..++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|
T Consensus       100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            99975 888887532      12235999999999999999999999   7899999999999999    6788999999


Q ss_pred             ccCcccccCCc-------eeeeccccc------c-CCCcHHHHHHhhhccCcHHHHhhHHhhhcCC---------CCHHH
Q 048535          259 FGLAKMHHHGQ-------VMSGRRPIE------E-GKRNLVDRMWSLTERSELLSVLDERLKAKGG---------YADEV  315 (409)
Q Consensus       259 FGla~~~~~~~-------~~~g~~p~~------~-~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~---------~~~~~  315 (409)
                      ||+|+......       ...|...+.      . ..++...|+|+++  ..+++++.......+.         +..+.
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG--~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG--CIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHH--HHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHH--HHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99998764321       122222221      1 3478899999997  4566666554433221         11223


Q ss_pred             HHHHHHHHHHccCcCCC------CCCCHHHHHHHHhcCcC----------CCCCCCCCcchhHHhhhcccCCCCcccccc
Q 048535          316 VEKVLHLGLLCAHPEAN------SRPTIRQVLKMLEGQTE----------GTGLEDEGMNVHLLKRIGTRAMTSSWKFAG  379 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~------~RPt~~evl~~L~~~~~----------~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  379 (409)
                      ...+.+   .+-.+.+.      +.|....+...+.....          ...........+++.+|+..+|.+|+++++
T Consensus       254 l~~i~~---~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          254 LDRIFN---VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHH---HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHH---hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            223222   22222211      12222333222211100          001111233478999999999999999999


Q ss_pred             cCCCCCccccc
Q 048535          380 SRGHPTFNEIN  390 (409)
Q Consensus       380 ~~~hp~~~~~~  390 (409)
                      ++.||||.+..
T Consensus       331 ~L~hp~f~~~~  341 (405)
T 3rgf_A          331 AMQDPYFLEDP  341 (405)
T ss_dssp             HHTSGGGTSSS
T ss_pred             HhcChhhccCC
Confidence            99999998754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.98  E-value=2.7e-32  Score=263.34  Aligned_cols=229  Identities=24%  Similarity=0.270  Sum_probs=162.4

Q ss_pred             hCCCCccc-eeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc---CCeEE
Q 048535          112 TKGFSEEN-VIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE---KESLI  185 (409)
Q Consensus       112 ~~~f~~~~-~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---~~~~~  185 (409)
                      .++|.+.+ .||+|+||.||+|...  ++.||||++... ....++   ....++.++||||+++++++...   ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~e---~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-PKARQE---VDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-HHHHHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-HHHHHH---HHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            46788854 6999999999999997  899999999653 222222   22335667999999999988642   33589


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC---CCcEEEecccCc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK---KMNARLGDFGLA  262 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kl~DFGla  262 (409)
                      +||||+++|+|.+++... ....+++.++..++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            999999999999999753 2346999999999999999999999   789999999999999976   455999999999


Q ss_pred             ccccCCce--eeecc---cc---ccCCCcHHHHHHhhhccCcHHHHhhHHhhh-----------------------cCCC
Q 048535          263 KMHHHGQV--MSGRR---PI---EEGKRNLVDRMWSLTERSELLSVLDERLKA-----------------------KGGY  311 (409)
Q Consensus       263 ~~~~~~~~--~~g~~---p~---~~~~~~~~~~vws~~~~~~~~~~~~~~l~~-----------------------~~~~  311 (409)
                      +.......  ..|..   +.   ....++...|+|+++  ..+++++......                       ....
T Consensus       179 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (336)
T 3fhr_A          179 KETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG--VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE  256 (336)
T ss_dssp             EEC----------------------CHHHHHHHHHHHH--HHHHHHHHSSCCC---------------------CCCTTT
T ss_pred             eeccccccccCCCCcCccChhhhCCCCCCchhhHHHHH--HHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchh
Confidence            86553321  11211   11   124456788999984  2233332221110                       0011


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH--HHhcCcCC
Q 048535          312 ADEVVEKVLHLGLLCAHPEANSRPTIRQVLK--MLEGQTEG  350 (409)
Q Consensus       312 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~  350 (409)
                      .......+.+++.+||+.||++|||+.|+++  .+++....
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  297 (336)
T 3fhr_A          257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV  297 (336)
T ss_dssp             STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGS
T ss_pred             hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccC
Confidence            1234567889999999999999999999987  45544333

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.98  E-value=4.8e-33  Score=266.73  Aligned_cols=224  Identities=24%  Similarity=0.353  Sum_probs=172.6

Q ss_pred             HHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh------HHHHHHHHHHHHhccCC--CCceeeEeeEEEc
Q 048535          110 AATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE------HGMREFLAEVSSLGRLK--HRNLVGLRGWCKK  179 (409)
Q Consensus       110 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~  179 (409)
                      ...++|++.+.||+|+||.||+|...  ++.||||++.....      ...+.+.+|+.++++++  ||||+++++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            34578999999999999999999986  89999999965421      12245778999999995  5999999999987


Q ss_pred             cCCeEEEEEEeCCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC-CCCcEEEe
Q 048535          180 EKESLILIYDYMEN-GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD-KKMNARLG  257 (409)
Q Consensus       180 ~~~~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~-~~~~~kl~  257 (409)
                       .+..++||||+.+ ++|.+++..   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++ +++.+||+
T Consensus       120 -~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          120 -PDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             -SSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             -CCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence             6789999999986 899999964   346899999999999999999999   89999999999999999 78999999


Q ss_pred             cccCcccccCCce--eeecccccc------CC-CcHHHHHHhhhccCcHHHHhhHHhh---------hcCCCCHHHHHHH
Q 048535          258 DFGLAKMHHHGQV--MSGRRPIEE------GK-RNLVDRMWSLTERSELLSVLDERLK---------AKGGYADEVVEKV  319 (409)
Q Consensus       258 DFGla~~~~~~~~--~~g~~p~~~------~~-~~~~~~vws~~~~~~~~~~~~~~l~---------~~~~~~~~~~~~l  319 (409)
                      |||+++.......  ..|...+..      .. .+...|+|+++  ..+++++.....         .....+......+
T Consensus       193 Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG--~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  270 (320)
T 3a99_A          193 DFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG--ILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC  270 (320)
T ss_dssp             CCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHH--HHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHH
T ss_pred             eCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHH--HHHHHHHHCCCCCCChhhhhcccccccccCCHHH
Confidence            9999987654321  122222211      22 36778999985  234444332221         1111223344578


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHH
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+++.+||+.||++|||+.|+++
T Consensus       271 ~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          271 QHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHccCChhhCcCHHHHhc
Confidence            88999999999999999998876

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=4.6e-32  Score=285.63  Aligned_cols=224  Identities=17%  Similarity=0.216  Sum_probs=172.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC---CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCe----
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL---GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES----  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~----  183 (409)
                      .++|++.+.||+|+||.||+|.+.   ++.||||++... .......+.+|+.++++++||||+++++++......    
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999985   789999998654 445567899999999999999999999999864332    


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      .||||||+++++|.+++..     .+++.+++.++.||+.||.|||   +.+|+||||||+|||++.+ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccch
Confidence            7999999999999988732     6999999999999999999999   7899999999999999886 89999999999


Q ss_pred             cccCCceeeecccccc-----CCCcHHHHHHhhhccCcHHHHhhHHhhhc-------CCC--CHHHHHHHHHHHHHccCc
Q 048535          264 MHHHGQVMSGRRPIEE-----GKRNLVDRMWSLTERSELLSVLDERLKAK-------GGY--ADEVVEKVLHLGLLCAHP  329 (409)
Q Consensus       264 ~~~~~~~~~g~~p~~~-----~~~~~~~~vws~~~~~~~~~~~~~~l~~~-------~~~--~~~~~~~l~~l~~~Cl~~  329 (409)
                      .........|...+..     ...+..+|+|+++  ..+++++.......       ...  .......+.+++.+||+.
T Consensus       230 ~~~~~~~~~gt~~y~aPE~~~~~~~~~sDi~slG--~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  307 (681)
T 2pzi_A          230 RINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVG--RTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAIDP  307 (681)
T ss_dssp             ETTCCSCCCCCTTTSCTTHHHHCSCHHHHHHHHH--HHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHHHHHTCS
T ss_pred             hcccCCccCCCccccCHHHHcCCCCCceehhhhH--HHHHHHHhCCCCCcccccccccccccccccCHHHHHHHhhhccC
Confidence            8766544445444322     2347889999996  23344332211100       001  112346789999999999


Q ss_pred             CCCCCCC-HHHHHHHHhc
Q 048535          330 EANSRPT-IRQVLKMLEG  346 (409)
Q Consensus       330 dP~~RPt-~~evl~~L~~  346 (409)
                      ||++||+ ++++...|.+
T Consensus       308 dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          308 DPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             SGGGSCSSHHHHHHHHHH
T ss_pred             ChhhCCCHHHHHHHHHHH
Confidence            9999995 5666665554

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=9e-32  Score=256.64  Aligned_cols=222  Identities=19%  Similarity=0.264  Sum_probs=152.3

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHH-HHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGM-REFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~-~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .++|+..+.||+|+||.||+|...  ++.||||++.... .... +.+.++..+++.++||||+++++++.+ .+..++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-NTDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCcEEEE
Confidence            367888999999999999999996  8999999997652 2233 334455567888899999999999987 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-ceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES-KVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      |||+ ++.+..+...  ....+++..+..++.|+++||.|||   +. +|+||||||+|||++.++.+||+|||+++...
T Consensus       103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  176 (318)
T 2dyl_A          103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV  176 (318)
T ss_dssp             ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence            9999 4466555533  2346899999999999999999999   64 99999999999999999999999999997654


Q ss_pred             CCce---eeecccc-----------ccCCCcHHHHHHhhhccCcHHHHhhH----------------HhhhcCC-C--CH
Q 048535          267 HGQV---MSGRRPI-----------EEGKRNLVDRMWSLTERSELLSVLDE----------------RLKAKGG-Y--AD  313 (409)
Q Consensus       267 ~~~~---~~g~~p~-----------~~~~~~~~~~vws~~~~~~~~~~~~~----------------~l~~~~~-~--~~  313 (409)
                      ....   ..|...+           ....++...|+|+++  ..+++++..                .+..... .  ..
T Consensus       177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG--~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (318)
T 2dyl_A          177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG--ISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHM  254 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHH--HHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSS
T ss_pred             CCccccccCCCccccChhhcccccccccCCccccchhhHH--HHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccC
Confidence            3321   1122111           123456788999984  222222222                1111010 0  11


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .....+.+++.+||+.||.+|||+.|+++
T Consensus       255 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          255 GFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            23456888999999999999999998875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=8.7e-32  Score=259.52  Aligned_cols=174  Identities=19%  Similarity=0.258  Sum_probs=138.7

Q ss_pred             hCCCCccceeecCCceEEEEEEECCcEEEEEEeccCC--------hHHHHHHHHHHHHhccCC---------CCceeeEe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDS--------EHGMREFLAEVSSLGRLK---------HRNLVGLR  174 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l~  174 (409)
                      .++|+..+.||+|+||+||+|++.|+.||||++....        ....+.+.+|+.+++.++         |||||++.
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            3568889999999999999999999999999997542        223467888999888885         77777777


Q ss_pred             eEEE-----------------c------------cCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHH
Q 048535          175 GWCK-----------------K------------EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGI  225 (409)
Q Consensus       175 g~~~-----------------~------------~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL  225 (409)
                      +.+.                 +            .....++|||||++|++.+.+.+    ..+++..+..++.||+.||
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHH
Confidence            6543                 1            15689999999999987776632    4589999999999999999


Q ss_pred             HHHHhcCCCceeecCCCCCCeeeCCCC--------------------cEEEecccCcccccCCceeeeccccc-----cC
Q 048535          226 LYLYEGWESKVLHRDIKASNVLLDKKM--------------------NARLGDFGLAKMHHHGQVMSGRRPIE-----EG  280 (409)
Q Consensus       226 ~yLH~~~~~~ivHrDlKp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~g~~p~~-----~~  280 (409)
                      +|||+  +.+|+||||||+|||++.++                    .+||+|||+|+...... ..|...+.     .+
T Consensus       175 ~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~-~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          175 AVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI-VVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTE-EECCCCTTCSGGGCC
T ss_pred             HHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCc-EEEeecccChhhhcC
Confidence            99993  37899999999999999887                    89999999999876543 23433322     13


Q ss_pred             CCcHHHHHHhhh
Q 048535          281 KRNLVDRMWSLT  292 (409)
Q Consensus       281 ~~~~~~~vws~~  292 (409)
                      ..+...|+|++.
T Consensus       252 ~~~~~~Diwsl~  263 (336)
T 2vuw_A          252 DGDYQFDIYRLM  263 (336)
T ss_dssp             CSSHHHHHHHHH
T ss_pred             CCccceehhhhh
Confidence            347889999973

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=1.3e-31  Score=267.68  Aligned_cols=219  Identities=22%  Similarity=0.270  Sum_probs=159.2

Q ss_pred             CCCccceeecCCceEEEEE-EECCcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          114 GFSEENVIGLGGNGKVYKG-QLLGVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~-~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      .|...+.||+|+||+||.+ ...|+.||||++..+.   .+.+.+|+.+|.++ +|||||++++++.+ ....++|||||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv~E~~   91 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIALELC   91 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEECCC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEEEecC
Confidence            3455688999999999754 4449999999986542   35678999999876 89999999999887 67899999999


Q ss_pred             CCCCHHHHHhcCCCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC-------------CcE
Q 048535          192 ENGSLDKWIFECDESI----ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK-------------MNA  254 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-------------~~~  254 (409)
                      + |+|.+++.......    ..++..+..++.||+.||+|||   +.+|+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 69999996532111    1133456789999999999999   7899999999999999754             489


Q ss_pred             EEecccCcccccCCc--------eeeeccccc-------------cCCCcHHHHHHhhhccCcHHHHhh-HHhhhc----
Q 048535          255 RLGDFGLAKMHHHGQ--------VMSGRRPIE-------------EGKRNLVDRMWSLTERSELLSVLD-ERLKAK----  308 (409)
Q Consensus       255 kl~DFGla~~~~~~~--------~~~g~~p~~-------------~~~~~~~~~vws~~~~~~~~~~~~-~~l~~~----  308 (409)
                      ||+|||+++......        ...|...+.             ...++...|+|+++  ..+++++. ......    
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG--~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG--CVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHH--HHHHHHHTTSCCTTCSTTT
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHH--HHHHHHHhCCCCCCCCchh
Confidence            999999998765432        112222221             13467889999984  22333332 111100    


Q ss_pred             ----------------CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          309 ----------------GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       309 ----------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                                      ..........+.+++.+||+.||.+|||+.|+++
T Consensus       246 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                            0113456678999999999999999999999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=2e-32  Score=283.67  Aligned_cols=224  Identities=22%  Similarity=0.299  Sum_probs=170.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEc-----cCCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKK-----EKES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~-----~~~~  183 (409)
                      .++|++.+.||+|+||.||+|...  |+.||||++... .....+.+.+|+.++++++||||+++++++..     ..+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            378999999999999999999986  889999999765 45566789999999999999999999998753     1456


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc---EEEeccc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN---ARLGDFG  260 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~---~kl~DFG  260 (409)
                      .++||||+++|+|.+++........+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            7899999999999999976554556999999999999999999999   789999999999999997665   9999999


Q ss_pred             CcccccCCcee---eeccc---c---ccCCCcHHHHHHhhhccCcHHHHhhHHhhh------------------------
Q 048535          261 LAKMHHHGQVM---SGRRP---I---EEGKRNLVDRMWSLTERSELLSVLDERLKA------------------------  307 (409)
Q Consensus       261 la~~~~~~~~~---~g~~p---~---~~~~~~~~~~vws~~~~~~~~~~~~~~l~~------------------------  307 (409)
                      +++........   .|...   .   ....++...|+|+++  ..+++++....+.                        
T Consensus       170 ~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLG--viLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG--TLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             CCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHH--HHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             cccccccccccccccCCcccCChHHhccCCCCchhHHHHHH--HHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            99876554321   12211   1   124567789999984  2233333221111                        


Q ss_pred             ---------------cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 048535          308 ---------------KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQV  340 (409)
Q Consensus       308 ---------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ev  340 (409)
                                     ...........+.+++..||+.||++|||+.|+
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence                           011233467789999999999999999999763

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.97  E-value=2.8e-31  Score=264.92  Aligned_cols=219  Identities=23%  Similarity=0.287  Sum_probs=159.9

Q ss_pred             hCCCCccceeecCCceEE-EEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKV-YKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~V-y~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ..+|...+.||+|+||+| |++...++.||||++.....   ..+.+|+.+|+++ +|||||++++++.+ ....|+|||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv~E   98 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKD-RQFQYIAIE   98 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEec-CCEEEEEEE
Confidence            346888899999999984 55666699999999965432   2356899999999 89999999999887 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC-----CCcEEEecccCccc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK-----KMNARLGDFGLAKM  264 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-----~~~~kl~DFGla~~  264 (409)
                      ||+ |+|.+++....  ..+.+..+..++.||+.||.|||   +.+|+||||||+|||++.     ...+||+|||+|+.
T Consensus        99 ~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           99 LCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             CCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             CCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            996 59999997532  33555567899999999999999   789999999999999953     34688999999987


Q ss_pred             ccCCc-------eeeecccc---c------cCCCcHHHHHHhhhccCcHHHHhh-HHhhhc------------------C
Q 048535          265 HHHGQ-------VMSGRRPI---E------EGKRNLVDRMWSLTERSELLSVLD-ERLKAK------------------G  309 (409)
Q Consensus       265 ~~~~~-------~~~g~~p~---~------~~~~~~~~~vws~~~~~~~~~~~~-~~l~~~------------------~  309 (409)
                      .....       ...|...+   +      ...++...|+|+++  ..+++++. ......                  .
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG--~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~  250 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG--CVFYYVISEGSHPFGKSLQRQANILLGACSLDCL  250 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHH--HHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHH--HHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence            65332       11222222   1      13345689999985  23333333 111110                  0


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          310 GYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       310 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .........+.+++.+||+.||.+|||+.|+++
T Consensus       251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            112234456789999999999999999999984

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=4.6e-30  Score=254.79  Aligned_cols=224  Identities=14%  Similarity=0.107  Sum_probs=156.8

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHHHHHHHHhccCCC-Ccee--------------
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREFLAEVSSLGRLKH-RNLV--------------  171 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H-~niv--------------  171 (409)
                      +..|...+.||+|+||.||+|++.  |+.||||++....   ....+.|.+|+.+++.++| +|..              
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            345777889999999999999987  9999999997442   2335789999999999977 3211              


Q ss_pred             -eE------eeEEEcc----CCeEEEEEEeCCCCCHHHHHhcC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 048535          172 -GL------RGWCKKE----KESLILIYDYMENGSLDKWIFEC----DESIALSWEQRIKVLKDVASGILYLYEGWESKV  236 (409)
Q Consensus       172 -~l------~g~~~~~----~~~~~lv~E~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  236 (409)
                       .+      ..++...    ....+++|+++ +|+|.+++...    .....+++..++.++.|+++||+|||   +.+|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence             11      1111110    12356777765 67999988421    23456889999999999999999999   8999


Q ss_pred             eecCCCCCCeeeCCCCcEEEecccCcccccCCc-eeeecccc----------------ccCCCcHHHHHHhhhccCcHHH
Q 048535          237 LHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ-VMSGRRPI----------------EEGKRNLVDRMWSLTERSELLS  299 (409)
Q Consensus       237 vHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-~~~g~~p~----------------~~~~~~~~~~vws~~~~~~~~~  299 (409)
                      +||||||+|||++.++.+||+|||+++...... ...| ..+                ....++...|+|+++  ..+++
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlG--vil~e  309 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLG--LAIYW  309 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHH--HHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHH--HHHHH
Confidence            999999999999999999999999998654321 1222 211                112256789999985  23344


Q ss_pred             HhhHHhhhcCC-----------CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          300 VLDERLKAKGG-----------YADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       300 ~~~~~l~~~~~-----------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ++....+....           .....+..+.+++.+||+.||++|||+.|+++
T Consensus       310 lltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            43322211100           01123467899999999999999999887754

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=2.1e-27  Score=244.35  Aligned_cols=138  Identities=19%  Similarity=0.195  Sum_probs=110.7

Q ss_pred             eeecCCceEEEEEEEC--CcEEEEEEeccC----------ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEE
Q 048535          120 VIGLGGNGKVYKGQLL--GVEVALKRISLD----------SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       120 ~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~----------~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ..+.|++|.+..++..  |+.+|+|.+...          .....++|.+|+++|+++ .|+||+++++++.+ ++..||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~yL  319 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGWL  319 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEEE
Confidence            4566777766665543  899999999653          123456799999999999 79999999999987 789999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||++||+|.++|..   ..+++..   +|+.||+.||+|+|   +++||||||||+||||++++++||+|||+|+...
T Consensus       320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            9999999999999954   3456654   58899999999999   8999999999999999999999999999998765


Q ss_pred             C
Q 048535          267 H  267 (409)
Q Consensus       267 ~  267 (409)
                      .
T Consensus       391 ~  391 (569)
T 4azs_A          391 Q  391 (569)
T ss_dssp             -
T ss_pred             C
Confidence            4

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=5.4e-25  Score=225.21  Aligned_cols=135  Identities=19%  Similarity=0.268  Sum_probs=107.6

Q ss_pred             CccceeecCCceEEEEEEECCcEEEEEEeccCC--------hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          116 SEENVIGLGGNGKVYKGQLLGVEVALKRISLDS--------EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       116 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ...+.||+|+||.||+|...+..+|+|+.....        ....+.|.+|+++|++++||||+++..++.. .+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-LDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-TTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-CCccEEE
Confidence            446789999999999998889999999874331        1124568999999999999999965555555 4566999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+++|+|.+++..           +..++.|+++||.|||   +++|+||||||+|||++.  ++||+|||+|+....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999943           5689999999999999   899999999999999998  999999999987654

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.91  E-value=1.3e-24  Score=204.54  Aligned_cols=142  Identities=16%  Similarity=0.179  Sum_probs=114.9

Q ss_pred             HHHHHHhCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCCh------------------HHHHHHHHHHHHhccCC
Q 048535          106 QEIHAATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSE------------------HGMREFLAEVSSLGRLK  166 (409)
Q Consensus       106 ~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~  166 (409)
                      ..+......|...+.||+|+||.||+|.+. |+.||+|.++....                  .....+.+|+.+|++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344444566777899999999999999996 89999999964321                  23567899999999999


Q ss_pred             CCceeeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 048535          167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNV  246 (409)
Q Consensus       167 H~niv~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NI  246 (409)
                        | +++.+++..  +..++||||+++|+|.+ +.   .      .....++.|++.||.|||   +.+|+||||||+||
T Consensus       163 --~-~~v~~~~~~--~~~~lvmE~~~g~~L~~-l~---~------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NI  224 (282)
T 1zar_A          163 --G-LAVPKVYAW--EGNAVLMELIDAKELYR-VR---V------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNV  224 (282)
T ss_dssp             --T-SSSCCEEEE--ETTEEEEECCCCEEGGG-CC---C------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSE
T ss_pred             --C-CCcCeEEec--cceEEEEEecCCCcHHH-cc---h------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHE
Confidence              5 666665543  44689999999999998 51   1      124479999999999999   89999999999999


Q ss_pred             eeCCCCcEEEecccCccccc
Q 048535          247 LLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       247 Ll~~~~~~kl~DFGla~~~~  266 (409)
                      |++ ++.+||+|||+|+...
T Consensus       225 Ll~-~~~vkl~DFG~a~~~~  243 (282)
T 1zar_A          225 LVS-EEGIWIIDFPQSVEVG  243 (282)
T ss_dssp             EEE-TTEEEECCCTTCEETT
T ss_pred             EEE-CCcEEEEECCCCeECC
Confidence            999 9999999999997543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=6.3e-22  Score=183.72  Aligned_cols=137  Identities=19%  Similarity=0.229  Sum_probs=106.7

Q ss_pred             CCccceeecCCceEEEEEEE--CCcE--EEEEEeccCCh------------------------HHHHHHHHHHHHhccCC
Q 048535          115 FSEENVIGLGGNGKVYKGQL--LGVE--VALKRISLDSE------------------------HGMREFLAEVSSLGRLK  166 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~--~~~~--vAvK~~~~~~~------------------------~~~~~~~~E~~~l~~l~  166 (409)
                      |.+.+.||+|+||.||+|..  .|+.  ||||+++....                        .....+.+|+.+|.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999998  4888  99998754311                        11236889999999998


Q ss_pred             CCce--eeEeeEEEccCCeEEEEEEeCCC-C----CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeec
Q 048535          167 HRNL--VGLRGWCKKEKESLILIYDYMEN-G----SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHR  239 (409)
Q Consensus       167 H~ni--v~l~g~~~~~~~~~~lv~E~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr  239 (409)
                      |+|+  ..++++     ...+|||||+.+ |    +|.++...      .++..+..++.|++.||.|||.  ..+|+||
T Consensus       129 ~~~i~~p~~~~~-----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~--~~givHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY-----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQ--EAELVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE-----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHH--TSCEECS
T ss_pred             hCCCCCCeEEEc-----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHH--HCCEEeC
Confidence            8864  344432     235799999942 4    67776522      2345678899999999999995  4799999


Q ss_pred             CCCCCCeeeCCCCcEEEecccCccccc
Q 048535          240 DIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       240 DlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      ||||+|||++.  .++|+|||+|....
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             CCCHHHEEEcC--cEEEEECcccccCC
Confidence            99999999998  89999999997653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=8.5e-19  Score=170.15  Aligned_cols=139  Identities=14%  Similarity=0.148  Sum_probs=100.0

Q ss_pred             CCCccceeecCCceEEEEEEEC-CcEEEEEEeccCCh--------------HHHH--------HHHHHHHHhccCCCCce
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSE--------------HGMR--------EFLAEVSSLGRLKHRNL  170 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~--------------~~~~--------~~~~E~~~l~~l~H~ni  170 (409)
                      -|++.+.||+|+||.||+|... |+.||||+++....              ....        ...+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3889999999999999999987 99999998753200              0001        12356667777754443


Q ss_pred             eeEeeEEEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC
Q 048535          171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK  250 (409)
Q Consensus       171 v~l~g~~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~  250 (409)
                      .-..-+...   ..+|||||+++++|.++..       .  .....++.|++.+|.|||   ..+||||||||.|||+++
T Consensus       176 ~vp~p~~~~---~~~LVME~i~G~~L~~l~~-------~--~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          176 PVPEPIAQS---RHTIVMSLVDALPMRQVSS-------V--PDPASLYADLIALILRLA---KHGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             SCCCEEEEE---TTEEEEECCSCEEGGGCCC-------C--SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEE
T ss_pred             CCCeeeecc---CceEEEEecCCccHhhhcc-------c--HHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeC
Confidence            211111111   2269999999999876541       1  123568899999999999   789999999999999988


Q ss_pred             CC----------cEEEecccCcccccC
Q 048535          251 KM----------NARLGDFGLAKMHHH  267 (409)
Q Consensus       251 ~~----------~~kl~DFGla~~~~~  267 (409)
                      ++          .+.|+||+-+-...+
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~~h  267 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSMDH  267 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred             CCCcccccccccceEEEEeCCcccCCC
Confidence            76          389999997765443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.50  E-value=5.2e-14  Score=130.06  Aligned_cols=147  Identities=13%  Similarity=-0.019  Sum_probs=114.9

Q ss_pred             HHHhCCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeEeeEEEccCCeEEEE
Q 048535          109 HAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       109 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~lv  187 (409)
                      .....+|.....++.|+.+.||+....+..+++|............+.+|+++++.+. +.++.++++++.. .+..|+|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCceEEE
Confidence            3445678888888989999999998778899999987532122345889999999884 6778889998876 6788999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW-----------------------------------  232 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----------------------------------  232 (409)
                      |||++|.+|.+.+.        +......++.+++++|..||...                                   
T Consensus        89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            99999999987641        11223478899999999999610                                   


Q ss_pred             ---------------------CCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          233 ---------------------ESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       233 ---------------------~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                                           ...++|+|++|.|||++++..+.|.||+.+..
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                 14599999999999998766667999998854

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.30  E-value=3.3e-12  Score=117.23  Aligned_cols=137  Identities=13%  Similarity=0.045  Sum_probs=99.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCc--eeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN--LVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++......+.|..+.||+.... |..+++|.....   ....+..|+.+++.+.+.+  +.+++++... .+..++|||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-~~~~~~v~e   95 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLG   95 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEE
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-CCCCEEEEE
Confidence            44544333345666999999776 678999997644   2245778999999885445  4568887765 567899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW-------------------------------------  232 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------  232 (409)
                      |++|.+|.  ..   .   .+   ...++.++++.|..||...                                     
T Consensus        96 ~i~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           96 EVPGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             CCSSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             ecCCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            99998884  21   1   11   2367788888888888531                                     


Q ss_pred             ------------------CCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          233 ------------------ESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       233 ------------------~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                                        ...++|+|++|.|||++++..+.|.|||.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                              11299999999999998876677999999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.26  E-value=1.5e-11  Score=118.94  Aligned_cols=143  Identities=12%  Similarity=0.137  Sum_probs=108.6

Q ss_pred             ccceeecCCceEEEEEEECCcEEEEEEec--cCC-hHHHHHHHHHHHHhccCC--CCceeeEeeEEEccC--CeEEEEEE
Q 048535          117 EENVIGLGGNGKVYKGQLLGVEVALKRIS--LDS-EHGMREFLAEVSSLGRLK--HRNLVGLRGWCKKEK--ESLILIYD  189 (409)
Q Consensus       117 ~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~--~~~~lv~E  189 (409)
                      ..+.|+.|.++.||+....+..+++|+..  ... ......+.+|+.+++.+.  +.++.++++++.+..  +..++|||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            45778999999999998888889999876  332 122356788999999886  456788898886531  34789999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW-------------------------------------  232 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------  232 (409)
                      |++|..+.+..     -..++..++..++.++++.|..||...                                     
T Consensus       122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99998775421     124788889999999999999999620                                     


Q ss_pred             ------------------CCceeecCCCCCCeeeCCCCc--EEEecccCccc
Q 048535          233 ------------------ESKVLHRDIKASNVLLDKKMN--ARLGDFGLAKM  264 (409)
Q Consensus       233 ------------------~~~ivHrDlKp~NILl~~~~~--~kl~DFGla~~  264 (409)
                                        ...++|+|+++.|||++.++.  +.|.||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              257999999999999997753  68999999875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.72  E-value=3.4e-08  Score=92.97  Aligned_cols=138  Identities=17%  Similarity=0.171  Sum_probs=100.6

Q ss_pred             cceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCc--eeeEeeEEEccC--CeEEEEEEeCC
Q 048535          118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRN--LVGLRGWCKKEK--ESLILIYDYME  192 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~l~g~~~~~~--~~~~lv~E~~~  192 (409)
                      .+.++.|....||+..   ..+++|....  ......+.+|+++|+.+ .+..  +.+++.......  ...|+|||+++
T Consensus        25 i~~~~~G~~n~v~~v~---~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN---RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST---TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC---CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            4568999999999863   5688998653  23456788999999887 3333  334544433211  13478999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGW----------------------------------------  232 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------  232 (409)
                      |.+|.+...     ..++..++..++.++++.|..||...                                        
T Consensus       100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            988865432     24778888889999999999998510                                        


Q ss_pred             ---------------CCceeecCCCCCCeeeCC--CCcEEEecccCcccc
Q 048535          233 ---------------ESKVLHRDIKASNVLLDK--KMNARLGDFGLAKMH  265 (409)
Q Consensus       233 ---------------~~~ivHrDlKp~NILl~~--~~~~kl~DFGla~~~  265 (409)
                                     ...++|+|++|.|||+++  ...+.|.||+.+...
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                           145899999999999998  456889999998654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.69  E-value=1.6e-07  Score=88.63  Aligned_cols=137  Identities=16%  Similarity=0.130  Sum_probs=98.1

Q ss_pred             cceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCC---ceeeEeeEEEccCCeEEEEEEeCCCC
Q 048535          118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHR---NLVGLRGWCKKEKESLILIYDYMENG  194 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~g~~~~~~~~~~lv~E~~~~g  194 (409)
                      .+.++.|....||+.   +..+++|+..  .......+..|.++|..+.+.   .+.+.+.++....+..++||||++|.
T Consensus        24 v~~l~~G~~n~v~~v---g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEEECSSEEEEEE---TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eeecCCCcceeEEEE---CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            456888999999987   6778898853  234456788999999998642   35566776653356678999999998


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 048535          195 SLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG-------------------------------------------  231 (409)
Q Consensus       195 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------  231 (409)
                      +|.+...     ..++..+...++.++++.|..||..                                           
T Consensus        99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            8866321     1245555566666666666666642                                           


Q ss_pred             --------------CCCceeecCCCCCCeeeCC---CCc-EEEecccCccc
Q 048535          232 --------------WESKVLHRDIKASNVLLDK---KMN-ARLGDFGLAKM  264 (409)
Q Consensus       232 --------------~~~~ivHrDlKp~NILl~~---~~~-~kl~DFGla~~  264 (409)
                                    ....++|+|++|.|||++.   ++. ..|.||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          1335799999999999987   455 48999998865

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B

Probab=98.62  E-value=1.5e-08  Score=68.19  Aligned_cols=26  Identities=42%  Similarity=0.874  Sum_probs=24.5

Q ss_pred             CEEEeeccCCCcccceEEEEEEEecC
Q 048535            1 MHVGFSAGTGQLVESHKILAWSFSNS   26 (409)
Q Consensus         1 ~~~~f~~~~~~~~~~~~~~~~~f~~~   26 (409)
                      |||||||+||...+.|+|++|+|+.+
T Consensus        20 v~VGFSAsTG~~~~~h~IlsWsF~s~   45 (52)
T 2ltn_B           20 VRIGFSATTGAEYAAHEVLSWSFHSE   45 (52)
T ss_dssp             EEEEEEEECCSSCCEEEEEEEEEEEE
T ss_pred             EEEEEEeccCCcceeEEEEEeEEEee
Confidence            79999999999999999999999864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.56  E-value=5.8e-07  Score=82.74  Aligned_cols=142  Identities=16%  Similarity=0.116  Sum_probs=99.4

Q ss_pred             HhCCCCccceeecCCce-EEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeEeeEEEccCCeEEE
Q 048535          111 ATKGFSEENVIGLGGNG-KVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg-~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~l  186 (409)
                      ...+|+. +.+..|..| .||+-...  +..+.+|+-...   ....+.+|...|+.+. +--+-++++++.+ .+..++
T Consensus        23 ~l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-~~~~~l   97 (272)
T 4gkh_A           23 DLYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRT-PDDAWL   97 (272)
T ss_dssp             HHTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEE
T ss_pred             cccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEE-CCeEEE
Confidence            3344543 345555555 68987665  567899986533   3456788999988773 3336678888876 678899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG-----------------------------------  231 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----------------------------------  231 (409)
                      |||++++.++.+....       .......++.++++.|..||..                                   
T Consensus        98 vme~l~G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (272)
T 4gkh_A           98 LTTAIPGKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE  170 (272)
T ss_dssp             EEECCCSEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred             EEEeeCCccccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence            9999999888776532       1123345666777777777741                                   


Q ss_pred             --------------------CCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          232 --------------------WESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       232 --------------------~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                                          ....++|+|+.+.|||+++++.+-|.||+.+..
T Consensus       171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                012389999999999999877777999999864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.41  E-value=4.7e-07  Score=87.01  Aligned_cols=80  Identities=8%  Similarity=-0.013  Sum_probs=54.9

Q ss_pred             ccee-ecCCceEEEEEEEC--------CcEEEEEEeccCC---hHHHHHHHHHHHHhccCC-C--CceeeEeeEEEccC-
Q 048535          118 ENVI-GLGGNGKVYKGQLL--------GVEVALKRISLDS---EHGMREFLAEVSSLGRLK-H--RNLVGLRGWCKKEK-  181 (409)
Q Consensus       118 ~~~l-G~G~fg~Vy~~~~~--------~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~-  181 (409)
                      .+.| +.|....+|+....        +..+++|......   ......+.+|+.+++.+. +  -.+.++++++.+.. 
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 78888999998765        6788999865432   001245678888888884 3  34667887775422 


Q ss_pred             -CeEEEEEEeCCCCCHH
Q 048535          182 -ESLILIYDYMENGSLD  197 (409)
Q Consensus       182 -~~~~lv~E~~~~gsL~  197 (409)
                       +..++||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999986654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.20  E-value=1.1e-05  Score=76.51  Aligned_cols=142  Identities=19%  Similarity=0.214  Sum_probs=81.2

Q ss_pred             ceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccC-----CCCceeeEe-e-EEEccCCeEEEEEEeC
Q 048535          119 NVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRL-----KHRNLVGLR-G-WCKKEKESLILIYDYM  191 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~-g-~~~~~~~~~~lv~E~~  191 (409)
                      +.|+.|..+.||+....+..+++|+.... .   ..+..|..++..|     ..|.++... | .+....+..+++|||+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             EECC----CEEEEEEETTEEEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eeccccccCcEEEEEeCCCCEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            45666778999999887667999998753 2   2233445555444     234444311 1 1111245788999999


Q ss_pred             CCCCHH--------------HHHhcCCC----C-------CCCCHHHHH-------------------------------
Q 048535          192 ENGSLD--------------KWIFECDE----S-------IALSWEQRI-------------------------------  215 (409)
Q Consensus       192 ~~gsL~--------------~~l~~~~~----~-------~~l~~~~~~-------------------------------  215 (409)
                      +|..+.              ..+|....    .       ..-.|....                               
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            986542              11221100    0       011232210                               


Q ss_pred             HHHHHHHHHHHHHHh----------cCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          216 KVLKDVASGILYLYE----------GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       216 ~i~~~ia~gL~yLH~----------~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      .+..++..++.+|+.          .....++|+|+.+.|||++.++.+.|.||+.+..
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            111224446666753          1257899999999999998888899999998854

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.09  E-value=1e-05  Score=78.91  Aligned_cols=74  Identities=14%  Similarity=-0.002  Sum_probs=48.6

Q ss_pred             cceeecCCceEEEEEEEC--CcEEEEEEeccCCh-------HHHHHHHHHHHHhccCCC--Cc-eeeEeeEEEccCCeEE
Q 048535          118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE-------HGMREFLAEVSSLGRLKH--RN-LVGLRGWCKKEKESLI  185 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~n-iv~l~g~~~~~~~~~~  185 (409)
                      .+.||.|.++.||++...  ++.++||.......       .....+..|.++|+.+..  +. +.+++.+.   .+..+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d---~~~~~  111 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD---TEMAV  111 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE---TTTTE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc---CCccE
Confidence            467999999999999654  68899998653211       122456778888887732  33 44555432   23457


Q ss_pred             EEEEeCCCC
Q 048535          186 LIYDYMENG  194 (409)
Q Consensus       186 lv~E~~~~g  194 (409)
                      +||||+++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=98.05  E-value=1.6e-06  Score=70.56  Aligned_cols=26  Identities=46%  Similarity=0.773  Sum_probs=24.6

Q ss_pred             CEEEeeccCCCcccceEEEEEEEecC
Q 048535            1 MHVGFSAGTGQLVESHKILAWSFSNS   26 (409)
Q Consensus         1 ~~~~f~~~~~~~~~~~~~~~~~f~~~   26 (409)
                      |||||||+||...+.|+|++|+|+++
T Consensus        88 v~VGFSAsTG~~~~~h~IlsWsF~s~  113 (133)
T 1qmo_E           88 VRVGLSASTGQDKERNTVHSWSFTSS  113 (133)
T ss_dssp             EEEEEEEECSSSCCEEEEEEEEEEEE
T ss_pred             EEEEEEeccCCCcceeEEEEEEEEee
Confidence            79999999999999999999999875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.02  E-value=3.4e-05  Score=72.74  Aligned_cols=139  Identities=12%  Similarity=0.065  Sum_probs=93.4

Q ss_pred             ccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCC---CCceeeEeeEEEccCCeEEEEEEeCCC
Q 048535          117 EENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLK---HRNLVGLRGWCKKEKESLILIYDYMEN  193 (409)
Q Consensus       117 ~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~g~~~~~~~~~~lv~E~~~~  193 (409)
                      ..+.|+.|....+|+....+..+++|+....   ....|..|.+.|+.|.   ...+.++++++.. .+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEEEeccC
Confidence            3467899999999998877888999987643   3466889999988883   3567888888776 5678999999998


Q ss_pred             CCHH--------H---HHhcCCC--CC-----------------CCCHHHHH---HHHH----------------HHHHH
Q 048535          194 GSLD--------K---WIFECDE--SI-----------------ALSWEQRI---KVLK----------------DVASG  224 (409)
Q Consensus       194 gsL~--------~---~l~~~~~--~~-----------------~l~~~~~~---~i~~----------------~ia~g  224 (409)
                      ..+.        +   -||....  ..                 .-+|....   ++..                .++..
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            7642        1   1333221  00                 12454322   1111                11111


Q ss_pred             H-HHHHh-cCCCceeecCCCCCCeeeCCCCcEEEeccc
Q 048535          225 I-LYLYE-GWESKVLHRDIKASNVLLDKKMNARLGDFG  260 (409)
Q Consensus       225 L-~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kl~DFG  260 (409)
                      + ..|.. .....++|+|+.+.|++++.++ +.|.||.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 23421 2257899999999999999887 8899984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.87  E-value=6.4e-05  Score=73.86  Aligned_cols=32  Identities=13%  Similarity=0.269  Sum_probs=28.6

Q ss_pred             CCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       233 ~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      ...++|+|++|.|||++.++ ++|.||+.+...
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            68899999999999998876 999999998753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.69  E-value=0.00013  Score=67.57  Aligned_cols=77  Identities=18%  Similarity=0.228  Sum_probs=54.9

Q ss_pred             CCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCC-C--CceeeEeeEEEccCCeEEEEEEe
Q 048535          115 FSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLK-H--RNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       115 f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      ....+.+|.|..+.||+.+.. |+.|.+|+...........|..|++.|+.|. .  --+.+++++.   .  -++||||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---~--~~lv~e~   91 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---D--RTLAMEW   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---T--TEEEEEC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---C--ceEEEEe
Confidence            444678999999999999987 8999999876544333346788999888773 2  1244555532   2  2689999


Q ss_pred             CCCCCH
Q 048535          191 MENGSL  196 (409)
Q Consensus       191 ~~~gsL  196 (409)
                      ++.+..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.57  E-value=0.00043  Score=64.99  Aligned_cols=159  Identities=13%  Similarity=0.065  Sum_probs=88.6

Q ss_pred             ccHHHHHHHhCCCCc-----cceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCc--eeeEee
Q 048535          103 VSYQEIHAATKGFSE-----ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN--LVGLRG  175 (409)
Q Consensus       103 ~~~~~l~~~~~~f~~-----~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~g  175 (409)
                      ++.+++......|..     .+.|+.|....+|+....+..+++|......  ....+..|+.++..+...+  +.+++.
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~   84 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   84 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence            455566666555654     2456778889999998775578899886521  1134456777776663212  223332


Q ss_pred             E------EEccCCeEEEEEEeCCCCCHHH--------------HHhcCC----CC-----CCCCHHHHHH----------
Q 048535          176 W------CKKEKESLILIYDYMENGSLDK--------------WIFECD----ES-----IALSWEQRIK----------  216 (409)
Q Consensus       176 ~------~~~~~~~~~lv~E~~~~gsL~~--------------~l~~~~----~~-----~~l~~~~~~~----------  216 (409)
                      .      ... .+..+++|+|++|..+..              -+|...    ..     ....|.....          
T Consensus        85 ~~~g~~~~~~-~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           85 RKDGELLGEL-SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             BTTCCSCEEE-TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCEEEEE-CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            1      111 356789999999854311              122110    00     0012322111          


Q ss_pred             --HHHHHHHHHHHHHhc----CCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          217 --VLKDVASGILYLYEG----WESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       217 --i~~~ia~gL~yLH~~----~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                        +...+.+.++++...    ....++|+|+.+.|||++++..+.|.||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              011244455566532    135799999999999998876668999998854

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=97.54  E-value=3e-05  Score=69.67  Aligned_cols=26  Identities=46%  Similarity=0.851  Sum_probs=24.6

Q ss_pred             CEEEeeccCCCcccceEEEEEEEecC
Q 048535            1 MHVGFSAGTGQLVESHKILAWSFSNS   26 (409)
Q Consensus         1 ~~~~f~~~~~~~~~~~~~~~~~f~~~   26 (409)
                      |||||||+||...+.|+|++|+|+.+
T Consensus        89 ~~VGFSAsTG~~~~~h~IlsWsF~s~  114 (237)
T 1nls_A           89 VRVGLSASTGLYKETNTILSWSFTSK  114 (237)
T ss_dssp             EEEEEEEECSSSCCCCEEEEEEEEEE
T ss_pred             cEEEEEeccCCcceeeeeEEEEEEec
Confidence            79999999999999999999999875

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.44  E-value=0.0004  Score=64.77  Aligned_cols=138  Identities=12%  Similarity=0.048  Sum_probs=74.4

Q ss_pred             cceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeEeeEEEccCCeEEEEEEeC-CCCC
Q 048535          118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL-VGLRGWCKKEKESLILIYDYM-ENGS  195 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~lv~E~~-~~gs  195 (409)
                      .+.|+.|....+|+.    ..+.+|+....... .....+|+.+++.+...++ .++++++   ...-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~---~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD---PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC---TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE---CCCCEEEEeecCCCcc
Confidence            678999999999998    56888887643211 1122467777776632222 3555443   22336899999 5544


Q ss_pred             HHH------------------HHhcCCCC--CCCC-HHHHHHHHHH--------------HHHHHH----HHHh-cCCCc
Q 048535          196 LDK------------------WIFECDES--IALS-WEQRIKVLKD--------------VASGIL----YLYE-GWESK  235 (409)
Q Consensus       196 L~~------------------~l~~~~~~--~~l~-~~~~~~i~~~--------------ia~gL~----yLH~-~~~~~  235 (409)
                      |..                  -+|.....  .... +.....+...              +.+.+.    .+.. .....
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            321                  01111110  0011 1111111110              111111    1111 12456


Q ss_pred             eeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          236 VLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       236 ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++|+|+.+.||| ..++.+.|.||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5667789999998864

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.30  E-value=0.0011  Score=62.51  Aligned_cols=142  Identities=15%  Similarity=0.094  Sum_probs=73.5

Q ss_pred             ceeecCCceE-EEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCC--CceeeEeeEEEccCCeEEEEEEeCCCC
Q 048535          119 NVIGLGGNGK-VYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKH--RNLVGLRGWCKKEKESLILIYDYMENG  194 (409)
Q Consensus       119 ~~lG~G~fg~-Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~~lv~E~~~~g  194 (409)
                      +.|+.|.... +|+.... +..+++|.......   ..+..|+.++..+..  -.+.+++.+..+ .+  +++||++.+.
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~-~g--~ll~e~l~~~   97 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA-RG--LLLIEDLGDA   97 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT-TT--EEEECCCCSC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC-CC--EEEEeeCCCc
Confidence            4465555444 6677764 77788876543321   223456666666532  234556665433 33  6899999876


Q ss_pred             CHHHHHhcC---------------------CCC--CCCCHHHHH-------H-------------HHHHHHHHHHHHH--
Q 048535          195 SLDKWIFEC---------------------DES--IALSWEQRI-------K-------------VLKDVASGILYLY--  229 (409)
Q Consensus       195 sL~~~l~~~---------------------~~~--~~l~~~~~~-------~-------------i~~~ia~gL~yLH--  229 (409)
                      .+.+++...                     ...  ..++.....       .             ....+...+..+.  
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            665443211                     000  011111100       0             0001112222221  


Q ss_pred             -hcCCCceeecCCCCCCeeeCCC----CcEEEecccCccccc
Q 048535          230 -EGWESKVLHRDIKASNVLLDKK----MNARLGDFGLAKMHH  266 (409)
Q Consensus       230 -~~~~~~ivHrDlKp~NILl~~~----~~~kl~DFGla~~~~  266 (409)
                       ......++|+|+.+.|||++.+    ..+.|.||+.+....
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence             1125689999999999999875    679999999987543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.19  E-value=0.0041  Score=58.36  Aligned_cols=142  Identities=13%  Similarity=0.128  Sum_probs=80.0

Q ss_pred             ceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCC--ceeeEeeE-----EEccCCeEEEEEEe
Q 048535          119 NVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHR--NLVGLRGW-----CKKEKESLILIYDY  190 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~g~-----~~~~~~~~~lv~E~  190 (409)
                      ..++ |....||+.... |+.+++|...... .....+..|..++..+...  .+.+++..     ... .+..+++|||
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~-~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNH-QGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEE-TTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEE-CCEEEEEEEe
Confidence            4566 778899988765 6689999986331 1234566677777766321  23444432     111 3466889999


Q ss_pred             CCCCCHH-----H------H---HhcC----C--CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc
Q 048535          191 MENGSLD-----K------W---IFEC----D--ESIALSWEQR----IKV---------------LKDVASGILYLYEG  231 (409)
Q Consensus       191 ~~~gsL~-----~------~---l~~~----~--~~~~l~~~~~----~~i---------------~~~ia~gL~yLH~~  231 (409)
                      ++|..+.     .      .   +|..    .  ....+++...    ..+               ...+...++.+...
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9875431     1      1   1111    0  0111222211    001               01111222333211


Q ss_pred             ----CCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          232 ----WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       232 ----~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                          ....++|+|+++.|||++ + .+.|.||+.+...
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence                246789999999999999 4 8999999988653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.18  E-value=0.00075  Score=66.44  Aligned_cols=71  Identities=18%  Similarity=0.128  Sum_probs=48.0

Q ss_pred             cceeecCCceEEEEEEEC---------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeEeeEEEccCCeEEEE
Q 048535          118 ENVIGLGGNGKVYKGQLL---------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL-VGLRGWCKKEKESLILI  187 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~lv  187 (409)
                      .+.|+.|....+|+....         +..+.+|+......  ...+..|..++..+...++ .++++.+.  +   .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~---g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G---GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T---EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C---CEE
Confidence            356788888999999875         47899998743211  1445679998888843333 56676543  2   279


Q ss_pred             EEeCCCCC
Q 048535          188 YDYMENGS  195 (409)
Q Consensus       188 ~E~~~~gs  195 (409)
                      +||+++.+
T Consensus       151 ~e~l~G~~  158 (429)
T 1nw1_A          151 EEYIPSRP  158 (429)
T ss_dssp             ECCCCEEE
T ss_pred             EEEeCCcc
Confidence            99998633

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.94  E-value=0.0015  Score=62.65  Aligned_cols=71  Identities=10%  Similarity=0.074  Sum_probs=42.4

Q ss_pred             ceeecCCceEEEEEEECC----------cEEEEEEeccCChHHHHHHHHHHHHhccCCCCc-eeeEeeEEEccCCeEEEE
Q 048535          119 NVIGLGGNGKVYKGQLLG----------VEVALKRISLDSEHGMREFLAEVSSLGRLKHRN-LVGLRGWCKKEKESLILI  187 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~~----------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~~lv  187 (409)
                      +.|+.|....+|+....+          ..+.+|+....... ......|..+++.+...+ +.++++..   .+  ++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~---~~--~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF---NG--GRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE---TT--EEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec---CC--cEE
Confidence            567778888999988763          68888887543221 112357888887774333 33566543   22  579


Q ss_pred             EEeCCCCC
Q 048535          188 YDYMENGS  195 (409)
Q Consensus       188 ~E~~~~gs  195 (409)
                      |||++|..
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.90  E-value=0.0033  Score=60.68  Aligned_cols=140  Identities=18%  Similarity=0.155  Sum_probs=82.5

Q ss_pred             ceeecCCceEEEEEEEC---------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCc-eeeEeeEEEccCCeEEEEE
Q 048535          119 NVIGLGGNGKVYKGQLL---------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN-LVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~~lv~  188 (409)
                      +.|..|-...+|+....         +..+.+|+.... ......+.+|..+++.|.-.+ ..++++++.+     .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-----g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE-----GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-----EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-----ccEE
Confidence            55767778889998764         368899886322 123455668999988874222 3566665532     2899


Q ss_pred             EeCCCCCHHH--------------H---HhcCCC--CCCC--CHHHHHHHHHHHHH-------------------HHHHH
Q 048535          189 DYMENGSLDK--------------W---IFECDE--SIAL--SWEQRIKVLKDVAS-------------------GILYL  228 (409)
Q Consensus       189 E~~~~gsL~~--------------~---l~~~~~--~~~l--~~~~~~~i~~~ia~-------------------gL~yL  228 (409)
                      ||++|..|..              .   ||....  ....  -|.++.++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            9999855431              0   122111  1112  24555555544422                   23333


Q ss_pred             Hh-----cCCCceeecCCCCCCeeeCCC----CcEEEecccCccc
Q 048535          229 YE-----GWESKVLHRDIKASNVLLDKK----MNARLGDFGLAKM  264 (409)
Q Consensus       229 H~-----~~~~~ivHrDlKp~NILl~~~----~~~kl~DFGla~~  264 (409)
                      ..     .....++|+|+.+.|||++.+    +.+.|.||..|..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            21     124579999999999999876    6899999999864

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.86  E-value=0.0036  Score=62.04  Aligned_cols=73  Identities=12%  Similarity=0.066  Sum_probs=46.8

Q ss_pred             cceeecCCceEEEEEEECC--cEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeEeeEEEccCCeEEEEEEeCCCC
Q 048535          118 ENVIGLGGNGKVYKGQLLG--VEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL-VGLRGWCKKEKESLILIYDYMENG  194 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~~--~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~lv~E~~~~g  194 (409)
                      .+.|+.|-...+|+....+  ..+.+|+........ -.-..|..++..|...++ .++++.+.  ++   +||||+++.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~G---~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--NG---RIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--TE---EEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce---EEEEeeCCc
Confidence            4578888889999998875  789999874332111 111478888888854444 46777652  22   599999874


Q ss_pred             CH
Q 048535          195 SL  196 (409)
Q Consensus       195 sL  196 (409)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            43

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.39  E-value=0.032  Score=52.79  Aligned_cols=33  Identities=24%  Similarity=0.325  Sum_probs=28.9

Q ss_pred             CCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          233 ESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       233 ~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      ...++|+|+.+.|||++.++.+.|.||+.+...
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            357999999999999998888999999887653

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=95.63  E-value=0.011  Score=37.75  Aligned_cols=28  Identities=14%  Similarity=0.128  Sum_probs=12.1

Q ss_pred             eEehhhHHHHHHHHHHHHHHhhhhhccC
Q 048535           55 FILGVSVGGLLIMGCGVVVYMVCLKRKG   82 (409)
Q Consensus        55 ~i~~~~~~~~~~~~~~~~~~~~~~~r~~   82 (409)
                      ++.+++.|.+++++++.+++++.+||+.
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            3444444444444444443444444443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=95.28  E-value=0.011  Score=37.68  Aligned_cols=28  Identities=14%  Similarity=0.214  Sum_probs=12.1

Q ss_pred             EehhhHH-HHHHHHHHHHHHhhhhhccCC
Q 048535           56 ILGVSVG-GLLIMGCGVVVYMVCLKRKGK   83 (409)
Q Consensus        56 i~~~~~~-~~~~~~~~~~~~~~~~~r~~~   83 (409)
                      |++.++| .+++++++.+.+++++||+++
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            4444444 444444444434444444433

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=95.13  E-value=0.013  Score=37.21  Aligned_cols=29  Identities=34%  Similarity=0.445  Sum_probs=14.7

Q ss_pred             eEehhhHHHHHHHHHHHHHHhhhhhccCC
Q 048535           55 FILGVSVGGLLIMGCGVVVYMVCLKRKGK   83 (409)
Q Consensus        55 ~i~~~~~~~~~~~~~~~~~~~~~~~r~~~   83 (409)
                      .|++.++|++++++++.+++++.+||+.+
T Consensus        13 ~Ia~~vVGvll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           13 SIISAVVGILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred             chHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence            45666667554444444444444444433

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.87  E-value=0.075  Score=51.93  Aligned_cols=140  Identities=13%  Similarity=0.145  Sum_probs=83.3

Q ss_pred             cceeecCCceEEEEEEEC---------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCc-eeeEeeEEEccCCeEEEE
Q 048535          118 ENVIGLGGNGKVYKGQLL---------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN-LVGLRGWCKKEKESLILI  187 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~~lv  187 (409)
                      .+.+..|-...+|+....         +..+.+++....... .-...+|..+++.+.-.+ ..++++.+   .+  ++|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~---~~--~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF---PE--GRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE---TT--EEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc---CC--CEE
Confidence            356777888899998876         578999886543211 112346888877774222 34555533   22  579


Q ss_pred             EEeCCCCCHHH--------------H---HhcC-------C---CCCCCCHHHHHHHHHHH-------------------
Q 048535          188 YDYMENGSLDK--------------W---IFEC-------D---ESIALSWEQRIKVLKDV-------------------  221 (409)
Q Consensus       188 ~E~~~~gsL~~--------------~---l~~~-------~---~~~~l~~~~~~~i~~~i-------------------  221 (409)
                      |||++|..|..              .   ||..       .   ...+..|.++.++..++                   
T Consensus       149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  228 (424)
T 3mes_A          149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI  228 (424)
T ss_dssp             EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred             EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence            99999865321              0   1110       0   11122355444444332                   


Q ss_pred             HHHHHHHHh---------------------cCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          222 ASGILYLYE---------------------GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       222 a~gL~yLH~---------------------~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ...+.+|..                     .....++|+|+.+.||+ +.++.+.|.||..|..
T Consensus       229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            222333321                     11356899999999999 7888899999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=94.30  E-value=0.0096  Score=56.65  Aligned_cols=30  Identities=17%  Similarity=0.084  Sum_probs=26.7

Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ...+..+.+|+.+||+.||++|||+.|+++
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            455678899999999999999999999976

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=94.26  E-value=0.025  Score=34.91  Aligned_cols=30  Identities=23%  Similarity=0.167  Sum_probs=17.1

Q ss_pred             ccceeEehhhHHHHHHHHHHHHHHhhhhhc
Q 048535           51 RSKGFILGVSVGGLLIMGCGVVVYMVCLKR   80 (409)
Q Consensus        51 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~r   80 (409)
                      .+.+.|.|+++|+++.+++++.+.++++||
T Consensus         8 ls~GaIAGiVvG~v~gv~li~~l~~~~~rr   37 (38)
T 2k1k_A            8 LTGGEIVAVIFGLLLGAALLLGILVFRSRR   37 (38)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence            356677788887776555444443444433

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=93.10  E-value=0.02  Score=55.93  Aligned_cols=30  Identities=17%  Similarity=0.084  Sum_probs=26.6

Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ...+..+.+|+.+||+.||++|||+.|+++
T Consensus       371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            445678899999999999999999999986

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=92.95  E-value=0.36  Score=46.58  Aligned_cols=30  Identities=30%  Similarity=0.410  Sum_probs=25.4

Q ss_pred             ceeecCCCCCCeee------CCCCcEEEecccCccc
Q 048535          235 KVLHRDIKASNVLL------DKKMNARLGDFGLAKM  264 (409)
Q Consensus       235 ~ivHrDlKp~NILl------~~~~~~kl~DFGla~~  264 (409)
                      .++|+|+.+.|||+      +++..+.+.||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4456799999999865

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=92.77  E-value=0.069  Score=51.09  Aligned_cols=31  Identities=16%  Similarity=-0.042  Sum_probs=27.3

Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          312 ADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       312 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .......+.+|+.+||+.||++|||+.|+++
T Consensus       342 ~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~  372 (382)
T 2vx3_A          342 TVADYLKFKDLILRMLDYDPKTRIQPYYALQ  372 (382)
T ss_dssp             CHHHHHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cchhhHHHHHHHHHhcCCChhhCCCHHHHhc
Confidence            4455678999999999999999999999976

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=92.77  E-value=0.034  Score=51.00  Aligned_cols=63  Identities=6%  Similarity=-0.063  Sum_probs=36.2

Q ss_pred             cCCCcHHHHHHhhhcc------CcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 048535          279 EGKRNLVDRMWSLTER------SELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVL  341 (409)
Q Consensus       279 ~~~~~~~~~vws~~~~------~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl  341 (409)
                      .+.+++..-+|.+...      ....++..........++...++.+.+++.+||+.||++|||++|++
T Consensus       193 ~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil  261 (275)
T 3hyh_A          193 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIM  261 (275)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             hhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence            4667777777777433      23344444444444444555556666666666666666666666554

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=92.29  E-value=0.18  Score=47.11  Aligned_cols=63  Identities=8%  Similarity=-0.134  Sum_probs=44.9

Q ss_pred             CcCCCCCCCHHHHHHHHhcC-cCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          328 HPEANSRPTIRQVLKMLEGQ-TEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      -..|-.-.+..++.+.+... ...+.. ......+++.+|+..+|.+|++.++++.||||+....
T Consensus       210 g~~pf~~~~~~~~~~~i~~~~~~~p~~-~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          210 GSLPFDGQNLKELRERVLRGKYRIPFY-MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             SSCSSCCSSHHHHHHHHHHCCCCCCTT-SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             CCCCCCCCCHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            45565666777777665443 222222 2223479999999999999999999999999987543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=92.26  E-value=0.052  Score=50.17  Aligned_cols=27  Identities=19%  Similarity=0.346  Sum_probs=24.5

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ++++.+|+.+||+.||++|||++|+++
T Consensus       256 ~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          256 IPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            456889999999999999999999986

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=91.94  E-value=0.014  Score=57.77  Aligned_cols=59  Identities=8%  Similarity=0.059  Sum_probs=17.9

Q ss_pred             ccceeecCCceEEEEEEECC--cEEEE------EEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEE
Q 048535          117 EENVIGLGGNGKVYKGQLLG--VEVAL------KRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCK  178 (409)
Q Consensus       117 ~~~~lG~G~fg~Vy~~~~~~--~~vAv------K~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~  178 (409)
                      ..+.||   ||.||+|.+.+  .+|||      |..+..  +.+....|.+|..+++.++|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345666   99999999974  57888      776543  2334567899999999999999999988765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=91.71  E-value=0.8  Score=40.20  Aligned_cols=146  Identities=14%  Similarity=0.036  Sum_probs=85.0

Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCceeee
Q 048535          194 GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSG  273 (409)
Q Consensus       194 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~g  273 (409)
                      -||.+.|...  +.++++++++.++.|.+.+|.-+-.  ...-..+=+-|..|++..+|.+...+ +.+..  ..... .
T Consensus        33 vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~~--~~~~~-~  104 (229)
T 2yle_A           33 LSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADDA--GEPPP-V  104 (229)
T ss_dssp             EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-ccccc--cccCC-C
Confidence            3788988653  4689999999999999999877621  11111222346899999999988774 22211  00000 0


Q ss_pred             ccccccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCc------------------------
Q 048535          274 RRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHP------------------------  329 (409)
Q Consensus       274 ~~p~~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~------------------------  329 (409)
                      .+.......+...-|++++  ..++..+|-.+.  .+.+.+.++.+-+|+..|.+.                        
T Consensus       105 ~pe~~~~~~te~~~IysLG--~tLY~ALDygL~--e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~  180 (229)
T 2yle_A          105 AGKLGYSQCMETEVIESLG--IIIYKALDYGLK--ENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEK  180 (229)
T ss_dssp             --CCSSSSSCHHHHHHHHH--HHHHHHHTTTCC--TTEEECCCHHHHHHHHHHTTCCC--------------------CC
T ss_pred             ChhhccccchHHHHHHHHH--HHHHHHhhcCCC--cccchhhCHHHHHHHHHHHhccccccccccccccccccccccccc
Confidence            0001111224556666665  445666665554  333334444555555555543                        


Q ss_pred             -CCCCCCCHHHHHHHHhcCcCCC
Q 048535          330 -EANSRPTIRQVLKMLEGQTEGT  351 (409)
Q Consensus       330 -dP~~RPt~~evl~~L~~~~~~~  351 (409)
                       .+..|++.++|++.-..-...+
T Consensus       181 ~~~~~~~sl~~Vi~~C~~hl~~p  203 (229)
T 2yle_A          181 RKISAIRSYRDVMKLCAAHLPTE  203 (229)
T ss_dssp             SCCCCCCSHHHHHHHHHTTSSSG
T ss_pred             ccccCcCCHHHHHHHHHhhccCc
Confidence             3568899999999887765544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=91.35  E-value=0.1  Score=47.51  Aligned_cols=28  Identities=25%  Similarity=0.188  Sum_probs=24.9

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ....+.+++.+||+.||++|||+.|+++
T Consensus       253 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          253 LDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            3457889999999999999999999976

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=91.31  E-value=0.11  Score=48.20  Aligned_cols=27  Identities=15%  Similarity=0.115  Sum_probs=24.5

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..++.+++.+||+.||++|||++|+++
T Consensus       274 ~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          274 CQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            356789999999999999999999986

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=90.53  E-value=0.13  Score=47.90  Aligned_cols=27  Identities=15%  Similarity=0.004  Sum_probs=24.5

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ...+.+++.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          255 DSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            356789999999999999999999987

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=90.36  E-value=0.11  Score=47.49  Aligned_cols=28  Identities=11%  Similarity=-0.068  Sum_probs=25.1

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ....+.+++.+||+.||++|||++|+++
T Consensus       255 ~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          255 LNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            4567889999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=90.03  E-value=0.14  Score=46.83  Aligned_cols=30  Identities=13%  Similarity=0.211  Sum_probs=26.0

Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ......+.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          246 SKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            344567899999999999999999999976

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=89.91  E-value=0.18  Score=46.08  Aligned_cols=67  Identities=10%  Similarity=-0.005  Sum_probs=45.7

Q ss_pred             cCcCCCCCCCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccccc
Q 048535          327 AHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNR  393 (409)
Q Consensus       327 l~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~~  393 (409)
                      ....|-.-.+..++.+.+..........-+..-.+++.+|+..+|..|.+..+++.||||.......
T Consensus       208 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~  274 (305)
T 2wtk_C          208 TGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA  274 (305)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred             hCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence            3455655666777777665433221111122237899999999999999999999999998765433

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=89.75  E-value=0.13  Score=48.08  Aligned_cols=27  Identities=15%  Similarity=0.095  Sum_probs=24.5

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ...+.+++.+||+.||++|||+.|+++
T Consensus       292 ~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          292 DDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            356789999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=89.69  E-value=0.089  Score=49.55  Aligned_cols=29  Identities=10%  Similarity=-0.111  Sum_probs=26.1

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ....+.+++.+||+.||.+|||+.|+++.
T Consensus       287 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          287 DAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             THHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            45689999999999999999999999863

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=89.61  E-value=0.075  Score=49.59  Aligned_cols=30  Identities=17%  Similarity=0.084  Sum_probs=26.2

Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      .....+.+++.+||+.||.+|||+.|+++.
T Consensus       259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          259 SVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            455678999999999999999999999863

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=89.55  E-value=0.075  Score=49.40  Aligned_cols=28  Identities=21%  Similarity=0.160  Sum_probs=25.7

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ....+.+++.+||+.||++|||++|+++
T Consensus       292 ~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          292 VSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            4578999999999999999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=89.53  E-value=0.3  Score=44.31  Aligned_cols=30  Identities=27%  Similarity=0.195  Sum_probs=26.6

Q ss_pred             chhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          359 NVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       359 ~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      -.+++.+|+..+|..|.++++++.||||++
T Consensus       255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            368889999999999999999999999975

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=89.39  E-value=0.22  Score=45.09  Aligned_cols=66  Identities=8%  Similarity=-0.019  Sum_probs=45.8

Q ss_pred             ccCcCCCCCCCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          326 CAHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      +....|-.-++..+..+.+..........-+..-.+++.+|+..+|..|.+..+++.||||.....
T Consensus       206 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          206 LVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             HHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            344566666677777666554322111111223478999999999999999999999999997654

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=89.25  E-value=0.14  Score=47.92  Aligned_cols=28  Identities=21%  Similarity=0.097  Sum_probs=25.1

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ....+.+++.+||+.||++|||+.|+++
T Consensus       278 ~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          278 VNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            3457889999999999999999999987

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=89.16  E-value=0.18  Score=47.41  Aligned_cols=28  Identities=29%  Similarity=0.103  Sum_probs=25.5

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ...+.+++.+||+.||++|||+.|+++.
T Consensus       265 ~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          265 GDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             CHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            4678999999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=89.10  E-value=0.19  Score=48.87  Aligned_cols=34  Identities=15%  Similarity=0.276  Sum_probs=30.8

Q ss_pred             chhHHhhhcccCCCCcccccccCCCCCccccccc
Q 048535          359 NVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKN  392 (409)
Q Consensus       359 ~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~  392 (409)
                      ..+++.+|+..+|.+|+++++++.||||++++..
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            4799999999999999999999999999987643

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=88.93  E-value=0.13  Score=47.62  Aligned_cols=27  Identities=11%  Similarity=0.062  Sum_probs=24.5

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ...+.+++.+||+.||++|||+.|+++
T Consensus       267 ~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          267 DGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            457899999999999999999999976

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=88.87  E-value=0.27  Score=47.98  Aligned_cols=62  Identities=8%  Similarity=-0.073  Sum_probs=43.8

Q ss_pred             CcCCCCCCCHHHHHHHHhcC-cCCCCCCCCCcchhHHhhhcccCCCCcc-----cccccCCCCCccccc
Q 048535          328 HPEANSRPTIRQVLKMLEGQ-TEGTGLEDEGMNVHLLKRIGTRAMTSSW-----KFAGSRGHPTFNEIN  390 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~-----~~~~~~~hp~~~~~~  390 (409)
                      -..|-.-.+..++.+.+... ...+.. -+....+++.+|+..+|..|+     ++++++.||||+.++
T Consensus       345 g~~Pf~~~~~~~~~~~i~~~~~~~p~~-~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          345 GRLPFYNQDHEKLFELILMEEIRFPRT-LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             SSCSSCCSSHHHHHHHHHHCCCCCCTT-SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             CCCCCCCCCHHHHHHHHHhCCCCCCcc-CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence            44555556667776665432 222222 122348999999999999999     899999999999875

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=88.75  E-value=0.11  Score=48.54  Aligned_cols=30  Identities=13%  Similarity=0.020  Sum_probs=26.3

Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ......+.+++.+||+.||++|||+.|+++
T Consensus       304 ~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          304 SLEHVQLFDLMRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             SHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             chhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            345668999999999999999999999864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=88.62  E-value=0.4  Score=43.15  Aligned_cols=69  Identities=7%  Similarity=-0.107  Sum_probs=46.2

Q ss_pred             CcCCCCCCCHHHHHHHHhcC-cCCCCCCC---CCcchhHHhhhcccCCCCcccccccCCCCCccccccccCCC
Q 048535          328 HPEANSRPTIRQVLKMLEGQ-TEGTGLED---EGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNRSSS  396 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~-~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~~~~s  396 (409)
                      ...|-...+..++...+... ...+.+..   +..-.+++.+|+..+|..|.+.++++.||||.+.....+..
T Consensus       203 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~  275 (284)
T 3kk8_A          203 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI  275 (284)
T ss_dssp             SSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGSC
T ss_pred             CCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhHh
Confidence            44555555666666655433 22222211   12237899999999999999999999999999876555443

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=88.57  E-value=0.56  Score=43.48  Aligned_cols=32  Identities=13%  Similarity=0.118  Sum_probs=29.1

Q ss_pred             chhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          359 NVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       359 ~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ..+++.+|+..+|..|++.++++.||||....
T Consensus       238 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          238 PLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            36899999999999999999999999998654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=88.31  E-value=0.18  Score=47.29  Aligned_cols=27  Identities=15%  Similarity=-0.050  Sum_probs=24.4

Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ..+.+|+.+||+.||++|||+.|+++.
T Consensus       286 ~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          286 PYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            457899999999999999999999874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=88.25  E-value=0.35  Score=44.03  Aligned_cols=30  Identities=17%  Similarity=0.124  Sum_probs=26.9

Q ss_pred             chhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          359 NVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       359 ~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      -.+++.+|+..+|..|+++++++.||||+.
T Consensus       269 l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          269 LKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             HHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence            368899999999999999999999999863

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=88.23  E-value=0.094  Score=51.49  Aligned_cols=32  Identities=28%  Similarity=0.419  Sum_probs=29.9

Q ss_pred             chhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          359 NVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       359 ~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ..+++.+|+..+|.+|+++++++.||||++++
T Consensus       373 ~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          373 AIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            47999999999999999999999999999875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=88.19  E-value=0.12  Score=50.32  Aligned_cols=27  Identities=22%  Similarity=0.138  Sum_probs=24.8

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ...+.+|+.+||+.||++|||+.|+++
T Consensus       382 ~~~~~dli~~~L~~dP~~Rpta~e~L~  408 (429)
T 3kvw_A          382 DPLFLDFLKQCLEWDPAVRMTPGQALR  408 (429)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hHHHHHHHHHHCCCChhhCCCHHHHhC
Confidence            356899999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=88.12  E-value=0.26  Score=46.91  Aligned_cols=28  Identities=21%  Similarity=0.073  Sum_probs=24.9

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .++++.+|+.+||+.||++|||++|+++
T Consensus       325 is~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          325 VPDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            3457889999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=88.11  E-value=0.16  Score=47.01  Aligned_cols=27  Identities=19%  Similarity=0.155  Sum_probs=16.1

Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHH
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQV  340 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~ev  340 (409)
                      .....+.+++.+||+.||.+|||+.|+
T Consensus       300 ~~~~~l~~li~~~L~~dP~~Rpt~~el  326 (339)
T 1z57_A          300 VEHERLFDLIQKMLEYDPAKRITLREA  326 (339)
T ss_dssp             HHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             hhHHHHHHHHHHHhCcCcccccCHHHH
Confidence            344556666666666666666666554

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=87.67  E-value=0.46  Score=45.05  Aligned_cols=63  Identities=6%  Similarity=0.113  Sum_probs=42.8

Q ss_pred             CcCCCCCCCHHHHHHHHhcCc-CCCCC---CCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          328 HPEANSRPTIRQVLKMLEGQT-EGTGL---EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~~-~~~~~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      -..|-.-.+..++++.+.... ..+..   .-.....+++.+|+..+|.+|+++++++.||||+.++
T Consensus       214 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          214 GASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             SCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            344555556667666654432 22110   1112247899999999999999999999999998765

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=87.52  E-value=0.35  Score=47.59  Aligned_cols=28  Identities=11%  Similarity=0.040  Sum_probs=25.6

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ...+.+|+.+||+.||++|||++|+++.
T Consensus       329 s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          329 ASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            5678999999999999999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=87.39  E-value=0.61  Score=42.17  Aligned_cols=55  Identities=7%  Similarity=0.119  Sum_probs=38.5

Q ss_pred             CCHHHHHHHHhcCcCCCCCCCCC--cchhHHhhhcccCCCCcccccccCCCCCcccc
Q 048535          335 PTIRQVLKMLEGQTEGTGLEDEG--MNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEI  389 (409)
Q Consensus       335 Pt~~evl~~L~~~~~~~~~~~~~--~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~  389 (409)
                      ....++.+.+.........+...  .-.+++.+|+..+|..|.++++++.||||++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          233 QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             SSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             CcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            56667776665543332222211  23789999999999999999999999999863

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=87.10  E-value=0.27  Score=47.51  Aligned_cols=27  Identities=19%  Similarity=0.068  Sum_probs=24.5

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..++.+|+.+||+.||++|||+.|+++
T Consensus       318 s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          318 DRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            456889999999999999999999986

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=87.00  E-value=0.36  Score=44.25  Aligned_cols=64  Identities=13%  Similarity=-0.003  Sum_probs=44.2

Q ss_pred             cCCCcHHHHHHhhhccC------cHHHHhhHHhhhcCCCCHH---------------------------HHHHHHHHHHH
Q 048535          279 EGKRNLVDRMWSLTERS------ELLSVLDERLKAKGGYADE---------------------------VVEKVLHLGLL  325 (409)
Q Consensus       279 ~~~~~~~~~vws~~~~~------~~~~~~~~~l~~~~~~~~~---------------------------~~~~l~~l~~~  325 (409)
                      .+.+++..-+|.+....      ...+.+.......+..+..                           ....+.+++.+
T Consensus       200 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  279 (308)
T 3g33_A          200 VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLE  279 (308)
T ss_dssp             HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHH
Confidence            46678888889886443      2334444444433333321                           34678999999


Q ss_pred             ccCcCCCCCCCHHHHHH
Q 048535          326 CAHPEANSRPTIRQVLK  342 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~  342 (409)
                      ||+.||++|||+.|+++
T Consensus       280 ~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          280 MLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HTCSSTTTSCCHHHHHT
T ss_pred             HhcCCCccCCCHHHHhc
Confidence            99999999999999976

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=86.99  E-value=0.25  Score=44.49  Aligned_cols=65  Identities=15%  Similarity=0.044  Sum_probs=45.0

Q ss_pred             cCcCCCCCCCHHHHHHHHhcCc-CCCCC---CCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          327 AHPEANSRPTIRQVLKMLEGQT-EGTGL---EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       327 l~~dP~~RPt~~evl~~L~~~~-~~~~~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      ....|-..++..++...+.... ..+..   .-+..-.+++.+|+..+|.+|++..+++.||||++...
T Consensus       202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          202 CGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             HCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence            3556666667777766655432 22211   11223378999999999999999999999999987543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=86.78  E-value=0.46  Score=44.60  Aligned_cols=62  Identities=10%  Similarity=-0.021  Sum_probs=42.0

Q ss_pred             CcCCCCCCCHHHHHHHHh-cCcCCCCCCCCCcchhHHhhhcccCCCCcc-----cccccCCCCCccccc
Q 048535          328 HPEANSRPTIRQVLKMLE-GQTEGTGLEDEGMNVHLLKRIGTRAMTSSW-----KFAGSRGHPTFNEIN  390 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-----~~~~~~~hp~~~~~~  390 (409)
                      -..|-.-.+..++.+.+. +....+..- +....+++.+|+..+|.+|+     +.++++.||||..++
T Consensus       201 g~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          201 GRLPFYNQDHERLFELILMEEIRFPRTL-SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             SSCSSCCSSHHHHHHHHHHCCCCCCTTS-CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCC-CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence            344544456666665543 333332221 22347999999999999998     788999999999875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=86.76  E-value=0.21  Score=47.65  Aligned_cols=31  Identities=16%  Similarity=0.166  Sum_probs=22.5

Q ss_pred             hhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          360 VHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       360 ~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      .+++.+|+..+|.+|+++++++.||||+.+.
T Consensus       311 ~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          311 HHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             HHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence            5677777777777777777777777777665

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=86.68  E-value=0.46  Score=43.87  Aligned_cols=65  Identities=6%  Similarity=0.094  Sum_probs=44.7

Q ss_pred             ccCcCCCCCCCHHHHHHHHhcCcCCCCC----CCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          326 CAHPEANSRPTIRQVLKMLEGQTEGTGL----EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~~L~~~~~~~~~----~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      +....|-.-.+..+.+..+.........    ..+..-.+++.+|+..+|..|++.++++.||||+.++
T Consensus       212 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          212 LSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             HHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             HHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            3344565556677777666554322110    1112237899999999999999999999999998765

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=86.61  E-value=0.15  Score=48.64  Aligned_cols=28  Identities=11%  Similarity=-0.040  Sum_probs=25.0

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+..+.+++.+||+.||++|||+.|+++
T Consensus       294 ~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          294 TPSLAIDLLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            4456899999999999999999999985

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=86.57  E-value=0.33  Score=46.02  Aligned_cols=62  Identities=6%  Similarity=-0.072  Sum_probs=42.6

Q ss_pred             cCcCCCCCCCHHHHHHHHhc-CcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          327 AHPEANSRPTIRQVLKMLEG-QTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       327 l~~dP~~RPt~~evl~~L~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      .-.-|-...+..+++..+.. ........-+....+++.+|+..+|.+|+++++++.||||+.
T Consensus       220 tG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          220 TLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             HCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence            34556666677777765543 222111111223479999999999999999999999999974

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=86.55  E-value=0.23  Score=44.67  Aligned_cols=62  Identities=11%  Similarity=-0.041  Sum_probs=43.5

Q ss_pred             CcCCCCCCCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCcccc
Q 048535          328 HPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEI  389 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~  389 (409)
                      ...|-...+..++.+.+..........-+..-.+++.+|+..+|..|.+..+++.||||++.
T Consensus       207 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          207 GTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             SSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             CCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            45565556677777766544322111112234789999999999999999999999999764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=86.53  E-value=0.25  Score=47.52  Aligned_cols=27  Identities=22%  Similarity=0.121  Sum_probs=24.5

Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ..+.+|+.+||+.||.+|||+.|+++.
T Consensus       308 ~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          308 SKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             SHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            467899999999999999999999874

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=86.42  E-value=0.34  Score=45.06  Aligned_cols=62  Identities=16%  Similarity=0.142  Sum_probs=41.6

Q ss_pred             CcCCCCCCCHHHHHHHHhc-CcCCCCCCCCCcchhHHhhhcccCCCCcc-----cccccCCCCCccccc
Q 048535          328 HPEANSRPTIRQVLKMLEG-QTEGTGLEDEGMNVHLLKRIGTRAMTSSW-----KFAGSRGHPTFNEIN  390 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-----~~~~~~~hp~~~~~~  390 (409)
                      -..|-.-.+..++++.+.. ....+. .-+....+++.+|+..+|..|+     +..+++.||||+.++
T Consensus       217 g~~pf~~~~~~~~~~~i~~~~~~~p~-~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~  284 (327)
T 3a62_A          217 GAPPFTGENRKKTIDKILKCKLNLPP-YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN  284 (327)
T ss_dssp             SSCSCCCSSHHHHHHHHHHTCCCCCT-TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred             CCCCCCCCCHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence            3455555566666555433 222222 1222347999999999999999     567999999999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=86.41  E-value=0.24  Score=46.65  Aligned_cols=22  Identities=14%  Similarity=0.285  Sum_probs=20.6

Q ss_pred             HHHHHccCcCCCCCCCHHHHHH
Q 048535          321 HLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       321 ~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +++.+||+.||++|||+.|+++
T Consensus       303 ~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          303 DFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             HHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhhcChhhCCCHHHHhh
Confidence            6899999999999999999975

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=86.33  E-value=0.53  Score=44.40  Aligned_cols=62  Identities=11%  Similarity=0.037  Sum_probs=42.2

Q ss_pred             CcCCCCCCCHHHHHHHHh-cCcCCCCCCCCCcchhHHhhhcccCCCCccc-----ccccCCCCCccccc
Q 048535          328 HPEANSRPTIRQVLKMLE-GQTEGTGLEDEGMNVHLLKRIGTRAMTSSWK-----FAGSRGHPTFNEIN  390 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-----~~~~~~hp~~~~~~  390 (409)
                      -..|-.-.+..++.+.+. +....+.. -+....+++.+|+..+|.+|++     .++++.||||..++
T Consensus       234 g~~Pf~~~~~~~~~~~i~~~~~~~p~~-~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~  301 (350)
T 1rdq_E          234 GYPPFFADQPIQIYEKIVSGKVRFPSH-FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             SSCSSCCSSHHHHHHHHHHCCCCCCTT-CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCC-CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence            344544456666665543 33333221 1223479999999999999998     78999999999876

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=86.22  E-value=0.2  Score=45.57  Aligned_cols=27  Identities=22%  Similarity=0.102  Sum_probs=24.8

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ...+.+++.+||+.||++|||+.|+++
T Consensus       257 ~~~~~~li~~~L~~dP~~Rpt~~~~l~  283 (299)
T 2r3i_A          257 DEDGRSLLSQMLHYDPNKRISAKAALA  283 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            467899999999999999999999976

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=86.11  E-value=0.15  Score=46.89  Aligned_cols=32  Identities=16%  Similarity=0.137  Sum_probs=18.3

Q ss_pred             hhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          360 VHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       360 ~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      .+++.+|+..+|.+|+++++++.||||.....
T Consensus       273 ~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          273 KDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             HHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence            45666666666666666666666788776543

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=85.99  E-value=0.19  Score=46.14  Aligned_cols=26  Identities=31%  Similarity=0.281  Sum_probs=18.0

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVL  341 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl  341 (409)
                      ...+.+++.+||+.||++|||++|++
T Consensus       258 ~~~~~~li~~~L~~dP~~Rpt~~ell  283 (311)
T 4agu_A          258 SYPALGLLKGCLHMDPTERLTCEQLL  283 (311)
T ss_dssp             CHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred             cHHHHHHHHHHccCChhhcCCHHHHh
Confidence            34567777777777777777776664

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=85.98  E-value=0.32  Score=43.90  Aligned_cols=31  Identities=13%  Similarity=0.126  Sum_probs=19.5

Q ss_pred             hhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          360 VHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       360 ~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      .+++.+|+..+|..|++.++++.||||+...
T Consensus       244 ~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          244 VDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            4555566666666666666666777777654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=85.96  E-value=0.16  Score=47.00  Aligned_cols=31  Identities=3%  Similarity=0.057  Sum_probs=28.6

Q ss_pred             hhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          360 VHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       360 ~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      .+++.+|+..+|.+|+++++++.||||++++
T Consensus       257 ~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          257 YVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            6799999999999999999999999999876

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=85.93  E-value=0.34  Score=46.54  Aligned_cols=10  Identities=40%  Similarity=0.833  Sum_probs=6.9

Q ss_pred             eeeecccccc
Q 048535          270 VMSGRRPIEE  279 (409)
Q Consensus       270 ~~~g~~p~~~  279 (409)
                      +++|..|+..
T Consensus       210 lltG~~Pf~~  219 (384)
T 4fr4_A          210 LLRGRRPYHI  219 (384)
T ss_dssp             HHHSSCSSCC
T ss_pred             HHhCCCCCCC
Confidence            5677877754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=85.87  E-value=0.25  Score=47.14  Aligned_cols=28  Identities=25%  Similarity=0.126  Sum_probs=25.1

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ...+.+|+.+||+.||++|||+.|+++.
T Consensus       302 ~~~~~dll~~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          302 NEEALDLLDKLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             CHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence            4568899999999999999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=85.78  E-value=0.4  Score=48.66  Aligned_cols=62  Identities=6%  Similarity=-0.010  Sum_probs=43.2

Q ss_pred             cCCCCCCCHHHHHHHHhcCc-CCCCCCCC---CcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          329 PEANSRPTIRQVLKMLEGQT-EGTGLEDE---GMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       329 ~dP~~RPt~~evl~~L~~~~-~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ..|-.-.+..++++.+.... ..+.....   ....+++.+|+..+|.+|+++++++.||||+..+
T Consensus       353 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          353 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             CCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             CCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence            44555556777776665432 22222111   1237999999999999999999999999998754

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=85.67  E-value=0.6  Score=44.09  Aligned_cols=62  Identities=10%  Similarity=0.015  Sum_probs=42.0

Q ss_pred             CcCCCCCCCHHHHHHHHhc-CcCCCCCCCCCcchhHHhhhcccCCCCcccc-----cccCCCCCccccc
Q 048535          328 HPEANSRPTIRQVLKMLEG-QTEGTGLEDEGMNVHLLKRIGTRAMTSSWKF-----AGSRGHPTFNEIN  390 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~-----~~~~~hp~~~~~~  390 (409)
                      -..|-.-.+..++.+.+.. ....+.. -+....+++.+|+..+|.+|+++     .+++.||||+.++
T Consensus       217 G~~Pf~~~~~~~~~~~i~~~~~~~p~~-~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          217 GQAPFEGEDEDELFQSIMEHNVAYPKS-MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             SSCSSCCSSHHHHHHHHHHCCCCCCTT-SCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             CCCCCCCCCHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence            3445555566676665543 2333221 22234799999999999999964     7999999999876

>2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens}

Probab=85.66  E-value=0.48  Score=29.54  Aligned_cols=8  Identities=50%  Similarity=0.634  Sum_probs=2.9

Q ss_pred             ehhhHHHH
Q 048535           57 LGVSVGGL   64 (409)
Q Consensus        57 ~~~~~~~~   64 (409)
                      +++++|.+
T Consensus        17 ~~vv~Gv~   24 (41)
T 2k9y_A           17 GGVAVGVV   24 (41)
T ss_dssp             HHHHHHHH
T ss_pred             eehhHHHH
Confidence            33333333

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=85.53  E-value=0.88  Score=42.64  Aligned_cols=57  Identities=12%  Similarity=0.039  Sum_probs=40.2

Q ss_pred             CCHHHHHHHHhcCc-CCCCC---CCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          335 PTIRQVLKMLEGQT-EGTGL---EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       335 Pt~~evl~~L~~~~-~~~~~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      .+..++++.+.... ..+..   .-.....+++.+|+..+|.+|.++++++.||||.+.+.
T Consensus       226 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  286 (342)
T 2qr7_A          226 DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ  286 (342)
T ss_dssp             SCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred             CCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence            46777777765432 22211   11223478999999999999999999999999976543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=85.29  E-value=0.19  Score=48.22  Aligned_cols=29  Identities=14%  Similarity=-0.033  Sum_probs=25.9

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ....+.+|+.+||+.||.+|||+.|+++.
T Consensus       294 ~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          294 TPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            44578999999999999999999999874

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=85.28  E-value=0.44  Score=44.38  Aligned_cols=31  Identities=13%  Similarity=0.115  Sum_probs=23.7

Q ss_pred             hhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          360 VHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       360 ~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      .+++.+|+..+|..|++..+++.||||+..+
T Consensus       300 ~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          300 IDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            5777777777777777777777888887655

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=85.28  E-value=0.52  Score=43.10  Aligned_cols=33  Identities=9%  Similarity=-0.087  Sum_probs=30.0

Q ss_pred             hhHHhhhcccCCCCcccccccCCCCCccccccc
Q 048535          360 VHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKN  392 (409)
Q Consensus       360 ~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~  392 (409)
                      .+++.+|+..+|.+|.++++++.||||+.....
T Consensus       247 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  279 (297)
T 3fxz_A          247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPL  279 (297)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HHHHHHHccCChhHCcCHHHHhhChhhcccCcc
Confidence            789999999999999999999999999976543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=85.20  E-value=0.18  Score=46.98  Aligned_cols=29  Identities=14%  Similarity=-0.016  Sum_probs=25.6

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ....+.+++.+||+.||.+|||+.|+++.
T Consensus       243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             SCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             CCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            45678999999999999999999999853

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=84.92  E-value=0.35  Score=45.91  Aligned_cols=28  Identities=18%  Similarity=0.005  Sum_probs=25.0

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ...+.+|+.+||+.||++|||+.|+++.
T Consensus       285 ~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          285 NPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            3568899999999999999999999874

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=84.86  E-value=0.33  Score=43.52  Aligned_cols=28  Identities=21%  Similarity=0.100  Sum_probs=22.3

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ....+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          234 IDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            4457888889999999999998887743

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=84.31  E-value=0.86  Score=41.26  Aligned_cols=64  Identities=5%  Similarity=-0.037  Sum_probs=43.2

Q ss_pred             cCcCCCCCCCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          327 AHPEANSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       327 l~~dP~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ....|-...+..+....+..........-+..-.+++.+|+..+|..|.+.++++.||||.+..
T Consensus       210 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          210 VGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             HSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             hCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence            3455655566666666554432211111122337899999999999999999999999998643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=84.19  E-value=0.078  Score=50.43  Aligned_cols=33  Identities=12%  Similarity=0.074  Sum_probs=17.1

Q ss_pred             hHHhhhcccCCCCcccccccCCCCCcccccccc
Q 048535          361 HLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNR  393 (409)
Q Consensus       361 ~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~~  393 (409)
                      +++.+|+..+|.+|+++++++.||||+++....
T Consensus       331 ~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  363 (371)
T 3q60_A          331 TLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEI  363 (371)
T ss_dssp             HHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHH
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHH
Confidence            344444444444444444555677877766443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=84.03  E-value=0.31  Score=48.08  Aligned_cols=65  Identities=12%  Similarity=0.034  Sum_probs=45.5

Q ss_pred             CcCCCCCCCHHHHHHHHhcCcCCCCCCC----CCcchhHHhhhcccCCCCcccccccCCCCCccccccc
Q 048535          328 HPEANSRPTIRQVLKMLEGQTEGTGLED----EGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKN  392 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~  392 (409)
                      -..|-...+..++++.+.........+.    +....+++.+|+..+|.+|+++.+++.||||......
T Consensus       223 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~  291 (484)
T 3nyv_A          223 GCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE  291 (484)
T ss_dssp             SSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence            4456666677777777655432222111    1123789999999999999999999999999987643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=84.01  E-value=0.24  Score=47.09  Aligned_cols=32  Identities=16%  Similarity=0.152  Sum_probs=20.4

Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       311 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+......+.+|+.+||+.||++|||+.|+++
T Consensus       360 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          360 WSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            34555566666777777777777776666653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=83.94  E-value=0.21  Score=47.46  Aligned_cols=31  Identities=19%  Similarity=0.318  Sum_probs=16.5

Q ss_pred             hhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          360 VHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       360 ~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      .+++.+|+..+|.+|+++++++.||||++..
T Consensus       285 ~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          285 VNLLEKMLVLDAEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence            4455555555555555555555566655543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=83.93  E-value=0.37  Score=45.35  Aligned_cols=34  Identities=3%  Similarity=0.064  Sum_probs=28.9

Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          309 GGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       309 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..++......+.+|+.+||+.||++|||+.|+++
T Consensus       300 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          300 YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             TCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             ccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence            3456778888999999999999999999998865

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=83.90  E-value=0.98  Score=40.84  Aligned_cols=33  Identities=15%  Similarity=0.160  Sum_probs=29.2

Q ss_pred             chhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          359 NVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       359 ~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      -.+++.+|+..+|..|.++++++.||||.+...
T Consensus       260 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  292 (298)
T 1phk_A          260 VKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV  292 (298)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred             HHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence            368999999999999999999999999987654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=83.85  E-value=0.37  Score=43.35  Aligned_cols=68  Identities=10%  Similarity=0.088  Sum_probs=45.9

Q ss_pred             CcCCCCCCCHHHHHHHHhcCcCCCC----CCCCCcchhHHhhhcccCCCCcccccccCCCCCccccccccCC
Q 048535          328 HPEANSRPTIRQVLKMLEGQTEGTG----LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNRSS  395 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~~~~~~----~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~~~~  395 (409)
                      ...|-.-.+..+.+..+........    ...+..-.+++.+|+..+|..|.+..+++.||||+.+......
T Consensus       207 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~  278 (283)
T 3bhy_A          207 GASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVR  278 (283)
T ss_dssp             SSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC-
T ss_pred             CCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhhh
Confidence            4455555566666666654332211    0111223789999999999999999999999999998766543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=83.67  E-value=0.49  Score=42.41  Aligned_cols=32  Identities=13%  Similarity=-0.068  Sum_probs=26.8

Q ss_pred             chhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          359 NVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       359 ~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      -.+++.+|+..+|..|+++.+++.||||.+..
T Consensus       256 ~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          256 FTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             HHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence            47899999999999999999999999998754

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=83.41  E-value=0.42  Score=44.88  Aligned_cols=26  Identities=19%  Similarity=0.194  Sum_probs=23.8

Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+.+++.+||+.||++|||+.|+++
T Consensus       330 ~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          330 ELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            56779999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=83.16  E-value=0.41  Score=45.21  Aligned_cols=31  Identities=16%  Similarity=0.226  Sum_probs=25.9

Q ss_pred             chhHHhhhcccCCCCcccccccCCCCCcccc
Q 048535          359 NVHLLKRIGTRAMTSSWKFAGSRGHPTFNEI  389 (409)
Q Consensus       359 ~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~  389 (409)
                      ..+++.+|+..+|.+|+++++++.||||++.
T Consensus       290 ~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          290 ALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            3688888888888888888888888888875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=83.11  E-value=0.44  Score=45.17  Aligned_cols=27  Identities=19%  Similarity=0.070  Sum_probs=18.8

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ...+.+++.+||+.||++|||+.|+++
T Consensus       297 ~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          297 SPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            346677777777777777777776654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=82.77  E-value=0.3  Score=47.39  Aligned_cols=28  Identities=11%  Similarity=-0.056  Sum_probs=25.3

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ....+.+|+.+||+.||.+|||+.|+++
T Consensus       309 ~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          309 TPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            3467899999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=82.29  E-value=0.32  Score=45.71  Aligned_cols=64  Identities=19%  Similarity=0.072  Sum_probs=46.1

Q ss_pred             cCCCcHHHHHHhhhcc------CcHHHHhhHHhhhcCCCCHHHH--------------------------------HHHH
Q 048535          279 EGKRNLVDRMWSLTER------SELLSVLDERLKAKGGYADEVV--------------------------------EKVL  320 (409)
Q Consensus       279 ~~~~~~~~~vws~~~~------~~~~~~~~~~l~~~~~~~~~~~--------------------------------~~l~  320 (409)
                      .+.+++..-+|.+...      ....+.+.......+.......                                ..+.
T Consensus       215 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (362)
T 3pg1_A          215 VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVAL  294 (362)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHH
T ss_pred             hHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHH
Confidence            4667788888887543      3445556566655555555443                                3488


Q ss_pred             HHHHHccCcCCCCCCCHHHHHH
Q 048535          321 HLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       321 ~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +++.+||+.||++|||+.|+++
T Consensus       295 ~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          295 DLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhcCChhhCCCHHHHHc
Confidence            9999999999999999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=82.03  E-value=0.55  Score=44.00  Aligned_cols=28  Identities=18%  Similarity=0.069  Sum_probs=19.4

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ....+.+++.+||+.||++|||+.|+++
T Consensus       278 ~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          278 ASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             SCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            3456777777777777777777776654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=81.90  E-value=0.83  Score=45.15  Aligned_cols=61  Identities=11%  Similarity=-0.012  Sum_probs=41.2

Q ss_pred             CcCCCCCCCHHHHHHHHhc-CcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCcccc
Q 048535          328 HPEANSRPTIRQVLKMLEG-QTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEI  389 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~  389 (409)
                      -..|-.-.+..++.+.+.. ....+.. -.....+++.+|+..+|.+|++..+++.||||+..
T Consensus       212 G~~Pf~~~~~~~~~~~i~~~~~~~p~~-~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          212 GTLPFDDDHVPTLFKKICDGIFYTPQY-LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             SSCSSCCSSSHHHHHHHHTTCCCCCTT-CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             CCCCCCCCCHHHHHHHHhcCCcCCCcc-CCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            3445444555566555543 3222221 12234799999999999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=81.89  E-value=0.78  Score=42.55  Aligned_cols=63  Identities=10%  Similarity=0.067  Sum_probs=42.1

Q ss_pred             CcCCCCCCCHHHHHHHHhcCcC-CCCC---CCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          328 HPEANSRPTIRQVLKMLEGQTE-GTGL---EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~~~-~~~~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      -..|-.-.+..+.+..+..... .+..   ..+....+++.+|+..+|..|+++++++.||||...+
T Consensus       213 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          213 GASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             SCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             CcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            3445555566666665544321 1110   1112236899999999999999999999999998654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=81.86  E-value=0.48  Score=42.55  Aligned_cols=32  Identities=13%  Similarity=0.216  Sum_probs=27.5

Q ss_pred             chhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          359 NVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       359 ~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      -.+++.+|+..+|..|+++++++.||||....
T Consensus       239 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            37899999999999999999999999998644

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=81.83  E-value=0.51  Score=43.87  Aligned_cols=64  Identities=8%  Similarity=0.040  Sum_probs=42.9

Q ss_pred             CcCCCCCCCHHHHHHHH-hcCcCCCCCCC---CCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          328 HPEANSRPTIRQVLKML-EGQTEGTGLED---EGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L-~~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      -..|-...+..+....+ ++....+.+..   +..-.+++.+|+..+|..|++..+++.||||++...
T Consensus       272 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          272 GAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             SSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             CCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            34455555555555444 44333332221   122378999999999999999999999999998653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=81.62  E-value=1.1  Score=41.63  Aligned_cols=63  Identities=5%  Similarity=-0.043  Sum_probs=42.6

Q ss_pred             cCcCCCCCCCHHHHHHHHhcCc-CCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          327 AHPEANSRPTIRQVLKMLEGQT-EGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       327 l~~dP~~RPt~~evl~~L~~~~-~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ....|-...+..+....+.... ..+.. -+..-.+++.+|+..+|..|.+.++++.||||....
T Consensus       236 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          236 VGKPPFETSCLKETYLRIKKNEYSIPKH-INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             HSSCTTCCSSHHHHHHHHHHTCCCCCTT-SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HCcCCCCCCCHHHHHHHHhcCCCCCCcc-CCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence            3445555556666665554332 22211 122237899999999999999999999999998643

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=81.58  E-value=0.79  Score=44.81  Aligned_cols=63  Identities=10%  Similarity=-0.026  Sum_probs=43.6

Q ss_pred             CcCCCCCCCHHHHHHHHhcC-cCCCCCCC---CCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          328 HPEANSRPTIRQVLKMLEGQ-TEGTGLED---EGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~-~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      -..|-...+..++.+.+... ...+.+..   +....+++.+|+..+|.+|+++++++.||||+...
T Consensus       209 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~  275 (444)
T 3soa_A          209 GYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS  275 (444)
T ss_dssp             SSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHH
T ss_pred             CCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCc
Confidence            34455556677777665543 23322211   22247999999999999999999999999998654

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=80.51  E-value=0.48  Score=46.92  Aligned_cols=64  Identities=14%  Similarity=0.044  Sum_probs=45.1

Q ss_pred             CcCCCCCCCHHHHHHHHhcCcCC-CCCC---CCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          328 HPEANSRPTIRQVLKMLEGQTEG-TGLE---DEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~~~~-~~~~---~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      -..|-.-.+..++++.+...... +.+.   -+....+++.+|+..+|.+|+++.+++.||||++...
T Consensus       233 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~  300 (494)
T 3lij_A          233 GYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS  300 (494)
T ss_dssp             SSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence            44565666777877776554322 2111   1122378999999999999999999999999988643

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=80.47  E-value=1.2  Score=41.31  Aligned_cols=33  Identities=15%  Similarity=0.023  Sum_probs=26.9

Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHH
Q 048535          310 GYADEVVEKVLHLGLLCAHPEANSRP-----TIRQVLK  342 (409)
Q Consensus       310 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~  342 (409)
                      .++......+.+++.+||+.||++||     ++.|+++
T Consensus       221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            34445567789999999999999999     8888874

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=80.35  E-value=0.56  Score=46.27  Aligned_cols=66  Identities=12%  Similarity=0.047  Sum_probs=45.5

Q ss_pred             CcCCCCCCCHHHHHHHHhcCcCCCCCCC----CCcchhHHhhhcccCCCCcccccccCCCCCcccccccc
Q 048535          328 HPEANSRPTIRQVLKMLEGQTEGTGLED----EGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKNR  393 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~~  393 (409)
                      -..|-.-.+..++++.+.........+.    +....+++.+|+..+|..|+++.+++.||||.......
T Consensus       218 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~  287 (486)
T 3mwu_A          218 GTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET  287 (486)
T ss_dssp             SSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred             CCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence            4455555567777776654332222111    11237999999999999999999999999998866443

>2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens}

Probab=80.32  E-value=1.4  Score=29.06  Aligned_cols=23  Identities=22%  Similarity=0.192  Sum_probs=11.4

Q ss_pred             ceeEehhhHHHHHHHHHHHHHHh
Q 048535           53 KGFILGVSVGGLLIMGCGVVVYM   75 (409)
Q Consensus        53 ~~~i~~~~~~~~~~~~~~~~~~~   75 (409)
                      .++|++.++++++++++++++.+
T Consensus         9 ~WiIi~svl~GLLLL~Lii~~Lw   31 (54)
T 2l8s_A            9 LWVILLSAFAGLLLLMLLILALW   31 (54)
T ss_dssp             THHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHHHHHHH
Confidence            34555555555555554444444

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=80.25  E-value=0.16  Score=47.80  Aligned_cols=31  Identities=19%  Similarity=0.186  Sum_probs=28.5

Q ss_pred             chhHHhhhcccCCCCcccccccCCCCCcccc
Q 048535          359 NVHLLKRIGTRAMTSSWKFAGSRGHPTFNEI  389 (409)
Q Consensus       359 ~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~  389 (409)
                      ..+++.+|+..+|.+|+++++++.||||+..
T Consensus       235 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            3789999999999999999999999999853

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=80.22  E-value=1.6  Score=40.34  Aligned_cols=62  Identities=13%  Similarity=0.026  Sum_probs=40.8

Q ss_pred             cCCCCCCCHHHHHHHHhcCcCCCCCCC---CCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          329 PEANSRPTIRQVLKMLEGQTEGTGLED---EGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       329 ~dP~~RPt~~evl~~L~~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ..|-.-.+..+..+.+...........   +..-.+++.+|+..+|..|.++.+++.||||....
T Consensus       238 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          238 EPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             SCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence            344444455566666554332211111   11236899999999999999999999999998654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=80.18  E-value=0.78  Score=43.28  Aligned_cols=34  Identities=12%  Similarity=0.006  Sum_probs=27.0

Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCH------HHHHH
Q 048535          309 GGYADEVVEKVLHLGLLCAHPEANSRPTI------RQVLK  342 (409)
Q Consensus       309 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~  342 (409)
                      ..++......+.+++.+||+.||.+||++      .|+++
T Consensus       241 ~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            34455566778999999999999999998      66664

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=80.14  E-value=0.61  Score=43.22  Aligned_cols=63  Identities=11%  Similarity=0.014  Sum_probs=43.1

Q ss_pred             CcCCCCCCCHHHHHHHHhcCc-CCCCC---CCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          328 HPEANSRPTIRQVLKMLEGQT-EGTGL---EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~~~~-~~~~~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      -..|-.-.+..++++.+.... ..+..   .-+....+++.+|+..+|..|+++.+++.||||.+..
T Consensus       199 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          199 GINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             SSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             CCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            445655566777766654332 22211   1122337999999999999999999999999998654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	409
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-42
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-42
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-41
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-41
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-38
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-37
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-37
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-37
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-36
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-36
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-36
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-36
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	8e-36
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-35
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-35
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-35
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-35
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-35
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-35
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-34
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-34
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-34
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-34
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	8e-34
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-32
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-32
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-31
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-30
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-30
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-30
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-30
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-30
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-29
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-28
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-28
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-28
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	8e-28
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-27
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-26
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-26
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-25
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-24
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-24
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-24
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-23
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-23
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-22
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-22
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-22
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-22
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-22
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-21
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-20
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-20
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-20
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-19
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-19
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-18
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-18
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-17
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-16
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-13
d1g9fa_	251	b.29.1.1 (A:) Legume lectin {Soybean (Glycine max)	5e-08
g1qmo.1	230	b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich	9e-08
d1ukga_	241	b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero	1e-07
g2ltn.1	229	b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum	2e-07
d1g7ya_	253	b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos	1e-06
d1f9ka_	234	b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca	2e-06
d1n47a_	233	b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi	3e-06
d1dhkb_	204	b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar	3e-06
d1gzca_	239	b.29.1.1 (A:) Legume lectin {Cockspur coral tree (	4e-06
d1dbna_	239	b.29.1.1 (A:) Legume lectin {Maackia amurensis, le	4e-06
d1avba_	226	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	4e-06
d1g8wa_	233	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	5e-06
d1leda_	243	b.29.1.1 (A:) Legume lectin {West-central african	8e-06
d1hqla_	236	b.29.1.1 (A:) Legume lectin {Griffonia simplicifol	1e-05
d1qnwa_	237	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	1e-05
d1fx5a_	240	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	1e-05
d1ioaa_	228	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	1e-05
d1v6ia_	232	b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog	2e-05
d2d3sa1	237	b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso	4e-05
d1fnya_	237	b.29.1.1 (A:) Legume lectin {Black locust (Robinia	4e-05
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	3e-04
d1gv9a_	228	b.29.1.13 (A:) Carbohydrate-recognition domain of	0.001

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  149 bits (376), Expect = 2e-42
 Identities = 64/289 (22%), Positives = 128/289 (44%), Gaps = 55/289 (19%)

Query: 104 SYQEIHAATKGFSEE---------NVIGLGGNGKVYKGQL-----LGVEVALKRISLD-S 148
           ++++ + A + F++E          VIG G  G+V  G L       + VA+K +    +
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 149 EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIA 208
           E   R+FL+E S +G+  H N++ L G    +   +++I ++MENGSLD ++ + D    
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVT-KSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 209 LSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK----- 263
            +  Q + +L+ +A+G+ YL    +   +HRD+ A N+L++  +  ++ DFGL++     
Sbjct: 126 -TVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 264 --MHHHGQVMSGRRPIE--------EGKRNLVDRMWSL-----------------TERSE 296
                +   + G+ PI           K      +WS                      +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241

Query: 297 LLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE 345
           +++ +++  +       +    +  L L C   + N RP   Q++  L+
Sbjct: 242 VINAIEQDYRLP--PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 6e-42
 Identities = 58/299 (19%), Positives = 109/299 (36%), Gaps = 76/299 (25%)

Query: 92  EDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD--SE 149
           +DWE+                   +    IG G  G VYKG+  G +VA+K +++   + 
Sbjct: 1   DDWEIPD--------------GQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTP 45

Query: 150 HGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIAL 209
             ++ F  EV  L + +H N++   G+       L ++  + E  SL   +   +     
Sbjct: 46  QQLQAFKNEVGVLRKTRHVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHIIETK--F 101

Query: 210 SWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG- 268
              + I + +  A G+ YL       ++HRD+K++N+ L + +  ++GDFGLA +     
Sbjct: 102 EMIKLIDIARQTAQGMDYL---HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158

Query: 269 ------------------------------------------QVMSGRRPIEEGKRNLVD 286
                                                     ++M+G+ P      N  D
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN--INNRD 216

Query: 287 RMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE 345
           ++  +  R  L   L +             + +  L   C   + + RP   Q+L  +E
Sbjct: 217 QIIFMVGRGYLSPDLSK-------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  146 bits (368), Expect = 2e-41
 Identities = 59/287 (20%), Positives = 119/287 (41%), Gaps = 38/287 (13%)

Query: 100 PHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQL--LGVEVALKRISLDSEHGMREFLA 157
           P   +Y +        + ++ +G G  G+VY+G      + VA+K +  D+   + EFL 
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 62

Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV 217
           E + +  +KH NLV L G C   +    +I ++M  G+L  ++ EC+    +S    + +
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCT-REPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYM 120

Query: 218 LKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS----- 272
              ++S + YL    +   +HRD+ A N L+ +    ++ DFGL+++       +     
Sbjct: 121 ATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177

Query: 273 ---GRRPIEEGKRNLVD---RMWSL-----------------TERSELLSVLDERLKAKG 309
                   E    N       +W+                   + S++  +L++  + + 
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME- 236

Query: 310 GYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLEDE 356
              +   EKV  L   C     + RP+  ++ +  E   + + + DE
Sbjct: 237 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDE 282

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 2e-41
 Identities = 68/255 (26%), Positives = 106/255 (41%), Gaps = 32/255 (12%)

Query: 115 FSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLR 174
                 IG G  G V  G   G +VA+K I  D+    + FLAE S + +L+H NLV L 
Sbjct: 9   LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLL 66

Query: 175 GWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWES 234
           G   +EK  L ++ +YM  GSL  ++     S+ L  +  +K   DV   + YL     +
Sbjct: 67  GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYL---EGN 122

Query: 235 KVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRP-------IEEGKRNLVDR 287
             +HRD+ A NVL+ +   A++ DFGL K     Q              + E K +    
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSD 182

Query: 288 MWSL-----------------TERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPE 330
           +WS                      +++  +++  K      D     V  +   C H +
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD--APDGCPPAVYEVMKNCWHLD 240

Query: 331 ANSRPTIRQVLKMLE 345
           A  RP+  Q+ + LE
Sbjct: 241 AAMRPSFLQLREQLE 255

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 1e-38
 Identities = 61/283 (21%), Positives = 114/283 (40%), Gaps = 52/283 (18%)

Query: 92  EDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQL-LGVEVALKRISLDSEH 150
           ++WE+                +       +G G  G+V+ G      +VA+K +   S  
Sbjct: 6   DEWEVPR--------------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM- 50

Query: 151 GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALS 210
               FLAE + + +L+H+ LV L       +E + +I +YMENGSL  ++      I L+
Sbjct: 51  SPDAFLAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTP-SGIKLT 107

Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV 270
             + + +   +A G+ ++    E   +HRD++A+N+L+   ++ ++ DFGLA++    + 
Sbjct: 108 INKLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164

Query: 271 MSGRRP-----------IEEGKRNLVDRMWSL-----------------TERSELLSVLD 302
            +               I  G   +   +WS                      E++  L+
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

Query: 303 ERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE 345
              +      D   E++  L  LC       RPT   +  +LE
Sbjct: 225 RGYRMV--RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  135 bits (341), Expect = 2e-37
 Identities = 59/262 (22%), Positives = 96/262 (36%), Gaps = 40/262 (15%)

Query: 112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHG---MREFLAEVSSLGRLK 166
            K FS+   IG G  G VY  + +     VA+K++S   +      ++ + EV  L +L+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           H N +  RG     + +  L+ +Y    + D           L   +   V      G+ 
Sbjct: 74  HPNTIQYRGCYL-REHTAWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLA 129

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSG---------RRPI 277
           YL+      ++HRD+KA N+LL +    +LGDFG A +        G            +
Sbjct: 130 YLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAM 186

Query: 278 EEGKRNLVDRMWSL-----------------TERSELLSVLDERLKAKGGYADEVVEKVL 320
           +EG+ +    +WSL                    S L  +      A    +    E   
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFR 244

Query: 321 HLGLLCAHPEANSRPTIRQVLK 342
           +    C       RPT   +LK
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLK 266

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 3e-37
 Identities = 61/269 (22%), Positives = 112/269 (41%), Gaps = 45/269 (16%)

Query: 115 FSEENVIGLGGNGKVYKGQL------LGVEVALKRISLDSEHGMR-EFLAEVSSLGRLKH 167
            + + VIG G  G+VYKG L        V VA+K +        R +FL E   +G+  H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
            N++ L G    + + +++I +YMENG+LDK++ E D     S  Q + +L+ +A+G+ Y
Sbjct: 69  HNIIRLEGVIS-KYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRGIAAGMKY 125

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRR------------ 275
                    +HRD+ A N+L++  +  ++ DFGL+++       +               
Sbjct: 126 ---LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 276 -PIEEGKRNLVDRMWSL-----------------TERSELLSVLDERLKAKGGYADEVVE 317
             I   K      +WS                      E++  +++  +       +   
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP--TPMDCPS 240

Query: 318 KVLHLGLLCAHPEANSRPTIRQVLKMLEG 346
            +  L + C   E   RP    ++ +L+ 
Sbjct: 241 AIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 3e-37
 Identities = 57/300 (19%), Positives = 106/300 (35%), Gaps = 68/300 (22%)

Query: 118 ENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
           +  IG G  G+V++G+  G EVA+K  S   E       AE+     L+H N++G     
Sbjct: 8   QESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAAD 66

Query: 178 KKE---KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE---- 230
            K+      L L+ DY E+GSL  ++        ++ E  IK+    ASG+ +L+     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 231 -GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV------------------- 270
              +  + HRD+K+ N+L+ K     + D GLA  H                        
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 271 ----------------------------MSGRRPIEEGKRNLVDRMWSLTERSELLSVLD 302
                                       ++ R  I     +     + L      +  + 
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 303 ERLKAKG--------GYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEGTGLE 354
           + +  +           + E +  +  +   C +    +R T  ++ K L   ++  G++
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-36
 Identities = 62/276 (22%), Positives = 112/276 (40%), Gaps = 51/276 (18%)

Query: 115 FSEENVIGLGGNGKVYKGQLLG----VEVALKRISLD-SEHGMREFLAEVSSLGRL-KHR 168
              ++VIG G  G+V K ++      ++ A+KR+    S+   R+F  E+  L +L  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC-------------DESIALSWEQRI 215
           N++ L G C+     L L  +Y  +G+L  ++ +                +  LS +Q +
Sbjct: 72  NIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 216 KVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRR 275
               DVA G+ YL    + + +HRD+ A N+L+ +   A++ DFGL++        +  R
Sbjct: 131 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 187

Query: 276 ------PIEEGKRNLVDR---MWSL-----------------TERSELLSVLDERLKAKG 309
                  IE    ++      +WS                     +EL   L +  + + 
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE- 246

Query: 310 GYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE 345
                  ++V  L   C   +   RP+  Q+L  L 
Sbjct: 247 -KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-36
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 9/161 (5%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLV 171
           F + + +G G  G V+K      G+ +A K I L+ +  +R   + E+  L       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
           G  G        + +  ++M+ GSLD+ + +      +  +   KV   V  G+ YL E 
Sbjct: 68  GFYGAFY-SDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE- 122

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
            + K++HRD+K SN+L++ +   +L DFG++         S
Sbjct: 123 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 162

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 4e-36
 Identities = 60/263 (22%), Positives = 110/263 (41%), Gaps = 40/263 (15%)

Query: 118 ENVIGLGGNGKVYKGQLL-----GVEVALKRISLDSEHG-MREFLAEVSSLGRLKHRNLV 171
             VIG G  G VY G LL      +  A+K ++  ++ G + +FL E   +    H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G C + + S +++  YM++G L    F  +E+   + +  I     VA G   +   
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKG---MKFL 146

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRP--------------I 277
              K +HRD+ A N +LD+K   ++ DFGLA+  +  +  S                  +
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 278 EEGKRNLVDRMWS--------LTERS---ELLSVLDERLKAKGGYA----DEVVEKVLHL 322
           +  K      +WS        +T  +     ++  D  +    G      +   + +  +
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266

Query: 323 GLLCAHPEANSRPTIRQVLKMLE 345
            L C HP+A  RP+  +++  + 
Sbjct: 267 MLKCWHPKAEMRPSFSELVSRIS 289

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 5e-36
 Identities = 57/267 (21%), Positives = 105/267 (39%), Gaps = 45/267 (16%)

Query: 115 FSEENVIGLGGNGKVYKGQLL------GVEVALKRISL-DSEHGMREFLAEVSSLGRLKH 167
           F +  V+G G  G VYKG  +       + VA+K +    S    +E L E   +  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
            ++  L G C     ++ LI   M  G L  ++ E  ++I    +  +     +A G+ Y
Sbjct: 71  PHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNI--GSQYLLNWCVQIAKGMNY 126

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS---------GRRPIE 278
           L    + +++HRD+ A NVL+    + ++ DFGLAK+    +                +E
Sbjct: 127 L---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 279 EGKRNLVDR---MWSL-----------------TERSELLSVLDERLKAKGGYADEVVEK 318
                +      +WS                     SE+ S+L++  +            
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP--QPPICTID 241

Query: 319 VLHLGLLCAHPEANSRPTIRQVLKMLE 345
           V  + + C   +A+SRP  R+++    
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIEFS 268

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 7e-36
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 8/153 (5%)

Query: 119 NVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGW 176
             +G G  GKVYK Q     V  A K I   SE  + +++ E+  L    H N+V L   
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKV 236
               + +L ++ ++   G++D  + E +    L+  Q   V K     + YL++   +K+
Sbjct: 78  FY-YENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD---NKI 131

Query: 237 LHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
           +HRD+KA N+L     + +L DFG++  +    
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 8e-36
 Identities = 56/283 (19%), Positives = 104/283 (36%), Gaps = 52/283 (18%)

Query: 92  EDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEH 150
           + WE+                +    E  +G G  G+V+ G       VA+K +   +  
Sbjct: 10  DAWEIPR--------------ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM- 54

Query: 151 GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALS 210
               FL E   + +L+H  LV L       +E + ++ +YM  GSL  ++          
Sbjct: 55  SPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYL-R 111

Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV 270
             Q + +   +ASG+ Y+        +HRD++A+N+L+ + +  ++ DFGLA++    + 
Sbjct: 112 LPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168

Query: 271 MSGRRP-----------IEEGKRNLVDRMWSL-----------------TERSELLSVLD 302
            + +                G+  +   +WS                      E+L  ++
Sbjct: 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228

Query: 303 ERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE 345
              +       E  E +  L   C   E   RPT   +   LE
Sbjct: 229 RGYRMP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-35
 Identities = 53/260 (20%), Positives = 95/260 (36%), Gaps = 38/260 (14%)

Query: 115 FSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
            +    IG G  G V+ G  L   +VA+K I  +      +F+ E   + +L H  LV L
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C  E+  + L++++ME+G L  ++         + E  + +  DV  G   +    E
Sbjct: 66  YGVC-LEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEG---MAYLEE 119

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRP-----------IEEGKR 282
           + V+HRD+ A N L+ +    ++ DFG+ +     Q  S                   + 
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 283 NLVDRMWSL-----------------TERSELLSVLDERLKAKGGYADEVVEKVLHLGLL 325
           +    +WS                     SE++  +    +            V  +   
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY--KPRLASTHVYQIMNH 237

Query: 326 CAHPEANSRPTIRQVLKMLE 345
           C       RP   ++L+ L 
Sbjct: 238 CWKERPEDRPAFSRLLRQLA 257

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 2e-35
 Identities = 55/264 (20%), Positives = 102/264 (38%), Gaps = 44/264 (16%)

Query: 117 EENVIGLGGNGKVYKGQLL----GVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLV 171
            +  +G G  G V +G        ++VA+K +   +E    E  + E   + +L +  +V
Sbjct: 13  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G C  + E+L+L+ +    G L K++    E   +      ++L  V+ G+ YL   
Sbjct: 73  RLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL--- 125

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRP-------------IE 278
            E   +HRD+ A NVLL  +  A++ DFGL+K           R              I 
Sbjct: 126 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185

Query: 279 EGKRNLVDRMWSL-----------------TERSELLSVLDERLKAKGGYADEVVEKVLH 321
             K +    +WS                   +  E+++ +++  + +     E   ++  
Sbjct: 186 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME--CPPECPPELYA 243

Query: 322 LGLLCAHPEANSRPTIRQVLKMLE 345
           L   C   +   RP    V + + 
Sbjct: 244 LMSDCWIYKWEDRPDFLTVEQRMR 267

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 3e-35
 Identities = 60/260 (23%), Positives = 102/260 (39%), Gaps = 38/260 (14%)

Query: 115 FSEENVIGLGGNGKVYKGQL-LGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGL 173
            +    +G G  G V  G+     +VA+K I   S     EF+ E   +  L H  LV L
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQL 64

Query: 174 RGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWE 233
            G C  ++  + +I +YM NG L  ++ E         +Q +++ KDV   + YL     
Sbjct: 65  YGVCT-KQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYL---ES 118

Query: 234 SKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRR-----------PIEEGKR 282
            + LHRD+ A N L++ +   ++ DFGL++     +  S               +   K 
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 283 NLVDRMWSL-----------------TERSELLSVLDERLKAKGGYADEVVEKVLHLGLL 325
           +    +W+                     SE    + + L+          EKV  +   
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY--RPHLASEKVYTIMYS 236

Query: 326 CAHPEANSRPTIRQVLKMLE 345
           C H +A+ RPT + +L  + 
Sbjct: 237 CWHEKADERPTFKILLSNIL 256

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 3e-35
 Identities = 63/265 (23%), Positives = 113/265 (42%), Gaps = 46/265 (17%)

Query: 117 EENVIGLGGNGKVYKGQL----LGVEVALKRISLDSEHG--MREFLAEVSSLGRLKHRNL 170
           E+  +G G  G V KG      +   VA+K +  ++       E LAE + + +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
           V + G C  E ES +L+ +  E G L+K++ +      +  +  I+++  V+ G+ YL  
Sbjct: 71  VRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYL-- 123

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAK-----MHHHGQVMSGRRP--------I 277
             ES  +HRD+ A NVLL  +  A++ DFGL+K      +++     G+ P        I
Sbjct: 124 -EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 278 EEGKRNLVDRMWSL-----------------TERSELLSVLDERLKAKGGYADEVVEKVL 320
              K +    +WS                   + SE+ ++L++  +           ++ 
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--CPAGCPREMY 240

Query: 321 HLGLLCAHPEANSRPTIRQVLKMLE 345
            L  LC   +  +RP    V   L 
Sbjct: 241 DLMNLCWTYDVENRPGFAAVELRLR 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 4e-35
 Identities = 56/287 (19%), Positives = 100/287 (34%), Gaps = 60/287 (20%)

Query: 115 FSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLDSEHGMRE-FLAEVSSLGRLK 166
            S    +G G  GKV +            + VA+K +   +    RE  ++E+  L  L 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 167 -HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC---------------DESIALS 210
            H N+V L G C       ++I +Y   G L  ++                  D+ +AL 
Sbjct: 85  NHMNIVNLLGACT-IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV 270
            E  +     VA G+ +L        +HRD+ A N+LL      ++ DFGLA+   +   
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200

Query: 271 MSGRRP------------IEEGKRNLVDRMWSL------------------TERSELLSV 300
              +              I          +WS                      S+   +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 301 LDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ 347
           + E  +      +    ++  +   C   +   RPT +Q+++++E Q
Sbjct: 261 IKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 5e-35
 Identities = 55/263 (20%), Positives = 105/263 (39%), Gaps = 38/263 (14%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNL 170
           +     IG G  G+  K +    G  +  K +   S  E   +  ++EV+ L  LKH N+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 171 VGLRGWC-KKEKESLILIYDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYL 228
           V        +   +L ++ +Y E G L   I +   E   L  E  ++V+  +   +   
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 229 YE--GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPI-------EE 279
           +        VLHRD+K +NV LD K N +LGDFGLA++ +H    +            E+
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ 185

Query: 280 GKRNLVDR---MWSL-----------------TERSELLSVLDERLKAKGGYADEVVEKV 319
             R   +    +WSL                 +++     + + + +          +++
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYRYSDEL 242

Query: 320 LHLGLLCAHPEANSRPTIRQVLK 342
             +     + +   RP++ ++L+
Sbjct: 243 NEIITRMLNLKDYHRPSVEEILE 265

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  129 bits (324), Expect = 2e-34
 Identities = 53/276 (19%), Positives = 99/276 (35%), Gaps = 37/276 (13%)

Query: 97  EYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMRE 154
           +Y+P  V  +  H     +     +G G  G V++      G   A K +    E     
Sbjct: 11  QYYPQPVEIKHDHVLDH-YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET 69

Query: 155 FLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQR 214
              E+ ++  L+H  LV L     ++   +++IY++M  G L + +   DE   +S ++ 
Sbjct: 70  VRKEIQTMSVLRHPTLVNLHDAF-EDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEA 126

Query: 215 IKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNAR--LGDFGLAK------MHH 266
           ++ ++ V  G+ ++    E+  +H D+K  N++   K +    L DFGL           
Sbjct: 127 VEYMRQVCKGLCHM---HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183

Query: 267 HGQVMSGRRPIEEGKRNLVDR---MWSL-----------------TERSELLSVLDERLK 306
                +     E  +   V     MWS+                  +   L +V      
Sbjct: 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN 243

Query: 307 AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK 342
                   + E            + N+R TI Q L+
Sbjct: 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  127 bits (319), Expect = 2e-34
 Identities = 54/294 (18%), Positives = 106/294 (36%), Gaps = 66/294 (22%)

Query: 115 FSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLDSEHGMR-EFLAEVSSLGRLK 166
                 IG G  G+V++ +            VA+K +  ++   M+ +F  E + +    
Sbjct: 15  IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74

Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDE--------------------- 205
           + N+V L G C    + + L+++YM  G L++++                          
Sbjct: 75  NPNIVKLLGVCA-VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 206 SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
              LS  +++ + + VA+G+ YL    E K +HRD+   N L+ + M  ++ DFGL++  
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190

Query: 266 HHGQVMS---------GRRPIEEGKRNLVDR---MWSL------------------TERS 295
           +                  P E    N       +W+                       
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 296 ELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE 349
            +  V D  + A     +    ++ +L  LC       RP+   + ++L+   E
Sbjct: 251 VIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 5e-34
 Identities = 51/254 (20%), Positives = 96/254 (37%), Gaps = 33/254 (12%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRIS---LDSEHGMREFLAEVSSLGRLKHRN 169
           F     +G G  G VY  +       +ALK +    L+      +   EV     L+H N
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           ++ L G+   +   + LI +Y   G++ + + +  +      ++    + ++A+ + Y  
Sbjct: 68  ILRLYGYFH-DATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC- 122

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS-----GRRPIEEGKRNL 284
                +V+HRDIK  N+LL      ++ DFG +      +  +        P E  +  +
Sbjct: 123 --HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRM 180

Query: 285 VDR---MWSLT-------------ERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAH 328
            D    +WSL              E +          + +  + D V E    L      
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLK 240

Query: 329 PEANSRPTIRQVLK 342
              + RP +R+VL+
Sbjct: 241 HNPSQRPMLREVLE 254

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 6e-34
 Identities = 56/292 (19%), Positives = 98/292 (33%), Gaps = 65/292 (22%)

Query: 115 FSEENVIGLGGNGKVYKGQLLG-------VEVALKRISLDSEHGMRE-FLAEVSSLGRL- 165
                V+G G  GKV      G       ++VA+K +   ++   RE  ++E+  + +L 
Sbjct: 39  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98

Query: 166 KHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESI------------------ 207
            H N+V L G C      + LI++Y   G L  ++    E                    
Sbjct: 99  SHENIVNLLGACT-LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157

Query: 208 --ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH 265
              L++E  +     VA G+ +L        +HRD+ A NVL+      ++ DFGLA+  
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214

Query: 266 HHGQVMSGRR------------PIEEGKRNLVDRMWSL------------------TERS 295
                   R              + EG   +   +WS                      +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 296 ELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ 347
               ++    K          E++  +   C   ++  RP+   +   L  Q
Sbjct: 275 NFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 8e-34
 Identities = 58/310 (18%), Positives = 115/310 (37%), Gaps = 66/310 (21%)

Query: 85  MKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLLGV------- 137
             DV   ++WE+                +  +    +G G  G VY+G   GV       
Sbjct: 6   AADVYVPDEWEVAR--------------EKITMSRELGQGSFGMVYEGVAKGVVKDEPET 51

Query: 138 EVALKRISLDSEHGMR-EFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSL 196
            VA+K ++  +    R EFL E S +      ++V L G   + +   ++I + M  G L
Sbjct: 52  RVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP-TLVIMELMTRGDL 110

Query: 197 DKWIFECDESIA-------LSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD 249
             ++     ++A        S  + I++  ++A G+ YL     +K +HRD+ A N ++ 
Sbjct: 111 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVA 167

Query: 250 KKMNARLGDFGLAKMHHHGQVMSGRRP------------IEEGKRNLVDRMWSL------ 291
           +    ++GDFG+ +  +                      +++G       +WS       
Sbjct: 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 227

Query: 292 ------------TERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQ 339
                       +    L  V++  L  K    D   + +  L  +C       RP+  +
Sbjct: 228 IATLAEQPYQGLSNEQVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLE 284

Query: 340 VLKMLEGQTE 349
           ++  ++ + E
Sbjct: 285 IISSIKEEME 294

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  123 bits (309), Expect = 2e-32
 Identities = 44/253 (17%), Positives = 87/253 (34%), Gaps = 36/253 (14%)

Query: 120 VIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
            +G G  G V++      G     K I+            E+S + +L H  L+ L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
            ++K  ++LI +++  G L   I    E   +S  + I  ++    G+ ++    E  ++
Sbjct: 96  -EDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHM---HEHSIV 149

Query: 238 HRDIKASNVLLDKKMNAR--LGDFGLAKMHHHGQVMSGRRP---------IEEGKRNLVD 286
           H DIK  N++ + K  +   + DFGLA   +  +++              ++        
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209

Query: 287 RMWSL-----------------TERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHP 329
            MW++                  +   L +V     +        V  +           
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQK 269

Query: 330 EANSRPTIRQVLK 342
           E   R T+   L+
Sbjct: 270 EPRKRLTVHDALE 282

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 8e-32
 Identities = 51/270 (18%), Positives = 94/270 (34%), Gaps = 44/270 (16%)

Query: 113 KGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD---SEHGMREFLAEVSSLGR 164
           K       +G G  G V +G+        V VA+K +  D       M +F+ EV+++  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 165 LKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASG 224
           L HRNL+ L G        + ++ +    GSL   +               +    VA G
Sbjct: 68  LDHRNLIRLYGVV--LTPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEG 123

Query: 225 ILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRP-------- 276
           + YL      + +HRD+ A N+LL  +   ++GDFGL +           +         
Sbjct: 124 MGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 277 -----IEEGKRNLVDRMWSLTE-RSELLS-------------VLDERLKAKGGYA--DEV 315
                ++    +     W       E+ +             +L +  K        ++ 
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240

Query: 316 VEKVLHLGLLCAHPEANSRPTIRQVLKMLE 345
            + + ++ + C   +   RPT   +   L 
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 2e-31
 Identities = 45/257 (17%), Positives = 96/257 (37%), Gaps = 37/257 (14%)

Query: 118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGL 173
           +  IG G    VYKG      VEVA   +     ++   + F  E   L  L+H N+V  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 174 RGWCK---KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
               +   K K+ ++L+ + M +G+L  ++        +  +      + +  G+ +L+ 
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT 130

Query: 231 GWESKVLHRDIKASNVLLDKK-MNARLGDFGLAKMHHHGQVMSGRRPIE-------EGKR 282
                ++HRD+K  N+ +     + ++GD GLA +       +     E       E K 
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKY 189

Query: 283 NLVDRMWSL-----------------TERSELLSVLDERLKAKGGYADEVVEKVLHLGLL 325
           +    +++                     +++   +   +K    +    + +V  +   
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PASFDKVAIPEVKEIIEG 248

Query: 326 CAHPEANSRPTIRQVLK 342
           C     + R +I+ +L 
Sbjct: 249 CIRQNKDERYSIKDLLN 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 2e-30
 Identities = 48/259 (18%), Positives = 94/259 (36%), Gaps = 36/259 (13%)

Query: 112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRN 169
            K ++    IG G +G VY    +  G EVA+++++L  +      + E+  +   K+ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           +V          + L ++ +Y+  GSL   + E          Q   V ++    + +L+
Sbjct: 79  IVNYLDSYL-VGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLH 133

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRR-------PIEEGKR 282
               ++V+HRDIK+ N+LL    + +L DFG        Q               E   R
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 283 NLVDR---MWSL----------------TERSELLSVLDERLKAKGGYADEVVEKVLHLG 323
                   +WSL                      L ++      +    +++        
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFL 250

Query: 324 LLCAHPEANSRPTIRQVLK 342
             C   +   R + +++L+
Sbjct: 251 NRCLDMDVEKRGSAKELLQ 269

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 3e-30
 Identities = 55/274 (20%), Positives = 91/274 (33%), Gaps = 67/274 (24%)

Query: 118 ENVIGLGGNGKVYKGQLL-----GVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLV 171
              IG G  G V++G  +      + VA+K     +   +RE FL E  ++ +  H ++V
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L G     +  + +I +    G L  ++     S  L     I     +++ + YL   
Sbjct: 72  KLIGVI--TENPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYL--- 124

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAK---------------------------- 263
              + +HRDI A NVL+      +LGDFGL++                            
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 264 -------MHHHGQVM-----SGRRPIEEGKRNLVDRMWSLTERSELLSVLDERLKAKGGY 311
                  +   G  M      G +P +  K N V       ER  +       L      
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY----- 239

Query: 312 ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE 345
                     L   C   + + RP   ++   L 
Sbjct: 240 ---------SLMTKCWAYDPSRRPRFTELKAQLS 264

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 5e-30
 Identities = 47/261 (18%), Positives = 90/261 (34%), Gaps = 37/261 (14%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRIS---LDSEHGMREFLAEVSSLGRLKHRN 169
           F    ++G G    V   + L    E A+K +    +  E+ +     E   + RL H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
            V L    + + E L     Y +NG L K+I +     +           ++ S + YL+
Sbjct: 70  FVKLYFTFQ-DDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLH 125

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRP------------I 277
                 ++HRD+K  N+LL++ M+ ++ DFG AK+       +                +
Sbjct: 126 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182

Query: 278 EEGKRNLVDRMWSLT-------------ERSELLSVLDERLKAKGGYADEVVEKVLHLGL 324
            E        +W+L                     +  + +K +  + ++   K   L  
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVE 242

Query: 325 LCAHPEANSRPTIRQVLKMLE 345
                +A  R    ++     
Sbjct: 243 KLLVLDATKRLGCEEMEGYGP 263

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 6e-30
 Identities = 57/284 (20%), Positives = 106/284 (37%), Gaps = 59/284 (20%)

Query: 115 FSEENVIGLGGNGKVYKGQLL---------GVEVALKRISLD-SEHGMREFLAEVSSLGR 164
                 +G G  G+V   + +           +VA+K +  D +E  + + ++E+  +  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 165 L-KHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFEC-------------DESIALS 210
           + KH+N++ L G C  +   L +I +Y   G+L +++                +    LS
Sbjct: 75  IGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133

Query: 211 WEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV 270
            +  +     VA G+ YL      K +HRD+ A NVL+ +    ++ DFGLA+  HH   
Sbjct: 134 SKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 271 MS---------GRRPIEEGKRNLVDR---MWSL-----------------TERSELLSVL 301
                           E     +      +WS                      EL  +L
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

Query: 302 DERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE 345
            E  +           ++  +   C H   + RPT +Q+++ L+
Sbjct: 251 KEGHRMD--KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 8e-30
 Identities = 60/283 (21%), Positives = 102/283 (36%), Gaps = 57/283 (20%)

Query: 115 FSEENVIGLGGNGKVYKGQLLGV-------EVALKRISLDSEHG-MREFLAEVSSLGRLK 166
                 +G G  G+V +    G+        VA+K +   + H   R  ++E+  L  + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 167 HR-NLVGLRGWCKKEKESLILIYDYMENGSLDKWIF-------------ECDESIALSWE 212
           H  N+V L G C K    L++I ++ + G+L  ++              E      L+ E
Sbjct: 75  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 213 QRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ--- 269
             I     VA G+ +L      K +HRD+ A N+LL +K   ++ DFGLA+  +      
Sbjct: 135 HLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 270 ---------------------------VMSGRRPIEEGKRNLVDRMWSLTERSELLSVLD 302
                                      V S    + E           +    E    L 
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 303 ERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE 345
           E  + +    D    ++    L C H E + RPT  ++++ L 
Sbjct: 252 EGTRMR--APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (285), Expect = 1e-29
 Identities = 38/158 (24%), Positives = 64/158 (40%), Gaps = 10/158 (6%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLV 171
           +     +G G  G+V           VA+K + +       E    E+     L H N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
              G  ++      L  +Y   G L   I      I +      +    + +G++YL+  
Sbjct: 67  KFYGHRREGNI-QYLFLEYCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGI 122

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
               + HRDIK  N+LLD++ N ++ DFGLA +  +  
Sbjct: 123 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  111 bits (279), Expect = 1e-28
 Identities = 49/258 (18%), Positives = 87/258 (33%), Gaps = 35/258 (13%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLV 171
           +   +V+G G   +V   +       VA+K I+  +  G       E++ L ++KH N+V
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
            L    +     L LI   +  G L   I E       +     +++  V   + YL++ 
Sbjct: 71  ALDDIYE-SGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDL 126

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSG-------RRPIEEGKRNL 284
                  +        LD+     + DFGL+KM   G V+S          P    ++  
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 186

Query: 285 ---VDRMWSL-----------------TERSELLSVLDERLKAKGGYADEVVEKVLHLGL 324
              VD  WS+                  +      +L    +    Y D++ +       
Sbjct: 187 SKAVD-CWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 245

Query: 325 LCAHPEANSRPTIRQVLK 342
                +   R T  Q L+
Sbjct: 246 HLMEKDPEKRFTCEQALQ 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  111 bits (279), Expect = 3e-28
 Identities = 42/241 (17%), Positives = 85/241 (35%), Gaps = 18/241 (7%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRIS---LDSEHGMREFLAEV---SSLGRLK 166
           FS   +IG GG G+VY  +    G   A+K +    +  + G    L E    S +    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 167 HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
              +V +        + L  I D M  G L   + +                 ++  G+ 
Sbjct: 66  CPFIVCMSYAFH-TPDKLSFILDLMNGGDLHYHLSQHGVFS---EADMRFYAAEIILGLE 121

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPIEEGKRNLVD 286
           ++       V++RD+K +N+LLD+  + R+ D GLA      +  +           ++ 
Sbjct: 122 HM---HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQ 178

Query: 287 RMWSLTERSELLS---VLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKM 343
           +  +    ++  S   +L + L+    +     +    +  +          +    L+ 
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238

Query: 344 L 344
           L
Sbjct: 239 L 239

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 6e-28
 Identities = 45/165 (27%), Positives = 71/165 (43%), Gaps = 15/165 (9%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVG 172
           +++  VIG G  G VY+ +L   G  VA+K++  D     RE    +  + +L H N+V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVR 77

Query: 173 LRGWC-----KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           LR +      KK++  L L+ DY+                 L        +  +   + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 228 LYEGWESKVLHRDIKASNVLLDKK-MNARLGDFGLAKMHHHGQVM 271
           ++      + HRDIK  N+LLD      +L DFG AK    G+  
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 179

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  109 bits (272), Expect = 8e-28
 Identities = 52/272 (19%), Positives = 100/272 (36%), Gaps = 51/272 (18%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---------EHGMREFLAEVSSLG 163
           +  + ++G G +  V +        E A+K I +           +      L EV  L 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 164 RLK-HRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVA 222
           ++  H N++ L+   +       L++D M+ G L  ++    E + LS ++  K+++ + 
Sbjct: 65  KVSGHPNIIQLKDTYE-TNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALL 120

Query: 223 SGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS------GRRP 276
             I  L++     ++HRD+K  N+LLD  MN +L DFG +     G+ +           
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 177

Query: 277 IEEGKRNLVDR---------MWSL-----------------TERSELLSVLDERLKAKGG 310
            E  + ++ D          MWS                   +   L  ++    +    
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237

Query: 311 YADEVVEKVLHLGLLCAHPEANSRPTIRQVLK 342
             D+  + V  L       +   R T  + L 
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 3e-27
 Identities = 40/253 (15%), Positives = 89/253 (35%), Gaps = 37/253 (14%)

Query: 120 VIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWC 177
            +G G  G V++            K + +           E+S L   +HRN++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 178 KKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVL 237
            +  E L++I++++    + + I     +  L+  + +  +  V   + +L       + 
Sbjct: 71  -ESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFL---HSHNIG 124

Query: 238 HRDIKASNVLLDKKMNAR--LGDFGLAKMHHHGQVMS------GRRPIEEGKRNLVDR-- 287
           H DI+  N++   + ++   + +FG A+    G               E  + ++V    
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184

Query: 288 -MWSL-----------------TERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHP 329
            MWSL                 T +  + ++++           E+  + +         
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVK 244

Query: 330 EANSRPTIRQVLK 342
           E  SR T  + L+
Sbjct: 245 ERKSRMTASEALQ 257

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 3e-26
 Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 7/158 (4%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMRE-FLAEVSSLGRLKHRNLV 171
           ++  + IG G  G V         V VA+K+IS        +  L E+  L R +H N++
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
           G+    +       +   Y+    +   +++  ++  LS +     L  +  G+ Y+   
Sbjct: 70  GINDIIR-APTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI--- 125

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
             + VLHRD+K SN+LL+   + ++ DFGLA++     
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  104 bits (260), Expect = 4e-26
 Identities = 29/163 (17%), Positives = 71/163 (43%), Gaps = 14/163 (8%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRN 169
           +    ++G GG  +V+  + L    +VA+K +  D          F  E  +   L H  
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 170 LVGLRGWCKKEKES---LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGIL 226
           +V +    + E  +     ++ +Y++  +L   +        ++ ++ I+V+ D    + 
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALN 125

Query: 227 YLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
           +     ++ ++HRD+K +N+++      ++ DFG+A+      
Sbjct: 126 FS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 3e-25
 Identities = 36/166 (21%), Positives = 69/166 (41%), Gaps = 13/166 (7%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGR-LKHR 168
           F    ++G G  GKV+  +        A+K +  D    +  +   + E   L    +H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 169 NLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYL 228
            L  +    +  KE+L  + +Y+  G L   I  C +       +      ++  G+ +L
Sbjct: 64  FLTHMFCTFQ-TKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFL 119

Query: 229 YEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGR 274
                  +++RD+K  N+LLDK  + ++ DFG+ K +  G   +  
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 162

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 3e-24
 Identities = 47/166 (28%), Positives = 85/166 (51%), Gaps = 17/166 (10%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNL 170
           + +   IG G  G+V+K +    G +VALK++ +++  E      L E+  L  LKH N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 171 VGLRGWCK-------KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVAS 223
           V L   C+       + K S+ L++D+ E+          +  +  +  +  +V++ + +
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLN 128

Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
           G   LY    +K+LHRD+KA+NVL+ +    +L DFGLA+     +
Sbjct: 129 G---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 171

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 99.4 bits (247), Expect = 4e-24
 Identities = 36/167 (21%), Positives = 64/167 (38%), Gaps = 12/167 (7%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRN 169
           F     +G G  G+V+  +    G   A+K +  +       +     E   L  + H  
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           ++ + G  + + + + +I DY+E G L        +S             +V    L L 
Sbjct: 66  IIRMWGTFQ-DAQQIFMIMDYIEGGELFSL---LRKSQRFPNPVAKFYAAEVC---LALE 118

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRP 276
                 +++RD+K  N+LLDK  + ++ DFG AK            P
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP 165

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.8 bits (245), Expect = 5e-24
 Identities = 46/158 (29%), Positives = 73/158 (46%), Gaps = 14/158 (8%)

Query: 119 NVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMRE-----FLAEVSSLGRLKHRNLV 171
           + +G G    VYK +       VA+K+I L      ++      L E+  L  L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 172 GLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
           GL       K ++ L++D+ME           D S+ L+       +     G+ YL++ 
Sbjct: 64  GLLDAFG-HKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 232 WESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
           W   +LHRD+K +N+LLD+    +L DFGLAK      
Sbjct: 120 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.2 bits (241), Expect = 2e-23
 Identities = 44/159 (27%), Positives = 69/159 (43%), Gaps = 10/159 (6%)

Query: 115 FSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNL 170
           F +   IG G  G VYK +  L G  VALK+I LD  +E      + E+S L  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
           V L       +  L L+++++                 +        L  +  G+ + + 
Sbjct: 64  VKLLDVIH-TENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 120

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
                VLHRD+K  N+L++ +   +L DFGLA+      
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.3 bits (239), Expect = 3e-23
 Identities = 52/250 (20%), Positives = 84/250 (33%), Gaps = 33/250 (13%)

Query: 120 VIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMRE------FLAEVSSLGRLK--HRN 169
           ++G GG G VY G  +   + VA+K +  D      E         EV  L ++      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           ++ L  W +   +S +LI +  E            E  AL  E        V   + +  
Sbjct: 71  VIRLLDWFE-RPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHC- 126

Query: 230 EGWESKVLHRDIKASNVLLD-KKMNARLGDFGLAKMHHHGQVMS-----GRRPIE----E 279
                 VLHRDIK  N+L+D  +   +L DFG   +                P E     
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 184

Query: 280 GKRNLVDRMWS-------LTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEAN 332
                   +WS       +          +E ++ +  +   V  +  HL   C     +
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPS 244

Query: 333 SRPTIRQVLK 342
            RPT  ++  
Sbjct: 245 DRPTFEEIQN 254

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.0 bits (238), Expect = 1e-22
 Identities = 35/158 (22%), Positives = 64/158 (40%), Gaps = 12/158 (7%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRN 169
           F    ++G G  GKV   +    G   A+K +  +   ++  +   + E   L   +H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           L  L+ +  +  + L  + +Y   G L   +         + E+      ++ S    L 
Sbjct: 67  LTALK-YAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSA---LE 119

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
                 V++RDIK  N++LDK  + ++ DFGL K    
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 93.4 bits (231), Expect = 4e-22
 Identities = 45/154 (29%), Positives = 71/154 (46%), Gaps = 10/154 (6%)

Query: 119 NVIGLGGNGKVYKGQL-LGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRG 175
             IG G  G VYK Q   G   ALK+I L+   E      + E+S L  LKH N+V L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
                K+ L+L++++++                L        L  + +GI Y     + +
Sbjct: 68  VIH-TKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYC---HDRR 120

Query: 236 VLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
           VLHRD+K  N+L++++   ++ DFGLA+      
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.0 bits (233), Expect = 4e-22
 Identities = 37/163 (22%), Positives = 69/163 (42%), Gaps = 18/163 (11%)

Query: 118 ENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLR 174
             V+GLG NGKV +        + ALK +         +   EV    R  +  ++V + 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIV 71

Query: 175 GWCK---KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG 231
              +     ++ L+++ + ++ G L   I +  +  A +  +  +++K +   I YL+  
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS- 129

Query: 232 WESKVLHRDIKASNVLLDKKMN---ARLGDFGLAKMHHHGQVM 271
               + HRD+K  N+L   K      +L DFG AK       +
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 93.7 bits (232), Expect = 7e-22
 Identities = 32/158 (20%), Positives = 59/158 (37%), Gaps = 12/158 (7%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRIS---LDSEHGMREFLAEVSSLGRLKHRN 169
           F     +G G  G+V   +    G   A+K +    +     +   L E   L  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 170 LVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLY 229
           LV L    K +  +L ++ +Y+  G +   +         S          +     YL 
Sbjct: 103 LVKLEFSFK-DNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL- 157

Query: 230 EGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
                 +++RD+K  N+L+D++   ++ DFG AK    
Sbjct: 158 --HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.5 bits (229), Expect = 7e-22
 Identities = 56/275 (20%), Positives = 97/275 (35%), Gaps = 54/275 (19%)

Query: 115 FSEENV---------IGLGGNGKVYKGQLL--GVEVALKRISL------DSEHGMREFLA 157
           F +ENV         +G G    V K +    G++ A K I               +   
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 158 EVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKV 217
           EVS L  ++H N++ L     + K  +ILI + +  G L  ++ E +   +L+ E+  + 
Sbjct: 63  EVSILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEF 118

Query: 218 LKDVASGILYLYEGWESKVLHRDIKASNVLLDK----KMNARLGDFGLAKMHHHGQVMSG 273
           LK + +G   +Y     ++ H D+K  N++L      K   ++ DFGLA     G     
Sbjct: 119 LKQILNG---VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175

Query: 274 RR---------PIEEGKRNLVDRMWSL-----------------TERSELLSVLDERLKA 307
                       +      L   MWS+                 T++  L +V     + 
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235

Query: 308 KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLK 342
           +  Y                  +   R TI+  L+
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.4 bits (226), Expect = 4e-21
 Identities = 32/169 (18%), Positives = 69/169 (40%), Gaps = 11/169 (6%)

Query: 104 SYQEIHAATKGFSE----ENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREF 155
             QE+                +G G  G V        G +VA+K++     SE   +  
Sbjct: 5   YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA 64

Query: 156 LAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRI 215
             E+  L  ++H N++GL      ++        Y+    +   + +  +   L  ++  
Sbjct: 65  YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 124

Query: 216 KVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM 264
            ++  +  G+ Y+     + ++HRD+K  N+ +++    ++ DFGLA+ 
Sbjct: 125 FLVYQMLKGLRYI---HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 89.5 bits (221), Expect = 1e-20
 Identities = 37/197 (18%), Positives = 82/197 (41%), Gaps = 28/197 (14%)

Query: 83  KKMKDVEETEDWELEYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVA 140
            + ++  + E   +E W ++  YQ +            +G G   +V++   +    +V 
Sbjct: 16  HRPREYWDYESHVVE-WGNQDDYQLV----------RKLGRGKYSEVFEAINITNNEKVV 64

Query: 141 LKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLRGWCK-KEKESLILIYDYMENGSLDK 198
           +K +    +   ++   E+  L  L+   N++ L    K     +  L+++++ N    +
Sbjct: 65  VKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQ 121

Query: 199 WIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK-MNARLG 257
                     L+       + ++   + Y        ++HRD+K  NV++D +    RL 
Sbjct: 122 LYQ------TLTDYDIRFYMYEILKALDYC---HSMGIMHRDVKPHNVMIDHEHRKLRLI 172

Query: 258 DFGLAKMHHHGQVMSGR 274
           D+GLA+ +H GQ  + R
Sbjct: 173 DWGLAEFYHPGQEYNVR 189

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.5 bits (218), Expect = 2e-20
 Identities = 43/158 (27%), Positives = 67/158 (42%), Gaps = 11/158 (6%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNL 170
           + +   IG G  G V+K +       VALKR+ LD   E      L E+  L  LKH+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
           V L      +K+  +      E    D   +    +  L  E     L  +  G+ +   
Sbjct: 64  VRLHDVLHSDKKLTL----VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC-- 117

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG 268
                VLHRD+K  N+L+++    +L +FGLA+     
Sbjct: 118 -HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 88.4 bits (218), Expect = 2e-20
 Identities = 35/160 (21%), Positives = 64/160 (40%), Gaps = 13/160 (8%)

Query: 118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
              IG G  G +Y G  +  G EVA+K   + ++H   +   E      ++    +    
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIR 69

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
           WC  E +  +++ + +     D + F   +    S +  + +   + S I Y++      
Sbjct: 70  WCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIH---SKN 123

Query: 236 VLHRDIKASNVL---LDKKMNARLGDFGLAKMHHHGQVMS 272
            +HRD+K  N L     K     + DFGLAK +   +   
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.2 bits (212), Expect = 3e-19
 Identities = 37/185 (20%), Positives = 77/185 (41%), Gaps = 19/185 (10%)

Query: 97  EYWPHRVSYQEIHAATKGFSEENVIGLGGNGKVYKGQ--LLGVEVALKRISLD--SEHGM 152
           +++   V         + +     IG G  G V      +L   VA+K++S    ++   
Sbjct: 2   QFYSVEVGDSTFTVLKR-YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 60

Query: 153 REFLAEVSSLGRLKHRNLVGLRGWCKKEK-----ESLILIYDYMENGSLDKWIFECDESI 207
           +    E+  +  + H+N++ L      +K     + + L+ + M+         E D   
Sbjct: 61  KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--- 117

Query: 208 ALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
               E+   +L  +  GI +L+      ++HRD+K SN+++      ++ DFGLA+    
Sbjct: 118 ---HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171

Query: 268 GQVMS 272
             +M+
Sbjct: 172 SFMMT 176

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.9 bits (209), Expect = 6e-19
 Identities = 34/164 (20%), Positives = 66/164 (40%), Gaps = 15/164 (9%)

Query: 115 FSEENVIGLGGNGKVYKGQLL-----GVEVALKRIS----LDSEHGMREFLAEVSSLGRL 165
           F    V+G G  GKV+  + +     G   A+K +     +           E   L  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 166 KHRNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGI 225
           +    +    +  + +  L LI DY+  G L   + + +     +  +    + ++   +
Sbjct: 86  RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLAL 142

Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ 269
            +L    +  +++RDIK  N+LLD   +  L DFGL+K     +
Sbjct: 143 EHL---HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE 183

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.0 bits (204), Expect = 2e-18
 Identities = 41/167 (24%), Positives = 77/167 (46%), Gaps = 19/167 (11%)

Query: 119 NVIGLGGNGKVYKGQLL---GVEVALKRISLDS------EHGMREFLAEVSSLGRLKHRN 169
             IG G  GKV+K + L   G  VALKR+ + +         +RE +A +  L   +H N
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLETFEHPN 71

Query: 170 LVGLRGWCK----KEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGI 225
           +V L   C       +  L L++++++           +    +  E    ++  +  G+
Sbjct: 72  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--VPTETIKDMMFQLLRGL 129

Query: 226 LYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMS 272
            +L+     +V+HRD+K  N+L+      +L DFGLA+++     ++
Sbjct: 130 DFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 173

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.4 bits (205), Expect = 2e-18
 Identities = 32/167 (19%), Positives = 67/167 (40%), Gaps = 7/167 (4%)

Query: 115 FSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNL 170
           +   + +G G  G V        G+ VA+K++S    S    +    E+  L  +KH N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 171 VGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYE 230
           +GL       +        Y+    +   +    +   L+ +    ++  +  G+ Y++ 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139

Query: 231 GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVMSGRRPI 277
                ++HRD+K SN+ +++    ++ DFGLA+              
Sbjct: 140 AD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW 183

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 79.1 bits (194), Expect = 3e-17
 Identities = 29/154 (18%), Positives = 56/154 (36%), Gaps = 15/154 (9%)

Query: 118 ENVIGLGGNGKVYKGQ--LLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
              IG G  G +++G   L   +VA+K     S+    +   E  +   L     +    
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVY 67

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK 235
           +  +E    +L+ D +     D            S +      K + + +  ++E     
Sbjct: 68  YFGQEGLHNVLVIDLLGPSLEDLLD---LCGRKFSVKTVAMAAKQMLARVQSIHE---KS 121

Query: 236 VLHRDIKASNVLLDKKM-----NARLGDFGLAKM 264
           +++RDIK  N L+ +          + DFG+ K 
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 73.7 bits (180), Expect = 5e-16
 Identities = 26/160 (16%), Positives = 50/160 (31%), Gaps = 22/160 (13%)

Query: 119 NVIGLGGNGKVYKGQLL-GVEVALKRISLDS----------EHGMREFLAEVSSLGRLKH 167
            ++G G    V+        E  +K   +            ++G   F        R + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 168 RNLVGLRGWCKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILY 227
           R L  L+G        +  +Y +  N  L + I   +           +VL  +   +  
Sbjct: 66  RALQKLQGLA------VPKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAK 118

Query: 228 LYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH 267
            Y      ++H D+   NVL+  +    + DF  +     
Sbjct: 119 FYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 69.3 bits (168), Expect = 1e-13
 Identities = 24/169 (14%), Positives = 54/169 (31%), Gaps = 18/169 (10%)

Query: 118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRG 175
              +G G    V+  + +     VA+K +  D  +       E+  L R+   +      
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDS 76

Query: 176 WCKKEKESLILIYDYMENGSLDKWIFEC------------DESIALSWEQRIKVLKDVAS 223
                   L+  +++     +   +                E   +      ++ K +  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 224 GILYLYEGWESKVLHRDIKASNVLLDKK-MNARLGDFGLAKMHHHGQVM 271
           G+ Y++      ++H DIK  NVL++       L    +A + +     
Sbjct: 137 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

 Score = 51.3 bits (122), Expect = 5e-08
 Identities = 17/48 (35%), Positives = 27/48 (56%), Gaps = 2/48 (4%)

Query: 1   MHVGFSAGTGQLV--ESHKILAWSFSNSNFSIGDALVTTHLPSFELPK 46
           + +GFSA TG  +  ESH +L+WSF+++       +    L SF L +
Sbjct: 204 VRIGFSAATGLDIPGESHDVLSWSFASNLPHASSNIDPLDLTSFVLHE 251

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

 Score = 50.1 bits (119), Expect = 1e-07
 Identities = 10/26 (38%), Positives = 20/26 (76%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNS 26
           + VGFSA +G+  ++H + +WSF+++
Sbjct: 211 VRVGFSAASGEQYQTHTLESWSFTST 236

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

 Score = 47.4 bits (112), Expect = 1e-06
 Identities = 14/49 (28%), Positives = 23/49 (46%), Gaps = 4/49 (8%)

Query: 1   MHVGFSAGTG---QLVESHKILAWSFSNSNFSIGDALVTTHLPSFELPK 46
           + +GFSA TG      E+H +L+WSF+ S            + S+ +  
Sbjct: 204 VSIGFSATTGLSEGYTETHDVLSWSFA-SKLPDDSTTEPLDIASYLVRN 251

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

 Score = 46.2 bits (109), Expect = 2e-06
 Identities = 14/29 (48%), Positives = 22/29 (75%), Gaps = 3/29 (10%)

Query: 1   MHVGFSAGTG---QLVESHKILAWSFSNS 26
           ++VG SA TG     VE+H+I++WSF++S
Sbjct: 205 VNVGLSATTGYQKNAVETHEIISWSFTSS 233

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

 Score = 45.9 bits (108), Expect = 3e-06
 Identities = 14/32 (43%), Positives = 22/32 (68%), Gaps = 4/32 (12%)

Query: 1   MHVGFSAGTGQ---LVESHKILAWSFSNSNFS 29
           + VGFSA TG    +VE+H I++WSF+  + +
Sbjct: 203 VRVGFSATTGLNAGVVETHDIVSWSFA-VSLA 233

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 45.1 bits (106), Expect = 3e-06
 Identities = 15/31 (48%), Positives = 20/31 (64%), Gaps = 4/31 (12%)

Query: 1   MHVGFSAGTGQL---VESHKILAWSFSNSNF 28
           + VGFSA +G      E+H +L+WSFS S F
Sbjct: 175 VSVGFSATSGAYQWSYETHDVLSWSFS-SKF 204

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

 Score = 45.4 bits (107), Expect = 4e-06
 Identities = 11/29 (37%), Positives = 15/29 (51%), Gaps = 3/29 (10%)

Query: 1   MHVGFSAGTG---QLVESHKILAWSFSNS 26
           + VG S  TG      E+H + +WSF  S
Sbjct: 208 VDVGLSGATGAQRDAAETHDVYSWSFQAS 236

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

 Score = 45.1 bits (106), Expect = 4e-06
 Identities = 14/28 (50%), Positives = 21/28 (75%), Gaps = 2/28 (7%)

Query: 1   MHVGFSAGTGQL--VESHKILAWSFSNS 26
           + VGFSA TG    VE+H +L+WSF+++
Sbjct: 211 VRVGFSAATGYPTEVETHDVLSWSFTST 238

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 45.1 bits (106), Expect = 4e-06
 Identities = 16/31 (51%), Positives = 22/31 (70%), Gaps = 4/31 (12%)

Query: 1   MHVGFSAGTG---QLVESHKILAWSFSNSNF 28
           + VGFSA +G   +  E+H +L+WSFS SNF
Sbjct: 196 VSVGFSATSGSKKETTETHNVLSWSFS-SNF 225

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 45.1 bits (106), Expect = 5e-06
 Identities = 15/32 (46%), Positives = 21/32 (65%), Gaps = 4/32 (12%)

Query: 1   MHVGFSAGTGQL---VESHKILAWSFSNSNFS 29
           + VGFSA TG     VE++ +L+WSF+ S  S
Sbjct: 203 VSVGFSATTGINKGNVETNDVLSWSFA-SKLS 233

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

 Score = 44.7 bits (105), Expect = 8e-06
 Identities = 11/26 (42%), Positives = 16/26 (61%), Gaps = 1/26 (3%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNS 26
           + +GFSAG G   E   IL+W F ++
Sbjct: 213 VRIGFSAGVG-YDEVTYILSWHFFST 237

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

 Score = 44.3 bits (104), Expect = 1e-05
 Identities = 11/27 (40%), Positives = 16/27 (59%), Gaps = 1/27 (3%)

Query: 1   MHVGFSAGTGQ-LVESHKILAWSFSNS 26
           + VG SA TG     +  IL+W FS++
Sbjct: 209 VRVGISASTGNNQFLTVYILSWRFSSN 235

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

 Score = 44.3 bits (104), Expect = 1e-05
 Identities = 13/30 (43%), Positives = 18/30 (60%), Gaps = 3/30 (10%)

Query: 1   MHVGFSAGTGQLV--ESHKILAWSFSNSNF 28
           + VGFS G G     E+H +L+W F+ SN 
Sbjct: 208 VSVGFSGGVGNAAEFETHDVLSWYFT-SNL 236

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

 Score = 43.9 bits (103), Expect = 1e-05
 Identities = 9/27 (33%), Positives = 16/27 (59%), Gaps = 1/27 (3%)

Query: 1   MHVGFSAGTGQ-LVESHKILAWSFSNS 26
           + VGFS  T      +H++L W F+++
Sbjct: 210 VSVGFSGSTYIGRQATHEVLNWYFTST 236

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

 Score = 43.6 bits (102), Expect = 1e-05
 Identities = 14/31 (45%), Positives = 19/31 (61%), Gaps = 4/31 (12%)

Query: 1   MHVGFSAGTG---QLVESHKILAWSFSNSNF 28
           + VGFS  +G      E+H +L+WSFS S F
Sbjct: 198 VSVGFSPTSGLTEDTTETHDVLSWSFS-SKF 227

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

 Score = 43.2 bits (101), Expect = 2e-05
 Identities = 12/38 (31%), Positives = 19/38 (50%), Gaps = 8/38 (21%)

Query: 1   MHVGFSAGTGQL-VESHKILAWSFSNSNFSIGDALVTT 37
           +  GFSA       + H I +WSF+++       L+TT
Sbjct: 202 VKFGFSASGSLGGRQIHLIRSWSFTST-------LITT 232

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

 Score = 42.4 bits (99), Expect = 4e-05
 Identities = 16/33 (48%), Positives = 20/33 (60%), Gaps = 7/33 (21%)

Query: 1   MHVGFSAGTGQ-------LVESHKILAWSFSNS 26
           ++VGFSA TG          E+H IL+WSFS S
Sbjct: 202 VNVGFSAATGDPSGKQRNATETHDILSWSFSAS 234

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

 Score = 42.5 bits (99), Expect = 4e-05
 Identities = 11/27 (40%), Positives = 17/27 (62%), Gaps = 3/27 (11%)

Query: 1   MHVGFSAGTG---QLVESHKILAWSFS 24
           +  GFSA TG     V+++ +L+WSF 
Sbjct: 206 VRFGFSATTGIDKGYVQTNDVLSWSFE 232

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score = 39.9 bits (93), Expect = 3e-04
 Identities = 12/26 (46%), Positives = 18/26 (69%)

Query: 1   MHVGFSAGTGQLVESHKILAWSFSNS 26
           + VG SA TG   E++ IL+WSF++ 
Sbjct: 89  VRVGLSASTGLYKETNTILSWSFTSK 114

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.2 bits (88), Expect = 0.001
 Identities = 9/23 (39%), Positives = 13/23 (56%)

Query: 1   MHVGFSAGTGQLVESHKILAWSF 23
            H G SA TG L + H +L++  
Sbjct: 201 GHFGISAATGGLADDHDVLSFLT 223

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	409
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.76
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.98
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.62
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	97.37
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.51
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.38
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.19
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	94.33
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	94.29
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	94.22
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	93.54
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	92.72
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	92.61
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	92.29
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	92.26
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	92.25
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	92.23
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	91.98
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	91.96
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	91.78
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	91.7
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	91.29
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	91.28
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	91.1
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	90.59
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	90.57
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	90.57
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	89.7
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	89.59
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	89.43
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	89.41
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	89.19
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	89.13
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	89.09
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	88.22
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	86.97
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	86.11
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	85.74

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.3e-47  Score=355.74  Aligned_cols=236  Identities=23%  Similarity=0.392  Sum_probs=190.0

Q ss_pred             HHHHHhCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          107 EIHAATKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       107 ~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      +++...++|+..+.||+|+||+||+|++.  ++.||||+++.+. ...++|.+|+.+|++++|||||+++|+|.+ .+..
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~   88 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPF   88 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSC
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEee-CCee
Confidence            33334567888999999999999999997  8899999997553 345789999999999999999999999987 6788


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++|||||++|+|.+++... ....+++..++.++.|||+||+|||   +++|+||||||+||||++++.+||+|||+|+.
T Consensus        89 ~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          89 YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             EEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceee
Confidence            9999999999999999763 3457999999999999999999999   78999999999999999999999999999998


Q ss_pred             ccCCce-----eeecccc------ccCCCcHHHHHHhhhcc--------------CcHH---HHhhHHhhhcCCCCHHHH
Q 048535          265 HHHGQV-----MSGRRPI------EEGKRNLVDRMWSLTER--------------SELL---SVLDERLKAKGGYADEVV  316 (409)
Q Consensus       265 ~~~~~~-----~~g~~p~------~~~~~~~~~~vws~~~~--------------~~~~---~~~~~~l~~~~~~~~~~~  316 (409)
                      ......     ..|..++      ....++..+|+|+++..              ....   +.+.....  .+.+...+
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~--~~~~~~~~  242 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--MERPEGCP  242 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCTTCC
T ss_pred             cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCC--CCCCccch
Confidence            755431     1222222      12677899999998310              1111   12222211  34455667


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      ..+.+|+.+||+.||++||||+|+++.|+.+.+.
T Consensus       243 ~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         243 EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            7899999999999999999999999999877544

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-46  Score=353.55  Aligned_cols=229  Identities=27%  Similarity=0.441  Sum_probs=174.4

Q ss_pred             CCCccceeecCCceEEEEEEEC--C---cEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--G---VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~---~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      +|+..+.||+|+||+||+|++.  +   ..||||.+... .....+.|.+|+++|++++|||||+++|+|.+ .+..++|
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~iv  105 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-STPVMII  105 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCEEEEE
Confidence            3455689999999999999986  3   35999998755 55567789999999999999999999999987 6789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||||++|+|.+++..  ....++|.+++.++.|||+||.|||   +++|+||||||+||||+.++++||+|||+|+....
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999999864  2346999999999999999999999   79999999999999999999999999999987654


Q ss_pred             Cce---------eeecccc------ccCCCcHHHHHHhhhccCcHHHHh----------------hHHhh-hcCCCCHHH
Q 048535          268 GQV---------MSGRRPI------EEGKRNLVDRMWSLTERSELLSVL----------------DERLK-AKGGYADEV  315 (409)
Q Consensus       268 ~~~---------~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~-~~~~~~~~~  315 (409)
                      ...         ..|...+      ....++..+|||+++  ..+++++                ..... ...+.+.++
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~G--vvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYG--IVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC  258 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHH--HHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccch--HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            321         0111111      136678889999983  1222222                11111 012344556


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      +..+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus       259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            67899999999999999999999999999876543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-46  Score=343.59  Aligned_cols=229  Identities=23%  Similarity=0.345  Sum_probs=176.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      ++|+..+.||+|+||+||+|.+. +..||||+++... ...++|.+|+.++++++|||||+++|+|.+ ++..++|||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc-CCceEEEEEec
Confidence            56788899999999999999997 7889999997643 334689999999999999999999999987 67789999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce-
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV-  270 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~-  270 (409)
                      ++|+|.+++..  ....+++..++.++.|||+||.|||   +++|+||||||+|||+++++.+||+|||+|+....... 
T Consensus        83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             CCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            99999999864  3356899999999999999999999   89999999999999999999999999999987654321 


Q ss_pred             ----eeecccc------ccCCCcHHHHHHhhhcc--------------CcHHHHhhHHhhh-cCCCCHHHHHHHHHHHHH
Q 048535          271 ----MSGRRPI------EEGKRNLVDRMWSLTER--------------SELLSVLDERLKA-KGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       271 ----~~g~~p~------~~~~~~~~~~vws~~~~--------------~~~~~~~~~~l~~-~~~~~~~~~~~l~~l~~~  325 (409)
                          ..|...+      ....++..+|+|+++-.              ....+++...... ....+..+++++.+++.+
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  237 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH  237 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence                1222222      23667889999998310              1111222211111 123344556789999999


Q ss_pred             ccCcCCCCCCCHHHHHHHHhcCc
Q 048535          326 CAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      ||+.||++||||+|+++.|+++.
T Consensus       238 cl~~~p~~Rps~~~il~~L~~i~  260 (263)
T d1sm2a_         238 CWKERPEDRPAFSRLLRQLAEIA  260 (263)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HccCCHhHCcCHHHHHHHHHHHH
Confidence            99999999999999999998754

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=343.67  Aligned_cols=228  Identities=22%  Similarity=0.400  Sum_probs=179.3

Q ss_pred             hCCCCccceeecCCceEEEEEEECCcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|+..+.||+|+||+||+|++.+ .||||+++..  +....+.|.+|+.+|++++|||||+++|++.+  +.+++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEEEEEEe
Confidence            4678899999999999999998765 5999999654  45567889999999999999999999998864  56899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      ||++|+|.+++...  ...+++..++.++.|||+||+|||   +++||||||||+|||++.++.+||+|||+|+......
T Consensus        84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999999653  346999999999999999999999   7899999999999999999999999999998764321


Q ss_pred             ------eeeeccccc---------cCCCcHHHHHHhhhccCcHHHHhhHHhhhc---------------------CCCCH
Q 048535          270 ------VMSGRRPIE---------EGKRNLVDRMWSLTERSELLSVLDERLKAK---------------------GGYAD  313 (409)
Q Consensus       270 ------~~~g~~p~~---------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~---------------------~~~~~  313 (409)
                            ...|...+.         .+.++..+|+|+++  ..+++++....+..                     ...+.
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~G--v~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~  236 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFG--IVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS  236 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHH--HHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhH--HHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccc
Confidence                  123333221         23478899999983  12222222111100                     11233


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      .+++.+.+++.+||+.||++||||+|+++.|+.+.+
T Consensus       237 ~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         237 NCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            455788999999999999999999999999987643

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=344.40  Aligned_cols=227  Identities=25%  Similarity=0.414  Sum_probs=180.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      .++|+..+.||+|+||+||+|.+. +..||||+++... ...+.|.+|+.+|++++|||||+++|++.+  +..++||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~iv~Ey   88 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEY   88 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCeEEEEEe
Confidence            356888899999999999999998 6789999997543 334679999999999999999999998864  457899999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV  270 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  270 (409)
                      |++|+|.+++... ....+++..+++++.||++||.|||   +++|+||||||+||||++++.+||+|||+|+.......
T Consensus        89 ~~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~  164 (272)
T d1qpca_          89 MENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY  164 (272)
T ss_dssp             CTTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred             CCCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCcc
Confidence            9999999988542 2335999999999999999999999   79999999999999999999999999999998765432


Q ss_pred             -----eeeccccc------cCCCcHHHHHHhhhccCcHHHHh----------------hHHhh-hcCCCCHHHHHHHHHH
Q 048535          271 -----MSGRRPIE------EGKRNLVDRMWSLTERSELLSVL----------------DERLK-AKGGYADEVVEKVLHL  322 (409)
Q Consensus       271 -----~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~-~~~~~~~~~~~~l~~l  322 (409)
                           ..|...+.      ...++..+|+|+++  ..+++++                ..... .....+...++.+.+|
T Consensus       165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~G--vvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  242 (272)
T d1qpca_         165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFG--ILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL  242 (272)
T ss_dssp             ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHH--HHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ccccccCCcccccChHHHhCCCCCchhhhhhhH--HHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHH
Confidence                 12222221      25678899999983  1122222                11111 1123345566789999


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          323 GLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                      +.+||+.||++||||+||+++|+..
T Consensus       243 i~~cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         243 MRLCWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhhh
Confidence            9999999999999999999999853

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-45  Score=344.36  Aligned_cols=182  Identities=24%  Similarity=0.321  Sum_probs=151.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|++.+.||+|+||+||+|+..  |+.||||+++..   .....+.+.+|+++|++++|||||++++++.+ .+..|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-SSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-CCEEEEE
Confidence            56889999999999999999986  899999999643   22345679999999999999999999999987 7889999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||||++|+|.+++..   ...+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+....
T Consensus        87 mEy~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          87 LSYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceeccc
Confidence            999999999999854   346999999999999999999999   89999999999999999999999999999987653


Q ss_pred             Cc------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhH
Q 048535          268 GQ------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDE  303 (409)
Q Consensus       268 ~~------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~  303 (409)
                      ..      ...|...+.      ...++..+|+|+++  ..+++++..
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlG--vilyell~g  206 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALG--CIIYQLVAG  206 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHH--HHHHHHHHS
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhh--HHHHHHhhC
Confidence            22      233544433      25678899999995  334444433

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=339.39  Aligned_cols=230  Identities=26%  Similarity=0.459  Sum_probs=179.2

Q ss_pred             CCCCccceeecCCceEEEEEEECC------cEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLLG------VEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      +.|+..++||+|+||+||+|.+.+      ..||||+++.. ......+|.+|+.+|++++|||||+++|+|.+ .+..+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-~~~~~   85 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMM   85 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-CCceE
Confidence            457788999999999999999862      46999999755 44556789999999999999999999999987 67889


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +|||||.+|++.+++...  ...++|.+++.++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+..
T Consensus        86 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          86 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcc
Confidence            999999999999988653  346999999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCc----e---eeecccc------ccCCCcHHHHHHhhhcc--------------Cc---HHHHhhHHhhhcCCCCHHH
Q 048535          266 HHGQ----V---MSGRRPI------EEGKRNLVDRMWSLTER--------------SE---LLSVLDERLKAKGGYADEV  315 (409)
Q Consensus       266 ~~~~----~---~~g~~p~------~~~~~~~~~~vws~~~~--------------~~---~~~~~~~~l~~~~~~~~~~  315 (409)
                      ....    .   ..|...+      ....++..+|+|+++..              ..   +...+....+  .+.+..+
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~--~~~~~~~  238 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR--LPTPMDC  238 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--CCCCTTC
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC--CCCchhh
Confidence            4432    1   1122211      23677889999998310              01   1112222111  3445566


Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcCC
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTEG  350 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~  350 (409)
                      +..+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus       239 ~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         239 PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            77899999999999999999999999999876654

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=336.56  Aligned_cols=225  Identities=23%  Similarity=0.327  Sum_probs=178.3

Q ss_pred             CCCCccc-eeecCCceEEEEEEEC----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEEN-VIGLGGNGKVYKGQLL----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~-~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|...+ +||+|+||+||+|.+.    +..||||+++.. .....++|.+|+++|++++|||||+++|+|.+  +.+|+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~l   85 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALML   85 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CeEEE
Confidence            4455556 4999999999999875    457999999765 45567889999999999999999999999864  46899


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      |||||++|+|.+++..  ....+++..+..++.|||+||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus        86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence            9999999999999854  3356999999999999999999999   7999999999999999999999999999998765


Q ss_pred             CCc-------eeeecccc------ccCCCcHHHHHHhhhccCcHHHHh----------------hHHhh-hcCCCCHHHH
Q 048535          267 HGQ-------VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVL----------------DERLK-AKGGYADEVV  316 (409)
Q Consensus       267 ~~~-------~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~-~~~~~~~~~~  316 (409)
                      ...       ..+|...+      ....++..+|||+++  ..+++++                ..... ...+.+..++
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~G--v~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~  238 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG--VTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECP  238 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHH--HHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcch--HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCC
Confidence            432       11222222      125678899999883  1122221                11111 1134455667


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      .++.+|+.+||+.||++||||.+|++.|+.
T Consensus       239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         239 PELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            789999999999999999999999999874

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=334.19  Aligned_cols=184  Identities=21%  Similarity=0.311  Sum_probs=154.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|++.+.||+|+||+||+|+..  ++.||+|++...   .....+.+.+|+.++++++|||||++++++.+ ++..|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-CCEEEEE
Confidence            46888999999999999999997  889999999643   22345678999999999999999999999987 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||||++|+|.+++..   ...+++..+..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus        85 mEy~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          85 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             EeecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            999999999999964   346999999999999999999999   89999999999999999999999999999987665


Q ss_pred             Cc--eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHh
Q 048535          268 GQ--VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERL  305 (409)
Q Consensus       268 ~~--~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l  305 (409)
                      ..  ...|...+.      ...++..+|+|+++  ..+++++....
T Consensus       159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlG--vilyell~G~~  202 (263)
T d2j4za1         159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG--VLCYEFLVGKP  202 (263)
T ss_dssp             CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHH--HHHHHHHHSSC
T ss_pred             CcccccCCCCcccCHHHHcCCCCCchhhhhhHh--HHHHHHhcCCC
Confidence            43  334444432      24567889999996  34455554433

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-44  Score=340.89  Aligned_cols=240  Identities=20%  Similarity=0.321  Sum_probs=188.7

Q ss_pred             HHHHHHhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEE
Q 048535          106 QEIHAATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWC  177 (409)
Q Consensus       106 ~~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~  177 (409)
                      .+++.+.++|+..+.||+|+||+||+|++.       ++.||||+++.. .....++|.+|+++|++++||||++++++|
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            345556788999999999999999999975       368999999765 444567899999999999999999999999


Q ss_pred             EccCCeEEEEEEeCCCCCHHHHHhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCce
Q 048535          178 KKEKESLILIYDYMENGSLDKWIFECD---------------------ESIALSWEQRIKVLKDVASGILYLYEGWESKV  236 (409)
Q Consensus       178 ~~~~~~~~lv~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  236 (409)
                      .+ .+..+++|||+++|+|.+++....                     ....+++..++.++.|++.||+|||   +++|
T Consensus        86 ~~-~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~i  161 (301)
T d1lufa_          86 AV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF  161 (301)
T ss_dssp             CS-SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             cc-CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCe
Confidence            87 678899999999999999996432                     1234899999999999999999999   8999


Q ss_pred             eecCCCCCCeeeCCCCcEEEecccCcccccCCc------eeeeccccc------cCCCcHHHHHHhhhc-----------
Q 048535          237 LHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ------VMSGRRPIE------EGKRNLVDRMWSLTE-----------  293 (409)
Q Consensus       237 vHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~------~~~g~~p~~------~~~~~~~~~vws~~~-----------  293 (409)
                      |||||||+|||+|.++.+||+|||+|+......      ...|...+.      ...++..+|+|+++-           
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            999999999999999999999999998654322      112222221      256788999999831           


Q ss_pred             ---cCcHHHHhhHHhhh-cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          294 ---RSELLSVLDERLKA-KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       294 ---~~~~~~~~~~~l~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                         .....+++...... ..+.+..++.++.+|+.+||+.||++||||.||+++|+++.+
T Consensus       242 p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~  301 (301)
T d1lufa_         242 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  301 (301)
T ss_dssp             TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence               01112222221111 123455566789999999999999999999999999998753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=328.32  Aligned_cols=225  Identities=26%  Similarity=0.367  Sum_probs=181.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      ++|+..+.||+|+||+||+|+++ ++.||||+++.... ..++|.+|+.++++++|||||+++|+|.+ ++.+++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECC-SSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEee-CCceEEEEEcc
Confidence            68899999999999999999998 77899999986533 34689999999999999999999999987 67899999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce-
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV-  270 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~-  270 (409)
                      ++|+|.+++..  ....+++..+.+++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+|+....... 
T Consensus        82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             CCCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            99999999764  3456899999999999999999999   78999999999999999999999999999987654331 


Q ss_pred             ----eeecccc------ccCCCcHHHHHHhhhccCcHHHHhh----------------HHhh-hcCCCCHHHHHHHHHHH
Q 048535          271 ----MSGRRPI------EEGKRNLVDRMWSLTERSELLSVLD----------------ERLK-AKGGYADEVVEKVLHLG  323 (409)
Q Consensus       271 ----~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~----------------~~l~-~~~~~~~~~~~~l~~l~  323 (409)
                          ..|...+      ....++..+|+|+++  ..+++++.                .... .....+...++++.+++
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G--~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li  234 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFG--VLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM  234 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccc--hhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHH
Confidence                1111111      126678999999983  12222221                1111 01234455567899999


Q ss_pred             HHccCcCCCCCCCHHHHHHHHhc
Q 048535          324 LLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       324 ~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      .+||+.||++|||++++++.|.+
T Consensus       235 ~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         235 YSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             HHHccCCHhHCcCHHHHHHHhhC
Confidence            99999999999999999999865

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=334.02  Aligned_cols=183  Identities=24%  Similarity=0.380  Sum_probs=154.6

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|+..+.||+|+||+||+|...  |+.||||+++.......+.+.+|+++|++++|||||++++++.+ .+..|+|||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE   97 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVME   97 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-CCEEEEEEE
Confidence            357999999999999999999986  99999999976655556789999999999999999999999987 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      ||++|+|.+++.+    ..+++.++..++.||+.||+|||   +++|+||||||+|||++.++++||+|||+|+......
T Consensus        98 y~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1          98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             CCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             ecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            9999999998854    35999999999999999999999   8999999999999999999999999999998765432


Q ss_pred             ----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHH
Q 048535          270 ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDER  304 (409)
Q Consensus       270 ----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~  304 (409)
                          ...|...+.      ...++...|+|+++  ..+++++...
T Consensus       171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG--vilyemltG~  213 (293)
T d1yhwa1         171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG--IMAIEMIEGE  213 (293)
T ss_dssp             CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHH--HHHHHHHHSS
T ss_pred             ccccccccCCCccChhhhcCCCCCchhceehHh--HHHHHHhhCC
Confidence                223443332      25578899999995  3444544433

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-44  Score=333.44  Aligned_cols=218  Identities=26%  Similarity=0.343  Sum_probs=172.1

Q ss_pred             ceeecCCceEEEEEEEC----CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          119 NVIGLGGNGKVYKGQLL----GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       119 ~~lG~G~fg~Vy~~~~~----~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      ++||+|+||+||+|.+.    ++.||||+++..  +....++|.+|+.+|++++|||||+++|+|..  +..+||||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~--~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc--CCEEEEEEcCC
Confidence            57999999999999875    467999999654  34456789999999999999999999999864  45789999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc---
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ---  269 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~---  269 (409)
                      +|+|.+++..   ...+++..++.++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+......   
T Consensus        91 ~g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          91 LGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             TEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            9999999964   346999999999999999999999   7899999999999999999999999999998765432   


Q ss_pred             ----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHh----------------hHHhh-hcCCCCHHHHHHHHHH
Q 048535          270 ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVL----------------DERLK-AKGGYADEVVEKVLHL  322 (409)
Q Consensus       270 ----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~-~~~~~~~~~~~~l~~l  322 (409)
                          ...|...+.      ...++..+|+|+++  ..+++++                ..... ...+.+..++.++.+|
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~G--v~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~l  242 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFG--VLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDL  242 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHH--HHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccch--hhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence                112222221      25678899999983  1122221                11111 1134455667789999


Q ss_pred             HHHccCcCCCCCCCHHHHHHHHhc
Q 048535          323 GLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      +.+||+.||++|||+++|++.|+.
T Consensus       243 i~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         243 MNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhC
Confidence            999999999999999999998874

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-43  Score=328.45  Aligned_cols=244  Identities=21%  Similarity=0.274  Sum_probs=183.4

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|++.+.||+|+||+||+|++.  |+.||||+++... ....+.+.+|+.+|++++|||||++++++.+ ++..|+|||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-~~~~~ivmE   83 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFLE   83 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CceeEEEEe
Confidence            57899999999999999999987  8999999997653 3345678999999999999999999999987 788999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      ||++|+|.+++.   ....+++.++..++.||++||+|||   +++|+||||||+|||+++++.+||+|||+|+......
T Consensus        84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999994   3457999999999999999999999   8999999999999999999999999999998764322


Q ss_pred             ------eeeecccccc------CC-CcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCC
Q 048535          270 ------VMSGRRPIEE------GK-RNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPT  336 (409)
Q Consensus       270 ------~~~g~~p~~~------~~-~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt  336 (409)
                            ...|...+..      .. ++...|+|+++  ..+++++....+.....                       ..
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlG--vilyeml~G~~pf~~~~-----------------------~~  212 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCG--IVLTAMLAGELPWDQPS-----------------------DS  212 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHH--HHHHHHHHSSCSCSSSS-----------------------TT
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhH--HHHHHHHhCCCCCCCCC-----------------------hH
Confidence                  2234443322      33 45778999997  45566655443321111                       01


Q ss_pred             HHHHHHHHhcCcCCCC-CCCCCcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          337 IRQVLKMLEGQTEGTG-LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       337 ~~evl~~L~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      ........+.....+. ..-+....+++.+|++.+|.+|+++++++.||||++
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         213 CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             SHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            1111111111111100 001122368999999999999999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-44  Score=342.52  Aligned_cols=272  Identities=21%  Similarity=0.270  Sum_probs=196.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .++|++.+.||+|+||+||+|+..  |+.||+|+++.. .....+.+.+|+.+|++++|||||+++++|.+ .+.+|+||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~iVm   83 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM   83 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEE
Confidence            467999999999999999999987  899999999765 34456789999999999999999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      |||++|+|.+++.+.   ..+++..+..++.|++.||.|||+  .++|+||||||+|||+++++++||+|||+|+.....
T Consensus        84 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             ECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            999999999999642   469999999999999999999993  248999999999999999999999999999865432


Q ss_pred             --ceeeecccccc------CCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHH---------------HHHHHHHHHH
Q 048535          269 --QVMSGRRPIEE------GKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEV---------------VEKVLHLGLL  325 (409)
Q Consensus       269 --~~~~g~~p~~~------~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~---------------~~~l~~l~~~  325 (409)
                        ....|...+..      ..++...|+|+++  ..+++++....+..+....+.               ..........
T Consensus       159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlG--vil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMG--LSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             TC---CCSSCCCCHHHHHCSCCCTTHHHHHHH--HHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             ccccccCCccccCchHHcCCCCCcHHHHHHHH--HHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence              23345544432      5678899999997  456666665544322211111               1111112222


Q ss_pred             ccCcCCCCCCC--HHHHHHHHhcCcCCCCCCCC---CcchhHHhhhcccCCCCcccccccCCCCCccccccc
Q 048535          326 CAHPEANSRPT--IRQVLKMLEGQTEGTGLEDE---GMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKN  392 (409)
Q Consensus       326 Cl~~dP~~RPt--~~evl~~L~~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~  392 (409)
                      +.......+|.  ..+....+...... ..+..   ....+++.+|+..+|.+|+|+++++.||||++.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~  307 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE  307 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCC-CCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred             ccccccccccchhHHHHHhhhhccCCc-cCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcc
Confidence            33333444443  33444444332221 11111   123789999999999999999999999999876643

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-44  Score=332.10  Aligned_cols=227  Identities=31%  Similarity=0.372  Sum_probs=176.5

Q ss_pred             CCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeCC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYME  192 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~~  192 (409)
                      ++|+..+.||+|+||.||+|.++|..||||+++.+.  ..+.|.+|++++++++|||||+++|+|.+..+.+++||||++
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             HHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            457778999999999999999999999999997543  347799999999999999999999999765567899999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc-ee
Q 048535          193 NGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ-VM  271 (409)
Q Consensus       193 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-~~  271 (409)
                      +|+|.++|... ....++|..+++++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        85 ~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~  160 (262)
T d1byga_          85 KGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG  160 (262)
T ss_dssp             TEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCCccc
Confidence            99999999653 2335899999999999999999999   7999999999999999999999999999999755432 12


Q ss_pred             eeccccc------cCCCcHHHHHHhhhccCcHHHH----------------hhHHhh-hcCCCCHHHHHHHHHHHHHccC
Q 048535          272 SGRRPIE------EGKRNLVDRMWSLTERSELLSV----------------LDERLK-AKGGYADEVVEKVLHLGLLCAH  328 (409)
Q Consensus       272 ~g~~p~~------~~~~~~~~~vws~~~~~~~~~~----------------~~~~l~-~~~~~~~~~~~~l~~l~~~Cl~  328 (409)
                      .+..++.      ...++..+|+|+++  ..++++                .+.... ...+.+...++++.+|+.+||+
T Consensus       161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG--~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~  238 (262)
T d1byga_         161 KLPVKWTAPEALREKKFSTKSDVWSFG--ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWH  238 (262)
T ss_dssp             -CCTTTSCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             cccccCCChHHHhCCCCChHHHHHhHH--HHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcc
Confidence            2222221      26778899999983  112222                211111 1234556667789999999999


Q ss_pred             cCCCCCCCHHHHHHHHhcC
Q 048535          329 PEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       329 ~dP~~RPt~~evl~~L~~~  347 (409)
                      .||.+||||.+++++|+.+
T Consensus       239 ~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         239 LDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             SSGGGSCCHHHHHHHHHHH
T ss_pred             cCHhHCcCHHHHHHHHHHH
Confidence            9999999999999999865

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-44  Score=333.19  Aligned_cols=232  Identities=25%  Similarity=0.368  Sum_probs=181.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      ++|++.+.||+|+||+||+|++. +..||||+++... ...+.|.+|+.+|++++|||||+++|+|.+  +..++|||||
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~--~~~~lv~Ey~   93 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYM   93 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec--CCeEEEEEec
Confidence            56889999999999999999998 6789999997553 334789999999999999999999999854  4578999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCce-
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQV-  270 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~-  270 (409)
                      ++|+|..++... ....++|.+++.++.||+.||+|||   +++|+||||||+||||++++++||+|||+|+....+.. 
T Consensus        94 ~~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            999999998653 2345999999999999999999999   78999999999999999999999999999987654331 


Q ss_pred             ----eeecccc------ccCCCcHHHHHHhhhc--------------cCcHHHHhhHHhh-hcCCCCHHHHHHHHHHHHH
Q 048535          271 ----MSGRRPI------EEGKRNLVDRMWSLTE--------------RSELLSVLDERLK-AKGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       271 ----~~g~~p~------~~~~~~~~~~vws~~~--------------~~~~~~~~~~~l~-~~~~~~~~~~~~l~~l~~~  325 (409)
                          ..|...+      ..+.++..+|+|+++.              .....++++.... ...+.+..+++++.+++.+
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  249 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ  249 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHH
Confidence                1122212      1266788999999831              1112222222211 1134566677889999999


Q ss_pred             ccCcCCCCCCCHHHHHHHHhcCcCCC
Q 048535          326 CAHPEANSRPTIRQVLKMLEGQTEGT  351 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~~L~~~~~~~  351 (409)
                      ||+.||++||||++|+++|+......
T Consensus       250 cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         250 CWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            99999999999999999999866443

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=329.56  Aligned_cols=228  Identities=24%  Similarity=0.330  Sum_probs=163.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-CCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-KESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-~~~~~lv  187 (409)
                      ++|++.+.||+|+||+||+|+..  |+.||||.+...  +....+.|.+|+++|++++|||||++++++.+. .+.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            57899999999999999999987  899999999755  445567899999999999999999999998753 4568999


Q ss_pred             EEeCCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          188 YDYMENGSLDKWIFEC-DESIALSWEQRIKVLKDVASGILYLYEGW--ESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ||||++|+|.+++... .....+++..+..++.||+.||.|||+..  ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998643 22456999999999999999999999531  23599999999999999999999999999987


Q ss_pred             ccCCc----eeeecccc------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhc----------------CCCCHHHHHH
Q 048535          265 HHHGQ----VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVLDERLKAK----------------GGYADEVVEK  318 (409)
Q Consensus       265 ~~~~~----~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~----------------~~~~~~~~~~  318 (409)
                      .....    ...|...+      ....++..+|+|+++  ..+++++....+..                ...+...+++
T Consensus       164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlG--vilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~  241 (269)
T d2java1         164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLG--CLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE  241 (269)
T ss_dssp             C-----------CCCSCCCHHHHTTCCCCHHHHHHHHH--HHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred             cccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhC--HHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHH
Confidence            65432    22333332      235678999999985  22333332221110                1223344556


Q ss_pred             HHHHHHHccCcCCCCCCCHHHHHH
Q 048535          319 VLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       319 l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +.+|+.+||+.||++|||+.|+++
T Consensus       242 l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         242 LNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHh
Confidence            667777777777777777776653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=337.98  Aligned_cols=229  Identities=23%  Similarity=0.351  Sum_probs=178.3

Q ss_pred             HhCCCCccceeecCCceEEEEEEECC-------cEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccC
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLLG-------VEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEK  181 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-------~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  181 (409)
                      ..++|+..+.||+|+||+||+|++.+       ..||||.+... .......|.+|+.+|.++ +|||||+++|+|.+ .
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~  113 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-S  113 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee-C
Confidence            34678899999999999999999852       36999998654 344556899999999998 89999999999987 6


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCC
Q 048535          182 ESLILIYDYMENGSLDKWIFECDE--------------------SIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDI  241 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDl  241 (409)
                      +..++|||||++|+|.++|+....                    ...+++..++.++.||++||+|||   +++|+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccC
Confidence            789999999999999999975421                    235899999999999999999999   799999999


Q ss_pred             CCCCeeeCCCCcEEEecccCcccccCCc------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhh-------
Q 048535          242 KASNVLLDKKMNARLGDFGLAKMHHHGQ------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLD-------  302 (409)
Q Consensus       242 Kp~NILl~~~~~~kl~DFGla~~~~~~~------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~-------  302 (409)
                      ||+|||++.++.+||+|||+|+......      ...|...+.      ...++..+|+|+++  ..+++++.       
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~G--vil~emlt~g~~Pf~  268 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG--ILLWEIFSLGVNPYP  268 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHTTTSCCSST
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchh--HHHHHHHhCCCCCCC
Confidence            9999999999999999999998755432      111222221      36778999999983  11222211       


Q ss_pred             ---------HHhhh--cCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHh
Q 048535          303 ---------ERLKA--KGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLE  345 (409)
Q Consensus       303 ---------~~l~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~  345 (409)
                               ..+..  ..+.+..+++++.+|+.+||+.||++|||++||++.|.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence                     11110  13345566778999999999999999999999999985

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=333.43  Aligned_cols=220  Identities=23%  Similarity=0.322  Sum_probs=169.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      +.|++.+.||+|+||+||+|++.  ++.||||+++.......+.|.+|+++|++++|||||++++++.+ .+..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCeEEEEEec
Confidence            46888999999999999999987  88999999987766677889999999999999999999999987 7789999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc-
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ-  269 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-  269 (409)
                      |++|+|.+++.+.  ...+++.++..++.||+.||.|||   +++|+||||||+|||++.++++||+|||+|+...... 
T Consensus        91 ~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~  165 (288)
T d2jfla1          91 CAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  165 (288)
T ss_dssp             CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred             CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence            9999999998643  346999999999999999999999   8999999999999999999999999999997653221 


Q ss_pred             ---eeeecccc-----------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCC------------------CCHHHHH
Q 048535          270 ---VMSGRRPI-----------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGG------------------YADEVVE  317 (409)
Q Consensus       270 ---~~~g~~p~-----------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~------------------~~~~~~~  317 (409)
                         ...|...+           ....++..+|+|+++  ..+++++....+..+.                  .+...+.
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlG--vilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~  243 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG--ITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS  243 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHH--HHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCH
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHH--HHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCH
Confidence               12233222           123467889999995  3344444433222111                  1122334


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHH
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQV  340 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~ev  340 (409)
                      .+.+|+.+||+.||++|||+.|+
T Consensus       244 ~~~~li~~~L~~dp~~R~t~~el  266 (288)
T d2jfla1         244 NFKDFLKKCLEKNVDARWTTSQL  266 (288)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             HHHHHHHHHccCChhHCcCHHHH
Confidence            45555555555555555555554

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-43  Score=335.17  Aligned_cols=221  Identities=26%  Similarity=0.354  Sum_probs=178.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      +.|+..+.||+|+||+||+|+..  ++.||||+++..   .....+.|.+|+.+|++++|||||++++++.+ ++..|+|
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv   93 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV   93 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-CCEEEEE
Confidence            45888999999999999999986  889999999754   23445679999999999999999999999987 7889999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||||++|+|..++..   ...+++.++..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus        94 ~E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          94 MEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             EECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EEecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            999999999877643   346999999999999999999999   89999999999999999999999999999998776


Q ss_pred             Cceeeeccccc---------cCCCcHHHHHHhhhccCcHHHHhhH---------------Hhhhc--CCCCHHHHHHHHH
Q 048535          268 GQVMSGRRPIE---------EGKRNLVDRMWSLTERSELLSVLDE---------------RLKAK--GGYADEVVEKVLH  321 (409)
Q Consensus       268 ~~~~~g~~p~~---------~~~~~~~~~vws~~~~~~~~~~~~~---------------~l~~~--~~~~~~~~~~l~~  321 (409)
                      .....|...+.         ...++...|+|+++  ..+++++..               .....  ...+...++.+.+
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlG--vilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~  245 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG--ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN  245 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHH--HHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHH
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHH--HHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence            65555654432         23578899999984  222222222               11110  1122334567889


Q ss_pred             HHHHccCcCCCCCCCHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ++.+||+.||++|||+.|+++
T Consensus       246 li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         246 FVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHCcCChhHCcCHHHHHh
Confidence            999999999999999999876

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=323.73  Aligned_cols=181  Identities=22%  Similarity=0.346  Sum_probs=148.0

Q ss_pred             CccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc---CCeEEEEE
Q 048535          116 SEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE---KESLILIY  188 (409)
Q Consensus       116 ~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~---~~~~~lv~  188 (409)
                      +..++||+|+||+||+|.+.  ++.||+|++...  .....+.|.+|+++|++++|||||++++++.+.   ...+|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55678999999999999987  789999999654  445567899999999999999999999998642   34689999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCc--eeecCCCCCCeeeC-CCCcEEEecccCcccc
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESK--VLHRDIKASNVLLD-KKMNARLGDFGLAKMH  265 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDlKp~NILl~-~~~~~kl~DFGla~~~  265 (409)
                      |||++|+|.+++..   ...+++..+..++.||++||+|||   +++  |+||||||+|||++ +++.+||+|||+|+..
T Consensus        92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            99999999999964   346999999999999999999999   666  99999999999996 5789999999999875


Q ss_pred             cCCc--eeeeccccc-----cCCCcHHHHHHhhhccCcHHHHhhHH
Q 048535          266 HHGQ--VMSGRRPIE-----EGKRNLVDRMWSLTERSELLSVLDER  304 (409)
Q Consensus       266 ~~~~--~~~g~~p~~-----~~~~~~~~~vws~~~~~~~~~~~~~~  304 (409)
                      ....  ...|...+.     .+.++...|+|+++  ..+++++...
T Consensus       166 ~~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlG--vilyel~~g~  209 (270)
T d1t4ha_         166 RASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFG--MCMLEMATSE  209 (270)
T ss_dssp             CTTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHH--HHHHHHHHSS
T ss_pred             cCCccCCcccCccccCHHHhCCCCCCcCchhhHH--HHHHHHHHCC
Confidence            5432  233443332     25678899999996  3445554443

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.2e-43  Score=333.11  Aligned_cols=214  Identities=21%  Similarity=0.250  Sum_probs=169.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|++.+.||+|+||+||+|+..  |+.||||+++..   .....+.+.+|+.+|++++|||||++++++.+ .+.+|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-CCeeeeE
Confidence            56889999999999999999987  899999999743   22345789999999999999999999999987 7899999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||||++|+|.+++..   ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus        83 mE~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          83 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eeecCCccccccccc---cccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            999999999999854   346889999999999999999999   89999999999999999999999999999998654


Q ss_pred             Cc-eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHH---------------hhhcCCCCHHHHHHHHHHHHH
Q 048535          268 GQ-VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDER---------------LKAKGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       268 ~~-~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~---------------l~~~~~~~~~~~~~l~~l~~~  325 (409)
                      .. ..+|...+.      ...++...|+|+++  ..+++++...               +.....++...++.+.+++.+
T Consensus       157 ~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlG--vilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  234 (316)
T d1fota_         157 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFG--ILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR  234 (316)
T ss_dssp             CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHH--HHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             ccccccCcccccCHHHHcCCCCCchhhccccc--hhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            33 344554432      24577889999995  2333333332               222223334444556666666


Q ss_pred             ccCcCCCCCC
Q 048535          326 CAHPEANSRP  335 (409)
Q Consensus       326 Cl~~dP~~RP  335 (409)
                      ||+.||.+||
T Consensus       235 ~L~~dp~~R~  244 (316)
T d1fota_         235 LITRDLSQRL  244 (316)
T ss_dssp             HTCSCTTTCT
T ss_pred             HhhhCHHhcc
Confidence            6666666664

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=337.00  Aligned_cols=221  Identities=19%  Similarity=0.252  Sum_probs=177.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|++.+.||+|+||.||+|+..  |+.||||+++..   .....+.+.+|+.+|++++|||||++++++.+ ...+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-ccccccc
Confidence            57999999999999999999986  899999999754   23345778999999999999999999999987 7889999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      ||||++|+|.+++..   ...+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999999964   346899999999999999999999   89999999999999999999999999999987543


Q ss_pred             Cc----eeeeccccc------cCCCcHHHHHHhhhccCcHHHH---------------hhHHhhhcCCCCHHHHHHHHHH
Q 048535          268 GQ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSV---------------LDERLKAKGGYADEVVEKVLHL  322 (409)
Q Consensus       268 ~~----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~---------------~~~~l~~~~~~~~~~~~~l~~l  322 (409)
                      ..    ..+|.+.+.      ...++...|+|+++  ..++++               ..........++...+.++.+|
T Consensus       158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlG--vilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dl  235 (337)
T d1o6la_         158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG--VVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSL  235 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             CCcccccceeCHHHhhhhhccCCCCChhhcccchh--hHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHH
Confidence            22    345555442      35678899999984  223333               2333332334455566677888


Q ss_pred             HHHccCcCCCCCCC-----HHHHHH
Q 048535          323 GLLCAHPEANSRPT-----IRQVLK  342 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt-----~~evl~  342 (409)
                      +.+||+.||.+||+     +.|+++
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         236 LAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHhhccCCchhhcccccccHHHHHc
Confidence            88888888888884     666654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-43  Score=332.46  Aligned_cols=227  Identities=25%  Similarity=0.356  Sum_probs=178.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--Cc----EEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GV----EVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~----~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      .+|+..+.||+|+||+||+|.+.  |+    +||+|+++.. +.+..++|.+|+.+|++++|||||+++|+|.+  +..+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCee
Confidence            46889999999999999999986  33    6999998654 44556789999999999999999999999986  4577


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +++||+.+|+|.+++...  ...+++..+++++.|||.||+|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        87 ~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence            899999999999988653  456999999999999999999999   789999999999999999999999999999876


Q ss_pred             cCCc------eeeeccccc------cCCCcHHHHHHhhhcc-----------------CcHHHHhhHHhhhcCCCCHHHH
Q 048535          266 HHGQ------VMSGRRPIE------EGKRNLVDRMWSLTER-----------------SELLSVLDERLKAKGGYADEVV  316 (409)
Q Consensus       266 ~~~~------~~~g~~p~~------~~~~~~~~~vws~~~~-----------------~~~~~~~~~~l~~~~~~~~~~~  316 (409)
                      ....      ...|...+.      .+.++..+|+|+++..                 ..+...+....+  .+.+..++
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~  239 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--LPQPPICT  239 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC--CCCCTTBC
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC--CCCCcccC
Confidence            5432      111222221      2667899999998310                 111222222211  34455667


Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      ..+.+|+.+||+.||++|||+.|+++.|+.+.
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            78999999999999999999999999987643

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-43  Score=331.86  Aligned_cols=233  Identities=24%  Similarity=0.347  Sum_probs=175.2

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccC
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEK  181 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  181 (409)
                      ..++|+..+.||+|+||.||+|.+.       ++.||||+++.. .....+.+.+|...+.++ +|+|||++++++.+.+
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            3467889999999999999999874       368999999754 445567888999988887 7899999999988766


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeee
Q 048535          182 ESLILIYDYMENGSLDKWIFECD-------------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLL  248 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl  248 (409)
                      ..+++|||||++|+|.++++...             ....+++.+++.++.||++||.|||   +++|+||||||+||||
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl  167 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILL  167 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeE
Confidence            77899999999999999997532             1235899999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEecccCcccccCCc------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhh--------------
Q 048535          249 DKKMNARLGDFGLAKMHHHGQ------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLD--------------  302 (409)
Q Consensus       249 ~~~~~~kl~DFGla~~~~~~~------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~--------------  302 (409)
                      ++++.+||+|||+|+......      ...|...+.      ...++..+|+|+++  ..+++++.              
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~G--vil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG--VLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCSSTTCCCSHH
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehH--HHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999998654322      122333222      26678999999983  11222111              


Q ss_pred             --HHhh--hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          303 --ERLK--AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       303 --~~l~--~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                        ..+.  .....+...++++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         246 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              1111  113344556678999999999999999999999999998754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.3e-41  Score=327.98  Aligned_cols=229  Identities=20%  Similarity=0.282  Sum_probs=184.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      ++|++.+.||+|+||.||+|...  |+.||||+++.......+.+.+|+.+|++++|||||++++++.+ ++.+|+||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEc
Confidence            57999999999999999999986  89999999987766667789999999999999999999999987 7889999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC--CCCcEEEecccCcccccCC
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD--KKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~--~~~~~kl~DFGla~~~~~~  268 (409)
                      |++|+|.+++..  ....+++.++..++.||+.||+|||   +++|+||||||+||||+  .++.+||+|||+|+.....
T Consensus       108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999998753  3346999999999999999999999   89999999999999998  5789999999999987655


Q ss_pred             ce---eeeccccc------cCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhhcC----CCCHHHHHHHHHH
Q 048535          269 QV---MSGRRPIE------EGKRNLVDRMWSLTE-------------RSELLSVLDERLKAKG----GYADEVVEKVLHL  322 (409)
Q Consensus       269 ~~---~~g~~p~~------~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~~~----~~~~~~~~~l~~l  322 (409)
                      ..   ..|...+.      ...++...|+|+++.             .....+.+........    ......+.++.+|
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  262 (352)
T d1koba_         183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF  262 (352)
T ss_dssp             SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHH
Confidence            42   23333221      356789999999841             1112222222222111    1223456788999


Q ss_pred             HHHccCcCCCCCCCHHHHHHH--HhcC
Q 048535          323 GLLCAHPEANSRPTIRQVLKM--LEGQ  347 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl~~--L~~~  347 (409)
                      +.+||+.||.+|||+.|+++.  +++.
T Consensus       263 i~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         263 IKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999874  5543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-43  Score=330.60  Aligned_cols=233  Identities=25%  Similarity=0.374  Sum_probs=181.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC--Cc--EEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GV--EVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~--~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|+..++||+|+||+||+|++.  +.  .||||+++.. .....+.|.+|+++|+++ +|||||+++|+|.+ .+.+++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~i   88 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYL   88 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-CCeeEE
Confidence            57888899999999999999987  33  5889988644 444567899999999999 79999999999987 788999


Q ss_pred             EEEeCCCCCHHHHHhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc
Q 048535          187 IYDYMENGSLDKWIFEC-------------DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN  253 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~  253 (409)
                      ||||+++|+|.++|+..             .....+++..+.+++.|||.||.|||   +++|+||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCc
Confidence            99999999999999753             23457999999999999999999999   899999999999999999999


Q ss_pred             EEEecccCcccccCCc---eeeeccccc------cCCCcHHHHHHhhhc--------------cCcHHHHhhHHhh-hcC
Q 048535          254 ARLGDFGLAKMHHHGQ---VMSGRRPIE------EGKRNLVDRMWSLTE--------------RSELLSVLDERLK-AKG  309 (409)
Q Consensus       254 ~kl~DFGla~~~~~~~---~~~g~~p~~------~~~~~~~~~vws~~~--------------~~~~~~~~~~~l~-~~~  309 (409)
                      +||+|||+|+......   ...|..++.      ...++..+|+|+++.              .....++.+.... ...
T Consensus       166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~  245 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL  245 (309)
T ss_dssp             EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC
T ss_pred             eEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCC
Confidence            9999999998654322   222333222      266788999999731              1111222222111 123


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          310 GYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       310 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      +.+..+++++.+|+.+||+.||++||||+||++.|+++.+
T Consensus       246 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~  285 (309)
T d1fvra_         246 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  285 (309)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            4455667889999999999999999999999999987653

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-41  Score=328.14  Aligned_cols=226  Identities=21%  Similarity=0.292  Sum_probs=182.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|++.+.||+|+||.||+|+..  |+.||||++........+.+.+|+.+|++++|||||++++++.+ .+.+|+|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEE
Confidence            357999999999999999999987  89999999987766677889999999999999999999999987 788999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC--CCcEEEecccCcccccC
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK--KMNARLGDFGLAKMHHH  267 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~--~~~~kl~DFGla~~~~~  267 (409)
                      ||++|+|.+++..  ....+++..+..++.||+.||.|||   +++|+||||||+|||++.  ++.+||+|||+|+....
T Consensus       104 ~~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         104 FMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CCCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             cCCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            9999999999954  3346999999999999999999999   899999999999999964  57899999999998765


Q ss_pred             Cc---eeeeccccc------cCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhhcCCC----CHHHHHHHHH
Q 048535          268 GQ---VMSGRRPIE------EGKRNLVDRMWSLTE-------------RSELLSVLDERLKAKGGY----ADEVVEKVLH  321 (409)
Q Consensus       268 ~~---~~~g~~p~~------~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~~~~~----~~~~~~~l~~  321 (409)
                      ..   ...|...+.      ...++...|+|+++.             .....+.+..........    ....++.+.+
T Consensus       179 ~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  258 (350)
T d1koaa2         179 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  258 (350)
T ss_dssp             TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred             ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence            43   233433332      256788999999841             111222222222211111    1234567899


Q ss_pred             HHHHccCcCCCCCCCHHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      |+.+||+.||++|||++|+++.
T Consensus       259 li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         259 FIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHHS
T ss_pred             HHHHHccCChhHCcCHHHHhcC
Confidence            9999999999999999999874

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.5e-43  Score=331.14  Aligned_cols=225  Identities=23%  Similarity=0.306  Sum_probs=166.5

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC-hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS-EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      .+.|++.+.||+|+||+||+|+..  ++.||||++.... ......+.+|+.+|++++|||||++++++.+ ++.+|+||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lvm   86 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYLIM   86 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEE
Confidence            466889999999999999999987  8999999997553 2334568899999999999999999999987 78899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeC---CCCcEEEecccCcccc
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLD---KKMNARLGDFGLAKMH  265 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~---~~~~~kl~DFGla~~~  265 (409)
                      |||++|+|.+++..   ...+++.++..++.||+.||+|||   +++|+||||||+|||+.   +++.+||+|||+|+..
T Consensus        87 E~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            99999999999954   356999999999999999999999   89999999999999994   5789999999999877


Q ss_pred             cCCce---eeeccccc------cCCCcHHHHHHhhhc-------------cCcHHHHhhHHhhhc----CCCCHHHHHHH
Q 048535          266 HHGQV---MSGRRPIE------EGKRNLVDRMWSLTE-------------RSELLSVLDERLKAK----GGYADEVVEKV  319 (409)
Q Consensus       266 ~~~~~---~~g~~p~~------~~~~~~~~~vws~~~-------------~~~~~~~~~~~l~~~----~~~~~~~~~~l  319 (409)
                      .....   ..|...+.      ...++..+|+|+++.             .....+.....+...    .+.....++.+
T Consensus       161 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  240 (307)
T d1a06a_         161 DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA  240 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence            65442   23444332      256788999999841             111222222222211    12224556789


Q ss_pred             HHHHHHccCcCCCCCCCHHHHHHH
Q 048535          320 LHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       320 ~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      .+++.+||+.||++|||+.|+++.
T Consensus       241 ~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         241 KDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHccCCHhHCcCHHHHhcC
Confidence            999999999999999999999883

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-42  Score=324.58  Aligned_cols=225  Identities=26%  Similarity=0.408  Sum_probs=179.3

Q ss_pred             cceeecCCceEEEEEEEC-----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEeC
Q 048535          118 ENVIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDYM  191 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~~  191 (409)
                      .++||+|+||+||+|++.     ...||||+++.. +....++|.+|+++|++++|||||+++|+|.+.++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            468999999999999985     236999999753 56667889999999999999999999999887567899999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCcee
Q 048535          192 ENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQVM  271 (409)
Q Consensus       192 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~  271 (409)
                      ++|+|.+++..  ....+++..+++++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999999864  3446889999999999999999999   899999999999999999999999999999876543311


Q ss_pred             --------eecccc------ccCCCcHHHHHHhhhccCcHHHHhhH----------------Hhh-hcCCCCHHHHHHHH
Q 048535          272 --------SGRRPI------EEGKRNLVDRMWSLTERSELLSVLDE----------------RLK-AKGGYADEVVEKVL  320 (409)
Q Consensus       272 --------~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~~~----------------~l~-~~~~~~~~~~~~l~  320 (409)
                              .|...+      ..+.++..+|+|+++  ..+++++..                ... .....+..+.+.+.
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfG--ivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~  264 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG--VLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY  264 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhH--HHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHH
Confidence                    121111      126778899999984  222222221                111 01223344567899


Q ss_pred             HHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          321 HLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       321 ~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      +|+.+||+.||++||||.||++.|+++..
T Consensus       265 ~li~~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         265 EVMLKCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            99999999999999999999999987653

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-42  Score=322.82  Aligned_cols=228  Identities=20%  Similarity=0.274  Sum_probs=173.4

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~  185 (409)
                      .++|+..+.||+|+||.||+|++.     +..||||.++.. .....+.|.+|+.+|++++|||||+++|++.+  +..+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~   83 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVW   83 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CeEE
Confidence            357888999999999999999875     356999999654 44556789999999999999999999999864  5689


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      +|||||++|+|.+++...  ...+++..++.++.||++||.|||   +++|+||||||+|||+++++.+||+|||+|+..
T Consensus        84 iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheec
Confidence            999999999999988653  346999999999999999999999   899999999999999999999999999999876


Q ss_pred             cCCce-----eeeccccc------cCCCcHHHHHHhhhccCcHHHHh----------------hHHhhh-cCCCCHHHHH
Q 048535          266 HHGQV-----MSGRRPIE------EGKRNLVDRMWSLTERSELLSVL----------------DERLKA-KGGYADEVVE  317 (409)
Q Consensus       266 ~~~~~-----~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~~-~~~~~~~~~~  317 (409)
                      .....     ..|...+.      ...++..+|+|+++  ..+++++                ...... ..+.+..+++
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlG--vil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~  236 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFG--VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  236 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHH--HHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccch--HHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            54321     11221111      26778899999983  1122221                111111 1244556678


Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      .+.+|+.+||+.||++|||+.||++.|+.+.
T Consensus       237 ~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         237 TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            8999999999999999999999999987653

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-42  Score=324.49  Aligned_cols=234  Identities=21%  Similarity=0.336  Sum_probs=183.2

Q ss_pred             hCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~  183 (409)
                      .++|+..+.||+|+||+||+|.+.       ++.||||+++.. .......|.+|+.++++++|||||+++|+|.. .+.
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~   97 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQP   97 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-SSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-CCc
Confidence            366788899999999999999875       468999999754 44556679999999999999999999999986 677


Q ss_pred             EEEEEEeCCCCCHHHHHhcC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEE
Q 048535          184 LILIYDYMENGSLDKWIFEC-------DESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARL  256 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl  256 (409)
                      .++|||||++|+|.+++...       .....+++..+.+++.|+|+||.|||   +++|+||||||+|||+++++++||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEE
Confidence            89999999999999998642       22235799999999999999999999   789999999999999999999999


Q ss_pred             ecccCcccccCCce-e-----eecccc------ccCCCcHHHHHHhhhcc--------------CcHHHHhhHHhhh-cC
Q 048535          257 GDFGLAKMHHHGQV-M-----SGRRPI------EEGKRNLVDRMWSLTER--------------SELLSVLDERLKA-KG  309 (409)
Q Consensus       257 ~DFGla~~~~~~~~-~-----~g~~p~------~~~~~~~~~~vws~~~~--------------~~~~~~~~~~l~~-~~  309 (409)
                      +|||+|+....... .     .|...+      ....++...|+|+++..              ....+++...... ..
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~  254 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL  254 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence            99999987654321 1     122222      12567788999997311              1111122211110 12


Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCcC
Q 048535          310 GYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQTE  349 (409)
Q Consensus       310 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~  349 (409)
                      +.+..++..+.+++.+||+.||++||||.||+++|++..+
T Consensus       255 ~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         255 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            3345566789999999999999999999999999987654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.6e-42  Score=329.08  Aligned_cols=221  Identities=18%  Similarity=0.207  Sum_probs=175.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILI  187 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv  187 (409)
                      ++|++.+.||+|+||.||+|++.  |+.||||++...   .....+.+.+|+.+|+.++|||||++++++.+ ....++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-ccccccc
Confidence            57899999999999999999987  899999999643   22345678999999999999999999999987 7789999


Q ss_pred             EEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccC
Q 048535          188 YDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHH  267 (409)
Q Consensus       188 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~  267 (409)
                      |||+.+|+|.+++...   ..+++..+..++.||+.||.|||   +++||||||||+|||++.++.+||+|||+|+....
T Consensus       120 ~e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            9999999999999643   46999999999999999999999   89999999999999999999999999999998764


Q ss_pred             Cc-eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhH---------------HhhhcCCCCHHHHHHHHHHHHH
Q 048535          268 GQ-VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDE---------------RLKAKGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       268 ~~-~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~---------------~l~~~~~~~~~~~~~l~~l~~~  325 (409)
                      .. ...|...+.      ...++...|+|+++  ..+++++..               ........+...+..+.+++.+
T Consensus       194 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlG--vilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  271 (350)
T d1rdqe_         194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALG--VLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN  271 (350)
T ss_dssp             CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHH--HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred             ccccccCccccCCHHHHcCCCCCccccccchh--HHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence            33 344554432      25578899999995  223333332               2222233344455667777777


Q ss_pred             ccCcCCCCCC-----CHHHHHH
Q 048535          326 CAHPEANSRP-----TIRQVLK  342 (409)
Q Consensus       326 Cl~~dP~~RP-----t~~evl~  342 (409)
                      ||+.||.+|+     |++|+++
T Consensus       272 ~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         272 LLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             HSCSCTTTCTTSSTTTTHHHHT
T ss_pred             HhhhCHHhccccccccHHHHHc
Confidence            7777777773     6666654

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-42  Score=327.18  Aligned_cols=232  Identities=22%  Similarity=0.347  Sum_probs=185.0

Q ss_pred             HhCCCCccceeecCCceEEEEEEEC-------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEccC
Q 048535          111 ATKGFSEENVIGLGGNGKVYKGQLL-------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKEK  181 (409)
Q Consensus       111 ~~~~f~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~~  181 (409)
                      ..++|+..+.||+|+||.||+|++.       ++.||||+++.. ......+|.+|+.+++++ +|||||+++|+|.+ .
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-~   99 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-G   99 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee-C
Confidence            4578888999999999999999873       468999999765 445567899999999999 79999999999987 6


Q ss_pred             CeEEEEEEeCCCCCHHHHHhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCe
Q 048535          182 ESLILIYDYMENGSLDKWIFECD---------------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNV  246 (409)
Q Consensus       182 ~~~~lv~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NI  246 (409)
                      +..++|||||++|+|.++++...               ....+++..+..++.||++||+|||   +++|+||||||+||
T Consensus       100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NI  176 (311)
T d1t46a_         100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNI  176 (311)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccc
Confidence            77899999999999999997532               2236899999999999999999999   89999999999999


Q ss_pred             eeCCCCcEEEecccCcccccCCc------eeeeccccc------cCCCcHHHHHHhhhcc------------------Cc
Q 048535          247 LLDKKMNARLGDFGLAKMHHHGQ------VMSGRRPIE------EGKRNLVDRMWSLTER------------------SE  296 (409)
Q Consensus       247 Ll~~~~~~kl~DFGla~~~~~~~------~~~g~~p~~------~~~~~~~~~vws~~~~------------------~~  296 (409)
                      |++.++.+||+|||+++......      ...|...+.      ...++..+|+|+++..                  ..
T Consensus       177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999999765432      122222221      2667889999998310                  01


Q ss_pred             HHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          297 LLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       297 ~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                      +..++.....  ...+...+..+.+|+.+||+.||++||||.|++++|++..
T Consensus       257 ~~~~i~~~~~--~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i  306 (311)
T d1t46a_         257 FYKMIKEGFR--MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (311)
T ss_dssp             HHHHHHHTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhcCCC--CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence            1223333222  3334455678999999999999999999999999998653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.2e-41  Score=317.72  Aligned_cols=242  Identities=22%  Similarity=0.317  Sum_probs=184.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---------hHHHHHHHHHHHHhccCC-CCceeeEeeEEEcc
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---------EHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKE  180 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~  180 (409)
                      ++|++.+.||+|+||+||+|+..  |+.||||+++...         ....+.+.+|+.+|++++ |||||++++++.+ 
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-   81 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-   81 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence            67889999999999999999986  8999999996542         122356889999999996 9999999999987 


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEeccc
Q 048535          181 KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG  260 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG  260 (409)
                      ++..|||||||++|+|.++|..   ...+++.++..++.||++||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CcceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccch
Confidence            7889999999999999999964   346999999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCc---eeeeccccc------------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHH
Q 048535          261 LAKMHHHGQ---VMSGRRPIE------------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       261 la~~~~~~~---~~~g~~p~~------------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~  325 (409)
                      +|+....+.   ...|...+.            ...++..+|+|+++  ..+++++....+..+..              
T Consensus       156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslG--vilyeml~g~~Pf~~~~--------------  219 (277)
T d1phka_         156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG--VIMYTLLAGSPPFWHRK--------------  219 (277)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHH--HHHHHHHHSSCSSCCSS--------------
T ss_pred             heeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccc--hhhhhhccCCCCCCCCC--------------
Confidence            998776533   222333321            13356789999997  45666666554432211              


Q ss_pred             ccCcCCCCCCCHHHHHHH-HhcCcCCCCCCCC---CcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          326 CAHPEANSRPTIRQVLKM-LEGQTEGTGLEDE---GMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~~-L~~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                                 ..++.+. +++..+.+.+...   ....+++.+|++.+|..|+++++++.||||++
T Consensus       220 -----------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         220 -----------QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             -----------HHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             -----------HHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence                       1111111 1121111111111   12368888888888888888889999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-41  Score=316.44  Aligned_cols=183  Identities=25%  Similarity=0.352  Sum_probs=152.3

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC------hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS------EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      +.|++.+.||+|+||+||+|+..  |+.||||+++...      ....+.|.+|+.+|++++|||||++++++.+ .+.+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~   88 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTDV   88 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEE
Confidence            57899999999999999999987  8999999996431      1235789999999999999999999999987 7889


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC----cEEEeccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM----NARLGDFG  260 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~----~~kl~DFG  260 (409)
                      |||||||++|+|.+++..   ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchh
Confidence            999999999999999964   246999999999999999999999   89999999999999998876    49999999


Q ss_pred             CcccccCCce---eeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHH
Q 048535          261 LAKMHHHGQV---MSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDER  304 (409)
Q Consensus       261 la~~~~~~~~---~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~  304 (409)
                      +|+....+..   ..|...+.      ...++...|+|+++  ..+++++...
T Consensus       163 ~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlG--vilyell~g~  213 (293)
T d1jksa_         163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIG--VITYILLSGA  213 (293)
T ss_dssp             TCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHH--HHHHHHHHSS
T ss_pred             hhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhh--HHHHHHHcCC
Confidence            9987755431   22332221      25678899999996  3455555443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-42  Score=318.60  Aligned_cols=225  Identities=22%  Similarity=0.317  Sum_probs=170.6

Q ss_pred             CCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      ++|+..+.||+|+||+||+|++.     ...||||+++..   .....++|.+|+.+|++++|||||+++|+|.+  +..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--~~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--PPM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--cch
Confidence            56888999999999999999875     247999999754   34456789999999999999999999999965  467


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ++|||||++|+|.+++...  ...+++..++.++.|||+||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             heeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhh
Confidence            8999999999999988653  346999999999999999999999   79999999999999999999999999999997


Q ss_pred             ccCCc-------eeeecccc------ccCCCcHHHHHHhhhccCcHHHHh----------------hHHhhh--cCCCCH
Q 048535          265 HHHGQ-------VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVL----------------DERLKA--KGGYAD  313 (409)
Q Consensus       265 ~~~~~-------~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~----------------~~~l~~--~~~~~~  313 (409)
                      .....       ...|...+      ....++..+|+|+++  ..+++++                ......  ..+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~G--vil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  238 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG--VTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE  238 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHH--HHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCT
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhH--HHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcc
Confidence            64432       11122111      125677889999984  1222222                211111  123345


Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhc
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEG  346 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~  346 (409)
                      ..+..+.+|+.+||+.||++||||.||++.|++
T Consensus       239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         239 DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            566789999999999999999999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-41  Score=319.61  Aligned_cols=229  Identities=24%  Similarity=0.290  Sum_probs=172.9

Q ss_pred             CCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCC---eEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKE---SLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~---~~~lv~E  189 (409)
                      .+|...+.||+|+||+||+|++.|+.||||+++.+.. ....+..|+..+.+++|||||+++|+|.++..   .+++|||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            4566778999999999999999999999999975432 12223446666678899999999999986432   5899999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG-----WESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ||++|+|.++|++    ..++|.++++++.|+|.||+|||+.     .+++|+||||||+||||+.++.+||+|||+++.
T Consensus        82 y~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             cccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            9999999999964    2599999999999999999999953     247999999999999999999999999999987


Q ss_pred             ccCCc--------eeeecccccc-----C-------CCcHHHHHHhhhccCcHHHHhhHHh-------------------
Q 048535          265 HHHGQ--------VMSGRRPIEE-----G-------KRNLVDRMWSLTERSELLSVLDERL-------------------  305 (409)
Q Consensus       265 ~~~~~--------~~~g~~p~~~-----~-------~~~~~~~vws~~~~~~~~~~~~~~l-------------------  305 (409)
                      .....        ...|...+..     +       .++..+|+|+++  ..+++++....                   
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~G--vvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG--LVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH--HHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhH--HHHHHHhhCCCCCCcccccccchhhccccc
Confidence            64432        1123332211     1       245678999984  22333332110                   


Q ss_pred             ----------hh---cCCC-----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          306 ----------KA---KGGY-----ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       306 ----------~~---~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                                ..   .++.     +.+....+.+|+.+||+.||++||||.||++.|+.+.
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence                      00   0111     1235567899999999999999999999999998654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-40  Score=315.90  Aligned_cols=224  Identities=17%  Similarity=0.245  Sum_probs=179.0

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      .++|++.+.||+|+||+||+|...  ++.||||.++.... ....+.+|+++|++++|||||++++++.+ .+.+|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFES-MEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEe
Confidence            367899999999999999999987  88999999976543 34568899999999999999999999987 788999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC--CcEEEecccCcccccC
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK--MNARLGDFGLAKMHHH  267 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~--~~~kl~DFGla~~~~~  267 (409)
                      ||++|+|.+++..  ....+++.++..++.||+.||+|||   +.+|+||||||+|||++.+  ..+||+|||+++....
T Consensus        82 ~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            9999999999954  2346999999999999999999999   8999999999999999854  4799999999998765


Q ss_pred             Cc---eeeeccccc------cCCCcHHHHHHhhh-------------ccCcHHHHhhHHhhhcCCCCHH----HHHHHHH
Q 048535          268 GQ---VMSGRRPIE------EGKRNLVDRMWSLT-------------ERSELLSVLDERLKAKGGYADE----VVEKVLH  321 (409)
Q Consensus       268 ~~---~~~g~~p~~------~~~~~~~~~vws~~-------------~~~~~~~~~~~~l~~~~~~~~~----~~~~l~~  321 (409)
                      ..   ...|...+.      ...++...|+|+++             ......+++...+.....++..    .+.++.+
T Consensus       157 ~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence            43   222322221      25578899999984             1122223333333322233332    3467899


Q ss_pred             HHHHccCcCCCCCCCHHHHHH
Q 048535          322 LGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       322 l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ++.+||+.||++|||+.|+++
T Consensus       237 li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         237 FVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-41  Score=320.54  Aligned_cols=231  Identities=23%  Similarity=0.363  Sum_probs=179.1

Q ss_pred             hCCCCccceeecCCceEEEEEEEC---------CcEEEEEEeccC-ChHHHHHHHHHHHHhccC-CCCceeeEeeEEEcc
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL---------GVEVALKRISLD-SEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKKE  180 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~~  180 (409)
                      .++|.+.+.||+|+||.||+|+..         +..||||+++.+ ......++.+|...+.++ +|||||+++++|.+ 
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence            357888899999999999999874         246999999766 445567899999999888 89999999999987 


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCee
Q 048535          181 KESLILIYDYMENGSLDKWIFECD-------------ESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVL  247 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NIL  247 (409)
                      ++..++|||||++|+|.++|....             ....+++.+++.++.||+.||+|||   +.+||||||||+|||
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVL  167 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeeccccee
Confidence            678999999999999999997542             1245899999999999999999999   899999999999999


Q ss_pred             eCCCCcEEEecccCcccccCCc------eeeecccc------ccCCCcHHHHHHhhhccCcHHHHh--------------
Q 048535          248 LDKKMNARLGDFGLAKMHHHGQ------VMSGRRPI------EEGKRNLVDRMWSLTERSELLSVL--------------  301 (409)
Q Consensus       248 l~~~~~~kl~DFGla~~~~~~~------~~~g~~p~------~~~~~~~~~~vws~~~~~~~~~~~--------------  301 (409)
                      ++.++.+||+|||+++......      ...|...+      ....++..+|+|+++  ..+++++              
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~G--vvl~ell~~g~~p~~~~~~~~  245 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG--VLLWEIFTLGGSPYPGVPVEE  245 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHH--HHHHHHHTTSCCSSTTCCHHH
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhH--HHHHHhccCCCCCCCCCCHHH
Confidence            9999999999999998765432      12232222      236788899999983  1122222              


Q ss_pred             --hHHhh-hcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          302 --DERLK-AKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       302 --~~~l~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                        ..... ...+.+...++.+.+|+.+||+.||++|||+.||++.|+++.
T Consensus       246 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         246 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence              11111 113344556678999999999999999999999999998764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-41  Score=316.41  Aligned_cols=268  Identities=22%  Similarity=0.292  Sum_probs=193.7

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++|++.+.||+|+||+||+|++.  |+.||||+++...  ....+.+.+|+++|++++|||||++++++.+ ++.+|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-ccceeEEE
Confidence            57899999999999999999987  8999999996542  2335689999999999999999999999987 78899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      ||+.+ ++.+++.. .....+++..+..++.||+.||+|||   +.+||||||||+|||++.++.+||+|||+|+.....
T Consensus        81 e~~~~-~~~~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             ECCSE-EHHHHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             eecCC-chhhhhhh-hcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCC
Confidence            99976 55555543 23456999999999999999999999   899999999999999999999999999999876433


Q ss_pred             c----eeeeccccc-------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 048535          269 Q----VMSGRRPIE-------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI  337 (409)
Q Consensus       269 ~----~~~g~~p~~-------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  337 (409)
                      .    ...|...+.       ...++..+|+|+++  ..+++++....+..+..   ....+..+...+..++....+..
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlG--vily~m~~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG--CIFAEMVTRRALFPGDS---EIDQLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHH--HHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cccceeecccceeeehhhhccccCCCccccccccc--hhhhHHhhCCCCCCCCC---HHHHHHHHHHhcCCCchhhcccc
Confidence            2    122332221       13357889999997  55677776655432222   22334444444444444444433


Q ss_pred             HHHHHHHhcCcCCCC-------CCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          338 RQVLKMLEGQTEGTG-------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       338 ~evl~~L~~~~~~~~-------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      ....+..........       +.-.....+++.+|+..+|.+|+|+++++.||||+++.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence            222111111110000       000112368999999999999999999999999998864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-41  Score=315.95  Aligned_cols=261  Identities=22%  Similarity=0.238  Sum_probs=187.1

Q ss_pred             ccceeecCCceEEEEEEEC--CcEEEEEEeccCChH-----HHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          117 EENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEH-----GMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       117 ~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ..+.||+|+||+||+|+..  |+.||||+++.....     ..+.+.+|+.+|++++|||||++++++.+ ++..|+|||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCceeehhh
Confidence            3578999999999999986  899999999754221     13468899999999999999999999987 678999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      ||+++++..+.   .....+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus        81 ~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          81 FMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            99998777665   33456999999999999999999999   8999999999999999999999999999998765432


Q ss_pred             ----eeeeccccc-------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 048535          270 ----VMSGRRPIE-------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIR  338 (409)
Q Consensus       270 ----~~~g~~p~~-------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  338 (409)
                          ...|...+.       ...++...|+|+++  ..+++++.......+....   ..+..+...+-.+.....|...
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG--vil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~  229 (299)
T d1ua2a_         155 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVG--CILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMC  229 (299)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHH--HHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTT
T ss_pred             ccccceecChhhccHHHHccCCCCChhhhhhhcc--hHHHHHHhCcCCCCCCCHH---HHHHHHHHhcCCCChhhccchh
Confidence                122332221       23568999999998  5667777654433222222   2334444444444444333322


Q ss_pred             HHHHHHhcCcCCCCC-------CCCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          339 QVLKMLEGQTEGTGL-------EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       339 evl~~L~~~~~~~~~-------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ....... ....+..       .......+++.+|+..+|.+|+|+++++.||||++..
T Consensus       230 ~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         230 SLPDYVT-FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             SSTTCCC-CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccchhhh-hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence            2111000 0000000       0112247899999999999999999999999998765

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-40  Score=312.74  Aligned_cols=264  Identities=22%  Similarity=0.276  Sum_probs=197.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC-CcEEEEEEeccCC--hHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-GVEVALKRISLDS--EHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|+..+.||+|+||+||+|+++ |+.||||+++...  ....+.+.+|+.+|++++|||||++++++.. .+..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-CCceeEEEE
Confidence            57889999999999999999988 8999999997653  2335789999999999999999999999987 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCCc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHGQ  269 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~  269 (409)
                      |+.++.+..+..   ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|.......
T Consensus        81 ~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          81 HLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             eehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            998877777663   3457999999999999999999999   7899999999999999999999999999998765432


Q ss_pred             ----eeeeccccc-------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHH
Q 048535          270 ----VMSGRRPIE-------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIR  338 (409)
Q Consensus       270 ----~~~g~~p~~-------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  338 (409)
                          ...|...+.       ...++...|+|+++  ..+++++....+..+...   ...+..+....-.+.+...|.+.
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslG--v~l~el~~G~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~  229 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVG--CIFAEMVNGTPLFPGVSE---ADQLMRIFRILGTPNSKNWPNVT  229 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHH--HHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             cccceecccchhhhHHHHhCCCCCCcceeehhcC--cHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCCChhhccchh
Confidence                112222221       24467899999997  457777766654332222   22334444444455555556555


Q ss_pred             HHHHHHhcCcCCCCCCC-------CCcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          339 QVLKMLEGQTEGTGLED-------EGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       339 evl~~L~~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      +..+...........+.       .....|++.+|+..+|.+|+|+++++.||||++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            44333222211111110       112268999999999999999999999999974

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-40  Score=312.79  Aligned_cols=243  Identities=22%  Similarity=0.306  Sum_probs=180.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhc-cCCCCceeeEeeEEEccCCeEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLG-RLKHRNLVGLRGWCKKEKESLIL  186 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~g~~~~~~~~~~l  186 (409)
                      ++|.+.+.||+|+||+||+|+..  ++.||||+++..   .....+.+..|..++. .++|||||++++++.+ ++..|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-~~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-CCceeE
Confidence            57889999999999999999996  899999999753   2233456778887765 6899999999999987 788999


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHH  266 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~  266 (409)
                      |||||++|+|.+++..   ...+++.++..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|+...
T Consensus        81 vmEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcc
Confidence            9999999999999964   346899999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCc----eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCC
Q 048535          267 HGQ----VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPT  336 (409)
Q Consensus       267 ~~~----~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt  336 (409)
                      ...    ...|...+.      ...++..+|+|+++  ..+++++....+..+.                         +
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG--vilyemltG~~PF~~~-------------------------~  207 (320)
T d1xjda_         155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFG--VLLYEMLIGQSPFHGQ-------------------------D  207 (320)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHH--HHHHHHHHSSCSSCCS-------------------------S
T ss_pred             cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhh--HHHHHHHhCCCCCCCC-------------------------C
Confidence            322    233433332      25678899999997  4455555544332211                         2


Q ss_pred             HHHHHHHHhcC-cCCCCCCCCCcchhHHhhhcccCCCCccccc-ccCCCCCccccc
Q 048535          337 IRQVLKMLEGQ-TEGTGLEDEGMNVHLLKRIGTRAMTSSWKFA-GSRGHPTFNEIN  390 (409)
Q Consensus       337 ~~evl~~L~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~~hp~~~~~~  390 (409)
                      ..++.+.+... ...+..- +....+++.+|+..+|.+|++.. +++.||||++++
T Consensus       208 ~~~~~~~i~~~~~~~p~~~-s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         208 EEELFHSIRMDNPFYPRWL-EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             HHHHHHHHHHCCCCCCTTS-CHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             HHHHHHHHHcCCCCCCccC-CHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence            22222221111 1111111 11236777778888888887764 677788887654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.4e-40  Score=307.40  Aligned_cols=228  Identities=17%  Similarity=0.263  Sum_probs=178.4

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC---ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC---Ce
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD---SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK---ES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---~~  183 (409)
                      .++|++.+.||+|+||+||+|+..  |+.||||+++..   +....+.|.+|+.+|++++|||||++++++....   ..
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            367999999999999999999986  899999999754   3445678999999999999999999999987633   24


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      .|+|||||++|+|.+++..   ...+++.++..++.||+.||+|||   +++|+||||||+|||++.++..+|+|||.++
T Consensus        86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhh
Confidence            8999999999999999854   346999999999999999999999   8999999999999999999999999999987


Q ss_pred             cccCCc-------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhh---------------HHhhhcCC----C
Q 048535          264 MHHHGQ-------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLD---------------ERLKAKGG----Y  311 (409)
Q Consensus       264 ~~~~~~-------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~---------------~~l~~~~~----~  311 (409)
                      ......       ...|...+.      ...++..+|+|+++  ..+++++.               ..+.....    .
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlG--vilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~  237 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLG--CVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR  237 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHH--HHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGT
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccch--HHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchh
Confidence            654322       223444332      25678899999984  22222222               22221111    1


Q ss_pred             CHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHhcC
Q 048535          312 ADEVVEKVLHLGLLCAHPEANSRP-TIRQVLKMLEGQ  347 (409)
Q Consensus       312 ~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~  347 (409)
                      ....++.+.+++.+||+.||++|| |++++++.|.++
T Consensus       238 ~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         238 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            223456789999999999999999 899998887653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.8e-40  Score=319.16  Aligned_cols=221  Identities=21%  Similarity=0.218  Sum_probs=174.5

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCC---hHHHHHH---HHHHHHhccCCCCceeeEeeEEEccCCeE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDS---EHGMREF---LAEVSSLGRLKHRNLVGLRGWCKKEKESL  184 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~---~~~~~~~---~~E~~~l~~l~H~niv~l~g~~~~~~~~~  184 (409)
                      ++|++.+.||+|+||.||+|+..  |+.||||++....   ......+   ..|+.+++.++|||||++++++.+ .+.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-CCEE
Confidence            67999999999999999999987  8999999986431   1112233   345778888999999999999987 7889


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      |+|||||++|+|.++|..   ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeee
Confidence            999999999999999964   346899999999999999999999   89999999999999999999999999999997


Q ss_pred             ccCCc--eeeeccccc-------cCCCcHHHHHHhhhccCcHHHHhhH------------------HhhhcCCCCHHHHH
Q 048535          265 HHHGQ--VMSGRRPIE-------EGKRNLVDRMWSLTERSELLSVLDE------------------RLKAKGGYADEVVE  317 (409)
Q Consensus       265 ~~~~~--~~~g~~p~~-------~~~~~~~~~vws~~~~~~~~~~~~~------------------~l~~~~~~~~~~~~  317 (409)
                      .....  ...|...+.       ...++..+|+|+++  ..+++++..                  ........+...++
T Consensus       157 ~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlG--vilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~  234 (364)
T d1omwa3         157 FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLG--CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP  234 (364)
T ss_dssp             CSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHH--HHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCH
T ss_pred             cCCCcccccccccccchhHHhhcCCCCCcccchhHHH--HHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCH
Confidence            65543  233444332       13468899999984  222332222                  22222233445667


Q ss_pred             HHHHHHHHccCcCCCCCCC-----HHHHHH
Q 048535          318 KVLHLGLLCAHPEANSRPT-----IRQVLK  342 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt-----~~evl~  342 (409)
                      ++.+|+.+||+.||++|||     ++|+++
T Consensus       235 ~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         235 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             HHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            8999999999999999999     688874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-39  Score=305.45  Aligned_cols=266  Identities=21%  Similarity=0.243  Sum_probs=197.1

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~  188 (409)
                      ++|++.+.||+|+||+||+|++.  ++.||||+++..  ......++.+|+.+|++++|||||++++++.+ ....++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-ccceeEEe
Confidence            57899999999999999999987  889999999654  34456789999999999999999999999987 77899999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccccCC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMHHHG  268 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  268 (409)
                      |++.+++|..++..   ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.|+.....
T Consensus        81 ~~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          81 EFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             ECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eecccccccccccc---ccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            99999999888743   456899999999999999999999   899999999999999999999999999999876543


Q ss_pred             c----eeeecccc------c-cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCH
Q 048535          269 Q----VMSGRRPI------E-EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTI  337 (409)
Q Consensus       269 ~----~~~g~~p~------~-~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  337 (409)
                      .    ...+...+      . ...++...|+|+++  ..+++++....+...  ..+....+..+........+...|..
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG--~il~ell~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (292)
T d1unla_         155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG--CIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHH--HHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred             CccceeeccccchhhhhHhccCCCCCchhhccccc--hHHHHHhhCCCCCCC--CCCHHHHHHHHHhhcCCCChhhhhhh
Confidence            2    11111111      1 12357889999997  456666655443111  11222334444444555555555554


Q ss_pred             HHHHHHHhcC-----cCCCCC--CCCCcchhHHhhhcccCCCCcccccccCCCCCcccc
Q 048535          338 RQVLKMLEGQ-----TEGTGL--EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEI  389 (409)
Q Consensus       338 ~evl~~L~~~-----~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~  389 (409)
                      .+....-...     ......  .......+++.+|+..+|.+|+|+++++.||||++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~  289 (292)
T d1unla_         231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred             hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence            4332211100     000000  001123689999999999999999999999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-39  Score=310.70  Aligned_cols=228  Identities=23%  Similarity=0.245  Sum_probs=174.7

Q ss_pred             hCCCCccc-eeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccC-CCCceeeEeeEEEc---cCCeE
Q 048535          112 TKGFSEEN-VIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRL-KHRNLVGLRGWCKK---EKESL  184 (409)
Q Consensus       112 ~~~f~~~~-~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~g~~~~---~~~~~  184 (409)
                      .++|.+.. .||+|+||.||+|++.  ++.||||+++..     ..+.+|+.++.++ +|||||++++++.+   ....+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35787764 6999999999999986  899999999643     4567899987655 89999999998864   23568


Q ss_pred             EEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC---CCcEEEecccC
Q 048535          185 ILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK---KMNARLGDFGL  261 (409)
Q Consensus       185 ~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kl~DFGl  261 (409)
                      |+|||||++|+|.++|... ....+++.++..++.||+.||+|||   +.+|+||||||+|||+++   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccce
Confidence            9999999999999999753 3356999999999999999999999   899999999999999986   45799999999


Q ss_pred             cccccCCc---eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhc-------------------CCCC-
Q 048535          262 AKMHHHGQ---VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAK-------------------GGYA-  312 (409)
Q Consensus       262 a~~~~~~~---~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~-------------------~~~~-  312 (409)
                      |+......   ...|...+.      ...++...|+|+++  ..+++++....++.                   ..++ 
T Consensus       161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlG--vily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             CEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHH--HHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             eeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhc--hhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            98765433   223333321      24578899999995  23333333221110                   1111 


Q ss_pred             ---HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HhcCcCC
Q 048535          313 ---DEVVEKVLHLGLLCAHPEANSRPTIRQVLKM--LEGQTEG  350 (409)
Q Consensus       313 ---~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~  350 (409)
                         ...++++.+|+.+||+.||++|||+.|+++.  +.+....
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~  281 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV  281 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSS
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCC
Confidence               2446789999999999999999999999883  4444333

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-38  Score=306.85  Aligned_cols=260  Identities=23%  Similarity=0.253  Sum_probs=182.8

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-----CCeEEE
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-----KESLIL  186 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~~~l  186 (409)
                      +|+..++||+|+||+||+|++.  |+.||||++..+..    .+.+|+++|++++|||||+++++|...     ...+++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            4777899999999999999997  89999999976532    234799999999999999999998642     235799


Q ss_pred             EEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC-cEEEecccCcccc
Q 048535          187 IYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM-NARLGDFGLAKMH  265 (409)
Q Consensus       187 v~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~~  265 (409)
                      |||||++|.+..+.........+++.++..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987644444332234557999999999999999999999   89999999999999999875 8999999999876


Q ss_pred             cCCc---eeeeccccc-------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCC
Q 048535          266 HHGQ---VMSGRRPIE-------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRP  335 (409)
Q Consensus       266 ~~~~---~~~g~~p~~-------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  335 (409)
                      ....   ...|...+.       ...++...|+|+++  ..+++++.....+......   ..+..+...+-.      |
T Consensus       174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG--~il~el~~g~~pf~~~~~~---~~l~~i~~~~g~------~  242 (350)
T d1q5ka_         174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG--CVLAELLLGQPIFPGDSGV---DQLVEIIKVLGT------P  242 (350)
T ss_dssp             CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHH--HHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCC------C
T ss_pred             cCCcccccccccccccChHHhhcccCCCcceeecccc--eEEEehhhCCCCCCCCCHH---HHHHHHHHHhCC------C
Confidence            5433   122222221       24578999999997  4566776654433222222   222233222211      1


Q ss_pred             CHHHHHHHHhcCcC--CCC-----------CCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          336 TIRQVLKMLEGQTE--GTG-----------LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       336 t~~evl~~L~~~~~--~~~-----------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      ....+.........  .+.           ........+++.+|+..+|.+|+|+++++.||||+++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            12222222111100  000           011122478999999999999999999999999998753

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-39  Score=304.15  Aligned_cols=220  Identities=25%  Similarity=0.338  Sum_probs=162.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCCh------HHHHHHHHHHHHhccCC--CCceeeEeeEEEccCC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSE------HGMREFLAEVSSLGRLK--HRNLVGLRGWCKKEKE  182 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~g~~~~~~~  182 (409)
                      ++|++.+.||+|+||+||+|+..  |+.||||+++....      ....++.+|+.+|++++  |||||++++++.+ .+
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-~~   82 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-PD   82 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-SS
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-CC
Confidence            57899999999999999999987  89999999964311      12234678999999986  8999999999987 77


Q ss_pred             eEEEEEEeCCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCC-CcEEEeccc
Q 048535          183 SLILIYDYMEN-GSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKK-MNARLGDFG  260 (409)
Q Consensus       183 ~~~lv~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFG  260 (409)
                      ..++||||+.+ +++.+++..   ...+++.++..++.||++||+|||   +++|+||||||+|||++.+ +.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccc
Confidence            89999999976 688888854   346999999999999999999999   8999999999999999854 789999999


Q ss_pred             CcccccCCc--eeeecccccc------C-CCcHHHHHHhhhccCcHHHHhhHHhhhc---------CCCCHHHHHHHHHH
Q 048535          261 LAKMHHHGQ--VMSGRRPIEE------G-KRNLVDRMWSLTERSELLSVLDERLKAK---------GGYADEVVEKVLHL  322 (409)
Q Consensus       261 la~~~~~~~--~~~g~~p~~~------~-~~~~~~~vws~~~~~~~~~~~~~~l~~~---------~~~~~~~~~~l~~l  322 (409)
                      +|+......  ...|...+..      . .++...|+|+++  ..+++++....+..         ..++...+.++.++
T Consensus       157 ~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlG--vilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~l  234 (273)
T d1xwsa_         157 SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLG--ILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHL  234 (273)
T ss_dssp             TCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHH--HHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHH
T ss_pred             cceecccccccccccCCCcCCHHHHcCCCCCCcccccccce--eeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHHH
Confidence            998765433  2334443321      2 346778999996  34555554433211         11122223445555


Q ss_pred             HHHccCcCCCCCCCHHHHH
Q 048535          323 GLLCAHPEANSRPTIRQVL  341 (409)
Q Consensus       323 ~~~Cl~~dP~~RPt~~evl  341 (409)
                      +.+||+.||++|||++|++
T Consensus       235 i~~~L~~dp~~R~s~~eil  253 (273)
T d1xwsa_         235 IRWCLALRPSDRPTFEEIQ  253 (273)
T ss_dssp             HHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHh
Confidence            5555555555555555553

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-39  Score=306.43  Aligned_cols=270  Identities=20%  Similarity=0.259  Sum_probs=188.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC---CcEEEEEEeccC--ChHHHHHHHHHHHHhccC---CCCceeeEeeEEEc----
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL---GVEVALKRISLD--SEHGMREFLAEVSSLGRL---KHRNLVGLRGWCKK----  179 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l---~H~niv~l~g~~~~----  179 (409)
                      .++|++.+.||+|+||+||+|++.   ++.||||+++..  .......+.+|+.+|+.|   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999999985   567999999654  222233566777777665   89999999999863    


Q ss_pred             cCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecc
Q 048535          180 EKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDF  259 (409)
Q Consensus       180 ~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF  259 (409)
                      .....+++|||+++|++......  ....+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecch
Confidence            23468999999998777654432  3456999999999999999999999   899999999999999999999999999


Q ss_pred             cCcccccCCc---eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcC
Q 048535          260 GLAKMHHHGQ---VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPE  330 (409)
Q Consensus       260 Gla~~~~~~~---~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~d  330 (409)
                      |+++......   ...|...+.      ...++...|+|+++  ..+++++.....+.+....+.   +..+...+..+.
T Consensus       161 g~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG--~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~  235 (305)
T d1blxa_         161 GLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG--CIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPG  235 (305)
T ss_dssp             CSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHH--HHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC
T ss_pred             hhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchH--HHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCc
Confidence            9998764432   233433332      36678899999998  567777776654433222222   233333332222


Q ss_pred             CCCCCCHHHHHHHHhcCcCCC---CC--CCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          331 ANSRPTIRQVLKMLEGQTEGT---GL--EDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       331 P~~RPt~~evl~~L~~~~~~~---~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                      +..-|................   ..  .-.....+++.+|+..+|.+|+|+++++.||||+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence            222121111100000000000   00  01112378999999999999999999999999999875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-38  Score=305.06  Aligned_cols=260  Identities=20%  Similarity=0.261  Sum_probs=181.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC-ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC---CeEE
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD-SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK---ESLI  185 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~---~~~~  185 (409)
                      +.+|++.+.||+|+||+||+|+..  |+.||||+++.. .....+.+.+|+.+|++++||||+++++++....   ...+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            456889999999999999999986  999999999754 4455678999999999999999999999986532   1234


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcccc
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAKMH  265 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~  265 (409)
                      ++++|+.+|+|.+++..    ..+++..+..++.|+++||+|||   +++||||||||+|||++.++.+||+|||+|+..
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            45566779999999953    35999999999999999999999   899999999999999999999999999999865


Q ss_pred             cCCc-------eeeeccccc-------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHH-------
Q 048535          266 HHGQ-------VMSGRRPIE-------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGL-------  324 (409)
Q Consensus       266 ~~~~-------~~~g~~p~~-------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~-------  324 (409)
                      ....       ...|..++.       ...++...|+|+++  ..+++++............+.......+..       
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG--~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG--CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHH--HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccC--ceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            4322       112222221       24567889999997  455666554433222211222111111110       


Q ss_pred             ---------HccCcCC-CCCCCHHHHHHHHhcCcCCCCCCCCCcchhHHhhhcccCCCCcccccccCCCCCcccccc
Q 048535          325 ---------LCAHPEA-NSRPTIRQVLKMLEGQTEGTGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINK  391 (409)
Q Consensus       325 ---------~Cl~~dP-~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~  391 (409)
                               .+....| ..++...++..         ..  .....+++.+|+..||.+|+++++++.||||+....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~--s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFP---------NA--DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCT---------TS--CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCC---------CC--CHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence                     0011111 11122222110         00  112378999999999999999999999999996653

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.8e-38  Score=302.20  Aligned_cols=266  Identities=18%  Similarity=0.241  Sum_probs=184.0

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeEeeEEEcc-CCeEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKE-KESLILIY  188 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~-~~~~~lv~  188 (409)
                      ++|++.+.||+|+||+||+|+..  |+.||||+++...   .+++.+|+.+|++++ ||||+++++++... ...+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999986  8999999997543   357889999999995 99999999998743 45699999


Q ss_pred             EeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCC-cEEEecccCcccccC
Q 048535          189 DYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKM-NARLGDFGLAKMHHH  267 (409)
Q Consensus       189 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~~~~  267 (409)
                      |||++|+|.++.      ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999998764      35999999999999999999999   89999999999999998655 699999999987654


Q ss_pred             Cc---eeeeccccc-------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCH-HHHHHHHHHH------HHccCcC
Q 048535          268 GQ---VMSGRRPIE-------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYAD-EVVEKVLHLG------LLCAHPE  330 (409)
Q Consensus       268 ~~---~~~g~~p~~-------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~-~~~~~l~~l~------~~Cl~~d  330 (409)
                      ..   ...|...+.       ...++...|+|+++  ..+++++............ +....+..+.      ......+
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG--~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         183 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG--CMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHH--HHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCcccccccCccccCcccccCCCCCCcccchhhhh--hhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            33   112222211       13468899999997  3455555544332222111 1111111110      0000011


Q ss_pred             CCCCCCHHHHHHHHhc-----CcCCCC-CCCCCcchhHHhhhcccCCCCcccccccCCCCCccccccc
Q 048535          331 ANSRPTIRQVLKMLEG-----QTEGTG-LEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEINKN  392 (409)
Q Consensus       331 P~~RPt~~evl~~L~~-----~~~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~~~  392 (409)
                      ....|...+.......     ...... ..-.....|++.+|+..+|.+|+|+++++.||||.++.++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~~  328 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD  328 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCCC
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            1111111111110000     000000 0001123789999999999999999999999999998753

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-38  Score=302.10  Aligned_cols=184  Identities=20%  Similarity=0.307  Sum_probs=143.3

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEccC-----C
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEK-----E  182 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~-----~  182 (409)
                      .++|++.+.||+|+||+||+|.+.  |+.||||+++..  +....+.+.+|+.+|++++|||||+++++|...+     .
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            467899999999999999999987  899999999754  4455678999999999999999999999997532     2


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      .+|+||||| +++|..++..    ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccce
Confidence            579999999 5588887743    35999999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCc-eeeeccccc-------cCCCcHHHHHHhhhccCcHHHHhhHHh
Q 048535          263 KMHHHGQ-VMSGRRPIE-------EGKRNLVDRMWSLTERSELLSVLDERL  305 (409)
Q Consensus       263 ~~~~~~~-~~~g~~p~~-------~~~~~~~~~vws~~~~~~~~~~~~~~l  305 (409)
                      +...... ...|...+.       ...++...|+|+++  ..+++++....
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG--vil~ell~g~~  217 (346)
T d1cm8a_         169 RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVG--CIMAEMITGKT  217 (346)
T ss_dssp             EECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHH--HHHHHHHHSSC
T ss_pred             eccCCccccccccccccCHHHHcCCCCCCccchhhcch--HHHHHHHHCcC
Confidence            8765432 122222221       13457789999996  34555555443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-38  Score=297.71  Aligned_cols=266  Identities=21%  Similarity=0.316  Sum_probs=183.9

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-------
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-------  180 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-------  180 (409)
                      .++|++.++||+|+||+||+|++.  |+.||||++...  .....+++.+|+.+|++++||||+++++++...       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            367899999999999999999986  899999998654  333456789999999999999999999988642       


Q ss_pred             CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEeccc
Q 048535          181 KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFG  260 (409)
Q Consensus       181 ~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG  260 (409)
                      ....++||||++++.+..+.   .....+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecc
Confidence            24589999999987766554   33456899999999999999999999   8999999999999999999999999999


Q ss_pred             CcccccCCc--------eeeeccccc-------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHH
Q 048535          261 LAKMHHHGQ--------VMSGRRPIE-------EGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLL  325 (409)
Q Consensus       261 la~~~~~~~--------~~~g~~p~~-------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~  325 (409)
                      +++......        ...|...+.       ...++...|+|+++  ..+++++.......+..+...   +..+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlG--vil~el~~g~~pf~~~~~~~~---~~~i~~~  237 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG--CIMAEMWTRSPIMQGNTEQHQ---LALISQL  237 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHH--HHHHHHHHSSCSCCCSSHHHH---HHHHHHH
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCC--ceeeeHhhCCCCCCCCCHHHH---HHHHHHh
Confidence            998655322        112222221       23567899999997  456666665544322222222   2222223


Q ss_pred             ccCcCCCCCCCH--HHHHHHHhcCcCCCCCCC--------CCcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          326 CAHPEANSRPTI--RQVLKMLEGQTEGTGLED--------EGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       326 Cl~~dP~~RPt~--~evl~~L~~~~~~~~~~~--------~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      +....+..-+..  ......++..........        .....|++.+|+..+|.+|+|+++++.||||.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~  310 (318)
T d3blha1         238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  310 (318)
T ss_dssp             HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred             cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence            333333222111  111111111111111000        112368999999999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-37  Score=299.49  Aligned_cols=267  Identities=18%  Similarity=0.250  Sum_probs=183.7

Q ss_pred             hCCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc----CCe
Q 048535          112 TKGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE----KES  183 (409)
Q Consensus       112 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~----~~~  183 (409)
                      .++|++.+.||+|+||+||+|+..  |+.||||+++..  +....+.+.+|+.+|++++|||||++++++...    ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            467999999999999999999986  899999999754  344567889999999999999999999988632    233


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      .++++||+.+|+|.+++..    ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+|++|||+|.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhc
Confidence            4667788889999999942    36999999999999999999999   8999999999999999999999999999997


Q ss_pred             cccCCc-eeeecccc-------ccCCCcHHHHHHhhhccCcHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCC--C
Q 048535          264 MHHHGQ-VMSGRRPI-------EEGKRNLVDRMWSLTERSELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEAN--S  333 (409)
Q Consensus       264 ~~~~~~-~~~g~~p~-------~~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~--~  333 (409)
                      ...... ...|...+       ....++...|+|+++  ..+++++.....+.+........   .+........+.  .
T Consensus       170 ~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlG--v~l~~ll~g~~pF~~~~~~~~~~---~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVG--CIMAELLTGRTLFPGTDHIDQLK---LILRLVGTPGAELLK  244 (348)
T ss_dssp             CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHH--HHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCHHHHT
T ss_pred             ccCcccccccccccccCchhhcCCccCCcccchhhhh--HHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCChHHhh
Confidence            654322 11121111       113457789999997  44566655544322221111211   111111111110  1


Q ss_pred             CCCHHHHHHHHhcCcCCCCCC-------CCCcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          334 RPTIRQVLKMLEGQTEGTGLE-------DEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       334 RPt~~evl~~L~~~~~~~~~~-------~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      .................+...       ......+++.+|+..+|.+|+|++++++||||++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence            111111122222221111110       112247899999999999999999999999999765

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-38  Score=297.80  Aligned_cols=215  Identities=22%  Similarity=0.269  Sum_probs=163.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC-----CcEEEEEEeccC----ChHHHHHHHHHHHHhccCCC-CceeeEeeEEEccCC
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL-----GVEVALKRISLD----SEHGMREFLAEVSSLGRLKH-RNLVGLRGWCKKEKE  182 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~  182 (409)
                      ++|++.+.||+|+||+||+|...     |+.||||.++..    .....+.+.+|+++|++++| |||+++++++.+ ..
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-~~  102 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ET  102 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-TT
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc-CC
Confidence            56999999999999999999862     789999998643    22334678899999999966 899999999987 77


Q ss_pred             eEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCc
Q 048535          183 SLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLA  262 (409)
Q Consensus       183 ~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla  262 (409)
                      ..+++|||+.+|+|.+++...   ..+++.....++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             ceeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccch
Confidence            899999999999999999643   35788999999999999999999   899999999999999999999999999999


Q ss_pred             ccccCCc-----eeeeccccc--------cCCCcHHHHHHhhhccCcHHHHhhHH-------------------hhhcCC
Q 048535          263 KMHHHGQ-----VMSGRRPIE--------EGKRNLVDRMWSLTERSELLSVLDER-------------------LKAKGG  310 (409)
Q Consensus       263 ~~~~~~~-----~~~g~~p~~--------~~~~~~~~~vws~~~~~~~~~~~~~~-------------------l~~~~~  310 (409)
                      +......     ...|..++.        ...++..+|+|+++  ..+++++...                   ......
T Consensus       177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG--~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~  254 (322)
T d1vzoa_         177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG--VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP  254 (322)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHH--HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC
T ss_pred             hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHH--HHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC
Confidence            8654322     122222221        12356789999994  2333333322                   222223


Q ss_pred             CCHHHHHHHHHHHHHccCcCCCCCCC
Q 048535          311 YADEVVEKVLHLGLLCAHPEANSRPT  336 (409)
Q Consensus       311 ~~~~~~~~l~~l~~~Cl~~dP~~RPt  336 (409)
                      .+...+.++.+++.+||+.||++|||
T Consensus       255 ~~~~~s~~~~~li~~~l~~dP~~R~s  280 (322)
T d1vzoa_         255 YPQEMSALAKDLIQRLLMKDPKKRLG  280 (322)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred             CcccCCHHHHHHHHHHcccCHHHcCC
Confidence            33445556677777777777777764

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-36  Score=283.76  Aligned_cols=225  Identities=19%  Similarity=0.248  Sum_probs=171.2

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCceeeEeeEEEccCCeEEEEEEe
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKEKESLILIYDY  190 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~~~~~~lv~E~  190 (409)
                      ++|++.+.||+|+||.||+|++.  |+.||||++.....  ..++..|+++++.++|+|+|..++.+....+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            46899999999999999999987  89999999875432  245789999999998888777666665557889999999


Q ss_pred             CCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC---CCcEEEecccCcccccC
Q 048535          191 MENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK---KMNARLGDFGLAKMHHH  267 (409)
Q Consensus       191 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~---~~~~kl~DFGla~~~~~  267 (409)
                      + +|+|.+.+..  ....+++..+..++.|++.||+|||   +++|+||||||+|||++.   +..+||+|||+|+....
T Consensus        85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9 4577776654  2346999999999999999999999   899999999999999854   55799999999997654


Q ss_pred             Cc-----------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhcCC------------------C-
Q 048535          268 GQ-----------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAKGG------------------Y-  311 (409)
Q Consensus       268 ~~-----------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~~~------------------~-  311 (409)
                      ..           ...|...+.      ...++..+|+|+++  ..+++++....+....                  . 
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG--~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG--YVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHH--HHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecC--HHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence            32           223433332      24578999999995  2233333322211100                  0 


Q ss_pred             ----CHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcC
Q 048535          312 ----ADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQ  347 (409)
Q Consensus       312 ----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~  347 (409)
                          ....++++.+++..||+.||++||++.++.+.|+..
T Consensus       237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                112346788999999999999999999998888754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-36  Score=289.80  Aligned_cols=171  Identities=22%  Similarity=0.308  Sum_probs=133.9

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccC--ChHHHHHHHHHHHHhccCCCCceeeEeeEEEcc-----CCe
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLD--SEHGMREFLAEVSSLGRLKHRNLVGLRGWCKKE-----KES  183 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~g~~~~~-----~~~  183 (409)
                      ++|++.+.||+|+||+||+|.+.  |+.||||+++..  +....+.+.+|+.+|++++|||||++++++...     ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999987  899999999754  445567799999999999999999999998642     357


Q ss_pred             EEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEEecccCcc
Q 048535          184 LILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARLGDFGLAK  263 (409)
Q Consensus       184 ~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~  263 (409)
                      +|+|||||.++ +.+.+.     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~-l~~~~~-----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchH-HHHhhh-----cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhh
Confidence            89999999765 444442     35899999999999999999999   8999999999999999999999999999988


Q ss_pred             cccCCc---eeeecccc------ccCCCcHHHHHHhhh
Q 048535          264 MHHHGQ---VMSGRRPI------EEGKRNLVDRMWSLT  292 (409)
Q Consensus       264 ~~~~~~---~~~g~~p~------~~~~~~~~~~vws~~  292 (409)
                      ......   ...|...+      ....++...|+|+++
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG  205 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG  205 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCCCTTHHHHHHH
T ss_pred             ccccccccccccccccccChhhhcCCCCCCCccccccc
Confidence            765432   22222222      124567789999985

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.6e-35  Score=275.33  Aligned_cols=225  Identities=17%  Similarity=0.198  Sum_probs=172.8

Q ss_pred             CCCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCCC-CceeeEeeEEEccCCeEEEEEE
Q 048535          113 KGFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLKH-RNLVGLRGWCKKEKESLILIYD  189 (409)
Q Consensus       113 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~g~~~~~~~~~~lv~E  189 (409)
                      ++|++.+.||+|+||+||+|++.  |+.||||+++....  ...+.+|++.++.++| +|++.+++++.. +...++|||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~vme   81 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVID   81 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEEEE
Confidence            57899999999999999999987  89999999865422  2356788899999865 899999998877 778999999


Q ss_pred             eCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCC-----CCcEEEecccCccc
Q 048535          190 YMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDK-----KMNARLGDFGLAKM  264 (409)
Q Consensus       190 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~-----~~~~kl~DFGla~~  264 (409)
                      |+ +|+|.+++...  ...+++..+..++.|++.||+|||   +++|+||||||+|||++.     ++.+||+|||+|+.
T Consensus        82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99 67999998653  346999999999999999999999   899999999999999974     56799999999987


Q ss_pred             ccCCc-----------eeeeccccc------cCCCcHHHHHHhhhccCcHHHHhhHHhhhc-------------------
Q 048535          265 HHHGQ-----------VMSGRRPIE------EGKRNLVDRMWSLTERSELLSVLDERLKAK-------------------  308 (409)
Q Consensus       265 ~~~~~-----------~~~g~~p~~------~~~~~~~~~vws~~~~~~~~~~~~~~l~~~-------------------  308 (409)
                      .....           ...|...+.      ...++..+|+|+++  ..+++++....+..                   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG--~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~  233 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALG--HVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  233 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH--HHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhh--HHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence            64321           223444332      24578899999983  12222222111110                   


Q ss_pred             -CC---CCHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHhcCc
Q 048535          309 -GG---YADEVVEKVLHLGLLCAHPEANSRPTIRQVLKMLEGQT  348 (409)
Q Consensus       309 -~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~  348 (409)
                       ..   .....++++.+++..|++.+|++||+++.+.+.|++..
T Consensus       234 ~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence             00   01123457889999999999999999999988887643

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=2.8e-31  Score=256.36  Aligned_cols=176  Identities=16%  Similarity=0.188  Sum_probs=135.2

Q ss_pred             CCCccceeecCCceEEEEEEEC--CcEEEEEEeccCChHHHHHHHHHHHHhccCC-----------CCceeeEeeEEEcc
Q 048535          114 GFSEENVIGLGGNGKVYKGQLL--GVEVALKRISLDSEHGMREFLAEVSSLGRLK-----------HRNLVGLRGWCKKE  180 (409)
Q Consensus       114 ~f~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~g~~~~~  180 (409)
                      +|++.++||+|+||+||+|+..  |+.||||+++.+. ...+.+.+|+.+++.++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            4899999999999999999986  8999999997543 33467788999888775           57899999988642


Q ss_pred             -CCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCc------
Q 048535          181 -KESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMN------  253 (409)
Q Consensus       181 -~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~------  253 (409)
                       ....+++++++..+..............+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++.      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence             35667788877766544333333455678999999999999999999994  489999999999999986653      


Q ss_pred             EEEecccCcccccCCc-eeeeccccc------cCCCcHHHHHHhhh
Q 048535          254 ARLGDFGLAKMHHHGQ-VMSGRRPIE------EGKRNLVDRMWSLT  292 (409)
Q Consensus       254 ~kl~DFGla~~~~~~~-~~~g~~p~~------~~~~~~~~~vws~~  292 (409)
                      +|++|||.|+...... ...|...+.      ...++...|+|+++
T Consensus       171 ~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  216 (362)
T d1q8ya_         171 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTA  216 (362)
T ss_dssp             EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHH
T ss_pred             eeEeecccccccccccccccccccccChhhccccCCCccccccchH
Confidence            9999999998654332 222333222      25567889999984

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.5e-24  Score=190.05  Aligned_cols=133  Identities=17%  Similarity=0.225  Sum_probs=105.5

Q ss_pred             CccceeecCCceEEEEEEEC-CcEEEEEEeccCCh------------------HHHHHHHHHHHHhccCCCCceeeEeeE
Q 048535          116 SEENVIGLGGNGKVYKGQLL-GVEVALKRISLDSE------------------HGMREFLAEVSSLGRLKHRNLVGLRGW  176 (409)
Q Consensus       116 ~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~g~  176 (409)
                      .+.+.||+|+||+||+|+.. |+.||||+++....                  .....+..|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45789999999999999987 89999998753210                  112345678999999999999998865


Q ss_pred             EEccCCeEEEEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCceeecCCCCCCeeeCCCCcEEE
Q 048535          177 CKKEKESLILIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEGWESKVLHRDIKASNVLLDKKMNARL  256 (409)
Q Consensus       177 ~~~~~~~~~lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDlKp~NILl~~~~~~kl  256 (409)
                      .   .  .+++|||++++.+.+          ++......++.|+++||.|||   +.+|+||||||+|||++++ .++|
T Consensus        83 ~---~--~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          83 E---G--NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             E---T--TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEE
T ss_pred             c---C--CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEE
Confidence            3   2  268999999865543          333445689999999999999   7999999999999999865 4899


Q ss_pred             ecccCcccccC
Q 048535          257 GDFGLAKMHHH  267 (409)
Q Consensus       257 ~DFGla~~~~~  267 (409)
                      +|||+|+...+
T Consensus       144 iDFG~a~~~~~  154 (191)
T d1zara2         144 IDFPQSVEVGE  154 (191)
T ss_dssp             CCCTTCEETTS
T ss_pred             EECCCcccCCC
Confidence            99999976543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.76  E-value=1.5e-08  Score=90.88  Aligned_cols=149  Identities=13%  Similarity=0.003  Sum_probs=102.6

Q ss_pred             HHHHHhCCCCccceeecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCC-CCceeeEeeEEEccCCeEE
Q 048535          107 EIHAATKGFSEENVIGLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLK-HRNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       107 ~l~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~g~~~~~~~~~~  185 (409)
                      ++...-..|+..+..+.++.+.||+....+..+.+|+...........+.+|...+..+. +--+.+++.++.. ++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-CCceE
Confidence            555656677766655555567899988778888999886553333345677888877663 3335567776665 67889


Q ss_pred             EEEEeCCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 048535          186 LIYDYMENGSLDKWIFECDESIALSWEQRIKVLKDVASGILYLYEG----------------------------------  231 (409)
Q Consensus       186 lv~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------  231 (409)
                      +||+++++.++.+....        ......++.++++.|..||..                                  
T Consensus        87 lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            99999999888665421        011233456666666667641                                  


Q ss_pred             ----------------------CCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          232 ----------------------WESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       232 ----------------------~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                                            ....++|+|+.|.|||+++++..-|.||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                  012389999999999999877677999998864

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.98  E-value=1.1e-05  Score=71.10  Aligned_cols=130  Identities=14%  Similarity=0.050  Sum_probs=82.4

Q ss_pred             eeecCC-ceEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCC--CceeeEeeEEEccCCeEEEEEEeCCCCC
Q 048535          120 VIGLGG-NGKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKH--RNLVGLRGWCKKEKESLILIYDYMENGS  195 (409)
Q Consensus       120 ~lG~G~-fg~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~g~~~~~~~~~~lv~E~~~~gs  195 (409)
                      .+..|. .+.||+.... +..+.+|.......   ..+..|...++.+..  -.+.++++++.+ ++..++||||+++-+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeeccc-ccceEEEEEeeeccc
Confidence            344454 3689998887 66688888764432   345677777776633  235667777665 667899999998865


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 048535          196 LDKWIFECDESIALSWEQRIKVLKDVASGILYLYE---------------------------------------------  230 (409)
Q Consensus       196 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~---------------------------------------------  230 (409)
                      +.+..        ...   ...+.++++.|.-||.                                             
T Consensus        93 ~~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          93 LLSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             TTTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             ccccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            53210        111   1112233333333332                                             


Q ss_pred             ------c----CCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          231 ------G----WESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       231 ------~----~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                            .    ....++|+|+.|.|||++++..+-|.||+.+..
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                  1    123489999999999999876678999998864

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.62  E-value=4.4e-05  Score=72.06  Aligned_cols=75  Identities=15%  Similarity=-0.005  Sum_probs=47.2

Q ss_pred             cceeecCCceEEEEEEEC--CcEEEEEEeccC-------ChHHHHHHHHHHHHhccC-CC--CceeeEeeEEEccCCeEE
Q 048535          118 ENVIGLGGNGKVYKGQLL--GVEVALKRISLD-------SEHGMREFLAEVSSLGRL-KH--RNLVGLRGWCKKEKESLI  185 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~--~~~vAvK~~~~~-------~~~~~~~~~~E~~~l~~l-~H--~niv~l~g~~~~~~~~~~  185 (409)
                      .+.||.|....||+....  ++.|.||.-...       -+....+...|.+.|+.+ .+  ..+.+++.+.   ....+
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d---~~~~~  107 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD---TEMAV  107 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE---TTTTE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc---CCCCE
Confidence            457899999999999865  678999975321       011223345677777665 22  3456666543   23446


Q ss_pred             EEEEeCCCCC
Q 048535          186 LIYDYMENGS  195 (409)
Q Consensus       186 lv~E~~~~gs  195 (409)
                      +|||++++..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEeccCCcc
Confidence            8999997644

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=97.37  E-value=3.1e-05  Score=67.44  Aligned_cols=26  Identities=46%  Similarity=0.851  Sum_probs=24.5

Q ss_pred             CEEEeeccCCCcccceEEEEEEEecC
Q 048535            1 MHVGFSAGTGQLVESHKILAWSFSNS   26 (409)
Q Consensus         1 ~~~~f~~~~~~~~~~~~~~~~~f~~~   26 (409)
                      ||||||||||...+.|+|++|+|+++
T Consensus        89 vyvGFSAsTG~~~~~h~I~sWsFsS~  114 (237)
T d1nlsa_          89 VRVGLSASTGLYKETNTILSWSFTSK  114 (237)
T ss_dssp             EEEEEEEECSSSCCCCEEEEEEEEEE
T ss_pred             EEEEEEeecCCCccceEEEEEEEEee
Confidence            79999999999999999999999865

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.51  E-value=0.0038  Score=56.58  Aligned_cols=135  Identities=13%  Similarity=0.098  Sum_probs=73.9

Q ss_pred             eEEEEEEEC-CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCce--eeEee----EEEccCCeEEEEEEeCCCCCHH--
Q 048535          127 GKVYKGQLL-GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL--VGLRG----WCKKEKESLILIYDYMENGSLD--  197 (409)
Q Consensus       127 g~Vy~~~~~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~g----~~~~~~~~~~lv~E~~~~gsL~--  197 (409)
                      -.||+.+.. |..|++|..+... ...+++..|...+..|...++  +..+.    ......+..+.++++++|..+.  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            589999887 8889999986541 223567778887777642221  11111    0111245678899999763221  


Q ss_pred             ---HH---------Hhc----CC--CCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCce
Q 048535          198 ---KW---------IFE----CD--ESIALSWE-------------------QRIKVLKDVASGILYLYE----GWESKV  236 (409)
Q Consensus       198 ---~~---------l~~----~~--~~~~l~~~-------------------~~~~i~~~ia~gL~yLH~----~~~~~i  236 (409)
                         .+         ++.    ..  ....+++.                   ....+...+.+.++.+..    ....++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence               11         111    00  01111211                   111122222223333322    224579


Q ss_pred             eecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          237 LHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       237 vHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ||+|+.+.|||++++  ..+.||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45899998864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.38  E-value=0.004  Score=58.01  Aligned_cols=72  Identities=21%  Similarity=0.189  Sum_probs=47.1

Q ss_pred             cceeecCCceEEEEEEEC---------CcEEEEEEeccCChHHHHHHHHHHHHhccCCCCce-eeEeeEEEccCCeEEEE
Q 048535          118 ENVIGLGGNGKVYKGQLL---------GVEVALKRISLDSEHGMREFLAEVSSLGRLKHRNL-VGLRGWCKKEKESLILI  187 (409)
Q Consensus       118 ~~~lG~G~fg~Vy~~~~~---------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~~lv  187 (409)
                      .+.|+.|-.-.+|+....         .+.|.+++.- .... .....+|..+++.+.-.++ .++++++..     .+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~-----g~I  119 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG-----GRL  119 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT-----EEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-----ceE
Confidence            357888888999998864         2456666654 2222 2345578888888843344 467776632     479


Q ss_pred             EEeCCCCCH
Q 048535          188 YDYMENGSL  196 (409)
Q Consensus       188 ~E~~~~gsL  196 (409)
                      +||+++-.|
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.19  E-value=0.057  Score=47.88  Aligned_cols=159  Identities=12%  Similarity=0.050  Sum_probs=83.7

Q ss_pred             ccHHHHHHHhCCCCcccee-----ecCCceEEEEEEECCcEEEEEEeccCChHHHHHHHHHHHHhccCCCC-----ceee
Q 048535          103 VSYQEIHAATKGFSEENVI-----GLGGNGKVYKGQLLGVEVALKRISLDSEHGMREFLAEVSSLGRLKHR-----NLVG  172 (409)
Q Consensus       103 ~~~~~l~~~~~~f~~~~~l-----G~G~fg~Vy~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H~-----niv~  172 (409)
                      ++-+|+.....+|...+..     ..|---+.|+.+..+..+++|+.....  ..++...|++++..|...     ..+.
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence            5667888888888775443     355557889988886679999986431  123344566666655322     2221


Q ss_pred             Eee---EEEccCCeEEEEEEeCCCCCHHH--------------HHhcC------CCCCCCC------------------H
Q 048535          173 LRG---WCKKEKESLILIYDYMENGSLDK--------------WIFEC------DESIALS------------------W  211 (409)
Q Consensus       173 l~g---~~~~~~~~~~lv~E~~~~gsL~~--------------~l~~~------~~~~~l~------------------~  211 (409)
                      ..+   +..- ......++.+..+.....              .++..      .......                  .
T Consensus        81 ~~~g~~~~~~-~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          81 RKDGELLGEL-SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             BTTCCSCEEE-TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             ecCCCcceee-ecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            100   0111 345566777776532211              01100      0000000                  0


Q ss_pred             HHHHHHHHHHHHHHHHHHh-cCCCceeecCCCCCCeeeCCCCcEEEecccCccc
Q 048535          212 EQRIKVLKDVASGILYLYE-GWESKVLHRDIKASNVLLDKKMNARLGDFGLAKM  264 (409)
Q Consensus       212 ~~~~~i~~~ia~gL~yLH~-~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~  264 (409)
                      ......+......+.-.+. ....++||+|+.+.||+++.+...-|.||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            0111122222222222221 2357799999999999999887778999998853

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.33  E-value=0.0078  Score=52.98  Aligned_cols=29  Identities=21%  Similarity=0.110  Sum_probs=25.3

Q ss_pred             HHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          314 EVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       314 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+.++.+|+.+||+.||++|||++|+++
T Consensus       231 ~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         231 KIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            34567889999999999999999999865

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.29  E-value=0.03  Score=49.48  Aligned_cols=28  Identities=14%  Similarity=0.035  Sum_probs=24.0

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+..+.+|+.+||+.||++|||++|+++
T Consensus       243 ~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         243 TSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3457889999999999999999999865

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.22  E-value=0.0093  Score=52.20  Aligned_cols=63  Identities=16%  Similarity=0.097  Sum_probs=39.1

Q ss_pred             cCCCcHHHHHHhhhccC------cHHHHhhHHhhhcCCCCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 048535          279 EGKRNLVDRMWSLTERS------ELLSVLDERLKAKGGYADEVVEKVLHLGLLCAHPEANSRPTIRQVL  341 (409)
Q Consensus       279 ~~~~~~~~~vws~~~~~------~~~~~~~~~l~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl  341 (409)
                      .+.+++..-+|.+....      ...+...........++...++++.+++.+||+.||++|||++|++
T Consensus       185 ~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil  253 (263)
T d2j4za1         185 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL  253 (263)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence            36677888888875433      3344444444444455556666677777777777777777766664

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=93.54  E-value=0.015  Score=53.05  Aligned_cols=32  Identities=3%  Similarity=0.101  Sum_probs=25.1

Q ss_pred             CCCHHHHHHHHHHHHHccCcCCCCCCCHHHHH
Q 048535          310 GYADEVVEKVLHLGLLCAHPEANSRPTIRQVL  341 (409)
Q Consensus       310 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl  341 (409)
                      .........+.+|+.+|++.||.+|||++|++
T Consensus       295 ~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         295 KFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             CCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             ccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            45566777888888888888888888888774

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=92.72  E-value=0.027  Score=49.49  Aligned_cols=28  Identities=25%  Similarity=0.188  Sum_probs=24.8

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+.+.+++.+||+.||++|||++|+++
T Consensus       253 ~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         253 LDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3457889999999999999999999974

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=92.61  E-value=0.011  Score=52.04  Aligned_cols=30  Identities=20%  Similarity=0.139  Sum_probs=26.4

Q ss_pred             HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          313 DEVVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       313 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ...++++.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            345678999999999999999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.29  E-value=0.032  Score=50.02  Aligned_cols=27  Identities=11%  Similarity=0.182  Sum_probs=24.9

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      +.++.+++.+||+.||++|||++|+++
T Consensus       271 s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         271 SLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            457899999999999999999999987

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.26  E-value=0.067  Score=46.59  Aligned_cols=28  Identities=7%  Similarity=0.137  Sum_probs=24.7

Q ss_pred             hhHHhhhcccCCCCcccccccCCCCCcc
Q 048535          360 VHLLKRIGTRAMTSSWKFAGSRGHPTFN  387 (409)
Q Consensus       360 ~~~l~~~~~~~~~~~~~~~~~~~hp~~~  387 (409)
                      .+++.+|++.+|.+|+|+++++.||||+
T Consensus       243 ~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         243 KEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            6788899999999999999999999985

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.25  E-value=0.03  Score=49.60  Aligned_cols=27  Identities=26%  Similarity=0.054  Sum_probs=24.7

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+.+.+|+.+||+.||++|||++|+++
T Consensus       253 s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         253 GDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            356889999999999999999999987

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.23  E-value=0.034  Score=49.25  Aligned_cols=28  Identities=21%  Similarity=0.131  Sum_probs=24.9

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+.+.+|+.+||+.||++|||+.|+++
T Consensus       265 ~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         265 IDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            3456789999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.98  E-value=0.044  Score=48.78  Aligned_cols=27  Identities=15%  Similarity=-0.050  Sum_probs=24.1

Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      ..+++|+.+||+.||++|||++|+++.
T Consensus       279 ~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         279 PYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            456789999999999999999999874

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.96  E-value=0.038  Score=48.89  Aligned_cols=32  Identities=19%  Similarity=0.097  Sum_probs=27.1

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHHH--HhcC
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLKM--LEGQ  347 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~  347 (409)
                      ...+.+++.+||+.||++|||++|+++.  ++++
T Consensus       256 s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            3578899999999999999999999874  5544

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.78  E-value=0.046  Score=48.36  Aligned_cols=32  Identities=9%  Similarity=-0.084  Sum_probs=28.5

Q ss_pred             chhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          359 NVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       359 ~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ..+++.+|+..+|.+|+++++++.||||+...
T Consensus       246 ~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence            36899999999999999999999999997543

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.70  E-value=0.02  Score=51.91  Aligned_cols=25  Identities=20%  Similarity=0.062  Sum_probs=13.8

Q ss_pred             HHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          318 KVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       318 ~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      .+.+|+.+||+.||++|||++|+++
T Consensus       276 ~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         276 LAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHCcCChhHCcCHHHHhc
Confidence            4455555555555555555555543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.29  E-value=0.064  Score=47.19  Aligned_cols=60  Identities=12%  Similarity=0.117  Sum_probs=39.1

Q ss_pred             cCCCCCCCHHHHHHH-HhcCcCCCCCCCC--CcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          329 PEANSRPTIRQVLKM-LEGQTEGTGLEDE--GMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       329 ~dP~~RPt~~evl~~-L~~~~~~~~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      .-|-...+..+++.. +++.......+..  ....+++.+|++.+|.+|+|+++++.||||+.
T Consensus       212 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~  274 (288)
T d2jfla1         212 EPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV  274 (288)
T ss_dssp             SCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            345444455555544 4433222221111  12378999999999999999999999999974

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=91.28  E-value=0.044  Score=50.11  Aligned_cols=32  Identities=16%  Similarity=0.236  Sum_probs=29.0

Q ss_pred             chhHHhhhcccCCCCcccc-----cccCCCCCccccc
Q 048535          359 NVHLLKRIGTRAMTSSWKF-----AGSRGHPTFNEIN  390 (409)
Q Consensus       359 ~~~~l~~~~~~~~~~~~~~-----~~~~~hp~~~~~~  390 (409)
                      ..+++.+|+..+|.+|+++     ++++.||||.+++
T Consensus       236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  272 (364)
T ss_dssp             HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence            4899999999999999994     7999999999875

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.10  E-value=0.033  Score=48.87  Aligned_cols=28  Identities=11%  Similarity=-0.068  Sum_probs=24.9

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+.+.+|+.+||+.||.+|||++|+++
T Consensus       255 ~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         255 LNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3457889999999999999999999976

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.59  E-value=0.032  Score=50.74  Aligned_cols=27  Identities=11%  Similarity=0.019  Sum_probs=17.4

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVL  341 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl  341 (409)
                      ....+.+|+.+||+.||++|||++|++
T Consensus       283 ~s~~~~dll~~mL~~dP~~R~ta~elL  309 (355)
T d2b1pa1         283 KASQARDLLSKMLVIDPAKRISVDDAL  309 (355)
T ss_dssp             HHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence            345566677777777777777666653

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=90.57  E-value=0.096  Score=47.49  Aligned_cols=64  Identities=8%  Similarity=-0.049  Sum_probs=43.9

Q ss_pred             cCcCCCCCCCHHHHHHHHhc-CcCCCCCCCC---CcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          327 AHPEANSRPTIRQVLKMLEG-QTEGTGLEDE---GMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       327 l~~dP~~RPt~~evl~~L~~-~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      .-.-|-.-.+..++++.+.. ....+.....   ....+++.+|+..+|.+|+++++++.||||....
T Consensus       223 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         223 SGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             hCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            34456555667777665543 3333322111   1237899999999999999999999999997644

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=90.57  E-value=0.046  Score=48.94  Aligned_cols=28  Identities=21%  Similarity=0.160  Sum_probs=25.1

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ...++.+|+.+||+.||++|||++|+++
T Consensus       291 ~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         291 VSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3457889999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.70  E-value=0.081  Score=47.70  Aligned_cols=27  Identities=22%  Similarity=0.105  Sum_probs=24.7

Q ss_pred             HHHHHHHHHccCcCCCCCCCHHHHHHH
Q 048535          317 EKVLHLGLLCAHPEANSRPTIRQVLKM  343 (409)
Q Consensus       317 ~~l~~l~~~Cl~~dP~~RPt~~evl~~  343 (409)
                      .++.+++.+||+.||.+|||+.|+++.
T Consensus       269 ~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         269 SKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            468899999999999999999999874

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.59  E-value=0.062  Score=48.65  Aligned_cols=28  Identities=11%  Similarity=-0.056  Sum_probs=25.1

Q ss_pred             HHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 048535          315 VVEKVLHLGLLCAHPEANSRPTIRQVLK  342 (409)
Q Consensus       315 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~  342 (409)
                      ..+.+.+|+.+||+.||++|||+.|+++
T Consensus       275 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         275 TPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            4456889999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.43  E-value=0.064  Score=48.30  Aligned_cols=32  Identities=16%  Similarity=0.009  Sum_probs=26.8

Q ss_pred             HHHHHHHHHHccCcCCCCCCCHHHHHH--HHhcC
Q 048535          316 VEKVLHLGLLCAHPEANSRPTIRQVLK--MLEGQ  347 (409)
Q Consensus       316 ~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~  347 (409)
                      ...+.+|+.+||+.||++|||++|+++  .+++.
T Consensus       274 s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         274 NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             CHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            456789999999999999999999987  35443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=89.41  E-value=0.12  Score=46.73  Aligned_cols=62  Identities=6%  Similarity=-0.010  Sum_probs=42.3

Q ss_pred             cCCCCCCCHHHHHHHHhcCc-CCCCCCCC---CcchhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          329 PEANSRPTIRQVLKMLEGQT-EGTGLEDE---GMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       329 ~dP~~RPt~~evl~~L~~~~-~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      .-|-.-.+..++++.+.... ..+.....   ....+++.+|+..+|.+|+|+++++.||||++.+
T Consensus       222 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         222 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             CCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            44544456677776654332 22221111   1237899999999999999999999999998764

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.19  E-value=0.037  Score=48.31  Aligned_cols=32  Identities=16%  Similarity=0.199  Sum_probs=29.5

Q ss_pred             chhHHhhhcccCCCCcccccccCCCCCccccc
Q 048535          359 NVHLLKRIGTRAMTSSWKFAGSRGHPTFNEIN  390 (409)
Q Consensus       359 ~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~~~  390 (409)
                      ..+++.+|+..+|..|+|+++++.||||+++.
T Consensus       231 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            37999999999999999999999999998764

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.13  E-value=0.1  Score=46.64  Aligned_cols=32  Identities=19%  Similarity=0.234  Sum_probs=29.0

Q ss_pred             chhHHhhhcccCCCCccc-----ccccCCCCCccccc
Q 048535          359 NVHLLKRIGTRAMTSSWK-----FAGSRGHPTFNEIN  390 (409)
Q Consensus       359 ~~~~l~~~~~~~~~~~~~-----~~~~~~hp~~~~~~  390 (409)
                      ..+++.+|+..+|.+|++     +++++.||||+.++
T Consensus       263 ~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            479999999999999996     57899999999887

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.09  E-value=0.04  Score=49.44  Aligned_cols=34  Identities=15%  Similarity=0.074  Sum_probs=27.7

Q ss_pred             CCCCHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 048535          309 GGYADEVVEKVLHLGLLCAHPEANSRPTIR-QVLK  342 (409)
Q Consensus       309 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~  342 (409)
                      ..++...+..+.+|+.+||+.||++|||+. |+++
T Consensus       220 ~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         220 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            445556677899999999999999999995 6753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=88.22  E-value=0.26  Score=43.47  Aligned_cols=61  Identities=5%  Similarity=-0.015  Sum_probs=40.6

Q ss_pred             CcCCCCCCCHHHHHHHHh-cCcCCCCCCCCC---cchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          328 HPEANSRPTIRQVLKMLE-GQTEGTGLEDEG---MNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       328 ~~dP~~RPt~~evl~~L~-~~~~~~~~~~~~---~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      -..|-.--+..++...+. +....+.+..+.   ...+++.+|+..+|..|+|+++++.||||+.
T Consensus       205 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         205 GYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             SSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             CCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            344544445556655543 333333222222   2378999999999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.97  E-value=0.23  Score=42.86  Aligned_cols=61  Identities=7%  Similarity=-0.051  Sum_probs=41.6

Q ss_pred             ccCcCCCCCCCHHHHHHHHhcCcCC-CCCCCCCcchhHHhhhcccCCCCcccccccCCCCCc
Q 048535          326 CAHPEANSRPTIRQVLKMLEGQTEG-TGLEDEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTF  386 (409)
Q Consensus       326 Cl~~dP~~RPt~~evl~~L~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~  386 (409)
                      |.-..|-.-.+..++.+.+...... .+..-+..-.+++.+|+..+|.+|+++++++.|||.
T Consensus       208 ~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         208 CALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             hhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            3444565556777877766443221 111112234799999999999999999999999994

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=86.11  E-value=0.23  Score=43.97  Aligned_cols=60  Identities=3%  Similarity=-0.174  Sum_probs=39.1

Q ss_pred             cCCCCCCCHHHHH-HHHhcCcCCCCCC-CCCcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          329 PEANSRPTIRQVL-KMLEGQTEGTGLE-DEGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       329 ~dP~~RPt~~evl-~~L~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      ..|-.-.+..+.+ +..++........ -+....+++.+|+..+|.+|+|+++++.||||..
T Consensus       211 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~  272 (309)
T d1u5ra_         211 KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (309)
T ss_dssp             SCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             CCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence            3354444444444 4444433222211 1223479999999999999999999999999974

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.74  E-value=0.098  Score=46.70  Aligned_cols=62  Identities=10%  Similarity=0.024  Sum_probs=42.4

Q ss_pred             cCcCCCCCCCHHHHHHHHhc-CcCCCCCCC---CCcchhHHhhhcccCCCCcccccccCCCCCccc
Q 048535          327 AHPEANSRPTIRQVLKMLEG-QTEGTGLED---EGMNVHLLKRIGTRAMTSSWKFAGSRGHPTFNE  388 (409)
Q Consensus       327 l~~dP~~RPt~~evl~~L~~-~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~hp~~~~  388 (409)
                      .-..|-.-.+..++++.+.+ ....+....   .....+++.+|+..+|..|+++++++.||||++
T Consensus       198 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         198 SGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             hCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            34556555677777766543 322222111   112379999999999999999999999999974